data_2rm6_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2rm6 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.6 m . . . . . 0 N--CA 1.453 -0.283 0 N-CA-C 109.071 -0.714 . . . . 2.17 109.071 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.9 m -150.65 170.57 18.86 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 105.161 -2.163 . . . . 1.68 105.161 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.752 ' HB ' HD11 ' A' ' 118' ' ' LEU . 6.8 pt -63.74 -19.59 24.64 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.102 0 CA-C-O 121.416 0.627 . . . . 1.16 110.521 178.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.718 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 37.3 m-85 -73.5 0.9 11.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.858 -0.61 . . . . 0.3 111.997 -175.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -80.19 -8.73 59.57 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 108.203 -1.036 . . . . 2.11 108.203 176.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.801 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 58.1 m-85 -121.79 117.29 26.21 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 114.537 -1.211 . . . . 0.37 111.427 -174.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -48.92 138.49 11.39 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 112.876 -1.965 . . . . 2.86 110.534 173.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.788 HG12 ' HZ ' ' A' ' 74' ' ' PHE . 98.9 t -112.76 163.4 9.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 108.146 -1.057 . . . . 1.32 108.146 175.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.747 ' O ' ' HB3' ' A' ' 105' ' ' MET . 19.9 mt -134.9 121.88 21.19 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.9 -0.407 . . . . 1.29 109.9 -175.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.621 ' HA ' ' CE ' ' A' ' 105' ' ' MET . 29.9 t70 -63.96 177.36 0.79 Allowed 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 108.372 -0.973 . . . . 1.87 108.372 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.638 ' HA ' ' C ' ' A' ' 105' ' ' MET . . . -59.55 -4.38 0.62 Allowed 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 114.314 1.228 . . . . 1.2 114.314 -163.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -119.33 14.8 12.98 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.765 0.654 . . . . 2.34 112.765 173.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.707 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 10.6 m170 73.13 24.22 2.52 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 122.184 0.992 . . . . 2.26 109.695 174.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.419 ' HE3' ' HB2' ' A' ' 26' ' ' LYS . 16.3 mtmt -85.55 127.81 61.64 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 113.814 -1.539 . . . . 4.64 106.929 166.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.575 ' HA ' HD21 ' A' ' 21' ' ' LEU . 93.3 Cg_exo -50.76 112.44 0.77 Allowed 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 121.359 1.373 . . . . 0.62 112.607 -174.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.529 ' HE2' ' CD2' ' A' ' 72' ' ' LEU . 24.2 t80 -81.47 142.61 32.77 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 113.481 -1.69 . . . . 1.52 112.1 178.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.55 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.8 t-20 -77.73 82.37 4.13 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.648 -1.16 . . . . 2.16 109.904 178.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.637 HD12 HG21 ' A' ' 20' ' ' VAL . 62.1 tp -63.72 -45.16 91.21 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.559 0.695 . . . . 1.07 110.822 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.701 HG13 ' HB3' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -66.13 1.69 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 114.759 -1.109 . . . . 1.69 113.596 -171.764 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.55 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 11.0 pt20 -74.37 -5.34 41.77 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.342 0.591 . . . . 1.31 110.175 172.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.866 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 70.8 m-70 -104.3 24.06 12.14 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.84 0.828 . . . . 0.35 109.428 174.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.718 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 19.7 mtmm -82.69 110.01 17.36 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 114.608 -1.178 . . . . 2.07 109.535 171.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.27 -36.49 2.38 Favored Glycine 0 N--CA 1.44 -1.085 0 C-N-CA 120.534 -0.841 . . . . 0.24 112.031 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.439 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 40.1 m -131.01 133.41 24.72 Favored Pre-proline 0 N--CA 1.435 -1.213 0 N-CA-C 108.3 -1.0 . . . . 0.74 108.3 173.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.762 ' HG2' HD22 ' A' ' 171' ' ' LEU . 3.1 Cg_endo -42.56 152.3 0.19 Allowed 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.824 3.016 . . . . 0.22 112.566 177.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.827 ' HB2' HG22 ' A' ' 70' ' ' THR . 0.5 OUTLIER -136.98 140.76 42.41 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 106.872 -1.529 . . . . 1.09 106.872 179.395 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.858 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 1.3 mm? -106.65 111.09 23.47 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.077 -1.083 . . . . 1.82 108.077 176.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.864 HG23 ' HB2' ' A' ' 72' ' ' LEU . 2.4 mt -94.87 122.9 46.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-N 115.856 -0.611 . . . . 1.12 109.485 176.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.858 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -110.88 128.01 55.64 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 116.068 -0.514 . . . . 1.09 109.919 -176.182 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.62 ' OD1' ' HB ' ' A' ' 140' ' ' THR . 2.3 p30 -82.27 94.85 7.41 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 107.938 -1.134 . . . . 3.11 107.938 167.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.718 ' O ' ' HA ' ' A' ' 75' ' ' PRO . 19.3 m . . . . . 0 C--N 1.319 -0.753 0 CA-C-O 121.507 0.67 . . . . 1.69 110.615 -166.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.444 ' O ' ' HG3' ' A' ' 55' ' ' GLU . . . . . . . . 0 N--CA 1.452 -0.243 0 N-CA-C 112.476 -0.25 . . . . 0.85 112.476 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.452 ' HA2' ' HB ' ' A' ' 56' ' ' THR . . . -53.88 -23.98 24.93 Favored Glycine 0 C--O 1.218 -0.889 0 CA-C-O 119.523 -0.599 . . . . 0.67 114.398 -175.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.431 ' HA ' ' CE2' ' A' ' 139' ' ' PHE . 0.6 OUTLIER -67.74 -55.49 12.9 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 118.42 1.11 . . . . 1.2 110.642 -178.943 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.444 ' HG3' ' O ' ' A' ' 52' ' ' GLY . 2.7 pp20? -66.31 -31.24 71.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.521 0.677 . . . . 2.61 109.348 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.684 ' HA ' ' CG2' ' A' ' 160' ' ' VAL . 53.9 m -59.68 -60.15 4.31 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 114.597 -1.183 . . . . 1.06 110.691 175.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 1.038 ' HB3' HG13 ' A' ' 71' ' ' VAL . . . -61.27 -44.99 96.33 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.979 -1.01 . . . . 1.05 111.293 -177.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.595 ' HA ' ' HE1' ' A' ' 102' ' ' PHE . 95.9 m -55.25 -52.29 63.89 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.57 0.7 . . . . 1.08 110.344 -177.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.8 m -72.79 -36.07 67.52 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.916 -1.038 . . . . 1.22 111.309 -176.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.667 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 19.3 mt -65.87 -50.11 65.72 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 121.303 0.573 . . . . 1.14 110.374 -177.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.815 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 6.8 t80 -55.74 -53.54 55.31 Favored 'General case' 0 C--O 1.198 -1.613 0 CA-C-N 114.608 -1.178 . . . . 0.94 110.44 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.464 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 9.7 m-80 -73.11 -24.67 60.66 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 112.182 0.438 . . . . 1.6 112.182 -173.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.459 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 33.6 ttpt -82.46 -22.36 35.22 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.768 -0.827 . . . . 2.06 108.768 -178.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.753 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 37.8 m-85 -123.73 -5.73 8.05 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 114.767 1.395 . . . . 0.92 114.767 -172.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.678 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 11.1 ptmt -64.64 -25.74 68.09 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 107.931 -1.137 . . . . 1.89 107.931 170.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.2 m -48.01 -41.84 26.48 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 114.106 -1.406 . . . . 1.68 110.672 172.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -82.73 -37.93 23.99 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 111.747 0.277 . . . . 1.11 111.747 175.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 149.66 -8.55 0.86 Allowed Glycine 0 CA--C 1.519 0.332 0 N-CA-C 111.088 -0.805 . . . . 0.2 111.088 -176.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.753 ' HD2' ' HB2' ' A' ' 64' ' ' TYR . 18.5 t80 -63.53 144.92 56.59 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 115.024 -0.588 . . . . 0.21 111.24 -177.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.866 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 3.0 t -133.27 152.25 51.93 Favored 'General case' 0 N--CA 1.411 -2.396 0 N-CA-C 108.726 -0.842 . . . . 1.02 108.726 171.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 1.038 HG13 ' HB3' ' A' ' 57' ' ' ALA . 37.4 t -106.78 102.12 13.48 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.361 0 N-CA-C 107.645 -1.243 . . . . 1.04 107.645 158.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.864 ' HB2' HG23 ' A' ' 40' ' ' ILE . 88.5 mt -84.27 118.73 24.37 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 107.742 -1.207 . . . . 1.69 107.742 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.571 ' HB1' HG13 ' A' ' 104' ' ' ILE . . . -97.84 113.06 24.77 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 120.385 -0.526 . . . . 1.17 110.598 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.788 ' HZ ' HG12 ' A' ' 20' ' ' VAL . 34.5 m-85 -106.52 96.68 14.52 Favored Pre-proline 0 C--N 1.309 -1.171 0 N-CA-C 109.445 -0.576 . . . . 0.58 109.445 176.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.718 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 74.2 Cg_endo -80.43 75.08 5.24 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.481 2.787 . . . . 1.3 114.778 -166.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.435 ' HA ' ' O ' ' A' ' 108' ' ' ILE . 76.2 p . . . . . 0 N--CA 1.476 0.859 0 C-N-CA 126.028 1.731 . . . . 1.91 115.234 -177.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.505 ' HB2' ' CD2' ' A' ' 102' ' ' PHE . . . . . . . . 0 CA--C 1.513 -0.472 0 CA-C-O 120.855 0.36 . . . . 1.15 111.082 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -96.99 22.96 7.72 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.488 -0.778 . . . . 1.99 111.332 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.688 ' HB3' ' O ' ' A' ' 71' ' ' VAL . 2.9 m-85 -111.61 -176.63 0.39 Allowed Pre-proline 0 CA--C 1.514 -0.41 0 CA-C-O 121.561 0.695 . . . . 1.31 110.764 -177.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.674 ' HD3' ' CE2' ' A' ' 61' ' ' TYR . 8.6 Cg_exo -81.51 78.26 3.63 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 123.93 3.086 . . . . 1.07 109.449 157.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.571 HG13 ' HB1' ' A' ' 73' ' ' ALA . 4.0 mp -84.32 127.83 39.46 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 N-CA-C 108.09 -1.078 . . . . 1.97 108.09 178.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.76 ' HG3' ' CE1' ' A' ' 74' ' ' PHE . 3.4 mmt -96.82 -175.52 3.3 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.565 -0.743 . . . . 3.41 110.404 -169.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.624 ' O ' ' HG2' ' A' ' 107' ' ' LYS . . . -84.98 32.93 0.53 Allowed 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 113.013 0.746 . . . . 1.46 113.013 -167.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.624 ' HG2' ' O ' ' A' ' 106' ' ' ALA . 15.2 ptpt 53.83 127.6 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 123.467 1.603 . . . . 2.31 112.654 -177.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.772 HG13 HG11 ' A' ' 110' ' ' VAL . 20.4 pt -128.59 160.66 38.74 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 CA-C-N 113.538 -1.665 . . . . 1.65 108.681 177.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.54 52.31 0.2 Allowed 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.148 -0.933 . . . . 1.73 110.985 -178.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.772 HG11 HG13 ' A' ' 108' ' ' ILE . 0.7 OUTLIER -62.3 95.57 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-O 121.533 0.683 . . . . 1.4 109.379 179.611 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.1 t30 . . . . . 0 N--CA 1.439 -0.996 0 CA-C-N 114.683 -1.144 . . . . 2.1 108.389 -176.806 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.656 ' ND1' ' H ' ' A' ' 118' ' ' LEU . 4.0 t-80 . . . . . 0 N--CA 1.425 -1.69 0 N-CA-C 104.808 -2.293 . . . . 0.71 104.808 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -27.29 -45.75 0.07 OUTLIER 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 124.272 3.314 . . . . 0.47 113.913 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.752 HD11 ' HB ' ' A' ' 15' ' ' ILE . 24.0 tp -64.86 -50.81 65.15 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.608 0.763 . . . . 1.15 111.854 178.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.666 ' OH ' HG21 ' A' ' 40' ' ' ILE . 36.4 m-85 -75.9 -33.01 59.9 Favored 'General case' 0 CA--C 1.505 -0.788 0 O-C-N 122.203 -0.311 . . . . 3.33 111.509 178.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -56.51 -38.85 72.35 Favored 'General case' 0 CA--C 1.493 -1.239 0 N-CA-C 106.927 -1.509 . . . . 2.44 106.927 170.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.801 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 56.6 t80 -67.43 -32.18 72.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.224 -0.898 . . . . 1.08 110.661 175.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.642 ' HB2' ' HA ' ' A' ' 119' ' ' TYR . 0.6 OUTLIER -74.64 -54.5 7.31 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.248 -0.433 . . . . 1.25 110.142 -171.075 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.419 ' HE2' ' HB2' ' A' ' 123' ' ' LYS . 1.2 ptmm? -70.29 -24.57 63.06 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.191 -0.459 . . . . 1.86 111.396 176.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.5 ' HG3' ' O ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -74.43 -27.91 60.82 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 119.151 -1.02 . . . . 2.52 110.118 176.231 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 90.8 m -78.27 -43.04 29.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.887 -0.597 . . . . 1.21 110.265 175.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 41.0 tttm . . . . . 0 C--N 1.325 -0.475 0 N-CA-C 108.884 -0.784 . . . . 2.38 108.884 178.878 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.585 ' HB3' ' CG ' ' A' ' 156' ' ' PRO . 12.6 m-90 . . . . . 0 CA--C 1.518 -0.283 0 CA-C-O 121.279 0.561 . . . . 2.41 110.983 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.521 ' HB3' ' H ' ' A' ' 139' ' ' PHE . 6.1 m-20 -43.06 -156.22 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.725 -1.125 . . . . 2.04 112.157 157.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.627 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 2.8 m-85 -28.74 -47.25 0.05 Allowed 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 116.337 1.977 . . . . 2.53 116.337 -168.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.62 ' HB ' ' OD1' ' A' ' 42' ' ' ASN . 9.7 m 36.12 91.8 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.386 0.994 . . . . 1.24 113.21 176.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.443 ' CB ' HD12 ' A' ' 39' ' ' LEU . 0.7 OUTLIER -83.41 163.26 20.67 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.464 -0.789 . . . . 1.03 110.685 -175.023 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.528 ' HA ' ' HA ' ' A' ' 153' ' ' ARG . 76.4 m-85 -129.77 122.26 28.47 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 105.52 -2.03 . . . . 0.7 105.52 168.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.807 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 7.3 tp -80.19 103.51 10.11 Favored 'General case' 0 N--CA 1.422 -1.865 0 C-N-CA 118.528 -1.269 . . . . 1.16 108.372 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.711 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 42.9 mm -90.23 139.54 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.734 0 CA-C-N 112.965 -1.925 . . . . 1.05 107.468 -179.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.517 ' HA ' HD12 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -93.92 -176.95 4.18 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 119.71 -0.796 . . . . 0.98 111.276 -169.197 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.57 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 35.3 mtm180 -51.94 -41.45 62.06 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.994 0.426 . . . . 2.61 111.18 -177.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -95.65 14.68 22.21 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 109.646 -0.501 . . . . 2.0 109.646 -175.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.481 ' HA2' HG23 ' A' ' 144' ' ' ILE . . . 78.38 30.83 48.44 Favored Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 121.223 -0.513 . . . . 0.19 113.915 179.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 49.5 t -103.85 115.3 63.63 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 118.224 1.012 . . . . 1.74 111.428 177.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.686 ' HD3' HG22 ' A' ' 15' ' ' ILE . 29.6 Cg_endo -66.58 117.93 5.13 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 123.44 2.76 . . . . 0.6 110.86 177.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 16.0 m -119.42 -9.83 11.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 120.704 0.287 . . . . 2.06 110.247 -176.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.807 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 18.3 mm-40 -145.13 166.57 25.02 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-N 115.749 -0.659 . . . . 1.17 110.659 175.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.545 HH11 ' HG2' ' A' ' 153' ' ' ARG . 0.0 OUTLIER -147.58 126.65 12.87 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.757 -1.11 . . . . 2.9 109.253 161.96 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.674 ' HZ ' ' HB2' ' A' ' 166' ' ' LYS . 91.1 m-85 -99.28 148.37 24.21 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.028 -0.987 . . . . 0.36 109.563 -174.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 16.1 m -88.19 149.4 44.99 Favored Pre-proline 0 C--N 1.311 -1.085 0 N-CA-C 109.234 -0.654 . . . . 1.45 109.234 -179.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.585 ' CG ' ' HB3' ' A' ' 137' ' ' TRP . 33.8 Cg_endo -64.29 96.02 0.22 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 121.841 1.694 . . . . 0.78 108.446 170.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 151.07 -17.3 0.92 Allowed Glycine 0 N--CA 1.433 -1.561 0 N-CA-C 109.019 -1.632 . . . . 0.59 109.019 -164.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -92.18 145.91 24.13 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.919 -1.141 . . . . 1.07 107.919 166.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.568 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 31.1 t -109.94 -178.23 3.47 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.895 -0.409 . . . . 1.92 109.895 -174.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.684 ' CG2' ' HA ' ' A' ' 56' ' ' THR . 57.8 t -41.44 -51.11 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.301 0 O-C-N 124.081 0.863 . . . . 1.07 110.732 178.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 7.6 tttm -60.62 -46.11 91.51 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.088 -0.96 . . . . 3.89 111.108 -174.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -66.53 -30.64 71.0 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.912 -1.04 . . . . 1.4 110.333 -173.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.509 ' HA ' ' CE2' ' A' ' 154' ' ' PHE . 60.1 mt -81.89 -45.23 20.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.674 -0.694 . . . . 1.05 111.25 177.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.605 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 52.3 mt-10 -53.96 -43.15 69.66 Favored 'General case' 0 C--O 1.215 -0.747 0 CA-C-O 120.907 0.384 . . . . 0.67 111.379 -177.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -59.15 -19.18 42.71 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 112.279 0.474 . . . . 0.87 112.279 -176.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.674 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 75.4 mmtt -103.17 -27.3 12.61 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.54 0.686 . . . . 2.22 109.948 173.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.595 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 13.7 tp -77.27 -50.86 11.94 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.95 -1.023 . . . . 1.04 112.409 -177.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.461 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 73.4 mt -54.33 -45.8 99.16 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 115.734 -0.666 . . . . 1.08 112.201 -174.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.461 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 82.2 Cg_exo -51.42 -29.48 31.26 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.343 2.029 . . . . 0.62 113.015 173.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.754 HD13 HD12 ' A' ' 143' ' ' LEU . 73.6 mt -88.81 -42.12 12.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.663 -0.244 . . . . 1.36 111.251 178.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.762 HD22 ' HG2' ' A' ' 37' ' ' PRO . 93.0 mt -60.37 -56.4 21.89 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-O 122.052 0.93 . . . . 1.07 109.649 175.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.323 0 CA-C-N 113.385 -1.734 . . . . 1.12 112.106 178.137 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.4 p . . . . . 0 CA--C 1.527 0.065 0 CA-C-O 121.348 0.594 . . . . 2.17 110.352 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 85.7 p 178.21 152.75 0.3 Allowed 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 105.708 -1.96 . . . . 1.68 105.708 -178.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.806 ' HB ' HD12 ' A' ' 118' ' ' LEU . 5.1 pt -64.63 -18.36 23.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-N 114.769 -1.105 . . . . 1.16 111.519 -176.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.851 ' HB3' HG13 ' A' ' 31' ' ' VAL . 36.5 m-85 -70.45 -7.75 45.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.946 -0.57 . . . . 0.3 111.871 -176.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -68.29 -17.43 64.27 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.385 -0.969 . . . . 2.11 108.385 175.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.68 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 55.9 m-85 -115.67 108.03 15.86 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 115.12 -0.945 . . . . 0.37 111.096 -176.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -45.8 144.01 1.89 Allowed 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 113.687 -1.597 . . . . 2.86 110.396 171.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.704 HG11 ' CZ ' ' A' ' 74' ' ' PHE . 35.7 t -110.66 169.17 3.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 N-CA-C 107.485 -1.302 . . . . 1.32 107.485 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.742 ' O ' ' HB2' ' A' ' 105' ' ' MET . 61.6 mt -132.12 123.22 26.69 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 118.538 0.608 . . . . 1.29 111.605 -177.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.488 ' N ' ' HB2' ' A' ' 28' ' ' TYR . 14.7 t70 -62.03 161.51 10.67 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.187 -1.412 . . . . 1.87 107.187 167.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.767 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . . . -52.88 -15.39 0.75 Allowed 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 114.793 1.405 . . . . 1.2 114.793 -165.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.573 ' HB2' ' HE2' ' A' ' 26' ' ' LYS . 38.2 m-20 -91.93 -2.33 56.84 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.417 0.525 . . . . 2.34 112.417 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.632 ' CD2' ' HB2' ' A' ' 106' ' ' ALA . 68.8 m-70 82.84 11.27 0.54 Allowed 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.59 0.71 . . . . 2.26 109.477 -177.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.573 ' HE2' ' HB2' ' A' ' 24' ' ' ASP . 17.5 mtmt -77.0 120.7 82.79 Favored Pre-proline 0 C--N 1.323 -0.575 0 N-CA-C 107.148 -1.427 . . . . 4.64 107.148 169.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.696 ' HA ' HD21 ' A' ' 21' ' ' LEU . 78.9 Cg_exo -49.42 114.32 1.27 Allowed 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 122.055 1.837 . . . . 0.62 113.062 -174.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.544 ' HB3' HG12 ' A' ' 20' ' ' VAL . 6.8 t80 -81.32 139.14 35.56 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 113.53 -1.668 . . . . 1.52 111.356 176.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.643 ' ND2' HG22 ' A' ' 31' ' ' VAL . 2.6 t-20 -72.35 90.66 1.29 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.691 -1.141 . . . . 2.16 109.847 176.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.759 ' HG ' ' CD1' ' A' ' 16' ' ' PHE . 29.4 tp -70.65 -41.36 72.22 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.081 0.467 . . . . 1.07 109.949 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.851 HG13 ' HB3' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -63.47 0.64 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 115.181 -0.918 . . . . 1.69 113.054 -174.873 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.543 ' HB3' ' OD1' ' A' ' 29' ' ' ASN . 3.6 pt20 -74.35 -7.18 51.99 Favored 'General case' 0 CA--C 1.509 -0.623 0 O-C-N 121.92 -0.488 . . . . 1.31 110.762 176.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.806 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 63.3 m-70 -104.98 30.16 5.76 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.697 0.761 . . . . 0.35 109.647 173.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.752 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 23.6 mtmt -86.23 110.39 19.58 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 114.81 -1.086 . . . . 2.07 109.599 172.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 128.48 -41.1 1.61 Allowed Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 111.204 -0.758 . . . . 0.24 111.204 -176.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.466 ' HB2' ' HA3' ' A' ' 68' ' ' GLY . 18.0 m -129.25 130.63 23.37 Favored Pre-proline 0 N--CA 1.436 -1.171 0 N-CA-C 109.139 -0.689 . . . . 0.74 109.139 171.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.802 ' HG3' ' CB ' ' A' ' 170' ' ' LEU . 5.4 Cg_endo -43.51 150.77 0.43 Allowed 'Trans proline' 0 CA--C 1.513 -0.528 0 C-N-CA 124.768 3.645 . . . . 0.22 113.522 178.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.784 ' HB2' HG22 ' A' ' 70' ' ' THR . 1.2 pt? -130.13 149.0 52.03 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 107.491 -1.3 . . . . 1.09 107.491 174.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.978 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 1.5 mm? -111.35 112.46 24.23 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.329 -0.989 . . . . 1.82 108.329 174.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 1.003 HD13 ' HE2' ' A' ' 122' ' ' MET . 4.2 mt -96.93 125.23 49.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 C-N-CA 119.98 -0.688 . . . . 1.12 110.369 177.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.978 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -109.98 123.03 48.92 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 116.245 -0.434 . . . . 1.09 109.967 -175.543 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.701 HD22 ' HB ' ' A' ' 140' ' ' THR . 2.3 p-10 -81.21 94.07 6.61 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 107.696 -1.224 . . . . 3.11 107.696 170.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.835 ' O ' ' HA ' ' A' ' 75' ' ' PRO . 1.2 p . . . . . 0 C--N 1.294 -1.844 0 CA-C-N 115.262 -0.881 . . . . 1.69 111.626 -160.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 0.116 0 N-CA-C 112.307 -0.317 . . . . 0.85 112.307 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -41.57 -43.57 3.94 Favored Glycine 0 C--O 1.223 -0.547 0 O-C-N 124.013 0.478 . . . . 0.67 113.791 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.543 ' HA ' ' CZ ' ' A' ' 139' ' ' PHE . 0.1 OUTLIER -59.48 -60.12 4.36 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.739 0.269 . . . . 1.2 111.634 -174.852 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -60.86 -34.72 75.03 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.347 0.594 . . . . 2.61 109.632 -176.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.647 ' OG1' ' HA ' ' A' ' 159' ' ' SER . 72.1 m -62.63 -59.64 4.64 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.699 -1.137 . . . . 1.06 110.1 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 1.131 ' HB2' HG11 ' A' ' 71' ' ' VAL . . . -60.55 -49.28 78.18 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.042 -0.981 . . . . 1.05 111.424 -177.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.631 ' N ' ' HE1' ' A' ' 102' ' ' PHE . 37.6 m -55.15 -51.95 64.83 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.464 0.649 . . . . 1.08 110.479 -177.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.481 ' HA ' ' ND2' ' A' ' 62' ' ' ASN . 29.7 m -71.03 -31.8 68.38 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.264 -0.88 . . . . 1.22 111.442 -176.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.685 HD21 ' HG3' ' A' ' 164' ' ' GLU . 14.6 mt -71.91 -50.74 26.6 Favored 'General case' 0 CA--C 1.494 -1.186 0 CA-C-O 120.924 0.392 . . . . 1.14 110.6 -177.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.805 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 3.0 t80 -51.47 -60.34 3.24 Favored 'General case' 0 C--O 1.203 -1.374 0 CA-C-N 114.645 -1.161 . . . . 0.94 109.752 178.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 1.05 ' HA ' ' HG3' ' A' ' 65' ' ' LYS . 4.3 p30 -70.06 -24.55 63.26 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 121.11 -0.236 . . . . 1.6 111.006 -171.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.503 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 35.3 ttpt -76.48 -21.31 55.99 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.184 -1.043 . . . . 2.06 108.184 -177.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.762 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 65.4 m-85 -130.12 10.13 5.35 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 114.679 1.363 . . . . 0.92 114.679 -176.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 1.05 ' HG3' ' HA ' ' A' ' 62' ' ' ASN . 27.9 mtmt -54.11 -38.29 65.25 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 106.588 -1.634 . . . . 1.89 106.588 169.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -48.5 -42.17 32.19 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 111.697 -2.501 . . . . 1.68 112.908 -177.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -85.06 -36.3 21.3 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.671 -0.412 . . . . 1.11 111.751 177.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.466 ' HA3' ' HB2' ' A' ' 36' ' ' SER . . . 147.38 -5.73 1.03 Allowed Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 110.829 -0.909 . . . . 0.2 110.829 -176.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.762 ' HD2' ' HB2' ' A' ' 64' ' ' TYR . 17.1 t80 -66.9 139.25 57.72 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 114.951 -0.625 . . . . 0.21 110.973 -177.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.806 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 1.6 t -132.82 149.51 52.26 Favored 'General case' 0 N--CA 1.414 -2.238 0 N-CA-C 108.653 -0.869 . . . . 1.02 108.653 172.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 1.131 HG11 ' HB2' ' A' ' 57' ' ' ALA . 29.7 t -102.7 101.52 12.28 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.23 0 N-CA-C 108.058 -1.089 . . . . 1.04 108.058 160.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.838 ' HB2' HG21 ' A' ' 40' ' ' ILE . 66.1 mt -84.67 119.65 25.49 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 108.218 -1.03 . . . . 1.69 108.218 178.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.725 ' HB3' HG13 ' A' ' 43' ' ' VAL . . . -100.39 112.32 24.66 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 121.328 0.585 . . . . 1.17 111.632 -178.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.832 ' CG ' ' HG2' ' A' ' 105' ' ' MET . 2.9 m-85 -103.59 95.17 6.91 Favored Pre-proline 0 C--N 1.316 -0.872 0 N-CA-C 109.275 -0.639 . . . . 0.58 109.275 176.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.835 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 76.3 Cg_endo -83.5 95.75 0.78 Allowed 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.249 1.966 . . . . 1.3 113.84 -169.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.545 ' HB2' HG22 ' A' ' 110' ' ' VAL . 47.4 t . . . . . 0 CA--C 1.509 -0.634 0 CA-C-O 121.865 0.84 . . . . 1.91 112.628 -176.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.414 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . . . . . . 0 CA--C 1.512 -0.515 0 CA-C-O 121.124 0.488 . . . . 1.15 111.546 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -99.76 21.28 12.7 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.47 -0.786 . . . . 1.99 111.925 -178.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.689 ' HB3' ' O ' ' A' ' 71' ' ' VAL . 0.4 OUTLIER -109.43 177.8 1.17 Allowed Pre-proline 0 CA--C 1.511 -0.528 0 CA-C-O 121.317 0.579 . . . . 1.31 110.131 177.037 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.695 ' HD3' ' CE2' ' A' ' 61' ' ' TYR . 6.6 Cg_exo -80.81 76.16 4.66 Favored 'Trans proline' 0 N--CA 1.445 -1.37 0 C-N-CA 123.94 3.093 . . . . 1.07 110.003 162.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.596 HG12 ' HB1' ' A' ' 73' ' ' ALA . 34.8 mt -74.55 138.01 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 107.288 -1.375 . . . . 1.97 107.288 176.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.832 ' HG2' ' CG ' ' A' ' 74' ' ' PHE . 1.1 ppp? -96.62 -171.62 2.31 Favored 'General case' 0 N--CA 1.434 -1.255 0 C-N-CA 120.229 -0.588 . . . . 3.41 112.093 -170.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.767 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . . . -64.97 -7.69 12.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.417 -0.81 . . . . 1.46 112.194 -178.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.806 ' HB2' ' O ' ' A' ' 75' ' ' PRO . 3.9 ptpp? 66.04 133.72 0.02 OUTLIER 'General case' 0 CA--C 1.498 -1.036 0 C-N-CA 125.29 1.436 . . . . 2.31 110.702 -168.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.729 HG13 ' CB ' ' A' ' 116' ' ' HIS . 0.2 OUTLIER -135.78 171.54 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.857 0 CA-C-N 113.554 -1.657 . . . . 1.65 107.468 170.176 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -64.83 64.18 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 114.946 -1.025 . . . . 1.73 112.916 178.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.545 HG22 ' HB2' ' A' ' 76' ' ' SER . 3.2 m -71.4 95.99 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 117.857 -1.537 . . . . 1.4 107.867 172.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 25.3 p30 . . . . . 0 C--N 1.315 -0.921 0 CA-C-N 113.601 -1.636 . . . . 2.1 108.065 -169.355 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.729 ' CB ' HG13 ' A' ' 108' ' ' ILE . 1.6 t-80 . . . . . 0 N--CA 1.431 -1.412 0 N-CA-C 107.703 -1.221 . . . . 0.71 107.703 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -28.4 -49.92 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 124.683 3.589 . . . . 0.47 113.792 -178.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.806 HD12 ' HB ' ' A' ' 15' ' ' ILE . 48.0 tp -61.14 -51.6 68.4 Favored 'General case' 0 C--O 1.22 -0.468 0 C-N-CA 122.745 0.418 . . . . 1.15 111.787 178.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.684 ' HA ' ' HB2' ' A' ' 122' ' ' MET . 29.7 m-85 -76.53 -33.68 58.57 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 112.489 0.551 . . . . 3.33 112.489 -179.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.546 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 42.5 mt-10 -60.49 -34.92 74.76 Favored 'General case' 0 CA--C 1.491 -1.325 0 N-CA-C 107.121 -1.437 . . . . 2.44 107.121 171.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.68 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 45.0 t80 -69.48 -34.22 74.03 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 119.262 -0.975 . . . . 1.08 110.234 173.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 1.003 ' HE2' HD13 ' A' ' 40' ' ' ILE . 40.4 mtt -74.86 -52.23 11.87 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.89 -0.595 . . . . 1.25 112.057 -169.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.425 ' HB2' ' HE2' ' A' ' 123' ' ' LYS . 0.2 OUTLIER -69.56 -24.44 63.71 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 120.366 -0.534 . . . . 1.86 109.853 176.863 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.546 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 17.0 tttt -65.58 -38.15 88.7 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.248 -0.433 . . . . 2.52 110.309 170.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 36.2 m -65.43 -61.23 2.23 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.936 -0.574 . . . . 1.21 111.426 -176.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.529 ' HD2' ' O ' ' A' ' 151' ' ' VAL . 36.8 ttmt . . . . . 0 C--N 1.33 -0.269 0 N-CA-C 109.957 -0.386 . . . . 2.38 109.957 177.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.53 ' HB3' ' HG3' ' A' ' 156' ' ' PRO . 6.4 m-90 . . . . . 0 N--CA 1.448 -0.538 0 N-CA-C 109.509 -0.552 . . . . 2.41 109.509 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.46 ' N ' HD21 ' A' ' 138' ' ' ASN . 0.9 OUTLIER -45.26 -153.93 0.0 OUTLIER 'General case' 0 C--O 1.209 -1.029 0 C-N-CA 123.846 0.859 . . . . 2.04 111.163 162.342 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.634 ' CD1' HG21 ' A' ' 43' ' ' VAL . 2.0 m-85 -27.5 -48.89 0.04 OUTLIER 'General case' 0 C--O 1.21 -0.983 0 N-CA-C 115.239 1.57 . . . . 2.53 115.239 -169.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.701 ' HB ' HD22 ' A' ' 42' ' ' ASN . 8.6 m 39.17 108.46 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 122.746 1.26 . . . . 1.24 113.84 173.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.41 ' HB3' HD13 ' A' ' 39' ' ' LEU . 1.4 m -100.64 165.25 11.49 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 114.811 -1.086 . . . . 1.03 110.014 -170.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.608 ' HA ' ' HA ' ' A' ' 153' ' ' ARG . 28.4 m-85 -128.38 125.96 39.7 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 105.916 -1.883 . . . . 0.7 105.916 163.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.827 HD13 HD11 ' A' ' 170' ' ' LEU . 1.6 tp -81.17 104.11 11.43 Favored 'General case' 0 C--N 1.288 -2.103 0 C-N-CA 118.565 -1.254 . . . . 1.16 108.563 178.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.722 HD13 ' HE1' ' A' ' 122' ' ' MET . 28.3 mm -92.65 136.89 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.992 0 CA-C-N 113.097 -1.865 . . . . 1.05 107.592 -178.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.534 ' HA ' HD13 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -90.85 -174.18 3.95 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 119.704 -0.798 . . . . 0.98 111.52 -170.793 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.657 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 41.0 mtt85 -55.81 -40.19 72.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.015 -0.539 . . . . 2.61 111.109 -177.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.5 18.01 16.33 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.668 0.747 . . . . 2.0 109.085 -177.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.642 ' HA3' ' CE2' ' A' ' 16' ' ' PHE . . . 73.6 32.69 59.19 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 114.805 -1.089 . . . . 0.19 114.853 177.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 58.3 t -93.93 126.49 48.98 Favored Pre-proline 0 C--N 1.314 -0.962 0 CA-C-N 118.235 1.018 . . . . 1.74 110.72 175.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.496 ' HA ' HD11 ' A' ' 144' ' ' ILE . 12.2 Cg_endo -78.22 105.13 1.94 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.898 2.399 . . . . 0.6 110.073 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.529 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 4.6 t -93.94 -72.21 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 106.603 -1.628 . . . . 2.06 106.603 -178.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.795 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 0.3 OUTLIER -88.96 164.69 15.0 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 114.4 -1.273 . . . . 1.17 111.18 -177.476 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.608 ' HA ' ' HA ' ' A' ' 142' ' ' PHE . 0.0 OUTLIER -135.36 150.97 50.06 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 113.009 -1.905 . . . . 2.9 107.136 156.219 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.572 ' O ' ' HA ' ' A' ' 140' ' ' THR . 92.2 m-85 -125.46 145.44 50.08 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 108.442 -0.947 . . . . 0.36 108.442 -171.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.429 ' OG ' ' HD2' ' A' ' 156' ' ' PRO . 21.2 t -72.34 154.37 91.94 Favored Pre-proline 0 C--N 1.315 -0.918 0 N-CA-C 108.375 -0.972 . . . . 1.45 108.375 174.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.53 ' HG3' ' HB3' ' A' ' 137' ' ' TRP . 9.6 Cg_endo -51.45 -41.49 59.66 Favored 'Trans proline' 0 CA--C 1.519 -0.259 0 C-N-CA 122.185 1.923 . . . . 0.78 111.126 174.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -58.71 -19.35 42.42 Favored Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 114.645 -1.161 . . . . 0.59 113.725 176.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -70.62 136.41 49.13 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 109.005 -0.739 . . . . 1.07 109.005 177.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.647 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 19.8 m -108.46 -178.35 3.57 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 120.776 0.322 . . . . 1.92 110.705 -170.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.598 HG22 ' HA ' ' A' ' 56' ' ' THR . 46.7 t -44.8 -50.41 2.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 114.927 -1.033 . . . . 1.07 111.313 -178.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 26.0 tttm -64.75 -39.6 93.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.041 -0.527 . . . . 3.89 111.205 -176.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.495 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 32.7 m-20 -68.64 -39.54 80.69 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.52 -0.764 . . . . 1.4 109.632 -172.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.534 HD12 ' OH ' ' A' ' 41' ' ' TYR . 54.1 mt -75.1 -43.7 44.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 114.953 -1.021 . . . . 1.05 110.78 177.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.701 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 28.1 mt-10 -56.42 -39.9 73.82 Favored 'General case' 0 C--O 1.217 -0.624 0 N-CA-C 111.973 0.36 . . . . 0.67 111.973 -177.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.495 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 10.0 pt-20 -61.34 -23.91 66.08 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.673 -0.411 . . . . 0.87 111.249 -176.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.547 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 72.3 mmtt -99.08 -14.82 19.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.623 0.725 . . . . 2.22 109.759 175.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.701 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 12.8 tp -92.8 -51.91 4.86 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.059 -0.973 . . . . 1.04 112.385 -174.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.49 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 78.1 mt -53.03 -48.59 91.35 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.541 -0.754 . . . . 1.08 112.901 -171.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.49 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 74.2 Cg_exo -52.69 -33.9 61.66 Favored 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 121.974 1.783 . . . . 0.62 112.321 176.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.827 HD11 HD13 ' A' ' 143' ' ' LEU . 93.1 mt -77.18 -46.68 22.52 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 116.016 -0.538 . . . . 1.36 110.75 178.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.751 HD22 ' HG2' ' A' ' 37' ' ' PRO . 89.5 mt -58.33 -56.67 19.11 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 121.66 0.743 . . . . 1.07 110.37 177.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.265 0 CA-C-N 113.688 -1.597 . . . . 1.12 112.819 179.368 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.3 p . . . . . 0 N--CA 1.452 -0.343 0 CA-C-O 121.467 0.651 . . . . 2.17 109.543 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.535 ' HB3' ' O ' ' A' ' 147' ' ' ASP . 1.4 m -153.53 169.22 23.74 Favored 'General case' 0 N--CA 1.427 -1.575 0 N-CA-C 105.107 -2.182 . . . . 1.68 105.107 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.837 HD11 HD23 ' A' ' 30' ' ' LEU . 5.0 pt -61.55 -21.82 26.42 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.16 0 CA-C-O 121.777 0.799 . . . . 1.16 109.566 172.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.963 ' HB3' HG11 ' A' ' 31' ' ' VAL . 25.0 m-85 -70.6 -7.4 43.85 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.848 1.055 . . . . 0.3 113.848 -172.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -77.85 -5.32 50.52 Favored 'General case' 0 CA--C 1.502 -0.865 0 N-CA-C 107.951 -1.129 . . . . 2.11 107.951 178.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.741 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 41.9 m-85 -120.06 112.02 18.61 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 114.313 -1.312 . . . . 0.37 110.204 -175.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.92 149.52 2.63 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 113.521 -1.672 . . . . 2.86 110.632 174.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.802 HG12 ' CZ ' ' A' ' 74' ' ' PHE . 35.6 t -112.12 158.62 12.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 107.874 -1.158 . . . . 1.32 107.874 174.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.898 ' O ' ' HB3' ' A' ' 105' ' ' MET . 96.0 mt -126.88 109.04 11.55 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 119.183 -0.437 . . . . 1.29 110.87 -174.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.456 ' O ' ' HB1' ' A' ' 106' ' ' ALA . 17.0 t70 -46.81 158.0 0.14 Allowed 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 107.972 -1.121 . . . . 1.87 107.972 170.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.61 ' HA ' ' N ' ' A' ' 106' ' ' ALA . . . -53.79 -10.32 0.29 Allowed 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 113.251 0.834 . . . . 1.2 113.251 -167.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.535 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 25.9 t0 -93.46 -6.16 47.57 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 122.943 0.497 . . . . 2.34 111.899 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.678 ' CD2' ' HB2' ' A' ' 106' ' ' ALA . 60.8 m-70 82.38 24.5 0.19 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.77 0.795 . . . . 2.26 109.206 -177.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 26' ' ' LYS . 27.2 mmtt -106.74 125.69 32.1 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 114.307 -1.315 . . . . 4.64 108.362 176.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.588 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 73.0 Cg_exo -52.67 114.7 1.81 Allowed 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.329 2.019 . . . . 0.62 114.561 -167.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.953 ' HH ' ' HE2' ' A' ' 33' ' ' HIS . 6.9 t80 -81.76 128.06 33.6 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 113.391 -1.732 . . . . 1.52 109.285 165.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.457 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 0.4 OUTLIER -74.63 91.55 2.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 122.341 1.067 . . . . 2.16 110.976 -179.887 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.837 HD23 HD11 ' A' ' 15' ' ' ILE . 52.2 tp -58.0 -36.21 72.33 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.009 -0.996 . . . . 1.07 110.589 -178.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.963 HG11 ' HB3' ' A' ' 16' ' ' PHE . 3.6 m -66.75 -1.22 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 114.768 -1.105 . . . . 1.69 113.178 -172.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.457 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 18.3 pt20 -77.2 -15.28 59.56 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 119.406 -0.917 . . . . 1.31 109.542 175.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.983 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 95.9 m-70 -86.83 27.86 0.95 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.959 0.885 . . . . 0.35 109.6 174.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.417 ' H ' ' C ' ' A' ' 32' ' ' GLN . 45.7 mttm -80.7 124.32 28.93 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 114.275 -1.33 . . . . 2.07 109.747 172.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.96 -40.06 2.68 Favored Glycine 0 N--CA 1.438 -1.22 0 C-N-CA 120.671 -0.776 . . . . 0.24 112.045 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.504 ' HB2' ' HA3' ' A' ' 68' ' ' GLY . 16.7 m -124.28 126.52 25.51 Favored Pre-proline 0 N--CA 1.435 -1.221 0 N-CA-C 108.689 -0.856 . . . . 0.74 108.689 175.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.829 ' HG3' ' CB ' ' A' ' 170' ' ' LEU . 2.9 Cg_endo -42.67 157.34 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 124.271 3.314 . . . . 0.22 113.015 176.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.756 ' HB2' HG21 ' A' ' 70' ' ' THR . 0.8 OUTLIER -145.08 143.36 30.38 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 107.575 -1.269 . . . . 1.09 107.575 -177.386 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 1.001 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 1.9 mm? -108.08 114.03 27.63 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.014 -0.735 . . . . 1.82 109.014 178.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 1.036 HG22 ' HH ' ' A' ' 119' ' ' TYR . 1.2 mt -96.23 125.61 49.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 C-N-CA 120.422 -0.511 . . . . 1.12 110.087 177.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 1.001 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.6 OUTLIER -107.07 133.09 52.22 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 120.449 -0.501 . . . . 1.09 110.254 -176.684 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.622 HD21 ' N ' ' A' ' 42' ' ' ASN . 0.3 OUTLIER -92.38 91.91 7.88 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 105.526 -2.027 . . . . 3.11 105.526 174.396 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.992 HG13 ' HB3' ' A' ' 73' ' ' ALA . 2.8 p . . . . . 0 C--N 1.302 -1.467 0 N-CA-C 112.813 0.672 . . . . 1.69 112.813 -160.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.54 ' O ' ' HG2' ' A' ' 55' ' ' GLU . . . . . . . . 0 N--CA 1.444 -0.784 0 N-CA-C 111.397 -0.681 . . . . 0.85 111.397 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -56.52 -24.91 48.57 Favored Glycine 0 C--O 1.222 -0.623 0 CA-C-O 119.792 -0.449 . . . . 0.67 113.326 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.506 ' HA ' ' CZ ' ' A' ' 139' ' ' PHE . 0.4 OUTLIER -61.09 -60.94 2.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.509 0.654 . . . . 1.2 110.298 179.167 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.54 ' HG2' ' O ' ' A' ' 52' ' ' GLY . 11.9 pt-20 -63.28 -21.21 66.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.647 -0.706 . . . . 2.61 110.349 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.655 ' HA ' ' CG2' ' A' ' 160' ' ' VAL . 54.1 m -73.01 -59.93 2.47 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.065 -0.971 . . . . 1.06 109.617 178.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 1.078 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -60.66 -42.04 96.23 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.552 -1.204 . . . . 1.05 110.876 -178.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.557 ' HA ' ' CD1' ' A' ' 102' ' ' PHE . 85.7 m -57.18 -57.31 13.16 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.541 -0.754 . . . . 1.08 110.471 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 22.7 m -70.6 -33.26 70.85 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.474 -0.784 . . . . 1.22 111.694 -174.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.737 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 18.7 mt -65.07 -47.67 76.48 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-O 121.435 0.636 . . . . 1.14 110.321 -178.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.862 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 10.0 t80 -59.7 -49.73 76.58 Favored 'General case' 0 C--O 1.205 -1.262 0 CA-C-N 114.757 -1.11 . . . . 0.94 111.045 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -72.35 -24.34 61.27 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 120.658 0.266 . . . . 1.6 110.659 -173.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.628 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 35.3 ttpt -85.76 -25.13 26.57 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 109.338 -0.616 . . . . 2.06 109.338 -178.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.798 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 32.5 m-85 -124.07 -6.74 7.78 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 115.491 1.663 . . . . 0.92 115.491 -169.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.683 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 3.8 ptmt -64.96 -26.99 68.53 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 108.004 -1.11 . . . . 1.89 108.004 170.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.6 t -47.63 -34.02 7.45 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.022 -1.444 . . . . 1.68 110.526 173.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.412 ' OE1' ' HB3' ' A' ' 171' ' ' LEU . 47.7 mt-30 -90.43 -39.65 12.51 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.681 0.277 . . . . 1.11 111.218 174.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.504 ' HA3' ' HB2' ' A' ' 36' ' ' SER . . . 151.81 -3.53 0.42 Allowed Glycine 0 CA--C 1.52 0.386 0 N-CA-C 111.23 -0.748 . . . . 0.2 111.23 -177.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.798 ' HD2' ' HB2' ' A' ' 64' ' ' TYR . 20.7 t80 -70.31 140.64 52.31 Favored 'General case' 0 C--O 1.218 -0.595 0 C-N-CA 123.029 0.532 . . . . 0.21 111.544 -177.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.983 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 2.2 t -134.49 145.57 48.92 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 108.818 -0.808 . . . . 1.02 108.818 174.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 1.078 HG11 ' HB1' ' A' ' 57' ' ' ALA . 42.8 t -104.94 99.99 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.257 0 N-CA-C 108.359 -0.978 . . . . 1.04 108.359 160.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.703 HD22 ' HE2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -96.51 120.97 37.79 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 118.842 -1.143 . . . . 1.69 108.044 174.422 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.992 ' HB3' HG13 ' A' ' 43' ' ' VAL . . . -108.16 128.69 54.92 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 116.214 -0.448 . . . . 1.17 110.0 179.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.891 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 2.6 m-30 -102.43 105.62 44.59 Favored Pre-proline 0 C--N 1.312 -1.056 0 N-CA-C 108.162 -1.051 . . . . 0.58 108.162 175.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.913 ' HG2' ' HB3' ' A' ' 107' ' ' LYS . 59.7 Cg_endo -74.8 68.04 5.64 Favored 'Trans proline' 0 N--CA 1.474 0.324 0 C-N-CA 123.545 2.83 . . . . 1.3 114.98 -168.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 85.3 p . . . . . 0 N--CA 1.483 1.179 0 C-N-CA 126.978 2.111 . . . . 1.91 116.542 178.827 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.483 ' N ' HD13 ' A' ' 104' ' ' ILE . . . . . . . . 0 CA--C 1.505 -0.758 0 CA-C-O 121.048 0.451 . . . . 1.15 111.386 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -91.6 26.52 2.3 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.435 -0.802 . . . . 1.99 110.437 176.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.559 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 25.9 p90 -146.76 155.76 48.29 Favored Pre-proline 0 N--CA 1.441 -0.886 0 N-CA-C 108.712 -0.847 . . . . 1.31 108.712 175.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.619 ' HG2' ' HA ' ' A' ' 72' ' ' LEU . 35.9 Cg_endo -60.25 88.97 0.08 OUTLIER 'Trans proline' 0 CA--C 1.513 -0.53 0 C-N-CA 124.638 3.559 . . . . 1.07 114.137 -171.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.671 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 18.3 mt -100.6 126.78 54.16 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.348 0 N-CA-C 107.631 -1.248 . . . . 1.97 107.631 174.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.898 ' HB3' ' O ' ' A' ' 21' ' ' LEU . 13.4 mmt -103.02 -159.82 0.75 Allowed 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.211 -0.904 . . . . 3.41 113.176 -158.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.678 ' HB2' ' CD2' ' A' ' 25' ' ' HIS . . . -65.81 -3.58 5.23 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.074 -0.966 . . . . 1.46 112.65 -172.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.913 ' HB3' ' HG2' ' A' ' 75' ' ' PRO . 14.3 ptpt 58.47 129.06 0.01 OUTLIER 'General case' 0 CA--C 1.494 -1.201 0 CA-C-O 122.889 1.328 . . . . 2.31 110.38 -168.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.49 HD13 ' CE2' ' A' ' 119' ' ' TYR . 1.7 pp -138.1 167.92 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.657 0 CA-C-N 114.05 -1.432 . . . . 1.65 108.382 173.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -46.27 110.67 0.29 Allowed 'General case' 0 C--N 1.296 -1.732 0 O-C-N 124.393 1.058 . . . . 1.73 110.006 171.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.497 ' CB ' ' HB3' ' A' ' 42' ' ' ASN . 5.5 m -117.77 91.45 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.135 0 N-CA-C 107.271 -1.381 . . . . 1.4 107.271 163.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.9 t30 . . . . . 0 C--N 1.312 -1.023 0 CA-C-N 114.188 -1.369 . . . . 2.1 109.225 -174.599 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.646 ' ND1' ' H ' ' A' ' 118' ' ' LEU . 2.7 t-80 . . . . . 0 N--CA 1.424 -1.732 0 N-CA-C 106.5 -1.667 . . . . 0.71 106.5 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -26.82 -48.12 0.08 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 124.456 3.437 . . . . 0.47 113.537 178.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.756 HD12 ' HB ' ' A' ' 15' ' ' ILE . 48.3 tp -60.15 -52.74 64.02 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.364 0.665 . . . . 1.15 112.288 177.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 1.036 ' HH ' HG22 ' A' ' 40' ' ' ILE . 70.2 m-85 -77.28 -35.12 55.45 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-N 116.663 -0.244 . . . . 3.33 111.511 -178.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.494 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 7.0 mm-40 -56.79 -36.1 69.49 Favored 'General case' 0 CA--C 1.491 -1.319 0 N-CA-C 107.803 -1.184 . . . . 2.44 107.803 170.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.741 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 60.8 t80 -69.86 -31.89 69.96 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 119.252 -0.979 . . . . 1.08 110.403 174.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.644 ' HE2' HD13 ' A' ' 40' ' ' ILE . 1.1 ttm -76.63 -55.06 5.85 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.551 -0.295 . . . . 1.25 111.244 -170.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.426 ' HE2' ' HB2' ' A' ' 123' ' ' LYS . 0.4 OUTLIER -69.29 -24.77 64.0 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.337 -0.392 . . . . 1.86 110.551 178.913 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.494 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 12.8 pttp -72.41 -28.64 63.11 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 119.384 -0.926 . . . . 2.52 109.696 175.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.445 ' HB ' ' HG2' ' A' ' 150' ' ' PRO . 97.4 m -76.57 -57.08 4.06 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.974 -0.557 . . . . 1.21 111.053 178.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 71.6 tttt . . . . . 0 N--CA 1.453 -0.319 0 CA-C-O 121.29 0.567 . . . . 2.38 112.005 -177.997 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.894 ' HB3' ' HG3' ' A' ' 156' ' ' PRO . 9.7 m-90 . . . . . 0 N--CA 1.454 -0.25 0 CA-C-O 120.961 0.41 . . . . 2.41 111.441 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.473 ' OD1' ' HD1' ' A' ' 139' ' ' PHE . 5.2 t-20 -38.96 -153.13 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 125.727 1.611 . . . . 2.04 111.565 157.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.732 ' CD1' HG23 ' A' ' 43' ' ' VAL . 2.4 m-85 -25.59 -52.18 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 115.461 1.652 . . . . 2.53 115.461 -169.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.624 ' HA ' ' O ' ' A' ' 154' ' ' PHE . 1.9 m 32.67 106.0 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.422 1.268 . . . . 1.24 114.422 175.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.411 ' HB3' HD11 ' A' ' 39' ' ' LEU . 2.8 m -92.58 174.04 7.48 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 114.084 -1.416 . . . . 1.03 111.393 -169.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.536 ' CD1' ' HB2' ' A' ' 153' ' ' ARG . 57.6 m-85 -138.64 123.01 18.29 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 105.985 -1.858 . . . . 0.7 105.985 165.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.894 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 2.9 tp -79.64 104.06 9.97 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 118.345 -1.342 . . . . 1.16 108.48 -179.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.727 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 40.2 mm -91.57 140.45 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.96 0 CA-C-N 113.647 -1.615 . . . . 1.05 107.873 -178.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.404 ' HA ' HD11 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -94.64 -172.26 2.7 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 120.062 -0.655 . . . . 0.98 111.515 -169.588 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.735 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 17.1 mtm180 -55.8 -36.77 67.78 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 123.168 0.293 . . . . 2.61 111.28 -176.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.535 ' O ' ' HB3' ' A' ' 14' ' ' SER . 34.8 t70 -102.2 23.22 11.98 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.33 -0.618 . . . . 2.0 109.33 -178.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.673 ' HA2' HG22 ' A' ' 144' ' ' ILE . . . 67.12 38.69 92.43 Favored Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 120.863 -0.684 . . . . 0.19 114.305 177.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 42.7 t -104.7 128.37 26.99 Favored Pre-proline 0 C--N 1.313 -0.979 0 CA-C-N 118.187 0.993 . . . . 1.74 110.618 173.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.463 ' HA ' HD11 ' A' ' 144' ' ' ILE . 1.3 Cg_endo -71.12 118.85 5.9 Favored 'Trans proline' 0 CA--C 1.531 0.335 0 C-N-CA 122.662 2.241 . . . . 0.6 110.814 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.458 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 14.2 t -119.71 -7.0 11.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.825 -0.435 . . . . 2.06 109.825 -175.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.894 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 6.0 mm-40 -155.14 168.13 28.06 Favored 'General case' 0 CA--C 1.5 -0.948 0 CA-C-O 121.52 0.676 . . . . 1.17 111.007 176.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.536 ' HB2' ' CD1' ' A' ' 142' ' ' PHE . 1.4 ttm180 -147.91 132.99 18.24 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 113.851 -1.522 . . . . 2.9 108.726 164.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.624 ' O ' ' HA ' ' A' ' 140' ' ' THR . 96.7 m-85 -114.27 146.72 40.08 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.678 -0.692 . . . . 0.36 109.338 -168.018 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 15.8 m -65.1 150.14 95.85 Favored Pre-proline 0 C--N 1.313 -1.014 0 N-CA-C 109.001 -0.74 . . . . 1.45 109.001 175.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.894 ' HG3' ' HB3' ' A' ' 137' ' ' TRP . 38.5 Cg_endo -66.39 -16.31 50.91 Favored 'Trans proline' 0 CA--C 1.514 -0.519 0 C-N-CA 122.57 2.18 . . . . 0.78 110.974 177.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -88.31 2.07 84.83 Favored Glycine 0 N--CA 1.439 -1.158 0 CA-C-N 114.473 -1.239 . . . . 0.59 112.72 173.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -76.46 153.07 35.9 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.272 -0.64 . . . . 1.07 109.272 173.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.568 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 24.4 m -112.31 169.64 8.73 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 116.3 -0.409 . . . . 1.92 110.245 -175.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.655 ' CG2' ' HA ' ' A' ' 56' ' ' THR . 88.7 t -40.9 -52.53 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 O-C-N 124.363 1.039 . . . . 1.07 111.788 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 52.3 tttm -66.4 -32.99 74.71 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.031 -0.531 . . . . 3.89 111.166 -173.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -69.99 -31.45 69.15 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.859 -0.61 . . . . 1.4 109.847 -176.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.777 ' CD1' ' HH ' ' A' ' 41' ' ' TYR . 70.1 mt -83.89 -43.24 17.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 115.184 -0.916 . . . . 1.05 110.954 176.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.568 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 35.0 mt-10 -53.05 -42.94 66.25 Favored 'General case' 0 C--O 1.216 -0.668 0 N-CA-C 111.723 0.268 . . . . 0.67 111.723 -177.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -54.88 -29.01 54.64 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 112.254 0.464 . . . . 0.87 112.254 -177.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.759 ' HB3' HD22 ' A' ' 143' ' ' LEU . 35.8 mmtm -94.68 -20.84 19.2 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.651 0.739 . . . . 2.22 110.103 177.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.568 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 14.1 tp -86.46 -49.34 7.67 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.617 -1.174 . . . . 1.04 112.413 -174.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.502 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 78.0 mt -55.66 -47.47 98.61 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.385 -0.825 . . . . 1.08 112.557 -172.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.502 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 76.5 Cg_exo -53.54 -28.53 45.81 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 122.356 2.037 . . . . 0.62 112.756 174.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.829 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 80.1 mt -86.23 -47.1 9.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.357 -0.383 . . . . 1.36 111.14 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.733 HD22 ' HG2' ' A' ' 37' ' ' PRO . 84.9 mt -57.45 -57.86 10.82 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-O 122.113 0.959 . . . . 1.07 109.781 176.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.393 0 CA-C-N 113.36 -1.745 . . . . 1.12 112.214 -178.708 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.8 p . . . . . 0 C--O 1.235 0.298 0 CA-C-O 121.307 0.575 . . . . 2.17 110.086 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 79.7 p 177.12 153.7 0.23 Allowed 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 105.842 -1.911 . . . . 1.68 105.842 -178.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.838 ' HB ' ' CD1' ' A' ' 118' ' ' LEU . 5.8 pt -69.26 -12.39 15.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 CA-C-N 115.063 -0.972 . . . . 1.16 112.133 -170.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.658 ' CD1' ' HA ' ' A' ' 31' ' ' VAL . 48.0 m-85 -74.83 -8.2 55.74 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 120.752 0.31 . . . . 0.3 111.184 -178.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -63.24 -21.13 66.03 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 108.91 -0.774 . . . . 2.11 108.91 170.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.823 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 60.8 m-85 -117.63 105.35 11.95 Favored 'General case' 0 CA--C 1.49 -1.341 0 CA-C-N 114.614 -1.175 . . . . 0.37 110.253 176.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -58.25 158.95 6.51 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 114.88 -1.054 . . . . 2.86 108.165 172.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.759 HG13 ' HZ ' ' A' ' 74' ' ' PHE . 20.3 t -108.33 169.28 3.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 107.393 -1.336 . . . . 1.32 107.393 -175.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.781 ' O ' ' HB2' ' A' ' 105' ' ' MET . 33.0 mt -127.21 141.52 51.71 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 109.534 -0.543 . . . . 1.29 109.534 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -71.21 -173.55 0.87 Allowed 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.24 -1.022 . . . . 1.87 108.24 174.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.748 ' HA ' ' CA ' ' A' ' 106' ' ' ALA . . . -66.93 -3.05 6.08 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 112.494 0.553 . . . . 1.2 112.494 -176.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.453 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 29.1 t70 -102.84 -3.25 26.55 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.803 -0.359 . . . . 2.34 110.832 176.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.631 ' CD2' ' HB1' ' A' ' 106' ' ' ALA . 1.9 m170 75.72 20.94 1.75 Allowed 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.741 0.781 . . . . 2.26 109.417 -178.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.443 ' HA ' ' HD3' ' A' ' 26' ' ' LYS . 45.9 mmtt -102.15 135.46 19.64 Favored Pre-proline 0 N--CA 1.443 -0.804 0 CA-C-N 114.397 -1.274 . . . . 4.64 108.45 171.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.639 ' HA ' HD23 ' A' ' 21' ' ' LEU . 84.7 Cg_exo -47.21 115.29 1.27 Allowed 'Trans proline' 0 C--N 1.335 -0.178 0 C-N-CA 123.341 2.694 . . . . 0.62 115.361 -165.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 1.028 ' HH ' ' HB3' ' A' ' 103' ' ' PRO . 0.2 OUTLIER -78.0 142.94 37.94 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 112.947 -1.933 . . . . 1.52 108.977 164.928 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.524 ' N ' ' HD1' ' A' ' 28' ' ' TYR . 2.7 t-20 -79.72 86.24 5.33 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.537 -0.542 . . . . 2.16 109.537 178.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.652 HD22 HD12 ' A' ' 15' ' ' ILE . 68.2 tp -67.61 -42.47 82.35 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.576 0.703 . . . . 1.07 110.01 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.658 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 1.6 m -69.56 -0.61 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.398 -1.274 . . . . 1.69 112.855 -167.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.523 ' HB3' ' OD1' ' A' ' 29' ' ' ASN . 10.2 pt20 -75.03 -11.32 60.07 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.541 0.686 . . . . 1.31 109.289 174.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.945 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 91.0 m-70 -95.83 22.53 7.22 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 115.315 -0.857 . . . . 0.35 109.495 176.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.526 ' CE ' ' HB ' ' A' ' 31' ' ' VAL . 45.6 mttm -77.77 126.86 31.5 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 114.475 -1.239 . . . . 2.07 108.382 167.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.22 -44.81 1.42 Allowed Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 120.295 -0.955 . . . . 0.24 111.926 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.546 ' HB2' ' HA3' ' A' ' 68' ' ' GLY . 21.6 m -127.07 133.57 25.19 Favored Pre-proline 0 N--CA 1.435 -1.203 0 N-CA-C 108.9 -0.778 . . . . 0.74 108.9 174.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.77 ' HG3' ' CB ' ' A' ' 170' ' ' LEU . 6.1 Cg_endo -43.88 152.83 0.32 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 124.086 3.191 . . . . 0.22 112.891 177.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.84 HD11 ' HB2' ' A' ' 33' ' ' HIS . 0.8 OUTLIER -139.02 152.97 48.04 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 106.375 -1.713 . . . . 1.09 106.375 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.944 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 2.8 mp -120.59 128.19 52.81 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.776 -0.578 . . . . 1.82 109.546 177.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.812 HD13 ' HE3' ' A' ' 122' ' ' MET . 1.0 OUTLIER -109.89 125.11 67.09 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-N 115.248 -0.887 . . . . 1.12 109.92 179.304 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.944 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.6 OUTLIER -110.62 124.94 52.83 Favored 'General case' 0 C--O 1.215 -0.729 0 CA-C-N 115.674 -0.693 . . . . 1.09 110.971 -172.031 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.662 ' OD1' ' HB3' ' A' ' 76' ' ' SER . 0.7 OUTLIER -77.83 121.96 24.8 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 105.726 -1.953 . . . . 3.11 105.726 165.177 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.85 HG11 ' HB2' ' A' ' 73' ' ' ALA . 1.5 p . . . . . 0 C--N 1.297 -1.703 0 C-N-CA 119.158 -1.017 . . . . 1.69 113.109 -164.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.467 0 N-CA-C 112.097 -0.401 . . . . 0.85 112.097 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -47.19 -40.83 14.63 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 112.115 -0.394 . . . . 0.67 112.115 177.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.0 -62.09 1.99 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.754 0.312 . . . . 1.2 110.407 -178.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.0 mp0 -59.55 -34.2 72.38 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.716 -0.675 . . . . 2.61 111.539 -178.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.649 ' HA ' HG22 ' A' ' 160' ' ' VAL . 97.0 m -68.47 -58.39 4.4 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.598 -0.728 . . . . 1.06 109.211 -176.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 1.067 ' HB2' HG11 ' A' ' 71' ' ' VAL . . . -59.5 -42.75 92.9 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.526 -1.216 . . . . 1.05 111.157 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.512 ' HA ' ' HD1' ' A' ' 102' ' ' PHE . 60.4 m -58.83 -56.86 16.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.86 -0.609 . . . . 1.08 110.923 -177.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 26.6 m -68.34 -35.36 77.65 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.417 -0.811 . . . . 1.22 111.344 -175.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.811 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 20.3 mt -65.61 -50.69 64.13 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-O 121.311 0.577 . . . . 1.14 110.432 -176.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.916 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 6.7 t80 -55.16 -51.89 65.03 Favored 'General case' 0 C--O 1.205 -1.268 0 CA-C-N 114.814 -1.085 . . . . 0.94 110.969 178.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -73.71 -24.49 59.93 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 116.488 -0.324 . . . . 1.6 110.961 -170.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.519 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 34.9 ttpt -85.84 -23.5 27.11 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 109.039 -0.726 . . . . 2.06 109.039 -178.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.579 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 28.2 m-85 -124.86 -3.72 7.65 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 115.504 1.668 . . . . 0.92 115.504 -170.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.664 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 40.5 pttt -67.58 -26.23 66.17 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 107.897 -1.149 . . . . 1.89 107.897 170.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.3 m -49.23 -28.24 4.42 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 113.854 -1.521 . . . . 1.68 111.294 172.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -99.18 -34.54 10.32 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.496 0.189 . . . . 1.11 111.481 173.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.546 ' HA3' ' HB2' ' A' ' 36' ' ' SER . . . 150.95 -6.06 0.6 Allowed Glycine 0 CA--C 1.521 0.408 0 N-CA-C 111.863 -0.495 . . . . 0.2 111.863 -177.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.811 ' HE2' ' HB3' ' A' ' 60' ' ' LEU . 19.3 t80 -71.15 143.13 50.66 Favored 'General case' 0 C--O 1.218 -0.598 0 C-N-CA 122.705 0.402 . . . . 0.21 111.605 -176.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.945 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 4.8 t -134.65 153.99 51.73 Favored 'General case' 0 CA--C 1.483 -1.606 0 N-CA-C 108.354 -0.98 . . . . 1.02 108.354 172.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 1.067 HG11 ' HB2' ' A' ' 57' ' ' ALA . 42.7 t -113.27 99.86 9.51 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.407 0 N-CA-C 108.586 -0.894 . . . . 1.04 108.586 160.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.741 ' HA ' ' HG2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -94.73 120.47 35.0 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 118.498 -1.281 . . . . 1.69 107.735 174.423 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.952 ' HB3' HD13 ' A' ' 104' ' ' ILE . . . -109.53 127.39 54.43 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.915 0.864 . . . . 1.17 111.085 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.785 ' CG ' ' HG2' ' A' ' 105' ' ' MET . 5.8 m-30 -102.92 106.95 53.12 Favored Pre-proline 0 C--N 1.313 -1.009 0 CA-C-N 114.565 -1.198 . . . . 0.58 108.806 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.719 ' O ' ' HB2' ' A' ' 107' ' ' LYS . 65.2 Cg_endo -77.21 93.13 1.09 Allowed 'Trans proline' 0 C--O 1.221 -0.334 0 C-N-CA 122.474 2.116 . . . . 1.3 113.4 -168.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.662 ' HB3' ' OD1' ' A' ' 42' ' ' ASN . 70.6 p . . . . . 0 C--N 1.325 -0.459 0 CA-C-N 114.633 -1.167 . . . . 1.91 114.042 -167.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.663 0 CA-C-O 121.344 0.592 . . . . 1.15 111.528 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -86.04 24.25 1.34 Allowed 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.123 -0.944 . . . . 1.99 110.068 172.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.609 ' HB2' ' O ' ' A' ' 71' ' ' VAL . 26.1 p90 -147.69 156.07 44.95 Favored Pre-proline 0 N--CA 1.446 -0.673 0 N-CA-C 109.048 -0.723 . . . . 1.31 109.048 176.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 1.028 ' HB3' ' HH ' ' A' ' 28' ' ' TYR . 14.0 Cg_endo -54.13 101.81 0.08 OUTLIER 'Trans proline' 0 N--CA 1.479 0.639 0 C-N-CA 124.838 3.692 . . . . 1.07 114.97 -172.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.952 HD13 ' HB3' ' A' ' 73' ' ' ALA . 4.8 mm -101.84 122.15 53.7 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 N-CA-C 108.724 -0.843 . . . . 1.97 108.724 173.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.785 ' HG2' ' CG ' ' A' ' 74' ' ' PHE . 0.3 OUTLIER -81.61 -171.21 3.2 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.767 -0.651 . . . . 3.41 110.474 -176.005 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.748 ' CA ' ' HA ' ' A' ' 23' ' ' ALA . . . -66.49 -23.04 66.2 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 121.024 -0.271 . . . . 1.46 110.949 -177.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.719 ' HB2' ' O ' ' A' ' 75' ' ' PRO . 4.9 ptpp? 94.42 139.19 0.02 OUTLIER 'General case' 0 CA--C 1.493 -1.227 0 O-C-N 125.8 1.937 . . . . 2.31 109.13 -167.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.813 HG13 ' HB2' ' A' ' 116' ' ' HIS . 0.2 OUTLIER -130.87 176.7 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.099 0 N-CA-C 106.284 -1.747 . . . . 1.65 106.284 166.808 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -82.55 68.66 9.09 Favored 'General case' 0 C--N 1.293 -1.886 0 C-N-CA 120.299 -0.56 . . . . 1.73 110.156 -178.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.508 ' HB ' ' OD1' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -65.37 96.3 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 CA-C-N 115.54 -0.755 . . . . 1.4 110.434 -176.192 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.411 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 5.5 t-20 . . . . . 0 N--CA 1.448 -0.553 0 CA-C-N 115.118 -0.946 . . . . 2.1 108.681 171.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.813 ' HB2' HG13 ' A' ' 108' ' ' ILE . 7.8 t-80 . . . . . 0 N--CA 1.424 -1.756 0 CA-C-O 118.003 -0.999 . . . . 0.71 108.698 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -29.3 -41.77 0.07 OUTLIER 'Trans proline' 0 CA--C 1.535 0.525 0 C-N-CA 124.247 3.298 . . . . 0.47 113.323 179.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.838 ' CD1' ' HB ' ' A' ' 15' ' ' ILE . 22.1 tp -65.59 -50.94 63.24 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 123.435 0.694 . . . . 1.15 111.928 177.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.564 ' HA ' ' HB2' ' A' ' 122' ' ' MET . 48.0 m-85 -75.91 -33.45 59.9 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 111.678 0.251 . . . . 3.33 111.678 176.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.47 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 21.9 mm-40 -58.38 -33.41 69.58 Favored 'General case' 0 CA--C 1.498 -1.037 0 N-CA-C 107.807 -1.183 . . . . 2.44 107.807 168.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.823 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 76.0 t80 -71.91 -31.08 66.03 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 119.581 -0.847 . . . . 1.08 110.682 171.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.812 ' HE3' HD13 ' A' ' 40' ' ' ILE . 49.1 mtt -74.65 -51.62 13.93 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 120.403 -0.519 . . . . 1.25 110.595 -170.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.468 ' HB2' ' HE2' ' A' ' 123' ' ' LYS . 0.1 OUTLIER -70.8 -25.89 63.07 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.936 -0.574 . . . . 1.86 111.192 176.734 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.568 ' HG2' ' HA ' ' A' ' 121' ' ' TYR . 10.0 ptmm? -70.02 -27.16 64.45 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 119.584 -0.847 . . . . 2.52 109.516 176.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 62.6 m -85.22 -56.99 3.26 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.495 -0.775 . . . . 1.21 110.839 178.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.537 ' HG2' HH22 ' A' ' 153' ' ' ARG . 20.7 ttmm . . . . . 0 C--N 1.326 -0.431 0 N-CA-C 109.819 -0.437 . . . . 2.38 109.819 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.223 -0.324 0 N-CA-C 111.671 0.248 . . . . 2.41 111.671 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.482 ' O ' ' N ' ' A' ' 140' ' ' THR . 8.5 m120 -37.04 -152.29 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 126.043 1.737 . . . . 2.04 112.685 158.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.738 ' HD1' ' HD2' ' A' ' 41' ' ' TYR . 0.2 OUTLIER -29.05 -22.54 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 116.76 2.134 . . . . 2.53 116.76 -171.411 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.713 ' HA ' ' O ' ' A' ' 154' ' ' PHE . 3.3 m -5.37 121.75 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 115.494 1.664 . . . . 1.24 115.494 168.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.457 ' CB ' HD23 ' A' ' 39' ' ' LEU . 0.7 OUTLIER -97.45 176.36 5.9 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.649 -1.16 . . . . 1.03 110.938 -177.661 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.517 ' HA ' ' HA ' ' A' ' 153' ' ' ARG . 23.7 m-85 -131.24 123.7 28.97 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 105.498 -2.038 . . . . 0.7 105.498 162.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.849 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 6.4 tp -79.87 104.33 10.38 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 118.075 -1.45 . . . . 1.16 108.289 178.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.701 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 45.8 mm -89.24 138.58 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.688 0 CA-C-N 112.722 -2.036 . . . . 1.05 107.586 -178.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.454 ' HA ' HD11 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -92.07 -174.83 3.9 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 119.282 -0.967 . . . . 0.98 110.939 -169.342 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.569 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 71.6 mtm180 -54.21 -38.88 66.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.98 0.419 . . . . 2.61 111.511 -177.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -95.91 15.56 20.1 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.31 -0.626 . . . . 2.0 109.31 -176.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.58 ' HA2' HG23 ' A' ' 144' ' ' ILE . . . 74.39 33.92 55.46 Favored Glycine 0 N--CA 1.442 -0.91 0 CA-C-N 115.821 -0.627 . . . . 0.19 114.499 -178.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.483 ' HA ' ' HD2' ' A' ' 150' ' ' PRO . 49.9 t -103.57 109.69 62.45 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-N 118.415 1.108 . . . . 1.74 111.633 176.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.794 ' HD3' HG21 ' A' ' 15' ' ' ILE . 6.5 Cg_endo -57.38 113.35 1.45 Allowed 'Trans proline' 0 CA--C 1.53 0.325 0 C-N-CA 123.715 2.943 . . . . 0.6 111.159 173.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.557 HG23 ' HG2' ' A' ' 152' ' ' GLU . 22.9 m -115.76 -16.86 8.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.331 0.586 . . . . 2.06 110.189 -177.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.849 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 53.9 mm-40 -139.61 167.48 22.01 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-N 115.376 -0.829 . . . . 1.17 110.088 178.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.537 HH22 ' HG2' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -148.22 129.95 15.11 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 114.608 -1.178 . . . . 2.9 108.664 163.943 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.713 ' O ' ' HA ' ' A' ' 140' ' ' THR . 94.2 m-85 -108.68 137.06 47.23 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.951 -0.568 . . . . 0.36 109.879 -170.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 20.1 m -62.77 156.61 64.34 Favored Pre-proline 0 C--N 1.323 -0.556 0 N-CA-C 109.393 -0.595 . . . . 1.45 109.393 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.563 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 14.1 Cg_endo -56.72 -48.22 19.73 Favored 'Trans proline' 0 CA--C 1.527 0.167 0 C-N-CA 121.765 1.643 . . . . 0.78 111.462 -177.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -55.64 -7.2 1.39 Allowed Glycine 0 CA--C 1.528 0.844 0 N-CA-C 115.692 1.037 . . . . 0.59 115.692 172.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -71.94 140.04 48.99 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 118.777 1.288 . . . . 1.07 109.256 176.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 22.2 t -103.69 170.26 8.04 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 109.629 -0.508 . . . . 1.92 109.629 -173.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.649 HG22 ' HA ' ' A' ' 56' ' ' THR . 60.5 t -41.14 -53.43 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 114.877 -1.056 . . . . 1.07 111.698 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 14.7 ttpp -63.58 -40.24 96.45 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.039 0.447 . . . . 3.89 111.104 -173.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -66.12 -30.43 70.92 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.432 -0.804 . . . . 1.4 109.795 -174.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.57 ' HA ' ' CE2' ' A' ' 154' ' ' PHE . 48.5 mt -82.77 -46.56 19.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.87 -1.059 . . . . 1.05 110.992 175.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.588 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 47.4 mt-10 -52.77 -43.33 65.74 Favored 'General case' 0 C--O 1.217 -0.626 0 O-C-N 123.314 0.384 . . . . 0.67 111.254 -175.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -55.51 -27.47 48.81 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.418 0.525 . . . . 0.87 112.418 -177.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.59 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 14.0 mmmm -97.98 -18.88 18.37 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.421 0.629 . . . . 2.22 109.938 176.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.561 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 12.4 tp -86.2 -49.14 7.95 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.029 -0.987 . . . . 1.04 112.142 -176.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 164' ' ' GLU . 81.0 mt -55.47 -44.7 99.78 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-N 115.501 -0.772 . . . . 1.08 112.799 -173.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.405 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 72.3 Cg_exo -51.96 -35.33 60.14 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 122.002 1.802 . . . . 0.62 112.375 173.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.77 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 96.6 mt -80.91 -44.25 18.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.358 -0.383 . . . . 1.36 111.378 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.66 HD23 ' HG2' ' A' ' 37' ' ' PRO . 90.9 mt -59.88 -59.28 5.68 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 122.028 0.918 . . . . 1.07 109.899 176.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.434 0 CA-C-N 113.327 -1.76 . . . . 1.12 113.298 -177.526 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.0 t . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 121.079 0.466 . . . . 2.17 109.806 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 99.5 p -168.49 177.07 5.44 Favored 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 107.48 -1.304 . . . . 1.68 107.48 -177.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.94 HD11 HD21 ' A' ' 30' ' ' LEU . 5.2 pt -83.7 -18.77 9.92 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 CA-C-N 114.863 -1.062 . . . . 1.16 109.817 176.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.733 ' CD1' ' HA ' ' A' ' 31' ' ' VAL . 48.4 m-85 -70.95 -5.78 33.54 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.255 0.55 . . . . 0.3 110.713 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -69.18 -18.22 63.89 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.201 -0.909 . . . . 2.11 108.665 172.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.748 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 61.1 m-85 -119.35 108.05 14.12 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-O 121.781 0.801 . . . . 0.37 111.509 -178.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -48.48 146.88 2.69 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 113.488 -1.687 . . . . 2.86 110.336 170.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.769 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 37.1 t -110.86 165.0 6.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 109.393 -0.595 . . . . 1.32 109.393 -175.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.814 ' O ' ' HB3' ' A' ' 105' ' ' MET . 97.1 mt -126.49 111.28 14.23 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-O 119.505 -0.283 . . . . 1.29 111.332 -176.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -53.9 161.84 1.08 Allowed 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 107.03 -1.47 . . . . 1.87 107.03 170.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.609 ' HA ' ' N ' ' A' ' 106' ' ' ALA . . . -57.02 -11.1 1.34 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 113.153 0.797 . . . . 1.2 113.153 -164.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 10.9 t70 -90.21 -4.18 57.38 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 122.386 0.274 . . . . 2.34 111.598 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.645 ' CD2' ' HB3' ' A' ' 106' ' ' ALA . 74.4 m-70 79.95 20.71 0.57 Allowed 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.93 0.872 . . . . 2.26 108.995 -177.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.435 ' HA ' ' HD3' ' A' ' 26' ' ' LYS . 11.3 mmtp -104.69 125.96 32.55 Favored Pre-proline 0 N--CA 1.441 -0.892 0 CA-C-N 114.344 -1.298 . . . . 4.64 108.398 175.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.645 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 80.3 Cg_exo -48.79 114.74 1.34 Allowed 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.995 2.463 . . . . 0.62 114.917 -168.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.867 ' HH ' ' HE2' ' A' ' 33' ' ' HIS . 8.8 t80 -83.8 128.3 34.44 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 113.589 -1.641 . . . . 1.52 109.313 164.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.423 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 1.7 p-10 -75.29 99.53 4.1 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 122.777 1.275 . . . . 2.16 110.143 176.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.94 HD21 HD11 ' A' ' 15' ' ' ILE . 61.7 tp -61.62 -32.82 72.97 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.507 -1.224 . . . . 1.07 110.591 178.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.733 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 3.7 m -63.77 -6.12 2.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 114.793 -1.094 . . . . 1.69 113.164 -169.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.423 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 9.7 pt20 -72.81 -7.88 52.85 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.006 -0.678 . . . . 1.31 109.737 177.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.917 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 90.1 m-70 -98.94 22.11 10.68 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.8 0.81 . . . . 0.35 109.866 176.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.499 ' HE2' ' HB ' ' A' ' 31' ' ' VAL . 62.2 mttm -78.75 122.09 25.58 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 114.683 -1.144 . . . . 2.07 109.156 169.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.05 -41.09 2.08 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.585 -0.817 . . . . 0.24 111.912 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.557 ' HB2' ' HA3' ' A' ' 68' ' ' GLY . 52.7 m -129.77 132.93 24.49 Favored Pre-proline 0 N--CA 1.437 -1.121 0 N-CA-C 108.839 -0.801 . . . . 0.74 108.839 173.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.78 ' HG3' ' CB ' ' A' ' 170' ' ' LEU . 4.2 Cg_endo -43.29 152.22 0.27 Allowed 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.951 3.1 . . . . 0.22 112.55 176.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.795 ' HB2' HG22 ' A' ' 70' ' ' THR . 0.7 OUTLIER -137.04 150.8 48.3 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.353 -1.721 . . . . 1.09 106.353 179.171 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.954 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 1.8 mp -116.26 122.61 45.49 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 121.419 0.628 . . . . 1.82 109.536 176.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 1.062 HG23 ' OH ' ' A' ' 119' ' ' TYR . 0.9 OUTLIER -102.51 123.6 55.93 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 CA-C-N 114.908 -1.042 . . . . 1.12 109.394 177.45 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.954 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.3 OUTLIER -109.25 129.7 55.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.31 -0.405 . . . . 1.09 110.569 -175.013 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.821 HD22 ' HE2' ' A' ' 142' ' ' PHE . 2.9 m-80 -78.89 93.13 4.98 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.213 -1.402 . . . . 3.11 107.213 169.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.665 HG12 ' CG ' ' A' ' 139' ' ' PHE . 34.9 m . . . . . 0 C--N 1.308 -1.234 0 C-N-CA 119.038 -1.065 . . . . 1.69 111.227 -170.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.893 0 N-CA-C 110.32 -1.112 . . . . 0.85 110.32 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -45.31 -47.98 11.06 Favored Glycine 0 C--O 1.223 -0.592 0 CA-C-N 115.011 -0.595 . . . . 0.67 113.222 175.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.01 -61.88 2.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.877 0.338 . . . . 1.2 111.524 -174.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -62.06 -23.88 66.75 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.268 0.556 . . . . 2.61 111.149 -178.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.634 ' HA ' HG22 ' A' ' 160' ' ' VAL . 23.4 m -75.79 -57.66 3.75 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.518 -0.765 . . . . 1.06 110.363 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 1.027 ' HB1' HG12 ' A' ' 71' ' ' VAL . . . -57.87 -38.48 75.81 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.942 -1.026 . . . . 1.05 110.949 -179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.534 ' HA ' ' CD1' ' A' ' 102' ' ' PHE . 54.8 m -60.92 -57.78 11.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.837 -0.619 . . . . 1.08 110.415 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 26.6 m -66.74 -37.84 85.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.378 -0.828 . . . . 1.22 111.534 -175.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.781 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 18.9 mt -65.3 -48.0 74.65 Favored 'General case' 0 CA--C 1.503 -0.849 0 CA-C-O 121.049 0.452 . . . . 1.14 110.679 -175.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.882 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 8.7 t80 -56.58 -50.96 70.38 Favored 'General case' 0 C--O 1.203 -1.394 0 CA-C-N 115.217 -0.901 . . . . 0.94 110.453 178.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -72.21 -24.57 61.42 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 120.745 0.307 . . . . 1.6 110.502 -172.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.3 ttmm -82.62 -26.35 32.32 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 109.107 -0.701 . . . . 2.06 109.107 -177.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.737 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 30.2 m-85 -127.61 -5.77 5.81 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 115.452 1.649 . . . . 0.92 115.452 -168.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.685 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 11.5 ptmt -63.65 -28.18 69.73 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 108.033 -1.099 . . . . 1.89 108.033 170.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.4 m -48.77 -34.83 12.97 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 113.84 -1.527 . . . . 1.68 110.782 172.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -93.64 -30.91 14.7 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.679 0.276 . . . . 1.11 111.52 176.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.557 ' HA3' ' HB2' ' A' ' 36' ' ' SER . . . 144.79 -7.64 1.71 Allowed Glycine 0 CA--C 1.519 0.323 0 N-CA-C 111.431 -0.668 . . . . 0.2 111.431 -177.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.781 ' HE2' ' HB3' ' A' ' 60' ' ' LEU . 21.5 t80 -69.52 141.71 53.82 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 122.744 0.418 . . . . 0.21 111.122 -177.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.917 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 3.8 t -133.91 152.17 51.76 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 107.985 -1.117 . . . . 1.02 107.985 173.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 1.027 HG12 ' HB1' ' A' ' 57' ' ' ALA . 33.4 t -110.82 100.32 10.52 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.454 0 N-CA-C 108.158 -1.053 . . . . 1.04 108.158 159.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.789 HD23 ' HE2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -96.7 121.5 38.61 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 107.829 -1.174 . . . . 1.69 107.829 175.18 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 1.018 ' HB2' HD12 ' A' ' 104' ' ' ILE . . . -111.28 116.81 31.65 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 115.705 -0.679 . . . . 1.17 110.295 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.957 ' HD2' HD13 ' A' ' 108' ' ' ILE . 1.4 m-30 -89.66 108.07 22.89 Favored Pre-proline 0 C--N 1.314 -0.951 0 N-CA-C 107.918 -1.141 . . . . 0.58 107.918 173.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.949 ' HG2' ' HB3' ' A' ' 107' ' ' LYS . 73.2 Cg_endo -75.24 64.22 6.24 Favored 'Trans proline' 0 N--CA 1.476 0.459 0 C-N-CA 123.632 2.888 . . . . 1.3 115.199 -168.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.3 t . . . . . 0 N--CA 1.483 1.211 0 N-CA-C 116.589 2.07 . . . . 1.91 116.589 175.247 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.511 ' HB1' ' CE1' ' A' ' 102' ' ' PHE . . . . . . . . 0 CA--C 1.513 -0.479 0 CA-C-O 121.306 0.574 . . . . 1.15 112.011 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -93.05 11.97 25.72 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.242 -0.89 . . . . 1.99 109.589 177.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.609 ' CE2' HD13 ' A' ' 104' ' ' ILE . 7.5 p90 -134.48 163.39 51.56 Favored Pre-proline 0 N--CA 1.444 -0.725 0 N-CA-C 108.175 -1.046 . . . . 1.31 108.175 178.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.725 ' HG2' ' HA ' ' A' ' 72' ' ' LEU . 26.4 Cg_endo -57.12 97.03 0.07 OUTLIER 'Trans proline' 0 N--CA 1.477 0.554 0 C-N-CA 123.57 2.847 . . . . 1.07 114.063 -173.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 1.018 HD12 ' HB2' ' A' ' 73' ' ' ALA . 7.6 mm -99.59 123.55 52.41 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.931 0 N-CA-C 107.969 -1.123 . . . . 1.97 107.969 173.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.826 ' HG3' ' CE1' ' A' ' 74' ' ' PHE . 13.5 mmt -100.99 -163.87 1.06 Allowed 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.304 -0.862 . . . . 3.41 111.791 -165.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.645 ' HB3' ' CD2' ' A' ' 25' ' ' HIS . . . -71.37 4.07 3.24 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.228 -0.897 . . . . 1.46 113.337 -169.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.949 ' HB3' ' HG2' ' A' ' 75' ' ' PRO . 15.8 ptpt 53.77 123.57 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.048 0 CA-C-O 122.701 1.239 . . . . 2.31 111.5 -170.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.957 HD13 ' HD2' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -122.73 177.68 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.689 0 N-CA-C 108.249 -1.019 . . . . 1.65 108.249 171.183 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.413 ' C ' HD21 ' A' ' 109' ' ' ASN . 0.1 OUTLIER -70.87 72.16 0.55 Allowed 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 114.46 -1.246 . . . . 1.73 111.252 179.946 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.432 ' O ' HG21 ' A' ' 110' ' ' VAL . 13.7 m -72.28 92.49 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 CA-C-O 122.338 1.066 . . . . 1.4 108.202 175.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 . . . . . 0 N--CA 1.436 -1.135 0 CA-C-N 114.442 -1.254 . . . . 2.1 109.525 -175.072 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.89 ' CB ' HG13 ' A' ' 108' ' ' ILE . 5.9 t-80 . . . . . 0 N--CA 1.425 -1.717 0 N-CA-C 106.995 -1.483 . . . . 0.71 106.995 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -26.42 -46.28 0.07 OUTLIER 'Trans proline' 0 C--O 1.219 -0.471 0 C-N-CA 124.456 3.437 . . . . 0.47 113.592 178.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.762 HD13 ' HB ' ' A' ' 15' ' ' ILE . 42.3 tp -61.63 -51.64 67.64 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.168 0.587 . . . . 1.15 112.251 177.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 1.062 ' OH ' HG23 ' A' ' 40' ' ' ILE . 46.5 m-85 -79.74 -33.39 40.84 Favored 'General case' 0 CA--C 1.489 -1.403 0 CA-C-O 121.238 0.542 . . . . 3.33 109.789 -177.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.494 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 13.3 tt0 -56.41 -40.7 75.12 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 107.017 -1.475 . . . . 2.44 107.017 172.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.748 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 88.8 t80 -65.97 -33.91 76.9 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 114.915 -1.038 . . . . 1.08 110.203 174.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.79 ' HE1' HD13 ' A' ' 40' ' ' ILE . 2.1 ttm -75.36 -54.93 6.24 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.207 -0.451 . . . . 1.25 110.955 -168.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.483 ' HB2' ' HE2' ' A' ' 123' ' ' LYS . 0.1 OUTLIER -68.77 -26.11 65.05 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 116.13 -0.486 . . . . 1.86 110.904 178.349 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.494 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 12.6 pttp -74.95 -26.71 59.8 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 119.587 -0.845 . . . . 2.52 109.838 177.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.461 HG22 ' HG2' ' A' ' 150' ' ' PRO . 52.6 m -71.45 -57.69 4.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.832 -0.622 . . . . 1.21 111.359 177.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 42.8 tttp . . . . . 0 N--CA 1.452 -0.374 0 C-N-CA 120.181 -0.607 . . . . 2.38 112.294 -174.006 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.46 ' HB3' ' HG3' ' A' ' 156' ' ' PRO . 10.7 m-90 . . . . . 0 N--CA 1.453 -0.283 0 CA-C-O 121.51 0.671 . . . . 2.41 112.492 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.592 ' HB3' ' HB3' ' A' ' 156' ' ' PRO . 8.5 t-20 -39.46 -154.93 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.895 1.678 . . . . 2.04 112.064 157.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.665 ' CG ' HG12 ' A' ' 43' ' ' VAL . 2.2 m-85 -27.96 -44.96 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 115.66 1.726 . . . . 2.53 115.66 -166.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.753 ' HA ' ' O ' ' A' ' 154' ' ' PHE . 26.9 m 33.87 97.38 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.793 1.035 . . . . 1.24 113.793 171.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.478 ' O ' ' HA ' ' A' ' 153' ' ' ARG . 5.0 m -86.45 170.82 11.62 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.534 -1.212 . . . . 1.03 111.892 -171.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.821 ' HE2' HD22 ' A' ' 42' ' ' ASN . 88.8 m-85 -133.39 121.87 22.93 Favored 'General case' 0 CA--C 1.489 -1.366 0 N-CA-C 106.111 -1.811 . . . . 0.7 106.111 162.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.805 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 7.7 tp -79.6 104.56 10.28 Favored 'General case' 0 N--CA 1.422 -1.838 0 C-N-CA 118.089 -1.444 . . . . 1.16 108.291 178.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.741 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 47.9 mm -89.62 140.28 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.938 0 CA-C-N 112.709 -2.041 . . . . 1.05 107.731 -178.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.605 ' OD1' HG13 ' A' ' 149' ' ' VAL . 0.0 OUTLIER -91.94 -174.23 3.73 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 119.588 -0.845 . . . . 0.98 111.61 -170.276 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.693 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 35.8 mtt85 -56.28 -38.39 71.14 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 122.468 0.307 . . . . 2.61 111.556 -176.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -100.76 21.39 13.61 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.036 -1.098 . . . . 2.0 108.036 -178.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.639 ' HA2' HG21 ' A' ' 144' ' ' ILE . . . 69.31 37.45 80.3 Favored Glycine 0 N--CA 1.435 -1.388 0 CA-C-N 114.661 -1.154 . . . . 0.19 115.263 176.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.605 HG13 ' OD1' ' A' ' 145' ' ' ASP . 4.3 p -106.69 122.05 43.1 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 119.469 1.634 . . . . 1.74 110.806 171.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.608 ' HD3' HG22 ' A' ' 15' ' ' ILE . 11.6 Cg_endo -64.64 124.17 12.82 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 123.253 2.636 . . . . 0.6 111.468 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.9 m -124.54 -9.43 6.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 120.758 0.313 . . . . 2.06 110.468 -177.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.805 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 19.9 mm-40 -142.82 166.06 25.68 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 121.266 0.555 . . . . 1.17 110.861 175.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.49 ' HB2' ' CD1' ' A' ' 142' ' ' PHE . 5.8 ttm180 -148.14 135.61 20.62 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.551 -1.204 . . . . 2.9 108.849 166.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.753 ' O ' ' HA ' ' A' ' 140' ' ' THR . 97.2 m-85 -117.23 155.05 30.09 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.08 -0.711 . . . . 0.36 109.08 -169.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.448 ' HB3' ' HD2' ' A' ' 156' ' ' PRO . 22.3 m -83.22 163.04 52.22 Favored Pre-proline 0 C--N 1.316 -0.857 0 N-CA-C 109.497 -0.557 . . . . 1.45 109.497 175.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.592 ' HB3' ' HB3' ' A' ' 138' ' ' ASN . 20.1 Cg_endo -60.48 -31.13 92.1 Favored 'Trans proline' 0 CA--C 1.52 -0.176 0 C-N-CA 122.238 1.959 . . . . 0.78 110.681 174.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -68.97 -16.55 70.67 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 114.367 -1.288 . . . . 0.59 112.938 174.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -76.84 137.52 39.25 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 108.572 -0.899 . . . . 1.07 108.572 176.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.452 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 6.0 m -116.37 -177.06 3.09 Favored 'General case' 0 N--CA 1.436 -1.156 0 C-N-CA 120.48 -0.488 . . . . 1.92 110.727 -170.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.634 HG22 ' HA ' ' A' ' 56' ' ' THR . 54.9 t -42.43 -50.28 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.23 -0.895 . . . . 1.07 111.799 -178.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -68.62 -35.05 76.79 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.046 0.451 . . . . 3.89 111.081 -174.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.4 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 15.9 m-20 -69.91 -34.9 74.11 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.644 0.735 . . . . 1.4 109.737 -177.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.521 HD12 HG22 ' A' ' 56' ' ' THR . 54.8 mt -81.03 -49.1 18.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 114.797 -1.092 . . . . 1.05 111.369 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.6 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 39.3 mt-10 -52.41 -42.78 64.36 Favored 'General case' 0 C--O 1.216 -0.685 0 O-C-N 123.211 0.319 . . . . 0.67 111.082 -176.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.4 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 12.7 pt-20 -56.51 -25.73 52.42 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.418 -0.355 . . . . 0.87 111.535 -175.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.428 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 31.1 mmtp -96.84 -31.1 12.78 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.645 0.736 . . . . 2.22 109.857 176.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.6 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 14.7 tp -75.08 -48.56 23.29 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.302 -1.317 . . . . 1.04 112.149 -175.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.459 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 72.5 mt -56.31 -46.78 99.76 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.412 -0.813 . . . . 1.08 112.629 -172.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.459 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 73.4 Cg_exo -52.24 -26.02 25.52 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.233 1.956 . . . . 0.62 112.738 174.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.78 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 89.6 mt -89.92 -46.82 8.27 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 122.334 -0.228 . . . . 1.36 111.294 178.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.685 HD21 ' HG2' ' A' ' 37' ' ' PRO . 93.0 mt -59.22 -55.84 29.77 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-O 122.119 0.961 . . . . 1.07 109.874 176.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.701 0 CA-C-N 113.332 -1.758 . . . . 1.12 113.473 -174.759 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.1 t . . . . . 0 N--CA 1.452 -0.33 0 CA-C-O 121.187 0.517 . . . . 2.17 109.698 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.9 m -159.02 155.41 27.42 Favored 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 105.534 -2.024 . . . . 1.68 105.534 -176.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.778 ' HB ' HD11 ' A' ' 118' ' ' LEU . 5.9 pt -57.73 -18.91 10.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-N 115.011 -0.995 . . . . 1.16 111.805 -177.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.821 ' HB3' HG11 ' A' ' 31' ' ' VAL . 26.1 m-85 -70.16 -0.01 7.04 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.998 0.74 . . . . 0.3 112.998 -173.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -78.67 -17.09 56.48 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.429 -0.952 . . . . 2.11 108.429 177.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.612 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 39.8 m-85 -111.98 112.2 23.67 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 114.56 -1.2 . . . . 0.37 111.636 -172.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -45.21 137.02 4.76 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 113.599 -1.637 . . . . 2.86 111.072 172.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.774 HG12 ' HZ ' ' A' ' 74' ' ' PHE . 65.3 t -112.19 164.47 8.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 107.877 -1.157 . . . . 1.32 107.877 178.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.718 HD22 ' HA ' ' A' ' 27' ' ' PRO . 60.0 mt -130.85 157.68 42.22 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.692 0.282 . . . . 1.29 111.053 -177.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.515 ' HB3' ' HE3' ' A' ' 26' ' ' LYS . 20.5 t70 -85.18 172.94 10.8 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 106.795 -1.558 . . . . 1.87 106.795 163.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.695 ' HA ' ' C ' ' A' ' 105' ' ' MET . . . -62.78 -3.83 1.76 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.28 0.844 . . . . 1.2 113.28 -170.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.687 ' HB2' ' HE2' ' A' ' 26' ' ' LYS . 47.7 m-20 -117.05 17.42 14.89 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.764 -0.374 . . . . 2.34 111.526 176.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.432 ' HB2' ' O ' ' A' ' 24' ' ' ASP . 91.5 m-70 74.55 15.02 3.43 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-O 121.839 0.828 . . . . 2.26 109.17 174.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.687 ' HE2' ' HB2' ' A' ' 24' ' ' ASP . 35.2 mtmt -77.81 109.15 8.9 Favored Pre-proline 0 N--CA 1.446 -0.634 0 N-CA-C 107.367 -1.345 . . . . 4.64 107.367 169.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.718 ' HA ' HD22 ' A' ' 21' ' ' LEU . 93.7 Cg_exo -48.39 116.22 1.94 Allowed 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.503 2.135 . . . . 0.62 113.501 -171.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.799 ' OH ' ' HB3' ' A' ' 103' ' ' PRO . 0.2 OUTLIER -76.45 146.73 38.37 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 113.721 -1.581 . . . . 1.52 111.649 176.273 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.54 ' OD1' ' HB3' ' A' ' 32' ' ' GLN . 2.3 t-20 -84.9 96.69 9.42 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.171 -0.922 . . . . 2.16 109.597 175.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.682 HD12 HG21 ' A' ' 20' ' ' VAL . 61.4 tp -79.13 -45.99 18.89 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.877 -0.601 . . . . 1.07 110.914 -177.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.827 HG12 ' HE2' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -65.31 -0.08 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.435 0 CA-C-N 115.611 -0.722 . . . . 1.69 112.771 -173.594 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.54 ' HB3' ' OD1' ' A' ' 29' ' ' ASN . 3.9 pt20 -76.71 -12.49 60.0 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 119.832 -0.747 . . . . 1.31 109.323 175.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.935 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 92.8 m-70 -92.98 24.75 3.53 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 122.405 1.098 . . . . 0.35 108.685 175.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.827 ' HE2' HG12 ' A' ' 31' ' ' VAL . 36.8 mttm -77.67 109.73 11.9 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 113.419 -1.718 . . . . 2.07 109.446 170.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.35 -38.04 2.48 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 120.191 -1.004 . . . . 0.24 112.348 177.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.473 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 17.1 m -126.98 133.77 25.4 Favored Pre-proline 0 N--CA 1.437 -1.082 0 N-CA-C 108.748 -0.834 . . . . 0.74 108.748 172.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.732 ' HG3' ' CB ' ' A' ' 170' ' ' LEU . 5.3 Cg_endo -44.27 158.13 0.15 Allowed 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 124.136 3.224 . . . . 0.22 112.732 176.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.75 ' HB2' HG22 ' A' ' 70' ' ' THR . 1.0 OUTLIER -145.14 141.2 28.55 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.296 -1.372 . . . . 1.09 107.296 -179.215 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.975 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 2.2 mm? -106.38 112.96 26.2 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.838 -0.801 . . . . 1.82 108.838 178.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.694 HG13 HG13 ' A' ' 144' ' ' ILE . 1.3 mt -96.59 123.98 49.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 109.403 -0.591 . . . . 1.12 109.403 176.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.975 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.5 OUTLIER -110.68 131.2 55.26 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.433 -0.349 . . . . 1.09 110.561 -174.552 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.464 ' HB2' ' CB ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -79.1 117.53 20.22 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 105.874 -1.898 . . . . 3.11 105.874 166.598 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.835 HG13 ' HA ' ' A' ' 139' ' ' PHE . 35.0 m . . . . . 0 C--N 1.307 -1.261 0 O-C-N 120.973 -1.079 . . . . 1.69 111.603 -172.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.281 0 N-CA-C 113.713 0.245 . . . . 0.85 113.713 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.421 ' HA2' ' HB ' ' A' ' 56' ' ' THR . . . -55.58 -24.13 38.27 Favored Glycine 0 C--O 1.223 -0.562 0 C-N-CA 121.604 -0.331 . . . . 0.67 112.557 175.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.65 -50.3 69.85 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.345 -0.613 . . . . 1.2 109.345 175.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -61.85 -29.98 70.54 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.292 -0.867 . . . . 2.61 109.813 177.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.553 ' OG1' ' HA ' ' A' ' 159' ' ' SER . 67.1 m -73.6 -59.07 2.89 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 114.177 -1.374 . . . . 1.06 110.133 -175.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 1.026 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -59.13 -43.42 92.0 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.664 -1.153 . . . . 1.05 111.129 -178.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.5 ' HA ' ' CD1' ' A' ' 102' ' ' PHE . 54.3 m -55.53 -58.0 9.59 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.572 0.701 . . . . 1.08 110.599 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 86.5 m -68.25 -38.61 81.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.745 -1.116 . . . . 1.22 111.772 -176.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.734 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 16.2 mt -63.05 -48.65 77.8 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 121.499 0.666 . . . . 1.14 110.293 -177.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.861 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 10.6 t80 -59.35 -48.71 80.6 Favored 'General case' 0 C--O 1.203 -1.345 0 CA-C-N 114.718 -1.128 . . . . 0.94 110.881 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.426 HD21 ' N ' ' A' ' 62' ' ' ASN . 1.0 OUTLIER -73.52 -23.94 60.08 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 120.577 0.227 . . . . 1.6 110.686 -173.751 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.424 ' HB2' ' HE2' ' A' ' 63' ' ' LYS . 24.2 ttmm -84.4 -25.42 29.08 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 108.687 -0.857 . . . . 2.06 108.687 -177.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.698 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 44.5 m-85 -127.88 -2.21 5.92 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 115.583 1.697 . . . . 0.92 115.583 -170.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.663 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 15.0 pttp -67.26 -24.99 65.85 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 108.332 -0.988 . . . . 1.89 108.332 171.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.8 m -47.99 -38.01 16.01 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 114.035 -1.439 . . . . 1.68 110.978 173.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -86.61 -37.69 17.84 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 111.915 0.339 . . . . 1.11 111.915 174.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 149.83 -4.41 0.64 Allowed Glycine 0 N--CA 1.45 -0.367 0 N-CA-C 111.265 -0.734 . . . . 0.2 111.265 -177.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.734 ' HE2' ' HB3' ' A' ' 60' ' ' LEU . 22.9 t80 -67.6 141.36 56.81 Favored 'General case' 0 C--O 1.22 -0.461 0 C-N-CA 122.794 0.437 . . . . 0.21 111.323 -178.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.935 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 1.5 t -135.92 144.56 45.55 Favored 'General case' 0 CA--C 1.487 -1.476 0 N-CA-C 109.016 -0.735 . . . . 1.02 109.016 173.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 1.026 HG11 ' HB1' ' A' ' 57' ' ' ALA . 38.6 t -104.07 101.37 12.17 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.199 0 N-CA-C 108.613 -0.884 . . . . 1.04 108.613 160.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.627 ' HA ' ' HG2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -96.11 121.66 38.11 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 118.475 -1.29 . . . . 1.69 108.113 173.174 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 1.001 ' HB2' HD13 ' A' ' 104' ' ' ILE . . . -108.64 140.05 42.57 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.405 0.621 . . . . 1.17 110.351 179.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.816 ' CG ' ' HG2' ' A' ' 105' ' ' MET . 6.4 m-30 -115.31 110.39 45.36 Favored Pre-proline 0 C--N 1.311 -1.091 0 CA-C-N 115.507 -0.77 . . . . 0.58 109.234 -177.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.701 ' HG2' ' HB3' ' A' ' 107' ' ' LYS . 60.4 Cg_endo -78.18 46.58 2.13 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.567 2.844 . . . . 1.3 115.454 -164.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.482 ' O ' ' HD3' ' A' ' 107' ' ' LYS . 73.6 p . . . . . 0 N--CA 1.478 0.967 0 N-CA-C 117.215 2.302 . . . . 1.91 117.215 176.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.511 -0.536 0 CA-C-O 121.226 0.536 . . . . 1.15 111.826 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -85.33 8.74 17.59 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.166 -0.925 . . . . 1.99 109.876 175.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.594 ' HB2' ' O ' ' A' ' 71' ' ' VAL . 16.9 p90 -138.81 161.22 59.53 Favored Pre-proline 0 N--CA 1.442 -0.842 0 CA-C-N 115.588 -0.733 . . . . 1.31 109.619 -178.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.799 ' HB3' ' OH ' ' A' ' 28' ' ' TYR . 18.2 Cg_endo -57.41 110.98 0.69 Allowed 'Trans proline' 0 CA--C 1.51 -0.701 0 C-N-CA 124.122 3.215 . . . . 1.07 114.1 -175.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 1.001 HD13 ' HB2' ' A' ' 73' ' ' ALA . 7.0 mm -108.56 134.24 51.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 C-N-CA 119.925 -0.71 . . . . 1.97 109.227 172.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.816 ' HG2' ' CG ' ' A' ' 74' ' ' PHE . 0.0 OUTLIER -89.54 -177.08 5.22 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.988 -0.551 . . . . 3.41 109.657 179.577 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.686 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . . . -57.25 -51.53 68.97 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.241 0.544 . . . . 1.46 110.418 -177.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.701 ' HB3' ' HG2' ' A' ' 75' ' ' PRO . 13.9 ptpt 128.57 121.96 0.0 OUTLIER 'General case' 0 CA--C 1.492 -1.28 0 C-N-CA 127.407 2.283 . . . . 2.31 106.036 -176.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.634 HD12 ' HD2' ' A' ' 74' ' ' PHE . 2.1 pp -129.41 156.58 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.242 0 N-CA-C 106.161 -1.792 . . . . 1.65 106.161 177.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -52.06 117.82 3.04 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 123.696 0.623 . . . . 1.73 109.942 -179.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.464 ' CB ' ' HB2' ' A' ' 42' ' ' ASN . 3.5 m -113.67 86.83 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.621 0 N-CA-C 107.625 -1.25 . . . . 1.4 107.625 169.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 . . . . . 0 N--CA 1.445 -0.704 0 CA-C-N 113.844 -1.525 . . . . 2.1 109.435 -178.519 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.659 ' ND1' ' H ' ' A' ' 118' ' ' LEU . 6.4 t-80 . . . . . 0 N--CA 1.419 -2.006 0 N-CA-C 107.166 -1.42 . . . . 0.71 107.166 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.562 ' HB2' ' CD1' ' A' ' 18' ' ' PHE . 11.5 Cg_exo -33.9 -41.35 0.2 Allowed 'Trans proline' 0 C--O 1.218 -0.483 0 C-N-CA 123.872 3.048 . . . . 0.47 113.099 -178.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.778 HD11 ' HB ' ' A' ' 15' ' ' ILE . 33.5 tp -63.65 -48.53 76.86 Favored 'General case' 0 C--O 1.222 -0.369 0 C-N-CA 123.208 0.603 . . . . 1.15 111.726 176.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.67 ' OH ' HG21 ' A' ' 40' ' ' ILE . 23.3 m-85 -78.04 -34.36 50.59 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 111.944 0.35 . . . . 3.33 111.944 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.491 ' HA ' ' HD2' ' A' ' 123' ' ' LYS . 0.8 OUTLIER -60.32 -35.82 76.51 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 106.809 -1.552 . . . . 2.44 106.809 171.617 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.612 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 55.1 t80 -70.29 -30.69 67.76 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 119.525 -0.87 . . . . 1.08 110.051 173.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.67 ' HB2' ' HA ' ' A' ' 119' ' ' TYR . 1.5 ttm -76.15 -54.58 6.6 Favored 'General case' 0 CA--C 1.509 -0.616 0 C-N-CA 120.388 -0.525 . . . . 1.25 110.479 -169.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.62 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -70.78 -25.43 62.89 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.297 -0.41 . . . . 1.86 111.437 179.398 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.521 ' N ' ' HD3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -71.67 -29.0 64.12 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 119.552 -0.859 . . . . 2.52 109.609 178.244 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 27.1 m -92.21 -24.94 18.88 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.571 -0.741 . . . . 1.21 111.52 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.49 ' HE2' ' HA ' ' A' ' 151' ' ' VAL . 23.5 mmtm . . . . . 0 C--N 1.325 -0.472 0 N-CA-C 112.387 0.514 . . . . 2.38 112.387 -173.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.656 ' HB3' ' HG3' ' A' ' 156' ' ' PRO . 0.7 OUTLIER . . . . . 0 CA--C 1.52 -0.208 0 CA-C-O 120.516 0.198 . . . . 2.41 111.122 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.477 ' O ' ' N ' ' A' ' 140' ' ' THR . 12.7 m120 -35.56 -153.6 0.0 OUTLIER 'General case' 0 C--O 1.207 -1.168 0 CA-C-N 114.527 -1.215 . . . . 2.04 112.409 155.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.835 ' HA ' HG13 ' A' ' 43' ' ' VAL . 0.9 OUTLIER -29.65 -21.97 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 117.495 2.406 . . . . 2.53 117.495 -172.162 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.667 ' HA ' ' O ' ' A' ' 154' ' ' PHE . 0.2 OUTLIER -7.58 120.32 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 120.141 1.337 . . . . 1.24 114.559 173.948 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.575 ' O ' ' HA ' ' A' ' 153' ' ' ARG . 1.0 OUTLIER -104.9 163.63 12.38 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.33 -1.305 . . . . 1.03 111.101 -167.971 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.516 ' HA ' ' O ' ' A' ' 152' ' ' GLU . 97.4 m-85 -125.1 123.24 39.3 Favored 'General case' 0 CA--C 1.491 -1.32 0 N-CA-C 106.28 -1.748 . . . . 0.7 106.28 166.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.737 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 5.0 tp -79.46 102.25 8.66 Favored 'General case' 0 N--CA 1.425 -1.713 0 C-N-CA 118.242 -1.383 . . . . 1.16 108.157 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.697 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 39.1 mm -88.24 141.4 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 CA-C-N 113.8 -1.546 . . . . 1.05 107.611 -177.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.429 ' HA ' HD12 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -95.81 -174.83 3.24 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 119.359 -0.936 . . . . 0.98 111.234 -168.377 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.508 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 57.0 mtm180 -55.13 -40.11 70.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.818 0.342 . . . . 2.61 111.619 -176.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -92.44 14.39 16.79 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 109.443 -0.577 . . . . 2.0 109.443 -178.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.541 ' HA2' HG22 ' A' ' 144' ' ' ILE . . . 73.6 33.87 57.64 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 121.211 -0.519 . . . . 0.19 113.601 -178.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.437 ' HA ' ' HD2' ' A' ' 150' ' ' PRO . 31.7 t -107.41 107.39 60.33 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 117.961 0.88 . . . . 1.74 111.239 176.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.676 ' HD3' HG23 ' A' ' 15' ' ' ILE . 5.9 Cg_exo -47.4 125.3 10.49 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 123.888 3.059 . . . . 0.6 112.158 173.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.49 ' HA ' ' HE2' ' A' ' 126' ' ' LYS . 44.2 t -116.13 -37.12 2.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 109.046 -0.724 . . . . 2.06 109.046 -177.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.737 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 6.8 mm-40 -130.86 167.07 19.55 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 115.612 -0.722 . . . . 1.17 111.665 -175.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.575 ' HA ' ' O ' ' A' ' 141' ' ' SER . 20.4 ttm180 -138.87 133.07 31.47 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.022 -0.99 . . . . 2.9 109.655 165.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.667 ' O ' ' HA ' ' A' ' 140' ' ' THR . 96.3 m-85 -117.03 137.25 52.37 Favored 'General case' 0 C--O 1.213 -0.837 0 CA-C-N 116.336 -0.393 . . . . 0.36 109.982 -172.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.565 ' HA ' HG21 ' A' ' 140' ' ' THR . 37.4 m -67.13 153.43 94.63 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 109.381 -0.6 . . . . 1.45 109.381 179.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.656 ' HG3' ' HB3' ' A' ' 137' ' ' TRP . 10.0 Cg_endo -53.26 -48.27 22.94 Favored 'Trans proline' 0 N--CA 1.473 0.272 0 C-N-CA 122.647 2.232 . . . . 0.78 112.732 -174.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -67.05 10.34 0.84 Allowed Glycine 0 CA--C 1.527 0.841 0 N-CA-C 114.937 0.735 . . . . 0.59 114.937 176.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -74.45 146.21 43.02 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-N 118.481 1.141 . . . . 1.07 108.669 171.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.553 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 90.9 p -102.61 171.61 7.33 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 120.513 -0.475 . . . . 1.92 109.864 -174.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.527 ' CG2' ' HA ' ' A' ' 56' ' ' THR . 58.3 t -42.28 -48.97 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 O-C-N 124.202 0.939 . . . . 1.07 110.767 175.077 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.414 ' HB2' ' HE3' ' A' ' 161' ' ' LYS . 37.2 ttmt -71.75 -31.89 67.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.429 -0.805 . . . . 3.89 111.249 -172.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -67.03 -38.0 85.13 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.565 0.698 . . . . 1.4 109.634 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.54 HD13 ' CG2' ' A' ' 56' ' ' THR . 73.8 mt -82.3 -39.8 16.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 114.903 -1.044 . . . . 1.05 111.022 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.554 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 30.2 mt-10 -53.4 -44.54 68.76 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-O 120.503 0.192 . . . . 0.67 111.478 -178.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -57.15 -24.8 56.79 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.956 0.354 . . . . 0.87 111.956 -174.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.635 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 44.0 mmtm -98.15 -24.86 15.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.532 0.682 . . . . 2.22 109.987 175.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.554 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 10.0 tp -78.4 -50.09 12.35 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.97 -1.014 . . . . 1.04 112.353 -177.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.471 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 70.6 mt -55.61 -46.63 99.7 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 115.499 -0.773 . . . . 1.08 112.352 -173.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.471 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 53.3 Cg_exo -54.92 -26.76 50.36 Favored 'Trans proline' 0 C--N 1.356 0.921 0 C-N-CA 122.128 1.885 . . . . 0.62 112.669 174.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.732 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 62.4 mt -86.32 -42.48 13.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.725 -0.216 . . . . 1.36 111.267 177.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.665 HD22 ' HG2' ' A' ' 37' ' ' PRO . 97.3 mt -60.04 -54.11 49.84 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 122.127 0.965 . . . . 1.07 109.53 176.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.106 0 CA-C-N 113.365 -1.743 . . . . 1.12 113.142 179.981 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 43.6 t . . . . . 0 C--O 1.235 0.307 0 CA-C-O 120.993 0.425 . . . . 2.17 110.22 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 91.4 p 178.52 157.98 0.49 Allowed 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 105.823 -1.918 . . . . 1.68 105.823 -177.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.8 HG21 ' HD3' ' A' ' 150' ' ' PRO . 6.7 pt -67.66 -17.63 22.72 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 CA-C-N 114.949 -1.023 . . . . 1.16 110.745 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.809 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 45.9 m-85 -74.74 -3.48 31.78 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 116.113 -0.494 . . . . 0.3 111.607 -176.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -67.14 -12.59 60.41 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.991 -1.114 . . . . 2.11 107.991 170.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.576 ' HE2' ' HB2' ' A' ' 121' ' ' TYR . 61.1 m-85 -129.07 109.81 11.5 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 114.794 -1.094 . . . . 0.37 110.007 -175.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -55.98 157.64 4.36 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 114.116 -1.402 . . . . 2.86 109.488 174.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.763 HG12 ' CZ ' ' A' ' 74' ' ' PHE . 40.4 t -109.65 161.02 8.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 107.792 -1.188 . . . . 1.32 107.792 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.827 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 55.2 mt -126.09 122.49 35.91 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 120.552 -0.459 . . . . 1.29 109.901 -178.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.61 ' HA ' ' SD ' ' A' ' 105' ' ' MET . 0.8 OUTLIER -59.44 -175.85 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.387 0 O-C-N 124.31 1.006 . . . . 1.87 109.469 -179.179 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.676 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . . . -62.19 -3.93 1.52 Allowed 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 113.19 0.811 . . . . 1.2 113.19 -171.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -118.68 12.64 13.12 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.505 -0.478 . . . . 2.34 111.73 175.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.827 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 6.3 m170 72.3 26.06 2.74 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.677 0.751 . . . . 2.26 110.266 174.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 26' ' ' LYS . 54.2 mmtt -102.5 133.21 20.65 Favored Pre-proline 0 N--CA 1.448 -0.533 0 CA-C-N 114.618 -1.174 . . . . 4.64 107.879 171.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.651 ' HA ' HD23 ' A' ' 21' ' ' LEU . 83.5 Cg_exo -51.38 112.8 0.89 Allowed 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.111 1.874 . . . . 0.62 114.208 -166.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.77 ' CE2' HD23 ' A' ' 72' ' ' LEU . 50.0 t80 -83.58 126.0 32.37 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 113.79 -1.55 . . . . 1.52 108.617 165.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.536 HD22 ' NE2' ' A' ' 32' ' ' GLN . 0.1 OUTLIER -67.67 82.0 0.18 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.911 0.862 . . . . 2.16 110.848 -178.068 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.76 ' HB2' HG23 ' A' ' 20' ' ' VAL . 44.5 tp -51.98 -37.76 54.22 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.536 -0.756 . . . . 1.07 109.653 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.664 HG11 ' HB3' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -67.75 0.13 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 114.687 -1.142 . . . . 1.69 113.0 -173.857 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.536 ' NE2' HD22 ' A' ' 29' ' ' ASN . 3.4 pt20 -72.7 -18.87 61.5 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 119.815 -0.754 . . . . 1.31 108.968 173.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.921 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 79.4 m-70 -92.33 29.86 1.6 Allowed 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 115.497 -0.774 . . . . 0.35 109.749 175.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.809 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 29.0 mtmt -92.35 111.04 22.47 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 114.896 -1.047 . . . . 2.07 109.584 173.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.94 -38.14 2.03 Favored Glycine 0 N--CA 1.443 -0.899 0 N-CA-C 110.759 -0.936 . . . . 0.24 110.759 -177.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.0 m -132.24 136.03 27.42 Favored Pre-proline 0 N--CA 1.435 -1.202 0 N-CA-C 109.127 -0.694 . . . . 0.74 109.127 169.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.685 ' O ' ' HA ' ' A' ' 69' ' ' PHE . 10.3 Cg_endo -47.42 156.83 0.9 Allowed 'Trans proline' 0 CA--C 1.511 -0.651 0 C-N-CA 124.481 3.454 . . . . 0.22 113.499 178.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.787 HD22 ' HB2' ' A' ' 33' ' ' HIS . 0.9 OUTLIER -133.65 152.06 51.8 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 106.978 -1.49 . . . . 1.09 106.978 173.4 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.83 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 1.6 mm? -110.82 117.23 32.84 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.896 -1.15 . . . . 1.82 107.896 174.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 1.02 HD12 ' HE3' ' A' ' 122' ' ' MET . 9.1 mt -98.92 119.05 46.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 C-N-CA 119.714 -0.795 . . . . 1.12 110.195 178.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.83 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -105.11 127.29 52.83 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.469 -0.787 . . . . 1.09 109.916 -176.239 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.554 ' HB2' ' CG1' ' A' ' 110' ' ' VAL . 0.0 OUTLIER -78.39 104.93 9.31 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 106.233 -1.765 . . . . 3.11 106.233 165.81 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.549 ' HB ' ' CE1' ' A' ' 139' ' ' PHE . 4.5 m . . . . . 0 C--N 1.308 -1.21 0 C-N-CA 118.986 -1.086 . . . . 1.69 111.32 -171.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.524 0 N-CA-C 110.472 -1.051 . . . . 0.85 110.472 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -45.96 -41.12 10.31 Favored Glycine 0 C--O 1.216 -1.03 0 CA-C-N 114.635 -0.782 . . . . 0.67 113.132 176.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -64.82 -52.2 58.05 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.948 0.404 . . . . 1.2 111.006 -178.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -63.29 -29.15 70.53 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.711 -0.677 . . . . 2.61 109.984 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.874 HG22 HD12 ' A' ' 163' ' ' ILE . 87.7 m -75.14 -55.74 5.43 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.207 -0.906 . . . . 1.06 109.159 -179.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 1.028 ' HB3' HG11 ' A' ' 71' ' ' VAL . . . -54.1 -43.93 70.8 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.58 -1.191 . . . . 1.05 111.379 -178.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.454 ' HA ' ' CD1' ' A' ' 102' ' ' PHE . 30.3 m -61.68 -54.5 41.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.395 0.617 . . . . 1.08 110.142 -177.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.7 m -68.34 -35.61 78.03 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.235 -0.893 . . . . 1.22 111.591 -176.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.737 HD21 ' HA ' ' A' ' 160' ' ' VAL . 0.6 OUTLIER -63.83 -52.82 58.39 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-O 121.774 0.797 . . . . 1.14 110.162 -176.822 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.888 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 8.1 t80 -55.31 -49.19 72.8 Favored 'General case' 0 C--O 1.204 -1.337 0 CA-C-N 113.83 -1.532 . . . . 0.94 110.597 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.838 ' HA ' ' HE2' ' A' ' 65' ' ' LYS . 28.7 m-80 -72.97 -24.71 60.82 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 116.638 -0.255 . . . . 1.6 110.632 -173.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.402 ' HD2' ' CE2' ' A' ' 64' ' ' TYR . 39.2 ttmt -81.47 -29.59 33.68 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 108.674 -0.862 . . . . 2.06 108.674 -178.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.64 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 42.3 m-85 -125.5 -2.97 7.37 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 116.185 1.92 . . . . 0.92 116.185 -168.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.838 ' HE2' ' HA ' ' A' ' 62' ' ' ASN . 47.3 pttt -65.25 -24.94 67.46 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 107.906 -1.146 . . . . 1.89 107.906 170.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.5 t -48.63 -38.91 22.25 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 113.882 -1.508 . . . . 1.68 110.483 172.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -86.53 -36.13 19.13 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 111.818 0.303 . . . . 1.11 111.818 173.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 149.4 -7.47 0.84 Allowed Glycine 0 CA--C 1.521 0.408 0 N-CA-C 111.888 -0.485 . . . . 0.2 111.888 -175.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.718 ' HE2' ' HB3' ' A' ' 60' ' ' LEU . 17.9 t80 -65.34 142.47 58.22 Favored 'General case' 0 C--O 1.22 -0.45 0 C-N-CA 123.036 0.534 . . . . 0.21 111.586 -177.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.921 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 1.6 t -133.9 147.75 51.15 Favored 'General case' 0 N--CA 1.423 -1.799 0 N-CA-C 108.521 -0.918 . . . . 1.02 108.521 170.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 1.028 HG11 ' HB3' ' A' ' 57' ' ' ALA . 36.5 t -98.93 101.9 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.734 0 N-CA-C 107.832 -1.173 . . . . 1.04 107.832 158.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.77 HD23 ' CE2' ' A' ' 28' ' ' TYR . 6.3 mt -83.69 119.56 24.93 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 108.051 -1.092 . . . . 1.69 108.051 177.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.477 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -95.84 111.22 23.25 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.401 -0.592 . . . . 1.17 109.401 177.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.992 ' HD2' HD13 ' A' ' 108' ' ' ILE . 3.3 m-85 -101.18 91.95 2.28 Favored Pre-proline 0 C--N 1.312 -1.026 0 N-CA-C 107.386 -1.338 . . . . 0.58 107.386 172.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.637 ' HG2' ' HB3' ' A' ' 107' ' ' LYS . 80.8 Cg_endo -77.11 77.72 3.7 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.854 2.369 . . . . 1.3 114.626 -166.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.483 ' OG ' HG21 ' A' ' 110' ' ' VAL . 14.6 m . . . . . 0 C--N 1.32 -0.675 0 C-N-CA 126.744 2.018 . . . . 1.91 116.185 -178.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.515 ' HB1' HD12 ' A' ' 104' ' ' ILE . . . . . . . . 0 CA--C 1.514 -0.422 0 CA-C-O 120.546 0.212 . . . . 1.15 110.634 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -91.2 -20.69 21.69 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.195 -0.457 . . . . 1.99 111.1 173.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.717 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 0.7 OUTLIER -89.52 175.04 4.21 Favored Pre-proline 0 N--CA 1.443 -0.784 0 CA-C-N 116.476 -0.329 . . . . 1.31 110.373 -177.513 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.717 ' HD2' ' HB2' ' A' ' 102' ' ' PHE . 70.7 Cg_endo -69.29 103.56 1.1 Allowed 'Trans proline' 0 C--N 1.336 -0.093 0 C-N-CA 122.818 2.345 . . . . 1.07 112.381 178.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.515 HD12 ' HB1' ' A' ' 100' ' ' ALA . 3.9 mp -101.1 120.75 51.07 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.018 0 N-CA-C 107.684 -1.228 . . . . 1.97 107.684 175.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.76 ' HG3' ' CE1' ' A' ' 74' ' ' PHE . 27.3 mmt -87.33 -164.54 1.1 Allowed 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.992 -1.004 . . . . 3.41 111.494 -169.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.676 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . . . -68.58 -16.22 63.79 Favored 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 120.315 -0.554 . . . . 1.46 111.07 -172.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.637 ' HB3' ' HG2' ' A' ' 75' ' ' PRO . 10.5 ptpt 81.1 139.68 0.07 Allowed 'General case' 0 CA--C 1.493 -1.215 0 O-C-N 125.71 1.881 . . . . 2.31 108.397 -163.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.992 HD13 ' HD2' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -131.26 159.84 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.599 0 N-CA-C 104.785 -2.302 . . . . 1.65 104.785 169.604 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -64.48 80.53 0.04 OUTLIER 'General case' 0 C--N 1.287 -2.148 0 O-C-N 123.603 0.564 . . . . 1.73 110.427 177.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.836 ' HA ' ' OH ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -78.81 90.38 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 C-N-CA 118.701 -1.2 . . . . 1.4 108.2 -179.711 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.443 ' N ' ' OH ' ' A' ' 119' ' ' TYR . 2.1 t-20 . . . . . 0 N--CA 1.441 -0.889 0 CA-C-N 113.354 -1.748 . . . . 2.1 107.499 178.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.647 ' CB ' HG13 ' A' ' 108' ' ' ILE . 8.6 t-80 . . . . . 0 N--CA 1.418 -2.026 0 N-CA-C 107.542 -1.281 . . . . 0.71 107.542 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.571 ' HB2' ' CD1' ' A' ' 18' ' ' PHE . 5.4 Cg_exo -33.43 -37.72 0.1 OUTLIER 'Trans proline' 0 C--O 1.214 -0.717 1 C-N-CA 125.403 4.068 . . . . 0.47 114.064 -172.905 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.746 ' CD1' ' HB ' ' A' ' 15' ' ' ILE . 7.5 tp -63.5 -60.32 3.5 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 114.046 1.128 . . . . 1.15 114.046 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.836 ' OH ' ' HA ' ' A' ' 110' ' ' VAL . 3.8 p90 -82.7 -25.82 32.61 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 107.486 -1.302 . . . . 3.33 107.486 -177.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.591 ' HA ' ' HD2' ' A' ' 123' ' ' LYS . 1.9 tm-20 -59.25 -39.86 84.14 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.334 -1.358 . . . . 2.44 107.334 172.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.599 ' O ' ' HG3' ' A' ' 124' ' ' LYS . 29.6 t80 -64.21 -29.3 70.41 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.007 -0.997 . . . . 1.08 110.145 169.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 1.02 ' HE3' HD12 ' A' ' 40' ' ' ILE . 66.9 mtt -73.4 -55.3 6.55 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 121.134 0.493 . . . . 1.25 110.797 -173.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.695 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -70.45 -22.49 62.69 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.154 -0.93 . . . . 1.86 110.817 177.754 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.599 ' HG3' ' O ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -73.37 -26.3 60.95 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 119.636 -0.826 . . . . 2.52 109.502 171.318 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 93.2 m -74.87 -55.91 5.31 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.221 0.534 . . . . 1.21 110.06 173.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.696 ' HG2' ' NH2' ' A' ' 153' ' ' ARG . 22.7 ttmm . . . . . 0 C--N 1.325 -0.493 0 CA-C-N 115.669 -0.696 . . . . 2.38 109.424 177.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.754 ' HB3' ' HG3' ' A' ' 156' ' ' PRO . 6.8 m-90 . . . . . 0 CA--C 1.519 -0.219 0 CA-C-O 121.01 0.433 . . . . 2.41 111.78 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.482 ' O ' ' N ' ' A' ' 140' ' ' THR . 10.7 t-20 -39.5 -155.32 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 113.852 -1.522 . . . . 2.04 111.37 157.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.588 ' HD2' ' HD2' ' A' ' 41' ' ' TYR . 1.6 m-85 -29.12 -25.06 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 117.924 2.565 . . . . 2.53 117.924 -171.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.704 ' HA ' ' O ' ' A' ' 154' ' ' PHE . 29.5 m -0.6 105.96 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 114.472 1.286 . . . . 1.24 114.472 175.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.433 ' CB ' HD12 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -86.12 170.33 12.3 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.167 -1.378 . . . . 1.03 110.302 -172.912 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.473 ' O ' HD11 ' A' ' 39' ' ' LEU . 86.7 m-85 -127.68 127.47 43.79 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 105.803 -1.925 . . . . 0.7 105.803 164.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.819 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 9.1 tp -80.55 104.71 11.26 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 118.238 -1.385 . . . . 1.16 108.534 176.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.757 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 41.7 mm -93.6 141.0 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.929 0 CA-C-N 113.746 -1.57 . . . . 1.05 107.154 -177.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.688 ' HA ' HD13 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -92.39 178.18 5.91 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 120.508 -0.477 . . . . 0.98 111.518 -171.736 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.451 ' N ' ' CG ' ' A' ' 145' ' ' ASP . 66.8 mtm180 -48.71 -46.39 40.59 Favored 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 123.135 0.574 . . . . 2.61 111.494 -178.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -96.41 24.04 6.21 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.187 -0.672 . . . . 2.0 109.187 -178.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.531 ' HA2' ' CG2' ' A' ' 144' ' ' ILE . . . 71.68 42.6 53.94 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.083 -0.962 . . . . 0.19 113.789 175.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.469 ' O ' HG23 ' A' ' 151' ' ' VAL . 49.9 t -103.87 114.85 64.23 Favored Pre-proline 0 C--N 1.311 -1.074 0 C-N-CA 119.631 -0.828 . . . . 1.74 110.882 177.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.8 ' HD3' HG21 ' A' ' 15' ' ' ILE . 21.6 Cg_endo -67.02 113.06 2.68 Favored 'Trans proline' 0 CA--C 1.529 0.27 0 C-N-CA 122.998 2.465 . . . . 0.6 110.251 176.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 149' ' ' VAL . 16.3 t -113.66 -28.06 2.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-O 121.398 0.618 . . . . 2.06 109.788 -173.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.819 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 17.3 mm-40 -137.37 168.24 20.03 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 115.077 -0.965 . . . . 1.17 110.423 -177.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.696 ' NH2' ' HG2' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -145.92 137.71 25.1 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 114.59 -1.187 . . . . 2.9 108.901 161.729 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.714 ' HZ ' ' HB2' ' A' ' 166' ' ' LYS . 94.0 m-85 -112.25 145.56 39.72 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.126 -0.488 . . . . 0.36 110.161 -170.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 10.2 m -63.79 152.12 87.41 Favored Pre-proline 0 C--N 1.317 -0.842 0 N-CA-C 109.345 -0.613 . . . . 1.45 109.345 175.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.754 ' HG3' ' HB3' ' A' ' 137' ' ' TRP . 43.8 Cg_endo -66.69 -22.88 49.62 Favored 'Trans proline' 0 CA--C 1.512 -0.585 0 C-N-CA 122.28 1.987 . . . . 0.78 110.7 178.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -85.38 13.73 53.92 Favored Glycine 0 N--CA 1.44 -1.085 0 CA-C-N 114.773 -1.103 . . . . 0.59 112.87 173.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -87.63 149.83 24.04 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.225 -0.657 . . . . 1.07 109.225 172.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.482 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 17.5 m -108.66 171.99 7.1 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 121.181 0.515 . . . . 1.92 111.526 -174.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.771 ' HA ' HG23 ' A' ' 56' ' ' THR . 52.0 t -39.07 -55.74 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 114.463 -1.244 . . . . 1.07 111.853 176.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -64.56 -31.87 73.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.472 -0.786 . . . . 3.89 111.567 -174.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.431 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 23.6 m-20 -75.75 -32.62 60.05 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.24 -0.891 . . . . 1.4 110.305 -173.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.874 HD12 HG22 ' A' ' 56' ' ' THR . 57.3 mt -83.3 -44.48 18.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.234 -0.894 . . . . 1.05 110.913 177.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.564 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 37.9 mt-10 -54.31 -40.44 67.96 Favored 'General case' 0 C--O 1.218 -0.575 0 CA-C-N 116.613 -0.267 . . . . 0.67 111.506 -178.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 9.2 pt-20 -56.9 -27.24 60.52 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 112.1 0.407 . . . . 0.87 112.1 -177.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.714 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 46.2 mmtm -96.69 -26.04 15.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.394 0.616 . . . . 2.22 110.276 175.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.564 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 12.1 tp -76.96 -49.49 15.38 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.068 -0.969 . . . . 1.04 112.031 -177.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.513 HG13 ' O ' ' A' ' 164' ' ' GLU . 81.8 mt -53.29 -44.82 98.21 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-N 115.511 -0.768 . . . . 1.08 112.165 -174.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.41 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 85.5 Cg_exo -50.37 -39.35 53.78 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.133 1.889 . . . . 0.62 112.917 172.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.688 HD13 ' HA ' ' A' ' 145' ' ' ASP . 96.0 mt -79.34 -43.52 23.37 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.728 -0.389 . . . . 1.36 111.284 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.612 HD22 ' HB2' ' A' ' 69' ' ' PHE . 95.7 mt -57.93 -54.11 50.58 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 122.083 0.944 . . . . 1.07 109.674 176.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.235 0 CA-C-N 113.297 -1.774 . . . . 1.12 113.397 -177.995 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.2 t . . . . . 0 CA--C 1.533 0.289 0 CA-C-O 121.307 0.575 . . . . 2.17 109.853 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 65.5 p 179.05 152.34 0.36 Allowed 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 105.47 -2.048 . . . . 1.68 105.47 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.778 HD12 HD22 ' A' ' 30' ' ' LEU . 5.6 pt -64.99 -12.95 14.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-N 115.061 -0.972 . . . . 1.16 112.187 -171.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.755 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 43.6 m-85 -75.44 0.96 15.24 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.378 0.51 . . . . 0.3 112.378 -175.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -73.43 -19.26 61.01 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 108.242 -1.021 . . . . 2.11 108.242 174.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.677 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 57.1 m-85 -111.34 107.34 16.57 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 114.628 -1.169 . . . . 0.37 111.045 -174.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -51.07 140.96 14.91 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 113.843 -1.526 . . . . 2.86 109.03 174.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.786 HG12 ' HZ ' ' A' ' 74' ' ' PHE . 40.3 t -110.32 166.27 5.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 108.118 -1.067 . . . . 1.32 108.118 -177.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.7 ' O ' ' HB2' ' A' ' 105' ' ' MET . 24.7 mt -127.0 143.61 51.25 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.884 -0.413 . . . . 1.29 109.884 179.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.445 ' OD2' ' HE2' ' A' ' 26' ' ' LYS . 18.6 m-20 -77.59 177.37 8.13 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 106.742 -1.577 . . . . 1.87 106.742 165.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.743 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . . . -64.39 -5.25 4.89 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 113.068 0.766 . . . . 1.2 113.068 -171.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.862 ' HB2' ' HG2' ' A' ' 26' ' ' LYS . 15.8 m-20 -94.66 -8.1 38.88 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 111.591 0.219 . . . . 2.34 111.591 178.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.546 ' HB2' ' O ' ' A' ' 24' ' ' ASP . 49.0 m-70 80.8 -0.66 1.83 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.506 0.723 . . . . 2.26 109.829 -175.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.862 ' HG2' ' HB2' ' A' ' 24' ' ' ASP . 6.4 ptmt -67.1 120.0 68.77 Favored Pre-proline 0 N--CA 1.45 -0.472 0 N-CA-C 108.158 -1.053 . . . . 4.64 108.158 165.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.678 ' HA ' HD23 ' A' ' 21' ' ' LEU . 90.0 Cg_exo -50.26 116.54 2.54 Favored 'Trans proline' 0 N--CA 1.465 -0.19 0 C-N-CA 122.638 2.225 . . . . 0.62 113.828 -175.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.874 ' HE2' HD22 ' A' ' 72' ' ' LEU . 15.0 t80 -79.74 143.66 34.32 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 113.865 -1.516 . . . . 1.52 111.212 174.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.497 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.7 t-20 -80.72 82.47 6.71 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.085 -0.962 . . . . 2.16 109.931 178.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.778 HD22 HD12 ' A' ' 15' ' ' ILE . 59.2 tp -57.91 -41.33 82.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.302 0.572 . . . . 1.07 109.784 177.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.682 HG11 ' HG3' ' A' ' 34' ' ' LYS . 2.0 t -68.16 -3.72 2.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 114.638 -1.165 . . . . 1.69 112.256 -170.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.497 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 3.4 pt20 -70.18 -17.25 63.16 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.919 -0.771 . . . . 1.31 108.919 175.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.899 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 92.4 m-70 -92.68 23.58 4.01 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.318 -0.855 . . . . 0.35 109.644 177.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.755 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 10.1 mtmt -81.99 121.76 26.93 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 114.639 -1.164 . . . . 2.07 109.335 168.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.42 -42.05 1.89 Allowed Glycine 0 N--CA 1.436 -1.31 0 C-N-CA 120.633 -0.794 . . . . 0.24 111.67 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.492 ' HB2' ' HA3' ' A' ' 68' ' ' GLY . 19.3 m -128.69 127.86 23.52 Favored Pre-proline 0 N--CA 1.435 -1.183 0 N-CA-C 108.462 -0.94 . . . . 0.74 108.462 173.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.807 ' HG3' ' CB ' ' A' ' 170' ' ' LEU . 4.9 Cg_endo -42.74 152.61 0.18 Allowed 'Trans proline' 0 CA--C 1.508 -0.777 0 C-N-CA 124.401 3.401 . . . . 0.22 113.205 178.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.862 HD13 ' HB2' ' A' ' 33' ' ' HIS . 0.9 OUTLIER -137.5 142.33 41.47 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.052 -1.431 . . . . 1.09 107.361 -178.341 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.967 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 1.8 mm? -107.79 114.78 28.98 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.473 -0.936 . . . . 1.82 108.473 176.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.784 HG21 HD11 ' A' ' 72' ' ' LEU . 1.1 mt -95.38 127.99 46.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 C-N-CA 119.81 -0.756 . . . . 1.12 109.647 177.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.967 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 1.1 m-85 -112.47 124.43 52.48 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.215 -0.448 . . . . 1.09 110.435 -175.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.63 HD21 ' HB ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -83.01 92.54 7.39 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 107.31 -1.367 . . . . 3.11 107.31 173.691 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.774 HG21 ' HB3' ' A' ' 139' ' ' PHE . 11.1 p . . . . . 0 C--N 1.312 -1.026 0 CA-C-O 121.02 0.438 . . . . 1.69 111.394 -161.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.869 0 N-CA-C 111.388 -0.685 . . . . 0.85 111.388 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.539 ' HA2' ' HB ' ' A' ' 56' ' ' THR . . . -61.98 -19.12 58.56 Favored Glycine 0 C--O 1.22 -0.746 0 CA-C-O 119.688 -0.506 . . . . 0.67 114.359 -177.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -77.19 -57.0 4.08 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 118.305 1.053 . . . . 1.2 109.983 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.18 -39.27 72.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.575 0.703 . . . . 2.61 109.587 173.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.719 HG22 ' HA ' ' A' ' 160' ' ' VAL . 18.3 m -57.06 -59.28 5.3 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 114.625 -1.171 . . . . 1.06 111.296 174.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 1.053 ' HB1' HG13 ' A' ' 71' ' ' VAL . . . -55.98 -45.45 78.97 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.869 -0.605 . . . . 1.05 111.047 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.57 ' HA ' ' HE1' ' A' ' 102' ' ' PHE . 92.1 m -55.02 -51.33 66.62 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.589 0.709 . . . . 1.08 110.354 -178.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 28.1 m -72.96 -36.79 67.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.861 -1.063 . . . . 1.22 111.483 -177.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.702 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 14.5 mt -64.23 -52.67 57.61 Favored 'General case' 0 CA--C 1.498 -1.054 0 CA-C-O 121.311 0.577 . . . . 1.14 110.381 -178.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.788 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 2.1 t80 -51.73 -53.26 41.37 Favored 'General case' 0 C--O 1.199 -1.586 0 CA-C-N 114.218 -1.356 . . . . 0.94 110.167 178.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -72.91 -25.56 61.1 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 112.097 0.406 . . . . 1.6 112.097 -170.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.44 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 35.4 ttpt -84.06 -23.24 30.94 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 119.401 -0.92 . . . . 2.06 108.924 -178.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.633 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 36.7 m-85 -122.37 -4.31 8.87 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 114.959 1.466 . . . . 0.92 114.959 -172.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.711 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 13.7 ptmt -64.93 -25.31 67.82 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 108.238 -1.023 . . . . 1.89 108.238 171.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.9 m -47.76 -41.9 24.33 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.113 -1.403 . . . . 1.68 110.74 172.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -85.37 -33.09 22.09 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.059 0.392 . . . . 1.11 112.059 175.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.492 ' HA3' ' HB2' ' A' ' 36' ' ' SER . . . 145.82 -7.46 1.47 Allowed Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 111.454 -0.659 . . . . 0.2 111.454 -177.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.702 ' HE2' ' HB3' ' A' ' 60' ' ' LEU . 19.5 t80 -64.38 140.86 58.91 Favored 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 122.709 0.403 . . . . 0.21 111.027 -178.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.899 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 1.6 t -134.34 151.3 51.15 Favored 'General case' 0 N--CA 1.413 -2.294 0 N-CA-C 108.425 -0.954 . . . . 1.02 108.425 173.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 1.053 HG13 ' HB1' ' A' ' 57' ' ' ALA . 50.2 t -109.16 100.27 10.42 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.341 0 N-CA-C 107.488 -1.301 . . . . 1.04 107.488 159.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.874 HD22 ' HE2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -89.85 121.07 31.63 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 118.254 -1.378 . . . . 1.69 108.375 177.496 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.819 ' HB2' HG13 ' A' ' 104' ' ' ILE . . . -98.09 112.68 24.55 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.914 -0.585 . . . . 1.17 110.842 -177.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.847 ' CD2' ' HE2' ' A' ' 119' ' ' TYR . 3.1 m-30 -96.56 102.16 10.74 Favored Pre-proline 0 C--N 1.31 -1.143 0 N-CA-C 108.827 -0.805 . . . . 0.58 108.827 176.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.714 ' HG2' ' HB3' ' A' ' 107' ' ' LYS . 87.8 Cg_endo -80.33 71.02 7.27 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 123.239 2.626 . . . . 1.3 114.302 -166.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 77.3 p . . . . . 0 N--CA 1.475 0.798 0 N-CA-C 116.767 2.136 . . . . 1.91 116.767 179.491 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.613 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . . . . . . 0 CA--C 1.51 -0.586 0 CA-C-O 120.82 0.343 . . . . 1.15 110.235 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -104.57 28.51 6.93 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.637 -0.711 . . . . 1.99 111.012 178.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.868 ' HB3' ' O ' ' A' ' 71' ' ' VAL . 3.5 m-85 -113.14 -177.11 0.42 Allowed Pre-proline 0 CA--C 1.513 -0.454 0 CA-C-O 121.853 0.835 . . . . 1.31 111.426 -177.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.704 ' HD3' ' CE2' ' A' ' 61' ' ' TYR . 12.9 Cg_exo -79.87 71.73 6.89 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 124.095 3.197 . . . . 1.07 110.442 156.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.819 HG13 ' HB2' ' A' ' 73' ' ' ALA . 5.3 mp -73.77 119.92 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 108.143 -1.058 . . . . 1.97 108.143 173.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.823 ' HG2' ' CG ' ' A' ' 74' ' ' PHE . 0.3 OUTLIER -80.26 -175.53 5.14 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.079 -0.509 . . . . 3.41 110.768 -173.358 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.743 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . . . -71.36 -0.01 9.19 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.592 -0.731 . . . . 1.46 111.958 -176.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.714 ' HB3' ' HG2' ' A' ' 75' ' ' PRO . 3.1 ptpp? 70.45 137.59 0.04 OUTLIER 'General case' 0 CA--C 1.499 -1.001 0 C-N-CA 125.256 1.422 . . . . 2.31 110.604 -170.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.685 HG13 ' CB ' ' A' ' 116' ' ' HIS . 0.1 OUTLIER -140.51 167.44 18.12 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 CA-C-N 113.262 -1.79 . . . . 1.65 106.358 168.297 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.509 ' O ' HG12 ' A' ' 108' ' ' ILE . 0.2 OUTLIER -49.72 119.13 3.25 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.785 -0.82 . . . . 1.73 108.785 168.556 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.63 ' HB ' HD21 ' A' ' 42' ' ' ASN . 0.0 OUTLIER -128.28 87.84 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 C-N-CA 119.442 -0.903 . . . . 1.4 108.688 166.763 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.5 t30 . . . . . 0 N--CA 1.438 -1.032 0 CA-C-N 113.981 -1.463 . . . . 2.1 108.908 176.64 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.685 ' CB ' HG13 ' A' ' 108' ' ' ILE . 0.9 OUTLIER . . . . . 0 N--CA 1.43 -1.455 0 N-CA-C 107.057 -1.46 . . . . 0.71 107.057 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -27.44 -50.42 0.11 Allowed 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 124.701 3.6 . . . . 0.47 113.891 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.757 HD11 ' HB ' ' A' ' 15' ' ' ILE . 64.7 tp -57.12 -53.41 58.39 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 122.912 0.485 . . . . 1.15 112.259 176.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.847 ' HE2' ' CD2' ' A' ' 74' ' ' PHE . 80.0 m-85 -77.38 -35.37 54.49 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 112.299 0.481 . . . . 3.33 112.299 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.734 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 5.7 mm-40 -57.48 -34.0 68.57 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 107.221 -1.399 . . . . 2.44 107.221 172.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.677 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 70.8 t80 -71.48 -33.5 69.34 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 119.262 -0.975 . . . . 1.08 111.065 173.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.589 ' HE1' HD11 ' A' ' 40' ' ' ILE . 1.8 ttm -74.64 -55.0 6.37 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.275 -0.42 . . . . 1.25 110.465 -171.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.481 ' HB2' ' HE2' ' A' ' 123' ' ' LYS . 0.6 OUTLIER -70.57 -25.74 63.22 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 116.514 -0.312 . . . . 1.86 111.42 178.029 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.734 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 9.4 pttp -68.58 -27.28 65.92 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 119.486 -0.886 . . . . 2.52 109.485 177.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 29.1 m -89.47 -28.01 19.97 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.244 -0.889 . . . . 1.21 110.703 176.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.53 ' HB3' ' NH2' ' A' ' 153' ' ' ARG . 39.9 mmtt . . . . . 0 C--N 1.326 -0.428 0 CA-C-N 116.087 -0.506 . . . . 2.38 110.945 -177.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.598 ' HB3' ' HG3' ' A' ' 156' ' ' PRO . 2.4 m95 . . . . . 0 N--CA 1.452 -0.363 0 CA-C-O 120.877 0.37 . . . . 2.41 111.599 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.414 ' O ' ' N ' ' A' ' 140' ' ' THR . 1.6 m120 -39.48 -155.61 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 126.603 1.961 . . . . 2.04 114.128 165.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.774 ' HB3' HG21 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -34.14 -22.19 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 116.063 1.875 . . . . 2.53 116.063 -177.084 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.448 ' C ' ' O ' ' A' ' 139' ' ' PHE . 3.7 m 10.49 108.12 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 119.965 1.257 . . . . 1.24 113.911 166.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.48 ' HB3' ' CE1' ' A' ' 41' ' ' TYR . 0.9 OUTLIER -90.75 161.08 15.48 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 114.066 -1.425 . . . . 1.03 110.484 -167.34 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.471 ' HA ' ' HA ' ' A' ' 153' ' ' ARG . 38.6 m-85 -124.64 122.82 38.59 Favored 'General case' 0 CA--C 1.494 -1.206 0 N-CA-C 106.389 -1.708 . . . . 0.7 106.389 168.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.775 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 8.9 tp -79.73 104.88 10.62 Favored 'General case' 0 N--CA 1.425 -1.708 0 C-N-CA 118.348 -1.341 . . . . 1.16 108.416 179.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.679 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 39.3 mm -92.0 142.05 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.717 0 CA-C-N 112.744 -2.025 . . . . 1.05 107.605 -178.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.414 ' HA ' HD13 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -94.43 -175.57 3.67 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 119.131 -1.028 . . . . 0.98 111.316 -170.194 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.601 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 29.9 mtm180 -52.33 -39.6 60.85 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 121.097 0.475 . . . . 2.61 110.909 -178.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -97.33 20.99 10.66 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.334 0.588 . . . . 2.0 109.711 -175.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.696 ' HA3' ' CE2' ' A' ' 16' ' ' PHE . . . 68.73 35.58 80.55 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 115.812 -0.631 . . . . 0.19 114.185 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.457 ' HA ' ' HD2' ' A' ' 150' ' ' PRO . 65.5 t -106.17 108.31 61.46 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 118.387 1.093 . . . . 1.74 111.666 175.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.666 ' HD3' HG21 ' A' ' 15' ' ' ILE . 5.3 Cg_endo -52.05 114.78 1.78 Allowed 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 123.876 3.051 . . . . 0.6 111.256 171.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.94 HG12 ' HG2' ' A' ' 152' ' ' GLU . 13.8 p -116.79 -21.88 4.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-O 121.489 0.661 . . . . 2.06 109.488 -177.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.94 ' HG2' HG12 ' A' ' 151' ' ' VAL . 30.1 mm-40 -138.25 167.54 21.63 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 115.351 -0.841 . . . . 1.17 110.372 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.53 ' NH2' ' HB3' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -145.14 146.29 31.72 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.137 -0.938 . . . . 2.9 109.571 161.517 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.624 ' CE2' ' HA ' ' A' ' 163' ' ' ILE . 93.2 m-85 -121.95 140.46 52.42 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.874 -0.603 . . . . 0.36 109.457 -172.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 6.3 m -68.14 158.57 83.73 Favored Pre-proline 0 C--N 1.315 -0.913 0 N-CA-C 109.847 -0.427 . . . . 1.45 109.847 178.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.598 ' HG3' ' HB3' ' A' ' 137' ' ' TRP . 18.4 Cg_endo -59.46 -32.4 96.31 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.137 1.891 . . . . 0.78 110.624 174.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -73.06 -0.0 49.29 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 114.515 -1.221 . . . . 0.59 113.724 173.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -85.97 146.15 26.81 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.83 -0.804 . . . . 1.07 108.83 173.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 4.0 t -110.35 -178.83 3.6 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-O 121.082 0.468 . . . . 1.92 110.259 -173.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.719 ' HA ' HG22 ' A' ' 56' ' ' THR . 60.8 t -45.84 -57.25 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 114.609 -1.178 . . . . 1.07 111.79 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 42.5 tttm -63.46 -38.44 91.14 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 120.624 0.25 . . . . 3.89 111.034 -172.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -57.26 -43.27 82.85 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.812 0.815 . . . . 1.4 109.124 -177.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.787 HD11 ' HH ' ' A' ' 41' ' ' TYR . 90.5 mt -75.52 -47.29 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 CA-C-N 114.216 -1.356 . . . . 1.05 111.017 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.622 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 58.2 mt-10 -55.39 -43.49 75.23 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-O 121.089 0.471 . . . . 0.67 111.07 -176.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -63.63 -16.21 60.31 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 116.269 -0.423 . . . . 0.87 111.684 -173.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.573 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 31.5 mmmt -104.51 -21.34 13.46 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.47 0.653 . . . . 2.22 109.964 172.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.59 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 12.8 tp -84.96 -49.53 8.26 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.997 -1.001 . . . . 1.04 112.289 -176.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.571 ' N ' ' HD2' ' A' ' 169' ' ' PRO . 64.1 mt -57.46 -43.7 99.14 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.661 -0.699 . . . . 1.08 112.4 -174.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 168' ' ' ILE . 8.0 Cg_endo -53.65 -20.62 17.12 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 121.894 1.729 . . . . 0.62 112.939 172.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.807 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 99.3 mt -96.42 -43.14 7.78 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 122.416 -0.178 . . . . 1.36 111.205 177.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.607 HD21 ' HB2' ' A' ' 69' ' ' PHE . 96.6 mt -60.08 -56.95 15.31 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-O 121.962 0.887 . . . . 1.07 108.738 173.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.424 -2.154 0 CA-C-N 113.892 -1.504 . . . . 1.12 110.552 178.838 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.1 m . . . . . 0 N--CA 1.463 0.179 0 CA-C-O 121.507 0.67 . . . . 2.17 110.007 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 90.9 p -178.48 151.81 0.62 Allowed 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.678 -1.971 . . . . 1.68 105.678 175.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.745 ' HB ' HD13 ' A' ' 118' ' ' LEU . 6.5 pt -69.12 -13.99 17.95 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 CA-C-N 114.787 -1.097 . . . . 1.16 111.801 -171.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.808 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 54.8 m-85 -77.21 -3.26 38.72 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.273 -0.421 . . . . 0.3 111.189 -177.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -69.24 -21.06 63.94 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.275 -1.009 . . . . 2.11 108.275 172.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.663 ' HE2' ' HB2' ' A' ' 121' ' ' TYR . 49.6 m-85 -114.14 111.1 21.03 Favored 'General case' 0 CA--C 1.503 -0.853 0 CA-C-N 114.718 -1.128 . . . . 0.37 111.84 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -50.42 150.35 2.66 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.142 -1.39 . . . . 2.86 109.941 169.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.746 HG11 ' CZ ' ' A' ' 74' ' ' PHE . 38.0 t -111.43 164.02 7.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 N-CA-C 108.894 -0.78 . . . . 1.32 108.894 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.757 ' O ' ' HB3' ' A' ' 105' ' ' MET . 89.6 mt -126.4 113.11 16.45 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 120.873 -0.331 . . . . 1.29 111.65 -176.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.631 ' HA ' ' CE ' ' A' ' 105' ' ' MET . 12.1 t70 -51.6 160.42 0.63 Allowed 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 107.779 -1.193 . . . . 1.87 107.779 169.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.66 ' HA ' ' C ' ' A' ' 105' ' ' MET . . . -54.53 -16.69 2.53 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 114.147 1.166 . . . . 1.2 114.147 -163.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.552 ' HB2' ' HE2' ' A' ' 26' ' ' LYS . 33.4 m-20 -96.15 5.32 51.35 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 112.325 0.491 . . . . 2.34 112.325 178.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.711 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 82.8 m-70 78.13 15.21 1.43 Allowed 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.699 0.762 . . . . 2.26 109.163 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.552 ' HE2' ' HB2' ' A' ' 24' ' ' ASP . 13.2 mtmt -79.64 119.15 75.89 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 107.212 -1.403 . . . . 4.64 107.212 169.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.628 ' HA ' HD21 ' A' ' 21' ' ' LEU . 84.6 Cg_exo -51.7 113.91 1.36 Allowed 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 121.582 1.521 . . . . 0.62 113.157 -173.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.554 ' HB3' HG12 ' A' ' 20' ' ' VAL . 32.3 t80 -79.35 144.8 33.86 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.074 -1.421 . . . . 1.52 111.366 175.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.431 ' OD1' ' HB3' ' A' ' 32' ' ' GLN . 2.4 t-20 -78.85 85.38 4.83 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.026 -0.988 . . . . 2.16 109.934 178.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.594 ' HG ' ' CD1' ' A' ' 16' ' ' PHE . 49.1 tp -63.26 -42.37 99.14 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.393 -0.821 . . . . 1.07 110.471 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.775 ' HA ' ' CE1' ' A' ' 16' ' ' PHE . 2.0 t -68.99 -0.64 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 114.424 -1.262 . . . . 1.69 112.481 -167.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.431 ' HB3' ' OD1' ' A' ' 29' ' ' ASN . 10.4 pt20 -76.52 -5.26 46.79 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.531 0.681 . . . . 1.31 110.321 177.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.954 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 87.9 m-70 -100.71 24.29 9.31 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.843 0.83 . . . . 0.35 109.335 173.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.808 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 0.5 OUTLIER -82.82 110.42 17.82 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.724 -1.125 . . . . 2.07 109.311 171.762 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.26 -37.42 2.2 Favored Glycine 0 N--CA 1.437 -1.249 0 C-N-CA 120.917 -0.659 . . . . 0.24 111.506 -177.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.467 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 17.6 m -132.33 133.11 23.34 Favored Pre-proline 0 N--CA 1.435 -1.197 0 N-CA-C 108.626 -0.879 . . . . 0.74 108.626 173.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.799 ' HG3' ' CB ' ' A' ' 170' ' ' LEU . 6.8 Cg_endo -44.04 153.45 0.31 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 124.124 3.216 . . . . 0.22 112.614 178.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.775 ' HB2' HG22 ' A' ' 70' ' ' THR . 0.7 OUTLIER -140.61 139.41 34.89 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.027 -1.471 . . . . 1.09 107.027 -179.919 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.785 ' HB3' ' CE1' ' A' ' 41' ' ' TYR . 3.0 mp -107.17 116.66 32.32 Favored 'General case' 0 C--N 1.293 -1.881 0 O-C-N 121.518 -0.739 . . . . 1.82 109.449 176.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.905 HG22 ' HB2' ' A' ' 72' ' ' LEU . 2.6 mt -95.77 120.35 45.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-N 115.557 -0.747 . . . . 1.12 109.761 176.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.785 ' CE1' ' HB3' ' A' ' 39' ' ' LEU . 0.5 OUTLIER -103.87 124.95 49.88 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.493 -0.776 . . . . 1.09 110.041 -174.555 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.677 ' OD1' ' HB ' ' A' ' 140' ' ' THR . 0.2 OUTLIER -75.61 125.66 29.47 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 104.309 -2.478 . . . . 3.11 104.309 168.525 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.675 ' O ' ' HA ' ' A' ' 75' ' ' PRO . 2.8 p . . . . . 0 C--N 1.294 -1.817 0 C-N-CA 117.665 -1.614 . . . . 1.69 113.114 -169.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 N-CA-C 112.077 -0.409 . . . . 0.85 112.077 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -47.55 -45.16 23.18 Favored Glycine 0 C--O 1.224 -0.517 0 O-C-N 123.792 0.348 . . . . 0.67 113.686 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.467 ' HA ' ' CZ ' ' A' ' 139' ' ' PHE . 1.1 t80 -61.38 -62.97 1.45 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.049 0.389 . . . . 1.2 112.049 -172.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -59.24 -40.14 84.98 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.188 0.518 . . . . 2.61 111.121 -178.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.543 ' HA ' ' CG2' ' A' ' 160' ' ' VAL . 40.8 m -54.97 -59.92 4.09 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.163 -0.926 . . . . 1.06 111.193 174.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 1.036 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -61.81 -42.55 99.16 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.417 -0.811 . . . . 1.05 111.15 -176.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.594 ' N ' ' HE1' ' A' ' 102' ' ' PHE . 61.5 m -55.33 -51.08 67.92 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.814 0.816 . . . . 1.08 109.825 -177.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 26.5 m -72.11 -35.15 69.1 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 114.402 -1.272 . . . . 1.22 111.22 -177.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.613 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 17.4 mt -67.57 -50.04 60.35 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 121.365 0.602 . . . . 1.14 110.413 -176.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.844 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 8.4 t80 -59.36 -47.21 86.29 Favored 'General case' 0 C--O 1.205 -1.27 0 CA-C-N 114.967 -1.015 . . . . 0.94 110.502 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -73.76 -24.29 59.84 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 112.022 0.379 . . . . 1.6 112.022 -174.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.467 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 32.2 ttpt -84.54 -25.99 28.36 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 120.02 -0.672 . . . . 2.06 109.275 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.703 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 35.9 m-85 -123.2 -5.79 8.34 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 115.121 1.526 . . . . 0.92 115.121 -169.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.697 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 41.4 pttt -65.48 -26.59 67.99 Favored 'General case' 0 CA--C 1.5 -0.975 0 N-CA-C 108.434 -0.95 . . . . 1.89 108.434 172.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.2 t -47.91 -41.86 25.65 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.458 -1.246 . . . . 1.68 110.733 172.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -82.03 -37.41 26.56 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 111.821 0.304 . . . . 1.11 111.821 175.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.444 ' HA3' ' HB2' ' A' ' 36' ' ' SER . . . 150.58 -7.95 0.72 Allowed Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 111.622 -0.591 . . . . 0.2 111.622 -176.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.703 ' HD2' ' HB2' ' A' ' 64' ' ' TYR . 13.7 t80 -64.41 143.33 57.98 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 122.777 0.431 . . . . 0.21 110.841 -178.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.954 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 5.3 t -132.91 148.16 52.29 Favored 'General case' 0 N--CA 1.416 -2.127 0 N-CA-C 108.848 -0.797 . . . . 1.02 108.848 168.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 1.036 HG11 ' HB1' ' A' ' 57' ' ' ALA . 21.8 t -100.07 100.78 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.419 0 N-CA-C 107.199 -1.408 . . . . 1.04 107.199 158.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.905 ' HB2' HG22 ' A' ' 40' ' ' ILE . 79.8 mt -84.26 118.87 24.45 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 107.085 -1.45 . . . . 1.69 107.085 178.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.622 ' HB1' HG11 ' A' ' 43' ' ' VAL . . . -96.44 113.41 24.99 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.939 -0.704 . . . . 1.17 109.838 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.869 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 5.0 m-85 -108.96 95.22 16.62 Favored Pre-proline 0 N--CA 1.433 -1.286 0 N-CA-C 107.337 -1.357 . . . . 0.58 107.337 -177.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.898 ' HB2' ' HG2' ' A' ' 107' ' ' LYS . 3.4 Cg_endo -67.33 148.37 79.71 Favored 'Trans proline' 0 N--CA 1.429 -2.314 0 N-CA-C 109.091 -1.157 . . . . 1.3 109.091 -174.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.436 ' O ' ' HD3' ' A' ' 107' ' ' LYS . 29.2 p . . . . . 0 C--N 1.287 -2.117 0 CA-C-O 121.988 0.899 . . . . 1.91 112.76 -177.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.432 ' HB3' HD13 ' A' ' 104' ' ' ILE . . . . . . . . 0 CA--C 1.51 -0.571 0 CA-C-O 121.381 0.61 . . . . 1.15 111.518 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.638 ' O ' ' HD2' ' A' ' 61' ' ' TYR . 62.6 mm-40 -100.92 48.12 0.9 Allowed 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 114.665 -1.152 . . . . 1.99 110.837 176.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.712 ' HB3' ' O ' ' A' ' 71' ' ' VAL . 1.6 m-85 -128.25 175.98 3.07 Favored Pre-proline 0 CA--C 1.511 -0.543 0 CA-C-O 121.466 0.651 . . . . 1.31 109.724 172.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.667 ' HD3' ' CE2' ' A' ' 61' ' ' TYR . 14.4 Cg_exo -76.48 77.75 3.51 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 123.519 2.813 . . . . 1.07 109.936 158.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.565 HG12 ' HB2' ' A' ' 73' ' ' ALA . 76.4 mt -80.44 126.52 39.55 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.504 0 N-CA-C 107.978 -1.119 . . . . 1.97 107.978 176.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.869 ' HG3' ' CE1' ' A' ' 74' ' ' PHE . 7.1 mmt -105.56 -168.12 1.41 Allowed 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 121.727 0.775 . . . . 3.41 113.032 -163.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.628 ' HB2' ' CD2' ' A' ' 25' ' ' HIS . . . -76.47 6.81 5.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.637 -1.165 . . . . 1.46 113.755 -167.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.898 ' HG2' ' HB2' ' A' ' 75' ' ' PRO . 57.1 mttp 65.99 139.29 0.03 OUTLIER 'General case' 0 CA--C 1.491 -1.315 0 CA-C-O 122.51 1.148 . . . . 2.31 110.847 -169.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.778 HG13 ' HB3' ' A' ' 116' ' ' HIS . 0.1 OUTLIER -138.45 163.71 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.576 0 N-CA-C 106.428 -1.693 . . . . 1.65 106.428 165.96 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.519 ' C ' HD21 ' A' ' 109' ' ' ASN . 0.2 OUTLIER -73.16 83.56 1.33 Allowed 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 120.612 0.244 . . . . 1.73 110.375 -177.428 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.722 HG13 ' CD2' ' A' ' 119' ' ' TYR . 2.6 m -80.25 90.15 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-O 121.848 0.832 . . . . 1.4 109.299 176.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 . . . . . 0 N--CA 1.44 -0.973 0 CA-C-N 114.177 -1.374 . . . . 2.1 107.988 179.952 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.778 ' HB3' HG13 ' A' ' 108' ' ' ILE . 1.6 t-80 . . . . . 0 N--CA 1.439 -1.017 0 N-CA-C 107.557 -1.275 . . . . 0.71 107.557 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -24.99 -48.03 0.06 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 124.678 3.585 . . . . 0.47 113.847 178.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.745 HD13 ' HB ' ' A' ' 15' ' ' ILE . 38.5 tp -69.35 -45.92 68.24 Favored 'General case' 0 C--O 1.216 -0.684 0 C-N-CA 122.598 0.359 . . . . 1.15 111.827 -179.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.722 ' CD2' HG13 ' A' ' 110' ' ' VAL . 9.7 m-85 -82.54 -32.16 28.75 Favored 'General case' 0 CA--C 1.491 -1.303 0 CA-C-O 121.709 0.766 . . . . 3.33 110.9 -175.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.512 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 2.9 tm-20 -64.03 -35.03 79.38 Favored 'General case' 0 N--CA 1.424 -1.749 0 N-CA-C 107.031 -1.47 . . . . 2.44 107.031 172.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.663 ' HB2' ' HE2' ' A' ' 18' ' ' PHE . 28.7 t80 -72.45 -26.75 61.94 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.96 -1.018 . . . . 1.08 110.253 170.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.683 ' HG2' ' O ' ' A' ' 118' ' ' LEU . 15.4 mmt -71.95 -55.93 6.59 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 121.66 0.743 . . . . 1.25 110.287 -170.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.656 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -72.84 -25.48 61.14 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.214 -0.903 . . . . 1.86 110.565 178.655 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.512 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 27.2 tttt -60.96 -38.42 85.82 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 109.079 -0.712 . . . . 2.52 109.079 169.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.428 ' HB ' ' O ' ' A' ' 122' ' ' MET . 96.2 m -65.43 -55.71 16.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.29 -0.868 . . . . 1.21 110.644 177.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm . . . . . 0 N--CA 1.452 -0.369 0 N-CA-C 113.392 0.886 . . . . 2.38 113.392 -174.68 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.533 ' HB3' ' HG3' ' A' ' 156' ' ' PRO . 1.9 m-90 . . . . . 0 CA--C 1.507 -0.696 0 CA-C-O 120.558 0.218 . . . . 2.41 110.525 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.489 ' HB2' ' HB3' ' A' ' 156' ' ' PRO . 6.6 m120 -39.46 -154.23 0.0 OUTLIER 'General case' 0 C--O 1.203 -1.366 0 O-C-N 124.822 1.326 . . . . 2.04 111.5 160.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.623 ' HD2' ' CD2' ' A' ' 41' ' ' TYR . 2.2 m-85 -31.35 -25.19 0.0 OUTLIER 'General case' 0 CA--C 1.567 1.597 0 N-CA-C 117.691 2.478 . . . . 2.53 117.691 -171.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.746 ' HA ' ' O ' ' A' ' 154' ' ' PHE . 1.4 m 6.56 101.3 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 120.495 1.498 . . . . 1.24 114.086 170.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.467 ' O ' ' HA ' ' A' ' 153' ' ' ARG . 4.5 m -89.12 176.03 7.14 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.22 -0.9 . . . . 1.03 112.195 -170.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.585 ' HA ' ' O ' ' A' ' 152' ' ' GLU . 79.5 m-85 -134.25 124.44 25.93 Favored 'General case' 0 CA--C 1.491 -1.297 0 N-CA-C 106.422 -1.695 . . . . 0.7 106.422 161.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.809 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 5.8 tp -80.52 103.97 10.74 Favored 'General case' 0 N--CA 1.423 -1.82 0 C-N-CA 118.487 -1.285 . . . . 1.16 108.342 177.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.772 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 27.9 mm -90.76 141.35 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.822 0 CA-C-N 113.41 -1.723 . . . . 1.05 107.656 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.533 ' OD1' HG13 ' A' ' 149' ' ' VAL . 0.0 OUTLIER -94.71 -173.68 3.08 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 119.541 -0.863 . . . . 0.98 111.234 -169.905 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.433 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 44.2 mtm180 -54.83 -36.48 65.05 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.14 0.275 . . . . 2.61 111.326 -177.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -104.05 20.97 17.26 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 121.569 0.7 . . . . 2.0 109.245 -176.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.637 ' HA2' ' CG2' ' A' ' 144' ' ' ILE . . . 70.43 36.37 69.26 Favored Glycine 0 N--CA 1.435 -1.396 0 CA-C-N 114.624 -1.171 . . . . 0.19 115.126 175.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.533 HG13 ' OD1' ' A' ' 145' ' ' ASP . 5.2 p -103.67 129.98 24.34 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 119.528 1.664 . . . . 1.74 110.379 172.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.559 ' HA ' HD11 ' A' ' 144' ' ' ILE . 3.6 Cg_exo -69.84 121.33 8.0 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.6 2.2 . . . . 0.6 110.493 179.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 22.1 t -114.7 -27.01 2.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-O 121.426 0.631 . . . . 2.06 109.401 -176.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.809 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 60.7 mm-40 -138.17 165.47 26.57 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.363 -0.835 . . . . 1.17 111.441 -178.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.51 ' HB2' ' CD1' ' A' ' 142' ' ' PHE . 2.6 ttm180 -145.6 125.2 13.26 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.761 -1.109 . . . . 2.9 109.146 165.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.746 ' O ' ' HA ' ' A' ' 140' ' ' THR . 91.2 m-85 -107.19 149.95 27.14 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.203 -0.908 . . . . 0.36 108.74 -169.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 19.4 m -76.98 158.51 80.13 Favored Pre-proline 0 C--N 1.313 -0.998 0 N-CA-C 108.795 -0.817 . . . . 1.45 108.795 175.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.533 ' HG3' ' HB3' ' A' ' 137' ' ' TRP . 10.8 Cg_endo -54.52 -48.91 18.86 Favored 'Trans proline' 0 N--CA 1.465 -0.202 0 C-N-CA 121.874 1.716 . . . . 0.78 110.685 178.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -59.52 -2.0 1.45 Allowed Glycine 0 CA--C 1.529 0.964 0 CA-C-N 114.753 -1.112 . . . . 0.59 114.902 174.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -84.69 134.07 34.37 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 107.982 -1.118 . . . . 1.07 107.982 171.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.516 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 6.8 t -110.68 -174.58 2.51 Favored 'General case' 0 N--CA 1.435 -1.177 0 C-N-CA 119.976 -0.69 . . . . 1.92 110.757 -167.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.543 ' CG2' ' HA ' ' A' ' 56' ' ' THR . 64.0 t -45.44 -50.92 2.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 114.7 -1.137 . . . . 1.07 111.202 -176.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -68.79 -35.07 76.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.137 -0.483 . . . . 3.89 111.22 -174.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.437 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 28.2 m-20 -68.91 -35.17 76.52 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.779 0.799 . . . . 1.4 109.553 -177.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.486 HG22 HD13 ' A' ' 60' ' ' LEU . 46.5 mt -80.56 -48.08 20.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 114.494 -1.23 . . . . 1.05 111.354 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.616 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 49.3 mt-10 -53.81 -39.3 65.4 Favored 'General case' 0 C--O 1.217 -0.631 0 CA-C-O 120.888 0.375 . . . . 0.67 111.39 -176.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.437 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 12.1 pt-20 -60.86 -21.93 63.74 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.636 0.255 . . . . 0.87 111.544 -176.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.555 ' HB3' HD23 ' A' ' 143' ' ' LEU . 35.7 mmtp -100.07 -22.85 15.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.382 0.61 . . . . 2.22 110.13 174.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.616 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 12.9 tp -85.8 -50.03 7.46 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.037 -0.983 . . . . 1.04 112.36 -174.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.548 ' N ' ' HD2' ' A' ' 169' ' ' PRO . 73.8 mt -54.09 -46.95 98.55 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.628 -0.715 . . . . 1.08 112.643 -173.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 168' ' ' ILE . 14.7 Cg_endo -58.62 -16.23 29.31 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.192 1.928 . . . . 0.62 113.026 175.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.799 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 95.4 mt -97.11 -41.31 8.4 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 122.006 -0.433 . . . . 1.36 110.784 177.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.599 HD21 ' HG2' ' A' ' 37' ' ' PRO . 96.0 mt -63.28 -53.61 50.22 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-O 122.21 1.005 . . . . 1.07 109.727 175.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.55 0 CA-C-N 113.323 -1.762 . . . . 1.12 112.365 -176.579 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.9 m . . . . . 0 C--O 1.233 0.194 0 CA-C-O 121.514 0.673 . . . . 2.17 110.175 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 80.0 p 178.85 177.8 0.47 Allowed 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 105.89 -1.893 . . . . 1.68 105.89 -173.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.838 HG22 ' HD3' ' A' ' 150' ' ' PRO . 3.7 pt -89.71 -15.36 8.8 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 CA-C-N 115.579 -0.737 . . . . 1.16 110.378 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.796 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 36.3 m-85 -70.52 -13.23 62.02 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.259 0.552 . . . . 0.3 110.854 -179.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -63.93 -24.67 67.82 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.64 -0.874 . . . . 2.11 108.64 173.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.584 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 50.9 m-85 -112.49 105.6 13.87 Favored 'General case' 0 CA--C 1.495 -1.145 0 CA-C-N 114.972 -1.013 . . . . 0.37 110.341 178.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -52.16 146.19 9.4 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.68 -1.145 . . . . 2.86 109.903 174.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.768 HG13 ' HZ ' ' A' ' 74' ' ' PHE . 54.7 t -109.26 159.17 8.85 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 107.464 -1.31 . . . . 1.32 107.464 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.846 ' O ' ' HB2' ' A' ' 105' ' ' MET . 26.2 mt -126.99 167.82 15.38 Favored 'General case' 0 N--CA 1.433 -1.312 0 C-N-CA 120.323 -0.551 . . . . 1.29 110.279 -176.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -86.69 -179.27 6.55 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.64 -0.874 . . . . 1.87 108.64 175.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.684 ' HA ' ' N ' ' A' ' 106' ' ' ALA . . . -63.58 -9.13 11.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 118.527 0.603 . . . . 1.2 111.415 -178.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.497 ' HB2' ' HE2' ' A' ' 26' ' ' LYS . 11.8 m-20 -107.85 7.74 28.3 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.559 -0.291 . . . . 2.34 111.562 174.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.692 ' CD2' ' HB2' ' A' ' 106' ' ' ALA . 3.8 m170 72.29 15.1 5.37 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 121.68 0.753 . . . . 2.26 110.181 174.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.497 ' HE2' ' HB2' ' A' ' 24' ' ' ASP . 27.5 mtmt -76.39 133.38 71.35 Favored Pre-proline 0 C--O 1.221 -0.426 0 N-CA-C 107.228 -1.397 . . . . 4.64 107.228 165.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.674 ' HA ' HD21 ' A' ' 21' ' ' LEU . 85.2 Cg_exo -48.86 115.94 1.91 Allowed 'Trans proline' 0 CA--C 1.532 0.418 0 C-N-CA 122.11 1.873 . . . . 0.62 113.719 -175.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.705 ' H ' ' HA ' ' A' ' 21' ' ' LEU . 0.4 OUTLIER -77.32 153.07 34.19 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.32 -1.309 . . . . 1.52 109.031 168.898 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.607 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.1 t-20 -92.32 84.15 5.13 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.446 0.641 . . . . 2.16 109.34 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.739 HD21 HG21 ' A' ' 20' ' ' VAL . 64.0 tp -67.27 -47.41 70.75 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.499 -0.773 . . . . 1.07 110.746 -178.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.84 HG13 ' HG3' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -69.55 -0.68 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.351 -0.841 . . . . 1.69 112.704 -168.199 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.607 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 3.9 pt20 -75.08 -11.04 60.0 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.393 -0.595 . . . . 1.31 109.393 174.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.95 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 89.5 m-70 -95.81 18.05 13.91 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.933 0.873 . . . . 0.35 109.124 175.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.84 ' HG3' HG13 ' A' ' 31' ' ' VAL . 23.7 mtmt -77.69 110.97 12.98 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 114.464 -1.244 . . . . 2.07 108.874 166.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 131.86 -44.99 1.16 Allowed Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 120.754 -0.736 . . . . 0.24 111.499 -178.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.459 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 43.4 m -129.05 134.93 26.87 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 108.721 -0.844 . . . . 0.74 108.721 172.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.734 ' HG3' ' CB ' ' A' ' 170' ' ' LEU . 5.2 Cg_endo -42.38 153.9 0.13 Allowed 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 124.403 3.402 . . . . 0.22 113.093 177.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.8 HD13 ' HB2' ' A' ' 33' ' ' HIS . 0.6 OUTLIER -138.32 143.6 40.02 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 113.737 -1.574 . . . . 1.09 106.847 179.79 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 1.026 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 1.6 mm? -109.78 117.87 35.01 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.199 -1.038 . . . . 1.82 108.199 178.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.93 HD12 ' HE2' ' A' ' 122' ' ' MET . 5.8 mt -108.24 129.85 61.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 C-N-CA 120.107 -0.637 . . . . 1.12 109.679 -178.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 1.026 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.5 OUTLIER -114.31 130.28 56.66 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 116.132 -0.485 . . . . 1.09 111.315 -168.664 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.722 ' ND2' ' HB ' ' A' ' 140' ' ' THR . 2.5 p-10 -84.36 93.54 8.28 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 107.798 -1.186 . . . . 3.11 107.798 166.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 1.046 HG13 ' HB2' ' A' ' 73' ' ' ALA . 2.7 p . . . . . 0 C--N 1.301 -1.524 0 CA-C-N 115.444 -0.798 . . . . 1.69 111.481 -161.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.6 ' O ' ' HG3' ' A' ' 55' ' ' GLU . . . . . . . . 0 CA--C 1.518 0.278 0 N-CA-C 113.721 0.249 . . . . 0.85 113.721 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -54.06 -21.5 17.87 Favored Glycine 0 C--O 1.221 -0.712 0 C-N-CA 121.379 -0.439 . . . . 0.67 113.676 -177.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.568 ' HA ' ' CZ ' ' A' ' 139' ' ' PHE . 0.1 OUTLIER -65.14 -61.53 2.08 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 117.595 0.697 . . . . 1.2 109.921 179.825 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.6 ' HG3' ' O ' ' A' ' 52' ' ' GLY . 0.1 OUTLIER -59.57 -21.8 60.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.612 -0.722 . . . . 2.61 110.044 179.896 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.65 ' HA ' ' CG2' ' A' ' 160' ' ' VAL . 29.6 m -77.4 -59.76 2.65 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 114.814 -1.085 . . . . 1.06 110.623 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 1.03 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -61.19 -35.08 76.2 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.339 -0.846 . . . . 1.05 110.684 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.651 ' HA ' ' CD1' ' A' ' 102' ' ' PHE . 89.6 m -60.21 -59.18 5.83 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.742 -0.663 . . . . 1.08 110.59 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 56.5 m -70.0 -35.13 74.14 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-N 115.515 -0.766 . . . . 1.22 111.936 -176.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.716 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 21.7 mt -62.33 -52.03 65.29 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 121.302 0.572 . . . . 1.14 110.481 -177.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.775 ' HD1' ' HA ' ' A' ' 70' ' ' THR . 34.3 t80 -51.86 -56.01 16.61 Favored 'General case' 0 C--O 1.204 -1.298 0 CA-C-N 114.584 -1.189 . . . . 0.94 111.108 177.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -71.62 -23.93 61.79 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 122.395 0.278 . . . . 1.6 111.078 -172.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.561 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 37.3 ttpt -86.03 -20.68 28.46 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 109.312 -0.625 . . . . 2.06 109.312 -177.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.62 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 44.1 m-85 -128.02 -6.43 5.52 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 114.547 1.314 . . . . 0.92 114.547 -171.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.738 ' HD2' ' CZ ' ' A' ' 61' ' ' TYR . 13.6 ptmt -63.57 -24.46 67.81 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 108.1 -1.074 . . . . 1.89 108.1 171.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -47.88 -38.57 16.56 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 113.963 -1.471 . . . . 1.68 110.81 172.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -89.35 -32.42 17.32 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.702 0.287 . . . . 1.11 111.67 175.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 147.45 -1.88 0.76 Allowed Glycine 0 C--N 1.332 0.319 0 N-CA-C 111.674 -0.57 . . . . 0.2 111.674 -178.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.716 ' HE2' ' HB3' ' A' ' 60' ' ' LEU . 25.3 t80 -69.51 145.02 53.0 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-O 121.4 0.619 . . . . 0.21 112.003 -177.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.95 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 1.6 t -135.59 152.93 51.74 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 108.839 -0.8 . . . . 1.02 108.839 173.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 1.03 HG11 ' HB1' ' A' ' 57' ' ' ALA . 51.9 t -113.35 101.65 12.78 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.426 0 N-CA-C 108.422 -0.955 . . . . 1.04 108.422 158.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.858 ' HA ' ' HB2' ' A' ' 103' ' ' PRO . 0.4 OUTLIER -94.4 122.05 36.56 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 107.222 -1.399 . . . . 1.69 107.222 173.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 1.046 ' HB2' HG13 ' A' ' 43' ' ' VAL . . . -108.49 130.34 55.26 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.397 0.618 . . . . 1.17 111.596 -178.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.768 ' HZ ' HG13 ' A' ' 20' ' ' VAL . 3.8 m-30 -109.07 102.82 50.36 Favored Pre-proline 0 C--N 1.319 -0.735 0 N-CA-C 108.72 -0.844 . . . . 0.58 108.72 177.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.85 ' HG2' ' HD2' ' A' ' 107' ' ' LYS . 60.7 Cg_endo -76.87 45.36 1.65 Allowed 'Trans proline' 0 N--CA 1.481 0.784 0 C-N-CA 123.676 2.918 . . . . 1.3 116.076 -163.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.464 ' O ' ' HB2' ' A' ' 107' ' ' LYS . 30.8 t . . . . . 0 N--CA 1.479 0.989 0 N-CA-C 117.128 2.27 . . . . 1.91 117.128 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.58 0 CA-C-O 121.184 0.516 . . . . 1.15 111.558 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -102.87 28.61 6.03 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 115.548 -0.751 . . . . 1.99 109.984 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.651 ' CD1' ' HA ' ' A' ' 58' ' ' THR . 40.3 p90 -151.64 165.25 17.83 Favored Pre-proline 0 N--CA 1.443 -0.822 0 N-CA-C 108.042 -1.096 . . . . 1.31 108.042 176.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.858 ' HB2' ' HA ' ' A' ' 72' ' ' LEU . 74.2 Cg_exo -50.92 132.03 36.29 Favored 'Trans proline' 0 CA--C 1.512 -0.59 0 C-N-CA 123.489 2.793 . . . . 1.07 113.8 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.534 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 50.6 mt -140.76 140.26 33.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 107.461 -1.311 . . . . 1.97 107.461 170.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.846 ' HB2' ' O ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -118.91 -179.22 3.75 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 120.779 -0.368 . . . . 3.41 110.98 -173.319 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.692 ' HB2' ' CD2' ' A' ' 25' ' ' HIS . . . -69.74 104.35 2.41 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 108.928 -0.767 . . . . 1.46 108.928 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.85 ' HD2' ' HG2' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -43.72 132.26 5.08 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-O 122.075 0.94 . . . . 2.31 112.888 -174.679 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.82 HG13 ' HB2' ' A' ' 116' ' ' HIS . 0.1 OUTLIER -119.49 173.25 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.012 0 CA-C-N 113.887 -1.506 . . . . 1.65 108.734 176.035 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.531 ' C ' HD21 ' A' ' 109' ' ' ASN . 0.1 OUTLIER -74.26 87.4 1.97 Allowed 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 114.555 -1.202 . . . . 1.73 110.595 -174.831 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.508 HG11 ' CB ' ' A' ' 42' ' ' ASN . 6.6 m -84.4 89.38 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 CA-C-O 122.311 1.053 . . . . 1.4 108.84 178.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.5 t30 . . . . . 0 C--N 1.315 -0.928 0 CA-C-N 113.683 -1.599 . . . . 2.1 107.945 179.793 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.82 ' HB2' HG13 ' A' ' 108' ' ' ILE . 3.5 t-80 . . . . . 0 N--CA 1.42 -1.956 0 N-CA-C 108.791 -0.818 . . . . 0.71 108.791 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -31.2 -45.86 0.17 Allowed 'Trans proline' 0 C--O 1.217 -0.539 0 C-N-CA 124.358 3.372 . . . . 0.47 113.031 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.776 HD11 ' HB ' ' A' ' 15' ' ' ILE . 27.4 tp -60.11 -53.05 62.3 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.289 0.636 . . . . 1.15 112.597 175.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.806 ' OH ' HG23 ' A' ' 40' ' ' ILE . 3.1 m-85 -77.91 -32.88 51.95 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-O 121.343 0.592 . . . . 3.33 110.834 -176.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.73 -40.01 95.87 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 106.726 -1.583 . . . . 2.44 106.726 174.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.788 ' HA ' ' HE2' ' A' ' 124' ' ' LYS . 81.4 t80 -65.26 -29.64 70.44 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.308 -0.86 . . . . 1.08 109.791 173.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.93 ' HE2' HD12 ' A' ' 40' ' ' ILE . 40.8 mtt -75.01 -55.95 5.23 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.837 -0.62 . . . . 1.25 110.958 -168.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.462 ' HE2' ' HB2' ' A' ' 123' ' ' LYS . 0.3 OUTLIER -70.41 -30.47 67.35 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.972 -0.558 . . . . 1.86 111.235 179.725 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.788 ' HE2' ' HA ' ' A' ' 121' ' ' TYR . 46.0 pttt -76.32 -26.65 56.01 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 119.238 -0.985 . . . . 2.52 111.422 -178.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.474 HG22 ' HG3' ' A' ' 126' ' ' LYS . 51.7 m -73.75 -44.93 54.79 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.915 0.388 . . . . 1.21 110.314 176.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.759 ' HZ3' ' HB2' ' A' ' 126' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.318 0 CA-C-O 121.24 0.543 . . . . 2.38 111.506 178.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.622 ' HB3' ' HG3' ' A' ' 156' ' ' PRO . 21.7 m-90 . . . . . 0 CA--C 1.508 -0.653 0 N-CA-C 110.033 -0.358 . . . . 2.41 110.033 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.66 ' HB2' ' CB ' ' A' ' 156' ' ' PRO . 7.6 m120 -49.63 -157.71 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.129 -0.941 . . . . 2.04 110.581 164.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.715 ' CD1' HG23 ' A' ' 43' ' ' VAL . 4.3 m-85 -28.81 -47.09 0.05 Allowed 'General case' 0 CA--C 1.56 1.34 0 N-CA-C 116.533 2.049 . . . . 2.53 116.533 -166.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.722 ' HB ' ' ND2' ' A' ' 42' ' ' ASN . 7.2 m 38.02 98.53 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 120.239 1.381 . . . . 1.24 113.902 175.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.426 ' HB3' HD11 ' A' ' 39' ' ' LEU . 1.2 m -90.72 163.06 14.63 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.153 -0.93 . . . . 1.03 111.831 -174.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.4 ' HA ' ' O ' ' A' ' 152' ' ' GLU . 88.4 m-85 -126.92 126.06 42.61 Favored 'General case' 0 CA--C 1.493 -1.234 0 N-CA-C 106.215 -1.772 . . . . 0.7 106.215 166.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.777 HD12 HD13 ' A' ' 170' ' ' LEU . 10.7 tp -79.4 105.03 10.42 Favored 'General case' 0 N--CA 1.418 -2.06 0 C-N-CA 118.326 -1.349 . . . . 1.16 108.109 177.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.665 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 24.4 mm -92.24 135.17 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.783 0 CA-C-N 112.821 -1.99 . . . . 1.05 107.256 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.657 ' HA ' HD12 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -89.71 -177.14 5.19 Favored 'General case' 0 C--N 1.31 -1.109 0 C-N-CA 120.43 -0.508 . . . . 0.98 110.81 -168.192 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.51 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 47.9 mtm180 -53.97 -42.65 69.17 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 122.581 0.353 . . . . 2.61 111.902 -176.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -94.54 23.18 5.48 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.164 -0.68 . . . . 2.0 109.164 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.673 ' HA3' ' CE2' ' A' ' 16' ' ' PHE . . . 71.3 37.42 63.12 Favored Glycine 0 N--CA 1.441 -1.002 0 CA-C-N 115.149 -0.932 . . . . 0.19 113.64 176.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.452 ' HA ' ' HD2' ' A' ' 150' ' ' PRO . 46.5 t -103.88 107.46 56.82 Favored Pre-proline 0 C--N 1.316 -0.885 0 C-N-CA 119.809 -0.756 . . . . 1.74 111.43 177.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.838 ' HD3' HG22 ' A' ' 15' ' ' ILE . 15.6 Cg_endo -61.3 127.12 21.06 Favored 'Trans proline' 0 CA--C 1.516 -0.384 0 C-N-CA 123.396 2.731 . . . . 0.6 110.201 174.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.75 ' HA ' ' HG2' ' A' ' 126' ' ' LYS . 4.5 m -135.08 -31.85 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 C-N-CA 120.494 -0.482 . . . . 2.06 112.079 -178.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.761 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 14.4 mm-40 -112.95 159.54 19.0 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.543 -0.54 . . . . 1.17 109.543 174.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.3 131.73 26.88 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 120.281 -0.568 . . . . 2.9 109.604 165.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.784 ' HZ ' ' HB2' ' A' ' 166' ' ' LYS . 97.9 m-85 -104.55 145.43 30.31 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.135 -0.939 . . . . 0.36 109.284 -174.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 3.2 p -78.51 158.1 76.62 Favored Pre-proline 0 C--N 1.314 -0.95 0 N-CA-C 108.985 -0.746 . . . . 1.45 108.985 176.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.66 ' CB ' ' HB2' ' A' ' 138' ' ' ASN . 11.3 Cg_endo -55.6 -45.05 42.37 Favored 'Trans proline' 0 CA--C 1.517 -0.331 0 C-N-CA 121.618 1.546 . . . . 0.78 110.754 178.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -52.87 -16.16 3.85 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-N 114.255 -1.339 . . . . 0.59 114.468 173.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -87.39 137.08 32.65 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 117.767 0.784 . . . . 1.07 109.304 175.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.401 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 68.1 m -114.14 -172.37 2.08 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 120.957 0.408 . . . . 1.92 112.033 -170.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.65 ' CG2' ' HA ' ' A' ' 56' ' ' THR . 57.8 t -40.04 -56.65 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 114.88 -1.055 . . . . 1.07 112.552 -175.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.435 ' HZ1' ' HB2' ' A' ' 161' ' ' LYS . 0.3 OUTLIER -69.75 -31.53 69.55 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.623 0.249 . . . . 3.89 110.917 -172.895 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -66.43 -37.94 86.31 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.316 0.579 . . . . 1.4 109.631 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.81 HD11 ' HH ' ' A' ' 41' ' ' TYR . 81.7 mt -79.89 -43.72 22.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.389 -0.823 . . . . 1.05 111.257 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.585 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 36.7 mt-10 -54.01 -43.24 69.92 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-N 116.565 -0.289 . . . . 0.67 111.413 -177.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -59.56 -19.97 52.31 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.41 0.522 . . . . 0.87 112.41 -175.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.784 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 19.1 mmtp -101.9 -23.91 14.09 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.277 -0.569 . . . . 2.22 110.697 171.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.585 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 12.9 tp -76.8 -54.05 7.12 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.415 -0.811 . . . . 1.04 111.959 -178.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.454 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 72.1 mt -51.52 -45.5 90.71 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.085 -0.961 . . . . 1.08 112.296 -174.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.454 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 88.8 Cg_exo -49.45 -44.26 35.39 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 122.049 1.833 . . . . 0.62 112.71 173.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.777 HD13 HD12 ' A' ' 143' ' ' LEU . 90.5 mt -76.9 -38.82 52.8 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 120.911 -0.316 . . . . 1.36 111.093 -179.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.702 HD23 ' HG2' ' A' ' 37' ' ' PRO . 82.2 mt -59.45 -59.95 4.63 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-O 121.926 0.869 . . . . 1.07 109.908 177.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.571 0 CA-C-N 113.476 -1.693 . . . . 1.12 112.638 179.163 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.9 p . . . . . 0 CA--C 1.523 -0.08 0 CA-C-O 121.04 0.448 . . . . 2.17 110.36 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.502 ' HB3' ' O ' ' A' ' 147' ' ' ASP . 1.5 m -161.16 151.58 17.83 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 105.878 -1.897 . . . . 1.68 105.878 -176.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.796 ' HB ' HD13 ' A' ' 118' ' ' LEU . 4.8 pt -64.61 -16.01 18.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-N 114.927 -1.033 . . . . 1.16 112.015 -172.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.806 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 41.6 m-85 -69.73 -3.12 14.01 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 112.117 0.414 . . . . 0.3 112.117 -178.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -71.84 -25.1 61.84 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.37 -0.974 . . . . 2.11 108.37 174.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.573 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 50.1 m-85 -108.51 110.41 21.9 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 114.407 -1.27 . . . . 0.37 111.162 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -53.73 142.82 22.3 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.069 -1.423 . . . . 2.86 110.215 174.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.776 HG12 ' HZ ' ' A' ' 74' ' ' PHE . 53.7 t -110.71 161.97 8.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 N-CA-C 108.031 -1.1 . . . . 1.32 108.031 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.721 ' O ' ' HB2' ' A' ' 105' ' ' MET . 25.5 mt -130.61 152.44 49.98 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 120.603 -0.439 . . . . 1.29 110.455 -178.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -73.92 -178.46 3.27 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.332 -0.618 . . . . 1.87 109.332 176.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.625 ' HA ' ' N ' ' A' ' 106' ' ' ALA . . . -64.35 -4.41 3.8 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.803 0.335 . . . . 1.2 111.647 -178.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.519 ' HB2' ' HE2' ' A' ' 26' ' ' LYS . 9.7 m-20 -116.95 9.08 13.63 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.704 -0.226 . . . . 2.34 111.452 175.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.639 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 11.1 m170 73.02 11.93 5.12 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-O 121.419 0.628 . . . . 2.26 110.25 174.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.519 ' HE2' ' HB2' ' A' ' 24' ' ' ASP . 26.6 mtmt -69.52 130.68 90.43 Favored Pre-proline 0 N--CA 1.453 -0.322 0 N-CA-C 107.211 -1.403 . . . . 4.64 107.211 165.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.639 ' HA ' HD22 ' A' ' 21' ' ' LEU . 79.7 Cg_exo -51.16 114.79 1.68 Allowed 'Trans proline' 0 CA--C 1.53 0.28 0 C-N-CA 121.895 1.73 . . . . 0.62 113.147 -176.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.56 ' H ' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -76.93 149.9 35.99 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.174 -1.375 . . . . 1.52 110.602 173.179 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.49 ' OD1' ' HB3' ' A' ' 32' ' ' GLN . 2.4 t-20 -93.41 81.57 4.41 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.954 -0.758 . . . . 2.16 108.954 177.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.695 HD23 HD12 ' A' ' 15' ' ' ILE . 61.1 tp -62.01 -41.79 98.46 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.506 -0.77 . . . . 1.07 110.294 -178.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.692 ' HA ' ' CE1' ' A' ' 16' ' ' PHE . 1.6 t -70.12 -1.32 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.099 -0.955 . . . . 1.69 111.93 -170.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.49 ' HB3' ' OD1' ' A' ' 29' ' ' ASN . 2.3 pt20 -74.72 -10.36 59.44 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.06 -0.718 . . . . 1.31 109.06 174.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.954 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 93.9 m-70 -99.41 25.6 6.84 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 121.934 0.873 . . . . 0.35 109.649 176.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.806 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 14.8 mtmt -83.73 132.39 34.85 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 114.297 -1.32 . . . . 2.07 109.155 169.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.83 -42.02 2.03 Favored Glycine 0 N--CA 1.438 -1.233 0 C-N-CA 120.759 -0.734 . . . . 0.24 111.765 -178.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.422 ' HB2' ' HA3' ' A' ' 68' ' ' GLY . 15.7 m -125.31 124.95 25.2 Favored Pre-proline 0 N--CA 1.435 -1.21 0 N-CA-C 108.082 -1.081 . . . . 0.74 108.082 173.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.853 ' HG3' ' HB3' ' A' ' 170' ' ' LEU . 2.2 Cg_endo -39.65 153.9 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 124.266 3.31 . . . . 0.22 113.346 176.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.869 HD13 ' HB2' ' A' ' 33' ' ' HIS . 0.9 OUTLIER -139.34 143.58 37.86 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.427 -1.323 . . . . 1.09 107.427 -179.209 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 1.02 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 1.2 mm? -107.8 121.71 45.28 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.66 -0.867 . . . . 1.82 108.66 176.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.711 HG13 HG13 ' A' ' 144' ' ' ILE . 1.3 mt -105.57 125.61 60.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 C-N-CA 120.109 -0.636 . . . . 1.12 109.551 177.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 1.02 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.4 OUTLIER -109.38 123.29 49.09 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 116.091 -0.504 . . . . 1.09 109.992 -174.408 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.658 ' ND2' ' HB ' ' A' ' 140' ' ' THR . 2.7 p-10 -80.56 93.22 6.04 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 122.3 1.047 . . . . 3.11 108.185 171.45 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.714 ' O ' ' HA ' ' A' ' 75' ' ' PRO . 7.7 p . . . . . 0 C--N 1.306 -1.317 0 CA-C-N 115.388 -0.824 . . . . 1.69 111.367 -164.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.835 0 N-CA-C 109.895 -1.282 . . . . 0.85 109.895 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -45.43 -46.13 11.71 Favored Glycine 0 C--O 1.219 -0.833 0 CA-C-N 114.821 -0.689 . . . . 0.67 113.65 177.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.548 ' HB3' ' OE2' ' A' ' 55' ' ' GLU . 0.6 OUTLIER -60.84 -61.43 2.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.186 0.493 . . . . 1.2 110.872 -175.469 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.548 ' OE2' ' HB3' ' A' ' 54' ' ' TYR . 0.2 OUTLIER -54.04 -31.87 52.71 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.62 0.724 . . . . 2.61 110.995 178.243 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.687 ' HA ' HG23 ' A' ' 160' ' ' VAL . 52.9 m -75.84 -58.99 2.95 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.079 -0.964 . . . . 1.06 110.684 -174.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 1.091 ' HB1' HG13 ' A' ' 71' ' ' VAL . . . -59.2 -40.3 85.33 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.876 -1.056 . . . . 1.05 110.828 -178.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.508 ' HA ' ' CD1' ' A' ' 102' ' ' PHE . 96.9 m -58.64 -55.17 38.53 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 115.695 -0.684 . . . . 1.08 110.358 179.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 61.5 m -69.4 -39.68 77.79 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.182 -0.917 . . . . 1.22 111.736 -176.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.75 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 17.4 mt -64.87 -47.65 77.11 Favored 'General case' 0 CA--C 1.498 -1.038 0 CA-C-O 121.055 0.455 . . . . 1.14 110.367 -175.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.871 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 7.8 t80 -54.56 -54.39 41.96 Favored 'General case' 0 C--O 1.197 -1.68 0 CA-C-N 114.904 -1.043 . . . . 0.94 110.32 177.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -72.54 -24.33 61.11 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 111.866 0.321 . . . . 1.6 111.866 -171.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.517 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 36.7 ttpt -83.6 -20.73 33.19 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 108.688 -0.856 . . . . 2.06 108.688 -178.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.694 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 47.9 m-85 -128.52 -1.93 5.51 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 115.835 1.791 . . . . 0.92 115.835 -173.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.725 ' HG2' ' O ' ' A' ' 61' ' ' TYR . 11.9 ptmt -65.8 -26.97 67.93 Favored 'General case' 0 CA--C 1.497 -1.092 0 N-CA-C 107.834 -1.173 . . . . 1.89 107.834 171.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.3 m -47.73 -38.68 15.89 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 113.893 -1.503 . . . . 1.68 110.837 173.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -86.14 -39.63 16.49 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 111.621 0.23 . . . . 1.11 111.621 174.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.422 ' HA3' ' HB2' ' A' ' 36' ' ' SER . . . 149.63 -3.28 0.61 Allowed Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.263 -0.735 . . . . 0.2 111.263 -176.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.75 ' HE2' ' HB3' ' A' ' 60' ' ' LEU . 28.1 t80 -71.07 140.75 50.79 Favored 'General case' 0 C--O 1.222 -0.346 0 C-N-CA 122.856 0.462 . . . . 0.21 111.381 -177.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.954 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 3.7 t -132.96 152.42 51.93 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 108.452 -0.944 . . . . 1.02 108.452 175.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 1.091 HG13 ' HB1' ' A' ' 57' ' ' ALA . 42.2 t -111.83 101.54 12.68 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.532 0 N-CA-C 108.286 -1.005 . . . . 1.04 108.286 160.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.493 ' HA ' ' O ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -95.06 121.74 36.99 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 118.37 -1.332 . . . . 1.69 107.73 172.984 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.887 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -111.51 128.27 55.96 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 120.581 -0.448 . . . . 1.17 110.71 178.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.776 ' HZ ' HG12 ' A' ' 20' ' ' VAL . 5.3 m-30 -100.8 112.62 65.03 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 116.149 -0.478 . . . . 0.58 110.057 -178.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.714 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 73.6 Cg_endo -80.65 82.45 2.47 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 123.213 2.609 . . . . 1.3 113.504 -169.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.558 ' HB2' ' CG2' ' A' ' 110' ' ' VAL . 19.3 t . . . . . 0 C--O 1.237 0.43 0 CA-C-O 122.782 1.277 . . . . 1.91 114.403 -174.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.495 ' HB1' ' CE1' ' A' ' 102' ' ' PHE . . . . . . . . 0 CA--C 1.518 -0.262 0 CA-C-O 121.152 0.501 . . . . 1.15 112.329 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -94.91 30.28 2.14 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 115.344 -0.844 . . . . 1.99 110.784 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.579 ' CE2' HD13 ' A' ' 104' ' ' ILE . 27.2 p90 -150.07 157.01 37.92 Favored Pre-proline 0 N--CA 1.446 -0.663 0 N-CA-C 108.332 -0.988 . . . . 1.31 108.332 177.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.682 ' HD3' ' CE2' ' A' ' 61' ' ' TYR . 97.7 Cg_exo -51.2 84.12 0.02 OUTLIER 'Trans proline' 0 N--CA 1.479 0.673 0 C-N-CA 124.794 3.663 . . . . 1.07 116.081 -172.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.887 HD12 ' HB3' ' A' ' 73' ' ' ALA . 7.5 mm -85.89 120.6 36.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.092 -1.077 . . . . 1.97 108.092 170.061 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.772 ' HG2' ' CG ' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -76.53 -177.69 4.31 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.753 -0.832 . . . . 3.41 108.753 178.272 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.625 ' N ' ' HA ' ' A' ' 23' ' ' ALA . . . -63.44 -53.75 47.35 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.384 -0.598 . . . . 1.46 109.384 -177.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.601 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 17.4 ptpt 146.15 151.07 0.0 OUTLIER 'General case' 0 CA--C 1.489 -1.385 0 O-C-N 125.823 1.952 . . . . 2.31 108.371 174.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.469 HD11 ' HD2' ' A' ' 74' ' ' PHE . 2.0 pp -152.08 174.53 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 CA-C-N 113.726 -1.579 . . . . 1.65 107.802 169.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -74.24 87.15 1.95 Allowed 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.462 -0.79 . . . . 1.73 110.932 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.558 ' CG2' ' HB2' ' A' ' 76' ' ' SER . 3.6 m -86.0 95.81 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 C-N-CA 118.145 -1.422 . . . . 1.4 108.187 169.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.3 t30 . . . . . 0 C--N 1.311 -1.076 0 CA-C-N 113.63 -1.623 . . . . 2.1 107.815 178.358 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.582 ' ND1' ' H ' ' A' ' 118' ' ' LEU . 2.1 t-80 . . . . . 0 N--CA 1.423 -1.794 0 N-CA-C 106.275 -1.75 . . . . 0.71 106.275 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -27.23 -50.13 0.1 Allowed 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 124.503 3.469 . . . . 0.47 113.598 -178.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.796 HD13 ' HB ' ' A' ' 15' ' ' ILE . 29.1 tp -63.51 -49.28 74.16 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.922 0.489 . . . . 1.15 112.171 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.677 ' OH ' HG22 ' A' ' 40' ' ' ILE . 25.5 m-85 -79.97 -33.96 39.05 Favored 'General case' 0 CA--C 1.492 -1.258 0 CA-C-O 120.935 0.398 . . . . 3.33 110.881 -176.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.483 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 4.7 tt0 -60.42 -37.36 80.63 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 106.589 -1.634 . . . . 2.44 106.589 174.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.573 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 51.5 t80 -68.53 -33.07 73.46 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.047 -0.979 . . . . 1.08 110.492 174.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.683 ' HE2' HD13 ' A' ' 40' ' ' ILE . 2.9 ttm -75.77 -55.58 5.5 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.09 -0.504 . . . . 1.25 110.418 -169.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.426 ' HB2' ' HE2' ' A' ' 123' ' ' LYS . 0.8 OUTLIER -70.82 -25.44 62.85 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 120.616 -0.433 . . . . 1.86 111.721 178.294 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.483 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -72.35 -29.73 64.07 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 119.379 -0.928 . . . . 2.52 109.394 178.447 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 88.0 m -87.26 -31.2 20.39 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.489 -0.778 . . . . 1.21 111.285 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.654 ' HG3' ' HB2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.382 0 N-CA-C 112.727 0.64 . . . . 2.38 112.727 -172.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.536 ' HB3' ' HG3' ' A' ' 156' ' ' PRO . 8.9 m-90 . . . . . 0 CA--C 1.51 -0.586 0 CA-C-O 120.872 0.368 . . . . 2.41 110.446 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.586 ' HB2' ' CB ' ' A' ' 156' ' ' PRO . 3.4 m120 -43.86 -155.71 0.0 OUTLIER 'General case' 0 C--O 1.212 -0.884 0 CA-C-N 114.784 -1.098 . . . . 2.04 111.298 163.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.675 ' HD2' ' HD2' ' A' ' 41' ' ' TYR . 2.9 m-85 -27.4 -52.51 0.07 Allowed 'General case' 0 C--O 1.209 -1.076 0 N-CA-C 115.724 1.75 . . . . 2.53 115.724 -166.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.658 ' HB ' ' ND2' ' A' ' 42' ' ' ASN . 7.5 m 41.6 109.17 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 120.542 1.519 . . . . 1.24 113.648 173.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.569 ' O ' ' HA ' ' A' ' 153' ' ' ARG . 3.5 m -106.0 158.53 16.73 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 114.825 -1.08 . . . . 1.03 111.085 -167.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.546 ' CD1' ' HB2' ' A' ' 153' ' ' ARG . 63.6 m-85 -125.38 124.34 41.29 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 106.899 -1.519 . . . . 0.7 106.899 166.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.768 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 7.1 tp -79.88 104.01 10.17 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 118.337 -1.345 . . . . 1.16 108.369 179.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.745 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 32.3 mm -92.94 137.92 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.612 0 CA-C-N 113.574 -1.648 . . . . 1.05 107.803 -175.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.629 ' OD1' HG13 ' A' ' 149' ' ' VAL . 0.0 OUTLIER -89.18 -173.72 4.15 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 119.74 -0.784 . . . . 0.98 111.592 -168.14 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.697 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 21.1 mtm180 -56.24 -37.7 70.11 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-O 121.373 0.606 . . . . 2.61 110.543 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.502 ' O ' ' HB3' ' A' ' 14' ' ' SER . 27.6 t70 -93.48 13.74 20.81 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.736 -0.838 . . . . 2.0 108.736 -176.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.71 ' HA2' HG22 ' A' ' 144' ' ' ILE . . . 67.6 33.98 82.6 Favored Glycine 0 N--CA 1.434 -1.437 0 CA-C-N 115.359 -0.837 . . . . 0.19 114.404 -177.099 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.629 HG13 ' OD1' ' A' ' 145' ' ' ASP . 9.2 p -105.15 114.02 64.0 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 119.206 1.503 . . . . 1.74 111.44 172.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.69 ' HD3' HG21 ' A' ' 15' ' ' ILE . 2.5 Cg_endo -49.71 126.93 17.49 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 123.869 3.046 . . . . 0.6 111.771 174.002 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 23.0 t -120.09 -32.26 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.397 0.617 . . . . 2.06 109.345 -178.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.768 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 47.8 mm-40 -132.03 167.19 20.12 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-N 115.303 -0.862 . . . . 1.17 111.032 -177.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.569 ' HA ' ' O ' ' A' ' 141' ' ' SER . 1.6 ttm180 -146.33 132.74 19.63 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.266 -0.879 . . . . 2.9 110.744 163.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.563 ' HZ ' ' HB2' ' A' ' 166' ' ' LYS . 98.8 m-85 -110.97 151.55 27.81 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 114.713 -1.13 . . . . 0.36 109.614 -170.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 43.2 t -72.99 156.0 90.02 Favored Pre-proline 0 C--N 1.317 -0.821 0 N-CA-C 109.029 -0.73 . . . . 1.45 109.029 174.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.586 ' CB ' ' HB2' ' A' ' 138' ' ' ASN . 22.8 Cg_endo -61.44 -29.89 85.96 Favored 'Trans proline' 0 CA--C 1.517 -0.341 0 C-N-CA 121.852 1.702 . . . . 0.78 110.247 171.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -73.41 -1.64 57.94 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 114.225 -1.352 . . . . 0.59 113.058 172.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -93.01 140.22 29.7 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 108.421 -0.955 . . . . 1.07 108.421 172.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.532 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 6.7 t -114.2 -170.82 1.79 Allowed 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 120.305 -0.558 . . . . 1.92 111.148 -170.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.687 HG23 ' HA ' ' A' ' 56' ' ' THR . 38.2 t -46.83 -49.47 6.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 114.556 -1.202 . . . . 1.07 111.612 -175.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 50.3 tttp -67.41 -39.9 85.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.873 0.368 . . . . 3.89 111.201 -175.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.411 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 31.2 m-20 -64.25 -37.45 87.51 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.716 -0.674 . . . . 1.4 109.946 -177.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.678 HD11 ' HH ' ' A' ' 41' ' ' TYR . 88.6 mt -80.01 -47.69 21.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.069 -0.969 . . . . 1.05 111.281 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.667 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 30.7 mt-10 -54.5 -40.62 68.71 Favored 'General case' 0 C--O 1.215 -0.714 0 O-C-N 123.151 0.282 . . . . 0.67 111.572 -176.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 10.1 pt-20 -59.57 -21.07 59.79 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.667 0.27 . . . . 0.87 111.493 -175.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.563 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 12.6 mmmm -104.1 -23.92 13.24 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.432 0.634 . . . . 2.22 109.904 175.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.667 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 12.7 tp -79.2 -52.29 8.36 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.725 -1.125 . . . . 1.04 112.106 -178.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.459 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 74.4 mt -53.36 -45.03 98.64 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.31 -0.859 . . . . 1.08 111.959 -174.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.459 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 92.3 Cg_exo -49.06 -44.93 31.2 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 121.929 1.753 . . . . 0.62 112.23 171.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.853 ' HB3' ' HG3' ' A' ' 37' ' ' PRO . 43.5 mt -74.26 -42.78 59.07 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.926 0.343 . . . . 1.36 111.926 -178.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.793 HD22 ' HG2' ' A' ' 37' ' ' PRO . 89.3 mt -60.62 -54.91 39.69 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 122.197 0.998 . . . . 1.07 109.643 177.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.381 0 CA-C-N 113.377 -1.738 . . . . 1.12 114.059 -175.216 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.489 ' C ' ' HH ' ' A' ' 121' ' ' TYR . 14.2 m . . . . . 0 C--O 1.234 0.274 0 CA-C-O 121.365 0.602 . . . . 2.17 110.121 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.425 ' HB3' ' O ' ' A' ' 147' ' ' ASP . 5.9 m -164.76 152.21 11.45 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 104.498 -2.408 . . . . 1.68 104.498 179.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.776 ' HB ' HD12 ' A' ' 118' ' ' LEU . 4.9 pt -62.09 -11.81 6.79 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 CA-C-N 115.59 -0.732 . . . . 1.16 112.302 -172.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.762 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 53.0 m-85 -75.34 0.75 15.7 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.949 0.722 . . . . 0.3 112.949 -176.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -82.2 -19.27 40.15 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.41 -0.959 . . . . 2.11 108.41 175.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.687 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 50.0 m-85 -106.3 113.92 27.73 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 114.855 -1.066 . . . . 0.37 111.791 -178.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -48.56 136.56 12.93 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 113.404 -1.725 . . . . 2.86 111.032 174.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.798 HG13 ' HZ ' ' A' ' 74' ' ' PHE . 94.4 t -112.18 163.91 8.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 108.92 -0.77 . . . . 1.32 108.92 178.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.698 HD23 ' HA ' ' A' ' 27' ' ' PRO . 47.2 mt -130.83 148.97 52.66 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 110.113 -0.328 . . . . 1.29 110.113 -178.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -76.53 177.01 7.77 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.281 -1.377 . . . . 1.87 107.281 166.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.794 ' HA ' ' N ' ' A' ' 106' ' ' ALA . . . -64.62 -4.7 4.43 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.238 0.459 . . . . 1.2 112.238 -176.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.589 ' HB2' ' HE2' ' A' ' 26' ' ' LYS . 54.6 m-20 -105.05 3.03 30.06 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.444 -0.344 . . . . 2.34 111.273 178.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.563 ' HD1' HD13 ' A' ' 21' ' ' LEU . 71.7 m-70 75.48 2.77 3.87 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 122.724 0.41 . . . . 2.26 109.944 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.589 ' HE2' ' HB2' ' A' ' 24' ' ' ASP . 22.1 mtmt -63.01 118.04 38.75 Favored Pre-proline 0 CA--C 1.512 -0.501 0 N-CA-C 106.777 -1.564 . . . . 4.64 106.777 166.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.698 ' HA ' HD23 ' A' ' 21' ' ' LEU . 96.5 Cg_exo -51.2 114.5 1.57 Allowed 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 121.488 1.458 . . . . 0.62 112.222 -177.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.763 ' HE2' HD23 ' A' ' 72' ' ' LEU . 3.6 t80 -78.73 139.17 38.49 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 113.839 -1.528 . . . . 1.52 110.823 177.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.462 ' OD1' ' HB3' ' A' ' 32' ' ' GLN . 2.6 t-20 -80.9 82.76 6.79 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.595 -0.729 . . . . 2.16 109.288 178.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.773 HD13 HG23 ' A' ' 20' ' ' VAL . 52.7 tp -58.44 -43.38 88.75 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.657 -0.701 . . . . 1.07 110.454 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.719 HG11 ' HG3' ' A' ' 34' ' ' LYS . 1.8 t -69.1 -0.26 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 114.918 -1.037 . . . . 1.69 112.384 -168.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.462 ' HB3' ' OD1' ' A' ' 29' ' ' ASN . 9.3 pt20 -77.1 -8.9 58.28 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.247 -0.649 . . . . 1.31 109.247 174.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.919 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 91.2 m-70 -98.95 29.7 3.71 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 122.042 0.925 . . . . 0.35 109.007 175.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.762 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 5.7 mtmt -92.31 109.29 20.67 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 114.25 -1.341 . . . . 2.07 109.768 174.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.73 -38.44 1.99 Allowed Glycine 0 N--CA 1.436 -1.328 0 N-CA-C 111.319 -0.712 . . . . 0.24 111.319 -177.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.468 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 25.4 m -127.49 130.91 23.63 Favored Pre-proline 0 N--CA 1.433 -1.282 0 N-CA-C 108.192 -1.04 . . . . 0.74 108.192 171.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.817 ' HG2' HD23 ' A' ' 171' ' ' LEU . 2.7 Cg_endo -43.43 157.82 0.11 Allowed 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 124.135 3.223 . . . . 0.22 113.016 176.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.732 ' HB2' HG21 ' A' ' 70' ' ' THR . 0.7 OUTLIER -143.12 144.0 32.05 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 106.981 -1.488 . . . . 1.09 106.981 -179.105 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.774 HD21 ' CE1' ' A' ' 69' ' ' PHE . 2.7 mm? -107.92 113.39 26.56 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.075 -0.713 . . . . 1.82 109.075 177.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.906 HG21 HD11 ' A' ' 72' ' ' LEU . 0.9 OUTLIER -97.0 125.35 50.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 109.676 -0.49 . . . . 1.12 109.676 177.219 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.756 ' CE1' HG11 ' A' ' 71' ' ' VAL . 2.4 m-85 -108.26 155.73 20.16 Favored 'General case' 0 C--O 1.216 -0.698 0 CA-C-O 120.899 0.38 . . . . 1.09 111.537 -171.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.742 ' OD1' ' HB2' ' A' ' 76' ' ' SER . 7.0 t30 -105.33 115.35 30.12 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.306 -1.368 . . . . 3.11 107.306 165.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.788 ' O ' ' HA ' ' A' ' 75' ' ' PRO . 34.7 m . . . . . 0 C--N 1.31 -1.151 0 CA-C-O 121.223 0.535 . . . . 1.69 112.124 -171.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.44 0 N-CA-C 110.208 -1.157 . . . . 0.85 110.208 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.462 ' HA2' ' HB ' ' A' ' 56' ' ' THR . . . -61.7 -15.65 48.45 Favored Glycine 0 C--O 1.216 -0.991 0 CA-C-N 114.729 -0.735 . . . . 0.67 112.433 175.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -68.43 -59.99 2.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 117.358 0.579 . . . . 1.2 109.844 178.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -51.85 -32.63 32.68 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.861 0.838 . . . . 2.61 110.456 174.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.728 ' HA ' HG23 ' A' ' 160' ' ' VAL . 43.3 m -72.83 -59.36 2.75 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 114.396 -1.274 . . . . 1.06 110.578 -175.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 1.091 ' HB2' HG13 ' A' ' 71' ' ' VAL . . . -58.52 -42.17 87.1 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.693 -1.14 . . . . 1.05 111.115 -178.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.537 ' HA ' ' CD1' ' A' ' 102' ' ' PHE . 91.5 m -59.63 -55.14 38.16 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.566 0.698 . . . . 1.08 110.442 -178.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 61.4 m -66.82 -36.89 83.42 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.655 -1.157 . . . . 1.22 111.406 -177.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.761 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 14.9 mt -65.42 -47.98 74.38 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 121.364 0.602 . . . . 1.14 110.345 -177.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.87 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 6.7 t80 -59.22 -46.3 88.82 Favored 'General case' 0 C--O 1.207 -1.135 0 CA-C-N 114.896 -1.047 . . . . 0.94 110.489 178.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.69 -25.12 60.09 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 116.416 -0.357 . . . . 1.6 110.981 -174.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.418 ' HB2' ' HE2' ' A' ' 63' ' ' LYS . 6.5 tppt? -80.0 -32.72 39.7 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 108.316 -0.994 . . . . 2.06 108.316 -178.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.745 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 46.0 m-85 -125.67 -2.04 7.32 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 115.802 1.779 . . . . 0.92 115.802 -165.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.659 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 16.3 pttp -67.13 -23.33 65.8 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 107.881 -1.155 . . . . 1.89 107.881 169.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 29.2 t -48.57 -36.94 16.63 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 114.161 -1.381 . . . . 1.68 110.565 169.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.493 HE21 ' HD1' ' A' ' 64' ' ' TYR . 48.0 mt-30 -90.31 -32.44 16.51 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 111.875 0.324 . . . . 1.11 111.875 175.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 142.25 -6.81 2.27 Favored Glycine 0 C--N 1.331 0.264 0 N-CA-C 111.119 -0.792 . . . . 0.2 111.119 -176.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.774 ' CE1' HD21 ' A' ' 39' ' ' LEU . 19.9 t80 -66.91 138.61 57.42 Favored 'General case' 0 C--O 1.22 -0.463 0 C-N-CA 123.045 0.538 . . . . 0.21 111.17 -177.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.919 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 2.0 t -133.51 144.21 49.26 Favored 'General case' 0 N--CA 1.428 -1.573 0 N-CA-C 109.39 -0.596 . . . . 1.02 109.39 175.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 1.091 HG13 ' HB2' ' A' ' 57' ' ' ALA . 19.6 t -103.28 100.61 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.465 0 N-CA-C 108.614 -0.884 . . . . 1.04 108.614 162.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.906 HD11 HG21 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -98.73 120.09 38.58 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.237 -0.985 . . . . 1.69 108.414 174.636 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 1.038 ' HB1' HD13 ' A' ' 104' ' ' ILE . . . -105.49 131.22 53.17 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.64 0.733 . . . . 1.17 111.304 -177.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.798 ' HZ ' HG13 ' A' ' 20' ' ' VAL . 3.0 m-30 -107.76 108.94 62.08 Favored Pre-proline 0 C--N 1.31 -1.116 0 CA-C-N 114.998 -1.001 . . . . 0.58 108.905 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.788 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 18.0 Cg_endo -82.13 87.48 1.4 Allowed 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.551 2.167 . . . . 1.3 113.321 -171.052 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.742 ' HB2' ' OD1' ' A' ' 42' ' ' ASN . 1.6 t . . . . . 0 CA--C 1.506 -0.739 0 CA-C-N 115.157 -0.929 . . . . 1.91 113.013 -173.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.634 0 CA-C-O 121.114 0.483 . . . . 1.15 111.24 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -87.4 -5.39 58.87 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.353 -0.839 . . . . 1.99 110.108 174.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.705 ' HB2' ' O ' ' A' ' 71' ' ' VAL . 16.6 p90 -121.09 160.26 45.98 Favored Pre-proline 0 N--CA 1.44 -0.932 0 CA-C-N 115.639 -0.71 . . . . 1.31 110.37 -175.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.629 ' HG2' ' HA ' ' A' ' 72' ' ' LEU . 44.0 Cg_endo -61.65 95.99 0.13 Allowed 'Trans proline' 0 N--CA 1.479 0.624 0 C-N-CA 124.71 3.606 . . . . 1.07 114.284 -174.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 1.038 HD13 ' HB1' ' A' ' 73' ' ' ALA . 4.8 mm -87.02 129.8 37.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 108.591 -0.892 . . . . 1.97 108.591 171.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.754 ' HG2' ' CG ' ' A' ' 74' ' ' PHE . 0.1 OUTLIER -82.66 174.03 11.38 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.709 -0.848 . . . . 3.41 108.709 177.114 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.794 ' N ' ' HA ' ' A' ' 23' ' ' ALA . . . -56.09 -56.51 19.98 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.16 0.505 . . . . 1.46 110.127 -176.046 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.718 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 4.7 ptpp? 144.33 137.03 0.0 OUTLIER 'General case' 0 CA--C 1.488 -1.416 0 O-C-N 125.734 1.896 . . . . 2.31 106.952 176.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.459 HG12 ' HD2' ' A' ' 74' ' ' PHE . 2.9 pp -136.21 163.32 34.32 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.281 0 CA-C-N 113.945 -1.479 . . . . 1.65 107.497 177.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -71.19 57.58 0.23 Allowed 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 122.947 0.499 . . . . 1.73 111.894 -173.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.562 HG21 ' CB ' ' A' ' 76' ' ' SER . 0.0 OUTLIER -61.16 94.83 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 N-CA-C 108.92 -0.77 . . . . 1.4 108.92 -178.121 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.8 t30 . . . . . 0 N--CA 1.441 -0.918 0 CA-C-N 114.245 -1.343 . . . . 2.1 108.717 -177.221 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.703 ' ND1' ' H ' ' A' ' 118' ' ' LEU . 3.2 t-80 . . . . . 0 N--CA 1.422 -1.828 0 N-CA-C 105.636 -1.987 . . . . 0.71 105.636 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -29.38 -44.31 0.1 OUTLIER 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 124.128 3.219 . . . . 0.47 113.577 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.776 HD12 ' HB ' ' A' ' 15' ' ' ILE . 39.4 tp -59.63 -52.25 66.34 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.495 0.718 . . . . 1.15 112.079 176.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.641 ' HA ' ' HB2' ' A' ' 122' ' ' MET . 43.0 m-85 -77.39 -36.27 53.55 Favored 'General case' 0 CA--C 1.5 -0.953 0 N-CA-C 111.871 0.322 . . . . 3.33 111.871 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.727 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 7.0 mm-40 -59.33 -32.81 70.42 Favored 'General case' 0 CA--C 1.494 -1.182 0 N-CA-C 107.828 -1.175 . . . . 2.44 107.828 172.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.687 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 55.0 t80 -70.81 -33.71 70.99 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 119.731 -0.788 . . . . 1.08 110.651 172.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.692 ' HG3' ' HG3' ' A' ' 150' ' ' PRO . 2.6 ttm -73.59 -55.22 6.58 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.903 -0.589 . . . . 1.25 110.102 -168.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 126' ' ' LYS . 0.2 OUTLIER -71.31 -24.13 62.07 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.088 -0.505 . . . . 1.86 111.614 176.372 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.727 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 9.8 pttp -68.71 -27.54 66.03 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 119.088 -1.045 . . . . 2.52 108.889 175.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 56.0 m -76.73 -50.04 14.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.463 -0.79 . . . . 1.21 109.546 173.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.64 ' HB3' ' NH2' ' A' ' 153' ' ' ARG . 31.4 mttm . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 115.902 -0.59 . . . . 2.38 111.077 176.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.573 ' HB2' ' OG1' ' A' ' 140' ' ' THR . 12.0 m-90 . . . . . 0 N--CA 1.448 -0.561 0 N-CA-C 108.159 -1.052 . . . . 2.41 108.159 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.651 ' HB2' ' CB ' ' A' ' 156' ' ' PRO . 11.5 m120 -45.25 -155.31 0.0 OUTLIER 'General case' 0 C--O 1.21 -1.019 0 C-N-CA 123.907 0.883 . . . . 2.04 111.403 163.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.68 ' HA ' HG12 ' A' ' 43' ' ' VAL . 1.3 m-85 -30.47 -27.65 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.308 0 N-CA-C 117.317 2.34 . . . . 2.53 117.317 -167.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.672 ' HA ' ' O ' ' A' ' 154' ' ' PHE . 3.1 m 9.08 108.55 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 115.162 1.541 . . . . 1.24 115.162 169.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.584 ' OG ' HD13 ' A' ' 39' ' ' LEU . 3.1 t -105.84 165.59 11.08 Favored 'General case' 0 C--O 1.207 -1.177 0 CA-C-N 114.903 -1.044 . . . . 1.03 110.855 -173.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.428 ' CG ' ' HG2' ' A' ' 122' ' ' MET . 15.1 m-85 -121.51 125.22 46.3 Favored 'General case' 0 CA--C 1.49 -1.337 0 N-CA-C 106.486 -1.672 . . . . 0.7 106.486 167.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.76 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 11.1 tp -80.36 104.14 10.7 Favored 'General case' 0 N--CA 1.419 -2.004 0 C-N-CA 118.222 -1.391 . . . . 1.16 108.457 178.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.682 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 41.1 mm -89.21 141.7 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.658 0 CA-C-N 113.012 -1.904 . . . . 1.05 107.701 -177.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.649 ' HA ' HD11 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -93.46 -176.01 3.97 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 119.938 -0.705 . . . . 0.98 111.137 -170.865 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.667 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 50.4 mtm180 -54.49 -37.12 64.92 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.878 0.37 . . . . 2.61 111.301 -177.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.425 ' O ' ' HB3' ' A' ' 14' ' ' SER . 7.5 m-20 -94.36 13.96 22.0 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.716 -0.22 . . . . 2.0 110.782 -178.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.635 ' HA3' ' CE2' ' A' ' 16' ' ' PHE . . . 73.14 36.82 56.04 Favored Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 120.858 -0.687 . . . . 0.19 113.286 -176.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.458 ' HA ' ' HD2' ' A' ' 150' ' ' PRO . 52.6 t -107.82 106.32 58.24 Favored Pre-proline 0 C--N 1.317 -0.829 0 CA-C-N 117.701 0.75 . . . . 1.74 111.078 175.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.692 ' HG3' ' HG3' ' A' ' 122' ' ' MET . 2.1 Cg_endo -51.48 117.24 3.28 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 123.746 2.964 . . . . 0.6 111.462 172.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.837 HG23 ' HG2' ' A' ' 152' ' ' GLU . 27.5 m -118.33 -13.02 10.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 121.133 0.492 . . . . 2.06 109.754 -178.215 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.837 ' HG2' HG23 ' A' ' 151' ' ' VAL . 17.2 mm-40 -145.99 165.9 27.65 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.582 -0.736 . . . . 1.17 109.652 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.64 ' NH2' ' HB3' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -148.03 144.23 27.77 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.634 -0.712 . . . . 2.9 110.044 159.459 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.705 ' HZ ' ' HB2' ' A' ' 166' ' ' LYS . 91.5 m-85 -120.58 148.25 44.12 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.333 -0.849 . . . . 0.36 108.802 -166.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.419 ' HB3' ' HD2' ' A' ' 156' ' ' PRO . 10.8 m -74.56 162.67 72.67 Favored Pre-proline 0 C--N 1.316 -0.889 0 N-CA-C 109.654 -0.498 . . . . 1.45 109.654 178.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.651 ' CB ' ' HB2' ' A' ' 138' ' ' ASN . 28.6 Cg_endo -63.82 -33.04 66.3 Favored 'Trans proline' 0 CA--C 1.516 -0.386 0 C-N-CA 121.973 1.782 . . . . 0.78 110.42 174.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -63.96 -5.54 14.84 Favored Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 113.926 -1.488 . . . . 0.59 113.822 170.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -87.74 142.32 27.92 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 117.765 0.782 . . . . 1.07 109.408 174.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.445 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 20.3 t -109.92 -179.82 3.91 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 120.881 0.372 . . . . 1.92 110.414 -172.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.728 HG23 ' HA ' ' A' ' 56' ' ' THR . 62.9 t -43.68 -52.13 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.082 -0.963 . . . . 1.07 111.452 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.33 -27.58 62.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.956 -0.566 . . . . 3.89 111.486 -173.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -71.12 -37.75 72.32 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 109.144 -0.687 . . . . 1.4 109.144 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.534 ' HA ' ' CE2' ' A' ' 154' ' ' PHE . 75.0 mt -77.35 -49.09 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-N 115.027 -0.988 . . . . 1.05 110.639 176.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.665 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 25.5 mt-10 -51.78 -45.47 63.82 Favored 'General case' 0 C--O 1.219 -0.54 0 O-C-N 123.302 0.376 . . . . 0.67 111.305 -177.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -56.31 -23.34 36.3 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.041 0.386 . . . . 0.87 112.041 -175.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.705 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 14.2 mmmm -102.1 -23.91 14.01 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.342 0.591 . . . . 2.22 110.064 174.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.665 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 7.5 tp -76.74 -48.06 19.91 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.262 -0.881 . . . . 1.04 111.95 -177.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.487 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 80.6 mt -53.76 -46.39 98.41 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.616 -0.72 . . . . 1.08 112.175 -174.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.487 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 58.0 Cg_exo -54.65 -22.93 30.53 Favored 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 122.311 2.007 . . . . 0.62 113.12 174.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.765 ' HB3' ' HG3' ' A' ' 37' ' ' PRO . 31.2 mt -92.98 -38.5 11.63 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 111.68 0.252 . . . . 1.36 111.68 178.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.817 HD23 ' HG2' ' A' ' 37' ' ' PRO . 94.9 mt -63.29 -52.04 63.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-O 122.212 1.006 . . . . 1.07 109.313 175.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.563 0 CA-C-N 113.265 -1.789 . . . . 1.12 114.184 -174.963 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.2 t . . . . . 0 C--O 1.233 0.221 0 CA-C-O 121.834 0.826 . . . . 2.17 108.794 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.421 ' HB2' ' O ' ' A' ' 147' ' ' ASP . 92.0 p -179.91 152.69 0.48 Allowed 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 104.831 -2.285 . . . . 1.68 104.831 -177.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.944 HD11 HD23 ' A' ' 30' ' ' LEU . 4.7 pt -66.96 -12.66 15.42 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 CA-C-N 115.371 -0.831 . . . . 1.16 112.021 -171.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.651 ' CD1' ' HA ' ' A' ' 31' ' ' VAL . 54.9 m-85 -76.28 6.97 4.74 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.028 0.442 . . . . 0.3 111.167 178.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -81.7 -27.74 33.8 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 107.24 -1.393 . . . . 2.11 107.24 174.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.642 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 50.9 m-85 -105.05 121.02 42.92 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 113.963 -1.472 . . . . 0.37 111.008 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -60.18 150.08 30.99 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.29 -1.323 . . . . 2.86 109.818 173.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.781 HG11 ' HZ ' ' A' ' 74' ' ' PHE . 53.0 t -112.23 170.66 3.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 107.71 -1.219 . . . . 1.32 107.71 178.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.729 HD21 ' HA ' ' A' ' 27' ' ' PRO . 88.7 mt -132.37 141.05 48.74 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 118.334 0.515 . . . . 1.29 111.409 -176.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -74.36 169.07 18.42 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 106.878 -1.527 . . . . 1.87 106.878 166.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.805 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . . . -62.4 -3.73 1.53 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 114.046 1.128 . . . . 1.2 114.046 -167.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.545 ' HB2' ' HE2' ' A' ' 26' ' ' LYS . 64.7 m-20 -111.5 12.06 21.37 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 121.008 -0.277 . . . . 2.34 111.349 176.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.546 ' CD2' ' HB1' ' A' ' 106' ' ' ALA . 72.1 m-70 77.13 8.96 2.77 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.366 0.603 . . . . 2.26 109.72 177.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.545 ' HE2' ' HB2' ' A' ' 24' ' ' ASP . 21.1 mtmt -74.65 119.3 76.0 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 107.54 -1.282 . . . . 4.64 107.54 169.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.729 ' HA ' HD21 ' A' ' 21' ' ' LEU . 93.9 Cg_exo -50.39 115.27 1.83 Allowed 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.329 2.019 . . . . 0.62 114.203 -172.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.608 ' CE2' ' HB3' ' A' ' 103' ' ' PRO . 0.2 OUTLIER -78.6 120.4 23.23 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 113.275 -1.784 . . . . 1.52 109.635 169.201 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -72.96 103.1 3.65 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 122.446 1.117 . . . . 2.16 108.82 174.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.944 HD23 HD11 ' A' ' 15' ' ' ILE . 67.3 tp -71.4 -31.48 67.32 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.834 -1.076 . . . . 1.07 110.343 -178.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.651 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 3.3 m -66.14 -4.13 2.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 114.439 -1.255 . . . . 1.69 113.109 -167.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 -74.67 -6.64 49.84 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.557 0.694 . . . . 1.31 110.01 175.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.949 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 88.6 m-70 -102.13 24.97 9.36 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 115.339 -0.846 . . . . 0.35 109.397 176.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.56 ' HE3' ' HB ' ' A' ' 31' ' ' VAL . 93.0 mttt -83.99 123.79 30.36 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 114.426 -1.261 . . . . 2.07 109.323 170.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.14 -36.08 4.07 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.366 -0.921 . . . . 0.24 111.925 178.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.452 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 22.5 m -130.38 132.33 23.95 Favored Pre-proline 0 N--CA 1.436 -1.162 0 N-CA-C 108.252 -1.018 . . . . 0.74 108.252 171.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.755 ' HG3' ' CB ' ' A' ' 170' ' ' LEU . 5.1 Cg_endo -43.18 153.86 0.18 Allowed 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.899 3.066 . . . . 0.22 112.795 176.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.808 HD11 ' HB2' ' A' ' 33' ' ' HIS . 0.7 OUTLIER -139.65 149.17 43.42 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 106.313 -1.736 . . . . 1.09 106.313 -179.733 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.949 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 2.3 mp -116.3 130.84 56.98 Favored 'General case' 0 C--N 1.292 -1.92 0 O-C-N 121.629 -0.669 . . . . 1.82 109.606 176.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.924 HG23 ' OH ' ' A' ' 119' ' ' TYR . 1.1 mt -111.72 126.75 69.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 CA-C-N 115.065 -0.971 . . . . 1.12 109.596 178.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.949 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.6 OUTLIER -111.86 124.72 52.95 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.954 -0.566 . . . . 1.09 110.992 -171.662 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.613 ' ND2' ' HB2' ' A' ' 76' ' ' SER . 0.9 OUTLIER -79.66 95.12 5.84 Favored 'General case' 0 CA--C 1.504 -0.827 0 N-CA-C 107.206 -1.405 . . . . 3.11 107.206 167.194 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.704 ' O ' ' HA ' ' A' ' 75' ' ' PRO . 4.1 p . . . . . 0 C--N 1.294 -1.831 0 CA-C-N 114.833 -1.076 . . . . 1.69 109.649 -172.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.452 0 N-CA-C 110.301 -1.12 . . . . 0.85 110.301 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -49.85 -46.69 40.06 Favored Glycine 0 C--O 1.222 -0.62 0 CA-C-N 114.424 -0.888 . . . . 0.67 113.969 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -59.31 -59.14 5.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.328 0.564 . . . . 1.2 111.554 -171.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.14 -27.87 69.67 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.291 0.567 . . . . 2.61 110.48 -177.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.677 HG23 ' HA ' ' A' ' 160' ' ' VAL . 31.8 m -75.83 -57.77 3.68 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.084 -0.962 . . . . 1.06 110.02 -175.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 1.05 ' HB3' HG11 ' A' ' 71' ' ' VAL . . . -60.3 -41.67 93.88 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.202 -0.908 . . . . 1.05 111.039 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.531 ' HA ' ' CD2' ' A' ' 102' ' ' PHE . 96.7 m -57.69 -55.69 31.53 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.433 0.635 . . . . 1.08 110.466 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 27.3 m -69.46 -36.11 76.27 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.001 -0.999 . . . . 1.22 111.484 -175.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.733 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 16.3 mt -66.93 -47.07 72.82 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-O 120.974 0.416 . . . . 1.14 110.472 -176.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.862 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 5.0 t80 -55.31 -56.14 23.4 Favored 'General case' 0 C--O 1.198 -1.637 0 CA-C-N 115.208 -0.905 . . . . 0.94 109.916 177.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -69.75 -24.04 63.47 Favored 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 122.707 0.403 . . . . 1.6 111.566 -173.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.408 ' HE2' ' HB2' ' A' ' 63' ' ' LYS . 13.8 tppt? -76.01 -32.25 59.3 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 108.388 -0.968 . . . . 2.06 108.388 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.698 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 48.4 m-85 -125.86 -2.44 7.18 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 115.7 1.741 . . . . 0.92 115.7 -166.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.754 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 12.6 ptmt -63.84 -29.27 70.48 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 107.686 -1.227 . . . . 1.89 107.686 170.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.6 m -47.94 -36.63 12.76 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 113.822 -1.536 . . . . 1.68 111.009 173.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.448 HE21 ' HD1' ' A' ' 64' ' ' TYR . 49.7 mt-30 -88.44 -39.75 14.0 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 120.96 -0.296 . . . . 1.11 111.619 173.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.439 ' HA3' ' HB2' ' A' ' 36' ' ' SER . . . 151.49 -4.03 0.47 Allowed Glycine 0 CA--C 1.52 0.388 0 N-CA-C 111.505 -0.638 . . . . 0.2 111.505 -175.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.733 ' HE2' ' HB3' ' A' ' 60' ' ' LEU . 21.4 t80 -71.2 142.59 50.64 Favored 'General case' 0 C--O 1.222 -0.392 0 C-N-CA 122.644 0.377 . . . . 0.21 111.131 -177.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.949 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 2.3 t -133.76 153.15 51.92 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 108.063 -1.088 . . . . 1.02 108.063 173.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 1.05 HG11 ' HB3' ' A' ' 57' ' ' ALA . 25.6 t -112.97 99.5 8.79 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.541 0 N-CA-C 108.018 -1.104 . . . . 1.04 108.018 160.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.469 HD12 HG22 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -93.68 120.2 33.65 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 118.365 -1.334 . . . . 1.69 107.557 174.554 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.81 ' HB1' HD12 ' A' ' 104' ' ' ILE . . . -112.21 117.23 31.99 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.538 0.685 . . . . 1.17 110.901 -178.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.84 ' CG ' ' HG2' ' A' ' 105' ' ' MET . 5.3 m-30 -93.31 112.54 56.86 Favored Pre-proline 0 C--N 1.318 -0.779 0 CA-C-N 115.241 -0.891 . . . . 0.58 109.388 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.723 ' O ' ' HB2' ' A' ' 107' ' ' LYS . 44.2 Cg_endo -82.29 87.4 1.4 Allowed 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.082 1.855 . . . . 1.3 112.694 -172.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.613 ' HB2' ' ND2' ' A' ' 42' ' ' ASN . 7.0 t . . . . . 0 C--N 1.321 -0.655 0 CA-C-N 114.382 -1.281 . . . . 1.91 111.765 -177.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.514 -0.434 0 CA-C-O 121.048 0.452 . . . . 1.15 111.36 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -85.86 22.52 1.65 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.308 -0.86 . . . . 1.99 110.606 -177.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.561 ' HB2' ' O ' ' A' ' 71' ' ' VAL . 19.1 p90 -147.33 163.67 26.89 Favored Pre-proline 0 N--CA 1.447 -0.609 0 CA-C-N 115.711 -0.677 . . . . 1.31 109.312 -178.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.658 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 71.3 Cg_exo -57.12 89.39 0.04 OUTLIER 'Trans proline' 0 N--CA 1.478 0.608 0 C-N-CA 124.608 3.538 . . . . 1.07 115.44 -172.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.81 HD12 ' HB1' ' A' ' 73' ' ' ALA . 3.6 mm -89.52 127.54 42.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 108.259 -1.015 . . . . 1.97 108.259 171.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.84 ' HG2' ' CG ' ' A' ' 74' ' ' PHE . 0.7 OUTLIER -88.83 -171.37 3.28 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.8 0.333 . . . . 3.41 111.563 -172.206 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.805 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . . . -61.19 -16.88 49.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.808 -0.633 . . . . 1.46 111.795 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.723 ' HB2' ' O ' ' A' ' 75' ' ' PRO . 3.7 ptpp? 78.27 128.2 0.05 OUTLIER 'General case' 0 CA--C 1.494 -1.193 0 O-C-N 125.477 1.736 . . . . 2.31 109.846 -166.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.407 HD13 ' HB3' ' A' ' 116' ' ' HIS . 2.4 pp -128.87 163.64 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.162 0 CA-C-N 113.028 -1.897 . . . . 1.65 107.042 171.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.15 58.1 0.16 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 123.897 0.748 . . . . 1.73 111.556 -172.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.558 ' HB ' ' ND2' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -63.91 96.64 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 CA-C-O 120.849 0.357 . . . . 1.4 111.08 -171.977 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.481 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 3.5 t-20 . . . . . 0 N--CA 1.445 -0.681 0 N-CA-C 108.337 -0.986 . . . . 2.1 108.337 167.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.677 ' ND1' ' H ' ' A' ' 118' ' ' LEU . 2.0 t-80 . . . . . 0 N--CA 1.43 -1.456 0 N-CA-C 106.254 -1.758 . . . . 0.71 106.254 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -30.31 -46.26 0.14 Allowed 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 124.303 3.336 . . . . 0.47 113.621 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.732 HD13 ' HB ' ' A' ' 15' ' ' ILE . 22.6 tp -62.64 -51.34 67.64 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.174 0.589 . . . . 1.15 111.886 178.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.924 ' OH ' HG23 ' A' ' 40' ' ' ILE . 36.6 m-85 -76.58 -36.55 57.51 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 112.285 0.476 . . . . 3.33 112.285 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.777 ' HA ' ' HD2' ' A' ' 123' ' ' LYS . 48.5 mt-10 -61.61 -30.79 70.92 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 107.462 -1.31 . . . . 2.44 107.462 174.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.642 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 59.5 t80 -71.62 -32.87 68.43 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.426 -0.806 . . . . 1.08 110.682 171.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.728 ' HE3' HD12 ' A' ' 40' ' ' ILE . 2.5 ttm -73.73 -52.46 13.13 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.178 -0.465 . . . . 1.25 110.367 -169.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.777 ' HD2' ' HA ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -71.04 -24.73 62.4 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.196 -0.456 . . . . 1.86 111.079 175.463 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.752 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -65.0 -30.75 71.76 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.461 0.648 . . . . 2.52 109.741 172.257 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 85.9 m -79.51 -47.32 15.78 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.245 -0.889 . . . . 1.21 111.038 178.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.563 ' HE3' ' O ' ' A' ' 151' ' ' VAL . 19.9 ttmm . . . . . 0 C--N 1.326 -0.441 0 CA-C-O 121.06 0.457 . . . . 2.38 111.982 -178.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.752 ' HB3' ' HG3' ' A' ' 156' ' ' PRO . 2.3 m-90 . . . . . 0 CA--C 1.51 -0.565 0 N-CA-C 110.229 -0.286 . . . . 2.41 110.229 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -42.26 -155.8 0.0 OUTLIER 'General case' 0 C--O 1.205 -1.245 0 C-N-CA 124.022 0.929 . . . . 2.04 110.535 159.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.683 ' CD1' HG23 ' A' ' 43' ' ' VAL . 5.0 m-85 -26.04 -46.72 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.046 0 N-CA-C 116.025 1.861 . . . . 2.53 116.025 -163.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.699 ' HA ' ' O ' ' A' ' 154' ' ' PHE . 5.7 m 28.34 96.16 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 119.675 1.125 . . . . 1.24 113.664 171.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.433 ' HB3' HD23 ' A' ' 39' ' ' LEU . 1.6 m -85.07 170.74 12.65 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.041 -0.982 . . . . 1.03 111.714 -170.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.493 ' HA ' ' O ' ' A' ' 152' ' ' GLU . 81.1 m-85 -130.46 120.3 23.97 Favored 'General case' 0 CA--C 1.496 -1.116 0 N-CA-C 105.886 -1.894 . . . . 0.7 105.886 161.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.748 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 4.9 tp -78.82 103.64 8.91 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 118.054 -1.458 . . . . 1.16 108.062 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.748 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 45.6 mm -88.77 141.27 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.788 0 CA-C-N 113.474 -1.694 . . . . 1.05 107.564 -177.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.411 ' HA ' HD11 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -92.37 -176.05 4.2 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 119.179 -1.008 . . . . 0.98 110.601 -171.92 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.684 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 11.5 mtm180 -54.55 -40.89 69.14 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.141 0.496 . . . . 2.61 111.031 -176.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.421 ' O ' ' HB2' ' A' ' 14' ' ' SER . 5.0 m-20 -94.83 18.01 12.61 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.558 -0.534 . . . . 2.0 109.558 -175.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.552 ' HA3' ' CE2' ' A' ' 16' ' ' PHE . . . 73.12 33.68 59.11 Favored Glycine 0 N--CA 1.44 -1.077 0 CA-C-N 115.688 -0.687 . . . . 0.19 114.128 178.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.497 ' HA ' ' HD2' ' A' ' 150' ' ' PRO . 62.1 t -107.45 106.93 59.63 Favored Pre-proline 0 C--N 1.314 -0.953 0 CA-C-N 118.298 1.049 . . . . 1.74 111.291 176.077 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.546 ' HG3' ' HG3' ' A' ' 122' ' ' MET . 5.7 Cg_exo -46.34 122.9 6.04 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 124.155 3.237 . . . . 0.6 112.087 171.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.563 ' O ' ' HE3' ' A' ' 126' ' ' LYS . 46.8 t -117.99 -29.66 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 109.369 -0.604 . . . . 2.06 109.369 -176.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.748 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 31.0 mm-40 -136.84 167.03 22.23 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.562 -0.745 . . . . 1.17 110.848 -177.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.418 ' HA ' ' O ' ' A' ' 141' ' ' SER . 0.2 OUTLIER -144.02 131.37 20.89 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.473 -0.785 . . . . 2.9 109.712 163.552 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.699 ' O ' ' HA ' ' A' ' 140' ' ' THR . 96.8 m-85 -111.02 152.32 26.98 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.866 -0.606 . . . . 0.36 109.63 -170.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 12.5 m -74.76 156.94 86.31 Favored Pre-proline 0 C--N 1.319 -0.719 0 N-CA-C 109.469 -0.567 . . . . 1.45 109.469 176.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.752 ' HG3' ' HB3' ' A' ' 137' ' ' TRP . 34.4 Cg_endo -64.88 -24.89 60.46 Favored 'Trans proline' 0 CA--C 1.519 -0.267 0 C-N-CA 122.181 1.92 . . . . 0.78 111.039 177.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -80.44 5.6 63.54 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 114.691 -1.14 . . . . 0.59 113.453 173.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -79.19 151.33 31.3 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.388 -0.597 . . . . 1.07 109.388 173.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 33.8 t -108.34 169.33 8.71 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 109.494 -0.558 . . . . 1.92 109.494 -177.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.677 ' HA ' HG23 ' A' ' 56' ' ' THR . 99.3 t -40.14 -59.48 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 O-C-N 124.356 1.035 . . . . 1.07 111.683 178.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.484 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 0.9 OUTLIER -65.74 -30.26 70.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.299 -0.409 . . . . 3.89 111.986 -173.483 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -65.25 -35.95 82.63 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-O 122.247 1.022 . . . . 1.4 108.756 -178.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.576 ' HA ' ' CE2' ' A' ' 154' ' ' PHE . 54.5 mt -78.17 -44.25 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 CA-C-N 113.7 -1.591 . . . . 1.05 110.483 175.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.613 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 47.7 mt-10 -54.93 -43.12 73.07 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 116.048 -0.524 . . . . 0.67 111.492 -177.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 161' ' ' LYS . 7.0 pt-20 -61.03 -16.69 46.36 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.235 0.457 . . . . 0.87 112.235 -176.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.623 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 34.0 mmtp -100.72 -28.89 12.58 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.667 0.746 . . . . 2.22 109.793 172.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.613 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 12.5 tp -78.84 -50.97 10.37 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.857 -1.065 . . . . 1.04 112.749 -175.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.491 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 63.3 mt -55.14 -45.78 99.79 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.85 -0.614 . . . . 1.08 112.387 -174.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.491 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 58.2 Cg_exo -56.14 -17.29 19.54 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 122.081 1.854 . . . . 0.62 113.124 174.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.755 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 78.0 mt -97.7 -42.72 7.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.741 -0.209 . . . . 1.36 111.08 176.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.674 HD22 ' HG2' ' A' ' 37' ' ' PRO . 93.7 mt -61.08 -52.1 66.37 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-O 122.165 0.983 . . . . 1.07 109.595 175.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.331 0 CA-C-N 113.565 -1.652 . . . . 1.12 112.923 -178.655 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.1 t . . . . . 0 CA--C 1.529 0.169 0 CA-C-O 120.965 0.412 . . . . 2.17 110.318 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 27.8 m -163.64 151.55 13.05 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 104.854 -2.276 . . . . 1.68 104.854 -179.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.789 ' HB ' ' CD1' ' A' ' 118' ' ' LEU . 6.3 pt -58.93 -20.55 17.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 CA-C-N 115.042 -0.981 . . . . 1.16 111.756 -174.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.837 ' HB3' HG13 ' A' ' 31' ' ' VAL . 42.2 m-85 -67.2 -6.24 17.19 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.293 0.849 . . . . 0.3 113.293 -175.229 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -78.4 -15.78 58.31 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 107.873 -1.158 . . . . 2.11 107.873 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.551 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 37.3 m-85 -107.61 115.88 30.94 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 114.577 -1.192 . . . . 0.37 110.829 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -55.62 144.32 27.06 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 113.896 -1.502 . . . . 2.86 110.054 175.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.79 HG13 ' HZ ' ' A' ' 74' ' ' PHE . 66.5 t -112.14 166.14 6.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 107.879 -1.156 . . . . 1.32 107.879 179.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.691 HD22 ' HA ' ' A' ' 27' ' ' PRO . 55.7 mt -125.6 146.59 49.63 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 109.949 -0.389 . . . . 1.29 109.949 178.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.558 ' HB3' ' HE3' ' A' ' 26' ' ' LYS . 16.5 t70 -77.8 169.79 17.68 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 106.146 -1.798 . . . . 1.87 106.146 165.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.675 ' HA ' ' N ' ' A' ' 106' ' ' ALA . . . -63.68 -3.65 2.45 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 113.253 0.834 . . . . 1.2 113.253 -168.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.947 ' HB2' ' HE2' ' A' ' 26' ' ' LYS . 3.3 m-20 -107.0 6.01 28.67 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 111.451 0.167 . . . . 2.34 111.451 176.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.557 ' CD2' ' HB1' ' A' ' 106' ' ' ALA . 59.9 m-70 79.85 6.04 1.86 Allowed 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.521 0.677 . . . . 2.26 109.61 177.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.947 ' HE2' ' HB2' ' A' ' 24' ' ' ASP . 29.8 mtmt -66.68 115.94 29.66 Favored Pre-proline 0 N--CA 1.447 -0.595 0 N-CA-C 107.656 -1.238 . . . . 4.64 107.656 167.057 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.691 ' HA ' HD22 ' A' ' 21' ' ' LEU . 75.4 Cg_exo -48.76 114.86 1.38 Allowed 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 121.796 1.664 . . . . 0.62 112.313 -178.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.502 ' HE2' HD22 ' A' ' 72' ' ' LEU . 0.8 OUTLIER -78.39 151.55 32.74 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 113.573 -1.649 . . . . 1.52 111.761 179.589 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.605 ' OD1' ' HB3' ' A' ' 32' ' ' GLN . 2.8 t-20 -86.82 90.2 8.22 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.8 -1.091 . . . . 2.16 109.836 174.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.632 HD21 ' HA ' ' A' ' 16' ' ' PHE . 63.2 tp -71.56 -43.79 65.7 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.179 0.514 . . . . 1.07 110.601 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.837 HG13 ' HB3' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -67.56 0.89 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.18 -0.918 . . . . 1.69 113.174 -172.12 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.605 ' HB3' ' OD1' ' A' ' 29' ' ' ASN . 3.7 pt20 -72.54 -11.88 60.84 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.553 0.692 . . . . 1.31 109.322 172.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.951 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 91.6 m-70 -98.73 21.18 11.76 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 115.267 -0.879 . . . . 0.35 109.087 176.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.769 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 11.0 mtmm -80.1 110.4 15.47 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.541 -1.209 . . . . 2.07 109.118 169.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 133.45 -43.06 1.3 Allowed Glycine 0 N--CA 1.439 -1.106 0 C-N-CA 120.75 -0.738 . . . . 0.24 111.841 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.414 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 72.3 m -126.88 138.09 31.91 Favored Pre-proline 0 N--CA 1.439 -0.987 0 N-CA-C 108.576 -0.898 . . . . 0.74 108.576 173.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.755 ' HD3' ' HG2' ' A' ' 146' ' ' ARG . 3.2 Cg_endo -43.37 149.15 0.58 Allowed 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 123.574 2.85 . . . . 0.22 112.079 174.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.812 ' HB2' HG22 ' A' ' 70' ' ' THR . 0.6 OUTLIER -135.78 150.24 49.41 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 106.051 -1.833 . . . . 1.09 106.051 178.475 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.908 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 2.7 mp -116.21 129.34 56.25 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 109.206 -0.664 . . . . 1.82 109.206 175.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.844 HG22 ' OH ' ' A' ' 119' ' ' TYR . 1.2 mt -111.02 123.71 67.16 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 CA-C-N 115.025 -0.989 . . . . 1.12 109.002 178.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.908 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.5 OUTLIER -108.74 123.64 49.33 Favored 'General case' 0 C--O 1.215 -0.738 0 CA-C-N 115.996 -0.547 . . . . 1.09 110.796 -172.267 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.482 HD21 ' HB ' ' A' ' 140' ' ' THR . 0.0 OUTLIER -76.56 122.09 24.11 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 104.88 -2.267 . . . . 3.11 104.88 165.948 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 1.006 HG13 ' HB1' ' A' ' 73' ' ' ALA . 2.5 p . . . . . 0 C--N 1.298 -1.631 0 C-N-CA 118.724 -1.19 . . . . 1.69 112.94 -165.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.728 0 N-CA-C 110.128 -1.189 . . . . 0.85 110.128 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -37.13 -50.99 1.63 Allowed Glycine 0 C--O 1.223 -0.566 0 CA-C-N 114.364 -0.918 . . . . 0.67 114.952 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.459 ' HA ' ' CZ ' ' A' ' 139' ' ' PHE . 0.1 OUTLIER -57.71 -59.18 5.59 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 117.743 0.772 . . . . 1.2 111.469 -172.41 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -62.56 -26.96 68.85 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.733 -0.667 . . . . 2.61 110.136 -178.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.675 ' HA ' HG22 ' A' ' 160' ' ' VAL . 77.5 m -71.91 -59.61 2.66 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 114.891 -1.05 . . . . 1.06 109.916 -177.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 1.049 ' HB3' HG11 ' A' ' 71' ' ' VAL . . . -60.59 -39.9 89.79 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 114.675 -1.148 . . . . 1.05 111.371 -178.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.535 ' HA ' ' CD1' ' A' ' 102' ' ' PHE . 89.8 m -58.57 -58.71 7.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.598 0.713 . . . . 1.08 110.6 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.4 m -68.31 -33.78 74.95 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 114.955 -1.021 . . . . 1.22 111.473 -174.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.716 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 20.6 mt -67.53 -50.58 58.02 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 121.25 0.547 . . . . 1.14 110.37 -177.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.833 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 10.5 t80 -54.83 -50.3 68.92 Favored 'General case' 0 C--O 1.204 -1.325 0 CA-C-N 114.983 -1.008 . . . . 0.94 110.681 177.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.41 ' N ' HD21 ' A' ' 62' ' ' ASN . 0.9 OUTLIER -72.48 -25.7 61.53 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 122.443 0.297 . . . . 1.6 110.75 -171.119 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.486 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 35.3 ttpt -86.47 -23.28 26.03 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 109.044 -0.724 . . . . 2.06 109.044 -178.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.751 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 30.4 m-85 -123.51 -5.49 8.19 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 115.291 1.589 . . . . 0.92 115.291 -169.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.667 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -64.63 -23.22 67.19 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 108.055 -1.091 . . . . 1.89 108.055 169.976 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 37.5 t -47.19 -40.35 15.84 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 114.118 -1.401 . . . . 1.68 110.848 171.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -90.06 -32.35 16.76 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 120.725 0.298 . . . . 1.11 111.337 177.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 143.44 -5.67 1.86 Allowed Glycine 0 N--CA 1.449 -0.468 0 N-CA-C 111.364 -0.694 . . . . 0.2 111.364 -175.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.751 ' HD2' ' HB2' ' A' ' 64' ' ' TYR . 24.6 t80 -66.92 141.32 57.67 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 120.978 0.418 . . . . 0.21 110.822 -178.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.951 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 5.3 t -132.55 152.96 51.42 Favored 'General case' 0 N--CA 1.422 -1.835 0 N-CA-C 107.991 -1.114 . . . . 1.02 107.991 174.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 1.049 HG11 ' HB3' ' A' ' 57' ' ' ALA . 38.2 t -112.09 99.86 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.702 0 N-CA-C 107.65 -1.241 . . . . 1.04 107.65 158.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.623 HD11 HG21 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -93.46 121.23 34.65 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 106.911 -1.514 . . . . 1.69 106.911 174.33 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 1.036 ' HB2' HD13 ' A' ' 104' ' ' ILE . . . -108.02 121.16 44.23 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.961 0.886 . . . . 1.17 111.265 -178.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.887 ' CG ' ' HG2' ' A' ' 105' ' ' MET . 2.6 m-30 -95.7 101.04 7.13 Favored Pre-proline 0 C--N 1.314 -0.935 0 CA-C-N 114.379 -1.282 . . . . 0.58 109.009 178.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.688 ' HG2' ' HG2' ' A' ' 107' ' ' LYS . 87.8 Cg_endo -82.12 74.99 4.94 Favored 'Trans proline' 0 CA--C 1.512 -0.612 0 C-N-CA 122.798 2.332 . . . . 1.3 113.423 -167.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.8 p . . . . . 0 N--CA 1.469 0.505 0 N-CA-C 116.967 2.21 . . . . 1.91 116.967 -177.146 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.46 0 CA-C-O 121.041 0.448 . . . . 1.15 111.231 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -95.33 26.3 3.89 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.792 -0.64 . . . . 1.99 111.033 178.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.535 ' CD1' ' HA ' ' A' ' 58' ' ' THR . 12.7 p90 -146.18 164.71 23.45 Favored Pre-proline 0 N--CA 1.448 -0.527 0 N-CA-C 108.571 -0.9 . . . . 1.31 108.571 176.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.694 ' HD3' ' CE2' ' A' ' 61' ' ' TYR . 52.7 Cg_exo -59.07 85.79 0.06 OUTLIER 'Trans proline' 0 N--CA 1.482 0.832 0 C-N-CA 124.697 3.598 . . . . 1.07 115.35 -173.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 1.036 HD13 ' HB2' ' A' ' 73' ' ' ALA . 3.9 mm -85.56 131.67 33.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 108.61 -0.885 . . . . 1.97 108.61 171.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.887 ' HG2' ' CG ' ' A' ' 74' ' ' PHE . 1.9 ppp? -96.68 -175.64 3.36 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.149 0.5 . . . . 3.41 110.482 -176.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.675 ' N ' ' HA ' ' A' ' 23' ' ' ALA . . . -79.33 19.5 0.59 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.391 -0.822 . . . . 1.46 112.654 -170.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.688 ' HG2' ' HG2' ' A' ' 75' ' ' PRO . 50.7 mttp 60.92 131.25 0.01 OUTLIER 'General case' 0 CA--C 1.496 -1.114 0 CA-C-O 122.365 1.079 . . . . 2.31 110.784 -168.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.542 ' CG1' ' HD2' ' A' ' 74' ' ' PHE . 2.4 pp -128.01 163.9 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.392 0 N-CA-C 106.326 -1.731 . . . . 1.65 106.326 160.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -76.53 84.29 3.23 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 120.38 -0.528 . . . . 1.73 110.439 -172.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.439 HG12 ' CD1' ' A' ' 108' ' ' ILE . 0.0 OUTLIER -79.28 90.33 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.225 0 C-N-CA 119.325 -0.95 . . . . 1.4 109.128 179.594 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.5 t30 . . . . . 0 N--CA 1.445 -0.717 0 CA-C-N 114.252 -1.34 . . . . 2.1 108.608 175.346 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.596 ' ND1' ' H ' ' A' ' 118' ' ' LEU . 1.6 t-80 . . . . . 0 N--CA 1.433 -1.311 0 N-CA-C 107.13 -1.433 . . . . 0.71 107.13 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -24.09 -46.9 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 124.805 3.67 . . . . 0.47 113.988 -178.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.789 ' CD1' ' HB ' ' A' ' 15' ' ' ILE . 24.8 tp -67.97 -50.31 56.53 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.012 0.525 . . . . 1.15 111.783 -178.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.844 ' OH ' HG22 ' A' ' 40' ' ' ILE . 16.6 m-85 -80.96 -34.19 33.31 Favored 'General case' 0 CA--C 1.483 -1.611 0 CA-C-O 121.504 0.668 . . . . 3.33 110.378 -176.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.601 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 5.6 tp10 -63.09 -34.37 77.44 Favored 'General case' 0 N--CA 1.419 -1.987 0 N-CA-C 106.889 -1.523 . . . . 2.44 106.889 175.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.599 ' HD1' ' HE3' ' A' ' 124' ' ' LYS . 43.4 t80 -72.31 -28.86 63.34 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.591 -0.732 . . . . 1.08 109.82 170.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.703 ' HB2' ' HA ' ' A' ' 119' ' ' TYR . 2.9 ttm -75.66 -56.12 5.0 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.11 -0.636 . . . . 1.25 110.393 -169.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.431 ' HD2' ' HA ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -72.29 -23.28 61.17 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 120.773 -0.371 . . . . 1.86 111.948 176.849 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.601 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 12.4 pttp -70.53 -27.66 64.34 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 119.201 -0.999 . . . . 2.52 109.823 175.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.421 HG23 ' HZ1' ' A' ' 126' ' ' LYS . 38.8 m -89.73 -24.81 21.44 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.683 -0.689 . . . . 1.21 110.341 176.028 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.464 ' HE2' ' HA ' ' A' ' 151' ' ' VAL . 29.9 mmtm . . . . . 0 C--N 1.324 -0.502 0 CA-C-N 115.614 -0.721 . . . . 2.38 110.78 -178.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.874 ' HB3' ' HG3' ' A' ' 156' ' ' PRO . 9.7 m-90 . . . . . 0 CA--C 1.511 -0.535 0 N-CA-C 109.777 -0.453 . . . . 2.41 109.777 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.603 ' HB2' ' CB ' ' A' ' 156' ' ' PRO . 9.6 m120 -44.49 -156.89 0.0 OUTLIER 'General case' 0 C--O 1.211 -0.937 0 O-C-N 123.849 0.718 . . . . 2.04 111.311 161.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.664 ' CD1' HG21 ' A' ' 43' ' ' VAL . 3.9 m-85 -31.41 -26.38 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.338 0 N-CA-C 118.036 2.606 . . . . 2.53 118.036 -168.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.705 ' HA ' ' O ' ' A' ' 154' ' ' PHE . 1.9 m 7.49 103.43 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 120.5 1.5 . . . . 1.24 114.678 171.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.439 ' HB3' HD22 ' A' ' 39' ' ' LEU . 1.1 m -91.56 173.61 7.8 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.552 -1.204 . . . . 1.03 111.039 -172.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.527 ' HA ' ' HA ' ' A' ' 153' ' ' ARG . 60.5 m-85 -132.52 122.68 25.23 Favored 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 105.858 -1.904 . . . . 0.7 105.858 164.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.77 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 7.3 tp -80.0 104.6 10.68 Favored 'General case' 0 N--CA 1.422 -1.834 0 C-N-CA 118.302 -1.359 . . . . 1.16 108.474 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.739 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 36.8 mm -89.03 141.84 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.741 0 CA-C-N 112.854 -1.976 . . . . 1.05 107.581 -177.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.475 ' HA ' HD11 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -94.38 -175.34 3.61 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 119.411 -0.916 . . . . 0.98 111.395 -170.358 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.755 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 30.7 mtm180 -55.98 -33.42 64.81 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.803 0.335 . . . . 2.61 111.566 -176.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -103.78 22.99 13.48 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 109.864 -0.421 . . . . 2.0 109.864 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.587 ' HA2' HG21 ' A' ' 144' ' ' ILE . . . 70.18 37.09 71.93 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 121.219 -0.515 . . . . 0.19 114.184 177.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.503 ' HA ' ' HD2' ' A' ' 150' ' ' PRO . 57.8 t -107.04 108.3 61.79 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 118.192 0.996 . . . . 1.74 111.243 174.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.757 ' HD3' HG21 ' A' ' 15' ' ' ILE . 8.5 Cg_endo -58.3 110.13 0.6 Allowed 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 123.757 2.971 . . . . 0.6 111.307 174.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.666 HG23 ' HG2' ' A' ' 152' ' ' GLU . 17.8 m -108.86 -23.41 4.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.299 0.571 . . . . 2.06 109.569 -176.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.77 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 47.2 mm-40 -133.3 168.22 18.97 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-N 115.298 -0.865 . . . . 1.17 110.434 179.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.557 HH11 ' HG2' ' A' ' 153' ' ' ARG . 0.0 OUTLIER -144.63 148.63 34.54 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 114.614 -1.176 . . . . 2.9 108.582 163.019 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.705 ' O ' ' HA ' ' A' ' 140' ' ' THR . 91.9 m-85 -121.77 144.36 48.85 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 110.207 -0.294 . . . . 0.36 110.207 -169.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 12.9 p -63.87 149.5 93.12 Favored Pre-proline 0 C--N 1.318 -0.787 0 N-CA-C 109.536 -0.542 . . . . 1.45 109.536 174.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.874 ' HG3' ' HB3' ' A' ' 137' ' ' TRP . 30.3 Cg_endo -63.2 -26.38 72.42 Favored 'Trans proline' 0 CA--C 1.511 -0.659 0 C-N-CA 122.349 2.033 . . . . 0.78 110.714 176.149 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -79.2 16.67 8.87 Favored Glycine 0 N--CA 1.438 -1.177 0 CA-C-N 113.785 -1.552 . . . . 0.59 113.405 171.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -95.64 152.98 17.96 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 109.514 -0.55 . . . . 1.07 109.514 170.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.577 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 22.9 t -113.44 176.83 4.86 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 109.71 -0.478 . . . . 1.92 109.71 -175.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.675 HG22 ' HA ' ' A' ' 56' ' ' THR . 48.4 t -45.62 -48.38 4.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 O-C-N 124.04 0.837 . . . . 1.07 110.9 178.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.582 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 40.8 tttm -65.54 -41.16 93.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.823 -0.626 . . . . 3.89 111.148 -175.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -64.93 -34.26 77.99 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 121.732 0.777 . . . . 1.4 109.47 -173.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.578 HD12 ' CG2' ' A' ' 56' ' ' THR . 46.3 mt -80.54 -46.21 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 CA-C-N 114.451 -1.249 . . . . 1.05 111.106 177.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.524 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 36.5 mt-10 -53.09 -44.26 67.45 Favored 'General case' 0 C--O 1.218 -0.587 0 N-CA-C 111.688 0.255 . . . . 0.67 111.688 -175.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.582 ' HG2' ' O ' ' A' ' 161' ' ' LYS . 4.5 pt-20 -62.35 -14.23 37.57 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.568 0.581 . . . . 0.87 112.568 -175.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.675 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 13.0 mmmt -105.3 -23.9 12.79 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.009 -0.737 . . . . 2.22 109.009 175.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.524 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 10.5 tp -83.26 -50.77 8.07 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.48 -1.236 . . . . 1.04 112.222 -176.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.48 HG13 ' O ' ' A' ' 164' ' ' GLU . 65.4 mt -54.32 -44.94 99.31 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 115.586 -0.734 . . . . 1.08 112.077 -175.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.452 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 86.8 Cg_exo -50.53 -24.59 12.78 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 122.182 1.921 . . . . 0.62 113.287 173.093 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.734 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 88.1 mt -95.19 -42.5 8.54 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 122.28 -0.263 . . . . 1.36 111.547 177.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.704 HD23 ' HG2' ' A' ' 37' ' ' PRO . 89.1 mt -61.45 -52.4 64.72 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-O 122.19 0.995 . . . . 1.07 109.883 177.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.648 0 CA-C-N 113.065 -1.88 . . . . 1.12 114.356 -172.18 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.5 m . . . . . 0 C--O 1.235 0.292 0 CA-C-O 121.062 0.458 . . . . 2.17 110.582 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.8 m -145.39 -176.42 5.11 Favored 'General case' 0 N--CA 1.423 -1.785 0 N-CA-C 104.896 -2.261 . . . . 1.68 104.896 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.815 HG23 ' HE1' ' A' ' 122' ' ' MET . 5.7 pt -81.42 -17.73 11.83 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.481 0 CA-C-O 121.447 0.641 . . . . 1.16 109.847 177.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.787 ' HB3' HG12 ' A' ' 31' ' ' VAL . 39.7 m-85 -71.0 -2.75 16.37 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.503 -0.771 . . . . 0.3 112.45 -176.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -77.2 -20.5 55.28 Favored 'General case' 0 CA--C 1.501 -0.904 0 N-CA-C 107.595 -1.261 . . . . 2.11 107.595 176.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.566 ' CD2' ' HA ' ' A' ' 118' ' ' LEU . 58.1 m-85 -113.39 122.32 47.0 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 114.334 -1.303 . . . . 0.37 111.8 -174.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -48.19 139.4 8.48 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 112.561 -2.109 . . . . 2.86 111.709 172.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.768 HG12 ' HZ ' ' A' ' 74' ' ' PHE . 79.2 t -113.43 166.34 7.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 107.637 -1.246 . . . . 1.32 107.637 174.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.719 HD23 ' HA ' ' A' ' 27' ' ' PRO . 80.4 mt -132.88 131.87 41.44 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 120.001 -0.68 . . . . 1.29 112.47 -177.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.476 ' O ' ' HB3' ' A' ' 106' ' ' ALA . 15.1 t70 -64.43 159.23 21.8 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 106.457 -1.683 . . . . 1.87 106.457 165.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.78 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . . . -60.51 -6.76 1.74 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 113.801 1.038 . . . . 1.2 113.801 -165.001 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.625 ' HB2' ' HE2' ' A' ' 26' ' ' LYS . 54.7 m-20 -97.14 -0.19 47.38 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.751 0.278 . . . . 2.34 111.751 176.241 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.676 ' CD2' ' HB1' ' A' ' 106' ' ' ALA . 72.9 m-70 83.64 10.06 0.51 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.727 0.775 . . . . 2.26 109.01 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.625 ' HE2' ' HB2' ' A' ' 24' ' ' ASP . 21.7 mtmt -75.16 119.31 76.37 Favored Pre-proline 0 N--CA 1.447 -0.609 0 CA-C-N 114.298 -1.319 . . . . 4.64 107.578 168.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.719 ' HA ' HD23 ' A' ' 21' ' ' LEU . 47.3 Cg_exo -45.79 116.33 1.36 Allowed 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 122.415 2.076 . . . . 0.62 113.16 -176.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 1.08 ' HH ' ' HB3' ' A' ' 103' ' ' PRO . 0.1 OUTLIER -75.81 147.47 39.15 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 113.885 -1.507 . . . . 1.52 111.299 177.821 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.523 ' N ' ' HD1' ' A' ' 28' ' ' TYR . 2.5 t-20 -82.47 97.22 8.3 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 114.838 -1.074 . . . . 2.16 108.803 175.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.674 HD13 HG21 ' A' ' 20' ' ' VAL . 61.1 tp -83.82 -45.31 13.43 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.647 -0.706 . . . . 1.07 110.888 -176.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.787 HG12 ' HB3' ' A' ' 16' ' ' PHE . 0.1 OUTLIER -67.28 0.25 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.316 -0.857 . . . . 1.69 112.801 -171.712 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.446 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 28.7 pt20 -74.01 -12.21 60.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.418 0.627 . . . . 1.31 109.477 172.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.918 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 90.5 m-70 -97.7 20.49 11.85 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 121.876 0.845 . . . . 0.35 109.092 175.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.724 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 18.3 mtmt -80.42 114.18 19.13 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 114.381 -1.281 . . . . 2.07 109.245 169.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.87 -38.9 2.22 Favored Glycine 0 N--CA 1.434 -1.489 0 C-N-CA 120.607 -0.806 . . . . 0.24 111.927 178.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.466 ' HB2' ' HA3' ' A' ' 68' ' ' GLY . 20.2 m -129.49 128.02 23.09 Favored Pre-proline 0 N--CA 1.434 -1.257 0 N-CA-C 108.377 -0.972 . . . . 0.74 108.377 172.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.821 ' HG3' ' CB ' ' A' ' 170' ' ' LEU . 1.8 Cg_endo -41.18 151.92 0.12 Allowed 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 124.393 3.395 . . . . 0.22 113.097 177.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.753 ' HB2' HG21 ' A' ' 70' ' ' THR . 0.8 OUTLIER -136.96 145.1 43.79 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 106.949 -1.5 . . . . 1.09 106.949 -179.41 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.973 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 1.2 mm? -111.63 117.4 32.82 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.992 -0.744 . . . . 1.82 108.992 178.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 1.082 HD11 ' HE2' ' A' ' 122' ' ' MET . 8.2 mt -101.65 124.38 55.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-N 116.112 -0.495 . . . . 1.12 110.932 178.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.973 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -111.05 123.0 49.33 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.484 -0.78 . . . . 1.09 109.948 -174.194 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.774 ' HB3' HG11 ' A' ' 110' ' ' VAL . 1.3 p30 -81.79 94.97 7.14 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.855 -1.165 . . . . 3.11 107.855 169.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.895 HG12 ' HB2' ' A' ' 73' ' ' ALA . 1.4 p . . . . . 0 C--N 1.306 -1.306 0 CA-C-N 115.447 -0.797 . . . . 1.69 113.059 -159.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.919 0 N-CA-C 110.761 -0.935 . . . . 0.85 110.761 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -58.19 -43.37 95.42 Favored Glycine 0 C--O 1.222 -0.604 0 CA-C-N 115.469 -0.366 . . . . 0.67 112.805 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.553 ' HA ' ' CZ ' ' A' ' 139' ' ' PHE . 1.0 OUTLIER -64.44 -54.57 30.5 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.074 0.464 . . . . 1.2 110.776 -174.903 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.443 ' H ' ' CD ' ' A' ' 55' ' ' GLU . 1.9 pm0 -66.44 -22.95 66.22 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.542 -0.754 . . . . 2.61 111.115 -178.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.779 HG21 ' HA ' ' A' ' 160' ' ' VAL . 30.4 m -79.92 -57.45 3.64 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 109.44 -0.578 . . . . 1.06 109.44 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 1.01 ' HB3' HG12 ' A' ' 71' ' ' VAL . . . -54.08 -40.51 67.28 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.145 -0.934 . . . . 1.05 110.838 -179.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.444 ' HA ' ' HD2' ' A' ' 102' ' ' PHE . 99.8 m -60.04 -57.1 14.29 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.609 -0.723 . . . . 1.08 110.647 178.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 22.3 m -66.76 -35.18 79.49 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.461 -0.79 . . . . 1.22 111.312 -176.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.713 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 0.6 OUTLIER -66.72 -52.37 45.33 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 121.595 0.712 . . . . 1.14 110.409 -175.416 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.85 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 8.0 t80 -55.92 -54.6 42.77 Favored 'General case' 0 C--O 1.205 -1.27 0 CA-C-N 114.413 -1.267 . . . . 0.94 110.777 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -67.34 -24.16 65.69 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.73 -0.214 . . . . 1.6 111.018 -174.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.438 ' HB2' ' HE2' ' A' ' 63' ' ' LYS . 24.4 ttmm -85.5 -27.34 25.69 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 108.965 -0.754 . . . . 2.06 108.965 -176.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.766 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 48.3 m-85 -123.67 -4.75 8.16 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 115.289 1.588 . . . . 0.92 115.289 -169.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.662 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 12.9 pttp -67.86 -24.28 65.23 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 107.709 -1.219 . . . . 1.89 107.709 171.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.3 t -48.76 -37.61 19.47 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 113.855 -1.521 . . . . 1.68 110.18 171.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -88.06 -35.18 17.67 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 111.948 0.351 . . . . 1.11 111.948 173.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.466 ' HA3' ' HB2' ' A' ' 36' ' ' SER . . . 147.51 -7.3 1.11 Allowed Glycine 0 CA--C 1.52 0.388 0 N-CA-C 111.619 -0.592 . . . . 0.2 111.619 -176.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.766 ' HD2' ' HB2' ' A' ' 64' ' ' TYR . 17.9 t80 -67.07 140.37 57.61 Favored 'General case' 0 C--O 1.217 -0.61 0 C-N-CA 123.003 0.521 . . . . 0.21 111.251 -177.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.918 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 2.2 t -134.17 143.19 47.76 Favored 'General case' 0 CA--C 1.482 -1.657 0 N-CA-C 108.189 -1.041 . . . . 1.02 108.189 174.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 1.01 HG12 ' HB3' ' A' ' 57' ' ' ALA . 39.9 t -98.6 98.87 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.535 0 C-N-CA 118.959 -1.096 . . . . 1.04 108.182 161.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.795 ' HA ' ' HG2' ' A' ' 103' ' ' PRO . 8.4 mt -85.94 119.01 25.78 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 107.36 -1.348 . . . . 1.69 107.36 175.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.913 ' HB3' HD13 ' A' ' 104' ' ' ILE . . . -111.67 116.28 30.52 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.826 0.822 . . . . 1.17 111.694 -178.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.768 ' HZ ' HG12 ' A' ' 20' ' ' VAL . 2.8 m-30 -98.38 99.09 6.65 Favored Pre-proline 0 C--N 1.315 -0.904 0 CA-C-N 114.519 -1.219 . . . . 0.58 109.051 178.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.741 ' O ' ' HB2' ' A' ' 107' ' ' LYS . 80.7 Cg_endo -78.34 93.22 1.1 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.214 1.943 . . . . 1.3 113.361 -171.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 84.3 p . . . . . 0 C--N 1.323 -0.56 0 CA-C-N 114.93 -1.032 . . . . 1.91 111.886 -175.764 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.307 0 CA-C-O 121.52 0.676 . . . . 1.15 112.457 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -92.81 14.05 18.51 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 114.664 -1.153 . . . . 1.99 110.231 176.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.64 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 17.2 p90 -140.36 161.99 52.09 Favored Pre-proline 0 N--CA 1.444 -0.754 0 N-CA-C 108.859 -0.793 . . . . 1.31 108.859 -179.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 1.08 ' HB3' ' HH ' ' A' ' 28' ' ' TYR . 30.9 Cg_endo -58.95 92.82 0.08 OUTLIER 'Trans proline' 0 CA--C 1.514 -0.489 0 C-N-CA 123.965 3.11 . . . . 1.07 114.398 -172.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.913 HD13 ' HB3' ' A' ' 73' ' ' ALA . 5.4 mm -82.4 124.62 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 108.325 -0.991 . . . . 1.97 108.325 170.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.772 ' HG3' ' N ' ' A' ' 106' ' ' ALA . 0.0 OUTLIER -78.66 172.1 14.18 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.074 -1.421 . . . . 3.41 110.812 -176.933 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.78 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . . . -61.0 -0.15 0.28 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.359 -0.837 . . . . 1.46 112.575 178.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.741 ' HB2' ' O ' ' A' ' 75' ' ' PRO . 12.3 ptpt 60.72 144.58 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.244 0 C-N-CA 124.941 1.297 . . . . 2.31 110.742 -168.145 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.603 ' O ' HG21 ' A' ' 110' ' ' VAL . 0.3 OUTLIER -133.72 176.62 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.074 0 CA-C-N 113.615 -1.629 . . . . 1.65 108.331 168.086 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -70.05 66.85 0.28 Allowed 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 114.759 -1.11 . . . . 1.73 109.795 176.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.971 ' HA ' ' OH ' ' A' ' 119' ' ' TYR . 0.6 OUTLIER -72.6 92.64 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-O 122.11 0.957 . . . . 1.4 109.589 -172.657 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.7 t30 . . . . . 0 C--N 1.313 -0.983 0 N-CA-C 104.684 -2.339 . . . . 2.1 104.684 169.659 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.602 ' CE1' ' HB3' ' A' ' 118' ' ' LEU . 4.9 t-80 . . . . . 0 N--CA 1.418 -2.051 0 N-CA-C 107.998 -1.112 . . . . 0.71 107.998 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.474 ' HB2' ' CD1' ' A' ' 18' ' ' PHE . 11.2 Cg_exo -31.47 -43.45 0.13 Allowed 'Trans proline' 0 C--O 1.215 -0.668 1 C-N-CA 125.531 4.154 . . . . 0.47 114.241 -174.115 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.76 ' HG ' ' HE3' ' A' ' 122' ' ' MET . 4.8 tp -62.45 -60.17 3.92 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 113.471 0.915 . . . . 1.15 113.471 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.971 ' OH ' ' HA ' ' A' ' 110' ' ' VAL . 3.4 p90 -81.02 -25.66 37.0 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 109.113 -0.699 . . . . 3.33 109.113 -177.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.53 -39.23 90.3 Favored 'General case' 0 CA--C 1.495 -1.161 0 N-CA-C 106.546 -1.65 . . . . 2.44 106.546 173.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.476 ' HA ' ' HG2' ' A' ' 124' ' ' LYS . 71.4 t80 -65.45 -26.09 67.8 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.85 -1.068 . . . . 1.08 109.892 171.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 1.082 ' HE2' HD11 ' A' ' 40' ' ' ILE . 65.2 mtt -75.93 -56.89 4.24 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.182 -0.463 . . . . 1.25 111.716 -173.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.62 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -70.39 -24.04 62.88 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.779 -0.646 . . . . 1.86 110.65 179.621 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.476 ' HG2' ' HA ' ' A' ' 121' ' ' TYR . 17.1 ptmt -74.05 -28.41 61.4 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 119.722 -0.791 . . . . 2.52 109.456 174.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 51.8 m -76.83 -42.62 39.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.852 -0.613 . . . . 1.21 110.484 173.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.428 ' HD3' ' C ' ' A' ' 151' ' ' VAL . 8.0 tptm . . . . . 0 C--N 1.325 -0.471 0 CA-C-N 116.258 -0.428 . . . . 2.38 111.447 -175.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.419 ' HB3' ' HG3' ' A' ' 156' ' ' PRO . 10.2 m-90 . . . . . 0 CA--C 1.501 -0.916 0 N-CA-C 109.886 -0.413 . . . . 2.41 109.886 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.569 ' HB2' ' CB ' ' A' ' 156' ' ' PRO . 3.4 m120 -47.54 -158.29 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.154 -0.93 . . . . 2.04 110.073 162.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.669 ' CD1' HG23 ' A' ' 43' ' ' VAL . 5.7 m-85 -28.42 -53.63 0.1 Allowed 'General case' 0 CA--C 1.552 1.033 0 N-CA-C 115.944 1.831 . . . . 2.53 115.944 -164.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.591 ' HB ' ' OD1' ' A' ' 42' ' ' ASN . 8.5 m 42.75 93.92 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 120.44 1.473 . . . . 1.24 112.832 174.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' A' ' 153' ' ' ARG . 2.5 m -88.98 161.69 16.47 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.744 -0.662 . . . . 1.03 111.556 -172.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.402 ' HA ' ' HA ' ' A' ' 153' ' ' ARG . 70.3 m-85 -122.72 126.49 47.65 Favored 'General case' 0 CA--C 1.487 -1.471 0 N-CA-C 105.872 -1.899 . . . . 0.7 105.872 165.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.79 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 11.3 tp -80.39 101.96 9.32 Favored 'General case' 0 N--CA 1.418 -2.042 0 C-N-CA 117.823 -1.551 . . . . 1.16 107.877 176.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.694 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 39.1 mm -89.22 135.13 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.671 0 CA-C-N 113.018 -1.901 . . . . 1.05 107.311 -178.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.459 ' HA ' HD13 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -91.35 -174.85 4.06 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 119.201 -1.0 . . . . 0.98 111.545 -167.586 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.583 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 53.5 mtm180 -54.66 -36.23 64.37 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.157 0.503 . . . . 2.61 110.983 -177.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -100.11 23.28 10.16 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.625 -0.509 . . . . 2.0 109.625 -178.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.63 ' HA2' HG21 ' A' ' 144' ' ' ILE . . . 65.76 34.44 88.79 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 115.943 -0.571 . . . . 0.19 114.002 178.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 64.1 t -103.07 116.19 62.8 Favored Pre-proline 0 C--N 1.314 -0.944 0 CA-C-N 118.024 0.912 . . . . 1.74 110.875 175.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.702 ' HD3' HG21 ' A' ' 15' ' ' ILE . 36.5 Cg_endo -66.13 109.05 1.45 Allowed 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 123.757 2.971 . . . . 0.6 110.664 178.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.531 HG21 ' HG2' ' A' ' 152' ' ' GLU . 19.6 m -113.71 -12.11 11.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 121.062 0.458 . . . . 2.06 110.486 -172.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.79 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 33.8 mm-40 -142.83 165.83 26.3 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-N 115.563 -0.744 . . . . 1.17 109.611 177.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.484 ' HA ' ' O ' ' A' ' 141' ' ' SER . 0.0 OUTLIER -148.65 122.41 9.28 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.404 -0.816 . . . . 2.9 110.76 165.347 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.683 ' HZ ' ' HB2' ' A' ' 166' ' ' LYS . 88.1 m-85 -95.67 155.81 16.59 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.616 -1.175 . . . . 0.36 109.291 -175.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 12.0 m -82.83 160.89 59.98 Favored Pre-proline 0 C--N 1.314 -0.937 0 N-CA-C 108.733 -0.84 . . . . 1.45 108.733 175.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.569 ' CB ' ' HB2' ' A' ' 138' ' ' ASN . 14.5 Cg_endo -58.76 -48.8 13.42 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 121.317 1.344 . . . . 0.78 110.479 173.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -48.59 -12.8 0.22 Allowed Glycine 0 CA--C 1.537 1.422 0 CA-C-N 114.588 -1.187 . . . . 0.59 115.54 167.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -87.64 138.88 31.08 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 118.464 1.132 . . . . 1.07 109.285 173.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.422 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 15.5 m -111.99 -173.03 2.16 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 112.819 0.674 . . . . 1.92 112.819 -168.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.779 ' HA ' HG21 ' A' ' 56' ' ' THR . 83.0 t -40.98 -60.49 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 114.134 -1.394 . . . . 1.07 112.335 -178.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -62.88 -39.16 93.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.287 -0.415 . . . . 3.89 110.534 -173.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.468 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 7.7 m-20 -55.56 -49.0 73.86 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 115.322 -0.854 . . . . 1.4 109.844 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.661 HD12 ' HH ' ' A' ' 41' ' ' TYR . 81.4 mt -73.4 -46.75 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 CA-C-N 114.581 -1.19 . . . . 1.05 111.691 -177.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.473 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 49.5 mt-10 -54.75 -45.19 74.14 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-O 120.804 0.335 . . . . 0.67 111.251 -177.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 11.5 pt-20 -63.35 -15.42 57.37 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 111.993 0.368 . . . . 0.87 111.993 -173.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.683 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 28.3 mmmt -104.75 -22.97 13.12 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.607 0.717 . . . . 2.22 109.783 173.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.489 HD22 HD11 ' A' ' 171' ' ' LEU . 8.3 tp -83.61 -48.88 9.74 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.762 -1.108 . . . . 1.04 112.296 -176.045 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 164' ' ' GLU . 68.9 mt -55.05 -46.06 99.73 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.617 -0.72 . . . . 1.08 112.302 -174.059 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.467 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 84.8 Cg_exo -51.39 -27.05 22.84 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.287 1.992 . . . . 0.62 113.178 173.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.821 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 74.8 mt -89.67 -42.58 11.28 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.846 -0.161 . . . . 1.36 111.124 178.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.719 HD22 ' HG2' ' A' ' 37' ' ' PRO . 91.9 mt -59.87 -58.26 9.31 Favored 'General case' 0 CA--C 1.505 -0.75 0 CA-C-O 121.996 0.903 . . . . 1.07 109.86 176.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.591 0 CA-C-N 113.338 -1.755 . . . . 1.12 112.171 -178.555 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.3 t . . . . . 0 C--O 1.234 0.244 0 CA-C-O 121.475 0.655 . . . . 2.17 109.899 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 96.5 p 179.78 168.49 1.2 Allowed 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 105.044 -2.206 . . . . 1.68 105.044 -177.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.848 HD13 HD23 ' A' ' 30' ' ' LEU . 4.8 pt -67.62 -12.96 16.14 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 CA-C-O 121.399 0.619 . . . . 1.16 110.274 177.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.772 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 33.4 m-85 -75.3 4.04 7.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.661 -0.699 . . . . 0.3 111.893 -175.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.57 -7.28 59.57 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.474 -0.936 . . . . 2.11 108.474 175.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.842 ' HE2' ' HB2' ' A' ' 121' ' ' TYR . 58.1 m-85 -125.67 113.66 17.65 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-N 114.988 -1.006 . . . . 0.37 111.964 -175.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -50.78 142.15 11.91 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 113.546 -1.661 . . . . 2.86 110.21 172.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.784 HG13 ' HZ ' ' A' ' 74' ' ' PHE . 68.8 t -113.8 169.6 5.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.5 -0.773 . . . . 1.32 109.114 -178.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.763 HD23 ' HA ' ' A' ' 27' ' ' PRO . 94.2 mt -127.53 150.51 49.66 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.019 0.438 . . . . 1.29 111.399 178.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.38 165.1 18.5 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 106.318 -1.734 . . . . 1.87 106.318 162.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.613 ' HA ' ' C ' ' A' ' 105' ' ' MET . . . -59.53 -7.73 1.57 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 113.721 1.008 . . . . 1.2 113.721 -169.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.566 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 1.3 m-20 -99.08 2.06 45.75 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.914 0.339 . . . . 2.34 111.914 176.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.566 ' HB2' ' O ' ' A' ' 24' ' ' ASP . 83.2 m-70 80.55 17.36 0.61 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.611 0.72 . . . . 2.26 109.266 178.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 11.9 mmtt -86.13 120.46 72.44 Favored Pre-proline 0 CA--C 1.508 -0.654 0 N-CA-C 107.682 -1.229 . . . . 4.64 107.682 172.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.763 ' HA ' HD23 ' A' ' 21' ' ' LEU . 86.1 Cg_exo -53.21 112.39 0.92 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 121.742 1.628 . . . . 0.62 113.087 -172.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.84 ' HE2' HD21 ' A' ' 72' ' ' LEU . 9.0 t80 -79.22 116.78 19.7 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 113.487 -1.688 . . . . 1.52 109.735 172.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.503 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.7 p-10 -71.43 89.15 0.92 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 122.653 1.216 . . . . 2.16 109.95 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.848 HD23 HD13 ' A' ' 15' ' ' ILE . 58.9 tp -50.93 -39.99 56.16 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 113.939 -1.482 . . . . 1.07 111.947 -179.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.646 ' HB ' ' HZ3' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -66.47 1.03 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 114.046 1.128 . . . . 1.69 114.046 -170.478 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.503 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 28.4 pt20 -77.82 -6.81 55.38 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.043 -0.663 . . . . 1.31 109.679 171.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.924 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 93.8 m-70 -101.54 24.52 9.6 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 122.001 0.905 . . . . 0.35 109.005 174.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.772 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 21.5 mtmm -83.54 110.56 18.32 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 114.344 -1.298 . . . . 2.07 108.686 169.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 131.78 -41.58 1.49 Allowed Glycine 0 N--CA 1.442 -0.959 0 C-N-CA 120.629 -0.796 . . . . 0.24 111.538 -178.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.456 ' HB2' ' HA3' ' A' ' 68' ' ' GLY . 35.9 m -129.38 136.93 29.9 Favored Pre-proline 0 N--CA 1.433 -1.295 0 N-CA-C 108.796 -0.816 . . . . 0.74 108.796 172.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.824 ' HG3' ' CB ' ' A' ' 170' ' ' LEU . 7.0 Cg_endo -44.96 153.08 0.45 Allowed 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 124.069 3.18 . . . . 0.22 112.563 176.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.772 ' O ' ' HB ' ' A' ' 144' ' ' ILE . 1.0 OUTLIER -140.13 146.28 38.65 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 106.889 -1.523 . . . . 1.09 106.889 179.098 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.992 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 3.5 mp -113.3 115.3 27.94 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.484 -0.76 . . . . 1.82 109.853 176.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.862 HG23 HD13 ' A' ' 72' ' ' LEU . 0.8 OUTLIER -95.46 116.97 38.4 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 CA-C-N 115.071 -0.968 . . . . 1.12 108.681 176.961 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.992 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.4 OUTLIER -101.14 130.6 47.23 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 119.622 -0.831 . . . . 1.09 109.637 -176.207 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.515 ' OD1' ' HB ' ' A' ' 140' ' ' THR . 0.5 OUTLIER -77.59 122.97 26.01 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 104.4 -2.444 . . . . 3.11 104.4 163.923 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.862 HG12 ' HA ' ' A' ' 139' ' ' PHE . 28.2 m . . . . . 0 C--N 1.3 -1.574 0 C-N-CA 118.702 -1.199 . . . . 1.69 111.797 -171.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.226 -0.354 0 CA-C-O 120.174 -0.236 . . . . 0.85 113.167 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.498 ' HA2' ' HB ' ' A' ' 56' ' ' THR . . . -51.39 -25.09 11.98 Favored Glycine 0 C--O 1.219 -0.814 0 CA-C-O 119.909 -0.384 . . . . 0.67 113.414 176.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.643 ' HH ' ' HB3' ' A' ' 100' ' ' ALA . 0.8 OUTLIER -66.13 -55.01 18.58 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 117.745 0.772 . . . . 1.2 109.421 175.724 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -61.34 -31.32 71.18 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.238 -0.892 . . . . 2.61 109.745 178.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.666 HG21 ' HA ' ' A' ' 160' ' ' VAL . 74.0 m -66.61 -54.82 19.25 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 114.496 -1.229 . . . . 1.06 109.533 179.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 1.041 ' HB2' HG11 ' A' ' 71' ' ' VAL . . . -57.98 -48.7 79.21 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.647 -1.16 . . . . 1.05 111.625 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.425 ' HA ' ' CD1' ' A' ' 102' ' ' PHE . 18.5 m -55.89 -54.62 42.38 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-O 121.61 0.719 . . . . 1.08 110.745 -179.048 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.6 m -69.24 -33.38 73.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.026 -0.988 . . . . 1.22 111.549 -175.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.714 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 18.2 mt -71.63 -48.2 49.44 Favored 'General case' 0 CA--C 1.492 -1.272 0 CA-C-N 116.54 -0.3 . . . . 1.14 110.634 -177.238 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.874 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 6.7 t80 -53.45 -62.26 1.77 Allowed 'General case' 0 C--O 1.194 -1.819 0 O-C-N 124.09 0.869 . . . . 0.94 109.49 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.65 ' HA ' ' CG ' ' A' ' 65' ' ' LYS . 1.8 p30 -67.93 -25.63 65.57 Favored 'General case' 0 C--N 1.314 -0.966 0 O-C-N 122.887 0.117 . . . . 1.6 110.908 -168.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.453 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 36.4 ttpt -79.7 -20.65 46.01 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 107.936 -1.135 . . . . 2.06 107.936 -177.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.663 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 49.9 m-85 -126.5 0.86 6.92 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 115.22 1.563 . . . . 0.92 115.22 -174.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.65 ' CG ' ' HA ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -60.82 -34.59 74.77 Favored 'General case' 0 CA--C 1.496 -1.128 0 N-CA-C 105.986 -1.857 . . . . 1.89 105.986 170.107 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.2 m -47.43 -34.36 7.13 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 112.3 -2.227 . . . . 1.68 111.782 178.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -94.63 -36.06 11.94 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 120.863 -0.335 . . . . 1.11 111.584 174.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.456 ' HA3' ' HB2' ' A' ' 36' ' ' SER . . . 149.31 -0.56 0.49 Allowed Glycine 0 CA--C 1.52 0.35 0 N-CA-C 111.869 -0.492 . . . . 0.2 111.869 -178.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.714 ' HE2' ' HB3' ' A' ' 60' ' ' LEU . 14.4 t80 -74.12 141.58 45.59 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 122.743 0.417 . . . . 0.21 111.182 -177.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.924 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 5.5 t -134.54 142.49 47.0 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 108.675 -0.861 . . . . 1.02 108.675 172.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 1.041 HG11 ' HB2' ' A' ' 57' ' ' ALA . 41.2 t -101.82 99.61 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.249 0 N-CA-C 107.746 -1.205 . . . . 1.04 107.746 160.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.887 ' H ' HD11 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -96.44 119.25 34.58 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 107.689 -1.226 . . . . 1.69 107.689 176.15 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.627 ' HB1' HG13 ' A' ' 104' ' ' ILE . . . -102.35 140.55 36.48 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.426 0.631 . . . . 1.17 111.156 -176.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.795 ' CG ' ' HG2' ' A' ' 105' ' ' MET . 3.1 m-30 -121.41 96.17 47.96 Favored Pre-proline 0 C--N 1.304 -1.39 0 N-CA-C 108.288 -1.005 . . . . 0.58 108.288 -177.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 1.0 ' HG2' ' HB3' ' A' ' 107' ' ' LYS . 93.3 Cg_endo -79.34 72.43 6.52 Favored 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 122.562 2.175 . . . . 1.3 114.149 -167.226 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 108' ' ' ILE . 79.0 p . . . . . 0 C--N 1.323 -0.561 0 N-CA-C 117.023 2.231 . . . . 1.91 117.023 178.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.797 ' H ' HD11 ' A' ' 104' ' ' ILE . . . . . . . . 0 CA--C 1.51 -0.593 0 CA-C-O 120.994 0.426 . . . . 1.15 111.649 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -86.41 10.1 16.12 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.721 -0.672 . . . . 1.99 110.955 -176.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.561 ' HB3' ' CD2' ' A' ' 61' ' ' TYR . 0.7 OUTLIER -125.18 174.63 3.7 Favored Pre-proline 0 N--CA 1.448 -0.543 0 CA-C-N 115.514 -0.766 . . . . 1.31 109.553 177.262 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.621 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 12.1 Cg_exo -76.74 84.1 1.96 Allowed 'Trans proline' 0 CA--C 1.517 -0.344 0 C-N-CA 123.702 2.935 . . . . 1.07 113.632 -177.094 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.797 HD11 ' H ' ' A' ' 100' ' ' ALA . 3.9 mp -84.91 133.33 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 N-CA-C 109.1 -0.704 . . . . 1.97 109.1 173.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.795 ' HG2' ' CG ' ' A' ' 74' ' ' PHE . 0.1 OUTLIER -86.98 -179.43 6.49 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.336 -0.847 . . . . 3.41 110.576 -175.602 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.671 ' O ' ' HG2' ' A' ' 107' ' ' LYS . . . -76.85 19.06 0.31 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.063 -0.971 . . . . 1.46 112.388 -173.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 1.0 ' HB3' ' HG2' ' A' ' 75' ' ' PRO . 12.1 ptmt 51.22 128.13 0.0 OUTLIER 'General case' 0 CA--C 1.504 -0.803 0 C-N-CA 125.685 1.594 . . . . 2.31 113.645 -173.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.773 HG13 ' CB ' ' A' ' 116' ' ' HIS . 0.1 OUTLIER -124.34 173.42 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.922 0 CA-C-N 113.141 -1.845 . . . . 1.65 108.371 171.978 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -69.43 58.69 0.12 Allowed 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.131 -0.94 . . . . 1.73 112.35 179.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.44 HG11 HD13 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -68.97 93.35 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 C-N-CA 119.49 -0.884 . . . . 1.4 110.295 178.654 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 . . . . . 0 C--N 1.315 -0.932 0 N-CA-C 106.187 -1.783 . . . . 2.1 106.187 168.671 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.773 ' CB ' HG13 ' A' ' 108' ' ' ILE . 2.2 t-80 . . . . . 0 N--CA 1.43 -1.451 0 N-CA-C 106.992 -1.485 . . . . 0.71 106.992 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -28.16 -46.63 0.1 OUTLIER 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 124.729 3.619 . . . . 0.47 113.606 -178.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.753 HD13 ' HB ' ' A' ' 15' ' ' ILE . 37.9 tp -64.86 -51.43 62.09 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 122.977 0.511 . . . . 1.15 112.007 178.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.642 ' HA ' ' HB2' ' A' ' 122' ' ' MET . 31.9 m-85 -77.77 -31.95 52.25 Favored 'General case' 0 CA--C 1.497 -1.085 0 O-C-N 122.185 -0.322 . . . . 3.33 110.664 -178.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.529 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 0.2 OUTLIER -59.29 -39.45 83.0 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 106.656 -1.609 . . . . 2.44 106.656 172.068 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.842 ' HB2' ' HE2' ' A' ' 18' ' ' PHE . 65.0 t80 -65.98 -30.79 71.41 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 119.647 -0.821 . . . . 1.08 110.183 175.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.654 ' HE2' ' CG2' ' A' ' 15' ' ' ILE . 1.5 ttm -75.4 -55.37 5.76 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.573 -0.74 . . . . 1.25 110.744 -170.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.501 ' HB2' ' HE2' ' A' ' 123' ' ' LYS . 1.0 OUTLIER -70.79 -25.68 62.99 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.398 -0.365 . . . . 1.86 111.164 177.045 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.597 ' HZ2' ' HB2' ' A' ' 124' ' ' LYS . 0.0 OUTLIER -73.18 -26.26 61.11 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 119.355 -0.938 . . . . 2.52 109.991 178.442 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 65.7 m -85.41 -42.11 14.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.969 -0.559 . . . . 1.21 110.43 174.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.486 ' HE3' ' O ' ' A' ' 151' ' ' VAL . 39.9 tttm . . . . . 0 C--N 1.324 -0.514 0 N-CA-C 109.118 -0.697 . . . . 2.38 109.118 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.868 ' HB3' ' HG3' ' A' ' 156' ' ' PRO . 0.8 OUTLIER . . . . . 0 CA--C 1.512 -0.498 0 CA-C-O 120.481 0.181 . . . . 2.41 110.881 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.494 ' O ' ' N ' ' A' ' 140' ' ' THR . 7.7 m120 -34.87 -151.35 0.0 OUTLIER 'General case' 0 C--O 1.205 -1.267 0 CA-C-N 113.837 -1.529 . . . . 2.04 111.8 156.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.862 ' HA ' HG12 ' A' ' 43' ' ' VAL . 0.6 OUTLIER -28.69 -21.01 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 118.098 2.629 . . . . 2.53 118.098 -171.702 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.541 ' HA ' ' O ' ' A' ' 154' ' ' PHE . 0.9 OUTLIER -9.05 113.27 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 120.191 1.36 . . . . 1.24 113.951 170.438 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.617 ' HA ' ' HA ' ' A' ' 41' ' ' TYR . 0.7 OUTLIER -90.47 171.77 9.19 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.851 -1.068 . . . . 1.03 110.089 -174.132 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.62 ' HA ' ' HA ' ' A' ' 153' ' ' ARG . 10.6 m-85 -126.04 120.26 29.79 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 105.372 -2.084 . . . . 0.7 105.372 161.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.862 HD21 ' HB2' ' A' ' 152' ' ' GLU . 1.1 tp -79.67 105.42 10.96 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 118.69 -1.204 . . . . 1.16 108.52 -178.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.772 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 45.1 mm -92.81 145.5 7.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 CA-C-N 113.975 -1.466 . . . . 1.05 107.933 -176.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.64 -174.88 2.91 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 119.532 -0.867 . . . . 0.98 111.357 -170.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.529 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 32.1 mtm180 -51.08 -42.23 60.47 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 121.077 0.465 . . . . 2.61 111.444 -176.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -98.8 21.56 11.3 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.97 -0.559 . . . . 2.0 109.955 -175.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.478 ' HA3' ' CE2' ' A' ' 16' ' ' PHE . . . 71.64 34.2 63.14 Favored Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 115.732 -0.667 . . . . 0.19 113.908 178.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.458 ' HA ' ' HD2' ' A' ' 150' ' ' PRO . 43.0 t -112.07 107.03 56.13 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 117.988 0.894 . . . . 1.74 111.544 176.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.634 ' HG3' ' HG3' ' A' ' 122' ' ' MET . 4.4 Cg_exo -45.39 118.53 2.16 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 124.441 3.427 . . . . 0.6 112.403 173.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.486 ' O ' ' HE3' ' A' ' 126' ' ' LYS . 1.8 t -103.64 -20.8 5.55 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.879 0 N-CA-C 108.116 -1.068 . . . . 2.06 108.116 178.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.862 ' HB2' HD21 ' A' ' 143' ' ' LEU . 0.0 OUTLIER -152.5 167.65 28.11 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 113.998 -1.455 . . . . 1.17 110.957 -168.531 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.62 ' HA ' ' HA ' ' A' ' 142' ' ' PHE . 0.0 OUTLIER -141.82 129.21 21.22 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 107.091 -1.448 . . . . 2.9 107.091 159.301 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.723 ' HZ ' ' HB2' ' A' ' 166' ' ' LYS . 70.0 m-85 -101.34 141.02 34.83 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.902 -0.407 . . . . 0.36 109.902 -173.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 18.3 m -64.54 150.58 93.43 Favored Pre-proline 0 C--N 1.325 -0.497 0 N-CA-C 109.979 -0.378 . . . . 1.45 109.979 177.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.868 ' HG3' ' HB3' ' A' ' 137' ' ' TRP . 18.6 Cg_endo -57.41 -50.29 11.33 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.138 1.892 . . . . 0.78 112.253 -174.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -66.89 16.44 0.29 Allowed Glycine 0 CA--C 1.526 0.758 0 N-CA-C 114.829 0.692 . . . . 0.59 114.829 175.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -78.59 154.23 30.49 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 118.262 1.031 . . . . 1.07 108.572 169.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.435 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 50.1 m -106.97 167.36 9.94 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 109.64 -0.504 . . . . 1.92 109.64 -177.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.666 ' HA ' HG21 ' A' ' 56' ' ' THR . 91.2 t -40.81 -54.59 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 O-C-N 124.2 0.938 . . . . 1.07 111.731 178.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.761 ' HZ1' ' HB2' ' A' ' 161' ' ' LYS . 0.1 OUTLIER -70.13 -27.65 64.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.232 -0.44 . . . . 3.89 111.409 -172.856 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -68.0 -35.22 77.94 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.478 0.656 . . . . 1.4 109.59 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.579 HD13 ' CG2' ' A' ' 56' ' ' THR . 47.4 mt -80.42 -44.55 22.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 114.988 -1.006 . . . . 1.05 110.522 176.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.594 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 41.2 mt-10 -50.84 -41.73 57.95 Favored 'General case' 0 C--O 1.217 -0.653 0 CA-C-N 116.122 -0.49 . . . . 0.67 111.503 -177.115 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -60.88 -26.77 67.65 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 112.486 0.55 . . . . 0.87 112.486 -175.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.723 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 40.8 mmtm -100.93 -5.35 26.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.544 0.688 . . . . 2.22 109.83 175.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.594 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 11.9 tp -97.82 -51.1 4.2 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.119 -0.946 . . . . 1.04 111.971 -176.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.503 HD11 ' HB3' ' A' ' 164' ' ' GLU . 69.5 mt -56.24 -46.72 99.76 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 112.957 0.725 . . . . 1.08 112.957 -171.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.451 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 63.3 Cg_exo -53.67 -25.03 32.03 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.092 1.861 . . . . 0.62 112.577 175.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.824 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 94.8 mt -86.66 -45.41 11.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.241 -0.436 . . . . 1.36 110.744 177.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.722 HD21 ' HG2' ' A' ' 37' ' ' PRO . 96.5 mt -59.89 -54.83 41.54 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-O 122.048 0.928 . . . . 1.07 110.204 177.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.401 0 CA-C-N 113.305 -1.77 . . . . 1.12 112.962 -179.08 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.8 m . . . . . 0 C--O 1.235 0.3 0 CA-C-O 120.81 0.338 . . . . 2.17 110.407 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.47 ' HB3' ' O ' ' A' ' 147' ' ' ASP . 3.1 m -159.78 152.39 21.29 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 107.075 -1.454 . . . . 1.68 107.075 -173.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.872 ' HB ' HD13 ' A' ' 118' ' ' LEU . 4.6 pt -66.54 -13.63 16.53 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 CA-C-N 114.079 -1.418 . . . . 1.16 112.298 -173.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.813 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 57.1 m-85 -70.45 -8.11 48.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.819 0.342 . . . . 0.3 111.908 -178.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -64.88 -25.86 68.07 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 108.103 -1.073 . . . . 2.11 108.103 175.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.851 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 61.4 m-85 -109.52 113.72 26.75 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 114.191 -1.368 . . . . 0.37 111.632 -176.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -47.72 142.26 4.79 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 113.122 -1.854 . . . . 2.86 110.652 169.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.762 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 54.8 t -111.66 159.2 11.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 108.395 -0.965 . . . . 1.32 108.395 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.722 HD23 ' HA ' ' A' ' 27' ' ' PRO . 74.9 mt -124.05 121.08 34.25 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 121.103 -0.239 . . . . 1.29 110.889 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.596 ' HA ' ' HE3' ' A' ' 105' ' ' MET . 6.2 t0 -62.1 170.5 2.18 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 107.314 -1.365 . . . . 1.87 107.314 173.062 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.628 ' HA ' ' C ' ' A' ' 105' ' ' MET . . . -53.05 -20.31 3.48 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 114.673 1.36 . . . . 1.2 114.673 -164.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.482 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 7.9 t70 -103.31 11.66 36.44 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.541 -0.463 . . . . 2.34 111.665 -177.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.679 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 54.7 m-70 76.04 18.42 2.0 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.823 0.82 . . . . 2.26 109.503 176.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.714 ' HE2' ' HA ' ' A' ' 26' ' ' LYS . 10.6 mmpt? -88.98 127.97 53.77 Favored Pre-proline 0 N--CA 1.445 -0.691 0 N-CA-C 107.488 -1.301 . . . . 4.64 107.488 171.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.722 ' HA ' HD23 ' A' ' 21' ' ' LEU . 80.0 Cg_exo -49.82 114.08 1.23 Allowed 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 122.242 1.961 . . . . 0.62 113.206 -171.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.679 ' HH ' ' HE2' ' A' ' 33' ' ' HIS . 49.5 t80 -79.99 146.71 31.88 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 113.813 -1.54 . . . . 1.52 111.675 173.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.497 ' OD1' ' HB3' ' A' ' 32' ' ' GLN . 2.5 t-20 -86.34 92.39 8.79 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 114.917 -1.038 . . . . 2.16 109.289 175.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.63 HD21 ' HA ' ' A' ' 16' ' ' PHE . 54.0 tp -72.62 -41.25 65.75 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.756 -0.656 . . . . 1.07 109.976 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.772 ' HA ' ' CE1' ' A' ' 16' ' ' PHE . 1.5 t -70.22 -0.83 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 114.698 -1.137 . . . . 1.69 112.517 -167.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.497 ' HB3' ' OD1' ' A' ' 29' ' ' ASN . 30.1 pt20 -76.14 -6.92 53.44 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.342 0.591 . . . . 1.31 109.687 174.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.925 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 93.0 m-70 -100.29 28.53 4.91 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 115.279 -0.873 . . . . 0.35 108.798 175.15 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.813 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 8.0 mtmt -90.45 118.16 29.71 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 114.687 -1.142 . . . . 2.07 109.595 173.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.66 -40.4 1.97 Allowed Glycine 0 N--CA 1.439 -1.159 0 N-CA-C 111.239 -0.745 . . . . 0.24 111.239 -177.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.46 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 40.7 m -126.97 135.69 27.74 Favored Pre-proline 0 N--CA 1.435 -1.204 0 N-CA-C 108.583 -0.895 . . . . 0.74 108.583 172.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.708 ' HG3' ' CB ' ' A' ' 170' ' ' LEU . 5.9 Cg_endo -44.5 155.36 0.27 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.837 3.025 . . . . 0.22 112.591 175.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.814 ' HB2' HG21 ' A' ' 70' ' ' THR . 0.7 OUTLIER -141.68 149.83 41.09 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 106.59 -1.633 . . . . 1.09 106.59 -179.752 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.837 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 2.3 mp -119.89 118.63 31.26 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.603 -0.686 . . . . 1.82 110.188 177.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.944 HD13 ' HE1' ' A' ' 122' ' ' MET . 2.2 mt -103.11 127.95 56.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-N 115.408 -0.815 . . . . 1.12 110.374 178.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.837 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.3 OUTLIER -114.81 128.53 56.35 Favored 'General case' 0 C--O 1.218 -0.597 0 CA-C-N 116.055 -0.52 . . . . 1.09 111.225 -172.089 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.519 ' OD1' ' HB3' ' A' ' 76' ' ' SER . 0.3 OUTLIER -76.51 105.53 7.62 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 106.024 -1.843 . . . . 3.11 106.024 165.428 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.972 HG13 ' HB3' ' A' ' 73' ' ' ALA . 2.4 p . . . . . 0 C--N 1.293 -1.869 0 C-N-CA 119.27 -0.972 . . . . 1.69 113.372 -164.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.257 0 N-CA-C 113.851 0.3 . . . . 0.85 113.851 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.15 -21.81 59.88 Favored Glycine 0 C--O 1.219 -0.829 0 C-N-CA 121.147 -0.549 . . . . 0.67 113.475 -175.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.7 -56.89 16.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 117.815 0.807 . . . . 1.2 109.437 177.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -60.15 -32.59 71.17 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.869 -1.06 . . . . 2.61 110.145 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.546 ' HA ' ' CG2' ' A' ' 160' ' ' VAL . 92.4 m -71.44 -59.53 2.71 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 114.827 -1.079 . . . . 1.06 109.94 -175.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 1.124 ' HB3' HG11 ' A' ' 71' ' ' VAL . . . -63.07 -42.56 99.69 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.439 -1.255 . . . . 1.05 111.454 -175.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.555 ' HA ' ' CD1' ' A' ' 102' ' ' PHE . 6.4 m -58.53 -56.89 16.26 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.237 0.541 . . . . 1.08 111.059 -179.205 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.4 m -68.29 -33.31 74.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.634 -0.712 . . . . 1.22 111.213 -173.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.719 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 20.6 mt -67.74 -48.33 66.75 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-O 121.29 0.566 . . . . 1.14 110.077 -178.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.921 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 10.9 t80 -59.3 -46.52 88.34 Favored 'General case' 0 C--O 1.205 -1.267 0 CA-C-N 115.053 -0.976 . . . . 0.94 110.427 178.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -73.52 -26.96 61.11 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 116.625 -0.261 . . . . 1.6 111.551 -172.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.478 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 34.4 ttpt -85.96 -23.8 26.77 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 108.83 -0.804 . . . . 2.06 108.83 -177.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.647 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 30.1 m-85 -122.98 -6.66 8.42 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 115.21 1.559 . . . . 0.92 115.21 -169.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.645 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 26.6 pttt -66.82 -23.77 66.08 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 108.242 -1.022 . . . . 1.89 108.242 170.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.8 t -49.25 -36.18 19.71 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 114.292 -1.322 . . . . 1.68 110.504 171.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -92.31 -30.3 15.91 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.041 0.386 . . . . 1.11 112.041 176.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.403 ' HA3' ' HB2' ' A' ' 36' ' ' SER . . . 143.0 -6.39 2.04 Favored Glycine 0 CA--C 1.52 0.372 0 N-CA-C 111.576 -0.61 . . . . 0.2 111.576 -176.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.719 ' HE2' ' HB3' ' A' ' 60' ' ' LEU . 23.1 t80 -67.58 143.57 56.01 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-N 115.329 -0.436 . . . . 0.21 111.209 -178.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.925 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 7.1 t -132.59 152.65 51.56 Favored 'General case' 0 N--CA 1.415 -2.181 0 N-CA-C 108.095 -1.076 . . . . 1.02 108.095 172.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 1.124 HG11 ' HB3' ' A' ' 57' ' ' ALA . 33.4 t -106.2 101.18 12.07 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.501 0 N-CA-C 107.482 -1.303 . . . . 1.04 107.482 157.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.866 ' HB2' HG23 ' A' ' 40' ' ' ILE . 65.9 mt -85.87 120.3 27.13 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.48 -1.304 . . . . 1.69 107.48 177.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.972 ' HB3' HG13 ' A' ' 43' ' ' VAL . . . -99.49 112.09 24.35 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.918 -0.713 . . . . 1.17 110.49 177.138 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.976 ' HD2' HD13 ' A' ' 108' ' ' ILE . 4.6 m-85 -99.04 95.37 3.21 Favored Pre-proline 0 N--CA 1.438 -1.041 0 N-CA-C 106.593 -1.632 . . . . 0.58 106.593 176.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.847 ' HB2' ' HG2' ' A' ' 107' ' ' LYS . 9.8 Cg_endo -71.22 142.69 42.16 Favored 'Trans proline' 0 N--CA 1.431 -2.155 0 C-N-CA 120.49 0.793 . . . . 1.3 110.281 -172.203 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.519 ' HB3' ' OD1' ' A' ' 42' ' ' ASN . 57.2 p . . . . . 0 C--N 1.297 -1.7 0 CA-C-O 122.175 0.988 . . . . 1.91 112.678 -177.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.402 ' H ' HG12 ' A' ' 104' ' ' ILE . . . . . . . . 0 N--CA 1.449 -0.478 0 CA-C-O 121.225 0.536 . . . . 1.15 111.942 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -83.33 17.55 2.07 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.077 -0.965 . . . . 1.99 110.687 -178.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.584 ' HB3' ' CD2' ' A' ' 61' ' ' TYR . 13.0 p90 -143.65 165.98 22.01 Favored Pre-proline 0 N--CA 1.445 -0.723 0 N-CA-C 109.497 -0.557 . . . . 1.31 109.497 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.65 ' HD3' ' CE2' ' A' ' 61' ' ' TYR . 31.2 Cg_exo -62.4 95.78 0.15 Allowed 'Trans proline' 0 CA--C 1.52 -0.202 0 C-N-CA 123.962 3.108 . . . . 1.07 113.19 -174.199 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.783 HD13 ' HB1' ' A' ' 73' ' ' ALA . 4.0 mm -90.48 116.14 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 107.513 -1.292 . . . . 1.97 107.513 175.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.641 ' HG3' ' CD1' ' A' ' 74' ' ' PHE . 1.2 mmt -92.93 -174.1 3.49 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.456 -0.793 . . . . 3.41 111.704 -166.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.488 ' N ' ' HA ' ' A' ' 23' ' ' ALA . . . -71.58 130.91 42.38 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.003 -0.998 . . . . 1.46 108.741 172.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.847 ' HG2' ' HB2' ' A' ' 75' ' ' PRO . 92.4 mttt -62.81 131.73 49.8 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-O 121.836 0.827 . . . . 2.31 109.265 176.015 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.976 HD13 ' HD2' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -122.36 165.39 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.419 0 N-CA-C 105.167 -2.16 . . . . 1.65 105.167 169.855 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -78.7 69.44 4.87 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 119.78 -0.768 . . . . 1.73 110.309 -178.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.4 HG11 HD11 ' A' ' 108' ' ' ILE . 0.1 OUTLIER -67.36 92.89 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-O 122.101 0.953 . . . . 1.4 108.853 178.51 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.6 t30 . . . . . 0 N--CA 1.438 -1.064 0 CA-C-N 113.286 -1.779 . . . . 2.1 106.555 177.691 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.642 ' ND1' ' H ' ' A' ' 118' ' ' LEU . 5.5 t-80 . . . . . 0 N--CA 1.426 -1.639 0 N-CA-C 107.058 -1.46 . . . . 0.71 107.058 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -30.93 -45.33 0.14 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 124.364 3.376 . . . . 0.47 113.211 -178.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.872 HD13 ' HB ' ' A' ' 15' ' ' ILE . 43.3 tp -65.05 -50.36 66.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.905 -0.589 . . . . 1.15 111.83 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.551 ' OH ' HG21 ' A' ' 40' ' ' ILE . 32.9 m-85 -76.34 -33.04 58.98 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 112.026 0.38 . . . . 3.33 112.026 178.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.613 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 43.9 mt-10 -57.94 -37.49 74.21 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 107.111 -1.44 . . . . 2.44 107.111 170.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.851 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 74.3 t80 -66.25 -35.65 80.97 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.368 -0.833 . . . . 1.08 110.646 173.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.944 ' HE1' HD13 ' A' ' 40' ' ' ILE . 53.1 mtt -73.61 -55.08 6.75 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.75 -0.659 . . . . 1.25 110.806 -168.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.48 ' HB2' ' HE2' ' A' ' 123' ' ' LYS . 0.2 OUTLIER -70.0 -24.26 63.28 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.108 -0.496 . . . . 1.86 111.144 177.785 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.613 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 9.5 pttp -72.57 -30.14 64.14 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 119.61 -0.836 . . . . 2.52 109.624 174.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 87.8 m -76.86 -48.0 19.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.775 -0.648 . . . . 1.21 110.514 176.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.769 ' HG2' HH22 ' A' ' 153' ' ' ARG . 22.8 ttmm . . . . . 0 N--CA 1.452 -0.367 0 CA-C-N 116.283 -0.417 . . . . 2.38 110.848 -179.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.466 0.337 0 N-CA-C 111.414 0.154 . . . . 2.41 111.414 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.655 ' HB2' ' HB3' ' A' ' 156' ' ' PRO . 1.8 m120 -38.2 -153.05 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 125.507 1.523 . . . . 2.04 111.955 158.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.698 ' CD1' HG23 ' A' ' 43' ' ' VAL . 1.6 m-85 -25.27 -46.56 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 114.815 1.413 . . . . 2.53 114.815 -167.309 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.788 ' HA ' ' O ' ' A' ' 154' ' ' PHE . 16.3 m 25.75 101.3 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.719 1.377 . . . . 1.24 114.719 172.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.551 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.7 OUTLIER -86.12 169.18 13.36 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.61 -1.177 . . . . 1.03 110.235 -175.058 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -126.04 124.41 40.59 Favored 'General case' 0 CA--C 1.495 -1.15 0 N-CA-C 105.118 -2.179 . . . . 0.7 105.118 162.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.749 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 7.3 tp -79.99 105.56 11.36 Favored 'General case' 0 N--CA 1.422 -1.867 0 C-N-CA 118.143 -1.423 . . . . 1.16 108.682 178.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.688 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 39.7 mm -91.59 138.16 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.022 0 CA-C-N 112.542 -2.117 . . . . 1.05 107.118 -178.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.533 ' HA ' HD11 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -92.04 179.94 5.45 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 120.396 -0.522 . . . . 0.98 111.055 -170.273 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.532 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 40.1 mtm180 -47.36 -42.6 21.92 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 122.893 0.477 . . . . 2.61 111.626 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.47 ' O ' ' HB3' ' A' ' 14' ' ' SER . 8.1 m-20 -96.72 23.43 7.02 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 109.685 -0.487 . . . . 2.0 109.685 -176.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.612 ' HA2' HG21 ' A' ' 144' ' ' ILE . . . 65.26 37.88 94.48 Favored Glycine 0 N--CA 1.437 -1.275 0 CA-C-N 115.666 -0.697 . . . . 0.19 114.139 178.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.49 ' HA ' ' HD2' ' A' ' 150' ' ' PRO . 6.9 p -108.74 110.1 61.22 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 118.615 1.208 . . . . 1.74 111.73 173.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.663 ' HD3' HG23 ' A' ' 15' ' ' ILE . 10.2 Cg_endo -57.09 115.05 2.22 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 124.081 3.187 . . . . 0.6 111.168 175.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.761 HG23 ' HG2' ' A' ' 152' ' ' GLU . 17.6 m -116.27 -17.86 7.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-O 121.187 0.518 . . . . 2.06 109.982 -177.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.761 ' HG2' HG23 ' A' ' 151' ' ' VAL . 24.6 mm-40 -138.57 167.24 22.36 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-N 115.49 -0.777 . . . . 1.17 109.956 -179.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.769 HH22 ' HG2' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -148.43 141.6 25.03 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 114.904 -1.044 . . . . 2.9 108.937 163.267 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.788 ' O ' ' HA ' ' A' ' 140' ' ' THR . 79.7 m-85 -117.45 151.12 37.72 Favored 'General case' 0 C--O 1.217 -0.632 0 N-CA-C 109.483 -0.562 . . . . 0.36 109.483 -174.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.539 ' HB3' ' HD2' ' A' ' 156' ' ' PRO . 51.1 m -73.27 163.76 66.07 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 109.388 -0.597 . . . . 1.45 109.388 177.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.655 ' HB3' ' HB2' ' A' ' 138' ' ' ASN . 10.6 Cg_endo -53.15 -67.02 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.763 2.309 . . . . 0.78 112.729 -179.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -57.2 15.37 0.01 OUTLIER Glycine 0 CA--C 1.53 0.999 0 N-CA-C 116.368 1.307 . . . . 0.59 116.368 172.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.415 ' H ' ' C ' ' A' ' 156' ' ' PRO . . . -79.85 138.09 37.11 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 119.061 1.431 . . . . 1.07 107.392 167.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.485 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 8.6 t -104.85 173.47 6.29 Favored 'General case' 0 N--CA 1.429 -1.51 0 C-N-CA 119.988 -0.685 . . . . 1.92 110.072 -169.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.546 ' CG2' ' HA ' ' A' ' 56' ' ' THR . 69.3 t -43.57 -54.76 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 114.358 -1.292 . . . . 1.07 112.126 -177.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.84 -29.96 68.39 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.98 0.419 . . . . 3.89 110.78 -173.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -71.05 -31.41 67.84 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.642 0.734 . . . . 1.4 109.123 -176.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.472 HD11 ' CG2' ' A' ' 56' ' ' THR . 33.1 mt -82.58 -45.33 19.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 114.492 -1.231 . . . . 1.05 110.741 176.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.563 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 41.8 mt-10 -51.2 -41.87 60.53 Favored 'General case' 0 C--O 1.218 -0.595 0 CA-C-N 116.308 -0.405 . . . . 0.67 111.362 -178.015 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -60.8 -20.69 62.05 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 112.056 0.391 . . . . 0.87 112.056 -174.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.683 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 31.3 mmtp -100.38 -24.44 14.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.477 0.656 . . . . 2.22 110.273 172.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.563 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 10.8 tp -80.73 -49.02 11.71 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.183 -0.917 . . . . 1.04 112.183 -175.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 164' ' ' GLU . 73.1 mt -55.75 -43.7 99.31 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.478 -0.783 . . . . 1.08 112.568 -173.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -49.98 -33.67 34.99 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 122.02 1.813 . . . . 0.62 112.659 172.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.708 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 91.3 mt -86.01 -42.67 13.78 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 121.122 -0.231 . . . . 1.36 111.348 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.613 HD23 ' HB2' ' A' ' 69' ' ' PHE . 93.8 mt -59.39 -53.2 60.95 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 122.264 1.031 . . . . 1.07 109.624 175.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.425 0 CA-C-N 113.321 -1.763 . . . . 1.12 113.958 -174.515 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.5 m . . . . . 0 C--O 1.233 0.224 0 N-CA-C 109.585 -0.524 . . . . 2.17 109.585 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.9 m -166.16 159.19 14.99 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 105.431 -2.062 . . . . 1.68 105.431 -177.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.779 ' HB ' HD12 ' A' ' 118' ' ' LEU . 8.0 pt -59.99 -20.18 19.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 CA-C-N 116.015 -0.538 . . . . 1.16 111.437 -176.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.717 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 40.3 m-85 -68.68 -2.75 9.87 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.059 0.457 . . . . 0.3 111.632 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.96 -12.99 61.37 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 108.469 -0.937 . . . . 2.11 108.469 172.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.73 ' HE2' ' HB2' ' A' ' 121' ' ' TYR . 58.5 m-85 -129.73 111.3 12.5 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 114.837 -1.074 . . . . 0.37 110.871 -173.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -51.38 150.27 3.64 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 113.792 -1.549 . . . . 2.86 110.099 172.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.836 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 34.4 t -111.04 157.06 12.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 115.457 -0.792 . . . . 1.32 108.906 -178.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.837 ' O ' ' HB3' ' A' ' 105' ' ' MET . 96.2 mt -122.31 116.09 23.47 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 116.546 -0.297 . . . . 1.29 110.502 -177.138 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.529 ' HA ' ' SD ' ' A' ' 105' ' ' MET . 6.2 t70 -58.29 170.87 0.64 Allowed 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 107.624 -1.25 . . . . 1.87 107.624 174.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.67 ' HA ' ' C ' ' A' ' 105' ' ' MET . . . -54.56 -26.34 31.55 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 118.761 0.709 . . . . 1.2 112.515 -168.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.429 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 8.8 t70 -78.22 -7.51 57.21 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.47 -0.332 . . . . 2.34 111.047 -178.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.623 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 57.1 m-70 80.09 19.53 0.6 Allowed 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 122.01 0.91 . . . . 2.26 108.628 -177.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.85 ' HE2' ' HA ' ' A' ' 26' ' ' LYS . 9.3 mmpt? -99.83 128.96 29.69 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 114.071 -1.422 . . . . 4.64 108.388 172.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.694 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 74.9 Cg_exo -47.12 115.73 1.44 Allowed 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 123.136 2.557 . . . . 0.62 114.989 -170.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.769 ' CE2' HD22 ' A' ' 72' ' ' LEU . 34.5 t80 -80.08 146.61 31.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.123 -1.399 . . . . 1.52 110.356 166.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.627 ' OD1' ' HB3' ' A' ' 32' ' ' GLN . 2.6 t-20 -76.56 90.76 3.34 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.662 -0.699 . . . . 2.16 110.133 179.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.706 ' HG ' ' CD1' ' A' ' 16' ' ' PHE . 56.3 tp -69.34 -46.51 66.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.162 0.506 . . . . 1.07 110.191 178.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.713 HG12 ' HB3' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -66.2 0.7 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 115.315 -0.857 . . . . 1.69 113.289 -171.598 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.627 ' HB3' ' OD1' ' A' ' 29' ' ' ASN . 3.8 pt20 -72.07 -16.22 62.02 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.109 -0.7 . . . . 1.31 109.109 172.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.976 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 91.2 m-70 -93.99 22.99 5.21 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 121.85 0.833 . . . . 0.35 109.356 178.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.717 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 29.7 mtmt -84.91 109.97 18.53 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 114.266 -1.334 . . . . 2.07 108.834 169.161 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 130.78 -38.05 2.0 Favored Glycine 0 N--CA 1.439 -1.113 0 C-N-CA 120.987 -0.625 . . . . 0.24 111.774 -178.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.44 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 22.7 m -133.99 137.04 27.46 Favored Pre-proline 0 N--CA 1.435 -1.192 0 N-CA-C 108.91 -0.774 . . . . 0.74 108.91 172.037 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.685 ' HG3' ' CB ' ' A' ' 170' ' ' LEU . 7.4 Cg_endo -45.81 156.54 0.43 Allowed 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 124.057 3.171 . . . . 0.22 112.94 178.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.783 ' HB2' HG23 ' A' ' 70' ' ' THR . 0.9 OUTLIER -141.07 145.65 36.11 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 106.745 -1.576 . . . . 1.09 106.745 178.823 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 1.055 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 1.5 mm? -107.2 111.88 24.49 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.199 -1.038 . . . . 1.82 108.199 177.075 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.856 HG23 ' HH ' ' A' ' 119' ' ' TYR . 4.9 mt -95.27 124.51 47.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 C-N-CA 119.622 -0.831 . . . . 1.12 109.954 177.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 1.055 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 1.3 m-85 -106.94 124.39 49.55 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.212 -0.904 . . . . 1.09 110.355 -174.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -80.04 90.03 5.39 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 106.421 -1.696 . . . . 3.11 106.421 169.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 1.042 HG13 ' HB1' ' A' ' 73' ' ' ALA . 5.9 p . . . . . 0 C--N 1.3 -1.552 0 C-N-CA 120.175 -0.61 . . . . 1.69 110.865 -166.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.81 0 N-CA-C 111.603 -0.599 . . . . 0.85 111.603 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.57 ' HA2' ' HB ' ' A' ' 56' ' ' THR . . . -75.05 -17.16 80.28 Favored Glycine 0 C--O 1.221 -0.718 0 CA-C-O 119.628 -0.54 . . . . 0.67 114.404 -174.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -71.22 -58.54 3.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 118.44 1.12 . . . . 1.2 109.152 177.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -62.67 -24.21 67.52 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.241 -0.89 . . . . 2.61 110.223 178.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.658 HG22 ' HA ' ' A' ' 160' ' ' VAL . 16.2 m -74.57 -57.5 3.89 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.278 -0.874 . . . . 1.06 110.306 177.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 1.054 ' HB3' HG11 ' A' ' 71' ' ' VAL . . . -58.13 -40.54 81.53 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.76 -0.655 . . . . 1.05 110.986 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.517 ' HA ' ' CD1' ' A' ' 102' ' ' PHE . 86.9 m -57.01 -56.05 26.76 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-O 121.379 0.609 . . . . 1.08 110.532 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.6 m -69.78 -37.7 76.46 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.116 -0.947 . . . . 1.22 111.46 -176.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.685 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 15.2 mt -62.15 -50.06 73.36 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-O 121.523 0.677 . . . . 1.14 110.302 -177.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.914 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 10.8 t80 -57.7 -51.51 69.24 Favored 'General case' 0 C--O 1.2 -1.544 0 CA-C-N 114.46 -1.245 . . . . 0.94 111.052 -179.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.525 ' HA ' ' HD3' ' A' ' 65' ' ' LYS . 5.1 m-80 -73.63 -24.26 60.0 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 120.635 0.255 . . . . 1.6 111.182 -173.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.412 ' HE2' ' HB2' ' A' ' 63' ' ' LYS . 24.4 ttmm -80.53 -26.52 38.0 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 108.548 -0.908 . . . . 2.06 108.548 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.691 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 45.0 m-85 -124.74 -1.53 7.92 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 115.522 1.675 . . . . 0.92 115.522 -169.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.626 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -64.86 -20.74 66.58 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 107.507 -1.294 . . . . 1.89 107.507 169.218 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -46.72 -44.5 18.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 113.794 -1.548 . . . . 1.68 111.014 171.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.408 ' OE1' ' HA ' ' A' ' 64' ' ' TYR . 23.4 mp0 -86.33 -33.11 20.69 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.454 -0.339 . . . . 1.11 111.731 178.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 143.69 -1.52 1.35 Allowed Glycine 0 N--CA 1.452 -0.293 0 N-CA-C 111.562 -0.615 . . . . 0.2 111.562 -174.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.692 ' CE1' HD21 ' A' ' 39' ' ' LEU . 22.0 t80 -68.73 142.77 54.88 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 122.989 0.515 . . . . 0.21 111.25 -178.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.976 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 1.9 t -133.92 147.01 51.04 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 107.633 -1.247 . . . . 1.02 107.633 170.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 1.054 HG11 ' HB3' ' A' ' 57' ' ' ALA . 39.1 t -99.02 99.12 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.441 0 N-CA-C 107.338 -1.356 . . . . 1.04 107.338 157.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.769 HD22 ' CE2' ' A' ' 28' ' ' TYR . 4.2 mt -84.88 118.51 24.55 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 107.895 -1.15 . . . . 1.69 107.895 177.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 1.042 ' HB1' HG13 ' A' ' 43' ' ' VAL . . . -116.58 112.62 21.57 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 119.879 -0.729 . . . . 1.17 110.937 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.836 ' CZ ' HG13 ' A' ' 20' ' ' VAL . 1.6 m-30 -91.75 110.26 42.31 Favored Pre-proline 0 C--N 1.318 -0.77 0 N-CA-C 107.741 -1.207 . . . . 0.58 107.741 173.141 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.896 ' HG2' ' HB3' ' A' ' 107' ' ' LYS . 60.9 Cg_endo -72.2 40.77 0.46 Allowed 'Trans proline' 0 N--CA 1.48 0.73 0 C-N-CA 123.961 3.107 . . . . 1.3 116.629 -165.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.47 ' O ' ' HD3' ' A' ' 107' ' ' LYS . 4.8 t . . . . . 0 N--CA 1.474 0.759 0 N-CA-C 115.845 1.794 . . . . 1.91 115.845 175.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.698 0 CA-C-O 120.78 0.324 . . . . 1.15 110.94 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -88.09 12.07 14.52 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.96 -0.563 . . . . 1.99 110.604 175.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.636 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 15.5 p90 -128.93 160.71 62.03 Favored Pre-proline 0 N--CA 1.438 -1.037 0 N-CA-C 108.209 -1.034 . . . . 1.31 108.209 175.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.735 ' HG2' ' HA ' ' A' ' 72' ' ' LEU . 57.6 Cg_endo -64.27 104.27 0.5 Allowed 'Trans proline' 0 N--CA 1.472 0.222 0 C-N-CA 123.432 2.755 . . . . 1.07 113.2 -171.156 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.901 HD13 ' HB2' ' A' ' 73' ' ' ALA . 5.4 mm -100.48 121.03 50.75 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.818 0 N-CA-C 108.053 -1.091 . . . . 1.97 108.053 175.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.837 ' HB3' ' O ' ' A' ' 21' ' ' LEU . 20.1 mmt -97.68 -159.26 0.72 Allowed 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.32 -0.854 . . . . 3.41 113.246 -163.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.703 ' O ' ' HG2' ' A' ' 107' ' ' LYS . . . -56.96 -27.53 61.37 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.29 -0.868 . . . . 1.46 112.623 -173.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.896 ' HB3' ' HG2' ' A' ' 75' ' ' PRO . 4.5 ptpp? 76.88 133.94 0.06 Allowed 'General case' 0 CA--C 1.481 -1.684 0 O-C-N 125.044 1.465 . . . . 2.31 108.802 -163.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.686 HG13 ' CB ' ' A' ' 116' ' ' HIS . 0.1 OUTLIER -134.65 162.59 38.53 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 CA-C-N 113.4 -1.727 . . . . 1.65 108.206 173.824 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -75.93 70.04 2.61 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.248 -0.887 . . . . 1.73 111.438 -171.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.5 HG12 ' CD1' ' A' ' 108' ' ' ILE . 2.4 m -70.91 91.56 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 CA-C-O 121.493 0.663 . . . . 1.4 111.272 -173.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 . . . . . 0 C--N 1.316 -0.849 0 CA-C-N 114.608 -1.178 . . . . 2.1 108.51 168.917 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.686 ' CB ' HG13 ' A' ' 108' ' ' ILE . 3.2 t-80 . . . . . 0 N--CA 1.431 -1.4 0 N-CA-C 105.846 -1.909 . . . . 0.71 105.846 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -30.89 -49.44 0.22 Allowed 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 123.899 3.066 . . . . 0.47 113.141 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.779 HD12 ' HB ' ' A' ' 15' ' ' ILE . 40.0 tp -58.7 -52.16 66.89 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.459 0.704 . . . . 1.15 112.389 176.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.856 ' HH ' HG23 ' A' ' 40' ' ' ILE . 65.5 m-85 -75.6 -36.54 60.28 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-N 116.472 -0.331 . . . . 3.33 111.652 -178.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.435 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 42.8 mt-10 -56.5 -36.79 69.57 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 107.137 -1.431 . . . . 2.44 107.137 171.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.73 ' HB2' ' HE2' ' A' ' 18' ' ' PHE . 49.5 t80 -68.36 -31.11 70.27 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 119.825 -0.75 . . . . 1.08 111.167 175.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.594 ' HE3' ' CG2' ' A' ' 15' ' ' ILE . 0.5 OUTLIER -74.4 -56.41 4.89 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.27 0.557 . . . . 1.25 109.958 -171.748 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.636 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -72.28 -24.3 61.32 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.221 -0.9 . . . . 1.86 112.258 178.912 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.663 ' HG2' ' HA ' ' A' ' 121' ' ' TYR . 16.0 ptmt -68.05 -34.37 76.32 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 118.945 -1.102 . . . . 2.52 109.318 175.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 44.3 m -77.11 -43.88 32.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.206 -0.906 . . . . 1.21 110.126 178.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 2.38 110.849 175.912 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.748 ' HB3' ' HG3' ' A' ' 156' ' ' PRO . 0.2 OUTLIER . . . . . 0 CA--C 1.515 -0.37 0 N-CA-C 110.143 -0.318 . . . . 2.41 110.143 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.482 ' O ' ' N ' ' A' ' 140' ' ' THR . 7.1 m120 -36.23 -154.91 0.0 OUTLIER 'General case' 0 C--O 1.206 -1.188 0 O-C-N 125.052 1.47 . . . . 2.04 112.672 163.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.903 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 0.5 OUTLIER -31.63 -21.29 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 117.362 2.356 . . . . 2.53 117.362 -170.277 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.482 ' N ' ' O ' ' A' ' 138' ' ' ASN . 5.9 m 5.62 114.73 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 120.56 1.527 . . . . 1.24 113.906 165.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.555 ' HB3' ' CE1' ' A' ' 41' ' ' TYR . 0.8 OUTLIER -94.14 159.88 14.95 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 114.114 -1.403 . . . . 1.03 110.764 -164.527 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.476 ' O ' HD11 ' A' ' 39' ' ' LEU . 48.2 m-85 -122.5 125.53 45.96 Favored 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 106.306 -1.739 . . . . 0.7 106.306 167.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.746 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 9.8 tp -80.67 105.95 12.3 Favored 'General case' 0 N--CA 1.424 -1.752 0 C-N-CA 117.927 -1.509 . . . . 1.16 108.592 177.02 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.756 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 40.7 mm -92.29 141.29 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.926 0 CA-C-N 112.981 -1.918 . . . . 1.05 107.228 -178.594 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.62 ' HA ' HD12 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -91.98 179.09 5.69 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 120.716 -0.394 . . . . 0.98 111.641 -170.188 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.486 ' CG ' ' HD3' ' A' ' 37' ' ' PRO . 17.4 mtm180 -50.43 -41.71 52.9 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 122.845 0.458 . . . . 2.61 111.392 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.416 ' C ' ' HE2' ' A' ' 16' ' ' PHE . 4.8 m-20 -93.96 12.8 24.86 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 109.476 -0.565 . . . . 2.0 109.476 -176.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.637 ' HA3' ' CE2' ' A' ' 16' ' ' PHE . . . 76.36 32.12 52.6 Favored Glycine 0 N--CA 1.433 -1.52 0 CA-C-N 115.354 -0.839 . . . . 0.19 113.911 178.109 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.47 ' HA ' ' HD2' ' A' ' 150' ' ' PRO . 7.1 p -108.53 109.62 61.45 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 118.806 1.303 . . . . 1.74 111.923 174.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.657 ' HD3' HG22 ' A' ' 15' ' ' ILE . 1.9 Cg_endo -50.48 124.3 12.98 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 124.294 3.33 . . . . 0.6 112.106 174.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.743 HG22 ' HG2' ' A' ' 152' ' ' GLU . 15.9 m -125.0 -15.11 4.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.929 0.395 . . . . 2.06 110.385 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.746 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 13.7 mm-40 -140.99 166.9 23.53 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 116.107 -0.497 . . . . 1.17 110.598 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.496 ' HB3' ' CZ ' ' A' ' 153' ' ' ARG . 0.0 OUTLIER -148.07 143.92 27.52 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.254 -0.884 . . . . 2.9 109.697 162.315 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.624 ' HZ ' ' HB2' ' A' ' 166' ' ' LYS . 91.0 m-85 -120.35 138.02 53.96 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.691 -0.686 . . . . 0.36 110.436 -171.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.49 ' OG ' ' HD2' ' A' ' 156' ' ' PRO . 8.2 t -65.49 151.74 93.76 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 107.853 -1.166 . . . . 1.45 107.853 177.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.748 ' HG3' ' HB3' ' A' ' 137' ' ' TRP . 25.2 Cg_endo -59.32 -25.19 77.47 Favored 'Trans proline' 0 N--CA 1.474 0.376 0 C-N-CA 123.056 2.504 . . . . 0.78 113.221 -176.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -75.94 -2.96 73.06 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.961 -0.563 . . . . 0.59 113.853 174.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -70.44 146.78 50.1 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 117.659 0.729 . . . . 1.07 109.502 175.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.534 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 17.1 m -104.66 170.09 8.08 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.566 -0.531 . . . . 1.92 109.566 -178.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.658 ' HA ' HG22 ' A' ' 56' ' ' THR . 87.1 t -40.52 -55.51 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 O-C-N 124.286 0.991 . . . . 1.07 111.409 177.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.436 ' HZ1' ' HB2' ' A' ' 161' ' ' LYS . 0.1 OUTLIER -70.42 -28.52 65.12 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.225 -0.443 . . . . 3.89 111.366 -173.033 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -65.72 -35.54 81.02 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.583 0.706 . . . . 1.4 109.265 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.752 HD13 ' HH ' ' A' ' 41' ' ' TYR . 72.1 mt -83.27 -43.0 18.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 114.432 -1.258 . . . . 1.05 110.952 178.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.59 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 46.0 mt-10 -51.98 -43.38 63.57 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-O 120.842 0.353 . . . . 0.67 111.19 -179.111 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -60.64 -17.04 44.85 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 112.149 0.425 . . . . 0.87 112.149 -174.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.624 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 13.7 mmmm -106.0 -25.28 12.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.259 0.552 . . . . 2.22 109.941 172.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.59 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 12.0 tp -76.81 -49.35 16.02 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.138 -0.937 . . . . 1.04 111.979 -177.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.442 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 67.1 mt -55.28 -44.12 99.46 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.718 -0.674 . . . . 1.08 111.91 -175.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.442 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 86.0 Cg_exo -50.26 -24.01 10.87 Favored 'Trans proline' 0 C--N 1.353 0.816 0 C-N-CA 122.499 2.132 . . . . 0.62 113.592 172.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.685 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 86.2 mt -97.78 -40.3 8.61 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 120.636 -0.426 . . . . 1.36 111.118 177.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.663 HD21 ' HG2' ' A' ' 37' ' ' PRO . 95.6 mt -59.92 -59.29 5.66 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 122.141 0.972 . . . . 1.07 109.102 175.126 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.526 0 CA-C-N 113.358 -1.746 . . . . 1.12 111.713 -178.926 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.4 m . . . . . 0 N--CA 1.474 0.741 0 N-CA-C 111.822 0.304 . . . . 2.17 111.822 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 86.8 p 177.9 154.59 0.33 Allowed 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 106.173 -1.788 . . . . 1.68 106.173 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.813 ' HB ' HD13 ' A' ' 118' ' ' LEU . 5.1 pt -70.25 -17.59 20.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-N 115.068 -0.969 . . . . 1.16 112.236 -172.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.74 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 51.9 m-85 -69.91 -3.33 15.48 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.186 0.517 . . . . 0.3 111.463 -178.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -71.97 -17.99 62.02 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.249 -1.019 . . . . 2.11 108.249 176.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.707 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 72.5 m-85 -117.84 112.54 20.51 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 114.818 -1.083 . . . . 0.37 110.881 -175.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -47.9 142.06 5.24 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 113.494 -1.685 . . . . 2.86 110.452 172.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.77 HG13 ' HZ ' ' A' ' 74' ' ' PHE . 54.9 t -111.13 164.6 6.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 107.466 -1.309 . . . . 1.32 107.466 176.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.642 ' O ' ' HB3' ' A' ' 105' ' ' MET . 10.3 mt -133.16 125.68 30.0 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.224 -0.658 . . . . 1.29 109.224 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.527 ' HA ' ' SD ' ' A' ' 105' ' ' MET . 17.2 m-20 -56.21 178.6 0.05 OUTLIER 'General case' 0 CA--C 1.514 -0.408 0 O-C-N 123.768 0.667 . . . . 1.87 110.086 177.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.605 ' HA ' ' N ' ' A' ' 106' ' ' ALA . . . -61.41 -1.79 0.6 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.826 0.676 . . . . 1.2 112.826 -175.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -112.95 4.95 17.06 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.135 0.421 . . . . 2.34 112.135 175.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.773 ' CD2' ' HB1' ' A' ' 106' ' ' ALA . 8.0 m170 72.59 19.63 4.05 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.752 0.787 . . . . 2.26 110.241 177.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.486 ' HE3' ' HB2' ' A' ' 26' ' ' LYS . 2.9 mtmt -84.05 135.54 42.08 Favored Pre-proline 0 CA--C 1.509 -0.614 0 N-CA-C 106.591 -1.633 . . . . 4.64 106.591 164.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.608 ' HA ' HD21 ' A' ' 21' ' ' LEU . 80.4 Cg_exo -53.27 113.26 1.2 Allowed 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 121.187 1.258 . . . . 0.62 112.868 -178.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.653 ' HB3' HG11 ' A' ' 20' ' ' VAL . 45.8 t80 -78.86 144.01 35.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 113.701 -1.59 . . . . 1.52 110.969 173.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.615 HD22 HG21 ' A' ' 31' ' ' VAL . 2.5 t-20 -79.31 81.38 5.58 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 115.147 -0.933 . . . . 2.16 109.573 178.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.652 ' HG ' ' CD1' ' A' ' 16' ' ' PHE . 54.7 tp -60.79 -39.64 89.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.228 0.537 . . . . 1.07 109.558 177.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.707 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 1.1 m -72.11 -0.04 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.022 -0.99 . . . . 1.69 112.47 -168.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.589 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 3.8 pt20 -73.44 -13.92 61.16 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.359 -0.608 . . . . 1.31 109.359 173.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.843 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 91.6 m-70 -94.35 21.98 6.51 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-O 121.812 0.815 . . . . 0.35 109.561 176.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.74 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 45.5 mtmt -85.74 109.7 18.81 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 114.553 -1.203 . . . . 2.07 108.76 169.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 134.68 -41.02 1.5 Allowed Glycine 0 N--CA 1.435 -1.373 0 N-CA-C 111.308 -0.717 . . . . 0.24 111.308 -177.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.425 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 41.2 m -131.71 136.28 28.18 Favored Pre-proline 0 N--CA 1.438 -1.066 0 N-CA-C 108.616 -0.883 . . . . 0.74 108.616 171.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.718 ' HG2' HD22 ' A' ' 171' ' ' LEU . 3.5 Cg_endo -43.17 156.94 0.11 Allowed 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.936 3.091 . . . . 0.22 112.875 175.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.762 ' HB2' HG22 ' A' ' 70' ' ' THR . 1.0 OUTLIER -144.62 140.51 28.76 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 107.525 -1.287 . . . . 1.09 107.525 -179.736 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.908 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 1.7 mm? -106.04 112.17 25.11 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.403 -0.962 . . . . 1.82 108.403 176.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.943 HD11 ' HE3' ' A' ' 122' ' ' MET . 5.1 mt -98.63 130.06 48.04 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 CA-C-N 115.95 -0.568 . . . . 1.12 109.95 177.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.908 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.4 OUTLIER -117.56 140.5 49.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.636 -0.711 . . . . 1.09 110.492 -172.604 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.604 ' OD1' ' HB ' ' A' ' 140' ' ' THR . 22.8 p-10 -92.54 105.1 17.33 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 108.116 -1.068 . . . . 3.11 108.116 168.323 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.714 ' HB ' ' CE1' ' A' ' 139' ' ' PHE . 3.3 m . . . . . 0 C--N 1.31 -1.14 0 O-C-N 121.228 -0.92 . . . . 1.69 110.529 -170.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.693 0 N-CA-C 110.913 -0.875 . . . . 0.85 110.913 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.458 ' HA2' ' HB ' ' A' ' 56' ' ' THR . . . -70.17 -17.98 74.45 Favored Glycine 0 C--O 1.217 -0.919 0 C-N-CA 121.264 -0.493 . . . . 0.67 113.208 -178.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.418 ' HA ' ' CE2' ' A' ' 139' ' ' PHE . 1.1 t80 -74.14 -56.67 4.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 117.786 0.793 . . . . 1.2 109.896 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -62.93 -21.79 66.3 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.269 0.557 . . . . 2.61 110.115 176.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.684 ' HA ' HG23 ' A' ' 160' ' ' VAL . 16.0 m -76.34 -53.91 7.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.421 -0.809 . . . . 1.06 109.669 177.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 1.053 ' HB2' HG13 ' A' ' 71' ' ' VAL . . . -55.03 -43.06 73.37 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 114.905 -1.043 . . . . 1.05 110.758 177.27 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.494 ' HA ' ' CD1' ' A' ' 102' ' ' PHE . 39.4 m -60.84 -56.98 14.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.472 -0.785 . . . . 1.08 110.515 -178.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 98.6 m -66.29 -38.99 89.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.995 -1.002 . . . . 1.22 112.238 -175.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.749 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 18.7 mt -64.39 -48.5 75.21 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-O 121.425 0.631 . . . . 1.14 110.275 -176.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.887 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 13.5 t80 -56.84 -47.89 79.29 Favored 'General case' 0 C--O 1.207 -1.182 0 CA-C-N 114.545 -1.207 . . . . 0.94 110.897 178.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.563 ' HA ' ' HE3' ' A' ' 65' ' ' LYS . 1.1 m-80 -73.84 -25.5 60.11 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 116.602 -0.272 . . . . 1.6 111.132 -171.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -86.21 -23.15 26.56 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 109.015 -0.735 . . . . 2.06 109.015 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.718 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 29.1 m-85 -125.47 -4.53 7.21 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 115.808 1.781 . . . . 0.92 115.808 -169.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.639 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 22.2 pttp -67.04 -25.28 66.19 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 108.009 -1.108 . . . . 1.89 108.009 169.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.5 m -48.85 -30.25 5.58 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 114.203 -1.362 . . . . 1.68 111.27 172.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -96.26 -36.64 10.84 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.592 0.234 . . . . 1.11 111.547 174.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 149.83 -5.49 0.7 Allowed Glycine 0 C--O 1.237 0.319 0 N-CA-C 111.17 -0.772 . . . . 0.2 111.17 -176.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.749 ' HE2' ' HB3' ' A' ' 60' ' ' LEU . 21.6 t80 -69.59 141.53 53.73 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 115.368 -0.416 . . . . 0.21 111.089 -177.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.887 ' HA ' ' CD1' ' A' ' 61' ' ' TYR . 5.5 t -133.46 146.37 51.09 Favored 'General case' 0 N--CA 1.421 -1.898 0 N-CA-C 108.826 -0.805 . . . . 1.02 108.826 173.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 1.053 HG13 ' HB2' ' A' ' 57' ' ' ALA . 25.1 t -100.7 103.3 14.63 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.376 0 N-CA-C 107.485 -1.302 . . . . 1.04 107.485 157.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.81 ' HB2' HG22 ' A' ' 40' ' ' ILE . 35.8 mt -83.94 120.7 26.41 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.626 -1.25 . . . . 1.69 107.626 178.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.709 ' HB3' ' HE2' ' A' ' 102' ' ' PHE . . . -95.08 115.76 27.84 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.229 0.538 . . . . 1.17 109.601 178.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.77 ' HZ ' HG13 ' A' ' 20' ' ' VAL . 11.5 m-85 -113.96 97.28 44.45 Favored Pre-proline 0 C--N 1.308 -1.218 0 N-CA-C 108.517 -0.92 . . . . 0.58 108.517 -178.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.699 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 2.0 Cg_endo -67.66 142.36 58.17 Favored 'Trans proline' 0 N--CA 1.438 -1.773 0 C-N-CA 121.175 1.25 . . . . 1.3 110.748 -175.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.477 ' HA ' ' O ' ' A' ' 108' ' ' ILE . 8.1 t . . . . . 0 C--N 1.297 -1.678 0 CA-C-O 121.807 0.813 . . . . 1.91 110.009 173.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.419 ' HB2' HD12 ' A' ' 104' ' ' ILE . . . . . . . . 0 CA--C 1.518 -0.269 0 CA-C-O 120.732 0.301 . . . . 1.15 110.891 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -104.02 28.51 6.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.931 -0.577 . . . . 1.99 111.507 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.709 ' HE2' ' HB3' ' A' ' 73' ' ' ALA . 1.1 p90 -135.47 176.89 2.52 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 108.756 -0.831 . . . . 1.31 108.756 173.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.599 ' HD3' ' CE2' ' A' ' 61' ' ' TYR . 18.9 Cg_exo -71.28 97.1 0.75 Allowed 'Trans proline' 0 CA--C 1.518 -0.276 0 C-N-CA 123.067 2.511 . . . . 1.07 112.884 -179.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.683 HG13 ' HB2' ' A' ' 73' ' ' ALA . 4.2 mp -92.61 138.6 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 N-CA-C 108.475 -0.935 . . . . 1.97 108.475 174.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.642 ' HB3' ' O ' ' A' ' 21' ' ' LEU . 13.5 mmt -101.19 179.84 4.25 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.755 -0.657 . . . . 3.41 109.997 -177.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.773 ' HB1' ' CD2' ' A' ' 25' ' ' HIS . . . -83.83 34.11 0.49 Allowed 'General case' 0 CA--C 1.5 -0.944 0 C-N-CA 120.65 -0.42 . . . . 1.46 111.89 -168.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.768 ' HG2' ' O ' ' A' ' 106' ' ' ALA . 8.9 ptpt 56.02 144.78 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 123.953 1.835 . . . . 2.31 111.979 -174.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.477 ' O ' ' HA ' ' A' ' 76' ' ' SER . 35.7 pt -139.75 170.69 14.99 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 CA-C-N 112.324 -2.216 . . . . 1.65 107.478 175.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -80.68 50.8 1.38 Allowed 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.684 -0.689 . . . . 1.73 110.747 -176.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.433 HG22 ' CB ' ' A' ' 76' ' ' SER . 0.0 OUTLIER -64.36 94.33 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 CA-C-O 122.021 0.915 . . . . 1.4 110.884 -175.434 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 . . . . . 0 C--N 1.316 -0.881 0 N-CA-C 105.787 -1.931 . . . . 2.1 105.787 176.912 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.637 ' ND1' ' H ' ' A' ' 118' ' ' LEU . 3.5 t-80 . . . . . 0 N--CA 1.429 -1.52 0 N-CA-C 105.18 -2.156 . . . . 0.71 105.18 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -28.67 -47.97 0.12 Allowed 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 124.125 3.217 . . . . 0.47 113.568 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.813 HD13 ' HB ' ' A' ' 15' ' ' ILE . 28.1 tp -62.46 -51.67 66.58 Favored 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 123.365 0.666 . . . . 1.15 111.875 177.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.787 ' OH ' HG23 ' A' ' 40' ' ' ILE . 32.6 m-85 -75.69 -32.65 60.21 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-N 116.458 -0.337 . . . . 3.33 111.856 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.404 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 46.6 mt-10 -57.84 -40.15 79.39 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 107.169 -1.419 . . . . 2.44 107.169 170.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.707 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 31.6 t80 -66.65 -31.67 72.5 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.194 -0.912 . . . . 1.08 110.549 175.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.943 ' HE3' HD11 ' A' ' 40' ' ' ILE . 45.9 mtt -74.99 -52.86 10.05 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.488 -0.778 . . . . 1.25 110.958 -171.315 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.437 ' HE2' ' HB2' ' A' ' 123' ' ' LYS . 0.5 OUTLIER -71.61 -25.97 62.39 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 121.057 -0.257 . . . . 1.86 111.403 176.563 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 19.4 ptmt -72.17 -31.18 65.7 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 119.665 -0.814 . . . . 2.52 109.725 179.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 39.0 m -90.78 -38.31 13.08 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.394 -0.821 . . . . 1.21 111.004 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.451 ' HE3' ' HA ' ' A' ' 126' ' ' LYS . 1.6 tpmt? . . . . . 0 C--N 1.32 -0.693 0 CA-C-N 115.686 -0.688 . . . . 2.38 110.576 -174.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.683 ' HB3' ' HG3' ' A' ' 156' ' ' PRO . 0.5 OUTLIER . . . . . 0 CA--C 1.511 -0.551 0 N-CA-C 109.905 -0.405 . . . . 2.41 109.905 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.545 ' CG ' ' H ' ' A' ' 139' ' ' PHE . 60.6 t30 -31.99 -152.14 0.0 OUTLIER 'General case' 0 C--O 1.2 -1.506 0 O-C-N 125.359 1.662 . . . . 2.04 111.979 158.099 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.714 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 2.1 m-85 -27.64 -28.29 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.264 0 N-CA-C 118.037 2.606 . . . . 2.53 118.037 -167.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.681 ' HA ' ' O ' ' A' ' 154' ' ' PHE . 7.7 m 12.29 102.3 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 120.105 1.32 . . . . 1.24 114.373 172.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.448 ' O ' ' HA ' ' A' ' 153' ' ' ARG . 1.6 m -90.11 167.52 12.68 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.571 -1.195 . . . . 1.03 111.473 -170.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.481 ' HA ' ' O ' ' A' ' 152' ' ' GLU . 95.2 m-85 -129.95 125.79 36.28 Favored 'General case' 0 CA--C 1.49 -1.339 0 N-CA-C 106.404 -1.702 . . . . 0.7 106.404 163.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.688 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 4.9 tp -80.33 102.94 9.86 Favored 'General case' 0 N--CA 1.422 -1.851 0 C-N-CA 118.204 -1.398 . . . . 1.16 108.125 176.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.668 HG22 ' HA2' ' A' ' 148' ' ' GLY . 43.2 mm -90.84 137.26 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.738 0 CA-C-N 113.724 -1.58 . . . . 1.05 107.625 -176.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.595 ' OD1' HG12 ' A' ' 149' ' ' VAL . 0.0 OUTLIER -88.74 -175.62 4.96 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 119.527 -0.869 . . . . 0.98 111.675 -168.914 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.596 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 33.8 mtm180 -53.65 -37.15 62.85 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-O 120.976 0.417 . . . . 2.61 111.037 -178.227 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -103.17 19.43 19.59 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.413 -0.958 . . . . 2.0 108.413 -175.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.725 ' HA3' ' CE2' ' A' ' 16' ' ' PHE . . . 71.86 35.08 61.92 Favored Glycine 0 N--CA 1.439 -1.13 0 CA-C-N 114.794 -1.094 . . . . 0.19 115.531 176.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.595 HG12 ' OD1' ' A' ' 145' ' ' ASP . 10.0 p -106.06 113.51 63.51 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 119.356 1.578 . . . . 1.74 111.398 172.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.634 ' HD3' HG21 ' A' ' 15' ' ' ILE . 2.5 Cg_endo -51.11 115.55 2.11 Favored 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 124.027 3.152 . . . . 0.6 111.799 172.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 26.2 t -108.27 -28.58 2.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.707 0.765 . . . . 2.06 109.098 -176.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.688 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 22.6 mm-40 -136.86 166.39 23.73 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.509 -1.223 . . . . 1.17 110.317 -176.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.448 ' HA ' ' O ' ' A' ' 141' ' ' SER . 1.5 ttm180 -143.78 140.7 30.05 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.826 -1.079 . . . . 2.9 109.17 165.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.681 ' O ' ' HA ' ' A' ' 140' ' ' THR . 97.3 m-85 -120.8 149.95 41.77 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.932 -0.766 . . . . 0.36 108.932 -171.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 62.9 m -78.51 160.04 73.33 Favored Pre-proline 0 C--N 1.317 -0.83 0 N-CA-C 108.549 -0.908 . . . . 1.45 108.549 175.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.683 ' HG3' ' HB3' ' A' ' 137' ' ' TRP . 32.0 Cg_endo -63.74 -22.14 69.65 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.028 1.819 . . . . 0.78 111.896 178.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -78.93 -7.1 88.57 Favored Glycine 0 N--CA 1.446 -0.7 0 CA-C-N 115.696 -0.683 . . . . 0.59 112.626 173.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -72.88 144.99 47.19 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 108.62 -0.881 . . . . 1.07 108.62 174.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 14.5 m -110.91 173.74 6.19 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 120.835 -0.346 . . . . 1.92 110.168 -172.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.684 HG23 ' HA ' ' A' ' 56' ' ' THR . 58.9 t -40.7 -55.93 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 114.93 -1.032 . . . . 1.07 111.384 177.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 12.9 tppt? -67.25 -29.87 69.61 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.217 -0.447 . . . . 3.89 111.299 -171.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.421 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 8.0 m-20 -68.88 -38.27 79.58 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 121.481 0.657 . . . . 1.4 109.545 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.591 ' HA ' ' CZ ' ' A' ' 154' ' ' PHE . 71.3 mt -77.82 -43.68 28.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 114.76 -1.109 . . . . 1.05 110.715 178.346 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.605 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 53.9 mt-10 -55.02 -43.3 73.55 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-N 116.523 -0.308 . . . . 0.67 111.5 -176.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 8.6 pt-20 -58.45 -23.01 56.46 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.716 0.294 . . . . 0.87 111.7 -176.084 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.631 ' HB3' HD23 ' A' ' 143' ' ' LEU . 45.9 mmtm -99.51 -25.94 14.27 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.591 0.71 . . . . 2.22 109.982 176.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.589 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 13.6 tp -79.06 -50.76 10.55 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.897 -1.047 . . . . 1.04 112.215 -177.038 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 164' ' ' GLU . 73.6 mt -54.57 -44.6 99.2 Favored Pre-proline 0 CA--C 1.537 0.452 0 CA-C-N 115.511 -0.768 . . . . 1.08 112.637 -173.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.441 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 53.8 Cg_exo -54.54 -33.06 76.88 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.077 1.851 . . . . 0.62 112.762 173.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.718 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 78.5 mt -83.23 -40.64 19.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.652 -0.249 . . . . 1.36 111.288 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.718 HD22 ' HG2' ' A' ' 37' ' ' PRO . 87.0 mt -61.76 -60.42 3.69 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 121.996 0.903 . . . . 1.07 109.603 175.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.315 0 CA-C-N 113.406 -1.724 . . . . 1.12 112.526 -178.988 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.9 t . . . . . 0 N--CA 1.454 -0.247 0 CA-C-O 121.022 0.439 . . . . 2.17 110.246 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.453 ' HB3' ' O ' ' A' ' 147' ' ' ASP . 5.9 m -158.51 151.83 22.94 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 105.975 -1.861 . . . . 1.68 105.975 -177.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.838 ' HB ' HD12 ' A' ' 118' ' ' LEU . 5.8 pt -61.75 -16.04 14.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 CA-C-N 114.32 -1.309 . . . . 1.16 111.823 -174.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.758 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 46.9 m-85 -73.79 5.9 3.68 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 113.028 0.751 . . . . 0.3 113.028 -174.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -79.81 -17.82 52.41 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 107.694 -1.224 . . . . 2.11 107.694 175.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.703 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 51.5 m-85 -112.07 115.29 28.65 Favored 'General case' 0 N--CA 1.434 -1.257 0 CA-C-N 114.078 -1.419 . . . . 0.37 111.432 -171.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -50.66 142.02 11.79 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 113.752 -1.567 . . . . 2.86 110.752 174.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.726 HG11 ' CZ ' ' A' ' 74' ' ' PHE . 37.9 t -112.34 158.53 12.72 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 107.981 -1.118 . . . . 1.32 107.981 176.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.727 HD21 ' HA ' ' A' ' 27' ' ' PRO . 60.4 mt -126.66 135.0 50.59 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 120.454 -0.499 . . . . 1.29 111.347 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.501 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 15.8 t70 -63.88 159.36 19.88 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 106.193 -1.78 . . . . 1.87 106.193 164.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.771 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . . . -57.35 -3.92 0.19 Allowed 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.973 1.101 . . . . 1.2 113.973 -166.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.472 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 23.3 t70 -100.16 0.01 39.7 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 111.454 0.168 . . . . 2.34 111.454 177.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.585 ' CD2' ' HB3' ' A' ' 106' ' ' ALA . 78.8 m-70 80.57 20.1 0.5 Allowed 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 121.811 0.815 . . . . 2.26 109.427 177.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.482 ' HA ' ' HD3' ' A' ' 26' ' ' LYS . 12.0 mmtp -96.13 123.42 55.21 Favored Pre-proline 0 N--CA 1.441 -0.904 0 CA-C-N 114.499 -1.228 . . . . 4.64 108.543 173.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.727 ' HA ' HD21 ' A' ' 21' ' ' LEU . 95.9 Cg_exo -49.18 114.14 1.18 Allowed 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 122.924 2.416 . . . . 0.62 114.165 -167.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.68 ' CE2' HD21 ' A' ' 72' ' ' LEU . 2.1 t80 -83.86 136.67 34.02 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 113.109 -1.86 . . . . 1.52 110.019 169.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.522 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 0.3 OUTLIER -81.89 83.16 7.29 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.499 0.666 . . . . 2.16 110.806 179.366 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.65 ' HG ' ' CD1' ' A' ' 16' ' ' PHE . 56.8 tp -50.4 -37.73 39.16 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.432 0.634 . . . . 1.07 110.383 178.388 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.657 HG13 ' HB3' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -69.43 -0.35 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 114.551 -1.204 . . . . 1.69 113.129 -172.502 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.522 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 3.6 pt20 -71.42 -20.25 62.14 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.731 -0.84 . . . . 1.31 108.731 172.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.961 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 93.4 m-70 -91.83 24.8 3.01 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 115.205 -0.907 . . . . 0.35 110.07 177.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.758 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 38.1 mtmt -86.04 109.33 18.73 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 114.587 -1.188 . . . . 2.07 109.2 170.159 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 133.65 -43.13 1.3 Allowed Glycine 0 N--CA 1.438 -1.17 0 C-N-CA 120.861 -0.685 . . . . 0.24 111.741 -177.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.453 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 69.3 m -127.15 136.77 29.37 Favored Pre-proline 0 N--CA 1.434 -1.229 0 N-CA-C 108.637 -0.875 . . . . 0.74 108.637 172.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.806 ' HG3' ' CB ' ' A' ' 170' ' ' LEU . 3.3 Cg_endo -42.49 153.32 0.15 Allowed 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 123.985 3.123 . . . . 0.22 112.763 175.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.802 ' HB2' HG23 ' A' ' 70' ' ' THR . 0.6 OUTLIER -140.48 141.87 35.36 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.123 -1.436 . . . . 1.09 107.123 179.964 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 1.068 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 1.2 mm? -107.53 112.77 25.69 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.284 -1.006 . . . . 1.82 108.284 177.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 1.061 HG22 ' OH ' ' A' ' 119' ' ' TYR . 2.3 mt -100.71 124.06 54.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 120.082 -0.647 . . . . 1.12 110.183 179.123 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 1.068 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.6 OUTLIER -110.2 124.81 52.26 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.145 -0.934 . . . . 1.09 110.715 -171.83 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.548 ' OD1' ' HB ' ' A' ' 140' ' ' THR . 8.2 p-10 -80.96 96.7 7.17 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.624 -1.251 . . . . 3.11 107.624 169.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.945 ' HA ' ' HA ' ' A' ' 139' ' ' PHE . 10.7 p . . . . . 0 C--N 1.306 -1.318 0 O-C-N 121.179 -0.951 . . . . 1.69 111.802 -165.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.736 0 N-CA-C 111.512 -0.635 . . . . 0.85 111.512 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.703 ' HA2' ' HB ' ' A' ' 56' ' ' THR . . . -63.94 -16.07 59.03 Favored Glycine 0 C--O 1.22 -0.753 0 CA-C-O 119.594 -0.559 . . . . 0.67 114.327 -177.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -73.23 -56.87 4.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 118.34 1.07 . . . . 1.2 109.351 177.009 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -60.34 -26.37 66.53 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-O 121.838 0.828 . . . . 2.61 109.572 175.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.703 ' HB ' ' HA2' ' A' ' 53' ' ' GLY . 15.4 m -75.33 -54.65 6.72 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 114.28 -1.327 . . . . 1.06 109.441 -176.104 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 1.052 ' HB3' HG12 ' A' ' 71' ' ' VAL . . . -57.32 -43.39 83.26 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 114.709 -1.132 . . . . 1.05 110.644 176.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.539 ' HA ' ' HD2' ' A' ' 102' ' ' PHE . 74.2 m -58.76 -56.03 27.52 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.794 -0.639 . . . . 1.08 110.675 -179.046 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 61.8 m -68.82 -37.11 78.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.458 -0.792 . . . . 1.22 111.891 -175.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.761 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 17.1 mt -64.57 -46.93 80.66 Favored 'General case' 0 CA--C 1.502 -0.888 0 CA-C-O 121.265 0.555 . . . . 1.14 110.359 -176.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.877 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 8.1 t80 -58.08 -52.2 66.53 Favored 'General case' 0 C--O 1.202 -1.443 0 CA-C-N 114.856 -1.066 . . . . 0.94 110.64 178.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -70.19 -25.67 63.53 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 120.718 0.294 . . . . 1.6 110.81 -172.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.532 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 36.2 ttpt -84.84 -23.4 29.06 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.946 -0.761 . . . . 2.06 108.946 -177.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.617 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 43.1 m-85 -126.88 -4.25 6.4 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 116.084 1.883 . . . . 0.92 116.084 -171.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.725 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 12.8 ptmt -64.04 -27.29 69.01 Favored 'General case' 0 CA--C 1.496 -1.114 0 N-CA-C 108.052 -1.092 . . . . 1.89 108.052 171.038 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.0 t -48.61 -35.26 13.23 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 114.154 -1.384 . . . . 1.68 111.033 173.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -92.57 -33.15 14.55 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.079 0.4 . . . . 1.11 112.079 175.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.413 ' HA3' ' HB2' ' A' ' 36' ' ' SER . . . 147.9 -5.54 0.95 Allowed Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 111.711 -0.556 . . . . 0.2 111.711 -176.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.761 ' HE2' ' HB3' ' A' ' 60' ' ' LEU . 18.5 t80 -69.97 144.71 52.24 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-O 121.047 0.451 . . . . 0.21 111.447 -178.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.961 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 1.5 t -134.92 149.96 50.34 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 108.283 -1.006 . . . . 1.02 108.283 173.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 1.052 HG12 ' HB3' ' A' ' 57' ' ' ALA . 45.2 t -106.34 100.1 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.322 0 N-CA-C 108.001 -1.111 . . . . 1.04 108.001 157.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.823 ' HA ' ' HG2' ' A' ' 103' ' ' PRO . 4.9 mt -85.6 118.66 25.24 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.68 -1.23 . . . . 1.69 107.68 177.099 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 1.004 ' HB1' HD13 ' A' ' 104' ' ' ILE . . . -107.83 112.04 24.49 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 119.363 -0.935 . . . . 1.17 110.957 178.011 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.726 ' CZ ' HG11 ' A' ' 20' ' ' VAL . 3.0 m-85 -93.35 99.59 3.44 Favored Pre-proline 0 C--N 1.311 -1.096 0 CA-C-N 114.445 -1.252 . . . . 0.58 108.425 176.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.773 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 92.2 Cg_endo -83.82 93.15 0.79 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.501 2.134 . . . . 1.3 113.286 -167.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.625 ' HA ' ' O ' ' A' ' 108' ' ' ILE . 44.0 m . . . . . 0 CA--C 1.499 -0.982 0 N-CA-C 115.08 1.511 . . . . 1.91 115.08 -172.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.509 ' HB2' ' CE2' ' A' ' 102' ' ' PHE . . . . . . . . 0 CA--C 1.506 -0.717 0 CA-C-O 120.727 0.298 . . . . 1.15 111.07 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -94.31 29.94 2.08 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.906 -0.588 . . . . 1.99 110.335 175.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.633 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 18.3 p90 -143.23 160.94 50.25 Favored Pre-proline 0 N--CA 1.442 -0.852 0 N-CA-C 108.161 -1.051 . . . . 1.31 108.161 175.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.823 ' HG2' ' HA ' ' A' ' 72' ' ' LEU . 36.0 Cg_endo -58.94 90.68 0.07 OUTLIER 'Trans proline' 0 N--CA 1.476 0.455 0 C-N-CA 123.982 3.121 . . . . 1.07 114.419 -172.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 1.004 HD13 ' HB1' ' A' ' 73' ' ' ALA . 2.8 mm -80.0 123.22 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 108.809 -0.811 . . . . 1.97 108.809 171.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.72 ' HE2' HD12 ' A' ' 21' ' ' LEU . 0.8 OUTLIER -77.13 170.03 17.26 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.412 -1.267 . . . . 3.41 111.11 -177.568 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.771 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . . . -69.33 11.42 0.24 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.688 -0.687 . . . . 1.46 112.377 178.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.768 ' HB2' ' O ' ' A' ' 75' ' ' PRO . 2.6 ptpp? 67.4 143.43 0.04 OUTLIER 'General case' 0 CA--C 1.495 -1.163 0 CA-C-O 123.363 1.554 . . . . 2.31 112.092 -175.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.875 HG13 HG22 ' A' ' 110' ' ' VAL . 36.1 pt -136.28 159.27 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.197 0 CA-C-N 111.81 -2.45 . . . . 1.65 106.557 175.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.35 64.27 0.58 Allowed 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 110.506 -0.183 . . . . 1.73 110.506 176.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.875 HG22 HG13 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -74.59 92.37 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.751 0 C-N-CA 119.644 -0.823 . . . . 1.4 109.928 -176.241 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.6 t30 . . . . . 0 N--CA 1.443 -0.796 0 CA-C-N 114.219 -1.355 . . . . 2.1 107.683 170.552 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.678 ' ND1' ' H ' ' A' ' 118' ' ' LEU . 2.1 t-80 . . . . . 0 N--CA 1.438 -1.065 0 CA-C-O 118.709 -0.663 . . . . 0.71 109.356 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -26.43 -45.04 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 124.886 3.724 . . . . 0.47 114.049 179.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.838 HD12 ' HB ' ' A' ' 15' ' ' ILE . 48.0 tp -65.14 -51.0 63.86 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 122.894 0.478 . . . . 1.15 112.288 179.141 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 1.061 ' OH ' HG22 ' A' ' 40' ' ' ILE . 24.1 m-85 -80.57 -32.33 36.6 Favored 'General case' 0 CA--C 1.486 -1.512 0 CA-C-O 121.433 0.635 . . . . 3.33 109.752 -176.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.554 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 4.4 tm-20 -60.07 -37.06 78.78 Favored 'General case' 0 N--CA 1.426 -1.635 0 N-CA-C 106.186 -1.783 . . . . 2.44 106.186 172.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.703 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 79.2 t80 -68.56 -30.45 69.23 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.135 -0.939 . . . . 1.08 110.605 173.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 1.016 ' HE3' HD12 ' A' ' 40' ' ' ILE . 53.3 mtt -75.83 -55.34 5.73 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.09 -0.505 . . . . 1.25 111.815 -170.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.695 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -70.48 -23.65 62.72 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.194 -0.457 . . . . 1.86 110.78 177.495 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.606 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 10.4 ptmt -72.96 -27.04 61.59 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 119.701 -0.799 . . . . 2.52 109.429 172.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 89.2 m -71.66 -50.99 25.45 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 116.044 -0.526 . . . . 1.21 109.59 172.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.777 ' HG2' HH22 ' A' ' 153' ' ' ARG . 23.2 ttmm . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 115.95 -0.568 . . . . 2.38 110.05 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.637 ' HB3' ' HG3' ' A' ' 156' ' ' PRO . 7.0 m-90 . . . . . 0 N--CA 1.452 -0.352 0 N-CA-C 110.574 -0.158 . . . . 2.41 110.574 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.464 ' HB3' ' H ' ' A' ' 139' ' ' PHE . 94.6 m-20 -39.48 -158.57 0.0 OUTLIER 'General case' 0 C--O 1.207 -1.162 0 C-N-CA 124.795 1.238 . . . . 2.04 113.017 163.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.945 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 0.1 OUTLIER -33.39 -26.71 0.01 OUTLIER 'General case' 0 C--O 1.203 -1.384 0 N-CA-C 116.427 2.01 . . . . 2.53 116.427 -171.24 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.548 ' HB ' ' OD1' ' A' ' 42' ' ' ASN . 14.1 m 23.11 109.65 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 120.909 1.686 . . . . 1.24 114.601 165.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.791 ' O ' ' HA ' ' A' ' 153' ' ' ARG . 0.8 OUTLIER -107.08 138.29 43.54 Favored 'General case' 0 C--O 1.199 -1.583 0 CA-C-N 114.933 -1.031 . . . . 1.03 112.389 -161.867 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.525 ' O ' HD13 ' A' ' 39' ' ' LEU . 50.9 m-85 -103.52 127.51 50.91 Favored 'General case' 0 CA--C 1.488 -1.424 0 N-CA-C 107.666 -1.235 . . . . 0.7 107.666 175.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.787 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 7.5 tp -80.65 103.23 10.36 Favored 'General case' 0 N--CA 1.417 -2.099 0 C-N-CA 118.07 -1.452 . . . . 1.16 107.947 174.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.747 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 45.8 mm -94.82 139.17 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.782 0 CA-C-N 113.131 -1.85 . . . . 1.05 107.394 -179.008 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.29 -175.36 3.8 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 119.64 -0.824 . . . . 0.98 111.329 -169.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.529 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 47.5 mtm180 -52.51 -41.04 63.1 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 123.356 0.41 . . . . 2.61 111.036 -177.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.453 ' O ' ' HB3' ' A' ' 14' ' ' SER . 34.1 m-20 -98.86 22.63 9.88 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.471 -0.566 . . . . 2.0 109.471 -176.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.568 ' HA2' HG21 ' A' ' 144' ' ' ILE . . . 67.53 39.66 90.98 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 114.728 0.651 . . . . 0.19 114.728 177.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.406 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 93.4 t -100.84 127.94 31.03 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-N 118.278 1.039 . . . . 1.74 110.497 173.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.548 ' HA ' HD12 ' A' ' 144' ' ' ILE . 10.2 Cg_endo -77.3 110.0 2.91 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.692 2.262 . . . . 0.6 110.319 178.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.443 ' O ' ' HE3' ' A' ' 126' ' ' LYS . 17.2 t -107.87 -28.28 2.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 121.433 0.635 . . . . 2.06 109.546 -173.027 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.787 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 5.5 mm-40 -135.75 164.64 27.43 Favored 'General case' 0 CA--C 1.501 -0.933 0 CA-C-N 115.328 -0.851 . . . . 1.17 110.511 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.791 ' HA ' ' O ' ' A' ' 141' ' ' SER . 0.0 OUTLIER -149.42 139.19 21.82 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.805 -1.088 . . . . 2.9 110.31 157.813 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.549 ' CZ ' ' HA ' ' A' ' 163' ' ' ILE . 86.8 m-85 -113.95 152.77 30.37 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.242 -1.344 . . . . 0.36 109.141 -160.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 15.3 m -71.37 157.03 90.85 Favored Pre-proline 0 C--N 1.312 -1.058 0 N-CA-C 109.464 -0.569 . . . . 1.45 109.464 176.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.637 ' HG3' ' HB3' ' A' ' 137' ' ' TRP . 18.4 Cg_endo -60.87 -26.62 83.42 Favored 'Trans proline' 0 CA--C 1.517 -0.348 0 C-N-CA 122.197 1.931 . . . . 0.78 110.179 171.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -81.55 7.87 60.48 Favored Glycine 0 N--CA 1.441 -1.01 0 CA-C-N 114.036 -1.438 . . . . 0.59 113.124 174.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -88.07 146.41 25.46 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.563 -0.903 . . . . 1.07 108.563 171.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 87.5 p -110.86 176.86 4.86 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 120.813 -0.355 . . . . 1.92 110.772 -173.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.617 HG23 ' HA ' ' A' ' 56' ' ' THR . 61.1 t -44.49 -46.57 2.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.211 -0.904 . . . . 1.07 110.582 174.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -68.97 -37.44 78.79 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.664 -0.698 . . . . 3.89 111.052 -174.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -65.26 -41.02 94.67 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.566 0.698 . . . . 1.4 109.551 -177.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.89 HD13 ' HH ' ' A' ' 41' ' ' TYR . 73.7 mt -77.78 -45.66 27.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 114.637 -1.165 . . . . 1.05 111.472 -179.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.613 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 25.2 mt-10 -52.97 -41.37 64.49 Favored 'General case' 0 C--O 1.22 -0.495 0 N-CA-C 111.994 0.368 . . . . 0.67 111.994 -176.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -63.3 -19.58 64.72 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.46 -0.496 . . . . 0.87 111.889 -174.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.568 ' HB3' HD23 ' A' ' 143' ' ' LEU . 13.0 mmmm -103.03 -11.12 18.37 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.42 0.628 . . . . 2.22 110.018 174.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.613 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 13.9 tp -93.05 -53.78 4.0 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.99 -1.005 . . . . 1.04 112.168 -176.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.541 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 64.1 mt -53.28 -48.2 93.28 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.282 -0.872 . . . . 1.08 112.59 -172.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.541 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 72.5 Cg_exo -51.86 -30.26 37.94 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 122.252 1.968 . . . . 0.62 112.728 175.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.806 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 96.4 mt -84.42 -42.78 15.31 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.468 -0.333 . . . . 1.36 111.038 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.754 HD22 ' HG2' ' A' ' 37' ' ' PRO . 95.5 mt -60.93 -57.88 10.77 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-O 122.13 0.967 . . . . 1.07 109.692 176.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.464 0 CA-C-N 113.334 -1.757 . . . . 1.12 113.011 -178.299 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.665 0 N-CA-C 111.814 -0.514 . . . . 5.58 111.814 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 95.1 mmm -106.71 141.48 37.9 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.761 0.315 . . . . 5.23 110.848 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 88.7 110.34 1.13 Allowed Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.908 -0.663 . . . . 1.55 112.896 177.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.6 m -98.28 -32.92 11.3 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.071 -0.714 . . . . 2.17 109.071 175.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.9 m -150.65 170.57 18.86 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 105.161 -2.163 . . . . 1.68 105.161 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.752 ' HB ' HD11 ' A' ' 118' ' ' LEU . 6.8 pt -63.74 -19.59 24.64 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.102 0 CA-C-O 121.416 0.627 . . . . 1.16 110.521 178.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.718 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 37.3 m-85 -73.5 0.9 11.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.858 -0.61 . . . . 0.3 111.997 -175.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -80.19 -8.73 59.57 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 108.203 -1.036 . . . . 2.11 108.203 176.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.801 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 58.1 m-85 -121.79 117.29 26.21 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 114.537 -1.211 . . . . 0.37 111.427 -174.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -48.92 138.49 11.39 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 112.876 -1.965 . . . . 2.86 110.534 173.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.788 HG12 ' HZ ' ' A' ' 74' ' ' PHE . 98.9 t -112.76 163.4 9.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 108.146 -1.057 . . . . 1.32 108.146 175.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.747 ' O ' ' HB3' ' A' ' 105' ' ' MET . 19.9 mt -134.9 121.88 21.19 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.9 -0.407 . . . . 1.29 109.9 -175.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.621 ' HA ' ' CE ' ' A' ' 105' ' ' MET . 29.9 t70 -63.96 177.36 0.79 Allowed 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 108.372 -0.973 . . . . 1.87 108.372 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.638 ' HA ' ' C ' ' A' ' 105' ' ' MET . . . -59.55 -4.38 0.62 Allowed 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 114.314 1.228 . . . . 1.2 114.314 -163.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -119.33 14.8 12.98 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.765 0.654 . . . . 2.34 112.765 173.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.707 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 10.6 m170 73.13 24.22 2.52 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 122.184 0.992 . . . . 2.26 109.695 174.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.419 ' HE3' ' HB2' ' A' ' 26' ' ' LYS . 16.3 mtmt -85.55 127.81 61.64 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 113.814 -1.539 . . . . 4.64 106.929 166.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.575 ' HA ' HD21 ' A' ' 21' ' ' LEU . 93.3 Cg_exo -50.76 112.44 0.77 Allowed 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 121.359 1.373 . . . . 0.62 112.607 -174.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.529 ' HE2' ' CD2' ' A' ' 72' ' ' LEU . 24.2 t80 -81.47 142.61 32.77 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 113.481 -1.69 . . . . 1.52 112.1 178.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.55 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.8 t-20 -77.73 82.37 4.13 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.648 -1.16 . . . . 2.16 109.904 178.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.637 HD12 HG21 ' A' ' 20' ' ' VAL . 62.1 tp -63.72 -45.16 91.21 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.559 0.695 . . . . 1.07 110.822 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.701 HG13 ' HB3' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -66.13 1.69 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 114.759 -1.109 . . . . 1.69 113.596 -171.764 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.55 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 11.0 pt20 -74.37 -5.34 41.77 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.342 0.591 . . . . 1.31 110.175 172.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.866 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 70.8 m-70 -104.3 24.06 12.14 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.84 0.828 . . . . 0.35 109.428 174.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.718 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 19.7 mtmm -82.69 110.01 17.36 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 114.608 -1.178 . . . . 2.07 109.535 171.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.27 -36.49 2.38 Favored Glycine 0 N--CA 1.44 -1.085 0 C-N-CA 120.534 -0.841 . . . . 0.24 112.031 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.439 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 40.1 m -131.01 133.41 24.72 Favored Pre-proline 0 N--CA 1.435 -1.213 0 N-CA-C 108.3 -1.0 . . . . 0.74 108.3 173.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.762 ' HG2' HD22 ' A' ' 171' ' ' LEU . 3.1 Cg_endo -42.56 152.3 0.19 Allowed 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.824 3.016 . . . . 0.22 112.566 177.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.827 ' HB2' HG22 ' A' ' 70' ' ' THR . 0.5 OUTLIER -136.98 140.76 42.41 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 106.872 -1.529 . . . . 1.09 106.872 179.395 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.858 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 1.3 mm? -106.65 111.09 23.47 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.077 -1.083 . . . . 1.82 108.077 176.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.864 HG23 ' HB2' ' A' ' 72' ' ' LEU . 2.4 mt -94.87 122.9 46.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-N 115.856 -0.611 . . . . 1.12 109.485 176.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.858 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -110.88 128.01 55.64 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 116.068 -0.514 . . . . 1.09 109.919 -176.182 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.62 ' OD1' ' HB ' ' A' ' 140' ' ' THR . 2.3 p30 -82.27 94.85 7.41 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 107.938 -1.134 . . . . 3.11 107.938 167.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.718 ' O ' ' HA ' ' A' ' 75' ' ' PRO . 19.3 m -102.69 137.14 31.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 121.507 0.67 . . . . 1.69 110.615 -166.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.49 ' HB2' ' HE2' ' A' ' 46' ' ' LYS . . . -88.56 100.61 13.21 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.914 -0.585 . . . . 1.45 109.704 177.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.708 ' HA ' ' HB2' ' A' ' 98' ' ' PHE . 5.1 p -28.94 -81.79 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 O-C-N 125.162 1.539 . . . . 1.99 113.631 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.49 ' HE2' ' HB2' ' A' ' 44' ' ' ALA . 0.3 OUTLIER 56.31 -168.48 0.1 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.665 0.745 . . . . 6.2 112.51 -179.716 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 32.6 t -145.61 116.47 7.75 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.091 -0.959 . . . . 4.12 109.783 178.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.36 -25.99 3.6 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 121.017 -0.611 . . . . 3.44 113.2 177.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -100.07 115.78 30.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.571 0.701 . . . . 4.84 111.717 -178.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.688 ' HG1' ' HB2' ' A' ' 54' ' ' TYR . 12.9 t -127.31 -169.62 2.07 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 107.511 -1.292 . . . . 2.41 107.511 171.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 55.5 tttt -148.89 63.87 1.05 Allowed 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.577 -0.449 . . . . 2.47 109.903 178.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.444 ' O ' ' HG3' ' A' ' 55' ' ' GLU . . . 76.63 -47.35 2.43 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 121.15 -0.548 . . . . 0.85 112.476 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.452 ' HA2' ' HB ' ' A' ' 56' ' ' THR . . . -53.88 -23.98 24.93 Favored Glycine 0 C--O 1.218 -0.889 0 CA-C-O 119.523 -0.599 . . . . 0.67 114.398 -175.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.688 ' HB2' ' HG1' ' A' ' 50' ' ' THR . 0.6 OUTLIER -67.74 -55.49 12.9 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 118.42 1.11 . . . . 1.2 110.642 -178.943 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.444 ' HG3' ' O ' ' A' ' 52' ' ' GLY . 2.7 pp20? -66.31 -31.24 71.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.521 0.677 . . . . 2.61 109.348 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.684 ' HA ' ' CG2' ' A' ' 160' ' ' VAL . 53.9 m -59.68 -60.15 4.31 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 114.597 -1.183 . . . . 1.06 110.691 175.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 1.038 ' HB3' HG13 ' A' ' 71' ' ' VAL . . . -61.27 -44.99 96.33 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.979 -1.01 . . . . 1.05 111.293 -177.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.595 ' HA ' ' HE1' ' A' ' 102' ' ' PHE . 95.9 m -55.25 -52.29 63.89 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.57 0.7 . . . . 1.08 110.344 -177.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.8 m -72.79 -36.07 67.52 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.916 -1.038 . . . . 1.22 111.309 -176.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.667 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 19.3 mt -65.87 -50.11 65.72 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 121.303 0.573 . . . . 1.14 110.374 -177.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.815 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 6.8 t80 -55.74 -53.54 55.31 Favored 'General case' 0 C--O 1.198 -1.613 0 CA-C-N 114.608 -1.178 . . . . 0.94 110.44 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.464 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 9.7 m-80 -73.11 -24.67 60.66 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 112.182 0.438 . . . . 1.6 112.182 -173.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.459 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 33.6 ttpt -82.46 -22.36 35.22 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.768 -0.827 . . . . 2.06 108.768 -178.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.753 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 37.8 m-85 -123.73 -5.73 8.05 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 114.767 1.395 . . . . 0.92 114.767 -172.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.678 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 11.1 ptmt -64.64 -25.74 68.09 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 107.931 -1.137 . . . . 1.89 107.931 170.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.2 m -48.01 -41.84 26.48 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 114.106 -1.406 . . . . 1.68 110.672 172.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -82.73 -37.93 23.99 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 111.747 0.277 . . . . 1.11 111.747 175.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 149.66 -8.55 0.86 Allowed Glycine 0 CA--C 1.519 0.332 0 N-CA-C 111.088 -0.805 . . . . 0.2 111.088 -176.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.753 ' HD2' ' HB2' ' A' ' 64' ' ' TYR . 18.5 t80 -63.53 144.92 56.59 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 115.024 -0.588 . . . . 0.21 111.24 -177.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.866 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 3.0 t -133.27 152.25 51.93 Favored 'General case' 0 N--CA 1.411 -2.396 0 N-CA-C 108.726 -0.842 . . . . 1.02 108.726 171.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 1.038 HG13 ' HB3' ' A' ' 57' ' ' ALA . 37.4 t -106.78 102.12 13.48 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.361 0 N-CA-C 107.645 -1.243 . . . . 1.04 107.645 158.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.864 ' HB2' HG23 ' A' ' 40' ' ' ILE . 88.5 mt -84.27 118.73 24.37 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 107.742 -1.207 . . . . 1.69 107.742 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.571 ' HB1' HG13 ' A' ' 104' ' ' ILE . . . -97.84 113.06 24.77 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 120.385 -0.526 . . . . 1.17 110.598 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.788 ' HZ ' HG12 ' A' ' 20' ' ' VAL . 34.5 m-85 -106.52 96.68 14.52 Favored Pre-proline 0 C--N 1.309 -1.171 0 N-CA-C 109.445 -0.576 . . . . 0.58 109.445 176.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.718 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 74.2 Cg_endo -80.43 75.08 5.24 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.481 2.787 . . . . 1.3 114.778 -166.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.435 ' HA ' ' O ' ' A' ' 108' ' ' ILE . 76.2 p -18.25 133.02 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 126.028 1.731 . . . . 1.91 115.234 -177.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.462 ' C ' ' H ' ' A' ' 79' ' ' PHE . 0.8 OUTLIER -91.1 84.7 5.74 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 114.876 -1.056 . . . . 1.93 109.243 -179.152 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.708 ' HA ' ' HG3' ' A' ' 83' ' ' GLU . 67.3 mt-30 -52.31 -10.97 0.16 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 114.956 -1.02 . . . . 3.97 111.716 -178.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.644 ' HA ' ' HD3' ' A' ' 91' ' ' LYS . 67.9 m-85 -63.58 -20.52 65.72 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.747 -0.66 . . . . 3.21 110.215 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.583 ' HA3' HE22 ' A' ' 82' ' ' GLN . . . -68.66 -47.26 57.36 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.649 -0.705 . . . . 1.98 111.698 176.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 119.82 -35.57 3.78 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.674 -0.774 . . . . 1.66 112.764 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.681 ' HG3' ' HB2' ' A' ' 113' ' ' GLU . 0.8 OUTLIER -85.04 -5.29 59.35 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 111.935 0.346 . . . . 1.74 111.935 -175.28 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.708 ' HG3' ' HA ' ' A' ' 78' ' ' GLN . 5.1 mm-40 -59.45 150.71 63.81 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-O 121.852 0.834 . . . . 3.07 113.246 -161.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.677 ' HB2' ' N ' ' A' ' 137' ' ' TRP . 94.9 Cg_endo -71.0 -31.84 14.4 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 123.931 3.087 . . . . 1.75 111.783 -167.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -70.81 -46.15 47.59 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.879 -0.677 . . . . 2.27 111.935 178.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.715 HD21 ' HB2' ' A' ' 89' ' ' GLU . 64.2 t30 -177.63 -105.59 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 122.177 0.191 . . . . 4.88 110.499 176.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.682 ' HG3' ' H ' ' A' ' 88' ' ' GLU . 6.6 pt-20 176.37 -72.03 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.726 0.298 . . . . 3.02 111.039 -175.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.682 ' H ' ' HG3' ' A' ' 87' ' ' GLU . 61.5 mm-40 -82.8 -11.6 58.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.843 0.354 . . . . 3.92 111.377 -176.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.715 ' HB2' HD21 ' A' ' 86' ' ' ASN . 14.5 tt0 -56.4 -60.95 2.78 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.659 -0.7 . . . . 2.65 112.373 -169.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.576 HG12 ' HB2' ' A' ' 78' ' ' GLN . 31.1 pt -77.36 3.71 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 111.979 0.363 . . . . 2.63 111.979 -178.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.644 ' HD3' ' HA ' ' A' ' 79' ' ' PHE . 50.1 mtmt -100.9 -39.24 7.87 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.646 0.26 . . . . 3.13 110.368 178.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.445 ' HG2' ' O ' ' A' ' 88' ' ' GLU . 11.8 pt-20 -87.17 -38.49 16.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.486 -0.325 . . . . 3.29 110.489 178.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -91.32 161.36 15.06 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.017 0.437 . . . . 4.08 109.942 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.7 p -80.12 112.31 17.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.675 -0.693 . . . . 3.05 110.326 174.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.546 ' SG ' ' HA ' ' A' ' 90' ' ' ILE . 3.7 m -140.77 121.9 14.73 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 121.399 0.619 . . . . 3.04 110.428 178.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.5 p -69.4 163.38 25.35 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 114.732 -1.122 . . . . 3.38 108.813 169.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -66.18 50.74 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.455 -0.338 . . . . 3.11 111.689 177.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.729 ' CZ ' ' HE2' ' A' ' 102' ' ' PHE . 64.8 t80 65.0 -89.07 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.464 0.706 . . . . 2.12 110.503 -178.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 25.2 ttmm 65.39 140.46 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 123.763 0.825 . . . . 3.1 111.726 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.505 ' HB2' ' CD2' ' A' ' 102' ' ' PHE . . . -170.69 -151.34 0.08 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.614 -0.721 . . . . 1.15 111.082 -172.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -96.99 22.96 7.72 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.488 -0.778 . . . . 1.99 111.332 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.729 ' HE2' ' CZ ' ' A' ' 98' ' ' PHE . 2.9 m-85 -111.61 -176.63 0.39 Allowed Pre-proline 0 CA--C 1.514 -0.41 0 CA-C-O 121.561 0.695 . . . . 1.31 110.764 -177.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.674 ' HD3' ' CE2' ' A' ' 61' ' ' TYR . 8.6 Cg_exo -81.51 78.26 3.63 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 123.93 3.086 . . . . 1.07 109.449 157.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.571 HG13 ' HB1' ' A' ' 73' ' ' ALA . 4.0 mp -84.32 127.83 39.46 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 N-CA-C 108.09 -1.078 . . . . 1.97 108.09 178.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.76 ' HG3' ' CE1' ' A' ' 74' ' ' PHE . 3.4 mmt -96.82 -175.52 3.3 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.565 -0.743 . . . . 3.41 110.404 -169.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.624 ' O ' ' HG2' ' A' ' 107' ' ' LYS . . . -84.98 32.93 0.53 Allowed 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 113.013 0.746 . . . . 1.46 113.013 -167.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.624 ' HG2' ' O ' ' A' ' 106' ' ' ALA . 15.2 ptpt 53.83 127.6 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 123.467 1.603 . . . . 2.31 112.654 -177.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.772 HG13 HG11 ' A' ' 110' ' ' VAL . 20.4 pt -128.59 160.66 38.74 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 CA-C-N 113.538 -1.665 . . . . 1.65 108.681 177.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.527 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 0.2 OUTLIER -71.54 52.31 0.2 Allowed 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.148 -0.933 . . . . 1.73 110.985 -178.338 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.772 HG11 HG13 ' A' ' 108' ' ' ILE . 0.7 OUTLIER -62.3 95.57 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-O 121.533 0.683 . . . . 1.4 109.379 179.611 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.599 ' ND2' ' H ' ' A' ' 112' ' ' GLY . 3.1 t30 177.6 -179.12 0.23 Allowed 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 114.683 -1.144 . . . . 2.1 108.389 -176.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.599 ' H ' ' ND2' ' A' ' 111' ' ' ASN . . . -73.82 12.6 4.83 Favored Glycine 0 N--CA 1.44 -1.037 0 N-CA-C 115.998 1.159 . . . . 1.47 115.998 -176.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.681 ' HB2' ' HG3' ' A' ' 82' ' ' GLN . 15.0 tt0 -107.57 -47.36 3.64 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 119.987 1.894 . . . . 2.81 113.084 178.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.41 ' HB3' ' HB3' ' A' ' 109' ' ' ASN . 18.2 t-20 -129.43 -32.9 1.93 Allowed 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.8 -0.36 . . . . 2.75 111.183 -178.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.527 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . 45.91 -109.53 0.21 Allowed 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.286 -0.87 . . . . 1.44 110.14 -172.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.656 ' ND1' ' H ' ' A' ' 118' ' ' LEU . 4.0 t-80 177.46 137.25 0.22 Allowed Pre-proline 0 N--CA 1.425 -1.69 0 N-CA-C 104.808 -2.293 . . . . 0.71 104.808 171.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -27.29 -45.75 0.07 OUTLIER 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 124.272 3.314 . . . . 0.47 113.913 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.752 HD11 ' HB ' ' A' ' 15' ' ' ILE . 24.0 tp -64.86 -50.81 65.15 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.608 0.763 . . . . 1.15 111.854 178.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.666 ' OH ' HG21 ' A' ' 40' ' ' ILE . 36.4 m-85 -75.9 -33.01 59.9 Favored 'General case' 0 CA--C 1.505 -0.788 0 O-C-N 122.203 -0.311 . . . . 3.33 111.509 178.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -56.51 -38.85 72.35 Favored 'General case' 0 CA--C 1.493 -1.239 0 N-CA-C 106.927 -1.509 . . . . 2.44 106.927 170.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.801 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 56.6 t80 -67.43 -32.18 72.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.224 -0.898 . . . . 1.08 110.661 175.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.642 ' HB2' ' HA ' ' A' ' 119' ' ' TYR . 0.6 OUTLIER -74.64 -54.5 7.31 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.248 -0.433 . . . . 1.25 110.142 -171.075 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.419 ' HE2' ' HB2' ' A' ' 123' ' ' LYS . 1.2 ptmm? -70.29 -24.57 63.06 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.191 -0.459 . . . . 1.86 111.396 176.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.5 ' HG3' ' O ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -74.43 -27.91 60.82 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 119.151 -1.02 . . . . 2.52 110.118 176.231 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 90.8 m -78.27 -43.04 29.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.887 -0.597 . . . . 1.21 110.265 175.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.426 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 41.0 tttm -148.74 104.88 3.44 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 108.884 -0.784 . . . . 2.38 108.884 178.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 126' ' ' LYS . 23.0 Cg_exo -64.84 -73.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.992 3.128 . . . . 1.69 114.332 -167.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.726 ' HA3' ' HB3' ' A' ' 133' ' ' LYS . . . -152.36 -176.62 25.18 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 119.628 -1.272 . . . . 2.59 113.005 -174.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.551 HD12 ' H ' ' A' ' 129' ' ' ILE . 4.2 mp -74.36 -19.73 17.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.454 -0.943 . . . . 3.93 108.454 178.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.496 ' HG ' ' H ' ' A' ' 131' ' ' ALA . 9.7 tp -77.56 -168.57 1.21 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.805 -1.089 . . . . 3.81 109.417 173.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.496 ' H ' ' HG ' ' A' ' 130' ' ' LEU . . . -60.75 -37.76 82.91 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.135 -1.061 . . . . 3.63 108.135 165.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -149.77 147.42 27.99 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 114.483 -1.235 . . . . 3.97 110.883 176.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.726 ' HB3' ' HA3' ' A' ' 128' ' ' GLY . 47.2 tptt -166.0 162.91 18.3 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.552 -1.277 . . . . 5.48 107.552 175.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -140.11 56.02 1.62 Allowed 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.415 -0.514 . . . . 1.59 111.707 -178.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.619 HG22 ' HB3' ' A' ' 84' ' ' PRO . 73.6 mt 67.74 120.38 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 O-C-N 123.92 0.762 . . . . 2.09 110.835 178.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.506 ' HA ' ' HA ' ' A' ' 84' ' ' PRO . 2.7 tmtm? -160.61 33.16 0.16 Allowed 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.712 -0.617 . . . . 5.16 111.877 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.677 ' N ' ' HB2' ' A' ' 84' ' ' PRO . 12.6 m-90 -143.16 174.05 11.04 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.279 0.561 . . . . 2.41 110.983 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.521 ' HB3' ' H ' ' A' ' 139' ' ' PHE . 6.1 m-20 -43.06 -156.22 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.725 -1.125 . . . . 2.04 112.157 157.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.627 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 2.8 m-85 -28.74 -47.25 0.05 Allowed 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 116.337 1.977 . . . . 2.53 116.337 -168.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.62 ' HB ' ' OD1' ' A' ' 42' ' ' ASN . 9.7 m 36.12 91.8 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.386 0.994 . . . . 1.24 113.21 176.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.443 ' CB ' HD12 ' A' ' 39' ' ' LEU . 0.7 OUTLIER -83.41 163.26 20.67 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.464 -0.789 . . . . 1.03 110.685 -175.023 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.528 ' HA ' ' HA ' ' A' ' 153' ' ' ARG . 76.4 m-85 -129.77 122.26 28.47 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 105.52 -2.03 . . . . 0.7 105.52 168.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.807 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 7.3 tp -80.19 103.51 10.11 Favored 'General case' 0 N--CA 1.422 -1.865 0 C-N-CA 118.528 -1.269 . . . . 1.16 108.372 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.711 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 42.9 mm -90.23 139.54 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.734 0 CA-C-N 112.965 -1.925 . . . . 1.05 107.468 -179.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.517 ' HA ' HD12 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -93.92 -176.95 4.18 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 119.71 -0.796 . . . . 0.98 111.276 -169.197 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.57 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 35.3 mtm180 -51.94 -41.45 62.06 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.994 0.426 . . . . 2.61 111.18 -177.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -95.65 14.68 22.21 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 109.646 -0.501 . . . . 2.0 109.646 -175.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.481 ' HA2' HG23 ' A' ' 144' ' ' ILE . . . 78.38 30.83 48.44 Favored Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 121.223 -0.513 . . . . 0.19 113.915 179.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 49.5 t -103.85 115.3 63.63 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 118.224 1.012 . . . . 1.74 111.428 177.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.686 ' HD3' HG22 ' A' ' 15' ' ' ILE . 29.6 Cg_endo -66.58 117.93 5.13 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 123.44 2.76 . . . . 0.6 110.86 177.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 16.0 m -119.42 -9.83 11.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 120.704 0.287 . . . . 2.06 110.247 -176.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.807 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 18.3 mm-40 -145.13 166.57 25.02 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-N 115.749 -0.659 . . . . 1.17 110.659 175.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.545 HH11 ' HG2' ' A' ' 153' ' ' ARG . 0.0 OUTLIER -147.58 126.65 12.87 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.757 -1.11 . . . . 2.9 109.253 161.96 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.674 ' HZ ' ' HB2' ' A' ' 166' ' ' LYS . 91.1 m-85 -99.28 148.37 24.21 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.028 -0.987 . . . . 0.36 109.563 -174.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 16.1 m -88.19 149.4 44.99 Favored Pre-proline 0 C--N 1.311 -1.085 0 N-CA-C 109.234 -0.654 . . . . 1.45 109.234 -179.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.585 ' CG ' ' HB3' ' A' ' 137' ' ' TRP . 33.8 Cg_endo -64.29 96.02 0.22 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 121.841 1.694 . . . . 0.78 108.446 170.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 151.07 -17.3 0.92 Allowed Glycine 0 N--CA 1.433 -1.561 0 N-CA-C 109.019 -1.632 . . . . 0.59 109.019 -164.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -92.18 145.91 24.13 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.919 -1.141 . . . . 1.07 107.919 166.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.568 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 31.1 t -109.94 -178.23 3.47 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.895 -0.409 . . . . 1.92 109.895 -174.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.684 ' CG2' ' HA ' ' A' ' 56' ' ' THR . 57.8 t -41.44 -51.11 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.301 0 O-C-N 124.081 0.863 . . . . 1.07 110.732 178.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 7.6 tttm -60.62 -46.11 91.51 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.088 -0.96 . . . . 3.89 111.108 -174.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -66.53 -30.64 71.0 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.912 -1.04 . . . . 1.4 110.333 -173.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.509 ' HA ' ' CE2' ' A' ' 154' ' ' PHE . 60.1 mt -81.89 -45.23 20.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.674 -0.694 . . . . 1.05 111.25 177.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.605 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 52.3 mt-10 -53.96 -43.15 69.66 Favored 'General case' 0 C--O 1.215 -0.747 0 CA-C-O 120.907 0.384 . . . . 0.67 111.379 -177.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -59.15 -19.18 42.71 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 112.279 0.474 . . . . 0.87 112.279 -176.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.674 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 75.4 mmtt -103.17 -27.3 12.61 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.54 0.686 . . . . 2.22 109.948 173.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.595 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 13.7 tp -77.27 -50.86 11.94 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.95 -1.023 . . . . 1.04 112.409 -177.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.461 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 73.4 mt -54.33 -45.8 99.16 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 115.734 -0.666 . . . . 1.08 112.201 -174.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.461 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 82.2 Cg_exo -51.42 -29.48 31.26 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.343 2.029 . . . . 0.62 113.015 173.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.754 HD13 HD12 ' A' ' 143' ' ' LEU . 73.6 mt -88.81 -42.12 12.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.663 -0.244 . . . . 1.36 111.251 178.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.762 HD22 ' HG2' ' A' ' 37' ' ' PRO . 93.0 mt -60.37 -56.4 21.89 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-O 122.052 0.93 . . . . 1.07 109.649 175.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -64.52 -18.05 63.0 Favored Glycine 0 N--CA 1.436 -1.323 0 CA-C-N 113.385 -1.734 . . . . 1.12 112.106 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 21.8 t 63.09 73.86 0.44 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.37 0.605 . . . . 2.88 111.367 174.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -82.39 -21.18 35.94 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.659 -0.7 . . . . 4.69 110.127 174.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.401 ' HB3' HD13 ' A' ' 176' ' ' LEU . 4.6 mmp_? 66.53 -80.11 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.329 -0.85 . . . . 9.17 111.455 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.401 HD13 ' HB3' ' A' ' 175' ' ' ARG . 6.6 mp . . . . . 0 C--O 1.245 0.86 0 CA-C-O 118.661 -0.685 . . . . 8.03 109.283 178.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.704 0 N-CA-C 111.681 -0.567 . . . . 5.58 111.681 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 66.2 mtt -76.18 90.39 3.12 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.284 0.564 . . . . 5.23 110.006 178.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.06 43.91 1.98 Allowed Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.664 -0.698 . . . . 1.55 112.355 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.4 p -111.11 15.28 21.68 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.348 0.594 . . . . 2.17 110.352 175.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 85.7 p 178.21 152.75 0.3 Allowed 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 105.708 -1.96 . . . . 1.68 105.708 -178.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.806 ' HB ' HD12 ' A' ' 118' ' ' LEU . 5.1 pt -64.63 -18.36 23.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-N 114.769 -1.105 . . . . 1.16 111.519 -176.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.851 ' HB3' HG13 ' A' ' 31' ' ' VAL . 36.5 m-85 -70.45 -7.75 45.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.946 -0.57 . . . . 0.3 111.871 -176.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -68.29 -17.43 64.27 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.385 -0.969 . . . . 2.11 108.385 175.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.68 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 55.9 m-85 -115.67 108.03 15.86 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 115.12 -0.945 . . . . 0.37 111.096 -176.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -45.8 144.01 1.89 Allowed 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 113.687 -1.597 . . . . 2.86 110.396 171.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.704 HG11 ' CZ ' ' A' ' 74' ' ' PHE . 35.7 t -110.66 169.17 3.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 N-CA-C 107.485 -1.302 . . . . 1.32 107.485 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.742 ' O ' ' HB2' ' A' ' 105' ' ' MET . 61.6 mt -132.12 123.22 26.69 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 118.538 0.608 . . . . 1.29 111.605 -177.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.488 ' N ' ' HB2' ' A' ' 28' ' ' TYR . 14.7 t70 -62.03 161.51 10.67 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.187 -1.412 . . . . 1.87 107.187 167.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.767 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . . . -52.88 -15.39 0.75 Allowed 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 114.793 1.405 . . . . 1.2 114.793 -165.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.573 ' HB2' ' HE2' ' A' ' 26' ' ' LYS . 38.2 m-20 -91.93 -2.33 56.84 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.417 0.525 . . . . 2.34 112.417 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.632 ' CD2' ' HB2' ' A' ' 106' ' ' ALA . 68.8 m-70 82.84 11.27 0.54 Allowed 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.59 0.71 . . . . 2.26 109.477 -177.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.573 ' HE2' ' HB2' ' A' ' 24' ' ' ASP . 17.5 mtmt -77.0 120.7 82.79 Favored Pre-proline 0 C--N 1.323 -0.575 0 N-CA-C 107.148 -1.427 . . . . 4.64 107.148 169.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.696 ' HA ' HD21 ' A' ' 21' ' ' LEU . 78.9 Cg_exo -49.42 114.32 1.27 Allowed 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 122.055 1.837 . . . . 0.62 113.062 -174.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.544 ' HB3' HG12 ' A' ' 20' ' ' VAL . 6.8 t80 -81.32 139.14 35.56 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 113.53 -1.668 . . . . 1.52 111.356 176.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.643 ' ND2' HG22 ' A' ' 31' ' ' VAL . 2.6 t-20 -72.35 90.66 1.29 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.691 -1.141 . . . . 2.16 109.847 176.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.759 ' HG ' ' CD1' ' A' ' 16' ' ' PHE . 29.4 tp -70.65 -41.36 72.22 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.081 0.467 . . . . 1.07 109.949 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.851 HG13 ' HB3' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -63.47 0.64 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 115.181 -0.918 . . . . 1.69 113.054 -174.873 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.543 ' HB3' ' OD1' ' A' ' 29' ' ' ASN . 3.6 pt20 -74.35 -7.18 51.99 Favored 'General case' 0 CA--C 1.509 -0.623 0 O-C-N 121.92 -0.488 . . . . 1.31 110.762 176.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.806 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 63.3 m-70 -104.98 30.16 5.76 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.697 0.761 . . . . 0.35 109.647 173.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.752 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 23.6 mtmt -86.23 110.39 19.58 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 114.81 -1.086 . . . . 2.07 109.599 172.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 128.48 -41.1 1.61 Allowed Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 111.204 -0.758 . . . . 0.24 111.204 -176.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.466 ' HB2' ' HA3' ' A' ' 68' ' ' GLY . 18.0 m -129.25 130.63 23.37 Favored Pre-proline 0 N--CA 1.436 -1.171 0 N-CA-C 109.139 -0.689 . . . . 0.74 109.139 171.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.802 ' HG3' ' CB ' ' A' ' 170' ' ' LEU . 5.4 Cg_endo -43.51 150.77 0.43 Allowed 'Trans proline' 0 CA--C 1.513 -0.528 0 C-N-CA 124.768 3.645 . . . . 0.22 113.522 178.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.784 ' HB2' HG22 ' A' ' 70' ' ' THR . 1.2 pt? -130.13 149.0 52.03 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 107.491 -1.3 . . . . 1.09 107.491 174.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.978 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 1.5 mm? -111.35 112.46 24.23 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.329 -0.989 . . . . 1.82 108.329 174.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 1.003 HD13 ' HE2' ' A' ' 122' ' ' MET . 4.2 mt -96.93 125.23 49.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 C-N-CA 119.98 -0.688 . . . . 1.12 110.369 177.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.978 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -109.98 123.03 48.92 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 116.245 -0.434 . . . . 1.09 109.967 -175.543 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.705 ' ND2' ' HB ' ' A' ' 135' ' ' ILE . 2.3 p-10 -81.21 94.07 6.61 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 107.696 -1.224 . . . . 3.11 107.696 170.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.835 ' O ' ' HA ' ' A' ' 75' ' ' PRO . 1.2 p -104.59 131.88 52.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 CA-C-N 115.262 -0.881 . . . . 1.69 111.626 -160.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -81.4 100.49 9.29 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 119.647 -0.821 . . . . 1.45 109.546 174.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 1.03 ' HA ' ' HB2' ' A' ' 98' ' ' PHE . 23.1 p -12.85 -76.12 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 O-C-N 125.595 1.81 . . . . 1.99 114.037 172.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? 65.72 173.46 0.22 Allowed 'General case' 0 C--O 1.237 0.412 0 CA-C-O 122.191 0.996 . . . . 6.2 113.055 176.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.713 ' HB2' ' HA ' ' A' ' 95' ' ' CYS . 49.1 t -149.66 114.67 5.4 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 114.434 -1.257 . . . . 4.12 108.66 170.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.66 -2.33 86.01 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 120.879 -0.677 . . . . 3.44 114.076 176.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -144.31 133.74 23.29 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 117.964 0.882 . . . . 4.84 112.385 -177.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.443 ' CB ' ' HB2' ' A' ' 54' ' ' TYR . 15.0 t -137.15 149.14 47.09 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.338 -0.986 . . . . 2.41 108.338 170.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.581 ' HB3' ' HB2' ' A' ' 156' ' ' PRO . 30.7 ttmt -93.88 46.45 1.18 Allowed 'General case' 0 C--O 1.223 -0.339 0 CA-C-N 118.507 0.594 . . . . 2.47 109.984 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.16 -35.41 3.81 Favored Glycine 0 CA--C 1.516 0.116 0 C-N-CA 120.934 -0.651 . . . . 0.85 112.307 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -41.57 -43.57 3.94 Favored Glycine 0 C--O 1.223 -0.547 0 O-C-N 124.013 0.478 . . . . 0.67 113.791 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.543 ' HA ' ' CZ ' ' A' ' 139' ' ' PHE . 0.1 OUTLIER -59.48 -60.12 4.36 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.739 0.269 . . . . 1.2 111.634 -174.852 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -60.86 -34.72 75.03 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.347 0.594 . . . . 2.61 109.632 -176.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.647 ' OG1' ' HA ' ' A' ' 159' ' ' SER . 72.1 m -62.63 -59.64 4.64 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.699 -1.137 . . . . 1.06 110.1 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 1.131 ' HB2' HG11 ' A' ' 71' ' ' VAL . . . -60.55 -49.28 78.18 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.042 -0.981 . . . . 1.05 111.424 -177.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.631 ' N ' ' HE1' ' A' ' 102' ' ' PHE . 37.6 m -55.15 -51.95 64.83 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.464 0.649 . . . . 1.08 110.479 -177.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.481 ' HA ' ' ND2' ' A' ' 62' ' ' ASN . 29.7 m -71.03 -31.8 68.38 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.264 -0.88 . . . . 1.22 111.442 -176.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.685 HD21 ' HG3' ' A' ' 164' ' ' GLU . 14.6 mt -71.91 -50.74 26.6 Favored 'General case' 0 CA--C 1.494 -1.186 0 CA-C-O 120.924 0.392 . . . . 1.14 110.6 -177.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.805 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 3.0 t80 -51.47 -60.34 3.24 Favored 'General case' 0 C--O 1.203 -1.374 0 CA-C-N 114.645 -1.161 . . . . 0.94 109.752 178.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 1.05 ' HA ' ' HG3' ' A' ' 65' ' ' LYS . 4.3 p30 -70.06 -24.55 63.26 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 121.11 -0.236 . . . . 1.6 111.006 -171.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.503 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 35.3 ttpt -76.48 -21.31 55.99 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.184 -1.043 . . . . 2.06 108.184 -177.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.762 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 65.4 m-85 -130.12 10.13 5.35 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 114.679 1.363 . . . . 0.92 114.679 -176.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 1.05 ' HG3' ' HA ' ' A' ' 62' ' ' ASN . 27.9 mtmt -54.11 -38.29 65.25 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 106.588 -1.634 . . . . 1.89 106.588 169.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -48.5 -42.17 32.19 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 111.697 -2.501 . . . . 1.68 112.908 -177.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -85.06 -36.3 21.3 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.671 -0.412 . . . . 1.11 111.751 177.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.466 ' HA3' ' HB2' ' A' ' 36' ' ' SER . . . 147.38 -5.73 1.03 Allowed Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 110.829 -0.909 . . . . 0.2 110.829 -176.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.762 ' HD2' ' HB2' ' A' ' 64' ' ' TYR . 17.1 t80 -66.9 139.25 57.72 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 114.951 -0.625 . . . . 0.21 110.973 -177.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.806 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 1.6 t -132.82 149.51 52.26 Favored 'General case' 0 N--CA 1.414 -2.238 0 N-CA-C 108.653 -0.869 . . . . 1.02 108.653 172.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 1.131 HG11 ' HB2' ' A' ' 57' ' ' ALA . 29.7 t -102.7 101.52 12.28 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.23 0 N-CA-C 108.058 -1.089 . . . . 1.04 108.058 160.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.838 ' HB2' HG21 ' A' ' 40' ' ' ILE . 66.1 mt -84.67 119.65 25.49 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 108.218 -1.03 . . . . 1.69 108.218 178.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.725 ' HB3' HG13 ' A' ' 43' ' ' VAL . . . -100.39 112.32 24.66 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 121.328 0.585 . . . . 1.17 111.632 -178.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.832 ' CG ' ' HG2' ' A' ' 105' ' ' MET . 2.9 m-85 -103.59 95.17 6.91 Favored Pre-proline 0 C--N 1.316 -0.872 0 N-CA-C 109.275 -0.639 . . . . 0.58 109.275 176.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.835 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 76.3 Cg_endo -83.5 95.75 0.78 Allowed 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.249 1.966 . . . . 1.3 113.84 -169.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.545 ' HB2' HG22 ' A' ' 110' ' ' VAL . 47.4 t -39.11 132.92 1.27 Allowed 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 121.865 0.84 . . . . 1.91 112.628 -176.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.634 ' C ' ' H ' ' A' ' 79' ' ' PHE . 21.3 p-10 -74.92 106.27 6.35 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-N 114.451 -1.25 . . . . 1.93 107.888 176.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 1.02 ' HA ' ' HG2' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -49.12 -9.69 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 113.95 -1.477 . . . . 3.97 112.088 173.886 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.634 ' H ' ' C ' ' A' ' 77' ' ' ASN . 72.7 m-85 -76.4 31.97 0.12 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 114.438 1.273 . . . . 3.21 114.438 -165.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.441 ' HA3' HE22 ' A' ' 82' ' ' GLN . . . -135.13 -77.55 0.09 OUTLIER Glycine 0 CA--C 1.518 0.228 0 C-N-CA 119.443 -1.36 . . . . 1.98 113.838 -179.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 142.95 16.3 0.28 Allowed Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.335 -0.706 . . . . 1.66 111.335 -171.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.75 ' HG3' ' HB3' ' A' ' 113' ' ' GLU . 4.1 pm0 -139.46 13.07 2.56 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 110.125 -0.324 . . . . 1.74 110.125 -173.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 1.02 ' HG2' ' HA ' ' A' ' 78' ' ' GLN . 2.9 mp0 -63.43 152.42 85.38 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.413 -0.812 . . . . 3.07 110.387 -173.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.57 ' HB2' ' N ' ' A' ' 137' ' ' TRP . 55.2 Cg_endo -84.48 128.37 4.04 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.317 2.678 . . . . 1.75 112.452 -175.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.42 ' CA ' ' HA ' ' A' ' 137' ' ' TRP . . . 97.99 -62.39 0.92 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.795 -0.717 . . . . 2.27 113.642 172.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -133.9 101.65 5.15 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.83 -0.433 . . . . 4.88 109.83 -177.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -86.62 32.29 0.66 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.94 -0.573 . . . . 3.02 111.459 -171.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.815 ' HA ' ' HD3' ' A' ' 91' ' ' LYS . 8.5 tp10 -166.84 -32.42 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 112.149 0.426 . . . . 3.92 112.149 178.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.513 ' O ' ' HB3' ' A' ' 93' ' ' PHE . 35.4 tt0 -56.2 -30.23 62.01 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.541 0.571 . . . . 2.65 112.541 -174.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.673 ' HA ' ' SG ' ' A' ' 95' ' ' CYS . 2.1 pt -99.18 4.32 10.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.211 0.529 . . . . 2.63 111.631 -178.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.815 ' HD3' ' HA ' ' A' ' 88' ' ' GLU . 11.4 mtpp -114.28 -50.81 2.79 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.878 -0.601 . . . . 3.13 110.205 -175.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 88' ' ' GLU . 15.8 pt-20 -72.98 -22.76 60.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.94 -0.573 . . . . 3.29 110.076 176.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.513 ' HB3' ' O ' ' A' ' 89' ' ' GLU . 34.0 t80 -118.08 145.7 44.66 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.605 -0.725 . . . . 4.08 110.117 -174.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 49.4 t -67.37 122.23 18.06 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.467 0 CA-C-O 121.273 0.559 . . . . 3.05 110.442 176.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.713 ' HA ' ' HB2' ' A' ' 47' ' ' CYS . 84.7 m -131.96 128.82 39.25 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 115.413 -0.812 . . . . 3.04 110.426 178.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.584 ' C ' ' H ' ' A' ' 98' ' ' PHE . 31.2 p -52.58 148.84 6.53 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 114.992 -1.003 . . . . 3.38 108.904 171.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -73.74 31.08 0.08 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.987 0.422 . . . . 3.11 110.972 -177.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 1.03 ' HB2' ' HA ' ' A' ' 45' ' ' SER . 55.6 t80 57.11 104.41 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.554 -1.203 . . . . 2.12 111.893 -175.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.446 ' HA ' ' CD1' ' A' ' 104' ' ' ILE . 33.7 ttpt -128.83 138.05 51.84 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.485 -0.561 . . . . 3.1 109.485 173.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.414 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -160.59 -158.49 0.61 Allowed 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 121.124 0.488 . . . . 1.15 111.546 -168.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -99.76 21.28 12.7 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.47 -0.786 . . . . 1.99 111.925 -178.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.804 ' HE2' ' CZ ' ' A' ' 98' ' ' PHE . 0.4 OUTLIER -109.43 177.8 1.17 Allowed Pre-proline 0 CA--C 1.511 -0.528 0 CA-C-O 121.317 0.579 . . . . 1.31 110.131 177.037 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.695 ' HD3' ' CE2' ' A' ' 61' ' ' TYR . 6.6 Cg_exo -80.81 76.16 4.66 Favored 'Trans proline' 0 N--CA 1.445 -1.37 0 C-N-CA 123.94 3.093 . . . . 1.07 110.003 162.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.596 HG12 ' HB1' ' A' ' 73' ' ' ALA . 34.8 mt -74.55 138.01 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 107.288 -1.375 . . . . 1.97 107.288 176.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.832 ' HG2' ' CG ' ' A' ' 74' ' ' PHE . 1.1 ppp? -96.62 -171.62 2.31 Favored 'General case' 0 N--CA 1.434 -1.255 0 C-N-CA 120.229 -0.588 . . . . 3.41 112.093 -170.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.767 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . . . -64.97 -7.69 12.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.417 -0.81 . . . . 1.46 112.194 -178.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.806 ' HB2' ' O ' ' A' ' 75' ' ' PRO . 3.9 ptpp? 66.04 133.72 0.02 OUTLIER 'General case' 0 CA--C 1.498 -1.036 0 C-N-CA 125.29 1.436 . . . . 2.31 110.702 -168.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.729 HG13 ' CB ' ' A' ' 116' ' ' HIS . 0.2 OUTLIER -135.78 171.54 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.857 0 CA-C-N 113.554 -1.657 . . . . 1.65 107.468 170.176 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.688 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 4.9 m120 -64.83 64.18 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 114.946 -1.025 . . . . 1.73 112.916 178.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.545 HG22 ' HB2' ' A' ' 76' ' ' SER . 3.2 m -71.4 95.99 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 117.857 -1.537 . . . . 1.4 107.867 172.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.539 ' HB2' ' O ' ' A' ' 82' ' ' GLN . 25.3 p30 178.47 179.9 0.34 Allowed 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 113.601 -1.636 . . . . 2.1 108.065 -169.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -86.89 11.44 64.61 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 119.927 -1.13 . . . . 1.47 115.164 -170.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.75 ' HB3' ' HG3' ' A' ' 82' ' ' GLN . 3.3 pt-20 -104.52 -44.6 4.86 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 119.492 1.646 . . . . 2.81 112.438 -178.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.465 ' N ' ' HG3' ' A' ' 113' ' ' GLU . 0.8 OUTLIER -130.03 -36.34 1.55 Allowed 'General case' 0 CA--C 1.508 -0.667 0 O-C-N 121.792 -0.567 . . . . 2.75 110.5 -175.898 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.688 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . 52.46 -146.46 0.51 Allowed 'General case' 0 N--CA 1.444 -0.771 0 O-C-N 123.74 0.65 . . . . 1.44 109.251 -177.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.729 ' CB ' HG13 ' A' ' 108' ' ' ILE . 1.6 t-80 -160.5 139.38 7.73 Favored Pre-proline 0 N--CA 1.431 -1.412 0 N-CA-C 107.703 -1.221 . . . . 0.71 107.703 176.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -28.4 -49.92 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 124.683 3.589 . . . . 0.47 113.792 -178.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.806 HD12 ' HB ' ' A' ' 15' ' ' ILE . 48.0 tp -61.14 -51.6 68.4 Favored 'General case' 0 C--O 1.22 -0.468 0 C-N-CA 122.745 0.418 . . . . 1.15 111.787 178.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.684 ' HA ' ' HB2' ' A' ' 122' ' ' MET . 29.7 m-85 -76.53 -33.68 58.57 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 112.489 0.551 . . . . 3.33 112.489 -179.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.546 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 42.5 mt-10 -60.49 -34.92 74.76 Favored 'General case' 0 CA--C 1.491 -1.325 0 N-CA-C 107.121 -1.437 . . . . 2.44 107.121 171.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.68 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 45.0 t80 -69.48 -34.22 74.03 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 119.262 -0.975 . . . . 1.08 110.234 173.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 1.003 ' HE2' HD13 ' A' ' 40' ' ' ILE . 40.4 mtt -74.86 -52.23 11.87 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.89 -0.595 . . . . 1.25 112.057 -169.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.425 ' HB2' ' HE2' ' A' ' 123' ' ' LYS . 0.2 OUTLIER -69.56 -24.44 63.71 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 120.366 -0.534 . . . . 1.86 109.853 176.863 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.546 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 17.0 tttt -65.58 -38.15 88.7 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.248 -0.433 . . . . 2.52 110.309 170.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 36.2 m -65.43 -61.23 2.23 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.936 -0.574 . . . . 1.21 111.426 -176.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.529 ' HD2' ' O ' ' A' ' 151' ' ' VAL . 36.8 ttmt -140.64 127.74 12.12 Favored Pre-proline 0 C--N 1.33 -0.269 0 N-CA-C 109.957 -0.386 . . . . 2.38 109.957 177.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 126' ' ' LYS . 27.4 Cg_exo -64.06 1.64 1.45 Allowed 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 123.743 2.962 . . . . 1.69 114.085 -178.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 81.84 70.73 1.33 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 121.164 -0.541 . . . . 2.59 113.545 170.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 76.7 mt 73.31 -57.76 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 122.823 0.449 . . . . 3.93 111.241 177.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 38.6 tp -104.18 151.04 23.81 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.736 0.303 . . . . 3.81 110.242 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -78.58 60.89 2.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.936 0.398 . . . . 3.63 111.165 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 5.2 m -98.26 -100.86 0.21 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.508 -0.314 . . . . 3.97 110.453 178.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 50.4 mttp -161.9 -87.98 0.03 OUTLIER 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.746 0.784 . . . . 5.48 110.916 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -103.45 164.65 11.52 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.978 -1.01 . . . . 1.59 112.366 -167.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.812 HG21 ' HD3' ' A' ' 153' ' ' ARG . 0.1 OUTLIER -64.69 46.68 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-N 113.862 -1.517 . . . . 2.09 110.998 169.119 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.47 ' HA ' ' HB3' ' A' ' 84' ' ' PRO . 9.2 tmtt? -75.75 44.34 0.29 Allowed 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.382 0.611 . . . . 5.16 112.497 -167.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.57 ' N ' ' HB2' ' A' ' 84' ' ' PRO . 6.4 m-90 -136.46 174.29 10.77 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.509 -0.552 . . . . 2.41 109.509 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.46 ' N ' HD21 ' A' ' 138' ' ' ASN . 0.9 OUTLIER -45.26 -153.93 0.0 OUTLIER 'General case' 0 C--O 1.209 -1.029 0 C-N-CA 123.846 0.859 . . . . 2.04 111.163 162.342 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.634 ' CD1' HG21 ' A' ' 43' ' ' VAL . 2.0 m-85 -27.5 -48.89 0.04 OUTLIER 'General case' 0 C--O 1.21 -0.983 0 N-CA-C 115.239 1.57 . . . . 2.53 115.239 -169.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.701 ' HB ' HD22 ' A' ' 42' ' ' ASN . 8.6 m 39.17 108.46 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 122.746 1.26 . . . . 1.24 113.84 173.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.41 ' HB3' HD13 ' A' ' 39' ' ' LEU . 1.4 m -100.64 165.25 11.49 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 114.811 -1.086 . . . . 1.03 110.014 -170.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.608 ' HA ' ' HA ' ' A' ' 153' ' ' ARG . 28.4 m-85 -128.38 125.96 39.7 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 105.916 -1.883 . . . . 0.7 105.916 163.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.827 HD13 HD11 ' A' ' 170' ' ' LEU . 1.6 tp -81.17 104.11 11.43 Favored 'General case' 0 C--N 1.288 -2.103 0 C-N-CA 118.565 -1.254 . . . . 1.16 108.563 178.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.722 HD13 ' HE1' ' A' ' 122' ' ' MET . 28.3 mm -92.65 136.89 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.992 0 CA-C-N 113.097 -1.865 . . . . 1.05 107.592 -178.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.534 ' HA ' HD13 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -90.85 -174.18 3.95 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 119.704 -0.798 . . . . 0.98 111.52 -170.793 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.657 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 41.0 mtt85 -55.81 -40.19 72.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.015 -0.539 . . . . 2.61 111.109 -177.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.5 18.01 16.33 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.668 0.747 . . . . 2.0 109.085 -177.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.642 ' HA3' ' CE2' ' A' ' 16' ' ' PHE . . . 73.6 32.69 59.19 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 114.805 -1.089 . . . . 0.19 114.853 177.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 58.3 t -93.93 126.49 48.98 Favored Pre-proline 0 C--N 1.314 -0.962 0 CA-C-N 118.235 1.018 . . . . 1.74 110.72 175.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.496 ' HA ' HD11 ' A' ' 144' ' ' ILE . 12.2 Cg_endo -78.22 105.13 1.94 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.898 2.399 . . . . 0.6 110.073 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.529 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 4.6 t -93.94 -72.21 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 106.603 -1.628 . . . . 2.06 106.603 -178.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.795 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 0.3 OUTLIER -88.96 164.69 15.0 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 114.4 -1.273 . . . . 1.17 111.18 -177.476 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.812 ' HD3' HG21 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -135.36 150.97 50.06 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 113.009 -1.905 . . . . 2.9 107.136 156.219 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.572 ' O ' ' HA ' ' A' ' 140' ' ' THR . 92.2 m-85 -125.46 145.44 50.08 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 108.442 -0.947 . . . . 0.36 108.442 -171.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.429 ' OG ' ' HD2' ' A' ' 156' ' ' PRO . 21.2 t -72.34 154.37 91.94 Favored Pre-proline 0 C--N 1.315 -0.918 0 N-CA-C 108.375 -0.972 . . . . 1.45 108.375 174.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.581 ' HB2' ' HB3' ' A' ' 51' ' ' LYS . 9.6 Cg_endo -51.45 -41.49 59.66 Favored 'Trans proline' 0 CA--C 1.519 -0.259 0 C-N-CA 122.185 1.923 . . . . 0.78 111.126 174.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -58.71 -19.35 42.42 Favored Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 114.645 -1.161 . . . . 0.59 113.725 176.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -70.62 136.41 49.13 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 109.005 -0.739 . . . . 1.07 109.005 177.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.647 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 19.8 m -108.46 -178.35 3.57 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 120.776 0.322 . . . . 1.92 110.705 -170.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.598 HG22 ' HA ' ' A' ' 56' ' ' THR . 46.7 t -44.8 -50.41 2.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 114.927 -1.033 . . . . 1.07 111.313 -178.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 26.0 tttm -64.75 -39.6 93.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.041 -0.527 . . . . 3.89 111.205 -176.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.495 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 32.7 m-20 -68.64 -39.54 80.69 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.52 -0.764 . . . . 1.4 109.632 -172.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.534 HD12 ' OH ' ' A' ' 41' ' ' TYR . 54.1 mt -75.1 -43.7 44.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 114.953 -1.021 . . . . 1.05 110.78 177.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.701 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 28.1 mt-10 -56.42 -39.9 73.82 Favored 'General case' 0 C--O 1.217 -0.624 0 N-CA-C 111.973 0.36 . . . . 0.67 111.973 -177.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.495 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 10.0 pt-20 -61.34 -23.91 66.08 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.673 -0.411 . . . . 0.87 111.249 -176.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.547 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 72.3 mmtt -99.08 -14.82 19.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.623 0.725 . . . . 2.22 109.759 175.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.701 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 12.8 tp -92.8 -51.91 4.86 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.059 -0.973 . . . . 1.04 112.385 -174.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.49 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 78.1 mt -53.03 -48.59 91.35 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.541 -0.754 . . . . 1.08 112.901 -171.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.49 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 74.2 Cg_exo -52.69 -33.9 61.66 Favored 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 121.974 1.783 . . . . 0.62 112.321 176.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.827 HD11 HD13 ' A' ' 143' ' ' LEU . 93.1 mt -77.18 -46.68 22.52 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 116.016 -0.538 . . . . 1.36 110.75 178.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.751 HD22 ' HG2' ' A' ' 37' ' ' PRO . 89.5 mt -58.33 -56.67 19.11 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 121.66 0.743 . . . . 1.07 110.37 177.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -49.31 -33.8 16.86 Favored Glycine 0 N--CA 1.437 -1.265 0 CA-C-N 113.688 -1.597 . . . . 1.12 112.819 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 33.7 m 58.01 48.11 13.75 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 112.234 0.457 . . . . 2.88 112.234 173.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -75.8 -36.31 59.77 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.361 -0.607 . . . . 4.69 109.361 172.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 53.9 mtm180 68.27 -65.46 0.26 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 114.559 -1.201 . . . . 9.17 112.291 174.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 92.3 mt . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.753 -0.641 . . . . 8.03 110.062 -179.817 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.579 0 N-CA-C 111.772 -0.531 . . . . 5.58 111.772 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 65.1 mtt -93.58 -28.32 16.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.203 0.525 . . . . 5.23 110.025 178.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -88.36 133.94 12.12 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.589 -0.732 . . . . 1.55 111.855 179.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.3 p -111.03 -24.45 10.34 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.467 0.651 . . . . 2.17 109.543 178.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.535 ' HB3' ' O ' ' A' ' 147' ' ' ASP . 1.4 m -153.53 169.22 23.74 Favored 'General case' 0 N--CA 1.427 -1.575 0 N-CA-C 105.107 -2.182 . . . . 1.68 105.107 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.837 HD11 HD23 ' A' ' 30' ' ' LEU . 5.0 pt -61.55 -21.82 26.42 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.16 0 CA-C-O 121.777 0.799 . . . . 1.16 109.566 172.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.963 ' HB3' HG11 ' A' ' 31' ' ' VAL . 25.0 m-85 -70.6 -7.4 43.85 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.848 1.055 . . . . 0.3 113.848 -172.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -77.85 -5.32 50.52 Favored 'General case' 0 CA--C 1.502 -0.865 0 N-CA-C 107.951 -1.129 . . . . 2.11 107.951 178.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.741 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 41.9 m-85 -120.06 112.02 18.61 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 114.313 -1.312 . . . . 0.37 110.204 -175.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.92 149.52 2.63 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 113.521 -1.672 . . . . 2.86 110.632 174.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.802 HG12 ' CZ ' ' A' ' 74' ' ' PHE . 35.6 t -112.12 158.62 12.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 107.874 -1.158 . . . . 1.32 107.874 174.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.898 ' O ' ' HB3' ' A' ' 105' ' ' MET . 96.0 mt -126.88 109.04 11.55 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 119.183 -0.437 . . . . 1.29 110.87 -174.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.456 ' O ' ' HB1' ' A' ' 106' ' ' ALA . 17.0 t70 -46.81 158.0 0.14 Allowed 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 107.972 -1.121 . . . . 1.87 107.972 170.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.61 ' HA ' ' N ' ' A' ' 106' ' ' ALA . . . -53.79 -10.32 0.29 Allowed 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 113.251 0.834 . . . . 1.2 113.251 -167.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.535 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 25.9 t0 -93.46 -6.16 47.57 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 122.943 0.497 . . . . 2.34 111.899 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.678 ' CD2' ' HB2' ' A' ' 106' ' ' ALA . 60.8 m-70 82.38 24.5 0.19 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.77 0.795 . . . . 2.26 109.206 -177.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 26' ' ' LYS . 27.2 mmtt -106.74 125.69 32.1 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 114.307 -1.315 . . . . 4.64 108.362 176.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.588 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 73.0 Cg_exo -52.67 114.7 1.81 Allowed 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.329 2.019 . . . . 0.62 114.561 -167.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.953 ' HH ' ' HE2' ' A' ' 33' ' ' HIS . 6.9 t80 -81.76 128.06 33.6 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 113.391 -1.732 . . . . 1.52 109.285 165.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.457 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 0.4 OUTLIER -74.63 91.55 2.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 122.341 1.067 . . . . 2.16 110.976 -179.887 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.837 HD23 HD11 ' A' ' 15' ' ' ILE . 52.2 tp -58.0 -36.21 72.33 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.009 -0.996 . . . . 1.07 110.589 -178.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.963 HG11 ' HB3' ' A' ' 16' ' ' PHE . 3.6 m -66.75 -1.22 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 114.768 -1.105 . . . . 1.69 113.178 -172.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.457 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 18.3 pt20 -77.2 -15.28 59.56 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 119.406 -0.917 . . . . 1.31 109.542 175.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.983 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 95.9 m-70 -86.83 27.86 0.95 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.959 0.885 . . . . 0.35 109.6 174.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.417 ' H ' ' C ' ' A' ' 32' ' ' GLN . 45.7 mttm -80.7 124.32 28.93 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 114.275 -1.33 . . . . 2.07 109.747 172.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.96 -40.06 2.68 Favored Glycine 0 N--CA 1.438 -1.22 0 C-N-CA 120.671 -0.776 . . . . 0.24 112.045 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.504 ' HB2' ' HA3' ' A' ' 68' ' ' GLY . 16.7 m -124.28 126.52 25.51 Favored Pre-proline 0 N--CA 1.435 -1.221 0 N-CA-C 108.689 -0.856 . . . . 0.74 108.689 175.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.829 ' HG3' ' CB ' ' A' ' 170' ' ' LEU . 2.9 Cg_endo -42.67 157.34 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 124.271 3.314 . . . . 0.22 113.015 176.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.756 ' HB2' HG21 ' A' ' 70' ' ' THR . 0.8 OUTLIER -145.08 143.36 30.38 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 107.575 -1.269 . . . . 1.09 107.575 -177.386 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 1.001 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 1.9 mm? -108.08 114.03 27.63 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.014 -0.735 . . . . 1.82 109.014 178.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 1.036 HG22 ' HH ' ' A' ' 119' ' ' TYR . 1.2 mt -96.23 125.61 49.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 C-N-CA 120.422 -0.511 . . . . 1.12 110.087 177.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 1.001 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.6 OUTLIER -107.07 133.09 52.22 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 120.449 -0.501 . . . . 1.09 110.254 -176.684 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.622 HD21 ' N ' ' A' ' 42' ' ' ASN . 0.3 OUTLIER -92.38 91.91 7.88 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 105.526 -2.027 . . . . 3.11 105.526 174.396 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.992 HG13 ' HB3' ' A' ' 73' ' ' ALA . 2.8 p -107.91 131.82 57.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 112.813 0.672 . . . . 1.69 112.813 -160.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -81.06 100.91 9.25 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.579 -0.737 . . . . 1.45 109.285 169.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.74 ' HA ' ' HB3' ' A' ' 98' ' ' PHE . 4.3 p -22.02 100.52 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 O-C-N 125.197 1.56 . . . . 1.99 112.692 175.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -63.49 109.73 1.73 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.641 -1.163 . . . . 6.2 112.373 -171.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 26.2 p -118.93 114.92 23.32 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.054 -1.091 . . . . 4.12 108.054 165.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.85 -58.23 0.99 Allowed Glycine 0 CA--C 1.526 0.745 0 C-N-CA 120.902 -0.666 . . . . 3.44 113.557 -177.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.49 ' HH ' ' NZ ' ' A' ' 51' ' ' LYS . 33.4 t80 -93.35 110.96 22.5 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.233 0.54 . . . . 4.84 112.315 -170.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.8 t -115.58 132.79 56.52 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.081 -1.081 . . . . 2.41 108.081 169.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.691 ' O ' ' HA2' ' A' ' 157' ' ' GLY . 28.3 mtpp -90.28 13.0 16.47 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 121.877 -0.515 . . . . 2.47 110.972 -178.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.54 ' O ' ' HG2' ' A' ' 55' ' ' GLU . . . 105.01 -29.2 12.1 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.675 -0.774 . . . . 0.85 111.397 -177.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -56.52 -24.91 48.57 Favored Glycine 0 C--O 1.222 -0.623 0 CA-C-O 119.792 -0.449 . . . . 0.67 113.326 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.604 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 0.4 OUTLIER -61.09 -60.94 2.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.509 0.654 . . . . 1.2 110.298 179.167 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.54 ' HG2' ' O ' ' A' ' 52' ' ' GLY . 11.9 pt-20 -63.28 -21.21 66.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.647 -0.706 . . . . 2.61 110.349 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.655 ' HA ' ' CG2' ' A' ' 160' ' ' VAL . 54.1 m -73.01 -59.93 2.47 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.065 -0.971 . . . . 1.06 109.617 178.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 1.078 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -60.66 -42.04 96.23 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.552 -1.204 . . . . 1.05 110.876 -178.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.557 ' HA ' ' CD1' ' A' ' 102' ' ' PHE . 85.7 m -57.18 -57.31 13.16 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.541 -0.754 . . . . 1.08 110.471 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 22.7 m -70.6 -33.26 70.85 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.474 -0.784 . . . . 1.22 111.694 -174.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.737 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 18.7 mt -65.07 -47.67 76.48 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-O 121.435 0.636 . . . . 1.14 110.321 -178.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.862 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 10.0 t80 -59.7 -49.73 76.58 Favored 'General case' 0 C--O 1.205 -1.262 0 CA-C-N 114.757 -1.11 . . . . 0.94 111.045 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -72.35 -24.34 61.27 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 120.658 0.266 . . . . 1.6 110.659 -173.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.628 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 35.3 ttpt -85.76 -25.13 26.57 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 109.338 -0.616 . . . . 2.06 109.338 -178.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.798 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 32.5 m-85 -124.07 -6.74 7.78 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 115.491 1.663 . . . . 0.92 115.491 -169.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.683 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 3.8 ptmt -64.96 -26.99 68.53 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 108.004 -1.11 . . . . 1.89 108.004 170.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.6 t -47.63 -34.02 7.45 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.022 -1.444 . . . . 1.68 110.526 173.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.412 ' OE1' ' HB3' ' A' ' 171' ' ' LEU . 47.7 mt-30 -90.43 -39.65 12.51 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.681 0.277 . . . . 1.11 111.218 174.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.504 ' HA3' ' HB2' ' A' ' 36' ' ' SER . . . 151.81 -3.53 0.42 Allowed Glycine 0 CA--C 1.52 0.386 0 N-CA-C 111.23 -0.748 . . . . 0.2 111.23 -177.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.798 ' HD2' ' HB2' ' A' ' 64' ' ' TYR . 20.7 t80 -70.31 140.64 52.31 Favored 'General case' 0 C--O 1.218 -0.595 0 C-N-CA 123.029 0.532 . . . . 0.21 111.544 -177.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.983 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 2.2 t -134.49 145.57 48.92 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 108.818 -0.808 . . . . 1.02 108.818 174.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 1.078 HG11 ' HB1' ' A' ' 57' ' ' ALA . 42.8 t -104.94 99.99 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.257 0 N-CA-C 108.359 -0.978 . . . . 1.04 108.359 160.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.703 HD22 ' HE2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -96.51 120.97 37.79 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 118.842 -1.143 . . . . 1.69 108.044 174.422 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.992 ' HB3' HG13 ' A' ' 43' ' ' VAL . . . -108.16 128.69 54.92 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 116.214 -0.448 . . . . 1.17 110.0 179.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.891 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 2.6 m-30 -102.43 105.62 44.59 Favored Pre-proline 0 C--N 1.312 -1.056 0 N-CA-C 108.162 -1.051 . . . . 0.58 108.162 175.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.913 ' HG2' ' HB3' ' A' ' 107' ' ' LYS . 59.7 Cg_endo -74.8 68.04 5.64 Favored 'Trans proline' 0 N--CA 1.474 0.324 0 C-N-CA 123.545 2.83 . . . . 1.3 114.98 -168.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 85.3 p 2.47 132.22 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 126.978 2.111 . . . . 1.91 116.542 178.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.522 ' C ' ' H ' ' A' ' 79' ' ' PHE . 1.3 p30 -87.71 75.09 9.03 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 123.287 1.518 . . . . 1.93 107.056 178.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.739 ' HG3' HG13 ' A' ' 90' ' ' ILE . 11.4 mm100 -51.97 -13.83 0.34 Allowed 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 113.733 -1.576 . . . . 3.97 110.151 175.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.522 ' H ' ' C ' ' A' ' 77' ' ' ASN . 99.0 m-85 -71.26 -14.86 62.37 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.555 -1.202 . . . . 3.21 110.871 -179.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.98 -46.93 12.3 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 111.552 -0.619 . . . . 1.98 111.552 175.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 106.88 29.32 4.68 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.966 -0.635 . . . . 1.66 113.848 175.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.838 ' HG3' ' HG2' ' A' ' 113' ' ' GLU . 4.3 pm0 -132.23 -18.23 2.6 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 122.448 -0.442 . . . . 1.74 111.187 173.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.558 ' HB2' ' NE2' ' A' ' 78' ' ' GLN . 4.2 mm-40 -61.45 150.61 80.08 Favored Pre-proline 0 C--N 1.315 -0.907 0 CA-C-N 115.26 -0.882 . . . . 3.07 112.221 -163.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 110' ' ' VAL . 53.1 Cg_endo -71.55 134.49 24.39 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 123.784 2.989 . . . . 1.75 114.871 -161.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 77.11 -85.96 1.0 Allowed Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.021 -0.99 . . . . 2.27 113.186 173.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.62 ' HB3' ' CB ' ' A' ' 89' ' ' GLU . 18.1 m120 -85.62 52.3 2.42 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.892 0.377 . . . . 4.88 111.319 -171.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.602 ' HA ' ' NE2' ' A' ' 78' ' ' GLN . 34.4 tt0 -57.74 -50.37 73.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.983 -0.553 . . . . 3.02 111.165 -178.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.466 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 39.3 mm-40 -77.43 -27.08 52.11 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.163 -0.471 . . . . 3.92 111.757 -178.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.62 ' CB ' ' HB3' ' A' ' 86' ' ' ASN . 10.6 tp10 -54.11 -61.61 2.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.659 -0.7 . . . . 2.65 111.978 -171.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.739 HG13 ' HG3' ' A' ' 78' ' ' GLN . 22.7 mm -73.88 -11.6 14.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.737 -0.665 . . . . 2.63 112.034 -167.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.466 ' HE2' ' HA ' ' A' ' 88' ' ' GLU . 49.9 mtmt -85.36 -42.11 14.86 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.375 -0.375 . . . . 3.13 111.026 -179.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -100.44 -24.21 14.55 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 111.742 0.275 . . . . 3.29 111.742 -176.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.401 ' HD2' ' O ' ' A' ' 89' ' ' GLU . 90.4 m-85 -89.74 162.62 15.46 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.82 -0.352 . . . . 4.08 110.166 177.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.4 t -81.24 111.21 17.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.933 -0.576 . . . . 3.05 110.178 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.687 ' SG ' ' HA ' ' A' ' 90' ' ' ILE . 1.2 m -139.71 121.8 15.75 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 121.48 0.657 . . . . 3.04 111.326 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.9 p -84.7 160.54 20.31 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 107.461 -1.311 . . . . 3.38 107.461 163.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -61.94 106.7 0.74 Allowed 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 107.884 -1.154 . . . . 3.11 107.884 174.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.74 ' HB3' ' HA ' ' A' ' 45' ' ' SER . 0.0 OUTLIER -45.93 117.07 1.38 Allowed 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 115.121 -0.945 . . . . 2.12 110.548 -173.237 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.414 ' HA ' HD13 ' A' ' 104' ' ' ILE . 35.1 ttmt -108.98 146.58 33.65 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.749 -0.659 . . . . 3.1 109.637 178.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.483 ' N ' HD13 ' A' ' 104' ' ' ILE . . . -147.71 -165.58 2.29 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-O 121.048 0.451 . . . . 1.15 111.386 -172.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -91.6 26.52 2.3 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.435 -0.802 . . . . 1.99 110.437 176.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.559 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 25.9 p90 -146.76 155.76 48.29 Favored Pre-proline 0 N--CA 1.441 -0.886 0 N-CA-C 108.712 -0.847 . . . . 1.31 108.712 175.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.619 ' HG2' ' HA ' ' A' ' 72' ' ' LEU . 35.9 Cg_endo -60.25 88.97 0.08 OUTLIER 'Trans proline' 0 CA--C 1.513 -0.53 0 C-N-CA 124.638 3.559 . . . . 1.07 114.137 -171.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.671 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 18.3 mt -100.6 126.78 54.16 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.348 0 N-CA-C 107.631 -1.248 . . . . 1.97 107.631 174.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.898 ' HB3' ' O ' ' A' ' 21' ' ' LEU . 13.4 mmt -103.02 -159.82 0.75 Allowed 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.211 -0.904 . . . . 3.41 113.176 -158.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.678 ' HB2' ' CD2' ' A' ' 25' ' ' HIS . . . -65.81 -3.58 5.23 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.074 -0.966 . . . . 1.46 112.65 -172.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.913 ' HB3' ' HG2' ' A' ' 75' ' ' PRO . 14.3 ptpt 58.47 129.06 0.01 OUTLIER 'General case' 0 CA--C 1.494 -1.201 0 CA-C-O 122.889 1.328 . . . . 2.31 110.38 -168.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.49 HD13 ' CE2' ' A' ' 119' ' ' TYR . 1.7 pp -138.1 167.92 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.657 0 CA-C-N 114.05 -1.432 . . . . 1.65 108.382 173.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.542 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 0.2 OUTLIER -46.27 110.67 0.29 Allowed 'General case' 0 C--N 1.296 -1.732 0 O-C-N 124.393 1.058 . . . . 1.73 110.006 171.584 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.497 ' CB ' ' HB3' ' A' ' 42' ' ' ASN . 5.5 m -117.77 91.45 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.135 0 N-CA-C 107.271 -1.381 . . . . 1.4 107.271 163.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.683 ' ND2' ' H ' ' A' ' 112' ' ' GLY . 3.9 t30 177.13 -178.13 0.17 Allowed 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.188 -1.369 . . . . 2.1 109.225 -174.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.683 ' H ' ' ND2' ' A' ' 111' ' ' ASN . . . -77.45 3.23 59.86 Favored Glycine 0 N--CA 1.43 -1.727 0 N-CA-C 118.24 2.056 . . . . 1.47 118.24 -163.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.838 ' HG2' ' HG3' ' A' ' 82' ' ' GLN . 7.8 pt-20 -105.78 -43.99 4.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 121.233 2.517 . . . . 2.81 113.315 -175.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -128.0 -32.78 2.27 Favored 'General case' 0 CA--C 1.5 -0.976 0 C-N-CA 119.979 -0.688 . . . . 2.75 109.16 177.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 1.051 ' HB3' ' HG2' ' A' ' 120' ' ' GLU . . . 42.81 -144.95 0.08 Allowed 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 114.409 -1.269 . . . . 1.44 108.931 -167.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.646 ' ND1' ' H ' ' A' ' 118' ' ' LEU . 2.7 t-80 -136.73 138.48 26.4 Favored Pre-proline 0 N--CA 1.424 -1.732 0 N-CA-C 106.5 -1.667 . . . . 0.71 106.5 169.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -26.82 -48.12 0.08 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 124.456 3.437 . . . . 0.47 113.537 178.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.756 HD12 ' HB ' ' A' ' 15' ' ' ILE . 48.3 tp -60.15 -52.74 64.02 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.364 0.665 . . . . 1.15 112.288 177.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 1.036 ' HH ' HG22 ' A' ' 40' ' ' ILE . 70.2 m-85 -77.28 -35.12 55.45 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-N 116.663 -0.244 . . . . 3.33 111.511 -178.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 1.051 ' HG2' ' HB3' ' A' ' 115' ' ' ALA . 7.0 mm-40 -56.79 -36.1 69.49 Favored 'General case' 0 CA--C 1.491 -1.319 0 N-CA-C 107.803 -1.184 . . . . 2.44 107.803 170.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.741 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 60.8 t80 -69.86 -31.89 69.96 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 119.252 -0.979 . . . . 1.08 110.403 174.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.644 ' HE2' HD13 ' A' ' 40' ' ' ILE . 1.1 ttm -76.63 -55.06 5.85 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.551 -0.295 . . . . 1.25 111.244 -170.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.426 ' HE2' ' HB2' ' A' ' 123' ' ' LYS . 0.4 OUTLIER -69.29 -24.77 64.0 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.337 -0.392 . . . . 1.86 110.551 178.913 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.494 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 12.8 pttp -72.41 -28.64 63.11 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 119.384 -0.926 . . . . 2.52 109.696 175.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.445 ' HB ' ' HG2' ' A' ' 150' ' ' PRO . 97.4 m -76.57 -57.08 4.06 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.974 -0.557 . . . . 1.21 111.053 178.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.536 ' HG2' ' H ' ' A' ' 128' ' ' GLY . 71.6 tttt -143.08 128.54 10.08 Favored Pre-proline 0 N--CA 1.453 -0.319 0 CA-C-O 121.29 0.567 . . . . 2.38 112.005 -177.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.691 ' HA ' ' NH2' ' A' ' 153' ' ' ARG . 2.8 Cg_exo -76.87 10.63 2.24 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 123.237 2.625 . . . . 1.69 111.811 172.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.536 ' H ' ' HG2' ' A' ' 126' ' ' LYS . . . 84.37 -133.4 11.81 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.88 -0.676 . . . . 2.59 112.18 178.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 22.3 pt -92.18 -9.79 9.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 120.955 0.407 . . . . 3.93 110.983 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.404 ' HG ' ' OG1' ' A' ' 132' ' ' THR . 49.4 tp -132.27 113.76 13.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.884 -0.598 . . . . 3.81 109.741 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.673 ' HA ' ' HB2' ' A' ' 127' ' ' PRO . . . -76.6 69.32 3.0 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.975 -0.557 . . . . 3.63 111.389 -174.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' THR . . . . . 0.404 ' OG1' ' HG ' ' A' ' 130' ' ' LEU . 28.8 m -102.2 -74.28 0.63 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.707 -0.679 . . . . 3.97 111.284 179.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.446 ' HB3' ' H ' ' A' ' 134' ' ' ALA . 20.6 tptm -164.58 -98.96 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.98 0.419 . . . . 5.48 110.944 -178.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.531 ' HB3' HD13 ' A' ' 135' ' ' ILE . . . -100.62 177.22 5.07 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.342 -0.39 . . . . 1.59 110.646 -176.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.779 ' H ' HD13 ' A' ' 135' ' ' ILE . 0.1 OUTLIER -42.72 -42.46 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 O-C-N 123.95 0.781 . . . . 2.09 111.53 178.532 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.681 ' HB3' ' CE3' ' A' ' 137' ' ' TRP . 76.7 tttt 73.62 -9.22 1.23 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.939 0.895 . . . . 5.16 112.88 168.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.894 ' HB3' ' HG3' ' A' ' 156' ' ' PRO . 9.7 m-90 -133.64 175.2 9.65 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.961 0.41 . . . . 2.41 111.441 -175.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.473 ' OD1' ' HD1' ' A' ' 139' ' ' PHE . 5.2 t-20 -38.96 -153.13 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 125.727 1.611 . . . . 2.04 111.565 157.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.732 ' CD1' HG23 ' A' ' 43' ' ' VAL . 2.4 m-85 -25.59 -52.18 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 115.461 1.652 . . . . 2.53 115.461 -169.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.624 ' HA ' ' O ' ' A' ' 154' ' ' PHE . 1.9 m 32.67 106.0 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.422 1.268 . . . . 1.24 114.422 175.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.411 ' HB3' HD11 ' A' ' 39' ' ' LEU . 2.8 m -92.58 174.04 7.48 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 114.084 -1.416 . . . . 1.03 111.393 -169.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.536 ' CD1' ' HB2' ' A' ' 153' ' ' ARG . 57.6 m-85 -138.64 123.01 18.29 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 105.985 -1.858 . . . . 0.7 105.985 165.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.894 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 2.9 tp -79.64 104.06 9.97 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 118.345 -1.342 . . . . 1.16 108.48 -179.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.727 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 40.2 mm -91.57 140.45 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.96 0 CA-C-N 113.647 -1.615 . . . . 1.05 107.873 -178.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.404 ' HA ' HD11 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -94.64 -172.26 2.7 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 120.062 -0.655 . . . . 0.98 111.515 -169.588 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.735 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 17.1 mtm180 -55.8 -36.77 67.78 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 123.168 0.293 . . . . 2.61 111.28 -176.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.535 ' O ' ' HB3' ' A' ' 14' ' ' SER . 34.8 t70 -102.2 23.22 11.98 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.33 -0.618 . . . . 2.0 109.33 -178.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.673 ' HA2' HG22 ' A' ' 144' ' ' ILE . . . 67.12 38.69 92.43 Favored Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 120.863 -0.684 . . . . 0.19 114.305 177.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 42.7 t -104.7 128.37 26.99 Favored Pre-proline 0 C--N 1.313 -0.979 0 CA-C-N 118.187 0.993 . . . . 1.74 110.618 173.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.463 ' HA ' HD11 ' A' ' 144' ' ' ILE . 1.3 Cg_endo -71.12 118.85 5.9 Favored 'Trans proline' 0 CA--C 1.531 0.335 0 C-N-CA 122.662 2.241 . . . . 0.6 110.814 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.458 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 14.2 t -119.71 -7.0 11.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.825 -0.435 . . . . 2.06 109.825 -175.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.894 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 6.0 mm-40 -155.14 168.13 28.06 Favored 'General case' 0 CA--C 1.5 -0.948 0 CA-C-O 121.52 0.676 . . . . 1.17 111.007 176.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.691 ' NH2' ' HA ' ' A' ' 127' ' ' PRO . 1.4 ttm180 -147.91 132.99 18.24 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 113.851 -1.522 . . . . 2.9 108.726 164.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.624 ' O ' ' HA ' ' A' ' 140' ' ' THR . 96.7 m-85 -114.27 146.72 40.08 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.678 -0.692 . . . . 0.36 109.338 -168.018 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 15.8 m -65.1 150.14 95.85 Favored Pre-proline 0 C--N 1.313 -1.014 0 N-CA-C 109.001 -0.74 . . . . 1.45 109.001 175.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.894 ' HG3' ' HB3' ' A' ' 137' ' ' TRP . 38.5 Cg_endo -66.39 -16.31 50.91 Favored 'Trans proline' 0 CA--C 1.514 -0.519 0 C-N-CA 122.57 2.18 . . . . 0.78 110.974 177.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.691 ' HA2' ' O ' ' A' ' 51' ' ' LYS . . . -88.31 2.07 84.83 Favored Glycine 0 N--CA 1.439 -1.158 0 CA-C-N 114.473 -1.239 . . . . 0.59 112.72 173.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -76.46 153.07 35.9 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.272 -0.64 . . . . 1.07 109.272 173.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.568 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 24.4 m -112.31 169.64 8.73 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 116.3 -0.409 . . . . 1.92 110.245 -175.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.655 ' CG2' ' HA ' ' A' ' 56' ' ' THR . 88.7 t -40.9 -52.53 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 O-C-N 124.363 1.039 . . . . 1.07 111.788 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 52.3 tttm -66.4 -32.99 74.71 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.031 -0.531 . . . . 3.89 111.166 -173.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -69.99 -31.45 69.15 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.859 -0.61 . . . . 1.4 109.847 -176.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.777 ' CD1' ' HH ' ' A' ' 41' ' ' TYR . 70.1 mt -83.89 -43.24 17.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 115.184 -0.916 . . . . 1.05 110.954 176.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.568 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 35.0 mt-10 -53.05 -42.94 66.25 Favored 'General case' 0 C--O 1.216 -0.668 0 N-CA-C 111.723 0.268 . . . . 0.67 111.723 -177.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -54.88 -29.01 54.64 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 112.254 0.464 . . . . 0.87 112.254 -177.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.759 ' HB3' HD22 ' A' ' 143' ' ' LEU . 35.8 mmtm -94.68 -20.84 19.2 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.651 0.739 . . . . 2.22 110.103 177.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.568 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 14.1 tp -86.46 -49.34 7.67 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.617 -1.174 . . . . 1.04 112.413 -174.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.502 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 78.0 mt -55.66 -47.47 98.61 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.385 -0.825 . . . . 1.08 112.557 -172.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.502 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 76.5 Cg_exo -53.54 -28.53 45.81 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 122.356 2.037 . . . . 0.62 112.756 174.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.829 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 80.1 mt -86.23 -47.1 9.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.357 -0.383 . . . . 1.36 111.14 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.733 HD22 ' HG2' ' A' ' 37' ' ' PRO . 84.9 mt -57.45 -57.86 10.82 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-O 122.113 0.959 . . . . 1.07 109.781 176.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -66.15 -21.08 69.71 Favored Glycine 0 N--CA 1.435 -1.393 0 CA-C-N 113.36 -1.745 . . . . 1.12 112.214 -178.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 40.9 m 62.97 68.53 0.63 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.457 0.646 . . . . 2.88 110.604 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -76.35 -6.66 52.57 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.333 -0.848 . . . . 4.69 110.442 177.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 29.7 ttp180 -143.0 122.51 13.2 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.392 -0.822 . . . . 9.17 109.0 176.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.5 mm? . . . . . 0 C--O 1.246 0.916 0 CA-C-O 118.312 -0.851 . . . . 8.03 109.806 179.619 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.879 0 N-CA-C 112.483 -0.247 . . . . 5.58 112.483 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -134.16 177.7 7.54 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.082 -0.34 . . . . 5.23 110.082 178.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.67 88.56 1.83 Allowed Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.887 -0.673 . . . . 1.55 112.153 -178.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.8 p -121.67 14.32 10.94 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.307 0.575 . . . . 2.17 110.086 177.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 79.7 p 177.12 153.7 0.23 Allowed 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 105.842 -1.911 . . . . 1.68 105.842 -178.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.838 ' HB ' ' CD1' ' A' ' 118' ' ' LEU . 5.8 pt -69.26 -12.39 15.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 CA-C-N 115.063 -0.972 . . . . 1.16 112.133 -170.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.658 ' CD1' ' HA ' ' A' ' 31' ' ' VAL . 48.0 m-85 -74.83 -8.2 55.74 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 120.752 0.31 . . . . 0.3 111.184 -178.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -63.24 -21.13 66.03 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 108.91 -0.774 . . . . 2.11 108.91 170.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.823 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 60.8 m-85 -117.63 105.35 11.95 Favored 'General case' 0 CA--C 1.49 -1.341 0 CA-C-N 114.614 -1.175 . . . . 0.37 110.253 176.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -58.25 158.95 6.51 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 114.88 -1.054 . . . . 2.86 108.165 172.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.759 HG13 ' HZ ' ' A' ' 74' ' ' PHE . 20.3 t -108.33 169.28 3.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 107.393 -1.336 . . . . 1.32 107.393 -175.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.781 ' O ' ' HB2' ' A' ' 105' ' ' MET . 33.0 mt -127.21 141.52 51.71 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 109.534 -0.543 . . . . 1.29 109.534 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -71.21 -173.55 0.87 Allowed 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.24 -1.022 . . . . 1.87 108.24 174.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.748 ' HA ' ' CA ' ' A' ' 106' ' ' ALA . . . -66.93 -3.05 6.08 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 112.494 0.553 . . . . 1.2 112.494 -176.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.453 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 29.1 t70 -102.84 -3.25 26.55 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.803 -0.359 . . . . 2.34 110.832 176.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.631 ' CD2' ' HB1' ' A' ' 106' ' ' ALA . 1.9 m170 75.72 20.94 1.75 Allowed 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.741 0.781 . . . . 2.26 109.417 -178.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.443 ' HA ' ' HD3' ' A' ' 26' ' ' LYS . 45.9 mmtt -102.15 135.46 19.64 Favored Pre-proline 0 N--CA 1.443 -0.804 0 CA-C-N 114.397 -1.274 . . . . 4.64 108.45 171.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.639 ' HA ' HD23 ' A' ' 21' ' ' LEU . 84.7 Cg_exo -47.21 115.29 1.27 Allowed 'Trans proline' 0 C--N 1.335 -0.178 0 C-N-CA 123.341 2.694 . . . . 0.62 115.361 -165.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 1.028 ' HH ' ' HB3' ' A' ' 103' ' ' PRO . 0.2 OUTLIER -78.0 142.94 37.94 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 112.947 -1.933 . . . . 1.52 108.977 164.928 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.524 ' N ' ' HD1' ' A' ' 28' ' ' TYR . 2.7 t-20 -79.72 86.24 5.33 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.537 -0.542 . . . . 2.16 109.537 178.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.652 HD22 HD12 ' A' ' 15' ' ' ILE . 68.2 tp -67.61 -42.47 82.35 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.576 0.703 . . . . 1.07 110.01 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.658 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 1.6 m -69.56 -0.61 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.398 -1.274 . . . . 1.69 112.855 -167.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.523 ' HB3' ' OD1' ' A' ' 29' ' ' ASN . 10.2 pt20 -75.03 -11.32 60.07 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.541 0.686 . . . . 1.31 109.289 174.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.945 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 91.0 m-70 -95.83 22.53 7.22 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 115.315 -0.857 . . . . 0.35 109.495 176.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.526 ' CE ' ' HB ' ' A' ' 31' ' ' VAL . 45.6 mttm -77.77 126.86 31.5 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 114.475 -1.239 . . . . 2.07 108.382 167.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.22 -44.81 1.42 Allowed Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 120.295 -0.955 . . . . 0.24 111.926 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.546 ' HB2' ' HA3' ' A' ' 68' ' ' GLY . 21.6 m -127.07 133.57 25.19 Favored Pre-proline 0 N--CA 1.435 -1.203 0 N-CA-C 108.9 -0.778 . . . . 0.74 108.9 174.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.77 ' HG3' ' CB ' ' A' ' 170' ' ' LEU . 6.1 Cg_endo -43.88 152.83 0.32 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 124.086 3.191 . . . . 0.22 112.891 177.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.84 HD11 ' HB2' ' A' ' 33' ' ' HIS . 0.8 OUTLIER -139.02 152.97 48.04 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 106.375 -1.713 . . . . 1.09 106.375 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.944 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 2.8 mp -120.59 128.19 52.81 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.776 -0.578 . . . . 1.82 109.546 177.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.812 HD13 ' HE3' ' A' ' 122' ' ' MET . 1.0 OUTLIER -109.89 125.11 67.09 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-N 115.248 -0.887 . . . . 1.12 109.92 179.304 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.944 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.6 OUTLIER -110.62 124.94 52.83 Favored 'General case' 0 C--O 1.215 -0.729 0 CA-C-N 115.674 -0.693 . . . . 1.09 110.971 -172.031 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.665 ' HB3' HG21 ' A' ' 135' ' ' ILE . 0.7 OUTLIER -77.83 121.96 24.8 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 105.726 -1.953 . . . . 3.11 105.726 165.177 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.85 HG11 ' HB2' ' A' ' 73' ' ' ALA . 1.5 p -130.24 140.01 49.95 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 C-N-CA 119.158 -1.017 . . . . 1.69 113.109 -164.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.45 ' HB3' ' HG ' ' A' ' 47' ' ' CYS . . . -75.91 102.61 5.63 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.742 -0.663 . . . . 1.45 109.504 173.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.54 ' OG ' ' HB2' ' A' ' 75' ' ' PRO . 1.1 m -46.78 77.17 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 113.436 -1.711 . . . . 1.99 114.392 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt 46.89 50.84 13.26 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.872 0.844 . . . . 6.2 110.769 177.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.73 ' SG ' HG22 ' A' ' 90' ' ' ILE . 23.6 p -150.35 141.96 23.56 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.232 -0.895 . . . . 4.12 109.93 -177.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.34 -111.64 3.9 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.863 -0.684 . . . . 3.44 112.782 176.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -112.57 126.52 55.43 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.628 0.728 . . . . 4.84 112.339 -174.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.3 p -75.06 -33.03 61.66 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.823 -1.08 . . . . 2.41 109.931 174.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.736 ' O ' ' HA2' ' A' ' 157' ' ' GLY . 28.2 mmmt 54.41 16.59 1.31 Allowed 'General case' 0 C--N 1.345 0.401 0 C-N-CA 124.726 1.21 . . . . 2.47 113.133 -179.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.94 -11.83 59.1 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.275 -0.964 . . . . 0.85 112.097 -177.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -47.19 -40.83 14.63 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 112.115 -0.394 . . . . 0.67 112.115 177.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.568 ' CZ ' ' HD2' ' A' ' 98' ' ' PHE . 0.1 OUTLIER -57.0 -62.09 1.99 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.754 0.312 . . . . 1.2 110.407 -178.76 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.0 mp0 -59.55 -34.2 72.38 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.716 -0.675 . . . . 2.61 111.539 -178.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.649 ' HA ' HG22 ' A' ' 160' ' ' VAL . 97.0 m -68.47 -58.39 4.4 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.598 -0.728 . . . . 1.06 109.211 -176.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 1.067 ' HB2' HG11 ' A' ' 71' ' ' VAL . . . -59.5 -42.75 92.9 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.526 -1.216 . . . . 1.05 111.157 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.512 ' HA ' ' HD1' ' A' ' 102' ' ' PHE . 60.4 m -58.83 -56.86 16.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.86 -0.609 . . . . 1.08 110.923 -177.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 26.6 m -68.34 -35.36 77.65 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.417 -0.811 . . . . 1.22 111.344 -175.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.811 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 20.3 mt -65.61 -50.69 64.13 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-O 121.311 0.577 . . . . 1.14 110.432 -176.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.916 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 6.7 t80 -55.16 -51.89 65.03 Favored 'General case' 0 C--O 1.205 -1.268 0 CA-C-N 114.814 -1.085 . . . . 0.94 110.969 178.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -73.71 -24.49 59.93 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 116.488 -0.324 . . . . 1.6 110.961 -170.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.519 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 34.9 ttpt -85.84 -23.5 27.11 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 109.039 -0.726 . . . . 2.06 109.039 -178.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.579 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 28.2 m-85 -124.86 -3.72 7.65 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 115.504 1.668 . . . . 0.92 115.504 -170.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.664 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 40.5 pttt -67.58 -26.23 66.17 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 107.897 -1.149 . . . . 1.89 107.897 170.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.3 m -49.23 -28.24 4.42 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 113.854 -1.521 . . . . 1.68 111.294 172.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -99.18 -34.54 10.32 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.496 0.189 . . . . 1.11 111.481 173.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.546 ' HA3' ' HB2' ' A' ' 36' ' ' SER . . . 150.95 -6.06 0.6 Allowed Glycine 0 CA--C 1.521 0.408 0 N-CA-C 111.863 -0.495 . . . . 0.2 111.863 -177.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.811 ' HE2' ' HB3' ' A' ' 60' ' ' LEU . 19.3 t80 -71.15 143.13 50.66 Favored 'General case' 0 C--O 1.218 -0.598 0 C-N-CA 122.705 0.402 . . . . 0.21 111.605 -176.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.945 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 4.8 t -134.65 153.99 51.73 Favored 'General case' 0 CA--C 1.483 -1.606 0 N-CA-C 108.354 -0.98 . . . . 1.02 108.354 172.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 1.067 HG11 ' HB2' ' A' ' 57' ' ' ALA . 42.7 t -113.27 99.86 9.51 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.407 0 N-CA-C 108.586 -0.894 . . . . 1.04 108.586 160.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.741 ' HA ' ' HG2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -94.73 120.47 35.0 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 118.498 -1.281 . . . . 1.69 107.735 174.423 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.952 ' HB3' HD13 ' A' ' 104' ' ' ILE . . . -109.53 127.39 54.43 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.915 0.864 . . . . 1.17 111.085 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.785 ' CG ' ' HG2' ' A' ' 105' ' ' MET . 5.8 m-30 -102.92 106.95 53.12 Favored Pre-proline 0 C--N 1.313 -1.009 0 CA-C-N 114.565 -1.198 . . . . 0.58 108.806 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.719 ' O ' ' HB2' ' A' ' 107' ' ' LYS . 65.2 Cg_endo -77.21 93.13 1.09 Allowed 'Trans proline' 0 C--O 1.221 -0.334 0 C-N-CA 122.474 2.116 . . . . 1.3 113.4 -168.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.662 ' HB3' ' OD1' ' A' ' 42' ' ' ASN . 70.6 p -43.1 145.51 0.51 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.633 -1.167 . . . . 1.91 114.042 -167.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.471 ' OD1' ' HB2' ' A' ' 79' ' ' PHE . 43.5 t-20 -92.56 119.06 31.65 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 114.608 -1.178 . . . . 1.93 109.918 -176.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.858 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . 3.7 pp0? -77.84 -12.67 60.0 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.618 -0.719 . . . . 3.97 111.89 -177.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.471 ' HB2' ' OD1' ' A' ' 77' ' ' ASN . 25.3 m-85 -70.59 29.48 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.069 0.766 . . . . 3.21 113.069 -174.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.513 ' HA3' HE22 ' A' ' 82' ' ' GLN . . . -142.98 174.86 23.44 Favored Glycine 0 N--CA 1.439 -1.141 0 N-CA-C 110.621 -0.991 . . . . 1.98 110.621 177.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -100.99 55.12 0.8 Allowed Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.136 -1.031 . . . . 1.66 112.369 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.541 ' HG3' ' HG2' ' A' ' 113' ' ' GLU . 0.4 OUTLIER -173.74 26.01 0.01 OUTLIER 'General case' 0 C--O 1.215 -0.752 0 N-CA-C 112.174 0.435 . . . . 1.74 112.174 -178.879 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.763 ' HG2' ' HA ' ' A' ' 78' ' ' GLN . 0.0 OUTLIER -81.97 142.09 47.92 Favored Pre-proline 0 C--N 1.318 -0.804 0 C-N-CA 119.358 -0.937 . . . . 3.07 110.823 -178.774 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.493 ' HG2' HD22 ' A' ' 42' ' ' ASN . 89.7 Cg_endo -83.77 6.25 5.89 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.263 2.642 . . . . 1.75 113.598 -170.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.78 -55.39 14.45 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 110.315 -1.114 . . . . 2.27 110.315 175.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -178.15 8.88 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.817 -0.691 . . . . 4.88 109.573 174.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.457 ' OE1' ' HG3' ' A' ' 83' ' ' GLU . 1.1 mm-40 59.32 32.24 21.74 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 115.727 -0.67 . . . . 3.02 111.106 -174.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -177.83 -39.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.39 -0.823 . . . . 3.92 109.835 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -50.18 -54.3 21.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.252 -0.885 . . . . 2.65 112.081 -177.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.858 ' HB ' ' HB3' ' A' ' 78' ' ' GLN . 23.3 mt -74.14 -19.71 17.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.203 -0.453 . . . . 2.63 111.152 -174.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.456 ' HG2' ' HB2' ' A' ' 78' ' ' GLN . 24.0 mttm -79.82 -45.56 18.51 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.332 0.587 . . . . 3.13 109.751 178.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -80.62 -13.58 58.92 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.017 -0.992 . . . . 3.29 110.901 -173.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.483 ' HB3' ' HB2' ' A' ' 47' ' ' CYS . 4.3 t80 -112.01 149.15 32.42 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.354 -0.61 . . . . 4.08 109.354 177.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.9 p -63.34 112.27 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.47 0.652 . . . . 3.05 110.96 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 3.9 p -101.11 127.37 47.69 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.535 0.683 . . . . 3.04 111.116 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.9 m -150.76 145.06 25.51 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 107.699 -1.223 . . . . 3.38 107.699 174.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.43 ' O ' ' HG3' ' A' ' 99' ' ' LYS . 18.5 pttp -54.37 110.76 0.66 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.824 -0.806 . . . . 3.11 108.824 177.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.797 ' CE2' ' HB1' ' A' ' 100' ' ' ALA . 24.7 p90 -63.56 -26.05 68.52 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.796 -1.093 . . . . 2.12 111.864 -163.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 97' ' ' LYS . 56.1 mtmt 60.39 111.15 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.74 0.781 . . . . 3.1 111.747 177.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.797 ' HB1' ' CE2' ' A' ' 98' ' ' PHE . . . -127.28 -168.63 1.91 Allowed 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.498 -0.774 . . . . 1.15 111.528 -172.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -86.04 24.25 1.34 Allowed 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.123 -0.944 . . . . 1.99 110.068 172.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.609 ' HB2' ' O ' ' A' ' 71' ' ' VAL . 26.1 p90 -147.69 156.07 44.95 Favored Pre-proline 0 N--CA 1.446 -0.673 0 N-CA-C 109.048 -0.723 . . . . 1.31 109.048 176.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 1.028 ' HB3' ' HH ' ' A' ' 28' ' ' TYR . 14.0 Cg_endo -54.13 101.81 0.08 OUTLIER 'Trans proline' 0 N--CA 1.479 0.639 0 C-N-CA 124.838 3.692 . . . . 1.07 114.97 -172.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.952 HD13 ' HB3' ' A' ' 73' ' ' ALA . 4.8 mm -101.84 122.15 53.7 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 N-CA-C 108.724 -0.843 . . . . 1.97 108.724 173.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.785 ' HG2' ' CG ' ' A' ' 74' ' ' PHE . 0.3 OUTLIER -81.61 -171.21 3.2 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.767 -0.651 . . . . 3.41 110.474 -176.005 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.748 ' CA ' ' HA ' ' A' ' 23' ' ' ALA . . . -66.49 -23.04 66.2 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 121.024 -0.271 . . . . 1.46 110.949 -177.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.719 ' HB2' ' O ' ' A' ' 75' ' ' PRO . 4.9 ptpp? 94.42 139.19 0.02 OUTLIER 'General case' 0 CA--C 1.493 -1.227 0 O-C-N 125.8 1.937 . . . . 2.31 109.13 -167.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.813 HG13 ' HB2' ' A' ' 116' ' ' HIS . 0.2 OUTLIER -130.87 176.7 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.099 0 N-CA-C 106.284 -1.747 . . . . 1.65 106.284 166.808 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.614 ' HB3' ' HB3' ' A' ' 114' ' ' ASN . 2.9 t-20 -82.55 68.66 9.09 Favored 'General case' 0 C--N 1.293 -1.886 0 C-N-CA 120.299 -0.56 . . . . 1.73 110.156 -178.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.508 ' HB ' ' OD1' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -65.37 96.3 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 CA-C-N 115.54 -0.755 . . . . 1.4 110.434 -176.192 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.436 ' O ' ' HB3' ' A' ' 115' ' ' ALA . 5.5 t-20 177.51 -176.71 0.17 Allowed 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.118 -0.946 . . . . 2.1 108.681 171.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.675 ' HA2' ' HE3' ' A' ' 123' ' ' LYS . . . -41.26 -37.94 1.76 Allowed Glycine 0 CA--C 1.529 0.925 0 N-CA-C 117.517 1.767 . . . . 1.47 117.517 -172.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.541 ' HG2' ' HG3' ' A' ' 82' ' ' GLN . 14.8 mm-40 -103.59 -43.62 5.32 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.312 1.556 . . . . 2.81 113.525 -164.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.614 ' HB3' ' HB3' ' A' ' 109' ' ' ASN . 3.0 t30 -128.58 26.97 5.58 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 119.354 -0.938 . . . . 2.75 109.297 -166.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 111' ' ' ASN . . . -60.96 168.83 2.21 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 114.892 -1.049 . . . . 1.44 109.276 175.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.813 ' HB2' HG13 ' A' ' 108' ' ' ILE . 7.8 t-80 -90.26 142.94 28.86 Favored Pre-proline 0 N--CA 1.424 -1.756 0 CA-C-O 118.003 -0.999 . . . . 0.71 108.698 -171.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -29.3 -41.77 0.07 OUTLIER 'Trans proline' 0 CA--C 1.535 0.525 0 C-N-CA 124.247 3.298 . . . . 0.47 113.323 179.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.838 ' CD1' ' HB ' ' A' ' 15' ' ' ILE . 22.1 tp -65.59 -50.94 63.24 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 123.435 0.694 . . . . 1.15 111.928 177.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.564 ' HA ' ' HB2' ' A' ' 122' ' ' MET . 48.0 m-85 -75.91 -33.45 59.9 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 111.678 0.251 . . . . 3.33 111.678 176.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.47 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 21.9 mm-40 -58.38 -33.41 69.58 Favored 'General case' 0 CA--C 1.498 -1.037 0 N-CA-C 107.807 -1.183 . . . . 2.44 107.807 168.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.823 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 76.0 t80 -71.91 -31.08 66.03 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 119.581 -0.847 . . . . 1.08 110.682 171.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.812 ' HE3' HD13 ' A' ' 40' ' ' ILE . 49.1 mtt -74.65 -51.62 13.93 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 120.403 -0.519 . . . . 1.25 110.595 -170.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.995 ' HD2' ' HB2' ' A' ' 134' ' ' ALA . 0.1 OUTLIER -70.8 -25.89 63.07 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.936 -0.574 . . . . 1.86 111.192 176.734 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.568 ' HG2' ' HA ' ' A' ' 121' ' ' TYR . 10.0 ptmm? -70.02 -27.16 64.45 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 119.584 -0.847 . . . . 2.52 109.516 176.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 62.6 m -85.22 -56.99 3.26 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.495 -0.775 . . . . 1.21 110.839 178.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.537 ' HG2' HH22 ' A' ' 153' ' ' ARG . 20.7 ttmm -133.9 112.64 12.5 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 109.819 -0.437 . . . . 2.38 109.819 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 126' ' ' LYS . 39.0 Cg_exo -61.01 -79.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 123.922 3.081 . . . . 1.69 113.389 -172.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.527 ' HA2' ' CZ ' ' A' ' 153' ' ' ARG . . . -158.07 13.28 0.25 Allowed Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 119.518 -1.325 . . . . 2.59 113.549 -178.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.987 HG12 HH12 ' A' ' 153' ' ' ARG . 48.8 mm 71.39 -42.48 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-O 121.584 0.707 . . . . 3.93 109.586 -173.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.478 ' HG ' ' H ' ' A' ' 131' ' ' ALA . 24.4 tp -94.8 174.0 7.32 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.74 -1.207 . . . . 3.81 107.74 170.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.478 ' H ' ' HG ' ' A' ' 130' ' ' LEU . . . -75.0 80.84 2.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.095 0.474 . . . . 3.63 110.887 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.9 m -157.44 159.22 37.1 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.062 -0.517 . . . . 3.97 109.665 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -97.25 141.06 30.82 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.697 0.284 . . . . 5.48 110.793 174.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.995 ' HB2' ' HD2' ' A' ' 123' ' ' LYS . . . 76.18 -167.34 0.07 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 113.818 1.044 . . . . 1.59 113.818 166.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.898 ' H ' HD12 ' A' ' 135' ' ' ILE . 0.1 OUTLIER -54.38 -25.73 14.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 114.393 -1.276 . . . . 2.09 112.091 179.124 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.675 ' HB3' ' CE3' ' A' ' 137' ' ' TRP . 7.7 mtmt 78.29 -64.47 0.27 Allowed 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.343 0.592 . . . . 5.16 111.67 -179.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.675 ' CE3' ' HB3' ' A' ' 136' ' ' LYS . 0.2 OUTLIER -104.97 177.97 4.7 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.909 -1.041 . . . . 2.41 111.671 -169.169 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.482 ' O ' ' N ' ' A' ' 140' ' ' THR . 8.5 m120 -37.04 -152.29 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 126.043 1.737 . . . . 2.04 112.685 158.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.738 ' HD1' ' HD2' ' A' ' 41' ' ' TYR . 0.2 OUTLIER -29.05 -22.54 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 116.76 2.134 . . . . 2.53 116.76 -171.411 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.713 ' HA ' ' O ' ' A' ' 154' ' ' PHE . 3.3 m -5.37 121.75 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 115.494 1.664 . . . . 1.24 115.494 168.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.457 ' CB ' HD23 ' A' ' 39' ' ' LEU . 0.7 OUTLIER -97.45 176.36 5.9 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.649 -1.16 . . . . 1.03 110.938 -177.661 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.621 ' HE1' HG22 ' A' ' 135' ' ' ILE . 23.7 m-85 -131.24 123.7 28.97 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 105.498 -2.038 . . . . 0.7 105.498 162.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.849 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 6.4 tp -79.87 104.33 10.38 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 118.075 -1.45 . . . . 1.16 108.289 178.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.701 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 45.8 mm -89.24 138.58 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.688 0 CA-C-N 112.722 -2.036 . . . . 1.05 107.586 -178.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.454 ' HA ' HD11 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -92.07 -174.83 3.9 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 119.282 -0.967 . . . . 0.98 110.939 -169.342 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.569 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 71.6 mtm180 -54.21 -38.88 66.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.98 0.419 . . . . 2.61 111.511 -177.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -95.91 15.56 20.1 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.31 -0.626 . . . . 2.0 109.31 -176.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.58 ' HA2' HG23 ' A' ' 144' ' ' ILE . . . 74.39 33.92 55.46 Favored Glycine 0 N--CA 1.442 -0.91 0 CA-C-N 115.821 -0.627 . . . . 0.19 114.499 -178.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.483 ' HA ' ' HD2' ' A' ' 150' ' ' PRO . 49.9 t -103.57 109.69 62.45 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-N 118.415 1.108 . . . . 1.74 111.633 176.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.794 ' HD3' HG21 ' A' ' 15' ' ' ILE . 6.5 Cg_endo -57.38 113.35 1.45 Allowed 'Trans proline' 0 CA--C 1.53 0.325 0 C-N-CA 123.715 2.943 . . . . 0.6 111.159 173.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.557 HG23 ' HG2' ' A' ' 152' ' ' GLU . 22.9 m -115.76 -16.86 8.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.331 0.586 . . . . 2.06 110.189 -177.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.849 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 53.9 mm-40 -139.61 167.48 22.01 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-N 115.376 -0.829 . . . . 1.17 110.088 178.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.987 HH12 HG12 ' A' ' 129' ' ' ILE . 0.0 OUTLIER -148.22 129.95 15.11 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 114.608 -1.178 . . . . 2.9 108.664 163.943 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.713 ' O ' ' HA ' ' A' ' 140' ' ' THR . 94.2 m-85 -108.68 137.06 47.23 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.951 -0.568 . . . . 0.36 109.879 -170.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 20.1 m -62.77 156.61 64.34 Favored Pre-proline 0 C--N 1.323 -0.556 0 N-CA-C 109.393 -0.595 . . . . 1.45 109.393 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.705 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 14.1 Cg_endo -56.72 -48.22 19.73 Favored 'Trans proline' 0 CA--C 1.527 0.167 0 C-N-CA 121.765 1.643 . . . . 0.78 111.462 -177.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.736 ' HA2' ' O ' ' A' ' 51' ' ' LYS . . . -55.64 -7.2 1.39 Allowed Glycine 0 CA--C 1.528 0.844 0 N-CA-C 115.692 1.037 . . . . 0.59 115.692 172.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -71.94 140.04 48.99 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 118.777 1.288 . . . . 1.07 109.256 176.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 22.2 t -103.69 170.26 8.04 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 109.629 -0.508 . . . . 1.92 109.629 -173.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.649 HG22 ' HA ' ' A' ' 56' ' ' THR . 60.5 t -41.14 -53.43 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 114.877 -1.056 . . . . 1.07 111.698 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 14.7 ttpp -63.58 -40.24 96.45 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.039 0.447 . . . . 3.89 111.104 -173.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -66.12 -30.43 70.92 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.432 -0.804 . . . . 1.4 109.795 -174.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.57 ' HA ' ' CE2' ' A' ' 154' ' ' PHE . 48.5 mt -82.77 -46.56 19.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.87 -1.059 . . . . 1.05 110.992 175.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.588 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 47.4 mt-10 -52.77 -43.33 65.74 Favored 'General case' 0 C--O 1.217 -0.626 0 O-C-N 123.314 0.384 . . . . 0.67 111.254 -175.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -55.51 -27.47 48.81 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.418 0.525 . . . . 0.87 112.418 -177.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.59 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 14.0 mmmm -97.98 -18.88 18.37 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.421 0.629 . . . . 2.22 109.938 176.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.561 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 12.4 tp -86.2 -49.14 7.95 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.029 -0.987 . . . . 1.04 112.142 -176.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 164' ' ' GLU . 81.0 mt -55.47 -44.7 99.78 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-N 115.501 -0.772 . . . . 1.08 112.799 -173.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.405 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 72.3 Cg_exo -51.96 -35.33 60.14 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 122.002 1.802 . . . . 0.62 112.375 173.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.77 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 96.6 mt -80.91 -44.25 18.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.358 -0.383 . . . . 1.36 111.378 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.66 HD23 ' HG2' ' A' ' 37' ' ' PRO . 90.9 mt -59.88 -59.28 5.68 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 122.028 0.918 . . . . 1.07 109.899 176.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -57.05 -36.9 76.39 Favored Glycine 0 N--CA 1.434 -1.434 0 CA-C-N 113.327 -1.76 . . . . 1.12 113.298 -177.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 36.9 t 68.5 9.49 7.32 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.866 0.467 . . . . 2.88 111.156 177.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -93.82 -16.68 23.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.479 -0.328 . . . . 4.69 111.413 -177.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 67.17 -80.07 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 O-C-N 123.86 0.725 . . . . 9.17 111.073 -176.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 44.0 tp . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.403 -0.808 . . . . 8.03 109.378 -178.494 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.583 0 N-CA-C 111.506 -0.637 . . . . 5.58 111.506 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -90.78 136.48 33.04 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.01 0.434 . . . . 5.23 109.869 178.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.67 37.52 5.5 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 111.043 -0.823 . . . . 1.55 111.043 -174.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.0 t -102.33 -2.56 28.73 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.079 0.466 . . . . 2.17 109.806 -177.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 99.5 p -168.49 177.07 5.44 Favored 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 107.48 -1.304 . . . . 1.68 107.48 -177.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.94 HD11 HD21 ' A' ' 30' ' ' LEU . 5.2 pt -83.7 -18.77 9.92 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 CA-C-N 114.863 -1.062 . . . . 1.16 109.817 176.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.733 ' CD1' ' HA ' ' A' ' 31' ' ' VAL . 48.4 m-85 -70.95 -5.78 33.54 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.255 0.55 . . . . 0.3 110.713 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -69.18 -18.22 63.89 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.201 -0.909 . . . . 2.11 108.665 172.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.748 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 61.1 m-85 -119.35 108.05 14.12 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-O 121.781 0.801 . . . . 0.37 111.509 -178.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -48.48 146.88 2.69 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 113.488 -1.687 . . . . 2.86 110.336 170.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.769 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 37.1 t -110.86 165.0 6.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 109.393 -0.595 . . . . 1.32 109.393 -175.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.814 ' O ' ' HB3' ' A' ' 105' ' ' MET . 97.1 mt -126.49 111.28 14.23 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-O 119.505 -0.283 . . . . 1.29 111.332 -176.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -53.9 161.84 1.08 Allowed 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 107.03 -1.47 . . . . 1.87 107.03 170.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.609 ' HA ' ' N ' ' A' ' 106' ' ' ALA . . . -57.02 -11.1 1.34 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 113.153 0.797 . . . . 1.2 113.153 -164.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 10.9 t70 -90.21 -4.18 57.38 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 122.386 0.274 . . . . 2.34 111.598 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.645 ' CD2' ' HB3' ' A' ' 106' ' ' ALA . 74.4 m-70 79.95 20.71 0.57 Allowed 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.93 0.872 . . . . 2.26 108.995 -177.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.435 ' HA ' ' HD3' ' A' ' 26' ' ' LYS . 11.3 mmtp -104.69 125.96 32.55 Favored Pre-proline 0 N--CA 1.441 -0.892 0 CA-C-N 114.344 -1.298 . . . . 4.64 108.398 175.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.645 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 80.3 Cg_exo -48.79 114.74 1.34 Allowed 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.995 2.463 . . . . 0.62 114.917 -168.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.867 ' HH ' ' HE2' ' A' ' 33' ' ' HIS . 8.8 t80 -83.8 128.3 34.44 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 113.589 -1.641 . . . . 1.52 109.313 164.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.423 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 1.7 p-10 -75.29 99.53 4.1 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 122.777 1.275 . . . . 2.16 110.143 176.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.94 HD21 HD11 ' A' ' 15' ' ' ILE . 61.7 tp -61.62 -32.82 72.97 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.507 -1.224 . . . . 1.07 110.591 178.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.733 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 3.7 m -63.77 -6.12 2.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 114.793 -1.094 . . . . 1.69 113.164 -169.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.423 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 9.7 pt20 -72.81 -7.88 52.85 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.006 -0.678 . . . . 1.31 109.737 177.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.917 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 90.1 m-70 -98.94 22.11 10.68 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.8 0.81 . . . . 0.35 109.866 176.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.499 ' HE2' ' HB ' ' A' ' 31' ' ' VAL . 62.2 mttm -78.75 122.09 25.58 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 114.683 -1.144 . . . . 2.07 109.156 169.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.05 -41.09 2.08 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.585 -0.817 . . . . 0.24 111.912 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.557 ' HB2' ' HA3' ' A' ' 68' ' ' GLY . 52.7 m -129.77 132.93 24.49 Favored Pre-proline 0 N--CA 1.437 -1.121 0 N-CA-C 108.839 -0.801 . . . . 0.74 108.839 173.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.78 ' HG3' ' CB ' ' A' ' 170' ' ' LEU . 4.2 Cg_endo -43.29 152.22 0.27 Allowed 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.951 3.1 . . . . 0.22 112.55 176.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.795 ' HB2' HG22 ' A' ' 70' ' ' THR . 0.7 OUTLIER -137.04 150.8 48.3 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.353 -1.721 . . . . 1.09 106.353 179.171 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.954 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 1.8 mp -116.26 122.61 45.49 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 121.419 0.628 . . . . 1.82 109.536 176.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 1.062 HG23 ' OH ' ' A' ' 119' ' ' TYR . 0.9 OUTLIER -102.51 123.6 55.93 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 CA-C-N 114.908 -1.042 . . . . 1.12 109.394 177.45 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.954 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.3 OUTLIER -109.25 129.7 55.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.31 -0.405 . . . . 1.09 110.569 -175.013 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.821 HD22 ' HE2' ' A' ' 142' ' ' PHE . 2.9 m-80 -78.89 93.13 4.98 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.213 -1.402 . . . . 3.11 107.213 169.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.665 HG12 ' CG ' ' A' ' 139' ' ' PHE . 34.9 m -104.31 145.67 12.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 C-N-CA 119.038 -1.065 . . . . 1.69 111.227 -170.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.671 ' O ' ' HG2' ' A' ' 46' ' ' LYS . . . -94.74 104.3 16.21 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 114.334 -1.303 . . . . 1.45 109.233 174.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.597 ' HA ' ' HB3' ' A' ' 98' ' ' PHE . 2.1 p -38.54 93.17 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.619 0 O-C-N 124.377 1.048 . . . . 1.99 111.469 168.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.671 ' HG2' ' O ' ' A' ' 44' ' ' ALA . 65.6 mmtt -102.8 153.29 20.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.839 -0.619 . . . . 6.2 110.451 -177.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.497 ' HB2' ' HA ' ' A' ' 95' ' ' CYS . 49.1 t -111.18 114.48 27.75 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 108.35 -0.981 . . . . 4.12 108.35 167.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 63.1 32.82 85.45 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-N 116.078 -0.51 . . . . 3.44 113.766 -178.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.512 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 14.5 m-85 -142.16 145.35 34.09 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 117.727 0.764 . . . . 4.84 112.499 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.5 t -159.93 169.48 23.4 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.21 -0.904 . . . . 2.41 108.607 177.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.7 ' HB3' ' HB2' ' A' ' 156' ' ' PRO . 8.5 tppt? -125.71 9.5 7.67 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.173 -0.677 . . . . 2.47 109.173 173.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 116.13 -30.88 6.3 Favored Glycine 0 N--CA 1.443 -0.893 0 N-CA-C 110.32 -1.112 . . . . 0.85 110.32 -170.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -45.31 -47.98 11.06 Favored Glycine 0 C--O 1.223 -0.592 0 CA-C-N 115.011 -0.595 . . . . 0.67 113.222 175.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.594 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 0.2 OUTLIER -61.01 -61.88 2.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.877 0.338 . . . . 1.2 111.524 -174.182 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -62.06 -23.88 66.75 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.268 0.556 . . . . 2.61 111.149 -178.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.634 ' HA ' HG22 ' A' ' 160' ' ' VAL . 23.4 m -75.79 -57.66 3.75 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.518 -0.765 . . . . 1.06 110.363 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 1.027 ' HB1' HG12 ' A' ' 71' ' ' VAL . . . -57.87 -38.48 75.81 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.942 -1.026 . . . . 1.05 110.949 -179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.534 ' HA ' ' CD1' ' A' ' 102' ' ' PHE . 54.8 m -60.92 -57.78 11.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.837 -0.619 . . . . 1.08 110.415 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 26.6 m -66.74 -37.84 85.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.378 -0.828 . . . . 1.22 111.534 -175.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.781 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 18.9 mt -65.3 -48.0 74.65 Favored 'General case' 0 CA--C 1.503 -0.849 0 CA-C-O 121.049 0.452 . . . . 1.14 110.679 -175.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.882 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 8.7 t80 -56.58 -50.96 70.38 Favored 'General case' 0 C--O 1.203 -1.394 0 CA-C-N 115.217 -0.901 . . . . 0.94 110.453 178.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -72.21 -24.57 61.42 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 120.745 0.307 . . . . 1.6 110.502 -172.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.3 ttmm -82.62 -26.35 32.32 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 109.107 -0.701 . . . . 2.06 109.107 -177.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.737 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 30.2 m-85 -127.61 -5.77 5.81 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 115.452 1.649 . . . . 0.92 115.452 -168.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.685 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 11.5 ptmt -63.65 -28.18 69.73 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 108.033 -1.099 . . . . 1.89 108.033 170.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.4 m -48.77 -34.83 12.97 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 113.84 -1.527 . . . . 1.68 110.782 172.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -93.64 -30.91 14.7 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.679 0.276 . . . . 1.11 111.52 176.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.557 ' HA3' ' HB2' ' A' ' 36' ' ' SER . . . 144.79 -7.64 1.71 Allowed Glycine 0 CA--C 1.519 0.323 0 N-CA-C 111.431 -0.668 . . . . 0.2 111.431 -177.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.781 ' HE2' ' HB3' ' A' ' 60' ' ' LEU . 21.5 t80 -69.52 141.71 53.82 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 122.744 0.418 . . . . 0.21 111.122 -177.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.917 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 3.8 t -133.91 152.17 51.76 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 107.985 -1.117 . . . . 1.02 107.985 173.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 1.027 HG12 ' HB1' ' A' ' 57' ' ' ALA . 33.4 t -110.82 100.32 10.52 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.454 0 N-CA-C 108.158 -1.053 . . . . 1.04 108.158 159.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.789 HD23 ' HE2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -96.7 121.5 38.61 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 107.829 -1.174 . . . . 1.69 107.829 175.18 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 1.018 ' HB2' HD12 ' A' ' 104' ' ' ILE . . . -111.28 116.81 31.65 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 115.705 -0.679 . . . . 1.17 110.295 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.957 ' HD2' HD13 ' A' ' 108' ' ' ILE . 1.4 m-30 -89.66 108.07 22.89 Favored Pre-proline 0 C--N 1.314 -0.951 0 N-CA-C 107.918 -1.141 . . . . 0.58 107.918 173.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.949 ' HG2' ' HB3' ' A' ' 107' ' ' LYS . 73.2 Cg_endo -75.24 64.22 6.24 Favored 'Trans proline' 0 N--CA 1.476 0.459 0 C-N-CA 123.632 2.888 . . . . 1.3 115.199 -168.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.3 t 13.17 125.51 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 116.589 2.07 . . . . 1.91 116.589 175.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.574 ' C ' ' H ' ' A' ' 79' ' ' PHE . 0.3 OUTLIER -79.85 70.54 6.4 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.074 -0.966 . . . . 1.93 109.045 174.627 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.635 ' HA ' ' HG3' ' A' ' 83' ' ' GLU . 21.9 mt-30 -48.99 -8.74 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 114.354 -1.294 . . . . 3.97 111.798 176.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.574 ' H ' ' C ' ' A' ' 77' ' ' ASN . 93.6 m-85 -64.22 -14.73 57.38 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.055 -0.975 . . . . 3.21 110.329 177.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.427 ' HA3' HE22 ' A' ' 82' ' ' GLN . . . -97.77 152.87 20.01 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 111.129 -0.788 . . . . 1.98 111.129 174.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.17 45.92 3.2 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.879 -0.677 . . . . 1.66 113.579 -175.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.756 ' HG3' ' HB3' ' A' ' 113' ' ' GLU . 4.1 pm0 -140.97 -16.27 0.87 Allowed 'General case' 0 C--N 1.324 -0.528 0 O-C-N 122.483 -0.422 . . . . 1.74 111.251 176.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.635 ' HG3' ' HA ' ' A' ' 78' ' ' GLN . 7.1 mm-40 -60.03 150.44 70.02 Favored Pre-proline 0 N--CA 1.464 0.273 0 CA-C-O 121.198 0.523 . . . . 3.07 112.153 -165.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.487 ' HB2' ' O ' ' A' ' 137' ' ' TRP . 83.7 Cg_endo -84.44 -15.28 6.39 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.174 2.583 . . . . 1.75 112.836 -168.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.605 ' HA3' ' HB2' ' A' ' 44' ' ' ALA . . . -86.27 69.98 3.06 Favored Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 110.864 -0.894 . . . . 2.27 110.864 175.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 68.21 -97.92 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.877 -0.786 . . . . 4.88 108.877 -172.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.445 ' CG ' ' H ' ' A' ' 88' ' ' GLU . 6.3 pt-20 170.23 -73.09 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 O-C-N 123.892 0.745 . . . . 3.02 110.089 175.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.445 ' H ' ' CG ' ' A' ' 87' ' ' GLU . 16.0 mm-40 -91.34 5.59 48.68 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 111.784 0.29 . . . . 3.92 111.784 -175.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.442 ' HA ' ' HG2' ' A' ' 92' ' ' GLU . 20.6 tt0 -58.64 -34.98 71.8 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.758 0.651 . . . . 2.65 112.758 -169.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.768 HG13 ' HD3' ' A' ' 91' ' ' LYS . 38.9 pt -81.46 -6.66 10.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.625 -0.43 . . . . 2.63 111.452 -178.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.768 ' HD3' HG13 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -105.08 -37.72 6.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.821 0.343 . . . . 3.13 110.557 177.073 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.442 ' HG2' ' HA ' ' A' ' 89' ' ' GLU . 15.9 pt-20 -79.17 -23.84 43.64 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.233 0.54 . . . . 3.29 109.816 177.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -131.27 133.71 45.68 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.842 -0.799 . . . . 4.08 108.842 176.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 53.0 t -60.67 109.66 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.021 0.439 . . . . 3.05 110.689 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.551 ' HB2' HG22 ' A' ' 90' ' ' ILE . 58.5 m -133.49 120.34 20.71 Favored 'General case' 0 CA--C 1.503 -0.827 0 CA-C-N 115.612 -0.722 . . . . 3.04 109.496 173.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.1 p -90.79 162.79 14.7 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 114.873 -1.058 . . . . 3.38 109.757 175.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 67.8 mttt -39.23 114.92 0.44 Allowed 'General case' 0 C--N 1.315 -0.907 0 O-C-N 124.248 0.967 . . . . 3.11 111.005 173.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.597 ' HB3' ' HA ' ' A' ' 45' ' ' SER . 0.0 OUTLIER -59.75 100.08 0.08 Allowed 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 108.507 -0.923 . . . . 2.12 108.507 171.398 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -94.57 132.4 39.3 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.521 -0.763 . . . . 3.1 109.044 177.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.565 ' HB3' ' CE1' ' A' ' 98' ' ' PHE . . . -128.91 -175.38 3.53 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.306 0.574 . . . . 1.15 112.011 -169.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -93.05 11.97 25.72 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.242 -0.89 . . . . 1.99 109.589 177.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.609 ' CE2' HD13 ' A' ' 104' ' ' ILE . 7.5 p90 -134.48 163.39 51.56 Favored Pre-proline 0 N--CA 1.444 -0.725 0 N-CA-C 108.175 -1.046 . . . . 1.31 108.175 178.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.725 ' HG2' ' HA ' ' A' ' 72' ' ' LEU . 26.4 Cg_endo -57.12 97.03 0.07 OUTLIER 'Trans proline' 0 N--CA 1.477 0.554 0 C-N-CA 123.57 2.847 . . . . 1.07 114.063 -173.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 1.018 HD12 ' HB2' ' A' ' 73' ' ' ALA . 7.6 mm -99.59 123.55 52.41 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.931 0 N-CA-C 107.969 -1.123 . . . . 1.97 107.969 173.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.826 ' HG3' ' CE1' ' A' ' 74' ' ' PHE . 13.5 mmt -100.99 -163.87 1.06 Allowed 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.304 -0.862 . . . . 3.41 111.791 -165.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.645 ' HB3' ' CD2' ' A' ' 25' ' ' HIS . . . -71.37 4.07 3.24 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.228 -0.897 . . . . 1.46 113.337 -169.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.949 ' HB3' ' HG2' ' A' ' 75' ' ' PRO . 15.8 ptpt 53.77 123.57 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.048 0 CA-C-O 122.701 1.239 . . . . 2.31 111.5 -170.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.957 HD13 ' HD2' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -122.73 177.68 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.689 0 N-CA-C 108.249 -1.019 . . . . 1.65 108.249 171.183 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.787 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 0.1 OUTLIER -70.87 72.16 0.55 Allowed 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 114.46 -1.246 . . . . 1.73 111.252 179.946 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.432 ' O ' HG21 ' A' ' 110' ' ' VAL . 13.7 m -72.28 92.49 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 CA-C-O 122.338 1.066 . . . . 1.4 108.202 175.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 176.27 -177.05 0.13 Allowed 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 114.442 -1.254 . . . . 2.1 109.525 -175.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -91.47 18.97 50.31 Favored Glycine 0 N--CA 1.432 -1.591 0 N-CA-C 115.361 0.904 . . . . 1.47 115.361 -172.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.756 ' HB3' ' HG3' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -105.38 -45.96 4.33 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 119.494 1.647 . . . . 2.81 111.72 179.314 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.614 ' N ' ' HG3' ' A' ' 113' ' ' GLU . 28.8 t-20 -132.02 -37.34 1.14 Allowed 'General case' 0 CA--C 1.508 -0.646 0 C-N-CA 119.685 -0.806 . . . . 2.75 110.568 -177.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.787 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . 52.6 178.87 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.841 0.829 . . . . 1.44 110.875 -177.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.89 ' CB ' HG13 ' A' ' 108' ' ' ILE . 5.9 t-80 -113.56 136.61 21.97 Favored Pre-proline 0 N--CA 1.425 -1.717 0 N-CA-C 106.995 -1.483 . . . . 0.71 106.995 163.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -26.42 -46.28 0.07 OUTLIER 'Trans proline' 0 C--O 1.219 -0.471 0 C-N-CA 124.456 3.437 . . . . 0.47 113.592 178.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.762 HD13 ' HB ' ' A' ' 15' ' ' ILE . 42.3 tp -61.63 -51.64 67.64 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.168 0.587 . . . . 1.15 112.251 177.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 1.062 ' OH ' HG23 ' A' ' 40' ' ' ILE . 46.5 m-85 -79.74 -33.39 40.84 Favored 'General case' 0 CA--C 1.489 -1.403 0 CA-C-O 121.238 0.542 . . . . 3.33 109.789 -177.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.494 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 13.3 tt0 -56.41 -40.7 75.12 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 107.017 -1.475 . . . . 2.44 107.017 172.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.748 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 88.8 t80 -65.97 -33.91 76.9 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 114.915 -1.038 . . . . 1.08 110.203 174.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.79 ' HE1' HD13 ' A' ' 40' ' ' ILE . 2.1 ttm -75.36 -54.93 6.24 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.207 -0.451 . . . . 1.25 110.955 -168.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.675 ' HD2' ' HB2' ' A' ' 134' ' ' ALA . 0.1 OUTLIER -68.77 -26.11 65.05 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 116.13 -0.486 . . . . 1.86 110.904 178.349 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.494 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 12.6 pttp -74.95 -26.71 59.8 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 119.587 -0.845 . . . . 2.52 109.838 177.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.461 HG22 ' HG2' ' A' ' 150' ' ' PRO . 52.6 m -71.45 -57.69 4.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.832 -0.622 . . . . 1.21 111.359 177.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.648 ' HG2' ' H ' ' A' ' 128' ' ' GLY . 42.8 tttp -146.51 130.23 8.39 Favored Pre-proline 0 N--CA 1.452 -0.374 0 C-N-CA 120.181 -0.607 . . . . 2.38 112.294 -174.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.693 ' HA ' ' NH2' ' A' ' 153' ' ' ARG . 12.9 Cg_exo -71.57 -2.31 11.14 Favored 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 123.51 2.806 . . . . 1.69 111.803 171.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.648 ' H ' ' HG2' ' A' ' 126' ' ' LYS . . . 96.37 -143.13 16.53 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.942 -0.572 . . . . 2.59 111.9 178.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 31.7 pt -102.63 3.03 10.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.151 0.5 . . . . 3.93 110.454 177.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.563 HD23 ' H ' ' A' ' 130' ' ' LEU . 2.4 pt? -124.98 153.86 42.11 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.729 -0.668 . . . . 3.81 109.686 -177.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -81.51 76.65 8.43 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.098 0.475 . . . . 3.63 110.46 -178.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' THR . . . . . 0.536 HG23 ' HZ3' ' A' ' 137' ' ' TRP . 40.4 m -140.57 126.55 19.5 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.002 -0.544 . . . . 3.97 110.049 178.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.429 ' HB2' ' HE3' ' A' ' 133' ' ' LYS . 39.8 mtmt -43.66 -73.79 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.836 0.68 . . . . 5.48 112.836 -173.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.675 ' HB2' ' HD2' ' A' ' 123' ' ' LYS . . . -146.12 101.72 3.54 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.133 -0.485 . . . . 1.59 112.296 -168.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.845 ' HA ' HG21 ' A' ' 140' ' ' THR . 5.3 mt 67.01 -78.93 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 O-C-N 123.72 0.637 . . . . 2.09 110.543 173.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.719 ' HB3' ' CE3' ' A' ' 137' ' ' TRP . 2.1 tmtp? 73.13 -30.7 0.21 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.856 1.263 . . . . 5.16 112.489 175.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.719 ' CE3' ' HB3' ' A' ' 136' ' ' LYS . 10.7 m-90 -111.86 174.51 5.84 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.51 0.671 . . . . 2.41 112.492 -174.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.592 ' HB3' ' HB3' ' A' ' 156' ' ' PRO . 8.5 t-20 -39.46 -154.93 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.895 1.678 . . . . 2.04 112.064 157.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.665 ' CG ' HG12 ' A' ' 43' ' ' VAL . 2.2 m-85 -27.96 -44.96 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 115.66 1.726 . . . . 2.53 115.66 -166.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.845 HG21 ' HA ' ' A' ' 135' ' ' ILE . 26.9 m 33.87 97.38 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.793 1.035 . . . . 1.24 113.793 171.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.478 ' O ' ' HA ' ' A' ' 153' ' ' ARG . 5.0 m -86.45 170.82 11.62 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.534 -1.212 . . . . 1.03 111.892 -171.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.821 ' HE2' HD22 ' A' ' 42' ' ' ASN . 88.8 m-85 -133.39 121.87 22.93 Favored 'General case' 0 CA--C 1.489 -1.366 0 N-CA-C 106.111 -1.811 . . . . 0.7 106.111 162.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.805 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 7.7 tp -79.6 104.56 10.28 Favored 'General case' 0 N--CA 1.422 -1.838 0 C-N-CA 118.089 -1.444 . . . . 1.16 108.291 178.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.741 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 47.9 mm -89.62 140.28 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.938 0 CA-C-N 112.709 -2.041 . . . . 1.05 107.731 -178.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.605 ' OD1' HG13 ' A' ' 149' ' ' VAL . 0.0 OUTLIER -91.94 -174.23 3.73 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 119.588 -0.845 . . . . 0.98 111.61 -170.276 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.693 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 35.8 mtt85 -56.28 -38.39 71.14 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 122.468 0.307 . . . . 2.61 111.556 -176.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -100.76 21.39 13.61 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.036 -1.098 . . . . 2.0 108.036 -178.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.639 ' HA2' HG21 ' A' ' 144' ' ' ILE . . . 69.31 37.45 80.3 Favored Glycine 0 N--CA 1.435 -1.388 0 CA-C-N 114.661 -1.154 . . . . 0.19 115.263 176.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.605 HG13 ' OD1' ' A' ' 145' ' ' ASP . 4.3 p -106.69 122.05 43.1 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 119.469 1.634 . . . . 1.74 110.806 171.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.608 ' HD3' HG22 ' A' ' 15' ' ' ILE . 11.6 Cg_endo -64.64 124.17 12.82 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 123.253 2.636 . . . . 0.6 111.468 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.9 m -124.54 -9.43 6.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 120.758 0.313 . . . . 2.06 110.468 -177.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.805 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 19.9 mm-40 -142.82 166.06 25.68 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 121.266 0.555 . . . . 1.17 110.861 175.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.693 ' NH2' ' HA ' ' A' ' 127' ' ' PRO . 5.8 ttm180 -148.14 135.61 20.62 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.551 -1.204 . . . . 2.9 108.849 166.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.753 ' O ' ' HA ' ' A' ' 140' ' ' THR . 97.2 m-85 -117.23 155.05 30.09 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.08 -0.711 . . . . 0.36 109.08 -169.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.448 ' HB3' ' HD2' ' A' ' 156' ' ' PRO . 22.3 m -83.22 163.04 52.22 Favored Pre-proline 0 C--N 1.316 -0.857 0 N-CA-C 109.497 -0.557 . . . . 1.45 109.497 175.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.7 ' HB2' ' HB3' ' A' ' 51' ' ' LYS . 20.1 Cg_endo -60.48 -31.13 92.1 Favored 'Trans proline' 0 CA--C 1.52 -0.176 0 C-N-CA 122.238 1.959 . . . . 0.78 110.681 174.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -68.97 -16.55 70.67 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 114.367 -1.288 . . . . 0.59 112.938 174.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -76.84 137.52 39.25 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 108.572 -0.899 . . . . 1.07 108.572 176.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.452 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 6.0 m -116.37 -177.06 3.09 Favored 'General case' 0 N--CA 1.436 -1.156 0 C-N-CA 120.48 -0.488 . . . . 1.92 110.727 -170.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.634 HG22 ' HA ' ' A' ' 56' ' ' THR . 54.9 t -42.43 -50.28 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.23 -0.895 . . . . 1.07 111.799 -178.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -68.62 -35.05 76.79 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.046 0.451 . . . . 3.89 111.081 -174.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.4 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 15.9 m-20 -69.91 -34.9 74.11 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.644 0.735 . . . . 1.4 109.737 -177.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.521 HD12 HG22 ' A' ' 56' ' ' THR . 54.8 mt -81.03 -49.1 18.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 114.797 -1.092 . . . . 1.05 111.369 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.6 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 39.3 mt-10 -52.41 -42.78 64.36 Favored 'General case' 0 C--O 1.216 -0.685 0 O-C-N 123.211 0.319 . . . . 0.67 111.082 -176.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.4 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 12.7 pt-20 -56.51 -25.73 52.42 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.418 -0.355 . . . . 0.87 111.535 -175.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.428 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 31.1 mmtp -96.84 -31.1 12.78 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.645 0.736 . . . . 2.22 109.857 176.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.6 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 14.7 tp -75.08 -48.56 23.29 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.302 -1.317 . . . . 1.04 112.149 -175.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.459 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 72.5 mt -56.31 -46.78 99.76 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.412 -0.813 . . . . 1.08 112.629 -172.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.459 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 73.4 Cg_exo -52.24 -26.02 25.52 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.233 1.956 . . . . 0.62 112.738 174.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.78 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 89.6 mt -89.92 -46.82 8.27 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 122.334 -0.228 . . . . 1.36 111.294 178.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.685 HD21 ' HG2' ' A' ' 37' ' ' PRO . 93.0 mt -59.22 -55.84 29.77 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-O 122.119 0.961 . . . . 1.07 109.874 176.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -74.58 -44.04 27.76 Favored Glycine 0 N--CA 1.43 -1.701 0 CA-C-N 113.332 -1.758 . . . . 1.12 113.473 -174.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 86.8 p 54.67 -148.91 0.46 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.09 0.556 . . . . 2.88 110.794 -175.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -92.99 -4.11 53.25 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.974 0.416 . . . . 4.69 110.586 176.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 61.1 mtt180 -90.53 131.6 36.17 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.906 -0.588 . . . . 9.17 111.117 -174.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.2 mm? . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.545 -0.74 . . . . 8.03 109.49 177.142 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.818 0 N-CA-C 112.155 -0.378 . . . . 5.58 112.155 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.8 ttt -84.29 78.49 9.79 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.083 0.468 . . . . 5.23 109.79 176.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -98.35 140.4 15.0 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.588 -0.815 . . . . 1.55 112.192 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.1 t -93.52 -0.25 56.39 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.187 0.517 . . . . 2.17 109.698 176.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.9 m -159.02 155.41 27.42 Favored 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 105.534 -2.024 . . . . 1.68 105.534 -176.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.778 ' HB ' HD11 ' A' ' 118' ' ' LEU . 5.9 pt -57.73 -18.91 10.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-N 115.011 -0.995 . . . . 1.16 111.805 -177.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.821 ' HB3' HG11 ' A' ' 31' ' ' VAL . 26.1 m-85 -70.16 -0.01 7.04 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.998 0.74 . . . . 0.3 112.998 -173.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -78.67 -17.09 56.48 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.429 -0.952 . . . . 2.11 108.429 177.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.612 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 39.8 m-85 -111.98 112.2 23.67 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 114.56 -1.2 . . . . 0.37 111.636 -172.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -45.21 137.02 4.76 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 113.599 -1.637 . . . . 2.86 111.072 172.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.774 HG12 ' HZ ' ' A' ' 74' ' ' PHE . 65.3 t -112.19 164.47 8.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 107.877 -1.157 . . . . 1.32 107.877 178.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.718 HD22 ' HA ' ' A' ' 27' ' ' PRO . 60.0 mt -130.85 157.68 42.22 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.692 0.282 . . . . 1.29 111.053 -177.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.515 ' HB3' ' HE3' ' A' ' 26' ' ' LYS . 20.5 t70 -85.18 172.94 10.8 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 106.795 -1.558 . . . . 1.87 106.795 163.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.695 ' HA ' ' C ' ' A' ' 105' ' ' MET . . . -62.78 -3.83 1.76 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.28 0.844 . . . . 1.2 113.28 -170.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.687 ' HB2' ' HE2' ' A' ' 26' ' ' LYS . 47.7 m-20 -117.05 17.42 14.89 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.764 -0.374 . . . . 2.34 111.526 176.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.432 ' HB2' ' O ' ' A' ' 24' ' ' ASP . 91.5 m-70 74.55 15.02 3.43 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-O 121.839 0.828 . . . . 2.26 109.17 174.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.687 ' HE2' ' HB2' ' A' ' 24' ' ' ASP . 35.2 mtmt -77.81 109.15 8.9 Favored Pre-proline 0 N--CA 1.446 -0.634 0 N-CA-C 107.367 -1.345 . . . . 4.64 107.367 169.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.718 ' HA ' HD22 ' A' ' 21' ' ' LEU . 93.7 Cg_exo -48.39 116.22 1.94 Allowed 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.503 2.135 . . . . 0.62 113.501 -171.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.799 ' OH ' ' HB3' ' A' ' 103' ' ' PRO . 0.2 OUTLIER -76.45 146.73 38.37 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 113.721 -1.581 . . . . 1.52 111.649 176.273 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.54 ' OD1' ' HB3' ' A' ' 32' ' ' GLN . 2.3 t-20 -84.9 96.69 9.42 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.171 -0.922 . . . . 2.16 109.597 175.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.682 HD12 HG21 ' A' ' 20' ' ' VAL . 61.4 tp -79.13 -45.99 18.89 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.877 -0.601 . . . . 1.07 110.914 -177.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.827 HG12 ' HE2' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -65.31 -0.08 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.435 0 CA-C-N 115.611 -0.722 . . . . 1.69 112.771 -173.594 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.54 ' HB3' ' OD1' ' A' ' 29' ' ' ASN . 3.9 pt20 -76.71 -12.49 60.0 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 119.832 -0.747 . . . . 1.31 109.323 175.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.935 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 92.8 m-70 -92.98 24.75 3.53 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 122.405 1.098 . . . . 0.35 108.685 175.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.827 ' HE2' HG12 ' A' ' 31' ' ' VAL . 36.8 mttm -77.67 109.73 11.9 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 113.419 -1.718 . . . . 2.07 109.446 170.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.35 -38.04 2.48 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 120.191 -1.004 . . . . 0.24 112.348 177.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.473 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 17.1 m -126.98 133.77 25.4 Favored Pre-proline 0 N--CA 1.437 -1.082 0 N-CA-C 108.748 -0.834 . . . . 0.74 108.748 172.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.732 ' HG3' ' CB ' ' A' ' 170' ' ' LEU . 5.3 Cg_endo -44.27 158.13 0.15 Allowed 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 124.136 3.224 . . . . 0.22 112.732 176.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.75 ' HB2' HG22 ' A' ' 70' ' ' THR . 1.0 OUTLIER -145.14 141.2 28.55 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.296 -1.372 . . . . 1.09 107.296 -179.215 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.975 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 2.2 mm? -106.38 112.96 26.2 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.838 -0.801 . . . . 1.82 108.838 178.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.694 HG13 HG13 ' A' ' 144' ' ' ILE . 1.3 mt -96.59 123.98 49.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 109.403 -0.591 . . . . 1.12 109.403 176.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.975 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.5 OUTLIER -110.68 131.2 55.26 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.433 -0.349 . . . . 1.09 110.561 -174.552 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.464 ' HB2' ' CB ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -79.1 117.53 20.22 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 105.874 -1.898 . . . . 3.11 105.874 166.598 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.835 HG13 ' HA ' ' A' ' 139' ' ' PHE . 35.0 m -126.39 155.74 36.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 O-C-N 120.973 -1.079 . . . . 1.69 111.603 -172.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.549 ' HB2' HD12 ' A' ' 90' ' ' ILE . . . -103.75 103.27 13.14 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.363 -0.835 . . . . 1.45 109.955 176.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.537 ' HA ' ' HB3' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -28.36 139.12 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 114.134 -1.394 . . . . 1.99 113.317 174.177 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -55.19 96.47 0.02 OUTLIER 'General case' 0 C--O 1.234 0.25 0 CA-C-N 114.567 -1.197 . . . . 6.2 112.872 -172.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.759 ' HB3' HG22 ' A' ' 90' ' ' ILE . 37.4 t -164.04 118.43 1.49 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.974 -1.012 . . . . 4.12 108.879 169.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 100.87 -74.52 0.4 Allowed Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.717 -0.754 . . . . 3.44 112.624 178.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.573 ' HE2' ' HD3' ' A' ' 51' ' ' LYS . 66.4 t80 -164.37 139.31 5.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.105 0.478 . . . . 4.84 111.305 -178.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 15.3 p -117.52 126.48 52.65 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.39 -0.823 . . . . 2.41 109.849 175.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.573 ' HD3' ' HE2' ' A' ' 49' ' ' TYR . 0.3 OUTLIER -66.36 167.72 10.04 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 109.922 -0.399 . . . . 2.47 109.922 178.447 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -55.97 -10.46 3.64 Favored Glycine 0 C--N 1.335 0.519 0 O-C-N 123.29 0.368 . . . . 0.85 113.713 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.421 ' HA2' ' HB ' ' A' ' 56' ' ' THR . . . -55.58 -24.13 38.27 Favored Glycine 0 C--O 1.223 -0.562 0 C-N-CA 121.604 -0.331 . . . . 0.67 112.557 175.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.433 ' CZ ' ' CE1' ' A' ' 98' ' ' PHE . 0.2 OUTLIER -63.65 -50.3 69.85 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.345 -0.613 . . . . 1.2 109.345 175.879 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -61.85 -29.98 70.54 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.292 -0.867 . . . . 2.61 109.813 177.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.553 ' OG1' ' HA ' ' A' ' 159' ' ' SER . 67.1 m -73.6 -59.07 2.89 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 114.177 -1.374 . . . . 1.06 110.133 -175.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 1.026 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -59.13 -43.42 92.0 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.664 -1.153 . . . . 1.05 111.129 -178.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.5 ' HA ' ' CD1' ' A' ' 102' ' ' PHE . 54.3 m -55.53 -58.0 9.59 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.572 0.701 . . . . 1.08 110.599 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 86.5 m -68.25 -38.61 81.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.745 -1.116 . . . . 1.22 111.772 -176.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.734 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 16.2 mt -63.05 -48.65 77.8 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 121.499 0.666 . . . . 1.14 110.293 -177.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.861 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 10.6 t80 -59.35 -48.71 80.6 Favored 'General case' 0 C--O 1.203 -1.345 0 CA-C-N 114.718 -1.128 . . . . 0.94 110.881 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.426 HD21 ' N ' ' A' ' 62' ' ' ASN . 1.0 OUTLIER -73.52 -23.94 60.08 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 120.577 0.227 . . . . 1.6 110.686 -173.751 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.424 ' HB2' ' HE2' ' A' ' 63' ' ' LYS . 24.2 ttmm -84.4 -25.42 29.08 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 108.687 -0.857 . . . . 2.06 108.687 -177.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.698 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 44.5 m-85 -127.88 -2.21 5.92 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 115.583 1.697 . . . . 0.92 115.583 -170.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.663 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 15.0 pttp -67.26 -24.99 65.85 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 108.332 -0.988 . . . . 1.89 108.332 171.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.8 m -47.99 -38.01 16.01 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 114.035 -1.439 . . . . 1.68 110.978 173.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -86.61 -37.69 17.84 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 111.915 0.339 . . . . 1.11 111.915 174.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 149.83 -4.41 0.64 Allowed Glycine 0 N--CA 1.45 -0.367 0 N-CA-C 111.265 -0.734 . . . . 0.2 111.265 -177.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.734 ' HE2' ' HB3' ' A' ' 60' ' ' LEU . 22.9 t80 -67.6 141.36 56.81 Favored 'General case' 0 C--O 1.22 -0.461 0 C-N-CA 122.794 0.437 . . . . 0.21 111.323 -178.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.935 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 1.5 t -135.92 144.56 45.55 Favored 'General case' 0 CA--C 1.487 -1.476 0 N-CA-C 109.016 -0.735 . . . . 1.02 109.016 173.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 1.026 HG11 ' HB1' ' A' ' 57' ' ' ALA . 38.6 t -104.07 101.37 12.17 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.199 0 N-CA-C 108.613 -0.884 . . . . 1.04 108.613 160.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.627 ' HA ' ' HG2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -96.11 121.66 38.11 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 118.475 -1.29 . . . . 1.69 108.113 173.174 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 1.001 ' HB2' HD13 ' A' ' 104' ' ' ILE . . . -108.64 140.05 42.57 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.405 0.621 . . . . 1.17 110.351 179.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.816 ' CG ' ' HG2' ' A' ' 105' ' ' MET . 6.4 m-30 -115.31 110.39 45.36 Favored Pre-proline 0 C--N 1.311 -1.091 0 CA-C-N 115.507 -0.77 . . . . 0.58 109.234 -177.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.701 ' HG2' ' HB3' ' A' ' 107' ' ' LYS . 60.4 Cg_endo -78.18 46.58 2.13 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.567 2.844 . . . . 1.3 115.454 -164.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.482 ' O ' ' HD3' ' A' ' 107' ' ' LYS . 73.6 p 40.11 137.54 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 117.215 2.302 . . . . 1.91 117.215 176.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.498 ' OD1' ' HB3' ' A' ' 79' ' ' PHE . 50.7 t-20 -87.32 64.34 8.21 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 113.556 -1.656 . . . . 1.93 107.605 177.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.679 ' HA ' ' HG2' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -56.4 -14.32 2.9 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 114.007 -1.451 . . . . 3.97 110.578 176.779 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.498 ' HB3' ' OD1' ' A' ' 77' ' ' ASN . 77.9 t80 -69.78 -21.8 63.39 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 114.04 -1.436 . . . . 3.21 110.957 -178.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.06 -45.39 9.02 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.585 -0.734 . . . . 1.98 111.51 178.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.68 38.07 3.54 Favored Glycine 0 CA--C 1.506 -0.498 0 C-N-CA 120.895 -0.669 . . . . 1.66 112.902 177.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -145.76 27.79 1.19 Allowed 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.769 -0.456 . . . . 1.74 109.769 174.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.679 ' HG2' ' HA ' ' A' ' 78' ' ' GLN . 1.2 mm-40 -81.65 146.38 56.63 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-O 121.73 0.776 . . . . 3.07 111.789 -173.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.42 -41.33 1.24 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 124.375 3.384 . . . . 1.75 112.7 -173.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -112.05 135.75 12.99 Favored Glycine 0 N--CA 1.437 -1.276 0 C-N-CA 120.884 -0.674 . . . . 2.27 111.975 -175.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.623 ' HB3' ' HB3' ' A' ' 89' ' ' GLU . 2.4 m-20 59.37 40.47 20.95 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.225 0.536 . . . . 4.88 110.147 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -47.59 -42.45 23.97 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 114.508 -1.224 . . . . 3.02 112.775 -176.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -103.87 -7.26 20.61 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.348 0.594 . . . . 3.92 110.384 -172.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.623 ' HB3' ' HB3' ' A' ' 86' ' ' ASN . 12.2 tp10 -91.48 -62.33 1.46 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.546 -0.752 . . . . 2.65 112.265 -172.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.759 HG22 ' HB3' ' A' ' 47' ' ' CYS . 18.7 pt -83.58 6.86 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 112.95 0.722 . . . . 2.63 112.95 -167.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 42.0 mtmt -85.57 -68.06 0.76 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.991 0.424 . . . . 3.13 110.658 178.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -82.49 -15.3 52.96 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.489 -0.778 . . . . 3.29 111.264 -174.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -105.98 144.83 32.15 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.142 -0.688 . . . . 4.08 109.142 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 6.0 p -67.71 111.74 2.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.915 0.864 . . . . 3.05 112.033 -175.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.521 ' HA ' ' HB2' ' A' ' 47' ' ' CYS . 9.1 p -106.76 121.66 44.82 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 114.826 -1.079 . . . . 3.04 109.501 173.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 12.2 p -68.74 139.54 55.34 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.806 -0.812 . . . . 3.38 108.806 174.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.464 ' HD3' ' HB3' ' A' ' 23' ' ' ALA . 18.6 ptpt -62.4 105.04 0.56 Allowed 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.306 -0.998 . . . . 3.11 108.306 178.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.827 ' CE1' ' HB3' ' A' ' 100' ' ' ALA . 0.0 OUTLIER -53.94 114.28 1.53 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.628 -1.169 . . . . 2.12 111.537 -170.578 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -107.95 136.27 47.95 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.221 -0.899 . . . . 3.1 109.118 175.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.827 ' HB3' ' CE1' ' A' ' 98' ' ' PHE . . . -134.64 -166.04 1.75 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.226 0.536 . . . . 1.15 111.826 -173.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -85.33 8.74 17.59 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.166 -0.925 . . . . 1.99 109.876 175.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.594 ' HB2' ' O ' ' A' ' 71' ' ' VAL . 16.9 p90 -138.81 161.22 59.53 Favored Pre-proline 0 N--CA 1.442 -0.842 0 CA-C-N 115.588 -0.733 . . . . 1.31 109.619 -178.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.799 ' HB3' ' OH ' ' A' ' 28' ' ' TYR . 18.2 Cg_endo -57.41 110.98 0.69 Allowed 'Trans proline' 0 CA--C 1.51 -0.701 0 C-N-CA 124.122 3.215 . . . . 1.07 114.1 -175.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 1.001 HD13 ' HB2' ' A' ' 73' ' ' ALA . 7.0 mm -108.56 134.24 51.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 C-N-CA 119.925 -0.71 . . . . 1.97 109.227 172.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.816 ' HG2' ' CG ' ' A' ' 74' ' ' PHE . 0.0 OUTLIER -89.54 -177.08 5.22 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.988 -0.551 . . . . 3.41 109.657 179.577 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.686 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . . . -57.25 -51.53 68.97 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.241 0.544 . . . . 1.46 110.418 -177.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.701 ' HB3' ' HG2' ' A' ' 75' ' ' PRO . 13.9 ptpt 128.57 121.96 0.0 OUTLIER 'General case' 0 CA--C 1.492 -1.28 0 C-N-CA 127.407 2.283 . . . . 2.31 106.036 -176.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.634 HD12 ' HD2' ' A' ' 74' ' ' PHE . 2.1 pp -129.41 156.58 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.242 0 N-CA-C 106.161 -1.792 . . . . 1.65 106.161 177.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.787 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 2.5 t-20 -52.06 117.82 3.04 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 123.696 0.623 . . . . 1.73 109.942 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.464 ' CB ' ' HB2' ' A' ' 42' ' ' ASN . 3.5 m -113.67 86.83 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.621 0 N-CA-C 107.625 -1.25 . . . . 1.4 107.625 169.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 173.4 -175.6 0.06 Allowed 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 113.844 -1.525 . . . . 2.1 109.435 -178.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -35.62 -54.57 1.06 Allowed Glycine 0 CA--C 1.507 -0.413 0 N-CA-C 118.199 2.039 . . . . 1.47 118.199 178.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.16 -45.79 25.55 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 117.215 -1.794 . . . . 2.81 114.366 -148.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -129.58 -33.41 1.86 Allowed 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.104 -0.702 . . . . 2.75 109.104 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.787 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . 47.48 -166.78 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.169 -1.378 . . . . 1.44 109.594 -167.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.659 ' ND1' ' H ' ' A' ' 118' ' ' LEU . 6.4 t-80 -113.83 138.03 22.56 Favored Pre-proline 0 N--CA 1.419 -2.006 0 N-CA-C 107.166 -1.42 . . . . 0.71 107.166 162.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.562 ' HB2' ' CD1' ' A' ' 18' ' ' PHE . 11.5 Cg_exo -33.9 -41.35 0.2 Allowed 'Trans proline' 0 C--O 1.218 -0.483 0 C-N-CA 123.872 3.048 . . . . 0.47 113.099 -178.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.778 HD11 ' HB ' ' A' ' 15' ' ' ILE . 33.5 tp -63.65 -48.53 76.86 Favored 'General case' 0 C--O 1.222 -0.369 0 C-N-CA 123.208 0.603 . . . . 1.15 111.726 176.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.67 ' OH ' HG21 ' A' ' 40' ' ' ILE . 23.3 m-85 -78.04 -34.36 50.59 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 111.944 0.35 . . . . 3.33 111.944 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.494 ' HG2' ' HB3' ' A' ' 115' ' ' ALA . 0.8 OUTLIER -60.32 -35.82 76.51 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 106.809 -1.552 . . . . 2.44 106.809 171.617 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.612 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 55.1 t80 -70.29 -30.69 67.76 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 119.525 -0.87 . . . . 1.08 110.051 173.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.67 ' HB2' ' HA ' ' A' ' 119' ' ' TYR . 1.5 ttm -76.15 -54.58 6.6 Favored 'General case' 0 CA--C 1.509 -0.616 0 C-N-CA 120.388 -0.525 . . . . 1.25 110.479 -169.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.62 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -70.78 -25.43 62.89 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.297 -0.41 . . . . 1.86 111.437 179.398 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.521 ' N ' ' HD3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -71.67 -29.0 64.12 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 119.552 -0.859 . . . . 2.52 109.609 178.244 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 27.1 m -92.21 -24.94 18.88 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.571 -0.741 . . . . 1.21 111.52 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.49 ' HE2' ' HA ' ' A' ' 151' ' ' VAL . 23.5 mmtm -146.41 106.49 4.09 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 112.387 0.514 . . . . 2.38 112.387 -173.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.644 ' HA ' ' NH2' ' A' ' 153' ' ' ARG . 3.6 Cg_exo -79.9 -10.28 14.13 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.654 2.236 . . . . 1.69 110.978 167.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.684 ' HA3' ' HB3' ' A' ' 153' ' ' ARG . . . 87.52 -140.93 17.01 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.758 -0.656 . . . . 2.59 113.65 170.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 25.6 pt -67.78 -21.04 26.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 112.237 0.458 . . . . 3.93 112.237 -175.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.3 pp -136.02 141.01 44.29 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.745 -0.382 . . . . 3.81 110.534 178.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.21 97.47 0.54 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.778 -0.646 . . . . 3.63 111.341 -178.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' THR . . . . . 0.551 ' O ' ' HB3' ' A' ' 127' ' ' PRO . 14.8 t -142.21 -164.6 1.84 Allowed 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.375 -0.602 . . . . 3.97 109.375 177.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -89.15 -90.6 0.13 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.495 0.664 . . . . 5.48 111.175 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.48 ' HA ' ' CB ' ' A' ' 123' ' ' LYS . . . -92.74 172.34 8.41 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.246 -0.888 . . . . 1.59 111.665 -173.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.755 ' O ' ' HB2' ' A' ' 136' ' ' LYS . 0.1 OUTLIER -36.05 -37.78 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 O-C-N 124.552 1.157 . . . . 2.09 113.039 -176.12 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.858 ' HB3' ' CE3' ' A' ' 137' ' ' TRP . 28.1 mtmt 108.12 -65.28 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 124.902 1.281 . . . . 5.16 112.752 177.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.858 ' CE3' ' HB3' ' A' ' 136' ' ' LYS . 0.7 OUTLIER -121.14 -175.81 3.14 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.139 -1.391 . . . . 2.41 111.122 -156.837 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.477 ' O ' ' N ' ' A' ' 140' ' ' THR . 12.7 m120 -35.56 -153.6 0.0 OUTLIER 'General case' 0 C--O 1.207 -1.168 0 CA-C-N 114.527 -1.215 . . . . 2.04 112.409 155.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.835 ' HA ' HG13 ' A' ' 43' ' ' VAL . 0.9 OUTLIER -29.65 -21.97 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 117.495 2.406 . . . . 2.53 117.495 -172.162 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.667 ' HA ' ' O ' ' A' ' 154' ' ' PHE . 0.2 OUTLIER -7.58 120.32 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 120.141 1.337 . . . . 1.24 114.559 173.948 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.575 ' O ' ' HA ' ' A' ' 153' ' ' ARG . 1.0 OUTLIER -104.9 163.63 12.38 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.33 -1.305 . . . . 1.03 111.101 -167.971 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.621 ' CE2' HG22 ' A' ' 135' ' ' ILE . 97.4 m-85 -125.1 123.24 39.3 Favored 'General case' 0 CA--C 1.491 -1.32 0 N-CA-C 106.28 -1.748 . . . . 0.7 106.28 166.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.737 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 5.0 tp -79.46 102.25 8.66 Favored 'General case' 0 N--CA 1.425 -1.713 0 C-N-CA 118.242 -1.383 . . . . 1.16 108.157 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.697 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 39.1 mm -88.24 141.4 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 CA-C-N 113.8 -1.546 . . . . 1.05 107.611 -177.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.429 ' HA ' HD12 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -95.81 -174.83 3.24 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 119.359 -0.936 . . . . 0.98 111.234 -168.377 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.508 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 57.0 mtm180 -55.13 -40.11 70.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.818 0.342 . . . . 2.61 111.619 -176.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -92.44 14.39 16.79 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 109.443 -0.577 . . . . 2.0 109.443 -178.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.541 ' HA2' HG22 ' A' ' 144' ' ' ILE . . . 73.6 33.87 57.64 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 121.211 -0.519 . . . . 0.19 113.601 -178.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.437 ' HA ' ' HD2' ' A' ' 150' ' ' PRO . 31.7 t -107.41 107.39 60.33 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 117.961 0.88 . . . . 1.74 111.239 176.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.676 ' HD3' HG23 ' A' ' 15' ' ' ILE . 5.9 Cg_exo -47.4 125.3 10.49 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 123.888 3.059 . . . . 0.6 112.158 173.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.49 ' HA ' ' HE2' ' A' ' 126' ' ' LYS . 44.2 t -116.13 -37.12 2.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 109.046 -0.724 . . . . 2.06 109.046 -177.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.737 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 6.8 mm-40 -130.86 167.07 19.55 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 115.612 -0.722 . . . . 1.17 111.665 -175.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.684 ' HB3' ' HA3' ' A' ' 128' ' ' GLY . 20.4 ttm180 -138.87 133.07 31.47 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.022 -0.99 . . . . 2.9 109.655 165.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.667 ' O ' ' HA ' ' A' ' 140' ' ' THR . 96.3 m-85 -117.03 137.25 52.37 Favored 'General case' 0 C--O 1.213 -0.837 0 CA-C-N 116.336 -0.393 . . . . 0.36 109.982 -172.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.565 ' HA ' HG21 ' A' ' 140' ' ' THR . 37.4 m -67.13 153.43 94.63 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 109.381 -0.6 . . . . 1.45 109.381 179.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.656 ' HG3' ' HB3' ' A' ' 137' ' ' TRP . 10.0 Cg_endo -53.26 -48.27 22.94 Favored 'Trans proline' 0 N--CA 1.473 0.272 0 C-N-CA 122.647 2.232 . . . . 0.78 112.732 -174.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -67.05 10.34 0.84 Allowed Glycine 0 CA--C 1.527 0.841 0 N-CA-C 114.937 0.735 . . . . 0.59 114.937 176.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -74.45 146.21 43.02 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-N 118.481 1.141 . . . . 1.07 108.669 171.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.553 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 90.9 p -102.61 171.61 7.33 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 120.513 -0.475 . . . . 1.92 109.864 -174.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.527 ' CG2' ' HA ' ' A' ' 56' ' ' THR . 58.3 t -42.28 -48.97 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 O-C-N 124.202 0.939 . . . . 1.07 110.767 175.077 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.414 ' HB2' ' HE3' ' A' ' 161' ' ' LYS . 37.2 ttmt -71.75 -31.89 67.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.429 -0.805 . . . . 3.89 111.249 -172.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -67.03 -38.0 85.13 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.565 0.698 . . . . 1.4 109.634 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.54 HD13 ' CG2' ' A' ' 56' ' ' THR . 73.8 mt -82.3 -39.8 16.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 114.903 -1.044 . . . . 1.05 111.022 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.554 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 30.2 mt-10 -53.4 -44.54 68.76 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-O 120.503 0.192 . . . . 0.67 111.478 -178.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -57.15 -24.8 56.79 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.956 0.354 . . . . 0.87 111.956 -174.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.635 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 44.0 mmtm -98.15 -24.86 15.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.532 0.682 . . . . 2.22 109.987 175.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.554 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 10.0 tp -78.4 -50.09 12.35 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.97 -1.014 . . . . 1.04 112.353 -177.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.471 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 70.6 mt -55.61 -46.63 99.7 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 115.499 -0.773 . . . . 1.08 112.352 -173.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.471 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 53.3 Cg_exo -54.92 -26.76 50.36 Favored 'Trans proline' 0 C--N 1.356 0.921 0 C-N-CA 122.128 1.885 . . . . 0.62 112.669 174.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.732 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 62.4 mt -86.32 -42.48 13.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.725 -0.216 . . . . 1.36 111.267 177.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.665 HD22 ' HG2' ' A' ' 37' ' ' PRO . 97.3 mt -60.04 -54.11 49.84 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 122.127 0.965 . . . . 1.07 109.53 176.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -69.74 -1.95 34.12 Favored Glycine 0 N--CA 1.439 -1.106 0 CA-C-N 113.365 -1.743 . . . . 1.12 113.142 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 60.6 m 56.48 78.09 0.23 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.375 0.67 . . . . 2.88 112.558 175.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -66.95 -29.57 69.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.854 -0.612 . . . . 4.69 110.314 172.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -112.59 159.42 18.86 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.599 -0.728 . . . . 9.17 109.474 176.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 41.9 tp . . . . . 0 C--O 1.246 0.895 0 CA-C-O 118.632 -0.699 . . . . 8.03 110.368 -178.967 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.765 0 N-CA-C 111.924 -0.471 . . . . 5.58 111.924 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 95.7 mmm -104.4 0.12 28.67 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.455 0.645 . . . . 5.23 109.652 178.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 130.89 83.35 0.28 Allowed Glycine 0 N--CA 1.441 -1.015 0 CA-C-N 115.081 -0.963 . . . . 1.55 111.416 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 43.6 t -119.7 1.6 11.08 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.993 0.425 . . . . 2.17 110.22 179.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 91.4 p 178.52 157.98 0.49 Allowed 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 105.823 -1.918 . . . . 1.68 105.823 -177.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.8 HG21 ' HD3' ' A' ' 150' ' ' PRO . 6.7 pt -67.66 -17.63 22.72 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 CA-C-N 114.949 -1.023 . . . . 1.16 110.745 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.809 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 45.9 m-85 -74.74 -3.48 31.78 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 116.113 -0.494 . . . . 0.3 111.607 -176.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -67.14 -12.59 60.41 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.991 -1.114 . . . . 2.11 107.991 170.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.576 ' HE2' ' HB2' ' A' ' 121' ' ' TYR . 61.1 m-85 -129.07 109.81 11.5 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 114.794 -1.094 . . . . 0.37 110.007 -175.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -55.98 157.64 4.36 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 114.116 -1.402 . . . . 2.86 109.488 174.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.763 HG12 ' CZ ' ' A' ' 74' ' ' PHE . 40.4 t -109.65 161.02 8.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 107.792 -1.188 . . . . 1.32 107.792 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.827 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 55.2 mt -126.09 122.49 35.91 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 120.552 -0.459 . . . . 1.29 109.901 -178.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.61 ' HA ' ' SD ' ' A' ' 105' ' ' MET . 0.8 OUTLIER -59.44 -175.85 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.387 0 O-C-N 124.31 1.006 . . . . 1.87 109.469 -179.179 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.676 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . . . -62.19 -3.93 1.52 Allowed 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 113.19 0.811 . . . . 1.2 113.19 -171.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -118.68 12.64 13.12 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.505 -0.478 . . . . 2.34 111.73 175.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.827 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 6.3 m170 72.3 26.06 2.74 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.677 0.751 . . . . 2.26 110.266 174.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 26' ' ' LYS . 54.2 mmtt -102.5 133.21 20.65 Favored Pre-proline 0 N--CA 1.448 -0.533 0 CA-C-N 114.618 -1.174 . . . . 4.64 107.879 171.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.651 ' HA ' HD23 ' A' ' 21' ' ' LEU . 83.5 Cg_exo -51.38 112.8 0.89 Allowed 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.111 1.874 . . . . 0.62 114.208 -166.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.77 ' CE2' HD23 ' A' ' 72' ' ' LEU . 50.0 t80 -83.58 126.0 32.37 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 113.79 -1.55 . . . . 1.52 108.617 165.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.536 HD22 ' NE2' ' A' ' 32' ' ' GLN . 0.1 OUTLIER -67.67 82.0 0.18 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.911 0.862 . . . . 2.16 110.848 -178.068 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.76 ' HB2' HG23 ' A' ' 20' ' ' VAL . 44.5 tp -51.98 -37.76 54.22 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.536 -0.756 . . . . 1.07 109.653 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.664 HG11 ' HB3' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -67.75 0.13 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 114.687 -1.142 . . . . 1.69 113.0 -173.857 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.536 ' NE2' HD22 ' A' ' 29' ' ' ASN . 3.4 pt20 -72.7 -18.87 61.5 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 119.815 -0.754 . . . . 1.31 108.968 173.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.921 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 79.4 m-70 -92.33 29.86 1.6 Allowed 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 115.497 -0.774 . . . . 0.35 109.749 175.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.809 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 29.0 mtmt -92.35 111.04 22.47 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 114.896 -1.047 . . . . 2.07 109.584 173.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.94 -38.14 2.03 Favored Glycine 0 N--CA 1.443 -0.899 0 N-CA-C 110.759 -0.936 . . . . 0.24 110.759 -177.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.0 m -132.24 136.03 27.42 Favored Pre-proline 0 N--CA 1.435 -1.202 0 N-CA-C 109.127 -0.694 . . . . 0.74 109.127 169.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.685 ' O ' ' HA ' ' A' ' 69' ' ' PHE . 10.3 Cg_endo -47.42 156.83 0.9 Allowed 'Trans proline' 0 CA--C 1.511 -0.651 0 C-N-CA 124.481 3.454 . . . . 0.22 113.499 178.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.787 HD22 ' HB2' ' A' ' 33' ' ' HIS . 0.9 OUTLIER -133.65 152.06 51.8 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 106.978 -1.49 . . . . 1.09 106.978 173.4 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.83 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 1.6 mm? -110.82 117.23 32.84 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.896 -1.15 . . . . 1.82 107.896 174.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 1.02 HD12 ' HE3' ' A' ' 122' ' ' MET . 9.1 mt -98.92 119.05 46.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 C-N-CA 119.714 -0.795 . . . . 1.12 110.195 178.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.83 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -105.11 127.29 52.83 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.469 -0.787 . . . . 1.09 109.916 -176.239 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.569 ' CG ' HG13 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -78.39 104.93 9.31 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 106.233 -1.765 . . . . 3.11 106.233 165.81 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.549 ' HB ' ' CE1' ' A' ' 139' ' ' PHE . 4.5 m -107.91 132.73 54.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 C-N-CA 118.986 -1.086 . . . . 1.69 111.32 -171.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.26 102.71 6.81 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 114.845 -1.07 . . . . 1.45 108.357 171.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.498 ' HA ' ' HB2' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -58.72 65.19 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.683 0 O-C-N 124.535 1.147 . . . . 1.99 112.107 175.462 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.642 ' HG2' ' HG2' ' A' ' 89' ' ' GLU . 86.8 mttt -89.24 174.75 7.67 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.098 -0.501 . . . . 6.2 110.544 -177.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.457 ' HB2' ' HA ' ' A' ' 95' ' ' CYS . 13.1 t -111.57 117.16 32.2 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.061 -0.518 . . . . 4.12 110.07 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 74.65 -5.59 29.36 Favored Glycine 0 CA--C 1.521 0.447 0 CA-C-N 116.168 -0.469 . . . . 3.44 113.3 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -93.35 154.33 18.04 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.566 0.698 . . . . 4.84 112.487 -174.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.4 t -168.49 142.53 3.21 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.636 -1.165 . . . . 2.41 108.309 175.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.705 ' O ' ' HA2' ' A' ' 157' ' ' GLY . 27.8 mmmt -104.09 7.5 36.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.294 0.569 . . . . 2.47 109.559 176.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 111.61 -35.51 4.68 Favored Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 110.472 -1.051 . . . . 0.85 110.472 -171.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -45.96 -41.12 10.31 Favored Glycine 0 C--O 1.216 -1.03 0 CA-C-N 114.635 -0.782 . . . . 0.67 113.132 176.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -64.82 -52.2 58.05 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.948 0.404 . . . . 1.2 111.006 -178.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -63.29 -29.15 70.53 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.711 -0.677 . . . . 2.61 109.984 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.874 HG22 HD12 ' A' ' 163' ' ' ILE . 87.7 m -75.14 -55.74 5.43 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.207 -0.906 . . . . 1.06 109.159 -179.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 1.028 ' HB3' HG11 ' A' ' 71' ' ' VAL . . . -54.1 -43.93 70.8 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.58 -1.191 . . . . 1.05 111.379 -178.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.454 ' HA ' ' CD1' ' A' ' 102' ' ' PHE . 30.3 m -61.68 -54.5 41.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.395 0.617 . . . . 1.08 110.142 -177.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.7 m -68.34 -35.61 78.03 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.235 -0.893 . . . . 1.22 111.591 -176.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.737 HD21 ' HA ' ' A' ' 160' ' ' VAL . 0.6 OUTLIER -63.83 -52.82 58.39 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-O 121.774 0.797 . . . . 1.14 110.162 -176.822 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.888 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 8.1 t80 -55.31 -49.19 72.8 Favored 'General case' 0 C--O 1.204 -1.337 0 CA-C-N 113.83 -1.532 . . . . 0.94 110.597 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.838 ' HA ' ' HE2' ' A' ' 65' ' ' LYS . 28.7 m-80 -72.97 -24.71 60.82 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 116.638 -0.255 . . . . 1.6 110.632 -173.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.402 ' HD2' ' CE2' ' A' ' 64' ' ' TYR . 39.2 ttmt -81.47 -29.59 33.68 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 108.674 -0.862 . . . . 2.06 108.674 -178.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.64 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 42.3 m-85 -125.5 -2.97 7.37 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 116.185 1.92 . . . . 0.92 116.185 -168.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.838 ' HE2' ' HA ' ' A' ' 62' ' ' ASN . 47.3 pttt -65.25 -24.94 67.46 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 107.906 -1.146 . . . . 1.89 107.906 170.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.5 t -48.63 -38.91 22.25 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 113.882 -1.508 . . . . 1.68 110.483 172.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -86.53 -36.13 19.13 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 111.818 0.303 . . . . 1.11 111.818 173.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 149.4 -7.47 0.84 Allowed Glycine 0 CA--C 1.521 0.408 0 N-CA-C 111.888 -0.485 . . . . 0.2 111.888 -175.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.718 ' HE2' ' HB3' ' A' ' 60' ' ' LEU . 17.9 t80 -65.34 142.47 58.22 Favored 'General case' 0 C--O 1.22 -0.45 0 C-N-CA 123.036 0.534 . . . . 0.21 111.586 -177.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.921 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 1.6 t -133.9 147.75 51.15 Favored 'General case' 0 N--CA 1.423 -1.799 0 N-CA-C 108.521 -0.918 . . . . 1.02 108.521 170.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 1.028 HG11 ' HB3' ' A' ' 57' ' ' ALA . 36.5 t -98.93 101.9 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.734 0 N-CA-C 107.832 -1.173 . . . . 1.04 107.832 158.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.77 HD23 ' CE2' ' A' ' 28' ' ' TYR . 6.3 mt -83.69 119.56 24.93 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 108.051 -1.092 . . . . 1.69 108.051 177.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.477 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -95.84 111.22 23.25 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.401 -0.592 . . . . 1.17 109.401 177.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.992 ' HD2' HD13 ' A' ' 108' ' ' ILE . 3.3 m-85 -101.18 91.95 2.28 Favored Pre-proline 0 C--N 1.312 -1.026 0 N-CA-C 107.386 -1.338 . . . . 0.58 107.386 172.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.637 ' HG2' ' HB3' ' A' ' 107' ' ' LYS . 80.8 Cg_endo -77.11 77.72 3.7 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.854 2.369 . . . . 1.3 114.626 -166.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.483 ' OG ' HG21 ' A' ' 110' ' ' VAL . 14.6 m -5.42 126.43 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 126.744 2.018 . . . . 1.91 116.185 -178.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.665 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 9.9 t30 -72.88 72.3 1.09 Allowed 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 113.351 -1.75 . . . . 1.93 109.315 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.529 ' HA ' ' HG3' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -47.42 -10.84 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 113.919 -1.491 . . . . 3.97 113.182 177.897 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.481 ' H ' ' C ' ' A' ' 77' ' ' ASN . 98.6 m-85 -65.8 -14.26 61.04 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.223 -0.444 . . . . 3.21 110.529 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.487 ' HA3' HE22 ' A' ' 82' ' ' GLN . . . -87.95 -179.32 47.38 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 116.039 -0.528 . . . . 1.98 112.053 176.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -117.12 30.09 6.46 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.903 -0.665 . . . . 1.66 112.251 -178.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.487 HE22 ' HA3' ' A' ' 80' ' ' GLY . 4.2 pm0 -136.21 -6.57 2.06 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 110.046 -0.353 . . . . 1.74 110.046 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.529 ' HG3' ' HA ' ' A' ' 78' ' ' GLN . 11.2 mm-40 -61.42 140.19 94.78 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.873 -0.603 . . . . 3.07 111.368 -168.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.402 ' HB2' ' O ' ' A' ' 137' ' ' TRP . 65.5 Cg_endo -81.61 177.97 7.05 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.962 2.442 . . . . 1.75 112.986 -167.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 86' ' ' ASN . . . 95.1 -38.72 3.04 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.585 -0.817 . . . . 2.27 112.457 178.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.733 ' HB3' ' HB2' ' A' ' 89' ' ' GLU . 63.7 t30 175.31 -12.74 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 122.733 0.413 . . . . 4.88 110.046 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.477 ' HA ' ' O ' ' A' ' 83' ' ' GLU . 38.0 mt-10 75.22 -67.06 0.26 Allowed 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.519 0.728 . . . . 3.02 112.047 174.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -86.11 -2.54 58.43 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.923 0.392 . . . . 3.92 111.453 -175.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.733 ' HB2' ' HB3' ' A' ' 86' ' ' ASN . 4.4 tp10 -51.61 -61.63 2.13 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.465 0.65 . . . . 2.65 111.673 -176.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.801 HG22 ' HB2' ' A' ' 95' ' ' CYS . 4.3 mt -94.43 67.19 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.84 0.829 . . . . 2.63 110.888 -170.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -172.08 -39.87 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 106.246 -1.761 . . . . 3.13 106.246 175.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -73.24 -55.26 6.68 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 113.659 -1.61 . . . . 3.29 109.116 166.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -84.98 141.69 30.15 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 115.964 -0.562 . . . . 4.08 110.771 -176.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 79.8 t -69.65 111.72 3.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.731 -0.668 . . . . 3.05 109.439 173.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.801 ' HB2' HG22 ' A' ' 90' ' ' ILE . 36.5 m -138.29 127.18 23.87 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.527 0.68 . . . . 3.04 111.751 -173.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.3 p -64.73 159.86 21.33 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 114.688 -1.142 . . . . 3.38 108.796 167.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.5 ' HE3' ' HB1' ' A' ' 23' ' ' ALA . 14.0 pttm -74.67 53.49 0.56 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.463 0.649 . . . . 3.11 110.81 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.603 ' CZ ' ' HZ ' ' A' ' 139' ' ' PHE . 24.3 t80 68.57 -87.51 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.083 -0.962 . . . . 2.12 111.606 178.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt 70.54 148.74 0.08 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.583 0.753 . . . . 3.1 111.064 -176.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.515 ' HB1' HD12 ' A' ' 104' ' ' ILE . . . -171.32 -164.3 0.33 Allowed 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 115.919 -0.582 . . . . 1.15 110.634 -172.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -91.2 -20.69 21.69 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.195 -0.457 . . . . 1.99 111.1 173.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.717 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 0.7 OUTLIER -89.52 175.04 4.21 Favored Pre-proline 0 N--CA 1.443 -0.784 0 CA-C-N 116.476 -0.329 . . . . 1.31 110.373 -177.513 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.717 ' HD2' ' HB2' ' A' ' 102' ' ' PHE . 70.7 Cg_endo -69.29 103.56 1.1 Allowed 'Trans proline' 0 C--N 1.336 -0.093 0 C-N-CA 122.818 2.345 . . . . 1.07 112.381 178.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.515 HD12 ' HB1' ' A' ' 100' ' ' ALA . 3.9 mp -101.1 120.75 51.07 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.018 0 N-CA-C 107.684 -1.228 . . . . 1.97 107.684 175.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.76 ' HG3' ' CE1' ' A' ' 74' ' ' PHE . 27.3 mmt -87.33 -164.54 1.1 Allowed 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.992 -1.004 . . . . 3.41 111.494 -169.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.676 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . . . -68.58 -16.22 63.79 Favored 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 120.315 -0.554 . . . . 1.46 111.07 -172.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.665 ' HD3' ' HA ' ' A' ' 77' ' ' ASN . 10.5 ptpt 81.1 139.68 0.07 Allowed 'General case' 0 CA--C 1.493 -1.215 0 O-C-N 125.71 1.881 . . . . 2.31 108.397 -163.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.992 HD13 ' HD2' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -131.26 159.84 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.599 0 N-CA-C 104.785 -2.302 . . . . 1.65 104.785 169.604 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.527 ' ND2' ' HG2' ' A' ' 113' ' ' GLU . 2.5 t30 -64.48 80.53 0.04 OUTLIER 'General case' 0 C--N 1.287 -2.148 0 O-C-N 123.603 0.564 . . . . 1.73 110.427 177.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.836 ' HA ' ' OH ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -78.81 90.38 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 C-N-CA 118.701 -1.2 . . . . 1.4 108.2 -179.711 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.443 ' N ' ' OH ' ' A' ' 119' ' ' TYR . 2.1 t-20 176.84 -179.06 0.17 Allowed 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 113.354 -1.748 . . . . 2.1 107.499 178.15 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -89.04 36.65 3.44 Favored Glycine 0 N--CA 1.44 -1.058 0 CA-C-O 118.686 -1.063 . . . . 1.47 115.656 -172.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.615 ' HG3' ' N ' ' A' ' 114' ' ' ASN . 0.8 OUTLIER -105.05 -44.54 4.76 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 120.067 1.933 . . . . 2.81 111.095 171.795 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.615 ' N ' ' HG3' ' A' ' 113' ' ' GLU . 52.4 t30 -132.09 -34.62 1.26 Allowed 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 109.307 -0.627 . . . . 2.75 109.307 -177.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.974 ' HA ' ' HH ' ' A' ' 119' ' ' TYR . . . 56.0 -164.44 0.14 Allowed 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 114.611 -1.177 . . . . 1.44 110.919 177.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.647 ' CB ' HG13 ' A' ' 108' ' ' ILE . 8.6 t-80 -150.25 121.31 3.95 Favored Pre-proline 0 N--CA 1.418 -2.026 0 N-CA-C 107.542 -1.281 . . . . 0.71 107.542 175.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.571 ' HB2' ' CD1' ' A' ' 18' ' ' PHE . 5.4 Cg_exo -33.43 -37.72 0.1 OUTLIER 'Trans proline' 0 C--O 1.214 -0.717 1 C-N-CA 125.403 4.068 . . . . 0.47 114.064 -172.905 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.746 ' CD1' ' HB ' ' A' ' 15' ' ' ILE . 7.5 tp -63.5 -60.32 3.5 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 114.046 1.128 . . . . 1.15 114.046 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.974 ' HH ' ' HA ' ' A' ' 115' ' ' ALA . 3.8 p90 -82.7 -25.82 32.61 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 107.486 -1.302 . . . . 3.33 107.486 -177.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.591 ' HA ' ' HD2' ' A' ' 123' ' ' LYS . 1.9 tm-20 -59.25 -39.86 84.14 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.334 -1.358 . . . . 2.44 107.334 172.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.599 ' O ' ' HG3' ' A' ' 124' ' ' LYS . 29.6 t80 -64.21 -29.3 70.41 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.007 -0.997 . . . . 1.08 110.145 169.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 1.02 ' HE3' HD12 ' A' ' 40' ' ' ILE . 66.9 mtt -73.4 -55.3 6.55 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 121.134 0.493 . . . . 1.25 110.797 -173.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.695 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -70.45 -22.49 62.69 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.154 -0.93 . . . . 1.86 110.817 177.754 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.599 ' HG3' ' O ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -73.37 -26.3 60.95 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 119.636 -0.826 . . . . 2.52 109.502 171.318 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 93.2 m -74.87 -55.91 5.31 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.221 0.534 . . . . 1.21 110.06 173.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.696 ' HG2' ' NH2' ' A' ' 153' ' ' ARG . 22.7 ttmm -137.74 102.45 8.57 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.669 -0.696 . . . . 2.38 109.424 177.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -69.65 -55.74 0.17 Allowed 'Trans proline' 0 CA--C 1.52 -0.2 0 C-N-CA 123.552 2.835 . . . . 1.69 112.25 -170.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.668 ' HA3' ' HB ' ' A' ' 132' ' ' THR . . . -158.37 170.88 35.13 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 120.762 -0.733 . . . . 2.59 111.668 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.433 HD13 ' HB2' ' A' ' 130' ' ' LEU . 2.3 pp -106.7 -5.86 10.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.408 0.623 . . . . 3.93 110.11 176.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.433 ' HB2' HD13 ' A' ' 129' ' ' ILE . 19.0 tp -128.06 38.9 3.94 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.069 -0.969 . . . . 3.81 109.57 -176.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 58.88 40.59 22.52 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.733 -1.121 . . . . 3.63 110.011 -171.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' THR . . . . . 0.668 ' HB ' ' HA3' ' A' ' 128' ' ' GLY . 0.7 OUTLIER -90.34 149.08 22.46 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.725 -1.125 . . . . 3.97 109.614 -179.178 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.453 ' HD2' ' N ' ' A' ' 133' ' ' LYS . 0.6 OUTLIER -92.68 -24.61 18.57 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.069 0.461 . . . . 5.48 111.038 -178.026 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.549 ' HB2' HD12 ' A' ' 135' ' ' ILE . . . -157.63 -164.63 1.59 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.85 -0.614 . . . . 1.59 110.145 -175.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.93 ' H ' HD12 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -53.91 -40.44 44.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.868 -0.605 . . . . 2.09 110.861 172.857 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.685 ' HB3' ' CE3' ' A' ' 137' ' ' TRP . 6.0 tmtt? 64.39 -38.89 0.22 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 124.673 1.189 . . . . 5.16 114.04 174.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.754 ' HB3' ' HG3' ' A' ' 156' ' ' PRO . 6.8 m-90 -100.22 177.73 4.98 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 122.889 0.476 . . . . 2.41 111.78 -177.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.482 ' O ' ' N ' ' A' ' 140' ' ' THR . 10.7 t-20 -39.5 -155.32 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 113.852 -1.522 . . . . 2.04 111.37 157.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.603 ' HZ ' ' CZ ' ' A' ' 98' ' ' PHE . 1.6 m-85 -29.12 -25.06 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 117.924 2.565 . . . . 2.53 117.924 -171.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.704 ' HA ' ' O ' ' A' ' 154' ' ' PHE . 29.5 m -0.6 105.96 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 114.472 1.286 . . . . 1.24 114.472 175.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.433 ' CB ' HD12 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -86.12 170.33 12.3 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.167 -1.378 . . . . 1.03 110.302 -172.912 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.49 ' CE2' HG22 ' A' ' 135' ' ' ILE . 86.7 m-85 -127.68 127.47 43.79 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 105.803 -1.925 . . . . 0.7 105.803 164.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.819 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 9.1 tp -80.55 104.71 11.26 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 118.238 -1.385 . . . . 1.16 108.534 176.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.757 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 41.7 mm -93.6 141.0 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.929 0 CA-C-N 113.746 -1.57 . . . . 1.05 107.154 -177.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.688 ' HA ' HD13 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -92.39 178.18 5.91 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 120.508 -0.477 . . . . 0.98 111.518 -171.736 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.451 ' N ' ' CG ' ' A' ' 145' ' ' ASP . 66.8 mtm180 -48.71 -46.39 40.59 Favored 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 123.135 0.574 . . . . 2.61 111.494 -178.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -96.41 24.04 6.21 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.187 -0.672 . . . . 2.0 109.187 -178.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.531 ' HA2' ' CG2' ' A' ' 144' ' ' ILE . . . 71.68 42.6 53.94 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.083 -0.962 . . . . 0.19 113.789 175.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.469 ' O ' HG23 ' A' ' 151' ' ' VAL . 49.9 t -103.87 114.85 64.23 Favored Pre-proline 0 C--N 1.311 -1.074 0 C-N-CA 119.631 -0.828 . . . . 1.74 110.882 177.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.8 ' HD3' HG21 ' A' ' 15' ' ' ILE . 21.6 Cg_endo -67.02 113.06 2.68 Favored 'Trans proline' 0 CA--C 1.529 0.27 0 C-N-CA 122.998 2.465 . . . . 0.6 110.251 176.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 149' ' ' VAL . 16.3 t -113.66 -28.06 2.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-O 121.398 0.618 . . . . 2.06 109.788 -173.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.819 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 17.3 mm-40 -137.37 168.24 20.03 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 115.077 -0.965 . . . . 1.17 110.423 -177.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.696 ' NH2' ' HG2' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -145.92 137.71 25.1 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 114.59 -1.187 . . . . 2.9 108.901 161.729 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.714 ' HZ ' ' HB2' ' A' ' 166' ' ' LYS . 94.0 m-85 -112.25 145.56 39.72 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.126 -0.488 . . . . 0.36 110.161 -170.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 10.2 m -63.79 152.12 87.41 Favored Pre-proline 0 C--N 1.317 -0.842 0 N-CA-C 109.345 -0.613 . . . . 1.45 109.345 175.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.754 ' HG3' ' HB3' ' A' ' 137' ' ' TRP . 43.8 Cg_endo -66.69 -22.88 49.62 Favored 'Trans proline' 0 CA--C 1.512 -0.585 0 C-N-CA 122.28 1.987 . . . . 0.78 110.7 178.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.705 ' HA2' ' O ' ' A' ' 51' ' ' LYS . . . -85.38 13.73 53.92 Favored Glycine 0 N--CA 1.44 -1.085 0 CA-C-N 114.773 -1.103 . . . . 0.59 112.87 173.081 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -87.63 149.83 24.04 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.225 -0.657 . . . . 1.07 109.225 172.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.482 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 17.5 m -108.66 171.99 7.1 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 121.181 0.515 . . . . 1.92 111.526 -174.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.771 ' HA ' HG23 ' A' ' 56' ' ' THR . 52.0 t -39.07 -55.74 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 114.463 -1.244 . . . . 1.07 111.853 176.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -64.56 -31.87 73.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.472 -0.786 . . . . 3.89 111.567 -174.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.431 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 23.6 m-20 -75.75 -32.62 60.05 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.24 -0.891 . . . . 1.4 110.305 -173.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.874 HD12 HG22 ' A' ' 56' ' ' THR . 57.3 mt -83.3 -44.48 18.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.234 -0.894 . . . . 1.05 110.913 177.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.564 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 37.9 mt-10 -54.31 -40.44 67.96 Favored 'General case' 0 C--O 1.218 -0.575 0 CA-C-N 116.613 -0.267 . . . . 0.67 111.506 -178.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 9.2 pt-20 -56.9 -27.24 60.52 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 112.1 0.407 . . . . 0.87 112.1 -177.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.714 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 46.2 mmtm -96.69 -26.04 15.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.394 0.616 . . . . 2.22 110.276 175.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.564 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 12.1 tp -76.96 -49.49 15.38 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.068 -0.969 . . . . 1.04 112.031 -177.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.513 HG13 ' O ' ' A' ' 164' ' ' GLU . 81.8 mt -53.29 -44.82 98.21 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-N 115.511 -0.768 . . . . 1.08 112.165 -174.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.41 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 85.5 Cg_exo -50.37 -39.35 53.78 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.133 1.889 . . . . 0.62 112.917 172.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.688 HD13 ' HA ' ' A' ' 145' ' ' ASP . 96.0 mt -79.34 -43.52 23.37 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.728 -0.389 . . . . 1.36 111.284 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.612 HD22 ' HB2' ' A' ' 69' ' ' PHE . 95.7 mt -57.93 -54.11 50.58 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 122.083 0.944 . . . . 1.07 109.674 176.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -66.98 -4.86 29.82 Favored Glycine 0 N--CA 1.437 -1.235 0 CA-C-N 113.297 -1.774 . . . . 1.12 113.397 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 31.9 t 63.78 51.65 2.35 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.146 0.498 . . . . 2.88 110.917 175.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -62.75 -40.96 98.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.059 -0.519 . . . . 4.69 110.403 177.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -96.81 151.38 19.72 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.533 -0.543 . . . . 9.17 109.533 177.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.4 mm? . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.625 -0.702 . . . . 8.03 110.121 -177.129 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.668 0 N-CA-C 112.529 -0.228 . . . . 5.58 112.529 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 60.9 mtm 57.43 87.09 0.07 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.718 0.771 . . . . 5.23 109.878 -174.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.616 ' CA ' ' HB2' ' A' ' 17' ' ' ASP . . . -59.82 -61.15 7.52 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 114.403 -1.272 . . . . 1.55 114.931 -170.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.2 t 63.74 16.89 10.09 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.307 0.575 . . . . 2.17 109.853 -170.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 65.5 p 179.05 152.34 0.36 Allowed 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 105.47 -2.048 . . . . 1.68 105.47 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.778 HD12 HD22 ' A' ' 30' ' ' LEU . 5.6 pt -64.99 -12.95 14.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-N 115.061 -0.972 . . . . 1.16 112.187 -171.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.755 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 43.6 m-85 -75.44 0.96 15.24 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.378 0.51 . . . . 0.3 112.378 -175.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.616 ' HB2' ' CA ' ' A' ' 12' ' ' GLY . 38.6 t70 -73.43 -19.26 61.01 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 108.242 -1.021 . . . . 2.11 108.242 174.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.677 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 57.1 m-85 -111.34 107.34 16.57 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 114.628 -1.169 . . . . 0.37 111.045 -174.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -51.07 140.96 14.91 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 113.843 -1.526 . . . . 2.86 109.03 174.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.786 HG12 ' HZ ' ' A' ' 74' ' ' PHE . 40.3 t -110.32 166.27 5.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 108.118 -1.067 . . . . 1.32 108.118 -177.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.7 ' O ' ' HB2' ' A' ' 105' ' ' MET . 24.7 mt -127.0 143.61 51.25 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.884 -0.413 . . . . 1.29 109.884 179.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.445 ' OD2' ' HE2' ' A' ' 26' ' ' LYS . 18.6 m-20 -77.59 177.37 8.13 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 106.742 -1.577 . . . . 1.87 106.742 165.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.743 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . . . -64.39 -5.25 4.89 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 113.068 0.766 . . . . 1.2 113.068 -171.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.862 ' HB2' ' HG2' ' A' ' 26' ' ' LYS . 15.8 m-20 -94.66 -8.1 38.88 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 111.591 0.219 . . . . 2.34 111.591 178.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.546 ' HB2' ' O ' ' A' ' 24' ' ' ASP . 49.0 m-70 80.8 -0.66 1.83 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.506 0.723 . . . . 2.26 109.829 -175.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.862 ' HG2' ' HB2' ' A' ' 24' ' ' ASP . 6.4 ptmt -67.1 120.0 68.77 Favored Pre-proline 0 N--CA 1.45 -0.472 0 N-CA-C 108.158 -1.053 . . . . 4.64 108.158 165.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.678 ' HA ' HD23 ' A' ' 21' ' ' LEU . 90.0 Cg_exo -50.26 116.54 2.54 Favored 'Trans proline' 0 N--CA 1.465 -0.19 0 C-N-CA 122.638 2.225 . . . . 0.62 113.828 -175.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.874 ' HE2' HD22 ' A' ' 72' ' ' LEU . 15.0 t80 -79.74 143.66 34.32 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 113.865 -1.516 . . . . 1.52 111.212 174.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.497 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.7 t-20 -80.72 82.47 6.71 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.085 -0.962 . . . . 2.16 109.931 178.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.778 HD22 HD12 ' A' ' 15' ' ' ILE . 59.2 tp -57.91 -41.33 82.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.302 0.572 . . . . 1.07 109.784 177.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.682 HG11 ' HG3' ' A' ' 34' ' ' LYS . 2.0 t -68.16 -3.72 2.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 114.638 -1.165 . . . . 1.69 112.256 -170.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.497 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 3.4 pt20 -70.18 -17.25 63.16 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.919 -0.771 . . . . 1.31 108.919 175.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.899 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 92.4 m-70 -92.68 23.58 4.01 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.318 -0.855 . . . . 0.35 109.644 177.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.755 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 10.1 mtmt -81.99 121.76 26.93 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 114.639 -1.164 . . . . 2.07 109.335 168.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.42 -42.05 1.89 Allowed Glycine 0 N--CA 1.436 -1.31 0 C-N-CA 120.633 -0.794 . . . . 0.24 111.67 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.492 ' HB2' ' HA3' ' A' ' 68' ' ' GLY . 19.3 m -128.69 127.86 23.52 Favored Pre-proline 0 N--CA 1.435 -1.183 0 N-CA-C 108.462 -0.94 . . . . 0.74 108.462 173.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.807 ' HG3' ' CB ' ' A' ' 170' ' ' LEU . 4.9 Cg_endo -42.74 152.61 0.18 Allowed 'Trans proline' 0 CA--C 1.508 -0.777 0 C-N-CA 124.401 3.401 . . . . 0.22 113.205 178.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.862 HD13 ' HB2' ' A' ' 33' ' ' HIS . 0.9 OUTLIER -137.5 142.33 41.47 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.052 -1.431 . . . . 1.09 107.361 -178.341 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.967 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 1.8 mm? -107.79 114.78 28.98 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.473 -0.936 . . . . 1.82 108.473 176.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.784 HG21 HD11 ' A' ' 72' ' ' LEU . 1.1 mt -95.38 127.99 46.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 C-N-CA 119.81 -0.756 . . . . 1.12 109.647 177.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.967 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 1.1 m-85 -112.47 124.43 52.48 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.215 -0.448 . . . . 1.09 110.435 -175.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.63 HD21 ' HB ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -83.01 92.54 7.39 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 107.31 -1.367 . . . . 3.11 107.31 173.691 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.774 HG21 ' HB3' ' A' ' 139' ' ' PHE . 11.1 p -103.48 147.0 10.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-O 121.02 0.438 . . . . 1.69 111.394 -161.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -88.35 103.72 16.09 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.815 -0.63 . . . . 1.45 111.424 -175.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.572 ' O ' HD12 ' A' ' 90' ' ' ILE . 0.3 OUTLIER -56.41 91.63 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.279 -0.873 . . . . 1.99 111.022 170.726 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.493 ' HZ3' ' CD ' ' A' ' 89' ' ' GLU . 38.4 ttmt -141.94 169.9 16.72 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.185 -0.672 . . . . 6.2 109.185 -179.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.449 ' H ' ' HG2' ' A' ' 46' ' ' LYS . 8.8 t -108.67 117.91 35.42 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.916 0.388 . . . . 4.12 110.049 -176.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 69.25 51.47 27.28 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.564 -0.744 . . . . 3.44 112.586 -178.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -141.86 149.06 39.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.283 0.563 . . . . 4.84 111.901 -177.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 7.3 t -179.28 164.9 1.41 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 107.585 -1.265 . . . . 2.41 107.585 -179.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.755 ' H ' ' HZ ' ' A' ' 139' ' ' PHE . 29.7 ttmt -134.78 20.24 3.54 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.775 -0.824 . . . . 2.47 108.775 175.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 108.14 -40.03 2.68 Favored Glycine 0 N--CA 1.443 -0.869 0 CA-C-N 115.263 -0.88 . . . . 0.85 111.388 -175.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.539 ' HA2' ' HB ' ' A' ' 56' ' ' THR . . . -61.98 -19.12 58.56 Favored Glycine 0 C--O 1.22 -0.746 0 CA-C-O 119.688 -0.506 . . . . 0.67 114.359 -177.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -77.19 -57.0 4.08 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 118.305 1.053 . . . . 1.2 109.983 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.18 -39.27 72.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.575 0.703 . . . . 2.61 109.587 173.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.719 HG22 ' HA ' ' A' ' 160' ' ' VAL . 18.3 m -57.06 -59.28 5.3 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 114.625 -1.171 . . . . 1.06 111.296 174.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 1.053 ' HB1' HG13 ' A' ' 71' ' ' VAL . . . -55.98 -45.45 78.97 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.869 -0.605 . . . . 1.05 111.047 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.57 ' HA ' ' HE1' ' A' ' 102' ' ' PHE . 92.1 m -55.02 -51.33 66.62 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.589 0.709 . . . . 1.08 110.354 -178.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 28.1 m -72.96 -36.79 67.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.861 -1.063 . . . . 1.22 111.483 -177.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.702 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 14.5 mt -64.23 -52.67 57.61 Favored 'General case' 0 CA--C 1.498 -1.054 0 CA-C-O 121.311 0.577 . . . . 1.14 110.381 -178.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.788 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 2.1 t80 -51.73 -53.26 41.37 Favored 'General case' 0 C--O 1.199 -1.586 0 CA-C-N 114.218 -1.356 . . . . 0.94 110.167 178.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -72.91 -25.56 61.1 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 112.097 0.406 . . . . 1.6 112.097 -170.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.44 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 35.4 ttpt -84.06 -23.24 30.94 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 119.401 -0.92 . . . . 2.06 108.924 -178.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.633 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 36.7 m-85 -122.37 -4.31 8.87 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 114.959 1.466 . . . . 0.92 114.959 -172.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.711 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 13.7 ptmt -64.93 -25.31 67.82 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 108.238 -1.023 . . . . 1.89 108.238 171.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.9 m -47.76 -41.9 24.33 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.113 -1.403 . . . . 1.68 110.74 172.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -85.37 -33.09 22.09 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.059 0.392 . . . . 1.11 112.059 175.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.492 ' HA3' ' HB2' ' A' ' 36' ' ' SER . . . 145.82 -7.46 1.47 Allowed Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 111.454 -0.659 . . . . 0.2 111.454 -177.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.702 ' HE2' ' HB3' ' A' ' 60' ' ' LEU . 19.5 t80 -64.38 140.86 58.91 Favored 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 122.709 0.403 . . . . 0.21 111.027 -178.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.899 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 1.6 t -134.34 151.3 51.15 Favored 'General case' 0 N--CA 1.413 -2.294 0 N-CA-C 108.425 -0.954 . . . . 1.02 108.425 173.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 1.053 HG13 ' HB1' ' A' ' 57' ' ' ALA . 50.2 t -109.16 100.27 10.42 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.341 0 N-CA-C 107.488 -1.301 . . . . 1.04 107.488 159.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.874 HD22 ' HE2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -89.85 121.07 31.63 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 118.254 -1.378 . . . . 1.69 108.375 177.496 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.819 ' HB2' HG13 ' A' ' 104' ' ' ILE . . . -98.09 112.68 24.55 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.914 -0.585 . . . . 1.17 110.842 -177.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.847 ' CD2' ' HE2' ' A' ' 119' ' ' TYR . 3.1 m-30 -96.56 102.16 10.74 Favored Pre-proline 0 C--N 1.31 -1.143 0 N-CA-C 108.827 -0.805 . . . . 0.58 108.827 176.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.714 ' HG2' ' HB3' ' A' ' 107' ' ' LYS . 87.8 Cg_endo -80.33 71.02 7.27 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 123.239 2.626 . . . . 1.3 114.302 -166.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 77.3 p 2.8 130.35 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 116.767 2.136 . . . . 1.91 116.767 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.593 ' C ' ' HG3' ' A' ' 83' ' ' GLU . 12.5 t30 -80.52 76.19 7.37 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 113.185 -1.825 . . . . 1.93 107.611 -179.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.977 ' HG3' HG23 ' A' ' 90' ' ' ILE . 7.6 mm-40 -48.16 -12.64 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.462 1.505 . . . . 3.97 111.574 -176.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.577 ' H ' ' C ' ' A' ' 77' ' ' ASN . 92.5 m-85 -90.04 29.53 1.2 Allowed 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.504 -1.225 . . . . 3.21 111.195 -175.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.46 ' HA3' HE22 ' A' ' 82' ' ' GLN . . . -109.64 -42.17 1.26 Allowed Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.653 -0.784 . . . . 1.98 112.831 -177.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 115.57 19.15 5.85 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.727 -0.749 . . . . 1.66 112.609 -176.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.46 HE22 ' HA3' ' A' ' 80' ' ' GLY . 0.8 OUTLIER -170.03 24.72 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 113.103 0.779 . . . . 1.74 113.103 -177.022 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.593 ' HG3' ' C ' ' A' ' 77' ' ' ASN . 6.1 mm-40 -89.03 153.95 49.41 Favored Pre-proline 0 C--N 1.314 -0.941 0 CA-C-O 121.366 0.603 . . . . 3.07 112.586 -173.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.482 ' HB3' ' HA ' ' A' ' 138' ' ' ASN . 89.2 Cg_exo -54.91 -0.66 0.13 Allowed 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 124.624 3.549 . . . . 1.75 114.811 176.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -97.68 13.08 64.3 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 121.123 -0.561 . . . . 2.27 112.088 176.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.502 HD22 ' HB2' ' A' ' 89' ' ' GLU . 4.1 p-10 50.04 37.19 13.56 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.329 1.052 . . . . 4.88 112.526 179.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 58.8 -86.33 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 114.439 1.274 . . . . 3.02 114.439 169.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.52 ' O ' ' HG2' ' A' ' 92' ' ' GLU . 33.5 mm-40 -58.95 -38.91 80.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.496 -0.775 . . . . 3.92 112.307 -166.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.502 ' HB2' HD22 ' A' ' 86' ' ' ASN . 32.3 tt0 -65.91 -14.14 60.98 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.019 0.438 . . . . 2.65 111.941 -173.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.977 HG23 ' HG3' ' A' ' 78' ' ' GLN . 12.0 mm -97.09 -29.36 3.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.444 0.64 . . . . 2.63 109.973 178.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -85.61 -41.72 14.98 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.595 -0.729 . . . . 3.13 111.353 -174.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.52 ' HG2' ' O ' ' A' ' 88' ' ' GLU . 10.4 pt-20 -84.41 -16.63 42.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.787 0.327 . . . . 3.29 110.706 -178.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.425 ' HB3' ' O ' ' A' ' 89' ' ' GLU . 19.0 t80 -113.55 158.77 20.35 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.014 -0.539 . . . . 4.08 109.713 -176.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 6.1 p -65.81 111.83 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.45 0.643 . . . . 3.05 110.341 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.424 ' HB3' ' CG2' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -96.03 123.78 39.78 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 121.625 0.726 . . . . 3.04 111.614 -178.86 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.489 ' C ' ' H ' ' A' ' 98' ' ' PHE . 14.2 p -90.8 149.68 21.88 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 108.114 -1.069 . . . . 3.38 108.114 166.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -73.29 41.86 0.11 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.917 0.389 . . . . 3.11 110.563 176.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.717 ' CZ ' ' HE2' ' A' ' 102' ' ' PHE . 61.9 t80 61.91 -85.97 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.185 -0.916 . . . . 2.12 110.749 -175.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 30.3 mtmm 69.51 144.85 0.05 Allowed 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 124.145 0.978 . . . . 3.1 111.816 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.613 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -176.29 -152.96 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.971 -1.013 . . . . 1.15 110.235 -174.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -104.57 28.51 6.93 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.637 -0.711 . . . . 1.99 111.012 178.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.868 ' HB3' ' O ' ' A' ' 71' ' ' VAL . 3.5 m-85 -113.14 -177.11 0.42 Allowed Pre-proline 0 CA--C 1.513 -0.454 0 CA-C-O 121.853 0.835 . . . . 1.31 111.426 -177.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.704 ' HD3' ' CE2' ' A' ' 61' ' ' TYR . 12.9 Cg_exo -79.87 71.73 6.89 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 124.095 3.197 . . . . 1.07 110.442 156.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.819 HG13 ' HB2' ' A' ' 73' ' ' ALA . 5.3 mp -73.77 119.92 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 108.143 -1.058 . . . . 1.97 108.143 173.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.823 ' HG2' ' CG ' ' A' ' 74' ' ' PHE . 0.3 OUTLIER -80.26 -175.53 5.14 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.079 -0.509 . . . . 3.41 110.768 -173.358 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.743 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . . . -71.36 -0.01 9.19 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.592 -0.731 . . . . 1.46 111.958 -176.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.714 ' HB3' ' HG2' ' A' ' 75' ' ' PRO . 3.1 ptpp? 70.45 137.59 0.04 OUTLIER 'General case' 0 CA--C 1.499 -1.001 0 C-N-CA 125.256 1.422 . . . . 2.31 110.604 -170.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.685 HG13 ' CB ' ' A' ' 116' ' ' HIS . 0.1 OUTLIER -140.51 167.44 18.12 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 CA-C-N 113.262 -1.79 . . . . 1.65 106.358 168.297 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.659 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 0.2 OUTLIER -49.72 119.13 3.25 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.785 -0.82 . . . . 1.73 108.785 168.556 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.63 ' HB ' HD21 ' A' ' 42' ' ' ASN . 0.0 OUTLIER -128.28 87.84 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 C-N-CA 119.442 -0.903 . . . . 1.4 108.688 166.763 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.5 t30 171.81 179.59 0.07 Allowed 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 113.981 -1.463 . . . . 2.1 108.908 176.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 3.84 -72.38 0.0 OUTLIER Glycine 0 CA--C 1.528 0.893 0 N-CA-C 118.602 2.201 . . . . 1.47 118.602 168.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -86.23 -46.65 10.16 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 114.462 1.282 . . . . 2.81 114.462 -151.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -129.11 -34.68 1.87 Allowed 'General case' 0 CA--C 1.504 -0.793 0 C-N-CA 119.412 -0.915 . . . . 2.75 111.06 -174.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.659 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . 46.42 -134.07 0.96 Allowed 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 108.833 -0.802 . . . . 1.44 108.833 -172.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.685 ' CB ' HG13 ' A' ' 108' ' ' ILE . 0.9 OUTLIER -161.55 139.99 7.16 Favored Pre-proline 0 N--CA 1.43 -1.455 0 N-CA-C 107.057 -1.46 . . . . 0.71 107.057 178.689 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -27.44 -50.42 0.11 Allowed 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 124.701 3.6 . . . . 0.47 113.891 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.757 HD11 ' HB ' ' A' ' 15' ' ' ILE . 64.7 tp -57.12 -53.41 58.39 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 122.912 0.485 . . . . 1.15 112.259 176.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.847 ' HE2' ' CD2' ' A' ' 74' ' ' PHE . 80.0 m-85 -77.38 -35.37 54.49 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 112.299 0.481 . . . . 3.33 112.299 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.734 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 5.7 mm-40 -57.48 -34.0 68.57 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 107.221 -1.399 . . . . 2.44 107.221 172.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.677 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 70.8 t80 -71.48 -33.5 69.34 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 119.262 -0.975 . . . . 1.08 111.065 173.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.589 ' HE1' HD11 ' A' ' 40' ' ' ILE . 1.8 ttm -74.64 -55.0 6.37 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.275 -0.42 . . . . 1.25 110.465 -171.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.561 ' HD2' ' CB ' ' A' ' 134' ' ' ALA . 0.6 OUTLIER -70.57 -25.74 63.22 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 116.514 -0.312 . . . . 1.86 111.42 178.029 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.734 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 9.4 pttp -68.58 -27.28 65.92 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 119.486 -0.886 . . . . 2.52 109.485 177.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 29.1 m -89.47 -28.01 19.97 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.244 -0.889 . . . . 1.21 110.703 176.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.53 ' HB3' ' NH2' ' A' ' 153' ' ' ARG . 39.9 mmtt -134.04 89.97 27.6 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.087 -0.506 . . . . 2.38 110.945 -177.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -61.51 -40.45 47.5 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.367 2.711 . . . . 1.69 113.851 -175.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.533 ' HA2' ' CZ ' ' A' ' 153' ' ' ARG . . . 149.35 145.99 4.24 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 119.76 -1.21 . . . . 2.59 113.229 178.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.411 HG21 HH12 ' A' ' 153' ' ' ARG . 24.8 pt -68.66 -19.74 24.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.222 0.534 . . . . 3.93 110.839 178.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.647 HD23 ' H ' ' A' ' 130' ' ' LEU . 2.6 pt? -104.18 8.59 36.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.563 0.697 . . . . 3.81 110.009 179.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 60.02 56.83 3.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.131 -1.395 . . . . 3.63 112.472 177.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' THR . . . . . 0.404 ' OG1' ' HG ' ' A' ' 130' ' ' LEU . 90.3 m -105.24 -81.48 0.53 Allowed 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.876 -0.33 . . . . 3.97 111.453 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 73.1 tttt -179.38 -37.2 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.871 0.367 . . . . 5.48 111.282 -175.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.732 ' HB2' HD11 ' A' ' 135' ' ' ILE . . . -142.46 -167.93 2.62 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.2 -0.455 . . . . 1.59 111.266 -174.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.732 HD11 ' HB2' ' A' ' 134' ' ' ALA . 0.2 OUTLIER -51.59 -42.21 29.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 115.585 -0.734 . . . . 2.09 110.18 171.594 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 61.3 tttm 68.09 -38.01 0.35 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.595 1.158 . . . . 5.16 112.797 177.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.598 ' HB3' ' HG3' ' A' ' 156' ' ' PRO . 2.4 m95 -98.85 177.03 5.4 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 122.928 0.491 . . . . 2.41 111.599 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.482 ' HA ' ' HB3' ' A' ' 84' ' ' PRO . 1.6 m120 -39.48 -155.61 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 126.603 1.961 . . . . 2.04 114.128 165.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.774 ' HB3' HG21 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -34.14 -22.19 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 116.063 1.875 . . . . 2.53 116.063 -177.084 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.631 ' HB ' ' HB ' ' A' ' 135' ' ' ILE . 3.7 m 10.49 108.12 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 119.965 1.257 . . . . 1.24 113.911 166.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.48 ' HB3' ' CE1' ' A' ' 41' ' ' TYR . 0.9 OUTLIER -90.75 161.08 15.48 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 114.066 -1.425 . . . . 1.03 110.484 -167.34 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.471 ' HA ' ' HA ' ' A' ' 153' ' ' ARG . 38.6 m-85 -124.64 122.82 38.59 Favored 'General case' 0 CA--C 1.494 -1.206 0 N-CA-C 106.389 -1.708 . . . . 0.7 106.389 168.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.775 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 8.9 tp -79.73 104.88 10.62 Favored 'General case' 0 N--CA 1.425 -1.708 0 C-N-CA 118.348 -1.341 . . . . 1.16 108.416 179.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.679 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 39.3 mm -92.0 142.05 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.717 0 CA-C-N 112.744 -2.025 . . . . 1.05 107.605 -178.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.414 ' HA ' HD13 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -94.43 -175.57 3.67 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 119.131 -1.028 . . . . 0.98 111.316 -170.194 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.601 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 29.9 mtm180 -52.33 -39.6 60.85 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 121.097 0.475 . . . . 2.61 110.909 -178.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -97.33 20.99 10.66 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.334 0.588 . . . . 2.0 109.711 -175.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.696 ' HA3' ' CE2' ' A' ' 16' ' ' PHE . . . 68.73 35.58 80.55 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 115.812 -0.631 . . . . 0.19 114.185 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.457 ' HA ' ' HD2' ' A' ' 150' ' ' PRO . 65.5 t -106.17 108.31 61.46 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 118.387 1.093 . . . . 1.74 111.666 175.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.666 ' HD3' HG21 ' A' ' 15' ' ' ILE . 5.3 Cg_endo -52.05 114.78 1.78 Allowed 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 123.876 3.051 . . . . 0.6 111.256 171.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.94 HG12 ' HG2' ' A' ' 152' ' ' GLU . 13.8 p -116.79 -21.88 4.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-O 121.489 0.661 . . . . 2.06 109.488 -177.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.94 ' HG2' HG12 ' A' ' 151' ' ' VAL . 30.1 mm-40 -138.25 167.54 21.63 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 115.351 -0.841 . . . . 1.17 110.372 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.533 ' CZ ' ' HA2' ' A' ' 128' ' ' GLY . 0.0 OUTLIER -145.14 146.29 31.72 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.137 -0.938 . . . . 2.9 109.571 161.517 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.624 ' CE2' ' HA ' ' A' ' 163' ' ' ILE . 93.2 m-85 -121.95 140.46 52.42 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.874 -0.603 . . . . 0.36 109.457 -172.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 6.3 m -68.14 158.57 83.73 Favored Pre-proline 0 C--N 1.315 -0.913 0 N-CA-C 109.847 -0.427 . . . . 1.45 109.847 178.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.598 ' HG3' ' HB3' ' A' ' 137' ' ' TRP . 18.4 Cg_endo -59.46 -32.4 96.31 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.137 1.891 . . . . 0.78 110.624 174.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -73.06 -0.0 49.29 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 114.515 -1.221 . . . . 0.59 113.724 173.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -85.97 146.15 26.81 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.83 -0.804 . . . . 1.07 108.83 173.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 4.0 t -110.35 -178.83 3.6 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-O 121.082 0.468 . . . . 1.92 110.259 -173.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.719 ' HA ' HG22 ' A' ' 56' ' ' THR . 60.8 t -45.84 -57.25 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 114.609 -1.178 . . . . 1.07 111.79 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 42.5 tttm -63.46 -38.44 91.14 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 120.624 0.25 . . . . 3.89 111.034 -172.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -57.26 -43.27 82.85 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.812 0.815 . . . . 1.4 109.124 -177.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.787 HD11 ' HH ' ' A' ' 41' ' ' TYR . 90.5 mt -75.52 -47.29 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 CA-C-N 114.216 -1.356 . . . . 1.05 111.017 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.622 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 58.2 mt-10 -55.39 -43.49 75.23 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-O 121.089 0.471 . . . . 0.67 111.07 -176.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -63.63 -16.21 60.31 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 116.269 -0.423 . . . . 0.87 111.684 -173.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.573 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 31.5 mmmt -104.51 -21.34 13.46 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.47 0.653 . . . . 2.22 109.964 172.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.59 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 12.8 tp -84.96 -49.53 8.26 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.997 -1.001 . . . . 1.04 112.289 -176.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.571 ' N ' ' HD2' ' A' ' 169' ' ' PRO . 64.1 mt -57.46 -43.7 99.14 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.661 -0.699 . . . . 1.08 112.4 -174.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 168' ' ' ILE . 8.0 Cg_endo -53.65 -20.62 17.12 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 121.894 1.729 . . . . 0.62 112.939 172.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.807 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 99.3 mt -96.42 -43.14 7.78 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 122.416 -0.178 . . . . 1.36 111.205 177.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.607 HD21 ' HB2' ' A' ' 69' ' ' PHE . 96.6 mt -60.08 -56.95 15.31 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-O 121.962 0.887 . . . . 1.07 108.738 173.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -97.27 53.74 1.33 Allowed Glycine 0 N--CA 1.424 -2.154 0 CA-C-N 113.892 -1.504 . . . . 1.12 110.552 178.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.435 ' OG ' ' HD3' ' A' ' 146' ' ' ARG . 3.4 p -72.08 68.75 0.71 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.644 -0.778 . . . . 2.88 112.389 -177.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -76.82 -22.95 52.88 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.406 -0.961 . . . . 4.69 108.406 168.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 53.23 61.73 3.01 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 114.899 -1.046 . . . . 9.17 112.435 167.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 7.2 mp . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.531 -0.747 . . . . 8.03 109.572 176.243 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.428 ' H1 ' ' CG ' ' A' ' 17' ' ' ASP . . . . . . . . 0 N--CA 1.483 1.802 0 N-CA-C 112.565 -0.214 . . . . 5.58 112.565 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.9 ptm 175.06 -30.58 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 122.913 0.485 . . . . 5.23 109.736 178.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 171.56 68.96 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.58 -0.819 . . . . 1.55 112.505 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.1 m -135.93 2.82 2.89 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.507 0.67 . . . . 2.17 110.007 175.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 90.9 p -178.48 151.81 0.62 Allowed 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.678 -1.971 . . . . 1.68 105.678 175.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.745 ' HB ' HD13 ' A' ' 118' ' ' LEU . 6.5 pt -69.12 -13.99 17.95 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 CA-C-N 114.787 -1.097 . . . . 1.16 111.801 -171.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.808 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 54.8 m-85 -77.21 -3.26 38.72 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.273 -0.421 . . . . 0.3 111.189 -177.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.428 ' CG ' ' H1 ' ' A' ' 10' ' ' GLY . 83.2 m-20 -69.24 -21.06 63.94 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.275 -1.009 . . . . 2.11 108.275 172.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.663 ' HE2' ' HB2' ' A' ' 121' ' ' TYR . 49.6 m-85 -114.14 111.1 21.03 Favored 'General case' 0 CA--C 1.503 -0.853 0 CA-C-N 114.718 -1.128 . . . . 0.37 111.84 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -50.42 150.35 2.66 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.142 -1.39 . . . . 2.86 109.941 169.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.746 HG11 ' CZ ' ' A' ' 74' ' ' PHE . 38.0 t -111.43 164.02 7.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 N-CA-C 108.894 -0.78 . . . . 1.32 108.894 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.757 ' O ' ' HB3' ' A' ' 105' ' ' MET . 89.6 mt -126.4 113.11 16.45 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 120.873 -0.331 . . . . 1.29 111.65 -176.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.631 ' HA ' ' CE ' ' A' ' 105' ' ' MET . 12.1 t70 -51.6 160.42 0.63 Allowed 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 107.779 -1.193 . . . . 1.87 107.779 169.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.66 ' HA ' ' C ' ' A' ' 105' ' ' MET . . . -54.53 -16.69 2.53 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 114.147 1.166 . . . . 1.2 114.147 -163.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.552 ' HB2' ' HE2' ' A' ' 26' ' ' LYS . 33.4 m-20 -96.15 5.32 51.35 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 112.325 0.491 . . . . 2.34 112.325 178.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.711 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 82.8 m-70 78.13 15.21 1.43 Allowed 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.699 0.762 . . . . 2.26 109.163 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.552 ' HE2' ' HB2' ' A' ' 24' ' ' ASP . 13.2 mtmt -79.64 119.15 75.89 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 107.212 -1.403 . . . . 4.64 107.212 169.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.628 ' HA ' HD21 ' A' ' 21' ' ' LEU . 84.6 Cg_exo -51.7 113.91 1.36 Allowed 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 121.582 1.521 . . . . 0.62 113.157 -173.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.554 ' HB3' HG12 ' A' ' 20' ' ' VAL . 32.3 t80 -79.35 144.8 33.86 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.074 -1.421 . . . . 1.52 111.366 175.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.431 ' OD1' ' HB3' ' A' ' 32' ' ' GLN . 2.4 t-20 -78.85 85.38 4.83 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.026 -0.988 . . . . 2.16 109.934 178.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.594 ' HG ' ' CD1' ' A' ' 16' ' ' PHE . 49.1 tp -63.26 -42.37 99.14 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.393 -0.821 . . . . 1.07 110.471 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.775 ' HA ' ' CE1' ' A' ' 16' ' ' PHE . 2.0 t -68.99 -0.64 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 114.424 -1.262 . . . . 1.69 112.481 -167.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.431 ' HB3' ' OD1' ' A' ' 29' ' ' ASN . 10.4 pt20 -76.52 -5.26 46.79 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.531 0.681 . . . . 1.31 110.321 177.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.954 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 87.9 m-70 -100.71 24.29 9.31 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.843 0.83 . . . . 0.35 109.335 173.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.808 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 0.5 OUTLIER -82.82 110.42 17.82 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.724 -1.125 . . . . 2.07 109.311 171.762 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.26 -37.42 2.2 Favored Glycine 0 N--CA 1.437 -1.249 0 C-N-CA 120.917 -0.659 . . . . 0.24 111.506 -177.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.467 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 17.6 m -132.33 133.11 23.34 Favored Pre-proline 0 N--CA 1.435 -1.197 0 N-CA-C 108.626 -0.879 . . . . 0.74 108.626 173.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.799 ' HG3' ' CB ' ' A' ' 170' ' ' LEU . 6.8 Cg_endo -44.04 153.45 0.31 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 124.124 3.216 . . . . 0.22 112.614 178.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.775 ' HB2' HG22 ' A' ' 70' ' ' THR . 0.7 OUTLIER -140.61 139.41 34.89 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.027 -1.471 . . . . 1.09 107.027 -179.919 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.785 ' HB3' ' CE1' ' A' ' 41' ' ' TYR . 3.0 mp -107.17 116.66 32.32 Favored 'General case' 0 C--N 1.293 -1.881 0 O-C-N 121.518 -0.739 . . . . 1.82 109.449 176.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.905 HG22 ' HB2' ' A' ' 72' ' ' LEU . 2.6 mt -95.77 120.35 45.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-N 115.557 -0.747 . . . . 1.12 109.761 176.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.785 ' CE1' ' HB3' ' A' ' 39' ' ' LEU . 0.5 OUTLIER -103.87 124.95 49.88 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.493 -0.776 . . . . 1.09 110.041 -174.555 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.677 ' OD1' ' HB ' ' A' ' 140' ' ' THR . 0.2 OUTLIER -75.61 125.66 29.47 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 104.309 -2.478 . . . . 3.11 104.309 168.525 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.675 ' O ' ' HA ' ' A' ' 75' ' ' PRO . 2.8 p -133.14 123.88 48.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 C-N-CA 117.665 -1.614 . . . . 1.69 113.114 -169.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.59 98.07 3.3 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.125 -0.943 . . . . 1.45 108.842 172.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.664 ' HA ' ' HB3' ' A' ' 98' ' ' PHE . 3.4 p -48.04 82.4 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 113.954 -1.475 . . . . 1.99 112.138 169.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.783 ' HE3' ' HB3' ' A' ' 49' ' ' TYR . 27.3 mtpp -101.49 163.86 12.05 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.282 -0.636 . . . . 6.2 109.282 178.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 33.9 t -110.12 116.95 32.47 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 120.934 0.397 . . . . 4.12 109.997 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 66.97 25.24 73.25 Favored Glycine 0 CA--C 1.519 0.319 0 CA-C-N 115.749 -0.66 . . . . 3.44 112.69 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.783 ' HB3' ' HE3' ' A' ' 46' ' ' LYS . 0.3 OUTLIER -136.23 135.11 38.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.014 0.435 . . . . 4.84 111.494 -177.542 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -147.9 141.32 25.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.517 -0.765 . . . . 2.41 110.148 178.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.533 ' HD3' ' OD1' ' A' ' 138' ' ' ASN . 27.8 mtpp -112.7 48.55 1.0 Allowed 'General case' 0 C--O 1.223 -0.333 0 N-CA-C 110.232 -0.284 . . . . 2.47 110.232 176.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.13 -42.12 3.03 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.775 -0.726 . . . . 0.85 112.077 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -47.55 -45.16 23.18 Favored Glycine 0 C--O 1.224 -0.517 0 O-C-N 123.792 0.348 . . . . 0.67 113.686 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.643 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 1.1 t80 -61.38 -62.97 1.45 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.049 0.389 . . . . 1.2 112.049 -172.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -59.24 -40.14 84.98 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.188 0.518 . . . . 2.61 111.121 -178.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.543 ' HA ' ' CG2' ' A' ' 160' ' ' VAL . 40.8 m -54.97 -59.92 4.09 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.163 -0.926 . . . . 1.06 111.193 174.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 1.036 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -61.81 -42.55 99.16 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.417 -0.811 . . . . 1.05 111.15 -176.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.594 ' N ' ' HE1' ' A' ' 102' ' ' PHE . 61.5 m -55.33 -51.08 67.92 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.814 0.816 . . . . 1.08 109.825 -177.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 26.5 m -72.11 -35.15 69.1 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 114.402 -1.272 . . . . 1.22 111.22 -177.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.613 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 17.4 mt -67.57 -50.04 60.35 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 121.365 0.602 . . . . 1.14 110.413 -176.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.844 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 8.4 t80 -59.36 -47.21 86.29 Favored 'General case' 0 C--O 1.205 -1.27 0 CA-C-N 114.967 -1.015 . . . . 0.94 110.502 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -73.76 -24.29 59.84 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 112.022 0.379 . . . . 1.6 112.022 -174.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.467 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 32.2 ttpt -84.54 -25.99 28.36 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 120.02 -0.672 . . . . 2.06 109.275 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.703 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 35.9 m-85 -123.2 -5.79 8.34 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 115.121 1.526 . . . . 0.92 115.121 -169.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.697 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 41.4 pttt -65.48 -26.59 67.99 Favored 'General case' 0 CA--C 1.5 -0.975 0 N-CA-C 108.434 -0.95 . . . . 1.89 108.434 172.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.2 t -47.91 -41.86 25.65 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.458 -1.246 . . . . 1.68 110.733 172.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -82.03 -37.41 26.56 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 111.821 0.304 . . . . 1.11 111.821 175.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.444 ' HA3' ' HB2' ' A' ' 36' ' ' SER . . . 150.58 -7.95 0.72 Allowed Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 111.622 -0.591 . . . . 0.2 111.622 -176.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.703 ' HD2' ' HB2' ' A' ' 64' ' ' TYR . 13.7 t80 -64.41 143.33 57.98 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 122.777 0.431 . . . . 0.21 110.841 -178.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.954 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 5.3 t -132.91 148.16 52.29 Favored 'General case' 0 N--CA 1.416 -2.127 0 N-CA-C 108.848 -0.797 . . . . 1.02 108.848 168.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 1.036 HG11 ' HB1' ' A' ' 57' ' ' ALA . 21.8 t -100.07 100.78 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.419 0 N-CA-C 107.199 -1.408 . . . . 1.04 107.199 158.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.905 ' HB2' HG22 ' A' ' 40' ' ' ILE . 79.8 mt -84.26 118.87 24.45 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 107.085 -1.45 . . . . 1.69 107.085 178.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.622 ' HB1' HG11 ' A' ' 43' ' ' VAL . . . -96.44 113.41 24.99 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.939 -0.704 . . . . 1.17 109.838 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.869 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 5.0 m-85 -108.96 95.22 16.62 Favored Pre-proline 0 N--CA 1.433 -1.286 0 N-CA-C 107.337 -1.357 . . . . 0.58 107.337 -177.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.898 ' HB2' ' HG2' ' A' ' 107' ' ' LYS . 3.4 Cg_endo -67.33 148.37 79.71 Favored 'Trans proline' 0 N--CA 1.429 -2.314 0 N-CA-C 109.091 -1.157 . . . . 1.3 109.091 -174.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.59 ' HB2' ' OE1' ' A' ' 83' ' ' GLU . 29.2 p -76.17 141.31 41.89 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-O 121.988 0.899 . . . . 1.91 112.76 -177.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.479 ' C ' ' H ' ' A' ' 79' ' ' PHE . 62.2 t30 -69.28 62.7 0.14 Allowed 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 113.56 -1.655 . . . . 1.93 108.622 170.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.8 ' HA ' ' HG3' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -51.24 -13.34 0.18 Allowed 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 114.577 -1.192 . . . . 3.97 111.135 174.313 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.479 ' H ' ' C ' ' A' ' 77' ' ' ASN . 50.1 t80 -66.7 -13.61 61.5 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.979 -1.01 . . . . 3.21 110.519 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.32 -135.36 5.05 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.192 -0.528 . . . . 1.98 112.109 175.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -159.02 54.32 0.37 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.932 -0.652 . . . . 1.66 112.153 178.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.58 ' HG3' ' HB3' ' A' ' 113' ' ' GLU . 3.5 pm0 -153.97 5.5 0.3 Allowed 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.348 0.594 . . . . 1.74 110.77 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.8 ' HG3' ' HA ' ' A' ' 78' ' ' GLN . 15.8 mm-40 -80.17 137.51 52.9 Favored Pre-proline 0 C--N 1.308 -1.208 0 N-CA-C 114.443 1.275 . . . . 3.07 114.443 -159.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.682 ' HA ' ' O ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -34.1 148.25 0.03 OUTLIER 'Trans proline' 0 C--O 1.235 0.357 1 C-N-CA 126.521 4.814 . . . . 1.75 116.447 176.351 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.67 -46.75 3.7 Favored Glycine 0 N--CA 1.441 -0.995 0 CA-C-N 114.857 -1.065 . . . . 2.27 113.972 167.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.509 ' O ' ' HB2' ' A' ' 87' ' ' GLU . 27.0 t-20 -171.69 -34.48 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.852 1.056 . . . . 4.88 113.852 -170.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.509 ' HB2' ' O ' ' A' ' 86' ' ' ASN . 52.1 mt-10 76.36 -63.17 0.4 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.787 0.435 . . . . 3.02 111.737 -177.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.654 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 41.5 mm-40 -68.51 -45.49 72.14 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.535 0.939 . . . . 3.92 113.535 -168.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.489 ' CD ' ' HZ2' ' A' ' 46' ' ' LYS . 36.1 tt0 -48.37 -54.29 14.47 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.719 0.637 . . . . 2.65 112.719 -168.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.68 HG23 ' HB2' ' A' ' 95' ' ' CYS . 4.0 mp -65.69 -26.03 37.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 111.976 0.361 . . . . 2.63 111.976 -171.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.654 ' HE2' ' HA ' ' A' ' 88' ' ' GLU . 38.6 mtmt -80.65 -37.27 31.23 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.208 0.527 . . . . 3.13 110.58 -178.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' A' ' 88' ' ' GLU . 32.1 mm-40 -90.26 -39.26 12.87 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.558 -0.746 . . . . 3.29 110.614 -173.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -88.97 162.22 16.18 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.082 -0.963 . . . . 4.08 109.435 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 73.3 t -79.21 107.66 11.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 108.949 -0.759 . . . . 3.05 108.949 173.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.68 ' HB2' HG23 ' A' ' 90' ' ' ILE . 33.2 m -152.84 122.41 6.81 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.202 -0.908 . . . . 3.04 108.855 178.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.459 ' C ' ' H ' ' A' ' 98' ' ' PHE . 1.4 m -146.23 123.83 11.8 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.485 -0.486 . . . . 3.38 110.432 174.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.777 ' HB2' ' HD2' ' A' ' 99' ' ' LYS . 99.5 mttt 72.71 -26.48 0.18 Allowed 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.059 -0.973 . . . . 3.11 113.207 172.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.953 ' HZ ' ' HE2' ' A' ' 102' ' ' PHE . 0.2 OUTLIER 67.87 -41.08 0.43 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.938 1.295 . . . . 2.12 110.913 -176.152 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.777 ' HD2' ' HB2' ' A' ' 97' ' ' LYS . 0.0 OUTLIER 66.42 142.8 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.223 1.009 . . . . 3.1 113.124 173.67 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.567 ' HB1' ' CE1' ' A' ' 98' ' ' PHE . . . -176.06 -167.63 0.23 Allowed 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 115.179 -0.919 . . . . 1.15 111.518 -168.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.638 ' O ' ' HD2' ' A' ' 61' ' ' TYR . 62.6 mm-40 -100.92 48.12 0.9 Allowed 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 114.665 -1.152 . . . . 1.99 110.837 176.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.953 ' HE2' ' HZ ' ' A' ' 98' ' ' PHE . 1.6 m-85 -128.25 175.98 3.07 Favored Pre-proline 0 CA--C 1.511 -0.543 0 CA-C-O 121.466 0.651 . . . . 1.31 109.724 172.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.667 ' HD3' ' CE2' ' A' ' 61' ' ' TYR . 14.4 Cg_exo -76.48 77.75 3.51 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 123.519 2.813 . . . . 1.07 109.936 158.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.565 HG12 ' HB2' ' A' ' 73' ' ' ALA . 76.4 mt -80.44 126.52 39.55 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.504 0 N-CA-C 107.978 -1.119 . . . . 1.97 107.978 176.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.869 ' HG3' ' CE1' ' A' ' 74' ' ' PHE . 7.1 mmt -105.56 -168.12 1.41 Allowed 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 121.727 0.775 . . . . 3.41 113.032 -163.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.628 ' HB2' ' CD2' ' A' ' 25' ' ' HIS . . . -76.47 6.81 5.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.637 -1.165 . . . . 1.46 113.755 -167.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.898 ' HG2' ' HB2' ' A' ' 75' ' ' PRO . 57.1 mttp 65.99 139.29 0.03 OUTLIER 'General case' 0 CA--C 1.491 -1.315 0 CA-C-O 122.51 1.148 . . . . 2.31 110.847 -169.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.778 HG13 ' HB3' ' A' ' 116' ' ' HIS . 0.1 OUTLIER -138.45 163.71 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.576 0 N-CA-C 106.428 -1.693 . . . . 1.65 106.428 165.96 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.556 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 0.2 OUTLIER -73.16 83.56 1.33 Allowed 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 120.612 0.244 . . . . 1.73 110.375 -177.428 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.722 HG13 ' CD2' ' A' ' 119' ' ' TYR . 2.6 m -80.25 90.15 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-O 121.848 0.832 . . . . 1.4 109.299 176.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.649 HD21 ' HD3' ' A' ' 84' ' ' PRO . 2.9 t-20 174.77 -177.17 0.09 Allowed 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 114.177 -1.374 . . . . 2.1 107.988 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -91.44 37.46 3.38 Favored Glycine 0 N--CA 1.435 -1.395 0 C-N-CA 120.12 -1.038 . . . . 1.47 114.49 -177.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.58 ' HB3' ' HG3' ' A' ' 82' ' ' GLN . 0.2 OUTLIER -105.28 -50.41 3.23 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 118.974 -1.09 . . . . 2.81 110.849 170.664 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.422 ' N ' ' HG3' ' A' ' 113' ' ' GLU . 3.0 t-20 -131.86 -42.12 1.02 Allowed 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 118.781 -1.167 . . . . 2.75 111.568 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.556 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . 54.52 139.57 0.0 OUTLIER 'General case' 0 C--N 1.345 0.404 0 CA-C-O 122.13 0.967 . . . . 1.44 111.651 -176.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.778 ' HB3' HG13 ' A' ' 108' ' ' ILE . 1.6 t-80 -88.26 143.12 32.22 Favored Pre-proline 0 C--N 1.312 -1.028 0 O-C-N 120.602 -1.311 . . . . 0.71 107.557 178.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -24.99 -48.03 0.06 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 124.678 3.585 . . . . 0.47 113.847 178.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.745 HD13 ' HB ' ' A' ' 15' ' ' ILE . 38.5 tp -69.35 -45.92 68.24 Favored 'General case' 0 C--O 1.216 -0.684 0 C-N-CA 122.598 0.359 . . . . 1.15 111.827 -179.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.722 ' CD2' HG13 ' A' ' 110' ' ' VAL . 9.7 m-85 -82.54 -32.16 28.75 Favored 'General case' 0 CA--C 1.491 -1.303 0 CA-C-O 121.709 0.766 . . . . 3.33 110.9 -175.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.512 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 2.9 tm-20 -64.03 -35.03 79.38 Favored 'General case' 0 N--CA 1.424 -1.749 0 N-CA-C 107.031 -1.47 . . . . 2.44 107.031 172.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.663 ' HB2' ' HE2' ' A' ' 18' ' ' PHE . 28.7 t80 -72.45 -26.75 61.94 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.96 -1.018 . . . . 1.08 110.253 170.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.683 ' HG2' ' O ' ' A' ' 118' ' ' LEU . 15.4 mmt -71.95 -55.93 6.59 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 121.66 0.743 . . . . 1.25 110.287 -170.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.656 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -72.84 -25.48 61.14 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.214 -0.903 . . . . 1.86 110.565 178.655 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.512 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 27.2 tttt -60.96 -38.42 85.82 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 109.079 -0.712 . . . . 2.52 109.079 169.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.428 ' HB ' ' O ' ' A' ' 122' ' ' MET . 96.2 m -65.43 -55.71 16.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.29 -0.868 . . . . 1.21 110.644 177.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -155.47 122.3 2.71 Favored Pre-proline 0 N--CA 1.452 -0.369 0 N-CA-C 113.392 0.886 . . . . 2.38 113.392 -174.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.796 ' HA ' ' NH2' ' A' ' 153' ' ' ARG . 1.6 Cg_endo -87.99 61.41 3.32 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 124.673 3.582 . . . . 1.69 109.418 166.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.415 ' C ' ' H ' ' A' ' 130' ' ' LEU . . . -62.89 139.4 44.87 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.039 -0.982 . . . . 2.59 113.274 -173.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 71.9 mt 72.33 -41.93 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 123.559 0.744 . . . . 3.93 111.539 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.431 ' C ' ' H ' ' A' ' 132' ' ' THR . 0.5 OUTLIER -130.8 112.72 13.29 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.906 0.384 . . . . 3.81 110.94 -178.813 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.421 ' HA ' ' HB2' ' A' ' 127' ' ' PRO . . . -79.35 38.52 0.36 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.376 0.608 . . . . 3.63 110.774 177.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' THR . . . . . 0.431 ' H ' ' C ' ' A' ' 130' ' ' LEU . 28.1 m -77.22 -76.75 0.16 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.492 -0.777 . . . . 3.97 110.716 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -153.33 -76.21 0.12 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 122.074 0.94 . . . . 5.48 109.053 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.631 ' HB1' HD12 ' A' ' 135' ' ' ILE . . . -135.59 -164.13 1.49 Allowed 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.279 -1.328 . . . . 1.59 110.159 -173.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.813 ' H ' HD12 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -41.75 -61.4 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 O-C-N 124.495 1.122 . . . . 2.09 111.971 177.432 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.882 ' HB3' ' CZ3' ' A' ' 137' ' ' TRP . 3.1 tmtp? 77.7 -27.67 0.17 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.064 0.946 . . . . 5.16 113.257 167.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.882 ' CZ3' ' HB3' ' A' ' 136' ' ' LYS . 1.9 m-90 -104.23 176.89 5.01 Favored 'General case' 0 CA--C 1.507 -0.696 0 O-C-N 122.235 -0.291 . . . . 2.41 110.525 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.533 ' OD1' ' HD3' ' A' ' 51' ' ' LYS . 6.6 m120 -39.46 -154.23 0.0 OUTLIER 'General case' 0 C--O 1.203 -1.366 0 O-C-N 124.822 1.326 . . . . 2.04 111.5 160.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.623 ' HD2' ' CD2' ' A' ' 41' ' ' TYR . 2.2 m-85 -31.35 -25.19 0.0 OUTLIER 'General case' 0 CA--C 1.567 1.597 0 N-CA-C 117.691 2.478 . . . . 2.53 117.691 -171.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.746 ' HA ' ' O ' ' A' ' 154' ' ' PHE . 1.4 m 6.56 101.3 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 120.495 1.498 . . . . 1.24 114.086 170.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.467 ' O ' ' HA ' ' A' ' 153' ' ' ARG . 4.5 m -89.12 176.03 7.14 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.22 -0.9 . . . . 1.03 112.195 -170.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.585 ' HA ' ' O ' ' A' ' 152' ' ' GLU . 79.5 m-85 -134.25 124.44 25.93 Favored 'General case' 0 CA--C 1.491 -1.297 0 N-CA-C 106.422 -1.695 . . . . 0.7 106.422 161.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.809 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 5.8 tp -80.52 103.97 10.74 Favored 'General case' 0 N--CA 1.423 -1.82 0 C-N-CA 118.487 -1.285 . . . . 1.16 108.342 177.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.772 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 27.9 mm -90.76 141.35 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.822 0 CA-C-N 113.41 -1.723 . . . . 1.05 107.656 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.533 ' OD1' HG13 ' A' ' 149' ' ' VAL . 0.0 OUTLIER -94.71 -173.68 3.08 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 119.541 -0.863 . . . . 0.98 111.234 -169.905 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.433 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 44.2 mtm180 -54.83 -36.48 65.05 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.14 0.275 . . . . 2.61 111.326 -177.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -104.05 20.97 17.26 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 121.569 0.7 . . . . 2.0 109.245 -176.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.637 ' HA2' ' CG2' ' A' ' 144' ' ' ILE . . . 70.43 36.37 69.26 Favored Glycine 0 N--CA 1.435 -1.396 0 CA-C-N 114.624 -1.171 . . . . 0.19 115.126 175.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.533 HG13 ' OD1' ' A' ' 145' ' ' ASP . 5.2 p -103.67 129.98 24.34 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 119.528 1.664 . . . . 1.74 110.379 172.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.559 ' HA ' HD11 ' A' ' 144' ' ' ILE . 3.6 Cg_exo -69.84 121.33 8.0 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.6 2.2 . . . . 0.6 110.493 179.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 22.1 t -114.7 -27.01 2.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-O 121.426 0.631 . . . . 2.06 109.401 -176.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.809 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 60.7 mm-40 -138.17 165.47 26.57 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.363 -0.835 . . . . 1.17 111.441 -178.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.796 ' NH2' ' HA ' ' A' ' 127' ' ' PRO . 2.6 ttm180 -145.6 125.2 13.26 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.761 -1.109 . . . . 2.9 109.146 165.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.746 ' O ' ' HA ' ' A' ' 140' ' ' THR . 91.2 m-85 -107.19 149.95 27.14 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.203 -0.908 . . . . 0.36 108.74 -169.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 19.4 m -76.98 158.51 80.13 Favored Pre-proline 0 C--N 1.313 -0.998 0 N-CA-C 108.795 -0.817 . . . . 1.45 108.795 175.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.533 ' HG3' ' HB3' ' A' ' 137' ' ' TRP . 10.8 Cg_endo -54.52 -48.91 18.86 Favored 'Trans proline' 0 N--CA 1.465 -0.202 0 C-N-CA 121.874 1.716 . . . . 0.78 110.685 178.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -59.52 -2.0 1.45 Allowed Glycine 0 CA--C 1.529 0.964 0 CA-C-N 114.753 -1.112 . . . . 0.59 114.902 174.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -84.69 134.07 34.37 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 107.982 -1.118 . . . . 1.07 107.982 171.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.516 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 6.8 t -110.68 -174.58 2.51 Favored 'General case' 0 N--CA 1.435 -1.177 0 C-N-CA 119.976 -0.69 . . . . 1.92 110.757 -167.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.543 ' CG2' ' HA ' ' A' ' 56' ' ' THR . 64.0 t -45.44 -50.92 2.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 114.7 -1.137 . . . . 1.07 111.202 -176.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -68.79 -35.07 76.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.137 -0.483 . . . . 3.89 111.22 -174.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.437 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 28.2 m-20 -68.91 -35.17 76.52 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.779 0.799 . . . . 1.4 109.553 -177.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.486 HG22 HD13 ' A' ' 60' ' ' LEU . 46.5 mt -80.56 -48.08 20.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 114.494 -1.23 . . . . 1.05 111.354 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.616 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 49.3 mt-10 -53.81 -39.3 65.4 Favored 'General case' 0 C--O 1.217 -0.631 0 CA-C-O 120.888 0.375 . . . . 0.67 111.39 -176.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.437 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 12.1 pt-20 -60.86 -21.93 63.74 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.636 0.255 . . . . 0.87 111.544 -176.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.555 ' HB3' HD23 ' A' ' 143' ' ' LEU . 35.7 mmtp -100.07 -22.85 15.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.382 0.61 . . . . 2.22 110.13 174.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.616 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 12.9 tp -85.8 -50.03 7.46 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.037 -0.983 . . . . 1.04 112.36 -174.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.548 ' N ' ' HD2' ' A' ' 169' ' ' PRO . 73.8 mt -54.09 -46.95 98.55 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.628 -0.715 . . . . 1.08 112.643 -173.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 168' ' ' ILE . 14.7 Cg_endo -58.62 -16.23 29.31 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.192 1.928 . . . . 0.62 113.026 175.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.799 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 95.4 mt -97.11 -41.31 8.4 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 122.006 -0.433 . . . . 1.36 110.784 177.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.599 HD21 ' HG2' ' A' ' 37' ' ' PRO . 96.0 mt -63.28 -53.61 50.22 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-O 122.21 1.005 . . . . 1.07 109.727 175.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -75.93 -11.46 84.68 Favored Glycine 0 N--CA 1.433 -1.55 0 CA-C-N 113.323 -1.762 . . . . 1.12 112.365 -176.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 8.7 t 62.9 92.39 0.06 Allowed 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.421 0.629 . . . . 2.88 110.538 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -58.29 -42.13 85.94 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.695 -0.684 . . . . 4.69 110.63 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 77.6 mtm180 56.74 -156.33 0.29 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.125 -0.488 . . . . 9.17 110.74 178.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 37.8 tp . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.244 -0.884 . . . . 8.03 109.263 176.315 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.9 0 N-CA-C 112.072 -0.411 . . . . 5.58 112.072 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.426 ' SD ' ' N ' ' A' ' 11' ' ' MET . 1.6 mpt? -79.62 55.54 2.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.268 0.556 . . . . 5.23 109.717 178.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.67 179.68 16.27 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.136 -1.186 . . . . 1.55 110.136 -170.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.9 m -141.31 13.17 2.18 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.514 0.673 . . . . 2.17 110.175 177.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 80.0 p 178.85 177.8 0.47 Allowed 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 105.89 -1.893 . . . . 1.68 105.89 -173.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.838 HG22 ' HD3' ' A' ' 150' ' ' PRO . 3.7 pt -89.71 -15.36 8.8 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 CA-C-N 115.579 -0.737 . . . . 1.16 110.378 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.796 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 36.3 m-85 -70.52 -13.23 62.02 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.259 0.552 . . . . 0.3 110.854 -179.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -63.93 -24.67 67.82 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.64 -0.874 . . . . 2.11 108.64 173.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.584 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 50.9 m-85 -112.49 105.6 13.87 Favored 'General case' 0 CA--C 1.495 -1.145 0 CA-C-N 114.972 -1.013 . . . . 0.37 110.341 178.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -52.16 146.19 9.4 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.68 -1.145 . . . . 2.86 109.903 174.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.768 HG13 ' HZ ' ' A' ' 74' ' ' PHE . 54.7 t -109.26 159.17 8.85 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 107.464 -1.31 . . . . 1.32 107.464 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.846 ' O ' ' HB2' ' A' ' 105' ' ' MET . 26.2 mt -126.99 167.82 15.38 Favored 'General case' 0 N--CA 1.433 -1.312 0 C-N-CA 120.323 -0.551 . . . . 1.29 110.279 -176.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -86.69 -179.27 6.55 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.64 -0.874 . . . . 1.87 108.64 175.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.684 ' HA ' ' N ' ' A' ' 106' ' ' ALA . . . -63.58 -9.13 11.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 118.527 0.603 . . . . 1.2 111.415 -178.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.497 ' HB2' ' HE2' ' A' ' 26' ' ' LYS . 11.8 m-20 -107.85 7.74 28.3 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.559 -0.291 . . . . 2.34 111.562 174.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.692 ' CD2' ' HB2' ' A' ' 106' ' ' ALA . 3.8 m170 72.29 15.1 5.37 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 121.68 0.753 . . . . 2.26 110.181 174.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.497 ' HE2' ' HB2' ' A' ' 24' ' ' ASP . 27.5 mtmt -76.39 133.38 71.35 Favored Pre-proline 0 C--O 1.221 -0.426 0 N-CA-C 107.228 -1.397 . . . . 4.64 107.228 165.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.674 ' HA ' HD21 ' A' ' 21' ' ' LEU . 85.2 Cg_exo -48.86 115.94 1.91 Allowed 'Trans proline' 0 CA--C 1.532 0.418 0 C-N-CA 122.11 1.873 . . . . 0.62 113.719 -175.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.705 ' H ' ' HA ' ' A' ' 21' ' ' LEU . 0.4 OUTLIER -77.32 153.07 34.19 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.32 -1.309 . . . . 1.52 109.031 168.898 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.607 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.1 t-20 -92.32 84.15 5.13 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.446 0.641 . . . . 2.16 109.34 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.739 HD21 HG21 ' A' ' 20' ' ' VAL . 64.0 tp -67.27 -47.41 70.75 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.499 -0.773 . . . . 1.07 110.746 -178.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.84 HG13 ' HG3' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -69.55 -0.68 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.351 -0.841 . . . . 1.69 112.704 -168.199 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.607 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 3.9 pt20 -75.08 -11.04 60.0 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.393 -0.595 . . . . 1.31 109.393 174.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.95 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 89.5 m-70 -95.81 18.05 13.91 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.933 0.873 . . . . 0.35 109.124 175.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.84 ' HG3' HG13 ' A' ' 31' ' ' VAL . 23.7 mtmt -77.69 110.97 12.98 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 114.464 -1.244 . . . . 2.07 108.874 166.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 131.86 -44.99 1.16 Allowed Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 120.754 -0.736 . . . . 0.24 111.499 -178.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.459 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 43.4 m -129.05 134.93 26.87 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 108.721 -0.844 . . . . 0.74 108.721 172.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.734 ' HG3' ' CB ' ' A' ' 170' ' ' LEU . 5.2 Cg_endo -42.38 153.9 0.13 Allowed 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 124.403 3.402 . . . . 0.22 113.093 177.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.8 HD13 ' HB2' ' A' ' 33' ' ' HIS . 0.6 OUTLIER -138.32 143.6 40.02 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 113.737 -1.574 . . . . 1.09 106.847 179.79 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 1.026 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 1.6 mm? -109.78 117.87 35.01 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.199 -1.038 . . . . 1.82 108.199 178.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.93 HD12 ' HE2' ' A' ' 122' ' ' MET . 5.8 mt -108.24 129.85 61.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 C-N-CA 120.107 -0.637 . . . . 1.12 109.679 -178.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 1.026 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.5 OUTLIER -114.31 130.28 56.66 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 116.132 -0.485 . . . . 1.09 111.315 -168.664 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.777 ' ND2' ' HB ' ' A' ' 135' ' ' ILE . 2.5 p-10 -84.36 93.54 8.28 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 107.798 -1.186 . . . . 3.11 107.798 166.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 1.046 HG13 ' HB2' ' A' ' 73' ' ' ALA . 2.7 p -105.33 154.99 6.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-N 115.444 -0.798 . . . . 1.69 111.481 -161.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.419 ' HB3' ' OD1' ' A' ' 86' ' ' ASN . . . -103.96 103.06 12.85 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 114.983 -1.008 . . . . 1.45 110.405 176.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.82 ' HA ' ' HB2' ' A' ' 98' ' ' PHE . 1.4 p -24.77 124.63 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 114.283 -1.326 . . . . 1.99 113.085 170.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.403 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 20.7 ptmt -60.46 105.22 0.41 Allowed 'General case' 0 C--O 1.232 0.156 0 CA-C-N 114.984 -1.007 . . . . 6.2 112.714 -170.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.505 ' SG ' ' HB3' ' A' ' 95' ' ' CYS . 9.3 p -163.91 114.66 1.32 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.266 -0.879 . . . . 4.12 109.266 172.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 69.84 -50.18 0.68 Allowed Glycine 0 CA--C 1.524 0.637 0 C-N-CA 121.258 -0.496 . . . . 3.44 113.397 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -119.23 118.98 32.74 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.442 0.639 . . . . 4.84 112.459 -174.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.85 HG22 ' HD2' ' A' ' 54' ' ' TYR . 7.8 m -145.08 93.33 2.38 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.466 -0.939 . . . . 2.41 108.466 170.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.607 ' HB3' ' HB2' ' A' ' 156' ' ' PRO . 54.4 tttp -79.26 59.19 2.74 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.543 0.572 . . . . 2.47 112.543 -167.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.6 ' O ' ' HG3' ' A' ' 55' ' ' GLU . . . 79.67 -33.97 2.09 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 120.904 -0.665 . . . . 0.85 113.721 172.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -54.06 -21.5 17.87 Favored Glycine 0 C--O 1.221 -0.712 0 C-N-CA 121.379 -0.439 . . . . 0.67 113.676 -177.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.85 ' HD2' HG22 ' A' ' 50' ' ' THR . 0.1 OUTLIER -65.14 -61.53 2.08 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 117.595 0.697 . . . . 1.2 109.921 179.825 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.6 ' HG3' ' O ' ' A' ' 52' ' ' GLY . 0.1 OUTLIER -59.57 -21.8 60.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.612 -0.722 . . . . 2.61 110.044 179.896 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.65 ' HA ' ' CG2' ' A' ' 160' ' ' VAL . 29.6 m -77.4 -59.76 2.65 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 114.814 -1.085 . . . . 1.06 110.623 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 1.03 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -61.19 -35.08 76.2 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.339 -0.846 . . . . 1.05 110.684 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.651 ' HA ' ' CD1' ' A' ' 102' ' ' PHE . 89.6 m -60.21 -59.18 5.83 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.742 -0.663 . . . . 1.08 110.59 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 56.5 m -70.0 -35.13 74.14 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-N 115.515 -0.766 . . . . 1.22 111.936 -176.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.716 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 21.7 mt -62.33 -52.03 65.29 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 121.302 0.572 . . . . 1.14 110.481 -177.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.775 ' HD1' ' HA ' ' A' ' 70' ' ' THR . 34.3 t80 -51.86 -56.01 16.61 Favored 'General case' 0 C--O 1.204 -1.298 0 CA-C-N 114.584 -1.189 . . . . 0.94 111.108 177.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -71.62 -23.93 61.79 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 122.395 0.278 . . . . 1.6 111.078 -172.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.561 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 37.3 ttpt -86.03 -20.68 28.46 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 109.312 -0.625 . . . . 2.06 109.312 -177.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.62 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 44.1 m-85 -128.02 -6.43 5.52 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 114.547 1.314 . . . . 0.92 114.547 -171.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.738 ' HD2' ' CZ ' ' A' ' 61' ' ' TYR . 13.6 ptmt -63.57 -24.46 67.81 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 108.1 -1.074 . . . . 1.89 108.1 171.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -47.88 -38.57 16.56 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 113.963 -1.471 . . . . 1.68 110.81 172.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -89.35 -32.42 17.32 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.702 0.287 . . . . 1.11 111.67 175.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 147.45 -1.88 0.76 Allowed Glycine 0 C--N 1.332 0.319 0 N-CA-C 111.674 -0.57 . . . . 0.2 111.674 -178.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.716 ' HE2' ' HB3' ' A' ' 60' ' ' LEU . 25.3 t80 -69.51 145.02 53.0 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-O 121.4 0.619 . . . . 0.21 112.003 -177.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.95 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 1.6 t -135.59 152.93 51.74 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 108.839 -0.8 . . . . 1.02 108.839 173.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 1.03 HG11 ' HB1' ' A' ' 57' ' ' ALA . 51.9 t -113.35 101.65 12.78 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.426 0 N-CA-C 108.422 -0.955 . . . . 1.04 108.422 158.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.858 ' HA ' ' HB2' ' A' ' 103' ' ' PRO . 0.4 OUTLIER -94.4 122.05 36.56 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 107.222 -1.399 . . . . 1.69 107.222 173.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 1.046 ' HB2' HG13 ' A' ' 43' ' ' VAL . . . -108.49 130.34 55.26 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.397 0.618 . . . . 1.17 111.596 -178.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.768 ' HZ ' HG13 ' A' ' 20' ' ' VAL . 3.8 m-30 -109.07 102.82 50.36 Favored Pre-proline 0 C--N 1.319 -0.735 0 N-CA-C 108.72 -0.844 . . . . 0.58 108.72 177.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.85 ' HG2' ' HD2' ' A' ' 107' ' ' LYS . 60.7 Cg_endo -76.87 45.36 1.65 Allowed 'Trans proline' 0 N--CA 1.481 0.784 0 C-N-CA 123.676 2.918 . . . . 1.3 116.076 -163.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.464 ' O ' ' HB2' ' A' ' 107' ' ' LYS . 30.8 t 46.03 146.82 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 117.128 2.27 . . . . 1.91 117.128 178.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.533 ' C ' ' H ' ' A' ' 79' ' ' PHE . 8.7 t-20 -100.25 62.05 1.09 Allowed 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 113.938 -1.483 . . . . 1.93 107.264 174.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.793 ' HA ' ' HG3' ' A' ' 83' ' ' GLU . 18.2 mp0 -54.15 -8.51 0.2 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 114.344 -1.298 . . . . 3.97 111.775 -178.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.533 ' H ' ' C ' ' A' ' 77' ' ' ASN . 41.8 m-85 -64.29 -16.78 62.8 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.895 -1.048 . . . . 3.21 110.464 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -99.31 143.84 16.77 Favored Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 111.185 -0.766 . . . . 1.98 111.185 173.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.01 63.56 4.46 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.673 -0.775 . . . . 1.66 113.048 -177.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.542 ' HG2' ' HB3' ' A' ' 111' ' ' ASN . 3.9 pm0 -151.82 -13.25 0.19 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.22 -0.289 . . . . 1.74 110.22 174.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.793 ' HG3' ' HA ' ' A' ' 78' ' ' GLN . 5.2 mm-40 -63.44 155.82 73.3 Favored Pre-proline 0 CA--C 1.531 0.235 0 N-CA-C 113.291 0.849 . . . . 3.07 113.291 -168.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.584 ' HA ' ' CA ' ' A' ' 136' ' ' LYS . 98.3 Cg_exo -23.87 -91.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.674 1 C-N-CA 126.813 5.008 . . . . 1.75 116.474 178.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.458 ' H ' ' HB2' ' A' ' 84' ' ' PRO . . . -124.12 -24.6 1.8 Allowed Glycine 0 C--O 1.227 -0.311 0 C-N-CA 120.323 -0.941 . . . . 2.27 113.265 -172.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.711 ' HB3' HG12 ' A' ' 90' ' ' ILE . 15.3 m120 -96.73 38.31 1.23 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.103 -0.332 . . . . 4.88 110.103 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -54.27 -42.39 69.93 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.163 -0.926 . . . . 3.02 111.449 -174.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.676 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 0.7 OUTLIER -112.16 -22.13 11.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.496 -0.32 . . . . 3.92 111.028 176.705 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.448 ' HB3' HD21 ' A' ' 86' ' ' ASN . 2.9 tp10 -53.45 -60.19 3.61 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.891 -0.595 . . . . 2.65 112.474 -172.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.711 HG12 ' HB3' ' A' ' 86' ' ' ASN . 28.6 mm -50.74 -40.21 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 112.79 0.663 . . . . 2.63 112.79 -176.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.676 ' HE2' ' HA ' ' A' ' 88' ' ' GLU . 18.2 pttt -89.2 18.32 5.17 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.911 0.386 . . . . 3.13 111.952 -172.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -146.2 -1.21 0.75 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.86 0.362 . . . . 3.29 110.791 170.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -121.47 159.9 25.3 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.261 -0.427 . . . . 4.08 109.984 -175.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 75.0 t -81.47 111.48 18.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.553 -0.536 . . . . 3.05 109.553 172.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.678 ' SG ' ' HA ' ' A' ' 90' ' ' ILE . 0.0 OUTLIER -132.68 126.07 31.73 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.089 0.471 . . . . 3.04 110.641 -176.949 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.477 ' C ' ' H ' ' A' ' 98' ' ' PHE . 1.6 p -70.8 151.02 45.26 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 108.141 -1.059 . . . . 3.38 108.141 166.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.453 ' HB3' ' HZ3' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -72.72 12.29 0.52 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.522 -0.308 . . . . 3.11 111.518 -174.532 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.82 ' HB2' ' HA ' ' A' ' 45' ' ' SER . 8.4 t80 67.23 98.04 0.05 Allowed 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 123.93 0.769 . . . . 2.12 110.543 -177.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -119.67 137.64 53.78 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.664 -0.865 . . . . 3.1 108.664 169.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -139.82 -164.66 1.73 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.184 0.516 . . . . 1.15 111.558 -169.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -102.87 28.61 6.03 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 115.548 -0.751 . . . . 1.99 109.984 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.651 ' CD1' ' HA ' ' A' ' 58' ' ' THR . 40.3 p90 -151.64 165.25 17.83 Favored Pre-proline 0 N--CA 1.443 -0.822 0 N-CA-C 108.042 -1.096 . . . . 1.31 108.042 176.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.858 ' HB2' ' HA ' ' A' ' 72' ' ' LEU . 74.2 Cg_exo -50.92 132.03 36.29 Favored 'Trans proline' 0 CA--C 1.512 -0.59 0 C-N-CA 123.489 2.793 . . . . 1.07 113.8 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.534 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 50.6 mt -140.76 140.26 33.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 107.461 -1.311 . . . . 1.97 107.461 170.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.846 ' HB2' ' O ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -118.91 -179.22 3.75 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 120.779 -0.368 . . . . 3.41 110.98 -173.319 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.692 ' HB2' ' CD2' ' A' ' 25' ' ' HIS . . . -69.74 104.35 2.41 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 108.928 -0.767 . . . . 1.46 108.928 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.85 ' HD2' ' HG2' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -43.72 132.26 5.08 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-O 122.075 0.94 . . . . 2.31 112.888 -174.679 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.82 HG13 ' HB2' ' A' ' 116' ' ' HIS . 0.1 OUTLIER -119.49 173.25 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.012 0 CA-C-N 113.887 -1.506 . . . . 1.65 108.734 176.035 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.614 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 0.1 OUTLIER -74.26 87.4 1.97 Allowed 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 114.555 -1.202 . . . . 1.73 110.595 -174.831 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.508 HG11 ' CB ' ' A' ' 42' ' ' ASN . 6.6 m -84.4 89.38 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 CA-C-O 122.311 1.053 . . . . 1.4 108.84 178.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.633 ' ND2' ' H ' ' A' ' 112' ' ' GLY . 5.5 t30 175.42 -178.84 0.12 Allowed 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 113.683 -1.599 . . . . 2.1 107.945 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.633 ' H ' ' ND2' ' A' ' 111' ' ' ASN . . . -48.48 -28.81 6.88 Favored Glycine 0 N--CA 1.441 -0.988 0 N-CA-C 117.766 1.866 . . . . 1.47 117.766 -168.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.529 ' C ' HD21 ' A' ' 114' ' ' ASN . 9.5 pt-20 -104.68 -43.19 5.19 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 120.412 2.106 . . . . 2.81 114.367 -161.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.529 HD21 ' C ' ' A' ' 113' ' ' GLU . 0.9 OUTLIER -126.49 20.81 7.26 Favored 'General case' 0 C--N 1.32 -0.678 0 O-C-N 121.589 -0.694 . . . . 2.75 109.847 -172.701 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.614 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -48.28 131.94 16.41 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 123.792 0.683 . . . . 1.44 109.409 174.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.82 ' HB2' HG13 ' A' ' 108' ' ' ILE . 3.5 t-80 -71.12 139.0 84.74 Favored Pre-proline 0 N--CA 1.42 -1.956 0 CA-C-N 115.153 -0.93 . . . . 0.71 108.791 -168.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -31.2 -45.86 0.17 Allowed 'Trans proline' 0 C--O 1.217 -0.539 0 C-N-CA 124.358 3.372 . . . . 0.47 113.031 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.776 HD11 ' HB ' ' A' ' 15' ' ' ILE . 27.4 tp -60.11 -53.05 62.3 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.289 0.636 . . . . 1.15 112.597 175.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.806 ' OH ' HG23 ' A' ' 40' ' ' ILE . 3.1 m-85 -77.91 -32.88 51.95 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-O 121.343 0.592 . . . . 3.33 110.834 -176.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.428 ' HG2' ' HB1' ' A' ' 115' ' ' ALA . 0.6 OUTLIER -62.73 -40.01 95.87 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 106.726 -1.583 . . . . 2.44 106.726 174.148 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.788 ' HA ' ' HE2' ' A' ' 124' ' ' LYS . 81.4 t80 -65.26 -29.64 70.44 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.308 -0.86 . . . . 1.08 109.791 173.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.93 ' HE2' HD12 ' A' ' 40' ' ' ILE . 40.8 mtt -75.01 -55.95 5.23 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.837 -0.62 . . . . 1.25 110.958 -168.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.462 ' HE2' ' HB2' ' A' ' 123' ' ' LYS . 0.3 OUTLIER -70.41 -30.47 67.35 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.972 -0.558 . . . . 1.86 111.235 179.725 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.788 ' HE2' ' HA ' ' A' ' 121' ' ' TYR . 46.0 pttt -76.32 -26.65 56.01 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 119.238 -0.985 . . . . 2.52 111.422 -178.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.474 HG22 ' HG3' ' A' ' 126' ' ' LYS . 51.7 m -73.75 -44.93 54.79 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.915 0.388 . . . . 1.21 110.314 176.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.759 ' HZ3' ' HB2' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -151.71 129.51 5.87 Favored Pre-proline 0 C--O 1.235 0.318 0 CA-C-O 121.24 0.543 . . . . 2.38 111.506 178.918 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.65 ' HA ' ' NH2' ' A' ' 153' ' ' ARG . 12.8 Cg_endo -60.45 -134.56 0.0 OUTLIER 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 123.725 2.95 . . . . 1.69 112.581 173.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.493 ' HA3' ' OG1' ' A' ' 132' ' ' THR . . . -132.69 177.98 18.44 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 119.536 -1.316 . . . . 2.59 112.917 -176.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 23.8 pt -63.57 -22.03 29.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.024 0.44 . . . . 3.93 111.134 178.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.515 ' HB3' HG22 ' A' ' 132' ' ' THR . 0.2 OUTLIER -102.94 16.96 25.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.509 0.671 . . . . 3.81 109.36 178.539 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 58.56 30.85 20.36 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.179 -0.919 . . . . 3.63 109.676 -170.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' THR . . . . . 0.515 HG22 ' HB3' ' A' ' 130' ' ' LEU . 33.1 p -62.05 123.86 19.24 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.248 -0.887 . . . . 3.97 110.094 179.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 37.7 mtmt -71.94 -73.58 0.18 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.453 0.644 . . . . 5.48 110.089 -177.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.409 ' O ' ' HZ3' ' A' ' 137' ' ' TRP . . . -92.47 171.43 9.04 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.484 -0.78 . . . . 1.59 109.859 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.777 ' HB ' ' ND2' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -99.7 46.32 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 121.375 0.607 . . . . 2.09 110.372 179.32 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.584 ' CA ' ' HA ' ' A' ' 84' ' ' PRO . 19.5 ttmm -80.28 53.91 1.88 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.488 -0.778 . . . . 5.16 111.423 -176.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.622 ' HB3' ' HG3' ' A' ' 156' ' ' PRO . 21.7 m-90 -143.27 172.52 12.63 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.409 -0.36 . . . . 2.41 110.033 178.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.66 ' HB2' ' CB ' ' A' ' 156' ' ' PRO . 7.6 m120 -49.63 -157.71 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.129 -0.941 . . . . 2.04 110.581 164.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.715 ' CD1' HG23 ' A' ' 43' ' ' VAL . 4.3 m-85 -28.81 -47.09 0.05 Allowed 'General case' 0 CA--C 1.56 1.34 0 N-CA-C 116.533 2.049 . . . . 2.53 116.533 -166.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.722 ' HB ' ' ND2' ' A' ' 42' ' ' ASN . 7.2 m 38.02 98.53 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 120.239 1.381 . . . . 1.24 113.902 175.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.426 ' HB3' HD11 ' A' ' 39' ' ' LEU . 1.2 m -90.72 163.06 14.63 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.153 -0.93 . . . . 1.03 111.831 -174.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.54 ' CZ ' HG21 ' A' ' 135' ' ' ILE . 88.4 m-85 -126.92 126.06 42.61 Favored 'General case' 0 CA--C 1.493 -1.234 0 N-CA-C 106.215 -1.772 . . . . 0.7 106.215 166.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.777 HD12 HD13 ' A' ' 170' ' ' LEU . 10.7 tp -79.4 105.03 10.42 Favored 'General case' 0 N--CA 1.418 -2.06 0 C-N-CA 118.326 -1.349 . . . . 1.16 108.109 177.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.665 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 24.4 mm -92.24 135.17 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.783 0 CA-C-N 112.821 -1.99 . . . . 1.05 107.256 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.657 ' HA ' HD12 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -89.71 -177.14 5.19 Favored 'General case' 0 C--N 1.31 -1.109 0 C-N-CA 120.43 -0.508 . . . . 0.98 110.81 -168.192 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.698 ' HD3' ' HB3' ' A' ' 173' ' ' SER . 47.9 mtm180 -53.97 -42.65 69.17 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 122.581 0.353 . . . . 2.61 111.902 -176.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -94.54 23.18 5.48 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.164 -0.68 . . . . 2.0 109.164 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.673 ' HA3' ' CE2' ' A' ' 16' ' ' PHE . . . 71.3 37.42 63.12 Favored Glycine 0 N--CA 1.441 -1.002 0 CA-C-N 115.149 -0.932 . . . . 0.19 113.64 176.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.452 ' HA ' ' HD2' ' A' ' 150' ' ' PRO . 46.5 t -103.88 107.46 56.82 Favored Pre-proline 0 C--N 1.316 -0.885 0 C-N-CA 119.809 -0.756 . . . . 1.74 111.43 177.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.838 ' HD3' HG22 ' A' ' 15' ' ' ILE . 15.6 Cg_endo -61.3 127.12 21.06 Favored 'Trans proline' 0 CA--C 1.516 -0.384 0 C-N-CA 123.396 2.731 . . . . 0.6 110.201 174.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.75 ' HA ' ' HG2' ' A' ' 126' ' ' LYS . 4.5 m -135.08 -31.85 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 C-N-CA 120.494 -0.482 . . . . 2.06 112.079 -178.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.761 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 14.4 mm-40 -112.95 159.54 19.0 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.543 -0.54 . . . . 1.17 109.543 174.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.65 ' NH2' ' HA ' ' A' ' 127' ' ' PRO . 0.0 OUTLIER -140.3 131.73 26.88 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 120.281 -0.568 . . . . 2.9 109.604 165.257 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.784 ' HZ ' ' HB2' ' A' ' 166' ' ' LYS . 97.9 m-85 -104.55 145.43 30.31 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.135 -0.939 . . . . 0.36 109.284 -174.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 3.2 p -78.51 158.1 76.62 Favored Pre-proline 0 C--N 1.314 -0.95 0 N-CA-C 108.985 -0.746 . . . . 1.45 108.985 176.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.66 ' CB ' ' HB2' ' A' ' 138' ' ' ASN . 11.3 Cg_endo -55.6 -45.05 42.37 Favored 'Trans proline' 0 CA--C 1.517 -0.331 0 C-N-CA 121.618 1.546 . . . . 0.78 110.754 178.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.447 ' HA3' ' HE3' ' A' ' 51' ' ' LYS . . . -52.87 -16.16 3.85 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-N 114.255 -1.339 . . . . 0.59 114.468 173.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -87.39 137.08 32.65 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 117.767 0.784 . . . . 1.07 109.304 175.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.401 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 68.1 m -114.14 -172.37 2.08 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 120.957 0.408 . . . . 1.92 112.033 -170.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.65 ' CG2' ' HA ' ' A' ' 56' ' ' THR . 57.8 t -40.04 -56.65 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 114.88 -1.055 . . . . 1.07 112.552 -175.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.435 ' HZ1' ' HB2' ' A' ' 161' ' ' LYS . 0.3 OUTLIER -69.75 -31.53 69.55 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.623 0.249 . . . . 3.89 110.917 -172.895 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -66.43 -37.94 86.31 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.316 0.579 . . . . 1.4 109.631 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.81 HD11 ' HH ' ' A' ' 41' ' ' TYR . 81.7 mt -79.89 -43.72 22.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.389 -0.823 . . . . 1.05 111.257 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.585 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 36.7 mt-10 -54.01 -43.24 69.92 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-N 116.565 -0.289 . . . . 0.67 111.413 -177.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -59.56 -19.97 52.31 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.41 0.522 . . . . 0.87 112.41 -175.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.784 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 19.1 mmtp -101.9 -23.91 14.09 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.277 -0.569 . . . . 2.22 110.697 171.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.585 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 12.9 tp -76.8 -54.05 7.12 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.415 -0.811 . . . . 1.04 111.959 -178.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.454 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 72.1 mt -51.52 -45.5 90.71 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.085 -0.961 . . . . 1.08 112.296 -174.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.454 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 88.8 Cg_exo -49.45 -44.26 35.39 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 122.049 1.833 . . . . 0.62 112.71 173.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.777 HD13 HD12 ' A' ' 143' ' ' LEU . 90.5 mt -76.9 -38.82 52.8 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 120.911 -0.316 . . . . 1.36 111.093 -179.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.702 HD23 ' HG2' ' A' ' 37' ' ' PRO . 82.2 mt -59.45 -59.95 4.63 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-O 121.926 0.869 . . . . 1.07 109.908 177.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.44 ' C ' ' HG ' ' A' ' 173' ' ' SER . . . -60.97 -34.59 88.36 Favored Glycine 0 N--CA 1.432 -1.571 0 CA-C-N 113.476 -1.693 . . . . 1.12 112.638 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.698 ' HB3' ' HD3' ' A' ' 146' ' ' ARG . 26.3 p 48.51 73.55 0.21 Allowed 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.486 0.714 . . . . 2.88 111.74 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -92.96 -18.94 22.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.616 -0.72 . . . . 4.69 111.017 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -172.05 -36.46 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.129 -0.487 . . . . 9.17 111.039 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 9.7 tt . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.531 -0.747 . . . . 8.03 109.553 -177.955 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.803 0 N-CA-C 111.966 -0.453 . . . . 5.58 111.966 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -60.03 -46.83 88.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.927 0.394 . . . . 5.23 110.936 -179.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.77 117.44 5.11 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.848 -0.691 . . . . 1.55 112.481 178.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.9 p -92.81 11.4 27.17 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.04 0.448 . . . . 2.17 110.36 176.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.502 ' HB3' ' O ' ' A' ' 147' ' ' ASP . 1.5 m -161.16 151.58 17.83 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 105.878 -1.897 . . . . 1.68 105.878 -176.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.796 ' HB ' HD13 ' A' ' 118' ' ' LEU . 4.8 pt -64.61 -16.01 18.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-N 114.927 -1.033 . . . . 1.16 112.015 -172.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.806 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 41.6 m-85 -69.73 -3.12 14.01 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 112.117 0.414 . . . . 0.3 112.117 -178.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -71.84 -25.1 61.84 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.37 -0.974 . . . . 2.11 108.37 174.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.573 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 50.1 m-85 -108.51 110.41 21.9 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 114.407 -1.27 . . . . 0.37 111.162 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -53.73 142.82 22.3 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.069 -1.423 . . . . 2.86 110.215 174.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.776 HG12 ' HZ ' ' A' ' 74' ' ' PHE . 53.7 t -110.71 161.97 8.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 N-CA-C 108.031 -1.1 . . . . 1.32 108.031 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.721 ' O ' ' HB2' ' A' ' 105' ' ' MET . 25.5 mt -130.61 152.44 49.98 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 120.603 -0.439 . . . . 1.29 110.455 -178.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -73.92 -178.46 3.27 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.332 -0.618 . . . . 1.87 109.332 176.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.625 ' HA ' ' N ' ' A' ' 106' ' ' ALA . . . -64.35 -4.41 3.8 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.803 0.335 . . . . 1.2 111.647 -178.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.519 ' HB2' ' HE2' ' A' ' 26' ' ' LYS . 9.7 m-20 -116.95 9.08 13.63 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.704 -0.226 . . . . 2.34 111.452 175.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.639 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 11.1 m170 73.02 11.93 5.12 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-O 121.419 0.628 . . . . 2.26 110.25 174.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.519 ' HE2' ' HB2' ' A' ' 24' ' ' ASP . 26.6 mtmt -69.52 130.68 90.43 Favored Pre-proline 0 N--CA 1.453 -0.322 0 N-CA-C 107.211 -1.403 . . . . 4.64 107.211 165.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.639 ' HA ' HD22 ' A' ' 21' ' ' LEU . 79.7 Cg_exo -51.16 114.79 1.68 Allowed 'Trans proline' 0 CA--C 1.53 0.28 0 C-N-CA 121.895 1.73 . . . . 0.62 113.147 -176.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.56 ' H ' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -76.93 149.9 35.99 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.174 -1.375 . . . . 1.52 110.602 173.179 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.49 ' OD1' ' HB3' ' A' ' 32' ' ' GLN . 2.4 t-20 -93.41 81.57 4.41 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.954 -0.758 . . . . 2.16 108.954 177.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.695 HD23 HD12 ' A' ' 15' ' ' ILE . 61.1 tp -62.01 -41.79 98.46 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.506 -0.77 . . . . 1.07 110.294 -178.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.692 ' HA ' ' CE1' ' A' ' 16' ' ' PHE . 1.6 t -70.12 -1.32 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.099 -0.955 . . . . 1.69 111.93 -170.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.49 ' HB3' ' OD1' ' A' ' 29' ' ' ASN . 2.3 pt20 -74.72 -10.36 59.44 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.06 -0.718 . . . . 1.31 109.06 174.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.954 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 93.9 m-70 -99.41 25.6 6.84 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 121.934 0.873 . . . . 0.35 109.649 176.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.806 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 14.8 mtmt -83.73 132.39 34.85 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 114.297 -1.32 . . . . 2.07 109.155 169.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.83 -42.02 2.03 Favored Glycine 0 N--CA 1.438 -1.233 0 C-N-CA 120.759 -0.734 . . . . 0.24 111.765 -178.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.422 ' HB2' ' HA3' ' A' ' 68' ' ' GLY . 15.7 m -125.31 124.95 25.2 Favored Pre-proline 0 N--CA 1.435 -1.21 0 N-CA-C 108.082 -1.081 . . . . 0.74 108.082 173.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.853 ' HG3' ' HB3' ' A' ' 170' ' ' LEU . 2.2 Cg_endo -39.65 153.9 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 124.266 3.31 . . . . 0.22 113.346 176.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.869 HD13 ' HB2' ' A' ' 33' ' ' HIS . 0.9 OUTLIER -139.34 143.58 37.86 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.427 -1.323 . . . . 1.09 107.427 -179.209 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 1.02 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 1.2 mm? -107.8 121.71 45.28 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.66 -0.867 . . . . 1.82 108.66 176.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.711 HG13 HG13 ' A' ' 144' ' ' ILE . 1.3 mt -105.57 125.61 60.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 C-N-CA 120.109 -0.636 . . . . 1.12 109.551 177.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 1.02 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.4 OUTLIER -109.38 123.29 49.09 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 116.091 -0.504 . . . . 1.09 109.992 -174.408 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.681 ' ND2' ' HB ' ' A' ' 135' ' ' ILE . 2.7 p-10 -80.56 93.22 6.04 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 122.3 1.047 . . . . 3.11 108.185 171.45 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.714 ' O ' ' HA ' ' A' ' 75' ' ' PRO . 7.7 p -105.67 125.48 61.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 115.388 -0.824 . . . . 1.69 111.367 -164.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.698 ' HB3' ' HB2' ' A' ' 86' ' ' ASN . . . -85.36 98.44 10.55 Favored 'General case' 0 N--CA 1.434 -1.248 0 C-N-CA 119.036 -1.066 . . . . 1.45 108.941 169.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.846 ' HA ' ' HB3' ' A' ' 98' ' ' PHE . 15.2 t -25.65 101.15 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 114.125 -1.398 . . . . 1.99 112.828 170.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.855 ' HB3' ' HB2' ' A' ' 49' ' ' TYR . 13.4 mtpt -103.47 145.03 30.61 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.748 -0.834 . . . . 6.2 108.748 173.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.9 t -110.13 114.1 27.33 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.991 -0.744 . . . . 4.12 108.991 178.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.27 16.66 75.44 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 121.042 -0.599 . . . . 3.44 112.927 -175.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.855 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 63.4 m-85 -125.95 164.16 21.41 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 117.031 0.415 . . . . 4.84 110.9 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.4 t -172.12 137.61 0.93 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.856 -0.611 . . . . 2.41 110.255 177.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.497 ' O ' ' HA2' ' A' ' 157' ' ' GLY . 21.0 mmmt -98.01 12.18 35.12 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.086 0.47 . . . . 2.47 109.969 176.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 109.55 -34.13 5.67 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 109.895 -1.282 . . . . 0.85 109.895 -170.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -45.43 -46.13 11.71 Favored Glycine 0 C--O 1.219 -0.833 0 CA-C-N 114.821 -0.689 . . . . 0.67 113.65 177.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.548 ' HB3' ' OE2' ' A' ' 55' ' ' GLU . 0.6 OUTLIER -60.84 -61.43 2.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.186 0.493 . . . . 1.2 110.872 -175.469 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.548 ' OE2' ' HB3' ' A' ' 54' ' ' TYR . 0.2 OUTLIER -54.04 -31.87 52.71 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.62 0.724 . . . . 2.61 110.995 178.243 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.687 ' HA ' HG23 ' A' ' 160' ' ' VAL . 52.9 m -75.84 -58.99 2.95 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.079 -0.964 . . . . 1.06 110.684 -174.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 1.091 ' HB1' HG13 ' A' ' 71' ' ' VAL . . . -59.2 -40.3 85.33 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.876 -1.056 . . . . 1.05 110.828 -178.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.508 ' HA ' ' CD1' ' A' ' 102' ' ' PHE . 96.9 m -58.64 -55.17 38.53 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 115.695 -0.684 . . . . 1.08 110.358 179.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 61.5 m -69.4 -39.68 77.79 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.182 -0.917 . . . . 1.22 111.736 -176.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.75 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 17.4 mt -64.87 -47.65 77.11 Favored 'General case' 0 CA--C 1.498 -1.038 0 CA-C-O 121.055 0.455 . . . . 1.14 110.367 -175.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.871 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 7.8 t80 -54.56 -54.39 41.96 Favored 'General case' 0 C--O 1.197 -1.68 0 CA-C-N 114.904 -1.043 . . . . 0.94 110.32 177.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -72.54 -24.33 61.11 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 111.866 0.321 . . . . 1.6 111.866 -171.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.517 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 36.7 ttpt -83.6 -20.73 33.19 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 108.688 -0.856 . . . . 2.06 108.688 -178.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.694 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 47.9 m-85 -128.52 -1.93 5.51 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 115.835 1.791 . . . . 0.92 115.835 -173.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.725 ' HG2' ' O ' ' A' ' 61' ' ' TYR . 11.9 ptmt -65.8 -26.97 67.93 Favored 'General case' 0 CA--C 1.497 -1.092 0 N-CA-C 107.834 -1.173 . . . . 1.89 107.834 171.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.3 m -47.73 -38.68 15.89 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 113.893 -1.503 . . . . 1.68 110.837 173.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -86.14 -39.63 16.49 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 111.621 0.23 . . . . 1.11 111.621 174.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.422 ' HA3' ' HB2' ' A' ' 36' ' ' SER . . . 149.63 -3.28 0.61 Allowed Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.263 -0.735 . . . . 0.2 111.263 -176.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.75 ' HE2' ' HB3' ' A' ' 60' ' ' LEU . 28.1 t80 -71.07 140.75 50.79 Favored 'General case' 0 C--O 1.222 -0.346 0 C-N-CA 122.856 0.462 . . . . 0.21 111.381 -177.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.954 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 3.7 t -132.96 152.42 51.93 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 108.452 -0.944 . . . . 1.02 108.452 175.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 1.091 HG13 ' HB1' ' A' ' 57' ' ' ALA . 42.2 t -111.83 101.54 12.68 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.532 0 N-CA-C 108.286 -1.005 . . . . 1.04 108.286 160.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.493 ' HA ' ' O ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -95.06 121.74 36.99 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 118.37 -1.332 . . . . 1.69 107.73 172.984 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.887 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -111.51 128.27 55.96 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 120.581 -0.448 . . . . 1.17 110.71 178.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.776 ' HZ ' HG12 ' A' ' 20' ' ' VAL . 5.3 m-30 -100.8 112.62 65.03 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 116.149 -0.478 . . . . 0.58 110.057 -178.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.714 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 73.6 Cg_endo -80.65 82.45 2.47 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 123.213 2.609 . . . . 1.3 113.504 -169.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.558 ' HB2' ' CG2' ' A' ' 110' ' ' VAL . 19.3 t -35.02 143.59 0.04 OUTLIER 'General case' 0 C--O 1.237 0.43 0 CA-C-O 122.782 1.277 . . . . 1.91 114.403 -174.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.592 ' HB2' ' HD1' ' A' ' 79' ' ' PHE . 17.3 p30 -92.55 131.32 37.77 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-N 113.069 -1.878 . . . . 1.93 109.828 -178.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.771 ' HA ' ' HG2' ' A' ' 83' ' ' GLU . 9.7 pt20 -61.33 -8.22 3.67 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.661 -1.154 . . . . 3.97 110.251 171.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.592 ' HD1' ' HB2' ' A' ' 77' ' ' ASN . 82.3 m-85 -76.46 32.36 0.13 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.698 -1.137 . . . . 3.21 113.384 -167.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -135.8 -57.99 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.052 -1.07 . . . . 1.98 112.984 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 110.57 36.71 1.86 Allowed Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 111.316 -0.714 . . . . 1.66 111.316 -173.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.641 ' HG3' ' HB2' ' A' ' 113' ' ' GLU . 0.4 OUTLIER -156.65 7.6 0.19 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.099 -0.551 . . . . 1.74 111.089 -176.558 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.771 ' HG2' ' HA ' ' A' ' 78' ' ' GLN . 2.7 mp0 -57.94 147.75 62.68 Favored Pre-proline 0 N--CA 1.468 0.461 0 CA-C-O 121.439 0.637 . . . . 3.07 111.261 -162.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.695 ' HB2' ' O ' ' A' ' 137' ' ' TRP . 40.9 Cg_endo -79.64 102.98 1.53 Allowed 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 123.6 2.867 . . . . 1.75 111.6 -172.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.46 -59.25 4.64 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.656 -0.783 . . . . 2.27 112.753 175.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.834 HD22 ' HG2' ' A' ' 46' ' ' LYS . 6.2 m-20 -81.76 20.68 0.92 Allowed 'General case' 0 C--N 1.328 -0.366 0 O-C-N 122.61 -0.347 . . . . 4.88 111.801 -177.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -55.47 -26.98 45.56 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 123.431 0.457 . . . . 3.02 111.284 178.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.633 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 39.5 mm-40 -111.85 -3.77 14.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.294 -0.412 . . . . 3.92 111.373 178.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -93.09 -61.18 1.63 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.093 0.473 . . . . 2.65 111.58 -173.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.789 HG23 ' HB2' ' A' ' 95' ' ' CYS . 7.6 pt -73.32 -23.25 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 113.132 0.79 . . . . 2.63 113.132 -168.041 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.633 ' HE2' ' HA ' ' A' ' 88' ' ' GLU . 56.2 pttt -72.79 -29.34 63.19 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 111.681 0.252 . . . . 3.13 111.681 -175.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -115.9 -24.9 7.94 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.925 -0.31 . . . . 3.29 111.772 -176.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -100.24 158.86 15.57 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.085 -0.339 . . . . 4.08 110.085 176.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 82.2 t -76.61 110.08 11.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.17 -0.468 . . . . 3.05 110.195 177.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.789 ' HB2' HG23 ' A' ' 90' ' ' ILE . 65.6 m -153.03 120.67 6.0 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.202 -0.453 . . . . 3.04 110.104 176.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.457 ' C ' ' H ' ' A' ' 98' ' ' PHE . 7.6 p -145.13 120.37 10.19 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.689 -0.232 . . . . 3.38 110.725 176.078 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.532 ' HA ' ' CB ' ' A' ' 75' ' ' PRO . 99.3 mttt 71.36 -27.31 0.17 Allowed 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 113.244 0.831 . . . . 3.11 113.244 176.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.846 ' HB3' ' HA ' ' A' ' 45' ' ' SER . 0.2 OUTLIER 67.09 -36.96 0.29 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.032 1.333 . . . . 2.12 111.523 -176.098 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.446 ' H ' ' C ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER 66.48 136.29 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.659 0.784 . . . . 3.1 111.69 174.901 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.783 ' HB3' ' CE1' ' A' ' 98' ' ' PHE . . . -162.15 -179.42 7.06 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.152 0.501 . . . . 1.15 112.329 -173.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -94.91 30.28 2.14 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 115.344 -0.844 . . . . 1.99 110.784 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.579 ' CE2' HD13 ' A' ' 104' ' ' ILE . 27.2 p90 -150.07 157.01 37.92 Favored Pre-proline 0 N--CA 1.446 -0.663 0 N-CA-C 108.332 -0.988 . . . . 1.31 108.332 177.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.682 ' HD3' ' CE2' ' A' ' 61' ' ' TYR . 97.7 Cg_exo -51.2 84.12 0.02 OUTLIER 'Trans proline' 0 N--CA 1.479 0.673 0 C-N-CA 124.794 3.663 . . . . 1.07 116.081 -172.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.887 HD12 ' HB3' ' A' ' 73' ' ' ALA . 7.5 mm -85.89 120.6 36.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.092 -1.077 . . . . 1.97 108.092 170.061 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.772 ' HG2' ' CG ' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -76.53 -177.69 4.31 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.753 -0.832 . . . . 3.41 108.753 178.272 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.625 ' N ' ' HA ' ' A' ' 23' ' ' ALA . . . -63.44 -53.75 47.35 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.384 -0.598 . . . . 1.46 109.384 -177.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.601 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 17.4 ptpt 146.15 151.07 0.0 OUTLIER 'General case' 0 CA--C 1.489 -1.385 0 O-C-N 125.823 1.952 . . . . 2.31 108.371 174.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.469 HD11 ' HD2' ' A' ' 74' ' ' PHE . 2.0 pp -152.08 174.53 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 CA-C-N 113.726 -1.579 . . . . 1.65 107.802 169.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.748 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 29.0 t-20 -74.24 87.15 1.95 Allowed 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.462 -0.79 . . . . 1.73 110.932 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.558 ' CG2' ' HB2' ' A' ' 76' ' ' SER . 3.6 m -86.0 95.81 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 C-N-CA 118.145 -1.422 . . . . 1.4 108.187 169.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.551 ' ND2' ' H ' ' A' ' 112' ' ' GLY . 2.3 t30 179.09 -179.17 0.36 Allowed 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 113.63 -1.623 . . . . 2.1 107.815 178.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.551 ' H ' ' ND2' ' A' ' 111' ' ' ASN . . . -78.45 9.27 35.77 Favored Glycine 0 N--CA 1.437 -1.291 0 N-CA-C 115.894 1.118 . . . . 1.47 115.894 -172.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.641 ' HB2' ' HG3' ' A' ' 82' ' ' GLN . 6.8 mt-10 -105.31 -45.4 4.49 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 119.855 1.828 . . . . 2.81 114.514 -172.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -127.77 -34.47 2.18 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.388 -0.967 . . . . 2.75 108.388 -174.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.748 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . 52.28 -169.42 0.04 OUTLIER 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 114.153 -1.385 . . . . 1.44 111.264 176.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.582 ' ND1' ' H ' ' A' ' 118' ' ' LEU . 2.1 t-80 -140.94 134.33 14.71 Favored Pre-proline 0 N--CA 1.423 -1.794 0 N-CA-C 106.275 -1.75 . . . . 0.71 106.275 171.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -27.23 -50.13 0.1 Allowed 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 124.503 3.469 . . . . 0.47 113.598 -178.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.796 HD13 ' HB ' ' A' ' 15' ' ' ILE . 29.1 tp -63.51 -49.28 74.16 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.922 0.489 . . . . 1.15 112.171 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.677 ' OH ' HG22 ' A' ' 40' ' ' ILE . 25.5 m-85 -79.97 -33.96 39.05 Favored 'General case' 0 CA--C 1.492 -1.258 0 CA-C-O 120.935 0.398 . . . . 3.33 110.881 -176.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.483 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 4.7 tt0 -60.42 -37.36 80.63 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 106.589 -1.634 . . . . 2.44 106.589 174.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.573 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 51.5 t80 -68.53 -33.07 73.46 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.047 -0.979 . . . . 1.08 110.492 174.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.683 ' HE2' HD13 ' A' ' 40' ' ' ILE . 2.9 ttm -75.77 -55.58 5.5 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.09 -0.504 . . . . 1.25 110.418 -169.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.426 ' HB2' ' HE2' ' A' ' 123' ' ' LYS . 0.8 OUTLIER -70.82 -25.44 62.85 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 120.616 -0.433 . . . . 1.86 111.721 178.294 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.483 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -72.35 -29.73 64.07 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 119.379 -0.928 . . . . 2.52 109.394 178.447 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 88.0 m -87.26 -31.2 20.39 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.489 -0.778 . . . . 1.21 111.285 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.654 ' HG3' ' HB2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -133.66 110.38 12.29 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 112.727 0.64 . . . . 2.38 112.727 -172.17 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.458 ' HB2' ' O ' ' A' ' 130' ' ' LEU . 6.7 Cg_exo -76.1 -17.86 16.88 Favored 'Trans proline' 0 CA--C 1.531 0.336 0 C-N-CA 123.654 2.903 . . . . 1.69 111.037 169.206 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 81.44 -131.3 10.31 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.564 -0.743 . . . . 2.59 112.812 175.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 38.0 mt -75.92 -23.87 16.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.343 0.592 . . . . 3.93 110.427 -179.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.741 HD12 ' H ' ' A' ' 131' ' ' ALA . 0.3 OUTLIER -96.05 158.69 15.33 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.554 -0.748 . . . . 3.81 109.033 -179.033 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.741 ' H ' HD12 ' A' ' 130' ' ' LEU . . . -67.08 -14.49 62.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.294 -0.412 . . . . 3.63 110.763 174.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' THR . . . . . 0.437 ' H ' HD13 ' A' ' 130' ' ' LEU . 4.4 m -149.91 -110.25 0.06 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.365 -0.379 . . . . 3.97 110.741 176.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.622 ' HG3' ' HG ' ' A' ' 130' ' ' LEU . 67.4 mttm 58.36 135.98 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.717 0.77 . . . . 5.48 112.22 -171.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -116.64 61.34 0.73 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.205 -0.452 . . . . 1.59 111.942 -175.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.681 ' HB ' ' ND2' ' A' ' 42' ' ' ASN . 16.0 pt 38.78 43.36 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 O-C-N 123.913 0.758 . . . . 2.09 112.037 178.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.517 ' HD3' ' O ' ' A' ' 136' ' ' LYS . 8.0 tmtm? -90.06 38.84 0.94 Allowed 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.76 0.791 . . . . 5.16 110.957 -172.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.695 ' O ' ' HB2' ' A' ' 84' ' ' PRO . 8.9 m-90 -133.63 174.08 10.81 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.108 -0.496 . . . . 2.41 110.446 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.586 ' HB2' ' CB ' ' A' ' 156' ' ' PRO . 3.4 m120 -43.86 -155.71 0.0 OUTLIER 'General case' 0 C--O 1.212 -0.884 0 CA-C-N 114.784 -1.098 . . . . 2.04 111.298 163.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.675 ' HD2' ' HD2' ' A' ' 41' ' ' TYR . 2.9 m-85 -27.4 -52.51 0.07 Allowed 'General case' 0 C--O 1.209 -1.076 0 N-CA-C 115.724 1.75 . . . . 2.53 115.724 -166.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.658 ' HB ' ' ND2' ' A' ' 42' ' ' ASN . 7.5 m 41.6 109.17 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 120.542 1.519 . . . . 1.24 113.648 173.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.569 ' O ' ' HA ' ' A' ' 153' ' ' ARG . 3.5 m -106.0 158.53 16.73 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 114.825 -1.08 . . . . 1.03 111.085 -167.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.633 ' CE2' HG21 ' A' ' 135' ' ' ILE . 63.6 m-85 -125.38 124.34 41.29 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 106.899 -1.519 . . . . 0.7 106.899 166.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.768 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 7.1 tp -79.88 104.01 10.17 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 118.337 -1.345 . . . . 1.16 108.369 179.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.745 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 32.3 mm -92.94 137.92 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.612 0 CA-C-N 113.574 -1.648 . . . . 1.05 107.803 -175.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.629 ' OD1' HG13 ' A' ' 149' ' ' VAL . 0.0 OUTLIER -89.18 -173.72 4.15 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 119.74 -0.784 . . . . 0.98 111.592 -168.14 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.697 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 21.1 mtm180 -56.24 -37.7 70.11 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-O 121.373 0.606 . . . . 2.61 110.543 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.502 ' O ' ' HB3' ' A' ' 14' ' ' SER . 27.6 t70 -93.48 13.74 20.81 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.736 -0.838 . . . . 2.0 108.736 -176.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.71 ' HA2' HG22 ' A' ' 144' ' ' ILE . . . 67.6 33.98 82.6 Favored Glycine 0 N--CA 1.434 -1.437 0 CA-C-N 115.359 -0.837 . . . . 0.19 114.404 -177.099 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.629 HG13 ' OD1' ' A' ' 145' ' ' ASP . 9.2 p -105.15 114.02 64.0 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 119.206 1.503 . . . . 1.74 111.44 172.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.69 ' HD3' HG21 ' A' ' 15' ' ' ILE . 2.5 Cg_endo -49.71 126.93 17.49 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 123.869 3.046 . . . . 0.6 111.771 174.002 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 23.0 t -120.09 -32.26 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.397 0.617 . . . . 2.06 109.345 -178.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.768 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 47.8 mm-40 -132.03 167.19 20.12 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-N 115.303 -0.862 . . . . 1.17 111.032 -177.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.569 ' HA ' ' O ' ' A' ' 141' ' ' SER . 1.6 ttm180 -146.33 132.74 19.63 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.266 -0.879 . . . . 2.9 110.744 163.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.563 ' HZ ' ' HB2' ' A' ' 166' ' ' LYS . 98.8 m-85 -110.97 151.55 27.81 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 114.713 -1.13 . . . . 0.36 109.614 -170.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 43.2 t -72.99 156.0 90.02 Favored Pre-proline 0 C--N 1.317 -0.821 0 N-CA-C 109.029 -0.73 . . . . 1.45 109.029 174.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.586 ' CB ' ' HB2' ' A' ' 138' ' ' ASN . 22.8 Cg_endo -61.44 -29.89 85.96 Favored 'Trans proline' 0 CA--C 1.517 -0.341 0 C-N-CA 121.852 1.702 . . . . 0.78 110.247 171.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.497 ' HA2' ' O ' ' A' ' 51' ' ' LYS . . . -73.41 -1.64 57.94 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 114.225 -1.352 . . . . 0.59 113.058 172.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -93.01 140.22 29.7 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 108.421 -0.955 . . . . 1.07 108.421 172.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.532 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 6.7 t -114.2 -170.82 1.79 Allowed 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 120.305 -0.558 . . . . 1.92 111.148 -170.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.687 HG23 ' HA ' ' A' ' 56' ' ' THR . 38.2 t -46.83 -49.47 6.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 114.556 -1.202 . . . . 1.07 111.612 -175.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 50.3 tttp -67.41 -39.9 85.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.873 0.368 . . . . 3.89 111.201 -175.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.411 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 31.2 m-20 -64.25 -37.45 87.51 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.716 -0.674 . . . . 1.4 109.946 -177.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.678 HD11 ' HH ' ' A' ' 41' ' ' TYR . 88.6 mt -80.01 -47.69 21.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.069 -0.969 . . . . 1.05 111.281 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.667 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 30.7 mt-10 -54.5 -40.62 68.71 Favored 'General case' 0 C--O 1.215 -0.714 0 O-C-N 123.151 0.282 . . . . 0.67 111.572 -176.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 10.1 pt-20 -59.57 -21.07 59.79 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.667 0.27 . . . . 0.87 111.493 -175.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.563 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 12.6 mmmm -104.1 -23.92 13.24 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.432 0.634 . . . . 2.22 109.904 175.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.667 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 12.7 tp -79.2 -52.29 8.36 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.725 -1.125 . . . . 1.04 112.106 -178.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.459 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 74.4 mt -53.36 -45.03 98.64 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.31 -0.859 . . . . 1.08 111.959 -174.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.459 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 92.3 Cg_exo -49.06 -44.93 31.2 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 121.929 1.753 . . . . 0.62 112.23 171.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.853 ' HB3' ' HG3' ' A' ' 37' ' ' PRO . 43.5 mt -74.26 -42.78 59.07 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.926 0.343 . . . . 1.36 111.926 -178.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.793 HD22 ' HG2' ' A' ' 37' ' ' PRO . 89.3 mt -60.62 -54.91 39.69 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 122.197 0.998 . . . . 1.07 109.643 177.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -67.26 -62.83 4.14 Favored Glycine 0 N--CA 1.435 -1.381 0 CA-C-N 113.377 -1.738 . . . . 1.12 114.059 -175.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 9.7 t -167.69 97.68 0.47 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.969 0.385 . . . . 2.88 110.044 -172.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -61.96 -39.91 93.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.966 -0.561 . . . . 4.69 111.104 -175.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 50.1 ttp180 64.82 90.74 0.08 Allowed 'General case' 0 N--CA 1.465 0.28 0 O-C-N 123.718 0.636 . . . . 9.17 111.946 175.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.0 mm? . . . . . 0 C--O 1.249 1.07 0 CA-C-N 115.63 -0.714 . . . . 8.03 109.682 178.025 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.694 0 N-CA-C 112.162 -0.375 . . . . 5.58 112.162 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 27.2 ttt -173.82 -32.46 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.685 -0.487 . . . . 5.23 109.685 -176.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.576 ' HA2' ' OD2' ' A' ' 17' ' ' ASP . . . -57.65 118.09 11.85 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.376 -0.829 . . . . 1.55 112.472 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.489 ' C ' ' HH ' ' A' ' 121' ' ' TYR . 14.2 m -123.6 -5.75 8.12 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.365 0.602 . . . . 2.17 110.121 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.425 ' HB3' ' O ' ' A' ' 147' ' ' ASP . 5.9 m -164.76 152.21 11.45 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 104.498 -2.408 . . . . 1.68 104.498 179.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.776 ' HB ' HD12 ' A' ' 118' ' ' LEU . 4.9 pt -62.09 -11.81 6.79 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 CA-C-N 115.59 -0.732 . . . . 1.16 112.302 -172.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.762 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 53.0 m-85 -75.34 0.75 15.7 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.949 0.722 . . . . 0.3 112.949 -176.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.576 ' OD2' ' HA2' ' A' ' 12' ' ' GLY . 58.3 m-20 -82.2 -19.27 40.15 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.41 -0.959 . . . . 2.11 108.41 175.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.687 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 50.0 m-85 -106.3 113.92 27.73 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 114.855 -1.066 . . . . 0.37 111.791 -178.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -48.56 136.56 12.93 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 113.404 -1.725 . . . . 2.86 111.032 174.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.798 HG13 ' HZ ' ' A' ' 74' ' ' PHE . 94.4 t -112.18 163.91 8.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 108.92 -0.77 . . . . 1.32 108.92 178.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.698 HD23 ' HA ' ' A' ' 27' ' ' PRO . 47.2 mt -130.83 148.97 52.66 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 110.113 -0.328 . . . . 1.29 110.113 -178.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -76.53 177.01 7.77 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.281 -1.377 . . . . 1.87 107.281 166.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.794 ' HA ' ' N ' ' A' ' 106' ' ' ALA . . . -64.62 -4.7 4.43 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.238 0.459 . . . . 1.2 112.238 -176.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.589 ' HB2' ' HE2' ' A' ' 26' ' ' LYS . 54.6 m-20 -105.05 3.03 30.06 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.444 -0.344 . . . . 2.34 111.273 178.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.563 ' HD1' HD13 ' A' ' 21' ' ' LEU . 71.7 m-70 75.48 2.77 3.87 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 122.724 0.41 . . . . 2.26 109.944 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.589 ' HE2' ' HB2' ' A' ' 24' ' ' ASP . 22.1 mtmt -63.01 118.04 38.75 Favored Pre-proline 0 CA--C 1.512 -0.501 0 N-CA-C 106.777 -1.564 . . . . 4.64 106.777 166.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.698 ' HA ' HD23 ' A' ' 21' ' ' LEU . 96.5 Cg_exo -51.2 114.5 1.57 Allowed 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 121.488 1.458 . . . . 0.62 112.222 -177.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.763 ' HE2' HD23 ' A' ' 72' ' ' LEU . 3.6 t80 -78.73 139.17 38.49 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 113.839 -1.528 . . . . 1.52 110.823 177.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.462 ' OD1' ' HB3' ' A' ' 32' ' ' GLN . 2.6 t-20 -80.9 82.76 6.79 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.595 -0.729 . . . . 2.16 109.288 178.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.773 HD13 HG23 ' A' ' 20' ' ' VAL . 52.7 tp -58.44 -43.38 88.75 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.657 -0.701 . . . . 1.07 110.454 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.719 HG11 ' HG3' ' A' ' 34' ' ' LYS . 1.8 t -69.1 -0.26 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 114.918 -1.037 . . . . 1.69 112.384 -168.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.462 ' HB3' ' OD1' ' A' ' 29' ' ' ASN . 9.3 pt20 -77.1 -8.9 58.28 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.247 -0.649 . . . . 1.31 109.247 174.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.919 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 91.2 m-70 -98.95 29.7 3.71 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 122.042 0.925 . . . . 0.35 109.007 175.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.762 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 5.7 mtmt -92.31 109.29 20.67 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 114.25 -1.341 . . . . 2.07 109.768 174.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.73 -38.44 1.99 Allowed Glycine 0 N--CA 1.436 -1.328 0 N-CA-C 111.319 -0.712 . . . . 0.24 111.319 -177.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.468 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 25.4 m -127.49 130.91 23.63 Favored Pre-proline 0 N--CA 1.433 -1.282 0 N-CA-C 108.192 -1.04 . . . . 0.74 108.192 171.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.817 ' HG2' HD23 ' A' ' 171' ' ' LEU . 2.7 Cg_endo -43.43 157.82 0.11 Allowed 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 124.135 3.223 . . . . 0.22 113.016 176.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.732 ' HB2' HG21 ' A' ' 70' ' ' THR . 0.7 OUTLIER -143.12 144.0 32.05 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 106.981 -1.488 . . . . 1.09 106.981 -179.105 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.774 HD21 ' CE1' ' A' ' 69' ' ' PHE . 2.7 mm? -107.92 113.39 26.56 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.075 -0.713 . . . . 1.82 109.075 177.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.906 HG21 HD11 ' A' ' 72' ' ' LEU . 0.9 OUTLIER -97.0 125.35 50.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 109.676 -0.49 . . . . 1.12 109.676 177.219 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.756 ' CE1' HG11 ' A' ' 71' ' ' VAL . 2.4 m-85 -108.26 155.73 20.16 Favored 'General case' 0 C--O 1.216 -0.698 0 CA-C-O 120.899 0.38 . . . . 1.09 111.537 -171.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.776 HD22 ' HG3' ' A' ' 84' ' ' PRO . 7.0 t30 -105.33 115.35 30.12 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.306 -1.368 . . . . 3.11 107.306 165.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.788 ' O ' ' HA ' ' A' ' 75' ' ' PRO . 34.7 m -126.71 159.4 36.32 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 CA-C-O 121.223 0.535 . . . . 1.69 112.124 -171.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.536 ' HB1' ' HA3' ' A' ' 48' ' ' GLY . . . -87.28 154.24 20.85 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 108.083 -1.081 . . . . 1.45 108.083 166.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.566 ' HB3' ' O ' ' A' ' 96' ' ' THR . 59.8 m -75.45 -159.44 0.1 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 110.135 -0.32 . . . . 1.99 110.135 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 51.7 tttm -61.49 -17.12 53.2 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.512 0.672 . . . . 6.2 110.195 -179.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.47 ' HB3' HG21 ' A' ' 90' ' ' ILE . 48.3 t -109.37 130.13 55.51 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 107.798 -1.186 . . . . 4.12 107.798 170.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.737 ' HA2' ' HG2' ' A' ' 89' ' ' GLU . . . 147.36 -121.5 1.4 Allowed Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 110.838 -0.905 . . . . 3.44 110.838 -174.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -165.84 121.15 1.26 Allowed 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.339 0.59 . . . . 4.84 111.786 177.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.704 HG22 ' HD2' ' A' ' 54' ' ' TYR . 62.6 p -92.77 96.5 10.19 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.433 -0.803 . . . . 2.41 110.023 175.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.576 ' HB3' ' HB2' ' A' ' 156' ' ' PRO . 14.0 tppt? -65.4 -13.51 58.81 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.049 0.452 . . . . 2.47 111.882 -176.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 131.9 -16.3 5.03 Favored Glycine 0 CA--C 1.507 -0.44 0 N-CA-C 110.208 -1.157 . . . . 0.85 110.208 -172.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.462 ' HA2' ' HB ' ' A' ' 56' ' ' THR . . . -61.7 -15.65 48.45 Favored Glycine 0 C--O 1.216 -0.991 0 CA-C-N 114.729 -0.735 . . . . 0.67 112.433 175.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.704 ' HD2' HG22 ' A' ' 50' ' ' THR . 0.4 OUTLIER -68.43 -59.99 2.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 117.358 0.579 . . . . 1.2 109.844 178.035 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -51.85 -32.63 32.68 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.861 0.838 . . . . 2.61 110.456 174.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.728 ' HA ' HG23 ' A' ' 160' ' ' VAL . 43.3 m -72.83 -59.36 2.75 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 114.396 -1.274 . . . . 1.06 110.578 -175.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 1.091 ' HB2' HG13 ' A' ' 71' ' ' VAL . . . -58.52 -42.17 87.1 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.693 -1.14 . . . . 1.05 111.115 -178.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.537 ' HA ' ' CD1' ' A' ' 102' ' ' PHE . 91.5 m -59.63 -55.14 38.16 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.566 0.698 . . . . 1.08 110.442 -178.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 61.4 m -66.82 -36.89 83.42 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.655 -1.157 . . . . 1.22 111.406 -177.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.761 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 14.9 mt -65.42 -47.98 74.38 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 121.364 0.602 . . . . 1.14 110.345 -177.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.87 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 6.7 t80 -59.22 -46.3 88.82 Favored 'General case' 0 C--O 1.207 -1.135 0 CA-C-N 114.896 -1.047 . . . . 0.94 110.489 178.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.69 -25.12 60.09 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 116.416 -0.357 . . . . 1.6 110.981 -174.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.418 ' HB2' ' HE2' ' A' ' 63' ' ' LYS . 6.5 tppt? -80.0 -32.72 39.7 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 108.316 -0.994 . . . . 2.06 108.316 -178.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.745 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 46.0 m-85 -125.67 -2.04 7.32 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 115.802 1.779 . . . . 0.92 115.802 -165.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.659 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 16.3 pttp -67.13 -23.33 65.8 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 107.881 -1.155 . . . . 1.89 107.881 169.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 29.2 t -48.57 -36.94 16.63 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 114.161 -1.381 . . . . 1.68 110.565 169.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.493 HE21 ' HD1' ' A' ' 64' ' ' TYR . 48.0 mt-30 -90.31 -32.44 16.51 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 111.875 0.324 . . . . 1.11 111.875 175.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 142.25 -6.81 2.27 Favored Glycine 0 C--N 1.331 0.264 0 N-CA-C 111.119 -0.792 . . . . 0.2 111.119 -176.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.774 ' CE1' HD21 ' A' ' 39' ' ' LEU . 19.9 t80 -66.91 138.61 57.42 Favored 'General case' 0 C--O 1.22 -0.463 0 C-N-CA 123.045 0.538 . . . . 0.21 111.17 -177.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.919 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 2.0 t -133.51 144.21 49.26 Favored 'General case' 0 N--CA 1.428 -1.573 0 N-CA-C 109.39 -0.596 . . . . 1.02 109.39 175.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 1.091 HG13 ' HB2' ' A' ' 57' ' ' ALA . 19.6 t -103.28 100.61 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.465 0 N-CA-C 108.614 -0.884 . . . . 1.04 108.614 162.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.906 HD11 HG21 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -98.73 120.09 38.58 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.237 -0.985 . . . . 1.69 108.414 174.636 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 1.038 ' HB1' HD13 ' A' ' 104' ' ' ILE . . . -105.49 131.22 53.17 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.64 0.733 . . . . 1.17 111.304 -177.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.798 ' HZ ' HG13 ' A' ' 20' ' ' VAL . 3.0 m-30 -107.76 108.94 62.08 Favored Pre-proline 0 C--N 1.31 -1.116 0 CA-C-N 114.998 -1.001 . . . . 0.58 108.905 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.788 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 18.0 Cg_endo -82.13 87.48 1.4 Allowed 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.551 2.167 . . . . 1.3 113.321 -171.052 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.742 ' HB2' ' OD1' ' A' ' 42' ' ' ASN . 1.6 t -40.51 135.51 1.52 Allowed 'General case' 0 CA--C 1.506 -0.739 0 CA-C-N 115.157 -0.929 . . . . 1.91 113.013 -173.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.604 ' C ' ' H ' ' A' ' 79' ' ' PHE . 4.8 p-10 -77.14 89.42 3.63 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 114.493 -1.23 . . . . 1.93 109.372 178.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 1.101 ' HA ' ' HG2' ' A' ' 83' ' ' GLU . 3.7 mt-30 -54.41 -7.92 0.18 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 113.674 -1.603 . . . . 3.97 109.941 167.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.604 ' H ' ' C ' ' A' ' 77' ' ' ASN . 59.5 m-85 -63.59 -12.71 35.39 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.59 -1.187 . . . . 3.21 111.969 -178.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -94.06 -125.34 4.18 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.485 -0.864 . . . . 1.98 111.864 177.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -170.32 71.25 0.12 Allowed Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 111.073 -0.811 . . . . 1.66 111.073 174.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.71 ' HG3' ' HG2' ' A' ' 113' ' ' GLU . 5.2 pm0 -169.16 -27.95 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.961 -0.619 . . . . 1.74 110.022 -172.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 1.101 ' HG2' ' HA ' ' A' ' 78' ' ' GLN . 0.0 OUTLIER -60.82 166.99 3.86 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 114.743 -1.117 . . . . 3.07 111.86 -165.482 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.776 ' HG3' HD22 ' A' ' 42' ' ' ASN . 31.3 Cg_exo -15.81 -58.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.804 1 C-N-CA 127.155 5.236 . . . . 1.75 115.781 -175.001 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 169.38 37.85 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 119.834 -1.174 . . . . 2.27 112.674 177.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.801 ' HB3' ' HB2' ' A' ' 89' ' ' GLU . 19.1 m120 -112.63 -43.4 3.47 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.726 -0.39 . . . . 4.88 110.686 -179.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.62 ' O ' ' HE2' ' A' ' 91' ' ' LYS . 22.8 tt0 68.33 -64.23 0.31 Allowed 'General case' 0 C--O 1.223 -0.301 0 C-N-CA 123.956 0.902 . . . . 3.02 113.072 170.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.483 ' O ' ' HG2' ' A' ' 92' ' ' GLU . 20.6 tp10 -115.86 -0.58 12.82 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.792 0.329 . . . . 3.92 110.473 -175.273 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.801 ' HB2' ' HB3' ' A' ' 86' ' ' ASN . 11.1 tp10 -49.49 -61.31 2.17 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.586 -0.733 . . . . 2.65 112.387 -170.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.87 HG12 ' HB2' ' A' ' 78' ' ' GLN . 24.4 pt -93.01 8.25 5.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.917 -0.313 . . . . 2.63 111.519 -176.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.62 ' HE2' ' O ' ' A' ' 87' ' ' GLU . 47.9 mtmt -97.1 -37.47 10.12 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.845 0.355 . . . . 3.13 110.317 179.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.483 ' HG2' ' O ' ' A' ' 88' ' ' GLU . 9.2 pt-20 -86.46 -27.67 23.95 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 116.003 -0.544 . . . . 3.29 109.989 176.083 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.448 ' HB3' ' SG ' ' A' ' 47' ' ' CYS . 17.2 t80 -113.38 152.97 29.31 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.99 0.424 . . . . 4.08 110.179 -176.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.2 p -70.82 123.39 24.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.96 -0.564 . . . . 3.05 110.686 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.682 ' SG ' ' HB ' ' A' ' 90' ' ' ILE . 1.4 p -108.6 120.04 41.28 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.369 0.604 . . . . 3.04 111.164 177.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.566 ' O ' ' HB3' ' A' ' 45' ' ' SER . 4.5 m -85.75 141.35 29.76 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 107.297 -1.372 . . . . 3.38 107.297 165.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.438 ' HD2' ' HB1' ' A' ' 23' ' ' ALA . 22.1 pttm -67.36 115.03 6.55 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 108.358 -0.978 . . . . 3.11 108.358 177.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.784 ' CE1' ' HB3' ' A' ' 100' ' ' ALA . 0.0 OUTLIER -59.27 115.8 3.47 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.099 -0.955 . . . . 2.12 110.066 -172.501 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -105.83 111.88 24.72 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.292 -0.867 . . . . 3.1 110.496 -178.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.784 ' HB3' ' CE1' ' A' ' 98' ' ' PHE . . . -107.09 -160.63 0.74 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.068 -0.969 . . . . 1.15 111.24 -177.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -87.4 -5.39 58.87 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.353 -0.839 . . . . 1.99 110.108 174.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.705 ' HB2' ' O ' ' A' ' 71' ' ' VAL . 16.6 p90 -121.09 160.26 45.98 Favored Pre-proline 0 N--CA 1.44 -0.932 0 CA-C-N 115.639 -0.71 . . . . 1.31 110.37 -175.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.629 ' HG2' ' HA ' ' A' ' 72' ' ' LEU . 44.0 Cg_endo -61.65 95.99 0.13 Allowed 'Trans proline' 0 N--CA 1.479 0.624 0 C-N-CA 124.71 3.606 . . . . 1.07 114.284 -174.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 1.038 HD13 ' HB1' ' A' ' 73' ' ' ALA . 4.8 mm -87.02 129.8 37.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 108.591 -0.892 . . . . 1.97 108.591 171.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.754 ' HG2' ' CG ' ' A' ' 74' ' ' PHE . 0.1 OUTLIER -82.66 174.03 11.38 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.709 -0.848 . . . . 3.41 108.709 177.114 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.794 ' N ' ' HA ' ' A' ' 23' ' ' ALA . . . -56.09 -56.51 19.98 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.16 0.505 . . . . 1.46 110.127 -176.046 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.718 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 4.7 ptpp? 144.33 137.03 0.0 OUTLIER 'General case' 0 CA--C 1.488 -1.416 0 O-C-N 125.734 1.896 . . . . 2.31 106.952 176.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.459 HG12 ' HD2' ' A' ' 74' ' ' PHE . 2.9 pp -136.21 163.32 34.32 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.281 0 CA-C-N 113.945 -1.479 . . . . 1.65 107.497 177.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.705 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 1.0 OUTLIER -71.19 57.58 0.23 Allowed 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 122.947 0.499 . . . . 1.73 111.894 -173.83 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.562 HG21 ' CB ' ' A' ' 76' ' ' SER . 0.0 OUTLIER -61.16 94.83 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 N-CA-C 108.92 -0.77 . . . . 1.4 108.92 -178.121 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.588 ' ND2' ' H ' ' A' ' 112' ' ' GLY . 3.8 t30 176.27 -177.4 0.13 Allowed 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 114.245 -1.343 . . . . 2.1 108.717 -177.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.588 ' H ' ' ND2' ' A' ' 111' ' ' ASN . . . -55.82 -34.66 61.48 Favored Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 116.573 1.389 . . . . 1.47 116.573 -177.435 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.71 ' HG2' ' HG3' ' A' ' 82' ' ' GLN . 0.5 OUTLIER -87.73 -42.79 12.38 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 119.59 1.695 . . . . 2.81 113.538 -156.403 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.4 ' N ' ' HG3' ' A' ' 113' ' ' GLU . 49.0 t30 -129.84 -33.8 1.77 Allowed 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.449 -0.501 . . . . 2.75 110.308 -176.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 1.048 ' HB3' ' HG2' ' A' ' 120' ' ' GLU . . . 39.44 -132.19 0.22 Allowed 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 114.694 -1.139 . . . . 1.44 110.33 -173.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.703 ' ND1' ' H ' ' A' ' 118' ' ' LEU . 3.2 t-80 -152.94 137.4 10.77 Favored Pre-proline 0 N--CA 1.422 -1.828 0 N-CA-C 105.636 -1.987 . . . . 0.71 105.636 170.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -29.38 -44.31 0.1 OUTLIER 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 124.128 3.219 . . . . 0.47 113.577 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.776 HD12 ' HB ' ' A' ' 15' ' ' ILE . 39.4 tp -59.63 -52.25 66.34 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.495 0.718 . . . . 1.15 112.079 176.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.641 ' HA ' ' HB2' ' A' ' 122' ' ' MET . 43.0 m-85 -77.39 -36.27 53.55 Favored 'General case' 0 CA--C 1.5 -0.953 0 N-CA-C 111.871 0.322 . . . . 3.33 111.871 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 1.048 ' HG2' ' HB3' ' A' ' 115' ' ' ALA . 7.0 mm-40 -59.33 -32.81 70.42 Favored 'General case' 0 CA--C 1.494 -1.182 0 N-CA-C 107.828 -1.175 . . . . 2.44 107.828 172.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.687 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 55.0 t80 -70.81 -33.71 70.99 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 119.731 -0.788 . . . . 1.08 110.651 172.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.692 ' HG3' ' HG3' ' A' ' 150' ' ' PRO . 2.6 ttm -73.59 -55.22 6.58 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.903 -0.589 . . . . 1.25 110.102 -168.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.634 ' HD2' ' CB ' ' A' ' 134' ' ' ALA . 0.2 OUTLIER -71.31 -24.13 62.07 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.088 -0.505 . . . . 1.86 111.614 176.372 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.727 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 9.8 pttp -68.71 -27.54 66.03 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 119.088 -1.045 . . . . 2.52 108.889 175.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 56.0 m -76.73 -50.04 14.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.463 -0.79 . . . . 1.21 109.546 173.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.64 ' HB3' ' NH2' ' A' ' 153' ' ' ARG . 31.4 mttm -138.22 109.81 8.28 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.902 -0.59 . . . . 2.38 111.077 176.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -72.49 -46.67 0.44 Allowed 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 123.084 2.523 . . . . 1.69 111.348 -177.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.52 ' HA2' ' CZ ' ' A' ' 153' ' ' ARG . . . -178.03 142.84 5.75 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.789 -0.72 . . . . 2.59 111.913 177.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.588 HG21 HH12 ' A' ' 153' ' ' ARG . 22.1 pt -66.41 -27.91 41.85 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 N-CA-C 108.252 -1.018 . . . . 3.93 108.252 170.077 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 38.4 tp -93.75 141.84 28.04 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 107.265 -1.383 . . . . 3.81 107.265 165.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -69.71 79.56 0.44 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.107 0.48 . . . . 3.63 110.985 -177.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 8.0 m -118.16 -93.36 0.51 Allowed 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 116.123 -0.489 . . . . 3.97 111.508 -179.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 61.5 tttp 179.46 -49.12 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.75 0.31 . . . . 5.48 111.197 -175.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.634 ' CB ' ' HD2' ' A' ' 123' ' ' LYS . . . -154.08 -174.15 4.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.297 0.57 . . . . 1.59 112.408 -172.224 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.851 HD11 ' H ' ' A' ' 135' ' ' ILE . 0.1 OUTLIER -69.45 46.95 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-N 114.7 -1.136 . . . . 2.09 111.118 173.235 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.52 ' C ' ' HA ' ' A' ' 84' ' ' PRO . 21.6 tttp -76.17 48.83 0.53 Allowed 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.495 0.664 . . . . 5.16 111.963 -172.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.638 ' C ' ' HB3' ' A' ' 84' ' ' PRO . 12.0 m-90 -144.56 173.06 12.14 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.159 -1.052 . . . . 2.41 108.159 178.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.651 ' HB2' ' CB ' ' A' ' 156' ' ' PRO . 11.5 m120 -45.25 -155.31 0.0 OUTLIER 'General case' 0 C--O 1.21 -1.019 0 C-N-CA 123.907 0.883 . . . . 2.04 111.403 163.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.68 ' HA ' HG12 ' A' ' 43' ' ' VAL . 1.3 m-85 -30.47 -27.65 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.308 0 N-CA-C 117.317 2.34 . . . . 2.53 117.317 -167.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.672 ' HA ' ' O ' ' A' ' 154' ' ' PHE . 3.1 m 9.08 108.55 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 115.162 1.541 . . . . 1.24 115.162 169.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.584 ' OG ' HD13 ' A' ' 39' ' ' LEU . 3.1 t -105.84 165.59 11.08 Favored 'General case' 0 C--O 1.207 -1.177 0 CA-C-N 114.903 -1.044 . . . . 1.03 110.855 -173.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.515 ' CE2' HG23 ' A' ' 135' ' ' ILE . 15.1 m-85 -121.51 125.22 46.3 Favored 'General case' 0 CA--C 1.49 -1.337 0 N-CA-C 106.486 -1.672 . . . . 0.7 106.486 167.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.76 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 11.1 tp -80.36 104.14 10.7 Favored 'General case' 0 N--CA 1.419 -2.004 0 C-N-CA 118.222 -1.391 . . . . 1.16 108.457 178.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.682 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 41.1 mm -89.21 141.7 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.658 0 CA-C-N 113.012 -1.904 . . . . 1.05 107.701 -177.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.649 ' HA ' HD11 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -93.46 -176.01 3.97 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 119.938 -0.705 . . . . 0.98 111.137 -170.865 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.667 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 50.4 mtm180 -54.49 -37.12 64.92 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.878 0.37 . . . . 2.61 111.301 -177.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.425 ' O ' ' HB3' ' A' ' 14' ' ' SER . 7.5 m-20 -94.36 13.96 22.0 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.716 -0.22 . . . . 2.0 110.782 -178.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.635 ' HA3' ' CE2' ' A' ' 16' ' ' PHE . . . 73.14 36.82 56.04 Favored Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 120.858 -0.687 . . . . 0.19 113.286 -176.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.458 ' HA ' ' HD2' ' A' ' 150' ' ' PRO . 52.6 t -107.82 106.32 58.24 Favored Pre-proline 0 C--N 1.317 -0.829 0 CA-C-N 117.701 0.75 . . . . 1.74 111.078 175.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.692 ' HG3' ' HG3' ' A' ' 122' ' ' MET . 2.1 Cg_endo -51.48 117.24 3.28 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 123.746 2.964 . . . . 0.6 111.462 172.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.837 HG23 ' HG2' ' A' ' 152' ' ' GLU . 27.5 m -118.33 -13.02 10.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 121.133 0.492 . . . . 2.06 109.754 -178.215 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.837 ' HG2' HG23 ' A' ' 151' ' ' VAL . 17.2 mm-40 -145.99 165.9 27.65 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.582 -0.736 . . . . 1.17 109.652 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.64 ' NH2' ' HB3' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -148.03 144.23 27.77 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.634 -0.712 . . . . 2.9 110.044 159.459 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.705 ' HZ ' ' HB2' ' A' ' 166' ' ' LYS . 91.5 m-85 -120.58 148.25 44.12 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.333 -0.849 . . . . 0.36 108.802 -166.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.419 ' HB3' ' HD2' ' A' ' 156' ' ' PRO . 10.8 m -74.56 162.67 72.67 Favored Pre-proline 0 C--N 1.316 -0.889 0 N-CA-C 109.654 -0.498 . . . . 1.45 109.654 178.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.651 ' CB ' ' HB2' ' A' ' 138' ' ' ASN . 28.6 Cg_endo -63.82 -33.04 66.3 Favored 'Trans proline' 0 CA--C 1.516 -0.386 0 C-N-CA 121.973 1.782 . . . . 0.78 110.42 174.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -63.96 -5.54 14.84 Favored Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 113.926 -1.488 . . . . 0.59 113.822 170.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -87.74 142.32 27.92 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 117.765 0.782 . . . . 1.07 109.408 174.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.445 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 20.3 t -109.92 -179.82 3.91 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 120.881 0.372 . . . . 1.92 110.414 -172.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.728 HG23 ' HA ' ' A' ' 56' ' ' THR . 62.9 t -43.68 -52.13 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.082 -0.963 . . . . 1.07 111.452 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.33 -27.58 62.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.956 -0.566 . . . . 3.89 111.486 -173.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -71.12 -37.75 72.32 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 109.144 -0.687 . . . . 1.4 109.144 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.534 ' HA ' ' CE2' ' A' ' 154' ' ' PHE . 75.0 mt -77.35 -49.09 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-N 115.027 -0.988 . . . . 1.05 110.639 176.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.665 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 25.5 mt-10 -51.78 -45.47 63.82 Favored 'General case' 0 C--O 1.219 -0.54 0 O-C-N 123.302 0.376 . . . . 0.67 111.305 -177.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -56.31 -23.34 36.3 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.041 0.386 . . . . 0.87 112.041 -175.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.705 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 14.2 mmmm -102.1 -23.91 14.01 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.342 0.591 . . . . 2.22 110.064 174.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.665 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 7.5 tp -76.74 -48.06 19.91 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.262 -0.881 . . . . 1.04 111.95 -177.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.487 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 80.6 mt -53.76 -46.39 98.41 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.616 -0.72 . . . . 1.08 112.175 -174.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.487 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 58.0 Cg_exo -54.65 -22.93 30.53 Favored 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 122.311 2.007 . . . . 0.62 113.12 174.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.765 ' HB3' ' HG3' ' A' ' 37' ' ' PRO . 31.2 mt -92.98 -38.5 11.63 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 111.68 0.252 . . . . 1.36 111.68 178.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.817 HD23 ' HG2' ' A' ' 37' ' ' PRO . 94.9 mt -63.29 -52.04 63.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-O 122.212 1.006 . . . . 1.07 109.313 175.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -73.63 -32.14 59.78 Favored Glycine 0 N--CA 1.433 -1.563 0 CA-C-N 113.265 -1.789 . . . . 1.12 114.184 -174.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 19.4 m -151.8 -169.48 3.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 117.615 0.708 . . . . 2.88 111.423 -175.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -93.02 -56.61 2.91 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.843 0.312 . . . . 4.69 111.843 -179.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 9.2 tpm_? -147.74 106.51 3.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.018 0.437 . . . . 9.17 111.715 -176.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 4.3 mm? . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.69 -0.671 . . . . 8.03 109.352 172.345 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.657 0 CA-C-O 120.133 -0.26 . . . . 5.58 112.506 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.6 ptm -171.39 -29.56 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.884 0.342 . . . . 5.23 111.206 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.43 74.94 0.83 Allowed Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.513 -0.851 . . . . 1.55 112.973 179.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.2 t -110.76 3.77 19.4 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.834 0.826 . . . . 2.17 108.794 173.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.421 ' HB2' ' O ' ' A' ' 147' ' ' ASP . 92.0 p -179.91 152.69 0.48 Allowed 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 104.831 -2.285 . . . . 1.68 104.831 -177.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.944 HD11 HD23 ' A' ' 30' ' ' LEU . 4.7 pt -66.96 -12.66 15.42 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 CA-C-N 115.371 -0.831 . . . . 1.16 112.021 -171.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.651 ' CD1' ' HA ' ' A' ' 31' ' ' VAL . 54.9 m-85 -76.28 6.97 4.74 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.028 0.442 . . . . 0.3 111.167 178.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -81.7 -27.74 33.8 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 107.24 -1.393 . . . . 2.11 107.24 174.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.642 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 50.9 m-85 -105.05 121.02 42.92 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 113.963 -1.472 . . . . 0.37 111.008 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -60.18 150.08 30.99 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.29 -1.323 . . . . 2.86 109.818 173.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.781 HG11 ' HZ ' ' A' ' 74' ' ' PHE . 53.0 t -112.23 170.66 3.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 107.71 -1.219 . . . . 1.32 107.71 178.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.729 HD21 ' HA ' ' A' ' 27' ' ' PRO . 88.7 mt -132.37 141.05 48.74 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 118.334 0.515 . . . . 1.29 111.409 -176.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -74.36 169.07 18.42 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 106.878 -1.527 . . . . 1.87 106.878 166.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.805 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . . . -62.4 -3.73 1.53 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 114.046 1.128 . . . . 1.2 114.046 -167.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.545 ' HB2' ' HE2' ' A' ' 26' ' ' LYS . 64.7 m-20 -111.5 12.06 21.37 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 121.008 -0.277 . . . . 2.34 111.349 176.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.546 ' CD2' ' HB1' ' A' ' 106' ' ' ALA . 72.1 m-70 77.13 8.96 2.77 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.366 0.603 . . . . 2.26 109.72 177.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.545 ' HE2' ' HB2' ' A' ' 24' ' ' ASP . 21.1 mtmt -74.65 119.3 76.0 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 107.54 -1.282 . . . . 4.64 107.54 169.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.729 ' HA ' HD21 ' A' ' 21' ' ' LEU . 93.9 Cg_exo -50.39 115.27 1.83 Allowed 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.329 2.019 . . . . 0.62 114.203 -172.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.608 ' CE2' ' HB3' ' A' ' 103' ' ' PRO . 0.2 OUTLIER -78.6 120.4 23.23 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 113.275 -1.784 . . . . 1.52 109.635 169.201 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -72.96 103.1 3.65 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 122.446 1.117 . . . . 2.16 108.82 174.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.944 HD23 HD11 ' A' ' 15' ' ' ILE . 67.3 tp -71.4 -31.48 67.32 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.834 -1.076 . . . . 1.07 110.343 -178.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.651 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 3.3 m -66.14 -4.13 2.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 114.439 -1.255 . . . . 1.69 113.109 -167.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 -74.67 -6.64 49.84 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.557 0.694 . . . . 1.31 110.01 175.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.949 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 88.6 m-70 -102.13 24.97 9.36 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 115.339 -0.846 . . . . 0.35 109.397 176.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.56 ' HE3' ' HB ' ' A' ' 31' ' ' VAL . 93.0 mttt -83.99 123.79 30.36 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 114.426 -1.261 . . . . 2.07 109.323 170.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.14 -36.08 4.07 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.366 -0.921 . . . . 0.24 111.925 178.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.452 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 22.5 m -130.38 132.33 23.95 Favored Pre-proline 0 N--CA 1.436 -1.162 0 N-CA-C 108.252 -1.018 . . . . 0.74 108.252 171.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.755 ' HG3' ' CB ' ' A' ' 170' ' ' LEU . 5.1 Cg_endo -43.18 153.86 0.18 Allowed 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.899 3.066 . . . . 0.22 112.795 176.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.808 HD11 ' HB2' ' A' ' 33' ' ' HIS . 0.7 OUTLIER -139.65 149.17 43.42 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 106.313 -1.736 . . . . 1.09 106.313 -179.733 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.949 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 2.3 mp -116.3 130.84 56.98 Favored 'General case' 0 C--N 1.292 -1.92 0 O-C-N 121.629 -0.669 . . . . 1.82 109.606 176.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.924 HG23 ' OH ' ' A' ' 119' ' ' TYR . 1.1 mt -111.72 126.75 69.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 CA-C-N 115.065 -0.971 . . . . 1.12 109.596 178.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.949 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.6 OUTLIER -111.86 124.72 52.95 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.954 -0.566 . . . . 1.09 110.992 -171.662 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.677 ' HB3' HG23 ' A' ' 135' ' ' ILE . 0.9 OUTLIER -79.66 95.12 5.84 Favored 'General case' 0 CA--C 1.504 -0.827 0 N-CA-C 107.206 -1.405 . . . . 3.11 107.206 167.194 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.704 ' O ' ' HA ' ' A' ' 75' ' ' PRO . 4.1 p -105.89 147.17 11.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 CA-C-N 114.833 -1.076 . . . . 1.69 109.649 -172.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.452 ' O ' ' HB3' ' A' ' 46' ' ' LYS . . . -106.6 95.76 5.98 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 119.035 -1.066 . . . . 1.45 109.879 172.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.886 ' HA ' ' HB2' ' A' ' 98' ' ' PHE . 9.2 p 17.64 -81.28 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 O-C-N 125.636 1.835 . . . . 1.99 113.824 165.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.522 ' HG3' ' HB2' ' A' ' 49' ' ' TYR . 0.0 OUTLIER 60.67 145.92 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.831 1.252 . . . . 6.2 112.939 174.074 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.951 ' HB2' ' HA ' ' A' ' 95' ' ' CYS . 46.7 t -111.2 115.31 29.15 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.801 -0.636 . . . . 4.12 110.158 178.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 63.11 13.4 48.57 Favored Glycine 0 CA--C 1.522 0.522 0 CA-C-N 115.968 -0.56 . . . . 3.44 113.624 179.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.522 ' HB2' ' HG3' ' A' ' 46' ' ' LYS . 36.7 m-85 -108.52 167.71 9.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.337 0.589 . . . . 4.84 111.866 -177.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.5 t -177.2 143.26 0.38 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.925 -1.034 . . . . 2.41 108.469 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.733 ' O ' ' HA2' ' A' ' 157' ' ' GLY . 21.9 mtpt -108.52 11.85 26.5 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.902 -0.777 . . . . 2.47 108.902 176.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 120.81 -29.32 5.87 Favored Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 110.301 -1.12 . . . . 0.85 110.301 -173.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -49.85 -46.69 40.06 Favored Glycine 0 C--O 1.222 -0.62 0 CA-C-N 114.424 -0.888 . . . . 0.67 113.969 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.472 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 0.2 OUTLIER -59.31 -59.14 5.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.328 0.564 . . . . 1.2 111.554 -171.855 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.14 -27.87 69.67 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.291 0.567 . . . . 2.61 110.48 -177.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.677 HG23 ' HA ' ' A' ' 160' ' ' VAL . 31.8 m -75.83 -57.77 3.68 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.084 -0.962 . . . . 1.06 110.02 -175.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 1.05 ' HB3' HG11 ' A' ' 71' ' ' VAL . . . -60.3 -41.67 93.88 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.202 -0.908 . . . . 1.05 111.039 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.531 ' HA ' ' CD2' ' A' ' 102' ' ' PHE . 96.7 m -57.69 -55.69 31.53 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.433 0.635 . . . . 1.08 110.466 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 27.3 m -69.46 -36.11 76.27 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.001 -0.999 . . . . 1.22 111.484 -175.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.733 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 16.3 mt -66.93 -47.07 72.82 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-O 120.974 0.416 . . . . 1.14 110.472 -176.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.862 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 5.0 t80 -55.31 -56.14 23.4 Favored 'General case' 0 C--O 1.198 -1.637 0 CA-C-N 115.208 -0.905 . . . . 0.94 109.916 177.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -69.75 -24.04 63.47 Favored 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 122.707 0.403 . . . . 1.6 111.566 -173.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.408 ' HE2' ' HB2' ' A' ' 63' ' ' LYS . 13.8 tppt? -76.01 -32.25 59.3 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 108.388 -0.968 . . . . 2.06 108.388 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.698 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 48.4 m-85 -125.86 -2.44 7.18 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 115.7 1.741 . . . . 0.92 115.7 -166.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.754 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 12.6 ptmt -63.84 -29.27 70.48 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 107.686 -1.227 . . . . 1.89 107.686 170.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.6 m -47.94 -36.63 12.76 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 113.822 -1.536 . . . . 1.68 111.009 173.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.448 HE21 ' HD1' ' A' ' 64' ' ' TYR . 49.7 mt-30 -88.44 -39.75 14.0 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 120.96 -0.296 . . . . 1.11 111.619 173.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.439 ' HA3' ' HB2' ' A' ' 36' ' ' SER . . . 151.49 -4.03 0.47 Allowed Glycine 0 CA--C 1.52 0.388 0 N-CA-C 111.505 -0.638 . . . . 0.2 111.505 -175.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.733 ' HE2' ' HB3' ' A' ' 60' ' ' LEU . 21.4 t80 -71.2 142.59 50.64 Favored 'General case' 0 C--O 1.222 -0.392 0 C-N-CA 122.644 0.377 . . . . 0.21 111.131 -177.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.949 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 2.3 t -133.76 153.15 51.92 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 108.063 -1.088 . . . . 1.02 108.063 173.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 1.05 HG11 ' HB3' ' A' ' 57' ' ' ALA . 25.6 t -112.97 99.5 8.79 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.541 0 N-CA-C 108.018 -1.104 . . . . 1.04 108.018 160.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.469 HD12 HG22 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -93.68 120.2 33.65 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 118.365 -1.334 . . . . 1.69 107.557 174.554 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.81 ' HB1' HD12 ' A' ' 104' ' ' ILE . . . -112.21 117.23 31.99 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.538 0.685 . . . . 1.17 110.901 -178.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.84 ' CG ' ' HG2' ' A' ' 105' ' ' MET . 5.3 m-30 -93.31 112.54 56.86 Favored Pre-proline 0 C--N 1.318 -0.779 0 CA-C-N 115.241 -0.891 . . . . 0.58 109.388 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.723 ' O ' ' HB2' ' A' ' 107' ' ' LYS . 44.2 Cg_endo -82.29 87.4 1.4 Allowed 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.082 1.855 . . . . 1.3 112.694 -172.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.613 ' HB2' ' ND2' ' A' ' 42' ' ' ASN . 7.0 t -43.18 140.56 1.48 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.382 -1.281 . . . . 1.91 111.765 -177.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.713 ' HB2' ' HD2' ' A' ' 79' ' ' PHE . 1.5 p-10 -112.82 132.28 55.33 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 113.989 -1.46 . . . . 1.93 110.379 -169.012 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.793 ' HA ' ' HG2' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -50.17 -8.96 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.636 -1.166 . . . . 3.97 113.396 -178.431 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.713 ' HD2' ' HB2' ' A' ' 77' ' ' ASN . 69.8 m-85 -65.24 -14.09 59.87 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.618 0.599 . . . . 3.21 112.618 -168.045 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -98.21 -23.58 12.69 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.318 -0.944 . . . . 1.98 112.664 -177.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.18 13.21 82.96 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 111.411 -0.676 . . . . 1.66 111.411 -176.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.463 ' NE2' ' HB3' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -123.2 20.17 9.82 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 122.765 0.426 . . . . 1.74 110.111 -175.979 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.793 ' HG2' ' HA ' ' A' ' 78' ' ' GLN . 0.0 OUTLIER -74.03 143.54 80.88 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-O 121.913 0.863 . . . . 3.07 112.885 -165.664 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.711 ' HB2' ' O ' ' A' ' 137' ' ' TRP . 80.0 Cg_endo -78.05 -43.57 0.19 Allowed 'Trans proline' 0 N--CA 1.478 0.605 0 C-N-CA 124.992 3.795 . . . . 1.75 113.867 -171.092 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -58.02 -24.44 54.5 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 121.364 -0.446 . . . . 2.27 112.941 -174.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.475 ' O ' ' HB3' ' A' ' 87' ' ' GLU . 43.5 t-20 177.02 -86.62 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.97 -1.122 . . . . 4.88 107.97 177.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.475 ' HB3' ' O ' ' A' ' 86' ' ' ASN . 13.8 pt-20 154.71 -41.31 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 O-C-N 124.859 1.349 . . . . 3.02 108.26 173.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.409 ' O ' ' HG2' ' A' ' 92' ' ' GLU . 11.1 tp10 -106.16 -26.15 11.71 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.001 -1.0 . . . . 3.92 111.213 -175.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -50.71 -45.34 58.39 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.943 0.72 . . . . 2.65 112.943 -170.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.615 ' HA ' ' SG ' ' A' ' 95' ' ' CYS . 33.2 pt -82.54 10.57 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.985 0.422 . . . . 2.63 111.861 -176.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -124.47 -42.79 2.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.145 0.498 . . . . 3.13 109.832 176.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 88' ' ' GLU . 12.0 pt-20 -66.92 -22.09 65.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.636 -0.711 . . . . 3.29 109.66 175.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -129.69 148.48 51.58 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.428 -0.953 . . . . 4.08 108.428 176.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 8.9 p -78.23 117.28 23.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-O 121.4 0.619 . . . . 3.05 110.159 176.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.951 ' HA ' ' HB2' ' A' ' 47' ' ' CYS . 61.8 m -119.08 126.71 52.31 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.344 0.592 . . . . 3.04 110.965 -178.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.5 p -64.43 157.32 26.79 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 114.648 -1.16 . . . . 3.38 108.667 169.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -75.64 43.8 0.26 Allowed 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 111.845 0.313 . . . . 3.11 111.845 -174.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.886 ' HB2' ' HA ' ' A' ' 45' ' ' SER . 0.9 OUTLIER 65.57 -92.36 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.743 -0.662 . . . . 2.12 110.721 177.782 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt 63.93 139.52 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 O-C-N 123.632 0.582 . . . . 3.1 111.12 -175.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.502 ' HB1' ' CE1' ' A' ' 98' ' ' PHE . . . -164.6 -173.21 2.94 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.048 0.452 . . . . 1.15 111.36 -176.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -85.86 22.52 1.65 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.308 -0.86 . . . . 1.99 110.606 -177.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.585 ' CZ ' ' HZ ' ' A' ' 98' ' ' PHE . 19.1 p90 -147.33 163.67 26.89 Favored Pre-proline 0 N--CA 1.447 -0.609 0 CA-C-N 115.711 -0.677 . . . . 1.31 109.312 -178.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.658 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 71.3 Cg_exo -57.12 89.39 0.04 OUTLIER 'Trans proline' 0 N--CA 1.478 0.608 0 C-N-CA 124.608 3.538 . . . . 1.07 115.44 -172.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.81 HD12 ' HB1' ' A' ' 73' ' ' ALA . 3.6 mm -89.52 127.54 42.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 108.259 -1.015 . . . . 1.97 108.259 171.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.84 ' HG2' ' CG ' ' A' ' 74' ' ' PHE . 0.7 OUTLIER -88.83 -171.37 3.28 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.8 0.333 . . . . 3.41 111.563 -172.206 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.805 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . . . -61.19 -16.88 49.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.808 -0.633 . . . . 1.46 111.795 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.723 ' HB2' ' O ' ' A' ' 75' ' ' PRO . 3.7 ptpp? 78.27 128.2 0.05 OUTLIER 'General case' 0 CA--C 1.494 -1.193 0 O-C-N 125.477 1.736 . . . . 2.31 109.846 -166.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.407 HD13 ' HB3' ' A' ' 116' ' ' HIS . 2.4 pp -128.87 163.64 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.162 0 CA-C-N 113.028 -1.897 . . . . 1.65 107.042 171.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.599 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 0.1 OUTLIER -70.15 58.1 0.16 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 123.897 0.748 . . . . 1.73 111.556 -172.576 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.558 ' HB ' ' ND2' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -63.91 96.64 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 CA-C-O 120.849 0.357 . . . . 1.4 111.08 -171.977 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.795 HD22 ' HA ' ' A' ' 136' ' ' LYS . 3.5 t-20 176.59 177.74 0.25 Allowed 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 108.337 -0.986 . . . . 2.1 108.337 167.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 29.1 -104.06 0.01 OUTLIER Glycine 0 C--N 1.331 0.273 0 O-C-N 124.7 1.25 . . . . 1.47 115.803 167.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -107.3 -32.41 7.79 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 113.438 0.903 . . . . 2.81 113.438 -169.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.575 ' HB2' ' HB3' ' A' ' 109' ' ' ASN . 14.9 m-80 -94.69 1.06 55.5 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-O 118.939 -0.553 . . . . 2.75 111.264 -169.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.599 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -36.53 -91.48 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.171 0 O-C-N 124.647 1.217 . . . . 1.44 112.796 -170.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.677 ' ND1' ' H ' ' A' ' 118' ' ' LEU . 2.0 t-80 176.9 138.47 0.22 Allowed Pre-proline 0 N--CA 1.43 -1.456 0 N-CA-C 106.254 -1.758 . . . . 0.71 106.254 173.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -30.31 -46.26 0.14 Allowed 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 124.303 3.336 . . . . 0.47 113.621 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.732 HD13 ' HB ' ' A' ' 15' ' ' ILE . 22.6 tp -62.64 -51.34 67.64 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.174 0.589 . . . . 1.15 111.886 178.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.924 ' OH ' HG23 ' A' ' 40' ' ' ILE . 36.6 m-85 -76.58 -36.55 57.51 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 112.285 0.476 . . . . 3.33 112.285 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.777 ' HA ' ' HD2' ' A' ' 123' ' ' LYS . 48.5 mt-10 -61.61 -30.79 70.92 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 107.462 -1.31 . . . . 2.44 107.462 174.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.642 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 59.5 t80 -71.62 -32.87 68.43 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.426 -0.806 . . . . 1.08 110.682 171.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.728 ' HE3' HD12 ' A' ' 40' ' ' ILE . 2.5 ttm -73.73 -52.46 13.13 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.178 -0.465 . . . . 1.25 110.367 -169.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.777 ' HD2' ' HA ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -71.04 -24.73 62.4 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.196 -0.456 . . . . 1.86 111.079 175.463 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.752 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -65.0 -30.75 71.76 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.461 0.648 . . . . 2.52 109.741 172.257 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 85.9 m -79.51 -47.32 15.78 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.245 -0.889 . . . . 1.21 111.038 178.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.563 ' HE3' ' O ' ' A' ' 151' ' ' VAL . 19.9 ttmm -140.42 121.8 9.37 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 121.06 0.457 . . . . 2.38 111.982 -178.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 126' ' ' LYS . 6.1 Cg_exo -78.97 32.27 0.46 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.711 2.94 . . . . 1.69 111.966 175.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.445 ' H ' ' HG2' ' A' ' 126' ' ' LYS . . . 85.93 165.6 40.93 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.569 -0.741 . . . . 2.59 113.242 172.032 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 153' ' ' ARG . 14.1 mt -73.95 -36.42 45.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 108.353 -0.98 . . . . 3.93 108.353 173.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.751 ' H ' HD22 ' A' ' 130' ' ' LEU . 2.2 pt? -90.17 147.22 23.72 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.531 -1.213 . . . . 3.81 108.213 169.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.406 ' C ' ' HG1' ' A' ' 132' ' ' THR . . . -70.92 87.54 0.73 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.974 0.416 . . . . 3.63 110.731 -176.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' THR . . . . . 0.715 HG22 ' HZ3' ' A' ' 137' ' ' TRP . 28.0 m -149.06 127.72 12.43 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.998 -0.547 . . . . 3.97 110.278 179.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -41.46 -67.79 0.23 Allowed 'General case' 0 N--CA 1.47 0.539 0 O-C-N 123.919 0.762 . . . . 5.48 112.105 -173.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -118.38 178.09 4.58 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.844 -0.617 . . . . 1.59 110.304 -179.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.772 HD11 ' H ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -34.43 -51.48 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 O-C-N 124.439 1.087 . . . . 2.09 111.791 173.292 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.88 ' HB3' ' CZ3' ' A' ' 137' ' ' TRP . 5.4 tmtp? 55.84 -14.04 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 116.11 1.892 . . . . 5.16 116.11 174.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.88 ' CZ3' ' HB3' ' A' ' 136' ' ' LYS . 2.3 m-90 -115.39 175.34 5.56 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 119.277 0.944 . . . . 2.41 110.229 176.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -42.26 -155.8 0.0 OUTLIER 'General case' 0 C--O 1.205 -1.245 0 C-N-CA 124.022 0.929 . . . . 2.04 110.535 159.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.683 ' CD1' HG23 ' A' ' 43' ' ' VAL . 5.0 m-85 -26.04 -46.72 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.046 0 N-CA-C 116.025 1.861 . . . . 2.53 116.025 -163.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.699 ' HA ' ' O ' ' A' ' 154' ' ' PHE . 5.7 m 28.34 96.16 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 119.675 1.125 . . . . 1.24 113.664 171.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.433 ' HB3' HD23 ' A' ' 39' ' ' LEU . 1.6 m -85.07 170.74 12.65 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.041 -0.982 . . . . 1.03 111.714 -170.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.549 ' CE1' HG21 ' A' ' 135' ' ' ILE . 81.1 m-85 -130.46 120.3 23.97 Favored 'General case' 0 CA--C 1.496 -1.116 0 N-CA-C 105.886 -1.894 . . . . 0.7 105.886 161.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.748 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 4.9 tp -78.82 103.64 8.91 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 118.054 -1.458 . . . . 1.16 108.062 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.748 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 45.6 mm -88.77 141.27 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.788 0 CA-C-N 113.474 -1.694 . . . . 1.05 107.564 -177.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.411 ' HA ' HD11 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -92.37 -176.05 4.2 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 119.179 -1.008 . . . . 0.98 110.601 -171.92 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.684 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 11.5 mtm180 -54.55 -40.89 69.14 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.141 0.496 . . . . 2.61 111.031 -176.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.421 ' O ' ' HB2' ' A' ' 14' ' ' SER . 5.0 m-20 -94.83 18.01 12.61 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.558 -0.534 . . . . 2.0 109.558 -175.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.552 ' HA3' ' CE2' ' A' ' 16' ' ' PHE . . . 73.12 33.68 59.11 Favored Glycine 0 N--CA 1.44 -1.077 0 CA-C-N 115.688 -0.687 . . . . 0.19 114.128 178.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.497 ' HA ' ' HD2' ' A' ' 150' ' ' PRO . 62.1 t -107.45 106.93 59.63 Favored Pre-proline 0 C--N 1.314 -0.953 0 CA-C-N 118.298 1.049 . . . . 1.74 111.291 176.077 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.546 ' HG3' ' HG3' ' A' ' 122' ' ' MET . 5.7 Cg_exo -46.34 122.9 6.04 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 124.155 3.237 . . . . 0.6 112.087 171.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.563 ' O ' ' HE3' ' A' ' 126' ' ' LYS . 46.8 t -117.99 -29.66 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 109.369 -0.604 . . . . 2.06 109.369 -176.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.748 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 31.0 mm-40 -136.84 167.03 22.23 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.562 -0.745 . . . . 1.17 110.848 -177.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.438 ' O ' HG13 ' A' ' 129' ' ' ILE . 0.2 OUTLIER -144.02 131.37 20.89 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.473 -0.785 . . . . 2.9 109.712 163.552 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.699 ' O ' ' HA ' ' A' ' 140' ' ' THR . 96.8 m-85 -111.02 152.32 26.98 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.866 -0.606 . . . . 0.36 109.63 -170.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 12.5 m -74.76 156.94 86.31 Favored Pre-proline 0 C--N 1.319 -0.719 0 N-CA-C 109.469 -0.567 . . . . 1.45 109.469 176.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.752 ' HG3' ' HB3' ' A' ' 137' ' ' TRP . 34.4 Cg_endo -64.88 -24.89 60.46 Favored 'Trans proline' 0 CA--C 1.519 -0.267 0 C-N-CA 122.181 1.92 . . . . 0.78 111.039 177.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.733 ' HA2' ' O ' ' A' ' 51' ' ' LYS . . . -80.44 5.6 63.54 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 114.691 -1.14 . . . . 0.59 113.453 173.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -79.19 151.33 31.3 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.388 -0.597 . . . . 1.07 109.388 173.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 33.8 t -108.34 169.33 8.71 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 109.494 -0.558 . . . . 1.92 109.494 -177.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.677 ' HA ' HG23 ' A' ' 56' ' ' THR . 99.3 t -40.14 -59.48 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 O-C-N 124.356 1.035 . . . . 1.07 111.683 178.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.484 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 0.9 OUTLIER -65.74 -30.26 70.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.299 -0.409 . . . . 3.89 111.986 -173.483 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -65.25 -35.95 82.63 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-O 122.247 1.022 . . . . 1.4 108.756 -178.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.576 ' HA ' ' CE2' ' A' ' 154' ' ' PHE . 54.5 mt -78.17 -44.25 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 CA-C-N 113.7 -1.591 . . . . 1.05 110.483 175.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.613 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 47.7 mt-10 -54.93 -43.12 73.07 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 116.048 -0.524 . . . . 0.67 111.492 -177.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 161' ' ' LYS . 7.0 pt-20 -61.03 -16.69 46.36 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.235 0.457 . . . . 0.87 112.235 -176.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.623 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 34.0 mmtp -100.72 -28.89 12.58 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.667 0.746 . . . . 2.22 109.793 172.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.613 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 12.5 tp -78.84 -50.97 10.37 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.857 -1.065 . . . . 1.04 112.749 -175.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.491 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 63.3 mt -55.14 -45.78 99.79 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.85 -0.614 . . . . 1.08 112.387 -174.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.491 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 58.2 Cg_exo -56.14 -17.29 19.54 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 122.081 1.854 . . . . 0.62 113.124 174.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.755 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 78.0 mt -97.7 -42.72 7.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.741 -0.209 . . . . 1.36 111.08 176.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.674 HD22 ' HG2' ' A' ' 37' ' ' PRO . 93.7 mt -61.08 -52.1 66.37 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-O 122.165 0.983 . . . . 1.07 109.595 175.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -77.38 26.96 1.83 Allowed Glycine 0 N--CA 1.436 -1.331 0 CA-C-N 113.565 -1.652 . . . . 1.12 112.923 -178.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.426 ' H ' ' C ' ' A' ' 171' ' ' LEU . 29.1 t -124.99 97.07 5.1 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.184 0.516 . . . . 2.88 109.991 177.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -85.08 -20.55 30.2 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.55 -0.537 . . . . 4.69 109.55 176.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.441 ' HG2' ' O ' ' A' ' 175' ' ' ARG . 19.5 ttm180 64.92 21.3 12.3 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 114.815 -1.084 . . . . 9.17 110.64 175.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 58.6 tp . . . . . 0 C--O 1.25 1.103 0 CA-C-N 115.258 -0.883 . . . . 8.03 109.687 176.312 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.566 0 N-CA-C 111.935 -0.466 . . . . 5.58 111.935 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 23.4 ptp -78.47 150.25 33.03 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.759 0.314 . . . . 5.23 110.428 178.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.28 89.55 2.11 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.863 -0.684 . . . . 1.55 112.439 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.1 t -97.05 -23.72 16.13 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.965 0.412 . . . . 2.17 110.318 178.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 27.8 m -163.64 151.55 13.05 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 104.854 -2.276 . . . . 1.68 104.854 -179.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.789 ' HB ' ' CD1' ' A' ' 118' ' ' LEU . 6.3 pt -58.93 -20.55 17.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 CA-C-N 115.042 -0.981 . . . . 1.16 111.756 -174.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.837 ' HB3' HG13 ' A' ' 31' ' ' VAL . 42.2 m-85 -67.2 -6.24 17.19 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.293 0.849 . . . . 0.3 113.293 -175.229 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -78.4 -15.78 58.31 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 107.873 -1.158 . . . . 2.11 107.873 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.551 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 37.3 m-85 -107.61 115.88 30.94 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 114.577 -1.192 . . . . 0.37 110.829 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -55.62 144.32 27.06 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 113.896 -1.502 . . . . 2.86 110.054 175.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.79 HG13 ' HZ ' ' A' ' 74' ' ' PHE . 66.5 t -112.14 166.14 6.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 107.879 -1.156 . . . . 1.32 107.879 179.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.691 HD22 ' HA ' ' A' ' 27' ' ' PRO . 55.7 mt -125.6 146.59 49.63 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 109.949 -0.389 . . . . 1.29 109.949 178.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.558 ' HB3' ' HE3' ' A' ' 26' ' ' LYS . 16.5 t70 -77.8 169.79 17.68 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 106.146 -1.798 . . . . 1.87 106.146 165.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.675 ' HA ' ' N ' ' A' ' 106' ' ' ALA . . . -63.68 -3.65 2.45 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 113.253 0.834 . . . . 1.2 113.253 -168.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.947 ' HB2' ' HE2' ' A' ' 26' ' ' LYS . 3.3 m-20 -107.0 6.01 28.67 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 111.451 0.167 . . . . 2.34 111.451 176.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.557 ' CD2' ' HB1' ' A' ' 106' ' ' ALA . 59.9 m-70 79.85 6.04 1.86 Allowed 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.521 0.677 . . . . 2.26 109.61 177.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.947 ' HE2' ' HB2' ' A' ' 24' ' ' ASP . 29.8 mtmt -66.68 115.94 29.66 Favored Pre-proline 0 N--CA 1.447 -0.595 0 N-CA-C 107.656 -1.238 . . . . 4.64 107.656 167.057 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.691 ' HA ' HD22 ' A' ' 21' ' ' LEU . 75.4 Cg_exo -48.76 114.86 1.38 Allowed 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 121.796 1.664 . . . . 0.62 112.313 -178.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.502 ' HE2' HD22 ' A' ' 72' ' ' LEU . 0.8 OUTLIER -78.39 151.55 32.74 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 113.573 -1.649 . . . . 1.52 111.761 179.589 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.605 ' OD1' ' HB3' ' A' ' 32' ' ' GLN . 2.8 t-20 -86.82 90.2 8.22 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.8 -1.091 . . . . 2.16 109.836 174.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.632 HD21 ' HA ' ' A' ' 16' ' ' PHE . 63.2 tp -71.56 -43.79 65.7 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.179 0.514 . . . . 1.07 110.601 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.837 HG13 ' HB3' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -67.56 0.89 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.18 -0.918 . . . . 1.69 113.174 -172.12 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.605 ' HB3' ' OD1' ' A' ' 29' ' ' ASN . 3.7 pt20 -72.54 -11.88 60.84 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.553 0.692 . . . . 1.31 109.322 172.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.951 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 91.6 m-70 -98.73 21.18 11.76 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 115.267 -0.879 . . . . 0.35 109.087 176.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.769 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 11.0 mtmm -80.1 110.4 15.47 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.541 -1.209 . . . . 2.07 109.118 169.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 133.45 -43.06 1.3 Allowed Glycine 0 N--CA 1.439 -1.106 0 C-N-CA 120.75 -0.738 . . . . 0.24 111.841 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.414 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 72.3 m -126.88 138.09 31.91 Favored Pre-proline 0 N--CA 1.439 -0.987 0 N-CA-C 108.576 -0.898 . . . . 0.74 108.576 173.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.755 ' HD3' ' HG2' ' A' ' 146' ' ' ARG . 3.2 Cg_endo -43.37 149.15 0.58 Allowed 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 123.574 2.85 . . . . 0.22 112.079 174.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.812 ' HB2' HG22 ' A' ' 70' ' ' THR . 0.6 OUTLIER -135.78 150.24 49.41 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 106.051 -1.833 . . . . 1.09 106.051 178.475 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.908 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 2.7 mp -116.21 129.34 56.25 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 109.206 -0.664 . . . . 1.82 109.206 175.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.844 HG22 ' OH ' ' A' ' 119' ' ' TYR . 1.2 mt -111.02 123.71 67.16 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 CA-C-N 115.025 -0.989 . . . . 1.12 109.002 178.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.908 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.5 OUTLIER -108.74 123.64 49.33 Favored 'General case' 0 C--O 1.215 -0.738 0 CA-C-N 115.996 -0.547 . . . . 1.09 110.796 -172.267 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.482 HD21 ' HB ' ' A' ' 140' ' ' THR . 0.0 OUTLIER -76.56 122.09 24.11 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 104.88 -2.267 . . . . 3.11 104.88 165.948 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 1.006 HG13 ' HB1' ' A' ' 73' ' ' ALA . 2.5 p -133.07 145.91 33.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 C-N-CA 118.724 -1.19 . . . . 1.69 112.94 -165.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -94.46 102.46 14.42 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 114.919 -1.037 . . . . 1.45 110.043 174.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.573 ' OG ' ' HB2' ' A' ' 75' ' ' PRO . 13.0 m -47.71 81.27 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 O-C-N 124.284 0.99 . . . . 1.99 111.373 167.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.759 ' HE2' ' HB3' ' A' ' 49' ' ' TYR . 18.9 mmmt -97.0 157.36 15.94 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.396 0.617 . . . . 6.2 111.741 -174.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.45 ' HB2' ' HA ' ' A' ' 95' ' ' CYS . 29.9 t -111.63 117.02 31.79 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.135 -0.939 . . . . 4.12 109.18 173.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 60.25 41.65 98.39 Favored Glycine 0 CA--C 1.52 0.347 0 CA-C-N 115.796 -0.638 . . . . 3.44 113.508 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.759 ' HB3' ' HE2' ' A' ' 46' ' ' LYS . 72.5 t80 -161.55 133.53 5.7 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.199 0.523 . . . . 4.84 111.31 178.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.4 t -143.39 143.25 31.56 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.69 -0.856 . . . . 2.41 108.69 175.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.635 ' O ' ' HA2' ' A' ' 157' ' ' GLY . 48.9 tttt -95.11 15.1 19.9 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 121.948 0.88 . . . . 2.47 108.838 176.21 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 116.66 -38.71 2.92 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 110.128 -1.189 . . . . 0.85 110.128 -173.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -37.13 -50.99 1.63 Allowed Glycine 0 C--O 1.223 -0.566 0 CA-C-N 114.364 -0.918 . . . . 0.67 114.952 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.482 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 0.1 OUTLIER -57.71 -59.18 5.59 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 117.743 0.772 . . . . 1.2 111.469 -172.41 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -62.56 -26.96 68.85 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.733 -0.667 . . . . 2.61 110.136 -178.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.675 ' HA ' HG22 ' A' ' 160' ' ' VAL . 77.5 m -71.91 -59.61 2.66 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 114.891 -1.05 . . . . 1.06 109.916 -177.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 1.049 ' HB3' HG11 ' A' ' 71' ' ' VAL . . . -60.59 -39.9 89.79 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 114.675 -1.148 . . . . 1.05 111.371 -178.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.535 ' HA ' ' CD1' ' A' ' 102' ' ' PHE . 89.8 m -58.57 -58.71 7.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.598 0.713 . . . . 1.08 110.6 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.4 m -68.31 -33.78 74.95 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 114.955 -1.021 . . . . 1.22 111.473 -174.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.716 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 20.6 mt -67.53 -50.58 58.02 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 121.25 0.547 . . . . 1.14 110.37 -177.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.833 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 10.5 t80 -54.83 -50.3 68.92 Favored 'General case' 0 C--O 1.204 -1.325 0 CA-C-N 114.983 -1.008 . . . . 0.94 110.681 177.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.41 ' N ' HD21 ' A' ' 62' ' ' ASN . 0.9 OUTLIER -72.48 -25.7 61.53 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 122.443 0.297 . . . . 1.6 110.75 -171.119 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.486 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 35.3 ttpt -86.47 -23.28 26.03 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 109.044 -0.724 . . . . 2.06 109.044 -178.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.751 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 30.4 m-85 -123.51 -5.49 8.19 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 115.291 1.589 . . . . 0.92 115.291 -169.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.667 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -64.63 -23.22 67.19 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 108.055 -1.091 . . . . 1.89 108.055 169.976 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 37.5 t -47.19 -40.35 15.84 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 114.118 -1.401 . . . . 1.68 110.848 171.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -90.06 -32.35 16.76 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 120.725 0.298 . . . . 1.11 111.337 177.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 143.44 -5.67 1.86 Allowed Glycine 0 N--CA 1.449 -0.468 0 N-CA-C 111.364 -0.694 . . . . 0.2 111.364 -175.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.751 ' HD2' ' HB2' ' A' ' 64' ' ' TYR . 24.6 t80 -66.92 141.32 57.67 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 120.978 0.418 . . . . 0.21 110.822 -178.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.951 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 5.3 t -132.55 152.96 51.42 Favored 'General case' 0 N--CA 1.422 -1.835 0 N-CA-C 107.991 -1.114 . . . . 1.02 107.991 174.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 1.049 HG11 ' HB3' ' A' ' 57' ' ' ALA . 38.2 t -112.09 99.86 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.702 0 N-CA-C 107.65 -1.241 . . . . 1.04 107.65 158.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.623 HD11 HG21 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -93.46 121.23 34.65 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 106.911 -1.514 . . . . 1.69 106.911 174.33 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 1.036 ' HB2' HD13 ' A' ' 104' ' ' ILE . . . -108.02 121.16 44.23 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.961 0.886 . . . . 1.17 111.265 -178.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.887 ' CG ' ' HG2' ' A' ' 105' ' ' MET . 2.6 m-30 -95.7 101.04 7.13 Favored Pre-proline 0 C--N 1.314 -0.935 0 CA-C-N 114.379 -1.282 . . . . 0.58 109.009 178.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.688 ' HG2' ' HG2' ' A' ' 107' ' ' LYS . 87.8 Cg_endo -82.12 74.99 4.94 Favored 'Trans proline' 0 CA--C 1.512 -0.612 0 C-N-CA 122.798 2.332 . . . . 1.3 113.423 -167.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.8 p 0.69 128.51 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 116.967 2.21 . . . . 1.91 116.967 -177.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.564 ' C ' ' H ' ' A' ' 79' ' ' PHE . 9.8 t30 -69.58 74.81 0.4 Allowed 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 112.468 -2.151 . . . . 1.93 109.062 177.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.594 ' HA ' ' HG3' ' A' ' 83' ' ' GLU . 1.0 OUTLIER -50.29 -11.63 0.07 Allowed 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.741 1.216 . . . . 3.97 111.887 177.865 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.564 ' H ' ' C ' ' A' ' 77' ' ' ASN . 98.4 m-85 -68.55 29.82 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.859 -1.064 . . . . 3.21 113.019 -173.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.478 ' H ' ' C ' ' A' ' 78' ' ' GLN . . . -144.21 -136.21 3.05 Favored Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 110.943 -0.863 . . . . 1.98 110.943 176.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -152.92 34.51 0.79 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.644 -0.789 . . . . 1.66 111.745 177.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.0 pm0 -128.94 -9.35 4.89 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.027 -0.087 . . . . 1.74 110.948 -177.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.594 ' HG3' ' HA ' ' A' ' 78' ' ' GLN . 4.1 mm-40 -62.19 142.35 95.75 Favored Pre-proline 0 CA--C 1.535 0.366 0 N-CA-C 112.438 0.533 . . . . 3.07 112.438 -168.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.667 ' HB3' ' N ' ' A' ' 137' ' ' TRP . 31.4 Cg_exo -19.28 -85.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.754 1 C-N-CA 127.242 5.295 . . . . 1.75 116.557 -178.93 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.457 ' H ' ' HB2' ' A' ' 84' ' ' PRO . . . -134.72 32.89 2.55 Favored Glycine 0 CA--C 1.5 -0.863 0 N-CA-C 110.195 -1.162 . . . . 2.27 110.195 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 1.043 ' HB2' HG12 ' A' ' 90' ' ' ILE . 2.7 p-10 -149.82 33.36 0.68 Allowed 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.525 -0.838 . . . . 4.88 110.048 -173.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.49 ' C ' ' HD3' ' A' ' 91' ' ' LYS . 1.8 pm0 -82.66 11.53 5.73 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.071 -0.968 . . . . 3.02 109.81 178.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -158.92 -42.75 0.06 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.12 -0.946 . . . . 3.92 109.316 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.652 ' O ' ' HB2' ' A' ' 93' ' ' PHE . 13.3 tp10 -48.88 -60.27 2.89 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 114.833 -1.076 . . . . 2.65 111.856 -177.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 1.043 HG12 ' HB2' ' A' ' 86' ' ' ASN . 29.0 pt -97.75 23.29 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 O-C-N 121.948 -0.47 . . . . 2.63 111.47 -175.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.49 ' HD3' ' C ' ' A' ' 87' ' ' GLU . 47.0 mtpt -101.48 -46.29 5.03 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.89 -0.595 . . . . 3.13 110.894 177.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -122.39 2.41 9.68 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.827 -0.624 . . . . 3.29 111.628 -177.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.652 ' HB2' ' O ' ' A' ' 89' ' ' GLU . 96.0 m-85 -108.47 169.04 8.89 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.909 -0.774 . . . . 4.08 108.909 173.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.6 t -65.47 125.13 21.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.433 -0.349 . . . . 3.05 110.975 -178.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.45 ' HA ' ' HB2' ' A' ' 47' ' ' CYS . 4.8 p -144.9 134.45 23.28 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.942 -0.572 . . . . 3.04 110.883 175.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.413 ' C ' ' H ' ' A' ' 98' ' ' PHE . 0.5 OUTLIER -79.33 152.12 30.65 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 106.138 -1.801 . . . . 3.38 106.138 161.291 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -79.73 50.65 1.19 Allowed 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 119.445 -0.902 . . . . 3.11 110.237 175.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.687 ' CE1' ' HB1' ' A' ' 100' ' ' ALA . 0.9 OUTLIER 60.49 -105.65 0.23 Allowed 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 114.254 -1.339 . . . . 2.12 110.431 178.877 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp 61.37 109.53 0.02 OUTLIER 'General case' 0 C--N 1.334 -0.09 0 CA-C-O 121.715 0.769 . . . . 3.1 111.593 -175.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.687 ' HB1' ' CE1' ' A' ' 98' ' ' PHE . . . -131.26 -159.69 0.99 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.493 -0.776 . . . . 1.15 111.231 -174.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -95.33 26.3 3.89 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.792 -0.64 . . . . 1.99 111.033 178.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.619 ' CZ ' ' HZ ' ' A' ' 98' ' ' PHE . 12.7 p90 -146.18 164.71 23.45 Favored Pre-proline 0 N--CA 1.448 -0.527 0 N-CA-C 108.571 -0.9 . . . . 1.31 108.571 176.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.694 ' HD3' ' CE2' ' A' ' 61' ' ' TYR . 52.7 Cg_exo -59.07 85.79 0.06 OUTLIER 'Trans proline' 0 N--CA 1.482 0.832 0 C-N-CA 124.697 3.598 . . . . 1.07 115.35 -173.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 1.036 HD13 ' HB2' ' A' ' 73' ' ' ALA . 3.9 mm -85.56 131.67 33.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 108.61 -0.885 . . . . 1.97 108.61 171.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.887 ' HG2' ' CG ' ' A' ' 74' ' ' PHE . 1.9 ppp? -96.68 -175.64 3.36 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.149 0.5 . . . . 3.41 110.482 -176.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.675 ' N ' ' HA ' ' A' ' 23' ' ' ALA . . . -79.33 19.5 0.59 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.391 -0.822 . . . . 1.46 112.654 -170.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.688 ' HG2' ' HG2' ' A' ' 75' ' ' PRO . 50.7 mttp 60.92 131.25 0.01 OUTLIER 'General case' 0 CA--C 1.496 -1.114 0 CA-C-O 122.365 1.079 . . . . 2.31 110.784 -168.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.542 ' CG1' ' HD2' ' A' ' 74' ' ' PHE . 2.4 pp -128.01 163.9 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.392 0 N-CA-C 106.326 -1.731 . . . . 1.65 106.326 160.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.659 ' HB3' ' HB2' ' A' ' 114' ' ' ASN . 1.9 t30 -76.53 84.29 3.23 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 120.38 -0.528 . . . . 1.73 110.439 -172.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.439 HG12 ' CD1' ' A' ' 108' ' ' ILE . 0.0 OUTLIER -79.28 90.33 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.225 0 C-N-CA 119.325 -0.95 . . . . 1.4 109.128 179.594 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.5 t30 174.86 161.26 0.21 Allowed 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 114.252 -1.34 . . . . 2.1 108.608 175.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 45.73 -123.51 6.44 Favored Glycine 0 CA--C 1.518 0.28 0 N-CA-C 115.319 0.888 . . . . 1.47 115.319 164.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.22 2.39 26.82 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 114.866 -0.667 . . . . 2.81 111.237 -169.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.659 ' HB2' ' HB3' ' A' ' 109' ' ' ASN . 0.1 OUTLIER -112.05 1.54 16.4 Favored 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 108.278 -1.008 . . . . 2.75 108.278 -168.957 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.51 ' HB2' ' CD ' ' A' ' 120' ' ' GLU . . . -49.16 139.17 11.28 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 112.753 -2.021 . . . . 1.44 110.363 176.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.596 ' ND1' ' H ' ' A' ' 118' ' ' LEU . 1.6 t-80 -80.03 139.63 53.31 Favored Pre-proline 0 N--CA 1.433 -1.311 0 N-CA-C 107.13 -1.433 . . . . 0.71 107.13 -173.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -24.09 -46.9 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 124.805 3.67 . . . . 0.47 113.988 -178.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.789 ' CD1' ' HB ' ' A' ' 15' ' ' ILE . 24.8 tp -67.97 -50.31 56.53 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.012 0.525 . . . . 1.15 111.783 -178.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.844 ' OH ' HG22 ' A' ' 40' ' ' ILE . 16.6 m-85 -80.96 -34.19 33.31 Favored 'General case' 0 CA--C 1.483 -1.611 0 CA-C-O 121.504 0.668 . . . . 3.33 110.378 -176.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.601 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 5.6 tp10 -63.09 -34.37 77.44 Favored 'General case' 0 N--CA 1.419 -1.987 0 N-CA-C 106.889 -1.523 . . . . 2.44 106.889 175.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.599 ' HD1' ' HE3' ' A' ' 124' ' ' LYS . 43.4 t80 -72.31 -28.86 63.34 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.591 -0.732 . . . . 1.08 109.82 170.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.703 ' HB2' ' HA ' ' A' ' 119' ' ' TYR . 2.9 ttm -75.66 -56.12 5.0 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.11 -0.636 . . . . 1.25 110.393 -169.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.431 ' HD2' ' HA ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -72.29 -23.28 61.17 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 120.773 -0.371 . . . . 1.86 111.948 176.849 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.601 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 12.4 pttp -70.53 -27.66 64.34 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 119.201 -0.999 . . . . 2.52 109.823 175.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.421 HG23 ' HZ1' ' A' ' 126' ' ' LYS . 38.8 m -89.73 -24.81 21.44 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.683 -0.689 . . . . 1.21 110.341 176.028 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.464 ' HE2' ' HA ' ' A' ' 151' ' ' VAL . 29.9 mmtm -138.38 82.55 22.91 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.614 -0.721 . . . . 2.38 110.78 -178.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.514 ' O ' ' HA ' ' A' ' 134' ' ' ALA . 23.7 Cg_exo -26.94 -84.53 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.816 1 C-N-CA 125.515 4.143 . . . . 1.69 115.057 -177.065 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.442 ' HA2' ' NE ' ' A' ' 153' ' ' ARG . . . 167.62 57.3 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.241 -0.98 . . . . 2.59 112.761 -177.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 15.7 mt 61.62 29.34 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-O 122.512 1.149 . . . . 3.93 109.126 -178.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.561 ' HG ' ' H ' ' A' ' 131' ' ' ALA . 32.0 tp -161.46 -178.68 6.78 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.38 -1.282 . . . . 3.81 108.485 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.561 ' H ' ' HG ' ' A' ' 130' ' ' LEU . . . -73.1 -20.2 61.0 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.297 0.57 . . . . 3.63 109.887 174.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.32 -146.13 0.29 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.318 -0.856 . . . . 3.97 109.171 176.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.6 ' HZ3' ' HH2' ' A' ' 137' ' ' TRP . 5.0 tptm 78.46 -165.17 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.199 0.6 . . . . 5.48 110.2 177.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.514 ' HA ' ' O ' ' A' ' 127' ' ' PRO . . . -165.16 -170.77 2.0 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.588 -0.278 . . . . 1.59 110.348 -176.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.528 HG22 ' HB ' ' A' ' 140' ' ' THR . 0.6 OUTLIER -67.01 52.42 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.913 0 CA-C-N 115.965 -0.561 . . . . 2.09 109.803 168.126 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.638 ' HD3' ' O ' ' A' ' 136' ' ' LYS . 9.9 tmtt? -86.99 39.47 0.86 Allowed 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.718 0.77 . . . . 5.16 111.29 -169.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.874 ' HB3' ' HG3' ' A' ' 156' ' ' PRO . 9.7 m-90 -142.16 175.46 9.73 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.758 -0.656 . . . . 2.41 109.777 -177.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.603 ' HB2' ' CB ' ' A' ' 156' ' ' PRO . 9.6 m120 -44.49 -156.89 0.0 OUTLIER 'General case' 0 C--O 1.211 -0.937 0 O-C-N 123.849 0.718 . . . . 2.04 111.311 161.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.664 ' CD1' HG21 ' A' ' 43' ' ' VAL . 3.9 m-85 -31.41 -26.38 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.338 0 N-CA-C 118.036 2.606 . . . . 2.53 118.036 -168.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.705 ' HA ' ' O ' ' A' ' 154' ' ' PHE . 1.9 m 7.49 103.43 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 120.5 1.5 . . . . 1.24 114.678 171.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.439 ' HB3' HD22 ' A' ' 39' ' ' LEU . 1.1 m -91.56 173.61 7.8 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.552 -1.204 . . . . 1.03 111.039 -172.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.527 ' HA ' ' HA ' ' A' ' 153' ' ' ARG . 60.5 m-85 -132.52 122.68 25.23 Favored 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 105.858 -1.904 . . . . 0.7 105.858 164.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.77 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 7.3 tp -80.0 104.6 10.68 Favored 'General case' 0 N--CA 1.422 -1.834 0 C-N-CA 118.302 -1.359 . . . . 1.16 108.474 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.739 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 36.8 mm -89.03 141.84 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.741 0 CA-C-N 112.854 -1.976 . . . . 1.05 107.581 -177.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.475 ' HA ' HD11 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -94.38 -175.34 3.61 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 119.411 -0.916 . . . . 0.98 111.395 -170.358 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.755 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 30.7 mtm180 -55.98 -33.42 64.81 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.803 0.335 . . . . 2.61 111.566 -176.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -103.78 22.99 13.48 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 109.864 -0.421 . . . . 2.0 109.864 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.587 ' HA2' HG21 ' A' ' 144' ' ' ILE . . . 70.18 37.09 71.93 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 121.219 -0.515 . . . . 0.19 114.184 177.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.503 ' HA ' ' HD2' ' A' ' 150' ' ' PRO . 57.8 t -107.04 108.3 61.79 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 118.192 0.996 . . . . 1.74 111.243 174.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.757 ' HD3' HG21 ' A' ' 15' ' ' ILE . 8.5 Cg_endo -58.3 110.13 0.6 Allowed 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 123.757 2.971 . . . . 0.6 111.307 174.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.666 HG23 ' HG2' ' A' ' 152' ' ' GLU . 17.8 m -108.86 -23.41 4.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.299 0.571 . . . . 2.06 109.569 -176.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.77 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 47.2 mm-40 -133.3 168.22 18.97 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-N 115.298 -0.865 . . . . 1.17 110.434 179.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.557 HH11 ' HG2' ' A' ' 153' ' ' ARG . 0.0 OUTLIER -144.63 148.63 34.54 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 114.614 -1.176 . . . . 2.9 108.582 163.019 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.705 ' O ' ' HA ' ' A' ' 140' ' ' THR . 91.9 m-85 -121.77 144.36 48.85 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 110.207 -0.294 . . . . 0.36 110.207 -169.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 12.9 p -63.87 149.5 93.12 Favored Pre-proline 0 C--N 1.318 -0.787 0 N-CA-C 109.536 -0.542 . . . . 1.45 109.536 174.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.874 ' HG3' ' HB3' ' A' ' 137' ' ' TRP . 30.3 Cg_endo -63.2 -26.38 72.42 Favored 'Trans proline' 0 CA--C 1.511 -0.659 0 C-N-CA 122.349 2.033 . . . . 0.78 110.714 176.149 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.635 ' HA2' ' O ' ' A' ' 51' ' ' LYS . . . -79.2 16.67 8.87 Favored Glycine 0 N--CA 1.438 -1.177 0 CA-C-N 113.785 -1.552 . . . . 0.59 113.405 171.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -95.64 152.98 17.96 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 109.514 -0.55 . . . . 1.07 109.514 170.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.577 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 22.9 t -113.44 176.83 4.86 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 109.71 -0.478 . . . . 1.92 109.71 -175.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.675 HG22 ' HA ' ' A' ' 56' ' ' THR . 48.4 t -45.62 -48.38 4.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 O-C-N 124.04 0.837 . . . . 1.07 110.9 178.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.582 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 40.8 tttm -65.54 -41.16 93.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.823 -0.626 . . . . 3.89 111.148 -175.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -64.93 -34.26 77.99 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 121.732 0.777 . . . . 1.4 109.47 -173.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.578 HD12 ' CG2' ' A' ' 56' ' ' THR . 46.3 mt -80.54 -46.21 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 CA-C-N 114.451 -1.249 . . . . 1.05 111.106 177.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.524 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 36.5 mt-10 -53.09 -44.26 67.45 Favored 'General case' 0 C--O 1.218 -0.587 0 N-CA-C 111.688 0.255 . . . . 0.67 111.688 -175.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.582 ' HG2' ' O ' ' A' ' 161' ' ' LYS . 4.5 pt-20 -62.35 -14.23 37.57 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.568 0.581 . . . . 0.87 112.568 -175.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.675 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 13.0 mmmt -105.3 -23.9 12.79 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.009 -0.737 . . . . 2.22 109.009 175.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.524 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 10.5 tp -83.26 -50.77 8.07 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.48 -1.236 . . . . 1.04 112.222 -176.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.48 HG13 ' O ' ' A' ' 164' ' ' GLU . 65.4 mt -54.32 -44.94 99.31 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 115.586 -0.734 . . . . 1.08 112.077 -175.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.452 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 86.8 Cg_exo -50.53 -24.59 12.78 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 122.182 1.921 . . . . 0.62 113.287 173.093 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.734 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 88.1 mt -95.19 -42.5 8.54 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 122.28 -0.263 . . . . 1.36 111.547 177.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.704 HD23 ' HG2' ' A' ' 37' ' ' PRO . 89.1 mt -61.45 -52.4 64.72 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-O 122.19 0.995 . . . . 1.07 109.883 177.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -74.56 -58.39 4.2 Favored Glycine 0 N--CA 1.431 -1.648 0 CA-C-N 113.065 -1.88 . . . . 1.12 114.356 -172.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 30.8 t -152.11 88.02 1.36 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.176 0.512 . . . . 2.88 111.539 -170.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -93.03 -4.34 52.72 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.881 -0.599 . . . . 4.69 110.015 176.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.607 ' HA ' ' NE ' ' A' ' 175' ' ' ARG . 3.5 mmp_? -110.03 97.89 7.29 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.538 -0.755 . . . . 9.17 110.319 177.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 49.2 tp . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.265 -0.874 . . . . 8.03 109.696 179.404 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.635 0 N-CA-C 111.971 -0.451 . . . . 5.58 111.971 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -76.08 127.01 32.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.969 0.414 . . . . 5.23 109.985 178.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.2 59.82 0.5 Allowed Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.439 -0.664 . . . . 1.55 111.439 -176.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.5 m -125.94 -22.67 4.1 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.062 0.458 . . . . 2.17 110.582 -178.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.8 m -145.39 -176.42 5.11 Favored 'General case' 0 N--CA 1.423 -1.785 0 N-CA-C 104.896 -2.261 . . . . 1.68 104.896 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.815 HG23 ' HE1' ' A' ' 122' ' ' MET . 5.7 pt -81.42 -17.73 11.83 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.481 0 CA-C-O 121.447 0.641 . . . . 1.16 109.847 177.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.787 ' HB3' HG12 ' A' ' 31' ' ' VAL . 39.7 m-85 -71.0 -2.75 16.37 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.503 -0.771 . . . . 0.3 112.45 -176.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -77.2 -20.5 55.28 Favored 'General case' 0 CA--C 1.501 -0.904 0 N-CA-C 107.595 -1.261 . . . . 2.11 107.595 176.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.566 ' CD2' ' HA ' ' A' ' 118' ' ' LEU . 58.1 m-85 -113.39 122.32 47.0 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 114.334 -1.303 . . . . 0.37 111.8 -174.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -48.19 139.4 8.48 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 112.561 -2.109 . . . . 2.86 111.709 172.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.768 HG12 ' HZ ' ' A' ' 74' ' ' PHE . 79.2 t -113.43 166.34 7.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 107.637 -1.246 . . . . 1.32 107.637 174.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.719 HD23 ' HA ' ' A' ' 27' ' ' PRO . 80.4 mt -132.88 131.87 41.44 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 120.001 -0.68 . . . . 1.29 112.47 -177.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.476 ' O ' ' HB3' ' A' ' 106' ' ' ALA . 15.1 t70 -64.43 159.23 21.8 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 106.457 -1.683 . . . . 1.87 106.457 165.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.78 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . . . -60.51 -6.76 1.74 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 113.801 1.038 . . . . 1.2 113.801 -165.001 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.625 ' HB2' ' HE2' ' A' ' 26' ' ' LYS . 54.7 m-20 -97.14 -0.19 47.38 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.751 0.278 . . . . 2.34 111.751 176.241 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.676 ' CD2' ' HB1' ' A' ' 106' ' ' ALA . 72.9 m-70 83.64 10.06 0.51 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.727 0.775 . . . . 2.26 109.01 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.625 ' HE2' ' HB2' ' A' ' 24' ' ' ASP . 21.7 mtmt -75.16 119.31 76.37 Favored Pre-proline 0 N--CA 1.447 -0.609 0 CA-C-N 114.298 -1.319 . . . . 4.64 107.578 168.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.719 ' HA ' HD23 ' A' ' 21' ' ' LEU . 47.3 Cg_exo -45.79 116.33 1.36 Allowed 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 122.415 2.076 . . . . 0.62 113.16 -176.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 1.08 ' HH ' ' HB3' ' A' ' 103' ' ' PRO . 0.1 OUTLIER -75.81 147.47 39.15 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 113.885 -1.507 . . . . 1.52 111.299 177.821 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.523 ' N ' ' HD1' ' A' ' 28' ' ' TYR . 2.5 t-20 -82.47 97.22 8.3 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 114.838 -1.074 . . . . 2.16 108.803 175.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.674 HD13 HG21 ' A' ' 20' ' ' VAL . 61.1 tp -83.82 -45.31 13.43 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.647 -0.706 . . . . 1.07 110.888 -176.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.787 HG12 ' HB3' ' A' ' 16' ' ' PHE . 0.1 OUTLIER -67.28 0.25 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.316 -0.857 . . . . 1.69 112.801 -171.712 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.446 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 28.7 pt20 -74.01 -12.21 60.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.418 0.627 . . . . 1.31 109.477 172.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.918 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 90.5 m-70 -97.7 20.49 11.85 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 121.876 0.845 . . . . 0.35 109.092 175.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.724 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 18.3 mtmt -80.42 114.18 19.13 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 114.381 -1.281 . . . . 2.07 109.245 169.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.87 -38.9 2.22 Favored Glycine 0 N--CA 1.434 -1.489 0 C-N-CA 120.607 -0.806 . . . . 0.24 111.927 178.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.466 ' HB2' ' HA3' ' A' ' 68' ' ' GLY . 20.2 m -129.49 128.02 23.09 Favored Pre-proline 0 N--CA 1.434 -1.257 0 N-CA-C 108.377 -0.972 . . . . 0.74 108.377 172.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.821 ' HG3' ' CB ' ' A' ' 170' ' ' LEU . 1.8 Cg_endo -41.18 151.92 0.12 Allowed 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 124.393 3.395 . . . . 0.22 113.097 177.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.753 ' HB2' HG21 ' A' ' 70' ' ' THR . 0.8 OUTLIER -136.96 145.1 43.79 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 106.949 -1.5 . . . . 1.09 106.949 -179.41 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.973 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 1.2 mm? -111.63 117.4 32.82 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.992 -0.744 . . . . 1.82 108.992 178.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 1.082 HD11 ' HE2' ' A' ' 122' ' ' MET . 8.2 mt -101.65 124.38 55.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-N 116.112 -0.495 . . . . 1.12 110.932 178.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.973 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -111.05 123.0 49.33 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.484 -0.78 . . . . 1.09 109.948 -174.194 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.774 ' HB3' HG11 ' A' ' 110' ' ' VAL . 1.3 p30 -81.79 94.97 7.14 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.855 -1.165 . . . . 3.11 107.855 169.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.895 HG12 ' HB2' ' A' ' 73' ' ' ALA . 1.4 p -105.18 133.35 49.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-N 115.447 -0.797 . . . . 1.69 113.059 -159.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.558 ' HB2' ' SG ' ' A' ' 47' ' ' CYS . . . -76.05 101.7 5.38 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.618 -0.719 . . . . 1.45 109.639 171.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.687 ' HB3' ' O ' ' A' ' 96' ' ' THR . 48.8 m -37.87 83.24 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 125.485 1.514 . . . . 1.99 113.977 176.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.453 ' HE2' ' HB2' ' A' ' 46' ' ' LYS . 8.7 ptmm? 36.19 55.3 1.03 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.112 1.365 . . . . 6.2 114.052 176.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.558 ' SG ' ' HB2' ' A' ' 44' ' ' ALA . 28.1 p -111.33 116.45 31.0 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 119.9 -0.72 . . . . 4.12 110.819 177.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.86 -73.82 1.21 Allowed Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.85 -0.614 . . . . 3.44 113.456 175.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -129.95 145.93 51.64 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.131 0.491 . . . . 4.84 111.138 -173.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 76.1 p -82.68 -20.39 36.26 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.058 -0.719 . . . . 2.41 109.058 174.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.615 ' HB2' ' HB2' ' A' ' 156' ' ' PRO . 31.5 mmmt 63.56 -1.46 0.59 Allowed 'General case' 0 C--N 1.347 0.469 0 C-N-CA 124.555 1.142 . . . . 2.47 112.557 -178.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.77 -19.75 48.73 Favored Glycine 0 N--CA 1.442 -0.919 0 N-CA-C 110.761 -0.935 . . . . 0.85 110.761 -172.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -58.19 -43.37 95.42 Favored Glycine 0 C--O 1.222 -0.604 0 CA-C-N 115.469 -0.366 . . . . 0.67 112.805 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.649 ' CE1' ' HE2' ' A' ' 98' ' ' PHE . 1.0 OUTLIER -64.44 -54.57 30.5 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.074 0.464 . . . . 1.2 110.776 -174.903 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.443 ' H ' ' CD ' ' A' ' 55' ' ' GLU . 1.9 pm0 -66.44 -22.95 66.22 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.542 -0.754 . . . . 2.61 111.115 -178.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.779 HG21 ' HA ' ' A' ' 160' ' ' VAL . 30.4 m -79.92 -57.45 3.64 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 109.44 -0.578 . . . . 1.06 109.44 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 1.01 ' HB3' HG12 ' A' ' 71' ' ' VAL . . . -54.08 -40.51 67.28 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.145 -0.934 . . . . 1.05 110.838 -179.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.444 ' HA ' ' HD2' ' A' ' 102' ' ' PHE . 99.8 m -60.04 -57.1 14.29 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.609 -0.723 . . . . 1.08 110.647 178.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 22.3 m -66.76 -35.18 79.49 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.461 -0.79 . . . . 1.22 111.312 -176.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.713 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 0.6 OUTLIER -66.72 -52.37 45.33 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 121.595 0.712 . . . . 1.14 110.409 -175.416 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.85 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 8.0 t80 -55.92 -54.6 42.77 Favored 'General case' 0 C--O 1.205 -1.27 0 CA-C-N 114.413 -1.267 . . . . 0.94 110.777 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -67.34 -24.16 65.69 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.73 -0.214 . . . . 1.6 111.018 -174.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.438 ' HB2' ' HE2' ' A' ' 63' ' ' LYS . 24.4 ttmm -85.5 -27.34 25.69 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 108.965 -0.754 . . . . 2.06 108.965 -176.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.766 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 48.3 m-85 -123.67 -4.75 8.16 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 115.289 1.588 . . . . 0.92 115.289 -169.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.662 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 12.9 pttp -67.86 -24.28 65.23 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 107.709 -1.219 . . . . 1.89 107.709 171.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.3 t -48.76 -37.61 19.47 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 113.855 -1.521 . . . . 1.68 110.18 171.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -88.06 -35.18 17.67 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 111.948 0.351 . . . . 1.11 111.948 173.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.466 ' HA3' ' HB2' ' A' ' 36' ' ' SER . . . 147.51 -7.3 1.11 Allowed Glycine 0 CA--C 1.52 0.388 0 N-CA-C 111.619 -0.592 . . . . 0.2 111.619 -176.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.766 ' HD2' ' HB2' ' A' ' 64' ' ' TYR . 17.9 t80 -67.07 140.37 57.61 Favored 'General case' 0 C--O 1.217 -0.61 0 C-N-CA 123.003 0.521 . . . . 0.21 111.251 -177.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.918 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 2.2 t -134.17 143.19 47.76 Favored 'General case' 0 CA--C 1.482 -1.657 0 N-CA-C 108.189 -1.041 . . . . 1.02 108.189 174.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 1.01 HG12 ' HB3' ' A' ' 57' ' ' ALA . 39.9 t -98.6 98.87 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.535 0 C-N-CA 118.959 -1.096 . . . . 1.04 108.182 161.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.795 ' HA ' ' HG2' ' A' ' 103' ' ' PRO . 8.4 mt -85.94 119.01 25.78 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 107.36 -1.348 . . . . 1.69 107.36 175.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.913 ' HB3' HD13 ' A' ' 104' ' ' ILE . . . -111.67 116.28 30.52 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.826 0.822 . . . . 1.17 111.694 -178.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.768 ' HZ ' HG12 ' A' ' 20' ' ' VAL . 2.8 m-30 -98.38 99.09 6.65 Favored Pre-proline 0 C--N 1.315 -0.904 0 CA-C-N 114.519 -1.219 . . . . 0.58 109.051 178.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.741 ' O ' ' HB2' ' A' ' 107' ' ' LYS . 80.7 Cg_endo -78.34 93.22 1.1 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.214 1.943 . . . . 1.3 113.361 -171.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.553 ' HG ' ' HG2' ' A' ' 84' ' ' PRO . 84.3 p -43.54 142.99 1.03 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.93 -1.032 . . . . 1.91 111.886 -175.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.466 ' HB3' ' HD3' ' A' ' 107' ' ' LYS . 0.3 OUTLIER -95.55 130.92 42.24 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 121.672 0.748 . . . . 1.93 111.247 -175.967 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.505 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . 0.0 OUTLIER -75.31 -9.22 58.37 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.821 -1.081 . . . . 3.97 110.765 177.461 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -69.26 31.68 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.066 0.765 . . . . 3.21 113.066 -177.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.494 ' HA3' HE22 ' A' ' 82' ' ' GLN . . . -145.25 -144.6 4.15 Favored Glycine 0 CA--C 1.518 0.226 0 C-N-CA 120.822 -0.704 . . . . 1.98 112.37 -179.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -152.25 75.56 0.24 Allowed Glycine 0 CA--C 1.509 -0.282 0 N-CA-C 111.424 -0.67 . . . . 1.66 111.424 176.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.556 ' HG3' ' HB3' ' A' ' 111' ' ' ASN . 4.4 pm0 -172.82 -20.74 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.357 0.599 . . . . 1.74 111.307 -172.466 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 77' ' ' ASN . 0.3 OUTLIER -75.39 158.58 83.43 Favored Pre-proline 0 C--N 1.308 -1.231 0 CA-C-N 114.423 -1.262 . . . . 3.07 114.048 -149.816 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.636 ' HA ' ' C ' ' A' ' 136' ' ' LYS . 2.8 Cg_exo -33.9 147.85 0.03 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 125.296 3.998 . . . . 1.75 114.695 173.155 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 79.91 25.88 57.06 Favored Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 120.393 -0.908 . . . . 2.27 111.212 -178.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.536 ' HA ' ' HD3' ' A' ' 136' ' ' LYS . 92.6 m-20 64.44 35.9 9.23 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.086 0.555 . . . . 4.88 111.885 174.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 60.62 23.64 13.41 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.784 -0.644 . . . . 3.02 112.426 176.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.645 ' HA ' ' HE3' ' A' ' 91' ' ' LYS . 12.6 pt-20 -134.64 -45.53 0.74 Allowed 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.132 -0.627 . . . . 3.92 112.491 -177.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.481 ' O ' ' HD1' ' A' ' 93' ' ' PHE . 26.9 tt0 -52.56 -58.43 6.79 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.455 0.539 . . . . 2.65 112.455 -170.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.522 HG12 ' SG ' ' A' ' 47' ' ' CYS . 3.0 mt -68.73 -34.2 63.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 112.405 0.52 . . . . 2.63 112.405 -171.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.645 ' HE3' ' HA ' ' A' ' 88' ' ' GLU . 0.0 OUTLIER -81.65 2.01 31.48 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.952 -0.299 . . . . 3.13 111.429 -175.622 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.464 ' HG3' ' O ' ' A' ' 88' ' ' GLU . 44.7 mt-10 -119.32 -45.27 2.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.463 -0.335 . . . . 3.29 110.811 177.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.481 ' HD1' ' O ' ' A' ' 89' ' ' GLU . 76.2 m-85 -73.06 159.49 33.53 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.074 -0.343 . . . . 4.08 110.074 177.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 79.6 t -67.63 110.36 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.123 -0.489 . . . . 3.05 110.081 178.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 1.8 p -114.2 139.8 49.08 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.953 0.882 . . . . 3.04 111.364 -178.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.687 ' O ' ' HB3' ' A' ' 45' ' ' SER . 7.4 m -143.22 146.72 33.91 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 106.092 -1.818 . . . . 3.38 106.092 172.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 52.4 pttt -64.16 98.54 0.23 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.797 0.808 . . . . 3.11 109.137 -178.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.748 ' CE2' ' HB3' ' A' ' 100' ' ' ALA . 0.1 OUTLIER -62.82 120.61 11.61 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 113.739 -1.573 . . . . 2.12 111.1 -164.416 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -92.65 132.34 36.97 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.122 -0.944 . . . . 3.1 110.477 176.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.748 ' HB3' ' CE2' ' A' ' 98' ' ' PHE . . . -131.36 -171.5 2.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.52 0.676 . . . . 1.15 112.457 -170.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -92.81 14.05 18.51 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 114.664 -1.153 . . . . 1.99 110.231 176.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.64 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 17.2 p90 -140.36 161.99 52.09 Favored Pre-proline 0 N--CA 1.444 -0.754 0 N-CA-C 108.859 -0.793 . . . . 1.31 108.859 -179.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 1.08 ' HB3' ' HH ' ' A' ' 28' ' ' TYR . 30.9 Cg_endo -58.95 92.82 0.08 OUTLIER 'Trans proline' 0 CA--C 1.514 -0.489 0 C-N-CA 123.965 3.11 . . . . 1.07 114.398 -172.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.913 HD13 ' HB3' ' A' ' 73' ' ' ALA . 5.4 mm -82.4 124.62 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 108.325 -0.991 . . . . 1.97 108.325 170.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.772 ' HG3' ' N ' ' A' ' 106' ' ' ALA . 0.0 OUTLIER -78.66 172.1 14.18 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.074 -1.421 . . . . 3.41 110.812 -176.933 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.78 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . . . -61.0 -0.15 0.28 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.359 -0.837 . . . . 1.46 112.575 178.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.741 ' HB2' ' O ' ' A' ' 75' ' ' PRO . 12.3 ptpt 60.72 144.58 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.244 0 C-N-CA 124.941 1.297 . . . . 2.31 110.742 -168.145 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.603 ' O ' HG21 ' A' ' 110' ' ' VAL . 0.3 OUTLIER -133.72 176.62 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.074 0 CA-C-N 113.615 -1.629 . . . . 1.65 108.331 168.086 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -70.05 66.85 0.28 Allowed 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 114.759 -1.11 . . . . 1.73 109.795 176.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.971 ' HA ' ' OH ' ' A' ' 119' ' ' TYR . 0.6 OUTLIER -72.6 92.64 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-O 122.11 0.957 . . . . 1.4 109.589 -172.657 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.556 ' HB3' ' HG3' ' A' ' 82' ' ' GLN . 4.7 t30 176.95 177.91 0.27 Allowed 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 104.684 -2.339 . . . . 2.1 104.684 169.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.418 ' H ' ' ND2' ' A' ' 111' ' ' ASN . . . -85.52 48.46 4.0 Favored Glycine 0 CA--C 1.498 -0.984 0 C-N-CA 119.581 -1.295 . . . . 1.47 114.214 -177.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -105.66 -47.98 3.77 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 119.046 -1.062 . . . . 2.81 110.699 169.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -131.15 -35.51 1.37 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.402 -0.962 . . . . 2.75 108.402 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 1.01 ' HA ' ' HH ' ' A' ' 119' ' ' TYR . . . 55.84 -166.22 0.11 Allowed 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 114.139 -1.391 . . . . 1.44 111.894 172.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.602 ' CE1' ' HB3' ' A' ' 118' ' ' LEU . 4.9 t-80 -149.55 121.98 4.31 Favored Pre-proline 0 N--CA 1.418 -2.051 0 N-CA-C 107.998 -1.112 . . . . 0.71 107.998 177.065 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.474 ' HB2' ' CD1' ' A' ' 18' ' ' PHE . 11.2 Cg_exo -31.47 -43.45 0.13 Allowed 'Trans proline' 0 C--O 1.215 -0.668 1 C-N-CA 125.531 4.154 . . . . 0.47 114.241 -174.115 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.76 ' HG ' ' HE3' ' A' ' 122' ' ' MET . 4.8 tp -62.45 -60.17 3.92 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 113.471 0.915 . . . . 1.15 113.471 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 1.01 ' HH ' ' HA ' ' A' ' 115' ' ' ALA . 3.4 p90 -81.02 -25.66 37.0 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 109.113 -0.699 . . . . 3.33 109.113 -177.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.53 -39.23 90.3 Favored 'General case' 0 CA--C 1.495 -1.161 0 N-CA-C 106.546 -1.65 . . . . 2.44 106.546 173.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.476 ' HA ' ' HG2' ' A' ' 124' ' ' LYS . 71.4 t80 -65.45 -26.09 67.8 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.85 -1.068 . . . . 1.08 109.892 171.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 1.082 ' HE2' HD11 ' A' ' 40' ' ' ILE . 65.2 mtt -75.93 -56.89 4.24 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.182 -0.463 . . . . 1.25 111.716 -173.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.62 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -70.39 -24.04 62.88 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.779 -0.646 . . . . 1.86 110.65 179.621 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.476 ' HG2' ' HA ' ' A' ' 121' ' ' TYR . 17.1 ptmt -74.05 -28.41 61.4 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 119.722 -0.791 . . . . 2.52 109.456 174.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 51.8 m -76.83 -42.62 39.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.852 -0.613 . . . . 1.21 110.484 173.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.428 ' HD3' ' C ' ' A' ' 151' ' ' VAL . 8.0 tptm -120.23 106.43 40.72 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.258 -0.428 . . . . 2.38 111.447 -175.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -53.99 -35.97 82.58 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.206 2.604 . . . . 1.69 110.67 169.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 102.72 -132.28 10.94 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.595 -0.729 . . . . 2.59 111.948 176.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 51.5 mt -79.44 -40.79 21.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.585 0.707 . . . . 3.93 109.275 175.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.937 ' HB3' ' HB2' ' A' ' 133' ' ' LYS . 19.6 tp -93.08 142.31 27.43 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.406 -0.961 . . . . 3.81 108.406 175.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -71.28 4.87 2.54 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.854 0.687 . . . . 3.63 112.854 -171.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 3.8 m -145.37 3.71 1.02 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.208 0.528 . . . . 3.97 110.564 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.937 ' HB2' ' HB3' ' A' ' 130' ' ' LEU . 26.3 tttp -58.36 133.63 55.89 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.377 -0.829 . . . . 5.48 111.34 -168.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -94.05 172.06 8.46 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.042 -1.096 . . . . 1.59 108.042 169.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.642 HG22 HG21 ' A' ' 140' ' ' THR . 1.4 pp -92.68 61.38 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 CA-C-O 121.793 0.806 . . . . 2.09 110.442 -178.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.636 ' C ' ' HA ' ' A' ' 84' ' ' PRO . 13.6 ttmm -95.54 35.43 1.35 Allowed 'General case' 0 C--O 1.237 0.427 0 CA-C-N 114.885 -1.052 . . . . 5.16 111.36 -175.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.599 ' O ' ' HB3' ' A' ' 84' ' ' PRO . 10.2 m-90 -127.62 173.12 10.15 Favored 'General case' 0 C--N 1.313 -1.007 0 O-C-N 121.708 -0.62 . . . . 2.41 109.886 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.569 ' HB2' ' CB ' ' A' ' 156' ' ' PRO . 3.4 m120 -47.54 -158.29 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.154 -0.93 . . . . 2.04 110.073 162.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.669 ' CD1' HG23 ' A' ' 43' ' ' VAL . 5.7 m-85 -28.42 -53.63 0.1 Allowed 'General case' 0 CA--C 1.552 1.033 0 N-CA-C 115.944 1.831 . . . . 2.53 115.944 -164.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.642 HG21 HG22 ' A' ' 135' ' ' ILE . 8.5 m 42.75 93.92 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 120.44 1.473 . . . . 1.24 112.832 174.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' A' ' 153' ' ' ARG . 2.5 m -88.98 161.69 16.47 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.744 -0.662 . . . . 1.03 111.556 -172.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.523 ' CZ ' HG23 ' A' ' 135' ' ' ILE . 70.3 m-85 -122.72 126.49 47.65 Favored 'General case' 0 CA--C 1.487 -1.471 0 N-CA-C 105.872 -1.899 . . . . 0.7 105.872 165.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.79 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 11.3 tp -80.39 101.96 9.32 Favored 'General case' 0 N--CA 1.418 -2.042 0 C-N-CA 117.823 -1.551 . . . . 1.16 107.877 176.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.694 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 39.1 mm -89.22 135.13 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.671 0 CA-C-N 113.018 -1.901 . . . . 1.05 107.311 -178.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.459 ' HA ' HD13 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -91.35 -174.85 4.06 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 119.201 -1.0 . . . . 0.98 111.545 -167.586 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.583 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 53.5 mtm180 -54.66 -36.23 64.37 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.157 0.503 . . . . 2.61 110.983 -177.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -100.11 23.28 10.16 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.625 -0.509 . . . . 2.0 109.625 -178.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.63 ' HA2' HG21 ' A' ' 144' ' ' ILE . . . 65.76 34.44 88.79 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 115.943 -0.571 . . . . 0.19 114.002 178.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 64.1 t -103.07 116.19 62.8 Favored Pre-proline 0 C--N 1.314 -0.944 0 CA-C-N 118.024 0.912 . . . . 1.74 110.875 175.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.702 ' HD3' HG21 ' A' ' 15' ' ' ILE . 36.5 Cg_endo -66.13 109.05 1.45 Allowed 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 123.757 2.971 . . . . 0.6 110.664 178.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.531 HG21 ' HG2' ' A' ' 152' ' ' GLU . 19.6 m -113.71 -12.11 11.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 121.062 0.458 . . . . 2.06 110.486 -172.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.79 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 33.8 mm-40 -142.83 165.83 26.3 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-N 115.563 -0.744 . . . . 1.17 109.611 177.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.484 ' HA ' ' O ' ' A' ' 141' ' ' SER . 0.0 OUTLIER -148.65 122.41 9.28 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.404 -0.816 . . . . 2.9 110.76 165.347 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.683 ' HZ ' ' HB2' ' A' ' 166' ' ' LYS . 88.1 m-85 -95.67 155.81 16.59 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.616 -1.175 . . . . 0.36 109.291 -175.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 12.0 m -82.83 160.89 59.98 Favored Pre-proline 0 C--N 1.314 -0.937 0 N-CA-C 108.733 -0.84 . . . . 1.45 108.733 175.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.615 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 14.5 Cg_endo -58.76 -48.8 13.42 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 121.317 1.344 . . . . 0.78 110.479 173.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.553 ' HA2' ' O ' ' A' ' 51' ' ' LYS . . . -48.59 -12.8 0.22 Allowed Glycine 0 CA--C 1.537 1.422 0 CA-C-N 114.588 -1.187 . . . . 0.59 115.54 167.284 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -87.64 138.88 31.08 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 118.464 1.132 . . . . 1.07 109.285 173.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.422 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 15.5 m -111.99 -173.03 2.16 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 112.819 0.674 . . . . 1.92 112.819 -168.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.779 ' HA ' HG21 ' A' ' 56' ' ' THR . 83.0 t -40.98 -60.49 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 114.134 -1.394 . . . . 1.07 112.335 -178.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -62.88 -39.16 93.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.287 -0.415 . . . . 3.89 110.534 -173.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.468 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 7.7 m-20 -55.56 -49.0 73.86 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 115.322 -0.854 . . . . 1.4 109.844 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.661 HD12 ' HH ' ' A' ' 41' ' ' TYR . 81.4 mt -73.4 -46.75 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 CA-C-N 114.581 -1.19 . . . . 1.05 111.691 -177.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.473 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 49.5 mt-10 -54.75 -45.19 74.14 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-O 120.804 0.335 . . . . 0.67 111.251 -177.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 11.5 pt-20 -63.35 -15.42 57.37 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 111.993 0.368 . . . . 0.87 111.993 -173.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.683 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 28.3 mmmt -104.75 -22.97 13.12 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.607 0.717 . . . . 2.22 109.783 173.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.489 HD22 HD11 ' A' ' 171' ' ' LEU . 8.3 tp -83.61 -48.88 9.74 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.762 -1.108 . . . . 1.04 112.296 -176.045 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 164' ' ' GLU . 68.9 mt -55.05 -46.06 99.73 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.617 -0.72 . . . . 1.08 112.302 -174.059 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.467 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 84.8 Cg_exo -51.39 -27.05 22.84 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.287 1.992 . . . . 0.62 113.178 173.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.821 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 74.8 mt -89.67 -42.58 11.28 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.846 -0.161 . . . . 1.36 111.124 178.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.719 HD22 ' HG2' ' A' ' 37' ' ' PRO . 91.9 mt -59.87 -58.26 9.31 Favored 'General case' 0 CA--C 1.505 -0.75 0 CA-C-O 121.996 0.903 . . . . 1.07 109.86 176.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -61.22 -59.16 10.46 Favored Glycine 0 N--CA 1.432 -1.591 0 CA-C-N 113.338 -1.755 . . . . 1.12 112.171 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 34.7 t 61.7 -87.99 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.083 0.553 . . . . 2.88 111.778 174.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -82.72 -22.96 34.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.248 0.546 . . . . 4.69 110.2 178.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -84.86 -52.92 5.67 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.47 -0.786 . . . . 9.17 109.796 177.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 95.0 mt . . . . . 0 C--O 1.246 0.894 0 CA-C-N 115.606 -0.725 . . . . 8.03 109.679 177.955 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.651 0 N-CA-C 111.988 -0.445 . . . . 5.58 111.988 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 61.9 mtt -78.62 90.47 4.56 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.759 -0.46 . . . . 5.23 109.759 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.85 90.96 2.17 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.246 -0.742 . . . . 1.55 111.246 -175.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.3 t -117.27 -1.43 11.81 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.475 0.655 . . . . 2.17 109.899 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 96.5 p 179.78 168.49 1.2 Allowed 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 105.044 -2.206 . . . . 1.68 105.044 -177.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.848 HD13 HD23 ' A' ' 30' ' ' LEU . 4.8 pt -67.62 -12.96 16.14 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 CA-C-O 121.399 0.619 . . . . 1.16 110.274 177.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.772 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 33.4 m-85 -75.3 4.04 7.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.661 -0.699 . . . . 0.3 111.893 -175.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.57 -7.28 59.57 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.474 -0.936 . . . . 2.11 108.474 175.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.842 ' HE2' ' HB2' ' A' ' 121' ' ' TYR . 58.1 m-85 -125.67 113.66 17.65 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-N 114.988 -1.006 . . . . 0.37 111.964 -175.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -50.78 142.15 11.91 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 113.546 -1.661 . . . . 2.86 110.21 172.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.784 HG13 ' HZ ' ' A' ' 74' ' ' PHE . 68.8 t -113.8 169.6 5.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.5 -0.773 . . . . 1.32 109.114 -178.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.763 HD23 ' HA ' ' A' ' 27' ' ' PRO . 94.2 mt -127.53 150.51 49.66 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.019 0.438 . . . . 1.29 111.399 178.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.38 165.1 18.5 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 106.318 -1.734 . . . . 1.87 106.318 162.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.613 ' HA ' ' C ' ' A' ' 105' ' ' MET . . . -59.53 -7.73 1.57 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 113.721 1.008 . . . . 1.2 113.721 -169.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.566 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 1.3 m-20 -99.08 2.06 45.75 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.914 0.339 . . . . 2.34 111.914 176.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.566 ' HB2' ' O ' ' A' ' 24' ' ' ASP . 83.2 m-70 80.55 17.36 0.61 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.611 0.72 . . . . 2.26 109.266 178.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 11.9 mmtt -86.13 120.46 72.44 Favored Pre-proline 0 CA--C 1.508 -0.654 0 N-CA-C 107.682 -1.229 . . . . 4.64 107.682 172.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.763 ' HA ' HD23 ' A' ' 21' ' ' LEU . 86.1 Cg_exo -53.21 112.39 0.92 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 121.742 1.628 . . . . 0.62 113.087 -172.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.84 ' HE2' HD21 ' A' ' 72' ' ' LEU . 9.0 t80 -79.22 116.78 19.7 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 113.487 -1.688 . . . . 1.52 109.735 172.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.503 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.7 p-10 -71.43 89.15 0.92 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 122.653 1.216 . . . . 2.16 109.95 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.848 HD23 HD13 ' A' ' 15' ' ' ILE . 58.9 tp -50.93 -39.99 56.16 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 113.939 -1.482 . . . . 1.07 111.947 -179.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.646 ' HB ' ' HZ3' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -66.47 1.03 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 114.046 1.128 . . . . 1.69 114.046 -170.478 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.503 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 28.4 pt20 -77.82 -6.81 55.38 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.043 -0.663 . . . . 1.31 109.679 171.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.924 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 93.8 m-70 -101.54 24.52 9.6 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 122.001 0.905 . . . . 0.35 109.005 174.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.772 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 21.5 mtmm -83.54 110.56 18.32 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 114.344 -1.298 . . . . 2.07 108.686 169.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 131.78 -41.58 1.49 Allowed Glycine 0 N--CA 1.442 -0.959 0 C-N-CA 120.629 -0.796 . . . . 0.24 111.538 -178.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.456 ' HB2' ' HA3' ' A' ' 68' ' ' GLY . 35.9 m -129.38 136.93 29.9 Favored Pre-proline 0 N--CA 1.433 -1.295 0 N-CA-C 108.796 -0.816 . . . . 0.74 108.796 172.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.824 ' HG3' ' CB ' ' A' ' 170' ' ' LEU . 7.0 Cg_endo -44.96 153.08 0.45 Allowed 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 124.069 3.18 . . . . 0.22 112.563 176.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.772 ' O ' ' HB ' ' A' ' 144' ' ' ILE . 1.0 OUTLIER -140.13 146.28 38.65 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 106.889 -1.523 . . . . 1.09 106.889 179.098 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.992 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 3.5 mp -113.3 115.3 27.94 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.484 -0.76 . . . . 1.82 109.853 176.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.862 HG23 HD13 ' A' ' 72' ' ' LEU . 0.8 OUTLIER -95.46 116.97 38.4 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 CA-C-N 115.071 -0.968 . . . . 1.12 108.681 176.961 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.992 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.4 OUTLIER -101.14 130.6 47.23 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 119.622 -0.831 . . . . 1.09 109.637 -176.207 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.515 ' OD1' ' HB ' ' A' ' 140' ' ' THR . 0.5 OUTLIER -77.59 122.97 26.01 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 104.4 -2.444 . . . . 3.11 104.4 163.923 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.862 HG12 ' HA ' ' A' ' 139' ' ' PHE . 28.2 m -128.62 156.35 40.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 C-N-CA 118.702 -1.199 . . . . 1.69 111.797 -171.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -83.37 158.13 22.26 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 107.476 -1.305 . . . . 1.45 107.476 165.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.554 ' HA ' ' HB3' ' A' ' 98' ' ' PHE . 26.1 m -86.72 -159.79 0.52 Allowed 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 116.133 -0.485 . . . . 1.99 109.975 -174.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -75.7 71.54 2.58 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.223 0.535 . . . . 6.2 110.247 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.621 ' HB2' ' HD2' ' A' ' 93' ' ' PHE . 28.4 p -163.7 -176.95 4.89 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.994 -0.548 . . . . 4.12 109.975 -178.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.63 ' HA3' ' HG3' ' A' ' 89' ' ' GLU . . . 52.73 -121.01 13.38 Favored Glycine 0 N--CA 1.451 -0.351 0 O-C-N 123.971 0.794 . . . . 3.44 113.226 175.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.527 ' HB2' ' HZ3' ' A' ' 51' ' ' LYS . 91.3 m-85 -130.13 111.49 12.5 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.337 0.589 . . . . 4.84 111.356 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -75.84 93.48 3.19 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.106 -0.952 . . . . 2.41 110.521 177.016 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.527 ' HZ3' ' HB2' ' A' ' 49' ' ' TYR . 0.8 OUTLIER -59.21 163.15 3.96 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.558 -0.292 . . . . 2.47 110.649 178.51 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -51.89 -20.3 6.07 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-N 116.069 -0.514 . . . . 0.85 113.167 -179.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.498 ' HA2' ' HB ' ' A' ' 56' ' ' THR . . . -51.39 -25.09 11.98 Favored Glycine 0 C--O 1.219 -0.814 0 CA-C-O 119.909 -0.384 . . . . 0.67 113.414 176.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.643 ' HH ' ' HB3' ' A' ' 100' ' ' ALA . 0.8 OUTLIER -66.13 -55.01 18.58 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 117.745 0.772 . . . . 1.2 109.421 175.724 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -61.34 -31.32 71.18 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.238 -0.892 . . . . 2.61 109.745 178.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.666 HG21 ' HA ' ' A' ' 160' ' ' VAL . 74.0 m -66.61 -54.82 19.25 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 114.496 -1.229 . . . . 1.06 109.533 179.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 1.041 ' HB2' HG11 ' A' ' 71' ' ' VAL . . . -57.98 -48.7 79.21 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.647 -1.16 . . . . 1.05 111.625 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.425 ' HA ' ' CD1' ' A' ' 102' ' ' PHE . 18.5 m -55.89 -54.62 42.38 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-O 121.61 0.719 . . . . 1.08 110.745 -179.048 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.6 m -69.24 -33.38 73.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.026 -0.988 . . . . 1.22 111.549 -175.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.714 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 18.2 mt -71.63 -48.2 49.44 Favored 'General case' 0 CA--C 1.492 -1.272 0 CA-C-N 116.54 -0.3 . . . . 1.14 110.634 -177.238 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.874 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 6.7 t80 -53.45 -62.26 1.77 Allowed 'General case' 0 C--O 1.194 -1.819 0 O-C-N 124.09 0.869 . . . . 0.94 109.49 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.65 ' HA ' ' CG ' ' A' ' 65' ' ' LYS . 1.8 p30 -67.93 -25.63 65.57 Favored 'General case' 0 C--N 1.314 -0.966 0 O-C-N 122.887 0.117 . . . . 1.6 110.908 -168.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.453 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 36.4 ttpt -79.7 -20.65 46.01 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 107.936 -1.135 . . . . 2.06 107.936 -177.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.663 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 49.9 m-85 -126.5 0.86 6.92 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 115.22 1.563 . . . . 0.92 115.22 -174.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.65 ' CG ' ' HA ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -60.82 -34.59 74.77 Favored 'General case' 0 CA--C 1.496 -1.128 0 N-CA-C 105.986 -1.857 . . . . 1.89 105.986 170.107 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.2 m -47.43 -34.36 7.13 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 112.3 -2.227 . . . . 1.68 111.782 178.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -94.63 -36.06 11.94 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 120.863 -0.335 . . . . 1.11 111.584 174.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.456 ' HA3' ' HB2' ' A' ' 36' ' ' SER . . . 149.31 -0.56 0.49 Allowed Glycine 0 CA--C 1.52 0.35 0 N-CA-C 111.869 -0.492 . . . . 0.2 111.869 -178.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.714 ' HE2' ' HB3' ' A' ' 60' ' ' LEU . 14.4 t80 -74.12 141.58 45.59 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 122.743 0.417 . . . . 0.21 111.182 -177.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.924 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 5.5 t -134.54 142.49 47.0 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 108.675 -0.861 . . . . 1.02 108.675 172.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 1.041 HG11 ' HB2' ' A' ' 57' ' ' ALA . 41.2 t -101.82 99.61 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.249 0 N-CA-C 107.746 -1.205 . . . . 1.04 107.746 160.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.887 ' H ' HD11 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -96.44 119.25 34.58 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 107.689 -1.226 . . . . 1.69 107.689 176.15 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.627 ' HB1' HG13 ' A' ' 104' ' ' ILE . . . -102.35 140.55 36.48 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.426 0.631 . . . . 1.17 111.156 -176.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.795 ' CG ' ' HG2' ' A' ' 105' ' ' MET . 3.1 m-30 -121.41 96.17 47.96 Favored Pre-proline 0 C--N 1.304 -1.39 0 N-CA-C 108.288 -1.005 . . . . 0.58 108.288 -177.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 1.0 ' HG2' ' HB3' ' A' ' 107' ' ' LYS . 93.3 Cg_endo -79.34 72.43 6.52 Favored 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 122.562 2.175 . . . . 1.3 114.149 -167.226 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 108' ' ' ILE . 79.0 p -0.78 130.17 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 117.023 2.231 . . . . 1.91 117.023 178.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -79.61 103.01 9.23 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 113.334 -1.757 . . . . 1.93 109.757 -178.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 1.062 ' HA ' ' HG2' ' A' ' 83' ' ' GLU . 0.4 OUTLIER -59.54 -13.27 8.5 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.751 -1.113 . . . . 3.97 113.018 -178.931 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -67.28 -11.67 58.14 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.183 0.438 . . . . 3.21 112.183 -175.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.534 ' HA3' HD22 ' A' ' 109' ' ' ASN . . . -86.37 -21.31 52.19 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.56 -0.829 . . . . 1.98 113.581 -174.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 64.47 30.25 77.36 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.432 -0.89 . . . . 1.66 111.176 -174.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.733 ' HG2' ' HB3' ' A' ' 113' ' ' GLU . 0.6 OUTLIER -133.74 2.49 3.44 Favored 'General case' 0 CA--C 1.498 -1.031 0 CA-C-N 114.99 -0.605 . . . . 1.74 110.238 -176.917 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 1.062 ' HG2' ' HA ' ' A' ' 78' ' ' GLN . 0.0 OUTLIER -79.19 142.32 59.04 Favored Pre-proline 0 C--N 1.308 -1.212 0 CA-C-O 121.821 0.819 . . . . 3.07 111.695 -160.891 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 83' ' ' GLU . 52.1 Cg_endo -79.02 170.6 17.63 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 123.954 3.102 . . . . 1.75 113.91 -164.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.27 -78.18 2.04 Favored Glycine 0 N--CA 1.443 -0.845 0 N-CA-C 109.851 -1.3 . . . . 2.27 109.851 -170.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.872 ' HB2' ' HB2' ' A' ' 89' ' ' GLU . 45.6 m-80 -144.77 118.55 9.25 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.646 -0.872 . . . . 4.88 108.646 171.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -71.33 64.42 0.39 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.898 0.856 . . . . 3.02 110.172 177.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 171.35 -24.71 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.4 -1.273 . . . . 3.92 108.886 -174.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.872 ' HB2' ' HB2' ' A' ' 86' ' ' ASN . 72.7 tt0 -63.52 -16.82 61.82 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.862 -1.063 . . . . 2.65 111.003 -178.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.902 ' HB ' ' HB3' ' A' ' 78' ' ' GLN . 1.1 mt -121.1 -50.2 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-N 116.02 -0.537 . . . . 2.63 111.61 -176.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.725 ' HB3' ' HB2' ' A' ' 78' ' ' GLN . 22.5 pttp -73.22 -24.41 60.49 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.874 0.694 . . . . 3.13 112.874 -172.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -124.5 27.83 6.82 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.714 0.769 . . . . 3.29 110.66 177.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.621 ' HD2' ' HB2' ' A' ' 47' ' ' CYS . 20.3 t80 -133.79 145.55 49.88 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.997 -1.112 . . . . 4.08 107.997 170.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.1 t -67.0 112.34 2.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.83 0.348 . . . . 3.05 110.87 -176.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.551 ' HB3' ' SG ' ' A' ' 47' ' ' CYS . 18.7 p -131.54 122.46 26.17 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.301 0.572 . . . . 3.04 111.927 -176.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.548 ' O ' ' HB3' ' A' ' 45' ' ' SER . 17.3 m -87.6 153.12 21.64 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 107.557 -1.275 . . . . 3.38 107.557 162.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -64.31 117.55 7.38 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.206 -0.665 . . . . 3.11 109.206 177.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.717 ' HE1' ' HB3' ' A' ' 100' ' ' ALA . 0.0 OUTLIER -62.78 113.98 3.35 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.436 -0.802 . . . . 2.12 110.224 -176.988 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.655 ' HZ3' ' HB2' ' A' ' 99' ' ' LYS . 9.0 mtmp? -118.59 127.55 53.71 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.691 -0.686 . . . . 3.1 109.8 174.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.797 ' H ' HD11 ' A' ' 104' ' ' ILE . . . -128.93 -159.24 0.94 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.847 -0.615 . . . . 1.15 111.649 -170.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -86.41 10.1 16.12 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.721 -0.672 . . . . 1.99 110.955 -176.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.642 ' CE2' ' HZ ' ' A' ' 98' ' ' PHE . 0.7 OUTLIER -125.18 174.63 3.7 Favored Pre-proline 0 N--CA 1.448 -0.543 0 CA-C-N 115.514 -0.766 . . . . 1.31 109.553 177.262 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.621 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 12.1 Cg_exo -76.74 84.1 1.96 Allowed 'Trans proline' 0 CA--C 1.517 -0.344 0 C-N-CA 123.702 2.935 . . . . 1.07 113.632 -177.094 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.797 HD11 ' H ' ' A' ' 100' ' ' ALA . 3.9 mp -84.91 133.33 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 N-CA-C 109.1 -0.704 . . . . 1.97 109.1 173.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.795 ' HG2' ' CG ' ' A' ' 74' ' ' PHE . 0.1 OUTLIER -86.98 -179.43 6.49 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.336 -0.847 . . . . 3.41 110.576 -175.602 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.671 ' O ' ' HG2' ' A' ' 107' ' ' LYS . . . -76.85 19.06 0.31 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.063 -0.971 . . . . 1.46 112.388 -173.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 1.0 ' HB3' ' HG2' ' A' ' 75' ' ' PRO . 12.1 ptmt 51.22 128.13 0.0 OUTLIER 'General case' 0 CA--C 1.504 -0.803 0 C-N-CA 125.685 1.594 . . . . 2.31 113.645 -173.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.773 HG13 ' CB ' ' A' ' 116' ' ' HIS . 0.1 OUTLIER -124.34 173.42 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.922 0 CA-C-N 113.141 -1.845 . . . . 1.65 108.371 171.978 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.534 HD22 ' HA3' ' A' ' 80' ' ' GLY . 1.3 m120 -69.43 58.69 0.12 Allowed 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.131 -0.94 . . . . 1.73 112.35 179.341 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.44 HG11 HD13 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -68.97 93.35 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 C-N-CA 119.49 -0.884 . . . . 1.4 110.295 178.654 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 175.41 -178.32 0.12 Allowed 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 106.187 -1.783 . . . . 2.1 106.187 168.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.03 48.35 3.83 Favored Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 119.505 -1.331 . . . . 1.47 115.33 -175.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.733 ' HB3' ' HG2' ' A' ' 82' ' ' GLN . 29.1 tt0 -107.49 -47.85 3.55 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 118.697 -1.201 . . . . 2.81 110.297 158.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -131.52 -36.81 1.24 Allowed 'General case' 0 CA--C 1.503 -0.833 0 C-N-CA 120.608 -0.437 . . . . 2.75 110.356 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . 55.93 -160.51 0.2 Allowed 'General case' 0 N--CA 1.439 -0.983 0 O-C-N 124.031 0.832 . . . . 1.44 109.14 -174.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.773 ' CB ' HG13 ' A' ' 108' ' ' ILE . 2.2 t-80 -140.94 137.14 16.73 Favored Pre-proline 0 C--N 1.302 -1.476 0 N-CA-C 106.992 -1.485 . . . . 0.71 106.992 173.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -28.16 -46.63 0.1 OUTLIER 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 124.729 3.619 . . . . 0.47 113.606 -178.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.753 HD13 ' HB ' ' A' ' 15' ' ' ILE . 37.9 tp -64.86 -51.43 62.09 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 122.977 0.511 . . . . 1.15 112.007 178.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.642 ' HA ' ' HB2' ' A' ' 122' ' ' MET . 31.9 m-85 -77.77 -31.95 52.25 Favored 'General case' 0 CA--C 1.497 -1.085 0 O-C-N 122.185 -0.322 . . . . 3.33 110.664 -178.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.529 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 0.2 OUTLIER -59.29 -39.45 83.0 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 106.656 -1.609 . . . . 2.44 106.656 172.068 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.842 ' HB2' ' HE2' ' A' ' 18' ' ' PHE . 65.0 t80 -65.98 -30.79 71.41 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 119.647 -0.821 . . . . 1.08 110.183 175.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.654 ' HE2' ' CG2' ' A' ' 15' ' ' ILE . 1.5 ttm -75.4 -55.37 5.76 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.573 -0.74 . . . . 1.25 110.744 -170.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.556 ' HD2' ' CB ' ' A' ' 134' ' ' ALA . 1.0 OUTLIER -70.79 -25.68 62.99 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.398 -0.365 . . . . 1.86 111.164 177.045 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.597 ' HZ2' ' HB2' ' A' ' 124' ' ' LYS . 0.0 OUTLIER -73.18 -26.26 61.11 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 119.355 -0.938 . . . . 2.52 109.991 178.442 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 65.7 m -85.41 -42.11 14.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.969 -0.559 . . . . 1.21 110.43 174.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.486 ' HE3' ' O ' ' A' ' 151' ' ' VAL . 39.9 tttm -141.88 90.55 8.5 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 109.118 -0.697 . . . . 2.38 109.118 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 126' ' ' LYS . 25.8 Cg_endo -61.76 -73.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.619 2.879 . . . . 1.69 113.799 -171.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.652 ' HA3' ' HB ' ' A' ' 132' ' ' THR . . . -155.78 168.38 33.34 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.16 -1.019 . . . . 2.59 112.558 -177.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.799 HD12 ' H ' ' A' ' 129' ' ' ILE . 0.2 OUTLIER -100.51 -18.94 6.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.275 0.56 . . . . 3.93 110.22 177.391 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.427 ' HA ' HD23 ' A' ' 130' ' ' LEU . 0.2 OUTLIER -100.12 34.01 2.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.225 -0.898 . . . . 3.81 108.65 179.033 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 52.18 34.45 14.45 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.15 -0.932 . . . . 3.63 109.107 -166.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' THR . . . . . 0.652 ' HB ' ' HA3' ' A' ' 128' ' ' GLY . 1.6 m -76.05 157.49 32.91 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.592 -1.185 . . . . 3.97 110.746 -173.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -74.58 -38.67 62.59 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.248 0.547 . . . . 5.48 110.389 175.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.598 ' HB1' HD12 ' A' ' 135' ' ' ILE . . . -147.53 -157.95 0.86 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.565 -0.743 . . . . 1.59 111.365 -169.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.992 ' HA ' ' HD3' ' A' ' 153' ' ' ARG . 0.0 OUTLIER -38.06 -61.52 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 O-C-N 124.322 1.014 . . . . 2.09 111.794 174.634 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.722 ' HB3' ' HE3' ' A' ' 137' ' ' TRP . 20.2 mtmt 125.5 -70.05 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.195 0 O-C-N 125.03 1.456 . . . . 5.16 110.844 -178.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.868 ' HB3' ' HG3' ' A' ' 156' ' ' PRO . 0.8 OUTLIER -120.27 -175.45 3.0 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 113.043 -1.89 . . . . 2.41 110.881 -158.527 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.494 ' O ' ' N ' ' A' ' 140' ' ' THR . 7.7 m120 -34.87 -151.35 0.0 OUTLIER 'General case' 0 C--O 1.205 -1.267 0 CA-C-N 113.837 -1.529 . . . . 2.04 111.8 156.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.862 ' HA ' HG12 ' A' ' 43' ' ' VAL . 0.6 OUTLIER -28.69 -21.01 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 118.098 2.629 . . . . 2.53 118.098 -171.702 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.541 ' HA ' ' O ' ' A' ' 154' ' ' PHE . 0.9 OUTLIER -9.05 113.27 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 120.191 1.36 . . . . 1.24 113.951 170.438 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.617 ' HA ' ' HA ' ' A' ' 41' ' ' TYR . 0.7 OUTLIER -90.47 171.77 9.19 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.851 -1.068 . . . . 1.03 110.089 -174.132 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.62 ' HA ' ' HA ' ' A' ' 153' ' ' ARG . 10.6 m-85 -126.04 120.26 29.79 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 105.372 -2.084 . . . . 0.7 105.372 161.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.862 HD21 ' HB2' ' A' ' 152' ' ' GLU . 1.1 tp -79.67 105.42 10.96 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 118.69 -1.204 . . . . 1.16 108.52 -178.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.772 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 45.1 mm -92.81 145.5 7.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 CA-C-N 113.975 -1.466 . . . . 1.05 107.933 -176.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.64 -174.88 2.91 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 119.532 -0.867 . . . . 0.98 111.357 -170.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.529 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 32.1 mtm180 -51.08 -42.23 60.47 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 121.077 0.465 . . . . 2.61 111.444 -176.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -98.8 21.56 11.3 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.97 -0.559 . . . . 2.0 109.955 -175.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.478 ' HA3' ' CE2' ' A' ' 16' ' ' PHE . . . 71.64 34.2 63.14 Favored Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 115.732 -0.667 . . . . 0.19 113.908 178.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.458 ' HA ' ' HD2' ' A' ' 150' ' ' PRO . 43.0 t -112.07 107.03 56.13 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 117.988 0.894 . . . . 1.74 111.544 176.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.634 ' HG3' ' HG3' ' A' ' 122' ' ' MET . 4.4 Cg_exo -45.39 118.53 2.16 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 124.441 3.427 . . . . 0.6 112.403 173.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.486 ' O ' ' HE3' ' A' ' 126' ' ' LYS . 1.8 t -103.64 -20.8 5.55 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.879 0 N-CA-C 108.116 -1.068 . . . . 2.06 108.116 178.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.862 ' HB2' HD21 ' A' ' 143' ' ' LEU . 0.0 OUTLIER -152.5 167.65 28.11 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 113.998 -1.455 . . . . 1.17 110.957 -168.531 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.992 ' HD3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -141.82 129.21 21.22 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 107.091 -1.448 . . . . 2.9 107.091 159.301 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.723 ' HZ ' ' HB2' ' A' ' 166' ' ' LYS . 70.0 m-85 -101.34 141.02 34.83 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.902 -0.407 . . . . 0.36 109.902 -173.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 18.3 m -64.54 150.58 93.43 Favored Pre-proline 0 C--N 1.325 -0.497 0 N-CA-C 109.979 -0.378 . . . . 1.45 109.979 177.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.868 ' HG3' ' HB3' ' A' ' 137' ' ' TRP . 18.6 Cg_endo -57.41 -50.29 11.33 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.138 1.892 . . . . 0.78 112.253 -174.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -66.89 16.44 0.29 Allowed Glycine 0 CA--C 1.526 0.758 0 N-CA-C 114.829 0.692 . . . . 0.59 114.829 175.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -78.59 154.23 30.49 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 118.262 1.031 . . . . 1.07 108.572 169.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.435 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 50.1 m -106.97 167.36 9.94 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 109.64 -0.504 . . . . 1.92 109.64 -177.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.666 ' HA ' HG21 ' A' ' 56' ' ' THR . 91.2 t -40.81 -54.59 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 O-C-N 124.2 0.938 . . . . 1.07 111.731 178.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.761 ' HZ1' ' HB2' ' A' ' 161' ' ' LYS . 0.1 OUTLIER -70.13 -27.65 64.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.232 -0.44 . . . . 3.89 111.409 -172.856 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -68.0 -35.22 77.94 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.478 0.656 . . . . 1.4 109.59 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.579 HD13 ' CG2' ' A' ' 56' ' ' THR . 47.4 mt -80.42 -44.55 22.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 114.988 -1.006 . . . . 1.05 110.522 176.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.594 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 41.2 mt-10 -50.84 -41.73 57.95 Favored 'General case' 0 C--O 1.217 -0.653 0 CA-C-N 116.122 -0.49 . . . . 0.67 111.503 -177.115 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -60.88 -26.77 67.65 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 112.486 0.55 . . . . 0.87 112.486 -175.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.723 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 40.8 mmtm -100.93 -5.35 26.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.544 0.688 . . . . 2.22 109.83 175.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.594 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 11.9 tp -97.82 -51.1 4.2 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.119 -0.946 . . . . 1.04 111.971 -176.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.503 HD11 ' HB3' ' A' ' 164' ' ' GLU . 69.5 mt -56.24 -46.72 99.76 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 112.957 0.725 . . . . 1.08 112.957 -171.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.451 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 63.3 Cg_exo -53.67 -25.03 32.03 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.092 1.861 . . . . 0.62 112.577 175.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.824 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 94.8 mt -86.66 -45.41 11.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.241 -0.436 . . . . 1.36 110.744 177.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.722 HD21 ' HG2' ' A' ' 37' ' ' PRO . 96.5 mt -59.89 -54.83 41.54 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-O 122.048 0.928 . . . . 1.07 110.204 177.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -62.7 -10.85 33.1 Favored Glycine 0 N--CA 1.435 -1.401 0 CA-C-N 113.305 -1.77 . . . . 1.12 112.962 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 6.2 t 58.54 70.42 0.65 Allowed 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.236 0.541 . . . . 2.88 110.359 177.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -66.37 -23.14 66.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.72 -0.673 . . . . 4.69 110.333 178.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 71.28 -67.22 0.26 Allowed 'General case' 0 N--CA 1.465 0.301 0 O-C-N 124.093 0.871 . . . . 9.17 111.282 175.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 22.7 tp . . . . . 0 C--O 1.247 0.921 0 CA-C-O 118.743 -0.646 . . . . 8.03 109.37 177.754 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.822 0 N-CA-C 111.833 -0.507 . . . . 5.58 111.833 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -118.72 140.54 49.77 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.817 0.341 . . . . 5.23 110.092 176.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -128.52 156.38 20.94 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.868 -0.682 . . . . 1.55 112.234 -177.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.8 m -108.96 -10.16 15.07 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.81 0.338 . . . . 2.17 110.407 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.47 ' HB3' ' O ' ' A' ' 147' ' ' ASP . 3.1 m -159.78 152.39 21.29 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 107.075 -1.454 . . . . 1.68 107.075 -173.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.872 ' HB ' HD13 ' A' ' 118' ' ' LEU . 4.6 pt -66.54 -13.63 16.53 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 CA-C-N 114.079 -1.418 . . . . 1.16 112.298 -173.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.813 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 57.1 m-85 -70.45 -8.11 48.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.819 0.342 . . . . 0.3 111.908 -178.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -64.88 -25.86 68.07 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 108.103 -1.073 . . . . 2.11 108.103 175.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.851 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 61.4 m-85 -109.52 113.72 26.75 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 114.191 -1.368 . . . . 0.37 111.632 -176.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -47.72 142.26 4.79 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 113.122 -1.854 . . . . 2.86 110.652 169.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.762 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 54.8 t -111.66 159.2 11.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 108.395 -0.965 . . . . 1.32 108.395 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.722 HD23 ' HA ' ' A' ' 27' ' ' PRO . 74.9 mt -124.05 121.08 34.25 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 121.103 -0.239 . . . . 1.29 110.889 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.596 ' HA ' ' HE3' ' A' ' 105' ' ' MET . 6.2 t0 -62.1 170.5 2.18 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 107.314 -1.365 . . . . 1.87 107.314 173.062 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.628 ' HA ' ' C ' ' A' ' 105' ' ' MET . . . -53.05 -20.31 3.48 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 114.673 1.36 . . . . 1.2 114.673 -164.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.482 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 7.9 t70 -103.31 11.66 36.44 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.541 -0.463 . . . . 2.34 111.665 -177.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.679 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 54.7 m-70 76.04 18.42 2.0 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.823 0.82 . . . . 2.26 109.503 176.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.714 ' HE2' ' HA ' ' A' ' 26' ' ' LYS . 10.6 mmpt? -88.98 127.97 53.77 Favored Pre-proline 0 N--CA 1.445 -0.691 0 N-CA-C 107.488 -1.301 . . . . 4.64 107.488 171.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.722 ' HA ' HD23 ' A' ' 21' ' ' LEU . 80.0 Cg_exo -49.82 114.08 1.23 Allowed 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 122.242 1.961 . . . . 0.62 113.206 -171.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.679 ' HH ' ' HE2' ' A' ' 33' ' ' HIS . 49.5 t80 -79.99 146.71 31.88 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 113.813 -1.54 . . . . 1.52 111.675 173.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.497 ' OD1' ' HB3' ' A' ' 32' ' ' GLN . 2.5 t-20 -86.34 92.39 8.79 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 114.917 -1.038 . . . . 2.16 109.289 175.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.63 HD21 ' HA ' ' A' ' 16' ' ' PHE . 54.0 tp -72.62 -41.25 65.75 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.756 -0.656 . . . . 1.07 109.976 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.772 ' HA ' ' CE1' ' A' ' 16' ' ' PHE . 1.5 t -70.22 -0.83 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 114.698 -1.137 . . . . 1.69 112.517 -167.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.497 ' HB3' ' OD1' ' A' ' 29' ' ' ASN . 30.1 pt20 -76.14 -6.92 53.44 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.342 0.591 . . . . 1.31 109.687 174.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.925 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 93.0 m-70 -100.29 28.53 4.91 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 115.279 -0.873 . . . . 0.35 108.798 175.15 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.813 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 8.0 mtmt -90.45 118.16 29.71 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 114.687 -1.142 . . . . 2.07 109.595 173.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.66 -40.4 1.97 Allowed Glycine 0 N--CA 1.439 -1.159 0 N-CA-C 111.239 -0.745 . . . . 0.24 111.239 -177.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.46 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 40.7 m -126.97 135.69 27.74 Favored Pre-proline 0 N--CA 1.435 -1.204 0 N-CA-C 108.583 -0.895 . . . . 0.74 108.583 172.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.708 ' HG3' ' CB ' ' A' ' 170' ' ' LEU . 5.9 Cg_endo -44.5 155.36 0.27 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.837 3.025 . . . . 0.22 112.591 175.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.814 ' HB2' HG21 ' A' ' 70' ' ' THR . 0.7 OUTLIER -141.68 149.83 41.09 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 106.59 -1.633 . . . . 1.09 106.59 -179.752 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.837 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 2.3 mp -119.89 118.63 31.26 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.603 -0.686 . . . . 1.82 110.188 177.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.944 HD13 ' HE1' ' A' ' 122' ' ' MET . 2.2 mt -103.11 127.95 56.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-N 115.408 -0.815 . . . . 1.12 110.374 178.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.837 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.3 OUTLIER -114.81 128.53 56.35 Favored 'General case' 0 C--O 1.218 -0.597 0 CA-C-N 116.055 -0.52 . . . . 1.09 111.225 -172.089 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.691 ' HB3' HG23 ' A' ' 135' ' ' ILE . 0.3 OUTLIER -76.51 105.53 7.62 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 106.024 -1.843 . . . . 3.11 106.024 165.428 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.972 HG13 ' HB3' ' A' ' 73' ' ' ALA . 2.4 p -113.91 128.61 70.76 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 C-N-CA 119.27 -0.972 . . . . 1.69 113.372 -164.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.18 109.06 3.39 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 114.623 -1.172 . . . . 1.45 108.481 167.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.424 ' OG ' ' HE2' ' A' ' 107' ' ' LYS . 2.7 m -64.37 178.88 0.65 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.09 -0.959 . . . . 1.99 111.641 -175.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 95' ' ' CYS . 45.1 tttp -57.9 99.86 0.05 OUTLIER 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.233 0.54 . . . . 6.2 111.892 -169.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.523 ' HG ' HG21 ' A' ' 90' ' ' ILE . 18.1 p -142.18 -165.12 1.95 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.28 -0.873 . . . . 4.12 108.776 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -55.33 -19.08 15.98 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 121.099 -0.572 . . . . 3.44 113.654 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -130.34 149.43 52.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 117.739 0.77 . . . . 4.84 112.385 -177.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.714 HG22 ' HB2' ' A' ' 54' ' ' TYR . 10.3 m -130.71 -26.88 2.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.186 -0.916 . . . . 2.41 110.363 177.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.554 ' CB ' ' HB2' ' A' ' 156' ' ' PRO . 10.5 mmmm 62.44 37.35 13.59 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-N 114.949 -1.023 . . . . 2.47 112.483 173.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.77 -23.12 1.33 Allowed Glycine 0 C--N 1.334 0.433 0 C-N-CA 121.045 -0.598 . . . . 0.85 113.851 173.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' A' ' 51' ' ' LYS . . . -61.15 -21.81 59.88 Favored Glycine 0 C--O 1.219 -0.829 0 C-N-CA 121.147 -0.549 . . . . 0.67 113.475 -175.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.714 ' HB2' HG22 ' A' ' 50' ' ' THR . 0.1 OUTLIER -59.7 -56.89 16.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 117.815 0.807 . . . . 1.2 109.437 177.852 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -60.15 -32.59 71.17 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.869 -1.06 . . . . 2.61 110.145 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.546 ' HA ' ' CG2' ' A' ' 160' ' ' VAL . 92.4 m -71.44 -59.53 2.71 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 114.827 -1.079 . . . . 1.06 109.94 -175.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 1.124 ' HB3' HG11 ' A' ' 71' ' ' VAL . . . -63.07 -42.56 99.69 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.439 -1.255 . . . . 1.05 111.454 -175.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.555 ' HA ' ' CD1' ' A' ' 102' ' ' PHE . 6.4 m -58.53 -56.89 16.26 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.237 0.541 . . . . 1.08 111.059 -179.205 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.4 m -68.29 -33.31 74.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.634 -0.712 . . . . 1.22 111.213 -173.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.719 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 20.6 mt -67.74 -48.33 66.75 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-O 121.29 0.566 . . . . 1.14 110.077 -178.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.921 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 10.9 t80 -59.3 -46.52 88.34 Favored 'General case' 0 C--O 1.205 -1.267 0 CA-C-N 115.053 -0.976 . . . . 0.94 110.427 178.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -73.52 -26.96 61.11 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 116.625 -0.261 . . . . 1.6 111.551 -172.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.478 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 34.4 ttpt -85.96 -23.8 26.77 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 108.83 -0.804 . . . . 2.06 108.83 -177.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.647 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 30.1 m-85 -122.98 -6.66 8.42 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 115.21 1.559 . . . . 0.92 115.21 -169.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.645 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 26.6 pttt -66.82 -23.77 66.08 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 108.242 -1.022 . . . . 1.89 108.242 170.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.8 t -49.25 -36.18 19.71 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 114.292 -1.322 . . . . 1.68 110.504 171.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -92.31 -30.3 15.91 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.041 0.386 . . . . 1.11 112.041 176.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.403 ' HA3' ' HB2' ' A' ' 36' ' ' SER . . . 143.0 -6.39 2.04 Favored Glycine 0 CA--C 1.52 0.372 0 N-CA-C 111.576 -0.61 . . . . 0.2 111.576 -176.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.719 ' HE2' ' HB3' ' A' ' 60' ' ' LEU . 23.1 t80 -67.58 143.57 56.01 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-N 115.329 -0.436 . . . . 0.21 111.209 -178.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.925 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 7.1 t -132.59 152.65 51.56 Favored 'General case' 0 N--CA 1.415 -2.181 0 N-CA-C 108.095 -1.076 . . . . 1.02 108.095 172.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 1.124 HG11 ' HB3' ' A' ' 57' ' ' ALA . 33.4 t -106.2 101.18 12.07 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.501 0 N-CA-C 107.482 -1.303 . . . . 1.04 107.482 157.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.866 ' HB2' HG23 ' A' ' 40' ' ' ILE . 65.9 mt -85.87 120.3 27.13 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.48 -1.304 . . . . 1.69 107.48 177.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.972 ' HB3' HG13 ' A' ' 43' ' ' VAL . . . -99.49 112.09 24.35 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.918 -0.713 . . . . 1.17 110.49 177.138 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.976 ' HD2' HD13 ' A' ' 108' ' ' ILE . 4.6 m-85 -99.04 95.37 3.21 Favored Pre-proline 0 N--CA 1.438 -1.041 0 N-CA-C 106.593 -1.632 . . . . 0.58 106.593 176.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.847 ' HB2' ' HG2' ' A' ' 107' ' ' LYS . 9.8 Cg_endo -71.22 142.69 42.16 Favored 'Trans proline' 0 N--CA 1.431 -2.155 0 C-N-CA 120.49 0.793 . . . . 1.3 110.281 -172.203 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.519 ' HB3' ' OD1' ' A' ' 42' ' ' ASN . 57.2 p -75.32 133.66 41.21 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 122.175 0.988 . . . . 1.91 112.678 -177.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.467 ' OD1' ' HD2' ' A' ' 79' ' ' PHE . 66.7 t30 -70.02 87.52 0.56 Allowed 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 113.597 -1.638 . . . . 1.93 109.192 174.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 1.017 ' HA ' ' HG2' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -56.64 -11.03 1.15 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.16 -0.927 . . . . 3.97 111.852 177.326 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.467 ' HD2' ' OD1' ' A' ' 77' ' ' ASN . 47.0 m-85 -75.78 31.57 0.11 Allowed 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 113.379 0.881 . . . . 3.21 113.379 -173.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.421 ' HA3' HE22 ' A' ' 82' ' ' GLN . . . -133.03 -133.38 3.38 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.622 -0.799 . . . . 1.98 112.388 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -154.5 36.47 0.69 Allowed Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 111.724 -0.55 . . . . 1.66 111.724 175.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.576 ' HG3' ' HB3' ' A' ' 113' ' ' GLU . 3.2 pm0 -145.3 4.96 1.07 Allowed 'General case' 0 C--O 1.221 -0.397 0 CA-C-N 115.953 -0.123 . . . . 1.74 111.032 -177.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 1.017 ' HG2' ' HA ' ' A' ' 78' ' ' GLN . 2.5 mp0 -60.89 139.7 93.73 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 120.854 0.359 . . . . 3.07 110.358 -169.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.647 ' HG2' HD22 ' A' ' 42' ' ' ASN . 60.1 Cg_endo -86.44 150.96 9.08 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.969 2.446 . . . . 1.75 112.282 -175.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 81.09 33.37 29.49 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 110.688 -0.965 . . . . 2.27 110.688 -175.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 74.87 96.93 0.07 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.309 -0.945 . . . . 4.88 110.442 -176.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.648 ' HA ' ' HB2' ' A' ' 83' ' ' GLU . 2.9 pm0 -55.6 -31.65 62.43 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.702 -1.135 . . . . 3.02 110.811 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.524 ' O ' ' HG2' ' A' ' 92' ' ' GLU . 37.8 tt0 -68.23 -42.57 79.56 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.121 -0.945 . . . . 3.92 111.663 -175.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -54.2 -59.37 4.75 Favored 'General case' 0 N--CA 1.464 0.237 0 O-C-N 123.258 0.348 . . . . 2.65 111.892 -173.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.523 HG21 ' HG ' ' A' ' 47' ' ' CYS . 5.6 pt -76.8 15.51 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.467 0.543 . . . . 2.63 112.467 -176.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.5 ttmt -120.56 -46.96 2.35 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.926 0.393 . . . . 3.13 110.524 177.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.524 ' HG2' ' O ' ' A' ' 88' ' ' GLU . 15.4 pt-20 -73.29 -20.36 60.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.99 -0.55 . . . . 3.29 109.562 176.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -115.24 127.03 55.22 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 108.725 -0.843 . . . . 4.08 108.725 173.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 96.9 t -65.64 112.25 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.141 0.495 . . . . 3.05 110.78 -178.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.653 ' SG ' ' HG2' ' A' ' 78' ' ' GLN . 26.7 p -106.42 121.63 44.64 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-O 121.826 0.822 . . . . 3.04 111.068 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 13.2 p -91.56 160.83 15.21 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.84 -1.073 . . . . 3.38 108.751 169.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.482 ' H ' ' HD2' ' A' ' 97' ' ' LYS . 0.1 OUTLIER -54.36 125.0 17.67 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.821 -1.177 . . . . 3.11 107.821 171.933 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.548 ' HZ ' ' CE2' ' A' ' 102' ' ' PHE . 2.9 p90 -77.97 38.14 0.26 Allowed 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.257 0.551 . . . . 2.12 110.439 -172.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.418 ' H ' ' C ' ' A' ' 97' ' ' LYS . 43.4 mtmt -31.72 113.92 0.13 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.687 1.195 . . . . 3.1 112.502 -170.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.402 ' H ' HG12 ' A' ' 104' ' ' ILE . . . -122.34 -162.27 0.99 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.021 -0.991 . . . . 1.15 111.942 -168.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -83.33 17.55 2.07 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.077 -0.965 . . . . 1.99 110.687 -178.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.584 ' HB3' ' CD2' ' A' ' 61' ' ' TYR . 13.0 p90 -143.65 165.98 22.01 Favored Pre-proline 0 N--CA 1.445 -0.723 0 N-CA-C 109.497 -0.557 . . . . 1.31 109.497 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.65 ' HD3' ' CE2' ' A' ' 61' ' ' TYR . 31.2 Cg_exo -62.4 95.78 0.15 Allowed 'Trans proline' 0 CA--C 1.52 -0.202 0 C-N-CA 123.962 3.108 . . . . 1.07 113.19 -174.199 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.783 HD13 ' HB1' ' A' ' 73' ' ' ALA . 4.0 mm -90.48 116.14 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 107.513 -1.292 . . . . 1.97 107.513 175.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.641 ' HG3' ' CD1' ' A' ' 74' ' ' PHE . 1.2 mmt -92.93 -174.1 3.49 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.456 -0.793 . . . . 3.41 111.704 -166.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.488 ' N ' ' HA ' ' A' ' 23' ' ' ALA . . . -71.58 130.91 42.38 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.003 -0.998 . . . . 1.46 108.741 172.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.847 ' HG2' ' HB2' ' A' ' 75' ' ' PRO . 92.4 mttt -62.81 131.73 49.8 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-O 121.836 0.827 . . . . 2.31 109.265 176.015 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.976 HD13 ' HD2' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -122.36 165.39 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.419 0 N-CA-C 105.167 -2.16 . . . . 1.65 105.167 169.855 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.478 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 1.9 t30 -78.7 69.44 4.87 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 119.78 -0.768 . . . . 1.73 110.309 -178.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.4 HG11 HD11 ' A' ' 108' ' ' ILE . 0.1 OUTLIER -67.36 92.89 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-O 122.101 0.953 . . . . 1.4 108.853 178.51 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.591 ' ND2' ' H ' ' A' ' 112' ' ' GLY . 4.6 t30 175.8 -179.84 0.15 Allowed 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 113.286 -1.779 . . . . 2.1 106.555 177.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.591 ' H ' ' ND2' ' A' ' 111' ' ' ASN . . . -79.73 24.31 3.3 Favored Glycine 0 N--CA 1.435 -1.371 0 N-CA-C 116.232 1.253 . . . . 1.47 116.232 -172.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.593 ' HG3' ' N ' ' A' ' 114' ' ' ASN . 0.0 OUTLIER -106.66 -44.2 4.52 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 120.306 2.053 . . . . 2.81 111.693 176.342 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.593 ' N ' ' HG3' ' A' ' 113' ' ' GLU . 4.2 t-20 -132.4 -36.35 1.12 Allowed 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 109.836 -0.431 . . . . 2.75 109.836 -178.386 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.516 ' HB2' ' HG2' ' A' ' 120' ' ' GLU . . . 50.49 -150.86 0.22 Allowed 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.898 -1.046 . . . . 1.44 109.524 -177.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.642 ' ND1' ' H ' ' A' ' 118' ' ' LEU . 5.5 t-80 -151.08 138.81 12.37 Favored Pre-proline 0 N--CA 1.426 -1.639 0 N-CA-C 107.058 -1.46 . . . . 0.71 107.058 174.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -30.93 -45.33 0.14 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 124.364 3.376 . . . . 0.47 113.211 -178.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.872 HD13 ' HB ' ' A' ' 15' ' ' ILE . 43.3 tp -65.05 -50.36 66.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.905 -0.589 . . . . 1.15 111.83 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.551 ' OH ' HG21 ' A' ' 40' ' ' ILE . 32.9 m-85 -76.34 -33.04 58.98 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 112.026 0.38 . . . . 3.33 112.026 178.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.613 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 43.9 mt-10 -57.94 -37.49 74.21 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 107.111 -1.44 . . . . 2.44 107.111 170.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.851 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 74.3 t80 -66.25 -35.65 80.97 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.368 -0.833 . . . . 1.08 110.646 173.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.944 ' HE1' HD13 ' A' ' 40' ' ' ILE . 53.1 mtt -73.61 -55.08 6.75 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.75 -0.659 . . . . 1.25 110.806 -168.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.596 ' HB3' ' HA ' ' A' ' 134' ' ' ALA . 0.2 OUTLIER -70.0 -24.26 63.28 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.108 -0.496 . . . . 1.86 111.144 177.785 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.613 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 9.5 pttp -72.57 -30.14 64.14 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 119.61 -0.836 . . . . 2.52 109.624 174.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 87.8 m -76.86 -48.0 19.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.775 -0.648 . . . . 1.21 110.514 176.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.769 ' HG2' HH22 ' A' ' 153' ' ' ARG . 22.8 ttmm -144.57 113.04 5.06 Favored Pre-proline 0 N--CA 1.452 -0.367 0 CA-C-N 116.283 -0.417 . . . . 2.38 110.848 -179.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 126' ' ' LYS . 11.9 Cg_exo -71.72 -54.29 0.15 Allowed 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 123.798 2.999 . . . . 1.69 112.25 -178.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.535 ' HA2' ' CZ ' ' A' ' 153' ' ' ARG . . . 178.56 168.47 37.89 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.139 -1.029 . . . . 2.59 112.524 178.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 6.9 pt -72.28 -17.11 18.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.5 0.667 . . . . 3.93 109.987 173.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.608 HD23 ' H ' ' A' ' 130' ' ' LEU . 2.3 pt? -120.19 177.52 4.98 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.028 -0.987 . . . . 3.81 109.28 177.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -75.54 72.86 2.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.202 0.525 . . . . 3.63 111.328 -178.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' THR . . . . . 0.405 HG21 ' HG2' ' A' ' 136' ' ' LYS . 1.5 m -151.81 168.97 23.41 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.677 -0.86 . . . . 3.97 108.677 178.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -119.79 167.59 11.93 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.74 0.305 . . . . 5.48 110.729 175.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.596 ' HA ' ' HB3' ' A' ' 123' ' ' LYS . . . 67.74 -166.97 0.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.185 -0.916 . . . . 1.59 112.122 173.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.91 ' H ' HD13 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -71.29 -23.19 22.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 114.889 -1.05 . . . . 2.09 110.509 176.513 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.819 ' HB3' ' CE3' ' A' ' 137' ' ' TRP . 9.8 mtmp? 72.55 -60.58 0.53 Allowed 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 121.528 0.68 . . . . 5.16 112.601 -176.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.819 ' CE3' ' HB3' ' A' ' 136' ' ' LYS . 0.1 OUTLIER -109.42 -179.91 3.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.492 -1.231 . . . . 2.41 111.414 -163.765 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.655 ' HB2' ' HB3' ' A' ' 156' ' ' PRO . 1.8 m120 -38.2 -153.05 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 125.507 1.523 . . . . 2.04 111.955 158.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.698 ' CD1' HG23 ' A' ' 43' ' ' VAL . 1.6 m-85 -25.27 -46.56 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 114.815 1.413 . . . . 2.53 114.815 -167.309 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.788 ' HA ' ' O ' ' A' ' 154' ' ' PHE . 16.3 m 25.75 101.3 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.719 1.377 . . . . 1.24 114.719 172.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.551 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.7 OUTLIER -86.12 169.18 13.36 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.61 -1.177 . . . . 1.03 110.235 -175.058 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.57 ' HE1' HG21 ' A' ' 135' ' ' ILE . 42.7 m-85 -126.04 124.41 40.59 Favored 'General case' 0 CA--C 1.495 -1.15 0 N-CA-C 105.118 -2.179 . . . . 0.7 105.118 162.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.749 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 7.3 tp -79.99 105.56 11.36 Favored 'General case' 0 N--CA 1.422 -1.867 0 C-N-CA 118.143 -1.423 . . . . 1.16 108.682 178.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.688 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 39.7 mm -91.59 138.16 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.022 0 CA-C-N 112.542 -2.117 . . . . 1.05 107.118 -178.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.533 ' HA ' HD11 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -92.04 179.94 5.45 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 120.396 -0.522 . . . . 0.98 111.055 -170.273 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.532 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 40.1 mtm180 -47.36 -42.6 21.92 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 122.893 0.477 . . . . 2.61 111.626 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.47 ' O ' ' HB3' ' A' ' 14' ' ' SER . 8.1 m-20 -96.72 23.43 7.02 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 109.685 -0.487 . . . . 2.0 109.685 -176.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.612 ' HA2' HG21 ' A' ' 144' ' ' ILE . . . 65.26 37.88 94.48 Favored Glycine 0 N--CA 1.437 -1.275 0 CA-C-N 115.666 -0.697 . . . . 0.19 114.139 178.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.49 ' HA ' ' HD2' ' A' ' 150' ' ' PRO . 6.9 p -108.74 110.1 61.22 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 118.615 1.208 . . . . 1.74 111.73 173.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.663 ' HD3' HG23 ' A' ' 15' ' ' ILE . 10.2 Cg_endo -57.09 115.05 2.22 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 124.081 3.187 . . . . 0.6 111.168 175.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.761 HG23 ' HG2' ' A' ' 152' ' ' GLU . 17.6 m -116.27 -17.86 7.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-O 121.187 0.518 . . . . 2.06 109.982 -177.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.761 ' HG2' HG23 ' A' ' 151' ' ' VAL . 24.6 mm-40 -138.57 167.24 22.36 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-N 115.49 -0.777 . . . . 1.17 109.956 -179.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.769 HH22 ' HG2' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -148.43 141.6 25.03 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 114.904 -1.044 . . . . 2.9 108.937 163.267 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.788 ' O ' ' HA ' ' A' ' 140' ' ' THR . 79.7 m-85 -117.45 151.12 37.72 Favored 'General case' 0 C--O 1.217 -0.632 0 N-CA-C 109.483 -0.562 . . . . 0.36 109.483 -174.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.539 ' HB3' ' HD2' ' A' ' 156' ' ' PRO . 51.1 m -73.27 163.76 66.07 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 109.388 -0.597 . . . . 1.45 109.388 177.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.655 ' HB3' ' HB2' ' A' ' 138' ' ' ASN . 10.6 Cg_endo -53.15 -67.02 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.763 2.309 . . . . 0.78 112.729 -179.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' A' ' 51' ' ' LYS . . . -57.2 15.37 0.01 OUTLIER Glycine 0 CA--C 1.53 0.999 0 N-CA-C 116.368 1.307 . . . . 0.59 116.368 172.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.415 ' H ' ' C ' ' A' ' 156' ' ' PRO . . . -79.85 138.09 37.11 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 119.061 1.431 . . . . 1.07 107.392 167.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.485 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 8.6 t -104.85 173.47 6.29 Favored 'General case' 0 N--CA 1.429 -1.51 0 C-N-CA 119.988 -0.685 . . . . 1.92 110.072 -169.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.546 ' CG2' ' HA ' ' A' ' 56' ' ' THR . 69.3 t -43.57 -54.76 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 114.358 -1.292 . . . . 1.07 112.126 -177.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.84 -29.96 68.39 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.98 0.419 . . . . 3.89 110.78 -173.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -71.05 -31.41 67.84 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.642 0.734 . . . . 1.4 109.123 -176.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.472 HD11 ' CG2' ' A' ' 56' ' ' THR . 33.1 mt -82.58 -45.33 19.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 114.492 -1.231 . . . . 1.05 110.741 176.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.563 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 41.8 mt-10 -51.2 -41.87 60.53 Favored 'General case' 0 C--O 1.218 -0.595 0 CA-C-N 116.308 -0.405 . . . . 0.67 111.362 -178.015 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -60.8 -20.69 62.05 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 112.056 0.391 . . . . 0.87 112.056 -174.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.683 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 31.3 mmtp -100.38 -24.44 14.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.477 0.656 . . . . 2.22 110.273 172.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.563 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 10.8 tp -80.73 -49.02 11.71 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.183 -0.917 . . . . 1.04 112.183 -175.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 164' ' ' GLU . 73.1 mt -55.75 -43.7 99.31 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.478 -0.783 . . . . 1.08 112.568 -173.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -49.98 -33.67 34.99 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 122.02 1.813 . . . . 0.62 112.659 172.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.708 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 91.3 mt -86.01 -42.67 13.78 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 121.122 -0.231 . . . . 1.36 111.348 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.613 HD23 ' HB2' ' A' ' 69' ' ' PHE . 93.8 mt -59.39 -53.2 60.95 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 122.264 1.031 . . . . 1.07 109.624 175.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -80.88 15.71 19.34 Favored Glycine 0 N--CA 1.435 -1.425 0 CA-C-N 113.321 -1.763 . . . . 1.12 113.958 -174.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.485 ' HB3' ' HD3' ' A' ' 146' ' ' ARG . 13.8 t -73.34 -5.9 42.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 117.249 0.525 . . . . 2.88 110.48 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -65.17 -27.42 68.69 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.216 0.531 . . . . 4.69 110.459 175.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 175' ' ' ARG . 0.3 OUTLIER -115.43 16.49 16.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.653 -0.703 . . . . 9.17 109.524 178.708 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 41.3 tp . . . . . 0 C--O 1.248 1.016 0 CA-C-N 115.259 -0.882 . . . . 8.03 109.46 -177.403 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.782 0 N-CA-C 111.747 -0.541 . . . . 5.58 111.747 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 53.3 ttp -77.95 88.1 4.13 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.021 0.439 . . . . 5.23 110.357 178.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.93 52.21 0.66 Allowed Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.58 -0.819 . . . . 1.55 112.486 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.5 m -89.33 -25.24 21.73 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.585 -0.524 . . . . 2.17 109.585 177.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.9 m -166.16 159.19 14.99 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 105.431 -2.062 . . . . 1.68 105.431 -177.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.779 ' HB ' HD12 ' A' ' 118' ' ' LEU . 8.0 pt -59.99 -20.18 19.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 CA-C-N 116.015 -0.538 . . . . 1.16 111.437 -176.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.717 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 40.3 m-85 -68.68 -2.75 9.87 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.059 0.457 . . . . 0.3 111.632 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.96 -12.99 61.37 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 108.469 -0.937 . . . . 2.11 108.469 172.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.73 ' HE2' ' HB2' ' A' ' 121' ' ' TYR . 58.5 m-85 -129.73 111.3 12.5 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 114.837 -1.074 . . . . 0.37 110.871 -173.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -51.38 150.27 3.64 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 113.792 -1.549 . . . . 2.86 110.099 172.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.836 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 34.4 t -111.04 157.06 12.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 115.457 -0.792 . . . . 1.32 108.906 -178.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.837 ' O ' ' HB3' ' A' ' 105' ' ' MET . 96.2 mt -122.31 116.09 23.47 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 116.546 -0.297 . . . . 1.29 110.502 -177.138 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.529 ' HA ' ' SD ' ' A' ' 105' ' ' MET . 6.2 t70 -58.29 170.87 0.64 Allowed 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 107.624 -1.25 . . . . 1.87 107.624 174.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.67 ' HA ' ' C ' ' A' ' 105' ' ' MET . . . -54.56 -26.34 31.55 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 118.761 0.709 . . . . 1.2 112.515 -168.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.429 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 8.8 t70 -78.22 -7.51 57.21 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.47 -0.332 . . . . 2.34 111.047 -178.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.623 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 57.1 m-70 80.09 19.53 0.6 Allowed 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 122.01 0.91 . . . . 2.26 108.628 -177.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.85 ' HE2' ' HA ' ' A' ' 26' ' ' LYS . 9.3 mmpt? -99.83 128.96 29.69 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 114.071 -1.422 . . . . 4.64 108.388 172.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.694 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 74.9 Cg_exo -47.12 115.73 1.44 Allowed 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 123.136 2.557 . . . . 0.62 114.989 -170.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.769 ' CE2' HD22 ' A' ' 72' ' ' LEU . 34.5 t80 -80.08 146.61 31.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.123 -1.399 . . . . 1.52 110.356 166.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.627 ' OD1' ' HB3' ' A' ' 32' ' ' GLN . 2.6 t-20 -76.56 90.76 3.34 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.662 -0.699 . . . . 2.16 110.133 179.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.706 ' HG ' ' CD1' ' A' ' 16' ' ' PHE . 56.3 tp -69.34 -46.51 66.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.162 0.506 . . . . 1.07 110.191 178.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.713 HG12 ' HB3' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -66.2 0.7 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 115.315 -0.857 . . . . 1.69 113.289 -171.598 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.627 ' HB3' ' OD1' ' A' ' 29' ' ' ASN . 3.8 pt20 -72.07 -16.22 62.02 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.109 -0.7 . . . . 1.31 109.109 172.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.976 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 91.2 m-70 -93.99 22.99 5.21 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 121.85 0.833 . . . . 0.35 109.356 178.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.717 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 29.7 mtmt -84.91 109.97 18.53 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 114.266 -1.334 . . . . 2.07 108.834 169.161 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 130.78 -38.05 2.0 Favored Glycine 0 N--CA 1.439 -1.113 0 C-N-CA 120.987 -0.625 . . . . 0.24 111.774 -178.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.44 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 22.7 m -133.99 137.04 27.46 Favored Pre-proline 0 N--CA 1.435 -1.192 0 N-CA-C 108.91 -0.774 . . . . 0.74 108.91 172.037 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.685 ' HG3' ' CB ' ' A' ' 170' ' ' LEU . 7.4 Cg_endo -45.81 156.54 0.43 Allowed 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 124.057 3.171 . . . . 0.22 112.94 178.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.783 ' HB2' HG23 ' A' ' 70' ' ' THR . 0.9 OUTLIER -141.07 145.65 36.11 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 106.745 -1.576 . . . . 1.09 106.745 178.823 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 1.055 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 1.5 mm? -107.2 111.88 24.49 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.199 -1.038 . . . . 1.82 108.199 177.075 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.856 HG23 ' HH ' ' A' ' 119' ' ' TYR . 4.9 mt -95.27 124.51 47.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 C-N-CA 119.622 -0.831 . . . . 1.12 109.954 177.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 1.055 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 1.3 m-85 -106.94 124.39 49.55 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.212 -0.904 . . . . 1.09 110.355 -174.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.612 ' ND2' HD13 ' A' ' 135' ' ' ILE . 0.8 OUTLIER -80.04 90.03 5.39 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 106.421 -1.696 . . . . 3.11 106.421 169.997 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 1.042 HG13 ' HB1' ' A' ' 73' ' ' ALA . 5.9 p -106.71 137.41 37.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 C-N-CA 120.175 -0.61 . . . . 1.69 110.865 -166.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.639 ' HA ' ' HB3' ' A' ' 76' ' ' SER . . . -84.21 118.61 24.26 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 115.896 -0.593 . . . . 1.45 109.653 173.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.3 p -47.8 148.95 1.4 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.517 -0.765 . . . . 1.99 109.608 169.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.844 ' HB2' ' HB3' ' A' ' 49' ' ' TYR . 0.0 OUTLIER -157.09 166.21 33.92 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 119.574 -0.85 . . . . 6.2 112.5 -166.177 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.854 ' HB2' ' HA ' ' A' ' 95' ' ' CYS . 53.3 t -126.15 114.03 17.82 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 114.516 -1.22 . . . . 4.12 107.708 164.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 54.48 42.38 75.43 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 121.212 -0.518 . . . . 3.44 113.156 -177.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.844 ' HB3' ' HB2' ' A' ' 46' ' ' LYS . 50.6 t80 -131.9 132.4 43.58 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.474 0.654 . . . . 4.84 111.589 -176.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.8 t -162.46 166.44 24.96 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.113 -1.069 . . . . 2.41 108.113 175.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.744 ' H ' ' HZ ' ' A' ' 139' ' ' PHE . 29.4 mtpp -129.35 13.12 6.06 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.635 -0.876 . . . . 2.47 108.635 177.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 119.28 -29.01 6.32 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.481 -0.781 . . . . 0.85 111.603 -175.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.57 ' HA2' ' HB ' ' A' ' 56' ' ' THR . . . -75.05 -17.16 80.28 Favored Glycine 0 C--O 1.221 -0.718 0 CA-C-O 119.628 -0.54 . . . . 0.67 114.404 -174.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -71.22 -58.54 3.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 118.44 1.12 . . . . 1.2 109.152 177.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -62.67 -24.21 67.52 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.241 -0.89 . . . . 2.61 110.223 178.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.658 HG22 ' HA ' ' A' ' 160' ' ' VAL . 16.2 m -74.57 -57.5 3.89 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.278 -0.874 . . . . 1.06 110.306 177.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 1.054 ' HB3' HG11 ' A' ' 71' ' ' VAL . . . -58.13 -40.54 81.53 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.76 -0.655 . . . . 1.05 110.986 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.517 ' HA ' ' CD1' ' A' ' 102' ' ' PHE . 86.9 m -57.01 -56.05 26.76 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-O 121.379 0.609 . . . . 1.08 110.532 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.6 m -69.78 -37.7 76.46 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.116 -0.947 . . . . 1.22 111.46 -176.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.685 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 15.2 mt -62.15 -50.06 73.36 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-O 121.523 0.677 . . . . 1.14 110.302 -177.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.914 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 10.8 t80 -57.7 -51.51 69.24 Favored 'General case' 0 C--O 1.2 -1.544 0 CA-C-N 114.46 -1.245 . . . . 0.94 111.052 -179.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.525 ' HA ' ' HD3' ' A' ' 65' ' ' LYS . 5.1 m-80 -73.63 -24.26 60.0 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 120.635 0.255 . . . . 1.6 111.182 -173.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.412 ' HE2' ' HB2' ' A' ' 63' ' ' LYS . 24.4 ttmm -80.53 -26.52 38.0 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 108.548 -0.908 . . . . 2.06 108.548 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.691 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 45.0 m-85 -124.74 -1.53 7.92 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 115.522 1.675 . . . . 0.92 115.522 -169.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.626 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -64.86 -20.74 66.58 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 107.507 -1.294 . . . . 1.89 107.507 169.218 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -46.72 -44.5 18.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 113.794 -1.548 . . . . 1.68 111.014 171.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.408 ' OE1' ' HA ' ' A' ' 64' ' ' TYR . 23.4 mp0 -86.33 -33.11 20.69 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.454 -0.339 . . . . 1.11 111.731 178.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 143.69 -1.52 1.35 Allowed Glycine 0 N--CA 1.452 -0.293 0 N-CA-C 111.562 -0.615 . . . . 0.2 111.562 -174.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.692 ' CE1' HD21 ' A' ' 39' ' ' LEU . 22.0 t80 -68.73 142.77 54.88 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 122.989 0.515 . . . . 0.21 111.25 -178.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.976 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 1.9 t -133.92 147.01 51.04 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 107.633 -1.247 . . . . 1.02 107.633 170.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 1.054 HG11 ' HB3' ' A' ' 57' ' ' ALA . 39.1 t -99.02 99.12 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.441 0 N-CA-C 107.338 -1.356 . . . . 1.04 107.338 157.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.769 HD22 ' CE2' ' A' ' 28' ' ' TYR . 4.2 mt -84.88 118.51 24.55 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 107.895 -1.15 . . . . 1.69 107.895 177.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 1.042 ' HB1' HG13 ' A' ' 43' ' ' VAL . . . -116.58 112.62 21.57 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 119.879 -0.729 . . . . 1.17 110.937 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.836 ' CZ ' HG13 ' A' ' 20' ' ' VAL . 1.6 m-30 -91.75 110.26 42.31 Favored Pre-proline 0 C--N 1.318 -0.77 0 N-CA-C 107.741 -1.207 . . . . 0.58 107.741 173.141 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.896 ' HG2' ' HB3' ' A' ' 107' ' ' LYS . 60.9 Cg_endo -72.2 40.77 0.46 Allowed 'Trans proline' 0 N--CA 1.48 0.73 0 C-N-CA 123.961 3.107 . . . . 1.3 116.629 -165.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.639 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 4.8 t 46.61 149.54 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 115.845 1.794 . . . . 1.91 115.845 175.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.516 ' HB3' ' HA ' ' A' ' 109' ' ' ASN . 57.8 t30 -102.2 55.51 0.79 Allowed 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 114.324 -1.307 . . . . 1.93 107.749 177.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.89 ' HA ' ' HG3' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -52.59 -15.31 0.66 Allowed 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 113.365 -1.743 . . . . 3.97 110.367 175.216 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.446 ' H ' ' C ' ' A' ' 77' ' ' ASN . 0.5 OUTLIER -66.24 -20.32 66.08 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.647 -1.161 . . . . 3.21 110.586 -178.612 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.19 -71.06 1.18 Allowed Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 111.093 -0.803 . . . . 1.98 111.093 174.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 131.63 40.04 0.23 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.771 -0.728 . . . . 1.66 112.722 177.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -149.17 25.22 0.9 Allowed 'General case' 0 CA--C 1.507 -0.687 0 CA-C-O 120.961 0.41 . . . . 1.74 110.882 178.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.89 ' HG3' ' HA ' ' A' ' 78' ' ' GLN . 9.2 mm-40 -90.4 152.09 45.11 Favored Pre-proline 0 C--N 1.31 -1.141 0 CA-C-N 115.446 -0.797 . . . . 3.07 111.278 -172.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -73.8 127.55 11.66 Favored 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 123.195 2.597 . . . . 1.75 112.754 -172.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.65 -64.24 4.15 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.725 -0.67 . . . . 2.27 112.307 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -134.83 126.9 29.77 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.375 -0.231 . . . . 4.88 110.375 -178.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.551 ' HG2' ' HG3' ' A' ' 88' ' ' GLU . 0.0 OUTLIER -123.41 -61.1 1.43 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.428 -0.351 . . . . 3.02 111.082 178.772 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.551 ' HG3' ' HG2' ' A' ' 87' ' ' GLU . 13.2 mt-10 -97.18 -12.78 22.64 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 122.019 -0.426 . . . . 3.92 111.788 -173.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -60.9 -37.33 81.87 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-O 121.212 0.53 . . . . 2.65 109.749 174.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.608 ' HB ' ' NE2' ' A' ' 78' ' ' GLN . 5.5 mm -73.83 -12.02 15.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.717 -0.674 . . . . 2.63 110.157 -178.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.493 ' HD3' ' HA ' ' A' ' 88' ' ' GLU . 38.6 mtpt -93.18 -47.23 7.04 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.36 -0.836 . . . . 3.13 110.472 179.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -80.18 -18.01 50.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 3.29 111.129 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -110.18 138.04 47.09 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.265 -0.643 . . . . 4.08 109.265 178.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 98.6 t -67.68 110.28 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.588 -0.523 . . . . 3.05 109.588 177.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.854 ' HA ' ' HB2' ' A' ' 47' ' ' CYS . 29.0 m -130.08 134.02 47.08 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.413 0.625 . . . . 3.04 110.758 -176.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.547 ' C ' ' H ' ' A' ' 98' ' ' PHE . 2.4 p -62.7 145.63 54.24 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.083 -0.962 . . . . 3.38 109.218 169.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -76.1 26.67 0.12 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.704 0.288 . . . . 3.11 110.958 -177.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.63 ' HZ ' ' CZ ' ' A' ' 102' ' ' PHE . 3.4 t80 65.98 113.56 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 124.328 1.017 . . . . 2.12 111.44 177.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -140.5 113.68 8.46 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.469 -0.787 . . . . 3.1 109.098 174.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.503 ' HB3' ' CE1' ' A' ' 98' ' ' PHE . . . -120.1 -166.48 1.31 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.585 -0.734 . . . . 1.15 110.94 -173.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -88.09 12.07 14.52 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.96 -0.563 . . . . 1.99 110.604 175.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.636 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 15.5 p90 -128.93 160.71 62.03 Favored Pre-proline 0 N--CA 1.438 -1.037 0 N-CA-C 108.209 -1.034 . . . . 1.31 108.209 175.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.735 ' HG2' ' HA ' ' A' ' 72' ' ' LEU . 57.6 Cg_endo -64.27 104.27 0.5 Allowed 'Trans proline' 0 N--CA 1.472 0.222 0 C-N-CA 123.432 2.755 . . . . 1.07 113.2 -171.156 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.901 HD13 ' HB2' ' A' ' 73' ' ' ALA . 5.4 mm -100.48 121.03 50.75 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.818 0 N-CA-C 108.053 -1.091 . . . . 1.97 108.053 175.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.837 ' HB3' ' O ' ' A' ' 21' ' ' LEU . 20.1 mmt -97.68 -159.26 0.72 Allowed 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.32 -0.854 . . . . 3.41 113.246 -163.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.703 ' O ' ' HG2' ' A' ' 107' ' ' LYS . . . -56.96 -27.53 61.37 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.29 -0.868 . . . . 1.46 112.623 -173.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.896 ' HB3' ' HG2' ' A' ' 75' ' ' PRO . 4.5 ptpp? 76.88 133.94 0.06 Allowed 'General case' 0 CA--C 1.481 -1.684 0 O-C-N 125.044 1.465 . . . . 2.31 108.802 -163.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.686 HG13 ' CB ' ' A' ' 116' ' ' HIS . 0.1 OUTLIER -134.65 162.59 38.53 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 CA-C-N 113.4 -1.727 . . . . 1.65 108.206 173.824 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.56 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 2.1 t30 -75.93 70.04 2.61 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.248 -0.887 . . . . 1.73 111.438 -171.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.5 HG12 ' CD1' ' A' ' 108' ' ' ILE . 2.4 m -70.91 91.56 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 CA-C-O 121.493 0.663 . . . . 1.4 111.272 -173.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 175.1 177.66 0.16 Allowed 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.608 -1.178 . . . . 2.1 108.51 168.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 43.85 -116.14 1.4 Allowed Glycine 0 N--CA 1.448 -0.501 0 O-C-N 124.412 1.07 . . . . 1.47 115.327 166.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.38 -13.78 15.27 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 114.378 1.251 . . . . 2.81 114.378 -166.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.402 ' O ' ' C ' ' A' ' 115' ' ' ALA . 2.5 t-20 -111.51 -37.62 5.17 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 119.003 -1.079 . . . . 2.75 112.884 -168.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.56 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . 22.51 -106.89 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 O-C-N 124.266 0.979 . . . . 1.44 111.786 -175.289 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.686 ' CB ' HG13 ' A' ' 108' ' ' ILE . 3.2 t-80 -170.53 140.56 1.49 Allowed Pre-proline 0 N--CA 1.431 -1.4 0 N-CA-C 105.846 -1.909 . . . . 0.71 105.846 169.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -30.89 -49.44 0.22 Allowed 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 123.899 3.066 . . . . 0.47 113.141 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.779 HD12 ' HB ' ' A' ' 15' ' ' ILE . 40.0 tp -58.7 -52.16 66.89 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.459 0.704 . . . . 1.15 112.389 176.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.856 ' HH ' HG23 ' A' ' 40' ' ' ILE . 65.5 m-85 -75.6 -36.54 60.28 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-N 116.472 -0.331 . . . . 3.33 111.652 -178.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.435 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 42.8 mt-10 -56.5 -36.79 69.57 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 107.137 -1.431 . . . . 2.44 107.137 171.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.73 ' HB2' ' HE2' ' A' ' 18' ' ' PHE . 49.5 t80 -68.36 -31.11 70.27 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 119.825 -0.75 . . . . 1.08 111.167 175.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.594 ' HE3' ' CG2' ' A' ' 15' ' ' ILE . 0.5 OUTLIER -74.4 -56.41 4.89 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.27 0.557 . . . . 1.25 109.958 -171.748 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.636 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -72.28 -24.3 61.32 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.221 -0.9 . . . . 1.86 112.258 178.912 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.663 ' HG2' ' HA ' ' A' ' 121' ' ' TYR . 16.0 ptmt -68.05 -34.37 76.32 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 118.945 -1.102 . . . . 2.52 109.318 175.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 44.3 m -77.11 -43.88 32.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.206 -0.906 . . . . 1.21 110.126 178.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.414 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 27.5 mtpp -134.79 103.74 10.92 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 2.38 110.849 175.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 126' ' ' LYS . 7.1 Cg_exo -74.38 -52.83 0.12 Allowed 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.579 2.853 . . . . 1.69 111.969 -176.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.687 ' HA3' ' HB ' ' A' ' 132' ' ' THR . . . -161.29 160.41 32.12 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.102 -1.046 . . . . 2.59 112.878 177.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 27.7 pt -101.81 -13.79 8.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.658 -0.867 . . . . 3.93 108.658 170.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.408 HD21 ' N ' ' A' ' 130' ' ' LEU . 1.6 pt? -128.7 -148.81 0.39 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.561 -1.2 . . . . 3.81 108.258 174.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.61 82.66 0.6 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.205 0.526 . . . . 3.63 109.658 171.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' THR . . . . . 0.687 ' HB ' ' HA3' ' A' ' 128' ' ' GLY . 11.4 m -150.26 146.81 27.02 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.258 -0.428 . . . . 3.97 110.411 -175.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -125.21 3.03 7.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.107 -0.497 . . . . 5.48 111.076 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.569 ' H ' HG21 ' A' ' 132' ' ' THR . . . -153.55 -90.26 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.364 -0.38 . . . . 1.59 110.753 -177.145 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.817 ' O ' ' HG2' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -125.24 -32.2 1.05 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.919 0 CA-C-N 116.013 -0.539 . . . . 2.09 110.047 176.436 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.817 ' HG2' ' O ' ' A' ' 135' ' ' ILE . 21.9 ptmt 93.16 -68.0 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 126.652 1.981 . . . . 5.16 110.78 -170.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.755 ' HE3' ' C ' ' A' ' 136' ' ' LYS . 0.2 OUTLIER -114.91 -178.21 3.31 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 123.594 0.758 . . . . 2.41 110.143 -162.988 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.482 ' O ' ' N ' ' A' ' 140' ' ' THR . 7.1 m120 -36.23 -154.91 0.0 OUTLIER 'General case' 0 C--O 1.206 -1.188 0 O-C-N 125.052 1.47 . . . . 2.04 112.672 163.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.903 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 0.5 OUTLIER -31.63 -21.29 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 117.362 2.356 . . . . 2.53 117.362 -170.277 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.71 HG23 ' O ' ' A' ' 135' ' ' ILE . 5.9 m 5.62 114.73 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 120.56 1.527 . . . . 1.24 113.906 165.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.555 ' HB3' ' CE1' ' A' ' 41' ' ' TYR . 0.8 OUTLIER -94.14 159.88 14.95 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 114.114 -1.403 . . . . 1.03 110.764 -164.527 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.476 ' O ' HD11 ' A' ' 39' ' ' LEU . 48.2 m-85 -122.5 125.53 45.96 Favored 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 106.306 -1.739 . . . . 0.7 106.306 167.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.746 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 9.8 tp -80.67 105.95 12.3 Favored 'General case' 0 N--CA 1.424 -1.752 0 C-N-CA 117.927 -1.509 . . . . 1.16 108.592 177.02 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.756 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 40.7 mm -92.29 141.29 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.926 0 CA-C-N 112.981 -1.918 . . . . 1.05 107.228 -178.594 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.62 ' HA ' HD12 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -91.98 179.09 5.69 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 120.716 -0.394 . . . . 0.98 111.641 -170.188 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.486 ' CG ' ' HD3' ' A' ' 37' ' ' PRO . 17.4 mtm180 -50.43 -41.71 52.9 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 122.845 0.458 . . . . 2.61 111.392 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.416 ' C ' ' HE2' ' A' ' 16' ' ' PHE . 4.8 m-20 -93.96 12.8 24.86 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 109.476 -0.565 . . . . 2.0 109.476 -176.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.637 ' HA3' ' CE2' ' A' ' 16' ' ' PHE . . . 76.36 32.12 52.6 Favored Glycine 0 N--CA 1.433 -1.52 0 CA-C-N 115.354 -0.839 . . . . 0.19 113.911 178.109 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.47 ' HA ' ' HD2' ' A' ' 150' ' ' PRO . 7.1 p -108.53 109.62 61.45 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 118.806 1.303 . . . . 1.74 111.923 174.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.657 ' HD3' HG22 ' A' ' 15' ' ' ILE . 1.9 Cg_endo -50.48 124.3 12.98 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 124.294 3.33 . . . . 0.6 112.106 174.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.743 HG22 ' HG2' ' A' ' 152' ' ' GLU . 15.9 m -125.0 -15.11 4.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.929 0.395 . . . . 2.06 110.385 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.746 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 13.7 mm-40 -140.99 166.9 23.53 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 116.107 -0.497 . . . . 1.17 110.598 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.64 ' HD3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -148.07 143.92 27.52 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.254 -0.884 . . . . 2.9 109.697 162.315 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.624 ' HZ ' ' HB2' ' A' ' 166' ' ' LYS . 91.0 m-85 -120.35 138.02 53.96 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.691 -0.686 . . . . 0.36 110.436 -171.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.49 ' OG ' ' HD2' ' A' ' 156' ' ' PRO . 8.2 t -65.49 151.74 93.76 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 107.853 -1.166 . . . . 1.45 107.853 177.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.748 ' HG3' ' HB3' ' A' ' 137' ' ' TRP . 25.2 Cg_endo -59.32 -25.19 77.47 Favored 'Trans proline' 0 N--CA 1.474 0.376 0 C-N-CA 123.056 2.504 . . . . 0.78 113.221 -176.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.651 ' HA2' ' O ' ' A' ' 51' ' ' LYS . . . -75.94 -2.96 73.06 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.961 -0.563 . . . . 0.59 113.853 174.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -70.44 146.78 50.1 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 117.659 0.729 . . . . 1.07 109.502 175.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.534 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 17.1 m -104.66 170.09 8.08 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.566 -0.531 . . . . 1.92 109.566 -178.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.658 ' HA ' HG22 ' A' ' 56' ' ' THR . 87.1 t -40.52 -55.51 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 O-C-N 124.286 0.991 . . . . 1.07 111.409 177.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.436 ' HZ1' ' HB2' ' A' ' 161' ' ' LYS . 0.1 OUTLIER -70.42 -28.52 65.12 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.225 -0.443 . . . . 3.89 111.366 -173.033 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -65.72 -35.54 81.02 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.583 0.706 . . . . 1.4 109.265 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.752 HD13 ' HH ' ' A' ' 41' ' ' TYR . 72.1 mt -83.27 -43.0 18.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 114.432 -1.258 . . . . 1.05 110.952 178.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.59 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 46.0 mt-10 -51.98 -43.38 63.57 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-O 120.842 0.353 . . . . 0.67 111.19 -179.111 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -60.64 -17.04 44.85 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 112.149 0.425 . . . . 0.87 112.149 -174.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.624 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 13.7 mmmm -106.0 -25.28 12.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.259 0.552 . . . . 2.22 109.941 172.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.59 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 12.0 tp -76.81 -49.35 16.02 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.138 -0.937 . . . . 1.04 111.979 -177.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.442 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 67.1 mt -55.28 -44.12 99.46 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.718 -0.674 . . . . 1.08 111.91 -175.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.442 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 86.0 Cg_exo -50.26 -24.01 10.87 Favored 'Trans proline' 0 C--N 1.353 0.816 0 C-N-CA 122.499 2.132 . . . . 0.62 113.592 172.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.685 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 86.2 mt -97.78 -40.3 8.61 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 120.636 -0.426 . . . . 1.36 111.118 177.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.663 HD21 ' HG2' ' A' ' 37' ' ' PRO . 95.6 mt -59.92 -59.29 5.66 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 122.141 0.972 . . . . 1.07 109.102 175.126 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -72.22 -27.37 70.16 Favored Glycine 0 N--CA 1.433 -1.526 0 CA-C-N 113.358 -1.746 . . . . 1.12 111.713 -178.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 73.7 m 71.03 119.64 0.04 OUTLIER 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.835 0.826 . . . . 2.88 112.121 178.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -72.34 -1.81 16.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.917 -1.038 . . . . 4.69 111.226 178.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -42.08 -36.02 1.05 Allowed 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.02 0.928 . . . . 9.17 113.188 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 99.1 mt . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.576 -0.726 . . . . 8.03 110.455 -179.522 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.933 0 N-CA-C 112.325 -0.31 . . . . 5.58 112.325 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -141.14 34.48 1.72 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.498 0.666 . . . . 5.23 109.872 178.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.468 ' C ' ' H ' ' A' ' 14' ' ' SER . . . 121.76 -127.45 6.87 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 115.396 -0.82 . . . . 1.55 111.721 -175.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.4 m 69.99 -14.12 0.39 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.348 0.659 . . . . 2.17 111.822 179.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.468 ' H ' ' C ' ' A' ' 12' ' ' GLY . 86.8 p 177.9 154.59 0.33 Allowed 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 106.173 -1.788 . . . . 1.68 106.173 179.281 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.813 ' HB ' HD13 ' A' ' 118' ' ' LEU . 5.1 pt -70.25 -17.59 20.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-N 115.068 -0.969 . . . . 1.16 112.236 -172.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.74 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 51.9 m-85 -69.91 -3.33 15.48 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.186 0.517 . . . . 0.3 111.463 -178.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -71.97 -17.99 62.02 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.249 -1.019 . . . . 2.11 108.249 176.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.707 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 72.5 m-85 -117.84 112.54 20.51 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 114.818 -1.083 . . . . 0.37 110.881 -175.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -47.9 142.06 5.24 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 113.494 -1.685 . . . . 2.86 110.452 172.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.77 HG13 ' HZ ' ' A' ' 74' ' ' PHE . 54.9 t -111.13 164.6 6.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 107.466 -1.309 . . . . 1.32 107.466 176.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.642 ' O ' ' HB3' ' A' ' 105' ' ' MET . 10.3 mt -133.16 125.68 30.0 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.224 -0.658 . . . . 1.29 109.224 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.527 ' HA ' ' SD ' ' A' ' 105' ' ' MET . 17.2 m-20 -56.21 178.6 0.05 OUTLIER 'General case' 0 CA--C 1.514 -0.408 0 O-C-N 123.768 0.667 . . . . 1.87 110.086 177.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.605 ' HA ' ' N ' ' A' ' 106' ' ' ALA . . . -61.41 -1.79 0.6 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.826 0.676 . . . . 1.2 112.826 -175.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -112.95 4.95 17.06 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.135 0.421 . . . . 2.34 112.135 175.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.773 ' CD2' ' HB1' ' A' ' 106' ' ' ALA . 8.0 m170 72.59 19.63 4.05 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.752 0.787 . . . . 2.26 110.241 177.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.486 ' HE3' ' HB2' ' A' ' 26' ' ' LYS . 2.9 mtmt -84.05 135.54 42.08 Favored Pre-proline 0 CA--C 1.509 -0.614 0 N-CA-C 106.591 -1.633 . . . . 4.64 106.591 164.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.608 ' HA ' HD21 ' A' ' 21' ' ' LEU . 80.4 Cg_exo -53.27 113.26 1.2 Allowed 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 121.187 1.258 . . . . 0.62 112.868 -178.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.653 ' HB3' HG11 ' A' ' 20' ' ' VAL . 45.8 t80 -78.86 144.01 35.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 113.701 -1.59 . . . . 1.52 110.969 173.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.615 HD22 HG21 ' A' ' 31' ' ' VAL . 2.5 t-20 -79.31 81.38 5.58 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 115.147 -0.933 . . . . 2.16 109.573 178.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.652 ' HG ' ' CD1' ' A' ' 16' ' ' PHE . 54.7 tp -60.79 -39.64 89.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.228 0.537 . . . . 1.07 109.558 177.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.707 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 1.1 m -72.11 -0.04 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.022 -0.99 . . . . 1.69 112.47 -168.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.589 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 3.8 pt20 -73.44 -13.92 61.16 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.359 -0.608 . . . . 1.31 109.359 173.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.843 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 91.6 m-70 -94.35 21.98 6.51 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-O 121.812 0.815 . . . . 0.35 109.561 176.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.74 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 45.5 mtmt -85.74 109.7 18.81 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 114.553 -1.203 . . . . 2.07 108.76 169.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 134.68 -41.02 1.5 Allowed Glycine 0 N--CA 1.435 -1.373 0 N-CA-C 111.308 -0.717 . . . . 0.24 111.308 -177.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.425 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 41.2 m -131.71 136.28 28.18 Favored Pre-proline 0 N--CA 1.438 -1.066 0 N-CA-C 108.616 -0.883 . . . . 0.74 108.616 171.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.718 ' HG2' HD22 ' A' ' 171' ' ' LEU . 3.5 Cg_endo -43.17 156.94 0.11 Allowed 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.936 3.091 . . . . 0.22 112.875 175.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.762 ' HB2' HG22 ' A' ' 70' ' ' THR . 1.0 OUTLIER -144.62 140.51 28.76 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 107.525 -1.287 . . . . 1.09 107.525 -179.736 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.908 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 1.7 mm? -106.04 112.17 25.11 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.403 -0.962 . . . . 1.82 108.403 176.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.943 HD11 ' HE3' ' A' ' 122' ' ' MET . 5.1 mt -98.63 130.06 48.04 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 CA-C-N 115.95 -0.568 . . . . 1.12 109.95 177.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.908 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.4 OUTLIER -117.56 140.5 49.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.636 -0.711 . . . . 1.09 110.492 -172.604 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.604 ' OD1' ' HB ' ' A' ' 140' ' ' THR . 22.8 p-10 -92.54 105.1 17.33 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 108.116 -1.068 . . . . 3.11 108.116 168.323 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.714 ' HB ' ' CE1' ' A' ' 139' ' ' PHE . 3.3 m -106.29 132.25 53.93 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 O-C-N 121.228 -0.92 . . . . 1.69 110.529 -170.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -81.46 96.19 7.31 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 119.285 -0.966 . . . . 1.45 110.215 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.2 p -21.26 -82.92 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 O-C-N 125.635 1.835 . . . . 1.99 113.016 175.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.769 ' HG2' ' H ' ' A' ' 47' ' ' CYS . 20.7 ttmm 51.51 -144.6 0.57 Allowed 'General case' 0 CA--C 1.537 0.448 0 O-C-N 123.87 0.732 . . . . 6.2 110.503 174.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.769 ' H ' ' HG2' ' A' ' 46' ' ' LYS . 12.7 t -159.1 116.48 2.76 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 109.679 -0.489 . . . . 4.12 109.679 176.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 65.13 66.0 2.66 Favored Glycine 0 CA--C 1.519 0.32 0 CA-C-N 115.869 -0.605 . . . . 3.44 113.319 178.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -152.15 123.89 7.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 117.197 0.499 . . . . 4.84 111.594 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.8 t -139.5 154.46 47.7 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.21 -0.45 . . . . 2.41 110.374 172.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.647 ' HB2' ' HB2' ' A' ' 156' ' ' PRO . 22.4 mmmt -114.73 14.42 17.49 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.905 -0.406 . . . . 2.47 109.905 174.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 107.98 -26.58 16.88 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 110.913 -0.875 . . . . 0.85 110.913 -174.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.458 ' HA2' ' HB ' ' A' ' 56' ' ' THR . . . -70.17 -17.98 74.45 Favored Glycine 0 C--O 1.217 -0.919 0 C-N-CA 121.264 -0.493 . . . . 0.67 113.208 -178.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.418 ' HA ' ' CE2' ' A' ' 139' ' ' PHE . 1.1 t80 -74.14 -56.67 4.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 117.786 0.793 . . . . 1.2 109.896 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -62.93 -21.79 66.3 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.269 0.557 . . . . 2.61 110.115 176.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.684 ' HA ' HG23 ' A' ' 160' ' ' VAL . 16.0 m -76.34 -53.91 7.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.421 -0.809 . . . . 1.06 109.669 177.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 1.053 ' HB2' HG13 ' A' ' 71' ' ' VAL . . . -55.03 -43.06 73.37 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 114.905 -1.043 . . . . 1.05 110.758 177.27 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.494 ' HA ' ' CD1' ' A' ' 102' ' ' PHE . 39.4 m -60.84 -56.98 14.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.472 -0.785 . . . . 1.08 110.515 -178.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 98.6 m -66.29 -38.99 89.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.995 -1.002 . . . . 1.22 112.238 -175.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.749 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 18.7 mt -64.39 -48.5 75.21 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-O 121.425 0.631 . . . . 1.14 110.275 -176.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.887 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 13.5 t80 -56.84 -47.89 79.29 Favored 'General case' 0 C--O 1.207 -1.182 0 CA-C-N 114.545 -1.207 . . . . 0.94 110.897 178.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.563 ' HA ' ' HE3' ' A' ' 65' ' ' LYS . 1.1 m-80 -73.84 -25.5 60.11 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 116.602 -0.272 . . . . 1.6 111.132 -171.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -86.21 -23.15 26.56 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 109.015 -0.735 . . . . 2.06 109.015 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.718 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 29.1 m-85 -125.47 -4.53 7.21 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 115.808 1.781 . . . . 0.92 115.808 -169.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.639 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 22.2 pttp -67.04 -25.28 66.19 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 108.009 -1.108 . . . . 1.89 108.009 169.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.5 m -48.85 -30.25 5.58 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 114.203 -1.362 . . . . 1.68 111.27 172.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -96.26 -36.64 10.84 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.592 0.234 . . . . 1.11 111.547 174.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 149.83 -5.49 0.7 Allowed Glycine 0 C--O 1.237 0.319 0 N-CA-C 111.17 -0.772 . . . . 0.2 111.17 -176.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.749 ' HE2' ' HB3' ' A' ' 60' ' ' LEU . 21.6 t80 -69.59 141.53 53.73 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 115.368 -0.416 . . . . 0.21 111.089 -177.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.887 ' HA ' ' CD1' ' A' ' 61' ' ' TYR . 5.5 t -133.46 146.37 51.09 Favored 'General case' 0 N--CA 1.421 -1.898 0 N-CA-C 108.826 -0.805 . . . . 1.02 108.826 173.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 1.053 HG13 ' HB2' ' A' ' 57' ' ' ALA . 25.1 t -100.7 103.3 14.63 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.376 0 N-CA-C 107.485 -1.302 . . . . 1.04 107.485 157.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.81 ' HB2' HG22 ' A' ' 40' ' ' ILE . 35.8 mt -83.94 120.7 26.41 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.626 -1.25 . . . . 1.69 107.626 178.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.709 ' HB3' ' HE2' ' A' ' 102' ' ' PHE . . . -95.08 115.76 27.84 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.229 0.538 . . . . 1.17 109.601 178.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.77 ' HZ ' HG13 ' A' ' 20' ' ' VAL . 11.5 m-85 -113.96 97.28 44.45 Favored Pre-proline 0 C--N 1.308 -1.218 0 N-CA-C 108.517 -0.92 . . . . 0.58 108.517 -178.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.699 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 2.0 Cg_endo -67.66 142.36 58.17 Favored 'Trans proline' 0 N--CA 1.438 -1.773 0 C-N-CA 121.175 1.25 . . . . 1.3 110.748 -175.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.795 ' HG ' ' HB3' ' A' ' 83' ' ' GLU . 8.1 t -87.17 146.56 25.97 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 121.807 0.813 . . . . 1.91 110.009 173.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.824 ' HB2' ' HD2' ' A' ' 79' ' ' PHE . 30.6 p-10 -105.34 125.54 51.1 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 113.991 -1.459 . . . . 1.93 108.851 -178.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.706 ' HB2' ' HB3' ' A' ' 91' ' ' LYS . 2.6 pp0? -55.68 -8.25 0.37 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.88 -1.055 . . . . 3.97 111.692 176.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.824 ' HD2' ' HB2' ' A' ' 77' ' ' ASN . 63.2 m-85 -66.36 -20.71 66.15 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.71 -0.677 . . . . 3.21 112.667 -167.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.82 -24.62 34.8 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.338 -0.934 . . . . 1.98 112.676 -177.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 70.18 54.6 10.78 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 110.289 -1.124 . . . . 1.66 110.289 -173.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.619 HE21 ' HB3' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -159.57 -14.18 0.06 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.577 0.584 . . . . 1.74 112.577 -170.959 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.795 ' HB3' ' HG ' ' A' ' 76' ' ' SER . 0.0 OUTLIER -62.09 137.1 95.58 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-O 121.841 0.829 . . . . 3.07 111.42 -160.198 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -59.07 116.86 3.56 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 124.613 3.542 . . . . 1.75 114.744 -164.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 98.78 -99.86 2.21 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.242 -0.89 . . . . 2.27 112.894 171.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.412 ' HB2' ' HZ3' ' A' ' 46' ' ' LYS . 10.1 m120 -91.53 83.22 5.36 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.782 -0.451 . . . . 4.88 109.782 -176.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -66.49 -85.35 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 114.704 -1.134 . . . . 3.02 112.813 -170.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.592 ' O ' ' HG2' ' A' ' 92' ' ' GLU . 20.9 mt-10 -59.46 -21.96 60.82 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.409 0.522 . . . . 3.92 112.409 -168.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.552 ' O ' ' HB3' ' A' ' 93' ' ' PHE . 64.5 tt0 -58.42 -12.88 4.31 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.108 -0.496 . . . . 2.65 111.845 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.521 ' HB ' ' HB3' ' A' ' 78' ' ' GLN . 46.9 mt -96.79 -32.96 4.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 O-C-N 121.745 -0.597 . . . . 2.63 111.745 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.706 ' HB3' ' HB2' ' A' ' 78' ' ' GLN . 21.5 pttp -91.19 -20.99 21.37 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.586 0.587 . . . . 3.13 112.586 -172.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.592 ' HG2' ' O ' ' A' ' 88' ' ' GLU . 0.3 OUTLIER -114.18 13.94 18.09 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.204 0.526 . . . . 3.29 111.04 175.368 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.552 ' HB3' ' O ' ' A' ' 89' ' ' GLU . 44.2 t80 -128.06 153.47 46.75 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.092 -0.707 . . . . 4.08 109.092 171.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.8 t -65.08 112.02 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.596 -0.275 . . . . 3.05 110.648 -179.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 2.8 p -117.27 124.59 49.4 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.71 0.766 . . . . 3.04 112.246 -177.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 19.8 p -92.42 155.88 17.57 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 107.372 -1.344 . . . . 3.38 107.372 165.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.8 pttm -76.14 57.99 1.18 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.26 0.553 . . . . 3.11 111.479 -179.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.615 ' HD2' HG12 ' A' ' 104' ' ' ILE . 38.9 t80 69.43 -86.23 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.722 -1.126 . . . . 2.12 112.331 173.354 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt 74.94 136.07 0.06 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.829 0.852 . . . . 3.1 111.412 -179.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.48 ' HB3' ' CZ ' ' A' ' 98' ' ' PHE . . . -168.81 -165.85 0.6 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.576 -0.738 . . . . 1.15 110.891 -173.144 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -104.02 28.51 6.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.931 -0.577 . . . . 1.99 111.507 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.709 ' HE2' ' HB3' ' A' ' 73' ' ' ALA . 1.1 p90 -135.47 176.89 2.52 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 108.756 -0.831 . . . . 1.31 108.756 173.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.599 ' HD3' ' CE2' ' A' ' 61' ' ' TYR . 18.9 Cg_exo -71.28 97.1 0.75 Allowed 'Trans proline' 0 CA--C 1.518 -0.276 0 C-N-CA 123.067 2.511 . . . . 1.07 112.884 -179.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.683 HG13 ' HB2' ' A' ' 73' ' ' ALA . 4.2 mp -92.61 138.6 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 N-CA-C 108.475 -0.935 . . . . 1.97 108.475 174.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.642 ' HB3' ' O ' ' A' ' 21' ' ' LEU . 13.5 mmt -101.19 179.84 4.25 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.755 -0.657 . . . . 3.41 109.997 -177.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.773 ' HB1' ' CD2' ' A' ' 25' ' ' HIS . . . -83.83 34.11 0.49 Allowed 'General case' 0 CA--C 1.5 -0.944 0 C-N-CA 120.65 -0.42 . . . . 1.46 111.89 -168.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.768 ' HG2' ' O ' ' A' ' 106' ' ' ALA . 8.9 ptpt 56.02 144.78 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 123.953 1.835 . . . . 2.31 111.979 -174.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.477 ' O ' ' HA ' ' A' ' 76' ' ' SER . 35.7 pt -139.75 170.69 14.99 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 CA-C-N 112.324 -2.216 . . . . 1.65 107.478 175.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.566 ' HA ' ' OD1' ' A' ' 77' ' ' ASN . 1.6 t30 -80.68 50.8 1.38 Allowed 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.684 -0.689 . . . . 1.73 110.747 -176.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.433 HG22 ' CB ' ' A' ' 76' ' ' SER . 0.0 OUTLIER -64.36 94.33 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 CA-C-O 122.021 0.915 . . . . 1.4 110.884 -175.434 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.619 ' HB3' HE21 ' A' ' 82' ' ' GLN . 12.7 t-20 175.55 -179.74 0.14 Allowed 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 105.787 -1.931 . . . . 2.1 105.787 176.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -85.08 41.35 3.05 Favored Glycine 0 N--CA 1.439 -1.148 0 C-N-CA 119.982 -1.104 . . . . 1.47 114.474 -177.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.463 ' HB3' ' HG2' ' A' ' 82' ' ' GLN . 2.3 tp10 -105.88 -51.03 3.06 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 119.248 -0.981 . . . . 2.81 109.846 165.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -133.18 -31.88 1.23 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.829 -0.623 . . . . 2.75 110.796 176.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . 52.85 -102.64 0.14 Allowed 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.078 -0.964 . . . . 1.44 109.969 -169.159 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.637 ' ND1' ' H ' ' A' ' 118' ' ' LEU . 3.5 t-80 173.35 138.71 0.13 Allowed Pre-proline 0 N--CA 1.429 -1.52 0 N-CA-C 105.18 -2.156 . . . . 0.71 105.18 174.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -28.67 -47.97 0.12 Allowed 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 124.125 3.217 . . . . 0.47 113.568 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.813 HD13 ' HB ' ' A' ' 15' ' ' ILE . 28.1 tp -62.46 -51.67 66.58 Favored 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 123.365 0.666 . . . . 1.15 111.875 177.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.787 ' OH ' HG23 ' A' ' 40' ' ' ILE . 32.6 m-85 -75.69 -32.65 60.21 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-N 116.458 -0.337 . . . . 3.33 111.856 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.404 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 46.6 mt-10 -57.84 -40.15 79.39 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 107.169 -1.419 . . . . 2.44 107.169 170.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.707 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 31.6 t80 -66.65 -31.67 72.5 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.194 -0.912 . . . . 1.08 110.549 175.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.943 ' HE3' HD11 ' A' ' 40' ' ' ILE . 45.9 mtt -74.99 -52.86 10.05 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.488 -0.778 . . . . 1.25 110.958 -171.315 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.437 ' HE2' ' HB2' ' A' ' 123' ' ' LYS . 0.5 OUTLIER -71.61 -25.97 62.39 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 121.057 -0.257 . . . . 1.86 111.403 176.563 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 19.4 ptmt -72.17 -31.18 65.7 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 119.665 -0.814 . . . . 2.52 109.725 179.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 39.0 m -90.78 -38.31 13.08 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.394 -0.821 . . . . 1.21 111.004 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.451 ' HE3' ' HA ' ' A' ' 126' ' ' LYS . 1.6 tpmt? -126.26 88.94 53.35 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.686 -0.688 . . . . 2.38 110.576 -174.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -74.23 -0.0 9.05 Favored 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 122.895 2.396 . . . . 1.69 112.119 176.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 97.92 158.9 30.42 Favored Glycine 0 N--CA 1.442 -0.937 0 CA-C-N 115.675 -0.693 . . . . 2.59 111.673 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.585 HD12 ' H ' ' A' ' 129' ' ' ILE . 3.7 mp -69.94 -25.18 27.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.402 0.62 . . . . 3.93 109.647 -179.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 34.1 tp -77.99 -9.78 59.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.371 -0.831 . . . . 3.81 110.542 175.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 56.69 40.72 29.08 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 114.76 -1.109 . . . . 3.63 111.431 -179.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.9 m -74.22 -76.94 0.12 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.942 -0.572 . . . . 3.97 111.533 -175.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.406 ' HB3' ' H ' ' A' ' 134' ' ' ALA . 46.5 tttm -176.2 -83.3 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.405 0.622 . . . . 5.48 109.65 -174.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.406 ' H ' ' HB3' ' A' ' 133' ' ' LYS . . . -119.03 -176.47 3.12 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.786 -0.643 . . . . 1.59 110.612 -178.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.502 ' HA ' HG21 ' A' ' 140' ' ' THR . 0.4 OUTLIER -50.71 84.82 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 O-C-N 124.28 0.988 . . . . 2.09 109.953 168.741 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.796 ' HB3' ' CE3' ' A' ' 137' ' ' TRP . 26.0 mtmt -36.42 -67.01 0.19 Allowed 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 114.399 1.259 . . . . 5.16 114.399 -172.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.796 ' CE3' ' HB3' ' A' ' 136' ' ' LYS . 0.5 OUTLIER -109.62 -172.32 2.02 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 113.644 -1.616 . . . . 2.41 109.905 -164.215 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.545 ' CG ' ' H ' ' A' ' 139' ' ' PHE . 60.6 t30 -31.99 -152.14 0.0 OUTLIER 'General case' 0 C--O 1.2 -1.506 0 O-C-N 125.359 1.662 . . . . 2.04 111.979 158.099 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.714 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 2.1 m-85 -27.64 -28.29 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.264 0 N-CA-C 118.037 2.606 . . . . 2.53 118.037 -167.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.681 ' HA ' ' O ' ' A' ' 154' ' ' PHE . 7.7 m 12.29 102.3 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 120.105 1.32 . . . . 1.24 114.373 172.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.448 ' O ' ' HA ' ' A' ' 153' ' ' ARG . 1.6 m -90.11 167.52 12.68 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.571 -1.195 . . . . 1.03 111.473 -170.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.481 ' HA ' ' O ' ' A' ' 152' ' ' GLU . 95.2 m-85 -129.95 125.79 36.28 Favored 'General case' 0 CA--C 1.49 -1.339 0 N-CA-C 106.404 -1.702 . . . . 0.7 106.404 163.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.688 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 4.9 tp -80.33 102.94 9.86 Favored 'General case' 0 N--CA 1.422 -1.851 0 C-N-CA 118.204 -1.398 . . . . 1.16 108.125 176.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.668 HG22 ' HA2' ' A' ' 148' ' ' GLY . 43.2 mm -90.84 137.26 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.738 0 CA-C-N 113.724 -1.58 . . . . 1.05 107.625 -176.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.595 ' OD1' HG12 ' A' ' 149' ' ' VAL . 0.0 OUTLIER -88.74 -175.62 4.96 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 119.527 -0.869 . . . . 0.98 111.675 -168.914 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.596 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 33.8 mtm180 -53.65 -37.15 62.85 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-O 120.976 0.417 . . . . 2.61 111.037 -178.227 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -103.17 19.43 19.59 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.413 -0.958 . . . . 2.0 108.413 -175.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.725 ' HA3' ' CE2' ' A' ' 16' ' ' PHE . . . 71.86 35.08 61.92 Favored Glycine 0 N--CA 1.439 -1.13 0 CA-C-N 114.794 -1.094 . . . . 0.19 115.531 176.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.595 HG12 ' OD1' ' A' ' 145' ' ' ASP . 10.0 p -106.06 113.51 63.51 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 119.356 1.578 . . . . 1.74 111.398 172.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.634 ' HD3' HG21 ' A' ' 15' ' ' ILE . 2.5 Cg_endo -51.11 115.55 2.11 Favored 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 124.027 3.152 . . . . 0.6 111.799 172.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 26.2 t -108.27 -28.58 2.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.707 0.765 . . . . 2.06 109.098 -176.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.688 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 22.6 mm-40 -136.86 166.39 23.73 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.509 -1.223 . . . . 1.17 110.317 -176.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.448 ' HA ' ' O ' ' A' ' 141' ' ' SER . 1.5 ttm180 -143.78 140.7 30.05 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.826 -1.079 . . . . 2.9 109.17 165.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.681 ' O ' ' HA ' ' A' ' 140' ' ' THR . 97.3 m-85 -120.8 149.95 41.77 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.932 -0.766 . . . . 0.36 108.932 -171.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 62.9 m -78.51 160.04 73.33 Favored Pre-proline 0 C--N 1.317 -0.83 0 N-CA-C 108.549 -0.908 . . . . 1.45 108.549 175.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.683 ' HG3' ' HB3' ' A' ' 137' ' ' TRP . 32.0 Cg_endo -63.74 -22.14 69.65 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.028 1.819 . . . . 0.78 111.896 178.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 51' ' ' LYS . . . -78.93 -7.1 88.57 Favored Glycine 0 N--CA 1.446 -0.7 0 CA-C-N 115.696 -0.683 . . . . 0.59 112.626 173.071 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -72.88 144.99 47.19 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 108.62 -0.881 . . . . 1.07 108.62 174.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 14.5 m -110.91 173.74 6.19 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 120.835 -0.346 . . . . 1.92 110.168 -172.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.684 HG23 ' HA ' ' A' ' 56' ' ' THR . 58.9 t -40.7 -55.93 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 114.93 -1.032 . . . . 1.07 111.384 177.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 12.9 tppt? -67.25 -29.87 69.61 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.217 -0.447 . . . . 3.89 111.299 -171.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.421 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 8.0 m-20 -68.88 -38.27 79.58 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 121.481 0.657 . . . . 1.4 109.545 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.591 ' HA ' ' CZ ' ' A' ' 154' ' ' PHE . 71.3 mt -77.82 -43.68 28.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 114.76 -1.109 . . . . 1.05 110.715 178.346 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.605 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 53.9 mt-10 -55.02 -43.3 73.55 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-N 116.523 -0.308 . . . . 0.67 111.5 -176.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 8.6 pt-20 -58.45 -23.01 56.46 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.716 0.294 . . . . 0.87 111.7 -176.084 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.631 ' HB3' HD23 ' A' ' 143' ' ' LEU . 45.9 mmtm -99.51 -25.94 14.27 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.591 0.71 . . . . 2.22 109.982 176.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.589 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 13.6 tp -79.06 -50.76 10.55 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.897 -1.047 . . . . 1.04 112.215 -177.038 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 164' ' ' GLU . 73.6 mt -54.57 -44.6 99.2 Favored Pre-proline 0 CA--C 1.537 0.452 0 CA-C-N 115.511 -0.768 . . . . 1.08 112.637 -173.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.441 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 53.8 Cg_exo -54.54 -33.06 76.88 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.077 1.851 . . . . 0.62 112.762 173.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.718 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 78.5 mt -83.23 -40.64 19.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.652 -0.249 . . . . 1.36 111.288 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.718 HD22 ' HG2' ' A' ' 37' ' ' PRO . 87.0 mt -61.76 -60.42 3.69 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 121.996 0.903 . . . . 1.07 109.603 175.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -55.41 -53.83 38.46 Favored Glycine 0 N--CA 1.436 -1.315 0 CA-C-N 113.406 -1.724 . . . . 1.12 112.526 -178.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 23.2 t 55.96 44.04 26.3 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.249 0.547 . . . . 2.88 111.054 175.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -92.89 -39.12 11.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.941 -0.572 . . . . 4.69 111.085 -177.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 48.95 70.32 0.48 Allowed 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.538 0.685 . . . . 9.17 110.961 -176.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 80.1 mt . . . . . 0 C--O 1.251 1.135 0 CA-C-O 118.36 -0.828 . . . . 8.03 109.71 177.647 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.624 0 N-CA-C 112.31 -0.316 . . . . 5.58 112.31 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 86.4 mtp -113.94 176.28 5.11 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 110.212 -0.292 . . . . 5.23 110.212 177.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 163.57 174.65 33.67 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.754 -0.736 . . . . 1.55 111.459 178.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.9 t -116.42 -5.09 11.75 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.022 0.439 . . . . 2.17 110.246 176.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.453 ' HB3' ' O ' ' A' ' 147' ' ' ASP . 5.9 m -158.51 151.83 22.94 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 105.975 -1.861 . . . . 1.68 105.975 -177.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.838 ' HB ' HD12 ' A' ' 118' ' ' LEU . 5.8 pt -61.75 -16.04 14.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 CA-C-N 114.32 -1.309 . . . . 1.16 111.823 -174.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.758 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 46.9 m-85 -73.79 5.9 3.68 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 113.028 0.751 . . . . 0.3 113.028 -174.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -79.81 -17.82 52.41 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 107.694 -1.224 . . . . 2.11 107.694 175.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.703 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 51.5 m-85 -112.07 115.29 28.65 Favored 'General case' 0 N--CA 1.434 -1.257 0 CA-C-N 114.078 -1.419 . . . . 0.37 111.432 -171.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -50.66 142.02 11.79 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 113.752 -1.567 . . . . 2.86 110.752 174.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.726 HG11 ' CZ ' ' A' ' 74' ' ' PHE . 37.9 t -112.34 158.53 12.72 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 107.981 -1.118 . . . . 1.32 107.981 176.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.727 HD21 ' HA ' ' A' ' 27' ' ' PRO . 60.4 mt -126.66 135.0 50.59 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 120.454 -0.499 . . . . 1.29 111.347 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.501 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 15.8 t70 -63.88 159.36 19.88 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 106.193 -1.78 . . . . 1.87 106.193 164.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.771 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . . . -57.35 -3.92 0.19 Allowed 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.973 1.101 . . . . 1.2 113.973 -166.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.472 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 23.3 t70 -100.16 0.01 39.7 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 111.454 0.168 . . . . 2.34 111.454 177.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.585 ' CD2' ' HB3' ' A' ' 106' ' ' ALA . 78.8 m-70 80.57 20.1 0.5 Allowed 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 121.811 0.815 . . . . 2.26 109.427 177.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.482 ' HA ' ' HD3' ' A' ' 26' ' ' LYS . 12.0 mmtp -96.13 123.42 55.21 Favored Pre-proline 0 N--CA 1.441 -0.904 0 CA-C-N 114.499 -1.228 . . . . 4.64 108.543 173.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.727 ' HA ' HD21 ' A' ' 21' ' ' LEU . 95.9 Cg_exo -49.18 114.14 1.18 Allowed 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 122.924 2.416 . . . . 0.62 114.165 -167.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.68 ' CE2' HD21 ' A' ' 72' ' ' LEU . 2.1 t80 -83.86 136.67 34.02 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 113.109 -1.86 . . . . 1.52 110.019 169.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.522 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 0.3 OUTLIER -81.89 83.16 7.29 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.499 0.666 . . . . 2.16 110.806 179.366 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.65 ' HG ' ' CD1' ' A' ' 16' ' ' PHE . 56.8 tp -50.4 -37.73 39.16 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.432 0.634 . . . . 1.07 110.383 178.388 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.657 HG13 ' HB3' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -69.43 -0.35 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 114.551 -1.204 . . . . 1.69 113.129 -172.502 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.522 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 3.6 pt20 -71.42 -20.25 62.14 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.731 -0.84 . . . . 1.31 108.731 172.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.961 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 93.4 m-70 -91.83 24.8 3.01 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 115.205 -0.907 . . . . 0.35 110.07 177.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.758 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 38.1 mtmt -86.04 109.33 18.73 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 114.587 -1.188 . . . . 2.07 109.2 170.159 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 133.65 -43.13 1.3 Allowed Glycine 0 N--CA 1.438 -1.17 0 C-N-CA 120.861 -0.685 . . . . 0.24 111.741 -177.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.453 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 69.3 m -127.15 136.77 29.37 Favored Pre-proline 0 N--CA 1.434 -1.229 0 N-CA-C 108.637 -0.875 . . . . 0.74 108.637 172.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.806 ' HG3' ' CB ' ' A' ' 170' ' ' LEU . 3.3 Cg_endo -42.49 153.32 0.15 Allowed 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 123.985 3.123 . . . . 0.22 112.763 175.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.802 ' HB2' HG23 ' A' ' 70' ' ' THR . 0.6 OUTLIER -140.48 141.87 35.36 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.123 -1.436 . . . . 1.09 107.123 179.964 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 1.068 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 1.2 mm? -107.53 112.77 25.69 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.284 -1.006 . . . . 1.82 108.284 177.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 1.061 HG22 ' OH ' ' A' ' 119' ' ' TYR . 2.3 mt -100.71 124.06 54.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 120.082 -0.647 . . . . 1.12 110.183 179.123 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 1.068 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.6 OUTLIER -110.2 124.81 52.26 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.145 -0.934 . . . . 1.09 110.715 -171.83 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.548 ' OD1' ' HB ' ' A' ' 140' ' ' THR . 8.2 p-10 -80.96 96.7 7.17 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.624 -1.251 . . . . 3.11 107.624 169.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.945 ' HA ' ' HA ' ' A' ' 139' ' ' PHE . 10.7 p -105.02 141.42 20.45 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 O-C-N 121.179 -0.951 . . . . 1.69 111.802 -165.061 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -89.04 106.19 18.27 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.566 -0.531 . . . . 1.45 109.566 173.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.897 ' HA ' ' HB3' ' A' ' 98' ' ' PHE . 3.3 p -44.57 108.28 0.11 Allowed 'General case' 0 C--N 1.327 -0.374 0 O-C-N 123.985 0.803 . . . . 1.99 110.334 172.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.896 ' HB3' ' HB2' ' A' ' 49' ' ' TYR . 60.8 mttm -138.69 157.93 45.18 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.276 0.56 . . . . 6.2 111.584 -174.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.567 ' H ' HG12 ' A' ' 94' ' ' VAL . 44.9 t -122.81 117.66 26.17 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.231 -0.895 . . . . 4.12 108.936 178.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 69.5 23.88 76.37 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.463 -0.875 . . . . 3.44 111.162 -175.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.896 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 13.3 m-85 -131.31 136.85 48.48 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.437 0.637 . . . . 4.84 111.013 -179.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.2 t -173.85 163.93 4.2 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 106.806 -1.553 . . . . 2.41 106.806 -178.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.84 ' H ' ' HZ ' ' A' ' 139' ' ' PHE . 10.3 tppt? -124.46 9.58 8.46 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.171 -1.048 . . . . 2.47 108.171 173.03 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 117.94 -33.5 4.88 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 114.664 -1.153 . . . . 0.85 111.512 -174.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.703 ' HA2' ' HB ' ' A' ' 56' ' ' THR . . . -63.94 -16.07 59.03 Favored Glycine 0 C--O 1.22 -0.753 0 CA-C-O 119.594 -0.559 . . . . 0.67 114.327 -177.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.708 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 1.0 OUTLIER -73.23 -56.87 4.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 118.34 1.07 . . . . 1.2 109.351 177.009 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -60.34 -26.37 66.53 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-O 121.838 0.828 . . . . 2.61 109.572 175.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.703 ' HB ' ' HA2' ' A' ' 53' ' ' GLY . 15.4 m -75.33 -54.65 6.72 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 114.28 -1.327 . . . . 1.06 109.441 -176.104 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 1.052 ' HB3' HG12 ' A' ' 71' ' ' VAL . . . -57.32 -43.39 83.26 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 114.709 -1.132 . . . . 1.05 110.644 176.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.539 ' HA ' ' HD2' ' A' ' 102' ' ' PHE . 74.2 m -58.76 -56.03 27.52 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.794 -0.639 . . . . 1.08 110.675 -179.046 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 61.8 m -68.82 -37.11 78.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.458 -0.792 . . . . 1.22 111.891 -175.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.761 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 17.1 mt -64.57 -46.93 80.66 Favored 'General case' 0 CA--C 1.502 -0.888 0 CA-C-O 121.265 0.555 . . . . 1.14 110.359 -176.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.877 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 8.1 t80 -58.08 -52.2 66.53 Favored 'General case' 0 C--O 1.202 -1.443 0 CA-C-N 114.856 -1.066 . . . . 0.94 110.64 178.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -70.19 -25.67 63.53 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 120.718 0.294 . . . . 1.6 110.81 -172.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.532 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 36.2 ttpt -84.84 -23.4 29.06 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.946 -0.761 . . . . 2.06 108.946 -177.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.617 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 43.1 m-85 -126.88 -4.25 6.4 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 116.084 1.883 . . . . 0.92 116.084 -171.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.725 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 12.8 ptmt -64.04 -27.29 69.01 Favored 'General case' 0 CA--C 1.496 -1.114 0 N-CA-C 108.052 -1.092 . . . . 1.89 108.052 171.038 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.0 t -48.61 -35.26 13.23 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 114.154 -1.384 . . . . 1.68 111.033 173.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -92.57 -33.15 14.55 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.079 0.4 . . . . 1.11 112.079 175.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.413 ' HA3' ' HB2' ' A' ' 36' ' ' SER . . . 147.9 -5.54 0.95 Allowed Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 111.711 -0.556 . . . . 0.2 111.711 -176.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.761 ' HE2' ' HB3' ' A' ' 60' ' ' LEU . 18.5 t80 -69.97 144.71 52.24 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-O 121.047 0.451 . . . . 0.21 111.447 -178.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.961 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 1.5 t -134.92 149.96 50.34 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 108.283 -1.006 . . . . 1.02 108.283 173.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 1.052 HG12 ' HB3' ' A' ' 57' ' ' ALA . 45.2 t -106.34 100.1 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.322 0 N-CA-C 108.001 -1.111 . . . . 1.04 108.001 157.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.823 ' HA ' ' HG2' ' A' ' 103' ' ' PRO . 4.9 mt -85.6 118.66 25.24 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.68 -1.23 . . . . 1.69 107.68 177.099 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 1.004 ' HB1' HD13 ' A' ' 104' ' ' ILE . . . -107.83 112.04 24.49 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 119.363 -0.935 . . . . 1.17 110.957 178.011 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.726 ' CZ ' HG11 ' A' ' 20' ' ' VAL . 3.0 m-85 -93.35 99.59 3.44 Favored Pre-proline 0 C--N 1.311 -1.096 0 CA-C-N 114.445 -1.252 . . . . 0.58 108.425 176.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.773 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 92.2 Cg_endo -83.82 93.15 0.79 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.501 2.134 . . . . 1.3 113.286 -167.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.625 ' HA ' ' O ' ' A' ' 108' ' ' ILE . 44.0 m -25.73 135.42 0.02 OUTLIER 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 115.08 1.511 . . . . 1.91 115.08 -172.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.696 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 58.0 t30 -71.5 82.86 0.82 Allowed 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 112.452 -2.158 . . . . 1.93 107.774 -179.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.979 ' HA ' ' HG3' ' A' ' 83' ' ' GLU . 75.6 mm-40 -49.38 -13.94 0.09 Allowed 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 114.589 -1.187 . . . . 3.97 111.059 -179.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.586 ' H ' ' C ' ' A' ' 77' ' ' ASN . 41.1 t80 -81.71 -13.59 57.63 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 114.121 -1.4 . . . . 3.21 110.894 -174.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.9 ' HA3' HD22 ' A' ' 109' ' ' ASN . . . -76.3 -27.11 62.35 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.652 -0.785 . . . . 1.98 111.684 179.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.52 25.89 60.14 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.928 -0.654 . . . . 1.66 112.452 179.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.635 ' NE2' HD21 ' A' ' 109' ' ' ASN . 0.2 OUTLIER -142.63 33.25 1.44 Allowed 'General case' 0 CA--C 1.503 -0.849 0 CA-C-O 120.67 0.271 . . . . 1.74 110.481 176.468 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.979 ' HG3' ' HA ' ' A' ' 78' ' ' GLN . 13.6 mm-40 -88.89 148.98 42.61 Favored Pre-proline 0 C--N 1.306 -1.283 0 CA-C-N 115.963 -0.562 . . . . 3.07 111.017 -166.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.526 ' HB2' ' O ' ' A' ' 137' ' ' TRP . 96.7 Cg_endo -78.91 98.53 1.2 Allowed 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 123.185 2.59 . . . . 1.75 113.483 -170.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.89 9.12 78.26 Favored Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 115.908 -0.587 . . . . 2.27 112.6 176.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.491 ' O ' ' HB2' ' A' ' 83' ' ' GLU . 2.8 t30 -158.67 158.99 34.82 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.125 -0.695 . . . . 4.88 109.125 -177.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -162.8 -57.64 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.926 -0.31 . . . . 3.02 110.783 177.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -139.59 21.28 2.53 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.422 0.527 . . . . 3.92 112.422 -168.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.407 ' O ' ' HB3' ' A' ' 93' ' ' PHE . 12.6 pt-20 -88.04 -17.87 30.19 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 121.691 -0.631 . . . . 2.65 110.362 177.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.777 ' HA ' ' HB ' ' A' ' 94' ' ' VAL . 8.4 pt -78.37 -159.88 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.621 -0.718 . . . . 2.63 112.195 -178.139 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.405 ' HG3' ' H ' ' A' ' 92' ' ' GLU . 60.4 pttt 55.37 -68.21 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.837 1.655 . . . . 3.13 113.64 176.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.405 ' H ' ' HG3' ' A' ' 91' ' ' LYS . 10.7 pt-20 -90.75 9.27 30.69 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.0 0.429 . . . . 3.29 111.012 -176.011 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.498 ' HD2' HG23 ' A' ' 94' ' ' VAL . 46.9 t80 -160.86 -77.1 0.06 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.415 0.626 . . . . 4.08 110.472 -176.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.777 ' HB ' ' HA ' ' A' ' 90' ' ' ILE . 64.9 t -73.28 153.73 7.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.141 -0.936 . . . . 3.05 110.3 179.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 96.0 m -81.96 124.07 29.43 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-O 121.162 0.506 . . . . 3.04 112.126 -171.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.511 ' O ' ' HB2' ' A' ' 97' ' ' LYS . 2.7 m -70.01 153.74 42.83 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 108.258 -1.016 . . . . 3.38 108.258 168.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.511 ' HB2' ' O ' ' A' ' 96' ' ' THR . 67.3 mttm 77.72 -42.58 0.38 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 123.73 0.812 . . . . 3.11 111.385 -176.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.897 ' HB3' ' HA ' ' A' ' 45' ' ' SER . 0.0 OUTLIER 71.77 -45.74 0.63 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.382 1.073 . . . . 2.12 110.209 -174.604 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt 64.03 125.52 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 122.168 0.985 . . . . 3.1 112.397 172.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.609 ' HB1' ' CE1' ' A' ' 98' ' ' PHE . . . -144.68 -177.24 5.4 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.351 -0.84 . . . . 1.15 111.07 -174.351 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -94.31 29.94 2.08 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.906 -0.588 . . . . 1.99 110.335 175.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.633 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 18.3 p90 -143.23 160.94 50.25 Favored Pre-proline 0 N--CA 1.442 -0.852 0 N-CA-C 108.161 -1.051 . . . . 1.31 108.161 175.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.823 ' HG2' ' HA ' ' A' ' 72' ' ' LEU . 36.0 Cg_endo -58.94 90.68 0.07 OUTLIER 'Trans proline' 0 N--CA 1.476 0.455 0 C-N-CA 123.982 3.121 . . . . 1.07 114.419 -172.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 1.004 HD13 ' HB1' ' A' ' 73' ' ' ALA . 2.8 mm -80.0 123.22 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 108.809 -0.811 . . . . 1.97 108.809 171.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.72 ' HE2' HD12 ' A' ' 21' ' ' LEU . 0.8 OUTLIER -77.13 170.03 17.26 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.412 -1.267 . . . . 3.41 111.11 -177.568 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.771 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . . . -69.33 11.42 0.24 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.688 -0.687 . . . . 1.46 112.377 178.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.768 ' HB2' ' O ' ' A' ' 75' ' ' PRO . 2.6 ptpp? 67.4 143.43 0.04 OUTLIER 'General case' 0 CA--C 1.495 -1.163 0 CA-C-O 123.363 1.554 . . . . 2.31 112.092 -175.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.875 HG13 HG22 ' A' ' 110' ' ' VAL . 36.1 pt -136.28 159.27 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.197 0 CA-C-N 111.81 -2.45 . . . . 1.65 106.557 175.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.9 HD22 ' HA3' ' A' ' 80' ' ' GLY . 0.8 OUTLIER -72.35 64.27 0.58 Allowed 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 110.506 -0.183 . . . . 1.73 110.506 176.26 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.875 HG22 HG13 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -74.59 92.37 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.751 0 C-N-CA 119.644 -0.823 . . . . 1.4 109.928 -176.241 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.6 t30 174.05 178.86 0.11 Allowed 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 114.219 -1.355 . . . . 2.1 107.683 170.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 36.29 -105.01 0.03 OUTLIER Glycine 0 CA--C 1.518 0.278 0 O-C-N 124.706 1.254 . . . . 1.47 116.023 161.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -108.19 -24.1 11.67 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 114.309 1.226 . . . . 2.81 114.309 -163.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.637 ' HB3' ' HB3' ' A' ' 109' ' ' ASN . 0.2 OUTLIER -118.78 20.17 12.93 Favored 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 119.993 -0.683 . . . . 2.75 109.593 -165.444 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -50.69 133.32 25.89 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.132 -0.94 . . . . 1.44 109.202 173.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.678 ' ND1' ' H ' ' A' ' 118' ' ' LEU . 2.1 t-80 -69.06 143.16 93.96 Favored Pre-proline 0 N--CA 1.438 -1.065 0 CA-C-N 115.739 -0.664 . . . . 0.71 109.356 -170.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -26.43 -45.04 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 124.886 3.724 . . . . 0.47 114.049 179.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.838 HD12 ' HB ' ' A' ' 15' ' ' ILE . 48.0 tp -65.14 -51.0 63.86 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 122.894 0.478 . . . . 1.15 112.288 179.141 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 1.061 ' OH ' HG22 ' A' ' 40' ' ' ILE . 24.1 m-85 -80.57 -32.33 36.6 Favored 'General case' 0 CA--C 1.486 -1.512 0 CA-C-O 121.433 0.635 . . . . 3.33 109.752 -176.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.554 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 4.4 tm-20 -60.07 -37.06 78.78 Favored 'General case' 0 N--CA 1.426 -1.635 0 N-CA-C 106.186 -1.783 . . . . 2.44 106.186 172.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.703 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 79.2 t80 -68.56 -30.45 69.23 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.135 -0.939 . . . . 1.08 110.605 173.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 1.016 ' HE3' HD12 ' A' ' 40' ' ' ILE . 53.3 mtt -75.83 -55.34 5.73 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.09 -0.505 . . . . 1.25 111.815 -170.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.695 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -70.48 -23.65 62.72 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.194 -0.457 . . . . 1.86 110.78 177.495 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.606 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 10.4 ptmt -72.96 -27.04 61.59 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 119.701 -0.799 . . . . 2.52 109.429 172.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 89.2 m -71.66 -50.99 25.45 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 116.044 -0.526 . . . . 1.21 109.59 172.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.777 ' HG2' HH22 ' A' ' 153' ' ' ARG . 23.2 ttmm -148.87 114.15 3.69 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.95 -0.568 . . . . 2.38 110.05 179.437 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.496 ' HD3' ' HA ' ' A' ' 126' ' ' LYS . 15.4 Cg_exo -69.21 -58.89 0.1 OUTLIER 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.688 2.925 . . . . 1.69 113.088 -174.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.562 ' HA2' ' CZ ' ' A' ' 153' ' ' ARG . . . -171.76 157.2 27.26 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.286 -0.959 . . . . 2.59 112.766 -178.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.68 HG12 HH12 ' A' ' 153' ' ' ARG . 34.9 mm -99.39 -20.18 5.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.731 0.777 . . . . 3.93 109.378 178.023 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.663 HD23 ' H ' ' A' ' 130' ' ' LEU . 1.8 pt? -114.02 -136.59 0.36 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.984 -1.007 . . . . 3.81 110.129 -176.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.38 92.23 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 108.806 -0.813 . . . . 3.63 108.806 170.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' THR . . . . . 0.407 ' OG1' ' HB2' ' A' ' 127' ' ' PRO . 2.9 t -100.34 157.02 16.92 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 113.356 0.873 . . . . 3.97 113.356 -162.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 22.1 tptm 166.35 -43.7 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 113.308 -1.769 . . . . 5.48 107.173 -174.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -175.94 179.52 1.32 Allowed 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 114.221 -1.354 . . . . 1.59 110.149 -178.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.54 ' HB ' ' OD1' ' A' ' 42' ' ' ASN . 1.7 pt -64.52 61.22 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 C-N-CA 124.392 1.077 . . . . 2.09 109.783 166.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.526 ' HB3' ' CZ3' ' A' ' 137' ' ' TRP . 75.5 tttt -72.74 0.54 10.53 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.997 0.919 . . . . 5.16 112.728 -167.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.637 ' HB3' ' HG3' ' A' ' 156' ' ' PRO . 7.0 m-90 -111.28 175.0 5.6 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.335 -0.393 . . . . 2.41 110.574 -176.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.464 ' HB3' ' H ' ' A' ' 139' ' ' PHE . 94.6 m-20 -39.48 -158.57 0.0 OUTLIER 'General case' 0 C--O 1.207 -1.162 0 C-N-CA 124.795 1.238 . . . . 2.04 113.017 163.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.945 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 0.1 OUTLIER -33.39 -26.71 0.01 OUTLIER 'General case' 0 C--O 1.203 -1.384 0 N-CA-C 116.427 2.01 . . . . 2.53 116.427 -171.24 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.548 ' HB ' ' OD1' ' A' ' 42' ' ' ASN . 14.1 m 23.11 109.65 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 120.909 1.686 . . . . 1.24 114.601 165.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.791 ' O ' ' HA ' ' A' ' 153' ' ' ARG . 0.8 OUTLIER -107.08 138.29 43.54 Favored 'General case' 0 C--O 1.199 -1.583 0 CA-C-N 114.933 -1.031 . . . . 1.03 112.389 -161.867 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.525 ' O ' HD13 ' A' ' 39' ' ' LEU . 50.9 m-85 -103.52 127.51 50.91 Favored 'General case' 0 CA--C 1.488 -1.424 0 N-CA-C 107.666 -1.235 . . . . 0.7 107.666 175.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.787 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 7.5 tp -80.65 103.23 10.36 Favored 'General case' 0 N--CA 1.417 -2.099 0 C-N-CA 118.07 -1.452 . . . . 1.16 107.947 174.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.747 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 45.8 mm -94.82 139.17 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.782 0 CA-C-N 113.131 -1.85 . . . . 1.05 107.394 -179.008 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.29 -175.36 3.8 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 119.64 -0.824 . . . . 0.98 111.329 -169.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.529 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 47.5 mtm180 -52.51 -41.04 63.1 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 123.356 0.41 . . . . 2.61 111.036 -177.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.453 ' O ' ' HB3' ' A' ' 14' ' ' SER . 34.1 m-20 -98.86 22.63 9.88 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.471 -0.566 . . . . 2.0 109.471 -176.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.568 ' HA2' HG21 ' A' ' 144' ' ' ILE . . . 67.53 39.66 90.98 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 114.728 0.651 . . . . 0.19 114.728 177.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.406 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 93.4 t -100.84 127.94 31.03 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-N 118.278 1.039 . . . . 1.74 110.497 173.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.548 ' HA ' HD12 ' A' ' 144' ' ' ILE . 10.2 Cg_endo -77.3 110.0 2.91 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.692 2.262 . . . . 0.6 110.319 178.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.443 ' O ' ' HE3' ' A' ' 126' ' ' LYS . 17.2 t -107.87 -28.28 2.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 121.433 0.635 . . . . 2.06 109.546 -173.027 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.787 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 5.5 mm-40 -135.75 164.64 27.43 Favored 'General case' 0 CA--C 1.501 -0.933 0 CA-C-N 115.328 -0.851 . . . . 1.17 110.511 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.791 ' HA ' ' O ' ' A' ' 141' ' ' SER . 0.0 OUTLIER -149.42 139.19 21.82 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.805 -1.088 . . . . 2.9 110.31 157.813 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.549 ' CZ ' ' HA ' ' A' ' 163' ' ' ILE . 86.8 m-85 -113.95 152.77 30.37 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.242 -1.344 . . . . 0.36 109.141 -160.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 15.3 m -71.37 157.03 90.85 Favored Pre-proline 0 C--N 1.312 -1.058 0 N-CA-C 109.464 -0.569 . . . . 1.45 109.464 176.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.637 ' HG3' ' HB3' ' A' ' 137' ' ' TRP . 18.4 Cg_endo -60.87 -26.62 83.42 Favored 'Trans proline' 0 CA--C 1.517 -0.348 0 C-N-CA 122.197 1.931 . . . . 0.78 110.179 171.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -81.55 7.87 60.48 Favored Glycine 0 N--CA 1.441 -1.01 0 CA-C-N 114.036 -1.438 . . . . 0.59 113.124 174.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -88.07 146.41 25.46 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.563 -0.903 . . . . 1.07 108.563 171.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 87.5 p -110.86 176.86 4.86 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 120.813 -0.355 . . . . 1.92 110.772 -173.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.617 HG23 ' HA ' ' A' ' 56' ' ' THR . 61.1 t -44.49 -46.57 2.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.211 -0.904 . . . . 1.07 110.582 174.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -68.97 -37.44 78.79 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.664 -0.698 . . . . 3.89 111.052 -174.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -65.26 -41.02 94.67 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.566 0.698 . . . . 1.4 109.551 -177.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.89 HD13 ' HH ' ' A' ' 41' ' ' TYR . 73.7 mt -77.78 -45.66 27.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 114.637 -1.165 . . . . 1.05 111.472 -179.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.613 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 25.2 mt-10 -52.97 -41.37 64.49 Favored 'General case' 0 C--O 1.22 -0.495 0 N-CA-C 111.994 0.368 . . . . 0.67 111.994 -176.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -63.3 -19.58 64.72 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.46 -0.496 . . . . 0.87 111.889 -174.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.568 ' HB3' HD23 ' A' ' 143' ' ' LEU . 13.0 mmmm -103.03 -11.12 18.37 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.42 0.628 . . . . 2.22 110.018 174.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.613 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 13.9 tp -93.05 -53.78 4.0 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.99 -1.005 . . . . 1.04 112.168 -176.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.541 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 64.1 mt -53.28 -48.2 93.28 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.282 -0.872 . . . . 1.08 112.59 -172.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.541 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 72.5 Cg_exo -51.86 -30.26 37.94 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 122.252 1.968 . . . . 0.62 112.728 175.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.806 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 96.4 mt -84.42 -42.78 15.31 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.468 -0.333 . . . . 1.36 111.038 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.754 HD22 ' HG2' ' A' ' 37' ' ' PRO . 95.5 mt -60.93 -57.88 10.77 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-O 122.13 0.967 . . . . 1.07 109.692 176.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -64.01 -29.57 75.26 Favored Glycine 0 N--CA 1.434 -1.464 0 CA-C-N 113.334 -1.757 . . . . 1.12 113.011 -178.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 22.8 t 60.37 24.85 14.35 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.469 0.652 . . . . 2.88 110.358 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -78.95 -15.92 57.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.538 -0.756 . . . . 4.69 111.032 -177.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.433 ' HD3' ' HA ' ' A' ' 175' ' ' ARG . 11.7 mmt180 -100.55 36.86 1.81 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.734 0.778 . . . . 9.17 109.719 178.623 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 65.7 tp . . . . . 0 C--O 1.244 0.767 0 CA-C-N 114.687 -1.142 . . . . 8.03 108.833 178.528 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.6 m . . . . . 0 N--CA 1.453 -0.283 0 N-CA-C 109.071 -0.714 . . . . 1.58 109.071 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.9 m -150.65 170.57 18.86 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 105.161 -2.163 . . . . 1.17 105.161 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.87 ' HB ' HD11 ' A' ' 118' ' ' LEU . 6.8 pt -63.74 -19.59 24.64 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.102 0 CA-C-O 121.416 0.627 . . . . 0.38 110.521 178.122 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.734 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 37.3 m-85 -73.5 0.9 11.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.858 -0.61 . . . . 0.3 111.997 -175.017 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -80.19 -8.73 59.57 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 108.203 -1.036 . . . . 2.11 108.203 176.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.812 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 58.1 m-85 -121.79 117.29 26.21 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 114.537 -1.211 . . . . 0.31 111.427 -174.438 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -48.92 138.49 11.39 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 112.876 -1.965 . . . . 2.86 110.534 173.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.914 HG13 ' HZ ' ' A' ' 74' ' ' PHE . 98.9 t -112.76 163.4 9.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 108.146 -1.057 . . . . 0.67 108.146 175.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.737 ' O ' ' HB3' ' A' ' 105' ' ' MET . 19.9 mt -134.9 121.88 21.19 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.9 -0.407 . . . . 0.69 109.9 -175.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.856 ' HA ' ' HE2' ' A' ' 105' ' ' MET . 29.9 t70 -63.96 177.36 0.79 Allowed 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 108.372 -0.973 . . . . 1.87 108.372 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.631 ' HA ' ' C ' ' A' ' 105' ' ' MET . . . -59.55 -4.38 0.62 Allowed 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 114.314 1.228 . . . . 0.59 114.314 -163.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -119.33 14.8 12.98 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.765 0.654 . . . . 2.34 112.765 173.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.709 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 8.2 m-70 73.13 24.22 2.52 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 122.184 0.992 . . . . 1.47 109.695 174.128 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.421 ' HE3' ' HB2' ' A' ' 26' ' ' LYS . 16.3 mtmt -85.55 127.81 61.64 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 113.814 -1.539 . . . . 4.25 106.929 166.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.598 ' HA ' HD23 ' A' ' 21' ' ' LEU . 93.3 Cg_exo -50.76 112.44 0.77 Allowed 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 121.359 1.373 . . . . 0.54 112.607 -174.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.521 ' HE2' ' CD2' ' A' ' 72' ' ' LEU . 24.2 t80 -81.47 142.61 32.77 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 113.481 -1.69 . . . . 1.2 112.1 178.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.544 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.8 t-20 -77.73 82.37 4.13 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.648 -1.16 . . . . 1.51 109.904 178.297 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.661 HD13 HG21 ' A' ' 20' ' ' VAL . 62.1 tp -63.72 -45.16 91.21 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.559 0.695 . . . . 0.28 110.822 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.685 HG13 ' HB3' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -66.13 1.69 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 114.759 -1.109 . . . . 1.02 113.596 -171.764 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.544 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 21.1 pt20 -74.37 -5.34 41.77 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.342 0.591 . . . . 1.02 110.175 172.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.866 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 70.8 m-70 -104.3 24.06 12.14 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.84 0.828 . . . . 0.28 109.428 174.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.734 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 19.7 mtmm -82.69 110.01 17.36 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 114.608 -1.178 . . . . 1.56 109.535 171.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.27 -36.49 2.38 Favored Glycine 0 N--CA 1.44 -1.085 0 C-N-CA 120.534 -0.841 . . . . 0.2 112.031 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.449 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 40.1 m -131.01 133.41 24.72 Favored Pre-proline 0 N--CA 1.435 -1.213 0 N-CA-C 108.3 -1.0 . . . . 0.29 108.3 173.236 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.757 ' HG2' HD23 ' A' ' 171' ' ' LEU . 3.1 Cg_endo -42.56 152.3 0.19 Allowed 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.824 3.016 . . . . 0.18 112.566 177.003 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.866 ' HB2' HG22 ' A' ' 70' ' ' THR . 0.5 OUTLIER -136.98 140.76 42.41 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 106.872 -1.529 . . . . 0.31 106.872 179.395 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.891 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 1.3 mm? -106.65 111.09 23.47 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.077 -1.083 . . . . 1.19 108.077 176.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.872 HG23 ' HB2' ' A' ' 72' ' ' LEU . 2.4 mt -94.87 122.9 46.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-N 115.856 -0.611 . . . . 0.37 109.485 176.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.891 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -110.88 128.01 55.64 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 116.068 -0.514 . . . . 0.42 109.919 -176.182 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.618 ' OD1' ' HB ' ' A' ' 140' ' ' THR . 2.3 p30 -82.27 94.85 7.41 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 107.938 -1.134 . . . . 2.35 107.938 167.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.777 ' O ' ' HA ' ' A' ' 75' ' ' PRO . 19.3 m . . . . . 0 C--N 1.319 -0.753 0 CA-C-O 121.507 0.67 . . . . 1.03 110.615 -166.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.45 ' O ' ' HG3' ' A' ' 55' ' ' GLU . . . . . . . . 0 N--CA 1.452 -0.243 0 N-CA-C 112.476 -0.25 . . . . 0.51 112.476 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.44 ' HA2' ' HB ' ' A' ' 56' ' ' THR . . . -53.88 -23.98 24.93 Favored Glycine 0 C--O 1.218 -0.889 0 CA-C-O 119.523 -0.599 . . . . 0.5 114.398 -175.095 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.431 ' HA ' ' CE2' ' A' ' 139' ' ' PHE . 0.6 OUTLIER -67.74 -55.49 12.9 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 118.42 1.11 . . . . 0.7 110.642 -178.943 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.45 ' HG3' ' O ' ' A' ' 52' ' ' GLY . 2.7 pp20? -66.31 -31.24 71.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.521 0.677 . . . . 2.61 109.348 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.697 ' HA ' ' CG2' ' A' ' 160' ' ' VAL . 53.9 m -59.68 -60.15 4.31 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 114.597 -1.183 . . . . 0.33 110.691 175.36 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 1.024 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -61.27 -44.99 96.33 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.979 -1.01 . . . . 0.22 111.293 -177.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.618 ' HA ' ' HE1' ' A' ' 102' ' ' PHE . 95.9 m -55.25 -52.29 63.89 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.57 0.7 . . . . 0.26 110.344 -177.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.8 m -72.79 -36.07 67.52 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.916 -1.038 . . . . 0.48 111.309 -176.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.682 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 19.3 mt -65.87 -50.11 65.72 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 121.303 0.573 . . . . 0.43 110.374 -177.562 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.817 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 6.8 t80 -55.74 -53.54 55.31 Favored 'General case' 0 C--O 1.198 -1.613 0 CA-C-N 114.608 -1.178 . . . . 0.31 110.44 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.481 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 9.7 m-80 -73.11 -24.67 60.66 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 112.182 0.438 . . . . 1.21 112.182 -173.308 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.477 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 33.6 ttpt -82.46 -22.36 35.22 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.768 -0.827 . . . . 1.54 108.768 -178.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.77 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 37.8 m-85 -123.73 -5.73 8.05 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 114.767 1.395 . . . . 0.31 114.767 -172.296 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.69 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 11.1 ptmt -64.64 -25.74 68.09 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 107.931 -1.137 . . . . 1.35 107.931 170.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.2 m -48.01 -41.84 26.48 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 114.106 -1.406 . . . . 1.28 110.672 172.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -82.73 -37.93 23.99 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 111.747 0.277 . . . . 1.11 111.747 175.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 149.66 -8.55 0.86 Allowed Glycine 0 CA--C 1.519 0.332 0 N-CA-C 111.088 -0.805 . . . . 0.18 111.088 -176.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.77 ' HD2' ' HB2' ' A' ' 64' ' ' TYR . 18.5 t80 -63.53 144.92 56.59 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 115.024 -0.588 . . . . 0.18 111.24 -177.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.866 HG22 ' HB2' ' A' ' 38' ' ' LEU . 3.0 t -133.27 152.25 51.93 Favored 'General case' 0 N--CA 1.411 -2.396 0 N-CA-C 108.726 -0.842 . . . . 0.2 108.726 171.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 1.024 HG11 ' HB1' ' A' ' 57' ' ' ALA . 37.4 t -106.78 102.12 13.48 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.361 0 N-CA-C 107.645 -1.243 . . . . 0.17 107.645 158.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.872 ' HB2' HG23 ' A' ' 40' ' ' ILE . 88.5 mt -84.27 118.73 24.37 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 107.742 -1.207 . . . . 1.04 107.742 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.757 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -97.84 113.06 24.77 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 120.385 -0.526 . . . . 0.51 110.598 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.914 ' HZ ' HG13 ' A' ' 20' ' ' VAL . 34.5 m-85 -106.52 96.68 14.52 Favored Pre-proline 0 C--N 1.309 -1.171 0 N-CA-C 109.445 -0.576 . . . . 0.44 109.445 176.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.777 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 74.2 Cg_endo -80.43 75.08 5.24 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.481 2.787 . . . . 1.3 114.778 -166.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 108' ' ' ILE . 76.2 p . . . . . 0 N--CA 1.476 0.859 0 C-N-CA 126.028 1.731 . . . . 1.44 115.234 -177.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.503 ' HB3' ' CD2' ' A' ' 102' ' ' PHE . . . . . . . . 0 CA--C 1.513 -0.472 0 CA-C-O 120.855 0.36 . . . . 0.55 111.082 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.41 ' H ' ' HB1' ' A' ' 100' ' ' ALA . 36.3 mm-40 -96.99 22.96 7.72 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.488 -0.778 . . . . 1.99 111.332 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.7 ' HB3' ' O ' ' A' ' 71' ' ' VAL . 2.9 m-85 -111.61 -176.63 0.39 Allowed Pre-proline 0 CA--C 1.514 -0.41 0 CA-C-O 121.561 0.695 . . . . 0.84 110.764 -177.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.67 ' HD3' ' CE2' ' A' ' 61' ' ' TYR . 8.6 Cg_exo -81.51 78.26 3.63 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 123.93 3.086 . . . . 0.62 109.449 157.155 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.757 HG13 ' HB3' ' A' ' 73' ' ' ALA . 4.0 mp -84.32 127.83 39.46 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 N-CA-C 108.09 -1.078 . . . . 1.34 108.09 178.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.856 ' HE2' ' HA ' ' A' ' 22' ' ' ASP . 3.4 mmt -96.82 -175.52 3.3 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.565 -0.743 . . . . 3.03 110.404 -169.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.638 ' O ' ' HG2' ' A' ' 107' ' ' LYS . . . -84.98 32.93 0.53 Allowed 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 113.013 0.746 . . . . 1.46 113.013 -167.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.638 ' HG2' ' O ' ' A' ' 106' ' ' ALA . 15.2 ptpt 53.83 127.6 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 123.467 1.603 . . . . 1.76 112.654 -177.08 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.785 HG13 HG13 ' A' ' 110' ' ' VAL . 20.4 pt -128.59 160.66 38.74 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 CA-C-N 113.538 -1.665 . . . . 0.82 108.681 177.187 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 -71.54 52.31 0.2 Allowed 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.148 -0.933 . . . . 1.73 110.985 -178.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.785 HG13 HG13 ' A' ' 108' ' ' ILE . 0.7 OUTLIER -62.3 95.57 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-O 121.533 0.683 . . . . 0.77 109.379 179.611 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.1 t30 . . . . . 0 N--CA 1.439 -0.996 0 CA-C-N 114.683 -1.144 . . . . 1.9 108.389 -176.806 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.587 ' CE1' ' H ' ' A' ' 118' ' ' LEU . 4.0 t-80 . . . . . 0 N--CA 1.425 -1.69 0 N-CA-C 104.808 -2.293 . . . . 0.42 104.808 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -27.29 -45.75 0.07 OUTLIER 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 124.272 3.314 . . . . 0.4 113.913 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.87 HD11 ' HB ' ' A' ' 15' ' ' ILE . 24.0 tp -64.86 -50.81 65.15 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.608 0.763 . . . . 0.39 111.854 178.29 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.672 ' OH ' HG22 ' A' ' 40' ' ' ILE . 36.4 m-85 -75.9 -33.01 59.9 Favored 'General case' 0 CA--C 1.505 -0.788 0 O-C-N 122.203 -0.311 . . . . 3.04 111.509 178.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -56.51 -38.85 72.35 Favored 'General case' 0 CA--C 1.493 -1.239 0 N-CA-C 106.927 -1.509 . . . . 2.44 106.927 170.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.812 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 56.6 t80 -67.43 -32.18 72.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.224 -0.898 . . . . 0.56 110.661 175.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.766 ' HE3' ' HG ' ' A' ' 118' ' ' LEU . 0.6 OUTLIER -74.64 -54.5 7.31 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.248 -0.433 . . . . 0.71 110.142 -171.075 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.407 ' HE2' ' HB2' ' A' ' 123' ' ' LYS . 1.2 ptmm? -70.29 -24.57 63.06 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.191 -0.459 . . . . 1.46 111.396 176.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.512 ' HG3' ' O ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -74.43 -27.91 60.82 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 119.151 -1.02 . . . . 1.99 110.118 176.231 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 90.8 m -78.27 -43.04 29.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.887 -0.597 . . . . 0.59 110.265 175.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 41.0 tttm . . . . . 0 C--N 1.325 -0.475 0 N-CA-C 108.884 -0.784 . . . . 1.85 108.884 178.878 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.606 ' HB3' ' HG3' ' A' ' 156' ' ' PRO . 12.6 m-90 . . . . . 0 CA--C 1.518 -0.283 0 CA-C-O 121.279 0.561 . . . . 1.97 110.983 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.481 ' HB3' ' H ' ' A' ' 139' ' ' PHE . 6.1 m-20 -43.06 -156.22 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.725 -1.125 . . . . 2.04 112.157 157.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.718 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 2.8 m-85 -28.74 -47.25 0.05 Allowed 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 116.337 1.977 . . . . 1.93 116.337 -168.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.618 ' HB ' ' OD1' ' A' ' 42' ' ' ASN . 9.7 m 36.12 91.8 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.386 0.994 . . . . 0.6 113.21 176.151 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.634 ' HB3' HD12 ' A' ' 39' ' ' LEU . 0.7 OUTLIER -83.41 163.26 20.67 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.464 -0.789 . . . . 0.62 110.685 -175.023 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.531 ' HA ' ' HA ' ' A' ' 153' ' ' ARG . 76.4 m-85 -129.77 122.26 28.47 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 105.52 -2.03 . . . . 0.57 105.52 168.233 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.832 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 7.3 tp -80.19 103.51 10.11 Favored 'General case' 0 N--CA 1.422 -1.865 0 C-N-CA 118.528 -1.269 . . . . 0.43 108.372 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.715 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 42.9 mm -90.23 139.54 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.734 0 CA-C-N 112.965 -1.925 . . . . 0.19 107.468 -179.099 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.546 ' HA ' HD13 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -93.92 -176.95 4.18 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 119.71 -0.796 . . . . 0.98 111.276 -169.197 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.639 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 35.3 mtm180 -51.94 -41.45 62.06 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.994 0.426 . . . . 2.22 111.18 -177.229 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -95.65 14.68 22.21 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 109.646 -0.501 . . . . 2.0 109.646 -175.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.489 ' HA2' HG22 ' A' ' 144' ' ' ILE . . . 78.38 30.83 48.44 Favored Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 121.223 -0.513 . . . . 0.17 113.915 179.245 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 49.5 t -103.85 115.3 63.63 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 118.224 1.012 . . . . 1.12 111.428 177.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.706 ' HD3' HG23 ' A' ' 15' ' ' ILE . 29.6 Cg_endo -66.58 117.93 5.13 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 123.44 2.76 . . . . 0.41 110.86 177.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 16.0 m -119.42 -9.83 11.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 120.704 0.287 . . . . 1.45 110.247 -176.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.832 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 18.3 mm-40 -145.13 166.57 25.02 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-N 115.749 -0.659 . . . . 1.17 110.659 175.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.54 HH11 ' HG2' ' A' ' 153' ' ' ARG . 0.0 OUTLIER -147.58 126.65 12.87 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.757 -1.11 . . . . 2.16 109.253 161.96 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.682 ' HZ ' ' HB2' ' A' ' 166' ' ' LYS . 91.1 m-85 -99.28 148.37 24.21 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.028 -0.987 . . . . 0.32 109.563 -174.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 16.1 m -88.19 149.4 44.99 Favored Pre-proline 0 C--N 1.311 -1.085 0 N-CA-C 109.234 -0.654 . . . . 1.11 109.234 -179.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.606 ' HG3' ' HB3' ' A' ' 137' ' ' TRP . 33.8 Cg_endo -64.29 96.02 0.22 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 121.841 1.694 . . . . 0.78 108.446 170.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 151.07 -17.3 0.92 Allowed Glycine 0 N--CA 1.433 -1.561 0 N-CA-C 109.019 -1.632 . . . . 0.5 109.019 -164.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.413 ' HB1' ' HB2' ' A' ' 162' ' ' ASP . . . -92.18 145.91 24.13 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.919 -1.141 . . . . 0.5 107.919 166.284 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.594 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 31.1 t -109.94 -178.23 3.47 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.895 -0.409 . . . . 1.42 109.895 -174.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.697 ' CG2' ' HA ' ' A' ' 56' ' ' THR . 57.8 t -41.44 -51.11 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.301 0 O-C-N 124.081 0.863 . . . . 0.28 110.732 178.139 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 7.6 tttm -60.62 -46.11 91.51 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.088 -0.96 . . . . 3.46 111.108 -174.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.413 ' HB2' ' HB1' ' A' ' 158' ' ' ALA . 42.0 m-20 -66.53 -30.64 71.0 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.912 -1.04 . . . . 1.4 110.333 -173.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.54 HD12 ' CG2' ' A' ' 56' ' ' THR . 60.1 mt -81.89 -45.23 20.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.674 -0.694 . . . . 0.21 111.25 177.009 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.609 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 52.3 mt-10 -53.96 -43.15 69.66 Favored 'General case' 0 C--O 1.215 -0.747 0 CA-C-O 120.907 0.384 . . . . 0.67 111.379 -177.363 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -59.15 -19.18 42.71 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 112.279 0.474 . . . . 0.87 112.279 -176.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.682 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 75.4 mmtt -103.17 -27.3 12.61 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.54 0.686 . . . . 1.71 109.948 173.04 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.609 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 13.7 tp -77.27 -50.86 11.94 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.95 -1.023 . . . . 0.16 112.409 -177.249 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.471 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 73.4 mt -54.33 -45.8 99.16 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 115.734 -0.666 . . . . 0.26 112.201 -174.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.471 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 82.2 Cg_exo -51.42 -29.48 31.26 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.343 2.029 . . . . 0.41 113.015 173.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.771 HD12 HD11 ' A' ' 143' ' ' LEU . 73.6 mt -88.81 -42.12 12.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.663 -0.244 . . . . 0.71 111.251 178.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.757 HD23 ' HG2' ' A' ' 37' ' ' PRO . 93.0 mt -60.37 -56.4 21.89 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-O 122.052 0.93 . . . . 0.34 109.649 175.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.323 0 CA-C-N 113.385 -1.734 . . . . 1.12 112.106 178.137 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.4 p . . . . . 0 CA--C 1.527 0.065 0 CA-C-O 121.348 0.594 . . . . 1.58 110.352 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 85.7 p 178.21 152.75 0.3 Allowed 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 105.708 -1.96 . . . . 1.17 105.708 -178.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.848 ' HB ' HD11 ' A' ' 118' ' ' LEU . 5.1 pt -64.63 -18.36 23.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-N 114.769 -1.105 . . . . 0.38 111.519 -176.297 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.85 ' HB3' HG13 ' A' ' 31' ' ' VAL . 36.5 m-85 -70.45 -7.75 45.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.946 -0.57 . . . . 0.3 111.871 -176.367 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -68.29 -17.43 64.27 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.385 -0.969 . . . . 2.11 108.385 175.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.697 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 55.9 m-85 -115.67 108.03 15.86 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 115.12 -0.945 . . . . 0.31 111.096 -176.361 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -45.8 144.01 1.89 Allowed 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 113.687 -1.597 . . . . 2.86 110.396 171.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.706 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 35.7 t -110.66 169.17 3.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 N-CA-C 107.485 -1.302 . . . . 0.67 107.485 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.851 ' HB2' ' HE1' ' A' ' 105' ' ' MET . 61.6 mt -132.12 123.22 26.69 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 118.538 0.608 . . . . 0.69 111.605 -177.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.516 ' N ' ' HB2' ' A' ' 28' ' ' TYR . 14.7 t70 -62.03 161.51 10.67 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.187 -1.412 . . . . 1.87 107.187 167.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.816 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . . . -52.88 -15.39 0.75 Allowed 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 114.793 1.405 . . . . 0.59 114.793 -165.145 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.56 ' HB2' ' HE2' ' A' ' 26' ' ' LYS . 38.2 m-20 -91.93 -2.33 56.84 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.417 0.525 . . . . 2.34 112.417 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.55 ' HB2' ' O ' ' A' ' 24' ' ' ASP . 67.4 m80 82.84 11.27 0.54 Allowed 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.59 0.71 . . . . 1.47 109.477 -177.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.56 ' HE2' ' HB2' ' A' ' 24' ' ' ASP . 17.5 mtmt -77.0 120.7 82.79 Favored Pre-proline 0 C--N 1.323 -0.575 0 N-CA-C 107.148 -1.427 . . . . 4.25 107.148 169.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.716 ' HA ' HD23 ' A' ' 21' ' ' LEU . 78.9 Cg_exo -49.42 114.32 1.27 Allowed 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 122.055 1.837 . . . . 0.54 113.062 -174.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.565 ' HB3' HG12 ' A' ' 20' ' ' VAL . 6.8 t80 -81.32 139.14 35.56 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 113.53 -1.668 . . . . 1.2 111.356 176.013 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.701 ' ND2' ' HB3' ' A' ' 32' ' ' GLN . 42.6 t30 -72.35 90.66 1.29 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.691 -1.141 . . . . 1.51 109.847 176.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.769 ' HG ' ' CD1' ' A' ' 16' ' ' PHE . 29.4 tp -70.65 -41.36 72.22 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.081 0.467 . . . . 0.28 109.949 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.85 HG13 ' HB3' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -63.47 0.64 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 115.181 -0.918 . . . . 1.02 113.054 -174.873 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.701 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . 3.6 pt20 -74.35 -7.18 51.99 Favored 'General case' 0 CA--C 1.509 -0.623 0 O-C-N 121.92 -0.488 . . . . 1.02 110.762 176.263 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.914 ' HB2' HD22 ' A' ' 38' ' ' LEU . 63.3 m-70 -104.98 30.16 5.76 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.697 0.761 . . . . 0.28 109.647 173.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.774 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 23.6 mtmt -86.23 110.39 19.58 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 114.81 -1.086 . . . . 1.56 109.599 172.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 128.48 -41.1 1.61 Allowed Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 111.204 -0.758 . . . . 0.2 111.204 -176.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.457 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 18.0 m -129.25 130.63 23.37 Favored Pre-proline 0 N--CA 1.436 -1.171 0 N-CA-C 109.139 -0.689 . . . . 0.29 109.139 171.483 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.802 ' HG2' HD23 ' A' ' 171' ' ' LEU . 5.4 Cg_endo -43.51 150.77 0.43 Allowed 'Trans proline' 0 CA--C 1.513 -0.528 0 C-N-CA 124.768 3.645 . . . . 0.18 113.522 178.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.914 HD22 ' HB2' ' A' ' 33' ' ' HIS . 1.2 pt? -130.13 149.0 52.03 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 107.491 -1.3 . . . . 0.31 107.491 174.269 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 1.005 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 1.5 mm? -111.35 112.46 24.23 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.329 -0.989 . . . . 1.19 108.329 174.263 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.868 HG23 ' HB2' ' A' ' 72' ' ' LEU . 4.2 mt -96.93 125.23 49.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 C-N-CA 119.98 -0.688 . . . . 0.37 110.369 177.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 1.005 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -109.98 123.03 48.92 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 116.245 -0.434 . . . . 0.42 109.967 -175.543 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.703 ' ND2' ' HB ' ' A' ' 140' ' ' THR . 2.3 p-10 -81.21 94.07 6.61 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 107.696 -1.224 . . . . 2.35 107.696 170.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.859 ' O ' ' HA ' ' A' ' 75' ' ' PRO . 1.2 p . . . . . 0 C--N 1.294 -1.844 0 CA-C-N 115.262 -0.881 . . . . 1.03 111.626 -160.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 0.116 0 N-CA-C 112.307 -0.317 . . . . 0.51 112.307 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -41.57 -43.57 3.94 Favored Glycine 0 C--O 1.223 -0.547 0 O-C-N 124.013 0.478 . . . . 0.5 113.791 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.551 ' HA ' ' CZ ' ' A' ' 139' ' ' PHE . 0.1 OUTLIER -59.48 -60.12 4.36 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.739 0.269 . . . . 0.7 111.634 -174.852 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -60.86 -34.72 75.03 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.347 0.594 . . . . 2.61 109.632 -176.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.672 ' OG1' ' HA ' ' A' ' 159' ' ' SER . 72.1 m -62.63 -59.64 4.64 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.699 -1.137 . . . . 0.33 110.1 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 1.094 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -60.55 -49.28 78.18 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.042 -0.981 . . . . 0.22 111.424 -177.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.649 ' N ' ' HE1' ' A' ' 102' ' ' PHE . 37.6 m -55.15 -51.95 64.83 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.464 0.649 . . . . 0.26 110.479 -177.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.497 ' HA ' ' ND2' ' A' ' 62' ' ' ASN . 29.7 m -71.03 -31.8 68.38 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.264 -0.88 . . . . 0.48 111.442 -176.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.708 HD21 ' HG3' ' A' ' 164' ' ' GLU . 14.6 mt -71.91 -50.74 26.6 Favored 'General case' 0 CA--C 1.494 -1.186 0 CA-C-O 120.924 0.392 . . . . 0.43 110.6 -177.15 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.81 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 3.0 t80 -51.47 -60.34 3.24 Favored 'General case' 0 C--O 1.203 -1.374 0 CA-C-N 114.645 -1.161 . . . . 0.31 109.752 178.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 1.046 ' HA ' ' HG3' ' A' ' 65' ' ' LYS . 4.3 p30 -70.06 -24.55 63.26 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 121.11 -0.236 . . . . 1.21 111.006 -171.214 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.519 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 35.3 ttpt -76.48 -21.31 55.99 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.184 -1.043 . . . . 1.54 108.184 -177.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.783 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 65.4 m-85 -130.12 10.13 5.35 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 114.679 1.363 . . . . 0.31 114.679 -176.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 1.046 ' HG3' ' HA ' ' A' ' 62' ' ' ASN . 27.9 mtmt -54.11 -38.29 65.25 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 106.588 -1.634 . . . . 1.35 106.588 169.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -48.5 -42.17 32.19 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 111.697 -2.501 . . . . 1.28 112.908 -177.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -85.06 -36.3 21.3 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.671 -0.412 . . . . 1.11 111.751 177.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.456 ' HA3' ' HB2' ' A' ' 36' ' ' SER . . . 147.38 -5.73 1.03 Allowed Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 110.829 -0.909 . . . . 0.18 110.829 -176.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.783 ' HD2' ' HB2' ' A' ' 64' ' ' TYR . 17.1 t80 -66.9 139.25 57.72 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 114.951 -0.625 . . . . 0.18 110.973 -177.293 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.901 HG22 ' HB2' ' A' ' 38' ' ' LEU . 1.6 t -132.82 149.51 52.26 Favored 'General case' 0 N--CA 1.414 -2.238 0 N-CA-C 108.653 -0.869 . . . . 0.2 108.653 172.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 1.094 HG11 ' HB1' ' A' ' 57' ' ' ALA . 29.7 t -102.7 101.52 12.28 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.23 0 N-CA-C 108.058 -1.089 . . . . 0.17 108.058 160.051 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.868 ' HB2' HG23 ' A' ' 40' ' ' ILE . 66.1 mt -84.67 119.65 25.49 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 108.218 -1.03 . . . . 1.04 108.218 178.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.741 ' HB1' HG11 ' A' ' 43' ' ' VAL . . . -100.39 112.32 24.66 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 121.328 0.585 . . . . 0.51 111.632 -178.13 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.843 ' CG ' ' HG2' ' A' ' 105' ' ' MET . 2.9 m-85 -103.59 95.17 6.91 Favored Pre-proline 0 C--N 1.316 -0.872 0 N-CA-C 109.275 -0.639 . . . . 0.44 109.275 176.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.859 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 76.3 Cg_endo -83.5 95.75 0.78 Allowed 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.249 1.966 . . . . 1.3 113.84 -169.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.774 ' HB2' HG23 ' A' ' 110' ' ' VAL . 47.4 t . . . . . 0 CA--C 1.509 -0.634 0 CA-C-O 121.865 0.84 . . . . 1.44 112.628 -176.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.453 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . . . . . . 0 CA--C 1.512 -0.515 0 CA-C-O 121.124 0.488 . . . . 0.55 111.546 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -99.76 21.28 12.7 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.47 -0.786 . . . . 1.99 111.925 -178.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.708 ' HB3' ' O ' ' A' ' 71' ' ' VAL . 0.4 OUTLIER -109.43 177.8 1.17 Allowed Pre-proline 0 CA--C 1.511 -0.528 0 CA-C-O 121.317 0.579 . . . . 0.84 110.131 177.037 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.693 ' HD3' ' CE2' ' A' ' 61' ' ' TYR . 6.6 Cg_exo -80.81 76.16 4.66 Favored 'Trans proline' 0 N--CA 1.445 -1.37 0 C-N-CA 123.94 3.093 . . . . 0.62 110.003 162.385 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.654 HG12 ' HB3' ' A' ' 73' ' ' ALA . 34.8 mt -74.55 138.01 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 107.288 -1.375 . . . . 1.34 107.288 176.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.851 ' HE1' ' HB2' ' A' ' 21' ' ' LEU . 1.1 ppp? -96.62 -171.62 2.31 Favored 'General case' 0 N--CA 1.434 -1.255 0 C-N-CA 120.229 -0.588 . . . . 3.03 112.093 -170.262 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.816 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . . . -64.97 -7.69 12.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.417 -0.81 . . . . 1.46 112.194 -178.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.838 ' HB2' ' O ' ' A' ' 75' ' ' PRO . 3.9 ptpp? 66.04 133.72 0.02 OUTLIER 'General case' 0 CA--C 1.498 -1.036 0 C-N-CA 125.29 1.436 . . . . 1.76 110.702 -168.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.745 HG13 ' HB2' ' A' ' 116' ' ' HIS . 0.2 OUTLIER -135.78 171.54 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.857 0 CA-C-N 113.554 -1.657 . . . . 0.82 107.468 170.176 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -64.83 64.18 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 114.946 -1.025 . . . . 1.73 112.916 178.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.774 HG23 ' HB2' ' A' ' 76' ' ' SER . 3.2 m -71.4 95.99 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 117.857 -1.537 . . . . 0.77 107.867 172.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 25.3 p30 . . . . . 0 C--N 1.315 -0.921 0 CA-C-N 113.601 -1.636 . . . . 1.9 108.065 -169.355 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.745 ' HB2' HG13 ' A' ' 108' ' ' ILE . 1.6 t-80 . . . . . 0 N--CA 1.431 -1.412 0 N-CA-C 107.703 -1.221 . . . . 0.42 107.703 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -28.4 -49.92 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 124.683 3.589 . . . . 0.4 113.792 -178.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.848 HD11 ' HB ' ' A' ' 15' ' ' ILE . 48.0 tp -61.14 -51.6 68.4 Favored 'General case' 0 C--O 1.22 -0.468 0 C-N-CA 122.745 0.418 . . . . 0.39 111.787 178.137 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.688 ' HA ' ' HB2' ' A' ' 122' ' ' MET . 29.7 m-85 -76.53 -33.68 58.57 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 112.489 0.551 . . . . 3.04 112.489 -179.169 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.566 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 42.5 mt-10 -60.49 -34.92 74.76 Favored 'General case' 0 CA--C 1.491 -1.325 0 N-CA-C 107.121 -1.437 . . . . 2.44 107.121 171.395 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.697 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 45.0 t80 -69.48 -34.22 74.03 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 119.262 -0.975 . . . . 0.56 110.234 173.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.688 ' HB2' ' HA ' ' A' ' 119' ' ' TYR . 40.4 mtt -74.86 -52.23 11.87 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.89 -0.595 . . . . 0.71 112.057 -169.436 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.422 ' HB2' ' HE2' ' A' ' 123' ' ' LYS . 0.2 OUTLIER -69.56 -24.44 63.71 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 120.366 -0.534 . . . . 1.46 109.853 176.863 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.566 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 17.0 tttt -65.58 -38.15 88.7 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.248 -0.433 . . . . 1.99 110.309 170.186 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 36.2 m -65.43 -61.23 2.23 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.936 -0.574 . . . . 0.59 111.426 -176.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.495 ' HD2' ' O ' ' A' ' 151' ' ' VAL . 36.8 ttmt . . . . . 0 C--N 1.33 -0.269 0 N-CA-C 109.957 -0.386 . . . . 1.85 109.957 177.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.545 ' HB3' ' HG3' ' A' ' 156' ' ' PRO . 6.4 m-90 . . . . . 0 N--CA 1.448 -0.538 0 N-CA-C 109.509 -0.552 . . . . 1.97 109.509 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.458 ' HB2' ' CB ' ' A' ' 156' ' ' PRO . 6.6 m-20 -45.26 -153.93 0.0 OUTLIER 'General case' 0 C--O 1.209 -1.029 0 C-N-CA 123.846 0.859 . . . . 2.04 111.163 162.342 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.649 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 2.0 m-85 -27.5 -48.89 0.04 OUTLIER 'General case' 0 C--O 1.21 -0.983 0 N-CA-C 115.239 1.57 . . . . 1.93 115.239 -169.171 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.703 ' HB ' ' ND2' ' A' ' 42' ' ' ASN . 8.6 m 39.17 108.46 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 122.746 1.26 . . . . 0.6 113.84 173.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.69 ' HB3' HD12 ' A' ' 39' ' ' LEU . 1.4 m -100.64 165.25 11.49 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 114.811 -1.086 . . . . 0.62 110.014 -170.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.624 ' HA ' ' HA ' ' A' ' 153' ' ' ARG . 28.4 m-85 -128.38 125.96 39.7 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 105.916 -1.883 . . . . 0.57 105.916 163.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.851 HD11 HD12 ' A' ' 170' ' ' LEU . 1.6 tp -81.17 104.11 11.43 Favored 'General case' 0 C--N 1.288 -2.103 0 C-N-CA 118.565 -1.254 . . . . 0.43 108.563 178.078 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.685 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 28.3 mm -92.65 136.89 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.992 0 CA-C-N 113.097 -1.865 . . . . 0.19 107.592 -178.168 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.576 ' HA ' HD13 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -90.85 -174.18 3.95 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 119.704 -0.798 . . . . 0.98 111.52 -170.793 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.724 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 41.0 mtt85 -55.81 -40.19 72.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.015 -0.539 . . . . 2.22 111.109 -177.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.5 18.01 16.33 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.668 0.747 . . . . 2.0 109.085 -177.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.647 ' HA3' ' CE2' ' A' ' 16' ' ' PHE . . . 73.6 32.69 59.19 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 114.805 -1.089 . . . . 0.17 114.853 177.021 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.402 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 58.3 t -93.93 126.49 48.98 Favored Pre-proline 0 C--N 1.314 -0.962 0 CA-C-N 118.235 1.018 . . . . 1.12 110.72 175.005 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.47 ' HA ' HD13 ' A' ' 144' ' ' ILE . 12.2 Cg_endo -78.22 105.13 1.94 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.898 2.399 . . . . 0.41 110.073 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.495 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 4.6 t -93.94 -72.21 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 106.603 -1.628 . . . . 1.45 106.603 -178.051 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.816 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 0.3 OUTLIER -88.96 164.69 15.0 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 114.4 -1.273 . . . . 1.17 111.18 -177.476 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.624 ' HA ' ' HA ' ' A' ' 142' ' ' PHE . 0.0 OUTLIER -135.36 150.97 50.06 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 113.009 -1.905 . . . . 2.16 107.136 156.219 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.556 ' O ' ' HA ' ' A' ' 140' ' ' THR . 92.2 m-85 -125.46 145.44 50.08 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 108.442 -0.947 . . . . 0.32 108.442 -171.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.413 ' OG ' ' HD2' ' A' ' 156' ' ' PRO . 21.2 t -72.34 154.37 91.94 Favored Pre-proline 0 C--N 1.315 -0.918 0 N-CA-C 108.375 -0.972 . . . . 1.11 108.375 174.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.545 ' HG3' ' HB3' ' A' ' 137' ' ' TRP . 9.6 Cg_endo -51.45 -41.49 59.66 Favored 'Trans proline' 0 CA--C 1.519 -0.259 0 C-N-CA 122.185 1.923 . . . . 0.78 111.126 174.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -58.71 -19.35 42.42 Favored Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 114.645 -1.161 . . . . 0.5 113.725 176.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -70.62 136.41 49.13 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 109.005 -0.739 . . . . 0.5 109.005 177.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.672 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 19.8 m -108.46 -178.35 3.57 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 120.776 0.322 . . . . 1.42 110.705 -170.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.619 HG22 ' HA ' ' A' ' 56' ' ' THR . 46.7 t -44.8 -50.41 2.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 114.927 -1.033 . . . . 0.28 111.313 -178.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 26.0 tttm -64.75 -39.6 93.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.041 -0.527 . . . . 3.46 111.205 -176.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.512 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 32.7 m-20 -68.64 -39.54 80.69 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.52 -0.764 . . . . 1.4 109.632 -172.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.563 HD13 ' OH ' ' A' ' 41' ' ' TYR . 54.1 mt -75.1 -43.7 44.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 114.953 -1.021 . . . . 0.21 110.78 177.13 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.718 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 28.1 mt-10 -56.42 -39.9 73.82 Favored 'General case' 0 C--O 1.217 -0.624 0 N-CA-C 111.973 0.36 . . . . 0.67 111.973 -177.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.512 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 10.0 pt-20 -61.34 -23.91 66.08 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.673 -0.411 . . . . 0.87 111.249 -176.428 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.556 ' HB3' HD22 ' A' ' 143' ' ' LEU . 72.3 mmtt -99.08 -14.82 19.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.623 0.725 . . . . 1.71 109.759 175.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.718 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 12.8 tp -92.8 -51.91 4.86 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.059 -0.973 . . . . 0.16 112.385 -174.439 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.511 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 78.1 mt -53.03 -48.59 91.35 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.541 -0.754 . . . . 0.26 112.901 -171.493 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.511 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 74.2 Cg_exo -52.69 -33.9 61.66 Favored 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 121.974 1.783 . . . . 0.41 112.321 176.161 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.851 HD12 HD11 ' A' ' 143' ' ' LEU . 93.1 mt -77.18 -46.68 22.52 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 116.016 -0.538 . . . . 0.71 110.75 178.493 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.802 HD23 ' HG2' ' A' ' 37' ' ' PRO . 89.5 mt -58.33 -56.67 19.11 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 121.66 0.743 . . . . 0.34 110.37 177.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.265 0 CA-C-N 113.688 -1.597 . . . . 1.12 112.819 179.368 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.3 p . . . . . 0 N--CA 1.452 -0.343 0 CA-C-O 121.467 0.651 . . . . 1.58 109.543 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.532 ' HB3' ' O ' ' A' ' 147' ' ' ASP . 1.4 m -153.53 169.22 23.74 Favored 'General case' 0 N--CA 1.427 -1.575 0 N-CA-C 105.107 -2.182 . . . . 1.17 105.107 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.864 HD12 HD21 ' A' ' 30' ' ' LEU . 5.0 pt -61.55 -21.82 26.42 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.16 0 CA-C-O 121.777 0.799 . . . . 0.38 109.566 172.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.95 ' HB3' HG12 ' A' ' 31' ' ' VAL . 25.0 m-85 -70.6 -7.4 43.85 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.848 1.055 . . . . 0.3 113.848 -172.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -77.85 -5.32 50.52 Favored 'General case' 0 CA--C 1.502 -0.865 0 N-CA-C 107.951 -1.129 . . . . 2.11 107.951 178.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.795 ' HE2' ' HB2' ' A' ' 121' ' ' TYR . 41.9 m-85 -120.06 112.02 18.61 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 114.313 -1.312 . . . . 0.31 110.204 -175.419 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.92 149.52 2.63 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 113.521 -1.672 . . . . 2.86 110.632 174.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.798 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 35.6 t -112.12 158.62 12.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 107.874 -1.158 . . . . 0.67 107.874 174.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.9 ' O ' ' HB3' ' A' ' 105' ' ' MET . 96.0 mt -126.88 109.04 11.55 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 119.183 -0.437 . . . . 0.69 110.87 -174.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 17.0 t70 -46.81 158.0 0.14 Allowed 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 107.972 -1.121 . . . . 1.87 107.972 170.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.631 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . . . -53.79 -10.32 0.29 Allowed 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 113.251 0.834 . . . . 0.59 113.251 -167.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.539 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 25.9 t0 -93.46 -6.16 47.57 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 122.943 0.497 . . . . 2.34 111.899 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.539 ' HB2' ' O ' ' A' ' 24' ' ' ASP . 61.6 m80 82.38 24.5 0.19 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.77 0.795 . . . . 1.47 109.206 -177.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.414 ' HA ' ' HD3' ' A' ' 26' ' ' LYS . 27.2 mmtt -106.74 125.69 32.1 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 114.307 -1.315 . . . . 4.25 108.362 176.202 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.619 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 73.0 Cg_exo -52.67 114.7 1.81 Allowed 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.329 2.019 . . . . 0.54 114.561 -167.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.737 ' HE2' HD23 ' A' ' 72' ' ' LEU . 6.9 t80 -81.76 128.06 33.6 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 113.391 -1.732 . . . . 1.2 109.285 165.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.462 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 0.4 OUTLIER -74.63 91.55 2.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 122.341 1.067 . . . . 1.51 110.976 -179.887 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.864 HD21 HD12 ' A' ' 15' ' ' ILE . 52.2 tp -58.0 -36.21 72.33 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.009 -0.996 . . . . 0.28 110.589 -178.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.95 HG12 ' HB3' ' A' ' 16' ' ' PHE . 3.6 m -66.75 -1.22 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 114.768 -1.105 . . . . 1.02 113.178 -172.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.462 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 18.3 pt20 -77.2 -15.28 59.56 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 119.406 -0.917 . . . . 1.02 109.542 175.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.989 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 95.9 m-70 -86.83 27.86 0.95 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.959 0.885 . . . . 0.28 109.6 174.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 45.7 mttm -80.7 124.32 28.93 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 114.275 -1.33 . . . . 1.56 109.747 172.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.96 -40.06 2.68 Favored Glycine 0 N--CA 1.438 -1.22 0 C-N-CA 120.671 -0.776 . . . . 0.2 112.045 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.497 ' HB2' ' HA3' ' A' ' 68' ' ' GLY . 16.7 m -124.28 126.52 25.51 Favored Pre-proline 0 N--CA 1.435 -1.221 0 N-CA-C 108.689 -0.856 . . . . 0.29 108.689 175.366 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.832 ' HG3' ' CB ' ' A' ' 170' ' ' LEU . 2.9 Cg_endo -42.67 157.34 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 124.271 3.314 . . . . 0.18 113.015 176.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.814 ' HB2' HG22 ' A' ' 70' ' ' THR . 0.8 OUTLIER -145.08 143.36 30.38 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 107.575 -1.269 . . . . 0.31 107.575 -177.386 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 1.051 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 1.9 mm? -108.08 114.03 27.63 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.014 -0.735 . . . . 1.19 109.014 178.256 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.68 HG23 HD13 ' A' ' 72' ' ' LEU . 1.2 mt -96.23 125.61 49.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 C-N-CA 120.422 -0.511 . . . . 0.37 110.087 177.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 1.051 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.6 OUTLIER -107.07 133.09 52.22 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 120.449 -0.501 . . . . 0.42 110.254 -176.684 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.591 HD21 ' HB ' ' A' ' 110' ' ' VAL . 1.2 m120 -92.38 91.91 7.88 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 105.526 -2.027 . . . . 2.35 105.526 174.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.765 HG11 ' HB1' ' A' ' 73' ' ' ALA . 2.8 p . . . . . 0 C--N 1.302 -1.467 0 N-CA-C 112.813 0.672 . . . . 1.03 112.813 -160.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.561 ' O ' ' HG2' ' A' ' 55' ' ' GLU . . . . . . . . 0 N--CA 1.444 -0.784 0 N-CA-C 111.397 -0.681 . . . . 0.51 111.397 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -56.52 -24.91 48.57 Favored Glycine 0 C--O 1.222 -0.623 0 CA-C-O 119.792 -0.449 . . . . 0.5 113.326 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.513 ' HA ' ' CZ ' ' A' ' 139' ' ' PHE . 0.4 OUTLIER -61.09 -60.94 2.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.509 0.654 . . . . 0.7 110.298 179.167 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.561 ' HG2' ' O ' ' A' ' 52' ' ' GLY . 11.9 pt-20 -63.28 -21.21 66.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.647 -0.706 . . . . 2.61 110.349 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.671 ' HA ' HG22 ' A' ' 160' ' ' VAL . 54.1 m -73.01 -59.93 2.47 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.065 -0.971 . . . . 0.33 109.617 178.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 1.097 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -60.66 -42.04 96.23 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.552 -1.204 . . . . 0.22 110.876 -178.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.557 ' HA ' ' CD1' ' A' ' 102' ' ' PHE . 85.7 m -57.18 -57.31 13.16 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.541 -0.754 . . . . 0.26 110.471 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 22.7 m -70.6 -33.26 70.85 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.474 -0.784 . . . . 0.48 111.694 -174.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.77 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 18.7 mt -65.07 -47.67 76.48 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-O 121.435 0.636 . . . . 0.43 110.321 -178.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.863 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 10.0 t80 -59.7 -49.73 76.58 Favored 'General case' 0 C--O 1.205 -1.262 0 CA-C-N 114.757 -1.11 . . . . 0.31 111.045 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -72.35 -24.34 61.27 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 120.658 0.266 . . . . 1.21 110.659 -173.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.641 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 35.3 ttpt -85.76 -25.13 26.57 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 109.338 -0.616 . . . . 1.54 109.338 -178.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.822 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 32.5 m-85 -124.07 -6.74 7.78 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 115.491 1.663 . . . . 0.31 115.491 -169.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.693 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 3.8 ptmt -64.96 -26.99 68.53 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 108.004 -1.11 . . . . 1.35 108.004 170.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.6 t -47.63 -34.02 7.45 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.022 -1.444 . . . . 1.28 110.526 173.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.425 ' OE1' ' HB3' ' A' ' 171' ' ' LEU . 47.7 mt-30 -90.43 -39.65 12.51 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.681 0.277 . . . . 1.11 111.218 174.177 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.497 ' HA3' ' HB2' ' A' ' 36' ' ' SER . . . 151.81 -3.53 0.42 Allowed Glycine 0 CA--C 1.52 0.386 0 N-CA-C 111.23 -0.748 . . . . 0.18 111.23 -177.133 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.822 ' HD2' ' HB2' ' A' ' 64' ' ' TYR . 20.7 t80 -70.31 140.64 52.31 Favored 'General case' 0 C--O 1.218 -0.595 0 C-N-CA 123.029 0.532 . . . . 0.18 111.544 -177.488 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.989 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 2.2 t -134.49 145.57 48.92 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 108.818 -0.808 . . . . 0.2 108.818 174.444 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 1.097 HG11 ' HB1' ' A' ' 57' ' ' ALA . 42.8 t -104.94 99.99 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.257 0 N-CA-C 108.359 -0.978 . . . . 0.17 108.359 160.384 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.774 HD12 ' H ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -96.51 120.97 37.79 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 118.842 -1.143 . . . . 1.04 108.044 174.422 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.765 ' HB1' HG11 ' A' ' 43' ' ' VAL . . . -108.16 128.69 54.92 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 116.214 -0.448 . . . . 0.51 110.0 179.002 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.907 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 2.6 m-30 -102.43 105.62 44.59 Favored Pre-proline 0 C--N 1.312 -1.056 0 N-CA-C 108.162 -1.051 . . . . 0.44 108.162 175.197 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.914 ' HG2' ' HB3' ' A' ' 107' ' ' LYS . 59.7 Cg_endo -74.8 68.04 5.64 Favored 'Trans proline' 0 N--CA 1.474 0.324 0 C-N-CA 123.545 2.83 . . . . 1.3 114.98 -168.325 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.402 ' HB3' ' CG2' ' A' ' 110' ' ' VAL . 85.3 p . . . . . 0 N--CA 1.483 1.179 0 C-N-CA 126.978 2.111 . . . . 1.44 116.542 178.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.566 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . . . . . . 0 CA--C 1.505 -0.758 0 CA-C-O 121.048 0.451 . . . . 0.55 111.386 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -91.6 26.52 2.3 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.435 -0.802 . . . . 1.99 110.437 176.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.577 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 25.9 p90 -146.76 155.76 48.29 Favored Pre-proline 0 N--CA 1.441 -0.886 0 N-CA-C 108.712 -0.847 . . . . 0.84 108.712 175.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.686 ' HG2' ' HA ' ' A' ' 72' ' ' LEU . 35.9 Cg_endo -60.25 88.97 0.08 OUTLIER 'Trans proline' 0 CA--C 1.513 -0.53 0 C-N-CA 124.638 3.559 . . . . 0.62 114.137 -171.482 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.66 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 18.3 mt -100.6 126.78 54.16 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.348 0 N-CA-C 107.631 -1.248 . . . . 1.34 107.631 174.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.907 ' HG3' ' CE1' ' A' ' 74' ' ' PHE . 13.4 mmt -103.02 -159.82 0.75 Allowed 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.211 -0.904 . . . . 3.03 113.176 -158.675 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.631 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . . . -65.81 -3.58 5.23 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.074 -0.966 . . . . 1.46 112.65 -172.06 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.914 ' HB3' ' HG2' ' A' ' 75' ' ' PRO . 14.3 ptpt 58.47 129.06 0.01 OUTLIER 'General case' 0 CA--C 1.494 -1.201 0 CA-C-O 122.889 1.328 . . . . 1.76 110.38 -168.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.499 HD11 ' CE2' ' A' ' 119' ' ' TYR . 1.7 pp -138.1 167.92 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.657 0 CA-C-N 114.05 -1.432 . . . . 0.82 108.382 173.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -46.27 110.67 0.29 Allowed 'General case' 0 C--N 1.296 -1.732 0 O-C-N 124.393 1.058 . . . . 1.73 110.006 171.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.591 ' HB ' HD21 ' A' ' 42' ' ' ASN . 5.5 m -117.77 91.45 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.135 0 N-CA-C 107.271 -1.381 . . . . 0.77 107.271 163.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.9 t30 . . . . . 0 C--N 1.312 -1.023 0 CA-C-N 114.188 -1.369 . . . . 1.9 109.225 -174.599 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.647 ' CE1' ' H ' ' A' ' 118' ' ' LEU . 2.7 t-80 . . . . . 0 N--CA 1.424 -1.732 0 N-CA-C 106.5 -1.667 . . . . 0.42 106.5 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -26.82 -48.12 0.08 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 124.456 3.437 . . . . 0.4 113.537 178.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.827 ' HG ' ' HE3' ' A' ' 122' ' ' MET . 48.3 tp -60.15 -52.74 64.02 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.364 0.665 . . . . 0.39 112.288 177.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.736 ' HE2' ' CD2' ' A' ' 74' ' ' PHE . 70.2 m-85 -77.28 -35.12 55.45 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-N 116.663 -0.244 . . . . 3.04 111.511 -178.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.486 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 7.0 mm-40 -56.79 -36.1 69.49 Favored 'General case' 0 CA--C 1.491 -1.319 0 N-CA-C 107.803 -1.184 . . . . 2.44 107.803 170.025 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.795 ' HB2' ' HE2' ' A' ' 18' ' ' PHE . 60.8 t80 -69.86 -31.89 69.96 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 119.252 -0.979 . . . . 0.56 110.403 174.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.827 ' HE3' ' HG ' ' A' ' 118' ' ' LEU . 1.1 ttm -76.63 -55.06 5.85 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.551 -0.295 . . . . 0.71 111.244 -170.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.412 ' HE2' ' HB2' ' A' ' 123' ' ' LYS . 0.4 OUTLIER -69.29 -24.77 64.0 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.337 -0.392 . . . . 1.46 110.551 178.913 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.486 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 12.8 pttp -72.41 -28.64 63.11 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 119.384 -0.926 . . . . 1.99 109.696 175.124 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.447 ' HB ' ' HG2' ' A' ' 150' ' ' PRO . 97.4 m -76.57 -57.08 4.06 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.974 -0.557 . . . . 0.59 111.053 178.223 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 71.6 tttt . . . . . 0 N--CA 1.453 -0.319 0 CA-C-O 121.29 0.567 . . . . 1.85 112.005 -177.997 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.916 ' HB3' ' HG3' ' A' ' 156' ' ' PRO . 9.7 m-90 . . . . . 0 N--CA 1.454 -0.25 0 CA-C-O 120.961 0.41 . . . . 1.97 111.441 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.464 ' OD1' ' HD1' ' A' ' 139' ' ' PHE . 5.2 t-20 -38.96 -153.13 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 125.727 1.611 . . . . 2.04 111.565 157.468 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.674 ' CD1' HG23 ' A' ' 43' ' ' VAL . 2.4 m-85 -25.59 -52.18 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 115.461 1.652 . . . . 1.93 115.461 -169.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.616 ' HA ' ' O ' ' A' ' 154' ' ' PHE . 1.9 m 32.67 106.0 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.422 1.268 . . . . 0.6 114.422 175.054 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.741 ' HB3' HD12 ' A' ' 39' ' ' LEU . 2.8 m -92.58 174.04 7.48 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 114.084 -1.416 . . . . 0.62 111.393 -169.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.557 ' CD1' ' HB2' ' A' ' 153' ' ' ARG . 57.6 m-85 -138.64 123.01 18.29 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 105.985 -1.858 . . . . 0.57 105.985 165.043 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.932 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 2.9 tp -79.64 104.06 9.97 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 118.345 -1.342 . . . . 0.43 108.48 -179.092 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.726 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 40.2 mm -91.57 140.45 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.96 0 CA-C-N 113.647 -1.615 . . . . 0.19 107.873 -178.094 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.438 ' HA ' HD13 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -94.64 -172.26 2.7 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 120.062 -0.655 . . . . 0.98 111.515 -169.588 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.782 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 17.1 mtm180 -55.8 -36.77 67.78 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 123.168 0.293 . . . . 2.22 111.28 -176.094 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.532 ' O ' ' HB3' ' A' ' 14' ' ' SER . 34.8 t70 -102.2 23.22 11.98 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.33 -0.618 . . . . 2.0 109.33 -178.355 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.679 ' HA2' HG22 ' A' ' 144' ' ' ILE . . . 67.12 38.69 92.43 Favored Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 120.863 -0.684 . . . . 0.17 114.305 177.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 42.7 t -104.7 128.37 26.99 Favored Pre-proline 0 C--N 1.313 -0.979 0 CA-C-N 118.187 0.993 . . . . 1.12 110.618 173.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.447 ' HG2' ' HB ' ' A' ' 125' ' ' THR . 1.3 Cg_endo -71.12 118.85 5.9 Favored 'Trans proline' 0 CA--C 1.531 0.335 0 C-N-CA 122.662 2.241 . . . . 0.41 110.814 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.428 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 14.2 t -119.71 -7.0 11.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.825 -0.435 . . . . 1.45 109.825 -175.213 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.932 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 6.0 mm-40 -155.14 168.13 28.06 Favored 'General case' 0 CA--C 1.5 -0.948 0 CA-C-O 121.52 0.676 . . . . 1.17 111.007 176.045 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.557 ' HB2' ' CD1' ' A' ' 142' ' ' PHE . 1.4 ttm180 -147.91 132.99 18.24 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 113.851 -1.522 . . . . 2.16 108.726 164.238 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.616 ' O ' ' HA ' ' A' ' 140' ' ' THR . 96.7 m-85 -114.27 146.72 40.08 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.678 -0.692 . . . . 0.32 109.338 -168.018 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 15.8 m -65.1 150.14 95.85 Favored Pre-proline 0 C--N 1.313 -1.014 0 N-CA-C 109.001 -0.74 . . . . 1.11 109.001 175.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.916 ' HG3' ' HB3' ' A' ' 137' ' ' TRP . 38.5 Cg_endo -66.39 -16.31 50.91 Favored 'Trans proline' 0 CA--C 1.514 -0.519 0 C-N-CA 122.57 2.18 . . . . 0.78 110.974 177.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -88.31 2.07 84.83 Favored Glycine 0 N--CA 1.439 -1.158 0 CA-C-N 114.473 -1.239 . . . . 0.5 112.72 173.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -76.46 153.07 35.9 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.272 -0.64 . . . . 0.5 109.272 173.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.584 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 24.4 m -112.31 169.64 8.73 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 116.3 -0.409 . . . . 1.42 110.245 -175.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.671 HG22 ' HA ' ' A' ' 56' ' ' THR . 88.7 t -40.9 -52.53 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 O-C-N 124.363 1.039 . . . . 0.28 111.788 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 52.3 tttm -66.4 -32.99 74.71 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.031 -0.531 . . . . 3.46 111.166 -173.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -69.99 -31.45 69.15 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.859 -0.61 . . . . 1.4 109.847 -176.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.564 HD12 ' CG2' ' A' ' 56' ' ' THR . 70.1 mt -83.89 -43.24 17.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 115.184 -0.916 . . . . 0.21 110.954 176.112 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.582 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 35.0 mt-10 -53.05 -42.94 66.25 Favored 'General case' 0 C--O 1.216 -0.668 0 N-CA-C 111.723 0.268 . . . . 0.67 111.723 -177.073 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -54.88 -29.01 54.64 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 112.254 0.464 . . . . 0.87 112.254 -177.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.789 ' HB3' HD22 ' A' ' 143' ' ' LEU . 35.8 mmtm -94.68 -20.84 19.2 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.651 0.739 . . . . 1.71 110.103 177.185 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.582 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 14.1 tp -86.46 -49.34 7.67 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.617 -1.174 . . . . 0.16 112.413 -174.146 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.517 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 78.0 mt -55.66 -47.47 98.61 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.385 -0.825 . . . . 0.26 112.557 -172.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.517 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 76.5 Cg_exo -53.54 -28.53 45.81 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 122.356 2.037 . . . . 0.41 112.756 174.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.832 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 80.1 mt -86.23 -47.1 9.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.357 -0.383 . . . . 0.71 111.14 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.78 HD23 ' HG2' ' A' ' 37' ' ' PRO . 84.9 mt -57.45 -57.86 10.82 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-O 122.113 0.959 . . . . 0.34 109.781 176.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.393 0 CA-C-N 113.36 -1.745 . . . . 1.12 112.214 -178.708 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.8 p . . . . . 0 C--O 1.235 0.298 0 CA-C-O 121.307 0.575 . . . . 1.58 110.086 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 79.7 p 177.12 153.7 0.23 Allowed 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 105.842 -1.911 . . . . 1.17 105.842 -178.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.847 ' HB ' ' CD1' ' A' ' 118' ' ' LEU . 5.8 pt -69.26 -12.39 15.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 CA-C-N 115.063 -0.972 . . . . 0.38 112.133 -170.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.659 ' CD1' ' HA ' ' A' ' 31' ' ' VAL . 48.0 m-85 -74.83 -8.2 55.74 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 120.752 0.31 . . . . 0.3 111.184 -178.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -63.24 -21.13 66.03 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 108.91 -0.774 . . . . 2.11 108.91 170.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.835 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 60.8 m-85 -117.63 105.35 11.95 Favored 'General case' 0 CA--C 1.49 -1.341 0 CA-C-N 114.614 -1.175 . . . . 0.31 110.253 176.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -58.25 158.95 6.51 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 114.88 -1.054 . . . . 2.86 108.165 172.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.739 HG13 ' HZ ' ' A' ' 74' ' ' PHE . 20.3 t -108.33 169.28 3.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 107.393 -1.336 . . . . 0.67 107.393 -175.378 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.794 ' O ' ' HB2' ' A' ' 105' ' ' MET . 33.0 mt -127.21 141.52 51.71 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 109.534 -0.543 . . . . 0.69 109.534 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -71.21 -173.55 0.87 Allowed 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.24 -1.022 . . . . 1.87 108.24 174.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.75 ' HA ' ' CA ' ' A' ' 106' ' ' ALA . . . -66.93 -3.05 6.08 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 112.494 0.553 . . . . 0.59 112.494 -176.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 29.1 t70 -102.84 -3.25 26.55 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.803 -0.359 . . . . 2.34 110.832 176.005 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.656 ' CD2' ' HB3' ' A' ' 106' ' ' ALA . 1.9 m170 75.72 20.94 1.75 Allowed 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.741 0.781 . . . . 1.47 109.417 -178.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.477 ' HA ' ' HD3' ' A' ' 26' ' ' LYS . 45.9 mmtt -102.15 135.46 19.64 Favored Pre-proline 0 N--CA 1.443 -0.804 0 CA-C-N 114.397 -1.274 . . . . 4.25 108.45 171.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.64 ' HA ' HD23 ' A' ' 21' ' ' LEU . 84.7 Cg_exo -47.21 115.29 1.27 Allowed 'Trans proline' 0 C--N 1.335 -0.178 0 C-N-CA 123.341 2.694 . . . . 0.54 115.361 -165.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.622 ' OH ' ' HB3' ' A' ' 103' ' ' PRO . 0.2 OUTLIER -78.0 142.94 37.94 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 112.947 -1.933 . . . . 1.2 108.977 164.928 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.683 ' ND2' ' HB3' ' A' ' 32' ' ' GLN . 53.7 t30 -79.72 86.24 5.33 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.537 -0.542 . . . . 1.51 109.537 178.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.701 HD21 HD12 ' A' ' 15' ' ' ILE . 68.2 tp -67.61 -42.47 82.35 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.576 0.703 . . . . 0.28 110.01 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.659 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 1.6 m -69.56 -0.61 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.398 -1.274 . . . . 1.02 112.855 -167.403 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.683 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . 18.4 pt20 -75.03 -11.32 60.07 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.541 0.686 . . . . 1.02 109.289 174.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.953 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 91.0 m-70 -95.83 22.53 7.22 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 115.315 -0.857 . . . . 0.28 109.495 176.303 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.533 ' CE ' ' HB ' ' A' ' 31' ' ' VAL . 45.6 mttm -77.77 126.86 31.5 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 114.475 -1.239 . . . . 1.56 108.382 167.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.22 -44.81 1.42 Allowed Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 120.295 -0.955 . . . . 0.2 111.926 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.542 ' HB2' ' HA3' ' A' ' 68' ' ' GLY . 21.6 m -127.07 133.57 25.19 Favored Pre-proline 0 N--CA 1.435 -1.203 0 N-CA-C 108.9 -0.778 . . . . 0.29 108.9 174.192 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.771 ' HG3' ' CB ' ' A' ' 170' ' ' LEU . 6.1 Cg_endo -43.88 152.83 0.32 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 124.086 3.191 . . . . 0.18 112.891 177.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.872 ' HB2' HG22 ' A' ' 70' ' ' THR . 0.8 OUTLIER -139.02 152.97 48.04 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 106.375 -1.713 . . . . 0.31 106.375 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.975 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 2.8 mp -120.59 128.19 52.81 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.776 -0.578 . . . . 1.19 109.546 177.488 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.607 HD12 ' CE ' ' A' ' 122' ' ' MET . 1.0 OUTLIER -109.89 125.11 67.09 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-N 115.248 -0.887 . . . . 0.37 109.92 179.304 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.975 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.6 OUTLIER -110.62 124.94 52.83 Favored 'General case' 0 C--O 1.215 -0.729 0 CA-C-N 115.674 -0.693 . . . . 0.42 110.971 -172.031 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.678 ' OD1' ' HB3' ' A' ' 76' ' ' SER . 0.7 OUTLIER -77.83 121.96 24.8 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 105.726 -1.953 . . . . 2.35 105.726 165.177 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.712 HG13 ' HA ' ' A' ' 75' ' ' PRO . 1.5 p . . . . . 0 C--N 1.297 -1.703 0 C-N-CA 119.158 -1.017 . . . . 1.03 113.109 -164.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.467 0 N-CA-C 112.097 -0.401 . . . . 0.51 112.097 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -47.19 -40.83 14.63 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 112.115 -0.394 . . . . 0.5 112.115 177.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.0 -62.09 1.99 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.754 0.312 . . . . 0.7 110.407 -178.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.0 mp0 -59.55 -34.2 72.38 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.716 -0.675 . . . . 2.61 111.539 -178.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.643 ' HA ' HG22 ' A' ' 160' ' ' VAL . 97.0 m -68.47 -58.39 4.4 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.598 -0.728 . . . . 0.33 109.211 -176.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 1.097 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -59.5 -42.75 92.9 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.526 -1.216 . . . . 0.22 111.157 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.53 ' HA ' ' HD1' ' A' ' 102' ' ' PHE . 60.4 m -58.83 -56.86 16.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.86 -0.609 . . . . 0.26 110.923 -177.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 26.6 m -68.34 -35.36 77.65 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.417 -0.811 . . . . 0.48 111.344 -175.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.835 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 20.3 mt -65.61 -50.69 64.13 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-O 121.311 0.577 . . . . 0.43 110.432 -176.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.922 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 6.7 t80 -55.16 -51.89 65.03 Favored 'General case' 0 C--O 1.205 -1.268 0 CA-C-N 114.814 -1.085 . . . . 0.31 110.969 178.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.407 HD21 ' HB3' ' A' ' 101' ' ' GLU . 36.9 m-80 -73.71 -24.49 59.93 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 116.488 -0.324 . . . . 1.21 110.961 -170.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.527 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 34.9 ttpt -85.84 -23.5 27.11 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 109.039 -0.726 . . . . 1.54 109.039 -178.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.609 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 28.2 m-85 -124.86 -3.72 7.65 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 115.504 1.668 . . . . 0.31 115.504 -170.381 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.676 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 40.5 pttt -67.58 -26.23 66.17 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 107.897 -1.149 . . . . 1.35 107.897 170.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.3 m -49.23 -28.24 4.42 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 113.854 -1.521 . . . . 1.28 111.294 172.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -99.18 -34.54 10.32 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.496 0.189 . . . . 1.11 111.481 173.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.542 ' HA3' ' HB2' ' A' ' 36' ' ' SER . . . 150.95 -6.06 0.6 Allowed Glycine 0 CA--C 1.521 0.408 0 N-CA-C 111.863 -0.495 . . . . 0.18 111.863 -177.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.835 ' HE2' ' HB3' ' A' ' 60' ' ' LEU . 19.3 t80 -71.15 143.13 50.66 Favored 'General case' 0 C--O 1.218 -0.598 0 C-N-CA 122.705 0.402 . . . . 0.18 111.605 -176.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.953 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 4.8 t -134.65 153.99 51.73 Favored 'General case' 0 CA--C 1.483 -1.606 0 N-CA-C 108.354 -0.98 . . . . 0.2 108.354 172.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 1.097 HG11 ' HB1' ' A' ' 57' ' ' ALA . 42.7 t -113.27 99.86 9.51 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.407 0 N-CA-C 108.586 -0.894 . . . . 0.17 108.586 160.106 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.797 ' HA ' ' HG2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -94.73 120.47 35.0 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 118.498 -1.281 . . . . 1.04 107.735 174.423 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.951 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -109.53 127.39 54.43 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.915 0.864 . . . . 0.51 111.085 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.797 ' CG ' ' HG2' ' A' ' 105' ' ' MET . 5.8 m-30 -102.92 106.95 53.12 Favored Pre-proline 0 C--N 1.313 -1.009 0 CA-C-N 114.565 -1.198 . . . . 0.44 108.806 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.75 ' O ' ' HB2' ' A' ' 107' ' ' LYS . 65.2 Cg_endo -77.21 93.13 1.09 Allowed 'Trans proline' 0 C--O 1.221 -0.334 0 C-N-CA 122.474 2.116 . . . . 1.3 113.4 -168.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.678 ' HB3' ' OD1' ' A' ' 42' ' ' ASN . 70.6 p . . . . . 0 C--N 1.325 -0.459 0 CA-C-N 114.633 -1.167 . . . . 1.44 114.042 -167.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.663 0 CA-C-O 121.344 0.592 . . . . 0.55 111.528 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.407 ' HB3' HD21 ' A' ' 62' ' ' ASN . 21.8 mm-40 -86.04 24.25 1.34 Allowed 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.123 -0.944 . . . . 1.99 110.068 172.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.61 ' HB2' ' O ' ' A' ' 71' ' ' VAL . 26.1 p90 -147.69 156.07 44.95 Favored Pre-proline 0 N--CA 1.446 -0.673 0 N-CA-C 109.048 -0.723 . . . . 0.84 109.048 176.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.797 ' HG2' ' HA ' ' A' ' 72' ' ' LEU . 14.0 Cg_endo -54.13 101.81 0.08 OUTLIER 'Trans proline' 0 N--CA 1.479 0.639 0 C-N-CA 124.838 3.692 . . . . 0.62 114.97 -172.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.951 HD12 ' HB3' ' A' ' 73' ' ' ALA . 4.8 mm -101.84 122.15 53.7 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 N-CA-C 108.724 -0.843 . . . . 1.34 108.724 173.021 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.797 ' HG2' ' CG ' ' A' ' 74' ' ' PHE . 0.3 OUTLIER -81.61 -171.21 3.2 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.767 -0.651 . . . . 3.03 110.474 -176.005 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.75 ' CA ' ' HA ' ' A' ' 23' ' ' ALA . . . -66.49 -23.04 66.2 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 121.024 -0.271 . . . . 1.46 110.949 -177.348 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.75 ' HB2' ' O ' ' A' ' 75' ' ' PRO . 4.9 ptpp? 94.42 139.19 0.02 OUTLIER 'General case' 0 CA--C 1.493 -1.227 0 O-C-N 125.8 1.937 . . . . 1.76 109.13 -167.367 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.838 HG13 ' HB2' ' A' ' 116' ' ' HIS . 0.2 OUTLIER -130.87 176.7 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.099 0 N-CA-C 106.284 -1.747 . . . . 0.82 106.284 166.808 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -82.55 68.66 9.09 Favored 'General case' 0 C--N 1.293 -1.886 0 C-N-CA 120.299 -0.56 . . . . 1.73 110.156 -178.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.588 HG13 HD11 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -65.37 96.3 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 CA-C-N 115.54 -0.755 . . . . 0.77 110.434 -176.192 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 5.5 t-20 . . . . . 0 N--CA 1.448 -0.553 0 CA-C-N 115.118 -0.946 . . . . 1.9 108.681 171.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.838 ' HB2' HG13 ' A' ' 108' ' ' ILE . 7.8 t-80 . . . . . 0 N--CA 1.424 -1.756 0 CA-C-O 118.003 -0.999 . . . . 0.42 108.698 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -29.3 -41.77 0.07 OUTLIER 'Trans proline' 0 CA--C 1.535 0.525 0 C-N-CA 124.247 3.298 . . . . 0.4 113.323 179.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.847 ' CD1' ' HB ' ' A' ' 15' ' ' ILE . 22.1 tp -65.59 -50.94 63.24 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 123.435 0.694 . . . . 0.39 111.928 177.17 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.552 ' OH ' HG22 ' A' ' 40' ' ' ILE . 48.0 m-85 -75.91 -33.45 59.9 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 111.678 0.251 . . . . 3.04 111.678 176.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.465 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 21.9 mm-40 -58.38 -33.41 69.58 Favored 'General case' 0 CA--C 1.498 -1.037 0 N-CA-C 107.807 -1.183 . . . . 2.44 107.807 168.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.835 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 76.0 t80 -71.91 -31.08 66.03 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 119.581 -0.847 . . . . 0.56 110.682 171.172 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.629 ' HE2' HG21 ' A' ' 15' ' ' ILE . 49.1 mtt -74.65 -51.62 13.93 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 120.403 -0.519 . . . . 0.71 110.595 -170.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.462 ' HB2' ' HE2' ' A' ' 123' ' ' LYS . 0.1 OUTLIER -70.8 -25.89 63.07 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.936 -0.574 . . . . 1.46 111.192 176.734 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.579 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 10.0 ptmm? -70.02 -27.16 64.45 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 119.584 -0.847 . . . . 1.99 109.516 176.125 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 62.6 m -85.22 -56.99 3.26 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.495 -0.775 . . . . 0.59 110.839 178.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.535 ' HG2' HH22 ' A' ' 153' ' ' ARG . 20.7 ttmm . . . . . 0 C--N 1.326 -0.431 0 N-CA-C 109.819 -0.437 . . . . 1.85 109.819 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.223 -0.324 0 N-CA-C 111.671 0.248 . . . . 1.97 111.671 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.482 ' O ' ' N ' ' A' ' 140' ' ' THR . 8.5 m120 -37.04 -152.29 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 126.043 1.737 . . . . 2.04 112.685 158.331 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.743 ' HD1' ' HD2' ' A' ' 41' ' ' TYR . 0.2 OUTLIER -29.05 -22.54 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 116.76 2.134 . . . . 1.93 116.76 -171.411 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.7 ' HA ' ' O ' ' A' ' 154' ' ' PHE . 3.3 m -5.37 121.75 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 115.494 1.664 . . . . 0.6 115.494 168.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.461 ' CB ' HD23 ' A' ' 39' ' ' LEU . 0.7 OUTLIER -97.45 176.36 5.9 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.649 -1.16 . . . . 0.62 110.938 -177.661 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.506 ' HA ' ' HA ' ' A' ' 153' ' ' ARG . 23.7 m-85 -131.24 123.7 28.97 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 105.498 -2.038 . . . . 0.57 105.498 162.399 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.873 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 6.4 tp -79.87 104.33 10.38 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 118.075 -1.45 . . . . 0.43 108.289 178.375 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.702 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 45.8 mm -89.24 138.58 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.688 0 CA-C-N 112.722 -2.036 . . . . 0.19 107.586 -178.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.484 ' HA ' HD13 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -92.07 -174.83 3.9 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 119.282 -0.967 . . . . 0.98 110.939 -169.342 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.644 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 71.6 mtm180 -54.21 -38.88 66.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.98 0.419 . . . . 2.22 111.511 -177.14 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -95.91 15.56 20.1 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.31 -0.626 . . . . 2.0 109.31 -176.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.589 ' HA2' HG22 ' A' ' 144' ' ' ILE . . . 74.39 33.92 55.46 Favored Glycine 0 N--CA 1.442 -0.91 0 CA-C-N 115.821 -0.627 . . . . 0.17 114.499 -178.484 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.488 ' HA ' ' HD2' ' A' ' 150' ' ' PRO . 49.9 t -103.57 109.69 62.45 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-N 118.415 1.108 . . . . 1.12 111.633 176.292 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.827 ' HD3' HG23 ' A' ' 15' ' ' ILE . 6.5 Cg_endo -57.38 113.35 1.45 Allowed 'Trans proline' 0 CA--C 1.53 0.325 0 C-N-CA 123.715 2.943 . . . . 0.41 111.159 173.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.591 HG23 ' HG2' ' A' ' 152' ' ' GLU . 22.9 m -115.76 -16.86 8.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.331 0.586 . . . . 1.45 110.189 -177.145 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.873 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 53.9 mm-40 -139.61 167.48 22.01 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-N 115.376 -0.829 . . . . 1.17 110.088 178.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.535 HH22 ' HG2' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -148.22 129.95 15.11 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 114.608 -1.178 . . . . 2.16 108.664 163.943 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.7 ' O ' ' HA ' ' A' ' 140' ' ' THR . 94.2 m-85 -108.68 137.06 47.23 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.951 -0.568 . . . . 0.32 109.879 -170.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 20.1 m -62.77 156.61 64.34 Favored Pre-proline 0 C--N 1.323 -0.556 0 N-CA-C 109.393 -0.595 . . . . 1.11 109.393 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.58 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 14.1 Cg_endo -56.72 -48.22 19.73 Favored 'Trans proline' 0 CA--C 1.527 0.167 0 C-N-CA 121.765 1.643 . . . . 0.78 111.462 -177.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -55.64 -7.2 1.39 Allowed Glycine 0 CA--C 1.528 0.844 0 N-CA-C 115.692 1.037 . . . . 0.5 115.692 172.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -71.94 140.04 48.99 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 118.777 1.288 . . . . 0.5 109.256 176.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 22.2 t -103.69 170.26 8.04 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 109.629 -0.508 . . . . 1.42 109.629 -173.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.643 HG22 ' HA ' ' A' ' 56' ' ' THR . 60.5 t -41.14 -53.43 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 114.877 -1.056 . . . . 0.28 111.698 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 14.7 ttpp -63.58 -40.24 96.45 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.039 0.447 . . . . 3.46 111.104 -173.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -66.12 -30.43 70.92 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.432 -0.804 . . . . 1.4 109.795 -174.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.58 ' HA ' ' CE2' ' A' ' 154' ' ' PHE . 48.5 mt -82.77 -46.56 19.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.87 -1.059 . . . . 0.21 110.992 175.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.591 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 47.4 mt-10 -52.77 -43.33 65.74 Favored 'General case' 0 C--O 1.217 -0.626 0 O-C-N 123.314 0.384 . . . . 0.67 111.254 -175.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -55.51 -27.47 48.81 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.418 0.525 . . . . 0.87 112.418 -177.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.596 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 14.0 mmmm -97.98 -18.88 18.37 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.421 0.629 . . . . 1.71 109.938 176.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.566 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 12.4 tp -86.2 -49.14 7.95 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.029 -0.987 . . . . 0.16 112.142 -176.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.439 HD11 ' HB3' ' A' ' 164' ' ' GLU . 81.0 mt -55.47 -44.7 99.78 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-N 115.501 -0.772 . . . . 0.26 112.799 -173.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.419 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 72.3 Cg_exo -51.96 -35.33 60.14 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 122.002 1.802 . . . . 0.41 112.375 173.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.771 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 96.6 mt -80.91 -44.25 18.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.358 -0.383 . . . . 0.71 111.378 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.728 HD23 ' HG2' ' A' ' 37' ' ' PRO . 90.9 mt -59.88 -59.28 5.68 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 122.028 0.918 . . . . 0.34 109.899 176.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.434 0 CA-C-N 113.327 -1.76 . . . . 1.12 113.298 -177.526 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.0 t . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 121.079 0.466 . . . . 1.58 109.806 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 99.5 p -168.49 177.07 5.44 Favored 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 107.48 -1.304 . . . . 1.17 107.48 -177.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.981 HD12 HD21 ' A' ' 30' ' ' LEU . 5.2 pt -83.7 -18.77 9.92 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 CA-C-N 114.863 -1.062 . . . . 0.38 109.817 176.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.745 ' CD1' ' HA ' ' A' ' 31' ' ' VAL . 48.4 m-85 -70.95 -5.78 33.54 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.255 0.55 . . . . 0.3 110.713 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -69.18 -18.22 63.89 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.201 -0.909 . . . . 2.11 108.665 172.243 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.806 ' HE2' ' HB2' ' A' ' 121' ' ' TYR . 61.1 m-85 -119.35 108.05 14.12 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-O 121.781 0.801 . . . . 0.31 111.509 -178.177 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -48.48 146.88 2.69 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 113.488 -1.687 . . . . 2.86 110.336 170.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.781 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 37.1 t -110.86 165.0 6.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 109.393 -0.595 . . . . 0.67 109.393 -175.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.819 ' O ' ' HB3' ' A' ' 105' ' ' MET . 97.1 mt -126.49 111.28 14.23 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-O 119.505 -0.283 . . . . 0.69 111.332 -176.123 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.408 ' HA ' ' HE2' ' A' ' 105' ' ' MET . 13.4 t70 -53.9 161.84 1.08 Allowed 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 107.03 -1.47 . . . . 1.87 107.03 170.428 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.613 ' HA ' ' N ' ' A' ' 106' ' ' ALA . . . -57.02 -11.1 1.34 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 113.153 0.797 . . . . 0.59 113.153 -164.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 10.9 t70 -90.21 -4.18 57.38 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 122.386 0.274 . . . . 2.34 111.598 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.596 ' CE1' ' HB1' ' A' ' 106' ' ' ALA . 74.1 m80 79.95 20.71 0.57 Allowed 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.93 0.872 . . . . 1.47 108.995 -177.474 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.455 ' HA ' ' HD3' ' A' ' 26' ' ' LYS . 11.3 mmtp -104.69 125.96 32.55 Favored Pre-proline 0 N--CA 1.441 -0.892 0 CA-C-N 114.344 -1.298 . . . . 4.25 108.398 175.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.675 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 80.3 Cg_exo -48.79 114.74 1.34 Allowed 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.995 2.463 . . . . 0.54 114.917 -168.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.813 ' HE2' HD23 ' A' ' 72' ' ' LEU . 8.8 t80 -83.8 128.3 34.44 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 113.589 -1.641 . . . . 1.2 109.313 164.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.429 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 10.2 p30 -75.29 99.53 4.1 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 122.777 1.275 . . . . 1.51 110.143 176.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.981 HD21 HD12 ' A' ' 15' ' ' ILE . 61.7 tp -61.62 -32.82 72.97 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.507 -1.224 . . . . 0.28 110.591 178.059 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.745 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 3.7 m -63.77 -6.12 2.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 114.793 -1.094 . . . . 1.02 113.164 -169.05 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.429 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 13.7 pt20 -72.81 -7.88 52.85 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.006 -0.678 . . . . 1.02 109.737 177.306 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.923 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 90.1 m-70 -98.94 22.11 10.68 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.8 0.81 . . . . 0.28 109.866 176.611 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.524 ' HE2' ' HB ' ' A' ' 31' ' ' VAL . 62.2 mttm -78.75 122.09 25.58 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 114.683 -1.144 . . . . 1.56 109.156 169.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.05 -41.09 2.08 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.585 -0.817 . . . . 0.2 111.912 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.545 ' HB2' ' HA3' ' A' ' 68' ' ' GLY . 52.7 m -129.77 132.93 24.49 Favored Pre-proline 0 N--CA 1.437 -1.121 0 N-CA-C 108.839 -0.801 . . . . 0.29 108.839 173.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.779 ' HG3' ' CB ' ' A' ' 170' ' ' LEU . 4.2 Cg_endo -43.29 152.22 0.27 Allowed 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.951 3.1 . . . . 0.18 112.55 176.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.875 ' HB2' HG22 ' A' ' 70' ' ' THR . 0.7 OUTLIER -137.04 150.8 48.3 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.353 -1.721 . . . . 0.31 106.353 179.171 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.97 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 1.8 mp -116.26 122.61 45.49 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 121.419 0.628 . . . . 1.19 109.536 176.118 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.078 HG22 ' OH ' ' A' ' 119' ' ' TYR . 0.9 OUTLIER -102.51 123.6 55.93 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 CA-C-N 114.908 -1.042 . . . . 0.37 109.394 177.45 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.97 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.3 OUTLIER -109.25 129.7 55.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.31 -0.405 . . . . 0.42 110.569 -175.013 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.877 HD21 ' HE2' ' A' ' 142' ' ' PHE . 2.9 m-80 -78.89 93.13 4.98 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.213 -1.402 . . . . 2.35 107.213 169.13 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.714 HG12 ' CG ' ' A' ' 139' ' ' PHE . 34.9 m . . . . . 0 C--N 1.308 -1.234 0 C-N-CA 119.038 -1.065 . . . . 1.03 111.227 -170.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.893 0 N-CA-C 110.32 -1.112 . . . . 0.51 110.32 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -45.31 -47.98 11.06 Favored Glycine 0 C--O 1.223 -0.592 0 CA-C-N 115.011 -0.595 . . . . 0.5 113.222 175.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.01 -61.88 2.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.877 0.338 . . . . 0.7 111.524 -174.182 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -62.06 -23.88 66.75 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.268 0.556 . . . . 2.61 111.149 -178.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.653 ' HA ' HG22 ' A' ' 160' ' ' VAL . 23.4 m -75.79 -57.66 3.75 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.518 -0.765 . . . . 0.33 110.363 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 1.069 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -57.87 -38.48 75.81 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.942 -1.026 . . . . 0.22 110.949 -179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.543 ' HA ' ' CD1' ' A' ' 102' ' ' PHE . 54.8 m -60.92 -57.78 11.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.837 -0.619 . . . . 0.26 110.415 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 26.6 m -66.74 -37.84 85.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.378 -0.828 . . . . 0.48 111.534 -175.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.802 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 18.9 mt -65.3 -48.0 74.65 Favored 'General case' 0 CA--C 1.503 -0.849 0 CA-C-O 121.049 0.452 . . . . 0.43 110.679 -175.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.88 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 8.7 t80 -56.58 -50.96 70.38 Favored 'General case' 0 C--O 1.203 -1.394 0 CA-C-N 115.217 -0.901 . . . . 0.31 110.453 178.287 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -72.21 -24.57 61.42 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 120.745 0.307 . . . . 1.21 110.502 -172.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.3 ttmm -82.62 -26.35 32.32 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 109.107 -0.701 . . . . 1.54 109.107 -177.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.759 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 30.2 m-85 -127.61 -5.77 5.81 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 115.452 1.649 . . . . 0.31 115.452 -168.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.704 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 11.5 ptmt -63.65 -28.18 69.73 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 108.033 -1.099 . . . . 1.35 108.033 170.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.4 m -48.77 -34.83 12.97 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 113.84 -1.527 . . . . 1.28 110.782 172.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -93.64 -30.91 14.7 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.679 0.276 . . . . 1.11 111.52 176.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.545 ' HA3' ' HB2' ' A' ' 36' ' ' SER . . . 144.79 -7.64 1.71 Allowed Glycine 0 CA--C 1.519 0.323 0 N-CA-C 111.431 -0.668 . . . . 0.18 111.431 -177.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.802 ' HE2' ' HB3' ' A' ' 60' ' ' LEU . 21.5 t80 -69.52 141.71 53.82 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 122.744 0.418 . . . . 0.18 111.122 -177.444 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.923 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 3.8 t -133.91 152.17 51.76 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 107.985 -1.117 . . . . 0.2 107.985 173.547 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 1.069 HG11 ' HB1' ' A' ' 57' ' ' ALA . 33.4 t -110.82 100.32 10.52 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.454 0 N-CA-C 108.158 -1.053 . . . . 0.17 108.158 159.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.813 HD23 ' HE2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -96.7 121.5 38.61 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 107.829 -1.174 . . . . 1.04 107.829 175.18 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 1.032 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -111.28 116.81 31.65 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 115.705 -0.679 . . . . 0.51 110.295 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.955 ' HD2' HD12 ' A' ' 108' ' ' ILE . 1.4 m-30 -89.66 108.07 22.89 Favored Pre-proline 0 C--N 1.314 -0.951 0 N-CA-C 107.918 -1.141 . . . . 0.44 107.918 173.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.948 ' HG2' ' HB3' ' A' ' 107' ' ' LYS . 73.2 Cg_endo -75.24 64.22 6.24 Favored 'Trans proline' 0 N--CA 1.476 0.459 0 C-N-CA 123.632 2.888 . . . . 1.3 115.199 -168.373 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.3 t . . . . . 0 N--CA 1.483 1.211 0 N-CA-C 116.589 2.07 . . . . 1.44 116.589 175.247 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.523 ' HB1' ' CE1' ' A' ' 102' ' ' PHE . . . . . . . . 0 CA--C 1.513 -0.479 0 CA-C-O 121.306 0.574 . . . . 0.55 112.011 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -93.05 11.97 25.72 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.242 -0.89 . . . . 1.99 109.589 177.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.616 ' CE2' HD11 ' A' ' 104' ' ' ILE . 7.5 p90 -134.48 163.39 51.56 Favored Pre-proline 0 N--CA 1.444 -0.725 0 N-CA-C 108.175 -1.046 . . . . 0.84 108.175 178.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.806 ' HG2' ' HA ' ' A' ' 72' ' ' LEU . 26.4 Cg_endo -57.12 97.03 0.07 OUTLIER 'Trans proline' 0 N--CA 1.477 0.554 0 C-N-CA 123.57 2.847 . . . . 0.62 114.063 -173.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 1.032 HD12 ' HB3' ' A' ' 73' ' ' ALA . 7.6 mm -99.59 123.55 52.41 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.931 0 N-CA-C 107.969 -1.123 . . . . 1.34 107.969 173.08 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.842 ' HG3' ' CE1' ' A' ' 74' ' ' PHE . 13.5 mmt -100.99 -163.87 1.06 Allowed 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.304 -0.862 . . . . 3.03 111.791 -165.342 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.613 ' N ' ' HA ' ' A' ' 23' ' ' ALA . . . -71.37 4.07 3.24 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.228 -0.897 . . . . 1.46 113.337 -169.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.948 ' HB3' ' HG2' ' A' ' 75' ' ' PRO . 15.8 ptpt 53.77 123.57 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.048 0 CA-C-O 122.701 1.239 . . . . 1.76 111.5 -170.265 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.955 HD12 ' HD2' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -122.73 177.68 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.689 0 N-CA-C 108.249 -1.019 . . . . 0.82 108.249 171.183 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 33.8 t-20 -70.87 72.16 0.55 Allowed 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 114.46 -1.246 . . . . 1.73 111.252 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 110' ' ' VAL . 13.7 m -72.28 92.49 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 CA-C-O 122.338 1.066 . . . . 0.77 108.202 175.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 . . . . . 0 N--CA 1.436 -1.135 0 CA-C-N 114.442 -1.254 . . . . 1.9 109.525 -175.072 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.899 ' CB ' HG13 ' A' ' 108' ' ' ILE . 5.9 t-80 . . . . . 0 N--CA 1.425 -1.717 0 N-CA-C 106.995 -1.483 . . . . 0.42 106.995 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -26.42 -46.28 0.07 OUTLIER 'Trans proline' 0 C--O 1.219 -0.471 0 C-N-CA 124.456 3.437 . . . . 0.4 113.592 178.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.898 HD11 ' HB ' ' A' ' 15' ' ' ILE . 42.3 tp -61.63 -51.64 67.64 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.168 0.587 . . . . 0.39 112.251 177.245 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 1.078 ' OH ' HG22 ' A' ' 40' ' ' ILE . 46.5 m-85 -79.74 -33.39 40.84 Favored 'General case' 0 CA--C 1.489 -1.403 0 CA-C-O 121.238 0.542 . . . . 3.04 109.789 -177.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.491 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 13.3 tt0 -56.41 -40.7 75.12 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 107.017 -1.475 . . . . 2.44 107.017 172.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.806 ' HB2' ' HE2' ' A' ' 18' ' ' PHE . 88.8 t80 -65.97 -33.91 76.9 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 114.915 -1.038 . . . . 0.56 110.203 174.392 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.688 ' HE3' ' HG ' ' A' ' 118' ' ' LEU . 2.1 ttm -75.36 -54.93 6.24 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.207 -0.451 . . . . 0.71 110.955 -168.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.478 ' HB2' ' HE2' ' A' ' 123' ' ' LYS . 0.1 OUTLIER -68.77 -26.11 65.05 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 116.13 -0.486 . . . . 1.46 110.904 178.349 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.491 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 12.6 pttp -74.95 -26.71 59.8 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 119.587 -0.845 . . . . 1.99 109.838 177.49 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.47 HG21 ' HG2' ' A' ' 150' ' ' PRO . 52.6 m -71.45 -57.69 4.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.832 -0.622 . . . . 0.59 111.359 177.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 42.8 tttp . . . . . 0 N--CA 1.452 -0.374 0 C-N-CA 120.181 -0.607 . . . . 1.85 112.294 -174.006 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.466 ' HB3' ' HG3' ' A' ' 156' ' ' PRO . 10.7 m-90 . . . . . 0 N--CA 1.453 -0.283 0 CA-C-O 121.51 0.671 . . . . 1.97 112.492 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.612 ' HB3' ' HB3' ' A' ' 156' ' ' PRO . 8.5 t-20 -39.46 -154.93 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.895 1.678 . . . . 2.04 112.064 157.376 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.714 ' CG ' HG12 ' A' ' 43' ' ' VAL . 2.2 m-85 -27.96 -44.96 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 115.66 1.726 . . . . 1.93 115.66 -166.194 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.743 ' HA ' ' O ' ' A' ' 154' ' ' PHE . 26.9 m 33.87 97.38 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.793 1.035 . . . . 0.6 113.793 171.204 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.644 ' HB3' HD23 ' A' ' 39' ' ' LEU . 5.0 m -86.45 170.82 11.62 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.534 -1.212 . . . . 0.62 111.892 -171.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.877 ' HE2' HD21 ' A' ' 42' ' ' ASN . 88.8 m-85 -133.39 121.87 22.93 Favored 'General case' 0 CA--C 1.489 -1.366 0 N-CA-C 106.111 -1.811 . . . . 0.57 106.111 162.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.825 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 7.7 tp -79.6 104.56 10.28 Favored 'General case' 0 N--CA 1.422 -1.838 0 C-N-CA 118.089 -1.444 . . . . 0.43 108.291 178.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.743 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 47.9 mm -89.62 140.28 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.938 0 CA-C-N 112.709 -2.041 . . . . 0.19 107.731 -178.097 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.613 ' OD1' HG12 ' A' ' 149' ' ' VAL . 0.0 OUTLIER -91.94 -174.23 3.73 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 119.588 -0.845 . . . . 0.98 111.61 -170.276 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.758 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 35.8 mtt85 -56.28 -38.39 71.14 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 122.468 0.307 . . . . 2.22 111.556 -176.282 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -100.76 21.39 13.61 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.036 -1.098 . . . . 2.0 108.036 -178.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.651 ' HA2' HG22 ' A' ' 144' ' ' ILE . . . 69.31 37.45 80.3 Favored Glycine 0 N--CA 1.435 -1.388 0 CA-C-N 114.661 -1.154 . . . . 0.17 115.263 176.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.613 HG12 ' OD1' ' A' ' 145' ' ' ASP . 4.3 p -106.69 122.05 43.1 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 119.469 1.634 . . . . 1.12 110.806 171.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.624 ' HD3' HG23 ' A' ' 15' ' ' ILE . 11.6 Cg_endo -64.64 124.17 12.82 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 123.253 2.636 . . . . 0.41 111.468 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.9 m -124.54 -9.43 6.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 120.758 0.313 . . . . 1.45 110.468 -177.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.825 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 19.9 mm-40 -142.82 166.06 25.68 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 121.266 0.555 . . . . 1.17 110.861 175.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.527 ' HA ' ' O ' ' A' ' 141' ' ' SER . 5.8 ttm180 -148.14 135.61 20.62 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.551 -1.204 . . . . 2.16 108.849 166.207 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.743 ' O ' ' HA ' ' A' ' 140' ' ' THR . 97.2 m-85 -117.23 155.05 30.09 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.08 -0.711 . . . . 0.32 109.08 -169.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.441 ' HB3' ' HD2' ' A' ' 156' ' ' PRO . 22.3 m -83.22 163.04 52.22 Favored Pre-proline 0 C--N 1.316 -0.857 0 N-CA-C 109.497 -0.557 . . . . 1.11 109.497 175.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.612 ' HB3' ' HB3' ' A' ' 138' ' ' ASN . 20.1 Cg_endo -60.48 -31.13 92.1 Favored 'Trans proline' 0 CA--C 1.52 -0.176 0 C-N-CA 122.238 1.959 . . . . 0.78 110.681 174.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -68.97 -16.55 70.67 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 114.367 -1.288 . . . . 0.5 112.938 174.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.402 ' HB3' ' HB3' ' A' ' 154' ' ' PHE . . . -76.84 137.52 39.25 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 108.572 -0.899 . . . . 0.5 108.572 176.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.485 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 6.0 m -116.37 -177.06 3.09 Favored 'General case' 0 N--CA 1.436 -1.156 0 C-N-CA 120.48 -0.488 . . . . 1.42 110.727 -170.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.653 HG22 ' HA ' ' A' ' 56' ' ' THR . 54.9 t -42.43 -50.28 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.23 -0.895 . . . . 0.28 111.799 -178.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -68.62 -35.05 76.79 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.046 0.451 . . . . 3.46 111.081 -174.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.411 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 15.9 m-20 -69.91 -34.9 74.11 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.644 0.735 . . . . 1.4 109.737 -177.323 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.548 HD12 HG21 ' A' ' 56' ' ' THR . 54.8 mt -81.03 -49.1 18.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 114.797 -1.092 . . . . 0.21 111.369 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.604 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 39.3 mt-10 -52.41 -42.78 64.36 Favored 'General case' 0 C--O 1.216 -0.685 0 O-C-N 123.211 0.319 . . . . 0.67 111.082 -176.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 12.7 pt-20 -56.51 -25.73 52.42 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.418 -0.355 . . . . 0.87 111.535 -175.202 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.436 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 31.1 mmtp -96.84 -31.1 12.78 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.645 0.736 . . . . 1.71 109.857 176.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.604 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 14.7 tp -75.08 -48.56 23.29 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.302 -1.317 . . . . 0.16 112.149 -175.232 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.478 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 72.5 mt -56.31 -46.78 99.76 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.412 -0.813 . . . . 0.26 112.629 -172.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.478 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 73.4 Cg_exo -52.24 -26.02 25.52 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.233 1.956 . . . . 0.41 112.738 174.115 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.779 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 89.6 mt -89.92 -46.82 8.27 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 122.334 -0.228 . . . . 0.71 111.294 178.265 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.732 HD23 ' HG2' ' A' ' 37' ' ' PRO . 93.0 mt -59.22 -55.84 29.77 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-O 122.119 0.961 . . . . 0.34 109.874 176.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.701 0 CA-C-N 113.332 -1.758 . . . . 1.12 113.473 -174.759 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.1 t . . . . . 0 N--CA 1.452 -0.33 0 CA-C-O 121.187 0.517 . . . . 1.58 109.698 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.9 m -159.02 155.41 27.42 Favored 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 105.534 -2.024 . . . . 1.17 105.534 -176.019 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.903 ' HB ' HD11 ' A' ' 118' ' ' LEU . 5.9 pt -57.73 -18.91 10.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-N 115.011 -0.995 . . . . 0.38 111.805 -177.164 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.83 ' HB3' HG13 ' A' ' 31' ' ' VAL . 26.1 m-85 -70.16 -0.01 7.04 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.998 0.74 . . . . 0.3 112.998 -173.543 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -78.67 -17.09 56.48 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.429 -0.952 . . . . 2.11 108.429 177.16 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.63 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 39.8 m-85 -111.98 112.2 23.67 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 114.56 -1.2 . . . . 0.31 111.636 -172.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -45.21 137.02 4.76 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 113.599 -1.637 . . . . 2.86 111.072 172.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.864 HG13 ' HZ ' ' A' ' 74' ' ' PHE . 65.3 t -112.19 164.47 8.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 107.877 -1.157 . . . . 0.67 107.877 178.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.706 HD23 ' HA ' ' A' ' 27' ' ' PRO . 60.0 mt -130.85 157.68 42.22 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.692 0.282 . . . . 0.69 111.053 -177.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.533 ' HB3' ' HE3' ' A' ' 26' ' ' LYS . 20.5 t70 -85.18 172.94 10.8 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 106.795 -1.558 . . . . 1.87 106.795 163.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.695 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . . . -62.78 -3.83 1.76 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.28 0.844 . . . . 0.59 113.28 -170.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.674 ' HB2' ' HE2' ' A' ' 26' ' ' LYS . 47.7 m-20 -117.05 17.42 14.89 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.764 -0.374 . . . . 2.34 111.526 176.217 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.464 ' HA ' HD13 ' A' ' 21' ' ' LEU . 91.5 m-70 74.55 15.02 3.43 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-O 121.839 0.828 . . . . 1.47 109.17 174.011 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.674 ' HE2' ' HB2' ' A' ' 24' ' ' ASP . 35.2 mtmt -77.81 109.15 8.9 Favored Pre-proline 0 N--CA 1.446 -0.634 0 N-CA-C 107.367 -1.345 . . . . 4.25 107.367 169.658 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.706 ' HA ' HD23 ' A' ' 21' ' ' LEU . 93.7 Cg_exo -48.39 116.22 1.94 Allowed 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.503 2.135 . . . . 0.54 113.501 -171.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.799 ' OH ' ' HB3' ' A' ' 103' ' ' PRO . 0.2 OUTLIER -76.45 146.73 38.37 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 113.721 -1.581 . . . . 1.2 111.649 176.273 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.696 ' ND2' ' HB3' ' A' ' 32' ' ' GLN . 58.6 t30 -84.9 96.69 9.42 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.171 -0.922 . . . . 1.51 109.597 175.484 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.702 HD13 HG21 ' A' ' 20' ' ' VAL . 61.4 tp -79.13 -45.99 18.89 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.877 -0.601 . . . . 0.28 110.914 -177.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.849 HG12 ' HE2' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -65.31 -0.08 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.435 0 CA-C-N 115.611 -0.722 . . . . 1.02 112.771 -173.594 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.696 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . 13.0 pt20 -76.71 -12.49 60.0 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 119.832 -0.747 . . . . 1.02 109.323 175.329 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.934 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 92.8 m-70 -92.98 24.75 3.53 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 122.405 1.098 . . . . 0.28 108.685 175.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.849 ' HE2' HG12 ' A' ' 31' ' ' VAL . 36.8 mttm -77.67 109.73 11.9 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 113.419 -1.718 . . . . 1.56 109.446 170.319 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.35 -38.04 2.48 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 120.191 -1.004 . . . . 0.2 112.348 177.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.479 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 17.1 m -126.98 133.77 25.4 Favored Pre-proline 0 N--CA 1.437 -1.082 0 N-CA-C 108.748 -0.834 . . . . 0.29 108.748 172.07 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.724 ' HG3' ' CB ' ' A' ' 170' ' ' LEU . 5.3 Cg_endo -44.27 158.13 0.15 Allowed 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 124.136 3.224 . . . . 0.18 112.732 176.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.809 ' HB2' HG22 ' A' ' 70' ' ' THR . 1.0 OUTLIER -145.14 141.2 28.55 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.296 -1.372 . . . . 0.31 107.296 -179.215 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 1.015 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 2.2 mm? -106.38 112.96 26.2 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.838 -0.801 . . . . 1.19 108.838 178.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.705 HG13 HG13 ' A' ' 144' ' ' ILE . 1.3 mt -96.59 123.98 49.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 109.403 -0.591 . . . . 0.37 109.403 176.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 1.015 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.5 OUTLIER -110.68 131.2 55.26 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.433 -0.349 . . . . 0.42 110.561 -174.552 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.508 ' HB2' HG21 ' A' ' 110' ' ' VAL . 0.6 OUTLIER -79.1 117.53 20.22 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 105.874 -1.898 . . . . 2.35 105.874 166.598 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.702 HG23 ' HA ' ' A' ' 75' ' ' PRO . 35.0 m . . . . . 0 C--N 1.307 -1.261 0 O-C-N 120.973 -1.079 . . . . 1.03 111.603 -172.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.281 0 N-CA-C 113.713 0.245 . . . . 0.51 113.713 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.409 ' HA2' ' HB ' ' A' ' 56' ' ' THR . . . -55.58 -24.13 38.27 Favored Glycine 0 C--O 1.223 -0.562 0 C-N-CA 121.604 -0.331 . . . . 0.5 112.557 175.219 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.65 -50.3 69.85 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.345 -0.613 . . . . 0.7 109.345 175.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -61.85 -29.98 70.54 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.292 -0.867 . . . . 2.61 109.813 177.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.576 ' CG2' HD12 ' A' ' 163' ' ' ILE . 67.1 m -73.6 -59.07 2.89 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 114.177 -1.374 . . . . 0.33 110.133 -175.276 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.998 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -59.13 -43.42 92.0 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.664 -1.153 . . . . 0.22 111.129 -178.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.496 ' HA ' ' CD1' ' A' ' 102' ' ' PHE . 54.3 m -55.53 -58.0 9.59 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.572 0.701 . . . . 0.26 110.599 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 86.5 m -68.25 -38.61 81.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.745 -1.116 . . . . 0.48 111.772 -176.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.759 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 16.2 mt -63.05 -48.65 77.8 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 121.499 0.666 . . . . 0.43 110.293 -177.246 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.861 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 10.6 t80 -59.35 -48.71 80.6 Favored 'General case' 0 C--O 1.203 -1.345 0 CA-C-N 114.718 -1.128 . . . . 0.31 110.881 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -73.52 -23.94 60.08 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 120.577 0.227 . . . . 1.21 110.686 -173.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.416 ' HB2' ' HE2' ' A' ' 63' ' ' LYS . 24.2 ttmm -84.4 -25.42 29.08 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 108.687 -0.857 . . . . 1.54 108.687 -177.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.718 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 44.5 m-85 -127.88 -2.21 5.92 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 115.583 1.697 . . . . 0.31 115.583 -170.197 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.678 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 15.0 pttp -67.26 -24.99 65.85 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 108.332 -0.988 . . . . 1.35 108.332 171.506 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.8 m -47.99 -38.01 16.01 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 114.035 -1.439 . . . . 1.28 110.978 173.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -86.61 -37.69 17.84 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 111.915 0.339 . . . . 1.11 111.915 174.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 149.83 -4.41 0.64 Allowed Glycine 0 N--CA 1.45 -0.367 0 N-CA-C 111.265 -0.734 . . . . 0.18 111.265 -177.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.759 ' HE2' ' HB3' ' A' ' 60' ' ' LEU . 22.9 t80 -67.6 141.36 56.81 Favored 'General case' 0 C--O 1.22 -0.461 0 C-N-CA 122.794 0.437 . . . . 0.18 111.323 -178.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.934 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 1.5 t -135.92 144.56 45.55 Favored 'General case' 0 CA--C 1.487 -1.476 0 N-CA-C 109.016 -0.735 . . . . 0.2 109.016 173.416 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.998 HG11 ' HB1' ' A' ' 57' ' ' ALA . 38.6 t -104.07 101.37 12.17 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.199 0 N-CA-C 108.613 -0.884 . . . . 0.17 108.613 160.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.691 ' HA ' ' HG2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -96.11 121.66 38.11 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 118.475 -1.29 . . . . 1.04 108.113 173.174 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.999 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -108.64 140.05 42.57 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.405 0.621 . . . . 0.51 110.351 179.431 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.864 ' HZ ' HG13 ' A' ' 20' ' ' VAL . 6.4 m-30 -115.31 110.39 45.36 Favored Pre-proline 0 C--N 1.311 -1.091 0 CA-C-N 115.507 -0.77 . . . . 0.44 109.234 -177.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.702 ' HA ' HG23 ' A' ' 43' ' ' VAL . 60.4 Cg_endo -78.18 46.58 2.13 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.567 2.844 . . . . 1.3 115.454 -164.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.474 ' O ' ' HD3' ' A' ' 107' ' ' LYS . 73.6 p . . . . . 0 N--CA 1.478 0.967 0 N-CA-C 117.215 2.302 . . . . 1.44 117.215 176.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.511 -0.536 0 CA-C-O 121.226 0.536 . . . . 0.55 111.826 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -85.33 8.74 17.59 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.166 -0.925 . . . . 1.99 109.876 175.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.613 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 16.9 p90 -138.81 161.22 59.53 Favored Pre-proline 0 N--CA 1.442 -0.842 0 CA-C-N 115.588 -0.733 . . . . 0.84 109.619 -178.03 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.799 ' HB3' ' OH ' ' A' ' 28' ' ' TYR . 18.2 Cg_endo -57.41 110.98 0.69 Allowed 'Trans proline' 0 CA--C 1.51 -0.701 0 C-N-CA 124.122 3.215 . . . . 0.62 114.1 -175.449 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.999 HD12 ' HB3' ' A' ' 73' ' ' ALA . 7.0 mm -108.56 134.24 51.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 C-N-CA 119.925 -0.71 . . . . 1.34 109.227 172.155 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.833 ' HG2' ' CG ' ' A' ' 74' ' ' PHE . 0.0 OUTLIER -89.54 -177.08 5.22 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.988 -0.551 . . . . 3.03 109.657 179.577 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.695 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . . . -57.25 -51.53 68.97 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.241 0.544 . . . . 1.46 110.418 -177.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.695 ' HB3' ' HG2' ' A' ' 75' ' ' PRO . 13.9 ptpt 128.57 121.96 0.0 OUTLIER 'General case' 0 CA--C 1.492 -1.28 0 C-N-CA 127.407 2.283 . . . . 1.76 106.036 -176.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.637 HD11 ' HD2' ' A' ' 74' ' ' PHE . 2.1 pp -129.41 156.58 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.242 0 N-CA-C 106.161 -1.792 . . . . 0.82 106.161 177.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -52.06 117.82 3.04 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 123.696 0.623 . . . . 1.73 109.942 -179.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.508 HG21 ' HB2' ' A' ' 42' ' ' ASN . 3.5 m -113.67 86.83 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.621 0 N-CA-C 107.625 -1.25 . . . . 0.77 107.625 169.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 . . . . . 0 N--CA 1.445 -0.704 0 CA-C-N 113.844 -1.525 . . . . 1.9 109.435 -178.519 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.582 ' HB2' ' HB ' ' A' ' 108' ' ' ILE . 6.4 t-80 . . . . . 0 N--CA 1.419 -2.006 0 N-CA-C 107.166 -1.42 . . . . 0.42 107.166 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.581 ' HB2' ' CD1' ' A' ' 18' ' ' PHE . 11.5 Cg_exo -33.9 -41.35 0.2 Allowed 'Trans proline' 0 C--O 1.218 -0.483 0 C-N-CA 123.872 3.048 . . . . 0.4 113.099 -178.061 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.911 ' HG ' ' HE3' ' A' ' 122' ' ' MET . 33.5 tp -63.65 -48.53 76.86 Favored 'General case' 0 C--O 1.222 -0.369 0 C-N-CA 123.208 0.603 . . . . 0.39 111.726 176.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.689 ' HA ' ' HB2' ' A' ' 122' ' ' MET . 23.3 m-85 -78.04 -34.36 50.59 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 111.944 0.35 . . . . 3.04 111.944 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.51 ' HA ' ' HD2' ' A' ' 123' ' ' LYS . 0.8 OUTLIER -60.32 -35.82 76.51 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 106.809 -1.552 . . . . 2.44 106.809 171.617 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.63 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 55.1 t80 -70.29 -30.69 67.76 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 119.525 -0.87 . . . . 0.56 110.051 173.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.911 ' HE3' ' HG ' ' A' ' 118' ' ' LEU . 1.5 ttm -76.15 -54.58 6.6 Favored 'General case' 0 CA--C 1.509 -0.616 0 C-N-CA 120.388 -0.525 . . . . 0.71 110.479 -169.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.623 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -70.78 -25.43 62.89 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.297 -0.41 . . . . 1.46 111.437 179.398 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.52 ' N ' ' HD3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -71.67 -29.0 64.12 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 119.552 -0.859 . . . . 1.99 109.609 178.244 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 27.1 m -92.21 -24.94 18.88 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.571 -0.741 . . . . 0.59 111.52 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.484 ' HE2' ' HA ' ' A' ' 151' ' ' VAL . 23.5 mmtm . . . . . 0 C--N 1.325 -0.472 0 N-CA-C 112.387 0.514 . . . . 1.85 112.387 -173.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.665 ' HB3' ' HG3' ' A' ' 156' ' ' PRO . 0.7 OUTLIER . . . . . 0 CA--C 1.52 -0.208 0 CA-C-O 120.516 0.198 . . . . 1.97 111.122 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.48 ' HB3' ' H ' ' A' ' 139' ' ' PHE . 88.7 m-20 -35.56 -153.6 0.0 OUTLIER 'General case' 0 C--O 1.207 -1.168 0 CA-C-N 114.527 -1.215 . . . . 2.04 112.409 155.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.694 ' O ' ' HB3' ' A' ' 41' ' ' TYR . 0.9 OUTLIER -29.65 -21.97 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 117.495 2.406 . . . . 1.93 117.495 -172.162 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.674 ' HA ' ' O ' ' A' ' 154' ' ' PHE . 0.2 OUTLIER -7.58 120.32 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 120.141 1.337 . . . . 0.6 114.559 173.948 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.61 ' O ' ' HA ' ' A' ' 153' ' ' ARG . 1.0 OUTLIER -104.9 163.63 12.38 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.33 -1.305 . . . . 0.62 111.101 -167.971 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.512 ' CG ' ' HG2' ' A' ' 122' ' ' MET . 97.4 m-85 -125.1 123.24 39.3 Favored 'General case' 0 CA--C 1.491 -1.32 0 N-CA-C 106.28 -1.748 . . . . 0.57 106.28 166.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.748 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 5.0 tp -79.46 102.25 8.66 Favored 'General case' 0 N--CA 1.425 -1.713 0 C-N-CA 118.242 -1.383 . . . . 0.43 108.157 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.705 HG13 HG13 ' A' ' 40' ' ' ILE . 39.1 mm -88.24 141.4 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 CA-C-N 113.8 -1.546 . . . . 0.19 107.611 -177.127 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.457 ' HA ' HD13 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -95.81 -174.83 3.24 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 119.359 -0.936 . . . . 0.98 111.234 -168.377 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.581 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 57.0 mtm180 -55.13 -40.11 70.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.818 0.342 . . . . 2.22 111.619 -176.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -92.44 14.39 16.79 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 109.443 -0.577 . . . . 2.0 109.443 -178.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.548 ' HA2' HG22 ' A' ' 144' ' ' ILE . . . 73.6 33.87 57.64 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 121.211 -0.519 . . . . 0.17 113.601 -178.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.447 ' HA ' ' HD2' ' A' ' 150' ' ' PRO . 31.7 t -107.41 107.39 60.33 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 117.961 0.88 . . . . 1.12 111.239 176.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.697 ' HD3' HG23 ' A' ' 15' ' ' ILE . 5.9 Cg_exo -47.4 125.3 10.49 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 123.888 3.059 . . . . 0.41 112.158 173.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.484 ' HA ' ' HE2' ' A' ' 126' ' ' LYS . 44.2 t -116.13 -37.12 2.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 109.046 -0.724 . . . . 1.45 109.046 -177.164 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.748 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 6.8 mm-40 -130.86 167.07 19.55 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 115.612 -0.722 . . . . 1.17 111.665 -175.56 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.61 ' HA ' ' O ' ' A' ' 141' ' ' SER . 20.4 ttm180 -138.87 133.07 31.47 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.022 -0.99 . . . . 2.16 109.655 165.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.674 ' O ' ' HA ' ' A' ' 140' ' ' THR . 96.3 m-85 -117.03 137.25 52.37 Favored 'General case' 0 C--O 1.213 -0.837 0 CA-C-N 116.336 -0.393 . . . . 0.32 109.982 -172.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.568 ' HA ' HG23 ' A' ' 140' ' ' THR . 37.4 m -67.13 153.43 94.63 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 109.381 -0.6 . . . . 1.11 109.381 179.215 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.665 ' HG3' ' HB3' ' A' ' 137' ' ' TRP . 10.0 Cg_endo -53.26 -48.27 22.94 Favored 'Trans proline' 0 N--CA 1.473 0.272 0 C-N-CA 122.647 2.232 . . . . 0.78 112.732 -174.167 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -67.05 10.34 0.84 Allowed Glycine 0 CA--C 1.527 0.841 0 N-CA-C 114.937 0.735 . . . . 0.5 114.937 176.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -74.45 146.21 43.02 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-N 118.481 1.141 . . . . 0.5 108.669 171.008 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.552 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 90.9 p -102.61 171.61 7.33 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 120.513 -0.475 . . . . 1.42 109.864 -174.059 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.574 HG22 ' HA ' ' A' ' 56' ' ' THR . 58.3 t -42.28 -48.97 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 O-C-N 124.202 0.939 . . . . 0.28 110.767 175.077 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.46 ' HE3' ' HB2' ' A' ' 161' ' ' LYS . 37.2 ttmt -71.75 -31.89 67.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.429 -0.805 . . . . 3.46 111.249 -172.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -67.03 -38.0 85.13 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.565 0.698 . . . . 1.4 109.634 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.576 HD12 ' CG2' ' A' ' 56' ' ' THR . 73.8 mt -82.3 -39.8 16.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 114.903 -1.044 . . . . 0.21 111.022 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.556 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 30.2 mt-10 -53.4 -44.54 68.76 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-O 120.503 0.192 . . . . 0.67 111.478 -178.334 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -57.15 -24.8 56.79 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.956 0.354 . . . . 0.87 111.956 -174.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.626 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 44.0 mmtm -98.15 -24.86 15.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.532 0.682 . . . . 1.71 109.987 175.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.556 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 10.0 tp -78.4 -50.09 12.35 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.97 -1.014 . . . . 0.16 112.353 -177.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.478 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 70.6 mt -55.61 -46.63 99.7 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 115.499 -0.773 . . . . 0.26 112.352 -173.233 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.478 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 53.3 Cg_exo -54.92 -26.76 50.36 Favored 'Trans proline' 0 C--N 1.356 0.921 0 C-N-CA 122.128 1.885 . . . . 0.41 112.669 174.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.724 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 62.4 mt -86.32 -42.48 13.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.725 -0.216 . . . . 0.71 111.267 177.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.703 HD23 ' HG2' ' A' ' 37' ' ' PRO . 97.3 mt -60.04 -54.11 49.84 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 122.127 0.965 . . . . 0.34 109.53 176.011 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.106 0 CA-C-N 113.365 -1.743 . . . . 1.12 113.142 179.981 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 43.6 t . . . . . 0 C--O 1.235 0.307 0 CA-C-O 120.993 0.425 . . . . 1.58 110.22 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 91.4 p 178.52 157.98 0.49 Allowed 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 105.823 -1.918 . . . . 1.17 105.823 -177.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.818 HG23 ' HD3' ' A' ' 150' ' ' PRO . 6.7 pt -67.66 -17.63 22.72 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 CA-C-N 114.949 -1.023 . . . . 0.38 110.745 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.83 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 45.9 m-85 -74.74 -3.48 31.78 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 116.113 -0.494 . . . . 0.3 111.607 -176.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -67.14 -12.59 60.41 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.991 -1.114 . . . . 2.11 107.991 170.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.64 ' HE2' ' HB2' ' A' ' 121' ' ' TYR . 61.1 m-85 -129.07 109.81 11.5 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 114.794 -1.094 . . . . 0.31 110.007 -175.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -55.98 157.64 4.36 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 114.116 -1.402 . . . . 2.86 109.488 174.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.762 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 40.4 t -109.65 161.02 8.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 107.792 -1.188 . . . . 0.67 107.792 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.852 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 55.2 mt -126.09 122.49 35.91 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 120.552 -0.459 . . . . 0.69 109.901 -178.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.607 ' HA ' ' SD ' ' A' ' 105' ' ' MET . 0.8 OUTLIER -59.44 -175.85 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.387 0 O-C-N 124.31 1.006 . . . . 1.87 109.469 -179.179 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.717 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . . . -62.19 -3.93 1.52 Allowed 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 113.19 0.811 . . . . 0.59 113.19 -171.009 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -118.68 12.64 13.12 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.505 -0.478 . . . . 2.34 111.73 175.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.852 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 3.7 m-70 72.3 26.06 2.74 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.677 0.751 . . . . 1.47 110.266 174.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.43 ' HA ' ' HD3' ' A' ' 26' ' ' LYS . 54.2 mmtt -102.5 133.21 20.65 Favored Pre-proline 0 N--CA 1.448 -0.533 0 CA-C-N 114.618 -1.174 . . . . 4.25 107.879 171.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.631 ' HA ' HD23 ' A' ' 21' ' ' LEU . 83.5 Cg_exo -51.38 112.8 0.89 Allowed 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.111 1.874 . . . . 0.54 114.208 -166.279 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.782 ' CE2' HD21 ' A' ' 72' ' ' LEU . 50.0 t80 -83.58 126.0 32.37 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 113.79 -1.55 . . . . 1.2 108.617 165.386 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.524 HD22 HE21 ' A' ' 32' ' ' GLN . 43.8 p-10 -67.67 82.0 0.18 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.911 0.862 . . . . 1.51 110.848 -178.068 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.744 ' HB2' HG23 ' A' ' 20' ' ' VAL . 44.5 tp -51.98 -37.76 54.22 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.536 -0.756 . . . . 0.28 109.653 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.634 HG13 ' HB3' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -67.75 0.13 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 114.687 -1.142 . . . . 1.02 113.0 -173.857 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.524 HE21 HD22 ' A' ' 29' ' ' ASN . 3.4 pt20 -72.7 -18.87 61.5 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 119.815 -0.754 . . . . 1.02 108.968 173.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.93 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 79.4 m-70 -92.33 29.86 1.6 Allowed 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 115.497 -0.774 . . . . 0.28 109.749 175.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.83 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 29.0 mtmt -92.35 111.04 22.47 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 114.896 -1.047 . . . . 1.56 109.584 173.026 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.94 -38.14 2.03 Favored Glycine 0 N--CA 1.443 -0.899 0 N-CA-C 110.759 -0.936 . . . . 0.2 110.759 -177.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.425 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 15.0 m -132.24 136.03 27.42 Favored Pre-proline 0 N--CA 1.435 -1.202 0 N-CA-C 109.127 -0.694 . . . . 0.29 109.127 169.246 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.687 ' O ' ' HA ' ' A' ' 69' ' ' PHE . 10.3 Cg_endo -47.42 156.83 0.9 Allowed 'Trans proline' 0 CA--C 1.511 -0.651 0 C-N-CA 124.481 3.454 . . . . 0.18 113.499 178.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.872 ' HB2' HG22 ' A' ' 70' ' ' THR . 0.9 OUTLIER -133.65 152.06 51.8 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 106.978 -1.49 . . . . 0.31 106.978 173.4 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.85 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 1.6 mm? -110.82 117.23 32.84 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.896 -1.15 . . . . 1.19 107.896 174.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.764 HD12 ' CE ' ' A' ' 122' ' ' MET . 9.1 mt -98.92 119.05 46.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 C-N-CA 119.714 -0.795 . . . . 0.37 110.195 178.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.85 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -105.11 127.29 52.83 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.469 -0.787 . . . . 0.42 109.916 -176.239 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.796 ' HB2' HG11 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -78.39 104.93 9.31 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 106.233 -1.765 . . . . 2.35 106.233 165.81 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.533 ' HB ' ' CE1' ' A' ' 139' ' ' PHE . 4.5 m . . . . . 0 C--N 1.308 -1.21 0 C-N-CA 118.986 -1.086 . . . . 1.03 111.32 -171.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.524 0 N-CA-C 110.472 -1.051 . . . . 0.51 110.472 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -45.96 -41.12 10.31 Favored Glycine 0 C--O 1.216 -1.03 0 CA-C-N 114.635 -0.782 . . . . 0.5 113.132 176.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -64.82 -52.2 58.05 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.948 0.404 . . . . 0.7 111.006 -178.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -63.29 -29.15 70.53 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.711 -0.677 . . . . 2.61 109.984 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.891 HG21 HD12 ' A' ' 163' ' ' ILE . 87.7 m -75.14 -55.74 5.43 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.207 -0.906 . . . . 0.33 109.159 -179.209 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 1.013 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -54.1 -43.93 70.8 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.58 -1.191 . . . . 0.22 111.379 -178.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.458 ' HA ' ' CD1' ' A' ' 102' ' ' PHE . 30.3 m -61.68 -54.5 41.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.395 0.617 . . . . 0.26 110.142 -177.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.7 m -68.34 -35.61 78.03 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.235 -0.893 . . . . 0.48 111.591 -176.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.719 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 0.6 OUTLIER -63.83 -52.82 58.39 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-O 121.774 0.797 . . . . 0.43 110.162 -176.822 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.892 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 8.1 t80 -55.31 -49.19 72.8 Favored 'General case' 0 C--O 1.204 -1.337 0 CA-C-N 113.83 -1.532 . . . . 0.31 110.597 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.863 ' HA ' ' HE2' ' A' ' 65' ' ' LYS . 28.7 m-80 -72.97 -24.71 60.82 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 116.638 -0.255 . . . . 1.21 110.632 -173.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.415 ' HD2' ' CE2' ' A' ' 64' ' ' TYR . 39.2 ttmt -81.47 -29.59 33.68 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 108.674 -0.862 . . . . 1.54 108.674 -178.223 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.657 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 42.3 m-85 -125.5 -2.97 7.37 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 116.185 1.92 . . . . 0.31 116.185 -168.105 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.863 ' HE2' ' HA ' ' A' ' 62' ' ' ASN . 47.3 pttt -65.25 -24.94 67.46 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 107.906 -1.146 . . . . 1.35 107.906 170.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.5 t -48.63 -38.91 22.25 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 113.882 -1.508 . . . . 1.28 110.483 172.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -86.53 -36.13 19.13 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 111.818 0.303 . . . . 1.11 111.818 173.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 149.4 -7.47 0.84 Allowed Glycine 0 CA--C 1.521 0.408 0 N-CA-C 111.888 -0.485 . . . . 0.18 111.888 -175.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.719 ' HE2' ' HB3' ' A' ' 60' ' ' LEU . 17.9 t80 -65.34 142.47 58.22 Favored 'General case' 0 C--O 1.22 -0.45 0 C-N-CA 123.036 0.534 . . . . 0.18 111.586 -177.462 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.93 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 1.6 t -133.9 147.75 51.15 Favored 'General case' 0 N--CA 1.423 -1.799 0 N-CA-C 108.521 -0.918 . . . . 0.2 108.521 170.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 1.013 HG11 ' HB1' ' A' ' 57' ' ' ALA . 36.5 t -98.93 101.9 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.734 0 N-CA-C 107.832 -1.173 . . . . 0.17 107.832 158.099 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.782 HD21 ' CE2' ' A' ' 28' ' ' TYR . 6.3 mt -83.69 119.56 24.93 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 108.051 -1.092 . . . . 1.04 108.051 177.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.509 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -95.84 111.22 23.25 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.401 -0.592 . . . . 0.51 109.401 177.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 1.009 ' HD2' HD12 ' A' ' 108' ' ' ILE . 3.3 m-85 -101.18 91.95 2.28 Favored Pre-proline 0 C--N 1.312 -1.026 0 N-CA-C 107.386 -1.338 . . . . 0.44 107.386 172.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.654 ' O ' ' HB2' ' A' ' 107' ' ' LYS . 80.8 Cg_endo -77.11 77.72 3.7 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.854 2.369 . . . . 1.3 114.626 -166.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 C--N 1.32 -0.675 0 C-N-CA 126.744 2.018 . . . . 1.44 116.185 -178.713 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.624 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . . . . . . 0 CA--C 1.514 -0.422 0 CA-C-O 120.546 0.212 . . . . 0.55 110.634 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -91.2 -20.69 21.69 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.195 -0.457 . . . . 1.99 111.1 173.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.768 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 0.7 OUTLIER -89.52 175.04 4.21 Favored Pre-proline 0 N--CA 1.443 -0.784 0 CA-C-N 116.476 -0.329 . . . . 0.84 110.373 -177.513 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.768 ' HD2' ' HB2' ' A' ' 102' ' ' PHE . 70.7 Cg_endo -69.29 103.56 1.1 Allowed 'Trans proline' 0 C--N 1.336 -0.093 0 C-N-CA 122.818 2.345 . . . . 0.62 112.381 178.573 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.624 HD11 ' HB3' ' A' ' 100' ' ' ALA . 3.9 mp -101.1 120.75 51.07 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.018 0 N-CA-C 107.684 -1.228 . . . . 1.34 107.684 175.345 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.789 ' HG3' ' CE1' ' A' ' 74' ' ' PHE . 27.3 mmt -87.33 -164.54 1.1 Allowed 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.992 -1.004 . . . . 3.03 111.494 -169.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.717 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . . . -68.58 -16.22 63.79 Favored 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 120.315 -0.554 . . . . 1.46 111.07 -172.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.654 ' HB2' ' O ' ' A' ' 75' ' ' PRO . 10.5 ptpt 81.1 139.68 0.07 Allowed 'General case' 0 CA--C 1.493 -1.215 0 O-C-N 125.71 1.881 . . . . 1.76 108.397 -163.188 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 1.009 HD12 ' HD2' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -131.26 159.84 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.599 0 N-CA-C 104.785 -2.302 . . . . 0.82 104.785 169.604 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -64.48 80.53 0.04 OUTLIER 'General case' 0 C--N 1.287 -2.148 0 O-C-N 123.603 0.564 . . . . 1.73 110.427 177.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.821 ' HA ' ' OH ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -78.81 90.38 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 C-N-CA 118.701 -1.2 . . . . 0.77 108.2 -179.711 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.443 ' N ' ' OH ' ' A' ' 119' ' ' TYR . 2.1 t-20 . . . . . 0 N--CA 1.441 -0.889 0 CA-C-N 113.354 -1.748 . . . . 1.9 107.499 178.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.658 ' CB ' HG13 ' A' ' 108' ' ' ILE . 8.6 t-80 . . . . . 0 N--CA 1.418 -2.026 0 N-CA-C 107.542 -1.281 . . . . 0.42 107.542 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.589 ' HB2' ' CD1' ' A' ' 18' ' ' PHE . 5.4 Cg_exo -33.43 -37.72 0.1 OUTLIER 'Trans proline' 0 C--O 1.214 -0.717 1 C-N-CA 125.403 4.068 . . . . 0.4 114.064 -172.905 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.773 ' CD1' ' HB ' ' A' ' 15' ' ' ILE . 7.5 tp -63.5 -60.32 3.5 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 114.046 1.128 . . . . 0.39 114.046 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.821 ' OH ' ' HA ' ' A' ' 110' ' ' VAL . 3.8 p90 -82.7 -25.82 32.61 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 107.486 -1.302 . . . . 3.04 107.486 -177.155 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.62 ' HA ' ' HD2' ' A' ' 123' ' ' LYS . 1.9 tm-20 -59.25 -39.86 84.14 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.334 -1.358 . . . . 2.44 107.334 172.195 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.64 ' HB2' ' HE2' ' A' ' 18' ' ' PHE . 29.6 t80 -64.21 -29.3 70.41 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.007 -0.997 . . . . 0.56 110.145 169.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.764 ' CE ' HD12 ' A' ' 40' ' ' ILE . 66.9 mtt -73.4 -55.3 6.55 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 121.134 0.493 . . . . 0.71 110.797 -173.06 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.705 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -70.45 -22.49 62.69 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.154 -0.93 . . . . 1.46 110.817 177.754 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.61 ' HG3' ' O ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -73.37 -26.3 60.95 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 119.636 -0.826 . . . . 1.99 109.502 171.318 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 93.2 m -74.87 -55.91 5.31 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.221 0.534 . . . . 0.59 110.06 173.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.696 ' HG2' ' NH2' ' A' ' 153' ' ' ARG . 22.7 ttmm . . . . . 0 C--N 1.325 -0.493 0 CA-C-N 115.669 -0.696 . . . . 1.85 109.424 177.163 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.78 ' HB3' ' HG3' ' A' ' 156' ' ' PRO . 6.8 m-90 . . . . . 0 CA--C 1.519 -0.219 0 CA-C-O 121.01 0.433 . . . . 1.97 111.78 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.482 ' O ' ' N ' ' A' ' 140' ' ' THR . 10.7 t-20 -39.5 -155.32 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 113.852 -1.522 . . . . 2.04 111.37 157.103 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.607 ' HD2' ' HD2' ' A' ' 41' ' ' TYR . 1.6 m-85 -29.12 -25.06 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 117.924 2.565 . . . . 1.93 117.924 -171.188 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.69 ' HA ' ' O ' ' A' ' 154' ' ' PHE . 29.5 m -0.6 105.96 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 114.472 1.286 . . . . 0.6 114.472 175.623 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.616 ' HB3' HD12 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -86.12 170.33 12.3 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.167 -1.378 . . . . 0.62 110.302 -172.912 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.531 ' O ' HD13 ' A' ' 39' ' ' LEU . 86.7 m-85 -127.68 127.47 43.79 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 105.803 -1.925 . . . . 0.57 105.803 164.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.827 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 9.1 tp -80.55 104.71 11.26 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 118.238 -1.385 . . . . 0.43 108.534 176.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.759 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 41.7 mm -93.6 141.0 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.929 0 CA-C-N 113.746 -1.57 . . . . 0.19 107.154 -177.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.708 ' HA ' HD13 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -92.39 178.18 5.91 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 120.508 -0.477 . . . . 0.98 111.518 -171.736 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.462 ' CG ' ' HD3' ' A' ' 37' ' ' PRO . 66.8 mtm180 -48.71 -46.39 40.59 Favored 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 123.135 0.574 . . . . 2.22 111.494 -178.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -96.41 24.04 6.21 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.187 -0.672 . . . . 2.0 109.187 -178.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.535 ' HA2' ' CG2' ' A' ' 144' ' ' ILE . . . 71.68 42.6 53.94 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.083 -0.962 . . . . 0.17 113.789 175.107 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.482 ' O ' HG23 ' A' ' 151' ' ' VAL . 49.9 t -103.87 114.85 64.23 Favored Pre-proline 0 C--N 1.311 -1.074 0 C-N-CA 119.631 -0.828 . . . . 1.12 110.882 177.156 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.818 ' HD3' HG23 ' A' ' 15' ' ' ILE . 21.6 Cg_endo -67.02 113.06 2.68 Favored 'Trans proline' 0 CA--C 1.529 0.27 0 C-N-CA 122.998 2.465 . . . . 0.41 110.251 176.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 149' ' ' VAL . 16.3 t -113.66 -28.06 2.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-O 121.398 0.618 . . . . 1.45 109.788 -173.516 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.827 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 17.3 mm-40 -137.37 168.24 20.03 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 115.077 -0.965 . . . . 1.17 110.423 -177.241 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.696 ' NH2' ' HG2' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -145.92 137.71 25.1 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 114.59 -1.187 . . . . 2.16 108.901 161.729 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.716 ' HZ ' ' HB2' ' A' ' 166' ' ' LYS . 94.0 m-85 -112.25 145.56 39.72 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.126 -0.488 . . . . 0.32 110.161 -170.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 10.2 m -63.79 152.12 87.41 Favored Pre-proline 0 C--N 1.317 -0.842 0 N-CA-C 109.345 -0.613 . . . . 1.11 109.345 175.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.78 ' HG3' ' HB3' ' A' ' 137' ' ' TRP . 43.8 Cg_endo -66.69 -22.88 49.62 Favored 'Trans proline' 0 CA--C 1.512 -0.585 0 C-N-CA 122.28 1.987 . . . . 0.78 110.7 178.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -85.38 13.73 53.92 Favored Glycine 0 N--CA 1.44 -1.085 0 CA-C-N 114.773 -1.103 . . . . 0.5 112.87 173.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -87.63 149.83 24.04 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.225 -0.657 . . . . 0.5 109.225 172.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.5 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 17.5 m -108.66 171.99 7.1 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 121.181 0.515 . . . . 1.42 111.526 -174.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.776 ' HA ' HG23 ' A' ' 56' ' ' THR . 52.0 t -39.07 -55.74 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 114.463 -1.244 . . . . 0.28 111.853 176.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -64.56 -31.87 73.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.472 -0.786 . . . . 3.46 111.567 -174.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.446 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 23.6 m-20 -75.75 -32.62 60.05 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.24 -0.891 . . . . 1.4 110.305 -173.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.891 HD12 HG21 ' A' ' 56' ' ' THR . 57.3 mt -83.3 -44.48 18.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.234 -0.894 . . . . 0.21 110.913 177.021 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.578 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 37.9 mt-10 -54.31 -40.44 67.96 Favored 'General case' 0 C--O 1.218 -0.575 0 CA-C-N 116.613 -0.267 . . . . 0.67 111.506 -178.452 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 9.2 pt-20 -56.9 -27.24 60.52 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 112.1 0.407 . . . . 0.87 112.1 -177.379 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.716 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 46.2 mmtm -96.69 -26.04 15.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.394 0.616 . . . . 1.71 110.276 175.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.578 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 12.1 tp -76.96 -49.49 15.38 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.068 -0.969 . . . . 0.16 112.031 -177.046 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.509 HG13 ' O ' ' A' ' 164' ' ' GLU . 81.8 mt -53.29 -44.82 98.21 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-N 115.511 -0.768 . . . . 0.26 112.165 -174.226 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.427 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 85.5 Cg_exo -50.37 -39.35 53.78 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.133 1.889 . . . . 0.41 112.917 172.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.708 HD13 ' HA ' ' A' ' 145' ' ' ASP . 96.0 mt -79.34 -43.52 23.37 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.728 -0.389 . . . . 0.71 111.284 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.63 HD21 ' HB2' ' A' ' 69' ' ' PHE . 95.7 mt -57.93 -54.11 50.58 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 122.083 0.944 . . . . 0.34 109.674 176.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.235 0 CA-C-N 113.297 -1.774 . . . . 1.12 113.397 -177.995 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.2 t . . . . . 0 CA--C 1.533 0.289 0 CA-C-O 121.307 0.575 . . . . 1.58 109.853 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 65.5 p 179.05 152.34 0.36 Allowed 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 105.47 -2.048 . . . . 1.17 105.47 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.827 ' HB ' HD11 ' A' ' 118' ' ' LEU . 5.6 pt -64.99 -12.95 14.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-N 115.061 -0.972 . . . . 0.38 112.187 -171.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.769 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 43.6 m-85 -75.44 0.96 15.24 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.378 0.51 . . . . 0.3 112.378 -175.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -73.43 -19.26 61.01 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 108.242 -1.021 . . . . 2.11 108.242 174.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.694 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 57.1 m-85 -111.34 107.34 16.57 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 114.628 -1.169 . . . . 0.31 111.045 -174.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -51.07 140.96 14.91 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 113.843 -1.526 . . . . 2.86 109.03 174.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.783 HG13 ' HZ ' ' A' ' 74' ' ' PHE . 40.3 t -110.32 166.27 5.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 108.118 -1.067 . . . . 0.67 108.118 -177.332 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.713 ' O ' ' HB2' ' A' ' 105' ' ' MET . 24.7 mt -127.0 143.61 51.25 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.884 -0.413 . . . . 0.69 109.884 179.165 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.442 ' OD2' ' HE2' ' A' ' 26' ' ' LYS . 18.6 m-20 -77.59 177.37 8.13 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 106.742 -1.577 . . . . 1.87 106.742 165.494 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.759 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . . . -64.39 -5.25 4.89 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 113.068 0.766 . . . . 0.59 113.068 -171.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.902 ' HB2' ' HG2' ' A' ' 26' ' ' LYS . 15.8 m-20 -94.66 -8.1 38.88 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 111.591 0.219 . . . . 2.34 111.591 178.23 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.545 ' HB2' ' O ' ' A' ' 24' ' ' ASP . 49.0 m-70 80.8 -0.66 1.83 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.506 0.723 . . . . 1.47 109.829 -175.41 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.902 ' HG2' ' HB2' ' A' ' 24' ' ' ASP . 6.4 ptmt -67.1 120.0 68.77 Favored Pre-proline 0 N--CA 1.45 -0.472 0 N-CA-C 108.158 -1.053 . . . . 4.25 108.158 165.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.635 ' HA ' HD23 ' A' ' 21' ' ' LEU . 90.0 Cg_exo -50.26 116.54 2.54 Favored 'Trans proline' 0 N--CA 1.465 -0.19 0 C-N-CA 122.638 2.225 . . . . 0.54 113.828 -175.173 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.834 ' HE2' HD23 ' A' ' 72' ' ' LEU . 15.0 t80 -79.74 143.66 34.32 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 113.865 -1.516 . . . . 1.2 111.212 174.34 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.488 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.7 t-20 -80.72 82.47 6.71 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.085 -0.962 . . . . 1.51 109.931 178.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.794 HD21 HD12 ' A' ' 15' ' ' ILE . 59.2 tp -57.91 -41.33 82.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.302 0.572 . . . . 0.28 109.784 177.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.71 HG12 ' HG3' ' A' ' 34' ' ' LYS . 2.0 t -68.16 -3.72 2.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 114.638 -1.165 . . . . 1.02 112.256 -170.09 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.488 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 3.4 pt20 -70.18 -17.25 63.16 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.919 -0.771 . . . . 1.02 108.919 175.32 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.904 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 92.4 m-70 -92.68 23.58 4.01 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.318 -0.855 . . . . 0.28 109.644 177.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.769 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 10.1 mtmt -81.99 121.76 26.93 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 114.639 -1.164 . . . . 1.56 109.335 168.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.42 -42.05 1.89 Allowed Glycine 0 N--CA 1.436 -1.31 0 C-N-CA 120.633 -0.794 . . . . 0.2 111.67 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.484 ' HB2' ' HA3' ' A' ' 68' ' ' GLY . 19.3 m -128.69 127.86 23.52 Favored Pre-proline 0 N--CA 1.435 -1.183 0 N-CA-C 108.462 -0.94 . . . . 0.29 108.462 173.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.805 ' HG3' ' CB ' ' A' ' 170' ' ' LEU . 4.9 Cg_endo -42.74 152.61 0.18 Allowed 'Trans proline' 0 CA--C 1.508 -0.777 0 C-N-CA 124.401 3.401 . . . . 0.18 113.205 178.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.853 HD13 ' HB2' ' A' ' 33' ' ' HIS . 0.9 OUTLIER -137.5 142.33 41.47 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.052 -1.431 . . . . 0.31 107.361 -178.341 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.989 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 1.8 mm? -107.79 114.78 28.98 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.473 -0.936 . . . . 1.19 108.473 176.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.825 HG23 HD13 ' A' ' 72' ' ' LEU . 1.1 mt -95.38 127.99 46.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 C-N-CA 119.81 -0.756 . . . . 0.37 109.647 177.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.989 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 1.1 m-85 -112.47 124.43 52.48 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.215 -0.448 . . . . 0.42 110.435 -175.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.667 HD22 ' HB ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -83.01 92.54 7.39 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 107.31 -1.367 . . . . 2.35 107.31 173.691 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.761 HG23 ' HB3' ' A' ' 139' ' ' PHE . 11.1 p . . . . . 0 C--N 1.312 -1.026 0 CA-C-O 121.02 0.438 . . . . 1.03 111.394 -161.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.869 0 N-CA-C 111.388 -0.685 . . . . 0.51 111.388 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.535 ' HA2' ' HB ' ' A' ' 56' ' ' THR . . . -61.98 -19.12 58.56 Favored Glycine 0 C--O 1.22 -0.746 0 CA-C-O 119.688 -0.506 . . . . 0.5 114.359 -177.168 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -77.19 -57.0 4.08 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 118.305 1.053 . . . . 0.7 109.983 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.18 -39.27 72.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.575 0.703 . . . . 2.61 109.587 173.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.714 HG23 ' HA ' ' A' ' 160' ' ' VAL . 18.3 m -57.06 -59.28 5.3 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 114.625 -1.171 . . . . 0.33 111.296 174.302 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 1.061 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -55.98 -45.45 78.97 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.869 -0.605 . . . . 0.22 111.047 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.586 ' HA ' ' HE1' ' A' ' 102' ' ' PHE . 92.1 m -55.02 -51.33 66.62 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.589 0.709 . . . . 0.26 110.354 -178.009 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 28.1 m -72.96 -36.79 67.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.861 -1.063 . . . . 0.48 111.483 -177.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.712 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 14.5 mt -64.23 -52.67 57.61 Favored 'General case' 0 CA--C 1.498 -1.054 0 CA-C-O 121.311 0.577 . . . . 0.43 110.381 -178.146 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.794 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 2.1 t80 -51.73 -53.26 41.37 Favored 'General case' 0 C--O 1.199 -1.586 0 CA-C-N 114.218 -1.356 . . . . 0.31 110.167 178.032 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.412 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 6.1 m-80 -72.91 -25.56 61.1 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 112.097 0.406 . . . . 1.21 112.097 -170.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.453 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 35.4 ttpt -84.06 -23.24 30.94 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 119.401 -0.92 . . . . 1.54 108.924 -178.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.654 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 36.7 m-85 -122.37 -4.31 8.87 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 114.959 1.466 . . . . 0.31 114.959 -172.115 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.722 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 13.7 ptmt -64.93 -25.31 67.82 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 108.238 -1.023 . . . . 1.35 108.238 171.387 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.9 m -47.76 -41.9 24.33 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.113 -1.403 . . . . 1.28 110.74 172.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -85.37 -33.09 22.09 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.059 0.392 . . . . 1.11 112.059 175.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.484 ' HA3' ' HB2' ' A' ' 36' ' ' SER . . . 145.82 -7.46 1.47 Allowed Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 111.454 -0.659 . . . . 0.18 111.454 -177.427 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.712 ' HE2' ' HB3' ' A' ' 60' ' ' LEU . 19.5 t80 -64.38 140.86 58.91 Favored 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 122.709 0.403 . . . . 0.18 111.027 -178.264 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.904 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 1.6 t -134.34 151.3 51.15 Favored 'General case' 0 N--CA 1.413 -2.294 0 N-CA-C 108.425 -0.954 . . . . 0.2 108.425 173.07 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 1.061 HG11 ' HB1' ' A' ' 57' ' ' ALA . 50.2 t -109.16 100.27 10.42 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.341 0 N-CA-C 107.488 -1.301 . . . . 0.17 107.488 159.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.834 HD23 ' HE2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -89.85 121.07 31.63 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 118.254 -1.378 . . . . 1.04 108.375 177.496 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.86 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -98.09 112.68 24.55 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.914 -0.585 . . . . 0.51 110.842 -177.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.849 ' CD2' ' HE2' ' A' ' 119' ' ' TYR . 3.1 m-30 -96.56 102.16 10.74 Favored Pre-proline 0 C--N 1.31 -1.143 0 N-CA-C 108.827 -0.805 . . . . 0.44 108.827 176.186 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.717 ' HG2' ' HB3' ' A' ' 107' ' ' LYS . 87.8 Cg_endo -80.33 71.02 7.27 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 123.239 2.626 . . . . 1.3 114.302 -166.476 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 77.3 p . . . . . 0 N--CA 1.475 0.798 0 N-CA-C 116.767 2.136 . . . . 1.44 116.767 179.491 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.629 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . . . . . . 0 CA--C 1.51 -0.586 0 CA-C-O 120.82 0.343 . . . . 0.55 110.235 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -104.57 28.51 6.93 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.637 -0.711 . . . . 1.99 111.012 178.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.873 ' HB3' ' O ' ' A' ' 71' ' ' VAL . 3.5 m-85 -113.14 -177.11 0.42 Allowed Pre-proline 0 CA--C 1.513 -0.454 0 CA-C-O 121.853 0.835 . . . . 0.84 111.426 -177.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.706 ' HD3' ' CE2' ' A' ' 61' ' ' TYR . 12.9 Cg_exo -79.87 71.73 6.89 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 124.095 3.197 . . . . 0.62 110.442 156.31 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.86 HG13 ' HB3' ' A' ' 73' ' ' ALA . 5.3 mp -73.77 119.92 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 108.143 -1.058 . . . . 1.34 108.143 173.127 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.828 ' HG2' ' CG ' ' A' ' 74' ' ' PHE . 0.3 OUTLIER -80.26 -175.53 5.14 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.079 -0.509 . . . . 3.03 110.768 -173.358 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.759 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . . . -71.36 -0.01 9.19 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.592 -0.731 . . . . 1.46 111.958 -176.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.776 ' H ' ' HG3' ' A' ' 105' ' ' MET . 3.1 ptpp? 70.45 137.59 0.04 OUTLIER 'General case' 0 CA--C 1.499 -1.001 0 C-N-CA 125.256 1.422 . . . . 1.76 110.604 -170.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.701 HG13 ' CB ' ' A' ' 116' ' ' HIS . 0.1 OUTLIER -140.51 167.44 18.12 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 CA-C-N 113.262 -1.79 . . . . 0.82 106.358 168.297 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.518 ' O ' HG12 ' A' ' 108' ' ' ILE . 48.5 t-20 -49.72 119.13 3.25 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.785 -0.82 . . . . 1.73 108.785 168.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.667 ' HB ' HD22 ' A' ' 42' ' ' ASN . 0.0 OUTLIER -128.28 87.84 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 C-N-CA 119.442 -0.903 . . . . 0.77 108.688 166.763 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.5 t30 . . . . . 0 N--CA 1.438 -1.032 0 CA-C-N 113.981 -1.463 . . . . 1.9 108.908 176.64 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.701 ' CB ' HG13 ' A' ' 108' ' ' ILE . 0.9 OUTLIER . . . . . 0 N--CA 1.43 -1.455 0 N-CA-C 107.057 -1.46 . . . . 0.42 107.057 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -27.44 -50.42 0.11 Allowed 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 124.701 3.6 . . . . 0.4 113.891 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.827 HD11 ' HB ' ' A' ' 15' ' ' ILE . 64.7 tp -57.12 -53.41 58.39 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 122.912 0.485 . . . . 0.39 112.259 176.005 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.849 ' HE2' ' CD2' ' A' ' 74' ' ' PHE . 80.0 m-85 -77.38 -35.37 54.49 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 112.299 0.481 . . . . 3.04 112.299 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.73 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 5.7 mm-40 -57.48 -34.0 68.57 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 107.221 -1.399 . . . . 2.44 107.221 172.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.694 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 70.8 t80 -71.48 -33.5 69.34 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 119.262 -0.975 . . . . 0.56 111.065 173.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.651 ' HE3' ' HG ' ' A' ' 118' ' ' LEU . 1.8 ttm -74.64 -55.0 6.37 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.275 -0.42 . . . . 0.71 110.465 -171.141 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.463 ' HB2' ' HE2' ' A' ' 123' ' ' LYS . 0.6 OUTLIER -70.57 -25.74 63.22 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 116.514 -0.312 . . . . 1.46 111.42 178.029 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.73 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 9.4 pttp -68.58 -27.28 65.92 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 119.486 -0.886 . . . . 1.99 109.485 177.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 29.1 m -89.47 -28.01 19.97 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.244 -0.889 . . . . 0.59 110.703 176.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.541 ' HB3' ' NH2' ' A' ' 153' ' ' ARG . 39.9 mmtt . . . . . 0 C--N 1.326 -0.428 0 CA-C-N 116.087 -0.506 . . . . 1.85 110.945 -177.037 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.604 ' HB3' ' HG3' ' A' ' 156' ' ' PRO . 2.4 m95 . . . . . 0 N--CA 1.452 -0.363 0 CA-C-O 120.877 0.37 . . . . 1.97 111.599 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.414 ' O ' ' N ' ' A' ' 140' ' ' THR . 1.6 m120 -39.48 -155.61 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 126.603 1.961 . . . . 2.04 114.128 165.404 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.761 ' HB3' HG23 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -34.14 -22.19 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 116.063 1.875 . . . . 1.93 116.063 -177.084 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.459 ' OG1' ' HD3' ' A' ' 156' ' ' PRO . 3.7 m 10.49 108.12 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 119.965 1.257 . . . . 0.6 113.911 166.476 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.514 ' CB ' HD12 ' A' ' 39' ' ' LEU . 0.9 OUTLIER -90.75 161.08 15.48 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 114.066 -1.425 . . . . 0.62 110.484 -167.34 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.478 ' HA ' ' HA ' ' A' ' 153' ' ' ARG . 38.6 m-85 -124.64 122.82 38.59 Favored 'General case' 0 CA--C 1.494 -1.206 0 N-CA-C 106.389 -1.708 . . . . 0.57 106.389 168.017 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.787 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 8.9 tp -79.73 104.88 10.62 Favored 'General case' 0 N--CA 1.425 -1.708 0 C-N-CA 118.348 -1.341 . . . . 0.43 108.416 179.144 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.679 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 39.3 mm -92.0 142.05 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.717 0 CA-C-N 112.744 -2.025 . . . . 0.19 107.605 -178.063 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.439 ' HA ' HD13 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -94.43 -175.57 3.67 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 119.131 -1.028 . . . . 0.98 111.316 -170.194 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.67 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 29.9 mtm180 -52.33 -39.6 60.85 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 121.097 0.475 . . . . 2.22 110.909 -178.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -97.33 20.99 10.66 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.334 0.588 . . . . 2.0 109.711 -175.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.7 ' HA3' ' CE2' ' A' ' 16' ' ' PHE . . . 68.73 35.58 80.55 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 115.812 -0.631 . . . . 0.17 114.185 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.467 ' HA ' ' HD2' ' A' ' 150' ' ' PRO . 65.5 t -106.17 108.31 61.46 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 118.387 1.093 . . . . 1.12 111.666 175.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.689 ' HD3' HG23 ' A' ' 15' ' ' ILE . 5.3 Cg_endo -52.05 114.78 1.78 Allowed 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 123.876 3.051 . . . . 0.41 111.256 171.369 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.959 HG13 ' HG2' ' A' ' 152' ' ' GLU . 13.8 p -116.79 -21.88 4.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-O 121.489 0.661 . . . . 1.45 109.488 -177.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.959 ' HG2' HG13 ' A' ' 151' ' ' VAL . 30.1 mm-40 -138.25 167.54 21.63 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 115.351 -0.841 . . . . 1.17 110.372 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.541 ' NH2' ' HB3' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -145.14 146.29 31.72 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.137 -0.938 . . . . 2.16 109.571 161.517 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.632 ' CE2' ' HA ' ' A' ' 163' ' ' ILE . 93.2 m-85 -121.95 140.46 52.42 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.874 -0.603 . . . . 0.32 109.457 -172.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 6.3 m -68.14 158.57 83.73 Favored Pre-proline 0 C--N 1.315 -0.913 0 N-CA-C 109.847 -0.427 . . . . 1.11 109.847 178.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.604 ' HG3' ' HB3' ' A' ' 137' ' ' TRP . 18.4 Cg_endo -59.46 -32.4 96.31 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.137 1.891 . . . . 0.78 110.624 174.214 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -73.06 -0.0 49.29 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 114.515 -1.221 . . . . 0.5 113.724 173.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -85.97 146.15 26.81 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.83 -0.804 . . . . 0.5 108.83 173.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 4.0 t -110.35 -178.83 3.6 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-O 121.082 0.468 . . . . 1.42 110.259 -173.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.714 ' HA ' HG23 ' A' ' 56' ' ' THR . 60.8 t -45.84 -57.25 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 114.609 -1.178 . . . . 0.28 111.79 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 42.5 tttm -63.46 -38.44 91.14 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 120.624 0.25 . . . . 3.46 111.034 -172.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.41 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 61.9 m-20 -57.26 -43.27 82.85 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.812 0.815 . . . . 1.4 109.124 -177.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.632 ' HA ' ' CE2' ' A' ' 154' ' ' PHE . 90.5 mt -75.52 -47.29 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 CA-C-N 114.216 -1.356 . . . . 0.21 111.017 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.624 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 58.2 mt-10 -55.39 -43.49 75.23 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-O 121.089 0.471 . . . . 0.67 111.07 -176.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 10.5 pt-20 -63.63 -16.21 60.31 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 116.269 -0.423 . . . . 0.87 111.684 -173.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.577 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 31.5 mmmt -104.51 -21.34 13.46 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.47 0.653 . . . . 1.71 109.964 172.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.601 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 12.8 tp -84.96 -49.53 8.26 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.997 -1.001 . . . . 0.16 112.289 -176.308 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.574 ' N ' ' HD2' ' A' ' 169' ' ' PRO . 64.1 mt -57.46 -43.7 99.14 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.661 -0.699 . . . . 0.26 112.4 -174.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 168' ' ' ILE . 8.0 Cg_endo -53.65 -20.62 17.12 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 121.894 1.729 . . . . 0.41 112.939 172.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.805 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 99.3 mt -96.42 -43.14 7.78 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 122.416 -0.178 . . . . 0.71 111.205 177.348 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.648 HD21 ' HB2' ' A' ' 69' ' ' PHE . 96.6 mt -60.08 -56.95 15.31 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-O 121.962 0.887 . . . . 0.34 108.738 173.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.424 -2.154 0 CA-C-N 113.892 -1.504 . . . . 1.12 110.552 178.838 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.1 m . . . . . 0 N--CA 1.463 0.179 0 CA-C-O 121.507 0.67 . . . . 1.58 110.007 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 90.9 p -178.48 151.81 0.62 Allowed 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.678 -1.971 . . . . 1.17 105.678 175.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.882 HG21 ' HE1' ' A' ' 122' ' ' MET . 6.5 pt -69.12 -13.99 17.95 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 CA-C-N 114.787 -1.097 . . . . 0.38 111.801 -171.357 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.824 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 54.8 m-85 -77.21 -3.26 38.72 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.273 -0.421 . . . . 0.3 111.189 -177.283 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -69.24 -21.06 63.94 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.275 -1.009 . . . . 2.11 108.275 172.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.753 ' HE2' ' HB2' ' A' ' 121' ' ' TYR . 49.6 m-85 -114.14 111.1 21.03 Favored 'General case' 0 CA--C 1.503 -0.853 0 CA-C-N 114.718 -1.128 . . . . 0.31 111.84 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -50.42 150.35 2.66 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.142 -1.39 . . . . 2.86 109.941 169.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.762 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 38.0 t -111.43 164.02 7.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 N-CA-C 108.894 -0.78 . . . . 0.67 108.894 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.759 ' O ' ' HB3' ' A' ' 105' ' ' MET . 89.6 mt -126.4 113.11 16.45 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 120.873 -0.331 . . . . 0.69 111.65 -176.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.716 ' HA ' ' HE2' ' A' ' 105' ' ' MET . 12.1 t70 -51.6 160.42 0.63 Allowed 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 107.779 -1.193 . . . . 1.87 107.779 169.059 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.635 ' HA ' ' C ' ' A' ' 105' ' ' MET . . . -54.53 -16.69 2.53 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 114.147 1.166 . . . . 0.59 114.147 -163.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.543 ' HB2' ' HE2' ' A' ' 26' ' ' LYS . 33.4 m-20 -96.15 5.32 51.35 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 112.325 0.491 . . . . 2.34 112.325 178.078 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.695 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 82.8 m-70 78.13 15.21 1.43 Allowed 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.699 0.762 . . . . 1.47 109.163 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.543 ' HE2' ' HB2' ' A' ' 24' ' ' ASP . 13.2 mtmt -79.64 119.15 75.89 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 107.212 -1.403 . . . . 4.25 107.212 169.11 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.61 ' HA ' HD23 ' A' ' 21' ' ' LEU . 84.6 Cg_exo -51.7 113.91 1.36 Allowed 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 121.582 1.521 . . . . 0.54 113.157 -173.339 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.56 ' HB3' HG12 ' A' ' 20' ' ' VAL . 32.3 t80 -79.35 144.8 33.86 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.074 -1.421 . . . . 1.2 111.366 175.022 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.441 ' OD1' ' HB3' ' A' ' 32' ' ' GLN . 2.4 t-20 -78.85 85.38 4.83 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.026 -0.988 . . . . 1.51 109.934 178.423 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.616 ' HG ' ' CD1' ' A' ' 16' ' ' PHE . 49.1 tp -63.26 -42.37 99.14 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.393 -0.821 . . . . 0.28 110.471 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.804 ' HA ' ' CE1' ' A' ' 16' ' ' PHE . 2.0 t -68.99 -0.64 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 114.424 -1.262 . . . . 1.02 112.481 -167.052 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.441 ' HB3' ' OD1' ' A' ' 29' ' ' ASN . 10.4 pt20 -76.52 -5.26 46.79 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.531 0.681 . . . . 1.02 110.321 177.194 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.955 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 87.9 m-70 -100.71 24.29 9.31 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.843 0.83 . . . . 0.28 109.335 173.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.824 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 0.5 OUTLIER -82.82 110.42 17.82 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.724 -1.125 . . . . 1.56 109.311 171.762 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.26 -37.42 2.2 Favored Glycine 0 N--CA 1.437 -1.249 0 C-N-CA 120.917 -0.659 . . . . 0.2 111.506 -177.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.479 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 17.6 m -132.33 133.11 23.34 Favored Pre-proline 0 N--CA 1.435 -1.197 0 N-CA-C 108.626 -0.879 . . . . 0.29 108.626 173.353 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.8 ' HG3' ' CB ' ' A' ' 170' ' ' LEU . 6.8 Cg_endo -44.04 153.45 0.31 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 124.124 3.216 . . . . 0.18 112.614 178.111 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.895 ' HB2' HG22 ' A' ' 70' ' ' THR . 0.7 OUTLIER -140.61 139.41 34.89 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.027 -1.471 . . . . 0.31 107.027 -179.919 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.818 ' HB3' ' CE1' ' A' ' 41' ' ' TYR . 3.0 mp -107.17 116.66 32.32 Favored 'General case' 0 C--N 1.293 -1.881 0 O-C-N 121.518 -0.739 . . . . 1.19 109.449 176.241 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.914 HG23 ' HB2' ' A' ' 72' ' ' LEU . 2.6 mt -95.77 120.35 45.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-N 115.557 -0.747 . . . . 0.37 109.761 176.198 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.818 ' CE1' ' HB3' ' A' ' 39' ' ' LEU . 0.5 OUTLIER -103.87 124.95 49.88 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.493 -0.776 . . . . 0.42 110.041 -174.555 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.675 ' OD1' ' HB ' ' A' ' 140' ' ' THR . 0.2 OUTLIER -75.61 125.66 29.47 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 104.309 -2.478 . . . . 2.35 104.309 168.525 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.703 ' O ' ' HA ' ' A' ' 75' ' ' PRO . 2.8 p . . . . . 0 C--N 1.294 -1.817 0 C-N-CA 117.665 -1.614 . . . . 1.03 113.114 -169.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 N-CA-C 112.077 -0.409 . . . . 0.51 112.077 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -47.55 -45.16 23.18 Favored Glycine 0 C--O 1.224 -0.517 0 O-C-N 123.792 0.348 . . . . 0.5 113.686 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.456 ' HA ' ' CZ ' ' A' ' 139' ' ' PHE . 1.1 t80 -61.38 -62.97 1.45 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.049 0.389 . . . . 0.7 112.049 -172.599 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -59.24 -40.14 84.98 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.188 0.518 . . . . 2.61 111.121 -178.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.55 ' HA ' ' CG2' ' A' ' 160' ' ' VAL . 40.8 m -54.97 -59.92 4.09 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.163 -0.926 . . . . 0.33 111.193 174.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 1.027 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -61.81 -42.55 99.16 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.417 -0.811 . . . . 0.22 111.15 -176.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.597 ' N ' ' HE1' ' A' ' 102' ' ' PHE . 61.5 m -55.33 -51.08 67.92 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.814 0.816 . . . . 0.26 109.825 -177.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 26.5 m -72.11 -35.15 69.1 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 114.402 -1.272 . . . . 0.48 111.22 -177.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.64 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 17.4 mt -67.57 -50.04 60.35 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 121.365 0.602 . . . . 0.43 110.413 -176.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.847 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 8.4 t80 -59.36 -47.21 86.29 Favored 'General case' 0 C--O 1.205 -1.27 0 CA-C-N 114.967 -1.015 . . . . 0.31 110.502 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -73.76 -24.29 59.84 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 112.022 0.379 . . . . 1.21 112.022 -174.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.48 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 32.2 ttpt -84.54 -25.99 28.36 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 120.02 -0.672 . . . . 1.54 109.275 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.734 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 35.9 m-85 -123.2 -5.79 8.34 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 115.121 1.526 . . . . 0.31 115.121 -169.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.71 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 41.4 pttt -65.48 -26.59 67.99 Favored 'General case' 0 CA--C 1.5 -0.975 0 N-CA-C 108.434 -0.95 . . . . 1.35 108.434 172.479 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.2 t -47.91 -41.86 25.65 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.458 -1.246 . . . . 1.28 110.733 172.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -82.03 -37.41 26.56 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 111.821 0.304 . . . . 1.11 111.821 175.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.429 ' HA3' ' HB2' ' A' ' 36' ' ' SER . . . 150.58 -7.95 0.72 Allowed Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 111.622 -0.591 . . . . 0.18 111.622 -176.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.734 ' HD2' ' HB2' ' A' ' 64' ' ' TYR . 13.7 t80 -64.41 143.33 57.98 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 122.777 0.431 . . . . 0.18 110.841 -178.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.955 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 5.3 t -132.91 148.16 52.29 Favored 'General case' 0 N--CA 1.416 -2.127 0 N-CA-C 108.848 -0.797 . . . . 0.2 108.848 168.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 1.027 HG11 ' HB1' ' A' ' 57' ' ' ALA . 21.8 t -100.07 100.78 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.419 0 N-CA-C 107.199 -1.408 . . . . 0.17 107.199 158.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.914 ' HB2' HG23 ' A' ' 40' ' ' ILE . 79.8 mt -84.26 118.87 24.45 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 107.085 -1.45 . . . . 1.04 107.085 178.171 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.618 ' HB3' HG12 ' A' ' 104' ' ' ILE . . . -96.44 113.41 24.99 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.939 -0.704 . . . . 0.51 109.838 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.882 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 5.0 m-85 -108.96 95.22 16.62 Favored Pre-proline 0 N--CA 1.433 -1.286 0 N-CA-C 107.337 -1.357 . . . . 0.44 107.337 -177.394 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.891 ' HB2' ' HG2' ' A' ' 107' ' ' LYS . 3.4 Cg_endo -67.33 148.37 79.71 Favored 'Trans proline' 0 N--CA 1.429 -2.314 0 N-CA-C 109.091 -1.157 . . . . 1.3 109.091 -174.095 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.439 ' O ' ' HD3' ' A' ' 107' ' ' LYS . 29.2 p . . . . . 0 C--N 1.287 -2.117 0 CA-C-O 121.988 0.899 . . . . 1.44 112.76 -177.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.51 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . . . . . . 0 CA--C 1.51 -0.571 0 CA-C-O 121.381 0.61 . . . . 0.55 111.518 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.638 ' O ' ' HD2' ' A' ' 61' ' ' TYR . 62.6 mm-40 -100.92 48.12 0.9 Allowed 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 114.665 -1.152 . . . . 1.99 110.837 176.097 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.721 ' HB3' ' O ' ' A' ' 71' ' ' VAL . 1.6 m-85 -128.25 175.98 3.07 Favored Pre-proline 0 CA--C 1.511 -0.543 0 CA-C-O 121.466 0.651 . . . . 0.84 109.724 172.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.674 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 14.4 Cg_exo -76.48 77.75 3.51 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 123.519 2.813 . . . . 0.62 109.936 158.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.618 HG12 ' HB3' ' A' ' 73' ' ' ALA . 76.4 mt -80.44 126.52 39.55 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.504 0 N-CA-C 107.978 -1.119 . . . . 1.34 107.978 176.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.882 ' HG3' ' CE1' ' A' ' 74' ' ' PHE . 7.1 mmt -105.56 -168.12 1.41 Allowed 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 121.727 0.775 . . . . 3.03 113.032 -163.305 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.629 ' N ' ' HA ' ' A' ' 23' ' ' ALA . . . -76.47 6.81 5.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.637 -1.165 . . . . 1.46 113.755 -167.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.891 ' HG2' ' HB2' ' A' ' 75' ' ' PRO . 57.1 mttp 65.99 139.29 0.03 OUTLIER 'General case' 0 CA--C 1.491 -1.315 0 CA-C-O 122.51 1.148 . . . . 1.76 110.847 -169.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.846 HD12 ' HD2' ' A' ' 74' ' ' PHE . 0.1 OUTLIER -138.45 163.71 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.576 0 N-CA-C 106.428 -1.693 . . . . 0.82 106.428 165.96 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -73.16 83.56 1.33 Allowed 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 120.612 0.244 . . . . 1.73 110.375 -177.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.65 HG13 HD11 ' A' ' 108' ' ' ILE . 2.6 m -80.25 90.15 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-O 121.848 0.832 . . . . 0.77 109.299 176.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 . . . . . 0 N--CA 1.44 -0.973 0 CA-C-N 114.177 -1.374 . . . . 1.9 107.988 179.952 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.826 ' HB3' HG13 ' A' ' 108' ' ' ILE . 1.6 t-80 . . . . . 0 N--CA 1.439 -1.017 0 N-CA-C 107.557 -1.275 . . . . 0.42 107.557 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -24.99 -48.03 0.06 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 124.678 3.585 . . . . 0.4 113.847 178.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.767 HD11 ' HB ' ' A' ' 15' ' ' ILE . 38.5 tp -69.35 -45.92 68.24 Favored 'General case' 0 C--O 1.216 -0.684 0 C-N-CA 122.598 0.359 . . . . 0.39 111.827 -179.028 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.668 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 9.7 m-85 -82.54 -32.16 28.75 Favored 'General case' 0 CA--C 1.491 -1.303 0 CA-C-O 121.709 0.766 . . . . 3.04 110.9 -175.058 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.531 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 2.9 tm-20 -64.03 -35.03 79.38 Favored 'General case' 0 N--CA 1.424 -1.749 0 N-CA-C 107.031 -1.47 . . . . 2.44 107.031 172.405 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.753 ' HB2' ' HE2' ' A' ' 18' ' ' PHE . 28.7 t80 -72.45 -26.75 61.94 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.96 -1.018 . . . . 0.56 110.253 170.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.882 ' HE1' HG21 ' A' ' 15' ' ' ILE . 15.4 mmt -71.95 -55.93 6.59 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 121.66 0.743 . . . . 0.71 110.287 -170.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.668 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -72.84 -25.48 61.14 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.214 -0.903 . . . . 1.46 110.565 178.655 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.531 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 27.2 tttt -60.96 -38.42 85.82 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 109.079 -0.712 . . . . 1.99 109.079 169.184 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.44 ' HB ' ' O ' ' A' ' 122' ' ' MET . 96.2 m -65.43 -55.71 16.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.29 -0.868 . . . . 0.59 110.644 177.524 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm . . . . . 0 N--CA 1.452 -0.369 0 N-CA-C 113.392 0.886 . . . . 1.85 113.392 -174.68 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.547 ' HB3' ' HG3' ' A' ' 156' ' ' PRO . 1.9 m-90 . . . . . 0 CA--C 1.507 -0.696 0 CA-C-O 120.558 0.218 . . . . 1.97 110.525 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.534 ' HB2' ' HB3' ' A' ' 156' ' ' PRO . 6.6 m120 -39.46 -154.23 0.0 OUTLIER 'General case' 0 C--O 1.203 -1.366 0 O-C-N 124.822 1.326 . . . . 2.04 111.5 160.282 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.622 ' HD2' ' CD2' ' A' ' 41' ' ' TYR . 2.2 m-85 -31.35 -25.19 0.0 OUTLIER 'General case' 0 CA--C 1.567 1.597 0 N-CA-C 117.691 2.478 . . . . 1.93 117.691 -171.294 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.728 ' HA ' ' O ' ' A' ' 154' ' ' PHE . 1.4 m 6.56 101.3 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 120.495 1.498 . . . . 0.6 114.086 170.114 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.515 ' O ' ' HA ' ' A' ' 153' ' ' ARG . 4.5 m -89.12 176.03 7.14 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.22 -0.9 . . . . 0.62 112.195 -170.227 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.562 ' HA ' ' O ' ' A' ' 152' ' ' GLU . 79.5 m-85 -134.25 124.44 25.93 Favored 'General case' 0 CA--C 1.491 -1.297 0 N-CA-C 106.422 -1.695 . . . . 0.57 106.422 161.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.821 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 5.8 tp -80.52 103.97 10.74 Favored 'General case' 0 N--CA 1.423 -1.82 0 C-N-CA 118.487 -1.285 . . . . 0.43 108.342 177.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.768 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 27.9 mm -90.76 141.35 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.822 0 CA-C-N 113.41 -1.723 . . . . 0.19 107.656 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.54 ' OD1' HG12 ' A' ' 149' ' ' VAL . 0.0 OUTLIER -94.71 -173.68 3.08 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 119.541 -0.863 . . . . 0.98 111.234 -169.905 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.503 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 44.2 mtm180 -54.83 -36.48 65.05 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.14 0.275 . . . . 2.22 111.326 -177.07 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -104.05 20.97 17.26 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 121.569 0.7 . . . . 2.0 109.245 -176.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.643 ' HA2' ' CG2' ' A' ' 144' ' ' ILE . . . 70.43 36.37 69.26 Favored Glycine 0 N--CA 1.435 -1.396 0 CA-C-N 114.624 -1.171 . . . . 0.17 115.126 175.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.54 HG12 ' OD1' ' A' ' 145' ' ' ASP . 5.2 p -103.67 129.98 24.34 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 119.528 1.664 . . . . 1.12 110.379 172.325 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.529 ' HA ' HD13 ' A' ' 144' ' ' ILE . 3.6 Cg_exo -69.84 121.33 8.0 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.6 2.2 . . . . 0.41 110.493 179.128 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 22.1 t -114.7 -27.01 2.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-O 121.426 0.631 . . . . 1.45 109.401 -176.106 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.821 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 60.7 mm-40 -138.17 165.47 26.57 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.363 -0.835 . . . . 1.17 111.441 -178.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.524 ' HB2' ' CD1' ' A' ' 142' ' ' PHE . 2.6 ttm180 -145.6 125.2 13.26 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.761 -1.109 . . . . 2.16 109.146 165.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.728 ' O ' ' HA ' ' A' ' 140' ' ' THR . 91.2 m-85 -107.19 149.95 27.14 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.203 -0.908 . . . . 0.32 108.74 -169.331 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 19.4 m -76.98 158.51 80.13 Favored Pre-proline 0 C--N 1.313 -0.998 0 N-CA-C 108.795 -0.817 . . . . 1.11 108.795 175.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.547 ' HG3' ' HB3' ' A' ' 137' ' ' TRP . 10.8 Cg_endo -54.52 -48.91 18.86 Favored 'Trans proline' 0 N--CA 1.465 -0.202 0 C-N-CA 121.874 1.716 . . . . 0.78 110.685 178.388 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -59.52 -2.0 1.45 Allowed Glycine 0 CA--C 1.529 0.964 0 CA-C-N 114.753 -1.112 . . . . 0.5 114.902 174.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -84.69 134.07 34.37 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 107.982 -1.118 . . . . 0.5 107.982 171.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.534 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 6.8 t -110.68 -174.58 2.51 Favored 'General case' 0 N--CA 1.435 -1.177 0 C-N-CA 119.976 -0.69 . . . . 1.42 110.757 -167.465 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.55 ' CG2' ' HA ' ' A' ' 56' ' ' THR . 64.0 t -45.44 -50.92 2.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 114.7 -1.137 . . . . 0.28 111.202 -176.474 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -68.79 -35.07 76.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.137 -0.483 . . . . 3.46 111.22 -174.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.451 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 28.2 m-20 -68.91 -35.17 76.52 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.779 0.799 . . . . 1.4 109.553 -177.281 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.46 ' HA ' ' CE2' ' A' ' 154' ' ' PHE . 46.5 mt -80.56 -48.08 20.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 114.494 -1.23 . . . . 0.21 111.354 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.631 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 49.3 mt-10 -53.81 -39.3 65.4 Favored 'General case' 0 C--O 1.217 -0.631 0 CA-C-O 120.888 0.375 . . . . 0.67 111.39 -176.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 12.1 pt-20 -60.86 -21.93 63.74 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.636 0.255 . . . . 0.87 111.544 -176.033 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.582 ' HB3' HD22 ' A' ' 143' ' ' LEU . 35.7 mmtp -100.07 -22.85 15.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.382 0.61 . . . . 1.71 110.13 174.488 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.631 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 12.9 tp -85.8 -50.03 7.46 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.037 -0.983 . . . . 0.16 112.36 -174.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.557 ' N ' ' HD2' ' A' ' 169' ' ' PRO . 73.8 mt -54.09 -46.95 98.55 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.628 -0.715 . . . . 0.26 112.643 -173.343 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 168' ' ' ILE . 14.7 Cg_endo -58.62 -16.23 29.31 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.192 1.928 . . . . 0.41 113.026 175.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.8 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 95.4 mt -97.11 -41.31 8.4 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 122.006 -0.433 . . . . 0.71 110.784 177.301 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.664 HD23 ' HG2' ' A' ' 37' ' ' PRO . 96.0 mt -63.28 -53.61 50.22 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-O 122.21 1.005 . . . . 0.34 109.727 175.086 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.55 0 CA-C-N 113.323 -1.762 . . . . 1.12 112.365 -176.579 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.9 m . . . . . 0 C--O 1.233 0.194 0 CA-C-O 121.514 0.673 . . . . 1.58 110.175 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 80.0 p 178.85 177.8 0.47 Allowed 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 105.89 -1.893 . . . . 1.17 105.89 -173.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.879 HG23 ' HD3' ' A' ' 150' ' ' PRO . 3.7 pt -89.71 -15.36 8.8 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 CA-C-N 115.579 -0.737 . . . . 0.38 110.378 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.816 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 36.3 m-85 -70.52 -13.23 62.02 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.259 0.552 . . . . 0.3 110.854 -179.01 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -63.93 -24.67 67.82 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.64 -0.874 . . . . 2.11 108.64 173.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.599 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 50.9 m-85 -112.49 105.6 13.87 Favored 'General case' 0 CA--C 1.495 -1.145 0 CA-C-N 114.972 -1.013 . . . . 0.31 110.341 178.207 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -52.16 146.19 9.4 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.68 -1.145 . . . . 2.86 109.903 174.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.733 HG23 HD22 ' A' ' 30' ' ' LEU . 54.7 t -109.26 159.17 8.85 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 107.464 -1.31 . . . . 0.67 107.464 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.857 ' O ' ' HB2' ' A' ' 105' ' ' MET . 26.2 mt -126.99 167.82 15.38 Favored 'General case' 0 N--CA 1.433 -1.312 0 C-N-CA 120.323 -0.551 . . . . 0.69 110.279 -176.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -86.69 -179.27 6.55 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.64 -0.874 . . . . 1.87 108.64 175.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.683 ' HA ' ' N ' ' A' ' 106' ' ' ALA . . . -63.58 -9.13 11.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 118.527 0.603 . . . . 0.59 111.415 -178.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.494 ' HB2' ' HE2' ' A' ' 26' ' ' LYS . 11.8 m-20 -107.85 7.74 28.3 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.559 -0.291 . . . . 2.34 111.562 174.337 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.543 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 2.0 m-70 72.29 15.1 5.37 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 121.68 0.753 . . . . 1.47 110.181 174.047 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.494 ' HE2' ' HB2' ' A' ' 24' ' ' ASP . 27.5 mtmt -76.39 133.38 71.35 Favored Pre-proline 0 C--O 1.221 -0.426 0 N-CA-C 107.228 -1.397 . . . . 4.25 107.228 165.434 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.679 ' HA ' HD23 ' A' ' 21' ' ' LEU . 85.2 Cg_exo -48.86 115.94 1.91 Allowed 'Trans proline' 0 CA--C 1.532 0.418 0 C-N-CA 122.11 1.873 . . . . 0.54 113.719 -175.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.68 ' H ' ' HA ' ' A' ' 21' ' ' LEU . 0.4 OUTLIER -77.32 153.07 34.19 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.32 -1.309 . . . . 1.2 109.031 168.898 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.608 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.1 t-20 -92.32 84.15 5.13 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.446 0.641 . . . . 1.51 109.34 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.733 HD22 HG23 ' A' ' 20' ' ' VAL . 64.0 tp -67.27 -47.41 70.75 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.499 -0.773 . . . . 0.28 110.746 -178.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.836 HG12 ' HG3' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -69.55 -0.68 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.351 -0.841 . . . . 1.02 112.704 -168.199 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.608 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 3.9 pt20 -75.08 -11.04 60.0 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.393 -0.595 . . . . 1.02 109.393 174.447 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.952 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 89.5 m-70 -95.81 18.05 13.91 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.933 0.873 . . . . 0.28 109.124 175.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.836 ' HG3' HG12 ' A' ' 31' ' ' VAL . 23.7 mtmt -77.69 110.97 12.98 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 114.464 -1.244 . . . . 1.56 108.874 166.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 131.86 -44.99 1.16 Allowed Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 120.754 -0.736 . . . . 0.2 111.499 -178.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.466 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 43.4 m -129.05 134.93 26.87 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 108.721 -0.844 . . . . 0.29 108.721 172.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.726 ' HG3' ' CB ' ' A' ' 170' ' ' LEU . 5.2 Cg_endo -42.38 153.9 0.13 Allowed 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 124.403 3.402 . . . . 0.18 113.093 177.038 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.876 ' HB2' HG22 ' A' ' 70' ' ' THR . 0.6 OUTLIER -138.32 143.6 40.02 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 113.737 -1.574 . . . . 0.31 106.847 179.79 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 1.037 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 1.6 mm? -109.78 117.87 35.01 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.199 -1.038 . . . . 1.19 108.199 178.16 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.817 HG22 ' OH ' ' A' ' 119' ' ' TYR . 5.8 mt -108.24 129.85 61.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 C-N-CA 120.107 -0.637 . . . . 0.37 109.679 -178.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 1.037 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.5 OUTLIER -114.31 130.28 56.66 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 116.132 -0.485 . . . . 0.42 111.315 -168.664 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.563 ' OD1' ' HB ' ' A' ' 140' ' ' THR . 2.9 p30 -84.36 93.54 8.28 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 107.798 -1.186 . . . . 2.35 107.798 166.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.913 HG11 ' HB1' ' A' ' 73' ' ' ALA . 2.7 p . . . . . 0 C--N 1.301 -1.524 0 CA-C-N 115.444 -0.798 . . . . 1.03 111.481 -161.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.612 ' O ' ' HG3' ' A' ' 55' ' ' GLU . . . . . . . . 0 CA--C 1.518 0.278 0 N-CA-C 113.721 0.249 . . . . 0.51 113.721 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -54.06 -21.5 17.87 Favored Glycine 0 C--O 1.221 -0.712 0 C-N-CA 121.379 -0.439 . . . . 0.5 113.676 -177.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.58 ' HA ' ' CZ ' ' A' ' 139' ' ' PHE . 0.1 OUTLIER -65.14 -61.53 2.08 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 117.595 0.697 . . . . 0.7 109.921 179.825 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.612 ' HG3' ' O ' ' A' ' 52' ' ' GLY . 0.1 OUTLIER -59.57 -21.8 60.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.612 -0.722 . . . . 2.61 110.044 179.896 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.661 ' HA ' ' CG2' ' A' ' 160' ' ' VAL . 29.6 m -77.4 -59.76 2.65 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 114.814 -1.085 . . . . 0.33 110.623 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 1.023 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -61.19 -35.08 76.2 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.339 -0.846 . . . . 0.22 110.684 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.653 ' HA ' ' CD1' ' A' ' 102' ' ' PHE . 89.6 m -60.21 -59.18 5.83 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.742 -0.663 . . . . 0.26 110.59 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 56.5 m -70.0 -35.13 74.14 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-N 115.515 -0.766 . . . . 0.48 111.936 -176.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.755 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 21.7 mt -62.33 -52.03 65.29 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 121.302 0.572 . . . . 0.43 110.481 -177.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.762 ' HD1' ' HA ' ' A' ' 70' ' ' THR . 34.3 t80 -51.86 -56.01 16.61 Favored 'General case' 0 C--O 1.204 -1.298 0 CA-C-N 114.584 -1.189 . . . . 0.31 111.108 177.399 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -71.62 -23.93 61.79 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 122.395 0.278 . . . . 1.21 111.078 -172.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.575 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 37.3 ttpt -86.03 -20.68 28.46 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 109.312 -0.625 . . . . 1.54 109.312 -177.227 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.646 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 44.1 m-85 -128.02 -6.43 5.52 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 114.547 1.314 . . . . 0.31 114.547 -171.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.739 ' HD2' ' CZ ' ' A' ' 61' ' ' TYR . 13.6 ptmt -63.57 -24.46 67.81 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 108.1 -1.074 . . . . 1.35 108.1 171.137 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -47.88 -38.57 16.56 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 113.963 -1.471 . . . . 1.28 110.81 172.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -89.35 -32.42 17.32 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.702 0.287 . . . . 1.11 111.67 175.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 147.45 -1.88 0.76 Allowed Glycine 0 C--N 1.332 0.319 0 N-CA-C 111.674 -0.57 . . . . 0.18 111.674 -178.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.755 ' HE2' ' HB3' ' A' ' 60' ' ' LEU . 25.3 t80 -69.51 145.02 53.0 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-O 121.4 0.619 . . . . 0.18 112.003 -177.246 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.952 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 1.6 t -135.59 152.93 51.74 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 108.839 -0.8 . . . . 0.2 108.839 173.325 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 1.023 HG11 ' HB1' ' A' ' 57' ' ' ALA . 51.9 t -113.35 101.65 12.78 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.426 0 N-CA-C 108.422 -0.955 . . . . 0.17 108.422 158.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.919 ' HA ' ' HB2' ' A' ' 103' ' ' PRO . 0.4 OUTLIER -94.4 122.05 36.56 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 107.222 -1.399 . . . . 1.04 107.222 173.992 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.913 ' HB1' HG11 ' A' ' 43' ' ' VAL . . . -108.49 130.34 55.26 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.397 0.618 . . . . 0.51 111.596 -178.257 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.671 ' CE1' ' HG2' ' A' ' 105' ' ' MET . 3.8 m-30 -109.07 102.82 50.36 Favored Pre-proline 0 C--N 1.319 -0.735 0 N-CA-C 108.72 -0.844 . . . . 0.44 108.72 177.479 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.837 ' HG2' ' HD2' ' A' ' 107' ' ' LYS . 60.7 Cg_endo -76.87 45.36 1.65 Allowed 'Trans proline' 0 N--CA 1.481 0.784 0 C-N-CA 123.676 2.918 . . . . 1.3 116.076 -163.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.471 ' C ' ' HB2' ' A' ' 107' ' ' LYS . 30.8 t . . . . . 0 N--CA 1.479 0.989 0 N-CA-C 117.128 2.27 . . . . 1.44 117.128 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.58 0 CA-C-O 121.184 0.516 . . . . 0.55 111.558 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -102.87 28.61 6.03 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 115.548 -0.751 . . . . 1.99 109.984 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.653 ' CD1' ' HA ' ' A' ' 58' ' ' THR . 40.3 p90 -151.64 165.25 17.83 Favored Pre-proline 0 N--CA 1.443 -0.822 0 N-CA-C 108.042 -1.096 . . . . 0.84 108.042 176.557 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.919 ' HB2' ' HA ' ' A' ' 72' ' ' LEU . 74.2 Cg_exo -50.92 132.03 36.29 Favored 'Trans proline' 0 CA--C 1.512 -0.59 0 C-N-CA 123.489 2.793 . . . . 0.62 113.8 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.524 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 50.6 mt -140.76 140.26 33.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 107.461 -1.311 . . . . 1.34 107.461 170.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.857 ' HB2' ' O ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -118.91 -179.22 3.75 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 120.779 -0.368 . . . . 3.03 110.98 -173.319 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.683 ' N ' ' HA ' ' A' ' 23' ' ' ALA . . . -69.74 104.35 2.41 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 108.928 -0.767 . . . . 1.46 108.928 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.837 ' HD2' ' HG2' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -43.72 132.26 5.08 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-O 122.075 0.94 . . . . 1.76 112.888 -174.679 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.848 HG13 ' HB2' ' A' ' 116' ' ' HIS . 0.1 OUTLIER -119.49 173.25 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.012 0 CA-C-N 113.887 -1.506 . . . . 0.82 108.734 176.035 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -74.26 87.4 1.97 Allowed 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 114.555 -1.202 . . . . 1.73 110.595 -174.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.524 HG11 ' CB ' ' A' ' 42' ' ' ASN . 6.6 m -84.4 89.38 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 CA-C-O 122.311 1.053 . . . . 0.77 108.84 178.058 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.5 t30 . . . . . 0 C--N 1.315 -0.928 0 CA-C-N 113.683 -1.599 . . . . 1.9 107.945 179.793 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.848 ' HB2' HG13 ' A' ' 108' ' ' ILE . 3.5 t-80 . . . . . 0 N--CA 1.42 -1.956 0 N-CA-C 108.791 -0.818 . . . . 0.42 108.791 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 116' ' ' HIS . 11.9 Cg_exo -31.2 -45.86 0.17 Allowed 'Trans proline' 0 C--O 1.217 -0.539 0 C-N-CA 124.358 3.372 . . . . 0.4 113.031 -179.108 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.874 HD11 ' HB ' ' A' ' 15' ' ' ILE . 27.4 tp -60.11 -53.05 62.3 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.289 0.636 . . . . 0.39 112.597 175.137 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.817 ' OH ' HG22 ' A' ' 40' ' ' ILE . 3.1 m-85 -77.91 -32.88 51.95 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-O 121.343 0.592 . . . . 3.04 110.834 -176.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.73 -40.01 95.87 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 106.726 -1.583 . . . . 2.44 106.726 174.148 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.808 ' HA ' ' HE2' ' A' ' 124' ' ' LYS . 81.4 t80 -65.26 -29.64 70.44 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.308 -0.86 . . . . 0.56 109.791 173.392 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.665 ' CE ' HD12 ' A' ' 40' ' ' ILE . 40.8 mtt -75.01 -55.95 5.23 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.837 -0.62 . . . . 0.71 110.958 -168.095 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.444 ' HE2' ' HB2' ' A' ' 123' ' ' LYS . 0.3 OUTLIER -70.41 -30.47 67.35 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.972 -0.558 . . . . 1.46 111.235 179.725 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.808 ' HE2' ' HA ' ' A' ' 121' ' ' TYR . 46.0 pttt -76.32 -26.65 56.01 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 119.238 -0.985 . . . . 1.99 111.422 -178.093 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.488 HG22 ' HG3' ' A' ' 126' ' ' LYS . 51.7 m -73.75 -44.93 54.79 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.915 0.388 . . . . 0.59 110.314 176.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.765 ' HD2' ' HB2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.318 0 CA-C-O 121.24 0.543 . . . . 1.85 111.506 178.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.656 ' HB3' ' HG3' ' A' ' 156' ' ' PRO . 21.7 m-90 . . . . . 0 CA--C 1.508 -0.653 0 N-CA-C 110.033 -0.358 . . . . 1.97 110.033 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.666 ' HB2' ' CB ' ' A' ' 156' ' ' PRO . 7.6 m120 -49.63 -157.71 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.129 -0.941 . . . . 2.04 110.581 164.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.708 ' CD1' HG23 ' A' ' 43' ' ' VAL . 4.3 m-85 -28.81 -47.09 0.05 Allowed 'General case' 0 CA--C 1.56 1.34 0 N-CA-C 116.533 2.049 . . . . 1.93 116.533 -166.23 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.563 ' HB ' ' OD1' ' A' ' 42' ' ' ASN . 7.2 m 38.02 98.53 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 120.239 1.381 . . . . 0.6 113.902 175.174 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.726 ' HB3' HD12 ' A' ' 39' ' ' LEU . 1.2 m -90.72 163.06 14.63 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.153 -0.93 . . . . 0.62 111.831 -174.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.418 ' O ' HD13 ' A' ' 39' ' ' LEU . 88.4 m-85 -126.92 126.06 42.61 Favored 'General case' 0 CA--C 1.493 -1.234 0 N-CA-C 106.215 -1.772 . . . . 0.57 106.215 166.192 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.775 HD11 HD12 ' A' ' 170' ' ' LEU . 10.7 tp -79.4 105.03 10.42 Favored 'General case' 0 N--CA 1.418 -2.06 0 C-N-CA 118.326 -1.349 . . . . 0.43 108.109 177.144 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.674 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 24.4 mm -92.24 135.17 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.783 0 CA-C-N 112.821 -1.99 . . . . 0.19 107.256 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.707 ' HA ' HD13 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -89.71 -177.14 5.19 Favored 'General case' 0 C--N 1.31 -1.109 0 C-N-CA 120.43 -0.508 . . . . 0.98 110.81 -168.192 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.584 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 47.9 mtm180 -53.97 -42.65 69.17 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 122.581 0.353 . . . . 2.22 111.902 -176.078 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -94.54 23.18 5.48 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.164 -0.68 . . . . 2.0 109.164 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.68 ' HA3' ' CE2' ' A' ' 16' ' ' PHE . . . 71.3 37.42 63.12 Favored Glycine 0 N--CA 1.441 -1.002 0 CA-C-N 115.149 -0.932 . . . . 0.17 113.64 176.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.461 ' HA ' ' HD2' ' A' ' 150' ' ' PRO . 46.5 t -103.88 107.46 56.82 Favored Pre-proline 0 C--N 1.316 -0.885 0 C-N-CA 119.809 -0.756 . . . . 1.12 111.43 177.262 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.879 ' HD3' HG23 ' A' ' 15' ' ' ILE . 15.6 Cg_endo -61.3 127.12 21.06 Favored 'Trans proline' 0 CA--C 1.516 -0.384 0 C-N-CA 123.396 2.731 . . . . 0.41 110.201 174.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.754 ' HA ' ' HG2' ' A' ' 126' ' ' LYS . 4.5 m -135.08 -31.85 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 C-N-CA 120.494 -0.482 . . . . 1.45 112.079 -178.332 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.762 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 14.4 mm-40 -112.95 159.54 19.0 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.543 -0.54 . . . . 1.17 109.543 174.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 141' ' ' SER . 0.0 OUTLIER -140.3 131.73 26.88 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 120.281 -0.568 . . . . 2.16 109.604 165.257 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.796 ' HZ ' ' HB2' ' A' ' 166' ' ' LYS . 97.9 m-85 -104.55 145.43 30.31 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.135 -0.939 . . . . 0.32 109.284 -174.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 3.2 p -78.51 158.1 76.62 Favored Pre-proline 0 C--N 1.314 -0.95 0 N-CA-C 108.985 -0.746 . . . . 1.11 108.985 176.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.666 ' CB ' ' HB2' ' A' ' 138' ' ' ASN . 11.3 Cg_endo -55.6 -45.05 42.37 Favored 'Trans proline' 0 CA--C 1.517 -0.331 0 C-N-CA 121.618 1.546 . . . . 0.78 110.754 178.045 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -52.87 -16.16 3.85 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-N 114.255 -1.339 . . . . 0.5 114.468 173.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -87.39 137.08 32.65 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 117.767 0.784 . . . . 0.5 109.304 175.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.417 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 68.1 m -114.14 -172.37 2.08 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 120.957 0.408 . . . . 1.42 112.033 -170.437 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.661 ' CG2' ' HA ' ' A' ' 56' ' ' THR . 57.8 t -40.04 -56.65 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 114.88 -1.055 . . . . 0.28 112.552 -175.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.75 -31.53 69.55 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.623 0.249 . . . . 3.46 110.917 -172.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -66.43 -37.94 86.31 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.316 0.579 . . . . 1.4 109.631 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.479 HD12 ' CG2' ' A' ' 56' ' ' THR . 81.7 mt -79.89 -43.72 22.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.389 -0.823 . . . . 0.21 111.257 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.592 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 36.7 mt-10 -54.01 -43.24 69.92 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-N 116.565 -0.289 . . . . 0.67 111.413 -177.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -59.56 -19.97 52.31 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.41 0.522 . . . . 0.87 112.41 -175.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.796 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 19.1 mmtp -101.9 -23.91 14.09 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.277 -0.569 . . . . 1.71 110.697 171.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.592 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 12.9 tp -76.8 -54.05 7.12 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.415 -0.811 . . . . 0.16 111.959 -178.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.469 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 72.1 mt -51.52 -45.5 90.71 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.085 -0.961 . . . . 0.26 112.296 -174.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.469 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 88.8 Cg_exo -49.45 -44.26 35.39 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 122.049 1.833 . . . . 0.41 112.71 173.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.775 HD12 HD11 ' A' ' 143' ' ' LEU . 90.5 mt -76.9 -38.82 52.8 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 120.911 -0.316 . . . . 0.71 111.093 -179.175 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.719 HD23 ' HG2' ' A' ' 37' ' ' PRO . 82.2 mt -59.45 -59.95 4.63 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-O 121.926 0.869 . . . . 0.34 109.908 177.329 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.571 0 CA-C-N 113.476 -1.693 . . . . 1.12 112.638 179.163 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.9 p . . . . . 0 CA--C 1.523 -0.08 0 CA-C-O 121.04 0.448 . . . . 1.58 110.36 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.514 ' HB3' ' O ' ' A' ' 147' ' ' ASP . 1.5 m -161.16 151.58 17.83 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 105.878 -1.897 . . . . 1.17 105.878 -176.13 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.924 ' HB ' HD11 ' A' ' 118' ' ' LEU . 4.8 pt -64.61 -16.01 18.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-N 114.927 -1.033 . . . . 0.38 112.015 -172.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.829 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 41.6 m-85 -69.73 -3.12 14.01 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 112.117 0.414 . . . . 0.3 112.117 -178.439 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -71.84 -25.1 61.84 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.37 -0.974 . . . . 2.11 108.37 174.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.586 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 50.1 m-85 -108.51 110.41 21.9 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 114.407 -1.27 . . . . 0.31 111.162 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -53.73 142.82 22.3 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.069 -1.423 . . . . 2.86 110.215 174.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.851 HG13 ' HZ ' ' A' ' 74' ' ' PHE . 53.7 t -110.71 161.97 8.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 N-CA-C 108.031 -1.1 . . . . 0.67 108.031 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.73 ' O ' ' HB2' ' A' ' 105' ' ' MET . 25.5 mt -130.61 152.44 49.98 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 120.603 -0.439 . . . . 0.69 110.455 -178.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -73.92 -178.46 3.27 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.332 -0.618 . . . . 1.87 109.332 176.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.633 ' HA ' ' N ' ' A' ' 106' ' ' ALA . . . -64.35 -4.41 3.8 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.803 0.335 . . . . 0.59 111.647 -178.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.525 ' HB2' ' HE2' ' A' ' 26' ' ' LYS . 9.7 m-20 -116.95 9.08 13.63 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.704 -0.226 . . . . 2.34 111.452 175.245 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.652 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 11.1 m170 73.02 11.93 5.12 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-O 121.419 0.628 . . . . 1.47 110.25 174.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.525 ' HE2' ' HB2' ' A' ' 24' ' ' ASP . 26.6 mtmt -69.52 130.68 90.43 Favored Pre-proline 0 N--CA 1.453 -0.322 0 N-CA-C 107.211 -1.403 . . . . 4.25 107.211 165.076 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.688 ' HA ' HD23 ' A' ' 21' ' ' LEU . 79.7 Cg_exo -51.16 114.79 1.68 Allowed 'Trans proline' 0 CA--C 1.53 0.28 0 C-N-CA 121.895 1.73 . . . . 0.54 113.147 -176.418 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.542 ' H ' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -76.93 149.9 35.99 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.174 -1.375 . . . . 1.2 110.602 173.179 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.506 ' OD1' ' HB3' ' A' ' 32' ' ' GLN . 2.4 t-20 -93.41 81.57 4.41 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.954 -0.758 . . . . 1.51 108.954 177.006 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.722 HD21 HD12 ' A' ' 15' ' ' ILE . 61.1 tp -62.01 -41.79 98.46 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.506 -0.77 . . . . 0.28 110.294 -178.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.721 ' HA ' ' CE1' ' A' ' 16' ' ' PHE . 1.6 t -70.12 -1.32 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.099 -0.955 . . . . 1.02 111.93 -170.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.506 ' HB3' ' OD1' ' A' ' 29' ' ' ASN . 17.8 pt20 -74.72 -10.36 59.44 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.06 -0.718 . . . . 1.02 109.06 174.456 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.962 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 93.9 m-70 -99.41 25.6 6.84 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 121.934 0.873 . . . . 0.28 109.649 176.113 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.829 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 14.8 mtmt -83.73 132.39 34.85 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 114.297 -1.32 . . . . 1.56 109.155 169.683 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.83 -42.02 2.03 Favored Glycine 0 N--CA 1.438 -1.233 0 C-N-CA 120.759 -0.734 . . . . 0.2 111.765 -178.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.516 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 15.7 m -125.31 124.95 25.2 Favored Pre-proline 0 N--CA 1.435 -1.21 0 N-CA-C 108.082 -1.081 . . . . 0.29 108.082 173.583 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.886 ' HG3' ' HB3' ' A' ' 170' ' ' LEU . 2.2 Cg_endo -39.65 153.9 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 124.266 3.31 . . . . 0.18 113.346 176.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.878 ' HB2' HG22 ' A' ' 70' ' ' THR . 0.9 OUTLIER -139.34 143.58 37.86 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.427 -1.323 . . . . 0.31 107.427 -179.209 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 1.046 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 1.2 mm? -107.8 121.71 45.28 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.66 -0.867 . . . . 1.19 108.66 176.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.719 HG13 HG13 ' A' ' 144' ' ' ILE . 1.3 mt -105.57 125.61 60.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 C-N-CA 120.109 -0.636 . . . . 0.37 109.551 177.144 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 1.046 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.4 OUTLIER -109.38 123.29 49.09 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 116.091 -0.504 . . . . 0.42 109.992 -174.408 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.657 ' ND2' ' HB ' ' A' ' 140' ' ' THR . 2.7 p-10 -80.56 93.22 6.04 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 122.3 1.047 . . . . 2.35 108.185 171.45 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.781 ' O ' ' HA ' ' A' ' 75' ' ' PRO . 7.7 p . . . . . 0 C--N 1.306 -1.317 0 CA-C-N 115.388 -0.824 . . . . 1.03 111.367 -164.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.835 0 N-CA-C 109.895 -1.282 . . . . 0.51 109.895 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -45.43 -46.13 11.71 Favored Glycine 0 C--O 1.219 -0.833 0 CA-C-N 114.821 -0.689 . . . . 0.5 113.65 177.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.559 ' HB3' ' OE2' ' A' ' 55' ' ' GLU . 0.6 OUTLIER -60.84 -61.43 2.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.186 0.493 . . . . 0.7 110.872 -175.469 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.559 ' OE2' ' HB3' ' A' ' 54' ' ' TYR . 0.2 OUTLIER -54.04 -31.87 52.71 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.62 0.724 . . . . 2.61 110.995 178.243 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.737 ' HA ' HG22 ' A' ' 160' ' ' VAL . 52.9 m -75.84 -58.99 2.95 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.079 -0.964 . . . . 0.33 110.684 -174.307 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 1.095 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -59.2 -40.3 85.33 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.876 -1.056 . . . . 0.22 110.828 -178.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.506 ' HA ' ' CD1' ' A' ' 102' ' ' PHE . 96.9 m -58.64 -55.17 38.53 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 115.695 -0.684 . . . . 0.26 110.358 179.048 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 61.5 m -69.4 -39.68 77.79 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.182 -0.917 . . . . 0.48 111.736 -176.105 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.764 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 17.4 mt -64.87 -47.65 77.11 Favored 'General case' 0 CA--C 1.498 -1.038 0 CA-C-O 121.055 0.455 . . . . 0.43 110.367 -175.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.86 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 7.8 t80 -54.56 -54.39 41.96 Favored 'General case' 0 C--O 1.197 -1.68 0 CA-C-N 114.904 -1.043 . . . . 0.31 110.32 177.486 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.404 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 9.0 m-80 -72.54 -24.33 61.11 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 111.866 0.321 . . . . 1.21 111.866 -171.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.534 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 36.7 ttpt -83.6 -20.73 33.19 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 108.688 -0.856 . . . . 1.54 108.688 -178.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.717 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 47.9 m-85 -128.52 -1.93 5.51 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 115.835 1.791 . . . . 0.31 115.835 -173.217 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.721 ' HG2' ' O ' ' A' ' 61' ' ' TYR . 11.9 ptmt -65.8 -26.97 67.93 Favored 'General case' 0 CA--C 1.497 -1.092 0 N-CA-C 107.834 -1.173 . . . . 1.35 107.834 171.069 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.3 m -47.73 -38.68 15.89 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 113.893 -1.503 . . . . 1.28 110.837 173.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -86.14 -39.63 16.49 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 111.621 0.23 . . . . 1.11 111.621 174.088 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.41 ' HA3' ' HB2' ' A' ' 36' ' ' SER . . . 149.63 -3.28 0.61 Allowed Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.263 -0.735 . . . . 0.18 111.263 -176.111 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.764 ' HE2' ' HB3' ' A' ' 60' ' ' LEU . 28.1 t80 -71.07 140.75 50.79 Favored 'General case' 0 C--O 1.222 -0.346 0 C-N-CA 122.856 0.462 . . . . 0.18 111.381 -177.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.962 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 3.7 t -132.96 152.42 51.93 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 108.452 -0.944 . . . . 0.2 108.452 175.051 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 1.095 HG11 ' HB1' ' A' ' 57' ' ' ALA . 42.2 t -111.83 101.54 12.68 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.532 0 N-CA-C 108.286 -1.005 . . . . 0.17 108.286 160.159 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.517 ' HA ' ' HB2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -95.06 121.74 36.99 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 118.37 -1.332 . . . . 1.04 107.73 172.984 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.895 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -111.51 128.27 55.96 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 120.581 -0.448 . . . . 0.51 110.71 178.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.851 ' HZ ' HG13 ' A' ' 20' ' ' VAL . 5.3 m-30 -100.8 112.62 65.03 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 116.149 -0.478 . . . . 0.44 110.057 -178.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.781 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 73.6 Cg_endo -80.65 82.45 2.47 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 123.213 2.609 . . . . 1.3 113.504 -169.4 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.552 ' HB2' ' CG2' ' A' ' 110' ' ' VAL . 19.3 t . . . . . 0 C--O 1.237 0.43 0 CA-C-O 122.782 1.277 . . . . 1.44 114.403 -174.227 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.532 ' HB1' ' CE1' ' A' ' 102' ' ' PHE . . . . . . . . 0 CA--C 1.518 -0.262 0 CA-C-O 121.152 0.501 . . . . 0.55 112.329 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -94.91 30.28 2.14 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 115.344 -0.844 . . . . 1.99 110.784 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.583 ' CE2' HD11 ' A' ' 104' ' ' ILE . 27.2 p90 -150.07 157.01 37.92 Favored Pre-proline 0 N--CA 1.446 -0.663 0 N-CA-C 108.332 -0.988 . . . . 0.84 108.332 177.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.698 ' HD3' ' CE2' ' A' ' 61' ' ' TYR . 97.7 Cg_exo -51.2 84.12 0.02 OUTLIER 'Trans proline' 0 N--CA 1.479 0.673 0 C-N-CA 124.794 3.663 . . . . 0.62 116.081 -172.6 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.895 HD12 ' HB3' ' A' ' 73' ' ' ALA . 7.5 mm -85.89 120.6 36.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.092 -1.077 . . . . 1.34 108.092 170.061 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.783 ' HG2' ' CG ' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -76.53 -177.69 4.31 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.753 -0.832 . . . . 3.03 108.753 178.272 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.633 ' N ' ' HA ' ' A' ' 23' ' ' ALA . . . -63.44 -53.75 47.35 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.384 -0.598 . . . . 1.46 109.384 -177.278 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.664 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 17.4 ptpt 146.15 151.07 0.0 OUTLIER 'General case' 0 CA--C 1.489 -1.385 0 O-C-N 125.823 1.952 . . . . 1.76 108.371 174.317 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.555 ' CD1' HG13 ' A' ' 110' ' ' VAL . 2.0 pp -152.08 174.53 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 CA-C-N 113.726 -1.579 . . . . 0.82 107.802 169.657 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -74.24 87.15 1.95 Allowed 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.462 -0.79 . . . . 1.73 110.932 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.555 HG13 ' CD1' ' A' ' 108' ' ' ILE . 3.6 m -86.0 95.81 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 C-N-CA 118.145 -1.422 . . . . 0.77 108.187 169.52 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.3 t30 . . . . . 0 C--N 1.311 -1.076 0 CA-C-N 113.63 -1.623 . . . . 1.9 107.815 178.358 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.613 ' CE1' ' H ' ' A' ' 118' ' ' LEU . 2.1 t-80 . . . . . 0 N--CA 1.423 -1.794 0 N-CA-C 106.275 -1.75 . . . . 0.42 106.275 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -27.23 -50.13 0.1 Allowed 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 124.503 3.469 . . . . 0.4 113.598 -178.2 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.924 HD11 ' HB ' ' A' ' 15' ' ' ILE . 29.1 tp -63.51 -49.28 74.16 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.922 0.489 . . . . 0.39 112.171 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.693 ' OH ' HG22 ' A' ' 40' ' ' ILE . 25.5 m-85 -79.97 -33.96 39.05 Favored 'General case' 0 CA--C 1.492 -1.258 0 CA-C-O 120.935 0.398 . . . . 3.04 110.881 -176.576 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.478 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 4.7 tt0 -60.42 -37.36 80.63 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 106.589 -1.634 . . . . 2.44 106.589 174.265 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.586 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 51.5 t80 -68.53 -33.07 73.46 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.047 -0.979 . . . . 0.56 110.492 174.298 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.698 ' HE3' ' HG ' ' A' ' 118' ' ' LEU . 2.9 ttm -75.77 -55.58 5.5 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.09 -0.504 . . . . 0.71 110.418 -169.406 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.416 ' HB2' ' HE2' ' A' ' 123' ' ' LYS . 0.8 OUTLIER -70.82 -25.44 62.85 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 120.616 -0.433 . . . . 1.46 111.721 178.294 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.478 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -72.35 -29.73 64.07 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 119.379 -0.928 . . . . 1.99 109.394 178.447 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 88.0 m -87.26 -31.2 20.39 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.489 -0.778 . . . . 0.59 111.285 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.678 ' HG3' ' HB2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.382 0 N-CA-C 112.727 0.64 . . . . 1.85 112.727 -172.17 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.574 ' HB3' ' HG3' ' A' ' 156' ' ' PRO . 8.9 m-90 . . . . . 0 CA--C 1.51 -0.586 0 CA-C-O 120.872 0.368 . . . . 1.97 110.446 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.593 ' HB2' ' CB ' ' A' ' 156' ' ' PRO . 3.4 m120 -43.86 -155.71 0.0 OUTLIER 'General case' 0 C--O 1.212 -0.884 0 CA-C-N 114.784 -1.098 . . . . 2.04 111.298 163.008 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.684 ' HD2' ' HD2' ' A' ' 41' ' ' TYR . 2.9 m-85 -27.4 -52.51 0.07 Allowed 'General case' 0 C--O 1.209 -1.076 0 N-CA-C 115.724 1.75 . . . . 1.93 115.724 -166.564 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.657 ' HB ' ' ND2' ' A' ' 42' ' ' ASN . 7.5 m 41.6 109.17 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 120.542 1.519 . . . . 0.6 113.648 173.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.788 ' HB3' HD12 ' A' ' 39' ' ' LEU . 3.5 m -106.0 158.53 16.73 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 114.825 -1.08 . . . . 0.62 111.085 -167.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.573 ' CD1' ' HB2' ' A' ' 153' ' ' ARG . 63.6 m-85 -125.38 124.34 41.29 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 106.899 -1.519 . . . . 0.57 106.899 166.427 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.776 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 7.1 tp -79.88 104.01 10.17 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 118.337 -1.345 . . . . 0.43 108.369 179.27 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.746 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 32.3 mm -92.94 137.92 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.612 0 CA-C-N 113.574 -1.648 . . . . 0.19 107.803 -175.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.64 ' OD1' HG12 ' A' ' 149' ' ' VAL . 0.0 OUTLIER -89.18 -173.72 4.15 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 119.74 -0.784 . . . . 0.98 111.592 -168.14 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.759 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 21.1 mtm180 -56.24 -37.7 70.11 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-O 121.373 0.606 . . . . 2.22 110.543 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.514 ' O ' ' HB3' ' A' ' 14' ' ' SER . 27.6 t70 -93.48 13.74 20.81 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.736 -0.838 . . . . 2.0 108.736 -176.159 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.719 ' HA2' HG22 ' A' ' 144' ' ' ILE . . . 67.6 33.98 82.6 Favored Glycine 0 N--CA 1.434 -1.437 0 CA-C-N 115.359 -0.837 . . . . 0.17 114.404 -177.099 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.64 HG12 ' OD1' ' A' ' 145' ' ' ASP . 9.2 p -105.15 114.02 64.0 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 119.206 1.503 . . . . 1.12 111.44 172.692 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.716 ' HD3' HG23 ' A' ' 15' ' ' ILE . 2.5 Cg_endo -49.71 126.93 17.49 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 123.869 3.046 . . . . 0.41 111.771 174.002 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 23.0 t -120.09 -32.26 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.397 0.617 . . . . 1.45 109.345 -178.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.776 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 47.8 mm-40 -132.03 167.19 20.12 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-N 115.303 -0.862 . . . . 1.17 111.032 -177.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.599 ' HA ' ' O ' ' A' ' 141' ' ' SER . 1.6 ttm180 -146.33 132.74 19.63 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.266 -0.879 . . . . 2.16 110.744 163.791 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.57 ' HZ ' ' HB2' ' A' ' 166' ' ' LYS . 98.8 m-85 -110.97 151.55 27.81 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 114.713 -1.13 . . . . 0.32 109.614 -170.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 43.2 t -72.99 156.0 90.02 Favored Pre-proline 0 C--N 1.317 -0.821 0 N-CA-C 109.029 -0.73 . . . . 1.11 109.029 174.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.593 ' CB ' ' HB2' ' A' ' 138' ' ' ASN . 22.8 Cg_endo -61.44 -29.89 85.96 Favored 'Trans proline' 0 CA--C 1.517 -0.341 0 C-N-CA 121.852 1.702 . . . . 0.78 110.247 171.08 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -73.41 -1.64 57.94 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 114.225 -1.352 . . . . 0.5 113.058 172.301 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -93.01 140.22 29.7 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 108.421 -0.955 . . . . 0.5 108.421 172.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.553 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 6.7 t -114.2 -170.82 1.79 Allowed 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 120.305 -0.558 . . . . 1.42 111.148 -170.344 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.737 HG22 ' HA ' ' A' ' 56' ' ' THR . 38.2 t -46.83 -49.47 6.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 114.556 -1.202 . . . . 0.28 111.612 -175.543 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 50.3 tttp -67.41 -39.9 85.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.873 0.368 . . . . 3.46 111.201 -175.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.429 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 31.2 m-20 -64.25 -37.45 87.51 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.716 -0.674 . . . . 1.4 109.946 -177.104 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.543 HD12 HG21 ' A' ' 56' ' ' THR . 88.6 mt -80.01 -47.69 21.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.069 -0.969 . . . . 0.21 111.281 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.677 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 30.7 mt-10 -54.5 -40.62 68.71 Favored 'General case' 0 C--O 1.215 -0.714 0 O-C-N 123.151 0.282 . . . . 0.67 111.572 -176.317 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 10.1 pt-20 -59.57 -21.07 59.79 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.667 0.27 . . . . 0.87 111.493 -175.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.57 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 12.6 mmmm -104.1 -23.92 13.24 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.432 0.634 . . . . 1.71 109.904 175.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.677 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 12.7 tp -79.2 -52.29 8.36 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.725 -1.125 . . . . 0.16 112.106 -178.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.484 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 74.4 mt -53.36 -45.03 98.64 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.31 -0.859 . . . . 0.26 111.959 -174.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.484 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 92.3 Cg_exo -49.06 -44.93 31.2 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 121.929 1.753 . . . . 0.41 112.23 171.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.886 ' HB3' ' HG3' ' A' ' 37' ' ' PRO . 43.5 mt -74.26 -42.78 59.07 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.926 0.343 . . . . 0.71 111.926 -178.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.813 HD23 ' HG2' ' A' ' 37' ' ' PRO . 89.3 mt -60.62 -54.91 39.69 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 122.197 0.998 . . . . 0.34 109.643 177.162 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.381 0 CA-C-N 113.377 -1.738 . . . . 1.12 114.059 -175.216 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.2 m . . . . . 0 C--O 1.234 0.274 0 CA-C-O 121.365 0.602 . . . . 1.58 110.121 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.435 ' HB3' ' O ' ' A' ' 147' ' ' ASP . 5.9 m -164.76 152.21 11.45 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 104.498 -2.408 . . . . 1.17 104.498 179.73 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.861 ' HB ' HD11 ' A' ' 118' ' ' LEU . 4.9 pt -62.09 -11.81 6.79 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 CA-C-N 115.59 -0.732 . . . . 0.38 112.302 -172.028 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.776 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 53.0 m-85 -75.34 0.75 15.7 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.949 0.722 . . . . 0.3 112.949 -176.712 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -82.2 -19.27 40.15 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.41 -0.959 . . . . 2.11 108.41 175.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.701 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 50.0 m-85 -106.3 113.92 27.73 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 114.855 -1.066 . . . . 0.31 111.791 -178.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -48.56 136.56 12.93 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 113.404 -1.725 . . . . 2.86 111.032 174.255 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.931 HG13 ' HZ ' ' A' ' 74' ' ' PHE . 94.4 t -112.18 163.91 8.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 108.92 -0.77 . . . . 0.67 108.92 178.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.699 HD23 ' HA ' ' A' ' 27' ' ' PRO . 47.2 mt -130.83 148.97 52.66 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 110.113 -0.328 . . . . 0.69 110.113 -178.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -76.53 177.01 7.77 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.281 -1.377 . . . . 1.87 107.281 166.099 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.79 ' HA ' ' N ' ' A' ' 106' ' ' ALA . . . -64.62 -4.7 4.43 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.238 0.459 . . . . 0.59 112.238 -176.744 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.571 ' HB2' ' HE2' ' A' ' 26' ' ' LYS . 54.6 m-20 -105.05 3.03 30.06 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.444 -0.344 . . . . 2.34 111.273 178.719 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.536 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 71.7 m-70 75.48 2.77 3.87 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 122.724 0.41 . . . . 1.47 109.944 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.571 ' HE2' ' HB2' ' A' ' 24' ' ' ASP . 22.1 mtmt -63.01 118.04 38.75 Favored Pre-proline 0 CA--C 1.512 -0.501 0 N-CA-C 106.777 -1.564 . . . . 4.25 106.777 166.464 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.699 ' HA ' HD23 ' A' ' 21' ' ' LEU . 96.5 Cg_exo -51.2 114.5 1.57 Allowed 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 121.488 1.458 . . . . 0.54 112.222 -177.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.751 ' HE2' HD23 ' A' ' 72' ' ' LEU . 3.6 t80 -78.73 139.17 38.49 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 113.839 -1.528 . . . . 1.2 110.823 177.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.469 ' OD1' ' HB3' ' A' ' 32' ' ' GLN . 2.6 t-20 -80.9 82.76 6.79 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.595 -0.729 . . . . 1.51 109.288 178.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.791 HD13 HG21 ' A' ' 20' ' ' VAL . 52.7 tp -58.44 -43.38 88.75 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.657 -0.701 . . . . 0.28 110.454 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.707 HG12 ' HG3' ' A' ' 34' ' ' LYS . 1.8 t -69.1 -0.26 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 114.918 -1.037 . . . . 1.02 112.384 -168.114 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.469 ' HB3' ' OD1' ' A' ' 29' ' ' ASN . 9.3 pt20 -77.1 -8.9 58.28 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.247 -0.649 . . . . 1.02 109.247 174.409 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.919 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 91.2 m-70 -98.95 29.7 3.71 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 122.042 0.925 . . . . 0.28 109.007 175.603 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.776 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 5.7 mtmt -92.31 109.29 20.67 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 114.25 -1.341 . . . . 1.56 109.768 174.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.73 -38.44 1.99 Allowed Glycine 0 N--CA 1.436 -1.328 0 N-CA-C 111.319 -0.712 . . . . 0.2 111.319 -177.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.465 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 25.4 m -127.49 130.91 23.63 Favored Pre-proline 0 N--CA 1.433 -1.282 0 N-CA-C 108.192 -1.04 . . . . 0.29 108.192 171.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.824 ' HG2' HD23 ' A' ' 171' ' ' LEU . 2.7 Cg_endo -43.43 157.82 0.11 Allowed 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 124.135 3.223 . . . . 0.18 113.016 176.634 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.777 ' HB2' HG22 ' A' ' 70' ' ' THR . 0.7 OUTLIER -143.12 144.0 32.05 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 106.981 -1.488 . . . . 0.31 106.981 -179.105 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.786 HD23 ' CE1' ' A' ' 69' ' ' PHE . 2.7 mm? -107.92 113.39 26.56 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.075 -0.713 . . . . 1.19 109.075 177.482 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.919 HG23 HD13 ' A' ' 72' ' ' LEU . 0.9 OUTLIER -97.0 125.35 50.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 109.676 -0.49 . . . . 0.37 109.676 177.219 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.765 ' CE1' HG13 ' A' ' 71' ' ' VAL . 2.4 m-85 -108.26 155.73 20.16 Favored 'General case' 0 C--O 1.216 -0.698 0 CA-C-O 120.899 0.38 . . . . 0.42 111.537 -171.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.745 ' OD1' ' HB2' ' A' ' 76' ' ' SER . 7.0 t30 -105.33 115.35 30.12 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.306 -1.368 . . . . 2.35 107.306 165.286 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.817 ' O ' ' HA ' ' A' ' 75' ' ' PRO . 34.7 m . . . . . 0 C--N 1.31 -1.151 0 CA-C-O 121.223 0.535 . . . . 1.03 112.124 -171.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.44 0 N-CA-C 110.208 -1.157 . . . . 0.51 110.208 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.452 ' HA2' ' HB ' ' A' ' 56' ' ' THR . . . -61.7 -15.65 48.45 Favored Glycine 0 C--O 1.216 -0.991 0 CA-C-N 114.729 -0.735 . . . . 0.5 112.433 175.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -68.43 -59.99 2.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 117.358 0.579 . . . . 0.7 109.844 178.035 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -51.85 -32.63 32.68 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.861 0.838 . . . . 2.61 110.456 174.138 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.808 ' HA ' HG22 ' A' ' 160' ' ' VAL . 43.3 m -72.83 -59.36 2.75 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 114.396 -1.274 . . . . 0.33 110.578 -175.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 1.073 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -58.52 -42.17 87.1 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.693 -1.14 . . . . 0.22 111.115 -178.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.542 ' HA ' ' CD1' ' A' ' 102' ' ' PHE . 91.5 m -59.63 -55.14 38.16 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.566 0.698 . . . . 0.26 110.442 -178.481 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 61.4 m -66.82 -36.89 83.42 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.655 -1.157 . . . . 0.48 111.406 -177.056 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.776 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 14.9 mt -65.42 -47.98 74.38 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 121.364 0.602 . . . . 0.43 110.345 -177.295 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.875 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 6.7 t80 -59.22 -46.3 88.82 Favored 'General case' 0 C--O 1.207 -1.135 0 CA-C-N 114.896 -1.047 . . . . 0.31 110.489 178.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -73.69 -25.12 60.09 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 116.416 -0.357 . . . . 1.21 110.981 -174.319 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.427 ' HB2' ' HE2' ' A' ' 63' ' ' LYS . 6.5 tppt? -80.0 -32.72 39.7 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 108.316 -0.994 . . . . 1.54 108.316 -178.744 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.763 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 46.0 m-85 -125.67 -2.04 7.32 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 115.802 1.779 . . . . 0.31 115.802 -165.543 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.675 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 16.3 pttp -67.13 -23.33 65.8 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 107.881 -1.155 . . . . 1.35 107.881 169.387 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 29.2 t -48.57 -36.94 16.63 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 114.161 -1.381 . . . . 1.28 110.565 169.55 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -90.31 -32.44 16.51 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 111.875 0.324 . . . . 1.11 111.875 175.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 142.25 -6.81 2.27 Favored Glycine 0 C--N 1.331 0.264 0 N-CA-C 111.119 -0.792 . . . . 0.18 111.119 -176.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.786 ' CE1' HD23 ' A' ' 39' ' ' LEU . 19.9 t80 -66.91 138.61 57.42 Favored 'General case' 0 C--O 1.22 -0.463 0 C-N-CA 123.045 0.538 . . . . 0.18 111.17 -177.799 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.919 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 2.0 t -133.51 144.21 49.26 Favored 'General case' 0 N--CA 1.428 -1.573 0 N-CA-C 109.39 -0.596 . . . . 0.2 109.39 175.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 1.073 HG11 ' HB1' ' A' ' 57' ' ' ALA . 19.6 t -103.28 100.61 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.465 0 N-CA-C 108.614 -0.884 . . . . 0.17 108.614 162.783 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.919 HD13 HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -98.73 120.09 38.58 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.237 -0.985 . . . . 1.04 108.414 174.636 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 1.042 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -105.49 131.22 53.17 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.64 0.733 . . . . 0.51 111.304 -177.47 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.931 ' HZ ' HG13 ' A' ' 20' ' ' VAL . 3.0 m-30 -107.76 108.94 62.08 Favored Pre-proline 0 C--N 1.31 -1.116 0 CA-C-N 114.998 -1.001 . . . . 0.44 108.905 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.817 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 18.0 Cg_endo -82.13 87.48 1.4 Allowed 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.551 2.167 . . . . 1.3 113.321 -171.052 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.745 ' HB2' ' OD1' ' A' ' 42' ' ' ASN . 1.6 t . . . . . 0 CA--C 1.506 -0.739 0 CA-C-N 115.157 -0.929 . . . . 1.44 113.013 -173.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.634 0 CA-C-O 121.114 0.483 . . . . 0.55 111.24 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -87.4 -5.39 58.87 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.353 -0.839 . . . . 1.99 110.108 174.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.709 ' HB2' ' O ' ' A' ' 71' ' ' VAL . 16.6 p90 -121.09 160.26 45.98 Favored Pre-proline 0 N--CA 1.44 -0.932 0 CA-C-N 115.639 -0.71 . . . . 0.84 110.37 -175.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.69 ' HG2' ' HA ' ' A' ' 72' ' ' LEU . 44.0 Cg_endo -61.65 95.99 0.13 Allowed 'Trans proline' 0 N--CA 1.479 0.624 0 C-N-CA 124.71 3.606 . . . . 0.62 114.284 -174.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 1.042 HD12 ' HB3' ' A' ' 73' ' ' ALA . 4.8 mm -87.02 129.8 37.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 108.591 -0.892 . . . . 1.34 108.591 171.701 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.772 ' HG2' ' CG ' ' A' ' 74' ' ' PHE . 0.1 OUTLIER -82.66 174.03 11.38 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.709 -0.848 . . . . 3.03 108.709 177.114 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.79 ' N ' ' HA ' ' A' ' 23' ' ' ALA . . . -56.09 -56.51 19.98 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.16 0.505 . . . . 1.46 110.127 -176.046 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.816 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 4.7 ptpp? 144.33 137.03 0.0 OUTLIER 'General case' 0 CA--C 1.488 -1.416 0 O-C-N 125.734 1.896 . . . . 1.76 106.952 176.66 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.496 HD12 HG22 ' A' ' 110' ' ' VAL . 2.9 pp -136.21 163.32 34.32 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.281 0 CA-C-N 113.945 -1.479 . . . . 0.82 107.497 177.213 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -71.19 57.58 0.23 Allowed 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 122.947 0.499 . . . . 1.73 111.894 -173.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.604 HG23 ' CB ' ' A' ' 76' ' ' SER . 0.0 OUTLIER -61.16 94.83 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 N-CA-C 108.92 -0.77 . . . . 0.77 108.92 -178.121 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.8 t30 . . . . . 0 N--CA 1.441 -0.918 0 CA-C-N 114.245 -1.343 . . . . 1.9 108.717 -177.221 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.62 ' CE1' ' H ' ' A' ' 118' ' ' LEU . 3.2 t-80 . . . . . 0 N--CA 1.422 -1.828 0 N-CA-C 105.636 -1.987 . . . . 0.42 105.636 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -29.38 -44.31 0.1 OUTLIER 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 124.128 3.219 . . . . 0.4 113.577 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.861 HD11 ' HB ' ' A' ' 15' ' ' ILE . 39.4 tp -59.63 -52.25 66.34 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.495 0.718 . . . . 0.39 112.079 176.043 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.665 ' HA ' ' HB2' ' A' ' 122' ' ' MET . 43.0 m-85 -77.39 -36.27 53.55 Favored 'General case' 0 CA--C 1.5 -0.953 0 N-CA-C 111.871 0.322 . . . . 3.04 111.871 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.727 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 7.0 mm-40 -59.33 -32.81 70.42 Favored 'General case' 0 CA--C 1.494 -1.182 0 N-CA-C 107.828 -1.175 . . . . 2.44 107.828 172.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.701 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 55.0 t80 -70.81 -33.71 70.99 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 119.731 -0.788 . . . . 0.56 110.651 172.228 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.745 ' HE3' ' HG ' ' A' ' 118' ' ' LEU . 2.6 ttm -73.59 -55.22 6.58 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.903 -0.589 . . . . 0.71 110.102 -168.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 126' ' ' LYS . 0.2 OUTLIER -71.31 -24.13 62.07 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.088 -0.505 . . . . 1.46 111.614 176.372 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.727 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 9.8 pttp -68.71 -27.54 66.03 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 119.088 -1.045 . . . . 1.99 108.889 175.291 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 56.0 m -76.73 -50.04 14.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.463 -0.79 . . . . 0.59 109.546 173.113 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.654 ' HB3' ' NH2' ' A' ' 153' ' ' ARG . 31.4 mttm . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 115.902 -0.59 . . . . 1.85 111.077 176.201 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.602 ' HB2' ' OG1' ' A' ' 140' ' ' THR . 12.0 m-90 . . . . . 0 N--CA 1.448 -0.561 0 N-CA-C 108.159 -1.052 . . . . 1.97 108.159 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.663 ' HB2' ' CB ' ' A' ' 156' ' ' PRO . 62.6 m-20 -45.25 -155.31 0.0 OUTLIER 'General case' 0 C--O 1.21 -1.019 0 C-N-CA 123.907 0.883 . . . . 2.04 111.403 163.512 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.599 ' HA ' HG12 ' A' ' 43' ' ' VAL . 1.3 m-85 -30.47 -27.65 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.308 0 N-CA-C 117.317 2.34 . . . . 1.93 117.317 -167.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.664 ' HA ' ' O ' ' A' ' 154' ' ' PHE . 3.1 m 9.08 108.55 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 115.162 1.541 . . . . 0.6 115.162 169.612 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.603 ' OG ' HD12 ' A' ' 39' ' ' LEU . 3.1 t -105.84 165.59 11.08 Favored 'General case' 0 C--O 1.207 -1.177 0 CA-C-N 114.903 -1.044 . . . . 0.62 110.855 -173.053 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.439 ' HA ' ' HA ' ' A' ' 153' ' ' ARG . 15.1 m-85 -121.51 125.22 46.3 Favored 'General case' 0 CA--C 1.49 -1.337 0 N-CA-C 106.486 -1.672 . . . . 0.57 106.486 167.414 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.768 HD23 ' HG3' ' A' ' 152' ' ' GLU . 11.1 tp -80.36 104.14 10.7 Favored 'General case' 0 N--CA 1.419 -2.004 0 C-N-CA 118.222 -1.391 . . . . 0.43 108.457 178.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.681 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 41.1 mm -89.21 141.7 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.658 0 CA-C-N 113.012 -1.904 . . . . 0.19 107.701 -177.453 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.665 ' HA ' HD13 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -93.46 -176.01 3.97 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 119.938 -0.705 . . . . 0.98 111.137 -170.865 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.728 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 50.4 mtm180 -54.49 -37.12 64.92 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.878 0.37 . . . . 2.22 111.301 -177.07 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.435 ' O ' ' HB3' ' A' ' 14' ' ' SER . 7.5 m-20 -94.36 13.96 22.0 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.716 -0.22 . . . . 2.0 110.782 -178.189 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.638 ' HA3' ' CE2' ' A' ' 16' ' ' PHE . . . 73.14 36.82 56.04 Favored Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 120.858 -0.687 . . . . 0.17 113.286 -176.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.474 ' HA ' ' HD2' ' A' ' 150' ' ' PRO . 52.6 t -107.82 106.32 58.24 Favored Pre-proline 0 C--N 1.317 -0.829 0 CA-C-N 117.701 0.75 . . . . 1.12 111.078 175.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.708 ' HG3' ' HG3' ' A' ' 122' ' ' MET . 2.1 Cg_endo -51.48 117.24 3.28 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 123.746 2.964 . . . . 0.41 111.462 172.152 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.873 HG23 ' HG2' ' A' ' 152' ' ' GLU . 27.5 m -118.33 -13.02 10.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 121.133 0.492 . . . . 1.45 109.754 -178.215 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.873 ' HG2' HG23 ' A' ' 151' ' ' VAL . 17.2 mm-40 -145.99 165.9 27.65 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.582 -0.736 . . . . 1.17 109.652 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.654 ' NH2' ' HB3' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -148.03 144.23 27.77 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.634 -0.712 . . . . 2.16 110.044 159.459 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.706 ' HZ ' ' HB2' ' A' ' 166' ' ' LYS . 91.5 m-85 -120.58 148.25 44.12 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.333 -0.849 . . . . 0.32 108.802 -166.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.426 ' HB3' ' HD2' ' A' ' 156' ' ' PRO . 10.8 m -74.56 162.67 72.67 Favored Pre-proline 0 C--N 1.316 -0.889 0 N-CA-C 109.654 -0.498 . . . . 1.11 109.654 178.348 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.663 ' CB ' ' HB2' ' A' ' 138' ' ' ASN . 28.6 Cg_endo -63.82 -33.04 66.3 Favored 'Trans proline' 0 CA--C 1.516 -0.386 0 C-N-CA 121.973 1.782 . . . . 0.78 110.42 174.644 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -63.96 -5.54 14.84 Favored Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 113.926 -1.488 . . . . 0.5 113.822 170.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -87.74 142.32 27.92 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 117.765 0.782 . . . . 0.5 109.408 174.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.467 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 20.3 t -109.92 -179.82 3.91 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 120.881 0.372 . . . . 1.42 110.414 -172.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.808 HG22 ' HA ' ' A' ' 56' ' ' THR . 62.9 t -43.68 -52.13 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.082 -0.963 . . . . 0.28 111.452 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.33 -27.58 62.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.956 -0.566 . . . . 3.46 111.486 -173.269 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -71.12 -37.75 72.32 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 109.144 -0.687 . . . . 1.4 109.144 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.546 ' HA ' ' CE2' ' A' ' 154' ' ' PHE . 75.0 mt -77.35 -49.09 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-N 115.027 -0.988 . . . . 0.21 110.639 176.491 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.673 ' HG3' HD21 ' A' ' 60' ' ' LEU . 25.5 mt-10 -51.78 -45.47 63.82 Favored 'General case' 0 C--O 1.219 -0.54 0 O-C-N 123.302 0.376 . . . . 0.67 111.305 -177.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -56.31 -23.34 36.3 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.041 0.386 . . . . 0.87 112.041 -175.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.706 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 14.2 mmmm -102.1 -23.91 14.01 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.342 0.591 . . . . 1.71 110.064 174.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.668 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 7.5 tp -76.74 -48.06 19.91 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.262 -0.881 . . . . 0.16 111.95 -177.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.5 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 80.6 mt -53.76 -46.39 98.41 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.616 -0.72 . . . . 0.26 112.175 -174.698 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.5 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 58.0 Cg_exo -54.65 -22.93 30.53 Favored 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 122.311 2.007 . . . . 0.41 113.12 174.243 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.763 ' HB3' ' HG3' ' A' ' 37' ' ' PRO . 31.2 mt -92.98 -38.5 11.63 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 111.68 0.252 . . . . 0.71 111.68 178.428 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.824 HD23 ' HG2' ' A' ' 37' ' ' PRO . 94.9 mt -63.29 -52.04 63.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-O 122.212 1.006 . . . . 0.34 109.313 175.694 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.563 0 CA-C-N 113.265 -1.789 . . . . 1.12 114.184 -174.963 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.2 t . . . . . 0 C--O 1.233 0.221 0 CA-C-O 121.834 0.826 . . . . 1.58 108.794 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.438 ' HB2' ' O ' ' A' ' 147' ' ' ASP . 92.0 p -179.91 152.69 0.48 Allowed 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 104.831 -2.285 . . . . 1.17 104.831 -177.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.984 HD12 HD21 ' A' ' 30' ' ' LEU . 4.7 pt -66.96 -12.66 15.42 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 CA-C-N 115.371 -0.831 . . . . 0.38 112.021 -171.412 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.656 ' CD1' ' HA ' ' A' ' 31' ' ' VAL . 54.9 m-85 -76.28 6.97 4.74 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.028 0.442 . . . . 0.3 111.167 178.645 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -81.7 -27.74 33.8 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 107.24 -1.393 . . . . 2.11 107.24 174.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.654 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 50.9 m-85 -105.05 121.02 42.92 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 113.963 -1.472 . . . . 0.31 111.008 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -60.18 150.08 30.99 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.29 -1.323 . . . . 2.86 109.818 173.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.852 HG13 ' HZ ' ' A' ' 74' ' ' PHE . 53.0 t -112.23 170.66 3.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 107.71 -1.219 . . . . 0.67 107.71 178.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.702 HD23 ' HA ' ' A' ' 27' ' ' PRO . 88.7 mt -132.37 141.05 48.74 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 118.334 0.515 . . . . 0.69 111.409 -176.691 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -74.36 169.07 18.42 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 106.878 -1.527 . . . . 1.87 106.878 166.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.82 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . . . -62.4 -3.73 1.53 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 114.046 1.128 . . . . 0.59 114.046 -167.613 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.531 ' HB2' ' HE2' ' A' ' 26' ' ' LYS . 64.7 m-20 -111.5 12.06 21.37 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 121.008 -0.277 . . . . 2.34 111.349 176.358 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.558 ' CD2' ' HB1' ' A' ' 106' ' ' ALA . 72.1 m-70 77.13 8.96 2.77 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.366 0.603 . . . . 1.47 109.72 177.344 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.531 ' HE2' ' HB2' ' A' ' 24' ' ' ASP . 21.1 mtmt -74.65 119.3 76.0 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 107.54 -1.282 . . . . 4.25 107.54 169.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.702 ' HA ' HD23 ' A' ' 21' ' ' LEU . 93.9 Cg_exo -50.39 115.27 1.83 Allowed 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.329 2.019 . . . . 0.54 114.203 -172.497 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.616 ' CE2' ' HB3' ' A' ' 103' ' ' PRO . 0.2 OUTLIER -78.6 120.4 23.23 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 113.275 -1.784 . . . . 1.2 109.635 169.201 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -72.96 103.1 3.65 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 122.446 1.117 . . . . 1.51 108.82 174.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.984 HD21 HD12 ' A' ' 15' ' ' ILE . 67.3 tp -71.4 -31.48 67.32 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.834 -1.076 . . . . 0.28 110.343 -178.235 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.656 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 3.3 m -66.14 -4.13 2.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 114.439 -1.255 . . . . 1.02 113.109 -167.022 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 -74.67 -6.64 49.84 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.557 0.694 . . . . 1.02 110.01 175.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.957 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 88.6 m-70 -102.13 24.97 9.36 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 115.339 -0.846 . . . . 0.28 109.397 176.461 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.556 ' HE3' ' HB ' ' A' ' 31' ' ' VAL . 93.0 mttt -83.99 123.79 30.36 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 114.426 -1.261 . . . . 1.56 109.323 170.713 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.14 -36.08 4.07 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.366 -0.921 . . . . 0.2 111.925 178.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.457 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 22.5 m -130.38 132.33 23.95 Favored Pre-proline 0 N--CA 1.436 -1.162 0 N-CA-C 108.252 -1.018 . . . . 0.29 108.252 171.457 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.752 ' HD3' ' HG2' ' A' ' 146' ' ' ARG . 5.1 Cg_endo -43.18 153.86 0.18 Allowed 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.899 3.066 . . . . 0.18 112.795 176.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.844 ' HB2' HG22 ' A' ' 70' ' ' THR . 0.7 OUTLIER -139.65 149.17 43.42 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 106.313 -1.736 . . . . 0.31 106.313 -179.733 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.989 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 2.3 mp -116.3 130.84 56.98 Favored 'General case' 0 C--N 1.292 -1.92 0 O-C-N 121.629 -0.669 . . . . 1.19 109.606 176.138 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.935 HG22 ' OH ' ' A' ' 119' ' ' TYR . 1.1 mt -111.72 126.75 69.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 CA-C-N 115.065 -0.971 . . . . 0.37 109.596 178.284 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.989 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.6 OUTLIER -111.86 124.72 52.95 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.954 -0.566 . . . . 0.42 110.992 -171.662 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.475 ' OD1' ' HB2' ' A' ' 76' ' ' SER . 5.0 t30 -79.66 95.12 5.84 Favored 'General case' 0 CA--C 1.504 -0.827 0 N-CA-C 107.206 -1.405 . . . . 2.35 107.206 167.194 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.765 ' O ' ' HA ' ' A' ' 75' ' ' PRO . 4.1 p . . . . . 0 C--N 1.294 -1.831 0 CA-C-N 114.833 -1.076 . . . . 1.03 109.649 -172.079 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.452 0 N-CA-C 110.301 -1.12 . . . . 0.51 110.301 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.404 ' HA3' ' CG ' ' A' ' 139' ' ' PHE . . . -49.85 -46.69 40.06 Favored Glycine 0 C--O 1.222 -0.62 0 CA-C-N 114.424 -0.888 . . . . 0.5 113.969 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -59.31 -59.14 5.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.328 0.564 . . . . 0.7 111.554 -171.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.14 -27.87 69.67 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.291 0.567 . . . . 2.61 110.48 -177.355 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.702 HG23 ' HA ' ' A' ' 160' ' ' VAL . 31.8 m -75.83 -57.77 3.68 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.084 -0.962 . . . . 0.33 110.02 -175.539 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 1.055 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -60.3 -41.67 93.88 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.202 -0.908 . . . . 0.22 111.039 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.536 ' HA ' ' CD2' ' A' ' 102' ' ' PHE . 96.7 m -57.69 -55.69 31.53 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.433 0.635 . . . . 0.26 110.466 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 27.3 m -69.46 -36.11 76.27 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.001 -0.999 . . . . 0.48 111.484 -175.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.749 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 16.3 mt -66.93 -47.07 72.82 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-O 120.974 0.416 . . . . 0.43 110.472 -176.397 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.857 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 5.0 t80 -55.31 -56.14 23.4 Favored 'General case' 0 C--O 1.198 -1.637 0 CA-C-N 115.208 -0.905 . . . . 0.31 109.916 177.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -69.75 -24.04 63.47 Favored 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 122.707 0.403 . . . . 1.21 111.566 -173.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.405 ' HE2' ' HB2' ' A' ' 63' ' ' LYS . 13.8 tppt? -76.01 -32.25 59.3 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 108.388 -0.968 . . . . 1.54 108.388 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.713 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 48.4 m-85 -125.86 -2.44 7.18 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 115.7 1.741 . . . . 0.31 115.7 -166.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.765 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 12.6 ptmt -63.84 -29.27 70.48 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 107.686 -1.227 . . . . 1.35 107.686 170.415 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.6 m -47.94 -36.63 12.76 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 113.822 -1.536 . . . . 1.28 111.009 173.199 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -88.44 -39.75 14.0 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 120.96 -0.296 . . . . 1.11 111.619 173.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.425 ' HA3' ' HB2' ' A' ' 36' ' ' SER . . . 151.49 -4.03 0.47 Allowed Glycine 0 CA--C 1.52 0.388 0 N-CA-C 111.505 -0.638 . . . . 0.18 111.505 -175.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.749 ' HE2' ' HB3' ' A' ' 60' ' ' LEU . 21.4 t80 -71.2 142.59 50.64 Favored 'General case' 0 C--O 1.222 -0.392 0 C-N-CA 122.644 0.377 . . . . 0.18 111.131 -177.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.957 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 2.3 t -133.76 153.15 51.92 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 108.063 -1.088 . . . . 0.2 108.063 173.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 1.055 HG11 ' HB1' ' A' ' 57' ' ' ALA . 25.6 t -112.97 99.5 8.79 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.541 0 N-CA-C 108.018 -1.104 . . . . 0.17 108.018 160.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.511 HD12 ' H ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -93.68 120.2 33.65 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 118.365 -1.334 . . . . 1.04 107.557 174.554 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.769 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -112.21 117.23 31.99 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.538 0.685 . . . . 0.51 110.901 -178.645 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.852 ' HZ ' HG13 ' A' ' 20' ' ' VAL . 5.3 m-30 -93.31 112.54 56.86 Favored Pre-proline 0 C--N 1.318 -0.779 0 CA-C-N 115.241 -0.891 . . . . 0.44 109.388 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.765 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 44.2 Cg_endo -82.29 87.4 1.4 Allowed 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.082 1.855 . . . . 1.3 112.694 -172.702 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.6 ' CB ' HG23 ' A' ' 110' ' ' VAL . 7.0 t . . . . . 0 C--N 1.321 -0.655 0 CA-C-N 114.382 -1.281 . . . . 1.44 111.765 -177.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.514 -0.434 0 CA-C-O 121.048 0.452 . . . . 0.55 111.36 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -85.86 22.52 1.65 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.308 -0.86 . . . . 1.99 110.606 -177.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.566 ' HB3' ' CD2' ' A' ' 61' ' ' TYR . 19.1 p90 -147.33 163.67 26.89 Favored Pre-proline 0 N--CA 1.447 -0.609 0 CA-C-N 115.711 -0.677 . . . . 0.84 109.312 -178.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.657 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 71.3 Cg_exo -57.12 89.39 0.04 OUTLIER 'Trans proline' 0 N--CA 1.478 0.608 0 C-N-CA 124.608 3.538 . . . . 0.62 115.44 -172.409 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.769 HD12 ' HB3' ' A' ' 73' ' ' ALA . 3.6 mm -89.52 127.54 42.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 108.259 -1.015 . . . . 1.34 108.259 171.215 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.847 ' HG2' ' CG ' ' A' ' 74' ' ' PHE . 0.7 OUTLIER -88.83 -171.37 3.28 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.8 0.333 . . . . 3.03 111.563 -172.206 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.82 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . . . -61.19 -16.88 49.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.808 -0.633 . . . . 1.46 111.795 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.752 ' HB2' ' O ' ' A' ' 75' ' ' PRO . 3.7 ptpp? 78.27 128.2 0.05 OUTLIER 'General case' 0 CA--C 1.494 -1.193 0 O-C-N 125.477 1.736 . . . . 1.76 109.846 -166.523 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.771 HD12 HG22 ' A' ' 110' ' ' VAL . 2.4 pp -128.87 163.64 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.162 0 CA-C-N 113.028 -1.897 . . . . 0.82 107.042 171.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.15 58.1 0.16 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 123.897 0.748 . . . . 1.73 111.556 -172.576 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.771 HG22 HD12 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -63.91 96.64 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 CA-C-O 120.849 0.357 . . . . 0.77 111.08 -171.977 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 3.5 t-20 . . . . . 0 N--CA 1.445 -0.681 0 N-CA-C 108.337 -0.986 . . . . 1.9 108.337 167.486 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.649 ' CE1' ' H ' ' A' ' 118' ' ' LEU . 2.0 t-80 . . . . . 0 N--CA 1.43 -1.456 0 N-CA-C 106.254 -1.758 . . . . 0.42 106.254 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -30.31 -46.26 0.14 Allowed 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 124.303 3.336 . . . . 0.4 113.621 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.836 HD11 ' HB ' ' A' ' 15' ' ' ILE . 22.6 tp -62.64 -51.34 67.64 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.174 0.589 . . . . 0.39 111.886 178.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.935 ' OH ' HG22 ' A' ' 40' ' ' ILE . 36.6 m-85 -76.58 -36.55 57.51 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 112.285 0.476 . . . . 3.04 112.285 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.793 ' HA ' ' HD2' ' A' ' 123' ' ' LYS . 48.5 mt-10 -61.61 -30.79 70.92 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 107.462 -1.31 . . . . 2.44 107.462 174.384 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.654 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 59.5 t80 -71.62 -32.87 68.43 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.426 -0.806 . . . . 0.56 110.682 171.221 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.737 ' HE3' ' HG ' ' A' ' 118' ' ' LEU . 2.5 ttm -73.73 -52.46 13.13 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.178 -0.465 . . . . 0.71 110.367 -169.571 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.793 ' HD2' ' HA ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -71.04 -24.73 62.4 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.196 -0.456 . . . . 1.46 111.079 175.463 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.767 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -65.0 -30.75 71.76 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.461 0.648 . . . . 1.99 109.741 172.257 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 85.9 m -79.51 -47.32 15.78 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.245 -0.889 . . . . 0.59 111.038 178.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.566 ' HE3' ' O ' ' A' ' 151' ' ' VAL . 19.9 ttmm . . . . . 0 C--N 1.326 -0.441 0 CA-C-O 121.06 0.457 . . . . 1.85 111.982 -178.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.777 ' HB3' ' HG3' ' A' ' 156' ' ' PRO . 2.3 m-90 . . . . . 0 CA--C 1.51 -0.565 0 N-CA-C 110.229 -0.286 . . . . 1.97 110.229 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -42.26 -155.8 0.0 OUTLIER 'General case' 0 C--O 1.205 -1.245 0 C-N-CA 124.022 0.929 . . . . 2.04 110.535 159.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.645 ' HD2' ' CD2' ' A' ' 41' ' ' TYR . 5.0 m-85 -26.04 -46.72 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.046 0 N-CA-C 116.025 1.861 . . . . 1.93 116.025 -163.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.689 ' HA ' ' O ' ' A' ' 154' ' ' PHE . 5.7 m 28.34 96.16 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 119.675 1.125 . . . . 0.6 113.664 171.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.674 ' HB3' HD23 ' A' ' 39' ' ' LEU . 1.6 m -85.07 170.74 12.65 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.041 -0.982 . . . . 0.62 111.714 -170.35 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.47 ' HA ' ' O ' ' A' ' 152' ' ' GLU . 81.1 m-85 -130.46 120.3 23.97 Favored 'General case' 0 CA--C 1.496 -1.116 0 N-CA-C 105.886 -1.894 . . . . 0.57 105.886 161.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.756 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 4.9 tp -78.82 103.64 8.91 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 118.054 -1.458 . . . . 0.43 108.062 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.748 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 45.6 mm -88.77 141.27 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.788 0 CA-C-N 113.474 -1.694 . . . . 0.19 107.564 -177.534 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.446 ' HA ' HD13 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -92.37 -176.05 4.2 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 119.179 -1.008 . . . . 0.98 110.601 -171.92 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.752 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 11.5 mtm180 -54.55 -40.89 69.14 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.141 0.496 . . . . 2.22 111.031 -176.392 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.438 ' O ' ' HB2' ' A' ' 14' ' ' SER . 5.0 m-20 -94.83 18.01 12.61 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.558 -0.534 . . . . 2.0 109.558 -175.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.56 ' HA3' ' CE2' ' A' ' 16' ' ' PHE . . . 73.12 33.68 59.11 Favored Glycine 0 N--CA 1.44 -1.077 0 CA-C-N 115.688 -0.687 . . . . 0.17 114.128 178.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.512 ' HA ' ' HD2' ' A' ' 150' ' ' PRO . 62.1 t -107.45 106.93 59.63 Favored Pre-proline 0 C--N 1.314 -0.953 0 CA-C-N 118.298 1.049 . . . . 1.12 111.291 176.077 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.577 ' HG3' ' HG3' ' A' ' 122' ' ' MET . 5.7 Cg_exo -46.34 122.9 6.04 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 124.155 3.237 . . . . 0.41 112.087 171.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.566 ' O ' ' HE3' ' A' ' 126' ' ' LYS . 46.8 t -117.99 -29.66 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 109.369 -0.604 . . . . 1.45 109.369 -176.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.756 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 31.0 mm-40 -136.84 167.03 22.23 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.562 -0.745 . . . . 1.17 110.848 -177.395 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.452 ' HA ' ' O ' ' A' ' 141' ' ' SER . 0.2 OUTLIER -144.02 131.37 20.89 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.473 -0.785 . . . . 2.16 109.712 163.552 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.689 ' O ' ' HA ' ' A' ' 140' ' ' THR . 96.8 m-85 -111.02 152.32 26.98 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.866 -0.606 . . . . 0.32 109.63 -170.052 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 12.5 m -74.76 156.94 86.31 Favored Pre-proline 0 C--N 1.319 -0.719 0 N-CA-C 109.469 -0.567 . . . . 1.11 109.469 176.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.777 ' HG3' ' HB3' ' A' ' 137' ' ' TRP . 34.4 Cg_endo -64.88 -24.89 60.46 Favored 'Trans proline' 0 CA--C 1.519 -0.267 0 C-N-CA 122.181 1.92 . . . . 0.78 111.039 177.394 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -80.44 5.6 63.54 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 114.691 -1.14 . . . . 0.5 113.453 173.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -79.19 151.33 31.3 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.388 -0.597 . . . . 0.5 109.388 173.046 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 33.8 t -108.34 169.33 8.71 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 109.494 -0.558 . . . . 1.42 109.494 -177.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.702 ' HA ' HG23 ' A' ' 56' ' ' THR . 99.3 t -40.14 -59.48 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 O-C-N 124.356 1.035 . . . . 0.28 111.683 178.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.484 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 0.9 OUTLIER -65.74 -30.26 70.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.299 -0.409 . . . . 3.46 111.986 -173.483 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -65.25 -35.95 82.63 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-O 122.247 1.022 . . . . 1.4 108.756 -178.241 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.585 ' HA ' ' CE2' ' A' ' 154' ' ' PHE . 54.5 mt -78.17 -44.25 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 CA-C-N 113.7 -1.591 . . . . 0.21 110.483 175.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.623 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 47.7 mt-10 -54.93 -43.12 73.07 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 116.048 -0.524 . . . . 0.67 111.492 -177.475 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 161' ' ' LYS . 7.0 pt-20 -61.03 -16.69 46.36 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.235 0.457 . . . . 0.87 112.235 -176.73 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.633 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 34.0 mmtp -100.72 -28.89 12.58 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.667 0.746 . . . . 1.71 109.793 172.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.623 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 12.5 tp -78.84 -50.97 10.37 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.857 -1.065 . . . . 0.16 112.749 -175.378 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.494 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 63.3 mt -55.14 -45.78 99.79 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.85 -0.614 . . . . 0.26 112.387 -174.522 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.494 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 58.2 Cg_exo -56.14 -17.29 19.54 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 122.081 1.854 . . . . 0.41 113.124 174.618 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.751 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 78.0 mt -97.7 -42.72 7.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.741 -0.209 . . . . 0.71 111.08 176.436 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.714 HD23 ' HG2' ' A' ' 37' ' ' PRO . 93.7 mt -61.08 -52.1 66.37 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-O 122.165 0.983 . . . . 0.34 109.595 175.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.331 0 CA-C-N 113.565 -1.652 . . . . 1.12 112.923 -178.655 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.1 t . . . . . 0 CA--C 1.529 0.169 0 CA-C-O 120.965 0.412 . . . . 1.58 110.318 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 27.8 m -163.64 151.55 13.05 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 104.854 -2.276 . . . . 1.17 104.854 -179.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.882 ' HB ' HD11 ' A' ' 118' ' ' LEU . 6.3 pt -58.93 -20.55 17.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 CA-C-N 115.042 -0.981 . . . . 0.38 111.756 -174.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.812 ' HB3' HG13 ' A' ' 31' ' ' VAL . 42.2 m-85 -67.2 -6.24 17.19 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.293 0.849 . . . . 0.3 113.293 -175.229 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -78.4 -15.78 58.31 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 107.873 -1.158 . . . . 2.11 107.873 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.566 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 37.3 m-85 -107.61 115.88 30.94 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 114.577 -1.192 . . . . 0.31 110.829 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -55.62 144.32 27.06 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 113.896 -1.502 . . . . 2.86 110.054 175.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.851 HG13 ' HZ ' ' A' ' 74' ' ' PHE . 66.5 t -112.14 166.14 6.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 107.879 -1.156 . . . . 0.67 107.879 179.122 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.756 ' HB2' ' HE1' ' A' ' 105' ' ' MET . 55.7 mt -125.6 146.59 49.63 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 109.949 -0.389 . . . . 0.69 109.949 178.278 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.583 ' HB3' ' HE3' ' A' ' 26' ' ' LYS . 16.5 t70 -77.8 169.79 17.68 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 106.146 -1.798 . . . . 1.87 106.146 165.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.674 ' HA ' ' N ' ' A' ' 106' ' ' ALA . . . -63.68 -3.65 2.45 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 113.253 0.834 . . . . 0.59 113.253 -168.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.937 ' HB2' ' HE2' ' A' ' 26' ' ' LYS . 3.3 m-20 -107.0 6.01 28.67 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 111.451 0.167 . . . . 2.34 111.451 176.127 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.582 ' CD2' ' HB1' ' A' ' 106' ' ' ALA . 59.9 m-70 79.85 6.04 1.86 Allowed 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.521 0.677 . . . . 1.47 109.61 177.041 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.937 ' HE2' ' HB2' ' A' ' 24' ' ' ASP . 29.8 mtmt -66.68 115.94 29.66 Favored Pre-proline 0 N--CA 1.447 -0.595 0 N-CA-C 107.656 -1.238 . . . . 4.25 107.656 167.057 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.659 ' HA ' HD23 ' A' ' 21' ' ' LEU . 75.4 Cg_exo -48.76 114.86 1.38 Allowed 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 121.796 1.664 . . . . 0.54 112.313 -178.288 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.508 ' CE2' ' HB3' ' A' ' 103' ' ' PRO . 0.8 OUTLIER -78.39 151.55 32.74 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 113.573 -1.649 . . . . 1.2 111.761 179.589 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.758 ' ND2' ' HB3' ' A' ' 32' ' ' GLN . 49.1 t30 -86.82 90.2 8.22 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.8 -1.091 . . . . 1.51 109.836 174.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.676 HD23 ' HA ' ' A' ' 16' ' ' PHE . 63.2 tp -71.56 -43.79 65.7 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.179 0.514 . . . . 0.28 110.601 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.812 HG13 ' HB3' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -67.56 0.89 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.18 -0.918 . . . . 1.02 113.174 -172.12 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.758 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . 13.7 pt20 -72.54 -11.88 60.84 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.553 0.692 . . . . 1.02 109.322 172.185 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.956 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 91.6 m-70 -98.73 21.18 11.76 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 115.267 -0.879 . . . . 0.28 109.087 176.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.788 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 11.0 mtmm -80.1 110.4 15.47 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.541 -1.209 . . . . 1.56 109.118 169.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 133.45 -43.06 1.3 Allowed Glycine 0 N--CA 1.439 -1.106 0 C-N-CA 120.75 -0.738 . . . . 0.2 111.841 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.422 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 72.3 m -126.88 138.09 31.91 Favored Pre-proline 0 N--CA 1.439 -0.987 0 N-CA-C 108.576 -0.898 . . . . 0.29 108.576 173.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.825 ' HD3' ' HG2' ' A' ' 146' ' ' ARG . 3.2 Cg_endo -43.37 149.15 0.58 Allowed 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 123.574 2.85 . . . . 0.18 112.079 174.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.91 ' HB2' HG22 ' A' ' 70' ' ' THR . 0.6 OUTLIER -135.78 150.24 49.41 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 106.051 -1.833 . . . . 0.31 106.051 178.475 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.942 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 2.7 mp -116.21 129.34 56.25 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 109.206 -0.664 . . . . 1.19 109.206 175.032 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.862 HG22 ' OH ' ' A' ' 119' ' ' TYR . 1.2 mt -111.02 123.71 67.16 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 CA-C-N 115.025 -0.989 . . . . 0.37 109.002 178.452 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.942 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.5 OUTLIER -108.74 123.64 49.33 Favored 'General case' 0 C--O 1.215 -0.738 0 CA-C-N 115.996 -0.547 . . . . 0.42 110.796 -172.267 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.636 ' HB2' HG11 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -76.56 122.09 24.11 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 104.88 -2.267 . . . . 2.35 104.88 165.948 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.807 HG11 ' HB1' ' A' ' 73' ' ' ALA . 2.5 p . . . . . 0 C--N 1.298 -1.631 0 C-N-CA 118.724 -1.19 . . . . 1.03 112.94 -165.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.728 0 N-CA-C 110.128 -1.189 . . . . 0.51 110.128 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -37.13 -50.99 1.63 Allowed Glycine 0 C--O 1.223 -0.566 0 CA-C-N 114.364 -0.918 . . . . 0.5 114.952 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.471 ' HA ' ' CZ ' ' A' ' 139' ' ' PHE . 0.1 OUTLIER -57.71 -59.18 5.59 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 117.743 0.772 . . . . 0.7 111.469 -172.41 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -62.56 -26.96 68.85 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.733 -0.667 . . . . 2.61 110.136 -178.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.726 ' HA ' HG22 ' A' ' 160' ' ' VAL . 77.5 m -71.91 -59.61 2.66 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 114.891 -1.05 . . . . 0.33 109.916 -177.534 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 1.055 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -60.59 -39.9 89.79 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 114.675 -1.148 . . . . 0.22 111.371 -178.307 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.543 ' HA ' ' CD1' ' A' ' 102' ' ' PHE . 89.8 m -58.57 -58.71 7.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.598 0.713 . . . . 0.26 110.6 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.4 m -68.31 -33.78 74.95 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 114.955 -1.021 . . . . 0.48 111.473 -174.24 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.749 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 20.6 mt -67.53 -50.58 58.02 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 121.25 0.547 . . . . 0.43 110.37 -177.136 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.812 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 10.5 t80 -54.83 -50.3 68.92 Favored 'General case' 0 C--O 1.204 -1.325 0 CA-C-N 114.983 -1.008 . . . . 0.31 110.681 177.304 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -72.48 -25.7 61.53 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 122.443 0.297 . . . . 1.21 110.75 -171.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.501 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 35.3 ttpt -86.47 -23.28 26.03 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 109.044 -0.724 . . . . 1.54 109.044 -178.431 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.772 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 30.4 m-85 -123.51 -5.49 8.19 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 115.291 1.589 . . . . 0.31 115.291 -169.57 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.679 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -64.63 -23.22 67.19 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 108.055 -1.091 . . . . 1.35 108.055 169.976 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 37.5 t -47.19 -40.35 15.84 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 114.118 -1.401 . . . . 1.28 110.848 171.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -90.06 -32.35 16.76 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 120.725 0.298 . . . . 1.11 111.337 177.229 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 143.44 -5.67 1.86 Allowed Glycine 0 N--CA 1.449 -0.468 0 N-CA-C 111.364 -0.694 . . . . 0.18 111.364 -175.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.772 ' HD2' ' HB2' ' A' ' 64' ' ' TYR . 24.6 t80 -66.92 141.32 57.67 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 120.978 0.418 . . . . 0.18 110.822 -178.786 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.956 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 5.3 t -132.55 152.96 51.42 Favored 'General case' 0 N--CA 1.422 -1.835 0 N-CA-C 107.991 -1.114 . . . . 0.2 107.991 174.338 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 1.055 HG11 ' HB1' ' A' ' 57' ' ' ALA . 38.2 t -112.09 99.86 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.702 0 N-CA-C 107.65 -1.241 . . . . 0.17 107.65 158.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.622 HD12 HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -93.46 121.23 34.65 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 106.911 -1.514 . . . . 1.04 106.911 174.33 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 1.023 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -108.02 121.16 44.23 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.961 0.886 . . . . 0.51 111.265 -178.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.913 ' CG ' ' HG2' ' A' ' 105' ' ' MET . 2.6 m-30 -95.7 101.04 7.13 Favored Pre-proline 0 C--N 1.314 -0.935 0 CA-C-N 114.379 -1.282 . . . . 0.44 109.009 178.332 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.715 ' HA ' HG13 ' A' ' 43' ' ' VAL . 87.8 Cg_endo -82.12 74.99 4.94 Favored 'Trans proline' 0 CA--C 1.512 -0.612 0 C-N-CA 122.798 2.332 . . . . 1.3 113.423 -167.082 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.8 p . . . . . 0 N--CA 1.469 0.505 0 N-CA-C 116.967 2.21 . . . . 1.44 116.967 -177.146 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.46 0 CA-C-O 121.041 0.448 . . . . 0.55 111.231 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -95.33 26.3 3.89 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.792 -0.64 . . . . 1.99 111.033 178.452 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.543 ' CD1' ' HA ' ' A' ' 58' ' ' THR . 12.7 p90 -146.18 164.71 23.45 Favored Pre-proline 0 N--CA 1.448 -0.527 0 N-CA-C 108.571 -0.9 . . . . 0.84 108.571 176.497 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.71 ' HD3' ' CE2' ' A' ' 61' ' ' TYR . 52.7 Cg_exo -59.07 85.79 0.06 OUTLIER 'Trans proline' 0 N--CA 1.482 0.832 0 C-N-CA 124.697 3.598 . . . . 0.62 115.35 -173.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 1.023 HD12 ' HB3' ' A' ' 73' ' ' ALA . 3.9 mm -85.56 131.67 33.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 108.61 -0.885 . . . . 1.34 108.61 171.677 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.913 ' HG2' ' CG ' ' A' ' 74' ' ' PHE . 1.9 ppp? -96.68 -175.64 3.36 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.149 0.5 . . . . 3.03 110.482 -176.104 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.674 ' N ' ' HA ' ' A' ' 23' ' ' ALA . . . -79.33 19.5 0.59 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.391 -0.822 . . . . 1.46 112.654 -170.295 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.699 ' HG2' ' HG2' ' A' ' 75' ' ' PRO . 50.7 mttp 60.92 131.25 0.01 OUTLIER 'General case' 0 CA--C 1.496 -1.114 0 CA-C-O 122.365 1.079 . . . . 1.76 110.784 -168.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.595 ' CD1' HG13 ' A' ' 110' ' ' VAL . 2.4 pp -128.01 163.9 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.392 0 N-CA-C 106.326 -1.731 . . . . 0.82 106.326 160.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -76.53 84.29 3.23 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 120.38 -0.528 . . . . 1.73 110.439 -172.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.636 HG11 ' HB2' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -79.28 90.33 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.225 0 C-N-CA 119.325 -0.95 . . . . 0.77 109.128 179.594 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.5 t30 . . . . . 0 N--CA 1.445 -0.717 0 CA-C-N 114.252 -1.34 . . . . 1.9 108.608 175.346 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.591 ' CE1' ' H ' ' A' ' 118' ' ' LEU . 1.6 t-80 . . . . . 0 N--CA 1.433 -1.311 0 N-CA-C 107.13 -1.433 . . . . 0.42 107.13 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -24.09 -46.9 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 124.805 3.67 . . . . 0.4 113.988 -178.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.882 HD11 ' HB ' ' A' ' 15' ' ' ILE . 24.8 tp -67.97 -50.31 56.53 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.012 0.525 . . . . 0.39 111.783 -178.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.862 ' OH ' HG22 ' A' ' 40' ' ' ILE . 16.6 m-85 -80.96 -34.19 33.31 Favored 'General case' 0 CA--C 1.483 -1.611 0 CA-C-O 121.504 0.668 . . . . 3.04 110.378 -176.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.598 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 5.6 tp10 -63.09 -34.37 77.44 Favored 'General case' 0 N--CA 1.419 -1.987 0 N-CA-C 106.889 -1.523 . . . . 2.44 106.889 175.153 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.625 ' HD1' ' HE3' ' A' ' 124' ' ' LYS . 43.4 t80 -72.31 -28.86 63.34 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.591 -0.732 . . . . 0.56 109.82 170.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.855 ' HE3' ' HG ' ' A' ' 118' ' ' LEU . 2.9 ttm -75.66 -56.12 5.0 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.11 -0.636 . . . . 0.71 110.393 -169.177 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.436 ' HD2' ' HA ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -72.29 -23.28 61.17 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 120.773 -0.371 . . . . 1.46 111.948 176.849 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.625 ' HE3' ' HD1' ' A' ' 121' ' ' TYR . 12.4 pttp -70.53 -27.66 64.34 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 119.201 -0.999 . . . . 1.99 109.823 175.484 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 38.8 m -89.73 -24.81 21.44 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.683 -0.689 . . . . 0.59 110.341 176.028 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.471 ' HE2' ' HA ' ' A' ' 151' ' ' VAL . 29.9 mmtm . . . . . 0 C--N 1.324 -0.502 0 CA-C-N 115.614 -0.721 . . . . 1.85 110.78 -178.155 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.893 ' HB3' ' HG3' ' A' ' 156' ' ' PRO . 9.7 m-90 . . . . . 0 CA--C 1.511 -0.535 0 N-CA-C 109.777 -0.453 . . . . 1.97 109.777 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.615 ' HB2' ' CB ' ' A' ' 156' ' ' PRO . 9.6 m120 -44.49 -156.89 0.0 OUTLIER 'General case' 0 C--O 1.211 -0.937 0 O-C-N 123.849 0.718 . . . . 2.04 111.311 161.614 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.653 ' CD1' HG23 ' A' ' 43' ' ' VAL . 3.9 m-85 -31.41 -26.38 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.338 0 N-CA-C 118.036 2.606 . . . . 1.93 118.036 -168.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.688 ' HA ' ' O ' ' A' ' 154' ' ' PHE . 1.9 m 7.49 103.43 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 120.5 1.5 . . . . 0.6 114.678 171.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.526 ' HB3' HD23 ' A' ' 39' ' ' LEU . 1.1 m -91.56 173.61 7.8 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.552 -1.204 . . . . 0.62 111.039 -172.364 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.526 ' HA ' ' HA ' ' A' ' 153' ' ' ARG . 60.5 m-85 -132.52 122.68 25.23 Favored 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 105.858 -1.904 . . . . 0.57 105.858 164.355 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.787 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 7.3 tp -80.0 104.6 10.68 Favored 'General case' 0 N--CA 1.422 -1.834 0 C-N-CA 118.302 -1.359 . . . . 0.43 108.474 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.741 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 36.8 mm -89.03 141.84 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.741 0 CA-C-N 112.854 -1.976 . . . . 0.19 107.581 -177.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.507 ' HA ' HD13 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -94.38 -175.34 3.61 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 119.411 -0.916 . . . . 0.98 111.395 -170.358 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.825 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 30.7 mtm180 -55.98 -33.42 64.81 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.803 0.335 . . . . 2.22 111.566 -176.674 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -103.78 22.99 13.48 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 109.864 -0.421 . . . . 2.0 109.864 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.595 ' HA2' HG22 ' A' ' 144' ' ' ILE . . . 70.18 37.09 71.93 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 121.219 -0.515 . . . . 0.17 114.184 177.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.511 ' HA ' ' HD2' ' A' ' 150' ' ' PRO . 57.8 t -107.04 108.3 61.79 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 118.192 0.996 . . . . 1.12 111.243 174.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.785 ' HD3' HG23 ' A' ' 15' ' ' ILE . 8.5 Cg_endo -58.3 110.13 0.6 Allowed 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 123.757 2.971 . . . . 0.41 111.307 174.462 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.697 HG23 ' HG2' ' A' ' 152' ' ' GLU . 17.8 m -108.86 -23.41 4.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.299 0.571 . . . . 1.45 109.569 -176.59 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.787 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 47.2 mm-40 -133.3 168.22 18.97 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-N 115.298 -0.865 . . . . 1.17 110.434 179.251 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.549 HH11 ' HG2' ' A' ' 153' ' ' ARG . 0.0 OUTLIER -144.63 148.63 34.54 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 114.614 -1.176 . . . . 2.16 108.582 163.019 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.688 ' O ' ' HA ' ' A' ' 140' ' ' THR . 91.9 m-85 -121.77 144.36 48.85 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 110.207 -0.294 . . . . 0.32 110.207 -169.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 12.9 p -63.87 149.5 93.12 Favored Pre-proline 0 C--N 1.318 -0.787 0 N-CA-C 109.536 -0.542 . . . . 1.11 109.536 174.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.893 ' HG3' ' HB3' ' A' ' 137' ' ' TRP . 30.3 Cg_endo -63.2 -26.38 72.42 Favored 'Trans proline' 0 CA--C 1.511 -0.659 0 C-N-CA 122.349 2.033 . . . . 0.78 110.714 176.149 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -79.2 16.67 8.87 Favored Glycine 0 N--CA 1.438 -1.177 0 CA-C-N 113.785 -1.552 . . . . 0.5 113.405 171.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -95.64 152.98 17.96 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 109.514 -0.55 . . . . 0.5 109.514 170.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.587 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 22.9 t -113.44 176.83 4.86 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 109.71 -0.478 . . . . 1.42 109.71 -175.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.726 HG22 ' HA ' ' A' ' 56' ' ' THR . 48.4 t -45.62 -48.38 4.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 O-C-N 124.04 0.837 . . . . 0.28 110.9 178.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.589 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 40.8 tttm -65.54 -41.16 93.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.823 -0.626 . . . . 3.46 111.148 -175.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -64.93 -34.26 77.99 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 121.732 0.777 . . . . 1.4 109.47 -173.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.593 HD12 ' CG2' ' A' ' 56' ' ' THR . 46.3 mt -80.54 -46.21 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 CA-C-N 114.451 -1.249 . . . . 0.21 111.106 177.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.529 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 36.5 mt-10 -53.09 -44.26 67.45 Favored 'General case' 0 C--O 1.218 -0.587 0 N-CA-C 111.688 0.255 . . . . 0.67 111.688 -175.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.589 ' HG2' ' O ' ' A' ' 161' ' ' LYS . 4.5 pt-20 -62.35 -14.23 37.57 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.568 0.581 . . . . 0.87 112.568 -175.386 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.682 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 13.0 mmmt -105.3 -23.9 12.79 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.009 -0.737 . . . . 1.71 109.009 175.171 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.529 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 10.5 tp -83.26 -50.77 8.07 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.48 -1.236 . . . . 0.16 112.222 -176.316 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 164' ' ' GLU . 65.4 mt -54.32 -44.94 99.31 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 115.586 -0.734 . . . . 0.26 112.077 -175.26 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.47 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 86.8 Cg_exo -50.53 -24.59 12.78 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 122.182 1.921 . . . . 0.41 113.287 173.093 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.732 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 88.1 mt -95.19 -42.5 8.54 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 122.28 -0.263 . . . . 0.71 111.547 177.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.766 HD23 ' HG2' ' A' ' 37' ' ' PRO . 89.1 mt -61.45 -52.4 64.72 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-O 122.19 0.995 . . . . 0.34 109.883 177.062 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.648 0 CA-C-N 113.065 -1.88 . . . . 1.12 114.356 -172.18 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.5 m . . . . . 0 C--O 1.235 0.292 0 CA-C-O 121.062 0.458 . . . . 1.58 110.582 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.8 m -145.39 -176.42 5.11 Favored 'General case' 0 N--CA 1.423 -1.785 0 N-CA-C 104.896 -2.261 . . . . 1.17 104.896 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.73 HG23 ' HD3' ' A' ' 150' ' ' PRO . 5.7 pt -81.42 -17.73 11.83 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.481 0 CA-C-O 121.447 0.641 . . . . 0.38 109.847 177.361 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.775 ' HB3' HG13 ' A' ' 31' ' ' VAL . 39.7 m-85 -71.0 -2.75 16.37 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.503 -0.771 . . . . 0.3 112.45 -176.614 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -77.2 -20.5 55.28 Favored 'General case' 0 CA--C 1.501 -0.904 0 N-CA-C 107.595 -1.261 . . . . 2.11 107.595 176.375 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.601 ' CD2' ' HA ' ' A' ' 118' ' ' LEU . 58.1 m-85 -113.39 122.32 47.0 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 114.334 -1.303 . . . . 0.31 111.8 -174.312 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -48.19 139.4 8.48 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 112.561 -2.109 . . . . 2.86 111.709 172.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.875 HG13 ' HZ ' ' A' ' 74' ' ' PHE . 79.2 t -113.43 166.34 7.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 107.637 -1.246 . . . . 0.67 107.637 174.525 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.72 HD23 ' HA ' ' A' ' 27' ' ' PRO . 80.4 mt -132.88 131.87 41.44 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 120.001 -0.68 . . . . 0.69 112.47 -177.122 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 15.1 t70 -64.43 159.23 21.8 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 106.457 -1.683 . . . . 1.87 106.457 165.501 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.768 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . . . -60.51 -6.76 1.74 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 113.801 1.038 . . . . 0.59 113.801 -165.001 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.608 ' HB2' ' HE2' ' A' ' 26' ' ' LYS . 54.7 m-20 -97.14 -0.19 47.38 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.751 0.278 . . . . 2.34 111.751 176.241 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.535 ' HB2' ' O ' ' A' ' 24' ' ' ASP . 74.8 m80 83.64 10.06 0.51 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.727 0.775 . . . . 1.47 109.01 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.608 ' HE2' ' HB2' ' A' ' 24' ' ' ASP . 21.7 mtmt -75.16 119.31 76.37 Favored Pre-proline 0 N--CA 1.447 -0.609 0 CA-C-N 114.298 -1.319 . . . . 4.25 107.578 168.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.72 ' HA ' HD23 ' A' ' 21' ' ' LEU . 47.3 Cg_exo -45.79 116.33 1.36 Allowed 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 122.415 2.076 . . . . 0.54 113.16 -176.299 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.762 ' OH ' ' HB3' ' A' ' 103' ' ' PRO . 0.1 OUTLIER -75.81 147.47 39.15 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 113.885 -1.507 . . . . 1.2 111.299 177.821 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.518 ' N ' ' HD1' ' A' ' 28' ' ' TYR . 2.5 t-20 -82.47 97.22 8.3 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 114.838 -1.074 . . . . 1.51 108.803 175.296 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.71 HD13 HG21 ' A' ' 20' ' ' VAL . 61.1 tp -83.82 -45.31 13.43 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.647 -0.706 . . . . 0.28 110.888 -176.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.775 HG13 ' HB3' ' A' ' 16' ' ' PHE . 0.1 OUTLIER -67.28 0.25 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.316 -0.857 . . . . 1.02 112.801 -171.712 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.451 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 28.7 pt20 -74.01 -12.21 60.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.418 0.627 . . . . 1.02 109.477 172.538 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.918 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 90.5 m-70 -97.7 20.49 11.85 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 121.876 0.845 . . . . 0.28 109.092 175.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.743 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 18.3 mtmt -80.42 114.18 19.13 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 114.381 -1.281 . . . . 1.56 109.245 169.042 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.87 -38.9 2.22 Favored Glycine 0 N--CA 1.434 -1.489 0 C-N-CA 120.607 -0.806 . . . . 0.2 111.927 178.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.455 ' HB2' ' HA3' ' A' ' 68' ' ' GLY . 20.2 m -129.49 128.02 23.09 Favored Pre-proline 0 N--CA 1.434 -1.257 0 N-CA-C 108.377 -0.972 . . . . 0.29 108.377 172.276 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.823 ' HG3' ' CB ' ' A' ' 170' ' ' LEU . 1.8 Cg_endo -41.18 151.92 0.12 Allowed 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 124.393 3.395 . . . . 0.18 113.097 177.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.842 ' HB2' HG22 ' A' ' 70' ' ' THR . 0.8 OUTLIER -136.96 145.1 43.79 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 106.949 -1.5 . . . . 0.31 106.949 -179.41 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.994 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 1.2 mm? -111.63 117.4 32.82 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.992 -0.744 . . . . 1.19 108.992 178.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.784 HD12 ' CE ' ' A' ' 122' ' ' MET . 8.2 mt -101.65 124.38 55.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-N 116.112 -0.495 . . . . 0.37 110.932 178.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.994 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -111.05 123.0 49.33 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.484 -0.78 . . . . 0.42 109.948 -174.194 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.804 ' HB3' HG11 ' A' ' 110' ' ' VAL . 1.3 p30 -81.79 94.97 7.14 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.855 -1.165 . . . . 2.35 107.855 169.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.787 HG11 ' HB1' ' A' ' 73' ' ' ALA . 1.4 p . . . . . 0 C--N 1.306 -1.306 0 CA-C-N 115.447 -0.797 . . . . 1.03 113.059 -159.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.919 0 N-CA-C 110.761 -0.935 . . . . 0.51 110.761 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -58.19 -43.37 95.42 Favored Glycine 0 C--O 1.222 -0.604 0 CA-C-N 115.469 -0.366 . . . . 0.5 112.805 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.537 ' HA ' ' CZ ' ' A' ' 139' ' ' PHE . 1.0 OUTLIER -64.44 -54.57 30.5 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.074 0.464 . . . . 0.7 110.776 -174.903 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.479 ' CD ' ' H ' ' A' ' 55' ' ' GLU . 1.9 pm0 -66.44 -22.95 66.22 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.542 -0.754 . . . . 2.61 111.115 -178.477 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.785 HG23 ' HA ' ' A' ' 160' ' ' VAL . 30.4 m -79.92 -57.45 3.64 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 109.44 -0.578 . . . . 0.33 109.44 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 1.029 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -54.08 -40.51 67.28 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.145 -0.934 . . . . 0.22 110.838 -179.228 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.457 ' HA ' ' HD2' ' A' ' 102' ' ' PHE . 99.8 m -60.04 -57.1 14.29 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.609 -0.723 . . . . 0.26 110.647 178.376 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 22.3 m -66.76 -35.18 79.49 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.461 -0.79 . . . . 0.48 111.312 -176.012 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.716 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 0.6 OUTLIER -66.72 -52.37 45.33 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 121.595 0.712 . . . . 0.43 110.409 -175.416 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.854 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 8.0 t80 -55.92 -54.6 42.77 Favored 'General case' 0 C--O 1.205 -1.27 0 CA-C-N 114.413 -1.267 . . . . 0.31 110.777 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -67.34 -24.16 65.69 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.73 -0.214 . . . . 1.21 111.018 -174.194 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.438 ' HB2' ' HE2' ' A' ' 63' ' ' LYS . 24.4 ttmm -85.5 -27.34 25.69 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 108.965 -0.754 . . . . 1.54 108.965 -176.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.784 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 48.3 m-85 -123.67 -4.75 8.16 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 115.289 1.588 . . . . 0.31 115.289 -169.702 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.676 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 12.9 pttp -67.86 -24.28 65.23 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 107.709 -1.219 . . . . 1.35 107.709 171.679 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.3 t -48.76 -37.61 19.47 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 113.855 -1.521 . . . . 1.28 110.18 171.11 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -88.06 -35.18 17.67 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 111.948 0.351 . . . . 1.11 111.948 173.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.455 ' HA3' ' HB2' ' A' ' 36' ' ' SER . . . 147.51 -7.3 1.11 Allowed Glycine 0 CA--C 1.52 0.388 0 N-CA-C 111.619 -0.592 . . . . 0.18 111.619 -176.127 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.784 ' HD2' ' HB2' ' A' ' 64' ' ' TYR . 17.9 t80 -67.07 140.37 57.61 Favored 'General case' 0 C--O 1.217 -0.61 0 C-N-CA 123.003 0.521 . . . . 0.18 111.251 -177.272 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.918 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 2.2 t -134.17 143.19 47.76 Favored 'General case' 0 CA--C 1.482 -1.657 0 N-CA-C 108.189 -1.041 . . . . 0.2 108.189 174.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 1.029 HG11 ' HB1' ' A' ' 57' ' ' ALA . 39.9 t -98.6 98.87 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.535 0 C-N-CA 118.959 -1.096 . . . . 0.17 108.182 161.224 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.827 HD23 ' HB2' ' A' ' 103' ' ' PRO . 8.4 mt -85.94 119.01 25.78 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 107.36 -1.348 . . . . 1.04 107.36 175.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.887 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -111.67 116.28 30.52 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.826 0.822 . . . . 0.51 111.694 -178.515 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.875 ' HZ ' HG13 ' A' ' 20' ' ' VAL . 2.8 m-30 -98.38 99.09 6.65 Favored Pre-proline 0 C--N 1.315 -0.904 0 CA-C-N 114.519 -1.219 . . . . 0.44 109.051 178.553 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.769 ' O ' ' HB2' ' A' ' 107' ' ' LYS . 80.7 Cg_endo -78.34 93.22 1.1 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.214 1.943 . . . . 1.3 113.361 -171.165 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.759 ' HA ' HG23 ' A' ' 110' ' ' VAL . 84.3 p . . . . . 0 C--N 1.323 -0.56 0 CA-C-N 114.93 -1.032 . . . . 1.44 111.886 -175.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.307 0 CA-C-O 121.52 0.676 . . . . 0.55 112.457 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -92.81 14.05 18.51 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 114.664 -1.153 . . . . 1.99 110.231 176.145 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.664 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 17.2 p90 -140.36 161.99 52.09 Favored Pre-proline 0 N--CA 1.444 -0.754 0 N-CA-C 108.859 -0.793 . . . . 0.84 108.859 -179.057 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.827 ' HB2' HD23 ' A' ' 72' ' ' LEU . 30.9 Cg_endo -58.95 92.82 0.08 OUTLIER 'Trans proline' 0 CA--C 1.514 -0.489 0 C-N-CA 123.965 3.11 . . . . 0.62 114.398 -172.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.887 HD12 ' HB3' ' A' ' 73' ' ' ALA . 5.4 mm -82.4 124.62 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 108.325 -0.991 . . . . 1.34 108.325 170.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.768 ' HG3' ' N ' ' A' ' 106' ' ' ALA . 0.0 OUTLIER -78.66 172.1 14.18 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.074 -1.421 . . . . 3.03 110.812 -176.933 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.768 ' N ' ' HG3' ' A' ' 105' ' ' MET . . . -61.0 -0.15 0.28 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.359 -0.837 . . . . 1.46 112.575 178.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.769 ' HB2' ' O ' ' A' ' 75' ' ' PRO . 12.3 ptpt 60.72 144.58 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.244 0 C-N-CA 124.941 1.297 . . . . 1.76 110.742 -168.145 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.604 HG13 ' HB2' ' A' ' 116' ' ' HIS . 0.3 OUTLIER -133.72 176.62 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.074 0 CA-C-N 113.615 -1.629 . . . . 0.82 108.331 168.086 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -70.05 66.85 0.28 Allowed 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 114.759 -1.11 . . . . 1.73 109.795 176.382 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.965 ' HA ' ' OH ' ' A' ' 119' ' ' TYR . 0.6 OUTLIER -72.6 92.64 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-O 122.11 0.957 . . . . 0.77 109.589 -172.657 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.7 t30 . . . . . 0 C--N 1.313 -0.983 0 N-CA-C 104.684 -2.339 . . . . 1.9 104.684 169.659 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.62 ' CE1' ' HB3' ' A' ' 118' ' ' LEU . 4.9 t-80 . . . . . 0 N--CA 1.418 -2.051 0 N-CA-C 107.998 -1.112 . . . . 0.42 107.998 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.491 ' HB2' ' CD1' ' A' ' 18' ' ' PHE . 11.2 Cg_exo -31.47 -43.45 0.13 Allowed 'Trans proline' 0 C--O 1.215 -0.668 1 C-N-CA 125.531 4.154 . . . . 0.4 114.241 -174.115 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.708 HD22 HG22 ' A' ' 20' ' ' VAL . 4.8 tp -62.45 -60.17 3.92 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 113.471 0.915 . . . . 0.39 113.471 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.965 ' OH ' ' HA ' ' A' ' 110' ' ' VAL . 3.4 p90 -81.02 -25.66 37.0 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 109.113 -0.699 . . . . 3.04 109.113 -177.702 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.53 -39.23 90.3 Favored 'General case' 0 CA--C 1.495 -1.161 0 N-CA-C 106.546 -1.65 . . . . 2.44 106.546 173.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.46 ' HA ' ' HG2' ' A' ' 124' ' ' LYS . 71.4 t80 -65.45 -26.09 67.8 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.85 -1.068 . . . . 0.56 109.892 171.346 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.784 ' CE ' HD12 ' A' ' 40' ' ' ILE . 65.2 mtt -75.93 -56.89 4.24 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.182 -0.463 . . . . 0.71 111.716 -173.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.622 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -70.39 -24.04 62.88 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.779 -0.646 . . . . 1.46 110.65 179.621 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.46 ' HG2' ' HA ' ' A' ' 121' ' ' TYR . 17.1 ptmt -74.05 -28.41 61.4 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 119.722 -0.791 . . . . 1.99 109.456 174.725 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 51.8 m -76.83 -42.62 39.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.852 -0.613 . . . . 0.59 110.484 173.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.428 ' HD3' ' C ' ' A' ' 151' ' ' VAL . 8.0 tptm . . . . . 0 C--N 1.325 -0.471 0 CA-C-N 116.258 -0.428 . . . . 1.85 111.447 -175.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.45 ' HB3' ' HG3' ' A' ' 156' ' ' PRO . 10.2 m-90 . . . . . 0 CA--C 1.501 -0.916 0 N-CA-C 109.886 -0.413 . . . . 1.97 109.886 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.577 ' HB2' ' CB ' ' A' ' 156' ' ' PRO . 3.4 m120 -47.54 -158.29 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.154 -0.93 . . . . 2.04 110.073 162.462 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.655 ' HD2' ' HD2' ' A' ' 41' ' ' TYR . 5.7 m-85 -28.42 -53.63 0.1 Allowed 'General case' 0 CA--C 1.552 1.033 0 N-CA-C 115.944 1.831 . . . . 1.93 115.944 -164.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.595 ' HB ' ' OD1' ' A' ' 42' ' ' ASN . 8.5 m 42.75 93.92 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 120.44 1.473 . . . . 0.6 112.832 174.23 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.71 ' HB3' HD12 ' A' ' 39' ' ' LEU . 2.5 m -88.98 161.69 16.47 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.744 -0.662 . . . . 0.62 111.556 -172.135 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.423 ' O ' HD13 ' A' ' 39' ' ' LEU . 70.3 m-85 -122.72 126.49 47.65 Favored 'General case' 0 CA--C 1.487 -1.471 0 N-CA-C 105.872 -1.899 . . . . 0.57 105.872 165.6 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.803 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 11.3 tp -80.39 101.96 9.32 Favored 'General case' 0 N--CA 1.418 -2.042 0 C-N-CA 117.823 -1.551 . . . . 0.43 107.877 176.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.706 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 39.1 mm -89.22 135.13 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.671 0 CA-C-N 113.018 -1.901 . . . . 0.19 107.311 -178.207 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.478 ' HA ' HD13 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -91.35 -174.85 4.06 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 119.201 -1.0 . . . . 0.98 111.545 -167.586 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.655 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 53.5 mtm180 -54.66 -36.23 64.37 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.157 0.503 . . . . 2.22 110.983 -177.78 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -100.11 23.28 10.16 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.625 -0.509 . . . . 2.0 109.625 -178.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.635 ' HA3' ' CE2' ' A' ' 16' ' ' PHE . . . 65.76 34.44 88.79 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 115.943 -0.571 . . . . 0.17 114.002 178.461 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 64.1 t -103.07 116.19 62.8 Favored Pre-proline 0 C--N 1.314 -0.944 0 CA-C-N 118.024 0.912 . . . . 1.12 110.875 175.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.73 ' HD3' HG23 ' A' ' 15' ' ' ILE . 36.5 Cg_endo -66.13 109.05 1.45 Allowed 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 123.757 2.971 . . . . 0.41 110.664 178.121 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.557 HG23 ' HG2' ' A' ' 152' ' ' GLU . 19.6 m -113.71 -12.11 11.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 121.062 0.458 . . . . 1.45 110.486 -172.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.803 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 33.8 mm-40 -142.83 165.83 26.3 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-N 115.563 -0.744 . . . . 1.17 109.611 177.3 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.525 ' HA ' ' O ' ' A' ' 141' ' ' SER . 0.0 OUTLIER -148.65 122.41 9.28 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.404 -0.816 . . . . 2.16 110.76 165.347 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.683 ' HZ ' ' HB2' ' A' ' 166' ' ' LYS . 88.1 m-85 -95.67 155.81 16.59 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.616 -1.175 . . . . 0.32 109.291 -175.427 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 12.0 m -82.83 160.89 59.98 Favored Pre-proline 0 C--N 1.314 -0.937 0 N-CA-C 108.733 -0.84 . . . . 1.11 108.733 175.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.577 ' CB ' ' HB2' ' A' ' 138' ' ' ASN . 14.5 Cg_endo -58.76 -48.8 13.42 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 121.317 1.344 . . . . 0.78 110.479 173.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -48.59 -12.8 0.22 Allowed Glycine 0 CA--C 1.537 1.422 0 CA-C-N 114.588 -1.187 . . . . 0.5 115.54 167.284 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -87.64 138.88 31.08 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 118.464 1.132 . . . . 0.5 109.285 173.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 15.5 m -111.99 -173.03 2.16 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 112.819 0.674 . . . . 1.42 112.819 -168.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.785 ' HA ' HG23 ' A' ' 56' ' ' THR . 83.0 t -40.98 -60.49 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 114.134 -1.394 . . . . 0.28 112.335 -178.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -62.88 -39.16 93.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.287 -0.415 . . . . 3.46 110.534 -173.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.486 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 7.7 m-20 -55.56 -49.0 73.86 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 115.322 -0.854 . . . . 1.4 109.844 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.667 HD12 HG21 ' A' ' 56' ' ' THR . 81.4 mt -73.4 -46.75 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 CA-C-N 114.581 -1.19 . . . . 0.21 111.691 -177.397 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.487 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 49.5 mt-10 -54.75 -45.19 74.14 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-O 120.804 0.335 . . . . 0.67 111.251 -177.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 11.5 pt-20 -63.35 -15.42 57.37 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 111.993 0.368 . . . . 0.87 111.993 -173.519 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.683 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 28.3 mmmt -104.75 -22.97 13.12 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.607 0.717 . . . . 1.71 109.783 173.515 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.549 HD21 HD11 ' A' ' 171' ' ' LEU . 8.3 tp -83.61 -48.88 9.74 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.762 -1.108 . . . . 0.16 112.296 -176.045 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.486 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 68.9 mt -55.05 -46.06 99.73 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.617 -0.72 . . . . 0.26 112.302 -174.059 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.486 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 84.8 Cg_exo -51.39 -27.05 22.84 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.287 1.992 . . . . 0.41 113.178 173.684 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.823 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 74.8 mt -89.67 -42.58 11.28 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.846 -0.161 . . . . 0.71 111.124 178.006 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.728 HD23 ' HG2' ' A' ' 37' ' ' PRO . 91.9 mt -59.87 -58.26 9.31 Favored 'General case' 0 CA--C 1.505 -0.75 0 CA-C-O 121.996 0.903 . . . . 0.34 109.86 176.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.591 0 CA-C-N 113.338 -1.755 . . . . 1.12 112.171 -178.555 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.3 t . . . . . 0 C--O 1.234 0.244 0 CA-C-O 121.475 0.655 . . . . 1.58 109.899 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 96.5 p 179.78 168.49 1.2 Allowed 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 105.044 -2.206 . . . . 1.17 105.044 -177.154 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.892 ' HB ' HD11 ' A' ' 118' ' ' LEU . 4.8 pt -67.62 -12.96 16.14 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 CA-C-O 121.399 0.619 . . . . 0.38 110.274 177.514 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.787 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 33.4 m-85 -75.3 4.04 7.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.661 -0.699 . . . . 0.3 111.893 -175.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.57 -7.28 59.57 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.474 -0.936 . . . . 2.11 108.474 175.231 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.925 ' HE2' ' HB2' ' A' ' 121' ' ' TYR . 58.1 m-85 -125.67 113.66 17.65 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-N 114.988 -1.006 . . . . 0.31 111.964 -175.057 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -50.78 142.15 11.91 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 113.546 -1.661 . . . . 2.86 110.21 172.259 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.966 HG13 ' HZ ' ' A' ' 74' ' ' PHE . 68.8 t -113.8 169.6 5.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.5 -0.773 . . . . 0.67 109.114 -178.644 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.772 HD23 ' HA ' ' A' ' 27' ' ' PRO . 94.2 mt -127.53 150.51 49.66 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.019 0.438 . . . . 0.69 111.399 178.449 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.38 165.1 18.5 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 106.318 -1.734 . . . . 1.87 106.318 162.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.604 ' HA ' ' N ' ' A' ' 106' ' ' ALA . . . -59.53 -7.73 1.57 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 113.721 1.008 . . . . 0.59 113.721 -169.06 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.554 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 1.3 m-20 -99.08 2.06 45.75 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.914 0.339 . . . . 2.34 111.914 176.459 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.554 ' HB2' ' O ' ' A' ' 24' ' ' ASP . 83.2 m-70 80.55 17.36 0.61 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.611 0.72 . . . . 1.47 109.266 178.742 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.405 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 11.9 mmtt -86.13 120.46 72.44 Favored Pre-proline 0 CA--C 1.508 -0.654 0 N-CA-C 107.682 -1.229 . . . . 4.25 107.682 172.026 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.772 ' HA ' HD23 ' A' ' 21' ' ' LEU . 86.1 Cg_exo -53.21 112.39 0.92 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 121.742 1.628 . . . . 0.54 113.087 -172.605 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.831 ' HE2' HD23 ' A' ' 72' ' ' LEU . 9.0 t80 -79.22 116.78 19.7 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 113.487 -1.688 . . . . 1.2 109.735 172.699 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.505 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 5.7 p30 -71.43 89.15 0.92 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 122.653 1.216 . . . . 1.51 109.95 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.863 HD21 HD12 ' A' ' 15' ' ' ILE . 58.9 tp -50.93 -39.99 56.16 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 113.939 -1.482 . . . . 0.28 111.947 -179.089 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.574 HG13 ' HB3' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -66.47 1.03 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 114.046 1.128 . . . . 1.02 114.046 -170.478 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.505 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 28.4 pt20 -77.82 -6.81 55.38 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.043 -0.663 . . . . 1.02 109.679 171.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.927 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 93.8 m-70 -101.54 24.52 9.6 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 122.001 0.905 . . . . 0.28 109.005 174.126 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.787 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 21.5 mtmm -83.54 110.56 18.32 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 114.344 -1.298 . . . . 1.56 108.686 169.545 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 131.78 -41.58 1.49 Allowed Glycine 0 N--CA 1.442 -0.959 0 C-N-CA 120.629 -0.796 . . . . 0.2 111.538 -178.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.446 ' HB2' ' HA3' ' A' ' 68' ' ' GLY . 35.9 m -129.38 136.93 29.9 Favored Pre-proline 0 N--CA 1.433 -1.295 0 N-CA-C 108.796 -0.816 . . . . 0.29 108.796 172.664 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.822 ' HG3' ' CB ' ' A' ' 170' ' ' LEU . 7.0 Cg_endo -44.96 153.08 0.45 Allowed 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 124.069 3.18 . . . . 0.18 112.563 176.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.81 ' HB2' HG22 ' A' ' 70' ' ' THR . 1.0 OUTLIER -140.13 146.28 38.65 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 106.889 -1.523 . . . . 0.31 106.889 179.098 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 1.017 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 3.5 mp -113.3 115.3 27.94 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.484 -0.76 . . . . 1.19 109.853 176.384 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.877 HG23 HD13 ' A' ' 72' ' ' LEU . 0.8 OUTLIER -95.46 116.97 38.4 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 CA-C-N 115.071 -0.968 . . . . 0.37 108.681 176.961 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 1.017 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.4 OUTLIER -101.14 130.6 47.23 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 119.622 -0.831 . . . . 0.42 109.637 -176.207 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.521 ' OD1' ' HB ' ' A' ' 140' ' ' THR . 0.5 OUTLIER -77.59 122.97 26.01 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 104.4 -2.444 . . . . 2.35 104.4 163.923 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.787 HG12 ' HA ' ' A' ' 139' ' ' PHE . 28.2 m . . . . . 0 C--N 1.3 -1.574 0 C-N-CA 118.702 -1.199 . . . . 1.03 111.797 -171.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.226 -0.354 0 CA-C-O 120.174 -0.236 . . . . 0.51 113.167 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.486 ' HA2' ' HB ' ' A' ' 56' ' ' THR . . . -51.39 -25.09 11.98 Favored Glycine 0 C--O 1.219 -0.814 0 CA-C-O 119.909 -0.384 . . . . 0.5 113.414 176.497 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.531 ' HA ' ' CE2' ' A' ' 139' ' ' PHE . 0.8 OUTLIER -66.13 -55.01 18.58 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 117.745 0.772 . . . . 0.7 109.421 175.724 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -61.34 -31.32 71.18 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.238 -0.892 . . . . 2.61 109.745 178.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.688 HG23 ' HA ' ' A' ' 160' ' ' VAL . 74.0 m -66.61 -54.82 19.25 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 114.496 -1.229 . . . . 0.33 109.533 179.203 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 1.028 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -57.98 -48.7 79.21 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.647 -1.16 . . . . 0.22 111.625 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.432 ' HA ' ' CD1' ' A' ' 102' ' ' PHE . 18.5 m -55.89 -54.62 42.38 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-O 121.61 0.719 . . . . 0.26 110.745 -179.048 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.6 m -69.24 -33.38 73.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.026 -0.988 . . . . 0.48 111.549 -175.229 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.732 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 18.2 mt -71.63 -48.2 49.44 Favored 'General case' 0 CA--C 1.492 -1.272 0 CA-C-N 116.54 -0.3 . . . . 0.43 110.634 -177.238 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.877 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 6.7 t80 -53.45 -62.26 1.77 Allowed 'General case' 0 C--O 1.194 -1.819 0 O-C-N 124.09 0.869 . . . . 0.31 109.49 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.654 ' HA ' ' CG ' ' A' ' 65' ' ' LYS . 1.8 p30 -67.93 -25.63 65.57 Favored 'General case' 0 C--N 1.314 -0.966 0 O-C-N 122.887 0.117 . . . . 1.21 110.908 -168.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.473 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 36.4 ttpt -79.7 -20.65 46.01 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 107.936 -1.135 . . . . 1.54 107.936 -177.524 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.68 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 49.9 m-85 -126.5 0.86 6.92 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 115.22 1.563 . . . . 0.31 115.22 -174.343 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.654 ' CG ' ' HA ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -60.82 -34.59 74.77 Favored 'General case' 0 CA--C 1.496 -1.128 0 N-CA-C 105.986 -1.857 . . . . 1.35 105.986 170.107 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.2 m -47.43 -34.36 7.13 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 112.3 -2.227 . . . . 1.28 111.782 178.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -94.63 -36.06 11.94 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 120.863 -0.335 . . . . 1.11 111.584 174.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.446 ' HA3' ' HB2' ' A' ' 36' ' ' SER . . . 149.31 -0.56 0.49 Allowed Glycine 0 CA--C 1.52 0.35 0 N-CA-C 111.869 -0.492 . . . . 0.18 111.869 -178.403 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.732 ' HE2' ' HB3' ' A' ' 60' ' ' LEU . 14.4 t80 -74.12 141.58 45.59 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 122.743 0.417 . . . . 0.18 111.182 -177.252 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.927 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 5.5 t -134.54 142.49 47.0 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 108.675 -0.861 . . . . 0.2 108.675 172.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 1.028 HG11 ' HB1' ' A' ' 57' ' ' ALA . 41.2 t -101.82 99.61 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.249 0 N-CA-C 107.746 -1.205 . . . . 0.17 107.746 160.672 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.961 HD12 ' H ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -96.44 119.25 34.58 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 107.689 -1.226 . . . . 1.04 107.689 176.15 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.914 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -102.35 140.55 36.48 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.426 0.631 . . . . 0.51 111.156 -176.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.966 ' HZ ' HG13 ' A' ' 20' ' ' VAL . 3.1 m-30 -121.41 96.17 47.96 Favored Pre-proline 0 C--N 1.304 -1.39 0 N-CA-C 108.288 -1.005 . . . . 0.44 108.288 -177.604 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 1.018 ' HG2' ' HB3' ' A' ' 107' ' ' LYS . 93.3 Cg_endo -79.34 72.43 6.52 Favored 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 122.562 2.175 . . . . 1.3 114.149 -167.226 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.592 ' HB3' HG23 ' A' ' 110' ' ' VAL . 79.0 p . . . . . 0 C--N 1.323 -0.561 0 N-CA-C 117.023 2.231 . . . . 1.44 117.023 178.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.491 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . . . . . . 0 CA--C 1.51 -0.593 0 CA-C-O 120.994 0.426 . . . . 0.55 111.649 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -86.41 10.1 16.12 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.721 -0.672 . . . . 1.99 110.955 -176.353 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.573 ' HB3' ' CD2' ' A' ' 61' ' ' TYR . 0.7 OUTLIER -125.18 174.63 3.7 Favored Pre-proline 0 N--CA 1.448 -0.543 0 CA-C-N 115.514 -0.766 . . . . 0.84 109.553 177.262 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.641 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 12.1 Cg_exo -76.74 84.1 1.96 Allowed 'Trans proline' 0 CA--C 1.517 -0.344 0 C-N-CA 123.702 2.935 . . . . 0.62 113.632 -177.094 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.914 HG13 ' HB3' ' A' ' 73' ' ' ALA . 3.9 mp -84.91 133.33 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 N-CA-C 109.1 -0.704 . . . . 1.34 109.1 173.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.811 ' HG2' ' CG ' ' A' ' 74' ' ' PHE . 0.1 OUTLIER -86.98 -179.43 6.49 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.336 -0.847 . . . . 3.03 110.576 -175.602 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.678 ' O ' ' HG2' ' A' ' 107' ' ' LYS . . . -76.85 19.06 0.31 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.063 -0.971 . . . . 1.46 112.388 -173.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 1.018 ' HB3' ' HG2' ' A' ' 75' ' ' PRO . 12.1 ptmt 51.22 128.13 0.0 OUTLIER 'General case' 0 CA--C 1.504 -0.803 0 C-N-CA 125.685 1.594 . . . . 1.76 113.645 -173.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.837 HD11 HG13 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -124.34 173.42 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.922 0 CA-C-N 113.141 -1.845 . . . . 0.82 108.371 171.978 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -69.43 58.69 0.12 Allowed 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.131 -0.94 . . . . 1.73 112.35 179.341 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.837 HG13 HD11 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -68.97 93.35 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 C-N-CA 119.49 -0.884 . . . . 0.77 110.295 178.654 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 . . . . . 0 C--N 1.315 -0.932 0 N-CA-C 106.187 -1.783 . . . . 1.9 106.187 168.671 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.791 ' CB ' HG13 ' A' ' 108' ' ' ILE . 2.2 t-80 . . . . . 0 N--CA 1.43 -1.451 0 N-CA-C 106.992 -1.485 . . . . 0.42 106.992 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -28.16 -46.63 0.1 OUTLIER 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 124.729 3.619 . . . . 0.4 113.606 -178.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.892 HD11 ' HB ' ' A' ' 15' ' ' ILE . 37.9 tp -64.86 -51.43 62.09 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 122.977 0.511 . . . . 0.39 112.007 178.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.663 ' HA ' ' HB2' ' A' ' 122' ' ' MET . 31.9 m-85 -77.77 -31.95 52.25 Favored 'General case' 0 CA--C 1.497 -1.085 0 O-C-N 122.185 -0.322 . . . . 3.04 110.664 -178.406 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.524 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 0.2 OUTLIER -59.29 -39.45 83.0 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 106.656 -1.609 . . . . 2.44 106.656 172.068 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.925 ' HB2' ' HE2' ' A' ' 18' ' ' PHE . 65.0 t80 -65.98 -30.79 71.41 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 119.647 -0.821 . . . . 0.56 110.183 175.114 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.776 ' HE3' ' HG ' ' A' ' 118' ' ' LEU . 1.5 ttm -75.4 -55.37 5.76 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.573 -0.74 . . . . 0.71 110.744 -170.635 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.491 ' HB2' ' HE2' ' A' ' 123' ' ' LYS . 1.0 OUTLIER -70.79 -25.68 62.99 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.398 -0.365 . . . . 1.46 111.164 177.045 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.524 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -73.18 -26.26 61.11 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 119.355 -0.938 . . . . 1.99 109.991 178.442 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 65.7 m -85.41 -42.11 14.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.969 -0.559 . . . . 0.59 110.43 174.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.477 ' HE3' ' O ' ' A' ' 151' ' ' VAL . 39.9 tttm . . . . . 0 C--N 1.324 -0.514 0 N-CA-C 109.118 -0.697 . . . . 1.85 109.118 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.889 ' HB3' ' HG3' ' A' ' 156' ' ' PRO . 0.8 OUTLIER . . . . . 0 CA--C 1.512 -0.498 0 CA-C-O 120.481 0.181 . . . . 1.97 110.881 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.494 ' O ' ' N ' ' A' ' 140' ' ' THR . 7.7 m120 -34.87 -151.35 0.0 OUTLIER 'General case' 0 C--O 1.205 -1.267 0 CA-C-N 113.837 -1.529 . . . . 2.04 111.8 156.65 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.787 ' HA ' HG12 ' A' ' 43' ' ' VAL . 0.6 OUTLIER -28.69 -21.01 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 118.098 2.629 . . . . 1.93 118.098 -171.702 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.523 ' HA ' ' O ' ' A' ' 154' ' ' PHE . 0.9 OUTLIER -9.05 113.27 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 120.191 1.36 . . . . 0.6 113.951 170.438 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.663 ' HA ' ' HA ' ' A' ' 41' ' ' TYR . 0.7 OUTLIER -90.47 171.77 9.19 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.851 -1.068 . . . . 0.62 110.089 -174.132 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.634 ' HA ' ' HA ' ' A' ' 153' ' ' ARG . 10.6 m-85 -126.04 120.26 29.79 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 105.372 -2.084 . . . . 0.57 105.372 161.201 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.902 HD23 ' HB2' ' A' ' 152' ' ' GLU . 1.1 tp -79.67 105.42 10.96 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 118.69 -1.204 . . . . 0.43 108.52 -178.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.769 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 45.1 mm -92.81 145.5 7.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 CA-C-N 113.975 -1.466 . . . . 0.19 107.933 -176.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.64 -174.88 2.91 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 119.532 -0.867 . . . . 0.98 111.357 -170.705 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.593 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 32.1 mtm180 -51.08 -42.23 60.47 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 121.077 0.465 . . . . 2.22 111.444 -176.373 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -98.8 21.56 11.3 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.97 -0.559 . . . . 2.0 109.955 -175.02 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.485 ' HA3' ' CE2' ' A' ' 16' ' ' PHE . . . 71.64 34.2 63.14 Favored Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 115.732 -0.667 . . . . 0.17 113.908 178.299 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.475 ' HA ' ' HD2' ' A' ' 150' ' ' PRO . 43.0 t -112.07 107.03 56.13 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 117.988 0.894 . . . . 1.12 111.544 176.31 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.67 ' HG3' ' HG3' ' A' ' 122' ' ' MET . 4.4 Cg_exo -45.39 118.53 2.16 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 124.441 3.427 . . . . 0.41 112.403 173.243 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.477 ' O ' ' HE3' ' A' ' 126' ' ' LYS . 1.8 t -103.64 -20.8 5.55 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.879 0 N-CA-C 108.116 -1.068 . . . . 1.45 108.116 178.222 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.902 ' HB2' HD23 ' A' ' 143' ' ' LEU . 0.0 OUTLIER -152.5 167.65 28.11 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 113.998 -1.455 . . . . 1.17 110.957 -168.531 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.634 ' HA ' ' HA ' ' A' ' 142' ' ' PHE . 0.0 OUTLIER -141.82 129.21 21.22 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 107.091 -1.448 . . . . 2.16 107.091 159.301 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.711 ' HZ ' ' HB2' ' A' ' 166' ' ' LYS . 70.0 m-85 -101.34 141.02 34.83 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.902 -0.407 . . . . 0.32 109.902 -173.414 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 18.3 m -64.54 150.58 93.43 Favored Pre-proline 0 C--N 1.325 -0.497 0 N-CA-C 109.979 -0.378 . . . . 1.11 109.979 177.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.889 ' HG3' ' HB3' ' A' ' 137' ' ' TRP . 18.6 Cg_endo -57.41 -50.29 11.33 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.138 1.892 . . . . 0.78 112.253 -174.36 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -66.89 16.44 0.29 Allowed Glycine 0 CA--C 1.526 0.758 0 N-CA-C 114.829 0.692 . . . . 0.5 114.829 175.351 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -78.59 154.23 30.49 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 118.262 1.031 . . . . 0.5 108.572 169.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.435 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 50.1 m -106.97 167.36 9.94 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 109.64 -0.504 . . . . 1.42 109.64 -177.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.688 ' HA ' HG23 ' A' ' 56' ' ' THR . 91.2 t -40.81 -54.59 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 O-C-N 124.2 0.938 . . . . 0.28 111.731 178.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.435 ' NZ ' ' HB2' ' A' ' 161' ' ' LYS . 0.1 OUTLIER -70.13 -27.65 64.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.232 -0.44 . . . . 3.46 111.409 -172.856 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -68.0 -35.22 77.94 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.478 0.656 . . . . 1.4 109.59 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.609 HD12 ' CG2' ' A' ' 56' ' ' THR . 47.4 mt -80.42 -44.55 22.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 114.988 -1.006 . . . . 0.21 110.522 176.544 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.604 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 41.2 mt-10 -50.84 -41.73 57.95 Favored 'General case' 0 C--O 1.217 -0.653 0 CA-C-N 116.122 -0.49 . . . . 0.67 111.503 -177.115 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -60.88 -26.77 67.65 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 112.486 0.55 . . . . 0.87 112.486 -175.586 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.711 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 40.8 mmtm -100.93 -5.35 26.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.544 0.688 . . . . 1.71 109.83 175.435 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.604 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 11.9 tp -97.82 -51.1 4.2 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.119 -0.946 . . . . 0.16 111.971 -176.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.485 HD11 ' HB3' ' A' ' 164' ' ' GLU . 69.5 mt -56.24 -46.72 99.76 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 112.957 0.725 . . . . 0.26 112.957 -171.491 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.463 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 63.3 Cg_exo -53.67 -25.03 32.03 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.092 1.861 . . . . 0.41 112.577 175.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.822 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 94.8 mt -86.66 -45.41 11.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.241 -0.436 . . . . 0.71 110.744 177.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.779 HD23 ' HG2' ' A' ' 37' ' ' PRO . 96.5 mt -59.89 -54.83 41.54 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-O 122.048 0.928 . . . . 0.34 110.204 177.521 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.401 0 CA-C-N 113.305 -1.77 . . . . 1.12 112.962 -179.08 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.8 m . . . . . 0 C--O 1.235 0.3 0 CA-C-O 120.81 0.338 . . . . 1.58 110.407 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.466 ' HB3' ' O ' ' A' ' 147' ' ' ASP . 3.1 m -159.78 152.39 21.29 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 107.075 -1.454 . . . . 1.17 107.075 -173.584 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.94 ' HB ' HD11 ' A' ' 118' ' ' LEU . 4.6 pt -66.54 -13.63 16.53 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 CA-C-N 114.079 -1.418 . . . . 0.38 112.298 -173.609 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.828 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 57.1 m-85 -70.45 -8.11 48.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.819 0.342 . . . . 0.3 111.908 -178.55 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -64.88 -25.86 68.07 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 108.103 -1.073 . . . . 2.11 108.103 175.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.858 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 61.4 m-85 -109.52 113.72 26.75 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 114.191 -1.368 . . . . 0.31 111.632 -176.463 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -47.72 142.26 4.79 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 113.122 -1.854 . . . . 2.86 110.652 169.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.769 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 54.8 t -111.66 159.2 11.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 108.395 -0.965 . . . . 0.67 108.395 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.729 HD23 ' HA ' ' A' ' 27' ' ' PRO . 74.9 mt -124.05 121.08 34.25 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 121.103 -0.239 . . . . 0.69 110.889 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.81 ' HA ' ' HE2' ' A' ' 105' ' ' MET . 6.2 t0 -62.1 170.5 2.18 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 107.314 -1.365 . . . . 1.87 107.314 173.062 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.617 ' HA ' ' C ' ' A' ' 105' ' ' MET . . . -53.05 -20.31 3.48 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 114.673 1.36 . . . . 0.59 114.673 -164.198 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 7.9 t70 -103.31 11.66 36.44 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.541 -0.463 . . . . 2.34 111.665 -177.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.676 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 54.7 m-70 76.04 18.42 2.0 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.823 0.82 . . . . 1.47 109.503 176.342 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.743 ' HE2' ' HA ' ' A' ' 26' ' ' LYS . 10.6 mmpt? -88.98 127.97 53.77 Favored Pre-proline 0 N--CA 1.445 -0.691 0 N-CA-C 107.488 -1.301 . . . . 4.25 107.488 171.168 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.729 ' HA ' HD23 ' A' ' 21' ' ' LEU . 80.0 Cg_exo -49.82 114.08 1.23 Allowed 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 122.242 1.961 . . . . 0.54 113.206 -171.615 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.551 ' HB3' HG12 ' A' ' 20' ' ' VAL . 49.5 t80 -79.99 146.71 31.88 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 113.813 -1.54 . . . . 1.2 111.675 173.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.501 ' OD1' ' HB3' ' A' ' 32' ' ' GLN . 2.5 t-20 -86.34 92.39 8.79 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 114.917 -1.038 . . . . 1.51 109.289 175.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.65 HD23 ' HA ' ' A' ' 16' ' ' PHE . 54.0 tp -72.62 -41.25 65.75 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.756 -0.656 . . . . 0.28 109.976 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.799 ' HA ' ' CE1' ' A' ' 16' ' ' PHE . 1.5 t -70.22 -0.83 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 114.698 -1.137 . . . . 1.02 112.517 -167.406 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.501 ' HB3' ' OD1' ' A' ' 29' ' ' ASN . 30.1 pt20 -76.14 -6.92 53.44 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.342 0.591 . . . . 1.02 109.687 174.627 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.931 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 93.0 m-70 -100.29 28.53 4.91 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 115.279 -0.873 . . . . 0.28 108.798 175.15 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.828 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 8.0 mtmt -90.45 118.16 29.71 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 114.687 -1.142 . . . . 1.56 109.595 173.461 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.66 -40.4 1.97 Allowed Glycine 0 N--CA 1.439 -1.159 0 N-CA-C 111.239 -0.745 . . . . 0.2 111.239 -177.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.469 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 40.7 m -126.97 135.69 27.74 Favored Pre-proline 0 N--CA 1.435 -1.204 0 N-CA-C 108.583 -0.895 . . . . 0.29 108.583 172.332 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.704 ' HG3' ' HB2' ' A' ' 170' ' ' LEU . 5.9 Cg_endo -44.5 155.36 0.27 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.837 3.025 . . . . 0.18 112.591 175.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.887 ' HB2' HG22 ' A' ' 70' ' ' THR . 0.7 OUTLIER -141.68 149.83 41.09 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 106.59 -1.633 . . . . 0.31 106.59 -179.752 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.862 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 2.3 mp -119.89 118.63 31.26 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.603 -0.686 . . . . 1.19 110.188 177.713 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.871 HG23 ' HB2' ' A' ' 72' ' ' LEU . 2.2 mt -103.11 127.95 56.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-N 115.408 -0.815 . . . . 0.37 110.374 178.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.862 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.3 OUTLIER -114.81 128.53 56.35 Favored 'General case' 0 C--O 1.218 -0.597 0 CA-C-N 116.055 -0.52 . . . . 0.42 111.225 -172.089 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.533 ' OD1' ' HB3' ' A' ' 76' ' ' SER . 0.3 OUTLIER -76.51 105.53 7.62 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 106.024 -1.843 . . . . 2.35 106.024 165.428 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.968 HG11 ' HB1' ' A' ' 73' ' ' ALA . 2.4 p . . . . . 0 C--N 1.293 -1.869 0 C-N-CA 119.27 -0.972 . . . . 1.03 113.372 -164.355 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.257 0 N-CA-C 113.851 0.3 . . . . 0.51 113.851 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.15 -21.81 59.88 Favored Glycine 0 C--O 1.219 -0.829 0 C-N-CA 121.147 -0.549 . . . . 0.5 113.475 -175.054 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.7 -56.89 16.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 117.815 0.807 . . . . 0.7 109.437 177.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -60.15 -32.59 71.17 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.869 -1.06 . . . . 2.61 110.145 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.559 ' HA ' ' CG2' ' A' ' 160' ' ' VAL . 92.4 m -71.44 -59.53 2.71 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 114.827 -1.079 . . . . 0.33 109.94 -175.751 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 1.127 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -63.07 -42.56 99.69 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.439 -1.255 . . . . 0.22 111.454 -175.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.557 ' HA ' ' CD1' ' A' ' 102' ' ' PHE . 6.4 m -58.53 -56.89 16.26 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.237 0.541 . . . . 0.26 111.059 -179.205 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.4 m -68.29 -33.31 74.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.634 -0.712 . . . . 0.48 111.213 -173.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.743 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 20.6 mt -67.74 -48.33 66.75 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-O 121.29 0.566 . . . . 0.43 110.077 -178.507 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.916 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 10.9 t80 -59.3 -46.52 88.34 Favored 'General case' 0 C--O 1.205 -1.267 0 CA-C-N 115.053 -0.976 . . . . 0.31 110.427 178.536 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -73.52 -26.96 61.11 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 116.625 -0.261 . . . . 1.21 111.551 -172.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.497 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 34.4 ttpt -85.96 -23.8 26.77 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 108.83 -0.804 . . . . 1.54 108.83 -177.724 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.682 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 30.1 m-85 -122.98 -6.66 8.42 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 115.21 1.559 . . . . 0.31 115.21 -169.486 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.659 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 26.6 pttt -66.82 -23.77 66.08 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 108.242 -1.022 . . . . 1.35 108.242 170.689 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.8 t -49.25 -36.18 19.71 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 114.292 -1.322 . . . . 1.28 110.504 171.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -92.31 -30.3 15.91 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.041 0.386 . . . . 1.11 112.041 176.259 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 143.0 -6.39 2.04 Favored Glycine 0 CA--C 1.52 0.372 0 N-CA-C 111.576 -0.61 . . . . 0.18 111.576 -176.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.743 ' HE2' ' HB3' ' A' ' 60' ' ' LEU . 23.1 t80 -67.58 143.57 56.01 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-N 115.329 -0.436 . . . . 0.18 111.209 -178.675 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.931 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 7.1 t -132.59 152.65 51.56 Favored 'General case' 0 N--CA 1.415 -2.181 0 N-CA-C 108.095 -1.076 . . . . 0.2 108.095 172.163 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 1.127 HG11 ' HB1' ' A' ' 57' ' ' ALA . 33.4 t -106.2 101.18 12.07 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.501 0 N-CA-C 107.482 -1.303 . . . . 0.17 107.482 157.22 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.871 ' HB2' HG23 ' A' ' 40' ' ' ILE . 65.9 mt -85.87 120.3 27.13 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.48 -1.304 . . . . 1.04 107.48 177.219 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.968 ' HB1' HG11 ' A' ' 43' ' ' VAL . . . -99.49 112.09 24.35 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.918 -0.713 . . . . 0.51 110.49 177.138 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.965 ' HD2' HD12 ' A' ' 108' ' ' ILE . 4.6 m-85 -99.04 95.37 3.21 Favored Pre-proline 0 N--CA 1.438 -1.041 0 N-CA-C 106.593 -1.632 . . . . 0.44 106.593 176.751 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.86 ' HB2' ' HG2' ' A' ' 107' ' ' LYS . 9.8 Cg_endo -71.22 142.69 42.16 Favored 'Trans proline' 0 N--CA 1.431 -2.155 0 C-N-CA 120.49 0.793 . . . . 1.3 110.281 -172.203 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.533 ' HB3' ' OD1' ' A' ' 42' ' ' ASN . 57.2 p . . . . . 0 C--N 1.297 -1.7 0 CA-C-O 122.175 0.988 . . . . 1.44 112.678 -177.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.478 0 CA-C-O 121.225 0.536 . . . . 0.55 111.942 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -83.33 17.55 2.07 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.077 -0.965 . . . . 1.99 110.687 -178.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.6 ' HB3' ' CD2' ' A' ' 61' ' ' TYR . 13.0 p90 -143.65 165.98 22.01 Favored Pre-proline 0 N--CA 1.445 -0.723 0 N-CA-C 109.497 -0.557 . . . . 0.84 109.497 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.662 ' HD3' ' CE2' ' A' ' 61' ' ' TYR . 31.2 Cg_exo -62.4 95.78 0.15 Allowed 'Trans proline' 0 CA--C 1.52 -0.202 0 C-N-CA 123.962 3.108 . . . . 0.62 113.19 -174.199 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.8 HD12 ' HB3' ' A' ' 73' ' ' ALA . 4.0 mm -90.48 116.14 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 107.513 -1.292 . . . . 1.34 107.513 175.773 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.81 ' HE2' ' HA ' ' A' ' 22' ' ' ASP . 1.2 mmt -92.93 -174.1 3.49 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.456 -0.793 . . . . 3.03 111.704 -166.553 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.518 ' N ' ' HA ' ' A' ' 23' ' ' ALA . . . -71.58 130.91 42.38 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.003 -0.998 . . . . 1.46 108.741 172.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.86 ' HG2' ' HB2' ' A' ' 75' ' ' PRO . 92.4 mttt -62.81 131.73 49.8 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-O 121.836 0.827 . . . . 1.76 109.265 176.015 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.965 HD12 ' HD2' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -122.36 165.39 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.419 0 N-CA-C 105.167 -2.16 . . . . 0.82 105.167 169.855 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -78.7 69.44 4.87 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 119.78 -0.768 . . . . 1.73 110.309 -178.055 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.482 HG13 HD11 ' A' ' 108' ' ' ILE . 0.1 OUTLIER -67.36 92.89 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-O 122.101 0.953 . . . . 0.77 108.853 178.51 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.6 t30 . . . . . 0 N--CA 1.438 -1.064 0 CA-C-N 113.286 -1.779 . . . . 1.9 106.555 177.691 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.611 ' CB ' HG13 ' A' ' 108' ' ' ILE . 5.5 t-80 . . . . . 0 N--CA 1.426 -1.639 0 N-CA-C 107.058 -1.46 . . . . 0.42 107.058 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -30.93 -45.33 0.14 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 124.364 3.376 . . . . 0.4 113.211 -178.183 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.94 HD11 ' HB ' ' A' ' 15' ' ' ILE . 43.3 tp -65.05 -50.36 66.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.905 -0.589 . . . . 0.39 111.83 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.546 ' OH ' HG22 ' A' ' 40' ' ' ILE . 32.9 m-85 -76.34 -33.04 58.98 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 112.026 0.38 . . . . 3.04 112.026 178.514 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.61 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 43.9 mt-10 -57.94 -37.49 74.21 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 107.111 -1.44 . . . . 2.44 107.111 170.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.858 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 74.3 t80 -66.25 -35.65 80.97 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.368 -0.833 . . . . 0.56 110.646 173.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.65 ' HE2' HG21 ' A' ' 15' ' ' ILE . 53.1 mtt -73.61 -55.08 6.75 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.75 -0.659 . . . . 0.71 110.806 -168.678 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.47 ' HB2' ' HE2' ' A' ' 123' ' ' LYS . 0.2 OUTLIER -70.0 -24.26 63.28 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.108 -0.496 . . . . 1.46 111.144 177.785 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.61 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 9.5 pttp -72.57 -30.14 64.14 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 119.61 -0.836 . . . . 1.99 109.624 174.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 87.8 m -76.86 -48.0 19.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.775 -0.648 . . . . 0.59 110.514 176.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.767 ' HG2' HH22 ' A' ' 153' ' ' ARG . 22.8 ttmm . . . . . 0 N--CA 1.452 -0.367 0 CA-C-N 116.283 -0.417 . . . . 1.85 110.848 -179.027 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.466 0.337 0 N-CA-C 111.414 0.154 . . . . 1.97 111.414 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.691 ' HB2' ' HB3' ' A' ' 156' ' ' PRO . 1.8 m120 -38.2 -153.05 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 125.507 1.523 . . . . 2.04 111.955 158.747 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.705 ' CD1' HG23 ' A' ' 43' ' ' VAL . 1.6 m-85 -25.27 -46.56 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 114.815 1.413 . . . . 1.93 114.815 -167.309 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.757 ' HA ' ' O ' ' A' ' 154' ' ' PHE . 16.3 m 25.75 101.3 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.719 1.377 . . . . 0.6 114.719 172.466 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.541 ' CB ' HD23 ' A' ' 39' ' ' LEU . 0.7 OUTLIER -86.12 169.18 13.36 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.61 -1.177 . . . . 0.62 110.235 -175.058 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -126.04 124.41 40.59 Favored 'General case' 0 CA--C 1.495 -1.15 0 N-CA-C 105.118 -2.179 . . . . 0.57 105.118 162.33 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.763 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 7.3 tp -79.99 105.56 11.36 Favored 'General case' 0 N--CA 1.422 -1.867 0 C-N-CA 118.143 -1.423 . . . . 0.43 108.682 178.067 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.692 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 39.7 mm -91.59 138.16 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.022 0 CA-C-N 112.542 -2.117 . . . . 0.19 107.118 -178.399 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.541 ' HA ' HD13 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -92.04 179.94 5.45 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 120.396 -0.522 . . . . 0.98 111.055 -170.273 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.606 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 40.1 mtm180 -47.36 -42.6 21.92 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 122.893 0.477 . . . . 2.22 111.626 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.466 ' O ' ' HB3' ' A' ' 14' ' ' SER . 8.1 m-20 -96.72 23.43 7.02 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 109.685 -0.487 . . . . 2.0 109.685 -176.494 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.623 ' HA2' HG22 ' A' ' 144' ' ' ILE . . . 65.26 37.88 94.48 Favored Glycine 0 N--CA 1.437 -1.275 0 CA-C-N 115.666 -0.697 . . . . 0.17 114.139 178.596 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.49 ' HA ' ' HD2' ' A' ' 150' ' ' PRO . 6.9 p -108.74 110.1 61.22 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 118.615 1.208 . . . . 1.12 111.73 173.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.691 ' HD3' HG23 ' A' ' 15' ' ' ILE . 10.2 Cg_endo -57.09 115.05 2.22 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 124.081 3.187 . . . . 0.41 111.168 175.267 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.787 HG23 ' HG2' ' A' ' 152' ' ' GLU . 17.6 m -116.27 -17.86 7.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-O 121.187 0.518 . . . . 1.45 109.982 -177.162 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.787 ' HG2' HG23 ' A' ' 151' ' ' VAL . 24.6 mm-40 -138.57 167.24 22.36 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-N 115.49 -0.777 . . . . 1.17 109.956 -179.108 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.767 HH22 ' HG2' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -148.43 141.6 25.03 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 114.904 -1.044 . . . . 2.16 108.937 163.267 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.757 ' O ' ' HA ' ' A' ' 140' ' ' THR . 79.7 m-85 -117.45 151.12 37.72 Favored 'General case' 0 C--O 1.217 -0.632 0 N-CA-C 109.483 -0.562 . . . . 0.32 109.483 -174.2 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.531 ' HB3' ' HD2' ' A' ' 156' ' ' PRO . 51.1 m -73.27 163.76 66.07 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 109.388 -0.597 . . . . 1.11 109.388 177.466 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.691 ' HB3' ' HB2' ' A' ' 138' ' ' ASN . 10.6 Cg_endo -53.15 -67.02 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.763 2.309 . . . . 0.78 112.729 -179.388 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -57.2 15.37 0.01 OUTLIER Glycine 0 CA--C 1.53 0.999 0 N-CA-C 116.368 1.307 . . . . 0.5 116.368 172.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -79.85 138.09 37.11 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 119.061 1.431 . . . . 0.5 107.392 167.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.499 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 8.6 t -104.85 173.47 6.29 Favored 'General case' 0 N--CA 1.429 -1.51 0 C-N-CA 119.988 -0.685 . . . . 1.42 110.072 -169.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.559 ' CG2' ' HA ' ' A' ' 56' ' ' THR . 69.3 t -43.57 -54.76 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 114.358 -1.292 . . . . 0.28 112.126 -177.723 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.84 -29.96 68.39 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.98 0.419 . . . . 3.46 110.78 -173.313 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -71.05 -31.41 67.84 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.642 0.734 . . . . 1.4 109.123 -176.014 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.52 HG21 HD22 ' A' ' 39' ' ' LEU . 33.1 mt -82.58 -45.33 19.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 114.492 -1.231 . . . . 0.21 110.741 176.078 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.574 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 41.8 mt-10 -51.2 -41.87 60.53 Favored 'General case' 0 C--O 1.218 -0.595 0 CA-C-N 116.308 -0.405 . . . . 0.67 111.362 -178.015 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -60.8 -20.69 62.05 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 112.056 0.391 . . . . 0.87 112.056 -174.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.693 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 31.3 mmtp -100.38 -24.44 14.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.477 0.656 . . . . 1.71 110.273 172.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.574 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 10.8 tp -80.73 -49.02 11.71 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.183 -0.917 . . . . 0.16 112.183 -175.65 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.463 HD11 ' HB3' ' A' ' 164' ' ' GLU . 73.1 mt -55.75 -43.7 99.31 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.478 -0.783 . . . . 0.26 112.568 -173.744 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.408 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 85.5 Cg_exo -49.98 -33.67 34.99 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 122.02 1.813 . . . . 0.41 112.659 172.557 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.704 ' HB2' ' HG3' ' A' ' 37' ' ' PRO . 91.3 mt -86.01 -42.67 13.78 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 121.122 -0.231 . . . . 0.71 111.348 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.644 HD21 ' HB2' ' A' ' 69' ' ' PHE . 93.8 mt -59.39 -53.2 60.95 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 122.264 1.031 . . . . 0.34 109.624 175.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.425 0 CA-C-N 113.321 -1.763 . . . . 1.12 113.958 -174.515 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.5 m . . . . . 0 C--O 1.233 0.224 0 N-CA-C 109.585 -0.524 . . . . 1.58 109.585 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.9 m -166.16 159.19 14.99 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 105.431 -2.062 . . . . 1.17 105.431 -177.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.891 ' HB ' HD11 ' A' ' 118' ' ' LEU . 8.0 pt -59.99 -20.18 19.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 CA-C-N 116.015 -0.538 . . . . 0.38 111.437 -176.541 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.736 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 40.3 m-85 -68.68 -2.75 9.87 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.059 0.457 . . . . 0.3 111.632 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.96 -12.99 61.37 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 108.469 -0.937 . . . . 2.11 108.469 172.543 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.74 ' HE2' ' HB2' ' A' ' 121' ' ' TYR . 58.5 m-85 -129.73 111.3 12.5 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 114.837 -1.074 . . . . 0.31 110.871 -173.689 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -51.38 150.27 3.64 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 113.792 -1.549 . . . . 2.86 110.099 172.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.809 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 34.4 t -111.04 157.06 12.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 115.457 -0.792 . . . . 0.67 108.906 -178.425 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.835 ' O ' ' HB3' ' A' ' 105' ' ' MET . 96.2 mt -122.31 116.09 23.47 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 116.546 -0.297 . . . . 0.69 110.502 -177.138 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.516 ' HA ' ' SD ' ' A' ' 105' ' ' MET . 6.2 t70 -58.29 170.87 0.64 Allowed 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 107.624 -1.25 . . . . 1.87 107.624 174.068 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.65 ' HA ' ' C ' ' A' ' 105' ' ' MET . . . -54.56 -26.34 31.55 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 118.761 0.709 . . . . 0.59 112.515 -168.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.42 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 8.8 t70 -78.22 -7.51 57.21 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.47 -0.332 . . . . 2.34 111.047 -178.572 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.605 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 57.1 m-70 80.09 19.53 0.6 Allowed 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 122.01 0.91 . . . . 1.47 108.628 -177.668 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.862 ' HE2' ' HA ' ' A' ' 26' ' ' LYS . 9.3 mmpt? -99.83 128.96 29.69 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 114.071 -1.422 . . . . 4.25 108.388 172.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.732 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 74.9 Cg_exo -47.12 115.73 1.44 Allowed 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 123.136 2.557 . . . . 0.54 114.989 -170.207 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.783 ' CE2' HD21 ' A' ' 72' ' ' LEU . 34.5 t80 -80.08 146.61 31.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.123 -1.399 . . . . 1.2 110.356 166.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.634 ' OD1' ' HB3' ' A' ' 32' ' ' GLN . 2.6 t-20 -76.56 90.76 3.34 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.662 -0.699 . . . . 1.51 110.133 179.286 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.711 ' HG ' ' CD1' ' A' ' 16' ' ' PHE . 56.3 tp -69.34 -46.51 66.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.162 0.506 . . . . 0.28 110.191 178.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.704 HG13 ' HB3' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -66.2 0.7 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 115.315 -0.857 . . . . 1.02 113.289 -171.598 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.634 ' HB3' ' OD1' ' A' ' 29' ' ' ASN . 3.8 pt20 -72.07 -16.22 62.02 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.109 -0.7 . . . . 1.02 109.109 172.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.981 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 91.2 m-70 -93.99 22.99 5.21 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 121.85 0.833 . . . . 0.28 109.356 178.012 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.736 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 29.7 mtmt -84.91 109.97 18.53 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 114.266 -1.334 . . . . 1.56 108.834 169.161 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 130.78 -38.05 2.0 Favored Glycine 0 N--CA 1.439 -1.113 0 C-N-CA 120.987 -0.625 . . . . 0.2 111.774 -178.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.458 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 22.7 m -133.99 137.04 27.46 Favored Pre-proline 0 N--CA 1.435 -1.192 0 N-CA-C 108.91 -0.774 . . . . 0.29 108.91 172.037 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.694 ' HG2' HD23 ' A' ' 171' ' ' LEU . 7.4 Cg_endo -45.81 156.54 0.43 Allowed 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 124.057 3.171 . . . . 0.18 112.94 178.254 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.838 ' HB2' HG22 ' A' ' 70' ' ' THR . 0.9 OUTLIER -141.07 145.65 36.11 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 106.745 -1.576 . . . . 0.31 106.745 178.823 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 1.055 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 1.5 mm? -107.2 111.88 24.49 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.199 -1.038 . . . . 1.19 108.199 177.075 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.765 HG13 HG13 ' A' ' 144' ' ' ILE . 4.9 mt -95.27 124.51 47.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 C-N-CA 119.622 -0.831 . . . . 0.37 109.954 177.521 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 1.055 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 1.3 m-85 -106.94 124.39 49.55 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.212 -0.904 . . . . 0.42 110.355 -174.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.42 ' HB3' HG11 ' A' ' 110' ' ' VAL . 0.8 OUTLIER -80.04 90.03 5.39 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 106.421 -1.696 . . . . 2.35 106.421 169.997 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.876 ' HA ' ' HA ' ' A' ' 139' ' ' PHE . 5.9 p . . . . . 0 C--N 1.3 -1.552 0 C-N-CA 120.175 -0.61 . . . . 1.03 110.865 -166.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.81 0 N-CA-C 111.603 -0.599 . . . . 0.51 111.603 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.562 ' HA2' ' HB ' ' A' ' 56' ' ' THR . . . -75.05 -17.16 80.28 Favored Glycine 0 C--O 1.221 -0.718 0 CA-C-O 119.628 -0.54 . . . . 0.5 114.404 -174.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -71.22 -58.54 3.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 118.44 1.12 . . . . 0.7 109.152 177.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -62.67 -24.21 67.52 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.241 -0.89 . . . . 2.61 110.223 178.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.664 HG23 ' HA ' ' A' ' 160' ' ' VAL . 16.2 m -74.57 -57.5 3.89 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.278 -0.874 . . . . 0.33 110.306 177.481 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 1.049 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -58.13 -40.54 81.53 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.76 -0.655 . . . . 0.22 110.986 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.524 ' HA ' ' CD1' ' A' ' 102' ' ' PHE . 86.9 m -57.01 -56.05 26.76 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-O 121.379 0.609 . . . . 0.26 110.532 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.6 m -69.78 -37.7 76.46 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.116 -0.947 . . . . 0.48 111.46 -176.256 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.713 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 15.2 mt -62.15 -50.06 73.36 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-O 121.523 0.677 . . . . 0.43 110.302 -177.596 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.913 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 10.8 t80 -57.7 -51.51 69.24 Favored 'General case' 0 C--O 1.2 -1.544 0 CA-C-N 114.46 -1.245 . . . . 0.31 111.052 -179.331 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.528 ' HA ' ' HD3' ' A' ' 65' ' ' LYS . 5.1 m-80 -73.63 -24.26 60.0 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 120.635 0.255 . . . . 1.21 111.182 -173.347 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -80.53 -26.52 38.0 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 108.548 -0.908 . . . . 1.54 108.548 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.72 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 45.0 m-85 -124.74 -1.53 7.92 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 115.522 1.675 . . . . 0.31 115.522 -169.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.638 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -64.86 -20.74 66.58 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 107.507 -1.294 . . . . 1.35 107.507 169.218 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -46.72 -44.5 18.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 113.794 -1.548 . . . . 1.28 111.014 171.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.463 ' OE1' ' HA ' ' A' ' 64' ' ' TYR . 23.4 mp0 -86.33 -33.11 20.69 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.454 -0.339 . . . . 1.11 111.731 178.41 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 143.69 -1.52 1.35 Allowed Glycine 0 N--CA 1.452 -0.293 0 N-CA-C 111.562 -0.615 . . . . 0.18 111.562 -174.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.72 ' HD2' ' HB2' ' A' ' 64' ' ' TYR . 22.0 t80 -68.73 142.77 54.88 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 122.989 0.515 . . . . 0.18 111.25 -178.205 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.981 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 1.9 t -133.92 147.01 51.04 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 107.633 -1.247 . . . . 0.2 107.633 170.475 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 1.049 HG11 ' HB1' ' A' ' 57' ' ' ALA . 39.1 t -99.02 99.12 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.441 0 N-CA-C 107.338 -1.356 . . . . 0.17 107.338 157.648 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.783 HD21 ' CE2' ' A' ' 28' ' ' TYR . 4.2 mt -84.88 118.51 24.55 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 107.895 -1.15 . . . . 1.04 107.895 177.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.88 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -116.58 112.62 21.57 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 119.879 -0.729 . . . . 0.51 110.937 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.809 ' CZ ' HG13 ' A' ' 20' ' ' VAL . 1.6 m-30 -91.75 110.26 42.31 Favored Pre-proline 0 C--N 1.318 -0.77 0 N-CA-C 107.741 -1.207 . . . . 0.44 107.741 173.141 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.893 ' HG2' ' HB3' ' A' ' 107' ' ' LYS . 60.9 Cg_endo -72.2 40.77 0.46 Allowed 'Trans proline' 0 N--CA 1.48 0.73 0 C-N-CA 123.961 3.107 . . . . 1.3 116.629 -165.449 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.491 ' HA ' ' O ' ' A' ' 108' ' ' ILE . 4.8 t . . . . . 0 N--CA 1.474 0.759 0 N-CA-C 115.845 1.794 . . . . 1.44 115.845 175.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.698 0 CA-C-O 120.78 0.324 . . . . 0.55 110.94 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -88.09 12.07 14.52 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.96 -0.563 . . . . 1.99 110.604 175.137 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.673 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 15.5 p90 -128.93 160.71 62.03 Favored Pre-proline 0 N--CA 1.438 -1.037 0 N-CA-C 108.209 -1.034 . . . . 0.84 108.209 175.143 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.762 ' HG2' ' HA ' ' A' ' 72' ' ' LEU . 57.6 Cg_endo -64.27 104.27 0.5 Allowed 'Trans proline' 0 N--CA 1.472 0.222 0 C-N-CA 123.432 2.755 . . . . 0.62 113.2 -171.156 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.88 HD12 ' HB3' ' A' ' 73' ' ' ALA . 5.4 mm -100.48 121.03 50.75 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.818 0 N-CA-C 108.053 -1.091 . . . . 1.34 108.053 175.701 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.835 ' HB3' ' O ' ' A' ' 21' ' ' LEU . 20.1 mmt -97.68 -159.26 0.72 Allowed 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.32 -0.854 . . . . 3.03 113.246 -163.471 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.706 ' O ' ' HG2' ' A' ' 107' ' ' LYS . . . -56.96 -27.53 61.37 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.29 -0.868 . . . . 1.46 112.623 -173.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.893 ' HB3' ' HG2' ' A' ' 75' ' ' PRO . 4.5 ptpp? 76.88 133.94 0.06 Allowed 'General case' 0 CA--C 1.481 -1.684 0 O-C-N 125.044 1.465 . . . . 1.76 108.802 -163.371 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.7 HG13 ' CB ' ' A' ' 116' ' ' HIS . 0.1 OUTLIER -134.65 162.59 38.53 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 CA-C-N 113.4 -1.727 . . . . 0.82 108.206 173.824 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -75.93 70.04 2.61 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.248 -0.887 . . . . 1.73 111.438 -171.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.554 HG13 HD11 ' A' ' 108' ' ' ILE . 2.4 m -70.91 91.56 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 CA-C-O 121.493 0.663 . . . . 0.77 111.272 -173.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 . . . . . 0 C--N 1.316 -0.849 0 CA-C-N 114.608 -1.178 . . . . 1.9 108.51 168.917 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.7 ' CB ' HG13 ' A' ' 108' ' ' ILE . 3.2 t-80 . . . . . 0 N--CA 1.431 -1.4 0 N-CA-C 105.846 -1.909 . . . . 0.42 105.846 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -30.89 -49.44 0.22 Allowed 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 123.899 3.066 . . . . 0.4 113.141 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.891 HD11 ' HB ' ' A' ' 15' ' ' ILE . 40.0 tp -58.7 -52.16 66.89 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.459 0.704 . . . . 0.39 112.389 176.307 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.777 ' HE2' ' CD2' ' A' ' 74' ' ' PHE . 65.5 m-85 -75.6 -36.54 60.28 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-N 116.472 -0.331 . . . . 3.04 111.652 -178.376 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.425 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 42.8 mt-10 -56.5 -36.79 69.57 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 107.137 -1.431 . . . . 2.44 107.137 171.649 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.74 ' HB2' ' HE2' ' A' ' 18' ' ' PHE . 49.5 t80 -68.36 -31.11 70.27 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 119.825 -0.75 . . . . 0.56 111.167 175.72 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.658 ' HE3' ' HG ' ' A' ' 118' ' ' LEU . 0.5 OUTLIER -74.4 -56.41 4.89 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.27 0.557 . . . . 0.71 109.958 -171.748 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.643 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -72.28 -24.3 61.32 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.221 -0.9 . . . . 1.46 112.258 178.912 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.663 ' HG2' ' HA ' ' A' ' 121' ' ' TYR . 16.0 ptmt -68.05 -34.37 76.32 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 118.945 -1.102 . . . . 1.99 109.318 175.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 44.3 m -77.11 -43.88 32.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.206 -0.906 . . . . 0.59 110.126 178.184 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 123' ' ' LYS . 27.5 mtpp . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 1.85 110.849 175.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.755 ' HB3' ' HG3' ' A' ' 156' ' ' PRO . 0.2 OUTLIER . . . . . 0 CA--C 1.515 -0.37 0 N-CA-C 110.143 -0.318 . . . . 1.97 110.143 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.482 ' O ' ' N ' ' A' ' 140' ' ' THR . 7.1 m120 -36.23 -154.91 0.0 OUTLIER 'General case' 0 C--O 1.206 -1.188 0 O-C-N 125.052 1.47 . . . . 2.04 112.672 163.348 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.876 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 0.5 OUTLIER -31.63 -21.29 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 117.362 2.356 . . . . 1.93 117.362 -170.277 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.482 ' N ' ' O ' ' A' ' 138' ' ' ASN . 5.9 m 5.62 114.73 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 120.56 1.527 . . . . 0.6 113.906 165.783 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.563 ' HB3' ' CE1' ' A' ' 41' ' ' TYR . 0.8 OUTLIER -94.14 159.88 14.95 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 114.114 -1.403 . . . . 0.62 110.764 -164.527 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.482 ' O ' HD13 ' A' ' 39' ' ' LEU . 48.2 m-85 -122.5 125.53 45.96 Favored 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 106.306 -1.739 . . . . 0.57 106.306 167.441 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.754 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 9.8 tp -80.67 105.95 12.3 Favored 'General case' 0 N--CA 1.424 -1.752 0 C-N-CA 117.927 -1.509 . . . . 0.43 108.592 177.02 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.765 HG13 HG13 ' A' ' 40' ' ' ILE . 40.7 mm -92.29 141.29 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.926 0 CA-C-N 112.981 -1.918 . . . . 0.19 107.228 -178.594 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.638 ' HA ' HD13 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -91.98 179.09 5.69 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 120.716 -0.394 . . . . 0.98 111.641 -170.188 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.521 ' CG ' ' HD3' ' A' ' 37' ' ' PRO . 17.4 mtm180 -50.43 -41.71 52.9 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 122.845 0.458 . . . . 2.22 111.392 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.443 ' C ' ' HE2' ' A' ' 16' ' ' PHE . 4.8 m-20 -93.96 12.8 24.86 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 109.476 -0.565 . . . . 2.0 109.476 -176.234 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.642 ' HA3' ' CE2' ' A' ' 16' ' ' PHE . . . 76.36 32.12 52.6 Favored Glycine 0 N--CA 1.433 -1.52 0 CA-C-N 115.354 -0.839 . . . . 0.17 113.911 178.109 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.472 ' HA ' ' HD2' ' A' ' 150' ' ' PRO . 7.1 p -108.53 109.62 61.45 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 118.806 1.303 . . . . 1.12 111.923 174.716 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.665 ' HD3' HG23 ' A' ' 15' ' ' ILE . 1.9 Cg_endo -50.48 124.3 12.98 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 124.294 3.33 . . . . 0.41 112.106 174.569 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.762 HG23 ' HG2' ' A' ' 152' ' ' GLU . 15.9 m -125.0 -15.11 4.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.929 0.395 . . . . 1.45 110.385 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.762 ' HG2' HG23 ' A' ' 151' ' ' VAL . 13.7 mm-40 -140.99 166.9 23.53 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 116.107 -0.497 . . . . 1.17 110.598 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.499 ' HB3' ' CZ ' ' A' ' 153' ' ' ARG . 0.0 OUTLIER -148.07 143.92 27.52 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.254 -0.884 . . . . 2.16 109.697 162.315 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.625 ' HZ ' ' HB2' ' A' ' 166' ' ' LYS . 91.0 m-85 -120.35 138.02 53.96 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.691 -0.686 . . . . 0.32 110.436 -171.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.495 ' OG ' ' HD2' ' A' ' 156' ' ' PRO . 8.2 t -65.49 151.74 93.76 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 107.853 -1.166 . . . . 1.11 107.853 177.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.755 ' HG3' ' HB3' ' A' ' 137' ' ' TRP . 25.2 Cg_endo -59.32 -25.19 77.47 Favored 'Trans proline' 0 N--CA 1.474 0.376 0 C-N-CA 123.056 2.504 . . . . 0.78 113.221 -176.48 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -75.94 -2.96 73.06 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.961 -0.563 . . . . 0.5 113.853 174.21 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -70.44 146.78 50.1 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 117.659 0.729 . . . . 0.5 109.502 175.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.54 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 17.1 m -104.66 170.09 8.08 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.566 -0.531 . . . . 1.42 109.566 -178.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.664 ' HA ' HG23 ' A' ' 56' ' ' THR . 87.1 t -40.52 -55.51 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 O-C-N 124.286 0.991 . . . . 0.28 111.409 177.105 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 161' ' ' LYS . 0.1 OUTLIER -70.42 -28.52 65.12 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.225 -0.443 . . . . 3.46 111.366 -173.033 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.416 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 4.4 m-20 -65.72 -35.54 81.02 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.583 0.706 . . . . 1.4 109.265 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.59 ' HA ' ' CE2' ' A' ' 154' ' ' PHE . 72.1 mt -83.27 -43.0 18.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 114.432 -1.258 . . . . 0.21 110.952 178.53 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.603 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 46.0 mt-10 -51.98 -43.38 63.57 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-O 120.842 0.353 . . . . 0.67 111.19 -179.111 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 13.1 pt-20 -60.64 -17.04 44.85 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 112.149 0.425 . . . . 0.87 112.149 -174.559 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.625 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 13.7 mmmm -106.0 -25.28 12.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.259 0.552 . . . . 1.71 109.941 172.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.603 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 12.0 tp -76.81 -49.35 16.02 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.138 -0.937 . . . . 0.16 111.979 -177.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.456 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 67.1 mt -55.28 -44.12 99.46 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.718 -0.674 . . . . 0.26 111.91 -175.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.456 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 86.0 Cg_exo -50.26 -24.01 10.87 Favored 'Trans proline' 0 C--N 1.353 0.816 0 C-N-CA 122.499 2.132 . . . . 0.41 113.592 172.365 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.674 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 86.2 mt -97.78 -40.3 8.61 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 120.636 -0.426 . . . . 0.71 111.118 177.176 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.694 HD23 ' HG2' ' A' ' 37' ' ' PRO . 95.6 mt -59.92 -59.29 5.66 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 122.141 0.972 . . . . 0.34 109.102 175.126 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.526 0 CA-C-N 113.358 -1.746 . . . . 1.12 111.713 -178.926 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.4 m . . . . . 0 N--CA 1.474 0.741 0 N-CA-C 111.822 0.304 . . . . 1.58 111.822 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 86.8 p 177.9 154.59 0.33 Allowed 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 106.173 -1.788 . . . . 1.17 106.173 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.835 ' HB ' HD11 ' A' ' 118' ' ' LEU . 5.1 pt -70.25 -17.59 20.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-N 115.068 -0.969 . . . . 0.38 112.236 -172.494 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.764 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 51.9 m-85 -69.91 -3.33 15.48 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.186 0.517 . . . . 0.3 111.463 -178.38 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -71.97 -17.99 62.02 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.249 -1.019 . . . . 2.11 108.249 176.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.726 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 72.5 m-85 -117.84 112.54 20.51 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 114.818 -1.083 . . . . 0.31 110.881 -175.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -47.9 142.06 5.24 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 113.494 -1.685 . . . . 2.86 110.452 172.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.827 HG13 ' HZ ' ' A' ' 74' ' ' PHE . 54.9 t -111.13 164.6 6.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 107.466 -1.309 . . . . 0.67 107.466 176.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.627 HD23 ' HA ' ' A' ' 27' ' ' PRO . 10.3 mt -133.16 125.68 30.0 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.224 -0.658 . . . . 0.69 109.224 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.533 ' HA ' ' SD ' ' A' ' 105' ' ' MET . 17.2 m-20 -56.21 178.6 0.05 OUTLIER 'General case' 0 CA--C 1.514 -0.408 0 O-C-N 123.768 0.667 . . . . 1.87 110.086 177.016 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.606 ' HA ' ' N ' ' A' ' 106' ' ' ALA . . . -61.41 -1.79 0.6 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.826 0.676 . . . . 0.59 112.826 -175.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -112.95 4.95 17.06 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.135 0.421 . . . . 2.34 112.135 175.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.766 ' CD2' ' HB3' ' A' ' 106' ' ' ALA . 8.0 m170 72.59 19.63 4.05 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.752 0.787 . . . . 1.47 110.241 177.688 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.485 ' HE3' ' HB2' ' A' ' 26' ' ' LYS . 2.9 mtmt -84.05 135.54 42.08 Favored Pre-proline 0 CA--C 1.509 -0.614 0 N-CA-C 106.591 -1.633 . . . . 4.25 106.591 164.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.627 ' HA ' HD23 ' A' ' 21' ' ' LEU . 80.4 Cg_exo -53.27 113.26 1.2 Allowed 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 121.187 1.258 . . . . 0.54 112.868 -178.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.622 ' HB3' HG12 ' A' ' 20' ' ' VAL . 45.8 t80 -78.86 144.01 35.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 113.701 -1.59 . . . . 1.2 110.969 173.221 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.666 ' ND2' ' HB3' ' A' ' 32' ' ' GLN . 58.5 t30 -79.31 81.38 5.58 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 115.147 -0.933 . . . . 1.51 109.573 178.459 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.661 ' HG ' ' CD1' ' A' ' 16' ' ' PHE . 54.7 tp -60.79 -39.64 89.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.228 0.537 . . . . 0.28 109.558 177.026 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.713 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 1.1 m -72.11 -0.04 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.022 -0.99 . . . . 1.02 112.47 -168.518 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.666 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . 3.8 pt20 -73.44 -13.92 61.16 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.359 -0.608 . . . . 1.02 109.359 173.61 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.845 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 91.6 m-70 -94.35 21.98 6.51 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-O 121.812 0.815 . . . . 0.28 109.561 176.604 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.764 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 45.5 mtmt -85.74 109.7 18.81 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 114.553 -1.203 . . . . 1.56 108.76 169.118 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 134.68 -41.02 1.5 Allowed Glycine 0 N--CA 1.435 -1.373 0 N-CA-C 111.308 -0.717 . . . . 0.2 111.308 -177.081 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 41.2 m -131.71 136.28 28.18 Favored Pre-proline 0 N--CA 1.438 -1.066 0 N-CA-C 108.616 -0.883 . . . . 0.29 108.616 171.63 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.736 ' HG2' HD23 ' A' ' 171' ' ' LEU . 3.5 Cg_endo -43.17 156.94 0.11 Allowed 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.936 3.091 . . . . 0.18 112.875 175.426 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.843 ' HB2' HG22 ' A' ' 70' ' ' THR . 1.0 OUTLIER -144.62 140.51 28.76 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 107.525 -1.287 . . . . 0.31 107.525 -179.736 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.941 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 1.7 mm? -106.04 112.17 25.11 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.403 -0.962 . . . . 1.19 108.403 176.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.816 HG23 ' HB2' ' A' ' 72' ' ' LEU . 5.1 mt -98.63 130.06 48.04 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 CA-C-N 115.95 -0.568 . . . . 0.37 109.95 177.564 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.941 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.4 OUTLIER -117.56 140.5 49.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.636 -0.711 . . . . 0.42 110.492 -172.604 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.615 ' OD1' ' HB ' ' A' ' 140' ' ' THR . 22.8 p-10 -92.54 105.1 17.33 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 108.116 -1.068 . . . . 2.35 108.116 168.323 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.723 ' O ' ' HA ' ' A' ' 75' ' ' PRO . 3.3 m . . . . . 0 C--N 1.31 -1.14 0 O-C-N 121.228 -0.92 . . . . 1.03 110.529 -170.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.693 0 N-CA-C 110.913 -0.875 . . . . 0.51 110.913 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.445 ' HA2' ' HB ' ' A' ' 56' ' ' THR . . . -70.17 -17.98 74.45 Favored Glycine 0 C--O 1.217 -0.919 0 C-N-CA 121.264 -0.493 . . . . 0.5 113.208 -178.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.411 ' HA ' ' CE2' ' A' ' 139' ' ' PHE . 1.1 t80 -74.14 -56.67 4.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 117.786 0.793 . . . . 0.7 109.896 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -62.93 -21.79 66.3 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.269 0.557 . . . . 2.61 110.115 176.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.706 ' HA ' HG22 ' A' ' 160' ' ' VAL . 16.0 m -76.34 -53.91 7.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.421 -0.809 . . . . 0.33 109.669 177.494 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 1.089 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -55.03 -43.06 73.37 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 114.905 -1.043 . . . . 0.22 110.758 177.27 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.497 ' HA ' ' CD1' ' A' ' 102' ' ' PHE . 39.4 m -60.84 -56.98 14.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.472 -0.785 . . . . 0.26 110.515 -178.563 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 98.6 m -66.29 -38.99 89.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.995 -1.002 . . . . 0.48 112.238 -175.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.785 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 18.7 mt -64.39 -48.5 75.21 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-O 121.425 0.631 . . . . 0.43 110.275 -176.613 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.877 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 13.5 t80 -56.84 -47.89 79.29 Favored 'General case' 0 C--O 1.207 -1.182 0 CA-C-N 114.545 -1.207 . . . . 0.31 110.897 178.373 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.587 ' HA ' ' HE3' ' A' ' 65' ' ' LYS . 3.5 m-20 -73.84 -25.5 60.11 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 116.602 -0.272 . . . . 1.21 111.132 -171.658 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.408 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 33.8 ttpt -86.21 -23.15 26.56 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 109.015 -0.735 . . . . 1.54 109.015 -178.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.743 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 29.1 m-85 -125.47 -4.53 7.21 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 115.808 1.781 . . . . 0.31 115.808 -169.37 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.65 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 22.2 pttp -67.04 -25.28 66.19 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 108.009 -1.108 . . . . 1.35 108.009 169.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.5 m -48.85 -30.25 5.58 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 114.203 -1.362 . . . . 1.28 111.27 172.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -96.26 -36.64 10.84 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.592 0.234 . . . . 1.11 111.547 174.234 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 149.83 -5.49 0.7 Allowed Glycine 0 C--O 1.237 0.319 0 N-CA-C 111.17 -0.772 . . . . 0.18 111.17 -176.194 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.785 ' HE2' ' HB3' ' A' ' 60' ' ' LEU . 21.6 t80 -69.59 141.53 53.73 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 115.368 -0.416 . . . . 0.18 111.089 -177.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.877 ' HA ' ' CD1' ' A' ' 61' ' ' TYR . 5.5 t -133.46 146.37 51.09 Favored 'General case' 0 N--CA 1.421 -1.898 0 N-CA-C 108.826 -0.805 . . . . 0.2 108.826 173.209 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 1.089 HG11 ' HB1' ' A' ' 57' ' ' ALA . 25.1 t -100.7 103.3 14.63 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.376 0 N-CA-C 107.485 -1.302 . . . . 0.17 107.485 157.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.816 ' HB2' HG23 ' A' ' 40' ' ' ILE . 35.8 mt -83.94 120.7 26.41 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.626 -1.25 . . . . 1.04 107.626 178.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.725 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -95.08 115.76 27.84 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.229 0.538 . . . . 0.51 109.601 178.569 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.827 ' HZ ' HG13 ' A' ' 20' ' ' VAL . 11.5 m-85 -113.96 97.28 44.45 Favored Pre-proline 0 C--N 1.308 -1.218 0 N-CA-C 108.517 -0.92 . . . . 0.44 108.517 -178.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.723 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 2.0 Cg_endo -67.66 142.36 58.17 Favored 'Trans proline' 0 N--CA 1.438 -1.773 0 C-N-CA 121.175 1.25 . . . . 1.3 110.748 -175.567 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.474 ' CB ' HG23 ' A' ' 110' ' ' VAL . 8.1 t . . . . . 0 C--N 1.297 -1.678 0 CA-C-O 121.807 0.813 . . . . 1.44 110.009 173.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.439 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . . . . . . 0 CA--C 1.518 -0.269 0 CA-C-O 120.732 0.301 . . . . 0.55 110.891 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -104.02 28.51 6.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.931 -0.577 . . . . 1.99 111.507 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.721 ' HE2' ' HB2' ' A' ' 73' ' ' ALA . 1.1 p90 -135.47 176.89 2.52 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 108.756 -0.831 . . . . 0.84 108.756 173.545 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.598 ' HD3' ' CE2' ' A' ' 61' ' ' TYR . 18.9 Cg_exo -71.28 97.1 0.75 Allowed 'Trans proline' 0 CA--C 1.518 -0.276 0 C-N-CA 123.067 2.511 . . . . 0.62 112.884 -179.57 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.725 HG13 ' HB3' ' A' ' 73' ' ' ALA . 4.2 mp -92.61 138.6 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 N-CA-C 108.475 -0.935 . . . . 1.34 108.475 174.254 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.627 ' HB3' ' O ' ' A' ' 21' ' ' LEU . 13.5 mmt -101.19 179.84 4.25 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.755 -0.657 . . . . 3.03 109.997 -177.441 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.777 ' O ' ' HG2' ' A' ' 107' ' ' LYS . . . -83.83 34.11 0.49 Allowed 'General case' 0 CA--C 1.5 -0.944 0 C-N-CA 120.65 -0.42 . . . . 1.46 111.89 -168.016 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.777 ' HG2' ' O ' ' A' ' 106' ' ' ALA . 8.9 ptpt 56.02 144.78 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 123.953 1.835 . . . . 1.76 111.979 -174.265 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.538 HD12 ' HB3' ' A' ' 116' ' ' HIS . 35.7 pt -139.75 170.69 14.99 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 CA-C-N 112.324 -2.216 . . . . 0.82 107.478 175.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -80.68 50.8 1.38 Allowed 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.684 -0.689 . . . . 1.73 110.747 -176.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.474 HG23 ' CB ' ' A' ' 76' ' ' SER . 0.0 OUTLIER -64.36 94.33 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 CA-C-O 122.021 0.915 . . . . 0.77 110.884 -175.434 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 . . . . . 0 C--N 1.316 -0.881 0 N-CA-C 105.787 -1.931 . . . . 1.9 105.787 176.912 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.65 ' CE1' ' H ' ' A' ' 118' ' ' LEU . 3.5 t-80 . . . . . 0 N--CA 1.429 -1.52 0 N-CA-C 105.18 -2.156 . . . . 0.42 105.18 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -28.67 -47.97 0.12 Allowed 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 124.125 3.217 . . . . 0.4 113.568 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.835 HD11 ' HB ' ' A' ' 15' ' ' ILE . 28.1 tp -62.46 -51.67 66.58 Favored 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 123.365 0.666 . . . . 0.39 111.875 177.245 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.804 ' OH ' HG22 ' A' ' 40' ' ' ILE . 32.6 m-85 -75.69 -32.65 60.21 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-N 116.458 -0.337 . . . . 3.04 111.856 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -57.84 -40.15 79.39 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 107.169 -1.419 . . . . 2.44 107.169 170.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.726 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 31.6 t80 -66.65 -31.67 72.5 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.194 -0.912 . . . . 0.56 110.549 175.207 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.7 ' HE2' HG21 ' A' ' 15' ' ' ILE . 45.9 mtt -74.99 -52.86 10.05 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.488 -0.778 . . . . 0.71 110.958 -171.315 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.425 ' HE2' ' HB2' ' A' ' 123' ' ' LYS . 0.5 OUTLIER -71.61 -25.97 62.39 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 121.057 -0.257 . . . . 1.46 111.403 176.563 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.522 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 19.4 ptmt -72.17 -31.18 65.7 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 119.665 -0.814 . . . . 1.99 109.725 179.463 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 39.0 m -90.78 -38.31 13.08 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.394 -0.821 . . . . 0.59 111.004 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.466 ' HE3' ' HA ' ' A' ' 126' ' ' LYS . 1.6 tpmt? . . . . . 0 C--N 1.32 -0.693 0 CA-C-N 115.686 -0.688 . . . . 1.85 110.576 -174.374 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.701 ' HB3' ' HG3' ' A' ' 156' ' ' PRO . 0.5 OUTLIER . . . . . 0 CA--C 1.511 -0.551 0 N-CA-C 109.905 -0.405 . . . . 1.97 109.905 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.517 ' CG ' ' H ' ' A' ' 139' ' ' PHE . 60.6 t30 -31.99 -152.14 0.0 OUTLIER 'General case' 0 C--O 1.2 -1.506 0 O-C-N 125.359 1.662 . . . . 2.04 111.979 158.099 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.699 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 2.1 m-85 -27.64 -28.29 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.264 0 N-CA-C 118.037 2.606 . . . . 1.93 118.037 -167.212 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.685 ' HA ' ' O ' ' A' ' 154' ' ' PHE . 7.7 m 12.29 102.3 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 120.105 1.32 . . . . 0.6 114.373 172.123 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.699 ' HB3' HD12 ' A' ' 39' ' ' LEU . 1.6 m -90.11 167.52 12.68 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.571 -1.195 . . . . 0.62 111.473 -170.447 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.452 ' HA ' ' O ' ' A' ' 152' ' ' GLU . 95.2 m-85 -129.95 125.79 36.28 Favored 'General case' 0 CA--C 1.49 -1.339 0 N-CA-C 106.404 -1.702 . . . . 0.57 106.404 163.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.693 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 4.9 tp -80.33 102.94 9.86 Favored 'General case' 0 N--CA 1.422 -1.851 0 C-N-CA 118.204 -1.398 . . . . 0.43 108.125 176.584 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.674 HG22 ' HA2' ' A' ' 148' ' ' GLY . 43.2 mm -90.84 137.26 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.738 0 CA-C-N 113.724 -1.58 . . . . 0.19 107.625 -176.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.607 ' OD1' HG12 ' A' ' 149' ' ' VAL . 0.0 OUTLIER -88.74 -175.62 4.96 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 119.527 -0.869 . . . . 0.98 111.675 -168.914 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.663 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 33.8 mtm180 -53.65 -37.15 62.85 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-O 120.976 0.417 . . . . 2.22 111.037 -178.227 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.402 ' C ' ' HE2' ' A' ' 16' ' ' PHE . 25.3 t70 -103.17 19.43 19.59 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.413 -0.958 . . . . 2.0 108.413 -175.512 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.729 ' HA3' ' CE2' ' A' ' 16' ' ' PHE . . . 71.86 35.08 61.92 Favored Glycine 0 N--CA 1.439 -1.13 0 CA-C-N 114.794 -1.094 . . . . 0.17 115.531 176.525 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.607 HG12 ' OD1' ' A' ' 145' ' ' ASP . 10.0 p -106.06 113.51 63.51 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 119.356 1.578 . . . . 1.12 111.398 172.427 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.672 ' HD3' HG23 ' A' ' 15' ' ' ILE . 2.5 Cg_endo -51.11 115.55 2.11 Favored 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 124.027 3.152 . . . . 0.41 111.799 172.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 26.2 t -108.27 -28.58 2.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.707 0.765 . . . . 1.45 109.098 -176.7 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.693 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 22.6 mm-40 -136.86 166.39 23.73 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.509 -1.223 . . . . 1.17 110.317 -176.242 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.489 ' HA ' ' O ' ' A' ' 141' ' ' SER . 1.5 ttm180 -143.78 140.7 30.05 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.826 -1.079 . . . . 2.16 109.17 165.124 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.685 ' O ' ' HA ' ' A' ' 140' ' ' THR . 97.3 m-85 -120.8 149.95 41.77 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.932 -0.766 . . . . 0.32 108.932 -171.421 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 62.9 m -78.51 160.04 73.33 Favored Pre-proline 0 C--N 1.317 -0.83 0 N-CA-C 108.549 -0.908 . . . . 1.11 108.549 175.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.701 ' HG3' ' HB3' ' A' ' 137' ' ' TRP . 32.0 Cg_endo -63.74 -22.14 69.65 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.028 1.819 . . . . 0.78 111.896 178.261 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -78.93 -7.1 88.57 Favored Glycine 0 N--CA 1.446 -0.7 0 CA-C-N 115.696 -0.683 . . . . 0.5 112.626 173.071 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -72.88 144.99 47.19 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 108.62 -0.881 . . . . 0.5 108.62 174.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 14.5 m -110.91 173.74 6.19 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 120.835 -0.346 . . . . 1.42 110.168 -172.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.706 HG22 ' HA ' ' A' ' 56' ' ' THR . 58.9 t -40.7 -55.93 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 114.93 -1.032 . . . . 0.28 111.384 177.549 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.427 ' HB2' ' HE2' ' A' ' 161' ' ' LYS . 12.9 tppt? -67.25 -29.87 69.61 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.217 -0.447 . . . . 3.46 111.299 -171.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.44 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 8.0 m-20 -68.88 -38.27 79.58 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 121.481 0.657 . . . . 1.4 109.545 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.599 ' HA ' ' CZ ' ' A' ' 154' ' ' PHE . 71.3 mt -77.82 -43.68 28.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 114.76 -1.109 . . . . 0.21 110.715 178.346 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.605 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 53.9 mt-10 -55.02 -43.3 73.55 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-N 116.523 -0.308 . . . . 0.67 111.5 -176.525 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.44 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 8.6 pt-20 -58.45 -23.01 56.46 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.716 0.294 . . . . 0.87 111.7 -176.084 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.658 ' HB3' HD22 ' A' ' 143' ' ' LEU . 45.9 mmtm -99.51 -25.94 14.27 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.591 0.71 . . . . 1.71 109.982 176.097 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.6 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 13.6 tp -79.06 -50.76 10.55 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.897 -1.047 . . . . 0.16 112.215 -177.038 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.452 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 73.6 mt -54.57 -44.6 99.2 Favored Pre-proline 0 CA--C 1.537 0.452 0 CA-C-N 115.511 -0.768 . . . . 0.26 112.637 -173.306 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.452 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 53.8 Cg_exo -54.54 -33.06 76.88 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.077 1.851 . . . . 0.41 112.762 173.584 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.722 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 78.5 mt -83.23 -40.64 19.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.652 -0.249 . . . . 0.71 111.288 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.736 HD23 ' HG2' ' A' ' 37' ' ' PRO . 87.0 mt -61.76 -60.42 3.69 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 121.996 0.903 . . . . 0.34 109.603 175.642 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.315 0 CA-C-N 113.406 -1.724 . . . . 1.12 112.526 -178.988 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.9 t . . . . . 0 N--CA 1.454 -0.247 0 CA-C-O 121.022 0.439 . . . . 1.58 110.246 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.455 ' HB3' ' O ' ' A' ' 147' ' ' ASP . 5.9 m -158.51 151.83 22.94 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 105.975 -1.861 . . . . 1.17 105.975 -177.705 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.953 ' HB ' HD11 ' A' ' 118' ' ' LEU . 5.8 pt -61.75 -16.04 14.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 CA-C-N 114.32 -1.309 . . . . 0.38 111.823 -174.717 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.782 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 46.9 m-85 -73.79 5.9 3.68 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 113.028 0.751 . . . . 0.3 113.028 -174.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -79.81 -17.82 52.41 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 107.694 -1.224 . . . . 2.11 107.694 175.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.749 ' HE2' ' HB2' ' A' ' 121' ' ' TYR . 51.5 m-85 -112.07 115.29 28.65 Favored 'General case' 0 N--CA 1.434 -1.257 0 CA-C-N 114.078 -1.419 . . . . 0.31 111.432 -171.345 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -50.66 142.02 11.79 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 113.752 -1.567 . . . . 2.86 110.752 174.256 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.73 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 37.9 t -112.34 158.53 12.72 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 107.981 -1.118 . . . . 0.67 107.981 176.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.739 HD23 ' HA ' ' A' ' 27' ' ' PRO . 60.4 mt -126.66 135.0 50.59 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 120.454 -0.499 . . . . 0.69 111.347 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.502 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 15.8 t70 -63.88 159.36 19.88 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 106.193 -1.78 . . . . 1.87 106.193 164.535 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.761 ' HA ' ' CA ' ' A' ' 106' ' ' ALA . . . -57.35 -3.92 0.19 Allowed 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.973 1.101 . . . . 0.59 113.973 -166.743 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.482 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 23.3 t70 -100.16 0.01 39.7 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 111.454 0.168 . . . . 2.34 111.454 177.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.632 ' CD2' ' HB1' ' A' ' 106' ' ' ALA . 78.8 m-70 80.57 20.1 0.5 Allowed 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 121.811 0.815 . . . . 1.47 109.427 177.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.484 ' HA ' ' HD3' ' A' ' 26' ' ' LYS . 12.0 mmtp -96.13 123.42 55.21 Favored Pre-proline 0 N--CA 1.441 -0.904 0 CA-C-N 114.499 -1.228 . . . . 4.25 108.543 173.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.739 ' HA ' HD23 ' A' ' 21' ' ' LEU . 95.9 Cg_exo -49.18 114.14 1.18 Allowed 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 122.924 2.416 . . . . 0.54 114.165 -167.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.628 ' HB3' HG12 ' A' ' 20' ' ' VAL . 2.1 t80 -83.86 136.67 34.02 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 113.109 -1.86 . . . . 1.2 110.019 169.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.522 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 0.3 OUTLIER -81.89 83.16 7.29 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.499 0.666 . . . . 1.51 110.806 179.366 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.655 ' HG ' ' CD1' ' A' ' 16' ' ' PHE . 56.8 tp -50.4 -37.73 39.16 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.432 0.634 . . . . 0.28 110.383 178.388 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.62 HG13 ' HB3' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -69.43 -0.35 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 114.551 -1.204 . . . . 1.02 113.129 -172.502 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.531 HE21 ' CE1' ' A' ' 33' ' ' HIS . 9.4 pt20 -71.42 -20.25 62.14 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.731 -0.84 . . . . 1.02 108.731 172.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.966 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 93.4 m-70 -91.83 24.8 3.01 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 115.205 -0.907 . . . . 0.28 110.07 177.439 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.782 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 38.1 mtmt -86.04 109.33 18.73 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 114.587 -1.188 . . . . 1.56 109.2 170.159 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 133.65 -43.13 1.3 Allowed Glycine 0 N--CA 1.438 -1.17 0 C-N-CA 120.861 -0.685 . . . . 0.2 111.741 -177.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.457 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 69.3 m -127.15 136.77 29.37 Favored Pre-proline 0 N--CA 1.434 -1.229 0 N-CA-C 108.637 -0.875 . . . . 0.29 108.637 172.506 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.804 ' HG3' ' CB ' ' A' ' 170' ' ' LEU . 3.3 Cg_endo -42.49 153.32 0.15 Allowed 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 123.985 3.123 . . . . 0.18 112.763 175.381 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.841 ' HB2' HG22 ' A' ' 70' ' ' THR . 0.6 OUTLIER -140.48 141.87 35.36 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.123 -1.436 . . . . 0.31 107.123 179.964 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 1.016 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 1.2 mm? -107.53 112.77 25.69 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.284 -1.006 . . . . 1.19 108.284 177.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.095 HG22 ' OH ' ' A' ' 119' ' ' TYR . 2.3 mt -100.71 124.06 54.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 120.082 -0.647 . . . . 0.37 110.183 179.123 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 1.016 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.6 OUTLIER -110.2 124.81 52.26 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.145 -0.934 . . . . 0.42 110.715 -171.83 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.562 ' OD1' ' HB ' ' A' ' 140' ' ' THR . 8.2 p-10 -80.96 96.7 7.17 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.624 -1.251 . . . . 2.35 107.624 169.547 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.9 ' HA ' ' HA ' ' A' ' 139' ' ' PHE . 10.7 p . . . . . 0 C--N 1.306 -1.318 0 O-C-N 121.179 -0.951 . . . . 1.03 111.802 -165.061 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.736 0 N-CA-C 111.512 -0.635 . . . . 0.51 111.512 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.684 ' HA2' ' HB ' ' A' ' 56' ' ' THR . . . -63.94 -16.07 59.03 Favored Glycine 0 C--O 1.22 -0.753 0 CA-C-O 119.594 -0.559 . . . . 0.5 114.327 -177.442 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -73.23 -56.87 4.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 118.34 1.07 . . . . 0.7 109.351 177.009 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -60.34 -26.37 66.53 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-O 121.838 0.828 . . . . 2.61 109.572 175.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.684 ' HB ' ' HA2' ' A' ' 53' ' ' GLY . 15.4 m -75.33 -54.65 6.72 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 114.28 -1.327 . . . . 0.33 109.441 -176.104 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 1.086 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -57.32 -43.39 83.26 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 114.709 -1.132 . . . . 0.22 110.644 176.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.558 ' HA ' ' HD2' ' A' ' 102' ' ' PHE . 74.2 m -58.76 -56.03 27.52 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.794 -0.639 . . . . 0.26 110.675 -179.046 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 61.8 m -68.82 -37.11 78.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.458 -0.792 . . . . 0.48 111.891 -175.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.786 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 17.1 mt -64.57 -46.93 80.66 Favored 'General case' 0 CA--C 1.502 -0.888 0 CA-C-O 121.265 0.555 . . . . 0.43 110.359 -176.578 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.877 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 8.1 t80 -58.08 -52.2 66.53 Favored 'General case' 0 C--O 1.202 -1.443 0 CA-C-N 114.856 -1.066 . . . . 0.31 110.64 178.403 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -70.19 -25.67 63.53 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 120.718 0.294 . . . . 1.21 110.81 -172.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.55 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 36.2 ttpt -84.84 -23.4 29.06 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.946 -0.761 . . . . 1.54 108.946 -177.253 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.636 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 43.1 m-85 -126.88 -4.25 6.4 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 116.084 1.883 . . . . 0.31 116.084 -171.428 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.737 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 12.8 ptmt -64.04 -27.29 69.01 Favored 'General case' 0 CA--C 1.496 -1.114 0 N-CA-C 108.052 -1.092 . . . . 1.35 108.052 171.038 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.0 t -48.61 -35.26 13.23 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 114.154 -1.384 . . . . 1.28 111.033 173.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -92.57 -33.15 14.55 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.079 0.4 . . . . 1.11 112.079 175.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.405 ' HA3' ' HB2' ' A' ' 36' ' ' SER . . . 147.9 -5.54 0.95 Allowed Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 111.711 -0.556 . . . . 0.18 111.711 -176.63 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.786 ' HE2' ' HB3' ' A' ' 60' ' ' LEU . 18.5 t80 -69.97 144.71 52.24 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-O 121.047 0.451 . . . . 0.18 111.447 -178.245 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.966 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 1.5 t -134.92 149.96 50.34 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 108.283 -1.006 . . . . 0.2 108.283 173.451 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 1.086 HG11 ' HB1' ' A' ' 57' ' ' ALA . 45.2 t -106.34 100.1 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.322 0 N-CA-C 108.001 -1.111 . . . . 0.17 108.001 157.257 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.852 ' HA ' ' HG2' ' A' ' 103' ' ' PRO . 4.9 mt -85.6 118.66 25.24 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.68 -1.23 . . . . 1.04 107.68 177.099 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 1.003 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -107.83 112.04 24.49 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 119.363 -0.935 . . . . 0.51 110.957 178.011 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.796 ' HD2' HD13 ' A' ' 108' ' ' ILE . 3.0 m-85 -93.35 99.59 3.44 Favored Pre-proline 0 C--N 1.311 -1.096 0 CA-C-N 114.445 -1.252 . . . . 0.44 108.425 176.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.807 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 92.2 Cg_endo -83.82 93.15 0.79 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.501 2.134 . . . . 1.3 113.286 -167.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.641 ' HA ' ' O ' ' A' ' 108' ' ' ILE . 44.0 m . . . . . 0 CA--C 1.499 -0.982 0 N-CA-C 115.08 1.511 . . . . 1.44 115.08 -172.322 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.539 ' HB1' ' CE2' ' A' ' 102' ' ' PHE . . . . . . . . 0 CA--C 1.506 -0.717 0 CA-C-O 120.727 0.298 . . . . 0.55 111.07 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -94.31 29.94 2.08 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.906 -0.588 . . . . 1.99 110.335 175.376 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.656 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 18.3 p90 -143.23 160.94 50.25 Favored Pre-proline 0 N--CA 1.442 -0.852 0 N-CA-C 108.161 -1.051 . . . . 0.84 108.161 175.239 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.852 ' HG2' ' HA ' ' A' ' 72' ' ' LEU . 36.0 Cg_endo -58.94 90.68 0.07 OUTLIER 'Trans proline' 0 N--CA 1.476 0.455 0 C-N-CA 123.982 3.121 . . . . 0.62 114.419 -172.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 1.003 HD12 ' HB3' ' A' ' 73' ' ' ALA . 2.8 mm -80.0 123.22 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 108.809 -0.811 . . . . 1.34 108.809 171.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.713 ' HG3' ' H ' ' A' ' 107' ' ' LYS . 0.8 OUTLIER -77.13 170.03 17.26 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.412 -1.267 . . . . 3.03 111.11 -177.568 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.761 ' CA ' ' HA ' ' A' ' 23' ' ' ALA . . . -69.33 11.42 0.24 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.688 -0.687 . . . . 1.46 112.377 178.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.797 ' HB2' ' O ' ' A' ' 75' ' ' PRO . 2.6 ptpp? 67.4 143.43 0.04 OUTLIER 'General case' 0 CA--C 1.495 -1.163 0 CA-C-O 123.363 1.554 . . . . 1.76 112.092 -175.353 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.914 HG13 HG22 ' A' ' 110' ' ' VAL . 36.1 pt -136.28 159.27 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.197 0 CA-C-N 111.81 -2.45 . . . . 0.82 106.557 175.134 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.35 64.27 0.58 Allowed 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 110.506 -0.183 . . . . 1.73 110.506 176.26 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.914 HG22 HG13 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -74.59 92.37 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.751 0 C-N-CA 119.644 -0.823 . . . . 0.77 109.928 -176.241 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.6 t30 . . . . . 0 N--CA 1.443 -0.796 0 CA-C-N 114.219 -1.355 . . . . 1.9 107.683 170.552 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.709 ' HB3' HD12 ' A' ' 108' ' ' ILE . 2.1 t-80 . . . . . 0 N--CA 1.438 -1.065 0 CA-C-O 118.709 -0.663 . . . . 0.42 109.356 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -26.43 -45.04 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 124.886 3.724 . . . . 0.4 114.049 179.286 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.953 HD11 ' HB ' ' A' ' 15' ' ' ILE . 48.0 tp -65.14 -51.0 63.86 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 122.894 0.478 . . . . 0.39 112.288 179.141 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 1.095 ' OH ' HG22 ' A' ' 40' ' ' ILE . 24.1 m-85 -80.57 -32.33 36.6 Favored 'General case' 0 CA--C 1.486 -1.512 0 CA-C-O 121.433 0.635 . . . . 3.04 109.752 -176.2 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.549 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 4.4 tm-20 -60.07 -37.06 78.78 Favored 'General case' 0 N--CA 1.426 -1.635 0 N-CA-C 106.186 -1.783 . . . . 2.44 106.186 172.258 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.749 ' HB2' ' HE2' ' A' ' 18' ' ' PHE . 79.2 t80 -68.56 -30.45 69.23 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.135 -0.939 . . . . 0.56 110.605 173.484 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.705 ' CE ' HD12 ' A' ' 40' ' ' ILE . 53.3 mtt -75.83 -55.34 5.73 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.09 -0.505 . . . . 0.71 111.815 -170.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.702 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -70.48 -23.65 62.72 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.194 -0.457 . . . . 1.46 110.78 177.495 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.62 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 10.4 ptmt -72.96 -27.04 61.59 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 119.701 -0.799 . . . . 1.99 109.429 172.587 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 89.2 m -71.66 -50.99 25.45 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 116.044 -0.526 . . . . 0.59 109.59 172.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.769 ' HG2' HH22 ' A' ' 153' ' ' ARG . 23.2 ttmm . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 115.95 -0.568 . . . . 1.85 110.05 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.647 ' HB3' ' HG3' ' A' ' 156' ' ' PRO . 7.0 m-90 . . . . . 0 N--CA 1.452 -0.352 0 N-CA-C 110.574 -0.158 . . . . 1.97 110.574 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.416 ' HB3' ' H ' ' A' ' 139' ' ' PHE . 94.6 m-20 -39.48 -158.57 0.0 OUTLIER 'General case' 0 C--O 1.207 -1.162 0 C-N-CA 124.795 1.238 . . . . 2.04 113.017 163.11 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.9 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 0.1 OUTLIER -33.39 -26.71 0.01 OUTLIER 'General case' 0 C--O 1.203 -1.384 0 N-CA-C 116.427 2.01 . . . . 1.93 116.427 -171.24 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.562 ' HB ' ' OD1' ' A' ' 42' ' ' ASN . 14.1 m 23.11 109.65 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 120.909 1.686 . . . . 0.6 114.601 165.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.85 ' O ' ' HA ' ' A' ' 153' ' ' ARG . 0.8 OUTLIER -107.08 138.29 43.54 Favored 'General case' 0 C--O 1.199 -1.583 0 CA-C-N 114.933 -1.031 . . . . 0.62 112.389 -161.867 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.534 ' O ' HD13 ' A' ' 39' ' ' LEU . 50.9 m-85 -103.52 127.51 50.91 Favored 'General case' 0 CA--C 1.488 -1.424 0 N-CA-C 107.666 -1.235 . . . . 0.57 107.666 175.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.794 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 7.5 tp -80.65 103.23 10.36 Favored 'General case' 0 N--CA 1.417 -2.099 0 C-N-CA 118.07 -1.452 . . . . 0.43 107.947 174.401 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.753 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 45.8 mm -94.82 139.17 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.782 0 CA-C-N 113.131 -1.85 . . . . 0.19 107.394 -179.008 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.29 -175.36 3.8 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 119.64 -0.824 . . . . 0.98 111.329 -169.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.598 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 47.5 mtm180 -52.51 -41.04 63.1 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 123.356 0.41 . . . . 2.22 111.036 -177.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.455 ' O ' ' HB3' ' A' ' 14' ' ' SER . 34.1 m-20 -98.86 22.63 9.88 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.471 -0.566 . . . . 2.0 109.471 -176.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.569 ' HA2' HG22 ' A' ' 144' ' ' ILE . . . 67.53 39.66 90.98 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 114.728 0.651 . . . . 0.17 114.728 177.302 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.423 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 93.4 t -100.84 127.94 31.03 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-N 118.278 1.039 . . . . 1.12 110.497 173.395 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.524 ' HA ' HD13 ' A' ' 144' ' ' ILE . 10.2 Cg_endo -77.3 110.0 2.91 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.692 2.262 . . . . 0.41 110.319 178.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.451 ' O ' ' HE3' ' A' ' 126' ' ' LYS . 17.2 t -107.87 -28.28 2.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 121.433 0.635 . . . . 1.45 109.546 -173.027 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.794 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 5.5 mm-40 -135.75 164.64 27.43 Favored 'General case' 0 CA--C 1.501 -0.933 0 CA-C-N 115.328 -0.851 . . . . 1.17 110.511 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.85 ' HA ' ' O ' ' A' ' 141' ' ' SER . 0.0 OUTLIER -149.42 139.19 21.82 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.805 -1.088 . . . . 2.16 110.31 157.813 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.557 ' CZ ' ' HA ' ' A' ' 163' ' ' ILE . 86.8 m-85 -113.95 152.77 30.37 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.242 -1.344 . . . . 0.32 109.141 -160.707 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 15.3 m -71.37 157.03 90.85 Favored Pre-proline 0 C--N 1.312 -1.058 0 N-CA-C 109.464 -0.569 . . . . 1.11 109.464 176.134 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.647 ' HG3' ' HB3' ' A' ' 137' ' ' TRP . 18.4 Cg_endo -60.87 -26.62 83.42 Favored 'Trans proline' 0 CA--C 1.517 -0.348 0 C-N-CA 122.197 1.931 . . . . 0.78 110.179 171.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -81.55 7.87 60.48 Favored Glycine 0 N--CA 1.441 -1.01 0 CA-C-N 114.036 -1.438 . . . . 0.5 113.124 174.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -88.07 146.41 25.46 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.563 -0.903 . . . . 0.5 108.563 171.165 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 87.5 p -110.86 176.86 4.86 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 120.813 -0.355 . . . . 1.42 110.772 -173.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.636 HG22 ' HA ' ' A' ' 56' ' ' THR . 61.1 t -44.49 -46.57 2.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.211 -0.904 . . . . 0.28 110.582 174.685 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -68.97 -37.44 78.79 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.664 -0.698 . . . . 3.46 111.052 -174.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -65.26 -41.02 94.67 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.566 0.698 . . . . 1.4 109.551 -177.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.63 HD13 ' OH ' ' A' ' 41' ' ' TYR . 73.7 mt -77.78 -45.66 27.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 114.637 -1.165 . . . . 0.21 111.472 -179.223 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.62 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 25.2 mt-10 -52.97 -41.37 64.49 Favored 'General case' 0 C--O 1.22 -0.495 0 N-CA-C 111.994 0.368 . . . . 0.67 111.994 -176.474 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -63.3 -19.58 64.72 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.46 -0.496 . . . . 0.87 111.889 -174.502 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.594 ' HB3' HD22 ' A' ' 143' ' ' LEU . 13.0 mmmm -103.03 -11.12 18.37 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.42 0.628 . . . . 1.71 110.018 174.496 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.62 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 13.9 tp -93.05 -53.78 4.0 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.99 -1.005 . . . . 0.16 112.168 -176.58 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.551 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 64.1 mt -53.28 -48.2 93.28 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.282 -0.872 . . . . 0.26 112.59 -172.508 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.551 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 72.5 Cg_exo -51.86 -30.26 37.94 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 122.252 1.968 . . . . 0.41 112.728 175.472 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.804 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 96.4 mt -84.42 -42.78 15.31 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.468 -0.333 . . . . 0.71 111.038 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.754 HD23 ' HG2' ' A' ' 37' ' ' PRO . 95.5 mt -60.93 -57.88 10.77 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-O 122.13 0.967 . . . . 0.34 109.692 176.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.464 0 CA-C-N 113.334 -1.757 . . . . 1.12 113.011 -178.299 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.665 0 N-CA-C 111.814 -0.514 . . . . 5.22 111.814 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 95.1 mmm -106.71 141.48 37.9 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.761 0.315 . . . . 4.85 110.848 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 88.7 110.34 1.13 Allowed Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.908 -0.663 . . . . 1.55 112.896 177.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.6 m -98.28 -32.92 11.3 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.071 -0.714 . . . . 1.58 109.071 175.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.9 m -150.65 170.57 18.86 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 105.161 -2.163 . . . . 1.17 105.161 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.87 ' HB ' HD11 ' A' ' 118' ' ' LEU . 6.8 pt -63.74 -19.59 24.64 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.102 0 CA-C-O 121.416 0.627 . . . . 0.38 110.521 178.122 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.734 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 37.3 m-85 -73.5 0.9 11.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.858 -0.61 . . . . 0.3 111.997 -175.017 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -80.19 -8.73 59.57 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 108.203 -1.036 . . . . 2.11 108.203 176.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.812 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 58.1 m-85 -121.79 117.29 26.21 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 114.537 -1.211 . . . . 0.31 111.427 -174.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -48.92 138.49 11.39 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 112.876 -1.965 . . . . 2.86 110.534 173.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.914 HG13 ' HZ ' ' A' ' 74' ' ' PHE . 98.9 t -112.76 163.4 9.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 108.146 -1.057 . . . . 0.67 108.146 175.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.737 ' O ' ' HB3' ' A' ' 105' ' ' MET . 19.9 mt -134.9 121.88 21.19 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.9 -0.407 . . . . 0.69 109.9 -175.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.856 ' HA ' ' HE2' ' A' ' 105' ' ' MET . 29.9 t70 -63.96 177.36 0.79 Allowed 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 108.372 -0.973 . . . . 1.87 108.372 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.631 ' HA ' ' C ' ' A' ' 105' ' ' MET . . . -59.55 -4.38 0.62 Allowed 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 114.314 1.228 . . . . 0.59 114.314 -163.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -119.33 14.8 12.98 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.765 0.654 . . . . 2.34 112.765 173.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.709 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 8.2 m-70 73.13 24.22 2.52 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 122.184 0.992 . . . . 1.47 109.695 174.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.421 ' HE3' ' HB2' ' A' ' 26' ' ' LYS . 16.3 mtmt -85.55 127.81 61.64 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 113.814 -1.539 . . . . 4.25 106.929 166.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.598 ' HA ' HD23 ' A' ' 21' ' ' LEU . 93.3 Cg_exo -50.76 112.44 0.77 Allowed 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 121.359 1.373 . . . . 0.54 112.607 -174.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.521 ' HE2' ' CD2' ' A' ' 72' ' ' LEU . 24.2 t80 -81.47 142.61 32.77 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 113.481 -1.69 . . . . 1.2 112.1 178.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.544 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.8 t-20 -77.73 82.37 4.13 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.648 -1.16 . . . . 1.51 109.904 178.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.661 HD13 HG21 ' A' ' 20' ' ' VAL . 62.1 tp -63.72 -45.16 91.21 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.559 0.695 . . . . 0.28 110.822 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.685 HG13 ' HB3' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -66.13 1.69 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 114.759 -1.109 . . . . 1.02 113.596 -171.764 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.544 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 21.1 pt20 -74.37 -5.34 41.77 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.342 0.591 . . . . 1.02 110.175 172.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.866 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 70.8 m-70 -104.3 24.06 12.14 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.84 0.828 . . . . 0.28 109.428 174.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.734 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 19.7 mtmm -82.69 110.01 17.36 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 114.608 -1.178 . . . . 1.56 109.535 171.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.27 -36.49 2.38 Favored Glycine 0 N--CA 1.44 -1.085 0 C-N-CA 120.534 -0.841 . . . . 0.2 112.031 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.449 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 40.1 m -131.01 133.41 24.72 Favored Pre-proline 0 N--CA 1.435 -1.213 0 N-CA-C 108.3 -1.0 . . . . 0.29 108.3 173.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.757 ' HG2' HD23 ' A' ' 171' ' ' LEU . 3.1 Cg_endo -42.56 152.3 0.19 Allowed 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.824 3.016 . . . . 0.18 112.566 177.003 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.866 ' HB2' HG22 ' A' ' 70' ' ' THR . 0.5 OUTLIER -136.98 140.76 42.41 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 106.872 -1.529 . . . . 0.31 106.872 179.395 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.891 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 1.3 mm? -106.65 111.09 23.47 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.077 -1.083 . . . . 1.19 108.077 176.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.872 HG23 ' HB2' ' A' ' 72' ' ' LEU . 2.4 mt -94.87 122.9 46.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-N 115.856 -0.611 . . . . 0.37 109.485 176.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.891 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -110.88 128.01 55.64 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 116.068 -0.514 . . . . 0.42 109.919 -176.182 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.618 ' OD1' ' HB ' ' A' ' 140' ' ' THR . 2.3 p30 -82.27 94.85 7.41 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 107.938 -1.134 . . . . 2.35 107.938 167.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.777 ' O ' ' HA ' ' A' ' 75' ' ' PRO . 19.3 m -102.69 137.14 31.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 121.507 0.67 . . . . 1.03 110.615 -166.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.488 ' CB ' ' HE2' ' A' ' 46' ' ' LYS . . . -88.56 100.61 13.21 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.914 -0.585 . . . . 0.88 109.704 177.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.694 ' HA ' ' HB2' ' A' ' 98' ' ' PHE . 5.1 p -28.94 -81.79 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 O-C-N 125.162 1.539 . . . . 1.78 113.631 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.488 ' HE2' ' CB ' ' A' ' 44' ' ' ALA . 0.3 OUTLIER 56.31 -168.48 0.1 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.665 0.745 . . . . 5.84 112.51 -179.716 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 32.6 t -145.61 116.47 7.75 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.091 -0.959 . . . . 3.55 109.783 178.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.36 -25.99 3.6 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 121.017 -0.611 . . . . 2.91 113.2 177.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.411 ' HD2' ' HZ1' ' A' ' 46' ' ' LYS . 86.3 t80 -100.07 115.78 30.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.571 0.701 . . . . 4.63 111.717 -178.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.636 ' OG1' ' HB2' ' A' ' 54' ' ' TYR . 12.9 t -127.31 -169.62 2.07 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 107.511 -1.292 . . . . 1.93 107.511 171.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 55.5 tttt -148.89 63.87 1.05 Allowed 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.577 -0.449 . . . . 2.01 109.903 178.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.45 ' O ' ' HG3' ' A' ' 55' ' ' GLU . . . 76.63 -47.35 2.43 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 121.15 -0.548 . . . . 0.51 112.476 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.44 ' HA2' ' HB ' ' A' ' 56' ' ' THR . . . -53.88 -23.98 24.93 Favored Glycine 0 C--O 1.218 -0.889 0 CA-C-O 119.523 -0.599 . . . . 0.5 114.398 -175.095 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.636 ' HB2' ' OG1' ' A' ' 50' ' ' THR . 0.6 OUTLIER -67.74 -55.49 12.9 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 118.42 1.11 . . . . 0.7 110.642 -178.943 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.45 ' HG3' ' O ' ' A' ' 52' ' ' GLY . 2.7 pp20? -66.31 -31.24 71.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.521 0.677 . . . . 2.61 109.348 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.697 ' HA ' ' CG2' ' A' ' 160' ' ' VAL . 53.9 m -59.68 -60.15 4.31 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 114.597 -1.183 . . . . 0.33 110.691 175.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 1.024 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -61.27 -44.99 96.33 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.979 -1.01 . . . . 0.22 111.293 -177.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.618 ' HA ' ' HE1' ' A' ' 102' ' ' PHE . 95.9 m -55.25 -52.29 63.89 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.57 0.7 . . . . 0.26 110.344 -177.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.8 m -72.79 -36.07 67.52 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.916 -1.038 . . . . 0.48 111.309 -176.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.682 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 19.3 mt -65.87 -50.11 65.72 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 121.303 0.573 . . . . 0.43 110.374 -177.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.817 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 6.8 t80 -55.74 -53.54 55.31 Favored 'General case' 0 C--O 1.198 -1.613 0 CA-C-N 114.608 -1.178 . . . . 0.31 110.44 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.481 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 9.7 m-80 -73.11 -24.67 60.66 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 112.182 0.438 . . . . 1.21 112.182 -173.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.477 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 33.6 ttpt -82.46 -22.36 35.22 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.768 -0.827 . . . . 1.54 108.768 -178.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.77 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 37.8 m-85 -123.73 -5.73 8.05 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 114.767 1.395 . . . . 0.31 114.767 -172.296 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.69 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 11.1 ptmt -64.64 -25.74 68.09 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 107.931 -1.137 . . . . 1.35 107.931 170.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.2 m -48.01 -41.84 26.48 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 114.106 -1.406 . . . . 1.28 110.672 172.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -82.73 -37.93 23.99 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 111.747 0.277 . . . . 1.11 111.747 175.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 149.66 -8.55 0.86 Allowed Glycine 0 CA--C 1.519 0.332 0 N-CA-C 111.088 -0.805 . . . . 0.18 111.088 -176.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.77 ' HD2' ' HB2' ' A' ' 64' ' ' TYR . 18.5 t80 -63.53 144.92 56.59 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 115.024 -0.588 . . . . 0.18 111.24 -177.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.866 HG22 ' HB2' ' A' ' 38' ' ' LEU . 3.0 t -133.27 152.25 51.93 Favored 'General case' 0 N--CA 1.411 -2.396 0 N-CA-C 108.726 -0.842 . . . . 0.2 108.726 171.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 1.024 HG11 ' HB1' ' A' ' 57' ' ' ALA . 37.4 t -106.78 102.12 13.48 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.361 0 N-CA-C 107.645 -1.243 . . . . 0.17 107.645 158.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.872 ' HB2' HG23 ' A' ' 40' ' ' ILE . 88.5 mt -84.27 118.73 24.37 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 107.742 -1.207 . . . . 1.04 107.742 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.757 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -97.84 113.06 24.77 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 120.385 -0.526 . . . . 0.51 110.598 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.914 ' HZ ' HG13 ' A' ' 20' ' ' VAL . 34.5 m-85 -106.52 96.68 14.52 Favored Pre-proline 0 C--N 1.309 -1.171 0 N-CA-C 109.445 -0.576 . . . . 0.44 109.445 176.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.777 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 74.2 Cg_endo -80.43 75.08 5.24 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.481 2.787 . . . . 1.3 114.778 -166.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 108' ' ' ILE . 76.2 p -18.25 133.02 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 126.028 1.731 . . . . 1.44 115.234 -177.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.471 ' C ' ' HG3' ' A' ' 83' ' ' GLU . 0.8 OUTLIER -91.1 84.7 5.74 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 114.876 -1.056 . . . . 1.81 109.243 -179.152 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.736 ' HA ' ' HG3' ' A' ' 83' ' ' GLU . 67.3 mt-30 -52.31 -10.97 0.16 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 114.956 -1.02 . . . . 3.34 111.716 -178.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.666 ' HA ' ' HD3' ' A' ' 91' ' ' LYS . 67.9 m-85 -63.58 -20.52 65.72 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.747 -0.66 . . . . 2.68 110.215 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -68.66 -47.26 57.36 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.649 -0.705 . . . . 1.98 111.698 176.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 119.82 -35.57 3.78 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.674 -0.774 . . . . 1.49 112.764 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.712 ' HG3' ' HB2' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -85.04 -5.29 59.35 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 111.935 0.346 . . . . 1.74 111.935 -175.28 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.736 ' HG3' ' HA ' ' A' ' 78' ' ' GLN . 5.1 mm-40 -59.45 150.71 63.81 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-O 121.852 0.834 . . . . 3.07 113.246 -161.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.685 ' HB2' ' N ' ' A' ' 137' ' ' TRP . 94.9 Cg_endo -71.0 -31.84 14.4 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 123.931 3.087 . . . . 1.75 111.783 -167.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -70.81 -46.15 47.59 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.879 -0.677 . . . . 2.2 111.935 178.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -177.63 -105.59 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 122.177 0.191 . . . . 4.2 110.499 176.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.677 ' HG3' ' H ' ' A' ' 88' ' ' GLU . 6.6 pt-20 176.37 -72.03 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.726 0.298 . . . . 3.02 111.039 -175.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.677 ' H ' ' HG3' ' A' ' 87' ' ' GLU . 61.5 mm-40 -82.8 -11.6 58.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.843 0.354 . . . . 3.92 111.377 -176.081 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.465 ' HB3' ' OE1' ' A' ' 78' ' ' GLN . 14.5 tt0 -56.4 -60.95 2.78 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.659 -0.7 . . . . 2.65 112.373 -169.233 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.583 HG12 ' HB2' ' A' ' 78' ' ' GLN . 31.1 pt -77.36 3.71 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 111.979 0.363 . . . . 2.15 111.979 -178.24 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.666 ' HD3' ' HA ' ' A' ' 79' ' ' PHE . 50.1 mtmt -100.9 -39.24 7.87 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.646 0.26 . . . . 2.79 110.368 178.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 88' ' ' GLU . 11.8 pt-20 -87.17 -38.49 16.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.486 -0.325 . . . . 3.29 110.489 178.025 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -91.32 161.36 15.06 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.017 0.437 . . . . 3.42 109.942 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.7 p -80.12 112.31 17.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.675 -0.693 . . . . 2.63 110.326 174.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.546 ' SG ' ' HA ' ' A' ' 90' ' ' ILE . 3.7 m -140.77 121.9 14.73 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 121.399 0.619 . . . . 2.83 110.428 178.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.5 p -69.4 163.38 25.35 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 114.732 -1.122 . . . . 2.98 108.813 169.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -66.18 50.74 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.455 -0.338 . . . . 2.72 111.689 177.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.727 ' CZ ' ' HE2' ' A' ' 102' ' ' PHE . 64.8 t80 65.0 -89.07 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.464 0.706 . . . . 2.12 110.503 -178.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 25.2 ttmm 65.39 140.46 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 123.763 0.825 . . . . 2.69 111.726 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.503 ' HB3' ' CD2' ' A' ' 102' ' ' PHE . . . -170.69 -151.34 0.08 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.614 -0.721 . . . . 0.55 111.082 -172.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.41 ' H ' ' HB1' ' A' ' 100' ' ' ALA . 36.3 mm-40 -96.99 22.96 7.72 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.488 -0.778 . . . . 1.99 111.332 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.727 ' HE2' ' CZ ' ' A' ' 98' ' ' PHE . 2.9 m-85 -111.61 -176.63 0.39 Allowed Pre-proline 0 CA--C 1.514 -0.41 0 CA-C-O 121.561 0.695 . . . . 0.84 110.764 -177.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.67 ' HD3' ' CE2' ' A' ' 61' ' ' TYR . 8.6 Cg_exo -81.51 78.26 3.63 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 123.93 3.086 . . . . 0.62 109.449 157.155 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.757 HG13 ' HB3' ' A' ' 73' ' ' ALA . 4.0 mp -84.32 127.83 39.46 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 N-CA-C 108.09 -1.078 . . . . 1.34 108.09 178.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.856 ' HE2' ' HA ' ' A' ' 22' ' ' ASP . 3.4 mmt -96.82 -175.52 3.3 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.565 -0.743 . . . . 3.03 110.404 -169.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.638 ' O ' ' HG2' ' A' ' 107' ' ' LYS . . . -84.98 32.93 0.53 Allowed 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 113.013 0.746 . . . . 1.46 113.013 -167.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.638 ' HG2' ' O ' ' A' ' 106' ' ' ALA . 15.2 ptpt 53.83 127.6 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 123.467 1.603 . . . . 1.76 112.654 -177.08 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.785 HG13 HG13 ' A' ' 110' ' ' VAL . 20.4 pt -128.59 160.66 38.74 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 CA-C-N 113.538 -1.665 . . . . 0.82 108.681 177.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.511 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 32.9 t-20 -71.54 52.31 0.2 Allowed 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.148 -0.933 . . . . 1.73 110.985 -178.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.785 HG13 HG13 ' A' ' 108' ' ' ILE . 0.7 OUTLIER -62.3 95.57 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-O 121.533 0.683 . . . . 0.77 109.379 179.611 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 177.6 -179.12 0.23 Allowed 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 114.683 -1.144 . . . . 1.9 108.389 -176.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -73.82 12.6 4.83 Favored Glycine 0 N--CA 1.44 -1.037 0 N-CA-C 115.998 1.159 . . . . 1.47 115.998 -176.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.712 ' HB2' ' HG3' ' A' ' 82' ' ' GLN . 15.0 tt0 -107.57 -47.36 3.64 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 119.987 1.894 . . . . 2.81 113.084 178.085 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.404 ' HB3' ' HB3' ' A' ' 109' ' ' ASN . 18.2 t-20 -129.43 -32.9 1.93 Allowed 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.8 -0.36 . . . . 2.16 111.183 -178.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.511 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . 45.91 -109.53 0.21 Allowed 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.286 -0.87 . . . . 1.26 110.14 -172.01 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.587 ' CE1' ' H ' ' A' ' 118' ' ' LEU . 4.0 t-80 177.46 137.25 0.22 Allowed Pre-proline 0 N--CA 1.425 -1.69 0 N-CA-C 104.808 -2.293 . . . . 0.42 104.808 171.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -27.29 -45.75 0.07 OUTLIER 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 124.272 3.314 . . . . 0.4 113.913 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.87 HD11 ' HB ' ' A' ' 15' ' ' ILE . 24.0 tp -64.86 -50.81 65.15 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.608 0.763 . . . . 0.39 111.854 178.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.672 ' OH ' HG22 ' A' ' 40' ' ' ILE . 36.4 m-85 -75.9 -33.01 59.9 Favored 'General case' 0 CA--C 1.505 -0.788 0 O-C-N 122.203 -0.311 . . . . 3.04 111.509 178.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -56.51 -38.85 72.35 Favored 'General case' 0 CA--C 1.493 -1.239 0 N-CA-C 106.927 -1.509 . . . . 2.44 106.927 170.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.812 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 56.6 t80 -67.43 -32.18 72.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.224 -0.898 . . . . 0.56 110.661 175.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.766 ' HE3' ' HG ' ' A' ' 118' ' ' LEU . 0.6 OUTLIER -74.64 -54.5 7.31 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.248 -0.433 . . . . 0.71 110.142 -171.075 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.407 ' HE2' ' HB2' ' A' ' 123' ' ' LYS . 1.2 ptmm? -70.29 -24.57 63.06 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.191 -0.459 . . . . 1.46 111.396 176.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.512 ' HG3' ' O ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -74.43 -27.91 60.82 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 119.151 -1.02 . . . . 1.99 110.118 176.231 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 90.8 m -78.27 -43.04 29.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.887 -0.597 . . . . 0.59 110.265 175.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.438 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 41.0 tttm -148.74 104.88 3.44 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 108.884 -0.784 . . . . 1.85 108.884 178.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 126' ' ' LYS . 23.0 Cg_exo -64.84 -73.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.992 3.128 . . . . 1.69 114.332 -167.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.762 ' HA3' ' HB3' ' A' ' 133' ' ' LYS . . . -152.36 -176.62 25.18 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 119.628 -1.272 . . . . 2.59 113.005 -174.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.635 HD12 ' H ' ' A' ' 129' ' ' ILE . 4.2 mp -74.36 -19.73 17.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.454 -0.943 . . . . 3.58 108.454 178.172 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.508 ' HG ' ' H ' ' A' ' 131' ' ' ALA . 9.7 tp -77.56 -168.57 1.21 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.805 -1.089 . . . . 3.47 109.417 173.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.508 ' H ' ' HG ' ' A' ' 130' ' ' LEU . . . -60.75 -37.76 82.91 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.135 -1.061 . . . . 3.28 108.135 165.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.404 ' O ' ' HB3' ' A' ' 130' ' ' LEU . 0.6 OUTLIER -149.77 147.42 27.99 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 114.483 -1.235 . . . . 3.56 110.883 176.845 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.762 ' HB3' ' HA3' ' A' ' 128' ' ' GLY . 47.2 tptt -166.0 162.91 18.3 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.552 -1.277 . . . . 5.17 107.552 175.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -140.11 56.02 1.62 Allowed 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.415 -0.514 . . . . 1.59 111.707 -178.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.658 HG22 ' HB3' ' A' ' 84' ' ' PRO . 73.6 mt 67.74 120.38 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 O-C-N 123.92 0.762 . . . . 2.0 110.835 178.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 84' ' ' PRO . 2.7 tmtm? -160.61 33.16 0.16 Allowed 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.712 -0.617 . . . . 4.81 111.877 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.685 ' N ' ' HB2' ' A' ' 84' ' ' PRO . 12.6 m-90 -143.16 174.05 11.04 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.279 0.561 . . . . 1.97 110.983 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.481 ' HB3' ' H ' ' A' ' 139' ' ' PHE . 6.1 m-20 -43.06 -156.22 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.725 -1.125 . . . . 2.04 112.157 157.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.718 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 2.8 m-85 -28.74 -47.25 0.05 Allowed 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 116.337 1.977 . . . . 1.93 116.337 -168.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.618 ' HB ' ' OD1' ' A' ' 42' ' ' ASN . 9.7 m 36.12 91.8 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.386 0.994 . . . . 0.6 113.21 176.151 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.634 ' HB3' HD12 ' A' ' 39' ' ' LEU . 0.7 OUTLIER -83.41 163.26 20.67 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.464 -0.789 . . . . 0.62 110.685 -175.023 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.531 ' HA ' ' HA ' ' A' ' 153' ' ' ARG . 76.4 m-85 -129.77 122.26 28.47 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 105.52 -2.03 . . . . 0.57 105.52 168.233 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.832 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 7.3 tp -80.19 103.51 10.11 Favored 'General case' 0 N--CA 1.422 -1.865 0 C-N-CA 118.528 -1.269 . . . . 0.43 108.372 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.715 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 42.9 mm -90.23 139.54 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.734 0 CA-C-N 112.965 -1.925 . . . . 0.19 107.468 -179.099 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.546 ' HA ' HD13 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -93.92 -176.95 4.18 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 119.71 -0.796 . . . . 0.98 111.276 -169.197 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.639 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 35.3 mtm180 -51.94 -41.45 62.06 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.994 0.426 . . . . 2.22 111.18 -177.229 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -95.65 14.68 22.21 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 109.646 -0.501 . . . . 2.0 109.646 -175.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.489 ' HA2' HG22 ' A' ' 144' ' ' ILE . . . 78.38 30.83 48.44 Favored Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 121.223 -0.513 . . . . 0.17 113.915 179.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 49.5 t -103.85 115.3 63.63 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 118.224 1.012 . . . . 1.12 111.428 177.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.706 ' HD3' HG23 ' A' ' 15' ' ' ILE . 29.6 Cg_endo -66.58 117.93 5.13 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 123.44 2.76 . . . . 0.41 110.86 177.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 16.0 m -119.42 -9.83 11.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 120.704 0.287 . . . . 1.45 110.247 -176.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.832 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 18.3 mm-40 -145.13 166.57 25.02 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-N 115.749 -0.659 . . . . 1.17 110.659 175.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.54 HH11 ' HG2' ' A' ' 153' ' ' ARG . 0.0 OUTLIER -147.58 126.65 12.87 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.757 -1.11 . . . . 2.16 109.253 161.96 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.682 ' HZ ' ' HB2' ' A' ' 166' ' ' LYS . 91.1 m-85 -99.28 148.37 24.21 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.028 -0.987 . . . . 0.32 109.563 -174.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 16.1 m -88.19 149.4 44.99 Favored Pre-proline 0 C--N 1.311 -1.085 0 N-CA-C 109.234 -0.654 . . . . 1.11 109.234 -179.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.606 ' HG3' ' HB3' ' A' ' 137' ' ' TRP . 33.8 Cg_endo -64.29 96.02 0.22 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 121.841 1.694 . . . . 0.78 108.446 170.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 151.07 -17.3 0.92 Allowed Glycine 0 N--CA 1.433 -1.561 0 N-CA-C 109.019 -1.632 . . . . 0.5 109.019 -164.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.413 ' HB1' ' HB2' ' A' ' 162' ' ' ASP . . . -92.18 145.91 24.13 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.919 -1.141 . . . . 0.5 107.919 166.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.594 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 31.1 t -109.94 -178.23 3.47 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.895 -0.409 . . . . 1.42 109.895 -174.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.697 ' CG2' ' HA ' ' A' ' 56' ' ' THR . 57.8 t -41.44 -51.11 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.301 0 O-C-N 124.081 0.863 . . . . 0.28 110.732 178.139 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 7.6 tttm -60.62 -46.11 91.51 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.088 -0.96 . . . . 3.46 111.108 -174.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.413 ' HB2' ' HB1' ' A' ' 158' ' ' ALA . 42.0 m-20 -66.53 -30.64 71.0 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.912 -1.04 . . . . 1.4 110.333 -173.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.54 HD12 ' CG2' ' A' ' 56' ' ' THR . 60.1 mt -81.89 -45.23 20.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.674 -0.694 . . . . 0.21 111.25 177.009 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.609 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 52.3 mt-10 -53.96 -43.15 69.66 Favored 'General case' 0 C--O 1.215 -0.747 0 CA-C-O 120.907 0.384 . . . . 0.67 111.379 -177.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -59.15 -19.18 42.71 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 112.279 0.474 . . . . 0.87 112.279 -176.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.682 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 75.4 mmtt -103.17 -27.3 12.61 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.54 0.686 . . . . 1.71 109.948 173.04 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.609 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 13.7 tp -77.27 -50.86 11.94 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.95 -1.023 . . . . 0.16 112.409 -177.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.471 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 73.4 mt -54.33 -45.8 99.16 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 115.734 -0.666 . . . . 0.26 112.201 -174.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.471 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 82.2 Cg_exo -51.42 -29.48 31.26 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.343 2.029 . . . . 0.41 113.015 173.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.771 HD12 HD11 ' A' ' 143' ' ' LEU . 73.6 mt -88.81 -42.12 12.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.663 -0.244 . . . . 0.71 111.251 178.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.757 HD23 ' HG2' ' A' ' 37' ' ' PRO . 93.0 mt -60.37 -56.4 21.89 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-O 122.052 0.93 . . . . 0.34 109.649 175.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -64.52 -18.05 63.0 Favored Glycine 0 N--CA 1.436 -1.323 0 CA-C-N 113.385 -1.734 . . . . 1.12 112.106 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 21.8 t 63.09 73.86 0.44 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.37 0.605 . . . . 2.64 111.367 174.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -82.39 -21.18 35.94 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.659 -0.7 . . . . 4.35 110.127 174.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.429 ' HB3' HD12 ' A' ' 176' ' ' LEU . 4.6 mmp_? 66.53 -80.11 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.329 -0.85 . . . . 8.45 111.455 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.429 HD12 ' HB3' ' A' ' 175' ' ' ARG . 6.6 mp . . . . . 0 C--O 1.245 0.86 0 CA-C-O 118.661 -0.685 . . . . 7.69 109.283 178.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.642 ' N ' ' HG ' ' A' ' 13' ' ' SER . . . . . . . . 0 N--CA 1.482 1.704 0 N-CA-C 111.681 -0.567 . . . . 5.22 111.681 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 66.2 mtt -76.18 90.39 3.12 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.284 0.564 . . . . 4.85 110.006 178.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.06 43.91 1.98 Allowed Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.664 -0.698 . . . . 1.55 112.355 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.642 ' HG ' ' N ' ' A' ' 10' ' ' GLY . 3.4 p -111.11 15.28 21.68 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.348 0.594 . . . . 1.58 110.352 175.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 85.7 p 178.21 152.75 0.3 Allowed 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 105.708 -1.96 . . . . 1.17 105.708 -178.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.848 ' HB ' HD11 ' A' ' 118' ' ' LEU . 5.1 pt -64.63 -18.36 23.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-N 114.769 -1.105 . . . . 0.38 111.519 -176.297 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.85 ' HB3' HG13 ' A' ' 31' ' ' VAL . 36.5 m-85 -70.45 -7.75 45.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.946 -0.57 . . . . 0.3 111.871 -176.367 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -68.29 -17.43 64.27 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.385 -0.969 . . . . 2.11 108.385 175.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.697 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 55.9 m-85 -115.67 108.03 15.86 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 115.12 -0.945 . . . . 0.31 111.096 -176.361 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -45.8 144.01 1.89 Allowed 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 113.687 -1.597 . . . . 2.86 110.396 171.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.706 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 35.7 t -110.66 169.17 3.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 N-CA-C 107.485 -1.302 . . . . 0.67 107.485 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.851 ' HB2' ' HE1' ' A' ' 105' ' ' MET . 61.6 mt -132.12 123.22 26.69 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 118.538 0.608 . . . . 0.69 111.605 -177.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.516 ' N ' ' HB2' ' A' ' 28' ' ' TYR . 14.7 t70 -62.03 161.51 10.67 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.187 -1.412 . . . . 1.87 107.187 167.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.816 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . . . -52.88 -15.39 0.75 Allowed 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 114.793 1.405 . . . . 0.59 114.793 -165.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.56 ' HB2' ' HE2' ' A' ' 26' ' ' LYS . 38.2 m-20 -91.93 -2.33 56.84 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.417 0.525 . . . . 2.34 112.417 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.55 ' HB2' ' O ' ' A' ' 24' ' ' ASP . 67.4 m80 82.84 11.27 0.54 Allowed 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.59 0.71 . . . . 1.47 109.477 -177.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.56 ' HE2' ' HB2' ' A' ' 24' ' ' ASP . 17.5 mtmt -77.0 120.7 82.79 Favored Pre-proline 0 C--N 1.323 -0.575 0 N-CA-C 107.148 -1.427 . . . . 4.25 107.148 169.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.716 ' HA ' HD23 ' A' ' 21' ' ' LEU . 78.9 Cg_exo -49.42 114.32 1.27 Allowed 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 122.055 1.837 . . . . 0.54 113.062 -174.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.565 ' HB3' HG12 ' A' ' 20' ' ' VAL . 6.8 t80 -81.32 139.14 35.56 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 113.53 -1.668 . . . . 1.2 111.356 176.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.701 ' ND2' ' HB3' ' A' ' 32' ' ' GLN . 42.6 t30 -72.35 90.66 1.29 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.691 -1.141 . . . . 1.51 109.847 176.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.769 ' HG ' ' CD1' ' A' ' 16' ' ' PHE . 29.4 tp -70.65 -41.36 72.22 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.081 0.467 . . . . 0.28 109.949 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.85 HG13 ' HB3' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -63.47 0.64 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 115.181 -0.918 . . . . 1.02 113.054 -174.873 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.701 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . 3.6 pt20 -74.35 -7.18 51.99 Favored 'General case' 0 CA--C 1.509 -0.623 0 O-C-N 121.92 -0.488 . . . . 1.02 110.762 176.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.914 ' HB2' HD22 ' A' ' 38' ' ' LEU . 63.3 m-70 -104.98 30.16 5.76 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.697 0.761 . . . . 0.28 109.647 173.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.774 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 23.6 mtmt -86.23 110.39 19.58 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 114.81 -1.086 . . . . 1.56 109.599 172.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 128.48 -41.1 1.61 Allowed Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 111.204 -0.758 . . . . 0.2 111.204 -176.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.457 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 18.0 m -129.25 130.63 23.37 Favored Pre-proline 0 N--CA 1.436 -1.171 0 N-CA-C 109.139 -0.689 . . . . 0.29 109.139 171.483 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.802 ' HG2' HD23 ' A' ' 171' ' ' LEU . 5.4 Cg_endo -43.51 150.77 0.43 Allowed 'Trans proline' 0 CA--C 1.513 -0.528 0 C-N-CA 124.768 3.645 . . . . 0.18 113.522 178.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.914 HD22 ' HB2' ' A' ' 33' ' ' HIS . 1.2 pt? -130.13 149.0 52.03 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 107.491 -1.3 . . . . 0.31 107.491 174.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 1.005 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 1.5 mm? -111.35 112.46 24.23 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.329 -0.989 . . . . 1.19 108.329 174.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.868 HG23 ' HB2' ' A' ' 72' ' ' LEU . 4.2 mt -96.93 125.23 49.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 C-N-CA 119.98 -0.688 . . . . 0.37 110.369 177.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 1.005 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -109.98 123.03 48.92 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 116.245 -0.434 . . . . 0.42 109.967 -175.543 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.734 ' ND2' ' HB ' ' A' ' 135' ' ' ILE . 2.3 p-10 -81.21 94.07 6.61 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 107.696 -1.224 . . . . 2.35 107.696 170.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.859 ' O ' ' HA ' ' A' ' 75' ' ' PRO . 1.2 p -104.59 131.88 52.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 CA-C-N 115.262 -0.881 . . . . 1.03 111.626 -160.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -81.4 100.49 9.29 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 119.647 -0.821 . . . . 0.88 109.546 174.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . 1.051 ' HA ' ' HB2' ' A' ' 98' ' ' PHE . 23.1 p -12.85 -76.12 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 O-C-N 125.595 1.81 . . . . 1.78 114.037 172.2 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? 65.72 173.46 0.22 Allowed 'General case' 0 C--O 1.237 0.412 0 CA-C-O 122.191 0.996 . . . . 5.84 113.055 176.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.746 ' HB2' ' HA ' ' A' ' 95' ' ' CYS . 49.1 t -149.66 114.67 5.4 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 114.434 -1.257 . . . . 3.55 108.66 170.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.66 -2.33 86.01 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 120.879 -0.677 . . . . 2.91 114.076 176.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -144.31 133.74 23.29 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 117.964 0.882 . . . . 4.63 112.385 -177.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.456 ' CB ' ' HB2' ' A' ' 54' ' ' TYR . 15.0 t -137.15 149.14 47.09 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.338 -0.986 . . . . 1.93 108.338 170.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.608 ' HB3' ' HB2' ' A' ' 156' ' ' PRO . 30.7 ttmt -93.88 46.45 1.18 Allowed 'General case' 0 C--O 1.223 -0.339 0 CA-C-N 118.507 0.594 . . . . 2.01 109.984 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.16 -35.41 3.81 Favored Glycine 0 CA--C 1.516 0.116 0 C-N-CA 120.934 -0.651 . . . . 0.51 112.307 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -41.57 -43.57 3.94 Favored Glycine 0 C--O 1.223 -0.547 0 O-C-N 124.013 0.478 . . . . 0.5 113.791 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.551 ' HA ' ' CZ ' ' A' ' 139' ' ' PHE . 0.1 OUTLIER -59.48 -60.12 4.36 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.739 0.269 . . . . 0.7 111.634 -174.852 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -60.86 -34.72 75.03 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.347 0.594 . . . . 2.61 109.632 -176.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.672 ' OG1' ' HA ' ' A' ' 159' ' ' SER . 72.1 m -62.63 -59.64 4.64 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.699 -1.137 . . . . 0.33 110.1 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 1.094 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -60.55 -49.28 78.18 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.042 -0.981 . . . . 0.22 111.424 -177.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.649 ' N ' ' HE1' ' A' ' 102' ' ' PHE . 37.6 m -55.15 -51.95 64.83 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.464 0.649 . . . . 0.26 110.479 -177.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.497 ' HA ' ' ND2' ' A' ' 62' ' ' ASN . 29.7 m -71.03 -31.8 68.38 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.264 -0.88 . . . . 0.48 111.442 -176.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.708 HD21 ' HG3' ' A' ' 164' ' ' GLU . 14.6 mt -71.91 -50.74 26.6 Favored 'General case' 0 CA--C 1.494 -1.186 0 CA-C-O 120.924 0.392 . . . . 0.43 110.6 -177.15 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.81 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 3.0 t80 -51.47 -60.34 3.24 Favored 'General case' 0 C--O 1.203 -1.374 0 CA-C-N 114.645 -1.161 . . . . 0.31 109.752 178.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 1.046 ' HA ' ' HG3' ' A' ' 65' ' ' LYS . 4.3 p30 -70.06 -24.55 63.26 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 121.11 -0.236 . . . . 1.21 111.006 -171.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.519 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 35.3 ttpt -76.48 -21.31 55.99 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.184 -1.043 . . . . 1.54 108.184 -177.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.783 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 65.4 m-85 -130.12 10.13 5.35 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 114.679 1.363 . . . . 0.31 114.679 -176.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 1.046 ' HG3' ' HA ' ' A' ' 62' ' ' ASN . 27.9 mtmt -54.11 -38.29 65.25 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 106.588 -1.634 . . . . 1.35 106.588 169.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -48.5 -42.17 32.19 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 111.697 -2.501 . . . . 1.28 112.908 -177.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -85.06 -36.3 21.3 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.671 -0.412 . . . . 1.11 111.751 177.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.456 ' HA3' ' HB2' ' A' ' 36' ' ' SER . . . 147.38 -5.73 1.03 Allowed Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 110.829 -0.909 . . . . 0.18 110.829 -176.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.783 ' HD2' ' HB2' ' A' ' 64' ' ' TYR . 17.1 t80 -66.9 139.25 57.72 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 114.951 -0.625 . . . . 0.18 110.973 -177.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.901 HG22 ' HB2' ' A' ' 38' ' ' LEU . 1.6 t -132.82 149.51 52.26 Favored 'General case' 0 N--CA 1.414 -2.238 0 N-CA-C 108.653 -0.869 . . . . 0.2 108.653 172.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 1.094 HG11 ' HB1' ' A' ' 57' ' ' ALA . 29.7 t -102.7 101.52 12.28 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.23 0 N-CA-C 108.058 -1.089 . . . . 0.17 108.058 160.051 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.868 ' HB2' HG23 ' A' ' 40' ' ' ILE . 66.1 mt -84.67 119.65 25.49 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 108.218 -1.03 . . . . 1.04 108.218 178.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.741 ' HB1' HG11 ' A' ' 43' ' ' VAL . . . -100.39 112.32 24.66 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 121.328 0.585 . . . . 0.51 111.632 -178.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.843 ' CG ' ' HG2' ' A' ' 105' ' ' MET . 2.9 m-85 -103.59 95.17 6.91 Favored Pre-proline 0 C--N 1.316 -0.872 0 N-CA-C 109.275 -0.639 . . . . 0.44 109.275 176.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.859 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 76.3 Cg_endo -83.5 95.75 0.78 Allowed 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.249 1.966 . . . . 1.3 113.84 -169.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.774 ' HB2' HG23 ' A' ' 110' ' ' VAL . 47.4 t -39.11 132.92 1.27 Allowed 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 121.865 0.84 . . . . 1.44 112.628 -176.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.603 ' HB2' ' HD2' ' A' ' 79' ' ' PHE . 21.3 p-10 -74.92 106.27 6.35 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-N 114.451 -1.25 . . . . 1.81 107.888 176.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 1.065 ' HA ' ' HG2' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -49.12 -9.69 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 113.95 -1.477 . . . . 3.34 112.088 173.886 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.603 ' HD2' ' HB2' ' A' ' 77' ' ' ASN . 72.7 m-85 -76.4 31.97 0.12 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 114.438 1.273 . . . . 2.68 114.438 -165.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.513 ' HA3' HE22 ' A' ' 82' ' ' GLN . . . -135.13 -77.55 0.09 OUTLIER Glycine 0 CA--C 1.518 0.228 0 C-N-CA 119.443 -1.36 . . . . 1.98 113.838 -179.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 142.95 16.3 0.28 Allowed Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.335 -0.706 . . . . 1.49 111.335 -171.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.726 ' HG3' ' HB3' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -139.46 13.07 2.56 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 110.125 -0.324 . . . . 1.74 110.125 -173.465 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 1.065 ' HG2' ' HA ' ' A' ' 78' ' ' GLN . 2.9 mp0 -63.43 152.42 85.38 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.413 -0.812 . . . . 3.07 110.387 -173.235 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.574 ' HB2' ' N ' ' A' ' 137' ' ' TRP . 55.2 Cg_endo -84.48 128.37 4.04 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.317 2.678 . . . . 1.75 112.452 -175.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.408 ' CA ' ' HA ' ' A' ' 137' ' ' TRP . . . 97.99 -62.39 0.92 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.795 -0.717 . . . . 2.2 113.642 172.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -133.9 101.65 5.15 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.83 -0.433 . . . . 4.2 109.83 -177.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -86.62 32.29 0.66 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.94 -0.573 . . . . 3.02 111.459 -171.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.84 ' HA ' ' HD3' ' A' ' 91' ' ' LYS . 8.5 tp10 -166.84 -32.42 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 112.149 0.426 . . . . 3.92 112.149 178.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.532 ' O ' ' HB3' ' A' ' 93' ' ' PHE . 35.4 tt0 -56.2 -30.23 62.01 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.541 0.571 . . . . 2.65 112.541 -174.024 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.672 ' HA ' ' SG ' ' A' ' 95' ' ' CYS . 2.1 pt -99.18 4.32 10.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.211 0.529 . . . . 2.15 111.631 -178.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.84 ' HD3' ' HA ' ' A' ' 88' ' ' GLU . 11.4 mtpp -114.28 -50.81 2.79 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.878 -0.601 . . . . 2.79 110.205 -175.105 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 88' ' ' GLU . 15.8 pt-20 -72.98 -22.76 60.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.94 -0.573 . . . . 3.29 110.076 176.121 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.532 ' HB3' ' O ' ' A' ' 89' ' ' GLU . 34.0 t80 -118.08 145.7 44.66 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.605 -0.725 . . . . 3.42 110.117 -174.384 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 49.4 t -67.37 122.23 18.06 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.467 0 CA-C-O 121.273 0.559 . . . . 2.63 110.442 176.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.746 ' HA ' ' HB2' ' A' ' 47' ' ' CYS . 84.7 m -131.96 128.82 39.25 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 115.413 -0.812 . . . . 2.83 110.426 178.088 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.567 ' O ' ' HB2' ' A' ' 45' ' ' SER . 31.2 p -52.58 148.84 6.53 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 114.992 -1.003 . . . . 2.98 108.904 171.083 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -73.74 31.08 0.08 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.987 0.422 . . . . 2.72 110.972 -177.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 1.051 ' HB2' ' HA ' ' A' ' 45' ' ' SER . 55.6 t80 57.11 104.41 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.554 -1.203 . . . . 2.12 111.893 -175.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.433 ' HA ' ' CD1' ' A' ' 104' ' ' ILE . 33.7 ttpt -128.83 138.05 51.84 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.485 -0.561 . . . . 2.69 109.485 173.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.453 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . -160.59 -158.49 0.61 Allowed 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 121.124 0.488 . . . . 0.55 111.546 -168.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -99.76 21.28 12.7 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.47 -0.786 . . . . 1.99 111.925 -178.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.816 ' HE2' ' CZ ' ' A' ' 98' ' ' PHE . 0.4 OUTLIER -109.43 177.8 1.17 Allowed Pre-proline 0 CA--C 1.511 -0.528 0 CA-C-O 121.317 0.579 . . . . 0.84 110.131 177.037 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.693 ' HD3' ' CE2' ' A' ' 61' ' ' TYR . 6.6 Cg_exo -80.81 76.16 4.66 Favored 'Trans proline' 0 N--CA 1.445 -1.37 0 C-N-CA 123.94 3.093 . . . . 0.62 110.003 162.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.654 HG12 ' HB3' ' A' ' 73' ' ' ALA . 34.8 mt -74.55 138.01 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 107.288 -1.375 . . . . 1.34 107.288 176.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.851 ' HE1' ' HB2' ' A' ' 21' ' ' LEU . 1.1 ppp? -96.62 -171.62 2.31 Favored 'General case' 0 N--CA 1.434 -1.255 0 C-N-CA 120.229 -0.588 . . . . 3.03 112.093 -170.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.816 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . . . -64.97 -7.69 12.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.417 -0.81 . . . . 1.46 112.194 -178.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.838 ' HB2' ' O ' ' A' ' 75' ' ' PRO . 3.9 ptpp? 66.04 133.72 0.02 OUTLIER 'General case' 0 CA--C 1.498 -1.036 0 C-N-CA 125.29 1.436 . . . . 1.76 110.702 -168.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.745 HG13 ' HB2' ' A' ' 116' ' ' HIS . 0.2 OUTLIER -135.78 171.54 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.857 0 CA-C-N 113.554 -1.657 . . . . 0.82 107.468 170.176 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.662 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 4.9 m120 -64.83 64.18 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 114.946 -1.025 . . . . 1.73 112.916 178.144 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.774 HG23 ' HB2' ' A' ' 76' ' ' SER . 3.2 m -71.4 95.99 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 117.857 -1.537 . . . . 0.77 107.867 172.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.554 ' HB2' ' O ' ' A' ' 82' ' ' GLN . 25.3 p30 178.47 179.9 0.34 Allowed 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 113.601 -1.636 . . . . 1.9 108.065 -169.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -86.89 11.44 64.61 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 119.927 -1.13 . . . . 1.47 115.164 -170.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.726 ' HB3' ' HG3' ' A' ' 82' ' ' GLN . 3.3 pt-20 -104.52 -44.6 4.86 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 119.492 1.646 . . . . 2.81 112.438 -178.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.482 ' N ' ' HG3' ' A' ' 113' ' ' GLU . 6.3 m-20 -130.03 -36.34 1.55 Allowed 'General case' 0 CA--C 1.508 -0.667 0 O-C-N 121.792 -0.567 . . . . 2.16 110.5 -175.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.662 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . 52.46 -146.46 0.51 Allowed 'General case' 0 N--CA 1.444 -0.771 0 O-C-N 123.74 0.65 . . . . 1.26 109.251 -177.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.745 ' HB2' HG13 ' A' ' 108' ' ' ILE . 1.6 t-80 -160.5 139.38 7.73 Favored Pre-proline 0 N--CA 1.431 -1.412 0 N-CA-C 107.703 -1.221 . . . . 0.42 107.703 176.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -28.4 -49.92 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 124.683 3.589 . . . . 0.4 113.792 -178.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.848 HD11 ' HB ' ' A' ' 15' ' ' ILE . 48.0 tp -61.14 -51.6 68.4 Favored 'General case' 0 C--O 1.22 -0.468 0 C-N-CA 122.745 0.418 . . . . 0.39 111.787 178.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.688 ' HA ' ' HB2' ' A' ' 122' ' ' MET . 29.7 m-85 -76.53 -33.68 58.57 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 112.489 0.551 . . . . 3.04 112.489 -179.169 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.566 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 42.5 mt-10 -60.49 -34.92 74.76 Favored 'General case' 0 CA--C 1.491 -1.325 0 N-CA-C 107.121 -1.437 . . . . 2.44 107.121 171.395 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.697 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 45.0 t80 -69.48 -34.22 74.03 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 119.262 -0.975 . . . . 0.56 110.234 173.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.688 ' HB2' ' HA ' ' A' ' 119' ' ' TYR . 40.4 mtt -74.86 -52.23 11.87 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.89 -0.595 . . . . 0.71 112.057 -169.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.422 ' HB2' ' HE2' ' A' ' 123' ' ' LYS . 0.2 OUTLIER -69.56 -24.44 63.71 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 120.366 -0.534 . . . . 1.46 109.853 176.863 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.566 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 17.0 tttt -65.58 -38.15 88.7 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.248 -0.433 . . . . 1.99 110.309 170.186 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 36.2 m -65.43 -61.23 2.23 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.936 -0.574 . . . . 0.59 111.426 -176.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.495 ' HD2' ' O ' ' A' ' 151' ' ' VAL . 36.8 ttmt -140.64 127.74 12.12 Favored Pre-proline 0 C--N 1.33 -0.269 0 N-CA-C 109.957 -0.386 . . . . 1.85 109.957 177.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 126' ' ' LYS . 27.4 Cg_exo -64.06 1.64 1.45 Allowed 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 123.743 2.962 . . . . 1.69 114.085 -178.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 81.84 70.73 1.33 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 121.164 -0.541 . . . . 2.59 113.545 170.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 76.7 mt 73.31 -57.76 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 122.823 0.449 . . . . 3.58 111.241 177.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 38.6 tp -104.18 151.04 23.81 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.736 0.303 . . . . 3.47 110.242 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -78.58 60.89 2.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.936 0.398 . . . . 3.28 111.165 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.444 ' HB ' ' H ' ' A' ' 133' ' ' LYS . 5.2 m -98.26 -100.86 0.21 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.508 -0.314 . . . . 3.56 110.453 178.335 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.444 ' H ' ' HB ' ' A' ' 132' ' ' THR . 50.4 mttp -161.9 -87.98 0.03 OUTLIER 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.746 0.784 . . . . 5.17 110.916 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -103.45 164.65 11.52 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.978 -1.01 . . . . 1.59 112.366 -167.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.875 ' H ' HD13 ' A' ' 135' ' ' ILE . 0.1 OUTLIER -64.69 46.68 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-N 113.862 -1.517 . . . . 2.0 110.998 169.119 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.506 ' HA ' ' HB3' ' A' ' 84' ' ' PRO . 9.2 tmtt? -75.75 44.34 0.29 Allowed 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.382 0.611 . . . . 4.81 112.497 -167.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.574 ' N ' ' HB2' ' A' ' 84' ' ' PRO . 6.4 m-90 -136.46 174.29 10.77 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.509 -0.552 . . . . 1.97 109.509 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.494 ' N ' HD22 ' A' ' 138' ' ' ASN . 0.9 OUTLIER -45.26 -153.93 0.0 OUTLIER 'General case' 0 C--O 1.209 -1.029 0 C-N-CA 123.846 0.859 . . . . 2.04 111.163 162.342 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.649 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 2.0 m-85 -27.5 -48.89 0.04 OUTLIER 'General case' 0 C--O 1.21 -0.983 0 N-CA-C 115.239 1.57 . . . . 1.93 115.239 -169.171 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.703 ' HB ' ' ND2' ' A' ' 42' ' ' ASN . 8.6 m 39.17 108.46 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 122.746 1.26 . . . . 0.6 113.84 173.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.69 ' HB3' HD12 ' A' ' 39' ' ' LEU . 1.4 m -100.64 165.25 11.49 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 114.811 -1.086 . . . . 0.62 110.014 -170.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.624 ' HA ' ' HA ' ' A' ' 153' ' ' ARG . 28.4 m-85 -128.38 125.96 39.7 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 105.916 -1.883 . . . . 0.57 105.916 163.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.851 HD11 HD12 ' A' ' 170' ' ' LEU . 1.6 tp -81.17 104.11 11.43 Favored 'General case' 0 C--N 1.288 -2.103 0 C-N-CA 118.565 -1.254 . . . . 0.43 108.563 178.078 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.685 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 28.3 mm -92.65 136.89 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.992 0 CA-C-N 113.097 -1.865 . . . . 0.19 107.592 -178.168 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.576 ' HA ' HD13 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -90.85 -174.18 3.95 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 119.704 -0.798 . . . . 0.98 111.52 -170.793 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.724 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 41.0 mtt85 -55.81 -40.19 72.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.015 -0.539 . . . . 2.22 111.109 -177.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.5 18.01 16.33 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.668 0.747 . . . . 2.0 109.085 -177.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.647 ' HA3' ' CE2' ' A' ' 16' ' ' PHE . . . 73.6 32.69 59.19 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 114.805 -1.089 . . . . 0.17 114.853 177.021 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.402 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 58.3 t -93.93 126.49 48.98 Favored Pre-proline 0 C--N 1.314 -0.962 0 CA-C-N 118.235 1.018 . . . . 1.12 110.72 175.005 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.47 ' HA ' HD13 ' A' ' 144' ' ' ILE . 12.2 Cg_endo -78.22 105.13 1.94 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.898 2.399 . . . . 0.41 110.073 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.495 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 4.6 t -93.94 -72.21 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 106.603 -1.628 . . . . 1.45 106.603 -178.051 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.816 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 0.3 OUTLIER -88.96 164.69 15.0 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 114.4 -1.273 . . . . 1.17 111.18 -177.476 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.836 ' HD3' HG22 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -135.36 150.97 50.06 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 113.009 -1.905 . . . . 2.16 107.136 156.219 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.556 ' O ' ' HA ' ' A' ' 140' ' ' THR . 92.2 m-85 -125.46 145.44 50.08 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 108.442 -0.947 . . . . 0.32 108.442 -171.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.413 ' OG ' ' HD2' ' A' ' 156' ' ' PRO . 21.2 t -72.34 154.37 91.94 Favored Pre-proline 0 C--N 1.315 -0.918 0 N-CA-C 108.375 -0.972 . . . . 1.11 108.375 174.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.608 ' HB2' ' HB3' ' A' ' 51' ' ' LYS . 9.6 Cg_endo -51.45 -41.49 59.66 Favored 'Trans proline' 0 CA--C 1.519 -0.259 0 C-N-CA 122.185 1.923 . . . . 0.78 111.126 174.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -58.71 -19.35 42.42 Favored Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 114.645 -1.161 . . . . 0.5 113.725 176.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -70.62 136.41 49.13 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 109.005 -0.739 . . . . 0.5 109.005 177.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.672 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 19.8 m -108.46 -178.35 3.57 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 120.776 0.322 . . . . 1.42 110.705 -170.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.619 HG22 ' HA ' ' A' ' 56' ' ' THR . 46.7 t -44.8 -50.41 2.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 114.927 -1.033 . . . . 0.28 111.313 -178.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 26.0 tttm -64.75 -39.6 93.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.041 -0.527 . . . . 3.46 111.205 -176.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.512 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 32.7 m-20 -68.64 -39.54 80.69 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.52 -0.764 . . . . 1.4 109.632 -172.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.563 HD13 ' OH ' ' A' ' 41' ' ' TYR . 54.1 mt -75.1 -43.7 44.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 114.953 -1.021 . . . . 0.21 110.78 177.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.718 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 28.1 mt-10 -56.42 -39.9 73.82 Favored 'General case' 0 C--O 1.217 -0.624 0 N-CA-C 111.973 0.36 . . . . 0.67 111.973 -177.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.512 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 10.0 pt-20 -61.34 -23.91 66.08 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.673 -0.411 . . . . 0.87 111.249 -176.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.556 ' HB3' HD22 ' A' ' 143' ' ' LEU . 72.3 mmtt -99.08 -14.82 19.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.623 0.725 . . . . 1.71 109.759 175.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.718 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 12.8 tp -92.8 -51.91 4.86 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.059 -0.973 . . . . 0.16 112.385 -174.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.511 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 78.1 mt -53.03 -48.59 91.35 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.541 -0.754 . . . . 0.26 112.901 -171.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.511 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 74.2 Cg_exo -52.69 -33.9 61.66 Favored 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 121.974 1.783 . . . . 0.41 112.321 176.161 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.851 HD12 HD11 ' A' ' 143' ' ' LEU . 93.1 mt -77.18 -46.68 22.52 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 116.016 -0.538 . . . . 0.71 110.75 178.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.802 HD23 ' HG2' ' A' ' 37' ' ' PRO . 89.5 mt -58.33 -56.67 19.11 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 121.66 0.743 . . . . 0.34 110.37 177.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -49.31 -33.8 16.86 Favored Glycine 0 N--CA 1.437 -1.265 0 CA-C-N 113.688 -1.597 . . . . 1.12 112.819 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 33.7 m 58.01 48.11 13.75 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 112.234 0.457 . . . . 2.64 112.234 173.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -75.8 -36.31 59.77 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.361 -0.607 . . . . 4.35 109.361 172.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 53.9 mtm180 68.27 -65.46 0.26 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 114.559 -1.201 . . . . 8.45 112.291 174.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 92.3 mt . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.753 -0.641 . . . . 7.69 110.062 -179.817 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.579 0 N-CA-C 111.772 -0.531 . . . . 5.22 111.772 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 65.1 mtt -93.58 -28.32 16.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.203 0.525 . . . . 4.85 110.025 178.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -88.36 133.94 12.12 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.589 -0.732 . . . . 1.55 111.855 179.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.3 p -111.03 -24.45 10.34 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.467 0.651 . . . . 1.58 109.543 178.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.532 ' HB3' ' O ' ' A' ' 147' ' ' ASP . 1.4 m -153.53 169.22 23.74 Favored 'General case' 0 N--CA 1.427 -1.575 0 N-CA-C 105.107 -2.182 . . . . 1.17 105.107 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.864 HD12 HD21 ' A' ' 30' ' ' LEU . 5.0 pt -61.55 -21.82 26.42 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.16 0 CA-C-O 121.777 0.799 . . . . 0.38 109.566 172.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.95 ' HB3' HG12 ' A' ' 31' ' ' VAL . 25.0 m-85 -70.6 -7.4 43.85 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.848 1.055 . . . . 0.3 113.848 -172.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -77.85 -5.32 50.52 Favored 'General case' 0 CA--C 1.502 -0.865 0 N-CA-C 107.951 -1.129 . . . . 2.11 107.951 178.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.795 ' HE2' ' HB2' ' A' ' 121' ' ' TYR . 41.9 m-85 -120.06 112.02 18.61 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 114.313 -1.312 . . . . 0.31 110.204 -175.419 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.92 149.52 2.63 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 113.521 -1.672 . . . . 2.86 110.632 174.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.798 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 35.6 t -112.12 158.62 12.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 107.874 -1.158 . . . . 0.67 107.874 174.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.9 ' O ' ' HB3' ' A' ' 105' ' ' MET . 96.0 mt -126.88 109.04 11.55 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 119.183 -0.437 . . . . 0.69 110.87 -174.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 17.0 t70 -46.81 158.0 0.14 Allowed 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 107.972 -1.121 . . . . 1.87 107.972 170.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.631 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . . . -53.79 -10.32 0.29 Allowed 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 113.251 0.834 . . . . 0.59 113.251 -167.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.539 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 25.9 t0 -93.46 -6.16 47.57 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 122.943 0.497 . . . . 2.34 111.899 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.539 ' HB2' ' O ' ' A' ' 24' ' ' ASP . 61.6 m80 82.38 24.5 0.19 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.77 0.795 . . . . 1.47 109.206 -177.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.414 ' HA ' ' HD3' ' A' ' 26' ' ' LYS . 27.2 mmtt -106.74 125.69 32.1 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 114.307 -1.315 . . . . 4.25 108.362 176.202 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.619 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 73.0 Cg_exo -52.67 114.7 1.81 Allowed 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.329 2.019 . . . . 0.54 114.561 -167.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.737 ' HE2' HD23 ' A' ' 72' ' ' LEU . 6.9 t80 -81.76 128.06 33.6 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 113.391 -1.732 . . . . 1.2 109.285 165.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.462 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 0.4 OUTLIER -74.63 91.55 2.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 122.341 1.067 . . . . 1.51 110.976 -179.887 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.864 HD21 HD12 ' A' ' 15' ' ' ILE . 52.2 tp -58.0 -36.21 72.33 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.009 -0.996 . . . . 0.28 110.589 -178.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.95 HG12 ' HB3' ' A' ' 16' ' ' PHE . 3.6 m -66.75 -1.22 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 114.768 -1.105 . . . . 1.02 113.178 -172.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.462 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 18.3 pt20 -77.2 -15.28 59.56 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 119.406 -0.917 . . . . 1.02 109.542 175.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.989 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 95.9 m-70 -86.83 27.86 0.95 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.959 0.885 . . . . 0.28 109.6 174.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 45.7 mttm -80.7 124.32 28.93 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 114.275 -1.33 . . . . 1.56 109.747 172.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.96 -40.06 2.68 Favored Glycine 0 N--CA 1.438 -1.22 0 C-N-CA 120.671 -0.776 . . . . 0.2 112.045 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.497 ' HB2' ' HA3' ' A' ' 68' ' ' GLY . 16.7 m -124.28 126.52 25.51 Favored Pre-proline 0 N--CA 1.435 -1.221 0 N-CA-C 108.689 -0.856 . . . . 0.29 108.689 175.366 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.832 ' HG3' ' CB ' ' A' ' 170' ' ' LEU . 2.9 Cg_endo -42.67 157.34 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 124.271 3.314 . . . . 0.18 113.015 176.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.814 ' HB2' HG22 ' A' ' 70' ' ' THR . 0.8 OUTLIER -145.08 143.36 30.38 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 107.575 -1.269 . . . . 0.31 107.575 -177.386 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 1.051 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 1.9 mm? -108.08 114.03 27.63 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.014 -0.735 . . . . 1.19 109.014 178.256 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.68 HG23 HD13 ' A' ' 72' ' ' LEU . 1.2 mt -96.23 125.61 49.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 C-N-CA 120.422 -0.511 . . . . 0.37 110.087 177.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 1.051 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.6 OUTLIER -107.07 133.09 52.22 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 120.449 -0.501 . . . . 0.42 110.254 -176.684 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.647 HD22 ' N ' ' A' ' 42' ' ' ASN . 0.3 OUTLIER -92.38 91.91 7.88 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 105.526 -2.027 . . . . 2.35 105.526 174.396 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.765 HG11 ' HB1' ' A' ' 73' ' ' ALA . 2.8 p -107.91 131.82 57.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 112.813 0.672 . . . . 1.03 112.813 -160.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -81.06 100.91 9.25 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.579 -0.737 . . . . 0.88 109.285 169.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.766 ' HA ' ' HB3' ' A' ' 98' ' ' PHE . 4.3 p -22.02 100.52 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 O-C-N 125.197 1.56 . . . . 1.78 112.692 175.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -63.49 109.73 1.73 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.641 -1.163 . . . . 5.84 112.373 -171.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 26.2 p -118.93 114.92 23.32 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.054 -1.091 . . . . 3.55 108.054 165.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.85 -58.23 0.99 Allowed Glycine 0 CA--C 1.526 0.745 0 C-N-CA 120.902 -0.666 . . . . 2.91 113.557 -177.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -93.35 110.96 22.5 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.233 0.54 . . . . 4.63 112.315 -170.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.8 t -115.58 132.79 56.52 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.081 -1.081 . . . . 1.93 108.081 169.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.707 ' O ' ' HA2' ' A' ' 157' ' ' GLY . 28.3 mtpp -90.28 13.0 16.47 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 121.877 -0.515 . . . . 2.01 110.972 -178.013 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.561 ' O ' ' HG2' ' A' ' 55' ' ' GLU . . . 105.01 -29.2 12.1 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.675 -0.774 . . . . 0.51 111.397 -177.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -56.52 -24.91 48.57 Favored Glycine 0 C--O 1.222 -0.623 0 CA-C-O 119.792 -0.449 . . . . 0.5 113.326 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.603 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 0.4 OUTLIER -61.09 -60.94 2.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.509 0.654 . . . . 0.7 110.298 179.167 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.561 ' HG2' ' O ' ' A' ' 52' ' ' GLY . 11.9 pt-20 -63.28 -21.21 66.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.647 -0.706 . . . . 2.61 110.349 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.671 ' HA ' HG22 ' A' ' 160' ' ' VAL . 54.1 m -73.01 -59.93 2.47 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.065 -0.971 . . . . 0.33 109.617 178.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 1.097 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -60.66 -42.04 96.23 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.552 -1.204 . . . . 0.22 110.876 -178.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.557 ' HA ' ' CD1' ' A' ' 102' ' ' PHE . 85.7 m -57.18 -57.31 13.16 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.541 -0.754 . . . . 0.26 110.471 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 22.7 m -70.6 -33.26 70.85 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.474 -0.784 . . . . 0.48 111.694 -174.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.77 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 18.7 mt -65.07 -47.67 76.48 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-O 121.435 0.636 . . . . 0.43 110.321 -178.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.863 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 10.0 t80 -59.7 -49.73 76.58 Favored 'General case' 0 C--O 1.205 -1.262 0 CA-C-N 114.757 -1.11 . . . . 0.31 111.045 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -72.35 -24.34 61.27 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 120.658 0.266 . . . . 1.21 110.659 -173.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.641 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 35.3 ttpt -85.76 -25.13 26.57 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 109.338 -0.616 . . . . 1.54 109.338 -178.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.822 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 32.5 m-85 -124.07 -6.74 7.78 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 115.491 1.663 . . . . 0.31 115.491 -169.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.693 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 3.8 ptmt -64.96 -26.99 68.53 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 108.004 -1.11 . . . . 1.35 108.004 170.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.6 t -47.63 -34.02 7.45 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.022 -1.444 . . . . 1.28 110.526 173.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.425 ' OE1' ' HB3' ' A' ' 171' ' ' LEU . 47.7 mt-30 -90.43 -39.65 12.51 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.681 0.277 . . . . 1.11 111.218 174.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.497 ' HA3' ' HB2' ' A' ' 36' ' ' SER . . . 151.81 -3.53 0.42 Allowed Glycine 0 CA--C 1.52 0.386 0 N-CA-C 111.23 -0.748 . . . . 0.18 111.23 -177.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.822 ' HD2' ' HB2' ' A' ' 64' ' ' TYR . 20.7 t80 -70.31 140.64 52.31 Favored 'General case' 0 C--O 1.218 -0.595 0 C-N-CA 123.029 0.532 . . . . 0.18 111.544 -177.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.989 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 2.2 t -134.49 145.57 48.92 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 108.818 -0.808 . . . . 0.2 108.818 174.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 1.097 HG11 ' HB1' ' A' ' 57' ' ' ALA . 42.8 t -104.94 99.99 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.257 0 N-CA-C 108.359 -0.978 . . . . 0.17 108.359 160.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.774 HD12 ' H ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -96.51 120.97 37.79 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 118.842 -1.143 . . . . 1.04 108.044 174.422 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.765 ' HB1' HG11 ' A' ' 43' ' ' VAL . . . -108.16 128.69 54.92 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 116.214 -0.448 . . . . 0.51 110.0 179.002 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.907 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 2.6 m-30 -102.43 105.62 44.59 Favored Pre-proline 0 C--N 1.312 -1.056 0 N-CA-C 108.162 -1.051 . . . . 0.44 108.162 175.197 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.914 ' HG2' ' HB3' ' A' ' 107' ' ' LYS . 59.7 Cg_endo -74.8 68.04 5.64 Favored 'Trans proline' 0 N--CA 1.474 0.324 0 C-N-CA 123.545 2.83 . . . . 1.3 114.98 -168.325 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.402 ' HB3' ' CG2' ' A' ' 110' ' ' VAL . 85.3 p 2.47 132.22 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 126.978 2.111 . . . . 1.44 116.542 178.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.444 ' C ' ' H ' ' A' ' 79' ' ' PHE . 0.7 OUTLIER -87.71 75.09 9.03 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 123.287 1.518 . . . . 1.81 107.056 178.045 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.776 ' HG3' HG13 ' A' ' 90' ' ' ILE . 77.0 mm-40 -51.97 -13.83 0.34 Allowed 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 113.733 -1.576 . . . . 3.34 110.151 175.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.444 ' H ' ' C ' ' A' ' 77' ' ' ASN . 99.0 m-85 -71.26 -14.86 62.37 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.555 -1.202 . . . . 2.68 110.871 -179.25 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.98 -46.93 12.3 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 111.552 -0.619 . . . . 1.98 111.552 175.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 106.88 29.32 4.68 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.966 -0.635 . . . . 1.49 113.848 175.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.848 ' HG3' ' HG2' ' A' ' 113' ' ' GLU . 4.3 pm0 -132.23 -18.23 2.6 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 122.448 -0.442 . . . . 1.74 111.187 173.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.435 ' HB2' ' CD ' ' A' ' 78' ' ' GLN . 4.2 mm-40 -61.45 150.61 80.08 Favored Pre-proline 0 C--N 1.315 -0.907 0 CA-C-N 115.26 -0.882 . . . . 3.07 112.221 -163.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 110' ' ' VAL . 53.1 Cg_endo -71.55 134.49 24.39 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 123.784 2.989 . . . . 1.75 114.871 -161.152 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 77.11 -85.96 1.0 Allowed Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.021 -0.99 . . . . 2.2 113.186 173.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.627 ' HB3' ' CB ' ' A' ' 89' ' ' GLU . 18.1 m120 -85.62 52.3 2.42 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.892 0.377 . . . . 4.2 111.319 -171.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.451 ' HA ' ' OE1' ' A' ' 78' ' ' GLN . 34.4 tt0 -57.74 -50.37 73.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.983 -0.553 . . . . 3.02 111.165 -178.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.506 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 39.3 mm-40 -77.43 -27.08 52.11 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.163 -0.471 . . . . 3.92 111.757 -178.435 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.627 ' CB ' ' HB3' ' A' ' 86' ' ' ASN . 10.6 tp10 -54.11 -61.61 2.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.659 -0.7 . . . . 2.65 111.978 -171.214 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.776 HG13 ' HG3' ' A' ' 78' ' ' GLN . 22.7 mm -73.88 -11.6 14.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.737 -0.665 . . . . 2.15 112.034 -167.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.506 ' HE2' ' HA ' ' A' ' 88' ' ' GLU . 49.9 mtmt -85.36 -42.11 14.86 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.375 -0.375 . . . . 2.79 111.026 -179.188 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -100.44 -24.21 14.55 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 111.742 0.275 . . . . 3.29 111.742 -176.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -89.74 162.62 15.46 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.82 -0.352 . . . . 3.42 110.166 177.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.4 t -81.24 111.21 17.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.933 -0.576 . . . . 2.63 110.178 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.689 ' SG ' ' HA ' ' A' ' 90' ' ' ILE . 1.2 m -139.71 121.8 15.75 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 121.48 0.657 . . . . 2.83 111.326 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.9 p -84.7 160.54 20.31 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 107.461 -1.311 . . . . 2.98 107.461 163.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -61.94 106.7 0.74 Allowed 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 107.884 -1.154 . . . . 2.72 107.884 174.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.766 ' HB3' ' HA ' ' A' ' 45' ' ' SER . 0.0 OUTLIER -45.93 117.07 1.38 Allowed 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 115.121 -0.945 . . . . 2.12 110.548 -173.237 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.446 ' HA ' HD12 ' A' ' 104' ' ' ILE . 35.1 ttmt -108.98 146.58 33.65 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.749 -0.659 . . . . 2.69 109.637 178.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.566 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . -147.71 -165.58 2.29 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-O 121.048 0.451 . . . . 0.55 111.386 -172.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -91.6 26.52 2.3 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.435 -0.802 . . . . 1.99 110.437 176.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.577 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 25.9 p90 -146.76 155.76 48.29 Favored Pre-proline 0 N--CA 1.441 -0.886 0 N-CA-C 108.712 -0.847 . . . . 0.84 108.712 175.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.686 ' HG2' ' HA ' ' A' ' 72' ' ' LEU . 35.9 Cg_endo -60.25 88.97 0.08 OUTLIER 'Trans proline' 0 CA--C 1.513 -0.53 0 C-N-CA 124.638 3.559 . . . . 0.62 114.137 -171.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.66 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 18.3 mt -100.6 126.78 54.16 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.348 0 N-CA-C 107.631 -1.248 . . . . 1.34 107.631 174.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.907 ' HG3' ' CE1' ' A' ' 74' ' ' PHE . 13.4 mmt -103.02 -159.82 0.75 Allowed 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.211 -0.904 . . . . 3.03 113.176 -158.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.631 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . . . -65.81 -3.58 5.23 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.074 -0.966 . . . . 1.46 112.65 -172.06 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.914 ' HB3' ' HG2' ' A' ' 75' ' ' PRO . 14.3 ptpt 58.47 129.06 0.01 OUTLIER 'General case' 0 CA--C 1.494 -1.201 0 CA-C-O 122.889 1.328 . . . . 1.76 110.38 -168.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.499 HD11 ' CE2' ' A' ' 119' ' ' TYR . 1.7 pp -138.1 167.92 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.657 0 CA-C-N 114.05 -1.432 . . . . 0.82 108.382 173.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.556 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 0.2 OUTLIER -46.27 110.67 0.29 Allowed 'General case' 0 C--N 1.296 -1.732 0 O-C-N 124.393 1.058 . . . . 1.73 110.006 171.584 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.502 ' CB ' ' HB3' ' A' ' 42' ' ' ASN . 5.5 m -117.77 91.45 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.135 0 N-CA-C 107.271 -1.381 . . . . 0.77 107.271 163.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.593 ' HB3' ' HG2' ' A' ' 82' ' ' GLN . 2.2 t-20 177.13 -178.13 0.17 Allowed 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.188 -1.369 . . . . 1.9 109.225 -174.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -77.45 3.23 59.86 Favored Glycine 0 N--CA 1.43 -1.727 0 N-CA-C 118.24 2.056 . . . . 1.47 118.24 -163.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.848 ' HG2' ' HG3' ' A' ' 82' ' ' GLN . 7.8 pt-20 -105.78 -43.99 4.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 121.233 2.517 . . . . 2.81 113.315 -175.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -128.0 -32.78 2.27 Favored 'General case' 0 CA--C 1.5 -0.976 0 C-N-CA 119.979 -0.688 . . . . 2.16 109.16 177.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 1.097 ' HB3' ' HG2' ' A' ' 120' ' ' GLU . . . 42.81 -144.95 0.08 Allowed 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 114.409 -1.269 . . . . 1.26 108.931 -167.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.647 ' CE1' ' H ' ' A' ' 118' ' ' LEU . 2.7 t-80 -136.73 138.48 26.4 Favored Pre-proline 0 N--CA 1.424 -1.732 0 N-CA-C 106.5 -1.667 . . . . 0.42 106.5 169.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -26.82 -48.12 0.08 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 124.456 3.437 . . . . 0.4 113.537 178.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.827 ' HG ' ' HE3' ' A' ' 122' ' ' MET . 48.3 tp -60.15 -52.74 64.02 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.364 0.665 . . . . 0.39 112.288 177.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.736 ' HE2' ' CD2' ' A' ' 74' ' ' PHE . 70.2 m-85 -77.28 -35.12 55.45 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-N 116.663 -0.244 . . . . 3.04 111.511 -178.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 1.097 ' HG2' ' HB3' ' A' ' 115' ' ' ALA . 7.0 mm-40 -56.79 -36.1 69.49 Favored 'General case' 0 CA--C 1.491 -1.319 0 N-CA-C 107.803 -1.184 . . . . 2.44 107.803 170.025 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.795 ' HB2' ' HE2' ' A' ' 18' ' ' PHE . 60.8 t80 -69.86 -31.89 69.96 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 119.252 -0.979 . . . . 0.56 110.403 174.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.827 ' HE3' ' HG ' ' A' ' 118' ' ' LEU . 1.1 ttm -76.63 -55.06 5.85 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.551 -0.295 . . . . 0.71 111.244 -170.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.412 ' HE2' ' HB2' ' A' ' 123' ' ' LYS . 0.4 OUTLIER -69.29 -24.77 64.0 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.337 -0.392 . . . . 1.46 110.551 178.913 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.486 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 12.8 pttp -72.41 -28.64 63.11 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 119.384 -0.926 . . . . 1.99 109.696 175.124 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.447 ' HB ' ' HG2' ' A' ' 150' ' ' PRO . 97.4 m -76.57 -57.08 4.06 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.974 -0.557 . . . . 0.59 111.053 178.223 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.603 ' HG2' ' H ' ' A' ' 128' ' ' GLY . 71.6 tttt -143.08 128.54 10.08 Favored Pre-proline 0 N--CA 1.453 -0.319 0 CA-C-O 121.29 0.567 . . . . 1.85 112.005 -177.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.738 ' HA ' ' NH2' ' A' ' 153' ' ' ARG . 2.8 Cg_exo -76.87 10.63 2.24 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 123.237 2.625 . . . . 1.69 111.811 172.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.603 ' H ' ' HG2' ' A' ' 126' ' ' LYS . . . 84.37 -133.4 11.81 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.88 -0.676 . . . . 2.59 112.18 178.229 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 22.3 pt -92.18 -9.79 9.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 120.955 0.407 . . . . 3.58 110.983 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.401 ' HG ' ' OG1' ' A' ' 132' ' ' THR . 49.4 tp -132.27 113.76 13.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.884 -0.598 . . . . 3.47 109.741 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.71 ' HA ' ' HB2' ' A' ' 127' ' ' PRO . . . -76.6 69.32 3.0 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.975 -0.557 . . . . 3.28 111.389 -174.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.401 ' OG1' ' HG ' ' A' ' 130' ' ' LEU . 28.8 m -102.2 -74.28 0.63 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.707 -0.679 . . . . 3.56 111.284 179.141 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.421 ' HB3' ' H ' ' A' ' 134' ' ' ALA . 20.6 tptm -164.58 -98.96 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.98 0.419 . . . . 5.17 110.944 -178.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.549 ' HB1' HD13 ' A' ' 135' ' ' ILE . . . -100.62 177.22 5.07 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.342 -0.39 . . . . 1.59 110.646 -176.202 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.848 ' H ' HD13 ' A' ' 135' ' ' ILE . 0.1 OUTLIER -42.72 -42.46 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 O-C-N 123.95 0.781 . . . . 2.0 111.53 178.532 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.674 ' HB3' ' CE3' ' A' ' 137' ' ' TRP . 76.7 tttt 73.62 -9.22 1.23 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.939 0.895 . . . . 4.81 112.88 168.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.916 ' HB3' ' HG3' ' A' ' 156' ' ' PRO . 9.7 m-90 -133.64 175.2 9.65 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.961 0.41 . . . . 1.97 111.441 -175.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.464 ' OD1' ' HD1' ' A' ' 139' ' ' PHE . 5.2 t-20 -38.96 -153.13 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 125.727 1.611 . . . . 2.04 111.565 157.468 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.674 ' CD1' HG23 ' A' ' 43' ' ' VAL . 2.4 m-85 -25.59 -52.18 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 115.461 1.652 . . . . 1.93 115.461 -169.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.616 ' HA ' ' O ' ' A' ' 154' ' ' PHE . 1.9 m 32.67 106.0 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.422 1.268 . . . . 0.6 114.422 175.054 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.741 ' HB3' HD12 ' A' ' 39' ' ' LEU . 2.8 m -92.58 174.04 7.48 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 114.084 -1.416 . . . . 0.62 111.393 -169.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.557 ' CD1' ' HB2' ' A' ' 153' ' ' ARG . 57.6 m-85 -138.64 123.01 18.29 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 105.985 -1.858 . . . . 0.57 105.985 165.043 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.932 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 2.9 tp -79.64 104.06 9.97 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 118.345 -1.342 . . . . 0.43 108.48 -179.092 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.726 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 40.2 mm -91.57 140.45 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.96 0 CA-C-N 113.647 -1.615 . . . . 0.19 107.873 -178.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.438 ' HA ' HD13 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -94.64 -172.26 2.7 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 120.062 -0.655 . . . . 0.98 111.515 -169.588 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.782 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 17.1 mtm180 -55.8 -36.77 67.78 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 123.168 0.293 . . . . 2.22 111.28 -176.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.532 ' O ' ' HB3' ' A' ' 14' ' ' SER . 34.8 t70 -102.2 23.22 11.98 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.33 -0.618 . . . . 2.0 109.33 -178.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.679 ' HA2' HG22 ' A' ' 144' ' ' ILE . . . 67.12 38.69 92.43 Favored Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 120.863 -0.684 . . . . 0.17 114.305 177.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 42.7 t -104.7 128.37 26.99 Favored Pre-proline 0 C--N 1.313 -0.979 0 CA-C-N 118.187 0.993 . . . . 1.12 110.618 173.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.447 ' HG2' ' HB ' ' A' ' 125' ' ' THR . 1.3 Cg_endo -71.12 118.85 5.9 Favored 'Trans proline' 0 CA--C 1.531 0.335 0 C-N-CA 122.662 2.241 . . . . 0.41 110.814 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.428 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 14.2 t -119.71 -7.0 11.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.825 -0.435 . . . . 1.45 109.825 -175.213 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.932 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 6.0 mm-40 -155.14 168.13 28.06 Favored 'General case' 0 CA--C 1.5 -0.948 0 CA-C-O 121.52 0.676 . . . . 1.17 111.007 176.045 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.738 ' NH2' ' HA ' ' A' ' 127' ' ' PRO . 1.4 ttm180 -147.91 132.99 18.24 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 113.851 -1.522 . . . . 2.16 108.726 164.238 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.616 ' O ' ' HA ' ' A' ' 140' ' ' THR . 96.7 m-85 -114.27 146.72 40.08 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.678 -0.692 . . . . 0.32 109.338 -168.018 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 15.8 m -65.1 150.14 95.85 Favored Pre-proline 0 C--N 1.313 -1.014 0 N-CA-C 109.001 -0.74 . . . . 1.11 109.001 175.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.916 ' HG3' ' HB3' ' A' ' 137' ' ' TRP . 38.5 Cg_endo -66.39 -16.31 50.91 Favored 'Trans proline' 0 CA--C 1.514 -0.519 0 C-N-CA 122.57 2.18 . . . . 0.78 110.974 177.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.707 ' HA2' ' O ' ' A' ' 51' ' ' LYS . . . -88.31 2.07 84.83 Favored Glycine 0 N--CA 1.439 -1.158 0 CA-C-N 114.473 -1.239 . . . . 0.5 112.72 173.346 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -76.46 153.07 35.9 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.272 -0.64 . . . . 0.5 109.272 173.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.584 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 24.4 m -112.31 169.64 8.73 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 116.3 -0.409 . . . . 1.42 110.245 -175.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.671 HG22 ' HA ' ' A' ' 56' ' ' THR . 88.7 t -40.9 -52.53 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 O-C-N 124.363 1.039 . . . . 0.28 111.788 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 52.3 tttm -66.4 -32.99 74.71 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.031 -0.531 . . . . 3.46 111.166 -173.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -69.99 -31.45 69.15 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.859 -0.61 . . . . 1.4 109.847 -176.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.564 HD12 ' CG2' ' A' ' 56' ' ' THR . 70.1 mt -83.89 -43.24 17.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 115.184 -0.916 . . . . 0.21 110.954 176.112 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.582 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 35.0 mt-10 -53.05 -42.94 66.25 Favored 'General case' 0 C--O 1.216 -0.668 0 N-CA-C 111.723 0.268 . . . . 0.67 111.723 -177.073 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -54.88 -29.01 54.64 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 112.254 0.464 . . . . 0.87 112.254 -177.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.789 ' HB3' HD22 ' A' ' 143' ' ' LEU . 35.8 mmtm -94.68 -20.84 19.2 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.651 0.739 . . . . 1.71 110.103 177.185 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.582 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 14.1 tp -86.46 -49.34 7.67 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.617 -1.174 . . . . 0.16 112.413 -174.146 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.517 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 78.0 mt -55.66 -47.47 98.61 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.385 -0.825 . . . . 0.26 112.557 -172.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.517 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 76.5 Cg_exo -53.54 -28.53 45.81 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 122.356 2.037 . . . . 0.41 112.756 174.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.832 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 80.1 mt -86.23 -47.1 9.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.357 -0.383 . . . . 0.71 111.14 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.78 HD23 ' HG2' ' A' ' 37' ' ' PRO . 84.9 mt -57.45 -57.86 10.82 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-O 122.113 0.959 . . . . 0.34 109.781 176.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -66.15 -21.08 69.71 Favored Glycine 0 N--CA 1.435 -1.393 0 CA-C-N 113.36 -1.745 . . . . 1.12 112.214 -178.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 40.9 m 62.97 68.53 0.63 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.457 0.646 . . . . 2.64 110.604 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -76.35 -6.66 52.57 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.333 -0.848 . . . . 4.35 110.442 177.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 29.7 ttp180 -143.0 122.51 13.2 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.392 -0.822 . . . . 8.45 109.0 176.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.5 mm? . . . . . 0 C--O 1.246 0.916 0 CA-C-O 118.312 -0.851 . . . . 7.69 109.806 179.619 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.879 0 N-CA-C 112.483 -0.247 . . . . 5.22 112.483 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -134.16 177.7 7.54 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.082 -0.34 . . . . 4.85 110.082 178.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.67 88.56 1.83 Allowed Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.887 -0.673 . . . . 1.55 112.153 -178.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.8 p -121.67 14.32 10.94 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.307 0.575 . . . . 1.58 110.086 177.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 79.7 p 177.12 153.7 0.23 Allowed 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 105.842 -1.911 . . . . 1.17 105.842 -178.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.847 ' HB ' ' CD1' ' A' ' 118' ' ' LEU . 5.8 pt -69.26 -12.39 15.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 CA-C-N 115.063 -0.972 . . . . 0.38 112.133 -170.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.659 ' CD1' ' HA ' ' A' ' 31' ' ' VAL . 48.0 m-85 -74.83 -8.2 55.74 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 120.752 0.31 . . . . 0.3 111.184 -178.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -63.24 -21.13 66.03 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 108.91 -0.774 . . . . 2.11 108.91 170.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.835 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 60.8 m-85 -117.63 105.35 11.95 Favored 'General case' 0 CA--C 1.49 -1.341 0 CA-C-N 114.614 -1.175 . . . . 0.31 110.253 176.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -58.25 158.95 6.51 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 114.88 -1.054 . . . . 2.86 108.165 172.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.739 HG13 ' HZ ' ' A' ' 74' ' ' PHE . 20.3 t -108.33 169.28 3.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 107.393 -1.336 . . . . 0.67 107.393 -175.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.794 ' O ' ' HB2' ' A' ' 105' ' ' MET . 33.0 mt -127.21 141.52 51.71 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 109.534 -0.543 . . . . 0.69 109.534 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -71.21 -173.55 0.87 Allowed 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.24 -1.022 . . . . 1.87 108.24 174.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.75 ' HA ' ' CA ' ' A' ' 106' ' ' ALA . . . -66.93 -3.05 6.08 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 112.494 0.553 . . . . 0.59 112.494 -176.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 29.1 t70 -102.84 -3.25 26.55 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.803 -0.359 . . . . 2.34 110.832 176.005 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.656 ' CD2' ' HB3' ' A' ' 106' ' ' ALA . 1.9 m170 75.72 20.94 1.75 Allowed 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.741 0.781 . . . . 1.47 109.417 -178.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.477 ' HA ' ' HD3' ' A' ' 26' ' ' LYS . 45.9 mmtt -102.15 135.46 19.64 Favored Pre-proline 0 N--CA 1.443 -0.804 0 CA-C-N 114.397 -1.274 . . . . 4.25 108.45 171.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.64 ' HA ' HD23 ' A' ' 21' ' ' LEU . 84.7 Cg_exo -47.21 115.29 1.27 Allowed 'Trans proline' 0 C--N 1.335 -0.178 0 C-N-CA 123.341 2.694 . . . . 0.54 115.361 -165.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.622 ' OH ' ' HB3' ' A' ' 103' ' ' PRO . 0.2 OUTLIER -78.0 142.94 37.94 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 112.947 -1.933 . . . . 1.2 108.977 164.928 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.683 ' ND2' ' HB3' ' A' ' 32' ' ' GLN . 53.7 t30 -79.72 86.24 5.33 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.537 -0.542 . . . . 1.51 109.537 178.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.701 HD21 HD12 ' A' ' 15' ' ' ILE . 68.2 tp -67.61 -42.47 82.35 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.576 0.703 . . . . 0.28 110.01 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.659 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 1.6 m -69.56 -0.61 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.398 -1.274 . . . . 1.02 112.855 -167.403 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.683 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . 18.4 pt20 -75.03 -11.32 60.07 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.541 0.686 . . . . 1.02 109.289 174.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.953 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 91.0 m-70 -95.83 22.53 7.22 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 115.315 -0.857 . . . . 0.28 109.495 176.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.533 ' CE ' ' HB ' ' A' ' 31' ' ' VAL . 45.6 mttm -77.77 126.86 31.5 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 114.475 -1.239 . . . . 1.56 108.382 167.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.22 -44.81 1.42 Allowed Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 120.295 -0.955 . . . . 0.2 111.926 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.542 ' HB2' ' HA3' ' A' ' 68' ' ' GLY . 21.6 m -127.07 133.57 25.19 Favored Pre-proline 0 N--CA 1.435 -1.203 0 N-CA-C 108.9 -0.778 . . . . 0.29 108.9 174.192 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.771 ' HG3' ' CB ' ' A' ' 170' ' ' LEU . 6.1 Cg_endo -43.88 152.83 0.32 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 124.086 3.191 . . . . 0.18 112.891 177.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.872 ' HB2' HG22 ' A' ' 70' ' ' THR . 0.8 OUTLIER -139.02 152.97 48.04 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 106.375 -1.713 . . . . 0.31 106.375 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.975 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 2.8 mp -120.59 128.19 52.81 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.776 -0.578 . . . . 1.19 109.546 177.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.607 HD12 ' CE ' ' A' ' 122' ' ' MET . 1.0 OUTLIER -109.89 125.11 67.09 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-N 115.248 -0.887 . . . . 0.37 109.92 179.304 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.975 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.6 OUTLIER -110.62 124.94 52.83 Favored 'General case' 0 C--O 1.215 -0.729 0 CA-C-N 115.674 -0.693 . . . . 0.42 110.971 -172.031 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.702 ' HB3' HG21 ' A' ' 135' ' ' ILE . 0.7 OUTLIER -77.83 121.96 24.8 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 105.726 -1.953 . . . . 2.35 105.726 165.177 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.712 HG13 ' HA ' ' A' ' 75' ' ' PRO . 1.5 p -130.24 140.01 49.95 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 C-N-CA 119.158 -1.017 . . . . 1.03 113.109 -164.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.416 ' HB2' HD22 ' A' ' 138' ' ' ASN . . . -75.91 102.61 5.63 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.742 -0.663 . . . . 0.88 109.504 173.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.547 ' OG ' ' HB2' ' A' ' 75' ' ' PRO . 1.1 m -46.78 77.17 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 113.436 -1.711 . . . . 1.78 114.392 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt 46.89 50.84 13.26 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.872 0.844 . . . . 5.84 110.769 177.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.739 ' SG ' HG23 ' A' ' 90' ' ' ILE . 23.6 p -150.35 141.96 23.56 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.232 -0.895 . . . . 3.55 109.93 -177.103 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.34 -111.64 3.9 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.863 -0.684 . . . . 2.91 112.782 176.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.402 ' HD1' ' OE1' ' A' ' 89' ' ' GLU . 96.1 m-85 -112.57 126.52 55.43 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.628 0.728 . . . . 4.63 112.339 -174.224 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.3 p -75.06 -33.03 61.66 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.823 -1.08 . . . . 1.93 109.931 174.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.738 ' O ' ' HA2' ' A' ' 157' ' ' GLY . 28.2 mmmt 54.41 16.59 1.31 Allowed 'General case' 0 C--N 1.345 0.401 0 C-N-CA 124.726 1.21 . . . . 2.01 113.133 -179.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.94 -11.83 59.1 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.275 -0.964 . . . . 0.51 112.097 -177.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -47.19 -40.83 14.63 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 112.115 -0.394 . . . . 0.5 112.115 177.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.573 ' CZ ' ' HD2' ' A' ' 98' ' ' PHE . 0.1 OUTLIER -57.0 -62.09 1.99 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.754 0.312 . . . . 0.7 110.407 -178.76 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.0 mp0 -59.55 -34.2 72.38 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.716 -0.675 . . . . 2.61 111.539 -178.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.643 ' HA ' HG22 ' A' ' 160' ' ' VAL . 97.0 m -68.47 -58.39 4.4 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.598 -0.728 . . . . 0.33 109.211 -176.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 1.097 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -59.5 -42.75 92.9 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.526 -1.216 . . . . 0.22 111.157 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.53 ' HA ' ' HD1' ' A' ' 102' ' ' PHE . 60.4 m -58.83 -56.86 16.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.86 -0.609 . . . . 0.26 110.923 -177.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 26.6 m -68.34 -35.36 77.65 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.417 -0.811 . . . . 0.48 111.344 -175.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.835 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 20.3 mt -65.61 -50.69 64.13 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-O 121.311 0.577 . . . . 0.43 110.432 -176.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.922 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 6.7 t80 -55.16 -51.89 65.03 Favored 'General case' 0 C--O 1.205 -1.268 0 CA-C-N 114.814 -1.085 . . . . 0.31 110.969 178.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.407 HD21 ' HB3' ' A' ' 101' ' ' GLU . 36.9 m-80 -73.71 -24.49 59.93 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 116.488 -0.324 . . . . 1.21 110.961 -170.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.527 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 34.9 ttpt -85.84 -23.5 27.11 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 109.039 -0.726 . . . . 1.54 109.039 -178.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.609 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 28.2 m-85 -124.86 -3.72 7.65 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 115.504 1.668 . . . . 0.31 115.504 -170.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.676 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 40.5 pttt -67.58 -26.23 66.17 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 107.897 -1.149 . . . . 1.35 107.897 170.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.3 m -49.23 -28.24 4.42 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 113.854 -1.521 . . . . 1.28 111.294 172.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -99.18 -34.54 10.32 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.496 0.189 . . . . 1.11 111.481 173.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.542 ' HA3' ' HB2' ' A' ' 36' ' ' SER . . . 150.95 -6.06 0.6 Allowed Glycine 0 CA--C 1.521 0.408 0 N-CA-C 111.863 -0.495 . . . . 0.18 111.863 -177.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.835 ' HE2' ' HB3' ' A' ' 60' ' ' LEU . 19.3 t80 -71.15 143.13 50.66 Favored 'General case' 0 C--O 1.218 -0.598 0 C-N-CA 122.705 0.402 . . . . 0.18 111.605 -176.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.953 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 4.8 t -134.65 153.99 51.73 Favored 'General case' 0 CA--C 1.483 -1.606 0 N-CA-C 108.354 -0.98 . . . . 0.2 108.354 172.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 1.097 HG11 ' HB1' ' A' ' 57' ' ' ALA . 42.7 t -113.27 99.86 9.51 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.407 0 N-CA-C 108.586 -0.894 . . . . 0.17 108.586 160.106 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.797 ' HA ' ' HG2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -94.73 120.47 35.0 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 118.498 -1.281 . . . . 1.04 107.735 174.423 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.951 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -109.53 127.39 54.43 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.915 0.864 . . . . 0.51 111.085 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.797 ' CG ' ' HG2' ' A' ' 105' ' ' MET . 5.8 m-30 -102.92 106.95 53.12 Favored Pre-proline 0 C--N 1.313 -1.009 0 CA-C-N 114.565 -1.198 . . . . 0.44 108.806 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.75 ' O ' ' HB2' ' A' ' 107' ' ' LYS . 65.2 Cg_endo -77.21 93.13 1.09 Allowed 'Trans proline' 0 C--O 1.221 -0.334 0 C-N-CA 122.474 2.116 . . . . 1.3 113.4 -168.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.678 ' HB3' ' OD1' ' A' ' 42' ' ' ASN . 70.6 p -43.1 145.51 0.51 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.633 -1.167 . . . . 1.44 114.042 -167.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.448 ' OD1' ' HB2' ' A' ' 79' ' ' PHE . 43.5 t-20 -92.56 119.06 31.65 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 114.608 -1.178 . . . . 1.81 109.918 -176.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.888 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . 3.7 pp0? -77.84 -12.67 60.0 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.618 -0.719 . . . . 3.34 111.89 -177.232 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.448 ' HB2' ' OD1' ' A' ' 77' ' ' ASN . 25.3 m-85 -70.59 29.48 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.069 0.766 . . . . 2.68 113.069 -174.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.426 ' H ' ' C ' ' A' ' 78' ' ' GLN . . . -142.98 174.86 23.44 Favored Glycine 0 N--CA 1.439 -1.141 0 N-CA-C 110.621 -0.991 . . . . 1.98 110.621 177.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -100.99 55.12 0.8 Allowed Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.136 -1.031 . . . . 1.49 112.369 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.553 ' HG3' ' HG2' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -173.74 26.01 0.01 OUTLIER 'General case' 0 C--O 1.215 -0.752 0 N-CA-C 112.174 0.435 . . . . 1.74 112.174 -178.879 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.773 ' HG2' ' HA ' ' A' ' 78' ' ' GLN . 0.0 OUTLIER -81.97 142.09 47.92 Favored Pre-proline 0 C--N 1.318 -0.804 0 C-N-CA 119.358 -0.937 . . . . 3.07 110.823 -178.774 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.552 ' HG2' HD21 ' A' ' 42' ' ' ASN . 89.7 Cg_endo -83.77 6.25 5.89 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.263 2.642 . . . . 1.75 113.598 -170.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.78 -55.39 14.45 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 110.315 -1.114 . . . . 2.2 110.315 175.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.435 ' HB3' ' HB2' ' A' ' 89' ' ' GLU . 66.5 t30 -178.15 8.88 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.817 -0.691 . . . . 4.2 109.573 174.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.468 ' OE1' ' HG3' ' A' ' 83' ' ' GLU . 1.1 mm-40 59.32 32.24 21.74 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 115.727 -0.67 . . . . 3.02 111.106 -174.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -177.83 -39.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.39 -0.823 . . . . 3.92 109.835 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.435 ' HB2' ' HB3' ' A' ' 86' ' ' ASN . 36.0 tt0 -50.18 -54.3 21.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.252 -0.885 . . . . 2.65 112.081 -177.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.888 ' HB ' ' HB3' ' A' ' 78' ' ' GLN . 23.3 mt -74.14 -19.71 17.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.203 -0.453 . . . . 2.15 111.152 -174.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.483 ' HG2' ' HB2' ' A' ' 78' ' ' GLN . 24.0 mttm -79.82 -45.56 18.51 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.332 0.587 . . . . 2.79 109.751 178.259 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -80.62 -13.58 58.92 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.017 -0.992 . . . . 3.29 110.901 -173.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.513 ' HB3' ' HB2' ' A' ' 47' ' ' CYS . 4.3 t80 -112.01 149.15 32.42 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.354 -0.61 . . . . 3.42 109.354 177.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.9 p -63.34 112.27 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.47 0.652 . . . . 2.63 110.96 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 3.9 p -101.11 127.37 47.69 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.535 0.683 . . . . 2.83 111.116 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.9 m -150.76 145.06 25.51 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 107.699 -1.223 . . . . 2.98 107.699 174.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.437 ' O ' ' HG3' ' A' ' 99' ' ' LYS . 18.5 pttp -54.37 110.76 0.66 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.824 -0.806 . . . . 2.72 108.824 177.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.788 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 24.7 p90 -63.56 -26.05 68.52 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.796 -1.093 . . . . 2.12 111.864 -163.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 97' ' ' LYS . 56.1 mtmt 60.39 111.15 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.74 0.781 . . . . 2.69 111.747 177.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.788 ' HB2' ' CE2' ' A' ' 98' ' ' PHE . . . -127.28 -168.63 1.91 Allowed 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.498 -0.774 . . . . 0.55 111.528 -172.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.407 ' HB3' HD21 ' A' ' 62' ' ' ASN . 21.8 mm-40 -86.04 24.25 1.34 Allowed 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.123 -0.944 . . . . 1.99 110.068 172.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.61 ' HB2' ' O ' ' A' ' 71' ' ' VAL . 26.1 p90 -147.69 156.07 44.95 Favored Pre-proline 0 N--CA 1.446 -0.673 0 N-CA-C 109.048 -0.723 . . . . 0.84 109.048 176.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.797 ' HG2' ' HA ' ' A' ' 72' ' ' LEU . 14.0 Cg_endo -54.13 101.81 0.08 OUTLIER 'Trans proline' 0 N--CA 1.479 0.639 0 C-N-CA 124.838 3.692 . . . . 0.62 114.97 -172.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.951 HD12 ' HB3' ' A' ' 73' ' ' ALA . 4.8 mm -101.84 122.15 53.7 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 N-CA-C 108.724 -0.843 . . . . 1.34 108.724 173.021 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.797 ' HG2' ' CG ' ' A' ' 74' ' ' PHE . 0.3 OUTLIER -81.61 -171.21 3.2 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.767 -0.651 . . . . 3.03 110.474 -176.005 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.75 ' CA ' ' HA ' ' A' ' 23' ' ' ALA . . . -66.49 -23.04 66.2 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 121.024 -0.271 . . . . 1.46 110.949 -177.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.75 ' HB2' ' O ' ' A' ' 75' ' ' PRO . 4.9 ptpp? 94.42 139.19 0.02 OUTLIER 'General case' 0 CA--C 1.493 -1.227 0 O-C-N 125.8 1.937 . . . . 1.76 109.13 -167.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.838 HG13 ' HB2' ' A' ' 116' ' ' HIS . 0.2 OUTLIER -130.87 176.7 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.099 0 N-CA-C 106.284 -1.747 . . . . 0.82 106.284 166.808 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.604 ' HB3' ' HB3' ' A' ' 114' ' ' ASN . 2.9 t-20 -82.55 68.66 9.09 Favored 'General case' 0 C--N 1.293 -1.886 0 C-N-CA 120.299 -0.56 . . . . 1.73 110.156 -178.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.588 HG13 HD11 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -65.37 96.3 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 CA-C-N 115.54 -0.755 . . . . 0.77 110.434 -176.192 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.425 ' O ' ' HB2' ' A' ' 115' ' ' ALA . 5.5 t-20 177.51 -176.71 0.17 Allowed 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.118 -0.946 . . . . 1.9 108.681 171.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.693 ' HA2' ' HE3' ' A' ' 123' ' ' LYS . . . -41.26 -37.94 1.76 Allowed Glycine 0 CA--C 1.529 0.925 0 N-CA-C 117.517 1.767 . . . . 1.47 117.517 -172.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.553 ' HG2' ' HG3' ' A' ' 82' ' ' GLN . 14.8 mm-40 -103.59 -43.62 5.32 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.312 1.556 . . . . 2.81 113.525 -164.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.604 ' HB3' ' HB3' ' A' ' 109' ' ' ASN . 3.0 t30 -128.58 26.97 5.58 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 119.354 -0.938 . . . . 2.16 109.297 -166.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.425 ' HB2' ' O ' ' A' ' 111' ' ' ASN . . . -60.96 168.83 2.21 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 114.892 -1.049 . . . . 1.26 109.276 175.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.838 ' HB2' HG13 ' A' ' 108' ' ' ILE . 7.8 t-80 -90.26 142.94 28.86 Favored Pre-proline 0 N--CA 1.424 -1.756 0 CA-C-O 118.003 -0.999 . . . . 0.42 108.698 -171.402 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -29.3 -41.77 0.07 OUTLIER 'Trans proline' 0 CA--C 1.535 0.525 0 C-N-CA 124.247 3.298 . . . . 0.4 113.323 179.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.847 ' CD1' ' HB ' ' A' ' 15' ' ' ILE . 22.1 tp -65.59 -50.94 63.24 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 123.435 0.694 . . . . 0.39 111.928 177.17 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.552 ' OH ' HG22 ' A' ' 40' ' ' ILE . 48.0 m-85 -75.91 -33.45 59.9 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 111.678 0.251 . . . . 3.04 111.678 176.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.465 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 21.9 mm-40 -58.38 -33.41 69.58 Favored 'General case' 0 CA--C 1.498 -1.037 0 N-CA-C 107.807 -1.183 . . . . 2.44 107.807 168.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.835 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 76.0 t80 -71.91 -31.08 66.03 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 119.581 -0.847 . . . . 0.56 110.682 171.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.629 ' HE2' HG21 ' A' ' 15' ' ' ILE . 49.1 mtt -74.65 -51.62 13.93 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 120.403 -0.519 . . . . 0.71 110.595 -170.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 1.059 ' HD2' ' HB2' ' A' ' 134' ' ' ALA . 0.1 OUTLIER -70.8 -25.89 63.07 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.936 -0.574 . . . . 1.46 111.192 176.734 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.579 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 10.0 ptmm? -70.02 -27.16 64.45 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 119.584 -0.847 . . . . 1.99 109.516 176.125 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 62.6 m -85.22 -56.99 3.26 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.495 -0.775 . . . . 0.59 110.839 178.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.535 ' HG2' HH22 ' A' ' 153' ' ' ARG . 20.7 ttmm -133.9 112.64 12.5 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 109.819 -0.437 . . . . 1.85 109.819 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 126' ' ' LYS . 39.0 Cg_exo -61.01 -79.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 123.922 3.081 . . . . 1.69 113.389 -172.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.522 ' HA2' ' CZ ' ' A' ' 153' ' ' ARG . . . -158.07 13.28 0.25 Allowed Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 119.518 -1.325 . . . . 2.59 113.549 -178.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 1.018 HG12 HH12 ' A' ' 153' ' ' ARG . 48.8 mm 71.39 -42.48 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-O 121.584 0.707 . . . . 3.58 109.586 -173.574 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.47 ' HG ' ' H ' ' A' ' 131' ' ' ALA . 24.4 tp -94.8 174.0 7.32 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.74 -1.207 . . . . 3.47 107.74 170.195 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.47 ' H ' ' HG ' ' A' ' 130' ' ' LEU . . . -75.0 80.84 2.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.095 0.474 . . . . 3.28 110.887 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.9 m -157.44 159.22 37.1 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.062 -0.517 . . . . 3.56 109.665 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -97.25 141.06 30.82 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.697 0.284 . . . . 5.17 110.793 174.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 1.059 ' HB2' ' HD2' ' A' ' 123' ' ' LYS . . . 76.18 -167.34 0.07 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 113.818 1.044 . . . . 1.59 113.818 166.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.934 ' H ' HD13 ' A' ' 135' ' ' ILE . 0.1 OUTLIER -54.38 -25.73 14.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 114.393 -1.276 . . . . 2.0 112.091 179.124 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.668 ' HB3' ' CE3' ' A' ' 137' ' ' TRP . 7.7 mtmt 78.29 -64.47 0.27 Allowed 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.343 0.592 . . . . 4.81 111.67 -179.204 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.668 ' CE3' ' HB3' ' A' ' 136' ' ' LYS . 0.2 OUTLIER -104.97 177.97 4.7 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.909 -1.041 . . . . 1.97 111.671 -169.169 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.482 ' O ' ' N ' ' A' ' 140' ' ' THR . 8.5 m120 -37.04 -152.29 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 126.043 1.737 . . . . 2.04 112.685 158.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.743 ' HD1' ' HD2' ' A' ' 41' ' ' TYR . 0.2 OUTLIER -29.05 -22.54 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 116.76 2.134 . . . . 1.93 116.76 -171.411 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.7 ' HA ' ' O ' ' A' ' 154' ' ' PHE . 3.3 m -5.37 121.75 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 115.494 1.664 . . . . 0.6 115.494 168.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.461 ' CB ' HD23 ' A' ' 39' ' ' LEU . 0.7 OUTLIER -97.45 176.36 5.9 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.649 -1.16 . . . . 0.62 110.938 -177.661 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.649 ' HE1' HG23 ' A' ' 135' ' ' ILE . 23.7 m-85 -131.24 123.7 28.97 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 105.498 -2.038 . . . . 0.57 105.498 162.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.873 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 6.4 tp -79.87 104.33 10.38 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 118.075 -1.45 . . . . 0.43 108.289 178.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.702 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 45.8 mm -89.24 138.58 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.688 0 CA-C-N 112.722 -2.036 . . . . 0.19 107.586 -178.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.484 ' HA ' HD13 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -92.07 -174.83 3.9 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 119.282 -0.967 . . . . 0.98 110.939 -169.342 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.644 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 71.6 mtm180 -54.21 -38.88 66.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.98 0.419 . . . . 2.22 111.511 -177.14 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -95.91 15.56 20.1 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.31 -0.626 . . . . 2.0 109.31 -176.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.589 ' HA2' HG22 ' A' ' 144' ' ' ILE . . . 74.39 33.92 55.46 Favored Glycine 0 N--CA 1.442 -0.91 0 CA-C-N 115.821 -0.627 . . . . 0.17 114.499 -178.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.488 ' HA ' ' HD2' ' A' ' 150' ' ' PRO . 49.9 t -103.57 109.69 62.45 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-N 118.415 1.108 . . . . 1.12 111.633 176.292 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.827 ' HD3' HG23 ' A' ' 15' ' ' ILE . 6.5 Cg_endo -57.38 113.35 1.45 Allowed 'Trans proline' 0 CA--C 1.53 0.325 0 C-N-CA 123.715 2.943 . . . . 0.41 111.159 173.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.591 HG23 ' HG2' ' A' ' 152' ' ' GLU . 22.9 m -115.76 -16.86 8.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.331 0.586 . . . . 1.45 110.189 -177.145 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.873 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 53.9 mm-40 -139.61 167.48 22.01 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-N 115.376 -0.829 . . . . 1.17 110.088 178.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 1.018 HH12 HG12 ' A' ' 129' ' ' ILE . 0.0 OUTLIER -148.22 129.95 15.11 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 114.608 -1.178 . . . . 2.16 108.664 163.943 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.7 ' O ' ' HA ' ' A' ' 140' ' ' THR . 94.2 m-85 -108.68 137.06 47.23 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.951 -0.568 . . . . 0.32 109.879 -170.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 20.1 m -62.77 156.61 64.34 Favored Pre-proline 0 C--N 1.323 -0.556 0 N-CA-C 109.393 -0.595 . . . . 1.11 109.393 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.735 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 14.1 Cg_endo -56.72 -48.22 19.73 Favored 'Trans proline' 0 CA--C 1.527 0.167 0 C-N-CA 121.765 1.643 . . . . 0.78 111.462 -177.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.738 ' HA2' ' O ' ' A' ' 51' ' ' LYS . . . -55.64 -7.2 1.39 Allowed Glycine 0 CA--C 1.528 0.844 0 N-CA-C 115.692 1.037 . . . . 0.5 115.692 172.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -71.94 140.04 48.99 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 118.777 1.288 . . . . 0.5 109.256 176.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 22.2 t -103.69 170.26 8.04 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 109.629 -0.508 . . . . 1.42 109.629 -173.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.643 HG22 ' HA ' ' A' ' 56' ' ' THR . 60.5 t -41.14 -53.43 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 114.877 -1.056 . . . . 0.28 111.698 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 14.7 ttpp -63.58 -40.24 96.45 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.039 0.447 . . . . 3.46 111.104 -173.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -66.12 -30.43 70.92 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.432 -0.804 . . . . 1.4 109.795 -174.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.58 ' HA ' ' CE2' ' A' ' 154' ' ' PHE . 48.5 mt -82.77 -46.56 19.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.87 -1.059 . . . . 0.21 110.992 175.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.591 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 47.4 mt-10 -52.77 -43.33 65.74 Favored 'General case' 0 C--O 1.217 -0.626 0 O-C-N 123.314 0.384 . . . . 0.67 111.254 -175.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -55.51 -27.47 48.81 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.418 0.525 . . . . 0.87 112.418 -177.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.596 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 14.0 mmmm -97.98 -18.88 18.37 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.421 0.629 . . . . 1.71 109.938 176.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.566 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 12.4 tp -86.2 -49.14 7.95 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.029 -0.987 . . . . 0.16 112.142 -176.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.439 HD11 ' HB3' ' A' ' 164' ' ' GLU . 81.0 mt -55.47 -44.7 99.78 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-N 115.501 -0.772 . . . . 0.26 112.799 -173.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.419 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 72.3 Cg_exo -51.96 -35.33 60.14 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 122.002 1.802 . . . . 0.41 112.375 173.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.771 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 96.6 mt -80.91 -44.25 18.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.358 -0.383 . . . . 0.71 111.378 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.728 HD23 ' HG2' ' A' ' 37' ' ' PRO . 90.9 mt -59.88 -59.28 5.68 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 122.028 0.918 . . . . 0.34 109.899 176.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -57.05 -36.9 76.39 Favored Glycine 0 N--CA 1.434 -1.434 0 CA-C-N 113.327 -1.76 . . . . 1.12 113.298 -177.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 36.9 t 68.5 9.49 7.32 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.866 0.467 . . . . 2.64 111.156 177.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -93.82 -16.68 23.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.479 -0.328 . . . . 4.35 111.413 -177.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 67.17 -80.07 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 O-C-N 123.86 0.725 . . . . 8.45 111.073 -176.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 44.0 tp . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.403 -0.808 . . . . 7.69 109.378 -178.494 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.583 0 N-CA-C 111.506 -0.637 . . . . 5.22 111.506 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -90.78 136.48 33.04 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.01 0.434 . . . . 4.85 109.869 178.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.67 37.52 5.5 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 111.043 -0.823 . . . . 1.55 111.043 -174.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.0 t -102.33 -2.56 28.73 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.079 0.466 . . . . 1.58 109.806 -177.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 99.5 p -168.49 177.07 5.44 Favored 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 107.48 -1.304 . . . . 1.17 107.48 -177.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.981 HD12 HD21 ' A' ' 30' ' ' LEU . 5.2 pt -83.7 -18.77 9.92 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 CA-C-N 114.863 -1.062 . . . . 0.38 109.817 176.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.745 ' CD1' ' HA ' ' A' ' 31' ' ' VAL . 48.4 m-85 -70.95 -5.78 33.54 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.255 0.55 . . . . 0.3 110.713 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -69.18 -18.22 63.89 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.201 -0.909 . . . . 2.11 108.665 172.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.806 ' HE2' ' HB2' ' A' ' 121' ' ' TYR . 61.1 m-85 -119.35 108.05 14.12 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-O 121.781 0.801 . . . . 0.31 111.509 -178.177 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -48.48 146.88 2.69 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 113.488 -1.687 . . . . 2.86 110.336 170.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.781 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 37.1 t -110.86 165.0 6.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 109.393 -0.595 . . . . 0.67 109.393 -175.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.819 ' O ' ' HB3' ' A' ' 105' ' ' MET . 97.1 mt -126.49 111.28 14.23 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-O 119.505 -0.283 . . . . 0.69 111.332 -176.123 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.408 ' HA ' ' HE2' ' A' ' 105' ' ' MET . 13.4 t70 -53.9 161.84 1.08 Allowed 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 107.03 -1.47 . . . . 1.87 107.03 170.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.613 ' HA ' ' N ' ' A' ' 106' ' ' ALA . . . -57.02 -11.1 1.34 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 113.153 0.797 . . . . 0.59 113.153 -164.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 10.9 t70 -90.21 -4.18 57.38 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 122.386 0.274 . . . . 2.34 111.598 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.596 ' CE1' ' HB1' ' A' ' 106' ' ' ALA . 74.1 m80 79.95 20.71 0.57 Allowed 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.93 0.872 . . . . 1.47 108.995 -177.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.455 ' HA ' ' HD3' ' A' ' 26' ' ' LYS . 11.3 mmtp -104.69 125.96 32.55 Favored Pre-proline 0 N--CA 1.441 -0.892 0 CA-C-N 114.344 -1.298 . . . . 4.25 108.398 175.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.675 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 80.3 Cg_exo -48.79 114.74 1.34 Allowed 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.995 2.463 . . . . 0.54 114.917 -168.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.813 ' HE2' HD23 ' A' ' 72' ' ' LEU . 8.8 t80 -83.8 128.3 34.44 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 113.589 -1.641 . . . . 1.2 109.313 164.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.429 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 10.2 p30 -75.29 99.53 4.1 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 122.777 1.275 . . . . 1.51 110.143 176.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.981 HD21 HD12 ' A' ' 15' ' ' ILE . 61.7 tp -61.62 -32.82 72.97 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.507 -1.224 . . . . 0.28 110.591 178.059 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.745 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 3.7 m -63.77 -6.12 2.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 114.793 -1.094 . . . . 1.02 113.164 -169.05 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.429 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 13.7 pt20 -72.81 -7.88 52.85 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.006 -0.678 . . . . 1.02 109.737 177.306 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.923 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 90.1 m-70 -98.94 22.11 10.68 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.8 0.81 . . . . 0.28 109.866 176.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.524 ' HE2' ' HB ' ' A' ' 31' ' ' VAL . 62.2 mttm -78.75 122.09 25.58 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 114.683 -1.144 . . . . 1.56 109.156 169.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.05 -41.09 2.08 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.585 -0.817 . . . . 0.2 111.912 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.545 ' HB2' ' HA3' ' A' ' 68' ' ' GLY . 52.7 m -129.77 132.93 24.49 Favored Pre-proline 0 N--CA 1.437 -1.121 0 N-CA-C 108.839 -0.801 . . . . 0.29 108.839 173.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.779 ' HG3' ' CB ' ' A' ' 170' ' ' LEU . 4.2 Cg_endo -43.29 152.22 0.27 Allowed 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.951 3.1 . . . . 0.18 112.55 176.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.875 ' HB2' HG22 ' A' ' 70' ' ' THR . 0.7 OUTLIER -137.04 150.8 48.3 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.353 -1.721 . . . . 0.31 106.353 179.171 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.97 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 1.8 mp -116.26 122.61 45.49 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 121.419 0.628 . . . . 1.19 109.536 176.118 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.078 HG22 ' OH ' ' A' ' 119' ' ' TYR . 0.9 OUTLIER -102.51 123.6 55.93 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 CA-C-N 114.908 -1.042 . . . . 0.37 109.394 177.45 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.97 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.3 OUTLIER -109.25 129.7 55.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.31 -0.405 . . . . 0.42 110.569 -175.013 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.877 HD21 ' HE2' ' A' ' 142' ' ' PHE . 2.9 m-80 -78.89 93.13 4.98 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.213 -1.402 . . . . 2.35 107.213 169.13 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.714 HG12 ' CG ' ' A' ' 139' ' ' PHE . 34.9 m -104.31 145.67 12.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 C-N-CA 119.038 -1.065 . . . . 1.03 111.227 -170.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.687 ' O ' ' HG2' ' A' ' 46' ' ' LYS . . . -94.74 104.3 16.21 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 114.334 -1.303 . . . . 0.88 109.233 174.055 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.623 ' HA ' ' HB3' ' A' ' 98' ' ' PHE . 2.1 p -38.54 93.17 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.619 0 O-C-N 124.377 1.048 . . . . 1.78 111.469 168.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.687 ' HG2' ' O ' ' A' ' 44' ' ' ALA . 65.6 mmtt -102.8 153.29 20.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.839 -0.619 . . . . 5.84 110.451 -177.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.535 ' HB2' ' HA ' ' A' ' 95' ' ' CYS . 49.1 t -111.18 114.48 27.75 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 108.35 -0.981 . . . . 3.55 108.35 167.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 63.1 32.82 85.45 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-N 116.078 -0.51 . . . . 2.91 113.766 -178.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.542 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 14.5 m-85 -142.16 145.35 34.09 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 117.727 0.764 . . . . 4.63 112.499 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.5 t -159.93 169.48 23.4 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.21 -0.904 . . . . 1.93 108.607 177.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.706 ' HB3' ' HB2' ' A' ' 156' ' ' PRO . 8.5 tppt? -125.71 9.5 7.67 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.173 -0.677 . . . . 2.01 109.173 173.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 116.13 -30.88 6.3 Favored Glycine 0 N--CA 1.443 -0.893 0 N-CA-C 110.32 -1.112 . . . . 0.51 110.32 -170.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -45.31 -47.98 11.06 Favored Glycine 0 C--O 1.223 -0.592 0 CA-C-N 115.011 -0.595 . . . . 0.5 113.222 175.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.601 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 0.2 OUTLIER -61.01 -61.88 2.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.877 0.338 . . . . 0.7 111.524 -174.182 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -62.06 -23.88 66.75 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.268 0.556 . . . . 2.61 111.149 -178.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.653 ' HA ' HG22 ' A' ' 160' ' ' VAL . 23.4 m -75.79 -57.66 3.75 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.518 -0.765 . . . . 0.33 110.363 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 1.069 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -57.87 -38.48 75.81 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.942 -1.026 . . . . 0.22 110.949 -179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.543 ' HA ' ' CD1' ' A' ' 102' ' ' PHE . 54.8 m -60.92 -57.78 11.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.837 -0.619 . . . . 0.26 110.415 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 26.6 m -66.74 -37.84 85.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.378 -0.828 . . . . 0.48 111.534 -175.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.802 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 18.9 mt -65.3 -48.0 74.65 Favored 'General case' 0 CA--C 1.503 -0.849 0 CA-C-O 121.049 0.452 . . . . 0.43 110.679 -175.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.88 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 8.7 t80 -56.58 -50.96 70.38 Favored 'General case' 0 C--O 1.203 -1.394 0 CA-C-N 115.217 -0.901 . . . . 0.31 110.453 178.287 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -72.21 -24.57 61.42 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 120.745 0.307 . . . . 1.21 110.502 -172.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.3 ttmm -82.62 -26.35 32.32 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 109.107 -0.701 . . . . 1.54 109.107 -177.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.759 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 30.2 m-85 -127.61 -5.77 5.81 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 115.452 1.649 . . . . 0.31 115.452 -168.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.704 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 11.5 ptmt -63.65 -28.18 69.73 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 108.033 -1.099 . . . . 1.35 108.033 170.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.4 m -48.77 -34.83 12.97 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 113.84 -1.527 . . . . 1.28 110.782 172.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -93.64 -30.91 14.7 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.679 0.276 . . . . 1.11 111.52 176.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.545 ' HA3' ' HB2' ' A' ' 36' ' ' SER . . . 144.79 -7.64 1.71 Allowed Glycine 0 CA--C 1.519 0.323 0 N-CA-C 111.431 -0.668 . . . . 0.18 111.431 -177.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.802 ' HE2' ' HB3' ' A' ' 60' ' ' LEU . 21.5 t80 -69.52 141.71 53.82 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 122.744 0.418 . . . . 0.18 111.122 -177.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.923 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 3.8 t -133.91 152.17 51.76 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 107.985 -1.117 . . . . 0.2 107.985 173.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 1.069 HG11 ' HB1' ' A' ' 57' ' ' ALA . 33.4 t -110.82 100.32 10.52 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.454 0 N-CA-C 108.158 -1.053 . . . . 0.17 108.158 159.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.813 HD23 ' HE2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -96.7 121.5 38.61 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 107.829 -1.174 . . . . 1.04 107.829 175.18 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 1.032 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -111.28 116.81 31.65 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 115.705 -0.679 . . . . 0.51 110.295 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.955 ' HD2' HD12 ' A' ' 108' ' ' ILE . 1.4 m-30 -89.66 108.07 22.89 Favored Pre-proline 0 C--N 1.314 -0.951 0 N-CA-C 107.918 -1.141 . . . . 0.44 107.918 173.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.948 ' HG2' ' HB3' ' A' ' 107' ' ' LYS . 73.2 Cg_endo -75.24 64.22 6.24 Favored 'Trans proline' 0 N--CA 1.476 0.459 0 C-N-CA 123.632 2.888 . . . . 1.3 115.199 -168.373 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.3 t 13.17 125.51 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 116.589 2.07 . . . . 1.44 116.589 175.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.505 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 22.3 p30 -79.85 70.54 6.4 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.074 -0.966 . . . . 1.81 109.045 174.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.649 ' HA ' ' HG3' ' A' ' 83' ' ' GLU . 74.5 mt-30 -48.99 -8.74 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 114.354 -1.294 . . . . 3.34 111.798 176.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.502 ' H ' ' C ' ' A' ' 77' ' ' ASN . 93.6 m-85 -64.22 -14.73 57.38 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.055 -0.975 . . . . 2.68 110.329 177.48 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.476 ' HA3' HE22 ' A' ' 82' ' ' GLN . . . -97.77 152.87 20.01 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 111.129 -0.788 . . . . 1.98 111.129 174.304 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.17 45.92 3.2 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.879 -0.677 . . . . 1.49 113.579 -175.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.741 ' HG3' ' HB3' ' A' ' 113' ' ' GLU . 4.1 pm0 -140.97 -16.27 0.87 Allowed 'General case' 0 C--N 1.324 -0.528 0 O-C-N 122.483 -0.422 . . . . 1.74 111.251 176.259 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.649 ' HG3' ' HA ' ' A' ' 78' ' ' GLN . 7.1 mm-40 -60.03 150.44 70.02 Favored Pre-proline 0 N--CA 1.464 0.273 0 CA-C-O 121.198 0.523 . . . . 3.07 112.153 -165.131 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.497 ' HB2' ' O ' ' A' ' 137' ' ' TRP . 83.7 Cg_endo -84.44 -15.28 6.39 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.174 2.583 . . . . 1.75 112.836 -168.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.638 ' HA3' ' HB2' ' A' ' 44' ' ' ALA . . . -86.27 69.98 3.06 Favored Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 110.864 -0.894 . . . . 2.2 110.864 175.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 68.21 -97.92 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.877 -0.786 . . . . 4.2 108.877 -172.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.455 ' O ' ' HB3' ' A' ' 78' ' ' GLN . 6.3 pt-20 170.23 -73.09 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 O-C-N 123.892 0.745 . . . . 3.02 110.089 175.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.435 ' H ' ' HG3' ' A' ' 87' ' ' GLU . 16.0 mm-40 -91.34 5.59 48.68 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 111.784 0.29 . . . . 3.92 111.784 -175.168 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.478 ' HA ' ' HG2' ' A' ' 92' ' ' GLU . 20.6 tt0 -58.64 -34.98 71.8 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.758 0.651 . . . . 2.65 112.758 -169.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.804 HG13 ' HD3' ' A' ' 91' ' ' LYS . 38.9 pt -81.46 -6.66 10.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.625 -0.43 . . . . 2.15 111.452 -178.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.804 ' HD3' HG13 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -105.08 -37.72 6.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.821 0.343 . . . . 2.79 110.557 177.073 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.478 ' HG2' ' HA ' ' A' ' 89' ' ' GLU . 15.9 pt-20 -79.17 -23.84 43.64 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.233 0.54 . . . . 3.29 109.816 177.267 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -131.27 133.71 45.68 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.842 -0.799 . . . . 3.42 108.842 176.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 53.0 t -60.67 109.66 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.021 0.439 . . . . 2.63 110.689 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.556 ' HB2' HG22 ' A' ' 90' ' ' ILE . 58.5 m -133.49 120.34 20.71 Favored 'General case' 0 CA--C 1.503 -0.827 0 CA-C-N 115.612 -0.722 . . . . 2.83 109.496 173.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.1 p -90.79 162.79 14.7 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 114.873 -1.058 . . . . 2.98 109.757 175.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 67.8 mttt -39.23 114.92 0.44 Allowed 'General case' 0 C--N 1.315 -0.907 0 O-C-N 124.248 0.967 . . . . 2.72 111.005 173.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.623 ' HB3' ' HA ' ' A' ' 45' ' ' SER . 0.0 OUTLIER -59.75 100.08 0.08 Allowed 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 108.507 -0.923 . . . . 2.12 108.507 171.398 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -94.57 132.4 39.3 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.521 -0.763 . . . . 2.69 109.044 177.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.6 ' HB2' ' CE1' ' A' ' 98' ' ' PHE . . . -128.91 -175.38 3.53 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.306 0.574 . . . . 0.55 112.011 -169.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -93.05 11.97 25.72 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.242 -0.89 . . . . 1.99 109.589 177.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.616 ' CE2' HD11 ' A' ' 104' ' ' ILE . 7.5 p90 -134.48 163.39 51.56 Favored Pre-proline 0 N--CA 1.444 -0.725 0 N-CA-C 108.175 -1.046 . . . . 0.84 108.175 178.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.806 ' HG2' ' HA ' ' A' ' 72' ' ' LEU . 26.4 Cg_endo -57.12 97.03 0.07 OUTLIER 'Trans proline' 0 N--CA 1.477 0.554 0 C-N-CA 123.57 2.847 . . . . 0.62 114.063 -173.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 1.032 HD12 ' HB3' ' A' ' 73' ' ' ALA . 7.6 mm -99.59 123.55 52.41 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.931 0 N-CA-C 107.969 -1.123 . . . . 1.34 107.969 173.08 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.842 ' HG3' ' CE1' ' A' ' 74' ' ' PHE . 13.5 mmt -100.99 -163.87 1.06 Allowed 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.304 -0.862 . . . . 3.03 111.791 -165.342 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.613 ' N ' ' HA ' ' A' ' 23' ' ' ALA . . . -71.37 4.07 3.24 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.228 -0.897 . . . . 1.46 113.337 -169.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.948 ' HB3' ' HG2' ' A' ' 75' ' ' PRO . 15.8 ptpt 53.77 123.57 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.048 0 CA-C-O 122.701 1.239 . . . . 1.76 111.5 -170.265 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.955 HD12 ' HD2' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -122.73 177.68 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.689 0 N-CA-C 108.249 -1.019 . . . . 0.82 108.249 171.183 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.792 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 0.1 OUTLIER -70.87 72.16 0.55 Allowed 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 114.46 -1.246 . . . . 1.73 111.252 179.946 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 110' ' ' VAL . 13.7 m -72.28 92.49 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 CA-C-O 122.338 1.066 . . . . 0.77 108.202 175.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.408 HD22 ' HD3' ' A' ' 84' ' ' PRO . 2.2 t-20 176.27 -177.05 0.13 Allowed 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 114.442 -1.254 . . . . 1.9 109.525 -175.072 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -91.47 18.97 50.31 Favored Glycine 0 N--CA 1.432 -1.591 0 N-CA-C 115.361 0.904 . . . . 1.47 115.361 -172.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.741 ' HB3' ' HG3' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -105.38 -45.96 4.33 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 119.494 1.647 . . . . 2.81 111.72 179.314 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.606 ' N ' ' HG3' ' A' ' 113' ' ' GLU . 28.8 t-20 -132.02 -37.34 1.14 Allowed 'General case' 0 CA--C 1.508 -0.646 0 C-N-CA 119.685 -0.806 . . . . 2.16 110.568 -177.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.792 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . 52.6 178.87 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.841 0.829 . . . . 1.26 110.875 -177.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.899 ' CB ' HG13 ' A' ' 108' ' ' ILE . 5.9 t-80 -113.56 136.61 21.97 Favored Pre-proline 0 N--CA 1.425 -1.717 0 N-CA-C 106.995 -1.483 . . . . 0.42 106.995 163.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -26.42 -46.28 0.07 OUTLIER 'Trans proline' 0 C--O 1.219 -0.471 0 C-N-CA 124.456 3.437 . . . . 0.4 113.592 178.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.898 HD11 ' HB ' ' A' ' 15' ' ' ILE . 42.3 tp -61.63 -51.64 67.64 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.168 0.587 . . . . 0.39 112.251 177.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 1.078 ' OH ' HG22 ' A' ' 40' ' ' ILE . 46.5 m-85 -79.74 -33.39 40.84 Favored 'General case' 0 CA--C 1.489 -1.403 0 CA-C-O 121.238 0.542 . . . . 3.04 109.789 -177.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.491 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 13.3 tt0 -56.41 -40.7 75.12 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 107.017 -1.475 . . . . 2.44 107.017 172.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.806 ' HB2' ' HE2' ' A' ' 18' ' ' PHE . 88.8 t80 -65.97 -33.91 76.9 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 114.915 -1.038 . . . . 0.56 110.203 174.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.688 ' HE3' ' HG ' ' A' ' 118' ' ' LEU . 2.1 ttm -75.36 -54.93 6.24 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.207 -0.451 . . . . 0.71 110.955 -168.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.655 ' HD2' ' HB1' ' A' ' 134' ' ' ALA . 0.1 OUTLIER -68.77 -26.11 65.05 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 116.13 -0.486 . . . . 1.46 110.904 178.349 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.491 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 12.6 pttp -74.95 -26.71 59.8 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 119.587 -0.845 . . . . 1.99 109.838 177.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.47 HG21 ' HG2' ' A' ' 150' ' ' PRO . 52.6 m -71.45 -57.69 4.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.832 -0.622 . . . . 0.59 111.359 177.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.738 ' HG2' ' H ' ' A' ' 128' ' ' GLY . 42.8 tttp -146.51 130.23 8.39 Favored Pre-proline 0 N--CA 1.452 -0.374 0 C-N-CA 120.181 -0.607 . . . . 1.85 112.294 -174.006 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.723 ' HA ' ' NH2' ' A' ' 153' ' ' ARG . 12.9 Cg_exo -71.57 -2.31 11.14 Favored 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 123.51 2.806 . . . . 1.69 111.803 171.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.738 ' H ' ' HG2' ' A' ' 126' ' ' LYS . . . 96.37 -143.13 16.53 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.942 -0.572 . . . . 2.59 111.9 178.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 31.7 pt -102.63 3.03 10.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.151 0.5 . . . . 3.58 110.454 177.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.632 HD23 ' H ' ' A' ' 130' ' ' LEU . 2.4 pt? -124.98 153.86 42.11 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.729 -0.668 . . . . 3.47 109.686 -177.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -81.51 76.65 8.43 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.098 0.475 . . . . 3.28 110.46 -178.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.556 HG21 ' HZ3' ' A' ' 137' ' ' TRP . 40.4 m -140.57 126.55 19.5 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.002 -0.544 . . . . 3.56 110.049 178.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.428 ' HB2' ' HE3' ' A' ' 133' ' ' LYS . 39.8 mtmt -43.66 -73.79 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.836 0.68 . . . . 5.17 112.836 -173.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.655 ' HB1' ' HD2' ' A' ' 123' ' ' LYS . . . -146.12 101.72 3.54 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.133 -0.485 . . . . 1.59 112.296 -168.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.835 ' HA ' HG21 ' A' ' 140' ' ' THR . 5.3 mt 67.01 -78.93 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 O-C-N 123.72 0.637 . . . . 2.0 110.543 173.124 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.722 ' HB3' ' CE3' ' A' ' 137' ' ' TRP . 2.1 tmtp? 73.13 -30.7 0.21 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.856 1.263 . . . . 4.81 112.489 175.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.722 ' CE3' ' HB3' ' A' ' 136' ' ' LYS . 10.7 m-90 -111.86 174.51 5.84 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.51 0.671 . . . . 1.97 112.492 -174.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.612 ' HB3' ' HB3' ' A' ' 156' ' ' PRO . 8.5 t-20 -39.46 -154.93 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.895 1.678 . . . . 2.04 112.064 157.376 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.714 ' CG ' HG12 ' A' ' 43' ' ' VAL . 2.2 m-85 -27.96 -44.96 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 115.66 1.726 . . . . 1.93 115.66 -166.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.835 HG21 ' HA ' ' A' ' 135' ' ' ILE . 26.9 m 33.87 97.38 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.793 1.035 . . . . 0.6 113.793 171.204 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.644 ' HB3' HD23 ' A' ' 39' ' ' LEU . 5.0 m -86.45 170.82 11.62 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.534 -1.212 . . . . 0.62 111.892 -171.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.877 ' HE2' HD21 ' A' ' 42' ' ' ASN . 88.8 m-85 -133.39 121.87 22.93 Favored 'General case' 0 CA--C 1.489 -1.366 0 N-CA-C 106.111 -1.811 . . . . 0.57 106.111 162.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.825 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 7.7 tp -79.6 104.56 10.28 Favored 'General case' 0 N--CA 1.422 -1.838 0 C-N-CA 118.089 -1.444 . . . . 0.43 108.291 178.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.743 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 47.9 mm -89.62 140.28 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.938 0 CA-C-N 112.709 -2.041 . . . . 0.19 107.731 -178.097 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.613 ' OD1' HG12 ' A' ' 149' ' ' VAL . 0.0 OUTLIER -91.94 -174.23 3.73 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 119.588 -0.845 . . . . 0.98 111.61 -170.276 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.758 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 35.8 mtt85 -56.28 -38.39 71.14 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 122.468 0.307 . . . . 2.22 111.556 -176.282 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -100.76 21.39 13.61 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.036 -1.098 . . . . 2.0 108.036 -178.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.651 ' HA2' HG22 ' A' ' 144' ' ' ILE . . . 69.31 37.45 80.3 Favored Glycine 0 N--CA 1.435 -1.388 0 CA-C-N 114.661 -1.154 . . . . 0.17 115.263 176.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.613 HG12 ' OD1' ' A' ' 145' ' ' ASP . 4.3 p -106.69 122.05 43.1 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 119.469 1.634 . . . . 1.12 110.806 171.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.624 ' HD3' HG23 ' A' ' 15' ' ' ILE . 11.6 Cg_endo -64.64 124.17 12.82 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 123.253 2.636 . . . . 0.41 111.468 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.9 m -124.54 -9.43 6.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 120.758 0.313 . . . . 1.45 110.468 -177.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.825 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 19.9 mm-40 -142.82 166.06 25.68 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 121.266 0.555 . . . . 1.17 110.861 175.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.723 ' NH2' ' HA ' ' A' ' 127' ' ' PRO . 5.8 ttm180 -148.14 135.61 20.62 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.551 -1.204 . . . . 2.16 108.849 166.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.743 ' O ' ' HA ' ' A' ' 140' ' ' THR . 97.2 m-85 -117.23 155.05 30.09 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.08 -0.711 . . . . 0.32 109.08 -169.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.441 ' HB3' ' HD2' ' A' ' 156' ' ' PRO . 22.3 m -83.22 163.04 52.22 Favored Pre-proline 0 C--N 1.316 -0.857 0 N-CA-C 109.497 -0.557 . . . . 1.11 109.497 175.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.706 ' HB2' ' HB3' ' A' ' 51' ' ' LYS . 20.1 Cg_endo -60.48 -31.13 92.1 Favored 'Trans proline' 0 CA--C 1.52 -0.176 0 C-N-CA 122.238 1.959 . . . . 0.78 110.681 174.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -68.97 -16.55 70.67 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 114.367 -1.288 . . . . 0.5 112.938 174.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.402 ' HB3' ' HB3' ' A' ' 154' ' ' PHE . . . -76.84 137.52 39.25 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 108.572 -0.899 . . . . 0.5 108.572 176.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.485 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 6.0 m -116.37 -177.06 3.09 Favored 'General case' 0 N--CA 1.436 -1.156 0 C-N-CA 120.48 -0.488 . . . . 1.42 110.727 -170.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.653 HG22 ' HA ' ' A' ' 56' ' ' THR . 54.9 t -42.43 -50.28 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.23 -0.895 . . . . 0.28 111.799 -178.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -68.62 -35.05 76.79 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.046 0.451 . . . . 3.46 111.081 -174.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.411 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 15.9 m-20 -69.91 -34.9 74.11 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.644 0.735 . . . . 1.4 109.737 -177.323 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.548 HD12 HG21 ' A' ' 56' ' ' THR . 54.8 mt -81.03 -49.1 18.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 114.797 -1.092 . . . . 0.21 111.369 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.604 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 39.3 mt-10 -52.41 -42.78 64.36 Favored 'General case' 0 C--O 1.216 -0.685 0 O-C-N 123.211 0.319 . . . . 0.67 111.082 -176.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 12.7 pt-20 -56.51 -25.73 52.42 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.418 -0.355 . . . . 0.87 111.535 -175.202 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.436 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 31.1 mmtp -96.84 -31.1 12.78 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.645 0.736 . . . . 1.71 109.857 176.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.604 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 14.7 tp -75.08 -48.56 23.29 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.302 -1.317 . . . . 0.16 112.149 -175.232 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.478 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 72.5 mt -56.31 -46.78 99.76 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.412 -0.813 . . . . 0.26 112.629 -172.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.478 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 73.4 Cg_exo -52.24 -26.02 25.52 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.233 1.956 . . . . 0.41 112.738 174.115 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.779 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 89.6 mt -89.92 -46.82 8.27 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 122.334 -0.228 . . . . 0.71 111.294 178.265 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.732 HD23 ' HG2' ' A' ' 37' ' ' PRO . 93.0 mt -59.22 -55.84 29.77 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-O 122.119 0.961 . . . . 0.34 109.874 176.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -74.58 -44.04 27.76 Favored Glycine 0 N--CA 1.43 -1.701 0 CA-C-N 113.332 -1.758 . . . . 1.12 113.473 -174.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 86.8 p 54.67 -148.91 0.46 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.09 0.556 . . . . 2.64 110.794 -175.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -92.99 -4.11 53.25 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.974 0.416 . . . . 4.35 110.586 176.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 61.1 mtt180 -90.53 131.6 36.17 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.906 -0.588 . . . . 8.45 111.117 -174.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.2 mm? . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.545 -0.74 . . . . 7.69 109.49 177.142 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.818 0 N-CA-C 112.155 -0.378 . . . . 5.22 112.155 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.8 ttt -84.29 78.49 9.79 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.083 0.468 . . . . 4.85 109.79 176.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -98.35 140.4 15.0 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.588 -0.815 . . . . 1.55 112.192 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.1 t -93.52 -0.25 56.39 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.187 0.517 . . . . 1.58 109.698 176.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.9 m -159.02 155.41 27.42 Favored 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 105.534 -2.024 . . . . 1.17 105.534 -176.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.903 ' HB ' HD11 ' A' ' 118' ' ' LEU . 5.9 pt -57.73 -18.91 10.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-N 115.011 -0.995 . . . . 0.38 111.805 -177.164 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.83 ' HB3' HG13 ' A' ' 31' ' ' VAL . 26.1 m-85 -70.16 -0.01 7.04 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.998 0.74 . . . . 0.3 112.998 -173.543 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -78.67 -17.09 56.48 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.429 -0.952 . . . . 2.11 108.429 177.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.63 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 39.8 m-85 -111.98 112.2 23.67 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 114.56 -1.2 . . . . 0.31 111.636 -172.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -45.21 137.02 4.76 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 113.599 -1.637 . . . . 2.86 111.072 172.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.864 HG13 ' HZ ' ' A' ' 74' ' ' PHE . 65.3 t -112.19 164.47 8.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 107.877 -1.157 . . . . 0.67 107.877 178.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.706 HD23 ' HA ' ' A' ' 27' ' ' PRO . 60.0 mt -130.85 157.68 42.22 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.692 0.282 . . . . 0.69 111.053 -177.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.533 ' HB3' ' HE3' ' A' ' 26' ' ' LYS . 20.5 t70 -85.18 172.94 10.8 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 106.795 -1.558 . . . . 1.87 106.795 163.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.695 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . . . -62.78 -3.83 1.76 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.28 0.844 . . . . 0.59 113.28 -170.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.674 ' HB2' ' HE2' ' A' ' 26' ' ' LYS . 47.7 m-20 -117.05 17.42 14.89 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.764 -0.374 . . . . 2.34 111.526 176.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.464 ' HA ' HD13 ' A' ' 21' ' ' LEU . 91.5 m-70 74.55 15.02 3.43 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-O 121.839 0.828 . . . . 1.47 109.17 174.011 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.674 ' HE2' ' HB2' ' A' ' 24' ' ' ASP . 35.2 mtmt -77.81 109.15 8.9 Favored Pre-proline 0 N--CA 1.446 -0.634 0 N-CA-C 107.367 -1.345 . . . . 4.25 107.367 169.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.706 ' HA ' HD23 ' A' ' 21' ' ' LEU . 93.7 Cg_exo -48.39 116.22 1.94 Allowed 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.503 2.135 . . . . 0.54 113.501 -171.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.799 ' OH ' ' HB3' ' A' ' 103' ' ' PRO . 0.2 OUTLIER -76.45 146.73 38.37 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 113.721 -1.581 . . . . 1.2 111.649 176.273 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.696 ' ND2' ' HB3' ' A' ' 32' ' ' GLN . 58.6 t30 -84.9 96.69 9.42 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.171 -0.922 . . . . 1.51 109.597 175.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.702 HD13 HG21 ' A' ' 20' ' ' VAL . 61.4 tp -79.13 -45.99 18.89 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.877 -0.601 . . . . 0.28 110.914 -177.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.849 HG12 ' HE2' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -65.31 -0.08 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.435 0 CA-C-N 115.611 -0.722 . . . . 1.02 112.771 -173.594 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.696 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . 13.0 pt20 -76.71 -12.49 60.0 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 119.832 -0.747 . . . . 1.02 109.323 175.329 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.934 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 92.8 m-70 -92.98 24.75 3.53 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 122.405 1.098 . . . . 0.28 108.685 175.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.849 ' HE2' HG12 ' A' ' 31' ' ' VAL . 36.8 mttm -77.67 109.73 11.9 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 113.419 -1.718 . . . . 1.56 109.446 170.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.35 -38.04 2.48 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 120.191 -1.004 . . . . 0.2 112.348 177.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.479 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 17.1 m -126.98 133.77 25.4 Favored Pre-proline 0 N--CA 1.437 -1.082 0 N-CA-C 108.748 -0.834 . . . . 0.29 108.748 172.07 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.724 ' HG3' ' CB ' ' A' ' 170' ' ' LEU . 5.3 Cg_endo -44.27 158.13 0.15 Allowed 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 124.136 3.224 . . . . 0.18 112.732 176.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.809 ' HB2' HG22 ' A' ' 70' ' ' THR . 1.0 OUTLIER -145.14 141.2 28.55 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.296 -1.372 . . . . 0.31 107.296 -179.215 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 1.015 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 2.2 mm? -106.38 112.96 26.2 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.838 -0.801 . . . . 1.19 108.838 178.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.705 HG13 HG13 ' A' ' 144' ' ' ILE . 1.3 mt -96.59 123.98 49.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 109.403 -0.591 . . . . 0.37 109.403 176.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 1.015 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.5 OUTLIER -110.68 131.2 55.26 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.433 -0.349 . . . . 0.42 110.561 -174.552 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.508 ' HB2' HG21 ' A' ' 110' ' ' VAL . 0.6 OUTLIER -79.1 117.53 20.22 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 105.874 -1.898 . . . . 2.35 105.874 166.598 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.702 HG23 ' HA ' ' A' ' 75' ' ' PRO . 35.0 m -126.39 155.74 36.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 O-C-N 120.973 -1.079 . . . . 1.03 111.603 -172.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.511 ' HB1' HD13 ' A' ' 90' ' ' ILE . . . -103.75 103.27 13.14 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.363 -0.835 . . . . 0.88 109.955 176.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.562 ' HA ' ' HB3' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -28.36 139.12 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 114.134 -1.394 . . . . 1.78 113.317 174.177 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -55.19 96.47 0.02 OUTLIER 'General case' 0 C--O 1.234 0.25 0 CA-C-N 114.567 -1.197 . . . . 5.84 112.872 -172.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.77 ' HB3' HG22 ' A' ' 90' ' ' ILE . 37.4 t -164.04 118.43 1.49 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.974 -1.012 . . . . 3.55 108.879 169.137 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 100.87 -74.52 0.4 Allowed Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.717 -0.754 . . . . 2.91 112.624 178.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.579 ' HE2' ' HD3' ' A' ' 51' ' ' LYS . 66.4 t80 -164.37 139.31 5.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.105 0.478 . . . . 4.63 111.305 -178.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 15.3 p -117.52 126.48 52.65 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.39 -0.823 . . . . 1.93 109.849 175.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.579 ' HD3' ' HE2' ' A' ' 49' ' ' TYR . 0.3 OUTLIER -66.36 167.72 10.04 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 109.922 -0.399 . . . . 2.01 109.922 178.447 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -55.97 -10.46 3.64 Favored Glycine 0 C--N 1.335 0.519 0 O-C-N 123.29 0.368 . . . . 0.51 113.713 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.409 ' HA2' ' HB ' ' A' ' 56' ' ' THR . . . -55.58 -24.13 38.27 Favored Glycine 0 C--O 1.223 -0.562 0 C-N-CA 121.604 -0.331 . . . . 0.5 112.557 175.219 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.433 ' CZ ' ' CE1' ' A' ' 98' ' ' PHE . 0.2 OUTLIER -63.65 -50.3 69.85 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.345 -0.613 . . . . 0.7 109.345 175.879 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -61.85 -29.98 70.54 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.292 -0.867 . . . . 2.61 109.813 177.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.576 ' CG2' HD12 ' A' ' 163' ' ' ILE . 67.1 m -73.6 -59.07 2.89 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 114.177 -1.374 . . . . 0.33 110.133 -175.276 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.998 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -59.13 -43.42 92.0 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.664 -1.153 . . . . 0.22 111.129 -178.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.496 ' HA ' ' CD1' ' A' ' 102' ' ' PHE . 54.3 m -55.53 -58.0 9.59 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.572 0.701 . . . . 0.26 110.599 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 86.5 m -68.25 -38.61 81.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.745 -1.116 . . . . 0.48 111.772 -176.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.759 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 16.2 mt -63.05 -48.65 77.8 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 121.499 0.666 . . . . 0.43 110.293 -177.246 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.861 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 10.6 t80 -59.35 -48.71 80.6 Favored 'General case' 0 C--O 1.203 -1.345 0 CA-C-N 114.718 -1.128 . . . . 0.31 110.881 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -73.52 -23.94 60.08 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 120.577 0.227 . . . . 1.21 110.686 -173.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.416 ' HB2' ' HE2' ' A' ' 63' ' ' LYS . 24.2 ttmm -84.4 -25.42 29.08 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 108.687 -0.857 . . . . 1.54 108.687 -177.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.718 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 44.5 m-85 -127.88 -2.21 5.92 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 115.583 1.697 . . . . 0.31 115.583 -170.197 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.678 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 15.0 pttp -67.26 -24.99 65.85 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 108.332 -0.988 . . . . 1.35 108.332 171.506 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.8 m -47.99 -38.01 16.01 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 114.035 -1.439 . . . . 1.28 110.978 173.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -86.61 -37.69 17.84 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 111.915 0.339 . . . . 1.11 111.915 174.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 149.83 -4.41 0.64 Allowed Glycine 0 N--CA 1.45 -0.367 0 N-CA-C 111.265 -0.734 . . . . 0.18 111.265 -177.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.759 ' HE2' ' HB3' ' A' ' 60' ' ' LEU . 22.9 t80 -67.6 141.36 56.81 Favored 'General case' 0 C--O 1.22 -0.461 0 C-N-CA 122.794 0.437 . . . . 0.18 111.323 -178.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.934 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 1.5 t -135.92 144.56 45.55 Favored 'General case' 0 CA--C 1.487 -1.476 0 N-CA-C 109.016 -0.735 . . . . 0.2 109.016 173.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.998 HG11 ' HB1' ' A' ' 57' ' ' ALA . 38.6 t -104.07 101.37 12.17 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.199 0 N-CA-C 108.613 -0.884 . . . . 0.17 108.613 160.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.691 ' HA ' ' HG2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -96.11 121.66 38.11 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 118.475 -1.29 . . . . 1.04 108.113 173.174 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.999 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -108.64 140.05 42.57 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.405 0.621 . . . . 0.51 110.351 179.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.864 ' HZ ' HG13 ' A' ' 20' ' ' VAL . 6.4 m-30 -115.31 110.39 45.36 Favored Pre-proline 0 C--N 1.311 -1.091 0 CA-C-N 115.507 -0.77 . . . . 0.44 109.234 -177.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.702 ' HA ' HG23 ' A' ' 43' ' ' VAL . 60.4 Cg_endo -78.18 46.58 2.13 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.567 2.844 . . . . 1.3 115.454 -164.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.474 ' O ' ' HD3' ' A' ' 107' ' ' LYS . 73.6 p 40.11 137.54 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 117.215 2.302 . . . . 1.44 117.215 176.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.5 ' OD1' ' HB3' ' A' ' 79' ' ' PHE . 50.7 t-20 -87.32 64.34 8.21 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 113.556 -1.656 . . . . 1.81 107.605 177.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.683 ' HA ' ' HG2' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -56.4 -14.32 2.9 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 114.007 -1.451 . . . . 3.34 110.578 176.779 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.5 ' HB3' ' OD1' ' A' ' 77' ' ' ASN . 77.9 t80 -69.78 -21.8 63.39 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 114.04 -1.436 . . . . 2.68 110.957 -178.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.06 -45.39 9.02 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.585 -0.734 . . . . 1.98 111.51 178.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.68 38.07 3.54 Favored Glycine 0 CA--C 1.506 -0.498 0 C-N-CA 120.895 -0.669 . . . . 1.49 112.902 177.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -145.76 27.79 1.19 Allowed 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.769 -0.456 . . . . 1.74 109.769 174.152 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.683 ' HG2' ' HA ' ' A' ' 78' ' ' GLN . 1.2 mm-40 -81.65 146.38 56.63 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-O 121.73 0.776 . . . . 3.07 111.789 -173.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.42 -41.33 1.24 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 124.375 3.384 . . . . 1.75 112.7 -173.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -112.05 135.75 12.99 Favored Glycine 0 N--CA 1.437 -1.276 0 C-N-CA 120.884 -0.674 . . . . 2.2 111.975 -175.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.631 ' HB3' ' HB3' ' A' ' 89' ' ' GLU . 2.4 m-20 59.37 40.47 20.95 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.225 0.536 . . . . 4.2 110.147 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -47.59 -42.45 23.97 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 114.508 -1.224 . . . . 3.02 112.775 -176.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -103.87 -7.26 20.61 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.348 0.594 . . . . 3.92 110.384 -172.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.631 ' HB3' ' HB3' ' A' ' 86' ' ' ASN . 12.2 tp10 -91.48 -62.33 1.46 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.546 -0.752 . . . . 2.65 112.265 -172.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.77 HG22 ' HB3' ' A' ' 47' ' ' CYS . 18.7 pt -83.58 6.86 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 112.95 0.722 . . . . 2.15 112.95 -167.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 42.0 mtmt -85.57 -68.06 0.76 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.991 0.424 . . . . 2.79 110.658 178.138 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -82.49 -15.3 52.96 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.489 -0.778 . . . . 3.29 111.264 -174.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -105.98 144.83 32.15 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.142 -0.688 . . . . 3.42 109.142 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 6.0 p -67.71 111.74 2.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.915 0.864 . . . . 2.63 112.033 -175.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.556 ' HA ' ' HB2' ' A' ' 47' ' ' CYS . 9.1 p -106.76 121.66 44.82 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 114.826 -1.079 . . . . 2.83 109.501 173.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 12.2 p -68.74 139.54 55.34 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.806 -0.812 . . . . 2.98 108.806 174.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.565 ' HD3' ' HB1' ' A' ' 23' ' ' ALA . 18.6 ptpt -62.4 105.04 0.56 Allowed 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.306 -0.998 . . . . 2.72 108.306 178.041 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.817 ' CE1' ' HB2' ' A' ' 100' ' ' ALA . 0.0 OUTLIER -53.94 114.28 1.53 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.628 -1.169 . . . . 2.12 111.537 -170.578 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -107.95 136.27 47.95 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.221 -0.899 . . . . 2.69 109.118 175.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.817 ' HB2' ' CE1' ' A' ' 98' ' ' PHE . . . -134.64 -166.04 1.75 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.226 0.536 . . . . 0.55 111.826 -173.275 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -85.33 8.74 17.59 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.166 -0.925 . . . . 1.99 109.876 175.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.613 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 16.9 p90 -138.81 161.22 59.53 Favored Pre-proline 0 N--CA 1.442 -0.842 0 CA-C-N 115.588 -0.733 . . . . 0.84 109.619 -178.03 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.799 ' HB3' ' OH ' ' A' ' 28' ' ' TYR . 18.2 Cg_endo -57.41 110.98 0.69 Allowed 'Trans proline' 0 CA--C 1.51 -0.701 0 C-N-CA 124.122 3.215 . . . . 0.62 114.1 -175.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.999 HD12 ' HB3' ' A' ' 73' ' ' ALA . 7.0 mm -108.56 134.24 51.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 C-N-CA 119.925 -0.71 . . . . 1.34 109.227 172.155 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.833 ' HG2' ' CG ' ' A' ' 74' ' ' PHE . 0.0 OUTLIER -89.54 -177.08 5.22 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.988 -0.551 . . . . 3.03 109.657 179.577 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.695 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . . . -57.25 -51.53 68.97 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.241 0.544 . . . . 1.46 110.418 -177.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.695 ' HB3' ' HG2' ' A' ' 75' ' ' PRO . 13.9 ptpt 128.57 121.96 0.0 OUTLIER 'General case' 0 CA--C 1.492 -1.28 0 C-N-CA 127.407 2.283 . . . . 1.76 106.036 -176.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.637 HD11 ' HD2' ' A' ' 74' ' ' PHE . 2.1 pp -129.41 156.58 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.242 0 N-CA-C 106.161 -1.792 . . . . 0.82 106.161 177.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.8 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 2.5 t-20 -52.06 117.82 3.04 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 123.696 0.623 . . . . 1.73 109.942 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.508 HG21 ' HB2' ' A' ' 42' ' ' ASN . 3.5 m -113.67 86.83 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.621 0 N-CA-C 107.625 -1.25 . . . . 0.77 107.625 169.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 173.4 -175.6 0.06 Allowed 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 113.844 -1.525 . . . . 1.9 109.435 -178.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -35.62 -54.57 1.06 Allowed Glycine 0 CA--C 1.507 -0.413 0 N-CA-C 118.199 2.039 . . . . 1.47 118.199 178.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.16 -45.79 25.55 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 117.215 -1.794 . . . . 2.81 114.366 -148.161 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -129.58 -33.41 1.86 Allowed 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.104 -0.702 . . . . 2.16 109.104 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.8 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . 47.48 -166.78 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.169 -1.378 . . . . 1.26 109.594 -167.361 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.582 ' HB2' ' HB ' ' A' ' 108' ' ' ILE . 6.4 t-80 -113.83 138.03 22.56 Favored Pre-proline 0 N--CA 1.419 -2.006 0 N-CA-C 107.166 -1.42 . . . . 0.42 107.166 162.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.581 ' HB2' ' CD1' ' A' ' 18' ' ' PHE . 11.5 Cg_exo -33.9 -41.35 0.2 Allowed 'Trans proline' 0 C--O 1.218 -0.483 0 C-N-CA 123.872 3.048 . . . . 0.4 113.099 -178.061 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.911 ' HG ' ' HE3' ' A' ' 122' ' ' MET . 33.5 tp -63.65 -48.53 76.86 Favored 'General case' 0 C--O 1.222 -0.369 0 C-N-CA 123.208 0.603 . . . . 0.39 111.726 176.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.689 ' HA ' ' HB2' ' A' ' 122' ' ' MET . 23.3 m-85 -78.04 -34.36 50.59 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 111.944 0.35 . . . . 3.04 111.944 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.686 ' HG2' ' HB3' ' A' ' 115' ' ' ALA . 0.8 OUTLIER -60.32 -35.82 76.51 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 106.809 -1.552 . . . . 2.44 106.809 171.617 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.63 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 55.1 t80 -70.29 -30.69 67.76 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 119.525 -0.87 . . . . 0.56 110.051 173.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.911 ' HE3' ' HG ' ' A' ' 118' ' ' LEU . 1.5 ttm -76.15 -54.58 6.6 Favored 'General case' 0 CA--C 1.509 -0.616 0 C-N-CA 120.388 -0.525 . . . . 0.71 110.479 -169.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.623 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -70.78 -25.43 62.89 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.297 -0.41 . . . . 1.46 111.437 179.398 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.52 ' N ' ' HD3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -71.67 -29.0 64.12 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 119.552 -0.859 . . . . 1.99 109.609 178.244 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 27.1 m -92.21 -24.94 18.88 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.571 -0.741 . . . . 0.59 111.52 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.484 ' HE2' ' HA ' ' A' ' 151' ' ' VAL . 23.5 mmtm -146.41 106.49 4.09 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 112.387 0.514 . . . . 1.85 112.387 -173.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.68 ' HA ' ' NH2' ' A' ' 153' ' ' ARG . 3.6 Cg_exo -79.9 -10.28 14.13 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.654 2.236 . . . . 1.69 110.978 167.102 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.707 ' HA3' ' HB3' ' A' ' 153' ' ' ARG . . . 87.52 -140.93 17.01 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.758 -0.656 . . . . 2.59 113.65 170.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 25.6 pt -67.78 -21.04 26.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 112.237 0.458 . . . . 3.58 112.237 -175.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.3 pp -136.02 141.01 44.29 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.745 -0.382 . . . . 3.47 110.534 178.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.21 97.47 0.54 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.778 -0.646 . . . . 3.28 111.341 -178.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.557 ' O ' ' HB3' ' A' ' 127' ' ' PRO . 14.8 t -142.21 -164.6 1.84 Allowed 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.375 -0.602 . . . . 3.56 109.375 177.015 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.422 ' HE2' ' HB3' ' A' ' 133' ' ' LYS . 52.4 mtpt -89.15 -90.6 0.13 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.495 0.664 . . . . 5.17 111.175 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.491 ' HA ' ' CB ' ' A' ' 123' ' ' LYS . . . -92.74 172.34 8.41 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.246 -0.888 . . . . 1.59 111.665 -173.19 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.752 ' O ' ' HB2' ' A' ' 136' ' ' LYS . 0.1 OUTLIER -36.05 -37.78 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 O-C-N 124.552 1.157 . . . . 2.0 113.039 -176.12 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.862 ' HB3' ' CE3' ' A' ' 137' ' ' TRP . 28.1 mtmt 108.12 -65.28 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 124.902 1.281 . . . . 4.81 112.752 177.253 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.862 ' CE3' ' HB3' ' A' ' 136' ' ' LYS . 0.7 OUTLIER -121.14 -175.81 3.14 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.139 -1.391 . . . . 1.97 111.122 -156.837 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.48 ' HB3' ' H ' ' A' ' 139' ' ' PHE . 12.7 m120 -35.56 -153.6 0.0 OUTLIER 'General case' 0 C--O 1.207 -1.168 0 CA-C-N 114.527 -1.215 . . . . 2.04 112.409 155.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.694 ' O ' ' HB3' ' A' ' 41' ' ' TYR . 0.9 OUTLIER -29.65 -21.97 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 117.495 2.406 . . . . 1.93 117.495 -172.162 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.674 ' HA ' ' O ' ' A' ' 154' ' ' PHE . 0.2 OUTLIER -7.58 120.32 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 120.141 1.337 . . . . 0.6 114.559 173.948 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.61 ' O ' ' HA ' ' A' ' 153' ' ' ARG . 1.0 OUTLIER -104.9 163.63 12.38 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.33 -1.305 . . . . 0.62 111.101 -167.971 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.567 ' CE2' HG23 ' A' ' 135' ' ' ILE . 97.4 m-85 -125.1 123.24 39.3 Favored 'General case' 0 CA--C 1.491 -1.32 0 N-CA-C 106.28 -1.748 . . . . 0.57 106.28 166.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.748 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 5.0 tp -79.46 102.25 8.66 Favored 'General case' 0 N--CA 1.425 -1.713 0 C-N-CA 118.242 -1.383 . . . . 0.43 108.157 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.705 HG13 HG13 ' A' ' 40' ' ' ILE . 39.1 mm -88.24 141.4 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 CA-C-N 113.8 -1.546 . . . . 0.19 107.611 -177.127 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.457 ' HA ' HD13 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -95.81 -174.83 3.24 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 119.359 -0.936 . . . . 0.98 111.234 -168.377 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.581 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 57.0 mtm180 -55.13 -40.11 70.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.818 0.342 . . . . 2.22 111.619 -176.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -92.44 14.39 16.79 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 109.443 -0.577 . . . . 2.0 109.443 -178.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.548 ' HA2' HG22 ' A' ' 144' ' ' ILE . . . 73.6 33.87 57.64 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 121.211 -0.519 . . . . 0.17 113.601 -178.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.447 ' HA ' ' HD2' ' A' ' 150' ' ' PRO . 31.7 t -107.41 107.39 60.33 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 117.961 0.88 . . . . 1.12 111.239 176.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.697 ' HD3' HG23 ' A' ' 15' ' ' ILE . 5.9 Cg_exo -47.4 125.3 10.49 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 123.888 3.059 . . . . 0.41 112.158 173.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.484 ' HA ' ' HE2' ' A' ' 126' ' ' LYS . 44.2 t -116.13 -37.12 2.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 109.046 -0.724 . . . . 1.45 109.046 -177.164 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.748 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 6.8 mm-40 -130.86 167.07 19.55 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 115.612 -0.722 . . . . 1.17 111.665 -175.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.707 ' HB3' ' HA3' ' A' ' 128' ' ' GLY . 20.4 ttm180 -138.87 133.07 31.47 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.022 -0.99 . . . . 2.16 109.655 165.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.674 ' O ' ' HA ' ' A' ' 140' ' ' THR . 96.3 m-85 -117.03 137.25 52.37 Favored 'General case' 0 C--O 1.213 -0.837 0 CA-C-N 116.336 -0.393 . . . . 0.32 109.982 -172.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.568 ' HA ' HG23 ' A' ' 140' ' ' THR . 37.4 m -67.13 153.43 94.63 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 109.381 -0.6 . . . . 1.11 109.381 179.215 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.665 ' HG3' ' HB3' ' A' ' 137' ' ' TRP . 10.0 Cg_endo -53.26 -48.27 22.94 Favored 'Trans proline' 0 N--CA 1.473 0.272 0 C-N-CA 122.647 2.232 . . . . 0.78 112.732 -174.167 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -67.05 10.34 0.84 Allowed Glycine 0 CA--C 1.527 0.841 0 N-CA-C 114.937 0.735 . . . . 0.5 114.937 176.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -74.45 146.21 43.02 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-N 118.481 1.141 . . . . 0.5 108.669 171.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.552 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 90.9 p -102.61 171.61 7.33 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 120.513 -0.475 . . . . 1.42 109.864 -174.059 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.574 HG22 ' HA ' ' A' ' 56' ' ' THR . 58.3 t -42.28 -48.97 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 O-C-N 124.202 0.939 . . . . 0.28 110.767 175.077 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.46 ' HE3' ' HB2' ' A' ' 161' ' ' LYS . 37.2 ttmt -71.75 -31.89 67.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.429 -0.805 . . . . 3.46 111.249 -172.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -67.03 -38.0 85.13 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.565 0.698 . . . . 1.4 109.634 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.576 HD12 ' CG2' ' A' ' 56' ' ' THR . 73.8 mt -82.3 -39.8 16.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 114.903 -1.044 . . . . 0.21 111.022 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.556 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 30.2 mt-10 -53.4 -44.54 68.76 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-O 120.503 0.192 . . . . 0.67 111.478 -178.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -57.15 -24.8 56.79 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.956 0.354 . . . . 0.87 111.956 -174.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.626 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 44.0 mmtm -98.15 -24.86 15.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.532 0.682 . . . . 1.71 109.987 175.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.556 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 10.0 tp -78.4 -50.09 12.35 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.97 -1.014 . . . . 0.16 112.353 -177.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.478 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 70.6 mt -55.61 -46.63 99.7 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 115.499 -0.773 . . . . 0.26 112.352 -173.233 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.478 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 53.3 Cg_exo -54.92 -26.76 50.36 Favored 'Trans proline' 0 C--N 1.356 0.921 0 C-N-CA 122.128 1.885 . . . . 0.41 112.669 174.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.724 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 62.4 mt -86.32 -42.48 13.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.725 -0.216 . . . . 0.71 111.267 177.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.703 HD23 ' HG2' ' A' ' 37' ' ' PRO . 97.3 mt -60.04 -54.11 49.84 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 122.127 0.965 . . . . 0.34 109.53 176.011 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -69.74 -1.95 34.12 Favored Glycine 0 N--CA 1.439 -1.106 0 CA-C-N 113.365 -1.743 . . . . 1.12 113.142 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 60.6 m 56.48 78.09 0.23 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.375 0.67 . . . . 2.64 112.558 175.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -66.95 -29.57 69.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.854 -0.612 . . . . 4.35 110.314 172.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -112.59 159.42 18.86 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.599 -0.728 . . . . 8.45 109.474 176.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 41.9 tp . . . . . 0 C--O 1.246 0.895 0 CA-C-O 118.632 -0.699 . . . . 7.69 110.368 -178.967 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.765 0 N-CA-C 111.924 -0.471 . . . . 5.22 111.924 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 95.7 mmm -104.4 0.12 28.67 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.455 0.645 . . . . 4.85 109.652 178.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 130.89 83.35 0.28 Allowed Glycine 0 N--CA 1.441 -1.015 0 CA-C-N 115.081 -0.963 . . . . 1.55 111.416 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 43.6 t -119.7 1.6 11.08 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.993 0.425 . . . . 1.58 110.22 179.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 91.4 p 178.52 157.98 0.49 Allowed 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 105.823 -1.918 . . . . 1.17 105.823 -177.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.818 HG23 ' HD3' ' A' ' 150' ' ' PRO . 6.7 pt -67.66 -17.63 22.72 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 CA-C-N 114.949 -1.023 . . . . 0.38 110.745 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.83 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 45.9 m-85 -74.74 -3.48 31.78 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 116.113 -0.494 . . . . 0.3 111.607 -176.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -67.14 -12.59 60.41 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.991 -1.114 . . . . 2.11 107.991 170.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.64 ' HE2' ' HB2' ' A' ' 121' ' ' TYR . 61.1 m-85 -129.07 109.81 11.5 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 114.794 -1.094 . . . . 0.31 110.007 -175.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -55.98 157.64 4.36 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 114.116 -1.402 . . . . 2.86 109.488 174.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.762 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 40.4 t -109.65 161.02 8.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 107.792 -1.188 . . . . 0.67 107.792 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.852 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 55.2 mt -126.09 122.49 35.91 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 120.552 -0.459 . . . . 0.69 109.901 -178.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.607 ' HA ' ' SD ' ' A' ' 105' ' ' MET . 0.8 OUTLIER -59.44 -175.85 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.387 0 O-C-N 124.31 1.006 . . . . 1.87 109.469 -179.179 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.717 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . . . -62.19 -3.93 1.52 Allowed 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 113.19 0.811 . . . . 0.59 113.19 -171.009 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -118.68 12.64 13.12 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.505 -0.478 . . . . 2.34 111.73 175.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.852 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 3.7 m-70 72.3 26.06 2.74 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.677 0.751 . . . . 1.47 110.266 174.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.43 ' HA ' ' HD3' ' A' ' 26' ' ' LYS . 54.2 mmtt -102.5 133.21 20.65 Favored Pre-proline 0 N--CA 1.448 -0.533 0 CA-C-N 114.618 -1.174 . . . . 4.25 107.879 171.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.631 ' HA ' HD23 ' A' ' 21' ' ' LEU . 83.5 Cg_exo -51.38 112.8 0.89 Allowed 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.111 1.874 . . . . 0.54 114.208 -166.279 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.782 ' CE2' HD21 ' A' ' 72' ' ' LEU . 50.0 t80 -83.58 126.0 32.37 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 113.79 -1.55 . . . . 1.2 108.617 165.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.524 HD22 HE21 ' A' ' 32' ' ' GLN . 43.8 p-10 -67.67 82.0 0.18 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.911 0.862 . . . . 1.51 110.848 -178.068 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.744 ' HB2' HG23 ' A' ' 20' ' ' VAL . 44.5 tp -51.98 -37.76 54.22 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.536 -0.756 . . . . 0.28 109.653 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.634 HG13 ' HB3' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -67.75 0.13 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 114.687 -1.142 . . . . 1.02 113.0 -173.857 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.524 HE21 HD22 ' A' ' 29' ' ' ASN . 3.4 pt20 -72.7 -18.87 61.5 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 119.815 -0.754 . . . . 1.02 108.968 173.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.93 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 79.4 m-70 -92.33 29.86 1.6 Allowed 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 115.497 -0.774 . . . . 0.28 109.749 175.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.83 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 29.0 mtmt -92.35 111.04 22.47 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 114.896 -1.047 . . . . 1.56 109.584 173.026 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.94 -38.14 2.03 Favored Glycine 0 N--CA 1.443 -0.899 0 N-CA-C 110.759 -0.936 . . . . 0.2 110.759 -177.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.425 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 15.0 m -132.24 136.03 27.42 Favored Pre-proline 0 N--CA 1.435 -1.202 0 N-CA-C 109.127 -0.694 . . . . 0.29 109.127 169.246 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.687 ' O ' ' HA ' ' A' ' 69' ' ' PHE . 10.3 Cg_endo -47.42 156.83 0.9 Allowed 'Trans proline' 0 CA--C 1.511 -0.651 0 C-N-CA 124.481 3.454 . . . . 0.18 113.499 178.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.872 ' HB2' HG22 ' A' ' 70' ' ' THR . 0.9 OUTLIER -133.65 152.06 51.8 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 106.978 -1.49 . . . . 0.31 106.978 173.4 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.85 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 1.6 mm? -110.82 117.23 32.84 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.896 -1.15 . . . . 1.19 107.896 174.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.764 HD12 ' CE ' ' A' ' 122' ' ' MET . 9.1 mt -98.92 119.05 46.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 C-N-CA 119.714 -0.795 . . . . 0.37 110.195 178.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.85 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -105.11 127.29 52.83 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.469 -0.787 . . . . 0.42 109.916 -176.239 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.796 ' HB2' HG11 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -78.39 104.93 9.31 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 106.233 -1.765 . . . . 2.35 106.233 165.81 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.533 ' HB ' ' CE1' ' A' ' 139' ' ' PHE . 4.5 m -107.91 132.73 54.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 C-N-CA 118.986 -1.086 . . . . 1.03 111.32 -171.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.401 ' O ' ' N ' ' A' ' 46' ' ' LYS . . . -77.26 102.71 6.81 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 114.845 -1.07 . . . . 0.88 108.357 171.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.497 ' HA ' ' HB2' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -58.72 65.19 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.683 0 O-C-N 124.535 1.147 . . . . 1.78 112.107 175.462 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.658 ' HG2' ' HG2' ' A' ' 89' ' ' GLU . 86.8 mttt -89.24 174.75 7.67 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.098 -0.501 . . . . 5.84 110.544 -177.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.45 ' HB2' ' HA ' ' A' ' 95' ' ' CYS . 13.1 t -111.57 117.16 32.2 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.061 -0.518 . . . . 3.55 110.07 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 74.65 -5.59 29.36 Favored Glycine 0 CA--C 1.521 0.447 0 CA-C-N 116.168 -0.469 . . . . 2.91 113.3 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.409 ' HB2' ' CB ' ' A' ' 46' ' ' LYS . 29.1 m-85 -93.35 154.33 18.04 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.566 0.698 . . . . 4.63 112.487 -174.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.4 t -168.49 142.53 3.21 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.636 -1.165 . . . . 1.93 108.309 175.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.714 ' O ' ' HA2' ' A' ' 157' ' ' GLY . 27.8 mmmt -104.09 7.5 36.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.294 0.569 . . . . 2.01 109.559 176.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 111.61 -35.51 4.68 Favored Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 110.472 -1.051 . . . . 0.51 110.472 -171.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -45.96 -41.12 10.31 Favored Glycine 0 C--O 1.216 -1.03 0 CA-C-N 114.635 -0.782 . . . . 0.5 113.132 176.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -64.82 -52.2 58.05 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.948 0.404 . . . . 0.7 111.006 -178.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -63.29 -29.15 70.53 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.711 -0.677 . . . . 2.61 109.984 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.891 HG21 HD12 ' A' ' 163' ' ' ILE . 87.7 m -75.14 -55.74 5.43 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.207 -0.906 . . . . 0.33 109.159 -179.209 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 1.013 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -54.1 -43.93 70.8 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.58 -1.191 . . . . 0.22 111.379 -178.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.458 ' HA ' ' CD1' ' A' ' 102' ' ' PHE . 30.3 m -61.68 -54.5 41.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.395 0.617 . . . . 0.26 110.142 -177.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.7 m -68.34 -35.61 78.03 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.235 -0.893 . . . . 0.48 111.591 -176.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.719 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 0.6 OUTLIER -63.83 -52.82 58.39 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-O 121.774 0.797 . . . . 0.43 110.162 -176.822 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.892 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 8.1 t80 -55.31 -49.19 72.8 Favored 'General case' 0 C--O 1.204 -1.337 0 CA-C-N 113.83 -1.532 . . . . 0.31 110.597 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.863 ' HA ' ' HE2' ' A' ' 65' ' ' LYS . 28.7 m-80 -72.97 -24.71 60.82 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 116.638 -0.255 . . . . 1.21 110.632 -173.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.415 ' HD2' ' CE2' ' A' ' 64' ' ' TYR . 39.2 ttmt -81.47 -29.59 33.68 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 108.674 -0.862 . . . . 1.54 108.674 -178.223 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.657 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 42.3 m-85 -125.5 -2.97 7.37 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 116.185 1.92 . . . . 0.31 116.185 -168.105 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.863 ' HE2' ' HA ' ' A' ' 62' ' ' ASN . 47.3 pttt -65.25 -24.94 67.46 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 107.906 -1.146 . . . . 1.35 107.906 170.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.5 t -48.63 -38.91 22.25 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 113.882 -1.508 . . . . 1.28 110.483 172.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -86.53 -36.13 19.13 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 111.818 0.303 . . . . 1.11 111.818 173.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 149.4 -7.47 0.84 Allowed Glycine 0 CA--C 1.521 0.408 0 N-CA-C 111.888 -0.485 . . . . 0.18 111.888 -175.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.719 ' HE2' ' HB3' ' A' ' 60' ' ' LEU . 17.9 t80 -65.34 142.47 58.22 Favored 'General case' 0 C--O 1.22 -0.45 0 C-N-CA 123.036 0.534 . . . . 0.18 111.586 -177.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.93 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 1.6 t -133.9 147.75 51.15 Favored 'General case' 0 N--CA 1.423 -1.799 0 N-CA-C 108.521 -0.918 . . . . 0.2 108.521 170.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 1.013 HG11 ' HB1' ' A' ' 57' ' ' ALA . 36.5 t -98.93 101.9 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.734 0 N-CA-C 107.832 -1.173 . . . . 0.17 107.832 158.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.782 HD21 ' CE2' ' A' ' 28' ' ' TYR . 6.3 mt -83.69 119.56 24.93 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 108.051 -1.092 . . . . 1.04 108.051 177.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.509 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -95.84 111.22 23.25 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.401 -0.592 . . . . 0.51 109.401 177.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 1.009 ' HD2' HD12 ' A' ' 108' ' ' ILE . 3.3 m-85 -101.18 91.95 2.28 Favored Pre-proline 0 C--N 1.312 -1.026 0 N-CA-C 107.386 -1.338 . . . . 0.44 107.386 172.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.654 ' O ' ' HB2' ' A' ' 107' ' ' LYS . 80.8 Cg_endo -77.11 77.72 3.7 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.854 2.369 . . . . 1.3 114.626 -166.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.6 m -5.42 126.43 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 126.744 2.018 . . . . 1.44 116.185 -178.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.674 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 25.2 t-20 -72.88 72.3 1.09 Allowed 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 113.351 -1.75 . . . . 1.81 109.315 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.564 ' HA ' ' HG3' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -47.42 -10.84 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 113.919 -1.491 . . . . 3.34 113.182 177.897 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.415 ' H ' ' C ' ' A' ' 77' ' ' ASN . 98.6 m-85 -65.8 -14.26 61.04 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.223 -0.444 . . . . 2.68 110.529 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.95 -179.32 47.38 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 116.039 -0.528 . . . . 1.98 112.053 176.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -117.12 30.09 6.46 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.903 -0.665 . . . . 1.49 112.251 -178.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.426 ' HG2' ' HB3' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -136.21 -6.57 2.06 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 110.046 -0.353 . . . . 1.74 110.046 179.272 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.564 ' HG3' ' HA ' ' A' ' 78' ' ' GLN . 11.2 mm-40 -61.42 140.19 94.78 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.873 -0.603 . . . . 3.07 111.368 -168.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.416 ' HB2' ' O ' ' A' ' 137' ' ' TRP . 65.5 Cg_endo -81.61 177.97 7.05 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.962 2.442 . . . . 1.75 112.986 -167.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 86' ' ' ASN . . . 95.1 -38.72 3.04 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.585 -0.817 . . . . 2.2 112.457 178.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.758 ' HB3' ' HB2' ' A' ' 89' ' ' GLU . 63.7 t30 175.31 -12.74 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 122.733 0.413 . . . . 4.2 110.046 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 38.0 mt-10 75.22 -67.06 0.26 Allowed 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.519 0.728 . . . . 3.02 112.047 174.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -86.11 -2.54 58.43 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.923 0.392 . . . . 3.92 111.453 -175.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.758 ' HB2' ' HB3' ' A' ' 86' ' ' ASN . 4.4 tp10 -51.61 -61.63 2.13 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.465 0.65 . . . . 2.65 111.673 -176.055 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.809 HG23 ' HB2' ' A' ' 95' ' ' CYS . 4.3 mt -94.43 67.19 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.84 0.829 . . . . 2.15 110.888 -170.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -172.08 -39.87 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 106.246 -1.761 . . . . 2.79 106.246 175.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -73.24 -55.26 6.68 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 113.659 -1.61 . . . . 3.29 109.116 166.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -84.98 141.69 30.15 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 115.964 -0.562 . . . . 3.42 110.771 -176.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 79.8 t -69.65 111.72 3.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.731 -0.668 . . . . 2.63 109.439 173.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.809 ' HB2' HG23 ' A' ' 90' ' ' ILE . 36.5 m -138.29 127.18 23.87 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.527 0.68 . . . . 2.83 111.751 -173.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.3 p -64.73 159.86 21.33 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 114.688 -1.142 . . . . 2.98 108.796 167.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.463 ' HE3' ' HB1' ' A' ' 23' ' ' ALA . 14.0 pttm -74.67 53.49 0.56 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.463 0.649 . . . . 2.72 110.81 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.531 ' CD2' HG12 ' A' ' 104' ' ' ILE . 24.3 t80 68.57 -87.51 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.083 -0.962 . . . . 2.12 111.606 178.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt 70.54 148.74 0.08 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.583 0.753 . . . . 2.69 111.064 -176.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.624 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . -171.32 -164.3 0.33 Allowed 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 115.919 -0.582 . . . . 0.55 110.634 -172.111 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -91.2 -20.69 21.69 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.195 -0.457 . . . . 1.99 111.1 173.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.768 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 0.7 OUTLIER -89.52 175.04 4.21 Favored Pre-proline 0 N--CA 1.443 -0.784 0 CA-C-N 116.476 -0.329 . . . . 0.84 110.373 -177.513 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.768 ' HD2' ' HB2' ' A' ' 102' ' ' PHE . 70.7 Cg_endo -69.29 103.56 1.1 Allowed 'Trans proline' 0 C--N 1.336 -0.093 0 C-N-CA 122.818 2.345 . . . . 0.62 112.381 178.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.624 HD11 ' HB3' ' A' ' 100' ' ' ALA . 3.9 mp -101.1 120.75 51.07 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.018 0 N-CA-C 107.684 -1.228 . . . . 1.34 107.684 175.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.789 ' HG3' ' CE1' ' A' ' 74' ' ' PHE . 27.3 mmt -87.33 -164.54 1.1 Allowed 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.992 -1.004 . . . . 3.03 111.494 -169.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.717 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . . . -68.58 -16.22 63.79 Favored 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 120.315 -0.554 . . . . 1.46 111.07 -172.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.674 ' HD3' ' HA ' ' A' ' 77' ' ' ASN . 10.5 ptpt 81.1 139.68 0.07 Allowed 'General case' 0 CA--C 1.493 -1.215 0 O-C-N 125.71 1.881 . . . . 1.76 108.397 -163.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 1.009 HD12 ' HD2' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -131.26 159.84 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.599 0 N-CA-C 104.785 -2.302 . . . . 0.82 104.785 169.604 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.404 ' OD1' ' HG2' ' A' ' 113' ' ' GLU . 12.0 t-20 -64.48 80.53 0.04 OUTLIER 'General case' 0 C--N 1.287 -2.148 0 O-C-N 123.603 0.564 . . . . 1.73 110.427 177.168 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.821 ' HA ' ' OH ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -78.81 90.38 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 C-N-CA 118.701 -1.2 . . . . 0.77 108.2 -179.711 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.443 ' N ' ' OH ' ' A' ' 119' ' ' TYR . 2.1 t-20 176.84 -179.06 0.17 Allowed 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 113.354 -1.748 . . . . 1.9 107.499 178.15 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -89.04 36.65 3.44 Favored Glycine 0 N--CA 1.44 -1.058 0 CA-C-O 118.686 -1.063 . . . . 1.47 115.656 -172.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.627 ' HG3' ' N ' ' A' ' 114' ' ' ASN . 0.8 OUTLIER -105.05 -44.54 4.76 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 120.067 1.933 . . . . 2.81 111.095 171.795 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.627 ' N ' ' HG3' ' A' ' 113' ' ' GLU . 52.4 t30 -132.09 -34.62 1.26 Allowed 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 109.307 -0.627 . . . . 2.16 109.307 -177.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.536 ' HA ' ' OH ' ' A' ' 119' ' ' TYR . . . 56.0 -164.44 0.14 Allowed 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 114.611 -1.177 . . . . 1.26 110.919 177.567 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.658 ' CB ' HG13 ' A' ' 108' ' ' ILE . 8.6 t-80 -150.25 121.31 3.95 Favored Pre-proline 0 N--CA 1.418 -2.026 0 N-CA-C 107.542 -1.281 . . . . 0.42 107.542 175.165 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.589 ' HB2' ' CD1' ' A' ' 18' ' ' PHE . 5.4 Cg_exo -33.43 -37.72 0.1 OUTLIER 'Trans proline' 0 C--O 1.214 -0.717 1 C-N-CA 125.403 4.068 . . . . 0.4 114.064 -172.905 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.773 ' CD1' ' HB ' ' A' ' 15' ' ' ILE . 7.5 tp -63.5 -60.32 3.5 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 114.046 1.128 . . . . 0.39 114.046 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.821 ' OH ' ' HA ' ' A' ' 110' ' ' VAL . 3.8 p90 -82.7 -25.82 32.61 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 107.486 -1.302 . . . . 3.04 107.486 -177.155 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.62 ' HA ' ' HD2' ' A' ' 123' ' ' LYS . 1.9 tm-20 -59.25 -39.86 84.14 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.334 -1.358 . . . . 2.44 107.334 172.195 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.64 ' HB2' ' HE2' ' A' ' 18' ' ' PHE . 29.6 t80 -64.21 -29.3 70.41 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.007 -0.997 . . . . 0.56 110.145 169.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.764 ' CE ' HD12 ' A' ' 40' ' ' ILE . 66.9 mtt -73.4 -55.3 6.55 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 121.134 0.493 . . . . 0.71 110.797 -173.06 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.705 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -70.45 -22.49 62.69 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.154 -0.93 . . . . 1.46 110.817 177.754 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.61 ' HG3' ' O ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -73.37 -26.3 60.95 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 119.636 -0.826 . . . . 1.99 109.502 171.318 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 93.2 m -74.87 -55.91 5.31 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.221 0.534 . . . . 0.59 110.06 173.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.696 ' HG2' ' NH2' ' A' ' 153' ' ' ARG . 22.7 ttmm -137.74 102.45 8.57 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.669 -0.696 . . . . 1.85 109.424 177.163 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -69.65 -55.74 0.17 Allowed 'Trans proline' 0 CA--C 1.52 -0.2 0 C-N-CA 123.552 2.835 . . . . 1.69 112.25 -170.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.685 ' HA3' ' HB ' ' A' ' 132' ' ' THR . . . -158.37 170.88 35.13 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 120.762 -0.733 . . . . 2.59 111.668 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.446 HD12 ' HB2' ' A' ' 130' ' ' LEU . 2.3 pp -106.7 -5.86 10.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.408 0.623 . . . . 3.58 110.11 176.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.446 ' HB2' HD12 ' A' ' 129' ' ' ILE . 19.0 tp -128.06 38.9 3.94 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.069 -0.969 . . . . 3.47 109.57 -176.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 58.88 40.59 22.52 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.733 -1.121 . . . . 3.28 110.011 -171.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.685 ' HB ' ' HA3' ' A' ' 128' ' ' GLY . 0.7 OUTLIER -90.34 149.08 22.46 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.725 -1.125 . . . . 3.56 109.614 -179.178 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.461 ' HD2' ' N ' ' A' ' 133' ' ' LYS . 0.6 OUTLIER -92.68 -24.61 18.57 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.069 0.461 . . . . 5.17 111.038 -178.026 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.568 ' HB1' HD13 ' A' ' 135' ' ' ILE . . . -157.63 -164.63 1.59 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.85 -0.614 . . . . 1.59 110.145 -175.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.977 ' H ' HD13 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -53.91 -40.44 44.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.868 -0.605 . . . . 2.0 110.861 172.857 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.696 ' HB3' ' CE3' ' A' ' 137' ' ' TRP . 6.0 tmtt? 64.39 -38.89 0.22 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 124.673 1.189 . . . . 4.81 114.04 174.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.78 ' HB3' ' HG3' ' A' ' 156' ' ' PRO . 6.8 m-90 -100.22 177.73 4.98 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 122.889 0.476 . . . . 1.97 111.78 -177.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.482 ' O ' ' N ' ' A' ' 140' ' ' THR . 10.7 t-20 -39.5 -155.32 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 113.852 -1.522 . . . . 2.04 111.37 157.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.607 ' HD2' ' HD2' ' A' ' 41' ' ' TYR . 1.6 m-85 -29.12 -25.06 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 117.924 2.565 . . . . 1.93 117.924 -171.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.69 ' HA ' ' O ' ' A' ' 154' ' ' PHE . 29.5 m -0.6 105.96 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 114.472 1.286 . . . . 0.6 114.472 175.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.616 ' HB3' HD12 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -86.12 170.33 12.3 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.167 -1.378 . . . . 0.62 110.302 -172.912 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.531 ' O ' HD13 ' A' ' 39' ' ' LEU . 86.7 m-85 -127.68 127.47 43.79 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 105.803 -1.925 . . . . 0.57 105.803 164.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.827 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 9.1 tp -80.55 104.71 11.26 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 118.238 -1.385 . . . . 0.43 108.534 176.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.759 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 41.7 mm -93.6 141.0 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.929 0 CA-C-N 113.746 -1.57 . . . . 0.19 107.154 -177.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.708 ' HA ' HD13 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -92.39 178.18 5.91 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 120.508 -0.477 . . . . 0.98 111.518 -171.736 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.462 ' CG ' ' HD3' ' A' ' 37' ' ' PRO . 66.8 mtm180 -48.71 -46.39 40.59 Favored 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 123.135 0.574 . . . . 2.22 111.494 -178.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -96.41 24.04 6.21 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.187 -0.672 . . . . 2.0 109.187 -178.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.535 ' HA2' ' CG2' ' A' ' 144' ' ' ILE . . . 71.68 42.6 53.94 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.083 -0.962 . . . . 0.17 113.789 175.107 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.482 ' O ' HG23 ' A' ' 151' ' ' VAL . 49.9 t -103.87 114.85 64.23 Favored Pre-proline 0 C--N 1.311 -1.074 0 C-N-CA 119.631 -0.828 . . . . 1.12 110.882 177.156 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.818 ' HD3' HG23 ' A' ' 15' ' ' ILE . 21.6 Cg_endo -67.02 113.06 2.68 Favored 'Trans proline' 0 CA--C 1.529 0.27 0 C-N-CA 122.998 2.465 . . . . 0.41 110.251 176.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 149' ' ' VAL . 16.3 t -113.66 -28.06 2.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-O 121.398 0.618 . . . . 1.45 109.788 -173.516 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.827 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 17.3 mm-40 -137.37 168.24 20.03 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 115.077 -0.965 . . . . 1.17 110.423 -177.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.696 ' NH2' ' HG2' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -145.92 137.71 25.1 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 114.59 -1.187 . . . . 2.16 108.901 161.729 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.716 ' HZ ' ' HB2' ' A' ' 166' ' ' LYS . 94.0 m-85 -112.25 145.56 39.72 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.126 -0.488 . . . . 0.32 110.161 -170.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 10.2 m -63.79 152.12 87.41 Favored Pre-proline 0 C--N 1.317 -0.842 0 N-CA-C 109.345 -0.613 . . . . 1.11 109.345 175.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.78 ' HG3' ' HB3' ' A' ' 137' ' ' TRP . 43.8 Cg_endo -66.69 -22.88 49.62 Favored 'Trans proline' 0 CA--C 1.512 -0.585 0 C-N-CA 122.28 1.987 . . . . 0.78 110.7 178.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.714 ' HA2' ' O ' ' A' ' 51' ' ' LYS . . . -85.38 13.73 53.92 Favored Glycine 0 N--CA 1.44 -1.085 0 CA-C-N 114.773 -1.103 . . . . 0.5 112.87 173.081 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -87.63 149.83 24.04 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.225 -0.657 . . . . 0.5 109.225 172.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.5 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 17.5 m -108.66 171.99 7.1 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 121.181 0.515 . . . . 1.42 111.526 -174.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.776 ' HA ' HG23 ' A' ' 56' ' ' THR . 52.0 t -39.07 -55.74 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 114.463 -1.244 . . . . 0.28 111.853 176.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -64.56 -31.87 73.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.472 -0.786 . . . . 3.46 111.567 -174.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.446 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 23.6 m-20 -75.75 -32.62 60.05 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.24 -0.891 . . . . 1.4 110.305 -173.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.891 HD12 HG21 ' A' ' 56' ' ' THR . 57.3 mt -83.3 -44.48 18.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.234 -0.894 . . . . 0.21 110.913 177.021 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.578 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 37.9 mt-10 -54.31 -40.44 67.96 Favored 'General case' 0 C--O 1.218 -0.575 0 CA-C-N 116.613 -0.267 . . . . 0.67 111.506 -178.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 9.2 pt-20 -56.9 -27.24 60.52 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 112.1 0.407 . . . . 0.87 112.1 -177.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.716 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 46.2 mmtm -96.69 -26.04 15.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.394 0.616 . . . . 1.71 110.276 175.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.578 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 12.1 tp -76.96 -49.49 15.38 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.068 -0.969 . . . . 0.16 112.031 -177.046 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.509 HG13 ' O ' ' A' ' 164' ' ' GLU . 81.8 mt -53.29 -44.82 98.21 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-N 115.511 -0.768 . . . . 0.26 112.165 -174.226 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.427 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 85.5 Cg_exo -50.37 -39.35 53.78 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.133 1.889 . . . . 0.41 112.917 172.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.708 HD13 ' HA ' ' A' ' 145' ' ' ASP . 96.0 mt -79.34 -43.52 23.37 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.728 -0.389 . . . . 0.71 111.284 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.63 HD21 ' HB2' ' A' ' 69' ' ' PHE . 95.7 mt -57.93 -54.11 50.58 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 122.083 0.944 . . . . 0.34 109.674 176.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -66.98 -4.86 29.82 Favored Glycine 0 N--CA 1.437 -1.235 0 CA-C-N 113.297 -1.774 . . . . 1.12 113.397 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 31.9 t 63.78 51.65 2.35 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.146 0.498 . . . . 2.64 110.917 175.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -62.75 -40.96 98.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.059 -0.519 . . . . 4.35 110.403 177.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -96.81 151.38 19.72 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.533 -0.543 . . . . 8.45 109.533 177.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.4 mm? . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.625 -0.702 . . . . 7.69 110.121 -177.129 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.668 0 N-CA-C 112.529 -0.228 . . . . 5.22 112.529 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 60.9 mtm 57.43 87.09 0.07 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.718 0.771 . . . . 4.85 109.878 -174.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.623 ' CA ' ' HB2' ' A' ' 17' ' ' ASP . . . -59.82 -61.15 7.52 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 114.403 -1.272 . . . . 1.55 114.931 -170.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.2 t 63.74 16.89 10.09 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.307 0.575 . . . . 1.58 109.853 -170.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 65.5 p 179.05 152.34 0.36 Allowed 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 105.47 -2.048 . . . . 1.17 105.47 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.827 ' HB ' HD11 ' A' ' 118' ' ' LEU . 5.6 pt -64.99 -12.95 14.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-N 115.061 -0.972 . . . . 0.38 112.187 -171.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.769 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 43.6 m-85 -75.44 0.96 15.24 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.378 0.51 . . . . 0.3 112.378 -175.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.623 ' HB2' ' CA ' ' A' ' 12' ' ' GLY . 38.6 t70 -73.43 -19.26 61.01 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 108.242 -1.021 . . . . 2.11 108.242 174.072 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.694 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 57.1 m-85 -111.34 107.34 16.57 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 114.628 -1.169 . . . . 0.31 111.045 -174.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -51.07 140.96 14.91 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 113.843 -1.526 . . . . 2.86 109.03 174.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.783 HG13 ' HZ ' ' A' ' 74' ' ' PHE . 40.3 t -110.32 166.27 5.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 108.118 -1.067 . . . . 0.67 108.118 -177.332 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.713 ' O ' ' HB2' ' A' ' 105' ' ' MET . 24.7 mt -127.0 143.61 51.25 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.884 -0.413 . . . . 0.69 109.884 179.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.442 ' OD2' ' HE2' ' A' ' 26' ' ' LYS . 18.6 m-20 -77.59 177.37 8.13 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 106.742 -1.577 . . . . 1.87 106.742 165.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.759 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . . . -64.39 -5.25 4.89 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 113.068 0.766 . . . . 0.59 113.068 -171.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.902 ' HB2' ' HG2' ' A' ' 26' ' ' LYS . 15.8 m-20 -94.66 -8.1 38.88 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 111.591 0.219 . . . . 2.34 111.591 178.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.545 ' HB2' ' O ' ' A' ' 24' ' ' ASP . 49.0 m-70 80.8 -0.66 1.83 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.506 0.723 . . . . 1.47 109.829 -175.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.902 ' HG2' ' HB2' ' A' ' 24' ' ' ASP . 6.4 ptmt -67.1 120.0 68.77 Favored Pre-proline 0 N--CA 1.45 -0.472 0 N-CA-C 108.158 -1.053 . . . . 4.25 108.158 165.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.635 ' HA ' HD23 ' A' ' 21' ' ' LEU . 90.0 Cg_exo -50.26 116.54 2.54 Favored 'Trans proline' 0 N--CA 1.465 -0.19 0 C-N-CA 122.638 2.225 . . . . 0.54 113.828 -175.173 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.834 ' HE2' HD23 ' A' ' 72' ' ' LEU . 15.0 t80 -79.74 143.66 34.32 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 113.865 -1.516 . . . . 1.2 111.212 174.34 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.488 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.7 t-20 -80.72 82.47 6.71 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.085 -0.962 . . . . 1.51 109.931 178.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.794 HD21 HD12 ' A' ' 15' ' ' ILE . 59.2 tp -57.91 -41.33 82.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.302 0.572 . . . . 0.28 109.784 177.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.71 HG12 ' HG3' ' A' ' 34' ' ' LYS . 2.0 t -68.16 -3.72 2.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 114.638 -1.165 . . . . 1.02 112.256 -170.09 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.488 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 3.4 pt20 -70.18 -17.25 63.16 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.919 -0.771 . . . . 1.02 108.919 175.32 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.904 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 92.4 m-70 -92.68 23.58 4.01 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.318 -0.855 . . . . 0.28 109.644 177.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.769 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 10.1 mtmt -81.99 121.76 26.93 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 114.639 -1.164 . . . . 1.56 109.335 168.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.42 -42.05 1.89 Allowed Glycine 0 N--CA 1.436 -1.31 0 C-N-CA 120.633 -0.794 . . . . 0.2 111.67 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.484 ' HB2' ' HA3' ' A' ' 68' ' ' GLY . 19.3 m -128.69 127.86 23.52 Favored Pre-proline 0 N--CA 1.435 -1.183 0 N-CA-C 108.462 -0.94 . . . . 0.29 108.462 173.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.805 ' HG3' ' CB ' ' A' ' 170' ' ' LEU . 4.9 Cg_endo -42.74 152.61 0.18 Allowed 'Trans proline' 0 CA--C 1.508 -0.777 0 C-N-CA 124.401 3.401 . . . . 0.18 113.205 178.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.853 HD13 ' HB2' ' A' ' 33' ' ' HIS . 0.9 OUTLIER -137.5 142.33 41.47 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.052 -1.431 . . . . 0.31 107.361 -178.341 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.989 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 1.8 mm? -107.79 114.78 28.98 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.473 -0.936 . . . . 1.19 108.473 176.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.825 HG23 HD13 ' A' ' 72' ' ' LEU . 1.1 mt -95.38 127.99 46.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 C-N-CA 119.81 -0.756 . . . . 0.37 109.647 177.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.989 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 1.1 m-85 -112.47 124.43 52.48 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.215 -0.448 . . . . 0.42 110.435 -175.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.667 HD22 ' HB ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -83.01 92.54 7.39 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 107.31 -1.367 . . . . 2.35 107.31 173.691 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.761 HG23 ' HB3' ' A' ' 139' ' ' PHE . 11.1 p -103.48 147.0 10.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-O 121.02 0.438 . . . . 1.03 111.394 -161.16 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -88.35 103.72 16.09 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.815 -0.63 . . . . 0.88 111.424 -175.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.581 ' O ' HD12 ' A' ' 90' ' ' ILE . 0.3 OUTLIER -56.41 91.63 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.279 -0.873 . . . . 1.78 111.022 170.726 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.463 ' HG2' ' N ' ' A' ' 47' ' ' CYS . 38.4 ttmt -141.94 169.9 16.72 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.185 -0.672 . . . . 5.84 109.185 -179.379 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.463 ' N ' ' HG2' ' A' ' 46' ' ' LYS . 8.8 t -108.67 117.91 35.42 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.916 0.388 . . . . 3.55 110.049 -176.355 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 69.25 51.47 27.28 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.564 -0.744 . . . . 2.91 112.586 -178.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -141.86 149.06 39.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.283 0.563 . . . . 4.63 111.901 -177.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 7.3 t -179.28 164.9 1.41 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 107.585 -1.265 . . . . 1.93 107.585 -179.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.735 ' H ' ' HZ ' ' A' ' 139' ' ' PHE . 29.7 ttmt -134.78 20.24 3.54 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.775 -0.824 . . . . 2.01 108.775 175.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 108.14 -40.03 2.68 Favored Glycine 0 N--CA 1.443 -0.869 0 CA-C-N 115.263 -0.88 . . . . 0.51 111.388 -175.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.535 ' HA2' ' HB ' ' A' ' 56' ' ' THR . . . -61.98 -19.12 58.56 Favored Glycine 0 C--O 1.22 -0.746 0 CA-C-O 119.688 -0.506 . . . . 0.5 114.359 -177.168 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -77.19 -57.0 4.08 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 118.305 1.053 . . . . 0.7 109.983 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.18 -39.27 72.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.575 0.703 . . . . 2.61 109.587 173.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.714 HG23 ' HA ' ' A' ' 160' ' ' VAL . 18.3 m -57.06 -59.28 5.3 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 114.625 -1.171 . . . . 0.33 111.296 174.302 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 1.061 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -55.98 -45.45 78.97 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.869 -0.605 . . . . 0.22 111.047 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.586 ' HA ' ' HE1' ' A' ' 102' ' ' PHE . 92.1 m -55.02 -51.33 66.62 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.589 0.709 . . . . 0.26 110.354 -178.009 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 28.1 m -72.96 -36.79 67.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.861 -1.063 . . . . 0.48 111.483 -177.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.712 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 14.5 mt -64.23 -52.67 57.61 Favored 'General case' 0 CA--C 1.498 -1.054 0 CA-C-O 121.311 0.577 . . . . 0.43 110.381 -178.146 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.794 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 2.1 t80 -51.73 -53.26 41.37 Favored 'General case' 0 C--O 1.199 -1.586 0 CA-C-N 114.218 -1.356 . . . . 0.31 110.167 178.032 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.412 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 6.1 m-80 -72.91 -25.56 61.1 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 112.097 0.406 . . . . 1.21 112.097 -170.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.453 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 35.4 ttpt -84.06 -23.24 30.94 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 119.401 -0.92 . . . . 1.54 108.924 -178.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.654 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 36.7 m-85 -122.37 -4.31 8.87 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 114.959 1.466 . . . . 0.31 114.959 -172.115 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.722 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 13.7 ptmt -64.93 -25.31 67.82 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 108.238 -1.023 . . . . 1.35 108.238 171.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.9 m -47.76 -41.9 24.33 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.113 -1.403 . . . . 1.28 110.74 172.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -85.37 -33.09 22.09 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.059 0.392 . . . . 1.11 112.059 175.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.484 ' HA3' ' HB2' ' A' ' 36' ' ' SER . . . 145.82 -7.46 1.47 Allowed Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 111.454 -0.659 . . . . 0.18 111.454 -177.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.712 ' HE2' ' HB3' ' A' ' 60' ' ' LEU . 19.5 t80 -64.38 140.86 58.91 Favored 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 122.709 0.403 . . . . 0.18 111.027 -178.264 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.904 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 1.6 t -134.34 151.3 51.15 Favored 'General case' 0 N--CA 1.413 -2.294 0 N-CA-C 108.425 -0.954 . . . . 0.2 108.425 173.07 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 1.061 HG11 ' HB1' ' A' ' 57' ' ' ALA . 50.2 t -109.16 100.27 10.42 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.341 0 N-CA-C 107.488 -1.301 . . . . 0.17 107.488 159.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.834 HD23 ' HE2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -89.85 121.07 31.63 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 118.254 -1.378 . . . . 1.04 108.375 177.496 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.86 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -98.09 112.68 24.55 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.914 -0.585 . . . . 0.51 110.842 -177.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.849 ' CD2' ' HE2' ' A' ' 119' ' ' TYR . 3.1 m-30 -96.56 102.16 10.74 Favored Pre-proline 0 C--N 1.31 -1.143 0 N-CA-C 108.827 -0.805 . . . . 0.44 108.827 176.186 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.717 ' HG2' ' HB3' ' A' ' 107' ' ' LYS . 87.8 Cg_endo -80.33 71.02 7.27 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 123.239 2.626 . . . . 1.3 114.302 -166.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 77.3 p 2.8 130.35 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 116.767 2.136 . . . . 1.44 116.767 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.621 ' C ' ' HG3' ' A' ' 83' ' ' GLU . 12.5 t30 -80.52 76.19 7.37 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 113.185 -1.825 . . . . 1.81 107.611 -179.241 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.982 ' HG3' HG21 ' A' ' 90' ' ' ILE . 7.6 mm-40 -48.16 -12.64 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.462 1.505 . . . . 3.34 111.574 -176.087 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.507 ' H ' ' C ' ' A' ' 77' ' ' ASN . 92.5 m-85 -90.04 29.53 1.2 Allowed 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.504 -1.225 . . . . 2.68 111.195 -175.274 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.488 ' HA3' HE22 ' A' ' 82' ' ' GLN . . . -109.64 -42.17 1.26 Allowed Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.653 -0.784 . . . . 1.98 112.831 -177.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 115.57 19.15 5.85 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.727 -0.749 . . . . 1.49 112.609 -176.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.488 HE22 ' HA3' ' A' ' 80' ' ' GLY . 0.8 OUTLIER -170.03 24.72 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 113.103 0.779 . . . . 1.74 113.103 -177.022 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.621 ' HG3' ' C ' ' A' ' 77' ' ' ASN . 6.1 mm-40 -89.03 153.95 49.41 Favored Pre-proline 0 C--N 1.314 -0.941 0 CA-C-O 121.366 0.603 . . . . 3.07 112.586 -173.194 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.562 ' HB3' ' HA ' ' A' ' 138' ' ' ASN . 89.2 Cg_exo -54.91 -0.66 0.13 Allowed 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 124.624 3.549 . . . . 1.75 114.811 176.12 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -97.68 13.08 64.3 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 121.123 -0.561 . . . . 2.2 112.088 176.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.545 HD21 ' HB2' ' A' ' 89' ' ' GLU . 4.1 p-10 50.04 37.19 13.56 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.329 1.052 . . . . 4.2 112.526 179.199 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 58.8 -86.33 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 114.439 1.274 . . . . 3.02 114.439 169.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.532 ' O ' ' HG2' ' A' ' 92' ' ' GLU . 33.5 mm-40 -58.95 -38.91 80.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.496 -0.775 . . . . 3.92 112.307 -166.523 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.545 ' HB2' HD21 ' A' ' 86' ' ' ASN . 32.3 tt0 -65.91 -14.14 60.98 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.019 0.438 . . . . 2.65 111.941 -173.071 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.982 HG21 ' HG3' ' A' ' 78' ' ' GLN . 12.0 mm -97.09 -29.36 3.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.444 0.64 . . . . 2.15 109.973 178.015 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -85.61 -41.72 14.98 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.595 -0.729 . . . . 2.79 111.353 -174.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.532 ' HG2' ' O ' ' A' ' 88' ' ' GLU . 10.4 pt-20 -84.41 -16.63 42.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.787 0.327 . . . . 3.29 110.706 -178.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.446 ' HB3' ' O ' ' A' ' 89' ' ' GLU . 19.0 t80 -113.55 158.77 20.35 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.014 -0.539 . . . . 3.42 109.713 -176.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 6.1 p -65.81 111.83 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.45 0.643 . . . . 2.63 110.341 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.445 ' HB3' HG23 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -96.03 123.78 39.78 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 121.625 0.726 . . . . 2.83 111.614 -178.86 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.451 ' C ' ' H ' ' A' ' 98' ' ' PHE . 14.2 p -90.8 149.68 21.88 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 108.114 -1.069 . . . . 2.98 108.114 166.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.423 ' H ' ' HG2' ' A' ' 97' ' ' LYS . 17.6 ptmt -73.29 41.86 0.11 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.917 0.389 . . . . 2.72 110.563 176.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.711 ' CZ ' ' HE2' ' A' ' 102' ' ' PHE . 61.9 t80 61.91 -85.97 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.185 -0.916 . . . . 2.12 110.749 -175.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.412 ' CG ' ' HG3' ' A' ' 97' ' ' LYS . 30.3 mtmm 69.51 144.85 0.05 Allowed 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 124.145 0.978 . . . . 2.69 111.816 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.629 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . -176.29 -152.96 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.971 -1.013 . . . . 0.55 110.235 -174.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -104.57 28.51 6.93 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.637 -0.711 . . . . 1.99 111.012 178.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.873 ' HB3' ' O ' ' A' ' 71' ' ' VAL . 3.5 m-85 -113.14 -177.11 0.42 Allowed Pre-proline 0 CA--C 1.513 -0.454 0 CA-C-O 121.853 0.835 . . . . 0.84 111.426 -177.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.706 ' HD3' ' CE2' ' A' ' 61' ' ' TYR . 12.9 Cg_exo -79.87 71.73 6.89 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 124.095 3.197 . . . . 0.62 110.442 156.31 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.86 HG13 ' HB3' ' A' ' 73' ' ' ALA . 5.3 mp -73.77 119.92 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 108.143 -1.058 . . . . 1.34 108.143 173.127 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.828 ' HG2' ' CG ' ' A' ' 74' ' ' PHE . 0.3 OUTLIER -80.26 -175.53 5.14 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.079 -0.509 . . . . 3.03 110.768 -173.358 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.759 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . . . -71.36 -0.01 9.19 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.592 -0.731 . . . . 1.46 111.958 -176.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.776 ' H ' ' HG3' ' A' ' 105' ' ' MET . 3.1 ptpp? 70.45 137.59 0.04 OUTLIER 'General case' 0 CA--C 1.499 -1.001 0 C-N-CA 125.256 1.422 . . . . 1.76 110.604 -170.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.701 HG13 ' CB ' ' A' ' 116' ' ' HIS . 0.1 OUTLIER -140.51 167.44 18.12 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 CA-C-N 113.262 -1.79 . . . . 0.82 106.358 168.297 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.664 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 48.5 t-20 -49.72 119.13 3.25 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.785 -0.82 . . . . 1.73 108.785 168.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.667 ' HB ' HD22 ' A' ' 42' ' ' ASN . 0.0 OUTLIER -128.28 87.84 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 C-N-CA 119.442 -0.903 . . . . 0.77 108.688 166.763 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.5 t30 171.81 179.59 0.07 Allowed 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 113.981 -1.463 . . . . 1.9 108.908 176.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 3.84 -72.38 0.0 OUTLIER Glycine 0 CA--C 1.528 0.893 0 N-CA-C 118.602 2.201 . . . . 1.47 118.602 168.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -86.23 -46.65 10.16 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 114.462 1.282 . . . . 2.81 114.462 -151.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -129.11 -34.68 1.87 Allowed 'General case' 0 CA--C 1.504 -0.793 0 C-N-CA 119.412 -0.915 . . . . 2.16 111.06 -174.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.664 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . 46.42 -134.07 0.96 Allowed 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 108.833 -0.802 . . . . 1.26 108.833 -172.098 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.701 ' CB ' HG13 ' A' ' 108' ' ' ILE . 0.9 OUTLIER -161.55 139.99 7.16 Favored Pre-proline 0 N--CA 1.43 -1.455 0 N-CA-C 107.057 -1.46 . . . . 0.42 107.057 178.689 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -27.44 -50.42 0.11 Allowed 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 124.701 3.6 . . . . 0.4 113.891 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.827 HD11 ' HB ' ' A' ' 15' ' ' ILE . 64.7 tp -57.12 -53.41 58.39 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 122.912 0.485 . . . . 0.39 112.259 176.005 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.849 ' HE2' ' CD2' ' A' ' 74' ' ' PHE . 80.0 m-85 -77.38 -35.37 54.49 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 112.299 0.481 . . . . 3.04 112.299 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.73 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 5.7 mm-40 -57.48 -34.0 68.57 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 107.221 -1.399 . . . . 2.44 107.221 172.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.694 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 70.8 t80 -71.48 -33.5 69.34 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 119.262 -0.975 . . . . 0.56 111.065 173.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.651 ' HE3' ' HG ' ' A' ' 118' ' ' LEU . 1.8 ttm -74.64 -55.0 6.37 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.275 -0.42 . . . . 0.71 110.465 -171.141 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.568 ' HD2' ' CB ' ' A' ' 134' ' ' ALA . 0.6 OUTLIER -70.57 -25.74 63.22 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 116.514 -0.312 . . . . 1.46 111.42 178.029 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.73 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 9.4 pttp -68.58 -27.28 65.92 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 119.486 -0.886 . . . . 1.99 109.485 177.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 29.1 m -89.47 -28.01 19.97 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.244 -0.889 . . . . 0.59 110.703 176.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.541 ' HB3' ' NH2' ' A' ' 153' ' ' ARG . 39.9 mmtt -134.04 89.97 27.6 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.087 -0.506 . . . . 1.85 110.945 -177.037 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -61.51 -40.45 47.5 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.367 2.711 . . . . 1.69 113.851 -175.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.531 ' HA2' ' CZ ' ' A' ' 153' ' ' ARG . . . 149.35 145.99 4.24 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 119.76 -1.21 . . . . 2.59 113.229 178.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.435 HG23 HH12 ' A' ' 153' ' ' ARG . 24.8 pt -68.66 -19.74 24.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.222 0.534 . . . . 3.58 110.839 178.169 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.725 HD23 ' H ' ' A' ' 130' ' ' LEU . 2.6 pt? -104.18 8.59 36.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.563 0.697 . . . . 3.47 110.009 179.083 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 60.02 56.83 3.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.131 -1.395 . . . . 3.28 112.472 177.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 90.3 m -105.24 -81.48 0.53 Allowed 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.876 -0.33 . . . . 3.56 111.453 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 73.1 tttt -179.38 -37.2 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.871 0.367 . . . . 5.17 111.282 -175.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.738 ' HB1' HD13 ' A' ' 135' ' ' ILE . . . -142.46 -167.93 2.62 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.2 -0.455 . . . . 1.59 111.266 -174.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.755 ' H ' HD13 ' A' ' 135' ' ' ILE . 0.2 OUTLIER -51.59 -42.21 29.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 115.585 -0.734 . . . . 2.0 110.18 171.594 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.416 ' HD3' HD11 ' A' ' 130' ' ' LEU . 61.3 tttm 68.09 -38.01 0.35 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.595 1.158 . . . . 4.81 112.797 177.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.604 ' HB3' ' HG3' ' A' ' 156' ' ' PRO . 2.4 m95 -98.85 177.03 5.4 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 122.928 0.491 . . . . 1.97 111.599 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.562 ' HA ' ' HB3' ' A' ' 84' ' ' PRO . 1.6 m120 -39.48 -155.61 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 126.603 1.961 . . . . 2.04 114.128 165.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.761 ' HB3' HG23 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -34.14 -22.19 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 116.063 1.875 . . . . 1.93 116.063 -177.084 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.613 ' HB ' ' HB ' ' A' ' 135' ' ' ILE . 3.7 m 10.49 108.12 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 119.965 1.257 . . . . 0.6 113.911 166.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.514 ' CB ' HD12 ' A' ' 39' ' ' LEU . 0.9 OUTLIER -90.75 161.08 15.48 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 114.066 -1.425 . . . . 0.62 110.484 -167.34 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.478 ' HA ' ' HA ' ' A' ' 153' ' ' ARG . 38.6 m-85 -124.64 122.82 38.59 Favored 'General case' 0 CA--C 1.494 -1.206 0 N-CA-C 106.389 -1.708 . . . . 0.57 106.389 168.017 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.787 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 8.9 tp -79.73 104.88 10.62 Favored 'General case' 0 N--CA 1.425 -1.708 0 C-N-CA 118.348 -1.341 . . . . 0.43 108.416 179.144 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.679 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 39.3 mm -92.0 142.05 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.717 0 CA-C-N 112.744 -2.025 . . . . 0.19 107.605 -178.063 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.439 ' HA ' HD13 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -94.43 -175.57 3.67 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 119.131 -1.028 . . . . 0.98 111.316 -170.194 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.67 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 29.9 mtm180 -52.33 -39.6 60.85 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 121.097 0.475 . . . . 2.22 110.909 -178.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -97.33 20.99 10.66 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.334 0.588 . . . . 2.0 109.711 -175.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.7 ' HA3' ' CE2' ' A' ' 16' ' ' PHE . . . 68.73 35.58 80.55 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 115.812 -0.631 . . . . 0.17 114.185 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.467 ' HA ' ' HD2' ' A' ' 150' ' ' PRO . 65.5 t -106.17 108.31 61.46 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 118.387 1.093 . . . . 1.12 111.666 175.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.689 ' HD3' HG23 ' A' ' 15' ' ' ILE . 5.3 Cg_endo -52.05 114.78 1.78 Allowed 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 123.876 3.051 . . . . 0.41 111.256 171.369 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.959 HG13 ' HG2' ' A' ' 152' ' ' GLU . 13.8 p -116.79 -21.88 4.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-O 121.489 0.661 . . . . 1.45 109.488 -177.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.959 ' HG2' HG13 ' A' ' 151' ' ' VAL . 30.1 mm-40 -138.25 167.54 21.63 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 115.351 -0.841 . . . . 1.17 110.372 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.541 ' NH2' ' HB3' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -145.14 146.29 31.72 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.137 -0.938 . . . . 2.16 109.571 161.517 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.632 ' CE2' ' HA ' ' A' ' 163' ' ' ILE . 93.2 m-85 -121.95 140.46 52.42 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.874 -0.603 . . . . 0.32 109.457 -172.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 6.3 m -68.14 158.57 83.73 Favored Pre-proline 0 C--N 1.315 -0.913 0 N-CA-C 109.847 -0.427 . . . . 1.11 109.847 178.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.604 ' HG3' ' HB3' ' A' ' 137' ' ' TRP . 18.4 Cg_endo -59.46 -32.4 96.31 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.137 1.891 . . . . 0.78 110.624 174.214 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -73.06 -0.0 49.29 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 114.515 -1.221 . . . . 0.5 113.724 173.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -85.97 146.15 26.81 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.83 -0.804 . . . . 0.5 108.83 173.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 4.0 t -110.35 -178.83 3.6 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-O 121.082 0.468 . . . . 1.42 110.259 -173.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.714 ' HA ' HG23 ' A' ' 56' ' ' THR . 60.8 t -45.84 -57.25 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 114.609 -1.178 . . . . 0.28 111.79 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 42.5 tttm -63.46 -38.44 91.14 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 120.624 0.25 . . . . 3.46 111.034 -172.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.41 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 61.9 m-20 -57.26 -43.27 82.85 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.812 0.815 . . . . 1.4 109.124 -177.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.632 ' HA ' ' CE2' ' A' ' 154' ' ' PHE . 90.5 mt -75.52 -47.29 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 CA-C-N 114.216 -1.356 . . . . 0.21 111.017 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.624 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 58.2 mt-10 -55.39 -43.49 75.23 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-O 121.089 0.471 . . . . 0.67 111.07 -176.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 10.5 pt-20 -63.63 -16.21 60.31 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 116.269 -0.423 . . . . 0.87 111.684 -173.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.577 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 31.5 mmmt -104.51 -21.34 13.46 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.47 0.653 . . . . 1.71 109.964 172.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.601 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 12.8 tp -84.96 -49.53 8.26 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.997 -1.001 . . . . 0.16 112.289 -176.308 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.574 ' N ' ' HD2' ' A' ' 169' ' ' PRO . 64.1 mt -57.46 -43.7 99.14 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.661 -0.699 . . . . 0.26 112.4 -174.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 168' ' ' ILE . 8.0 Cg_endo -53.65 -20.62 17.12 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 121.894 1.729 . . . . 0.41 112.939 172.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.805 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 99.3 mt -96.42 -43.14 7.78 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 122.416 -0.178 . . . . 0.71 111.205 177.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.648 HD21 ' HB2' ' A' ' 69' ' ' PHE . 96.6 mt -60.08 -56.95 15.31 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-O 121.962 0.887 . . . . 0.34 108.738 173.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -97.27 53.74 1.33 Allowed Glycine 0 N--CA 1.424 -2.154 0 CA-C-N 113.892 -1.504 . . . . 1.12 110.552 178.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.452 ' OG ' ' HD3' ' A' ' 146' ' ' ARG . 3.4 p -72.08 68.75 0.71 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.644 -0.778 . . . . 2.64 112.389 -177.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -76.82 -22.95 52.88 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.406 -0.961 . . . . 4.35 108.406 168.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 53.23 61.73 3.01 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 114.899 -1.046 . . . . 8.45 112.435 167.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 7.2 mp . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.531 -0.747 . . . . 7.69 109.572 176.243 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.802 0 N-CA-C 112.565 -0.214 . . . . 5.22 112.565 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.9 ptm 175.06 -30.58 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 122.913 0.485 . . . . 4.85 109.736 178.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 171.56 68.96 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.58 -0.819 . . . . 1.55 112.505 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.1 m -135.93 2.82 2.89 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.507 0.67 . . . . 1.58 110.007 175.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 90.9 p -178.48 151.81 0.62 Allowed 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.678 -1.971 . . . . 1.17 105.678 175.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.882 HG21 ' HE1' ' A' ' 122' ' ' MET . 6.5 pt -69.12 -13.99 17.95 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 CA-C-N 114.787 -1.097 . . . . 0.38 111.801 -171.357 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.824 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 54.8 m-85 -77.21 -3.26 38.72 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.273 -0.421 . . . . 0.3 111.189 -177.283 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -69.24 -21.06 63.94 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.275 -1.009 . . . . 2.11 108.275 172.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.753 ' HE2' ' HB2' ' A' ' 121' ' ' TYR . 49.6 m-85 -114.14 111.1 21.03 Favored 'General case' 0 CA--C 1.503 -0.853 0 CA-C-N 114.718 -1.128 . . . . 0.31 111.84 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -50.42 150.35 2.66 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.142 -1.39 . . . . 2.86 109.941 169.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.762 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 38.0 t -111.43 164.02 7.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 N-CA-C 108.894 -0.78 . . . . 0.67 108.894 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.759 ' O ' ' HB3' ' A' ' 105' ' ' MET . 89.6 mt -126.4 113.11 16.45 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 120.873 -0.331 . . . . 0.69 111.65 -176.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.716 ' HA ' ' HE2' ' A' ' 105' ' ' MET . 12.1 t70 -51.6 160.42 0.63 Allowed 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 107.779 -1.193 . . . . 1.87 107.779 169.059 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.635 ' HA ' ' C ' ' A' ' 105' ' ' MET . . . -54.53 -16.69 2.53 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 114.147 1.166 . . . . 0.59 114.147 -163.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.543 ' HB2' ' HE2' ' A' ' 26' ' ' LYS . 33.4 m-20 -96.15 5.32 51.35 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 112.325 0.491 . . . . 2.34 112.325 178.078 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.695 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 82.8 m-70 78.13 15.21 1.43 Allowed 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.699 0.762 . . . . 1.47 109.163 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.543 ' HE2' ' HB2' ' A' ' 24' ' ' ASP . 13.2 mtmt -79.64 119.15 75.89 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 107.212 -1.403 . . . . 4.25 107.212 169.11 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.61 ' HA ' HD23 ' A' ' 21' ' ' LEU . 84.6 Cg_exo -51.7 113.91 1.36 Allowed 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 121.582 1.521 . . . . 0.54 113.157 -173.339 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.56 ' HB3' HG12 ' A' ' 20' ' ' VAL . 32.3 t80 -79.35 144.8 33.86 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.074 -1.421 . . . . 1.2 111.366 175.022 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.441 ' OD1' ' HB3' ' A' ' 32' ' ' GLN . 2.4 t-20 -78.85 85.38 4.83 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.026 -0.988 . . . . 1.51 109.934 178.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.616 ' HG ' ' CD1' ' A' ' 16' ' ' PHE . 49.1 tp -63.26 -42.37 99.14 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.393 -0.821 . . . . 0.28 110.471 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.804 ' HA ' ' CE1' ' A' ' 16' ' ' PHE . 2.0 t -68.99 -0.64 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 114.424 -1.262 . . . . 1.02 112.481 -167.052 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.441 ' HB3' ' OD1' ' A' ' 29' ' ' ASN . 10.4 pt20 -76.52 -5.26 46.79 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.531 0.681 . . . . 1.02 110.321 177.194 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.955 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 87.9 m-70 -100.71 24.29 9.31 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.843 0.83 . . . . 0.28 109.335 173.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.824 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 0.5 OUTLIER -82.82 110.42 17.82 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.724 -1.125 . . . . 1.56 109.311 171.762 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.26 -37.42 2.2 Favored Glycine 0 N--CA 1.437 -1.249 0 C-N-CA 120.917 -0.659 . . . . 0.2 111.506 -177.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.479 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 17.6 m -132.33 133.11 23.34 Favored Pre-proline 0 N--CA 1.435 -1.197 0 N-CA-C 108.626 -0.879 . . . . 0.29 108.626 173.353 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.8 ' HG3' ' CB ' ' A' ' 170' ' ' LEU . 6.8 Cg_endo -44.04 153.45 0.31 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 124.124 3.216 . . . . 0.18 112.614 178.111 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.895 ' HB2' HG22 ' A' ' 70' ' ' THR . 0.7 OUTLIER -140.61 139.41 34.89 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.027 -1.471 . . . . 0.31 107.027 -179.919 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.818 ' HB3' ' CE1' ' A' ' 41' ' ' TYR . 3.0 mp -107.17 116.66 32.32 Favored 'General case' 0 C--N 1.293 -1.881 0 O-C-N 121.518 -0.739 . . . . 1.19 109.449 176.241 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.914 HG23 ' HB2' ' A' ' 72' ' ' LEU . 2.6 mt -95.77 120.35 45.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-N 115.557 -0.747 . . . . 0.37 109.761 176.198 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.818 ' CE1' ' HB3' ' A' ' 39' ' ' LEU . 0.5 OUTLIER -103.87 124.95 49.88 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.493 -0.776 . . . . 0.42 110.041 -174.555 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.675 ' OD1' ' HB ' ' A' ' 140' ' ' THR . 0.2 OUTLIER -75.61 125.66 29.47 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 104.309 -2.478 . . . . 2.35 104.309 168.525 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.703 ' O ' ' HA ' ' A' ' 75' ' ' PRO . 2.8 p -133.14 123.88 48.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 C-N-CA 117.665 -1.614 . . . . 1.03 113.114 -169.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.59 98.07 3.3 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.125 -0.943 . . . . 0.88 108.842 172.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.672 ' HA ' ' HB3' ' A' ' 98' ' ' PHE . 3.4 p -48.04 82.4 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 113.954 -1.475 . . . . 1.78 112.138 169.107 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.823 ' HE3' ' HB3' ' A' ' 49' ' ' TYR . 27.3 mtpp -101.49 163.86 12.05 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.282 -0.636 . . . . 5.84 109.282 178.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 33.9 t -110.12 116.95 32.47 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 120.934 0.397 . . . . 3.55 109.997 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 66.97 25.24 73.25 Favored Glycine 0 CA--C 1.519 0.319 0 CA-C-N 115.749 -0.66 . . . . 2.91 112.69 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.823 ' HB3' ' HE3' ' A' ' 46' ' ' LYS . 0.3 OUTLIER -136.23 135.11 38.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.014 0.435 . . . . 4.63 111.494 -177.542 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -147.9 141.32 25.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.517 -0.765 . . . . 1.93 110.148 178.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.548 ' HD3' ' OD1' ' A' ' 138' ' ' ASN . 27.8 mtpp -112.7 48.55 1.0 Allowed 'General case' 0 C--O 1.223 -0.333 0 N-CA-C 110.232 -0.284 . . . . 2.01 110.232 176.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.13 -42.12 3.03 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.775 -0.726 . . . . 0.51 112.077 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -47.55 -45.16 23.18 Favored Glycine 0 C--O 1.224 -0.517 0 O-C-N 123.792 0.348 . . . . 0.5 113.686 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.639 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 1.1 t80 -61.38 -62.97 1.45 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.049 0.389 . . . . 0.7 112.049 -172.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -59.24 -40.14 84.98 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.188 0.518 . . . . 2.61 111.121 -178.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.55 ' HA ' ' CG2' ' A' ' 160' ' ' VAL . 40.8 m -54.97 -59.92 4.09 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.163 -0.926 . . . . 0.33 111.193 174.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 1.027 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -61.81 -42.55 99.16 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.417 -0.811 . . . . 0.22 111.15 -176.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.597 ' N ' ' HE1' ' A' ' 102' ' ' PHE . 61.5 m -55.33 -51.08 67.92 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.814 0.816 . . . . 0.26 109.825 -177.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 26.5 m -72.11 -35.15 69.1 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 114.402 -1.272 . . . . 0.48 111.22 -177.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.64 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 17.4 mt -67.57 -50.04 60.35 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 121.365 0.602 . . . . 0.43 110.413 -176.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.847 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 8.4 t80 -59.36 -47.21 86.29 Favored 'General case' 0 C--O 1.205 -1.27 0 CA-C-N 114.967 -1.015 . . . . 0.31 110.502 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -73.76 -24.29 59.84 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 112.022 0.379 . . . . 1.21 112.022 -174.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.48 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 32.2 ttpt -84.54 -25.99 28.36 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 120.02 -0.672 . . . . 1.54 109.275 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.734 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 35.9 m-85 -123.2 -5.79 8.34 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 115.121 1.526 . . . . 0.31 115.121 -169.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.71 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 41.4 pttt -65.48 -26.59 67.99 Favored 'General case' 0 CA--C 1.5 -0.975 0 N-CA-C 108.434 -0.95 . . . . 1.35 108.434 172.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.2 t -47.91 -41.86 25.65 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.458 -1.246 . . . . 1.28 110.733 172.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -82.03 -37.41 26.56 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 111.821 0.304 . . . . 1.11 111.821 175.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.429 ' HA3' ' HB2' ' A' ' 36' ' ' SER . . . 150.58 -7.95 0.72 Allowed Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 111.622 -0.591 . . . . 0.18 111.622 -176.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.734 ' HD2' ' HB2' ' A' ' 64' ' ' TYR . 13.7 t80 -64.41 143.33 57.98 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 122.777 0.431 . . . . 0.18 110.841 -178.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.955 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 5.3 t -132.91 148.16 52.29 Favored 'General case' 0 N--CA 1.416 -2.127 0 N-CA-C 108.848 -0.797 . . . . 0.2 108.848 168.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 1.027 HG11 ' HB1' ' A' ' 57' ' ' ALA . 21.8 t -100.07 100.78 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.419 0 N-CA-C 107.199 -1.408 . . . . 0.17 107.199 158.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.914 ' HB2' HG23 ' A' ' 40' ' ' ILE . 79.8 mt -84.26 118.87 24.45 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 107.085 -1.45 . . . . 1.04 107.085 178.171 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.618 ' HB3' HG12 ' A' ' 104' ' ' ILE . . . -96.44 113.41 24.99 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.939 -0.704 . . . . 0.51 109.838 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.882 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 5.0 m-85 -108.96 95.22 16.62 Favored Pre-proline 0 N--CA 1.433 -1.286 0 N-CA-C 107.337 -1.357 . . . . 0.44 107.337 -177.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.891 ' HB2' ' HG2' ' A' ' 107' ' ' LYS . 3.4 Cg_endo -67.33 148.37 79.71 Favored 'Trans proline' 0 N--CA 1.429 -2.314 0 N-CA-C 109.091 -1.157 . . . . 1.3 109.091 -174.095 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.599 ' HB2' ' OE1' ' A' ' 83' ' ' GLU . 29.2 p -76.17 141.31 41.89 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-O 121.988 0.899 . . . . 1.44 112.76 -177.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.415 ' C ' ' H ' ' A' ' 79' ' ' PHE . 62.2 t30 -69.28 62.7 0.14 Allowed 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 113.56 -1.655 . . . . 1.81 108.622 170.096 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.82 ' HA ' ' HG3' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -51.24 -13.34 0.18 Allowed 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 114.577 -1.192 . . . . 3.34 111.135 174.313 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.415 ' H ' ' C ' ' A' ' 77' ' ' ASN . 50.1 t80 -66.7 -13.61 61.5 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.979 -1.01 . . . . 2.68 110.519 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.32 -135.36 5.05 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.192 -0.528 . . . . 1.98 112.109 175.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -159.02 54.32 0.37 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.932 -0.652 . . . . 1.49 112.153 178.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.59 ' HG3' ' HB3' ' A' ' 113' ' ' GLU . 3.5 pm0 -153.97 5.5 0.3 Allowed 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.348 0.594 . . . . 1.74 110.77 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.82 ' HG3' ' HA ' ' A' ' 78' ' ' GLN . 15.8 mm-40 -80.17 137.51 52.9 Favored Pre-proline 0 C--N 1.308 -1.208 0 N-CA-C 114.443 1.275 . . . . 3.07 114.443 -159.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.707 ' HD3' HD22 ' A' ' 111' ' ' ASN . 0.0 OUTLIER -34.1 148.25 0.03 OUTLIER 'Trans proline' 0 C--O 1.235 0.357 1 C-N-CA 126.521 4.814 . . . . 1.75 116.447 176.351 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.67 -46.75 3.7 Favored Glycine 0 N--CA 1.441 -0.995 0 CA-C-N 114.857 -1.065 . . . . 2.2 113.972 167.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.502 ' O ' ' HB2' ' A' ' 87' ' ' GLU . 27.0 t-20 -171.69 -34.48 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.852 1.056 . . . . 4.2 113.852 -170.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.502 ' HB2' ' O ' ' A' ' 86' ' ' ASN . 52.1 mt-10 76.36 -63.17 0.4 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.787 0.435 . . . . 3.02 111.737 -177.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.695 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 41.5 mm-40 -68.51 -45.49 72.14 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.535 0.939 . . . . 3.92 113.535 -168.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -48.37 -54.29 14.47 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.719 0.637 . . . . 2.65 112.719 -168.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.704 HG23 ' HB2' ' A' ' 95' ' ' CYS . 4.0 mp -65.69 -26.03 37.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 111.976 0.361 . . . . 2.15 111.976 -171.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.695 ' HE2' ' HA ' ' A' ' 88' ' ' GLU . 38.6 mtmt -80.65 -37.27 31.23 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.208 0.527 . . . . 2.79 110.58 -178.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 88' ' ' GLU . 32.1 mm-40 -90.26 -39.26 12.87 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.558 -0.746 . . . . 3.29 110.614 -173.141 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -88.97 162.22 16.18 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.082 -0.963 . . . . 3.42 109.435 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 73.3 t -79.21 107.66 11.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 108.949 -0.759 . . . . 2.63 108.949 173.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.704 ' HB2' HG23 ' A' ' 90' ' ' ILE . 33.2 m -152.84 122.41 6.81 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.202 -0.908 . . . . 2.83 108.855 178.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.423 HG22 ' HG3' ' A' ' 97' ' ' LYS . 1.4 m -146.23 123.83 11.8 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.485 -0.486 . . . . 2.98 110.432 174.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.816 ' HB2' ' HD2' ' A' ' 99' ' ' LYS . 99.5 mttt 72.71 -26.48 0.18 Allowed 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.059 -0.973 . . . . 2.72 113.207 172.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.95 ' HZ ' ' HE2' ' A' ' 102' ' ' PHE . 0.2 OUTLIER 67.87 -41.08 0.43 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.938 1.295 . . . . 2.12 110.913 -176.152 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.816 ' HD2' ' HB2' ' A' ' 97' ' ' LYS . 0.0 OUTLIER 66.42 142.8 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.223 1.009 . . . . 2.69 113.124 173.67 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.556 ' HB2' ' CE1' ' A' ' 98' ' ' PHE . . . -176.06 -167.63 0.23 Allowed 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 115.179 -0.919 . . . . 0.55 111.518 -168.195 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.638 ' O ' ' HD2' ' A' ' 61' ' ' TYR . 62.6 mm-40 -100.92 48.12 0.9 Allowed 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 114.665 -1.152 . . . . 1.99 110.837 176.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.95 ' HE2' ' HZ ' ' A' ' 98' ' ' PHE . 1.6 m-85 -128.25 175.98 3.07 Favored Pre-proline 0 CA--C 1.511 -0.543 0 CA-C-O 121.466 0.651 . . . . 0.84 109.724 172.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.674 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 14.4 Cg_exo -76.48 77.75 3.51 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 123.519 2.813 . . . . 0.62 109.936 158.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.618 HG12 ' HB3' ' A' ' 73' ' ' ALA . 76.4 mt -80.44 126.52 39.55 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.504 0 N-CA-C 107.978 -1.119 . . . . 1.34 107.978 176.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.882 ' HG3' ' CE1' ' A' ' 74' ' ' PHE . 7.1 mmt -105.56 -168.12 1.41 Allowed 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 121.727 0.775 . . . . 3.03 113.032 -163.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.629 ' N ' ' HA ' ' A' ' 23' ' ' ALA . . . -76.47 6.81 5.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.637 -1.165 . . . . 1.46 113.755 -167.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.891 ' HG2' ' HB2' ' A' ' 75' ' ' PRO . 57.1 mttp 65.99 139.29 0.03 OUTLIER 'General case' 0 CA--C 1.491 -1.315 0 CA-C-O 122.51 1.148 . . . . 1.76 110.847 -169.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.846 HD12 ' HD2' ' A' ' 74' ' ' PHE . 0.1 OUTLIER -138.45 163.71 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.576 0 N-CA-C 106.428 -1.693 . . . . 0.82 106.428 165.96 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.55 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 0.2 OUTLIER -73.16 83.56 1.33 Allowed 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 120.612 0.244 . . . . 1.73 110.375 -177.428 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.65 HG13 HD11 ' A' ' 108' ' ' ILE . 2.6 m -80.25 90.15 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-O 121.848 0.832 . . . . 0.77 109.299 176.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.707 HD22 ' HD3' ' A' ' 84' ' ' PRO . 2.9 t-20 174.77 -177.17 0.09 Allowed 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 114.177 -1.374 . . . . 1.9 107.988 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -91.44 37.46 3.38 Favored Glycine 0 N--CA 1.435 -1.395 0 C-N-CA 120.12 -1.038 . . . . 1.47 114.49 -177.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.59 ' HB3' ' HG3' ' A' ' 82' ' ' GLN . 0.2 OUTLIER -105.28 -50.41 3.23 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 118.974 -1.09 . . . . 2.81 110.849 170.664 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -131.86 -42.12 1.02 Allowed 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 118.781 -1.167 . . . . 2.16 111.568 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.55 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . 54.52 139.57 0.0 OUTLIER 'General case' 0 C--N 1.345 0.404 0 CA-C-O 122.13 0.967 . . . . 1.26 111.651 -176.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.826 ' HB3' HG13 ' A' ' 108' ' ' ILE . 1.6 t-80 -88.26 143.12 32.22 Favored Pre-proline 0 C--N 1.312 -1.028 0 O-C-N 120.602 -1.311 . . . . 0.42 107.557 178.22 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -24.99 -48.03 0.06 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 124.678 3.585 . . . . 0.4 113.847 178.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.767 HD11 ' HB ' ' A' ' 15' ' ' ILE . 38.5 tp -69.35 -45.92 68.24 Favored 'General case' 0 C--O 1.216 -0.684 0 C-N-CA 122.598 0.359 . . . . 0.39 111.827 -179.028 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.668 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 9.7 m-85 -82.54 -32.16 28.75 Favored 'General case' 0 CA--C 1.491 -1.303 0 CA-C-O 121.709 0.766 . . . . 3.04 110.9 -175.058 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.531 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 2.9 tm-20 -64.03 -35.03 79.38 Favored 'General case' 0 N--CA 1.424 -1.749 0 N-CA-C 107.031 -1.47 . . . . 2.44 107.031 172.405 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.753 ' HB2' ' HE2' ' A' ' 18' ' ' PHE . 28.7 t80 -72.45 -26.75 61.94 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.96 -1.018 . . . . 0.56 110.253 170.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.882 ' HE1' HG21 ' A' ' 15' ' ' ILE . 15.4 mmt -71.95 -55.93 6.59 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 121.66 0.743 . . . . 0.71 110.287 -170.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.668 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -72.84 -25.48 61.14 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.214 -0.903 . . . . 1.46 110.565 178.655 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.531 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 27.2 tttt -60.96 -38.42 85.82 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 109.079 -0.712 . . . . 1.99 109.079 169.184 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.44 ' HB ' ' O ' ' A' ' 122' ' ' MET . 96.2 m -65.43 -55.71 16.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.29 -0.868 . . . . 0.59 110.644 177.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -155.47 122.3 2.71 Favored Pre-proline 0 N--CA 1.452 -0.369 0 N-CA-C 113.392 0.886 . . . . 1.85 113.392 -174.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.799 ' HA ' ' NH2' ' A' ' 153' ' ' ARG . 1.6 Cg_endo -87.99 61.41 3.32 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 124.673 3.582 . . . . 1.69 109.418 166.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -62.89 139.4 44.87 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.039 -0.982 . . . . 2.59 113.274 -173.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 71.9 mt 72.33 -41.93 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 123.559 0.744 . . . . 3.58 111.539 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.8 112.72 13.29 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.906 0.384 . . . . 3.47 110.94 -178.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.455 ' HA ' ' HB2' ' A' ' 127' ' ' PRO . . . -79.35 38.52 0.36 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.376 0.608 . . . . 3.28 110.774 177.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 28.1 m -77.22 -76.75 0.16 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.492 -0.777 . . . . 3.56 110.716 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -153.33 -76.21 0.12 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 122.074 0.94 . . . . 5.17 109.053 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.617 ' HB1' HD13 ' A' ' 135' ' ' ILE . . . -135.59 -164.13 1.49 Allowed 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.279 -1.328 . . . . 1.59 110.159 -173.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.876 ' H ' HD13 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -41.75 -61.4 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 O-C-N 124.495 1.122 . . . . 2.0 111.971 177.432 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.886 ' HB3' ' CZ3' ' A' ' 137' ' ' TRP . 3.1 tmtp? 77.7 -27.67 0.17 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.064 0.946 . . . . 4.81 113.257 167.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.886 ' CZ3' ' HB3' ' A' ' 136' ' ' LYS . 1.9 m-90 -104.23 176.89 5.01 Favored 'General case' 0 CA--C 1.507 -0.696 0 O-C-N 122.235 -0.291 . . . . 1.97 110.525 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.548 ' OD1' ' HD3' ' A' ' 51' ' ' LYS . 6.6 m120 -39.46 -154.23 0.0 OUTLIER 'General case' 0 C--O 1.203 -1.366 0 O-C-N 124.822 1.326 . . . . 2.04 111.5 160.282 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.622 ' HD2' ' CD2' ' A' ' 41' ' ' TYR . 2.2 m-85 -31.35 -25.19 0.0 OUTLIER 'General case' 0 CA--C 1.567 1.597 0 N-CA-C 117.691 2.478 . . . . 1.93 117.691 -171.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.728 ' HA ' ' O ' ' A' ' 154' ' ' PHE . 1.4 m 6.56 101.3 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 120.495 1.498 . . . . 0.6 114.086 170.114 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.515 ' O ' ' HA ' ' A' ' 153' ' ' ARG . 4.5 m -89.12 176.03 7.14 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.22 -0.9 . . . . 0.62 112.195 -170.227 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.562 ' HA ' ' O ' ' A' ' 152' ' ' GLU . 79.5 m-85 -134.25 124.44 25.93 Favored 'General case' 0 CA--C 1.491 -1.297 0 N-CA-C 106.422 -1.695 . . . . 0.57 106.422 161.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.821 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 5.8 tp -80.52 103.97 10.74 Favored 'General case' 0 N--CA 1.423 -1.82 0 C-N-CA 118.487 -1.285 . . . . 0.43 108.342 177.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.768 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 27.9 mm -90.76 141.35 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.822 0 CA-C-N 113.41 -1.723 . . . . 0.19 107.656 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.54 ' OD1' HG12 ' A' ' 149' ' ' VAL . 0.0 OUTLIER -94.71 -173.68 3.08 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 119.541 -0.863 . . . . 0.98 111.234 -169.905 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.503 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 44.2 mtm180 -54.83 -36.48 65.05 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.14 0.275 . . . . 2.22 111.326 -177.07 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -104.05 20.97 17.26 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 121.569 0.7 . . . . 2.0 109.245 -176.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.643 ' HA2' ' CG2' ' A' ' 144' ' ' ILE . . . 70.43 36.37 69.26 Favored Glycine 0 N--CA 1.435 -1.396 0 CA-C-N 114.624 -1.171 . . . . 0.17 115.126 175.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.54 HG12 ' OD1' ' A' ' 145' ' ' ASP . 5.2 p -103.67 129.98 24.34 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 119.528 1.664 . . . . 1.12 110.379 172.325 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.529 ' HA ' HD13 ' A' ' 144' ' ' ILE . 3.6 Cg_exo -69.84 121.33 8.0 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.6 2.2 . . . . 0.41 110.493 179.128 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 22.1 t -114.7 -27.01 2.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-O 121.426 0.631 . . . . 1.45 109.401 -176.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.821 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 60.7 mm-40 -138.17 165.47 26.57 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.363 -0.835 . . . . 1.17 111.441 -178.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.799 ' NH2' ' HA ' ' A' ' 127' ' ' PRO . 2.6 ttm180 -145.6 125.2 13.26 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.761 -1.109 . . . . 2.16 109.146 165.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.728 ' O ' ' HA ' ' A' ' 140' ' ' THR . 91.2 m-85 -107.19 149.95 27.14 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.203 -0.908 . . . . 0.32 108.74 -169.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 19.4 m -76.98 158.51 80.13 Favored Pre-proline 0 C--N 1.313 -0.998 0 N-CA-C 108.795 -0.817 . . . . 1.11 108.795 175.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.547 ' HG3' ' HB3' ' A' ' 137' ' ' TRP . 10.8 Cg_endo -54.52 -48.91 18.86 Favored 'Trans proline' 0 N--CA 1.465 -0.202 0 C-N-CA 121.874 1.716 . . . . 0.78 110.685 178.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -59.52 -2.0 1.45 Allowed Glycine 0 CA--C 1.529 0.964 0 CA-C-N 114.753 -1.112 . . . . 0.5 114.902 174.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -84.69 134.07 34.37 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 107.982 -1.118 . . . . 0.5 107.982 171.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.534 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 6.8 t -110.68 -174.58 2.51 Favored 'General case' 0 N--CA 1.435 -1.177 0 C-N-CA 119.976 -0.69 . . . . 1.42 110.757 -167.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.55 ' CG2' ' HA ' ' A' ' 56' ' ' THR . 64.0 t -45.44 -50.92 2.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 114.7 -1.137 . . . . 0.28 111.202 -176.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -68.79 -35.07 76.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.137 -0.483 . . . . 3.46 111.22 -174.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.451 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 28.2 m-20 -68.91 -35.17 76.52 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.779 0.799 . . . . 1.4 109.553 -177.281 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.46 ' HA ' ' CE2' ' A' ' 154' ' ' PHE . 46.5 mt -80.56 -48.08 20.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 114.494 -1.23 . . . . 0.21 111.354 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.631 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 49.3 mt-10 -53.81 -39.3 65.4 Favored 'General case' 0 C--O 1.217 -0.631 0 CA-C-O 120.888 0.375 . . . . 0.67 111.39 -176.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 12.1 pt-20 -60.86 -21.93 63.74 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.636 0.255 . . . . 0.87 111.544 -176.033 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.582 ' HB3' HD22 ' A' ' 143' ' ' LEU . 35.7 mmtp -100.07 -22.85 15.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.382 0.61 . . . . 1.71 110.13 174.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.631 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 12.9 tp -85.8 -50.03 7.46 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.037 -0.983 . . . . 0.16 112.36 -174.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.557 ' N ' ' HD2' ' A' ' 169' ' ' PRO . 73.8 mt -54.09 -46.95 98.55 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.628 -0.715 . . . . 0.26 112.643 -173.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 168' ' ' ILE . 14.7 Cg_endo -58.62 -16.23 29.31 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.192 1.928 . . . . 0.41 113.026 175.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.8 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 95.4 mt -97.11 -41.31 8.4 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 122.006 -0.433 . . . . 0.71 110.784 177.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.664 HD23 ' HG2' ' A' ' 37' ' ' PRO . 96.0 mt -63.28 -53.61 50.22 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-O 122.21 1.005 . . . . 0.34 109.727 175.086 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -75.93 -11.46 84.68 Favored Glycine 0 N--CA 1.433 -1.55 0 CA-C-N 113.323 -1.762 . . . . 1.12 112.365 -176.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 8.7 t 62.9 92.39 0.06 Allowed 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.421 0.629 . . . . 2.64 110.538 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -58.29 -42.13 85.94 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.695 -0.684 . . . . 4.35 110.63 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 77.6 mtm180 56.74 -156.33 0.29 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.125 -0.488 . . . . 8.45 110.74 178.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 37.8 tp . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.244 -0.884 . . . . 7.69 109.263 176.315 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.9 0 N-CA-C 112.072 -0.411 . . . . 5.22 112.072 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.423 ' SD ' ' N ' ' A' ' 11' ' ' MET . 1.6 mpt? -79.62 55.54 2.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.268 0.556 . . . . 4.85 109.717 178.132 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.67 179.68 16.27 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.136 -1.186 . . . . 1.55 110.136 -170.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.9 m -141.31 13.17 2.18 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.514 0.673 . . . . 1.58 110.175 177.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 80.0 p 178.85 177.8 0.47 Allowed 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 105.89 -1.893 . . . . 1.17 105.89 -173.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.879 HG23 ' HD3' ' A' ' 150' ' ' PRO . 3.7 pt -89.71 -15.36 8.8 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 CA-C-N 115.579 -0.737 . . . . 0.38 110.378 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.816 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 36.3 m-85 -70.52 -13.23 62.02 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.259 0.552 . . . . 0.3 110.854 -179.01 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -63.93 -24.67 67.82 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.64 -0.874 . . . . 2.11 108.64 173.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.599 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 50.9 m-85 -112.49 105.6 13.87 Favored 'General case' 0 CA--C 1.495 -1.145 0 CA-C-N 114.972 -1.013 . . . . 0.31 110.341 178.207 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -52.16 146.19 9.4 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.68 -1.145 . . . . 2.86 109.903 174.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.733 HG23 HD22 ' A' ' 30' ' ' LEU . 54.7 t -109.26 159.17 8.85 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 107.464 -1.31 . . . . 0.67 107.464 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.857 ' O ' ' HB2' ' A' ' 105' ' ' MET . 26.2 mt -126.99 167.82 15.38 Favored 'General case' 0 N--CA 1.433 -1.312 0 C-N-CA 120.323 -0.551 . . . . 0.69 110.279 -176.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -86.69 -179.27 6.55 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.64 -0.874 . . . . 1.87 108.64 175.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.683 ' HA ' ' N ' ' A' ' 106' ' ' ALA . . . -63.58 -9.13 11.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 118.527 0.603 . . . . 0.59 111.415 -178.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.494 ' HB2' ' HE2' ' A' ' 26' ' ' LYS . 11.8 m-20 -107.85 7.74 28.3 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.559 -0.291 . . . . 2.34 111.562 174.337 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.543 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 2.0 m-70 72.29 15.1 5.37 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 121.68 0.753 . . . . 1.47 110.181 174.047 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.494 ' HE2' ' HB2' ' A' ' 24' ' ' ASP . 27.5 mtmt -76.39 133.38 71.35 Favored Pre-proline 0 C--O 1.221 -0.426 0 N-CA-C 107.228 -1.397 . . . . 4.25 107.228 165.434 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.679 ' HA ' HD23 ' A' ' 21' ' ' LEU . 85.2 Cg_exo -48.86 115.94 1.91 Allowed 'Trans proline' 0 CA--C 1.532 0.418 0 C-N-CA 122.11 1.873 . . . . 0.54 113.719 -175.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.68 ' H ' ' HA ' ' A' ' 21' ' ' LEU . 0.4 OUTLIER -77.32 153.07 34.19 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.32 -1.309 . . . . 1.2 109.031 168.898 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.608 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.1 t-20 -92.32 84.15 5.13 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.446 0.641 . . . . 1.51 109.34 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.733 HD22 HG23 ' A' ' 20' ' ' VAL . 64.0 tp -67.27 -47.41 70.75 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.499 -0.773 . . . . 0.28 110.746 -178.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.836 HG12 ' HG3' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -69.55 -0.68 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.351 -0.841 . . . . 1.02 112.704 -168.199 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.608 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 3.9 pt20 -75.08 -11.04 60.0 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.393 -0.595 . . . . 1.02 109.393 174.447 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.952 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 89.5 m-70 -95.81 18.05 13.91 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.933 0.873 . . . . 0.28 109.124 175.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.836 ' HG3' HG12 ' A' ' 31' ' ' VAL . 23.7 mtmt -77.69 110.97 12.98 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 114.464 -1.244 . . . . 1.56 108.874 166.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 131.86 -44.99 1.16 Allowed Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 120.754 -0.736 . . . . 0.2 111.499 -178.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.466 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 43.4 m -129.05 134.93 26.87 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 108.721 -0.844 . . . . 0.29 108.721 172.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.726 ' HG3' ' CB ' ' A' ' 170' ' ' LEU . 5.2 Cg_endo -42.38 153.9 0.13 Allowed 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 124.403 3.402 . . . . 0.18 113.093 177.038 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.876 ' HB2' HG22 ' A' ' 70' ' ' THR . 0.6 OUTLIER -138.32 143.6 40.02 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 113.737 -1.574 . . . . 0.31 106.847 179.79 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 1.037 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 1.6 mm? -109.78 117.87 35.01 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.199 -1.038 . . . . 1.19 108.199 178.16 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.817 HG22 ' OH ' ' A' ' 119' ' ' TYR . 5.8 mt -108.24 129.85 61.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 C-N-CA 120.107 -0.637 . . . . 0.37 109.679 -178.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 1.037 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.5 OUTLIER -114.31 130.28 56.66 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 116.132 -0.485 . . . . 0.42 111.315 -168.664 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.621 ' OD1' ' HB ' ' A' ' 135' ' ' ILE . 2.9 p30 -84.36 93.54 8.28 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 107.798 -1.186 . . . . 2.35 107.798 166.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.913 HG11 ' HB1' ' A' ' 73' ' ' ALA . 2.7 p -105.33 154.99 6.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-N 115.444 -0.798 . . . . 1.03 111.481 -161.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.571 ' HB1' ' ND2' ' A' ' 86' ' ' ASN . . . -103.96 103.06 12.85 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 114.983 -1.008 . . . . 0.88 110.405 176.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.872 ' HA ' ' HB2' ' A' ' 98' ' ' PHE . 1.4 p -24.77 124.63 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 114.283 -1.326 . . . . 1.78 113.085 170.328 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.407 ' HG3' ' O ' ' A' ' 46' ' ' LYS . 20.7 ptmt -60.46 105.22 0.41 Allowed 'General case' 0 C--O 1.232 0.156 0 CA-C-N 114.984 -1.007 . . . . 5.84 112.714 -170.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.493 ' SG ' ' HB3' ' A' ' 95' ' ' CYS . 9.3 p -163.91 114.66 1.32 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.266 -0.879 . . . . 3.55 109.266 172.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 69.84 -50.18 0.68 Allowed Glycine 0 CA--C 1.524 0.637 0 C-N-CA 121.258 -0.496 . . . . 2.91 113.397 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -119.23 118.98 32.74 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.442 0.639 . . . . 4.63 112.459 -174.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.853 HG21 ' HD2' ' A' ' 54' ' ' TYR . 7.8 m -145.08 93.33 2.38 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.466 -0.939 . . . . 1.93 108.466 170.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.629 ' HB3' ' HB2' ' A' ' 156' ' ' PRO . 54.4 tttp -79.26 59.19 2.74 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.543 0.572 . . . . 2.01 112.543 -167.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.612 ' O ' ' HG3' ' A' ' 55' ' ' GLU . . . 79.67 -33.97 2.09 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 120.904 -0.665 . . . . 0.51 113.721 172.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -54.06 -21.5 17.87 Favored Glycine 0 C--O 1.221 -0.712 0 C-N-CA 121.379 -0.439 . . . . 0.5 113.676 -177.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.853 ' HD2' HG21 ' A' ' 50' ' ' THR . 0.1 OUTLIER -65.14 -61.53 2.08 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 117.595 0.697 . . . . 0.7 109.921 179.825 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.612 ' HG3' ' O ' ' A' ' 52' ' ' GLY . 0.1 OUTLIER -59.57 -21.8 60.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.612 -0.722 . . . . 2.61 110.044 179.896 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.661 ' HA ' ' CG2' ' A' ' 160' ' ' VAL . 29.6 m -77.4 -59.76 2.65 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 114.814 -1.085 . . . . 0.33 110.623 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 1.023 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -61.19 -35.08 76.2 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.339 -0.846 . . . . 0.22 110.684 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.653 ' HA ' ' CD1' ' A' ' 102' ' ' PHE . 89.6 m -60.21 -59.18 5.83 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.742 -0.663 . . . . 0.26 110.59 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 56.5 m -70.0 -35.13 74.14 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-N 115.515 -0.766 . . . . 0.48 111.936 -176.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.755 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 21.7 mt -62.33 -52.03 65.29 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 121.302 0.572 . . . . 0.43 110.481 -177.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.762 ' HD1' ' HA ' ' A' ' 70' ' ' THR . 34.3 t80 -51.86 -56.01 16.61 Favored 'General case' 0 C--O 1.204 -1.298 0 CA-C-N 114.584 -1.189 . . . . 0.31 111.108 177.399 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -71.62 -23.93 61.79 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 122.395 0.278 . . . . 1.21 111.078 -172.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.575 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 37.3 ttpt -86.03 -20.68 28.46 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 109.312 -0.625 . . . . 1.54 109.312 -177.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.646 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 44.1 m-85 -128.02 -6.43 5.52 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 114.547 1.314 . . . . 0.31 114.547 -171.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.739 ' HD2' ' CZ ' ' A' ' 61' ' ' TYR . 13.6 ptmt -63.57 -24.46 67.81 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 108.1 -1.074 . . . . 1.35 108.1 171.137 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -47.88 -38.57 16.56 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 113.963 -1.471 . . . . 1.28 110.81 172.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -89.35 -32.42 17.32 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.702 0.287 . . . . 1.11 111.67 175.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 147.45 -1.88 0.76 Allowed Glycine 0 C--N 1.332 0.319 0 N-CA-C 111.674 -0.57 . . . . 0.18 111.674 -178.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.755 ' HE2' ' HB3' ' A' ' 60' ' ' LEU . 25.3 t80 -69.51 145.02 53.0 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-O 121.4 0.619 . . . . 0.18 112.003 -177.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.952 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 1.6 t -135.59 152.93 51.74 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 108.839 -0.8 . . . . 0.2 108.839 173.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 1.023 HG11 ' HB1' ' A' ' 57' ' ' ALA . 51.9 t -113.35 101.65 12.78 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.426 0 N-CA-C 108.422 -0.955 . . . . 0.17 108.422 158.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.919 ' HA ' ' HB2' ' A' ' 103' ' ' PRO . 0.4 OUTLIER -94.4 122.05 36.56 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 107.222 -1.399 . . . . 1.04 107.222 173.992 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.913 ' HB1' HG11 ' A' ' 43' ' ' VAL . . . -108.49 130.34 55.26 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.397 0.618 . . . . 0.51 111.596 -178.257 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.671 ' CE1' ' HG2' ' A' ' 105' ' ' MET . 3.8 m-30 -109.07 102.82 50.36 Favored Pre-proline 0 C--N 1.319 -0.735 0 N-CA-C 108.72 -0.844 . . . . 0.44 108.72 177.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.837 ' HG2' ' HD2' ' A' ' 107' ' ' LYS . 60.7 Cg_endo -76.87 45.36 1.65 Allowed 'Trans proline' 0 N--CA 1.481 0.784 0 C-N-CA 123.676 2.918 . . . . 1.3 116.076 -163.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.471 ' C ' ' HB2' ' A' ' 107' ' ' LYS . 30.8 t 46.03 146.82 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 117.128 2.27 . . . . 1.44 117.128 178.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.453 ' C ' ' H ' ' A' ' 79' ' ' PHE . 8.7 t-20 -100.25 62.05 1.09 Allowed 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 113.938 -1.483 . . . . 1.81 107.264 174.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.819 ' HA ' ' HG3' ' A' ' 83' ' ' GLU . 18.2 mp0 -54.15 -8.51 0.2 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 114.344 -1.298 . . . . 3.34 111.775 -178.006 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.453 ' H ' ' C ' ' A' ' 77' ' ' ASN . 41.8 m-85 -64.29 -16.78 62.8 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.895 -1.048 . . . . 2.68 110.464 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -99.31 143.84 16.77 Favored Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 111.185 -0.766 . . . . 1.98 111.185 173.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.01 63.56 4.46 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.673 -0.775 . . . . 1.49 113.048 -177.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.548 ' HG2' ' HB3' ' A' ' 111' ' ' ASN . 3.9 pm0 -151.82 -13.25 0.19 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.22 -0.289 . . . . 1.74 110.22 174.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.819 ' HG3' ' HA ' ' A' ' 78' ' ' GLN . 5.2 mm-40 -63.44 155.82 73.3 Favored Pre-proline 0 CA--C 1.531 0.235 0 N-CA-C 113.291 0.849 . . . . 3.07 113.291 -168.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.545 ' HB3' ' O ' ' A' ' 137' ' ' TRP . 98.3 Cg_exo -23.87 -91.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.674 1 C-N-CA 126.813 5.008 . . . . 1.75 116.474 178.994 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.498 ' H ' ' HB2' ' A' ' 84' ' ' PRO . . . -124.12 -24.6 1.8 Allowed Glycine 0 C--O 1.227 -0.311 0 C-N-CA 120.323 -0.941 . . . . 2.2 113.265 -172.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.741 ' HB3' HG12 ' A' ' 90' ' ' ILE . 23.9 m-80 -96.73 38.31 1.23 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.103 -0.332 . . . . 4.2 110.103 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -54.27 -42.39 69.93 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.163 -0.926 . . . . 3.02 111.449 -174.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.678 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 0.7 OUTLIER -112.16 -22.13 11.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.496 -0.32 . . . . 3.92 111.028 176.705 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -53.45 -60.19 3.61 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.891 -0.595 . . . . 2.65 112.474 -172.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.741 HG12 ' HB3' ' A' ' 86' ' ' ASN . 28.6 mm -50.74 -40.21 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 112.79 0.663 . . . . 2.15 112.79 -176.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.678 ' HE2' ' HA ' ' A' ' 88' ' ' GLU . 18.2 pttt -89.2 18.32 5.17 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.911 0.386 . . . . 2.79 111.952 -172.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -146.2 -1.21 0.75 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.86 0.362 . . . . 3.29 110.791 170.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -121.47 159.9 25.3 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.261 -0.427 . . . . 3.42 109.984 -175.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 75.0 t -81.47 111.48 18.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.553 -0.536 . . . . 2.63 109.553 172.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.681 ' SG ' ' HA ' ' A' ' 90' ' ' ILE . 0.0 OUTLIER -132.68 126.07 31.73 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.089 0.471 . . . . 2.83 110.641 -176.949 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.452 ' C ' ' H ' ' A' ' 98' ' ' PHE . 1.6 p -70.8 151.02 45.26 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 108.141 -1.059 . . . . 2.98 108.141 166.516 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.72 12.29 0.52 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.522 -0.308 . . . . 2.72 111.518 -174.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.872 ' HB2' ' HA ' ' A' ' 45' ' ' SER . 8.4 t80 67.23 98.04 0.05 Allowed 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 123.93 0.769 . . . . 2.12 110.543 -177.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.405 ' HA ' HD12 ' A' ' 104' ' ' ILE . 21.8 ttmm -119.67 137.64 53.78 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.664 -0.865 . . . . 2.69 108.664 169.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -139.82 -164.66 1.73 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.184 0.516 . . . . 0.55 111.558 -169.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -102.87 28.61 6.03 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 115.548 -0.751 . . . . 1.99 109.984 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.653 ' CD1' ' HA ' ' A' ' 58' ' ' THR . 40.3 p90 -151.64 165.25 17.83 Favored Pre-proline 0 N--CA 1.443 -0.822 0 N-CA-C 108.042 -1.096 . . . . 0.84 108.042 176.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.919 ' HB2' ' HA ' ' A' ' 72' ' ' LEU . 74.2 Cg_exo -50.92 132.03 36.29 Favored 'Trans proline' 0 CA--C 1.512 -0.59 0 C-N-CA 123.489 2.793 . . . . 0.62 113.8 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.524 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 50.6 mt -140.76 140.26 33.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 107.461 -1.311 . . . . 1.34 107.461 170.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.857 ' HB2' ' O ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -118.91 -179.22 3.75 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 120.779 -0.368 . . . . 3.03 110.98 -173.319 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.683 ' N ' ' HA ' ' A' ' 23' ' ' ALA . . . -69.74 104.35 2.41 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 108.928 -0.767 . . . . 1.46 108.928 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.837 ' HD2' ' HG2' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -43.72 132.26 5.08 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-O 122.075 0.94 . . . . 1.76 112.888 -174.679 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.848 HG13 ' HB2' ' A' ' 116' ' ' HIS . 0.1 OUTLIER -119.49 173.25 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.012 0 CA-C-N 113.887 -1.506 . . . . 0.82 108.734 176.035 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.612 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 41.1 t-20 -74.26 87.4 1.97 Allowed 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 114.555 -1.202 . . . . 1.73 110.595 -174.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.524 HG11 ' CB ' ' A' ' 42' ' ' ASN . 6.6 m -84.4 89.38 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 CA-C-O 122.311 1.053 . . . . 0.77 108.84 178.058 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.548 ' HB3' ' HG2' ' A' ' 82' ' ' GLN . 3.9 t-20 175.42 -178.84 0.12 Allowed 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 113.683 -1.599 . . . . 1.9 107.945 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -48.48 -28.81 6.88 Favored Glycine 0 N--CA 1.441 -0.988 0 N-CA-C 117.766 1.866 . . . . 1.47 117.766 -168.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -104.68 -43.19 5.19 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 120.412 2.106 . . . . 2.81 114.367 -161.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.514 ' HB2' ' ND2' ' A' ' 109' ' ' ASN . 7.0 m-20 -126.49 20.81 7.26 Favored 'General case' 0 C--N 1.32 -0.678 0 O-C-N 121.589 -0.694 . . . . 2.16 109.847 -172.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.612 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -48.28 131.94 16.41 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 123.792 0.683 . . . . 1.26 109.409 174.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.848 ' HB2' HG13 ' A' ' 108' ' ' ILE . 3.5 t-80 -71.12 139.0 84.74 Favored Pre-proline 0 N--CA 1.42 -1.956 0 CA-C-N 115.153 -0.93 . . . . 0.42 108.791 -168.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 116' ' ' HIS . 11.9 Cg_exo -31.2 -45.86 0.17 Allowed 'Trans proline' 0 C--O 1.217 -0.539 0 C-N-CA 124.358 3.372 . . . . 0.4 113.031 -179.108 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.874 HD11 ' HB ' ' A' ' 15' ' ' ILE . 27.4 tp -60.11 -53.05 62.3 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.289 0.636 . . . . 0.39 112.597 175.137 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.817 ' OH ' HG22 ' A' ' 40' ' ' ILE . 3.1 m-85 -77.91 -32.88 51.95 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-O 121.343 0.592 . . . . 3.04 110.834 -176.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.487 ' HG2' ' HB3' ' A' ' 115' ' ' ALA . 0.6 OUTLIER -62.73 -40.01 95.87 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 106.726 -1.583 . . . . 2.44 106.726 174.148 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.808 ' HA ' ' HE2' ' A' ' 124' ' ' LYS . 81.4 t80 -65.26 -29.64 70.44 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.308 -0.86 . . . . 0.56 109.791 173.392 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.665 ' CE ' HD12 ' A' ' 40' ' ' ILE . 40.8 mtt -75.01 -55.95 5.23 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.837 -0.62 . . . . 0.71 110.958 -168.095 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.444 ' HE2' ' HB2' ' A' ' 123' ' ' LYS . 0.3 OUTLIER -70.41 -30.47 67.35 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.972 -0.558 . . . . 1.46 111.235 179.725 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.808 ' HE2' ' HA ' ' A' ' 121' ' ' TYR . 46.0 pttt -76.32 -26.65 56.01 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 119.238 -0.985 . . . . 1.99 111.422 -178.093 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.488 HG22 ' HG3' ' A' ' 126' ' ' LYS . 51.7 m -73.75 -44.93 54.79 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.915 0.388 . . . . 0.59 110.314 176.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.765 ' HD2' ' HB2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -151.71 129.51 5.87 Favored Pre-proline 0 C--O 1.235 0.318 0 CA-C-O 121.24 0.543 . . . . 1.85 111.506 178.918 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.709 ' HA ' ' NH2' ' A' ' 153' ' ' ARG . 12.8 Cg_endo -60.45 -134.56 0.0 OUTLIER 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 123.725 2.95 . . . . 1.69 112.581 173.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.533 ' H ' ' HB2' ' A' ' 127' ' ' PRO . . . -132.69 177.98 18.44 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 119.536 -1.316 . . . . 2.59 112.917 -176.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 23.8 pt -63.57 -22.03 29.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.024 0.44 . . . . 3.58 111.134 178.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.543 ' HB3' HG23 ' A' ' 132' ' ' THR . 0.2 OUTLIER -102.94 16.96 25.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.509 0.671 . . . . 3.47 109.36 178.539 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 58.56 30.85 20.36 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.179 -0.919 . . . . 3.28 109.676 -170.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.543 HG23 ' HB3' ' A' ' 130' ' ' LEU . 33.1 p -62.05 123.86 19.24 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.248 -0.887 . . . . 3.56 110.094 179.14 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 37.7 mtmt -71.94 -73.58 0.18 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.453 0.644 . . . . 5.17 110.089 -177.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.414 ' O ' ' HZ3' ' A' ' 137' ' ' TRP . . . -92.47 171.43 9.04 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.484 -0.78 . . . . 1.59 109.859 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.828 ' H ' HD13 ' A' ' 135' ' ' ILE . 0.1 OUTLIER -99.7 46.32 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 121.375 0.607 . . . . 2.0 110.372 179.32 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.506 ' CA ' ' HA ' ' A' ' 84' ' ' PRO . 19.5 ttmm -80.28 53.91 1.88 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.488 -0.778 . . . . 4.81 111.423 -176.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.656 ' HB3' ' HG3' ' A' ' 156' ' ' PRO . 21.7 m-90 -143.27 172.52 12.63 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.409 -0.36 . . . . 1.97 110.033 178.254 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.666 ' HB2' ' CB ' ' A' ' 156' ' ' PRO . 7.6 m120 -49.63 -157.71 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.129 -0.941 . . . . 2.04 110.581 164.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.708 ' CD1' HG23 ' A' ' 43' ' ' VAL . 4.3 m-85 -28.81 -47.09 0.05 Allowed 'General case' 0 CA--C 1.56 1.34 0 N-CA-C 116.533 2.049 . . . . 1.93 116.533 -166.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.563 ' HB ' ' OD1' ' A' ' 42' ' ' ASN . 7.2 m 38.02 98.53 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 120.239 1.381 . . . . 0.6 113.902 175.174 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.726 ' HB3' HD12 ' A' ' 39' ' ' LEU . 1.2 m -90.72 163.06 14.63 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.153 -0.93 . . . . 0.62 111.831 -174.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.542 ' CZ ' HG21 ' A' ' 135' ' ' ILE . 88.4 m-85 -126.92 126.06 42.61 Favored 'General case' 0 CA--C 1.493 -1.234 0 N-CA-C 106.215 -1.772 . . . . 0.57 106.215 166.192 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.775 HD11 HD12 ' A' ' 170' ' ' LEU . 10.7 tp -79.4 105.03 10.42 Favored 'General case' 0 N--CA 1.418 -2.06 0 C-N-CA 118.326 -1.349 . . . . 0.43 108.109 177.144 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.674 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 24.4 mm -92.24 135.17 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.783 0 CA-C-N 112.821 -1.99 . . . . 0.19 107.256 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.707 ' HA ' HD13 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -89.71 -177.14 5.19 Favored 'General case' 0 C--N 1.31 -1.109 0 C-N-CA 120.43 -0.508 . . . . 0.98 110.81 -168.192 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.735 ' HD3' ' HB3' ' A' ' 173' ' ' SER . 47.9 mtm180 -53.97 -42.65 69.17 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 122.581 0.353 . . . . 2.22 111.902 -176.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -94.54 23.18 5.48 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.164 -0.68 . . . . 2.0 109.164 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.68 ' HA3' ' CE2' ' A' ' 16' ' ' PHE . . . 71.3 37.42 63.12 Favored Glycine 0 N--CA 1.441 -1.002 0 CA-C-N 115.149 -0.932 . . . . 0.17 113.64 176.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.461 ' HA ' ' HD2' ' A' ' 150' ' ' PRO . 46.5 t -103.88 107.46 56.82 Favored Pre-proline 0 C--N 1.316 -0.885 0 C-N-CA 119.809 -0.756 . . . . 1.12 111.43 177.262 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.879 ' HD3' HG23 ' A' ' 15' ' ' ILE . 15.6 Cg_endo -61.3 127.12 21.06 Favored 'Trans proline' 0 CA--C 1.516 -0.384 0 C-N-CA 123.396 2.731 . . . . 0.41 110.201 174.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.754 ' HA ' ' HG2' ' A' ' 126' ' ' LYS . 4.5 m -135.08 -31.85 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 C-N-CA 120.494 -0.482 . . . . 1.45 112.079 -178.332 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.762 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 14.4 mm-40 -112.95 159.54 19.0 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.543 -0.54 . . . . 1.17 109.543 174.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.709 ' NH2' ' HA ' ' A' ' 127' ' ' PRO . 0.0 OUTLIER -140.3 131.73 26.88 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 120.281 -0.568 . . . . 2.16 109.604 165.257 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.796 ' HZ ' ' HB2' ' A' ' 166' ' ' LYS . 97.9 m-85 -104.55 145.43 30.31 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.135 -0.939 . . . . 0.32 109.284 -174.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 3.2 p -78.51 158.1 76.62 Favored Pre-proline 0 C--N 1.314 -0.95 0 N-CA-C 108.985 -0.746 . . . . 1.11 108.985 176.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.666 ' CB ' ' HB2' ' A' ' 138' ' ' ASN . 11.3 Cg_endo -55.6 -45.05 42.37 Favored 'Trans proline' 0 CA--C 1.517 -0.331 0 C-N-CA 121.618 1.546 . . . . 0.78 110.754 178.045 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.46 ' HA3' ' HE3' ' A' ' 51' ' ' LYS . . . -52.87 -16.16 3.85 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-N 114.255 -1.339 . . . . 0.5 114.468 173.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -87.39 137.08 32.65 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 117.767 0.784 . . . . 0.5 109.304 175.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.417 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 68.1 m -114.14 -172.37 2.08 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 120.957 0.408 . . . . 1.42 112.033 -170.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.661 ' CG2' ' HA ' ' A' ' 56' ' ' THR . 57.8 t -40.04 -56.65 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 114.88 -1.055 . . . . 0.28 112.552 -175.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.75 -31.53 69.55 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.623 0.249 . . . . 3.46 110.917 -172.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -66.43 -37.94 86.31 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.316 0.579 . . . . 1.4 109.631 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.479 HD12 ' CG2' ' A' ' 56' ' ' THR . 81.7 mt -79.89 -43.72 22.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.389 -0.823 . . . . 0.21 111.257 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.592 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 36.7 mt-10 -54.01 -43.24 69.92 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-N 116.565 -0.289 . . . . 0.67 111.413 -177.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -59.56 -19.97 52.31 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.41 0.522 . . . . 0.87 112.41 -175.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.796 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 19.1 mmtp -101.9 -23.91 14.09 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.277 -0.569 . . . . 1.71 110.697 171.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.592 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 12.9 tp -76.8 -54.05 7.12 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.415 -0.811 . . . . 0.16 111.959 -178.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.469 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 72.1 mt -51.52 -45.5 90.71 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.085 -0.961 . . . . 0.26 112.296 -174.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.469 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 88.8 Cg_exo -49.45 -44.26 35.39 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 122.049 1.833 . . . . 0.41 112.71 173.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.775 HD12 HD11 ' A' ' 143' ' ' LEU . 90.5 mt -76.9 -38.82 52.8 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 120.911 -0.316 . . . . 0.71 111.093 -179.175 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.719 HD23 ' HG2' ' A' ' 37' ' ' PRO . 82.2 mt -59.45 -59.95 4.63 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-O 121.926 0.869 . . . . 0.34 109.908 177.329 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -60.97 -34.59 88.36 Favored Glycine 0 N--CA 1.432 -1.571 0 CA-C-N 113.476 -1.693 . . . . 1.12 112.638 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.735 ' HB3' ' HD3' ' A' ' 146' ' ' ARG . 26.3 p 48.51 73.55 0.21 Allowed 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.486 0.714 . . . . 2.64 111.74 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -92.96 -18.94 22.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.616 -0.72 . . . . 4.35 111.017 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -172.05 -36.46 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.129 -0.487 . . . . 8.45 111.039 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 9.7 tt . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.531 -0.747 . . . . 7.69 109.553 -177.955 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.803 0 N-CA-C 111.966 -0.453 . . . . 5.22 111.966 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -60.03 -46.83 88.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.927 0.394 . . . . 4.85 110.936 -179.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.77 117.44 5.11 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.848 -0.691 . . . . 1.55 112.481 178.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.9 p -92.81 11.4 27.17 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.04 0.448 . . . . 1.58 110.36 176.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.514 ' HB3' ' O ' ' A' ' 147' ' ' ASP . 1.5 m -161.16 151.58 17.83 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 105.878 -1.897 . . . . 1.17 105.878 -176.13 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.924 ' HB ' HD11 ' A' ' 118' ' ' LEU . 4.8 pt -64.61 -16.01 18.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-N 114.927 -1.033 . . . . 0.38 112.015 -172.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.829 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 41.6 m-85 -69.73 -3.12 14.01 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 112.117 0.414 . . . . 0.3 112.117 -178.439 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -71.84 -25.1 61.84 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.37 -0.974 . . . . 2.11 108.37 174.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.586 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 50.1 m-85 -108.51 110.41 21.9 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 114.407 -1.27 . . . . 0.31 111.162 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -53.73 142.82 22.3 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.069 -1.423 . . . . 2.86 110.215 174.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.851 HG13 ' HZ ' ' A' ' 74' ' ' PHE . 53.7 t -110.71 161.97 8.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 N-CA-C 108.031 -1.1 . . . . 0.67 108.031 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.73 ' O ' ' HB2' ' A' ' 105' ' ' MET . 25.5 mt -130.61 152.44 49.98 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 120.603 -0.439 . . . . 0.69 110.455 -178.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -73.92 -178.46 3.27 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.332 -0.618 . . . . 1.87 109.332 176.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.633 ' HA ' ' N ' ' A' ' 106' ' ' ALA . . . -64.35 -4.41 3.8 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.803 0.335 . . . . 0.59 111.647 -178.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.525 ' HB2' ' HE2' ' A' ' 26' ' ' LYS . 9.7 m-20 -116.95 9.08 13.63 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.704 -0.226 . . . . 2.34 111.452 175.245 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.652 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 11.1 m170 73.02 11.93 5.12 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-O 121.419 0.628 . . . . 1.47 110.25 174.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.525 ' HE2' ' HB2' ' A' ' 24' ' ' ASP . 26.6 mtmt -69.52 130.68 90.43 Favored Pre-proline 0 N--CA 1.453 -0.322 0 N-CA-C 107.211 -1.403 . . . . 4.25 107.211 165.076 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.688 ' HA ' HD23 ' A' ' 21' ' ' LEU . 79.7 Cg_exo -51.16 114.79 1.68 Allowed 'Trans proline' 0 CA--C 1.53 0.28 0 C-N-CA 121.895 1.73 . . . . 0.54 113.147 -176.418 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.542 ' H ' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -76.93 149.9 35.99 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.174 -1.375 . . . . 1.2 110.602 173.179 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.506 ' OD1' ' HB3' ' A' ' 32' ' ' GLN . 2.4 t-20 -93.41 81.57 4.41 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.954 -0.758 . . . . 1.51 108.954 177.006 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.722 HD21 HD12 ' A' ' 15' ' ' ILE . 61.1 tp -62.01 -41.79 98.46 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.506 -0.77 . . . . 0.28 110.294 -178.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.721 ' HA ' ' CE1' ' A' ' 16' ' ' PHE . 1.6 t -70.12 -1.32 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.099 -0.955 . . . . 1.02 111.93 -170.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.506 ' HB3' ' OD1' ' A' ' 29' ' ' ASN . 17.8 pt20 -74.72 -10.36 59.44 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.06 -0.718 . . . . 1.02 109.06 174.456 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.962 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 93.9 m-70 -99.41 25.6 6.84 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 121.934 0.873 . . . . 0.28 109.649 176.113 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.829 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 14.8 mtmt -83.73 132.39 34.85 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 114.297 -1.32 . . . . 1.56 109.155 169.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.83 -42.02 2.03 Favored Glycine 0 N--CA 1.438 -1.233 0 C-N-CA 120.759 -0.734 . . . . 0.2 111.765 -178.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.516 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 15.7 m -125.31 124.95 25.2 Favored Pre-proline 0 N--CA 1.435 -1.21 0 N-CA-C 108.082 -1.081 . . . . 0.29 108.082 173.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.886 ' HG3' ' HB3' ' A' ' 170' ' ' LEU . 2.2 Cg_endo -39.65 153.9 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 124.266 3.31 . . . . 0.18 113.346 176.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.878 ' HB2' HG22 ' A' ' 70' ' ' THR . 0.9 OUTLIER -139.34 143.58 37.86 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.427 -1.323 . . . . 0.31 107.427 -179.209 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 1.046 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 1.2 mm? -107.8 121.71 45.28 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.66 -0.867 . . . . 1.19 108.66 176.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.719 HG13 HG13 ' A' ' 144' ' ' ILE . 1.3 mt -105.57 125.61 60.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 C-N-CA 120.109 -0.636 . . . . 0.37 109.551 177.144 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 1.046 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.4 OUTLIER -109.38 123.29 49.09 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 116.091 -0.504 . . . . 0.42 109.992 -174.408 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.68 ' ND2' ' HB ' ' A' ' 135' ' ' ILE . 2.7 p-10 -80.56 93.22 6.04 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 122.3 1.047 . . . . 2.35 108.185 171.45 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.781 ' O ' ' HA ' ' A' ' 75' ' ' PRO . 7.7 p -105.67 125.48 61.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 115.388 -0.824 . . . . 1.03 111.367 -164.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.712 ' HB1' ' HB2' ' A' ' 86' ' ' ASN . . . -85.36 98.44 10.55 Favored 'General case' 0 N--CA 1.434 -1.248 0 C-N-CA 119.036 -1.066 . . . . 0.88 108.941 169.296 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.824 ' HA ' ' HB3' ' A' ' 98' ' ' PHE . 15.2 t -25.65 101.15 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 114.125 -1.398 . . . . 1.78 112.828 170.475 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.873 ' HB3' ' HB2' ' A' ' 49' ' ' TYR . 13.4 mtpt -103.47 145.03 30.61 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.748 -0.834 . . . . 5.84 108.748 173.142 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.9 t -110.13 114.1 27.33 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.991 -0.744 . . . . 3.55 108.991 178.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.27 16.66 75.44 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 121.042 -0.599 . . . . 2.91 112.927 -175.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.873 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 63.4 m-85 -125.95 164.16 21.41 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 117.031 0.415 . . . . 4.63 110.9 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.4 t -172.12 137.61 0.93 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.856 -0.611 . . . . 1.93 110.255 177.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.503 ' O ' ' HA2' ' A' ' 157' ' ' GLY . 21.0 mmmt -98.01 12.18 35.12 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.086 0.47 . . . . 2.01 109.969 176.323 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 109.55 -34.13 5.67 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 109.895 -1.282 . . . . 0.51 109.895 -170.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -45.43 -46.13 11.71 Favored Glycine 0 C--O 1.219 -0.833 0 CA-C-N 114.821 -0.689 . . . . 0.5 113.65 177.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.559 ' HB3' ' OE2' ' A' ' 55' ' ' GLU . 0.6 OUTLIER -60.84 -61.43 2.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.186 0.493 . . . . 0.7 110.872 -175.469 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.559 ' OE2' ' HB3' ' A' ' 54' ' ' TYR . 0.2 OUTLIER -54.04 -31.87 52.71 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.62 0.724 . . . . 2.61 110.995 178.243 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.737 ' HA ' HG22 ' A' ' 160' ' ' VAL . 52.9 m -75.84 -58.99 2.95 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.079 -0.964 . . . . 0.33 110.684 -174.307 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 1.095 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -59.2 -40.3 85.33 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.876 -1.056 . . . . 0.22 110.828 -178.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.506 ' HA ' ' CD1' ' A' ' 102' ' ' PHE . 96.9 m -58.64 -55.17 38.53 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 115.695 -0.684 . . . . 0.26 110.358 179.048 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 61.5 m -69.4 -39.68 77.79 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.182 -0.917 . . . . 0.48 111.736 -176.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.764 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 17.4 mt -64.87 -47.65 77.11 Favored 'General case' 0 CA--C 1.498 -1.038 0 CA-C-O 121.055 0.455 . . . . 0.43 110.367 -175.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.86 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 7.8 t80 -54.56 -54.39 41.96 Favored 'General case' 0 C--O 1.197 -1.68 0 CA-C-N 114.904 -1.043 . . . . 0.31 110.32 177.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.404 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 9.0 m-80 -72.54 -24.33 61.11 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 111.866 0.321 . . . . 1.21 111.866 -171.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.534 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 36.7 ttpt -83.6 -20.73 33.19 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 108.688 -0.856 . . . . 1.54 108.688 -178.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.717 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 47.9 m-85 -128.52 -1.93 5.51 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 115.835 1.791 . . . . 0.31 115.835 -173.217 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.721 ' HG2' ' O ' ' A' ' 61' ' ' TYR . 11.9 ptmt -65.8 -26.97 67.93 Favored 'General case' 0 CA--C 1.497 -1.092 0 N-CA-C 107.834 -1.173 . . . . 1.35 107.834 171.069 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.3 m -47.73 -38.68 15.89 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 113.893 -1.503 . . . . 1.28 110.837 173.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -86.14 -39.63 16.49 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 111.621 0.23 . . . . 1.11 111.621 174.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.41 ' HA3' ' HB2' ' A' ' 36' ' ' SER . . . 149.63 -3.28 0.61 Allowed Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.263 -0.735 . . . . 0.18 111.263 -176.111 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.764 ' HE2' ' HB3' ' A' ' 60' ' ' LEU . 28.1 t80 -71.07 140.75 50.79 Favored 'General case' 0 C--O 1.222 -0.346 0 C-N-CA 122.856 0.462 . . . . 0.18 111.381 -177.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.962 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 3.7 t -132.96 152.42 51.93 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 108.452 -0.944 . . . . 0.2 108.452 175.051 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 1.095 HG11 ' HB1' ' A' ' 57' ' ' ALA . 42.2 t -111.83 101.54 12.68 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.532 0 N-CA-C 108.286 -1.005 . . . . 0.17 108.286 160.159 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.517 ' HA ' ' HB2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -95.06 121.74 36.99 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 118.37 -1.332 . . . . 1.04 107.73 172.984 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.895 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -111.51 128.27 55.96 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 120.581 -0.448 . . . . 0.51 110.71 178.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.851 ' HZ ' HG13 ' A' ' 20' ' ' VAL . 5.3 m-30 -100.8 112.62 65.03 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 116.149 -0.478 . . . . 0.44 110.057 -178.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.781 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 73.6 Cg_endo -80.65 82.45 2.47 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 123.213 2.609 . . . . 1.3 113.504 -169.4 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.552 ' HB2' ' CG2' ' A' ' 110' ' ' VAL . 19.3 t -35.02 143.59 0.04 OUTLIER 'General case' 0 C--O 1.237 0.43 0 CA-C-O 122.782 1.277 . . . . 1.44 114.403 -174.227 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.606 ' HB2' ' HD1' ' A' ' 79' ' ' PHE . 17.3 p30 -92.55 131.32 37.77 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-N 113.069 -1.878 . . . . 1.81 109.828 -178.026 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.791 ' HA ' ' HG2' ' A' ' 83' ' ' GLU . 9.7 pt20 -61.33 -8.22 3.67 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.661 -1.154 . . . . 3.34 110.251 171.006 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.606 ' HD1' ' HB2' ' A' ' 77' ' ' ASN . 82.3 m-85 -76.46 32.36 0.13 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.698 -1.137 . . . . 2.68 113.384 -167.273 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -135.8 -57.99 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.052 -1.07 . . . . 1.98 112.984 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 110.57 36.71 1.86 Allowed Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 111.316 -0.714 . . . . 1.49 111.316 -173.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.634 ' HG3' ' HB2' ' A' ' 113' ' ' GLU . 0.4 OUTLIER -156.65 7.6 0.19 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.099 -0.551 . . . . 1.74 111.089 -176.558 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.791 ' HG2' ' HA ' ' A' ' 78' ' ' GLN . 2.7 mp0 -57.94 147.75 62.68 Favored Pre-proline 0 N--CA 1.468 0.461 0 CA-C-O 121.439 0.637 . . . . 3.07 111.261 -162.307 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.704 ' HB2' ' O ' ' A' ' 137' ' ' TRP . 40.9 Cg_endo -79.64 102.98 1.53 Allowed 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 123.6 2.867 . . . . 1.75 111.6 -172.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.46 -59.25 4.64 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.656 -0.783 . . . . 2.2 112.753 175.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.712 ' HB2' ' HB1' ' A' ' 44' ' ' ALA . 0.9 OUTLIER -81.76 20.68 0.92 Allowed 'General case' 0 C--N 1.328 -0.366 0 O-C-N 122.61 -0.347 . . . . 4.2 111.801 -177.052 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -55.47 -26.98 45.56 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 123.431 0.457 . . . . 3.02 111.284 178.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.646 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 39.5 mm-40 -111.85 -3.77 14.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.294 -0.412 . . . . 3.92 111.373 178.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -93.09 -61.18 1.63 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.093 0.473 . . . . 2.65 111.58 -173.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.813 HG22 ' HB2' ' A' ' 95' ' ' CYS . 7.6 pt -73.32 -23.25 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 113.132 0.79 . . . . 2.15 113.132 -168.041 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.646 ' HE2' ' HA ' ' A' ' 88' ' ' GLU . 56.2 pttt -72.79 -29.34 63.19 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 111.681 0.252 . . . . 2.79 111.681 -175.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -115.9 -24.9 7.94 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.925 -0.31 . . . . 3.29 111.772 -176.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -100.24 158.86 15.57 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.085 -0.339 . . . . 3.42 110.085 176.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 82.2 t -76.61 110.08 11.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.17 -0.468 . . . . 2.63 110.195 177.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.813 ' HB2' HG22 ' A' ' 90' ' ' ILE . 65.6 m -153.03 120.67 6.0 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.202 -0.453 . . . . 2.83 110.104 176.488 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.425 ' C ' ' H ' ' A' ' 98' ' ' PHE . 7.6 p -145.13 120.37 10.19 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.689 -0.232 . . . . 2.98 110.725 176.078 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.563 ' HA ' ' CB ' ' A' ' 75' ' ' PRO . 99.3 mttt 71.36 -27.31 0.17 Allowed 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 113.244 0.831 . . . . 2.72 113.244 176.268 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.824 ' HB3' ' HA ' ' A' ' 45' ' ' SER . 0.2 OUTLIER 67.09 -36.96 0.29 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.032 1.333 . . . . 2.12 111.523 -176.098 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.414 ' H ' ' C ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER 66.48 136.29 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.659 0.784 . . . . 2.69 111.69 174.901 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.779 ' HB2' ' CE1' ' A' ' 98' ' ' PHE . . . -162.15 -179.42 7.06 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.152 0.501 . . . . 0.55 112.329 -173.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -94.91 30.28 2.14 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 115.344 -0.844 . . . . 1.99 110.784 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.583 ' CE2' HD11 ' A' ' 104' ' ' ILE . 27.2 p90 -150.07 157.01 37.92 Favored Pre-proline 0 N--CA 1.446 -0.663 0 N-CA-C 108.332 -0.988 . . . . 0.84 108.332 177.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.698 ' HD3' ' CE2' ' A' ' 61' ' ' TYR . 97.7 Cg_exo -51.2 84.12 0.02 OUTLIER 'Trans proline' 0 N--CA 1.479 0.673 0 C-N-CA 124.794 3.663 . . . . 0.62 116.081 -172.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.895 HD12 ' HB3' ' A' ' 73' ' ' ALA . 7.5 mm -85.89 120.6 36.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.092 -1.077 . . . . 1.34 108.092 170.061 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.783 ' HG2' ' CG ' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -76.53 -177.69 4.31 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.753 -0.832 . . . . 3.03 108.753 178.272 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.633 ' N ' ' HA ' ' A' ' 23' ' ' ALA . . . -63.44 -53.75 47.35 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.384 -0.598 . . . . 1.46 109.384 -177.278 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.664 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 17.4 ptpt 146.15 151.07 0.0 OUTLIER 'General case' 0 CA--C 1.489 -1.385 0 O-C-N 125.823 1.952 . . . . 1.76 108.371 174.317 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.555 ' CD1' HG13 ' A' ' 110' ' ' VAL . 2.0 pp -152.08 174.53 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 CA-C-N 113.726 -1.579 . . . . 0.82 107.802 169.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.766 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 29.0 t-20 -74.24 87.15 1.95 Allowed 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.462 -0.79 . . . . 1.73 110.932 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.555 HG13 ' CD1' ' A' ' 108' ' ' ILE . 3.6 m -86.0 95.81 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 C-N-CA 118.145 -1.422 . . . . 0.77 108.187 169.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.559 ' ND2' ' H ' ' A' ' 112' ' ' GLY . 2.3 t30 179.09 -179.17 0.36 Allowed 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 113.63 -1.623 . . . . 1.9 107.815 178.358 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.559 ' H ' ' ND2' ' A' ' 111' ' ' ASN . . . -78.45 9.27 35.77 Favored Glycine 0 N--CA 1.437 -1.291 0 N-CA-C 115.894 1.118 . . . . 1.47 115.894 -172.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.634 ' HB2' ' HG3' ' A' ' 82' ' ' GLN . 6.8 mt-10 -105.31 -45.4 4.49 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 119.855 1.828 . . . . 2.81 114.514 -172.46 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -127.77 -34.47 2.18 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.388 -0.967 . . . . 2.16 108.388 -174.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.766 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . 52.28 -169.42 0.04 OUTLIER 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 114.153 -1.385 . . . . 1.26 111.264 176.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.613 ' CE1' ' H ' ' A' ' 118' ' ' LEU . 2.1 t-80 -140.94 134.33 14.71 Favored Pre-proline 0 N--CA 1.423 -1.794 0 N-CA-C 106.275 -1.75 . . . . 0.42 106.275 171.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -27.23 -50.13 0.1 Allowed 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 124.503 3.469 . . . . 0.4 113.598 -178.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.924 HD11 ' HB ' ' A' ' 15' ' ' ILE . 29.1 tp -63.51 -49.28 74.16 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.922 0.489 . . . . 0.39 112.171 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.693 ' OH ' HG22 ' A' ' 40' ' ' ILE . 25.5 m-85 -79.97 -33.96 39.05 Favored 'General case' 0 CA--C 1.492 -1.258 0 CA-C-O 120.935 0.398 . . . . 3.04 110.881 -176.576 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.478 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 4.7 tt0 -60.42 -37.36 80.63 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 106.589 -1.634 . . . . 2.44 106.589 174.265 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.586 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 51.5 t80 -68.53 -33.07 73.46 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.047 -0.979 . . . . 0.56 110.492 174.298 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.698 ' HE3' ' HG ' ' A' ' 118' ' ' LEU . 2.9 ttm -75.77 -55.58 5.5 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.09 -0.504 . . . . 0.71 110.418 -169.406 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.416 ' HB2' ' HE2' ' A' ' 123' ' ' LYS . 0.8 OUTLIER -70.82 -25.44 62.85 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 120.616 -0.433 . . . . 1.46 111.721 178.294 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.478 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -72.35 -29.73 64.07 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 119.379 -0.928 . . . . 1.99 109.394 178.447 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 88.0 m -87.26 -31.2 20.39 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.489 -0.778 . . . . 0.59 111.285 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.678 ' HG3' ' HB2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -133.66 110.38 12.29 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 112.727 0.64 . . . . 1.85 112.727 -172.17 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.467 ' HB2' ' O ' ' A' ' 130' ' ' LEU . 6.7 Cg_exo -76.1 -17.86 16.88 Favored 'Trans proline' 0 CA--C 1.531 0.336 0 C-N-CA 123.654 2.903 . . . . 1.69 111.037 169.206 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 81.44 -131.3 10.31 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.564 -0.743 . . . . 2.59 112.812 175.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 38.0 mt -75.92 -23.87 16.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.343 0.592 . . . . 3.58 110.427 -179.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.753 HD13 ' H ' ' A' ' 131' ' ' ALA . 0.3 OUTLIER -96.05 158.69 15.33 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.554 -0.748 . . . . 3.47 109.033 -179.033 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.753 ' H ' HD13 ' A' ' 130' ' ' LEU . . . -67.08 -14.49 62.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.294 -0.412 . . . . 3.28 110.763 174.497 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.499 ' H ' HD12 ' A' ' 130' ' ' LEU . 4.4 m -149.91 -110.25 0.06 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.365 -0.379 . . . . 3.56 110.741 176.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.64 ' HG3' ' HG ' ' A' ' 130' ' ' LEU . 67.4 mttm 58.36 135.98 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.717 0.77 . . . . 5.17 112.22 -171.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -116.64 61.34 0.73 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.205 -0.452 . . . . 1.59 111.942 -175.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.68 ' HB ' ' ND2' ' A' ' 42' ' ' ASN . 16.0 pt 38.78 43.36 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 O-C-N 123.913 0.758 . . . . 2.0 112.037 178.251 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.534 ' HD3' ' O ' ' A' ' 136' ' ' LYS . 8.0 tmtm? -90.06 38.84 0.94 Allowed 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.76 0.791 . . . . 4.81 110.957 -172.479 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.704 ' O ' ' HB2' ' A' ' 84' ' ' PRO . 8.9 m-90 -133.63 174.08 10.81 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.108 -0.496 . . . . 1.97 110.446 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.593 ' HB2' ' CB ' ' A' ' 156' ' ' PRO . 3.8 m-80 -43.86 -155.71 0.0 OUTLIER 'General case' 0 C--O 1.212 -0.884 0 CA-C-N 114.784 -1.098 . . . . 2.04 111.298 163.008 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.684 ' HD2' ' HD2' ' A' ' 41' ' ' TYR . 2.9 m-85 -27.4 -52.51 0.07 Allowed 'General case' 0 C--O 1.209 -1.076 0 N-CA-C 115.724 1.75 . . . . 1.93 115.724 -166.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.657 ' HB ' ' ND2' ' A' ' 42' ' ' ASN . 7.5 m 41.6 109.17 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 120.542 1.519 . . . . 0.6 113.648 173.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.788 ' HB3' HD12 ' A' ' 39' ' ' LEU . 3.5 m -106.0 158.53 16.73 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 114.825 -1.08 . . . . 0.62 111.085 -167.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.637 ' CE2' HG21 ' A' ' 135' ' ' ILE . 63.6 m-85 -125.38 124.34 41.29 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 106.899 -1.519 . . . . 0.57 106.899 166.427 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.776 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 7.1 tp -79.88 104.01 10.17 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 118.337 -1.345 . . . . 0.43 108.369 179.27 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.746 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 32.3 mm -92.94 137.92 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.612 0 CA-C-N 113.574 -1.648 . . . . 0.19 107.803 -175.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.64 ' OD1' HG12 ' A' ' 149' ' ' VAL . 0.0 OUTLIER -89.18 -173.72 4.15 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 119.74 -0.784 . . . . 0.98 111.592 -168.14 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.759 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 21.1 mtm180 -56.24 -37.7 70.11 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-O 121.373 0.606 . . . . 2.22 110.543 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.514 ' O ' ' HB3' ' A' ' 14' ' ' SER . 27.6 t70 -93.48 13.74 20.81 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.736 -0.838 . . . . 2.0 108.736 -176.159 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.719 ' HA2' HG22 ' A' ' 144' ' ' ILE . . . 67.6 33.98 82.6 Favored Glycine 0 N--CA 1.434 -1.437 0 CA-C-N 115.359 -0.837 . . . . 0.17 114.404 -177.099 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.64 HG12 ' OD1' ' A' ' 145' ' ' ASP . 9.2 p -105.15 114.02 64.0 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 119.206 1.503 . . . . 1.12 111.44 172.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.716 ' HD3' HG23 ' A' ' 15' ' ' ILE . 2.5 Cg_endo -49.71 126.93 17.49 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 123.869 3.046 . . . . 0.41 111.771 174.002 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 23.0 t -120.09 -32.26 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.397 0.617 . . . . 1.45 109.345 -178.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.776 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 47.8 mm-40 -132.03 167.19 20.12 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-N 115.303 -0.862 . . . . 1.17 111.032 -177.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.599 ' HA ' ' O ' ' A' ' 141' ' ' SER . 1.6 ttm180 -146.33 132.74 19.63 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.266 -0.879 . . . . 2.16 110.744 163.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.57 ' HZ ' ' HB2' ' A' ' 166' ' ' LYS . 98.8 m-85 -110.97 151.55 27.81 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 114.713 -1.13 . . . . 0.32 109.614 -170.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 43.2 t -72.99 156.0 90.02 Favored Pre-proline 0 C--N 1.317 -0.821 0 N-CA-C 109.029 -0.73 . . . . 1.11 109.029 174.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.593 ' CB ' ' HB2' ' A' ' 138' ' ' ASN . 22.8 Cg_endo -61.44 -29.89 85.96 Favored 'Trans proline' 0 CA--C 1.517 -0.341 0 C-N-CA 121.852 1.702 . . . . 0.78 110.247 171.08 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.503 ' HA2' ' O ' ' A' ' 51' ' ' LYS . . . -73.41 -1.64 57.94 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 114.225 -1.352 . . . . 0.5 113.058 172.301 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -93.01 140.22 29.7 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 108.421 -0.955 . . . . 0.5 108.421 172.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.553 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 6.7 t -114.2 -170.82 1.79 Allowed 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 120.305 -0.558 . . . . 1.42 111.148 -170.344 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.737 HG22 ' HA ' ' A' ' 56' ' ' THR . 38.2 t -46.83 -49.47 6.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 114.556 -1.202 . . . . 0.28 111.612 -175.543 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 50.3 tttp -67.41 -39.9 85.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.873 0.368 . . . . 3.46 111.201 -175.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.429 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 31.2 m-20 -64.25 -37.45 87.51 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.716 -0.674 . . . . 1.4 109.946 -177.104 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.543 HD12 HG21 ' A' ' 56' ' ' THR . 88.6 mt -80.01 -47.69 21.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.069 -0.969 . . . . 0.21 111.281 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.677 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 30.7 mt-10 -54.5 -40.62 68.71 Favored 'General case' 0 C--O 1.215 -0.714 0 O-C-N 123.151 0.282 . . . . 0.67 111.572 -176.317 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 10.1 pt-20 -59.57 -21.07 59.79 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.667 0.27 . . . . 0.87 111.493 -175.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.57 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 12.6 mmmm -104.1 -23.92 13.24 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.432 0.634 . . . . 1.71 109.904 175.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.677 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 12.7 tp -79.2 -52.29 8.36 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.725 -1.125 . . . . 0.16 112.106 -178.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.484 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 74.4 mt -53.36 -45.03 98.64 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.31 -0.859 . . . . 0.26 111.959 -174.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.484 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 92.3 Cg_exo -49.06 -44.93 31.2 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 121.929 1.753 . . . . 0.41 112.23 171.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.886 ' HB3' ' HG3' ' A' ' 37' ' ' PRO . 43.5 mt -74.26 -42.78 59.07 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.926 0.343 . . . . 0.71 111.926 -178.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.813 HD23 ' HG2' ' A' ' 37' ' ' PRO . 89.3 mt -60.62 -54.91 39.69 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 122.197 0.998 . . . . 0.34 109.643 177.162 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -67.26 -62.83 4.14 Favored Glycine 0 N--CA 1.435 -1.381 0 CA-C-N 113.377 -1.738 . . . . 1.12 114.059 -175.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 9.7 t -167.69 97.68 0.47 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.969 0.385 . . . . 2.64 110.044 -172.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -61.96 -39.91 93.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.966 -0.561 . . . . 4.35 111.104 -175.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 50.1 ttp180 64.82 90.74 0.08 Allowed 'General case' 0 N--CA 1.465 0.28 0 O-C-N 123.718 0.636 . . . . 8.45 111.946 175.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.0 mm? . . . . . 0 C--O 1.249 1.07 0 CA-C-N 115.63 -0.714 . . . . 7.69 109.682 178.025 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.694 0 N-CA-C 112.162 -0.375 . . . . 5.22 112.162 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 27.2 ttt -173.82 -32.46 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.685 -0.487 . . . . 4.85 109.685 -176.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.583 ' HA2' ' OD2' ' A' ' 17' ' ' ASP . . . -57.65 118.09 11.85 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.376 -0.829 . . . . 1.55 112.472 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.2 m -123.6 -5.75 8.12 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.365 0.602 . . . . 1.58 110.121 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.435 ' HB3' ' O ' ' A' ' 147' ' ' ASP . 5.9 m -164.76 152.21 11.45 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 104.498 -2.408 . . . . 1.17 104.498 179.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.861 ' HB ' HD11 ' A' ' 118' ' ' LEU . 4.9 pt -62.09 -11.81 6.79 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 CA-C-N 115.59 -0.732 . . . . 0.38 112.302 -172.028 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.776 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 53.0 m-85 -75.34 0.75 15.7 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.949 0.722 . . . . 0.3 112.949 -176.712 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.583 ' OD2' ' HA2' ' A' ' 12' ' ' GLY . 58.3 m-20 -82.2 -19.27 40.15 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.41 -0.959 . . . . 2.11 108.41 175.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.701 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 50.0 m-85 -106.3 113.92 27.73 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 114.855 -1.066 . . . . 0.31 111.791 -178.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -48.56 136.56 12.93 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 113.404 -1.725 . . . . 2.86 111.032 174.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.931 HG13 ' HZ ' ' A' ' 74' ' ' PHE . 94.4 t -112.18 163.91 8.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 108.92 -0.77 . . . . 0.67 108.92 178.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.699 HD23 ' HA ' ' A' ' 27' ' ' PRO . 47.2 mt -130.83 148.97 52.66 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 110.113 -0.328 . . . . 0.69 110.113 -178.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -76.53 177.01 7.77 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.281 -1.377 . . . . 1.87 107.281 166.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.79 ' HA ' ' N ' ' A' ' 106' ' ' ALA . . . -64.62 -4.7 4.43 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.238 0.459 . . . . 0.59 112.238 -176.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.571 ' HB2' ' HE2' ' A' ' 26' ' ' LYS . 54.6 m-20 -105.05 3.03 30.06 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.444 -0.344 . . . . 2.34 111.273 178.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.536 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 71.7 m-70 75.48 2.77 3.87 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 122.724 0.41 . . . . 1.47 109.944 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.571 ' HE2' ' HB2' ' A' ' 24' ' ' ASP . 22.1 mtmt -63.01 118.04 38.75 Favored Pre-proline 0 CA--C 1.512 -0.501 0 N-CA-C 106.777 -1.564 . . . . 4.25 106.777 166.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.699 ' HA ' HD23 ' A' ' 21' ' ' LEU . 96.5 Cg_exo -51.2 114.5 1.57 Allowed 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 121.488 1.458 . . . . 0.54 112.222 -177.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.751 ' HE2' HD23 ' A' ' 72' ' ' LEU . 3.6 t80 -78.73 139.17 38.49 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 113.839 -1.528 . . . . 1.2 110.823 177.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.469 ' OD1' ' HB3' ' A' ' 32' ' ' GLN . 2.6 t-20 -80.9 82.76 6.79 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.595 -0.729 . . . . 1.51 109.288 178.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.791 HD13 HG21 ' A' ' 20' ' ' VAL . 52.7 tp -58.44 -43.38 88.75 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.657 -0.701 . . . . 0.28 110.454 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.707 HG12 ' HG3' ' A' ' 34' ' ' LYS . 1.8 t -69.1 -0.26 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 114.918 -1.037 . . . . 1.02 112.384 -168.114 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.469 ' HB3' ' OD1' ' A' ' 29' ' ' ASN . 9.3 pt20 -77.1 -8.9 58.28 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.247 -0.649 . . . . 1.02 109.247 174.409 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.919 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 91.2 m-70 -98.95 29.7 3.71 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 122.042 0.925 . . . . 0.28 109.007 175.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.776 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 5.7 mtmt -92.31 109.29 20.67 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 114.25 -1.341 . . . . 1.56 109.768 174.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.73 -38.44 1.99 Allowed Glycine 0 N--CA 1.436 -1.328 0 N-CA-C 111.319 -0.712 . . . . 0.2 111.319 -177.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.465 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 25.4 m -127.49 130.91 23.63 Favored Pre-proline 0 N--CA 1.433 -1.282 0 N-CA-C 108.192 -1.04 . . . . 0.29 108.192 171.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.824 ' HG2' HD23 ' A' ' 171' ' ' LEU . 2.7 Cg_endo -43.43 157.82 0.11 Allowed 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 124.135 3.223 . . . . 0.18 113.016 176.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.777 ' HB2' HG22 ' A' ' 70' ' ' THR . 0.7 OUTLIER -143.12 144.0 32.05 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 106.981 -1.488 . . . . 0.31 106.981 -179.105 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.786 HD23 ' CE1' ' A' ' 69' ' ' PHE . 2.7 mm? -107.92 113.39 26.56 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.075 -0.713 . . . . 1.19 109.075 177.482 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.919 HG23 HD13 ' A' ' 72' ' ' LEU . 0.9 OUTLIER -97.0 125.35 50.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 109.676 -0.49 . . . . 0.37 109.676 177.219 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.765 ' CE1' HG13 ' A' ' 71' ' ' VAL . 2.4 m-85 -108.26 155.73 20.16 Favored 'General case' 0 C--O 1.216 -0.698 0 CA-C-O 120.899 0.38 . . . . 0.42 111.537 -171.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.793 HD21 ' HG3' ' A' ' 84' ' ' PRO . 7.0 t30 -105.33 115.35 30.12 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.306 -1.368 . . . . 2.35 107.306 165.286 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.817 ' O ' ' HA ' ' A' ' 75' ' ' PRO . 34.7 m -126.71 159.4 36.32 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 CA-C-O 121.223 0.535 . . . . 1.03 112.124 -171.181 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.553 ' HB1' ' HA3' ' A' ' 48' ' ' GLY . . . -87.28 154.24 20.85 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 108.083 -1.081 . . . . 0.88 108.083 166.249 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.586 ' HA ' ' HB3' ' A' ' 98' ' ' PHE . 59.8 m -75.45 -159.44 0.1 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 110.135 -0.32 . . . . 1.78 110.135 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 51.7 tttm -61.49 -17.12 53.2 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.512 0.672 . . . . 5.84 110.195 -179.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.474 ' HB3' HG22 ' A' ' 90' ' ' ILE . 48.3 t -109.37 130.13 55.51 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 107.798 -1.186 . . . . 3.55 107.798 170.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.764 ' HA2' ' HG2' ' A' ' 89' ' ' GLU . . . 147.36 -121.5 1.4 Allowed Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 110.838 -0.905 . . . . 2.91 110.838 -174.223 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -165.84 121.15 1.26 Allowed 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.339 0.59 . . . . 4.63 111.786 177.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.731 HG21 ' HD2' ' A' ' 54' ' ' TYR . 62.6 p -92.77 96.5 10.19 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.433 -0.803 . . . . 1.93 110.023 175.111 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.587 ' HB3' ' HB2' ' A' ' 156' ' ' PRO . 14.0 tppt? -65.4 -13.51 58.81 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.049 0.452 . . . . 2.01 111.882 -176.136 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 131.9 -16.3 5.03 Favored Glycine 0 CA--C 1.507 -0.44 0 N-CA-C 110.208 -1.157 . . . . 0.51 110.208 -172.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.452 ' HA2' ' HB ' ' A' ' 56' ' ' THR . . . -61.7 -15.65 48.45 Favored Glycine 0 C--O 1.216 -0.991 0 CA-C-N 114.729 -0.735 . . . . 0.5 112.433 175.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.731 ' HD2' HG21 ' A' ' 50' ' ' THR . 0.4 OUTLIER -68.43 -59.99 2.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 117.358 0.579 . . . . 0.7 109.844 178.035 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -51.85 -32.63 32.68 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.861 0.838 . . . . 2.61 110.456 174.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.808 ' HA ' HG22 ' A' ' 160' ' ' VAL . 43.3 m -72.83 -59.36 2.75 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 114.396 -1.274 . . . . 0.33 110.578 -175.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 1.073 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -58.52 -42.17 87.1 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.693 -1.14 . . . . 0.22 111.115 -178.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.542 ' HA ' ' CD1' ' A' ' 102' ' ' PHE . 91.5 m -59.63 -55.14 38.16 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.566 0.698 . . . . 0.26 110.442 -178.481 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 61.4 m -66.82 -36.89 83.42 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.655 -1.157 . . . . 0.48 111.406 -177.056 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.776 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 14.9 mt -65.42 -47.98 74.38 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 121.364 0.602 . . . . 0.43 110.345 -177.295 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.875 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 6.7 t80 -59.22 -46.3 88.82 Favored 'General case' 0 C--O 1.207 -1.135 0 CA-C-N 114.896 -1.047 . . . . 0.31 110.489 178.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -73.69 -25.12 60.09 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 116.416 -0.357 . . . . 1.21 110.981 -174.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.427 ' HB2' ' HE2' ' A' ' 63' ' ' LYS . 6.5 tppt? -80.0 -32.72 39.7 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 108.316 -0.994 . . . . 1.54 108.316 -178.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.763 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 46.0 m-85 -125.67 -2.04 7.32 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 115.802 1.779 . . . . 0.31 115.802 -165.543 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.675 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 16.3 pttp -67.13 -23.33 65.8 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 107.881 -1.155 . . . . 1.35 107.881 169.387 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 29.2 t -48.57 -36.94 16.63 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 114.161 -1.381 . . . . 1.28 110.565 169.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -90.31 -32.44 16.51 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 111.875 0.324 . . . . 1.11 111.875 175.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 142.25 -6.81 2.27 Favored Glycine 0 C--N 1.331 0.264 0 N-CA-C 111.119 -0.792 . . . . 0.18 111.119 -176.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.786 ' CE1' HD23 ' A' ' 39' ' ' LEU . 19.9 t80 -66.91 138.61 57.42 Favored 'General case' 0 C--O 1.22 -0.463 0 C-N-CA 123.045 0.538 . . . . 0.18 111.17 -177.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.919 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 2.0 t -133.51 144.21 49.26 Favored 'General case' 0 N--CA 1.428 -1.573 0 N-CA-C 109.39 -0.596 . . . . 0.2 109.39 175.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 1.073 HG11 ' HB1' ' A' ' 57' ' ' ALA . 19.6 t -103.28 100.61 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.465 0 N-CA-C 108.614 -0.884 . . . . 0.17 108.614 162.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.919 HD13 HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -98.73 120.09 38.58 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.237 -0.985 . . . . 1.04 108.414 174.636 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 1.042 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -105.49 131.22 53.17 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.64 0.733 . . . . 0.51 111.304 -177.47 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.931 ' HZ ' HG13 ' A' ' 20' ' ' VAL . 3.0 m-30 -107.76 108.94 62.08 Favored Pre-proline 0 C--N 1.31 -1.116 0 CA-C-N 114.998 -1.001 . . . . 0.44 108.905 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.817 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 18.0 Cg_endo -82.13 87.48 1.4 Allowed 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.551 2.167 . . . . 1.3 113.321 -171.052 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.745 ' HB2' ' OD1' ' A' ' 42' ' ' ASN . 1.6 t -40.51 135.51 1.52 Allowed 'General case' 0 CA--C 1.506 -0.739 0 CA-C-N 115.157 -0.929 . . . . 1.44 113.013 -173.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.527 ' C ' ' H ' ' A' ' 79' ' ' PHE . 4.8 p-10 -77.14 89.42 3.63 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 114.493 -1.23 . . . . 1.81 109.372 178.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 1.036 ' HA ' ' HG2' ' A' ' 83' ' ' GLU . 3.7 mt-30 -54.41 -7.92 0.18 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 113.674 -1.603 . . . . 3.34 109.941 167.519 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.537 ' HA ' ' HD3' ' A' ' 91' ' ' LYS . 59.5 m-85 -63.59 -12.71 35.39 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.59 -1.187 . . . . 2.68 111.969 -178.312 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -94.06 -125.34 4.18 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.485 -0.864 . . . . 1.98 111.864 177.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -170.32 71.25 0.12 Allowed Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 111.073 -0.811 . . . . 1.49 111.073 174.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.73 ' HG3' ' HG2' ' A' ' 113' ' ' GLU . 5.2 pm0 -169.16 -27.95 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.961 -0.619 . . . . 1.74 110.022 -172.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 1.036 ' HG2' ' HA ' ' A' ' 78' ' ' GLN . 0.0 OUTLIER -60.82 166.99 3.86 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 114.743 -1.117 . . . . 3.07 111.86 -165.482 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.793 ' HG3' HD21 ' A' ' 42' ' ' ASN . 31.3 Cg_exo -15.81 -58.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.804 1 C-N-CA 127.155 5.236 . . . . 1.75 115.781 -175.001 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 169.38 37.85 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 119.834 -1.174 . . . . 2.2 112.674 177.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.821 ' HB2' ' HG2' ' A' ' 78' ' ' GLN . 19.1 m120 -112.63 -43.4 3.47 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.726 -0.39 . . . . 4.2 110.686 -179.214 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.63 ' O ' ' HE2' ' A' ' 91' ' ' LYS . 22.8 tt0 68.33 -64.23 0.31 Allowed 'General case' 0 C--O 1.223 -0.301 0 C-N-CA 123.956 0.902 . . . . 3.02 113.072 170.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.492 ' O ' ' HG2' ' A' ' 92' ' ' GLU . 20.6 tp10 -115.86 -0.58 12.82 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.792 0.329 . . . . 3.92 110.473 -175.273 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.818 ' HB2' ' HB3' ' A' ' 86' ' ' ASN . 11.1 tp10 -49.49 -61.31 2.17 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.586 -0.733 . . . . 2.65 112.387 -170.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.887 HG12 ' HB2' ' A' ' 78' ' ' GLN . 24.4 pt -93.01 8.25 5.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.917 -0.313 . . . . 2.15 111.519 -176.014 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.63 ' HE2' ' O ' ' A' ' 87' ' ' GLU . 47.9 mtmt -97.1 -37.47 10.12 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.845 0.355 . . . . 2.79 110.317 179.37 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.492 ' HG2' ' O ' ' A' ' 88' ' ' GLU . 9.2 pt-20 -86.46 -27.67 23.95 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 116.003 -0.544 . . . . 3.29 109.989 176.083 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.454 ' HB3' ' SG ' ' A' ' 47' ' ' CYS . 17.2 t80 -113.38 152.97 29.31 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.99 0.424 . . . . 3.42 110.179 -176.115 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.2 p -70.82 123.39 24.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.96 -0.564 . . . . 2.63 110.686 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.692 ' SG ' ' HB ' ' A' ' 90' ' ' ILE . 1.4 p -108.6 120.04 41.28 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.369 0.604 . . . . 2.83 111.164 177.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.583 ' O ' ' HB3' ' A' ' 45' ' ' SER . 4.5 m -85.75 141.35 29.76 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 107.297 -1.372 . . . . 2.98 107.297 165.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.511 ' HD2' ' HB1' ' A' ' 23' ' ' ALA . 22.1 pttm -67.36 115.03 6.55 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 108.358 -0.978 . . . . 2.72 108.358 177.491 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.762 ' CE1' ' HB2' ' A' ' 100' ' ' ALA . 0.0 OUTLIER -59.27 115.8 3.47 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.099 -0.955 . . . . 2.12 110.066 -172.501 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -105.83 111.88 24.72 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.292 -0.867 . . . . 2.69 110.496 -178.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.762 ' HB2' ' CE1' ' A' ' 98' ' ' PHE . . . -107.09 -160.63 0.74 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.068 -0.969 . . . . 0.55 111.24 -177.283 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -87.4 -5.39 58.87 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.353 -0.839 . . . . 1.99 110.108 174.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.709 ' HB2' ' O ' ' A' ' 71' ' ' VAL . 16.6 p90 -121.09 160.26 45.98 Favored Pre-proline 0 N--CA 1.44 -0.932 0 CA-C-N 115.639 -0.71 . . . . 0.84 110.37 -175.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.69 ' HG2' ' HA ' ' A' ' 72' ' ' LEU . 44.0 Cg_endo -61.65 95.99 0.13 Allowed 'Trans proline' 0 N--CA 1.479 0.624 0 C-N-CA 124.71 3.606 . . . . 0.62 114.284 -174.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 1.042 HD12 ' HB3' ' A' ' 73' ' ' ALA . 4.8 mm -87.02 129.8 37.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 108.591 -0.892 . . . . 1.34 108.591 171.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.772 ' HG2' ' CG ' ' A' ' 74' ' ' PHE . 0.1 OUTLIER -82.66 174.03 11.38 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.709 -0.848 . . . . 3.03 108.709 177.114 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.79 ' N ' ' HA ' ' A' ' 23' ' ' ALA . . . -56.09 -56.51 19.98 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.16 0.505 . . . . 1.46 110.127 -176.046 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.816 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 4.7 ptpp? 144.33 137.03 0.0 OUTLIER 'General case' 0 CA--C 1.488 -1.416 0 O-C-N 125.734 1.896 . . . . 1.76 106.952 176.66 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.496 HD12 HG22 ' A' ' 110' ' ' VAL . 2.9 pp -136.21 163.32 34.32 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.281 0 CA-C-N 113.945 -1.479 . . . . 0.82 107.497 177.213 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.689 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 1.0 OUTLIER -71.19 57.58 0.23 Allowed 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 122.947 0.499 . . . . 1.73 111.894 -173.83 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.604 HG23 ' CB ' ' A' ' 76' ' ' SER . 0.0 OUTLIER -61.16 94.83 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 N-CA-C 108.92 -0.77 . . . . 0.77 108.92 -178.121 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.61 ' ND2' ' H ' ' A' ' 112' ' ' GLY . 3.8 t30 176.27 -177.4 0.13 Allowed 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 114.245 -1.343 . . . . 1.9 108.717 -177.221 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.61 ' H ' ' ND2' ' A' ' 111' ' ' ASN . . . -55.82 -34.66 61.48 Favored Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 116.573 1.389 . . . . 1.47 116.573 -177.435 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.73 ' HG2' ' HG3' ' A' ' 82' ' ' GLN . 0.5 OUTLIER -87.73 -42.79 12.38 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 119.59 1.695 . . . . 2.81 113.538 -156.403 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -129.84 -33.8 1.77 Allowed 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.449 -0.501 . . . . 2.16 110.308 -176.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 1.037 ' HB3' ' HG2' ' A' ' 120' ' ' GLU . . . 39.44 -132.19 0.22 Allowed 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 114.694 -1.139 . . . . 1.26 110.33 -173.027 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.62 ' CE1' ' H ' ' A' ' 118' ' ' LEU . 3.2 t-80 -152.94 137.4 10.77 Favored Pre-proline 0 N--CA 1.422 -1.828 0 N-CA-C 105.636 -1.987 . . . . 0.42 105.636 170.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -29.38 -44.31 0.1 OUTLIER 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 124.128 3.219 . . . . 0.4 113.577 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.861 HD11 ' HB ' ' A' ' 15' ' ' ILE . 39.4 tp -59.63 -52.25 66.34 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.495 0.718 . . . . 0.39 112.079 176.043 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.665 ' HA ' ' HB2' ' A' ' 122' ' ' MET . 43.0 m-85 -77.39 -36.27 53.55 Favored 'General case' 0 CA--C 1.5 -0.953 0 N-CA-C 111.871 0.322 . . . . 3.04 111.871 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 1.037 ' HG2' ' HB3' ' A' ' 115' ' ' ALA . 7.0 mm-40 -59.33 -32.81 70.42 Favored 'General case' 0 CA--C 1.494 -1.182 0 N-CA-C 107.828 -1.175 . . . . 2.44 107.828 172.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.701 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 55.0 t80 -70.81 -33.71 70.99 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 119.731 -0.788 . . . . 0.56 110.651 172.228 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.745 ' HE3' ' HG ' ' A' ' 118' ' ' LEU . 2.6 ttm -73.59 -55.22 6.58 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.903 -0.589 . . . . 0.71 110.102 -168.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.676 ' HD2' ' HB2' ' A' ' 134' ' ' ALA . 0.2 OUTLIER -71.31 -24.13 62.07 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.088 -0.505 . . . . 1.46 111.614 176.372 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.727 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 9.8 pttp -68.71 -27.54 66.03 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 119.088 -1.045 . . . . 1.99 108.889 175.291 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 56.0 m -76.73 -50.04 14.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.463 -0.79 . . . . 0.59 109.546 173.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.654 ' HB3' ' NH2' ' A' ' 153' ' ' ARG . 31.4 mttm -138.22 109.81 8.28 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.902 -0.59 . . . . 1.85 111.077 176.201 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 126' ' ' LYS . 7.4 Cg_exo -72.49 -46.67 0.44 Allowed 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 123.084 2.523 . . . . 1.69 111.348 -177.211 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.517 ' HA2' ' CZ ' ' A' ' 153' ' ' ARG . . . -178.03 142.84 5.75 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.789 -0.72 . . . . 2.59 111.913 177.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.614 HG23 HH12 ' A' ' 153' ' ' ARG . 22.1 pt -66.41 -27.91 41.85 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 N-CA-C 108.252 -1.018 . . . . 3.58 108.252 170.077 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 38.4 tp -93.75 141.84 28.04 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 107.265 -1.383 . . . . 3.47 107.265 165.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -69.71 79.56 0.44 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.107 0.48 . . . . 3.28 110.985 -177.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 8.0 m -118.16 -93.36 0.51 Allowed 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 116.123 -0.489 . . . . 3.56 111.508 -179.002 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 61.5 tttp 179.46 -49.12 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.75 0.31 . . . . 5.17 111.197 -175.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.676 ' HB2' ' HD2' ' A' ' 123' ' ' LYS . . . -154.08 -174.15 4.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.297 0.57 . . . . 1.59 112.408 -172.224 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.939 ' H ' HD13 ' A' ' 135' ' ' ILE . 0.1 OUTLIER -69.45 46.95 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-N 114.7 -1.136 . . . . 2.0 111.118 173.235 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.495 ' C ' ' HA ' ' A' ' 84' ' ' PRO . 21.6 tttp -76.17 48.83 0.53 Allowed 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.495 0.664 . . . . 4.81 111.963 -172.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.66 ' C ' ' HB3' ' A' ' 84' ' ' PRO . 12.0 m-90 -144.56 173.06 12.14 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.159 -1.052 . . . . 1.97 108.159 178.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.663 ' HB2' ' CB ' ' A' ' 156' ' ' PRO . 11.5 m120 -45.25 -155.31 0.0 OUTLIER 'General case' 0 C--O 1.21 -1.019 0 C-N-CA 123.907 0.883 . . . . 2.04 111.403 163.512 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.599 ' HA ' HG12 ' A' ' 43' ' ' VAL . 1.3 m-85 -30.47 -27.65 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.308 0 N-CA-C 117.317 2.34 . . . . 1.93 117.317 -167.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.664 ' HA ' ' O ' ' A' ' 154' ' ' PHE . 3.1 m 9.08 108.55 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 115.162 1.541 . . . . 0.6 115.162 169.612 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.603 ' OG ' HD12 ' A' ' 39' ' ' LEU . 3.1 t -105.84 165.59 11.08 Favored 'General case' 0 C--O 1.207 -1.177 0 CA-C-N 114.903 -1.044 . . . . 0.62 110.855 -173.053 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.497 ' CE2' HG23 ' A' ' 135' ' ' ILE . 15.1 m-85 -121.51 125.22 46.3 Favored 'General case' 0 CA--C 1.49 -1.337 0 N-CA-C 106.486 -1.672 . . . . 0.57 106.486 167.414 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.768 HD23 ' HG3' ' A' ' 152' ' ' GLU . 11.1 tp -80.36 104.14 10.7 Favored 'General case' 0 N--CA 1.419 -2.004 0 C-N-CA 118.222 -1.391 . . . . 0.43 108.457 178.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.681 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 41.1 mm -89.21 141.7 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.658 0 CA-C-N 113.012 -1.904 . . . . 0.19 107.701 -177.453 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.665 ' HA ' HD13 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -93.46 -176.01 3.97 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 119.938 -0.705 . . . . 0.98 111.137 -170.865 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.728 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 50.4 mtm180 -54.49 -37.12 64.92 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.878 0.37 . . . . 2.22 111.301 -177.07 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.435 ' O ' ' HB3' ' A' ' 14' ' ' SER . 7.5 m-20 -94.36 13.96 22.0 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.716 -0.22 . . . . 2.0 110.782 -178.189 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.638 ' HA3' ' CE2' ' A' ' 16' ' ' PHE . . . 73.14 36.82 56.04 Favored Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 120.858 -0.687 . . . . 0.17 113.286 -176.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.474 ' HA ' ' HD2' ' A' ' 150' ' ' PRO . 52.6 t -107.82 106.32 58.24 Favored Pre-proline 0 C--N 1.317 -0.829 0 CA-C-N 117.701 0.75 . . . . 1.12 111.078 175.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.708 ' HG3' ' HG3' ' A' ' 122' ' ' MET . 2.1 Cg_endo -51.48 117.24 3.28 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 123.746 2.964 . . . . 0.41 111.462 172.152 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.873 HG23 ' HG2' ' A' ' 152' ' ' GLU . 27.5 m -118.33 -13.02 10.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 121.133 0.492 . . . . 1.45 109.754 -178.215 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.873 ' HG2' HG23 ' A' ' 151' ' ' VAL . 17.2 mm-40 -145.99 165.9 27.65 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.582 -0.736 . . . . 1.17 109.652 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.654 ' NH2' ' HB3' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -148.03 144.23 27.77 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.634 -0.712 . . . . 2.16 110.044 159.459 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.706 ' HZ ' ' HB2' ' A' ' 166' ' ' LYS . 91.5 m-85 -120.58 148.25 44.12 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.333 -0.849 . . . . 0.32 108.802 -166.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.426 ' HB3' ' HD2' ' A' ' 156' ' ' PRO . 10.8 m -74.56 162.67 72.67 Favored Pre-proline 0 C--N 1.316 -0.889 0 N-CA-C 109.654 -0.498 . . . . 1.11 109.654 178.348 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.663 ' CB ' ' HB2' ' A' ' 138' ' ' ASN . 28.6 Cg_endo -63.82 -33.04 66.3 Favored 'Trans proline' 0 CA--C 1.516 -0.386 0 C-N-CA 121.973 1.782 . . . . 0.78 110.42 174.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -63.96 -5.54 14.84 Favored Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 113.926 -1.488 . . . . 0.5 113.822 170.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -87.74 142.32 27.92 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 117.765 0.782 . . . . 0.5 109.408 174.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.467 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 20.3 t -109.92 -179.82 3.91 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 120.881 0.372 . . . . 1.42 110.414 -172.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.808 HG22 ' HA ' ' A' ' 56' ' ' THR . 62.9 t -43.68 -52.13 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.082 -0.963 . . . . 0.28 111.452 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.33 -27.58 62.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.956 -0.566 . . . . 3.46 111.486 -173.269 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -71.12 -37.75 72.32 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 109.144 -0.687 . . . . 1.4 109.144 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.546 ' HA ' ' CE2' ' A' ' 154' ' ' PHE . 75.0 mt -77.35 -49.09 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-N 115.027 -0.988 . . . . 0.21 110.639 176.491 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.673 ' HG3' HD21 ' A' ' 60' ' ' LEU . 25.5 mt-10 -51.78 -45.47 63.82 Favored 'General case' 0 C--O 1.219 -0.54 0 O-C-N 123.302 0.376 . . . . 0.67 111.305 -177.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -56.31 -23.34 36.3 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.041 0.386 . . . . 0.87 112.041 -175.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.706 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 14.2 mmmm -102.1 -23.91 14.01 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.342 0.591 . . . . 1.71 110.064 174.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.668 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 7.5 tp -76.74 -48.06 19.91 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.262 -0.881 . . . . 0.16 111.95 -177.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.5 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 80.6 mt -53.76 -46.39 98.41 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.616 -0.72 . . . . 0.26 112.175 -174.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.5 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 58.0 Cg_exo -54.65 -22.93 30.53 Favored 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 122.311 2.007 . . . . 0.41 113.12 174.243 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.763 ' HB3' ' HG3' ' A' ' 37' ' ' PRO . 31.2 mt -92.98 -38.5 11.63 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 111.68 0.252 . . . . 0.71 111.68 178.428 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.824 HD23 ' HG2' ' A' ' 37' ' ' PRO . 94.9 mt -63.29 -52.04 63.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-O 122.212 1.006 . . . . 0.34 109.313 175.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -73.63 -32.14 59.78 Favored Glycine 0 N--CA 1.433 -1.563 0 CA-C-N 113.265 -1.789 . . . . 1.12 114.184 -174.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 19.4 m -151.8 -169.48 3.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 117.615 0.708 . . . . 2.64 111.423 -175.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -93.02 -56.61 2.91 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.843 0.312 . . . . 4.35 111.843 -179.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 9.2 tpm_? -147.74 106.51 3.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.018 0.437 . . . . 8.45 111.715 -176.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 4.3 mm? . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.69 -0.671 . . . . 7.69 109.352 172.345 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.657 0 CA-C-O 120.133 -0.26 . . . . 5.22 112.506 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.6 ptm -171.39 -29.56 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.884 0.342 . . . . 4.85 111.206 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.43 74.94 0.83 Allowed Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.513 -0.851 . . . . 1.55 112.973 179.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.2 t -110.76 3.77 19.4 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.834 0.826 . . . . 1.58 108.794 173.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.438 ' HB2' ' O ' ' A' ' 147' ' ' ASP . 92.0 p -179.91 152.69 0.48 Allowed 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 104.831 -2.285 . . . . 1.17 104.831 -177.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.984 HD12 HD21 ' A' ' 30' ' ' LEU . 4.7 pt -66.96 -12.66 15.42 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 CA-C-N 115.371 -0.831 . . . . 0.38 112.021 -171.412 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.656 ' CD1' ' HA ' ' A' ' 31' ' ' VAL . 54.9 m-85 -76.28 6.97 4.74 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.028 0.442 . . . . 0.3 111.167 178.645 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -81.7 -27.74 33.8 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 107.24 -1.393 . . . . 2.11 107.24 174.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.654 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 50.9 m-85 -105.05 121.02 42.92 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 113.963 -1.472 . . . . 0.31 111.008 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -60.18 150.08 30.99 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.29 -1.323 . . . . 2.86 109.818 173.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.852 HG13 ' HZ ' ' A' ' 74' ' ' PHE . 53.0 t -112.23 170.66 3.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 107.71 -1.219 . . . . 0.67 107.71 178.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.702 HD23 ' HA ' ' A' ' 27' ' ' PRO . 88.7 mt -132.37 141.05 48.74 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 118.334 0.515 . . . . 0.69 111.409 -176.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -74.36 169.07 18.42 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 106.878 -1.527 . . . . 1.87 106.878 166.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.82 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . . . -62.4 -3.73 1.53 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 114.046 1.128 . . . . 0.59 114.046 -167.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.531 ' HB2' ' HE2' ' A' ' 26' ' ' LYS . 64.7 m-20 -111.5 12.06 21.37 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 121.008 -0.277 . . . . 2.34 111.349 176.358 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.558 ' CD2' ' HB1' ' A' ' 106' ' ' ALA . 72.1 m-70 77.13 8.96 2.77 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.366 0.603 . . . . 1.47 109.72 177.344 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.531 ' HE2' ' HB2' ' A' ' 24' ' ' ASP . 21.1 mtmt -74.65 119.3 76.0 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 107.54 -1.282 . . . . 4.25 107.54 169.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.702 ' HA ' HD23 ' A' ' 21' ' ' LEU . 93.9 Cg_exo -50.39 115.27 1.83 Allowed 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.329 2.019 . . . . 0.54 114.203 -172.497 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.616 ' CE2' ' HB3' ' A' ' 103' ' ' PRO . 0.2 OUTLIER -78.6 120.4 23.23 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 113.275 -1.784 . . . . 1.2 109.635 169.201 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -72.96 103.1 3.65 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 122.446 1.117 . . . . 1.51 108.82 174.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.984 HD21 HD12 ' A' ' 15' ' ' ILE . 67.3 tp -71.4 -31.48 67.32 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.834 -1.076 . . . . 0.28 110.343 -178.235 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.656 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 3.3 m -66.14 -4.13 2.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 114.439 -1.255 . . . . 1.02 113.109 -167.022 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 -74.67 -6.64 49.84 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.557 0.694 . . . . 1.02 110.01 175.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.957 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 88.6 m-70 -102.13 24.97 9.36 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 115.339 -0.846 . . . . 0.28 109.397 176.461 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.556 ' HE3' ' HB ' ' A' ' 31' ' ' VAL . 93.0 mttt -83.99 123.79 30.36 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 114.426 -1.261 . . . . 1.56 109.323 170.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.14 -36.08 4.07 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.366 -0.921 . . . . 0.2 111.925 178.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.457 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 22.5 m -130.38 132.33 23.95 Favored Pre-proline 0 N--CA 1.436 -1.162 0 N-CA-C 108.252 -1.018 . . . . 0.29 108.252 171.457 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.752 ' HD3' ' HG2' ' A' ' 146' ' ' ARG . 5.1 Cg_endo -43.18 153.86 0.18 Allowed 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.899 3.066 . . . . 0.18 112.795 176.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.844 ' HB2' HG22 ' A' ' 70' ' ' THR . 0.7 OUTLIER -139.65 149.17 43.42 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 106.313 -1.736 . . . . 0.31 106.313 -179.733 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.989 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 2.3 mp -116.3 130.84 56.98 Favored 'General case' 0 C--N 1.292 -1.92 0 O-C-N 121.629 -0.669 . . . . 1.19 109.606 176.138 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.935 HG22 ' OH ' ' A' ' 119' ' ' TYR . 1.1 mt -111.72 126.75 69.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 CA-C-N 115.065 -0.971 . . . . 0.37 109.596 178.284 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.989 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.6 OUTLIER -111.86 124.72 52.95 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.954 -0.566 . . . . 0.42 110.992 -171.662 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.703 ' HB3' HG21 ' A' ' 135' ' ' ILE . 0.9 OUTLIER -79.66 95.12 5.84 Favored 'General case' 0 CA--C 1.504 -0.827 0 N-CA-C 107.206 -1.405 . . . . 2.35 107.206 167.194 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.765 ' O ' ' HA ' ' A' ' 75' ' ' PRO . 4.1 p -105.89 147.17 11.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 CA-C-N 114.833 -1.076 . . . . 1.03 109.649 -172.079 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.444 ' O ' ' HB3' ' A' ' 46' ' ' LYS . . . -106.6 95.76 5.98 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 119.035 -1.066 . . . . 0.88 109.879 172.55 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.94 ' HA ' ' HB2' ' A' ' 98' ' ' PHE . 9.2 p 17.64 -81.28 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 O-C-N 125.636 1.835 . . . . 1.78 113.824 165.082 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.548 ' HG3' ' HB2' ' A' ' 49' ' ' TYR . 0.0 OUTLIER 60.67 145.92 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.831 1.252 . . . . 5.84 112.939 174.074 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.986 ' HB2' ' HA ' ' A' ' 95' ' ' CYS . 46.7 t -111.2 115.31 29.15 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.801 -0.636 . . . . 3.55 110.158 178.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 63.11 13.4 48.57 Favored Glycine 0 CA--C 1.522 0.522 0 CA-C-N 115.968 -0.56 . . . . 2.91 113.624 179.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.548 ' HB2' ' HG3' ' A' ' 46' ' ' LYS . 36.7 m-85 -108.52 167.71 9.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.337 0.589 . . . . 4.63 111.866 -177.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.5 t -177.2 143.26 0.38 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.925 -1.034 . . . . 1.93 108.469 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.744 ' O ' ' HA2' ' A' ' 157' ' ' GLY . 21.9 mtpt -108.52 11.85 26.5 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.902 -0.777 . . . . 2.01 108.902 176.155 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 120.81 -29.32 5.87 Favored Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 110.301 -1.12 . . . . 0.51 110.301 -173.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.404 ' HA3' ' CG ' ' A' ' 139' ' ' PHE . . . -49.85 -46.69 40.06 Favored Glycine 0 C--O 1.222 -0.62 0 CA-C-N 114.424 -0.888 . . . . 0.5 113.969 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.472 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 0.2 OUTLIER -59.31 -59.14 5.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.328 0.564 . . . . 0.7 111.554 -171.855 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.14 -27.87 69.67 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.291 0.567 . . . . 2.61 110.48 -177.355 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.702 HG23 ' HA ' ' A' ' 160' ' ' VAL . 31.8 m -75.83 -57.77 3.68 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.084 -0.962 . . . . 0.33 110.02 -175.539 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 1.055 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -60.3 -41.67 93.88 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.202 -0.908 . . . . 0.22 111.039 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.536 ' HA ' ' CD2' ' A' ' 102' ' ' PHE . 96.7 m -57.69 -55.69 31.53 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.433 0.635 . . . . 0.26 110.466 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 27.3 m -69.46 -36.11 76.27 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.001 -0.999 . . . . 0.48 111.484 -175.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.749 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 16.3 mt -66.93 -47.07 72.82 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-O 120.974 0.416 . . . . 0.43 110.472 -176.397 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.857 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 5.0 t80 -55.31 -56.14 23.4 Favored 'General case' 0 C--O 1.198 -1.637 0 CA-C-N 115.208 -0.905 . . . . 0.31 109.916 177.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -69.75 -24.04 63.47 Favored 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 122.707 0.403 . . . . 1.21 111.566 -173.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.405 ' HE2' ' HB2' ' A' ' 63' ' ' LYS . 13.8 tppt? -76.01 -32.25 59.3 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 108.388 -0.968 . . . . 1.54 108.388 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.713 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 48.4 m-85 -125.86 -2.44 7.18 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 115.7 1.741 . . . . 0.31 115.7 -166.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.765 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 12.6 ptmt -63.84 -29.27 70.48 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 107.686 -1.227 . . . . 1.35 107.686 170.415 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.6 m -47.94 -36.63 12.76 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 113.822 -1.536 . . . . 1.28 111.009 173.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -88.44 -39.75 14.0 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 120.96 -0.296 . . . . 1.11 111.619 173.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.425 ' HA3' ' HB2' ' A' ' 36' ' ' SER . . . 151.49 -4.03 0.47 Allowed Glycine 0 CA--C 1.52 0.388 0 N-CA-C 111.505 -0.638 . . . . 0.18 111.505 -175.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.749 ' HE2' ' HB3' ' A' ' 60' ' ' LEU . 21.4 t80 -71.2 142.59 50.64 Favored 'General case' 0 C--O 1.222 -0.392 0 C-N-CA 122.644 0.377 . . . . 0.18 111.131 -177.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.957 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 2.3 t -133.76 153.15 51.92 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 108.063 -1.088 . . . . 0.2 108.063 173.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 1.055 HG11 ' HB1' ' A' ' 57' ' ' ALA . 25.6 t -112.97 99.5 8.79 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.541 0 N-CA-C 108.018 -1.104 . . . . 0.17 108.018 160.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.511 HD12 ' H ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -93.68 120.2 33.65 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 118.365 -1.334 . . . . 1.04 107.557 174.554 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.769 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -112.21 117.23 31.99 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.538 0.685 . . . . 0.51 110.901 -178.645 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.852 ' HZ ' HG13 ' A' ' 20' ' ' VAL . 5.3 m-30 -93.31 112.54 56.86 Favored Pre-proline 0 C--N 1.318 -0.779 0 CA-C-N 115.241 -0.891 . . . . 0.44 109.388 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.765 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 44.2 Cg_endo -82.29 87.4 1.4 Allowed 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.082 1.855 . . . . 1.3 112.694 -172.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.622 ' HB2' ' ND2' ' A' ' 42' ' ' ASN . 7.0 t -43.18 140.56 1.48 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.382 -1.281 . . . . 1.44 111.765 -177.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.728 HD22 ' HB2' ' A' ' 79' ' ' PHE . 1.5 p-10 -112.82 132.28 55.33 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 113.989 -1.46 . . . . 1.81 110.379 -169.012 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.843 ' HA ' ' HG2' ' A' ' 83' ' ' GLU . 3.5 pp0? -50.17 -8.96 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.636 -1.166 . . . . 3.34 113.396 -178.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.728 ' HB2' HD22 ' A' ' 77' ' ' ASN . 69.8 m-85 -65.24 -14.09 59.87 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.618 0.599 . . . . 2.68 112.618 -168.045 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -98.21 -23.58 12.69 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.318 -0.944 . . . . 1.98 112.664 -177.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.18 13.21 82.96 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 111.411 -0.676 . . . . 1.49 111.411 -176.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.493 ' NE2' ' HB3' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -123.2 20.17 9.82 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 122.765 0.426 . . . . 1.74 110.111 -175.979 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.843 ' HG2' ' HA ' ' A' ' 78' ' ' GLN . 0.0 OUTLIER -74.03 143.54 80.88 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-O 121.913 0.863 . . . . 3.07 112.885 -165.664 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.73 ' HB2' ' O ' ' A' ' 137' ' ' TRP . 80.0 Cg_endo -78.05 -43.57 0.19 Allowed 'Trans proline' 0 N--CA 1.478 0.605 0 C-N-CA 124.992 3.795 . . . . 1.75 113.867 -171.092 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -58.02 -24.44 54.5 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 121.364 -0.446 . . . . 2.2 112.941 -174.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.468 ' O ' ' HB3' ' A' ' 87' ' ' GLU . 43.5 t-20 177.02 -86.62 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.97 -1.122 . . . . 4.2 107.97 177.565 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.468 ' HB3' ' O ' ' A' ' 86' ' ' ASN . 13.8 pt-20 154.71 -41.31 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 O-C-N 124.859 1.349 . . . . 3.02 108.26 173.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.414 ' O ' ' HG2' ' A' ' 92' ' ' GLU . 11.1 tp10 -106.16 -26.15 11.71 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.001 -1.0 . . . . 3.92 111.213 -175.123 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.436 ' HA ' ' HG2' ' A' ' 92' ' ' GLU . 31.8 tt0 -50.71 -45.34 58.39 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.943 0.72 . . . . 2.65 112.943 -170.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.615 ' HA ' ' SG ' ' A' ' 95' ' ' CYS . 33.2 pt -82.54 10.57 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.985 0.422 . . . . 2.15 111.861 -176.357 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.409 ' HE3' ' OE2' ' A' ' 88' ' ' GLU . 48.2 mtmt -124.47 -42.79 2.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.145 0.498 . . . . 2.79 109.832 176.494 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.436 ' HG2' ' HA ' ' A' ' 89' ' ' GLU . 12.0 pt-20 -66.92 -22.09 65.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.636 -0.711 . . . . 3.29 109.66 175.323 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -129.69 148.48 51.58 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.428 -0.953 . . . . 3.42 108.428 176.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 8.9 p -78.23 117.28 23.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-O 121.4 0.619 . . . . 2.63 110.159 176.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.986 ' HA ' ' HB2' ' A' ' 47' ' ' CYS . 61.8 m -119.08 126.71 52.31 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.344 0.592 . . . . 2.83 110.965 -178.443 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.5 p -64.43 157.32 26.79 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 114.648 -1.16 . . . . 2.98 108.667 169.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -75.64 43.8 0.26 Allowed 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 111.845 0.313 . . . . 2.72 111.845 -174.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.94 ' HB2' ' HA ' ' A' ' 45' ' ' SER . 0.9 OUTLIER 65.57 -92.36 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.743 -0.662 . . . . 2.12 110.721 177.782 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt 63.93 139.52 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 O-C-N 123.632 0.582 . . . . 2.69 111.12 -175.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.489 ' HB2' ' CE1' ' A' ' 98' ' ' PHE . . . -164.6 -173.21 2.94 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.048 0.452 . . . . 0.55 111.36 -176.422 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -85.86 22.52 1.65 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.308 -0.86 . . . . 1.99 110.606 -177.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.636 ' CZ ' ' HZ ' ' A' ' 98' ' ' PHE . 19.1 p90 -147.33 163.67 26.89 Favored Pre-proline 0 N--CA 1.447 -0.609 0 CA-C-N 115.711 -0.677 . . . . 0.84 109.312 -178.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.657 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 71.3 Cg_exo -57.12 89.39 0.04 OUTLIER 'Trans proline' 0 N--CA 1.478 0.608 0 C-N-CA 124.608 3.538 . . . . 0.62 115.44 -172.409 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.769 HD12 ' HB3' ' A' ' 73' ' ' ALA . 3.6 mm -89.52 127.54 42.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 108.259 -1.015 . . . . 1.34 108.259 171.215 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.847 ' HG2' ' CG ' ' A' ' 74' ' ' PHE . 0.7 OUTLIER -88.83 -171.37 3.28 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.8 0.333 . . . . 3.03 111.563 -172.206 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.82 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . . . -61.19 -16.88 49.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.808 -0.633 . . . . 1.46 111.795 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.752 ' HB2' ' O ' ' A' ' 75' ' ' PRO . 3.7 ptpp? 78.27 128.2 0.05 OUTLIER 'General case' 0 CA--C 1.494 -1.193 0 O-C-N 125.477 1.736 . . . . 1.76 109.846 -166.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.771 HD12 HG22 ' A' ' 110' ' ' VAL . 2.4 pp -128.87 163.64 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.162 0 CA-C-N 113.028 -1.897 . . . . 0.82 107.042 171.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.615 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 0.1 OUTLIER -70.15 58.1 0.16 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 123.897 0.748 . . . . 1.73 111.556 -172.576 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.771 HG22 HD12 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -63.91 96.64 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 CA-C-O 120.849 0.357 . . . . 0.77 111.08 -171.977 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.512 ' OD1' ' HB3' ' A' ' 84' ' ' PRO . 3.0 t30 176.59 177.74 0.25 Allowed 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 108.337 -0.986 . . . . 1.9 108.337 167.486 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.462 ' H ' ' ND2' ' A' ' 111' ' ' ASN . . . 29.1 -104.06 0.01 OUTLIER Glycine 0 C--N 1.331 0.273 0 O-C-N 124.7 1.25 . . . . 1.47 115.803 167.55 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -107.3 -32.41 7.79 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 113.438 0.903 . . . . 2.81 113.438 -169.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.578 ' HB2' ' HB3' ' A' ' 109' ' ' ASN . 10.1 m120 -94.69 1.06 55.5 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-O 118.939 -0.553 . . . . 2.16 111.264 -169.441 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.615 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -36.53 -91.48 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.171 0 O-C-N 124.647 1.217 . . . . 1.26 112.796 -170.073 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.649 ' CE1' ' H ' ' A' ' 118' ' ' LEU . 2.0 t-80 176.9 138.47 0.22 Allowed Pre-proline 0 N--CA 1.43 -1.456 0 N-CA-C 106.254 -1.758 . . . . 0.42 106.254 173.692 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -30.31 -46.26 0.14 Allowed 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 124.303 3.336 . . . . 0.4 113.621 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.836 HD11 ' HB ' ' A' ' 15' ' ' ILE . 22.6 tp -62.64 -51.34 67.64 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.174 0.589 . . . . 0.39 111.886 178.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.935 ' OH ' HG22 ' A' ' 40' ' ' ILE . 36.6 m-85 -76.58 -36.55 57.51 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 112.285 0.476 . . . . 3.04 112.285 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.793 ' HA ' ' HD2' ' A' ' 123' ' ' LYS . 48.5 mt-10 -61.61 -30.79 70.92 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 107.462 -1.31 . . . . 2.44 107.462 174.384 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.654 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 59.5 t80 -71.62 -32.87 68.43 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.426 -0.806 . . . . 0.56 110.682 171.221 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.737 ' HE3' ' HG ' ' A' ' 118' ' ' LEU . 2.5 ttm -73.73 -52.46 13.13 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.178 -0.465 . . . . 0.71 110.367 -169.571 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.793 ' HD2' ' HA ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -71.04 -24.73 62.4 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.196 -0.456 . . . . 1.46 111.079 175.463 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.767 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -65.0 -30.75 71.76 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.461 0.648 . . . . 1.99 109.741 172.257 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 85.9 m -79.51 -47.32 15.78 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.245 -0.889 . . . . 0.59 111.038 178.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.566 ' HE3' ' O ' ' A' ' 151' ' ' VAL . 19.9 ttmm -140.42 121.8 9.37 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 121.06 0.457 . . . . 1.85 111.982 -178.159 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.521 ' HD3' ' HA ' ' A' ' 126' ' ' LYS . 6.1 Cg_exo -78.97 32.27 0.46 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.711 2.94 . . . . 1.69 111.966 175.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.526 ' H ' ' HG2' ' A' ' 126' ' ' LYS . . . 85.93 165.6 40.93 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.569 -0.741 . . . . 2.59 113.242 172.032 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.42 HG13 ' O ' ' A' ' 153' ' ' ARG . 14.1 mt -73.95 -36.42 45.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 108.353 -0.98 . . . . 3.58 108.353 173.367 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.816 HD23 ' H ' ' A' ' 130' ' ' LEU . 2.2 pt? -90.17 147.22 23.72 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.531 -1.213 . . . . 3.47 108.213 169.375 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.92 87.54 0.73 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.974 0.416 . . . . 3.28 110.731 -176.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.735 HG21 ' HZ3' ' A' ' 137' ' ' TRP . 28.0 m -149.06 127.72 12.43 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.998 -0.547 . . . . 3.56 110.278 179.471 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -41.46 -67.79 0.23 Allowed 'General case' 0 N--CA 1.47 0.539 0 O-C-N 123.919 0.762 . . . . 5.17 112.105 -173.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -118.38 178.09 4.58 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.844 -0.617 . . . . 1.59 110.304 -179.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.832 ' H ' HD13 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -34.43 -51.48 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 O-C-N 124.439 1.087 . . . . 2.0 111.791 173.292 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.891 ' HB3' ' CZ3' ' A' ' 137' ' ' TRP . 5.4 tmtp? 55.84 -14.04 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 116.11 1.892 . . . . 4.81 116.11 174.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.891 ' CZ3' ' HB3' ' A' ' 136' ' ' LYS . 2.3 m-90 -115.39 175.34 5.56 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 119.277 0.944 . . . . 1.97 110.229 176.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -42.26 -155.8 0.0 OUTLIER 'General case' 0 C--O 1.205 -1.245 0 C-N-CA 124.022 0.929 . . . . 2.04 110.535 159.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.645 ' HD2' ' CD2' ' A' ' 41' ' ' TYR . 5.0 m-85 -26.04 -46.72 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.046 0 N-CA-C 116.025 1.861 . . . . 1.93 116.025 -163.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.689 ' HA ' ' O ' ' A' ' 154' ' ' PHE . 5.7 m 28.34 96.16 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 119.675 1.125 . . . . 0.6 113.664 171.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.674 ' HB3' HD23 ' A' ' 39' ' ' LEU . 1.6 m -85.07 170.74 12.65 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.041 -0.982 . . . . 0.62 111.714 -170.35 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.56 ' CE1' HG23 ' A' ' 135' ' ' ILE . 81.1 m-85 -130.46 120.3 23.97 Favored 'General case' 0 CA--C 1.496 -1.116 0 N-CA-C 105.886 -1.894 . . . . 0.57 105.886 161.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.756 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 4.9 tp -78.82 103.64 8.91 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 118.054 -1.458 . . . . 0.43 108.062 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.748 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 45.6 mm -88.77 141.27 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.788 0 CA-C-N 113.474 -1.694 . . . . 0.19 107.564 -177.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.446 ' HA ' HD13 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -92.37 -176.05 4.2 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 119.179 -1.008 . . . . 0.98 110.601 -171.92 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.752 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 11.5 mtm180 -54.55 -40.89 69.14 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.141 0.496 . . . . 2.22 111.031 -176.392 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.438 ' O ' ' HB2' ' A' ' 14' ' ' SER . 5.0 m-20 -94.83 18.01 12.61 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.558 -0.534 . . . . 2.0 109.558 -175.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.56 ' HA3' ' CE2' ' A' ' 16' ' ' PHE . . . 73.12 33.68 59.11 Favored Glycine 0 N--CA 1.44 -1.077 0 CA-C-N 115.688 -0.687 . . . . 0.17 114.128 178.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.512 ' HA ' ' HD2' ' A' ' 150' ' ' PRO . 62.1 t -107.45 106.93 59.63 Favored Pre-proline 0 C--N 1.314 -0.953 0 CA-C-N 118.298 1.049 . . . . 1.12 111.291 176.077 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.577 ' HG3' ' HG3' ' A' ' 122' ' ' MET . 5.7 Cg_exo -46.34 122.9 6.04 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 124.155 3.237 . . . . 0.41 112.087 171.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.566 ' O ' ' HE3' ' A' ' 126' ' ' LYS . 46.8 t -117.99 -29.66 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 109.369 -0.604 . . . . 1.45 109.369 -176.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.756 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 31.0 mm-40 -136.84 167.03 22.23 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.562 -0.745 . . . . 1.17 110.848 -177.395 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.452 ' HA ' ' O ' ' A' ' 141' ' ' SER . 0.2 OUTLIER -144.02 131.37 20.89 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.473 -0.785 . . . . 2.16 109.712 163.552 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.689 ' O ' ' HA ' ' A' ' 140' ' ' THR . 96.8 m-85 -111.02 152.32 26.98 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.866 -0.606 . . . . 0.32 109.63 -170.052 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 12.5 m -74.76 156.94 86.31 Favored Pre-proline 0 C--N 1.319 -0.719 0 N-CA-C 109.469 -0.567 . . . . 1.11 109.469 176.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.777 ' HG3' ' HB3' ' A' ' 137' ' ' TRP . 34.4 Cg_endo -64.88 -24.89 60.46 Favored 'Trans proline' 0 CA--C 1.519 -0.267 0 C-N-CA 122.181 1.92 . . . . 0.78 111.039 177.394 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.744 ' HA2' ' O ' ' A' ' 51' ' ' LYS . . . -80.44 5.6 63.54 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 114.691 -1.14 . . . . 0.5 113.453 173.615 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -79.19 151.33 31.3 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.388 -0.597 . . . . 0.5 109.388 173.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 33.8 t -108.34 169.33 8.71 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 109.494 -0.558 . . . . 1.42 109.494 -177.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.702 ' HA ' HG23 ' A' ' 56' ' ' THR . 99.3 t -40.14 -59.48 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 O-C-N 124.356 1.035 . . . . 0.28 111.683 178.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.484 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 0.9 OUTLIER -65.74 -30.26 70.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.299 -0.409 . . . . 3.46 111.986 -173.483 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -65.25 -35.95 82.63 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-O 122.247 1.022 . . . . 1.4 108.756 -178.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.585 ' HA ' ' CE2' ' A' ' 154' ' ' PHE . 54.5 mt -78.17 -44.25 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 CA-C-N 113.7 -1.591 . . . . 0.21 110.483 175.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.623 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 47.7 mt-10 -54.93 -43.12 73.07 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 116.048 -0.524 . . . . 0.67 111.492 -177.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 161' ' ' LYS . 7.0 pt-20 -61.03 -16.69 46.36 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.235 0.457 . . . . 0.87 112.235 -176.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.633 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 34.0 mmtp -100.72 -28.89 12.58 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.667 0.746 . . . . 1.71 109.793 172.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.623 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 12.5 tp -78.84 -50.97 10.37 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.857 -1.065 . . . . 0.16 112.749 -175.378 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.494 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 63.3 mt -55.14 -45.78 99.79 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.85 -0.614 . . . . 0.26 112.387 -174.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.494 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 58.2 Cg_exo -56.14 -17.29 19.54 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 122.081 1.854 . . . . 0.41 113.124 174.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.751 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 78.0 mt -97.7 -42.72 7.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.741 -0.209 . . . . 0.71 111.08 176.436 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.714 HD23 ' HG2' ' A' ' 37' ' ' PRO . 93.7 mt -61.08 -52.1 66.37 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-O 122.165 0.983 . . . . 0.34 109.595 175.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -77.38 26.96 1.83 Allowed Glycine 0 N--CA 1.436 -1.331 0 CA-C-N 113.565 -1.652 . . . . 1.12 112.923 -178.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 29.1 t -124.99 97.07 5.1 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.184 0.516 . . . . 2.64 109.991 177.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -85.08 -20.55 30.2 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.55 -0.537 . . . . 4.35 109.55 176.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.443 ' HG2' ' O ' ' A' ' 175' ' ' ARG . 19.5 ttm180 64.92 21.3 12.3 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 114.815 -1.084 . . . . 8.45 110.64 175.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 58.6 tp . . . . . 0 C--O 1.25 1.103 0 CA-C-N 115.258 -0.883 . . . . 7.69 109.687 176.312 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.566 0 N-CA-C 111.935 -0.466 . . . . 5.22 111.935 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 23.4 ptp -78.47 150.25 33.03 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.759 0.314 . . . . 4.85 110.428 178.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.405 ' HA3' ' CE1' ' A' ' 121' ' ' TYR . . . 106.28 89.55 2.11 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.863 -0.684 . . . . 1.55 112.439 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.1 t -97.05 -23.72 16.13 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.965 0.412 . . . . 1.58 110.318 178.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 27.8 m -163.64 151.55 13.05 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 104.854 -2.276 . . . . 1.17 104.854 -179.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.882 ' HB ' HD11 ' A' ' 118' ' ' LEU . 6.3 pt -58.93 -20.55 17.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 CA-C-N 115.042 -0.981 . . . . 0.38 111.756 -174.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.812 ' HB3' HG13 ' A' ' 31' ' ' VAL . 42.2 m-85 -67.2 -6.24 17.19 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.293 0.849 . . . . 0.3 113.293 -175.229 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -78.4 -15.78 58.31 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 107.873 -1.158 . . . . 2.11 107.873 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.566 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 37.3 m-85 -107.61 115.88 30.94 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 114.577 -1.192 . . . . 0.31 110.829 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -55.62 144.32 27.06 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 113.896 -1.502 . . . . 2.86 110.054 175.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.851 HG13 ' HZ ' ' A' ' 74' ' ' PHE . 66.5 t -112.14 166.14 6.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 107.879 -1.156 . . . . 0.67 107.879 179.122 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.756 ' HB2' ' HE1' ' A' ' 105' ' ' MET . 55.7 mt -125.6 146.59 49.63 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 109.949 -0.389 . . . . 0.69 109.949 178.278 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.583 ' HB3' ' HE3' ' A' ' 26' ' ' LYS . 16.5 t70 -77.8 169.79 17.68 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 106.146 -1.798 . . . . 1.87 106.146 165.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.674 ' HA ' ' N ' ' A' ' 106' ' ' ALA . . . -63.68 -3.65 2.45 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 113.253 0.834 . . . . 0.59 113.253 -168.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.937 ' HB2' ' HE2' ' A' ' 26' ' ' LYS . 3.3 m-20 -107.0 6.01 28.67 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 111.451 0.167 . . . . 2.34 111.451 176.127 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.582 ' CD2' ' HB1' ' A' ' 106' ' ' ALA . 59.9 m-70 79.85 6.04 1.86 Allowed 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.521 0.677 . . . . 1.47 109.61 177.041 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.937 ' HE2' ' HB2' ' A' ' 24' ' ' ASP . 29.8 mtmt -66.68 115.94 29.66 Favored Pre-proline 0 N--CA 1.447 -0.595 0 N-CA-C 107.656 -1.238 . . . . 4.25 107.656 167.057 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.659 ' HA ' HD23 ' A' ' 21' ' ' LEU . 75.4 Cg_exo -48.76 114.86 1.38 Allowed 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 121.796 1.664 . . . . 0.54 112.313 -178.288 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.508 ' CE2' ' HB3' ' A' ' 103' ' ' PRO . 0.8 OUTLIER -78.39 151.55 32.74 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 113.573 -1.649 . . . . 1.2 111.761 179.589 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.758 ' ND2' ' HB3' ' A' ' 32' ' ' GLN . 49.1 t30 -86.82 90.2 8.22 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.8 -1.091 . . . . 1.51 109.836 174.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.676 HD23 ' HA ' ' A' ' 16' ' ' PHE . 63.2 tp -71.56 -43.79 65.7 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.179 0.514 . . . . 0.28 110.601 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.812 HG13 ' HB3' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -67.56 0.89 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.18 -0.918 . . . . 1.02 113.174 -172.12 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.758 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . 13.7 pt20 -72.54 -11.88 60.84 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.553 0.692 . . . . 1.02 109.322 172.185 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.956 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 91.6 m-70 -98.73 21.18 11.76 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 115.267 -0.879 . . . . 0.28 109.087 176.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.788 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 11.0 mtmm -80.1 110.4 15.47 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.541 -1.209 . . . . 1.56 109.118 169.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 133.45 -43.06 1.3 Allowed Glycine 0 N--CA 1.439 -1.106 0 C-N-CA 120.75 -0.738 . . . . 0.2 111.841 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.422 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 72.3 m -126.88 138.09 31.91 Favored Pre-proline 0 N--CA 1.439 -0.987 0 N-CA-C 108.576 -0.898 . . . . 0.29 108.576 173.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.825 ' HD3' ' HG2' ' A' ' 146' ' ' ARG . 3.2 Cg_endo -43.37 149.15 0.58 Allowed 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 123.574 2.85 . . . . 0.18 112.079 174.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.91 ' HB2' HG22 ' A' ' 70' ' ' THR . 0.6 OUTLIER -135.78 150.24 49.41 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 106.051 -1.833 . . . . 0.31 106.051 178.475 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.942 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 2.7 mp -116.21 129.34 56.25 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 109.206 -0.664 . . . . 1.19 109.206 175.032 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.862 HG22 ' OH ' ' A' ' 119' ' ' TYR . 1.2 mt -111.02 123.71 67.16 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 CA-C-N 115.025 -0.989 . . . . 0.37 109.002 178.452 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.942 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.5 OUTLIER -108.74 123.64 49.33 Favored 'General case' 0 C--O 1.215 -0.738 0 CA-C-N 115.996 -0.547 . . . . 0.42 110.796 -172.267 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.636 ' HB2' HG11 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -76.56 122.09 24.11 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 104.88 -2.267 . . . . 2.35 104.88 165.948 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.807 HG11 ' HB1' ' A' ' 73' ' ' ALA . 2.5 p -133.07 145.91 33.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 C-N-CA 118.724 -1.19 . . . . 1.03 112.94 -165.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -94.46 102.46 14.42 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 114.919 -1.037 . . . . 0.88 110.043 174.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.593 ' OG ' ' HB2' ' A' ' 75' ' ' PRO . 13.0 m -47.71 81.27 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 O-C-N 124.284 0.99 . . . . 1.78 111.373 167.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.786 ' HE2' ' HB3' ' A' ' 49' ' ' TYR . 18.9 mmmt -97.0 157.36 15.94 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.396 0.617 . . . . 5.84 111.741 -174.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.493 ' HB2' ' HA ' ' A' ' 95' ' ' CYS . 29.9 t -111.63 117.02 31.79 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.135 -0.939 . . . . 3.55 109.18 173.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 60.25 41.65 98.39 Favored Glycine 0 CA--C 1.52 0.347 0 CA-C-N 115.796 -0.638 . . . . 2.91 113.508 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.786 ' HB3' ' HE2' ' A' ' 46' ' ' LYS . 72.5 t80 -161.55 133.53 5.7 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.199 0.523 . . . . 4.63 111.31 178.398 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.4 t -143.39 143.25 31.56 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.69 -0.856 . . . . 1.93 108.69 175.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.645 ' O ' ' HA2' ' A' ' 157' ' ' GLY . 48.9 tttt -95.11 15.1 19.9 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 121.948 0.88 . . . . 2.01 108.838 176.21 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 116.66 -38.71 2.92 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 110.128 -1.189 . . . . 0.51 110.128 -173.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -37.13 -50.99 1.63 Allowed Glycine 0 C--O 1.223 -0.566 0 CA-C-N 114.364 -0.918 . . . . 0.5 114.952 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.498 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 0.1 OUTLIER -57.71 -59.18 5.59 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 117.743 0.772 . . . . 0.7 111.469 -172.41 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -62.56 -26.96 68.85 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.733 -0.667 . . . . 2.61 110.136 -178.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.726 ' HA ' HG22 ' A' ' 160' ' ' VAL . 77.5 m -71.91 -59.61 2.66 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 114.891 -1.05 . . . . 0.33 109.916 -177.534 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 1.055 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -60.59 -39.9 89.79 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 114.675 -1.148 . . . . 0.22 111.371 -178.307 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.543 ' HA ' ' CD1' ' A' ' 102' ' ' PHE . 89.8 m -58.57 -58.71 7.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.598 0.713 . . . . 0.26 110.6 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.4 m -68.31 -33.78 74.95 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 114.955 -1.021 . . . . 0.48 111.473 -174.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.749 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 20.6 mt -67.53 -50.58 58.02 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 121.25 0.547 . . . . 0.43 110.37 -177.136 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.812 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 10.5 t80 -54.83 -50.3 68.92 Favored 'General case' 0 C--O 1.204 -1.325 0 CA-C-N 114.983 -1.008 . . . . 0.31 110.681 177.304 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -72.48 -25.7 61.53 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 122.443 0.297 . . . . 1.21 110.75 -171.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.501 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 35.3 ttpt -86.47 -23.28 26.03 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 109.044 -0.724 . . . . 1.54 109.044 -178.431 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.772 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 30.4 m-85 -123.51 -5.49 8.19 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 115.291 1.589 . . . . 0.31 115.291 -169.57 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.679 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -64.63 -23.22 67.19 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 108.055 -1.091 . . . . 1.35 108.055 169.976 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 37.5 t -47.19 -40.35 15.84 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 114.118 -1.401 . . . . 1.28 110.848 171.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -90.06 -32.35 16.76 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 120.725 0.298 . . . . 1.11 111.337 177.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 143.44 -5.67 1.86 Allowed Glycine 0 N--CA 1.449 -0.468 0 N-CA-C 111.364 -0.694 . . . . 0.18 111.364 -175.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.772 ' HD2' ' HB2' ' A' ' 64' ' ' TYR . 24.6 t80 -66.92 141.32 57.67 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 120.978 0.418 . . . . 0.18 110.822 -178.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.956 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 5.3 t -132.55 152.96 51.42 Favored 'General case' 0 N--CA 1.422 -1.835 0 N-CA-C 107.991 -1.114 . . . . 0.2 107.991 174.338 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 1.055 HG11 ' HB1' ' A' ' 57' ' ' ALA . 38.2 t -112.09 99.86 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.702 0 N-CA-C 107.65 -1.241 . . . . 0.17 107.65 158.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.622 HD12 HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -93.46 121.23 34.65 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 106.911 -1.514 . . . . 1.04 106.911 174.33 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 1.023 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -108.02 121.16 44.23 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.961 0.886 . . . . 0.51 111.265 -178.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.913 ' CG ' ' HG2' ' A' ' 105' ' ' MET . 2.6 m-30 -95.7 101.04 7.13 Favored Pre-proline 0 C--N 1.314 -0.935 0 CA-C-N 114.379 -1.282 . . . . 0.44 109.009 178.332 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.715 ' HA ' HG13 ' A' ' 43' ' ' VAL . 87.8 Cg_endo -82.12 74.99 4.94 Favored 'Trans proline' 0 CA--C 1.512 -0.612 0 C-N-CA 122.798 2.332 . . . . 1.3 113.423 -167.082 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.8 p 0.69 128.51 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 116.967 2.21 . . . . 1.44 116.967 -177.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.491 ' C ' ' H ' ' A' ' 79' ' ' PHE . 15.3 t-20 -69.58 74.81 0.4 Allowed 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 112.468 -2.151 . . . . 1.81 109.062 177.313 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.626 ' HA ' ' HG3' ' A' ' 83' ' ' GLU . 1.0 OUTLIER -50.29 -11.63 0.07 Allowed 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.741 1.216 . . . . 3.34 111.887 177.865 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.491 ' H ' ' C ' ' A' ' 77' ' ' ASN . 98.4 m-85 -68.55 29.82 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.859 -1.064 . . . . 2.68 113.019 -173.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.444 ' H ' ' C ' ' A' ' 78' ' ' GLN . . . -144.21 -136.21 3.05 Favored Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 110.943 -0.863 . . . . 1.98 110.943 176.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -152.92 34.51 0.79 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.644 -0.789 . . . . 1.49 111.745 177.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.0 pm0 -128.94 -9.35 4.89 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.027 -0.087 . . . . 1.74 110.948 -177.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.626 ' HG3' ' HA ' ' A' ' 78' ' ' GLN . 4.1 mm-40 -62.19 142.35 95.75 Favored Pre-proline 0 CA--C 1.535 0.366 0 N-CA-C 112.438 0.533 . . . . 3.07 112.438 -168.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.666 ' HB3' ' N ' ' A' ' 137' ' ' TRP . 31.4 Cg_exo -19.28 -85.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.754 1 C-N-CA 127.242 5.295 . . . . 1.75 116.557 -178.93 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.484 ' H ' ' HB2' ' A' ' 84' ' ' PRO . . . -134.72 32.89 2.55 Favored Glycine 0 CA--C 1.5 -0.863 0 N-CA-C 110.195 -1.162 . . . . 2.2 110.195 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 1.053 ' HB2' HG12 ' A' ' 90' ' ' ILE . 2.7 p-10 -149.82 33.36 0.68 Allowed 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.525 -0.838 . . . . 4.2 110.048 -173.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.512 ' C ' ' HD3' ' A' ' 91' ' ' LYS . 1.8 pm0 -82.66 11.53 5.73 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.071 -0.968 . . . . 3.02 109.81 178.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -158.92 -42.75 0.06 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.12 -0.946 . . . . 3.92 109.316 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.654 ' O ' ' HB2' ' A' ' 93' ' ' PHE . 13.3 tp10 -48.88 -60.27 2.89 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 114.833 -1.076 . . . . 2.65 111.856 -177.553 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 1.053 HG12 ' HB2' ' A' ' 86' ' ' ASN . 29.0 pt -97.75 23.29 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 O-C-N 121.948 -0.47 . . . . 2.15 111.47 -175.062 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.512 ' HD3' ' C ' ' A' ' 87' ' ' GLU . 47.0 mtpt -101.48 -46.29 5.03 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.89 -0.595 . . . . 2.79 110.894 177.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -122.39 2.41 9.68 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.827 -0.624 . . . . 3.29 111.628 -177.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.654 ' HB2' ' O ' ' A' ' 89' ' ' GLU . 96.0 m-85 -108.47 169.04 8.89 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.909 -0.774 . . . . 3.42 108.909 173.402 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.6 t -65.47 125.13 21.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.433 -0.349 . . . . 2.63 110.975 -178.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.493 ' HA ' ' HB2' ' A' ' 47' ' ' CYS . 4.8 p -144.9 134.45 23.28 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.942 -0.572 . . . . 2.83 110.883 175.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.411 ' O ' ' HB3' ' A' ' 45' ' ' SER . 0.5 OUTLIER -79.33 152.12 30.65 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 106.138 -1.801 . . . . 2.98 106.138 161.291 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -79.73 50.65 1.19 Allowed 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 119.445 -0.902 . . . . 2.72 110.237 175.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.68 ' CE1' ' HB2' ' A' ' 100' ' ' ALA . 0.9 OUTLIER 60.49 -105.65 0.23 Allowed 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 114.254 -1.339 . . . . 2.12 110.431 178.877 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp 61.37 109.53 0.02 OUTLIER 'General case' 0 C--N 1.334 -0.09 0 CA-C-O 121.715 0.769 . . . . 2.69 111.593 -175.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.68 ' HB2' ' CE1' ' A' ' 98' ' ' PHE . . . -131.26 -159.69 0.99 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.493 -0.776 . . . . 0.55 111.231 -174.34 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -95.33 26.3 3.89 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.792 -0.64 . . . . 1.99 111.033 178.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.67 ' CZ ' ' HZ ' ' A' ' 98' ' ' PHE . 12.7 p90 -146.18 164.71 23.45 Favored Pre-proline 0 N--CA 1.448 -0.527 0 N-CA-C 108.571 -0.9 . . . . 0.84 108.571 176.497 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.71 ' HD3' ' CE2' ' A' ' 61' ' ' TYR . 52.7 Cg_exo -59.07 85.79 0.06 OUTLIER 'Trans proline' 0 N--CA 1.482 0.832 0 C-N-CA 124.697 3.598 . . . . 0.62 115.35 -173.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 1.023 HD12 ' HB3' ' A' ' 73' ' ' ALA . 3.9 mm -85.56 131.67 33.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 108.61 -0.885 . . . . 1.34 108.61 171.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.913 ' HG2' ' CG ' ' A' ' 74' ' ' PHE . 1.9 ppp? -96.68 -175.64 3.36 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.149 0.5 . . . . 3.03 110.482 -176.104 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.674 ' N ' ' HA ' ' A' ' 23' ' ' ALA . . . -79.33 19.5 0.59 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.391 -0.822 . . . . 1.46 112.654 -170.295 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.699 ' HG2' ' HG2' ' A' ' 75' ' ' PRO . 50.7 mttp 60.92 131.25 0.01 OUTLIER 'General case' 0 CA--C 1.496 -1.114 0 CA-C-O 122.365 1.079 . . . . 1.76 110.784 -168.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.595 ' CD1' HG13 ' A' ' 110' ' ' VAL . 2.4 pp -128.01 163.9 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.392 0 N-CA-C 106.326 -1.731 . . . . 0.82 106.326 160.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.667 ' HB3' ' HB2' ' A' ' 114' ' ' ASN . 1.9 t30 -76.53 84.29 3.23 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 120.38 -0.528 . . . . 1.73 110.439 -172.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.636 HG11 ' HB2' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -79.28 90.33 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.225 0 C-N-CA 119.325 -0.95 . . . . 0.77 109.128 179.594 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.5 t30 174.86 161.26 0.21 Allowed 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 114.252 -1.34 . . . . 1.9 108.608 175.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 45.73 -123.51 6.44 Favored Glycine 0 CA--C 1.518 0.28 0 N-CA-C 115.319 0.888 . . . . 1.47 115.319 164.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.22 2.39 26.82 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 114.866 -0.667 . . . . 2.81 111.237 -169.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.667 ' HB2' ' HB3' ' A' ' 109' ' ' ASN . 0.1 OUTLIER -112.05 1.54 16.4 Favored 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 108.278 -1.008 . . . . 2.16 108.278 -168.957 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.519 ' HB3' ' CD ' ' A' ' 120' ' ' GLU . . . -49.16 139.17 11.28 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 112.753 -2.021 . . . . 1.26 110.363 176.197 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.591 ' CE1' ' H ' ' A' ' 118' ' ' LEU . 1.6 t-80 -80.03 139.63 53.31 Favored Pre-proline 0 N--CA 1.433 -1.311 0 N-CA-C 107.13 -1.433 . . . . 0.42 107.13 -173.026 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -24.09 -46.9 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 124.805 3.67 . . . . 0.4 113.988 -178.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.882 HD11 ' HB ' ' A' ' 15' ' ' ILE . 24.8 tp -67.97 -50.31 56.53 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.012 0.525 . . . . 0.39 111.783 -178.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.862 ' OH ' HG22 ' A' ' 40' ' ' ILE . 16.6 m-85 -80.96 -34.19 33.31 Favored 'General case' 0 CA--C 1.483 -1.611 0 CA-C-O 121.504 0.668 . . . . 3.04 110.378 -176.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.598 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 5.6 tp10 -63.09 -34.37 77.44 Favored 'General case' 0 N--CA 1.419 -1.987 0 N-CA-C 106.889 -1.523 . . . . 2.44 106.889 175.153 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.625 ' HD1' ' HE3' ' A' ' 124' ' ' LYS . 43.4 t80 -72.31 -28.86 63.34 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.591 -0.732 . . . . 0.56 109.82 170.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.855 ' HE3' ' HG ' ' A' ' 118' ' ' LEU . 2.9 ttm -75.66 -56.12 5.0 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.11 -0.636 . . . . 0.71 110.393 -169.177 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.436 ' HD2' ' HA ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -72.29 -23.28 61.17 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 120.773 -0.371 . . . . 1.46 111.948 176.849 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.625 ' HE3' ' HD1' ' A' ' 121' ' ' TYR . 12.4 pttp -70.53 -27.66 64.34 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 119.201 -0.999 . . . . 1.99 109.823 175.484 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 38.8 m -89.73 -24.81 21.44 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.683 -0.689 . . . . 0.59 110.341 176.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.471 ' HE2' ' HA ' ' A' ' 151' ' ' VAL . 29.9 mmtm -138.38 82.55 22.91 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.614 -0.721 . . . . 1.85 110.78 -178.155 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.532 ' O ' ' HA ' ' A' ' 134' ' ' ALA . 23.7 Cg_exo -26.94 -84.53 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.816 1 C-N-CA 125.515 4.143 . . . . 1.69 115.057 -177.065 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.447 ' HA2' ' NE ' ' A' ' 153' ' ' ARG . . . 167.62 57.3 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.241 -0.98 . . . . 2.59 112.761 -177.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 15.7 mt 61.62 29.34 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-O 122.512 1.149 . . . . 3.58 109.126 -178.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.563 ' HG ' ' H ' ' A' ' 131' ' ' ALA . 32.0 tp -161.46 -178.68 6.78 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.38 -1.282 . . . . 3.47 108.485 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.563 ' H ' ' HG ' ' A' ' 130' ' ' LEU . . . -73.1 -20.2 61.0 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.297 0.57 . . . . 3.28 109.887 174.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.32 -146.13 0.29 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.318 -0.856 . . . . 3.56 109.171 176.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 5.0 tptm 78.46 -165.17 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.199 0.6 . . . . 5.17 110.2 177.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.532 ' HA ' ' O ' ' A' ' 127' ' ' PRO . . . -165.16 -170.77 2.0 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.588 -0.278 . . . . 1.59 110.348 -176.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.559 HG22 ' HB ' ' A' ' 140' ' ' THR . 0.6 OUTLIER -67.01 52.42 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.913 0 CA-C-N 115.965 -0.561 . . . . 2.0 109.803 168.126 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.641 ' HD3' ' O ' ' A' ' 136' ' ' LYS . 9.9 tmtt? -86.99 39.47 0.86 Allowed 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.718 0.77 . . . . 4.81 111.29 -169.239 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.893 ' HB3' ' HG3' ' A' ' 156' ' ' PRO . 9.7 m-90 -142.16 175.46 9.73 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.758 -0.656 . . . . 1.97 109.777 -177.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.615 ' HB2' ' CB ' ' A' ' 156' ' ' PRO . 14.8 m-80 -44.49 -156.89 0.0 OUTLIER 'General case' 0 C--O 1.211 -0.937 0 O-C-N 123.849 0.718 . . . . 2.04 111.311 161.614 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.653 ' CD1' HG23 ' A' ' 43' ' ' VAL . 3.9 m-85 -31.41 -26.38 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.338 0 N-CA-C 118.036 2.606 . . . . 1.93 118.036 -168.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.688 ' HA ' ' O ' ' A' ' 154' ' ' PHE . 1.9 m 7.49 103.43 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 120.5 1.5 . . . . 0.6 114.678 171.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.526 ' HB3' HD23 ' A' ' 39' ' ' LEU . 1.1 m -91.56 173.61 7.8 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.552 -1.204 . . . . 0.62 111.039 -172.364 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.526 ' HA ' ' HA ' ' A' ' 153' ' ' ARG . 60.5 m-85 -132.52 122.68 25.23 Favored 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 105.858 -1.904 . . . . 0.57 105.858 164.355 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.787 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 7.3 tp -80.0 104.6 10.68 Favored 'General case' 0 N--CA 1.422 -1.834 0 C-N-CA 118.302 -1.359 . . . . 0.43 108.474 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.741 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 36.8 mm -89.03 141.84 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.741 0 CA-C-N 112.854 -1.976 . . . . 0.19 107.581 -177.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.507 ' HA ' HD13 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -94.38 -175.34 3.61 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 119.411 -0.916 . . . . 0.98 111.395 -170.358 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.825 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 30.7 mtm180 -55.98 -33.42 64.81 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.803 0.335 . . . . 2.22 111.566 -176.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -103.78 22.99 13.48 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 109.864 -0.421 . . . . 2.0 109.864 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.595 ' HA2' HG22 ' A' ' 144' ' ' ILE . . . 70.18 37.09 71.93 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 121.219 -0.515 . . . . 0.17 114.184 177.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.511 ' HA ' ' HD2' ' A' ' 150' ' ' PRO . 57.8 t -107.04 108.3 61.79 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 118.192 0.996 . . . . 1.12 111.243 174.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.785 ' HD3' HG23 ' A' ' 15' ' ' ILE . 8.5 Cg_endo -58.3 110.13 0.6 Allowed 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 123.757 2.971 . . . . 0.41 111.307 174.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.697 HG23 ' HG2' ' A' ' 152' ' ' GLU . 17.8 m -108.86 -23.41 4.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.299 0.571 . . . . 1.45 109.569 -176.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.787 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 47.2 mm-40 -133.3 168.22 18.97 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-N 115.298 -0.865 . . . . 1.17 110.434 179.251 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.549 HH11 ' HG2' ' A' ' 153' ' ' ARG . 0.0 OUTLIER -144.63 148.63 34.54 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 114.614 -1.176 . . . . 2.16 108.582 163.019 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.688 ' O ' ' HA ' ' A' ' 140' ' ' THR . 91.9 m-85 -121.77 144.36 48.85 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 110.207 -0.294 . . . . 0.32 110.207 -169.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 12.9 p -63.87 149.5 93.12 Favored Pre-proline 0 C--N 1.318 -0.787 0 N-CA-C 109.536 -0.542 . . . . 1.11 109.536 174.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.893 ' HG3' ' HB3' ' A' ' 137' ' ' TRP . 30.3 Cg_endo -63.2 -26.38 72.42 Favored 'Trans proline' 0 CA--C 1.511 -0.659 0 C-N-CA 122.349 2.033 . . . . 0.78 110.714 176.149 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.645 ' HA2' ' O ' ' A' ' 51' ' ' LYS . . . -79.2 16.67 8.87 Favored Glycine 0 N--CA 1.438 -1.177 0 CA-C-N 113.785 -1.552 . . . . 0.5 113.405 171.614 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -95.64 152.98 17.96 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 109.514 -0.55 . . . . 0.5 109.514 170.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.587 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 22.9 t -113.44 176.83 4.86 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 109.71 -0.478 . . . . 1.42 109.71 -175.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.726 HG22 ' HA ' ' A' ' 56' ' ' THR . 48.4 t -45.62 -48.38 4.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 O-C-N 124.04 0.837 . . . . 0.28 110.9 178.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.589 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 40.8 tttm -65.54 -41.16 93.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.823 -0.626 . . . . 3.46 111.148 -175.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -64.93 -34.26 77.99 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 121.732 0.777 . . . . 1.4 109.47 -173.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.593 HD12 ' CG2' ' A' ' 56' ' ' THR . 46.3 mt -80.54 -46.21 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 CA-C-N 114.451 -1.249 . . . . 0.21 111.106 177.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.529 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 36.5 mt-10 -53.09 -44.26 67.45 Favored 'General case' 0 C--O 1.218 -0.587 0 N-CA-C 111.688 0.255 . . . . 0.67 111.688 -175.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.589 ' HG2' ' O ' ' A' ' 161' ' ' LYS . 4.5 pt-20 -62.35 -14.23 37.57 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.568 0.581 . . . . 0.87 112.568 -175.386 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.682 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 13.0 mmmt -105.3 -23.9 12.79 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.009 -0.737 . . . . 1.71 109.009 175.171 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.529 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 10.5 tp -83.26 -50.77 8.07 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.48 -1.236 . . . . 0.16 112.222 -176.316 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 164' ' ' GLU . 65.4 mt -54.32 -44.94 99.31 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 115.586 -0.734 . . . . 0.26 112.077 -175.26 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.47 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 86.8 Cg_exo -50.53 -24.59 12.78 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 122.182 1.921 . . . . 0.41 113.287 173.093 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.732 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 88.1 mt -95.19 -42.5 8.54 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 122.28 -0.263 . . . . 0.71 111.547 177.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.766 HD23 ' HG2' ' A' ' 37' ' ' PRO . 89.1 mt -61.45 -52.4 64.72 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-O 122.19 0.995 . . . . 0.34 109.883 177.062 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -74.56 -58.39 4.2 Favored Glycine 0 N--CA 1.431 -1.648 0 CA-C-N 113.065 -1.88 . . . . 1.12 114.356 -172.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 30.8 t -152.11 88.02 1.36 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.176 0.512 . . . . 2.64 111.539 -170.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -93.03 -4.34 52.72 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.881 -0.599 . . . . 4.35 110.015 176.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.617 ' HA ' ' NE ' ' A' ' 175' ' ' ARG . 3.5 mmp_? -110.03 97.89 7.29 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.538 -0.755 . . . . 8.45 110.319 177.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 49.2 tp . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.265 -0.874 . . . . 7.69 109.696 179.404 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.635 0 N-CA-C 111.971 -0.451 . . . . 5.22 111.971 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -76.08 127.01 32.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.969 0.414 . . . . 4.85 109.985 178.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.465 ' H ' ' CG ' ' A' ' 17' ' ' ASP . . . 110.2 59.82 0.5 Allowed Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.439 -0.664 . . . . 1.55 111.439 -176.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.5 m -125.94 -22.67 4.1 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.062 0.458 . . . . 1.58 110.582 -178.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.8 m -145.39 -176.42 5.11 Favored 'General case' 0 N--CA 1.423 -1.785 0 N-CA-C 104.896 -2.261 . . . . 1.17 104.896 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.73 HG23 ' HD3' ' A' ' 150' ' ' PRO . 5.7 pt -81.42 -17.73 11.83 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.481 0 CA-C-O 121.447 0.641 . . . . 0.38 109.847 177.361 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.775 ' HB3' HG13 ' A' ' 31' ' ' VAL . 39.7 m-85 -71.0 -2.75 16.37 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.503 -0.771 . . . . 0.3 112.45 -176.614 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.465 ' CG ' ' H ' ' A' ' 12' ' ' GLY . 7.1 m-20 -77.2 -20.5 55.28 Favored 'General case' 0 CA--C 1.501 -0.904 0 N-CA-C 107.595 -1.261 . . . . 2.11 107.595 176.375 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.601 ' CD2' ' HA ' ' A' ' 118' ' ' LEU . 58.1 m-85 -113.39 122.32 47.0 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 114.334 -1.303 . . . . 0.31 111.8 -174.312 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -48.19 139.4 8.48 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 112.561 -2.109 . . . . 2.86 111.709 172.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.875 HG13 ' HZ ' ' A' ' 74' ' ' PHE . 79.2 t -113.43 166.34 7.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 107.637 -1.246 . . . . 0.67 107.637 174.525 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.72 HD23 ' HA ' ' A' ' 27' ' ' PRO . 80.4 mt -132.88 131.87 41.44 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 120.001 -0.68 . . . . 0.69 112.47 -177.122 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 15.1 t70 -64.43 159.23 21.8 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 106.457 -1.683 . . . . 1.87 106.457 165.501 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.768 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . . . -60.51 -6.76 1.74 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 113.801 1.038 . . . . 0.59 113.801 -165.001 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.608 ' HB2' ' HE2' ' A' ' 26' ' ' LYS . 54.7 m-20 -97.14 -0.19 47.38 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.751 0.278 . . . . 2.34 111.751 176.241 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.535 ' HB2' ' O ' ' A' ' 24' ' ' ASP . 74.8 m80 83.64 10.06 0.51 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.727 0.775 . . . . 1.47 109.01 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.608 ' HE2' ' HB2' ' A' ' 24' ' ' ASP . 21.7 mtmt -75.16 119.31 76.37 Favored Pre-proline 0 N--CA 1.447 -0.609 0 CA-C-N 114.298 -1.319 . . . . 4.25 107.578 168.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.72 ' HA ' HD23 ' A' ' 21' ' ' LEU . 47.3 Cg_exo -45.79 116.33 1.36 Allowed 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 122.415 2.076 . . . . 0.54 113.16 -176.299 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.762 ' OH ' ' HB3' ' A' ' 103' ' ' PRO . 0.1 OUTLIER -75.81 147.47 39.15 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 113.885 -1.507 . . . . 1.2 111.299 177.821 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.518 ' N ' ' HD1' ' A' ' 28' ' ' TYR . 2.5 t-20 -82.47 97.22 8.3 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 114.838 -1.074 . . . . 1.51 108.803 175.296 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.71 HD13 HG21 ' A' ' 20' ' ' VAL . 61.1 tp -83.82 -45.31 13.43 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.647 -0.706 . . . . 0.28 110.888 -176.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.775 HG13 ' HB3' ' A' ' 16' ' ' PHE . 0.1 OUTLIER -67.28 0.25 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.316 -0.857 . . . . 1.02 112.801 -171.712 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.451 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 28.7 pt20 -74.01 -12.21 60.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.418 0.627 . . . . 1.02 109.477 172.538 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.918 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 90.5 m-70 -97.7 20.49 11.85 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 121.876 0.845 . . . . 0.28 109.092 175.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.743 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 18.3 mtmt -80.42 114.18 19.13 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 114.381 -1.281 . . . . 1.56 109.245 169.042 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.87 -38.9 2.22 Favored Glycine 0 N--CA 1.434 -1.489 0 C-N-CA 120.607 -0.806 . . . . 0.2 111.927 178.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.455 ' HB2' ' HA3' ' A' ' 68' ' ' GLY . 20.2 m -129.49 128.02 23.09 Favored Pre-proline 0 N--CA 1.434 -1.257 0 N-CA-C 108.377 -0.972 . . . . 0.29 108.377 172.276 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.823 ' HG3' ' CB ' ' A' ' 170' ' ' LEU . 1.8 Cg_endo -41.18 151.92 0.12 Allowed 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 124.393 3.395 . . . . 0.18 113.097 177.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.842 ' HB2' HG22 ' A' ' 70' ' ' THR . 0.8 OUTLIER -136.96 145.1 43.79 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 106.949 -1.5 . . . . 0.31 106.949 -179.41 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.994 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 1.2 mm? -111.63 117.4 32.82 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.992 -0.744 . . . . 1.19 108.992 178.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.784 HD12 ' CE ' ' A' ' 122' ' ' MET . 8.2 mt -101.65 124.38 55.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-N 116.112 -0.495 . . . . 0.37 110.932 178.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.994 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -111.05 123.0 49.33 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.484 -0.78 . . . . 0.42 109.948 -174.194 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.804 ' HB3' HG11 ' A' ' 110' ' ' VAL . 1.3 p30 -81.79 94.97 7.14 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.855 -1.165 . . . . 2.35 107.855 169.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.787 HG11 ' HB1' ' A' ' 73' ' ' ALA . 1.4 p -105.18 133.35 49.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-N 115.447 -0.797 . . . . 1.03 113.059 -159.206 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.594 ' HB1' ' SG ' ' A' ' 47' ' ' CYS . . . -76.05 101.7 5.38 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.618 -0.719 . . . . 0.88 109.639 171.566 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.701 ' HB3' ' O ' ' A' ' 96' ' ' THR . 48.8 m -37.87 83.24 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 125.485 1.514 . . . . 1.78 113.977 176.057 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.483 ' HE2' ' HB2' ' A' ' 46' ' ' LYS . 8.7 ptmm? 36.19 55.3 1.03 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.112 1.365 . . . . 5.84 114.052 176.159 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.594 ' SG ' ' HB1' ' A' ' 44' ' ' ALA . 28.1 p -111.33 116.45 31.0 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 119.9 -0.72 . . . . 3.55 110.819 177.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.86 -73.82 1.21 Allowed Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.85 -0.614 . . . . 2.91 113.456 175.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -129.95 145.93 51.64 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.131 0.491 . . . . 4.63 111.138 -173.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 76.1 p -82.68 -20.39 36.26 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.058 -0.719 . . . . 1.93 109.058 174.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.636 ' HB2' ' HB2' ' A' ' 156' ' ' PRO . 31.5 mmmt 63.56 -1.46 0.59 Allowed 'General case' 0 C--N 1.347 0.469 0 C-N-CA 124.555 1.142 . . . . 2.01 112.557 -178.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.77 -19.75 48.73 Favored Glycine 0 N--CA 1.442 -0.919 0 N-CA-C 110.761 -0.935 . . . . 0.51 110.761 -172.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -58.19 -43.37 95.42 Favored Glycine 0 C--O 1.222 -0.604 0 CA-C-N 115.469 -0.366 . . . . 0.5 112.805 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.651 ' CE1' ' HE2' ' A' ' 98' ' ' PHE . 1.0 OUTLIER -64.44 -54.57 30.5 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.074 0.464 . . . . 0.7 110.776 -174.903 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.479 ' CD ' ' H ' ' A' ' 55' ' ' GLU . 1.9 pm0 -66.44 -22.95 66.22 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.542 -0.754 . . . . 2.61 111.115 -178.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.785 HG23 ' HA ' ' A' ' 160' ' ' VAL . 30.4 m -79.92 -57.45 3.64 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 109.44 -0.578 . . . . 0.33 109.44 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 1.029 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -54.08 -40.51 67.28 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.145 -0.934 . . . . 0.22 110.838 -179.228 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.457 ' HA ' ' HD2' ' A' ' 102' ' ' PHE . 99.8 m -60.04 -57.1 14.29 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.609 -0.723 . . . . 0.26 110.647 178.376 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 22.3 m -66.76 -35.18 79.49 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.461 -0.79 . . . . 0.48 111.312 -176.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.716 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 0.6 OUTLIER -66.72 -52.37 45.33 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 121.595 0.712 . . . . 0.43 110.409 -175.416 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.854 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 8.0 t80 -55.92 -54.6 42.77 Favored 'General case' 0 C--O 1.205 -1.27 0 CA-C-N 114.413 -1.267 . . . . 0.31 110.777 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -67.34 -24.16 65.69 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.73 -0.214 . . . . 1.21 111.018 -174.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.438 ' HB2' ' HE2' ' A' ' 63' ' ' LYS . 24.4 ttmm -85.5 -27.34 25.69 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 108.965 -0.754 . . . . 1.54 108.965 -176.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.784 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 48.3 m-85 -123.67 -4.75 8.16 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 115.289 1.588 . . . . 0.31 115.289 -169.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.676 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 12.9 pttp -67.86 -24.28 65.23 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 107.709 -1.219 . . . . 1.35 107.709 171.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.3 t -48.76 -37.61 19.47 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 113.855 -1.521 . . . . 1.28 110.18 171.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -88.06 -35.18 17.67 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 111.948 0.351 . . . . 1.11 111.948 173.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.455 ' HA3' ' HB2' ' A' ' 36' ' ' SER . . . 147.51 -7.3 1.11 Allowed Glycine 0 CA--C 1.52 0.388 0 N-CA-C 111.619 -0.592 . . . . 0.18 111.619 -176.127 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.784 ' HD2' ' HB2' ' A' ' 64' ' ' TYR . 17.9 t80 -67.07 140.37 57.61 Favored 'General case' 0 C--O 1.217 -0.61 0 C-N-CA 123.003 0.521 . . . . 0.18 111.251 -177.272 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.918 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 2.2 t -134.17 143.19 47.76 Favored 'General case' 0 CA--C 1.482 -1.657 0 N-CA-C 108.189 -1.041 . . . . 0.2 108.189 174.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 1.029 HG11 ' HB1' ' A' ' 57' ' ' ALA . 39.9 t -98.6 98.87 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.535 0 C-N-CA 118.959 -1.096 . . . . 0.17 108.182 161.224 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.827 HD23 ' HB2' ' A' ' 103' ' ' PRO . 8.4 mt -85.94 119.01 25.78 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 107.36 -1.348 . . . . 1.04 107.36 175.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.887 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -111.67 116.28 30.52 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.826 0.822 . . . . 0.51 111.694 -178.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.875 ' HZ ' HG13 ' A' ' 20' ' ' VAL . 2.8 m-30 -98.38 99.09 6.65 Favored Pre-proline 0 C--N 1.315 -0.904 0 CA-C-N 114.519 -1.219 . . . . 0.44 109.051 178.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.769 ' O ' ' HB2' ' A' ' 107' ' ' LYS . 80.7 Cg_endo -78.34 93.22 1.1 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.214 1.943 . . . . 1.3 113.361 -171.165 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.759 ' HA ' HG23 ' A' ' 110' ' ' VAL . 84.3 p -43.54 142.99 1.03 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.93 -1.032 . . . . 1.44 111.886 -175.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.487 ' HB3' ' HD3' ' A' ' 107' ' ' LYS . 27.4 p30 -95.55 130.92 42.24 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 121.672 0.748 . . . . 1.81 111.247 -175.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.511 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . 0.0 OUTLIER -75.31 -9.22 58.37 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.821 -1.081 . . . . 3.34 110.765 177.461 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -69.26 31.68 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.066 0.765 . . . . 2.68 113.066 -177.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.521 ' HA3' HE22 ' A' ' 82' ' ' GLN . . . -145.25 -144.6 4.15 Favored Glycine 0 CA--C 1.518 0.226 0 C-N-CA 120.822 -0.704 . . . . 1.98 112.37 -179.185 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -152.25 75.56 0.24 Allowed Glycine 0 CA--C 1.509 -0.282 0 N-CA-C 111.424 -0.67 . . . . 1.49 111.424 176.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.592 ' HG3' ' HB3' ' A' ' 111' ' ' ASN . 4.4 pm0 -172.82 -20.74 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.357 0.599 . . . . 1.74 111.307 -172.466 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' A' ' 77' ' ' ASN . 0.3 OUTLIER -75.39 158.58 83.43 Favored Pre-proline 0 C--N 1.308 -1.231 0 CA-C-N 114.423 -1.262 . . . . 3.07 114.048 -149.816 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.615 ' HB3' ' O ' ' A' ' 137' ' ' TRP . 2.8 Cg_exo -33.9 147.85 0.03 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 125.296 3.998 . . . . 1.75 114.695 173.155 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 79.91 25.88 57.06 Favored Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 120.393 -0.908 . . . . 2.2 111.212 -178.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.559 ' HA ' ' HD3' ' A' ' 136' ' ' LYS . 92.6 m-20 64.44 35.9 9.23 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.086 0.555 . . . . 4.2 111.885 174.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 60.62 23.64 13.41 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.784 -0.644 . . . . 3.02 112.426 176.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.678 ' HA ' ' HE3' ' A' ' 91' ' ' LYS . 12.6 pt-20 -134.64 -45.53 0.74 Allowed 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.132 -0.627 . . . . 3.92 112.491 -177.193 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.479 ' O ' ' HD1' ' A' ' 93' ' ' PHE . 26.9 tt0 -52.56 -58.43 6.79 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.455 0.539 . . . . 2.65 112.455 -170.452 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.537 HG12 ' SG ' ' A' ' 47' ' ' CYS . 3.0 mt -68.73 -34.2 63.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 112.405 0.52 . . . . 2.15 112.405 -171.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.678 ' HE3' ' HA ' ' A' ' 88' ' ' GLU . 0.0 OUTLIER -81.65 2.01 31.48 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.952 -0.299 . . . . 2.79 111.429 -175.622 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.444 ' HG3' ' O ' ' A' ' 88' ' ' GLU . 44.7 mt-10 -119.32 -45.27 2.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.463 -0.335 . . . . 3.29 110.811 177.501 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.479 ' HD1' ' O ' ' A' ' 89' ' ' GLU . 76.2 m-85 -73.06 159.49 33.53 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.074 -0.343 . . . . 3.42 110.074 177.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 79.6 t -67.63 110.36 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.123 -0.489 . . . . 2.63 110.081 178.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 1.8 p -114.2 139.8 49.08 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.953 0.882 . . . . 2.83 111.364 -178.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.701 ' O ' ' HB3' ' A' ' 45' ' ' SER . 7.4 m -143.22 146.72 33.91 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 106.092 -1.818 . . . . 2.98 106.092 172.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 52.4 pttt -64.16 98.54 0.23 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.797 0.808 . . . . 2.72 109.137 -178.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.785 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 0.1 OUTLIER -62.82 120.61 11.61 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 113.739 -1.573 . . . . 2.12 111.1 -164.416 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -92.65 132.34 36.97 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.122 -0.944 . . . . 2.69 110.477 176.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.785 ' HB2' ' CE2' ' A' ' 98' ' ' PHE . . . -131.36 -171.5 2.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.52 0.676 . . . . 0.55 112.457 -170.471 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -92.81 14.05 18.51 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 114.664 -1.153 . . . . 1.99 110.231 176.145 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.664 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 17.2 p90 -140.36 161.99 52.09 Favored Pre-proline 0 N--CA 1.444 -0.754 0 N-CA-C 108.859 -0.793 . . . . 0.84 108.859 -179.057 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.827 ' HB2' HD23 ' A' ' 72' ' ' LEU . 30.9 Cg_endo -58.95 92.82 0.08 OUTLIER 'Trans proline' 0 CA--C 1.514 -0.489 0 C-N-CA 123.965 3.11 . . . . 0.62 114.398 -172.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.887 HD12 ' HB3' ' A' ' 73' ' ' ALA . 5.4 mm -82.4 124.62 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 108.325 -0.991 . . . . 1.34 108.325 170.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.768 ' HG3' ' N ' ' A' ' 106' ' ' ALA . 0.0 OUTLIER -78.66 172.1 14.18 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.074 -1.421 . . . . 3.03 110.812 -176.933 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.768 ' N ' ' HG3' ' A' ' 105' ' ' MET . . . -61.0 -0.15 0.28 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.359 -0.837 . . . . 1.46 112.575 178.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.769 ' HB2' ' O ' ' A' ' 75' ' ' PRO . 12.3 ptpt 60.72 144.58 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.244 0 C-N-CA 124.941 1.297 . . . . 1.76 110.742 -168.145 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.604 HG13 ' HB2' ' A' ' 116' ' ' HIS . 0.3 OUTLIER -133.72 176.62 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.074 0 CA-C-N 113.615 -1.629 . . . . 0.82 108.331 168.086 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -70.05 66.85 0.28 Allowed 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 114.759 -1.11 . . . . 1.73 109.795 176.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.965 ' HA ' ' OH ' ' A' ' 119' ' ' TYR . 0.6 OUTLIER -72.6 92.64 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-O 122.11 0.957 . . . . 0.77 109.589 -172.657 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.592 ' HB3' ' HG3' ' A' ' 82' ' ' GLN . 4.5 t-20 176.95 177.91 0.27 Allowed 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 104.684 -2.339 . . . . 1.9 104.684 169.659 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -85.52 48.46 4.0 Favored Glycine 0 CA--C 1.498 -0.984 0 C-N-CA 119.581 -1.295 . . . . 1.47 114.214 -177.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -105.66 -47.98 3.77 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 119.046 -1.062 . . . . 2.81 110.699 169.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -131.15 -35.51 1.37 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.402 -0.962 . . . . 2.16 108.402 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.673 ' HA ' ' OH ' ' A' ' 119' ' ' TYR . . . 55.84 -166.22 0.11 Allowed 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 114.139 -1.391 . . . . 1.26 111.894 172.39 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.62 ' CE1' ' HB3' ' A' ' 118' ' ' LEU . 4.9 t-80 -149.55 121.98 4.31 Favored Pre-proline 0 N--CA 1.418 -2.051 0 N-CA-C 107.998 -1.112 . . . . 0.42 107.998 177.065 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.491 ' HB2' ' CD1' ' A' ' 18' ' ' PHE . 11.2 Cg_exo -31.47 -43.45 0.13 Allowed 'Trans proline' 0 C--O 1.215 -0.668 1 C-N-CA 125.531 4.154 . . . . 0.4 114.241 -174.115 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.708 HD22 HG22 ' A' ' 20' ' ' VAL . 4.8 tp -62.45 -60.17 3.92 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 113.471 0.915 . . . . 0.39 113.471 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.965 ' OH ' ' HA ' ' A' ' 110' ' ' VAL . 3.4 p90 -81.02 -25.66 37.0 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 109.113 -0.699 . . . . 3.04 109.113 -177.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.53 -39.23 90.3 Favored 'General case' 0 CA--C 1.495 -1.161 0 N-CA-C 106.546 -1.65 . . . . 2.44 106.546 173.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.46 ' HA ' ' HG2' ' A' ' 124' ' ' LYS . 71.4 t80 -65.45 -26.09 67.8 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.85 -1.068 . . . . 0.56 109.892 171.346 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.784 ' CE ' HD12 ' A' ' 40' ' ' ILE . 65.2 mtt -75.93 -56.89 4.24 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.182 -0.463 . . . . 0.71 111.716 -173.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.622 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -70.39 -24.04 62.88 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.779 -0.646 . . . . 1.46 110.65 179.621 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.46 ' HG2' ' HA ' ' A' ' 121' ' ' TYR . 17.1 ptmt -74.05 -28.41 61.4 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 119.722 -0.791 . . . . 1.99 109.456 174.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 51.8 m -76.83 -42.62 39.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.852 -0.613 . . . . 0.59 110.484 173.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.428 ' HD3' ' C ' ' A' ' 151' ' ' VAL . 8.0 tptm -120.23 106.43 40.72 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.258 -0.428 . . . . 1.85 111.447 -175.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.406 ' HB3' ' C ' ' A' ' 131' ' ' ALA . 63.5 Cg_exo -53.99 -35.97 82.58 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.206 2.604 . . . . 1.69 110.67 169.039 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 102.72 -132.28 10.94 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.595 -0.729 . . . . 2.59 111.948 176.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 51.5 mt -79.44 -40.79 21.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.585 0.707 . . . . 3.58 109.275 175.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.954 ' HB3' ' HB2' ' A' ' 133' ' ' LYS . 19.6 tp -93.08 142.31 27.43 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.406 -0.961 . . . . 3.47 108.406 175.278 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.406 ' C ' ' HB3' ' A' ' 127' ' ' PRO . . . -71.28 4.87 2.54 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.854 0.687 . . . . 3.28 112.854 -171.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 3.8 m -145.37 3.71 1.02 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.208 0.528 . . . . 3.56 110.564 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.954 ' HB2' ' HB3' ' A' ' 130' ' ' LEU . 26.3 tttp -58.36 133.63 55.89 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.377 -0.829 . . . . 5.17 111.34 -168.434 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -94.05 172.06 8.46 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.042 -1.096 . . . . 1.59 108.042 169.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.672 HG22 HG21 ' A' ' 140' ' ' THR . 1.4 pp -92.68 61.38 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 CA-C-O 121.793 0.806 . . . . 2.0 110.442 -178.577 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.571 ' C ' ' HA ' ' A' ' 84' ' ' PRO . 13.6 ttmm -95.54 35.43 1.35 Allowed 'General case' 0 C--O 1.237 0.427 0 CA-C-N 114.885 -1.052 . . . . 4.81 111.36 -175.058 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.615 ' O ' ' HB3' ' A' ' 84' ' ' PRO . 10.2 m-90 -127.62 173.12 10.15 Favored 'General case' 0 C--N 1.313 -1.007 0 O-C-N 121.708 -0.62 . . . . 1.97 109.886 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.577 ' HB2' ' CB ' ' A' ' 156' ' ' PRO . 3.4 m120 -47.54 -158.29 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.154 -0.93 . . . . 2.04 110.073 162.462 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.655 ' HD2' ' HD2' ' A' ' 41' ' ' TYR . 5.7 m-85 -28.42 -53.63 0.1 Allowed 'General case' 0 CA--C 1.552 1.033 0 N-CA-C 115.944 1.831 . . . . 1.93 115.944 -164.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.672 HG21 HG22 ' A' ' 135' ' ' ILE . 8.5 m 42.75 93.92 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 120.44 1.473 . . . . 0.6 112.832 174.23 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.71 ' HB3' HD12 ' A' ' 39' ' ' LEU . 2.5 m -88.98 161.69 16.47 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.744 -0.662 . . . . 0.62 111.556 -172.135 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.536 ' CZ ' HG21 ' A' ' 135' ' ' ILE . 70.3 m-85 -122.72 126.49 47.65 Favored 'General case' 0 CA--C 1.487 -1.471 0 N-CA-C 105.872 -1.899 . . . . 0.57 105.872 165.6 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.803 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 11.3 tp -80.39 101.96 9.32 Favored 'General case' 0 N--CA 1.418 -2.042 0 C-N-CA 117.823 -1.551 . . . . 0.43 107.877 176.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.706 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 39.1 mm -89.22 135.13 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.671 0 CA-C-N 113.018 -1.901 . . . . 0.19 107.311 -178.207 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.478 ' HA ' HD13 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -91.35 -174.85 4.06 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 119.201 -1.0 . . . . 0.98 111.545 -167.586 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.655 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 53.5 mtm180 -54.66 -36.23 64.37 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.157 0.503 . . . . 2.22 110.983 -177.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -100.11 23.28 10.16 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.625 -0.509 . . . . 2.0 109.625 -178.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.635 ' HA3' ' CE2' ' A' ' 16' ' ' PHE . . . 65.76 34.44 88.79 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 115.943 -0.571 . . . . 0.17 114.002 178.461 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 64.1 t -103.07 116.19 62.8 Favored Pre-proline 0 C--N 1.314 -0.944 0 CA-C-N 118.024 0.912 . . . . 1.12 110.875 175.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.73 ' HD3' HG23 ' A' ' 15' ' ' ILE . 36.5 Cg_endo -66.13 109.05 1.45 Allowed 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 123.757 2.971 . . . . 0.41 110.664 178.121 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.557 HG23 ' HG2' ' A' ' 152' ' ' GLU . 19.6 m -113.71 -12.11 11.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 121.062 0.458 . . . . 1.45 110.486 -172.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.803 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 33.8 mm-40 -142.83 165.83 26.3 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-N 115.563 -0.744 . . . . 1.17 109.611 177.3 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.525 ' HA ' ' O ' ' A' ' 141' ' ' SER . 0.0 OUTLIER -148.65 122.41 9.28 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.404 -0.816 . . . . 2.16 110.76 165.347 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.683 ' HZ ' ' HB2' ' A' ' 166' ' ' LYS . 88.1 m-85 -95.67 155.81 16.59 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.616 -1.175 . . . . 0.32 109.291 -175.427 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 12.0 m -82.83 160.89 59.98 Favored Pre-proline 0 C--N 1.314 -0.937 0 N-CA-C 108.733 -0.84 . . . . 1.11 108.733 175.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.636 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 14.5 Cg_endo -58.76 -48.8 13.42 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 121.317 1.344 . . . . 0.78 110.479 173.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.554 ' HA2' ' O ' ' A' ' 51' ' ' LYS . . . -48.59 -12.8 0.22 Allowed Glycine 0 CA--C 1.537 1.422 0 CA-C-N 114.588 -1.187 . . . . 0.5 115.54 167.284 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -87.64 138.88 31.08 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 118.464 1.132 . . . . 0.5 109.285 173.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 15.5 m -111.99 -173.03 2.16 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 112.819 0.674 . . . . 1.42 112.819 -168.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.785 ' HA ' HG23 ' A' ' 56' ' ' THR . 83.0 t -40.98 -60.49 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 114.134 -1.394 . . . . 0.28 112.335 -178.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -62.88 -39.16 93.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.287 -0.415 . . . . 3.46 110.534 -173.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.486 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 7.7 m-20 -55.56 -49.0 73.86 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 115.322 -0.854 . . . . 1.4 109.844 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.667 HD12 HG21 ' A' ' 56' ' ' THR . 81.4 mt -73.4 -46.75 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 CA-C-N 114.581 -1.19 . . . . 0.21 111.691 -177.397 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.487 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 49.5 mt-10 -54.75 -45.19 74.14 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-O 120.804 0.335 . . . . 0.67 111.251 -177.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 11.5 pt-20 -63.35 -15.42 57.37 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 111.993 0.368 . . . . 0.87 111.993 -173.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.683 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 28.3 mmmt -104.75 -22.97 13.12 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.607 0.717 . . . . 1.71 109.783 173.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.549 HD21 HD11 ' A' ' 171' ' ' LEU . 8.3 tp -83.61 -48.88 9.74 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.762 -1.108 . . . . 0.16 112.296 -176.045 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.486 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 68.9 mt -55.05 -46.06 99.73 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.617 -0.72 . . . . 0.26 112.302 -174.059 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.486 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 84.8 Cg_exo -51.39 -27.05 22.84 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.287 1.992 . . . . 0.41 113.178 173.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.823 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 74.8 mt -89.67 -42.58 11.28 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.846 -0.161 . . . . 0.71 111.124 178.006 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.728 HD23 ' HG2' ' A' ' 37' ' ' PRO . 91.9 mt -59.87 -58.26 9.31 Favored 'General case' 0 CA--C 1.505 -0.75 0 CA-C-O 121.996 0.903 . . . . 0.34 109.86 176.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -61.22 -59.16 10.46 Favored Glycine 0 N--CA 1.432 -1.591 0 CA-C-N 113.338 -1.755 . . . . 1.12 112.171 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 34.7 t 61.7 -87.99 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.083 0.553 . . . . 2.64 111.778 174.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -82.72 -22.96 34.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.248 0.546 . . . . 4.35 110.2 178.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -84.86 -52.92 5.67 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.47 -0.786 . . . . 8.45 109.796 177.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 95.0 mt . . . . . 0 C--O 1.246 0.894 0 CA-C-N 115.606 -0.725 . . . . 7.69 109.679 177.955 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.651 0 N-CA-C 111.988 -0.445 . . . . 5.22 111.988 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 61.9 mtt -78.62 90.47 4.56 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.759 -0.46 . . . . 4.85 109.759 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.85 90.96 2.17 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.246 -0.742 . . . . 1.55 111.246 -175.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.3 t -117.27 -1.43 11.81 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.475 0.655 . . . . 1.58 109.899 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 96.5 p 179.78 168.49 1.2 Allowed 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 105.044 -2.206 . . . . 1.17 105.044 -177.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.892 ' HB ' HD11 ' A' ' 118' ' ' LEU . 4.8 pt -67.62 -12.96 16.14 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 CA-C-O 121.399 0.619 . . . . 0.38 110.274 177.514 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.787 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 33.4 m-85 -75.3 4.04 7.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.661 -0.699 . . . . 0.3 111.893 -175.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.57 -7.28 59.57 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.474 -0.936 . . . . 2.11 108.474 175.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.925 ' HE2' ' HB2' ' A' ' 121' ' ' TYR . 58.1 m-85 -125.67 113.66 17.65 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-N 114.988 -1.006 . . . . 0.31 111.964 -175.057 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -50.78 142.15 11.91 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 113.546 -1.661 . . . . 2.86 110.21 172.259 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.966 HG13 ' HZ ' ' A' ' 74' ' ' PHE . 68.8 t -113.8 169.6 5.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.5 -0.773 . . . . 0.67 109.114 -178.644 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.772 HD23 ' HA ' ' A' ' 27' ' ' PRO . 94.2 mt -127.53 150.51 49.66 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.019 0.438 . . . . 0.69 111.399 178.449 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.38 165.1 18.5 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 106.318 -1.734 . . . . 1.87 106.318 162.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.604 ' HA ' ' N ' ' A' ' 106' ' ' ALA . . . -59.53 -7.73 1.57 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 113.721 1.008 . . . . 0.59 113.721 -169.06 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.554 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 1.3 m-20 -99.08 2.06 45.75 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.914 0.339 . . . . 2.34 111.914 176.459 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.554 ' HB2' ' O ' ' A' ' 24' ' ' ASP . 83.2 m-70 80.55 17.36 0.61 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.611 0.72 . . . . 1.47 109.266 178.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.405 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 11.9 mmtt -86.13 120.46 72.44 Favored Pre-proline 0 CA--C 1.508 -0.654 0 N-CA-C 107.682 -1.229 . . . . 4.25 107.682 172.026 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.772 ' HA ' HD23 ' A' ' 21' ' ' LEU . 86.1 Cg_exo -53.21 112.39 0.92 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 121.742 1.628 . . . . 0.54 113.087 -172.605 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.831 ' HE2' HD23 ' A' ' 72' ' ' LEU . 9.0 t80 -79.22 116.78 19.7 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 113.487 -1.688 . . . . 1.2 109.735 172.699 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.505 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 5.7 p30 -71.43 89.15 0.92 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 122.653 1.216 . . . . 1.51 109.95 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.863 HD21 HD12 ' A' ' 15' ' ' ILE . 58.9 tp -50.93 -39.99 56.16 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 113.939 -1.482 . . . . 0.28 111.947 -179.089 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.574 HG13 ' HB3' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -66.47 1.03 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 114.046 1.128 . . . . 1.02 114.046 -170.478 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.505 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 28.4 pt20 -77.82 -6.81 55.38 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.043 -0.663 . . . . 1.02 109.679 171.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.927 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 93.8 m-70 -101.54 24.52 9.6 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 122.001 0.905 . . . . 0.28 109.005 174.126 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.787 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 21.5 mtmm -83.54 110.56 18.32 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 114.344 -1.298 . . . . 1.56 108.686 169.545 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 131.78 -41.58 1.49 Allowed Glycine 0 N--CA 1.442 -0.959 0 C-N-CA 120.629 -0.796 . . . . 0.2 111.538 -178.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.446 ' HB2' ' HA3' ' A' ' 68' ' ' GLY . 35.9 m -129.38 136.93 29.9 Favored Pre-proline 0 N--CA 1.433 -1.295 0 N-CA-C 108.796 -0.816 . . . . 0.29 108.796 172.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.822 ' HG3' ' CB ' ' A' ' 170' ' ' LEU . 7.0 Cg_endo -44.96 153.08 0.45 Allowed 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 124.069 3.18 . . . . 0.18 112.563 176.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.81 ' HB2' HG22 ' A' ' 70' ' ' THR . 1.0 OUTLIER -140.13 146.28 38.65 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 106.889 -1.523 . . . . 0.31 106.889 179.098 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 1.017 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 3.5 mp -113.3 115.3 27.94 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.484 -0.76 . . . . 1.19 109.853 176.384 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.877 HG23 HD13 ' A' ' 72' ' ' LEU . 0.8 OUTLIER -95.46 116.97 38.4 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 CA-C-N 115.071 -0.968 . . . . 0.37 108.681 176.961 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 1.017 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.4 OUTLIER -101.14 130.6 47.23 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 119.622 -0.831 . . . . 0.42 109.637 -176.207 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.521 ' OD1' ' HB ' ' A' ' 140' ' ' THR . 0.5 OUTLIER -77.59 122.97 26.01 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 104.4 -2.444 . . . . 2.35 104.4 163.923 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.787 HG12 ' HA ' ' A' ' 139' ' ' PHE . 28.2 m -128.62 156.35 40.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 C-N-CA 118.702 -1.199 . . . . 1.03 111.797 -171.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -83.37 158.13 22.26 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 107.476 -1.305 . . . . 0.88 107.476 165.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.587 ' HA ' ' HB3' ' A' ' 98' ' ' PHE . 26.1 m -86.72 -159.79 0.52 Allowed 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 116.133 -0.485 . . . . 1.78 109.975 -174.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -75.7 71.54 2.58 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.223 0.535 . . . . 5.84 110.247 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.643 ' HB2' ' HD2' ' A' ' 93' ' ' PHE . 28.4 p -163.7 -176.95 4.89 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.994 -0.548 . . . . 3.55 109.975 -178.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.662 ' HA3' ' HG3' ' A' ' 89' ' ' GLU . . . 52.73 -121.01 13.38 Favored Glycine 0 N--CA 1.451 -0.351 0 O-C-N 123.971 0.794 . . . . 2.91 113.226 175.061 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -130.13 111.49 12.5 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.337 0.589 . . . . 4.63 111.356 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -75.84 93.48 3.19 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.106 -0.952 . . . . 1.93 110.521 177.016 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -59.21 163.15 3.96 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.558 -0.292 . . . . 2.01 110.649 178.51 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -51.89 -20.3 6.07 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-N 116.069 -0.514 . . . . 0.51 113.167 -179.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.486 ' HA2' ' HB ' ' A' ' 56' ' ' THR . . . -51.39 -25.09 11.98 Favored Glycine 0 C--O 1.219 -0.814 0 CA-C-O 119.909 -0.384 . . . . 0.5 113.414 176.497 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.531 ' HA ' ' CE2' ' A' ' 139' ' ' PHE . 0.8 OUTLIER -66.13 -55.01 18.58 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 117.745 0.772 . . . . 0.7 109.421 175.724 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -61.34 -31.32 71.18 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.238 -0.892 . . . . 2.61 109.745 178.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.688 HG23 ' HA ' ' A' ' 160' ' ' VAL . 74.0 m -66.61 -54.82 19.25 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 114.496 -1.229 . . . . 0.33 109.533 179.203 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 1.028 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -57.98 -48.7 79.21 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.647 -1.16 . . . . 0.22 111.625 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.432 ' HA ' ' CD1' ' A' ' 102' ' ' PHE . 18.5 m -55.89 -54.62 42.38 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-O 121.61 0.719 . . . . 0.26 110.745 -179.048 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.6 m -69.24 -33.38 73.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.026 -0.988 . . . . 0.48 111.549 -175.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.732 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 18.2 mt -71.63 -48.2 49.44 Favored 'General case' 0 CA--C 1.492 -1.272 0 CA-C-N 116.54 -0.3 . . . . 0.43 110.634 -177.238 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.877 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 6.7 t80 -53.45 -62.26 1.77 Allowed 'General case' 0 C--O 1.194 -1.819 0 O-C-N 124.09 0.869 . . . . 0.31 109.49 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.654 ' HA ' ' CG ' ' A' ' 65' ' ' LYS . 1.8 p30 -67.93 -25.63 65.57 Favored 'General case' 0 C--N 1.314 -0.966 0 O-C-N 122.887 0.117 . . . . 1.21 110.908 -168.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.473 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 36.4 ttpt -79.7 -20.65 46.01 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 107.936 -1.135 . . . . 1.54 107.936 -177.524 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.68 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 49.9 m-85 -126.5 0.86 6.92 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 115.22 1.563 . . . . 0.31 115.22 -174.343 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.654 ' CG ' ' HA ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -60.82 -34.59 74.77 Favored 'General case' 0 CA--C 1.496 -1.128 0 N-CA-C 105.986 -1.857 . . . . 1.35 105.986 170.107 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.2 m -47.43 -34.36 7.13 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 112.3 -2.227 . . . . 1.28 111.782 178.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -94.63 -36.06 11.94 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 120.863 -0.335 . . . . 1.11 111.584 174.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.446 ' HA3' ' HB2' ' A' ' 36' ' ' SER . . . 149.31 -0.56 0.49 Allowed Glycine 0 CA--C 1.52 0.35 0 N-CA-C 111.869 -0.492 . . . . 0.18 111.869 -178.403 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.732 ' HE2' ' HB3' ' A' ' 60' ' ' LEU . 14.4 t80 -74.12 141.58 45.59 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 122.743 0.417 . . . . 0.18 111.182 -177.252 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.927 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 5.5 t -134.54 142.49 47.0 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 108.675 -0.861 . . . . 0.2 108.675 172.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 1.028 HG11 ' HB1' ' A' ' 57' ' ' ALA . 41.2 t -101.82 99.61 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.249 0 N-CA-C 107.746 -1.205 . . . . 0.17 107.746 160.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.961 HD12 ' H ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -96.44 119.25 34.58 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 107.689 -1.226 . . . . 1.04 107.689 176.15 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.914 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -102.35 140.55 36.48 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.426 0.631 . . . . 0.51 111.156 -176.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.966 ' HZ ' HG13 ' A' ' 20' ' ' VAL . 3.1 m-30 -121.41 96.17 47.96 Favored Pre-proline 0 C--N 1.304 -1.39 0 N-CA-C 108.288 -1.005 . . . . 0.44 108.288 -177.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 1.018 ' HG2' ' HB3' ' A' ' 107' ' ' LYS . 93.3 Cg_endo -79.34 72.43 6.52 Favored 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 122.562 2.175 . . . . 1.3 114.149 -167.226 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.592 ' HB3' HG23 ' A' ' 110' ' ' VAL . 79.0 p -0.78 130.17 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 117.023 2.231 . . . . 1.44 117.023 178.57 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -79.61 103.01 9.23 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 113.334 -1.757 . . . . 1.81 109.757 -178.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 1.061 ' HA ' ' HG2' ' A' ' 83' ' ' GLU . 0.4 OUTLIER -59.54 -13.27 8.5 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.751 -1.113 . . . . 3.34 113.018 -178.931 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -67.28 -11.67 58.14 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.183 0.438 . . . . 2.68 112.183 -175.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -86.37 -21.31 52.19 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.56 -0.829 . . . . 1.98 113.581 -174.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.407 ' HA2' ' HE2' ' A' ' 91' ' ' LYS . . . 64.47 30.25 77.36 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.432 -0.89 . . . . 1.49 111.176 -174.007 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.755 ' HG2' ' HB3' ' A' ' 113' ' ' GLU . 0.6 OUTLIER -133.74 2.49 3.44 Favored 'General case' 0 CA--C 1.498 -1.031 0 CA-C-N 114.99 -0.605 . . . . 1.74 110.238 -176.917 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 1.061 ' HG2' ' HA ' ' A' ' 78' ' ' GLN . 0.0 OUTLIER -79.19 142.32 59.04 Favored Pre-proline 0 C--N 1.308 -1.212 0 CA-C-O 121.821 0.819 . . . . 3.07 111.695 -160.891 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 83' ' ' GLU . 52.1 Cg_endo -79.02 170.6 17.63 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 123.954 3.102 . . . . 1.75 113.91 -164.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.27 -78.18 2.04 Favored Glycine 0 N--CA 1.443 -0.845 0 N-CA-C 109.851 -1.3 . . . . 2.2 109.851 -170.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.899 ' HB2' ' HB2' ' A' ' 89' ' ' GLU . 45.6 m-80 -144.77 118.55 9.25 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.646 -0.872 . . . . 4.2 108.646 171.461 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -71.33 64.42 0.39 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.898 0.856 . . . . 3.02 110.172 177.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 171.35 -24.71 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.4 -1.273 . . . . 3.92 108.886 -174.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.899 ' HB2' ' HB2' ' A' ' 86' ' ' ASN . 72.7 tt0 -63.52 -16.82 61.82 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.862 -1.063 . . . . 2.65 111.003 -178.522 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.923 ' HB ' ' HB3' ' A' ' 78' ' ' GLN . 1.1 mt -121.1 -50.2 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-N 116.02 -0.537 . . . . 2.15 111.61 -176.131 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.738 ' HB3' ' HB2' ' A' ' 78' ' ' GLN . 22.5 pttp -73.22 -24.41 60.49 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.874 0.694 . . . . 2.79 112.874 -172.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -124.5 27.83 6.82 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.714 0.769 . . . . 3.29 110.66 177.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.643 ' HD2' ' HB2' ' A' ' 47' ' ' CYS . 20.3 t80 -133.79 145.55 49.88 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.997 -1.112 . . . . 3.42 107.997 170.084 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.1 t -67.0 112.34 2.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.83 0.348 . . . . 2.63 110.87 -176.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.564 ' HB3' ' SG ' ' A' ' 47' ' ' CYS . 18.7 p -131.54 122.46 26.17 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.301 0.572 . . . . 2.83 111.927 -176.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.568 ' O ' ' HB3' ' A' ' 45' ' ' SER . 17.3 m -87.6 153.12 21.64 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 107.557 -1.275 . . . . 2.98 107.557 162.616 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -64.31 117.55 7.38 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.206 -0.665 . . . . 2.72 109.206 177.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.699 ' HE1' ' HB2' ' A' ' 100' ' ' ALA . 0.0 OUTLIER -62.78 113.98 3.35 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.436 -0.802 . . . . 2.12 110.224 -176.988 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.523 ' NZ ' ' HB2' ' A' ' 99' ' ' LYS . 9.0 mtmp? -118.59 127.55 53.71 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.691 -0.686 . . . . 2.69 109.8 174.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.85 ' H ' HD13 ' A' ' 104' ' ' ILE . . . -128.93 -159.24 0.94 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.847 -0.615 . . . . 0.55 111.649 -170.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -86.41 10.1 16.12 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.721 -0.672 . . . . 1.99 110.955 -176.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.636 ' CE2' ' HZ ' ' A' ' 98' ' ' PHE . 0.7 OUTLIER -125.18 174.63 3.7 Favored Pre-proline 0 N--CA 1.448 -0.543 0 CA-C-N 115.514 -0.766 . . . . 0.84 109.553 177.262 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.641 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 12.1 Cg_exo -76.74 84.1 1.96 Allowed 'Trans proline' 0 CA--C 1.517 -0.344 0 C-N-CA 123.702 2.935 . . . . 0.62 113.632 -177.094 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.914 HG13 ' HB3' ' A' ' 73' ' ' ALA . 3.9 mp -84.91 133.33 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 N-CA-C 109.1 -0.704 . . . . 1.34 109.1 173.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.811 ' HG2' ' CG ' ' A' ' 74' ' ' PHE . 0.1 OUTLIER -86.98 -179.43 6.49 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.336 -0.847 . . . . 3.03 110.576 -175.602 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.678 ' O ' ' HG2' ' A' ' 107' ' ' LYS . . . -76.85 19.06 0.31 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.063 -0.971 . . . . 1.46 112.388 -173.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 1.018 ' HB3' ' HG2' ' A' ' 75' ' ' PRO . 12.1 ptmt 51.22 128.13 0.0 OUTLIER 'General case' 0 CA--C 1.504 -0.803 0 C-N-CA 125.685 1.594 . . . . 1.76 113.645 -173.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.837 HD11 HG13 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -124.34 173.42 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.922 0 CA-C-N 113.141 -1.845 . . . . 0.82 108.371 171.978 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.413 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 1.4 m-80 -69.43 58.69 0.12 Allowed 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.131 -0.94 . . . . 1.73 112.35 179.341 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.837 HG13 HD11 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -68.97 93.35 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 C-N-CA 119.49 -0.884 . . . . 0.77 110.295 178.654 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 175.41 -178.32 0.12 Allowed 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 106.187 -1.783 . . . . 1.9 106.187 168.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.03 48.35 3.83 Favored Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 119.505 -1.331 . . . . 1.47 115.33 -175.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.755 ' HB3' ' HG2' ' A' ' 82' ' ' GLN . 29.1 tt0 -107.49 -47.85 3.55 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 118.697 -1.201 . . . . 2.81 110.297 158.252 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -131.52 -36.81 1.24 Allowed 'General case' 0 CA--C 1.503 -0.833 0 C-N-CA 120.608 -0.437 . . . . 2.16 110.356 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . 55.93 -160.51 0.2 Allowed 'General case' 0 N--CA 1.439 -0.983 0 O-C-N 124.031 0.832 . . . . 1.26 109.14 -174.004 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.791 ' CB ' HG13 ' A' ' 108' ' ' ILE . 2.2 t-80 -140.94 137.14 16.73 Favored Pre-proline 0 C--N 1.302 -1.476 0 N-CA-C 106.992 -1.485 . . . . 0.42 106.992 173.388 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -28.16 -46.63 0.1 OUTLIER 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 124.729 3.619 . . . . 0.4 113.606 -178.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.892 HD11 ' HB ' ' A' ' 15' ' ' ILE . 37.9 tp -64.86 -51.43 62.09 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 122.977 0.511 . . . . 0.39 112.007 178.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.663 ' HA ' ' HB2' ' A' ' 122' ' ' MET . 31.9 m-85 -77.77 -31.95 52.25 Favored 'General case' 0 CA--C 1.497 -1.085 0 O-C-N 122.185 -0.322 . . . . 3.04 110.664 -178.406 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.524 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 0.2 OUTLIER -59.29 -39.45 83.0 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 106.656 -1.609 . . . . 2.44 106.656 172.068 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.925 ' HB2' ' HE2' ' A' ' 18' ' ' PHE . 65.0 t80 -65.98 -30.79 71.41 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 119.647 -0.821 . . . . 0.56 110.183 175.114 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.776 ' HE3' ' HG ' ' A' ' 118' ' ' LEU . 1.5 ttm -75.4 -55.37 5.76 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.573 -0.74 . . . . 0.71 110.744 -170.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.561 ' HD2' ' HB2' ' A' ' 134' ' ' ALA . 1.0 OUTLIER -70.79 -25.68 62.99 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.398 -0.365 . . . . 1.46 111.164 177.045 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.524 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -73.18 -26.26 61.11 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 119.355 -0.938 . . . . 1.99 109.991 178.442 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 65.7 m -85.41 -42.11 14.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.969 -0.559 . . . . 0.59 110.43 174.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.477 ' HE3' ' O ' ' A' ' 151' ' ' VAL . 39.9 tttm -141.88 90.55 8.5 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 109.118 -0.697 . . . . 1.85 109.118 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 126' ' ' LYS . 25.8 Cg_endo -61.76 -73.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.619 2.879 . . . . 1.69 113.799 -171.518 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.667 ' HA3' ' HB ' ' A' ' 132' ' ' THR . . . -155.78 168.38 33.34 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.16 -1.019 . . . . 2.59 112.558 -177.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.883 ' H ' HD13 ' A' ' 129' ' ' ILE . 0.2 OUTLIER -100.51 -18.94 6.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.275 0.56 . . . . 3.58 110.22 177.391 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.423 HD22 ' HA ' ' A' ' 130' ' ' LEU . 0.2 OUTLIER -100.12 34.01 2.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.225 -0.898 . . . . 3.47 108.65 179.033 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 52.18 34.45 14.45 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.15 -0.932 . . . . 3.28 109.107 -166.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.667 ' HB ' ' HA3' ' A' ' 128' ' ' GLY . 1.6 m -76.05 157.49 32.91 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.592 -1.185 . . . . 3.56 110.746 -173.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -74.58 -38.67 62.59 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.248 0.547 . . . . 5.17 110.389 175.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.6 ' HB1' HD13 ' A' ' 135' ' ' ILE . . . -147.53 -157.95 0.86 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.565 -0.743 . . . . 1.59 111.365 -169.566 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.98 ' HA ' ' HD3' ' A' ' 153' ' ' ARG . 0.0 OUTLIER -38.06 -61.52 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 O-C-N 124.322 1.014 . . . . 2.0 111.794 174.634 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.699 ' HB3' ' HE3' ' A' ' 137' ' ' TRP . 20.2 mtmt 125.5 -70.05 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.195 0 O-C-N 125.03 1.456 . . . . 4.81 110.844 -178.679 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.889 ' HB3' ' HG3' ' A' ' 156' ' ' PRO . 0.8 OUTLIER -120.27 -175.45 3.0 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 113.043 -1.89 . . . . 1.97 110.881 -158.527 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.494 ' O ' ' N ' ' A' ' 140' ' ' THR . 9.4 m-80 -34.87 -151.35 0.0 OUTLIER 'General case' 0 C--O 1.205 -1.267 0 CA-C-N 113.837 -1.529 . . . . 2.04 111.8 156.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.787 ' HA ' HG12 ' A' ' 43' ' ' VAL . 0.6 OUTLIER -28.69 -21.01 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 118.098 2.629 . . . . 1.93 118.098 -171.702 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.523 ' HA ' ' O ' ' A' ' 154' ' ' PHE . 0.9 OUTLIER -9.05 113.27 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 120.191 1.36 . . . . 0.6 113.951 170.438 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.663 ' HA ' ' HA ' ' A' ' 41' ' ' TYR . 0.7 OUTLIER -90.47 171.77 9.19 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.851 -1.068 . . . . 0.62 110.089 -174.132 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.634 ' HA ' ' HA ' ' A' ' 153' ' ' ARG . 10.6 m-85 -126.04 120.26 29.79 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 105.372 -2.084 . . . . 0.57 105.372 161.201 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.902 HD23 ' HB2' ' A' ' 152' ' ' GLU . 1.1 tp -79.67 105.42 10.96 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 118.69 -1.204 . . . . 0.43 108.52 -178.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.769 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 45.1 mm -92.81 145.5 7.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 CA-C-N 113.975 -1.466 . . . . 0.19 107.933 -176.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.64 -174.88 2.91 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 119.532 -0.867 . . . . 0.98 111.357 -170.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.593 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 32.1 mtm180 -51.08 -42.23 60.47 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 121.077 0.465 . . . . 2.22 111.444 -176.373 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -98.8 21.56 11.3 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.97 -0.559 . . . . 2.0 109.955 -175.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.485 ' HA3' ' CE2' ' A' ' 16' ' ' PHE . . . 71.64 34.2 63.14 Favored Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 115.732 -0.667 . . . . 0.17 113.908 178.299 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.475 ' HA ' ' HD2' ' A' ' 150' ' ' PRO . 43.0 t -112.07 107.03 56.13 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 117.988 0.894 . . . . 1.12 111.544 176.31 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.67 ' HG3' ' HG3' ' A' ' 122' ' ' MET . 4.4 Cg_exo -45.39 118.53 2.16 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 124.441 3.427 . . . . 0.41 112.403 173.243 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.477 ' O ' ' HE3' ' A' ' 126' ' ' LYS . 1.8 t -103.64 -20.8 5.55 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.879 0 N-CA-C 108.116 -1.068 . . . . 1.45 108.116 178.222 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.902 ' HB2' HD23 ' A' ' 143' ' ' LEU . 0.0 OUTLIER -152.5 167.65 28.11 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 113.998 -1.455 . . . . 1.17 110.957 -168.531 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.98 ' HD3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -141.82 129.21 21.22 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 107.091 -1.448 . . . . 2.16 107.091 159.301 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.711 ' HZ ' ' HB2' ' A' ' 166' ' ' LYS . 70.0 m-85 -101.34 141.02 34.83 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.902 -0.407 . . . . 0.32 109.902 -173.414 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 18.3 m -64.54 150.58 93.43 Favored Pre-proline 0 C--N 1.325 -0.497 0 N-CA-C 109.979 -0.378 . . . . 1.11 109.979 177.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.889 ' HG3' ' HB3' ' A' ' 137' ' ' TRP . 18.6 Cg_endo -57.41 -50.29 11.33 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.138 1.892 . . . . 0.78 112.253 -174.36 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -66.89 16.44 0.29 Allowed Glycine 0 CA--C 1.526 0.758 0 N-CA-C 114.829 0.692 . . . . 0.5 114.829 175.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -78.59 154.23 30.49 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 118.262 1.031 . . . . 0.5 108.572 169.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.435 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 50.1 m -106.97 167.36 9.94 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 109.64 -0.504 . . . . 1.42 109.64 -177.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.688 ' HA ' HG23 ' A' ' 56' ' ' THR . 91.2 t -40.81 -54.59 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 O-C-N 124.2 0.938 . . . . 0.28 111.731 178.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.435 ' NZ ' ' HB2' ' A' ' 161' ' ' LYS . 0.1 OUTLIER -70.13 -27.65 64.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.232 -0.44 . . . . 3.46 111.409 -172.856 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -68.0 -35.22 77.94 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.478 0.656 . . . . 1.4 109.59 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.609 HD12 ' CG2' ' A' ' 56' ' ' THR . 47.4 mt -80.42 -44.55 22.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 114.988 -1.006 . . . . 0.21 110.522 176.544 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.604 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 41.2 mt-10 -50.84 -41.73 57.95 Favored 'General case' 0 C--O 1.217 -0.653 0 CA-C-N 116.122 -0.49 . . . . 0.67 111.503 -177.115 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -60.88 -26.77 67.65 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 112.486 0.55 . . . . 0.87 112.486 -175.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.711 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 40.8 mmtm -100.93 -5.35 26.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.544 0.688 . . . . 1.71 109.83 175.435 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.604 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 11.9 tp -97.82 -51.1 4.2 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.119 -0.946 . . . . 0.16 111.971 -176.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.485 HD11 ' HB3' ' A' ' 164' ' ' GLU . 69.5 mt -56.24 -46.72 99.76 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 112.957 0.725 . . . . 0.26 112.957 -171.491 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.463 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 63.3 Cg_exo -53.67 -25.03 32.03 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.092 1.861 . . . . 0.41 112.577 175.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.822 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 94.8 mt -86.66 -45.41 11.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.241 -0.436 . . . . 0.71 110.744 177.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.779 HD23 ' HG2' ' A' ' 37' ' ' PRO . 96.5 mt -59.89 -54.83 41.54 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-O 122.048 0.928 . . . . 0.34 110.204 177.521 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -62.7 -10.85 33.1 Favored Glycine 0 N--CA 1.435 -1.401 0 CA-C-N 113.305 -1.77 . . . . 1.12 112.962 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 6.2 t 58.54 70.42 0.65 Allowed 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.236 0.541 . . . . 2.64 110.359 177.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -66.37 -23.14 66.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.72 -0.673 . . . . 4.35 110.333 178.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 71.28 -67.22 0.26 Allowed 'General case' 0 N--CA 1.465 0.301 0 O-C-N 124.093 0.871 . . . . 8.45 111.282 175.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 22.7 tp . . . . . 0 C--O 1.247 0.921 0 CA-C-O 118.743 -0.646 . . . . 7.69 109.37 177.754 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.822 0 N-CA-C 111.833 -0.507 . . . . 5.22 111.833 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -118.72 140.54 49.77 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.817 0.341 . . . . 4.85 110.092 176.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -128.52 156.38 20.94 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.868 -0.682 . . . . 1.55 112.234 -177.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.8 m -108.96 -10.16 15.07 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.81 0.338 . . . . 1.58 110.407 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.466 ' HB3' ' O ' ' A' ' 147' ' ' ASP . 3.1 m -159.78 152.39 21.29 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 107.075 -1.454 . . . . 1.17 107.075 -173.584 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.94 ' HB ' HD11 ' A' ' 118' ' ' LEU . 4.6 pt -66.54 -13.63 16.53 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 CA-C-N 114.079 -1.418 . . . . 0.38 112.298 -173.609 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.828 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 57.1 m-85 -70.45 -8.11 48.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.819 0.342 . . . . 0.3 111.908 -178.55 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -64.88 -25.86 68.07 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 108.103 -1.073 . . . . 2.11 108.103 175.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.858 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 61.4 m-85 -109.52 113.72 26.75 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 114.191 -1.368 . . . . 0.31 111.632 -176.463 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -47.72 142.26 4.79 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 113.122 -1.854 . . . . 2.86 110.652 169.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.769 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 54.8 t -111.66 159.2 11.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 108.395 -0.965 . . . . 0.67 108.395 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.729 HD23 ' HA ' ' A' ' 27' ' ' PRO . 74.9 mt -124.05 121.08 34.25 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 121.103 -0.239 . . . . 0.69 110.889 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.81 ' HA ' ' HE2' ' A' ' 105' ' ' MET . 6.2 t0 -62.1 170.5 2.18 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 107.314 -1.365 . . . . 1.87 107.314 173.062 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.617 ' HA ' ' C ' ' A' ' 105' ' ' MET . . . -53.05 -20.31 3.48 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 114.673 1.36 . . . . 0.59 114.673 -164.198 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 7.9 t70 -103.31 11.66 36.44 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.541 -0.463 . . . . 2.34 111.665 -177.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.676 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 54.7 m-70 76.04 18.42 2.0 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.823 0.82 . . . . 1.47 109.503 176.342 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.743 ' HE2' ' HA ' ' A' ' 26' ' ' LYS . 10.6 mmpt? -88.98 127.97 53.77 Favored Pre-proline 0 N--CA 1.445 -0.691 0 N-CA-C 107.488 -1.301 . . . . 4.25 107.488 171.168 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.729 ' HA ' HD23 ' A' ' 21' ' ' LEU . 80.0 Cg_exo -49.82 114.08 1.23 Allowed 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 122.242 1.961 . . . . 0.54 113.206 -171.615 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.551 ' HB3' HG12 ' A' ' 20' ' ' VAL . 49.5 t80 -79.99 146.71 31.88 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 113.813 -1.54 . . . . 1.2 111.675 173.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.501 ' OD1' ' HB3' ' A' ' 32' ' ' GLN . 2.5 t-20 -86.34 92.39 8.79 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 114.917 -1.038 . . . . 1.51 109.289 175.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.65 HD23 ' HA ' ' A' ' 16' ' ' PHE . 54.0 tp -72.62 -41.25 65.75 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.756 -0.656 . . . . 0.28 109.976 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.799 ' HA ' ' CE1' ' A' ' 16' ' ' PHE . 1.5 t -70.22 -0.83 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 114.698 -1.137 . . . . 1.02 112.517 -167.406 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.501 ' HB3' ' OD1' ' A' ' 29' ' ' ASN . 30.1 pt20 -76.14 -6.92 53.44 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.342 0.591 . . . . 1.02 109.687 174.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.931 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 93.0 m-70 -100.29 28.53 4.91 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 115.279 -0.873 . . . . 0.28 108.798 175.15 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.828 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 8.0 mtmt -90.45 118.16 29.71 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 114.687 -1.142 . . . . 1.56 109.595 173.461 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.66 -40.4 1.97 Allowed Glycine 0 N--CA 1.439 -1.159 0 N-CA-C 111.239 -0.745 . . . . 0.2 111.239 -177.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.469 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 40.7 m -126.97 135.69 27.74 Favored Pre-proline 0 N--CA 1.435 -1.204 0 N-CA-C 108.583 -0.895 . . . . 0.29 108.583 172.332 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.704 ' HG3' ' HB2' ' A' ' 170' ' ' LEU . 5.9 Cg_endo -44.5 155.36 0.27 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.837 3.025 . . . . 0.18 112.591 175.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.887 ' HB2' HG22 ' A' ' 70' ' ' THR . 0.7 OUTLIER -141.68 149.83 41.09 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 106.59 -1.633 . . . . 0.31 106.59 -179.752 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.862 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 2.3 mp -119.89 118.63 31.26 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.603 -0.686 . . . . 1.19 110.188 177.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.871 HG23 ' HB2' ' A' ' 72' ' ' LEU . 2.2 mt -103.11 127.95 56.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-N 115.408 -0.815 . . . . 0.37 110.374 178.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.862 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.3 OUTLIER -114.81 128.53 56.35 Favored 'General case' 0 C--O 1.218 -0.597 0 CA-C-N 116.055 -0.52 . . . . 0.42 111.225 -172.089 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.718 ' HB3' HG21 ' A' ' 135' ' ' ILE . 0.3 OUTLIER -76.51 105.53 7.62 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 106.024 -1.843 . . . . 2.35 106.024 165.428 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.968 HG11 ' HB1' ' A' ' 73' ' ' ALA . 2.4 p -113.91 128.61 70.76 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 C-N-CA 119.27 -0.972 . . . . 1.03 113.372 -164.355 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.18 109.06 3.39 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 114.623 -1.172 . . . . 0.88 108.481 167.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.435 ' OG ' ' HE2' ' A' ' 107' ' ' LYS . 2.7 m -64.37 178.88 0.65 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.09 -0.959 . . . . 1.78 111.641 -175.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 95' ' ' CYS . 45.1 tttp -57.9 99.86 0.05 OUTLIER 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.233 0.54 . . . . 5.84 111.892 -169.2 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.488 ' HB3' ' HB3' ' A' ' 95' ' ' CYS . 18.1 p -142.18 -165.12 1.95 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.28 -0.873 . . . . 3.55 108.776 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -55.33 -19.08 15.98 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 121.099 -0.572 . . . . 2.91 113.654 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -130.34 149.43 52.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 117.739 0.77 . . . . 4.63 112.385 -177.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.736 HG21 ' HB2' ' A' ' 54' ' ' TYR . 10.3 m -130.71 -26.88 2.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.186 -0.916 . . . . 1.93 110.363 177.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.573 ' CB ' ' HB2' ' A' ' 156' ' ' PRO . 10.5 mmmm 62.44 37.35 13.59 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-N 114.949 -1.023 . . . . 2.01 112.483 173.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.77 -23.12 1.33 Allowed Glycine 0 C--N 1.334 0.433 0 C-N-CA 121.045 -0.598 . . . . 0.51 113.851 173.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.15 -21.81 59.88 Favored Glycine 0 C--O 1.219 -0.829 0 C-N-CA 121.147 -0.549 . . . . 0.5 113.475 -175.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.736 ' HB2' HG21 ' A' ' 50' ' ' THR . 0.1 OUTLIER -59.7 -56.89 16.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 117.815 0.807 . . . . 0.7 109.437 177.852 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -60.15 -32.59 71.17 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.869 -1.06 . . . . 2.61 110.145 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.559 ' HA ' ' CG2' ' A' ' 160' ' ' VAL . 92.4 m -71.44 -59.53 2.71 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 114.827 -1.079 . . . . 0.33 109.94 -175.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 1.127 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -63.07 -42.56 99.69 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.439 -1.255 . . . . 0.22 111.454 -175.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.557 ' HA ' ' CD1' ' A' ' 102' ' ' PHE . 6.4 m -58.53 -56.89 16.26 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.237 0.541 . . . . 0.26 111.059 -179.205 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.4 m -68.29 -33.31 74.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.634 -0.712 . . . . 0.48 111.213 -173.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.743 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 20.6 mt -67.74 -48.33 66.75 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-O 121.29 0.566 . . . . 0.43 110.077 -178.507 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.916 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 10.9 t80 -59.3 -46.52 88.34 Favored 'General case' 0 C--O 1.205 -1.267 0 CA-C-N 115.053 -0.976 . . . . 0.31 110.427 178.536 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -73.52 -26.96 61.11 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 116.625 -0.261 . . . . 1.21 111.551 -172.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.497 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 34.4 ttpt -85.96 -23.8 26.77 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 108.83 -0.804 . . . . 1.54 108.83 -177.724 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.682 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 30.1 m-85 -122.98 -6.66 8.42 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 115.21 1.559 . . . . 0.31 115.21 -169.486 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.659 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 26.6 pttt -66.82 -23.77 66.08 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 108.242 -1.022 . . . . 1.35 108.242 170.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.8 t -49.25 -36.18 19.71 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 114.292 -1.322 . . . . 1.28 110.504 171.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -92.31 -30.3 15.91 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.041 0.386 . . . . 1.11 112.041 176.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 143.0 -6.39 2.04 Favored Glycine 0 CA--C 1.52 0.372 0 N-CA-C 111.576 -0.61 . . . . 0.18 111.576 -176.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.743 ' HE2' ' HB3' ' A' ' 60' ' ' LEU . 23.1 t80 -67.58 143.57 56.01 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-N 115.329 -0.436 . . . . 0.18 111.209 -178.675 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.931 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 7.1 t -132.59 152.65 51.56 Favored 'General case' 0 N--CA 1.415 -2.181 0 N-CA-C 108.095 -1.076 . . . . 0.2 108.095 172.163 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 1.127 HG11 ' HB1' ' A' ' 57' ' ' ALA . 33.4 t -106.2 101.18 12.07 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.501 0 N-CA-C 107.482 -1.303 . . . . 0.17 107.482 157.22 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.871 ' HB2' HG23 ' A' ' 40' ' ' ILE . 65.9 mt -85.87 120.3 27.13 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.48 -1.304 . . . . 1.04 107.48 177.219 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.968 ' HB1' HG11 ' A' ' 43' ' ' VAL . . . -99.49 112.09 24.35 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.918 -0.713 . . . . 0.51 110.49 177.138 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.965 ' HD2' HD12 ' A' ' 108' ' ' ILE . 4.6 m-85 -99.04 95.37 3.21 Favored Pre-proline 0 N--CA 1.438 -1.041 0 N-CA-C 106.593 -1.632 . . . . 0.44 106.593 176.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.86 ' HB2' ' HG2' ' A' ' 107' ' ' LYS . 9.8 Cg_endo -71.22 142.69 42.16 Favored 'Trans proline' 0 N--CA 1.431 -2.155 0 C-N-CA 120.49 0.793 . . . . 1.3 110.281 -172.203 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.533 ' HB3' ' OD1' ' A' ' 42' ' ' ASN . 57.2 p -75.32 133.66 41.21 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 122.175 0.988 . . . . 1.44 112.678 -177.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.465 ' OD1' ' HD2' ' A' ' 79' ' ' PHE . 66.7 t30 -70.02 87.52 0.56 Allowed 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 113.597 -1.638 . . . . 1.81 109.192 174.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 1.018 ' HA ' ' HG2' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -56.64 -11.03 1.15 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.16 -0.927 . . . . 3.34 111.852 177.326 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.465 ' HD2' ' OD1' ' A' ' 77' ' ' ASN . 47.0 m-85 -75.78 31.57 0.11 Allowed 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 113.379 0.881 . . . . 2.68 113.379 -173.591 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -133.03 -133.38 3.38 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.622 -0.799 . . . . 1.98 112.388 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.742 ' H ' ' NE2' ' A' ' 82' ' ' GLN . . . -154.5 36.47 0.69 Allowed Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 111.724 -0.55 . . . . 1.49 111.724 175.151 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.742 ' NE2' ' H ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -145.3 4.96 1.07 Allowed 'General case' 0 C--O 1.221 -0.397 0 CA-C-N 115.953 -0.123 . . . . 1.74 111.032 -177.389 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 1.018 ' HG2' ' HA ' ' A' ' 78' ' ' GLN . 2.5 mp0 -60.89 139.7 93.73 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 120.854 0.359 . . . . 3.07 110.358 -169.084 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.717 ' HG2' HD21 ' A' ' 42' ' ' ASN . 60.1 Cg_endo -86.44 150.96 9.08 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.969 2.446 . . . . 1.75 112.282 -175.591 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 81.09 33.37 29.49 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 110.688 -0.965 . . . . 2.2 110.688 -175.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 74.87 96.93 0.07 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.309 -0.945 . . . . 4.2 110.442 -176.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.659 ' HA ' ' HB2' ' A' ' 83' ' ' GLU . 2.9 pm0 -55.6 -31.65 62.43 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.702 -1.135 . . . . 3.02 110.811 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.529 ' O ' ' HG2' ' A' ' 92' ' ' GLU . 37.8 tt0 -68.23 -42.57 79.56 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.121 -0.945 . . . . 3.92 111.663 -175.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -54.2 -59.37 4.75 Favored 'General case' 0 N--CA 1.464 0.237 0 O-C-N 123.258 0.348 . . . . 2.65 111.892 -173.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 5.6 pt -76.8 15.51 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.467 0.543 . . . . 2.15 112.467 -176.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.5 ttmt -120.56 -46.96 2.35 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.926 0.393 . . . . 2.79 110.524 177.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.529 ' HG2' ' O ' ' A' ' 88' ' ' GLU . 15.4 pt-20 -73.29 -20.36 60.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.99 -0.55 . . . . 3.29 109.562 176.357 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -115.24 127.03 55.22 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 108.725 -0.843 . . . . 3.42 108.725 173.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 96.9 t -65.64 112.25 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.141 0.495 . . . . 2.63 110.78 -178.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.666 ' SG ' ' HG2' ' A' ' 78' ' ' GLN . 26.7 p -106.42 121.63 44.64 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-O 121.826 0.822 . . . . 2.83 111.068 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.415 ' O ' ' HB3' ' A' ' 45' ' ' SER . 13.2 p -91.56 160.83 15.21 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.84 -1.073 . . . . 2.98 108.751 169.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.579 ' H ' ' HD2' ' A' ' 97' ' ' LYS . 0.1 OUTLIER -54.36 125.0 17.67 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.821 -1.177 . . . . 2.72 107.821 171.933 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.529 ' HZ ' ' CE2' ' A' ' 102' ' ' PHE . 2.9 p90 -77.97 38.14 0.26 Allowed 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.257 0.551 . . . . 2.12 110.439 -172.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -31.72 113.92 0.13 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.687 1.195 . . . . 2.69 112.502 -170.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.426 ' H ' HG12 ' A' ' 104' ' ' ILE . . . -122.34 -162.27 0.99 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.021 -0.991 . . . . 0.55 111.942 -168.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -83.33 17.55 2.07 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.077 -0.965 . . . . 1.99 110.687 -178.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.6 ' HB3' ' CD2' ' A' ' 61' ' ' TYR . 13.0 p90 -143.65 165.98 22.01 Favored Pre-proline 0 N--CA 1.445 -0.723 0 N-CA-C 109.497 -0.557 . . . . 0.84 109.497 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.662 ' HD3' ' CE2' ' A' ' 61' ' ' TYR . 31.2 Cg_exo -62.4 95.78 0.15 Allowed 'Trans proline' 0 CA--C 1.52 -0.202 0 C-N-CA 123.962 3.108 . . . . 0.62 113.19 -174.199 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.8 HD12 ' HB3' ' A' ' 73' ' ' ALA . 4.0 mm -90.48 116.14 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 107.513 -1.292 . . . . 1.34 107.513 175.773 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.81 ' HE2' ' HA ' ' A' ' 22' ' ' ASP . 1.2 mmt -92.93 -174.1 3.49 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.456 -0.793 . . . . 3.03 111.704 -166.553 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.518 ' N ' ' HA ' ' A' ' 23' ' ' ALA . . . -71.58 130.91 42.38 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.003 -0.998 . . . . 1.46 108.741 172.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.86 ' HG2' ' HB2' ' A' ' 75' ' ' PRO . 92.4 mttt -62.81 131.73 49.8 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-O 121.836 0.827 . . . . 1.76 109.265 176.015 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.965 HD12 ' HD2' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -122.36 165.39 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.419 0 N-CA-C 105.167 -2.16 . . . . 0.82 105.167 169.855 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.457 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 10.8 t-20 -78.7 69.44 4.87 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 119.78 -0.768 . . . . 1.73 110.309 -178.055 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.482 HG13 HD11 ' A' ' 108' ' ' ILE . 0.1 OUTLIER -67.36 92.89 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-O 122.101 0.953 . . . . 0.77 108.853 178.51 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 175.8 -179.84 0.15 Allowed 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 113.286 -1.779 . . . . 1.9 106.555 177.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -79.73 24.31 3.3 Favored Glycine 0 N--CA 1.435 -1.371 0 N-CA-C 116.232 1.253 . . . . 1.47 116.232 -172.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.588 ' HG3' ' N ' ' A' ' 114' ' ' ASN . 0.0 OUTLIER -106.66 -44.2 4.52 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 120.306 2.053 . . . . 2.81 111.693 176.342 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.588 ' N ' ' HG3' ' A' ' 113' ' ' GLU . 4.2 t-20 -132.4 -36.35 1.12 Allowed 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 109.836 -0.431 . . . . 2.16 109.836 -178.386 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.531 ' HB3' ' HG2' ' A' ' 120' ' ' GLU . . . 50.49 -150.86 0.22 Allowed 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.898 -1.046 . . . . 1.26 109.524 -177.542 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.611 ' CB ' HG13 ' A' ' 108' ' ' ILE . 5.5 t-80 -151.08 138.81 12.37 Favored Pre-proline 0 N--CA 1.426 -1.639 0 N-CA-C 107.058 -1.46 . . . . 0.42 107.058 174.206 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -30.93 -45.33 0.14 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 124.364 3.376 . . . . 0.4 113.211 -178.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.94 HD11 ' HB ' ' A' ' 15' ' ' ILE . 43.3 tp -65.05 -50.36 66.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.905 -0.589 . . . . 0.39 111.83 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.546 ' OH ' HG22 ' A' ' 40' ' ' ILE . 32.9 m-85 -76.34 -33.04 58.98 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 112.026 0.38 . . . . 3.04 112.026 178.514 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.61 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 43.9 mt-10 -57.94 -37.49 74.21 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 107.111 -1.44 . . . . 2.44 107.111 170.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.858 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 74.3 t80 -66.25 -35.65 80.97 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.368 -0.833 . . . . 0.56 110.646 173.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.65 ' HE2' HG21 ' A' ' 15' ' ' ILE . 53.1 mtt -73.61 -55.08 6.75 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.75 -0.659 . . . . 0.71 110.806 -168.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.63 ' HB3' ' HA ' ' A' ' 134' ' ' ALA . 0.2 OUTLIER -70.0 -24.26 63.28 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.108 -0.496 . . . . 1.46 111.144 177.785 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.61 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 9.5 pttp -72.57 -30.14 64.14 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 119.61 -0.836 . . . . 1.99 109.624 174.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 87.8 m -76.86 -48.0 19.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.775 -0.648 . . . . 0.59 110.514 176.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.767 ' HG2' HH22 ' A' ' 153' ' ' ARG . 22.8 ttmm -144.57 113.04 5.06 Favored Pre-proline 0 N--CA 1.452 -0.367 0 CA-C-N 116.283 -0.417 . . . . 1.85 110.848 -179.027 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 126' ' ' LYS . 11.9 Cg_exo -71.72 -54.29 0.15 Allowed 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 123.798 2.999 . . . . 1.69 112.25 -178.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.54 ' HA2' ' CZ ' ' A' ' 153' ' ' ARG . . . 178.56 168.47 37.89 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.139 -1.029 . . . . 2.59 112.524 178.289 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.413 ' H ' HG12 ' A' ' 129' ' ' ILE . 6.9 pt -72.28 -17.11 18.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.5 0.667 . . . . 3.58 109.987 173.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.688 HD23 ' H ' ' A' ' 130' ' ' LEU . 2.3 pt? -120.19 177.52 4.98 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.028 -0.987 . . . . 3.47 109.28 177.295 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -75.54 72.86 2.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.202 0.525 . . . . 3.28 111.328 -178.016 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.42 HG21 ' HG2' ' A' ' 136' ' ' LYS . 1.5 m -151.81 168.97 23.41 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.677 -0.86 . . . . 3.56 108.677 178.58 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -119.79 167.59 11.93 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.74 0.305 . . . . 5.17 110.729 175.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.63 ' HA ' ' HB3' ' A' ' 123' ' ' LYS . . . 67.74 -166.97 0.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.185 -0.916 . . . . 1.59 112.122 173.441 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.963 ' H ' HD13 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -71.29 -23.19 22.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 114.889 -1.05 . . . . 2.0 110.509 176.513 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.824 ' HB3' ' CE3' ' A' ' 137' ' ' TRP . 9.8 mtmp? 72.55 -60.58 0.53 Allowed 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 121.528 0.68 . . . . 4.81 112.601 -176.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.824 ' CE3' ' HB3' ' A' ' 136' ' ' LYS . 0.1 OUTLIER -109.42 -179.91 3.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.492 -1.231 . . . . 1.97 111.414 -163.765 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.691 ' HB2' ' HB3' ' A' ' 156' ' ' PRO . 1.8 m120 -38.2 -153.05 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 125.507 1.523 . . . . 2.04 111.955 158.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.705 ' CD1' HG23 ' A' ' 43' ' ' VAL . 1.6 m-85 -25.27 -46.56 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 114.815 1.413 . . . . 1.93 114.815 -167.309 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.757 ' HA ' ' O ' ' A' ' 154' ' ' PHE . 16.3 m 25.75 101.3 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.719 1.377 . . . . 0.6 114.719 172.466 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.541 ' CB ' HD23 ' A' ' 39' ' ' LEU . 0.7 OUTLIER -86.12 169.18 13.36 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.61 -1.177 . . . . 0.62 110.235 -175.058 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.584 ' HE1' HG23 ' A' ' 135' ' ' ILE . 42.7 m-85 -126.04 124.41 40.59 Favored 'General case' 0 CA--C 1.495 -1.15 0 N-CA-C 105.118 -2.179 . . . . 0.57 105.118 162.33 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.763 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 7.3 tp -79.99 105.56 11.36 Favored 'General case' 0 N--CA 1.422 -1.867 0 C-N-CA 118.143 -1.423 . . . . 0.43 108.682 178.067 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.692 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 39.7 mm -91.59 138.16 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.022 0 CA-C-N 112.542 -2.117 . . . . 0.19 107.118 -178.399 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.541 ' HA ' HD13 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -92.04 179.94 5.45 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 120.396 -0.522 . . . . 0.98 111.055 -170.273 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.606 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 40.1 mtm180 -47.36 -42.6 21.92 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 122.893 0.477 . . . . 2.22 111.626 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.466 ' O ' ' HB3' ' A' ' 14' ' ' SER . 8.1 m-20 -96.72 23.43 7.02 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 109.685 -0.487 . . . . 2.0 109.685 -176.494 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.623 ' HA2' HG22 ' A' ' 144' ' ' ILE . . . 65.26 37.88 94.48 Favored Glycine 0 N--CA 1.437 -1.275 0 CA-C-N 115.666 -0.697 . . . . 0.17 114.139 178.596 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.49 ' HA ' ' HD2' ' A' ' 150' ' ' PRO . 6.9 p -108.74 110.1 61.22 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 118.615 1.208 . . . . 1.12 111.73 173.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.691 ' HD3' HG23 ' A' ' 15' ' ' ILE . 10.2 Cg_endo -57.09 115.05 2.22 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 124.081 3.187 . . . . 0.41 111.168 175.267 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.787 HG23 ' HG2' ' A' ' 152' ' ' GLU . 17.6 m -116.27 -17.86 7.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-O 121.187 0.518 . . . . 1.45 109.982 -177.162 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.787 ' HG2' HG23 ' A' ' 151' ' ' VAL . 24.6 mm-40 -138.57 167.24 22.36 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-N 115.49 -0.777 . . . . 1.17 109.956 -179.108 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.767 HH22 ' HG2' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -148.43 141.6 25.03 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 114.904 -1.044 . . . . 2.16 108.937 163.267 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.757 ' O ' ' HA ' ' A' ' 140' ' ' THR . 79.7 m-85 -117.45 151.12 37.72 Favored 'General case' 0 C--O 1.217 -0.632 0 N-CA-C 109.483 -0.562 . . . . 0.32 109.483 -174.2 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.531 ' HB3' ' HD2' ' A' ' 156' ' ' PRO . 51.1 m -73.27 163.76 66.07 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 109.388 -0.597 . . . . 1.11 109.388 177.466 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.691 ' HB3' ' HB2' ' A' ' 138' ' ' ASN . 10.6 Cg_endo -53.15 -67.02 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.763 2.309 . . . . 0.78 112.729 -179.388 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' A' ' 51' ' ' LYS . . . -57.2 15.37 0.01 OUTLIER Glycine 0 CA--C 1.53 0.999 0 N-CA-C 116.368 1.307 . . . . 0.5 116.368 172.547 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -79.85 138.09 37.11 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 119.061 1.431 . . . . 0.5 107.392 167.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.499 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 8.6 t -104.85 173.47 6.29 Favored 'General case' 0 N--CA 1.429 -1.51 0 C-N-CA 119.988 -0.685 . . . . 1.42 110.072 -169.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.559 ' CG2' ' HA ' ' A' ' 56' ' ' THR . 69.3 t -43.57 -54.76 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 114.358 -1.292 . . . . 0.28 112.126 -177.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.84 -29.96 68.39 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.98 0.419 . . . . 3.46 110.78 -173.313 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -71.05 -31.41 67.84 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.642 0.734 . . . . 1.4 109.123 -176.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.52 HG21 HD22 ' A' ' 39' ' ' LEU . 33.1 mt -82.58 -45.33 19.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 114.492 -1.231 . . . . 0.21 110.741 176.078 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.574 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 41.8 mt-10 -51.2 -41.87 60.53 Favored 'General case' 0 C--O 1.218 -0.595 0 CA-C-N 116.308 -0.405 . . . . 0.67 111.362 -178.015 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -60.8 -20.69 62.05 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 112.056 0.391 . . . . 0.87 112.056 -174.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.693 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 31.3 mmtp -100.38 -24.44 14.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.477 0.656 . . . . 1.71 110.273 172.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.574 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 10.8 tp -80.73 -49.02 11.71 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.183 -0.917 . . . . 0.16 112.183 -175.65 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.463 HD11 ' HB3' ' A' ' 164' ' ' GLU . 73.1 mt -55.75 -43.7 99.31 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.478 -0.783 . . . . 0.26 112.568 -173.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.408 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 85.5 Cg_exo -49.98 -33.67 34.99 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 122.02 1.813 . . . . 0.41 112.659 172.557 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.704 ' HB2' ' HG3' ' A' ' 37' ' ' PRO . 91.3 mt -86.01 -42.67 13.78 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 121.122 -0.231 . . . . 0.71 111.348 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.644 HD21 ' HB2' ' A' ' 69' ' ' PHE . 93.8 mt -59.39 -53.2 60.95 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 122.264 1.031 . . . . 0.34 109.624 175.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -80.88 15.71 19.34 Favored Glycine 0 N--CA 1.435 -1.425 0 CA-C-N 113.321 -1.763 . . . . 1.12 113.958 -174.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.516 ' HB3' ' HD3' ' A' ' 146' ' ' ARG . 13.8 t -73.34 -5.9 42.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 117.249 0.525 . . . . 2.64 110.48 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -65.17 -27.42 68.69 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.216 0.531 . . . . 4.35 110.459 175.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 175' ' ' ARG . 0.3 OUTLIER -115.43 16.49 16.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.653 -0.703 . . . . 8.45 109.524 178.708 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 41.3 tp . . . . . 0 C--O 1.248 1.016 0 CA-C-N 115.259 -0.882 . . . . 7.69 109.46 -177.403 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.782 0 N-CA-C 111.747 -0.541 . . . . 5.22 111.747 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 53.3 ttp -77.95 88.1 4.13 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.021 0.439 . . . . 4.85 110.357 178.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.93 52.21 0.66 Allowed Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.58 -0.819 . . . . 1.55 112.486 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.5 m -89.33 -25.24 21.73 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.585 -0.524 . . . . 1.58 109.585 177.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.9 m -166.16 159.19 14.99 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 105.431 -2.062 . . . . 1.17 105.431 -177.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.891 ' HB ' HD11 ' A' ' 118' ' ' LEU . 8.0 pt -59.99 -20.18 19.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 CA-C-N 116.015 -0.538 . . . . 0.38 111.437 -176.541 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.736 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 40.3 m-85 -68.68 -2.75 9.87 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.059 0.457 . . . . 0.3 111.632 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.96 -12.99 61.37 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 108.469 -0.937 . . . . 2.11 108.469 172.543 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.74 ' HE2' ' HB2' ' A' ' 121' ' ' TYR . 58.5 m-85 -129.73 111.3 12.5 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 114.837 -1.074 . . . . 0.31 110.871 -173.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -51.38 150.27 3.64 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 113.792 -1.549 . . . . 2.86 110.099 172.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.809 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 34.4 t -111.04 157.06 12.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 115.457 -0.792 . . . . 0.67 108.906 -178.425 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.835 ' O ' ' HB3' ' A' ' 105' ' ' MET . 96.2 mt -122.31 116.09 23.47 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 116.546 -0.297 . . . . 0.69 110.502 -177.138 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.516 ' HA ' ' SD ' ' A' ' 105' ' ' MET . 6.2 t70 -58.29 170.87 0.64 Allowed 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 107.624 -1.25 . . . . 1.87 107.624 174.068 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.65 ' HA ' ' C ' ' A' ' 105' ' ' MET . . . -54.56 -26.34 31.55 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 118.761 0.709 . . . . 0.59 112.515 -168.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.42 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 8.8 t70 -78.22 -7.51 57.21 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.47 -0.332 . . . . 2.34 111.047 -178.572 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.605 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 57.1 m-70 80.09 19.53 0.6 Allowed 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 122.01 0.91 . . . . 1.47 108.628 -177.668 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.862 ' HE2' ' HA ' ' A' ' 26' ' ' LYS . 9.3 mmpt? -99.83 128.96 29.69 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 114.071 -1.422 . . . . 4.25 108.388 172.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.732 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 74.9 Cg_exo -47.12 115.73 1.44 Allowed 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 123.136 2.557 . . . . 0.54 114.989 -170.207 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.783 ' CE2' HD21 ' A' ' 72' ' ' LEU . 34.5 t80 -80.08 146.61 31.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.123 -1.399 . . . . 1.2 110.356 166.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.634 ' OD1' ' HB3' ' A' ' 32' ' ' GLN . 2.6 t-20 -76.56 90.76 3.34 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.662 -0.699 . . . . 1.51 110.133 179.286 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.711 ' HG ' ' CD1' ' A' ' 16' ' ' PHE . 56.3 tp -69.34 -46.51 66.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.162 0.506 . . . . 0.28 110.191 178.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.704 HG13 ' HB3' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -66.2 0.7 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 115.315 -0.857 . . . . 1.02 113.289 -171.598 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.634 ' HB3' ' OD1' ' A' ' 29' ' ' ASN . 3.8 pt20 -72.07 -16.22 62.02 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.109 -0.7 . . . . 1.02 109.109 172.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.981 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 91.2 m-70 -93.99 22.99 5.21 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 121.85 0.833 . . . . 0.28 109.356 178.012 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.736 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 29.7 mtmt -84.91 109.97 18.53 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 114.266 -1.334 . . . . 1.56 108.834 169.161 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 130.78 -38.05 2.0 Favored Glycine 0 N--CA 1.439 -1.113 0 C-N-CA 120.987 -0.625 . . . . 0.2 111.774 -178.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.458 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 22.7 m -133.99 137.04 27.46 Favored Pre-proline 0 N--CA 1.435 -1.192 0 N-CA-C 108.91 -0.774 . . . . 0.29 108.91 172.037 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.694 ' HG2' HD23 ' A' ' 171' ' ' LEU . 7.4 Cg_endo -45.81 156.54 0.43 Allowed 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 124.057 3.171 . . . . 0.18 112.94 178.254 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.838 ' HB2' HG22 ' A' ' 70' ' ' THR . 0.9 OUTLIER -141.07 145.65 36.11 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 106.745 -1.576 . . . . 0.31 106.745 178.823 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 1.055 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 1.5 mm? -107.2 111.88 24.49 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.199 -1.038 . . . . 1.19 108.199 177.075 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.765 HG13 HG13 ' A' ' 144' ' ' ILE . 4.9 mt -95.27 124.51 47.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 C-N-CA 119.622 -0.831 . . . . 0.37 109.954 177.521 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 1.055 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 1.3 m-85 -106.94 124.39 49.55 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.212 -0.904 . . . . 0.42 110.355 -174.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.622 ' ND2' HD12 ' A' ' 135' ' ' ILE . 0.8 OUTLIER -80.04 90.03 5.39 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 106.421 -1.696 . . . . 2.35 106.421 169.997 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.876 ' HA ' ' HA ' ' A' ' 139' ' ' PHE . 5.9 p -106.71 137.41 37.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 C-N-CA 120.175 -0.61 . . . . 1.03 110.865 -166.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.658 ' HA ' ' HB3' ' A' ' 76' ' ' SER . . . -84.21 118.61 24.26 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 115.896 -0.593 . . . . 0.88 109.653 173.519 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.419 ' HA ' ' HB2' ' A' ' 98' ' ' PHE . 1.3 p -47.8 148.95 1.4 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.517 -0.765 . . . . 1.78 109.608 169.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.856 ' HB2' ' HB3' ' A' ' 49' ' ' TYR . 0.0 OUTLIER -157.09 166.21 33.92 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 119.574 -0.85 . . . . 5.84 112.5 -166.177 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.888 ' HB2' ' HA ' ' A' ' 95' ' ' CYS . 53.3 t -126.15 114.03 17.82 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 114.516 -1.22 . . . . 3.55 107.708 164.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 54.48 42.38 75.43 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 121.212 -0.518 . . . . 2.91 113.156 -177.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.856 ' HB3' ' HB2' ' A' ' 46' ' ' LYS . 50.6 t80 -131.9 132.4 43.58 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.474 0.654 . . . . 4.63 111.589 -176.62 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.8 t -162.46 166.44 24.96 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.113 -1.069 . . . . 1.93 108.113 175.261 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.81 ' H ' ' HZ ' ' A' ' 139' ' ' PHE . 29.4 mtpp -129.35 13.12 6.06 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.635 -0.876 . . . . 2.01 108.635 177.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 119.28 -29.01 6.32 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.481 -0.781 . . . . 0.51 111.603 -175.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.562 ' HA2' ' HB ' ' A' ' 56' ' ' THR . . . -75.05 -17.16 80.28 Favored Glycine 0 C--O 1.221 -0.718 0 CA-C-O 119.628 -0.54 . . . . 0.5 114.404 -174.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -71.22 -58.54 3.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 118.44 1.12 . . . . 0.7 109.152 177.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -62.67 -24.21 67.52 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.241 -0.89 . . . . 2.61 110.223 178.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.664 HG23 ' HA ' ' A' ' 160' ' ' VAL . 16.2 m -74.57 -57.5 3.89 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.278 -0.874 . . . . 0.33 110.306 177.481 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 1.049 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -58.13 -40.54 81.53 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.76 -0.655 . . . . 0.22 110.986 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.524 ' HA ' ' CD1' ' A' ' 102' ' ' PHE . 86.9 m -57.01 -56.05 26.76 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-O 121.379 0.609 . . . . 0.26 110.532 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.6 m -69.78 -37.7 76.46 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.116 -0.947 . . . . 0.48 111.46 -176.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.713 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 15.2 mt -62.15 -50.06 73.36 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-O 121.523 0.677 . . . . 0.43 110.302 -177.596 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.913 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 10.8 t80 -57.7 -51.51 69.24 Favored 'General case' 0 C--O 1.2 -1.544 0 CA-C-N 114.46 -1.245 . . . . 0.31 111.052 -179.331 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.528 ' HA ' ' HD3' ' A' ' 65' ' ' LYS . 5.1 m-80 -73.63 -24.26 60.0 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 120.635 0.255 . . . . 1.21 111.182 -173.347 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -80.53 -26.52 38.0 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 108.548 -0.908 . . . . 1.54 108.548 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.72 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 45.0 m-85 -124.74 -1.53 7.92 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 115.522 1.675 . . . . 0.31 115.522 -169.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.638 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -64.86 -20.74 66.58 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 107.507 -1.294 . . . . 1.35 107.507 169.218 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -46.72 -44.5 18.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 113.794 -1.548 . . . . 1.28 111.014 171.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.463 ' OE1' ' HA ' ' A' ' 64' ' ' TYR . 23.4 mp0 -86.33 -33.11 20.69 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.454 -0.339 . . . . 1.11 111.731 178.41 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 143.69 -1.52 1.35 Allowed Glycine 0 N--CA 1.452 -0.293 0 N-CA-C 111.562 -0.615 . . . . 0.18 111.562 -174.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.72 ' HD2' ' HB2' ' A' ' 64' ' ' TYR . 22.0 t80 -68.73 142.77 54.88 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 122.989 0.515 . . . . 0.18 111.25 -178.205 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.981 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 1.9 t -133.92 147.01 51.04 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 107.633 -1.247 . . . . 0.2 107.633 170.475 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 1.049 HG11 ' HB1' ' A' ' 57' ' ' ALA . 39.1 t -99.02 99.12 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.441 0 N-CA-C 107.338 -1.356 . . . . 0.17 107.338 157.648 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.783 HD21 ' CE2' ' A' ' 28' ' ' TYR . 4.2 mt -84.88 118.51 24.55 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 107.895 -1.15 . . . . 1.04 107.895 177.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.88 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -116.58 112.62 21.57 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 119.879 -0.729 . . . . 0.51 110.937 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.809 ' CZ ' HG13 ' A' ' 20' ' ' VAL . 1.6 m-30 -91.75 110.26 42.31 Favored Pre-proline 0 C--N 1.318 -0.77 0 N-CA-C 107.741 -1.207 . . . . 0.44 107.741 173.141 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.893 ' HG2' ' HB3' ' A' ' 107' ' ' LYS . 60.9 Cg_endo -72.2 40.77 0.46 Allowed 'Trans proline' 0 N--CA 1.48 0.73 0 C-N-CA 123.961 3.107 . . . . 1.3 116.629 -165.449 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.658 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 4.8 t 46.61 149.54 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 115.845 1.794 . . . . 1.44 115.845 175.652 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.496 ' HB3' ' HA ' ' A' ' 109' ' ' ASN . 4.4 t-20 -102.2 55.51 0.79 Allowed 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 114.324 -1.307 . . . . 1.81 107.749 177.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.871 ' HA ' ' HG3' ' A' ' 83' ' ' GLU . 2.4 pp0? -52.59 -15.31 0.66 Allowed 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 113.365 -1.743 . . . . 3.34 110.367 175.216 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -66.24 -20.32 66.08 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.647 -1.161 . . . . 2.68 110.586 -178.612 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.19 -71.06 1.18 Allowed Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 111.093 -0.803 . . . . 1.98 111.093 174.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 131.63 40.04 0.23 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.771 -0.728 . . . . 1.49 112.722 177.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.17 25.22 0.9 Allowed 'General case' 0 CA--C 1.507 -0.687 0 CA-C-O 120.961 0.41 . . . . 1.74 110.882 178.545 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.871 ' HG3' ' HA ' ' A' ' 78' ' ' GLN . 9.2 mm-40 -90.4 152.09 45.11 Favored Pre-proline 0 C--N 1.31 -1.141 0 CA-C-N 115.446 -0.797 . . . . 3.07 111.278 -172.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -73.8 127.55 11.66 Favored 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 123.195 2.597 . . . . 1.75 112.754 -172.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.65 -64.24 4.15 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.725 -0.67 . . . . 2.2 112.307 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -134.83 126.9 29.77 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.375 -0.231 . . . . 4.2 110.375 -178.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.586 ' HG2' ' HG3' ' A' ' 88' ' ' GLU . 0.0 OUTLIER -123.41 -61.1 1.43 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.428 -0.351 . . . . 3.02 111.082 178.772 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.586 ' HG3' ' HG2' ' A' ' 87' ' ' GLU . 13.2 mt-10 -97.18 -12.78 22.64 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 122.019 -0.426 . . . . 3.92 111.788 -173.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -60.9 -37.33 81.87 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-O 121.212 0.53 . . . . 2.65 109.749 174.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.478 ' HB ' ' OE1' ' A' ' 78' ' ' GLN . 5.5 mm -73.83 -12.02 15.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.717 -0.674 . . . . 2.15 110.157 -178.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.49 ' HD3' ' HA ' ' A' ' 88' ' ' GLU . 38.6 mtpt -93.18 -47.23 7.04 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.36 -0.836 . . . . 2.79 110.472 179.147 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -80.18 -18.01 50.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 3.29 111.129 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -110.18 138.04 47.09 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.265 -0.643 . . . . 3.42 109.265 178.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 98.6 t -67.68 110.28 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.588 -0.523 . . . . 2.63 109.588 177.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.888 ' HA ' ' HB2' ' A' ' 47' ' ' CYS . 29.0 m -130.08 134.02 47.08 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.413 0.625 . . . . 2.83 110.758 -176.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.513 ' C ' ' H ' ' A' ' 98' ' ' PHE . 2.4 p -62.7 145.63 54.24 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.083 -0.962 . . . . 2.98 109.218 169.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -76.1 26.67 0.12 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.704 0.288 . . . . 2.72 110.958 -177.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.629 ' HZ ' ' CZ ' ' A' ' 102' ' ' PHE . 3.4 t80 65.98 113.56 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 124.328 1.017 . . . . 2.12 111.44 177.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -140.5 113.68 8.46 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.469 -0.787 . . . . 2.69 109.098 174.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.466 ' HB2' ' CE1' ' A' ' 98' ' ' PHE . . . -120.1 -166.48 1.31 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.585 -0.734 . . . . 0.55 110.94 -173.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -88.09 12.07 14.52 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.96 -0.563 . . . . 1.99 110.604 175.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.673 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 15.5 p90 -128.93 160.71 62.03 Favored Pre-proline 0 N--CA 1.438 -1.037 0 N-CA-C 108.209 -1.034 . . . . 0.84 108.209 175.143 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.762 ' HG2' ' HA ' ' A' ' 72' ' ' LEU . 57.6 Cg_endo -64.27 104.27 0.5 Allowed 'Trans proline' 0 N--CA 1.472 0.222 0 C-N-CA 123.432 2.755 . . . . 0.62 113.2 -171.156 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.88 HD12 ' HB3' ' A' ' 73' ' ' ALA . 5.4 mm -100.48 121.03 50.75 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.818 0 N-CA-C 108.053 -1.091 . . . . 1.34 108.053 175.701 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.835 ' HB3' ' O ' ' A' ' 21' ' ' LEU . 20.1 mmt -97.68 -159.26 0.72 Allowed 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.32 -0.854 . . . . 3.03 113.246 -163.471 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.706 ' O ' ' HG2' ' A' ' 107' ' ' LYS . . . -56.96 -27.53 61.37 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.29 -0.868 . . . . 1.46 112.623 -173.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.893 ' HB3' ' HG2' ' A' ' 75' ' ' PRO . 4.5 ptpp? 76.88 133.94 0.06 Allowed 'General case' 0 CA--C 1.481 -1.684 0 O-C-N 125.044 1.465 . . . . 1.76 108.802 -163.371 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.7 HG13 ' CB ' ' A' ' 116' ' ' HIS . 0.1 OUTLIER -134.65 162.59 38.53 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 CA-C-N 113.4 -1.727 . . . . 0.82 108.206 173.824 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.563 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 6.7 t-20 -75.93 70.04 2.61 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.248 -0.887 . . . . 1.73 111.438 -171.494 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.554 HG13 HD11 ' A' ' 108' ' ' ILE . 2.4 m -70.91 91.56 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 CA-C-O 121.493 0.663 . . . . 0.77 111.272 -173.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 175.1 177.66 0.16 Allowed 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.608 -1.178 . . . . 1.9 108.51 168.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 43.85 -116.14 1.4 Allowed Glycine 0 N--CA 1.448 -0.501 0 O-C-N 124.412 1.07 . . . . 1.47 115.327 166.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.38 -13.78 15.27 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 114.378 1.251 . . . . 2.81 114.378 -166.552 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.402 ' O ' ' C ' ' A' ' 115' ' ' ALA . 66.5 t30 -111.51 -37.62 5.17 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 119.003 -1.079 . . . . 2.16 112.884 -168.64 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.563 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . 22.51 -106.89 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 O-C-N 124.266 0.979 . . . . 1.26 111.786 -175.289 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.7 ' CB ' HG13 ' A' ' 108' ' ' ILE . 3.2 t-80 -170.53 140.56 1.49 Allowed Pre-proline 0 N--CA 1.431 -1.4 0 N-CA-C 105.846 -1.909 . . . . 0.42 105.846 169.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -30.89 -49.44 0.22 Allowed 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 123.899 3.066 . . . . 0.4 113.141 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.891 HD11 ' HB ' ' A' ' 15' ' ' ILE . 40.0 tp -58.7 -52.16 66.89 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.459 0.704 . . . . 0.39 112.389 176.307 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.777 ' HE2' ' CD2' ' A' ' 74' ' ' PHE . 65.5 m-85 -75.6 -36.54 60.28 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-N 116.472 -0.331 . . . . 3.04 111.652 -178.376 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.425 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 42.8 mt-10 -56.5 -36.79 69.57 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 107.137 -1.431 . . . . 2.44 107.137 171.649 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.74 ' HB2' ' HE2' ' A' ' 18' ' ' PHE . 49.5 t80 -68.36 -31.11 70.27 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 119.825 -0.75 . . . . 0.56 111.167 175.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.658 ' HE3' ' HG ' ' A' ' 118' ' ' LEU . 0.5 OUTLIER -74.4 -56.41 4.89 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.27 0.557 . . . . 0.71 109.958 -171.748 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.643 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -72.28 -24.3 61.32 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.221 -0.9 . . . . 1.46 112.258 178.912 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.663 ' HG2' ' HA ' ' A' ' 121' ' ' TYR . 16.0 ptmt -68.05 -34.37 76.32 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 118.945 -1.102 . . . . 1.99 109.318 175.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 44.3 m -77.11 -43.88 32.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.206 -0.906 . . . . 0.59 110.126 178.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.408 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 27.5 mtpp -134.79 103.74 10.92 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 1.85 110.849 175.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 126' ' ' LYS . 7.1 Cg_exo -74.38 -52.83 0.12 Allowed 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.579 2.853 . . . . 1.69 111.969 -176.521 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.718 ' HA3' ' HB ' ' A' ' 132' ' ' THR . . . -161.29 160.41 32.12 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.102 -1.046 . . . . 2.59 112.878 177.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 27.7 pt -101.81 -13.79 8.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.658 -0.867 . . . . 3.58 108.658 170.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.43 HD23 ' H ' ' A' ' 130' ' ' LEU . 1.6 pt? -128.7 -148.81 0.39 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.561 -1.2 . . . . 3.47 108.258 174.147 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.61 82.66 0.6 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.205 0.526 . . . . 3.28 109.658 171.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.718 ' HB ' ' HA3' ' A' ' 128' ' ' GLY . 11.4 m -150.26 146.81 27.02 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.258 -0.428 . . . . 3.56 110.411 -175.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -125.21 3.03 7.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.107 -0.497 . . . . 5.17 111.076 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.619 ' H ' HG22 ' A' ' 132' ' ' THR . . . -153.55 -90.26 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.364 -0.38 . . . . 1.59 110.753 -177.145 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.815 ' O ' ' HG2' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -125.24 -32.2 1.05 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.919 0 CA-C-N 116.013 -0.539 . . . . 2.0 110.047 176.436 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.815 ' HG2' ' O ' ' A' ' 135' ' ' ILE . 21.9 ptmt 93.16 -68.0 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 126.652 1.981 . . . . 4.81 110.78 -170.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.765 ' HE3' ' C ' ' A' ' 136' ' ' LYS . 0.2 OUTLIER -114.91 -178.21 3.31 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 123.594 0.758 . . . . 1.97 110.143 -162.988 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.482 ' O ' ' N ' ' A' ' 140' ' ' THR . 7.9 m-80 -36.23 -154.91 0.0 OUTLIER 'General case' 0 C--O 1.206 -1.188 0 O-C-N 125.052 1.47 . . . . 2.04 112.672 163.348 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.876 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 0.5 OUTLIER -31.63 -21.29 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 117.362 2.356 . . . . 1.93 117.362 -170.277 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.723 HG21 ' O ' ' A' ' 135' ' ' ILE . 5.9 m 5.62 114.73 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 120.56 1.527 . . . . 0.6 113.906 165.783 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.563 ' HB3' ' CE1' ' A' ' 41' ' ' TYR . 0.8 OUTLIER -94.14 159.88 14.95 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 114.114 -1.403 . . . . 0.62 110.764 -164.527 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.482 ' O ' HD13 ' A' ' 39' ' ' LEU . 48.2 m-85 -122.5 125.53 45.96 Favored 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 106.306 -1.739 . . . . 0.57 106.306 167.441 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.754 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 9.8 tp -80.67 105.95 12.3 Favored 'General case' 0 N--CA 1.424 -1.752 0 C-N-CA 117.927 -1.509 . . . . 0.43 108.592 177.02 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.765 HG13 HG13 ' A' ' 40' ' ' ILE . 40.7 mm -92.29 141.29 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.926 0 CA-C-N 112.981 -1.918 . . . . 0.19 107.228 -178.594 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.638 ' HA ' HD13 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -91.98 179.09 5.69 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 120.716 -0.394 . . . . 0.98 111.641 -170.188 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.521 ' CG ' ' HD3' ' A' ' 37' ' ' PRO . 17.4 mtm180 -50.43 -41.71 52.9 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 122.845 0.458 . . . . 2.22 111.392 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.443 ' C ' ' HE2' ' A' ' 16' ' ' PHE . 4.8 m-20 -93.96 12.8 24.86 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 109.476 -0.565 . . . . 2.0 109.476 -176.234 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.642 ' HA3' ' CE2' ' A' ' 16' ' ' PHE . . . 76.36 32.12 52.6 Favored Glycine 0 N--CA 1.433 -1.52 0 CA-C-N 115.354 -0.839 . . . . 0.17 113.911 178.109 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.472 ' HA ' ' HD2' ' A' ' 150' ' ' PRO . 7.1 p -108.53 109.62 61.45 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 118.806 1.303 . . . . 1.12 111.923 174.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.665 ' HD3' HG23 ' A' ' 15' ' ' ILE . 1.9 Cg_endo -50.48 124.3 12.98 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 124.294 3.33 . . . . 0.41 112.106 174.569 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.762 HG23 ' HG2' ' A' ' 152' ' ' GLU . 15.9 m -125.0 -15.11 4.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.929 0.395 . . . . 1.45 110.385 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.762 ' HG2' HG23 ' A' ' 151' ' ' VAL . 13.7 mm-40 -140.99 166.9 23.53 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 116.107 -0.497 . . . . 1.17 110.598 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.637 ' HD3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -148.07 143.92 27.52 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.254 -0.884 . . . . 2.16 109.697 162.315 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.625 ' HZ ' ' HB2' ' A' ' 166' ' ' LYS . 91.0 m-85 -120.35 138.02 53.96 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.691 -0.686 . . . . 0.32 110.436 -171.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.495 ' OG ' ' HD2' ' A' ' 156' ' ' PRO . 8.2 t -65.49 151.74 93.76 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 107.853 -1.166 . . . . 1.11 107.853 177.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.755 ' HG3' ' HB3' ' A' ' 137' ' ' TRP . 25.2 Cg_endo -59.32 -25.19 77.47 Favored 'Trans proline' 0 N--CA 1.474 0.376 0 C-N-CA 123.056 2.504 . . . . 0.78 113.221 -176.48 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.659 ' HA2' ' O ' ' A' ' 51' ' ' LYS . . . -75.94 -2.96 73.06 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.961 -0.563 . . . . 0.5 113.853 174.21 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -70.44 146.78 50.1 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 117.659 0.729 . . . . 0.5 109.502 175.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.54 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 17.1 m -104.66 170.09 8.08 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.566 -0.531 . . . . 1.42 109.566 -178.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.664 ' HA ' HG23 ' A' ' 56' ' ' THR . 87.1 t -40.52 -55.51 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 O-C-N 124.286 0.991 . . . . 0.28 111.409 177.105 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 161' ' ' LYS . 0.1 OUTLIER -70.42 -28.52 65.12 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.225 -0.443 . . . . 3.46 111.366 -173.033 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.416 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 4.4 m-20 -65.72 -35.54 81.02 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.583 0.706 . . . . 1.4 109.265 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.59 ' HA ' ' CE2' ' A' ' 154' ' ' PHE . 72.1 mt -83.27 -43.0 18.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 114.432 -1.258 . . . . 0.21 110.952 178.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.603 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 46.0 mt-10 -51.98 -43.38 63.57 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-O 120.842 0.353 . . . . 0.67 111.19 -179.111 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 13.1 pt-20 -60.64 -17.04 44.85 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 112.149 0.425 . . . . 0.87 112.149 -174.559 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.625 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 13.7 mmmm -106.0 -25.28 12.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.259 0.552 . . . . 1.71 109.941 172.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.603 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 12.0 tp -76.81 -49.35 16.02 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.138 -0.937 . . . . 0.16 111.979 -177.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.456 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 67.1 mt -55.28 -44.12 99.46 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.718 -0.674 . . . . 0.26 111.91 -175.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.456 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 86.0 Cg_exo -50.26 -24.01 10.87 Favored 'Trans proline' 0 C--N 1.353 0.816 0 C-N-CA 122.499 2.132 . . . . 0.41 113.592 172.365 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.674 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 86.2 mt -97.78 -40.3 8.61 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 120.636 -0.426 . . . . 0.71 111.118 177.176 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.694 HD23 ' HG2' ' A' ' 37' ' ' PRO . 95.6 mt -59.92 -59.29 5.66 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 122.141 0.972 . . . . 0.34 109.102 175.126 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -72.22 -27.37 70.16 Favored Glycine 0 N--CA 1.433 -1.526 0 CA-C-N 113.358 -1.746 . . . . 1.12 111.713 -178.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 73.7 m 71.03 119.64 0.04 OUTLIER 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.835 0.826 . . . . 2.64 112.121 178.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -72.34 -1.81 16.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.917 -1.038 . . . . 4.35 111.226 178.194 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -42.08 -36.02 1.05 Allowed 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.02 0.928 . . . . 8.45 113.188 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 99.1 mt . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.576 -0.726 . . . . 7.69 110.455 -179.522 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.933 0 N-CA-C 112.325 -0.31 . . . . 5.22 112.325 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -141.14 34.48 1.72 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.498 0.666 . . . . 4.85 109.872 178.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.472 ' C ' ' H ' ' A' ' 14' ' ' SER . . . 121.76 -127.45 6.87 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 115.396 -0.82 . . . . 1.55 111.721 -175.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.4 m 69.99 -14.12 0.39 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.348 0.659 . . . . 1.58 111.822 179.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.472 ' H ' ' C ' ' A' ' 12' ' ' GLY . 86.8 p 177.9 154.59 0.33 Allowed 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 106.173 -1.788 . . . . 1.17 106.173 179.281 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.835 ' HB ' HD11 ' A' ' 118' ' ' LEU . 5.1 pt -70.25 -17.59 20.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-N 115.068 -0.969 . . . . 0.38 112.236 -172.494 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.764 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 51.9 m-85 -69.91 -3.33 15.48 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.186 0.517 . . . . 0.3 111.463 -178.38 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -71.97 -17.99 62.02 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.249 -1.019 . . . . 2.11 108.249 176.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.726 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 72.5 m-85 -117.84 112.54 20.51 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 114.818 -1.083 . . . . 0.31 110.881 -175.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -47.9 142.06 5.24 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 113.494 -1.685 . . . . 2.86 110.452 172.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.827 HG13 ' HZ ' ' A' ' 74' ' ' PHE . 54.9 t -111.13 164.6 6.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 107.466 -1.309 . . . . 0.67 107.466 176.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.627 HD23 ' HA ' ' A' ' 27' ' ' PRO . 10.3 mt -133.16 125.68 30.0 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.224 -0.658 . . . . 0.69 109.224 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.533 ' HA ' ' SD ' ' A' ' 105' ' ' MET . 17.2 m-20 -56.21 178.6 0.05 OUTLIER 'General case' 0 CA--C 1.514 -0.408 0 O-C-N 123.768 0.667 . . . . 1.87 110.086 177.016 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.606 ' HA ' ' N ' ' A' ' 106' ' ' ALA . . . -61.41 -1.79 0.6 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.826 0.676 . . . . 0.59 112.826 -175.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -112.95 4.95 17.06 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.135 0.421 . . . . 2.34 112.135 175.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.766 ' CD2' ' HB3' ' A' ' 106' ' ' ALA . 8.0 m170 72.59 19.63 4.05 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.752 0.787 . . . . 1.47 110.241 177.688 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.485 ' HE3' ' HB2' ' A' ' 26' ' ' LYS . 2.9 mtmt -84.05 135.54 42.08 Favored Pre-proline 0 CA--C 1.509 -0.614 0 N-CA-C 106.591 -1.633 . . . . 4.25 106.591 164.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.627 ' HA ' HD23 ' A' ' 21' ' ' LEU . 80.4 Cg_exo -53.27 113.26 1.2 Allowed 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 121.187 1.258 . . . . 0.54 112.868 -178.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.622 ' HB3' HG12 ' A' ' 20' ' ' VAL . 45.8 t80 -78.86 144.01 35.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 113.701 -1.59 . . . . 1.2 110.969 173.221 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.666 ' ND2' ' HB3' ' A' ' 32' ' ' GLN . 58.5 t30 -79.31 81.38 5.58 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 115.147 -0.933 . . . . 1.51 109.573 178.459 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.661 ' HG ' ' CD1' ' A' ' 16' ' ' PHE . 54.7 tp -60.79 -39.64 89.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.228 0.537 . . . . 0.28 109.558 177.026 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.713 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 1.1 m -72.11 -0.04 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.022 -0.99 . . . . 1.02 112.47 -168.518 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.666 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . 3.8 pt20 -73.44 -13.92 61.16 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.359 -0.608 . . . . 1.02 109.359 173.61 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.845 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 91.6 m-70 -94.35 21.98 6.51 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-O 121.812 0.815 . . . . 0.28 109.561 176.604 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.764 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 45.5 mtmt -85.74 109.7 18.81 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 114.553 -1.203 . . . . 1.56 108.76 169.118 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 134.68 -41.02 1.5 Allowed Glycine 0 N--CA 1.435 -1.373 0 N-CA-C 111.308 -0.717 . . . . 0.2 111.308 -177.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 41.2 m -131.71 136.28 28.18 Favored Pre-proline 0 N--CA 1.438 -1.066 0 N-CA-C 108.616 -0.883 . . . . 0.29 108.616 171.63 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.736 ' HG2' HD23 ' A' ' 171' ' ' LEU . 3.5 Cg_endo -43.17 156.94 0.11 Allowed 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.936 3.091 . . . . 0.18 112.875 175.426 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.843 ' HB2' HG22 ' A' ' 70' ' ' THR . 1.0 OUTLIER -144.62 140.51 28.76 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 107.525 -1.287 . . . . 0.31 107.525 -179.736 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.941 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 1.7 mm? -106.04 112.17 25.11 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.403 -0.962 . . . . 1.19 108.403 176.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.816 HG23 ' HB2' ' A' ' 72' ' ' LEU . 5.1 mt -98.63 130.06 48.04 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 CA-C-N 115.95 -0.568 . . . . 0.37 109.95 177.564 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.941 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.4 OUTLIER -117.56 140.5 49.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.636 -0.711 . . . . 0.42 110.492 -172.604 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.615 ' OD1' ' HB ' ' A' ' 140' ' ' THR . 22.8 p-10 -92.54 105.1 17.33 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 108.116 -1.068 . . . . 2.35 108.116 168.323 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.723 ' O ' ' HA ' ' A' ' 75' ' ' PRO . 3.3 m -106.29 132.25 53.93 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 O-C-N 121.228 -0.92 . . . . 1.03 110.529 -170.47 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -81.46 96.19 7.31 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 119.285 -0.966 . . . . 0.88 110.215 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.2 p -21.26 -82.92 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 O-C-N 125.635 1.835 . . . . 1.78 113.016 175.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.755 ' HG2' ' H ' ' A' ' 47' ' ' CYS . 20.7 ttmm 51.51 -144.6 0.57 Allowed 'General case' 0 CA--C 1.537 0.448 0 O-C-N 123.87 0.732 . . . . 5.84 110.503 174.116 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.755 ' H ' ' HG2' ' A' ' 46' ' ' LYS . 12.7 t -159.1 116.48 2.76 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 109.679 -0.489 . . . . 3.55 109.679 176.458 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 65.13 66.0 2.66 Favored Glycine 0 CA--C 1.519 0.32 0 CA-C-N 115.869 -0.605 . . . . 2.91 113.319 178.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -152.15 123.89 7.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 117.197 0.499 . . . . 4.63 111.594 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.8 t -139.5 154.46 47.7 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.21 -0.45 . . . . 1.93 110.374 172.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.657 ' HB2' ' HB2' ' A' ' 156' ' ' PRO . 22.4 mmmt -114.73 14.42 17.49 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.905 -0.406 . . . . 2.01 109.905 174.15 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 107.98 -26.58 16.88 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 110.913 -0.875 . . . . 0.51 110.913 -174.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.445 ' HA2' ' HB ' ' A' ' 56' ' ' THR . . . -70.17 -17.98 74.45 Favored Glycine 0 C--O 1.217 -0.919 0 C-N-CA 121.264 -0.493 . . . . 0.5 113.208 -178.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.411 ' HA ' ' CE2' ' A' ' 139' ' ' PHE . 1.1 t80 -74.14 -56.67 4.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 117.786 0.793 . . . . 0.7 109.896 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -62.93 -21.79 66.3 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.269 0.557 . . . . 2.61 110.115 176.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.706 ' HA ' HG22 ' A' ' 160' ' ' VAL . 16.0 m -76.34 -53.91 7.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.421 -0.809 . . . . 0.33 109.669 177.494 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 1.089 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -55.03 -43.06 73.37 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 114.905 -1.043 . . . . 0.22 110.758 177.27 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.497 ' HA ' ' CD1' ' A' ' 102' ' ' PHE . 39.4 m -60.84 -56.98 14.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.472 -0.785 . . . . 0.26 110.515 -178.563 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 98.6 m -66.29 -38.99 89.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.995 -1.002 . . . . 0.48 112.238 -175.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.785 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 18.7 mt -64.39 -48.5 75.21 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-O 121.425 0.631 . . . . 0.43 110.275 -176.613 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.877 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 13.5 t80 -56.84 -47.89 79.29 Favored 'General case' 0 C--O 1.207 -1.182 0 CA-C-N 114.545 -1.207 . . . . 0.31 110.897 178.373 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.587 ' HA ' ' HE3' ' A' ' 65' ' ' LYS . 3.5 m-20 -73.84 -25.5 60.11 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 116.602 -0.272 . . . . 1.21 111.132 -171.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.408 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 33.8 ttpt -86.21 -23.15 26.56 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 109.015 -0.735 . . . . 1.54 109.015 -178.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.743 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 29.1 m-85 -125.47 -4.53 7.21 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 115.808 1.781 . . . . 0.31 115.808 -169.37 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.65 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 22.2 pttp -67.04 -25.28 66.19 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 108.009 -1.108 . . . . 1.35 108.009 169.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.5 m -48.85 -30.25 5.58 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 114.203 -1.362 . . . . 1.28 111.27 172.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -96.26 -36.64 10.84 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.592 0.234 . . . . 1.11 111.547 174.234 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 149.83 -5.49 0.7 Allowed Glycine 0 C--O 1.237 0.319 0 N-CA-C 111.17 -0.772 . . . . 0.18 111.17 -176.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.785 ' HE2' ' HB3' ' A' ' 60' ' ' LEU . 21.6 t80 -69.59 141.53 53.73 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 115.368 -0.416 . . . . 0.18 111.089 -177.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.877 ' HA ' ' CD1' ' A' ' 61' ' ' TYR . 5.5 t -133.46 146.37 51.09 Favored 'General case' 0 N--CA 1.421 -1.898 0 N-CA-C 108.826 -0.805 . . . . 0.2 108.826 173.209 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 1.089 HG11 ' HB1' ' A' ' 57' ' ' ALA . 25.1 t -100.7 103.3 14.63 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.376 0 N-CA-C 107.485 -1.302 . . . . 0.17 107.485 157.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.816 ' HB2' HG23 ' A' ' 40' ' ' ILE . 35.8 mt -83.94 120.7 26.41 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.626 -1.25 . . . . 1.04 107.626 178.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.725 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -95.08 115.76 27.84 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.229 0.538 . . . . 0.51 109.601 178.569 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.827 ' HZ ' HG13 ' A' ' 20' ' ' VAL . 11.5 m-85 -113.96 97.28 44.45 Favored Pre-proline 0 C--N 1.308 -1.218 0 N-CA-C 108.517 -0.92 . . . . 0.44 108.517 -178.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.723 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 2.0 Cg_endo -67.66 142.36 58.17 Favored 'Trans proline' 0 N--CA 1.438 -1.773 0 C-N-CA 121.175 1.25 . . . . 1.3 110.748 -175.567 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.486 ' OG ' ' HB3' ' A' ' 83' ' ' GLU . 8.1 t -87.17 146.56 25.97 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 121.807 0.813 . . . . 1.44 110.009 173.339 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.829 ' HB2' ' HD2' ' A' ' 79' ' ' PHE . 30.6 p-10 -105.34 125.54 51.1 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 113.991 -1.459 . . . . 1.81 108.851 -178.436 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.713 ' HB2' ' HB3' ' A' ' 91' ' ' LYS . 2.6 pp0? -55.68 -8.25 0.37 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.88 -1.055 . . . . 3.34 111.692 176.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.829 ' HD2' ' HB2' ' A' ' 77' ' ' ASN . 63.2 m-85 -66.36 -20.71 66.15 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.71 -0.677 . . . . 2.68 112.667 -167.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.82 -24.62 34.8 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.338 -0.934 . . . . 1.98 112.676 -177.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 70.18 54.6 10.78 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 110.289 -1.124 . . . . 1.49 110.289 -173.017 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.69 HE21 ' HB3' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -159.57 -14.18 0.06 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.577 0.584 . . . . 1.74 112.577 -170.959 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.593 ' CD ' ' HA ' ' A' ' 78' ' ' GLN . 0.0 OUTLIER -62.09 137.1 95.58 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-O 121.841 0.829 . . . . 3.07 111.42 -160.198 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.415 ' HB2' ' C ' ' A' ' 137' ' ' TRP . 12.4 Cg_endo -59.07 116.86 3.56 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 124.613 3.542 . . . . 1.75 114.744 -164.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 98.78 -99.86 2.21 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.242 -0.89 . . . . 2.2 112.894 171.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.415 ' HB2' ' NZ ' ' A' ' 46' ' ' LYS . 10.1 m120 -91.53 83.22 5.36 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.782 -0.451 . . . . 4.2 109.782 -176.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -66.49 -85.35 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 114.704 -1.134 . . . . 3.02 112.813 -170.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.602 ' O ' ' HG2' ' A' ' 92' ' ' GLU . 20.9 mt-10 -59.46 -21.96 60.82 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.409 0.522 . . . . 3.92 112.409 -168.507 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.575 ' O ' ' HB3' ' A' ' 93' ' ' PHE . 64.5 tt0 -58.42 -12.88 4.31 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.108 -0.496 . . . . 2.65 111.845 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.546 ' HB ' ' HB3' ' A' ' 78' ' ' GLN . 46.9 mt -96.79 -32.96 4.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 O-C-N 121.745 -0.597 . . . . 2.15 111.745 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.713 ' HB3' ' HB2' ' A' ' 78' ' ' GLN . 21.5 pttp -91.19 -20.99 21.37 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.586 0.587 . . . . 2.79 112.586 -172.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.602 ' HG2' ' O ' ' A' ' 88' ' ' GLU . 0.3 OUTLIER -114.18 13.94 18.09 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.204 0.526 . . . . 3.29 111.04 175.368 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.575 ' HB3' ' O ' ' A' ' 89' ' ' GLU . 44.2 t80 -128.06 153.47 46.75 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.092 -0.707 . . . . 3.42 109.092 171.028 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.8 t -65.08 112.02 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.596 -0.275 . . . . 2.63 110.648 -179.049 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 2.8 p -117.27 124.59 49.4 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.71 0.766 . . . . 2.83 112.246 -177.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 19.8 p -92.42 155.88 17.57 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 107.372 -1.344 . . . . 2.98 107.372 165.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.8 pttm -76.14 57.99 1.18 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.26 0.553 . . . . 2.72 111.479 -179.092 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.639 ' HD2' HG12 ' A' ' 104' ' ' ILE . 38.9 t80 69.43 -86.23 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.722 -1.126 . . . . 2.12 112.331 173.354 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt 74.94 136.07 0.06 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.829 0.852 . . . . 2.69 111.412 -179.135 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.479 ' HB2' ' CZ ' ' A' ' 98' ' ' PHE . . . -168.81 -165.85 0.6 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.576 -0.738 . . . . 0.55 110.891 -173.144 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -104.02 28.51 6.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.931 -0.577 . . . . 1.99 111.507 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.721 ' HE2' ' HB2' ' A' ' 73' ' ' ALA . 1.1 p90 -135.47 176.89 2.52 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 108.756 -0.831 . . . . 0.84 108.756 173.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.598 ' HD3' ' CE2' ' A' ' 61' ' ' TYR . 18.9 Cg_exo -71.28 97.1 0.75 Allowed 'Trans proline' 0 CA--C 1.518 -0.276 0 C-N-CA 123.067 2.511 . . . . 0.62 112.884 -179.57 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.725 HG13 ' HB3' ' A' ' 73' ' ' ALA . 4.2 mp -92.61 138.6 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 N-CA-C 108.475 -0.935 . . . . 1.34 108.475 174.254 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.627 ' HB3' ' O ' ' A' ' 21' ' ' LEU . 13.5 mmt -101.19 179.84 4.25 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.755 -0.657 . . . . 3.03 109.997 -177.441 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.777 ' O ' ' HG2' ' A' ' 107' ' ' LYS . . . -83.83 34.11 0.49 Allowed 'General case' 0 CA--C 1.5 -0.944 0 C-N-CA 120.65 -0.42 . . . . 1.46 111.89 -168.016 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.777 ' HG2' ' O ' ' A' ' 106' ' ' ALA . 8.9 ptpt 56.02 144.78 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 123.953 1.835 . . . . 1.76 111.979 -174.265 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.538 HD12 ' HB3' ' A' ' 116' ' ' HIS . 35.7 pt -139.75 170.69 14.99 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 CA-C-N 112.324 -2.216 . . . . 0.82 107.478 175.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.569 ' HA ' ' OD1' ' A' ' 77' ' ' ASN . 1.6 t30 -80.68 50.8 1.38 Allowed 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.684 -0.689 . . . . 1.73 110.747 -176.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.474 HG23 ' CB ' ' A' ' 76' ' ' SER . 0.0 OUTLIER -64.36 94.33 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 CA-C-O 122.021 0.915 . . . . 0.77 110.884 -175.434 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.69 ' HB3' HE21 ' A' ' 82' ' ' GLN . 12.7 t-20 175.55 -179.74 0.14 Allowed 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 105.787 -1.931 . . . . 1.9 105.787 176.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -85.08 41.35 3.05 Favored Glycine 0 N--CA 1.439 -1.148 0 C-N-CA 119.982 -1.104 . . . . 1.47 114.474 -177.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.52 ' HB3' ' HG2' ' A' ' 82' ' ' GLN . 2.3 tp10 -105.88 -51.03 3.06 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 119.248 -0.981 . . . . 2.81 109.846 165.57 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -133.18 -31.88 1.23 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.829 -0.623 . . . . 2.16 110.796 176.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . 52.85 -102.64 0.14 Allowed 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.078 -0.964 . . . . 1.26 109.969 -169.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.65 ' CE1' ' H ' ' A' ' 118' ' ' LEU . 3.5 t-80 173.35 138.71 0.13 Allowed Pre-proline 0 N--CA 1.429 -1.52 0 N-CA-C 105.18 -2.156 . . . . 0.42 105.18 174.016 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -28.67 -47.97 0.12 Allowed 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 124.125 3.217 . . . . 0.4 113.568 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.835 HD11 ' HB ' ' A' ' 15' ' ' ILE . 28.1 tp -62.46 -51.67 66.58 Favored 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 123.365 0.666 . . . . 0.39 111.875 177.245 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.804 ' OH ' HG22 ' A' ' 40' ' ' ILE . 32.6 m-85 -75.69 -32.65 60.21 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-N 116.458 -0.337 . . . . 3.04 111.856 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -57.84 -40.15 79.39 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 107.169 -1.419 . . . . 2.44 107.169 170.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.726 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 31.6 t80 -66.65 -31.67 72.5 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.194 -0.912 . . . . 0.56 110.549 175.207 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.7 ' HE2' HG21 ' A' ' 15' ' ' ILE . 45.9 mtt -74.99 -52.86 10.05 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.488 -0.778 . . . . 0.71 110.958 -171.315 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.425 ' HE2' ' HB2' ' A' ' 123' ' ' LYS . 0.5 OUTLIER -71.61 -25.97 62.39 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 121.057 -0.257 . . . . 1.46 111.403 176.563 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.522 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 19.4 ptmt -72.17 -31.18 65.7 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 119.665 -0.814 . . . . 1.99 109.725 179.463 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 39.0 m -90.78 -38.31 13.08 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.394 -0.821 . . . . 0.59 111.004 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.466 ' HE3' ' HA ' ' A' ' 126' ' ' LYS . 1.6 tpmt? -126.26 88.94 53.35 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.686 -0.688 . . . . 1.85 110.576 -174.374 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -74.23 -0.0 9.05 Favored 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 122.895 2.396 . . . . 1.69 112.119 176.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 97.92 158.9 30.42 Favored Glycine 0 N--CA 1.442 -0.937 0 CA-C-N 115.675 -0.693 . . . . 2.59 111.673 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.655 HD12 ' H ' ' A' ' 129' ' ' ILE . 3.7 mp -69.94 -25.18 27.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.402 0.62 . . . . 3.58 109.647 -179.091 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 34.1 tp -77.99 -9.78 59.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.371 -0.831 . . . . 3.47 110.542 175.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 56.69 40.72 29.08 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 114.76 -1.109 . . . . 3.28 111.431 -179.09 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.9 m -74.22 -76.94 0.12 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.942 -0.572 . . . . 3.56 111.533 -175.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 46.5 tttm -176.2 -83.3 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.405 0.622 . . . . 5.17 109.65 -174.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -119.03 -176.47 3.12 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.786 -0.643 . . . . 1.59 110.612 -178.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.506 ' HB ' ' ND2' ' A' ' 42' ' ' ASN . 0.4 OUTLIER -50.71 84.82 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 O-C-N 124.28 0.988 . . . . 2.0 109.953 168.741 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.8 ' HB3' ' CE3' ' A' ' 137' ' ' TRP . 26.0 mtmt -36.42 -67.01 0.19 Allowed 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 114.399 1.259 . . . . 4.81 114.399 -172.452 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.8 ' CE3' ' HB3' ' A' ' 136' ' ' LYS . 0.5 OUTLIER -109.62 -172.32 2.02 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 113.644 -1.616 . . . . 1.97 109.905 -164.215 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.517 ' CG ' ' H ' ' A' ' 139' ' ' PHE . 60.6 t30 -31.99 -152.14 0.0 OUTLIER 'General case' 0 C--O 1.2 -1.506 0 O-C-N 125.359 1.662 . . . . 2.04 111.979 158.099 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.699 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 2.1 m-85 -27.64 -28.29 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.264 0 N-CA-C 118.037 2.606 . . . . 1.93 118.037 -167.212 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.685 ' HA ' ' O ' ' A' ' 154' ' ' PHE . 7.7 m 12.29 102.3 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 120.105 1.32 . . . . 0.6 114.373 172.123 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.699 ' HB3' HD12 ' A' ' 39' ' ' LEU . 1.6 m -90.11 167.52 12.68 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.571 -1.195 . . . . 0.62 111.473 -170.447 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.464 ' CE2' HG23 ' A' ' 135' ' ' ILE . 95.2 m-85 -129.95 125.79 36.28 Favored 'General case' 0 CA--C 1.49 -1.339 0 N-CA-C 106.404 -1.702 . . . . 0.57 106.404 163.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.693 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 4.9 tp -80.33 102.94 9.86 Favored 'General case' 0 N--CA 1.422 -1.851 0 C-N-CA 118.204 -1.398 . . . . 0.43 108.125 176.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.674 HG22 ' HA2' ' A' ' 148' ' ' GLY . 43.2 mm -90.84 137.26 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.738 0 CA-C-N 113.724 -1.58 . . . . 0.19 107.625 -176.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.607 ' OD1' HG12 ' A' ' 149' ' ' VAL . 0.0 OUTLIER -88.74 -175.62 4.96 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 119.527 -0.869 . . . . 0.98 111.675 -168.914 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.663 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 33.8 mtm180 -53.65 -37.15 62.85 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-O 120.976 0.417 . . . . 2.22 111.037 -178.227 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.402 ' C ' ' HE2' ' A' ' 16' ' ' PHE . 25.3 t70 -103.17 19.43 19.59 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.413 -0.958 . . . . 2.0 108.413 -175.512 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.729 ' HA3' ' CE2' ' A' ' 16' ' ' PHE . . . 71.86 35.08 61.92 Favored Glycine 0 N--CA 1.439 -1.13 0 CA-C-N 114.794 -1.094 . . . . 0.17 115.531 176.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.607 HG12 ' OD1' ' A' ' 145' ' ' ASP . 10.0 p -106.06 113.51 63.51 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 119.356 1.578 . . . . 1.12 111.398 172.427 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.672 ' HD3' HG23 ' A' ' 15' ' ' ILE . 2.5 Cg_endo -51.11 115.55 2.11 Favored 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 124.027 3.152 . . . . 0.41 111.799 172.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 26.2 t -108.27 -28.58 2.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.707 0.765 . . . . 1.45 109.098 -176.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.693 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 22.6 mm-40 -136.86 166.39 23.73 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.509 -1.223 . . . . 1.17 110.317 -176.242 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.489 ' HA ' ' O ' ' A' ' 141' ' ' SER . 1.5 ttm180 -143.78 140.7 30.05 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.826 -1.079 . . . . 2.16 109.17 165.124 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.685 ' O ' ' HA ' ' A' ' 140' ' ' THR . 97.3 m-85 -120.8 149.95 41.77 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.932 -0.766 . . . . 0.32 108.932 -171.421 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 62.9 m -78.51 160.04 73.33 Favored Pre-proline 0 C--N 1.317 -0.83 0 N-CA-C 108.549 -0.908 . . . . 1.11 108.549 175.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.701 ' HG3' ' HB3' ' A' ' 137' ' ' TRP . 32.0 Cg_endo -63.74 -22.14 69.65 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.028 1.819 . . . . 0.78 111.896 178.261 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 51' ' ' LYS . . . -78.93 -7.1 88.57 Favored Glycine 0 N--CA 1.446 -0.7 0 CA-C-N 115.696 -0.683 . . . . 0.5 112.626 173.071 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -72.88 144.99 47.19 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 108.62 -0.881 . . . . 0.5 108.62 174.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 14.5 m -110.91 173.74 6.19 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 120.835 -0.346 . . . . 1.42 110.168 -172.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.706 HG22 ' HA ' ' A' ' 56' ' ' THR . 58.9 t -40.7 -55.93 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 114.93 -1.032 . . . . 0.28 111.384 177.549 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.427 ' HB2' ' HE2' ' A' ' 161' ' ' LYS . 12.9 tppt? -67.25 -29.87 69.61 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.217 -0.447 . . . . 3.46 111.299 -171.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.44 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 8.0 m-20 -68.88 -38.27 79.58 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 121.481 0.657 . . . . 1.4 109.545 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.599 ' HA ' ' CZ ' ' A' ' 154' ' ' PHE . 71.3 mt -77.82 -43.68 28.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 114.76 -1.109 . . . . 0.21 110.715 178.346 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.605 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 53.9 mt-10 -55.02 -43.3 73.55 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-N 116.523 -0.308 . . . . 0.67 111.5 -176.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.44 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 8.6 pt-20 -58.45 -23.01 56.46 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.716 0.294 . . . . 0.87 111.7 -176.084 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.658 ' HB3' HD22 ' A' ' 143' ' ' LEU . 45.9 mmtm -99.51 -25.94 14.27 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.591 0.71 . . . . 1.71 109.982 176.097 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.6 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 13.6 tp -79.06 -50.76 10.55 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.897 -1.047 . . . . 0.16 112.215 -177.038 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.452 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 73.6 mt -54.57 -44.6 99.2 Favored Pre-proline 0 CA--C 1.537 0.452 0 CA-C-N 115.511 -0.768 . . . . 0.26 112.637 -173.306 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.452 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 53.8 Cg_exo -54.54 -33.06 76.88 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.077 1.851 . . . . 0.41 112.762 173.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.722 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 78.5 mt -83.23 -40.64 19.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.652 -0.249 . . . . 0.71 111.288 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.736 HD23 ' HG2' ' A' ' 37' ' ' PRO . 87.0 mt -61.76 -60.42 3.69 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 121.996 0.903 . . . . 0.34 109.603 175.642 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -55.41 -53.83 38.46 Favored Glycine 0 N--CA 1.436 -1.315 0 CA-C-N 113.406 -1.724 . . . . 1.12 112.526 -178.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 23.2 t 55.96 44.04 26.3 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.249 0.547 . . . . 2.64 111.054 175.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -92.89 -39.12 11.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.941 -0.572 . . . . 4.35 111.085 -177.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 48.95 70.32 0.48 Allowed 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.538 0.685 . . . . 8.45 110.961 -176.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 80.1 mt . . . . . 0 C--O 1.251 1.135 0 CA-C-O 118.36 -0.828 . . . . 7.69 109.71 177.647 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.624 0 N-CA-C 112.31 -0.316 . . . . 5.22 112.31 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 86.4 mtp -113.94 176.28 5.11 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 110.212 -0.292 . . . . 4.85 110.212 177.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 163.57 174.65 33.67 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.754 -0.736 . . . . 1.55 111.459 178.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.9 t -116.42 -5.09 11.75 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.022 0.439 . . . . 1.58 110.246 176.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.455 ' HB3' ' O ' ' A' ' 147' ' ' ASP . 5.9 m -158.51 151.83 22.94 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 105.975 -1.861 . . . . 1.17 105.975 -177.705 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.953 ' HB ' HD11 ' A' ' 118' ' ' LEU . 5.8 pt -61.75 -16.04 14.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 CA-C-N 114.32 -1.309 . . . . 0.38 111.823 -174.717 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.782 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 46.9 m-85 -73.79 5.9 3.68 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 113.028 0.751 . . . . 0.3 113.028 -174.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -79.81 -17.82 52.41 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 107.694 -1.224 . . . . 2.11 107.694 175.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.749 ' HE2' ' HB2' ' A' ' 121' ' ' TYR . 51.5 m-85 -112.07 115.29 28.65 Favored 'General case' 0 N--CA 1.434 -1.257 0 CA-C-N 114.078 -1.419 . . . . 0.31 111.432 -171.345 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -50.66 142.02 11.79 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 113.752 -1.567 . . . . 2.86 110.752 174.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.73 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 37.9 t -112.34 158.53 12.72 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 107.981 -1.118 . . . . 0.67 107.981 176.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.739 HD23 ' HA ' ' A' ' 27' ' ' PRO . 60.4 mt -126.66 135.0 50.59 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 120.454 -0.499 . . . . 0.69 111.347 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.502 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 15.8 t70 -63.88 159.36 19.88 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 106.193 -1.78 . . . . 1.87 106.193 164.535 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.761 ' HA ' ' CA ' ' A' ' 106' ' ' ALA . . . -57.35 -3.92 0.19 Allowed 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.973 1.101 . . . . 0.59 113.973 -166.743 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.482 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 23.3 t70 -100.16 0.01 39.7 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 111.454 0.168 . . . . 2.34 111.454 177.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.632 ' CD2' ' HB1' ' A' ' 106' ' ' ALA . 78.8 m-70 80.57 20.1 0.5 Allowed 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 121.811 0.815 . . . . 1.47 109.427 177.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.484 ' HA ' ' HD3' ' A' ' 26' ' ' LYS . 12.0 mmtp -96.13 123.42 55.21 Favored Pre-proline 0 N--CA 1.441 -0.904 0 CA-C-N 114.499 -1.228 . . . . 4.25 108.543 173.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.739 ' HA ' HD23 ' A' ' 21' ' ' LEU . 95.9 Cg_exo -49.18 114.14 1.18 Allowed 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 122.924 2.416 . . . . 0.54 114.165 -167.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.628 ' HB3' HG12 ' A' ' 20' ' ' VAL . 2.1 t80 -83.86 136.67 34.02 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 113.109 -1.86 . . . . 1.2 110.019 169.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.522 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 0.3 OUTLIER -81.89 83.16 7.29 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.499 0.666 . . . . 1.51 110.806 179.366 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.655 ' HG ' ' CD1' ' A' ' 16' ' ' PHE . 56.8 tp -50.4 -37.73 39.16 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.432 0.634 . . . . 0.28 110.383 178.388 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.62 HG13 ' HB3' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -69.43 -0.35 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 114.551 -1.204 . . . . 1.02 113.129 -172.502 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.531 HE21 ' CE1' ' A' ' 33' ' ' HIS . 9.4 pt20 -71.42 -20.25 62.14 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.731 -0.84 . . . . 1.02 108.731 172.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.966 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 93.4 m-70 -91.83 24.8 3.01 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 115.205 -0.907 . . . . 0.28 110.07 177.439 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.782 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 38.1 mtmt -86.04 109.33 18.73 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 114.587 -1.188 . . . . 1.56 109.2 170.159 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 133.65 -43.13 1.3 Allowed Glycine 0 N--CA 1.438 -1.17 0 C-N-CA 120.861 -0.685 . . . . 0.2 111.741 -177.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.457 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 69.3 m -127.15 136.77 29.37 Favored Pre-proline 0 N--CA 1.434 -1.229 0 N-CA-C 108.637 -0.875 . . . . 0.29 108.637 172.506 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.804 ' HG3' ' CB ' ' A' ' 170' ' ' LEU . 3.3 Cg_endo -42.49 153.32 0.15 Allowed 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 123.985 3.123 . . . . 0.18 112.763 175.381 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.841 ' HB2' HG22 ' A' ' 70' ' ' THR . 0.6 OUTLIER -140.48 141.87 35.36 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.123 -1.436 . . . . 0.31 107.123 179.964 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 1.016 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 1.2 mm? -107.53 112.77 25.69 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.284 -1.006 . . . . 1.19 108.284 177.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.095 HG22 ' OH ' ' A' ' 119' ' ' TYR . 2.3 mt -100.71 124.06 54.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 120.082 -0.647 . . . . 0.37 110.183 179.123 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 1.016 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.6 OUTLIER -110.2 124.81 52.26 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.145 -0.934 . . . . 0.42 110.715 -171.83 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.562 ' OD1' ' HB ' ' A' ' 140' ' ' THR . 8.2 p-10 -80.96 96.7 7.17 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.624 -1.251 . . . . 2.35 107.624 169.547 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.9 ' HA ' ' HA ' ' A' ' 139' ' ' PHE . 10.7 p -105.02 141.42 20.45 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 O-C-N 121.179 -0.951 . . . . 1.03 111.802 -165.061 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -89.04 106.19 18.27 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.566 -0.531 . . . . 0.88 109.566 173.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.913 ' HA ' ' HB3' ' A' ' 98' ' ' PHE . 3.3 p -44.57 108.28 0.11 Allowed 'General case' 0 C--N 1.327 -0.374 0 O-C-N 123.985 0.803 . . . . 1.78 110.334 172.135 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.918 ' HB3' ' HB2' ' A' ' 49' ' ' TYR . 60.8 mttm -138.69 157.93 45.18 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.276 0.56 . . . . 5.84 111.584 -174.401 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.595 ' H ' HG13 ' A' ' 94' ' ' VAL . 44.9 t -122.81 117.66 26.17 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.231 -0.895 . . . . 3.55 108.936 178.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 69.5 23.88 76.37 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.463 -0.875 . . . . 2.91 111.162 -175.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.918 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 13.3 m-85 -131.31 136.85 48.48 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.437 0.637 . . . . 4.63 111.013 -179.066 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.2 t -173.85 163.93 4.2 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 106.806 -1.553 . . . . 1.93 106.806 -178.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.898 ' H ' ' HZ ' ' A' ' 139' ' ' PHE . 10.3 tppt? -124.46 9.58 8.46 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.171 -1.048 . . . . 2.01 108.171 173.03 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 117.94 -33.5 4.88 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 114.664 -1.153 . . . . 0.51 111.512 -174.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.684 ' HA2' ' HB ' ' A' ' 56' ' ' THR . . . -63.94 -16.07 59.03 Favored Glycine 0 C--O 1.22 -0.753 0 CA-C-O 119.594 -0.559 . . . . 0.5 114.327 -177.442 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.705 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 1.0 OUTLIER -73.23 -56.87 4.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 118.34 1.07 . . . . 0.7 109.351 177.009 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -60.34 -26.37 66.53 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-O 121.838 0.828 . . . . 2.61 109.572 175.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.684 ' HB ' ' HA2' ' A' ' 53' ' ' GLY . 15.4 m -75.33 -54.65 6.72 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 114.28 -1.327 . . . . 0.33 109.441 -176.104 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 1.086 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -57.32 -43.39 83.26 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 114.709 -1.132 . . . . 0.22 110.644 176.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.558 ' HA ' ' HD2' ' A' ' 102' ' ' PHE . 74.2 m -58.76 -56.03 27.52 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.794 -0.639 . . . . 0.26 110.675 -179.046 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 61.8 m -68.82 -37.11 78.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.458 -0.792 . . . . 0.48 111.891 -175.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.786 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 17.1 mt -64.57 -46.93 80.66 Favored 'General case' 0 CA--C 1.502 -0.888 0 CA-C-O 121.265 0.555 . . . . 0.43 110.359 -176.578 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.877 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 8.1 t80 -58.08 -52.2 66.53 Favored 'General case' 0 C--O 1.202 -1.443 0 CA-C-N 114.856 -1.066 . . . . 0.31 110.64 178.403 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -70.19 -25.67 63.53 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 120.718 0.294 . . . . 1.21 110.81 -172.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.55 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 36.2 ttpt -84.84 -23.4 29.06 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.946 -0.761 . . . . 1.54 108.946 -177.253 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.636 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 43.1 m-85 -126.88 -4.25 6.4 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 116.084 1.883 . . . . 0.31 116.084 -171.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.737 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 12.8 ptmt -64.04 -27.29 69.01 Favored 'General case' 0 CA--C 1.496 -1.114 0 N-CA-C 108.052 -1.092 . . . . 1.35 108.052 171.038 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.0 t -48.61 -35.26 13.23 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 114.154 -1.384 . . . . 1.28 111.033 173.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -92.57 -33.15 14.55 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.079 0.4 . . . . 1.11 112.079 175.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.405 ' HA3' ' HB2' ' A' ' 36' ' ' SER . . . 147.9 -5.54 0.95 Allowed Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 111.711 -0.556 . . . . 0.18 111.711 -176.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.786 ' HE2' ' HB3' ' A' ' 60' ' ' LEU . 18.5 t80 -69.97 144.71 52.24 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-O 121.047 0.451 . . . . 0.18 111.447 -178.245 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.966 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 1.5 t -134.92 149.96 50.34 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 108.283 -1.006 . . . . 0.2 108.283 173.451 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 1.086 HG11 ' HB1' ' A' ' 57' ' ' ALA . 45.2 t -106.34 100.1 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.322 0 N-CA-C 108.001 -1.111 . . . . 0.17 108.001 157.257 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.852 ' HA ' ' HG2' ' A' ' 103' ' ' PRO . 4.9 mt -85.6 118.66 25.24 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.68 -1.23 . . . . 1.04 107.68 177.099 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 1.003 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -107.83 112.04 24.49 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 119.363 -0.935 . . . . 0.51 110.957 178.011 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.796 ' HD2' HD13 ' A' ' 108' ' ' ILE . 3.0 m-85 -93.35 99.59 3.44 Favored Pre-proline 0 C--N 1.311 -1.096 0 CA-C-N 114.445 -1.252 . . . . 0.44 108.425 176.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.807 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 92.2 Cg_endo -83.82 93.15 0.79 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.501 2.134 . . . . 1.3 113.286 -167.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.641 ' HA ' ' O ' ' A' ' 108' ' ' ILE . 44.0 m -25.73 135.42 0.02 OUTLIER 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 115.08 1.511 . . . . 1.44 115.08 -172.322 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.729 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 3.3 t-20 -71.5 82.86 0.82 Allowed 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 112.452 -2.158 . . . . 1.81 107.774 -179.451 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 1.002 ' HA ' ' HG3' ' A' ' 83' ' ' GLU . 75.6 mm-40 -49.38 -13.94 0.09 Allowed 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 114.589 -1.187 . . . . 3.34 111.059 -179.513 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.504 ' H ' ' C ' ' A' ' 77' ' ' ASN . 41.1 t80 -81.71 -13.59 57.63 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 114.121 -1.4 . . . . 2.68 110.894 -174.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -76.3 -27.11 62.35 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.652 -0.785 . . . . 1.98 111.684 179.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.52 25.89 60.14 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.928 -0.654 . . . . 1.49 112.452 179.138 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -142.63 33.25 1.44 Allowed 'General case' 0 CA--C 1.503 -0.849 0 CA-C-O 120.67 0.271 . . . . 1.74 110.481 176.468 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 1.002 ' HG3' ' HA ' ' A' ' 78' ' ' GLN . 13.6 mm-40 -88.89 148.98 42.61 Favored Pre-proline 0 C--N 1.306 -1.283 0 CA-C-N 115.963 -0.562 . . . . 3.07 111.017 -166.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.543 ' HB2' ' O ' ' A' ' 137' ' ' TRP . 96.7 Cg_endo -78.91 98.53 1.2 Allowed 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 123.185 2.59 . . . . 1.75 113.483 -170.408 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.89 9.12 78.26 Favored Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 115.908 -0.587 . . . . 2.2 112.6 176.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.498 ' O ' ' HB2' ' A' ' 83' ' ' GLU . 2.8 t30 -158.67 158.99 34.82 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.125 -0.695 . . . . 4.2 109.125 -177.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -162.8 -57.64 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.926 -0.31 . . . . 3.02 110.783 177.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -139.59 21.28 2.53 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.422 0.527 . . . . 3.92 112.422 -168.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.409 ' O ' ' HB3' ' A' ' 93' ' ' PHE . 12.6 pt-20 -88.04 -17.87 30.19 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 121.691 -0.631 . . . . 2.65 110.362 177.122 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.842 ' HA ' ' HB ' ' A' ' 94' ' ' VAL . 8.4 pt -78.37 -159.88 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.621 -0.718 . . . . 2.15 112.195 -178.139 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.444 ' HG3' ' H ' ' A' ' 92' ' ' GLU . 60.4 pttt 55.37 -68.21 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.837 1.655 . . . . 2.79 113.64 176.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.444 ' H ' ' HG3' ' A' ' 91' ' ' LYS . 10.7 pt-20 -90.75 9.27 30.69 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.0 0.429 . . . . 3.29 111.012 -176.011 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.508 ' HD2' HG23 ' A' ' 94' ' ' VAL . 46.9 t80 -160.86 -77.1 0.06 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.415 0.626 . . . . 3.42 110.472 -176.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.842 ' HB ' ' HA ' ' A' ' 90' ' ' ILE . 64.9 t -73.28 153.73 7.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.141 -0.936 . . . . 2.63 110.3 179.295 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 96.0 m -81.96 124.07 29.43 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-O 121.162 0.506 . . . . 2.83 112.126 -171.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.507 ' O ' ' HB2' ' A' ' 97' ' ' LYS . 2.7 m -70.01 153.74 42.83 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 108.258 -1.016 . . . . 2.98 108.258 168.242 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 96' ' ' THR . 67.3 mttm 77.72 -42.58 0.38 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 123.73 0.812 . . . . 2.72 111.385 -176.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.913 ' HB3' ' HA ' ' A' ' 45' ' ' SER . 0.0 OUTLIER 71.77 -45.74 0.63 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.382 1.073 . . . . 2.12 110.209 -174.604 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt 64.03 125.52 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 122.168 0.985 . . . . 2.69 112.397 172.18 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.61 ' HB2' ' CE1' ' A' ' 98' ' ' PHE . . . -144.68 -177.24 5.4 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.351 -0.84 . . . . 0.55 111.07 -174.351 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -94.31 29.94 2.08 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.906 -0.588 . . . . 1.99 110.335 175.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.656 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 18.3 p90 -143.23 160.94 50.25 Favored Pre-proline 0 N--CA 1.442 -0.852 0 N-CA-C 108.161 -1.051 . . . . 0.84 108.161 175.239 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.852 ' HG2' ' HA ' ' A' ' 72' ' ' LEU . 36.0 Cg_endo -58.94 90.68 0.07 OUTLIER 'Trans proline' 0 N--CA 1.476 0.455 0 C-N-CA 123.982 3.121 . . . . 0.62 114.419 -172.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 1.003 HD12 ' HB3' ' A' ' 73' ' ' ALA . 2.8 mm -80.0 123.22 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 108.809 -0.811 . . . . 1.34 108.809 171.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.713 ' HG3' ' H ' ' A' ' 107' ' ' LYS . 0.8 OUTLIER -77.13 170.03 17.26 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.412 -1.267 . . . . 3.03 111.11 -177.568 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.761 ' CA ' ' HA ' ' A' ' 23' ' ' ALA . . . -69.33 11.42 0.24 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.688 -0.687 . . . . 1.46 112.377 178.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.797 ' HB2' ' O ' ' A' ' 75' ' ' PRO . 2.6 ptpp? 67.4 143.43 0.04 OUTLIER 'General case' 0 CA--C 1.495 -1.163 0 CA-C-O 123.363 1.554 . . . . 1.76 112.092 -175.353 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.914 HG13 HG22 ' A' ' 110' ' ' VAL . 36.1 pt -136.28 159.27 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.197 0 CA-C-N 111.81 -2.45 . . . . 0.82 106.557 175.134 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.65 ' HB3' ' HB3' ' A' ' 114' ' ' ASN . 1.1 m-80 -72.35 64.27 0.58 Allowed 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 110.506 -0.183 . . . . 1.73 110.506 176.26 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.914 HG22 HG13 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -74.59 92.37 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.751 0 C-N-CA 119.644 -0.823 . . . . 0.77 109.928 -176.241 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.6 t30 174.05 178.86 0.11 Allowed 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 114.219 -1.355 . . . . 1.9 107.683 170.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 36.29 -105.01 0.03 OUTLIER Glycine 0 CA--C 1.518 0.278 0 O-C-N 124.706 1.254 . . . . 1.47 116.023 161.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -108.19 -24.1 11.67 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 114.309 1.226 . . . . 2.81 114.309 -163.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.65 ' HB3' ' HB3' ' A' ' 109' ' ' ASN . 0.2 OUTLIER -118.78 20.17 12.93 Favored 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 119.993 -0.683 . . . . 2.16 109.593 -165.444 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -50.69 133.32 25.89 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.132 -0.94 . . . . 1.26 109.202 173.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.709 ' HB3' HD12 ' A' ' 108' ' ' ILE . 2.1 t-80 -69.06 143.16 93.96 Favored Pre-proline 0 N--CA 1.438 -1.065 0 CA-C-N 115.739 -0.664 . . . . 0.42 109.356 -170.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -26.43 -45.04 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 124.886 3.724 . . . . 0.4 114.049 179.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.953 HD11 ' HB ' ' A' ' 15' ' ' ILE . 48.0 tp -65.14 -51.0 63.86 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 122.894 0.478 . . . . 0.39 112.288 179.141 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 1.095 ' OH ' HG22 ' A' ' 40' ' ' ILE . 24.1 m-85 -80.57 -32.33 36.6 Favored 'General case' 0 CA--C 1.486 -1.512 0 CA-C-O 121.433 0.635 . . . . 3.04 109.752 -176.2 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.549 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 4.4 tm-20 -60.07 -37.06 78.78 Favored 'General case' 0 N--CA 1.426 -1.635 0 N-CA-C 106.186 -1.783 . . . . 2.44 106.186 172.258 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.749 ' HB2' ' HE2' ' A' ' 18' ' ' PHE . 79.2 t80 -68.56 -30.45 69.23 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.135 -0.939 . . . . 0.56 110.605 173.484 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.705 ' CE ' HD12 ' A' ' 40' ' ' ILE . 53.3 mtt -75.83 -55.34 5.73 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.09 -0.505 . . . . 0.71 111.815 -170.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.702 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -70.48 -23.65 62.72 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.194 -0.457 . . . . 1.46 110.78 177.495 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.62 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 10.4 ptmt -72.96 -27.04 61.59 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 119.701 -0.799 . . . . 1.99 109.429 172.587 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 89.2 m -71.66 -50.99 25.45 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 116.044 -0.526 . . . . 0.59 109.59 172.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.769 ' HG2' HH22 ' A' ' 153' ' ' ARG . 23.2 ttmm -148.87 114.15 3.69 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.95 -0.568 . . . . 1.85 110.05 179.437 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.51 ' HD3' ' HA ' ' A' ' 126' ' ' LYS . 15.4 Cg_exo -69.21 -58.89 0.1 OUTLIER 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.688 2.925 . . . . 1.69 113.088 -174.513 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.562 ' HA2' ' CZ ' ' A' ' 153' ' ' ARG . . . -171.76 157.2 27.26 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.286 -0.959 . . . . 2.59 112.766 -178.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.693 HG12 HH12 ' A' ' 153' ' ' ARG . 34.9 mm -99.39 -20.18 5.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.731 0.777 . . . . 3.58 109.378 178.023 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.74 HD23 ' H ' ' A' ' 130' ' ' LEU . 1.8 pt? -114.02 -136.59 0.36 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.984 -1.007 . . . . 3.47 110.129 -176.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.38 92.23 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 108.806 -0.813 . . . . 3.28 108.806 170.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.417 ' OG1' ' HB2' ' A' ' 127' ' ' PRO . 2.9 t -100.34 157.02 16.92 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 113.356 0.873 . . . . 3.56 113.356 -162.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 22.1 tptm 166.35 -43.7 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 113.308 -1.769 . . . . 5.17 107.173 -174.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -175.94 179.52 1.32 Allowed 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 114.221 -1.354 . . . . 1.59 110.149 -178.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.558 ' HB ' ' OD1' ' A' ' 42' ' ' ASN . 1.7 pt -64.52 61.22 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 C-N-CA 124.392 1.077 . . . . 2.0 109.783 166.146 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.538 ' HB3' ' CZ3' ' A' ' 137' ' ' TRP . 75.5 tttt -72.74 0.54 10.53 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.997 0.919 . . . . 4.81 112.728 -167.264 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.647 ' HB3' ' HG3' ' A' ' 156' ' ' PRO . 7.0 m-90 -111.28 175.0 5.6 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.335 -0.393 . . . . 1.97 110.574 -176.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.416 ' HB3' ' H ' ' A' ' 139' ' ' PHE . 94.6 m-20 -39.48 -158.57 0.0 OUTLIER 'General case' 0 C--O 1.207 -1.162 0 C-N-CA 124.795 1.238 . . . . 2.04 113.017 163.11 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.9 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 0.1 OUTLIER -33.39 -26.71 0.01 OUTLIER 'General case' 0 C--O 1.203 -1.384 0 N-CA-C 116.427 2.01 . . . . 1.93 116.427 -171.24 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.562 ' HB ' ' OD1' ' A' ' 42' ' ' ASN . 14.1 m 23.11 109.65 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 120.909 1.686 . . . . 0.6 114.601 165.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.85 ' O ' ' HA ' ' A' ' 153' ' ' ARG . 0.8 OUTLIER -107.08 138.29 43.54 Favored 'General case' 0 C--O 1.199 -1.583 0 CA-C-N 114.933 -1.031 . . . . 0.62 112.389 -161.867 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.534 ' O ' HD13 ' A' ' 39' ' ' LEU . 50.9 m-85 -103.52 127.51 50.91 Favored 'General case' 0 CA--C 1.488 -1.424 0 N-CA-C 107.666 -1.235 . . . . 0.57 107.666 175.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.794 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 7.5 tp -80.65 103.23 10.36 Favored 'General case' 0 N--CA 1.417 -2.099 0 C-N-CA 118.07 -1.452 . . . . 0.43 107.947 174.401 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.753 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 45.8 mm -94.82 139.17 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.782 0 CA-C-N 113.131 -1.85 . . . . 0.19 107.394 -179.008 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.29 -175.36 3.8 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 119.64 -0.824 . . . . 0.98 111.329 -169.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.598 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 47.5 mtm180 -52.51 -41.04 63.1 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 123.356 0.41 . . . . 2.22 111.036 -177.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.455 ' O ' ' HB3' ' A' ' 14' ' ' SER . 34.1 m-20 -98.86 22.63 9.88 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.471 -0.566 . . . . 2.0 109.471 -176.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.569 ' HA2' HG22 ' A' ' 144' ' ' ILE . . . 67.53 39.66 90.98 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 114.728 0.651 . . . . 0.17 114.728 177.302 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.423 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 93.4 t -100.84 127.94 31.03 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-N 118.278 1.039 . . . . 1.12 110.497 173.395 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.524 ' HA ' HD13 ' A' ' 144' ' ' ILE . 10.2 Cg_endo -77.3 110.0 2.91 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.692 2.262 . . . . 0.41 110.319 178.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.451 ' O ' ' HE3' ' A' ' 126' ' ' LYS . 17.2 t -107.87 -28.28 2.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 121.433 0.635 . . . . 1.45 109.546 -173.027 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.794 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 5.5 mm-40 -135.75 164.64 27.43 Favored 'General case' 0 CA--C 1.501 -0.933 0 CA-C-N 115.328 -0.851 . . . . 1.17 110.511 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.85 ' HA ' ' O ' ' A' ' 141' ' ' SER . 0.0 OUTLIER -149.42 139.19 21.82 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.805 -1.088 . . . . 2.16 110.31 157.813 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.557 ' CZ ' ' HA ' ' A' ' 163' ' ' ILE . 86.8 m-85 -113.95 152.77 30.37 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.242 -1.344 . . . . 0.32 109.141 -160.707 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 15.3 m -71.37 157.03 90.85 Favored Pre-proline 0 C--N 1.312 -1.058 0 N-CA-C 109.464 -0.569 . . . . 1.11 109.464 176.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.647 ' HG3' ' HB3' ' A' ' 137' ' ' TRP . 18.4 Cg_endo -60.87 -26.62 83.42 Favored 'Trans proline' 0 CA--C 1.517 -0.348 0 C-N-CA 122.197 1.931 . . . . 0.78 110.179 171.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -81.55 7.87 60.48 Favored Glycine 0 N--CA 1.441 -1.01 0 CA-C-N 114.036 -1.438 . . . . 0.5 113.124 174.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -88.07 146.41 25.46 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.563 -0.903 . . . . 0.5 108.563 171.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 87.5 p -110.86 176.86 4.86 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 120.813 -0.355 . . . . 1.42 110.772 -173.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.636 HG22 ' HA ' ' A' ' 56' ' ' THR . 61.1 t -44.49 -46.57 2.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.211 -0.904 . . . . 0.28 110.582 174.685 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -68.97 -37.44 78.79 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.664 -0.698 . . . . 3.46 111.052 -174.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -65.26 -41.02 94.67 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.566 0.698 . . . . 1.4 109.551 -177.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.63 HD13 ' OH ' ' A' ' 41' ' ' TYR . 73.7 mt -77.78 -45.66 27.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 114.637 -1.165 . . . . 0.21 111.472 -179.223 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.62 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 25.2 mt-10 -52.97 -41.37 64.49 Favored 'General case' 0 C--O 1.22 -0.495 0 N-CA-C 111.994 0.368 . . . . 0.67 111.994 -176.474 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -63.3 -19.58 64.72 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.46 -0.496 . . . . 0.87 111.889 -174.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.594 ' HB3' HD22 ' A' ' 143' ' ' LEU . 13.0 mmmm -103.03 -11.12 18.37 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.42 0.628 . . . . 1.71 110.018 174.496 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.62 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 13.9 tp -93.05 -53.78 4.0 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.99 -1.005 . . . . 0.16 112.168 -176.58 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.551 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 64.1 mt -53.28 -48.2 93.28 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.282 -0.872 . . . . 0.26 112.59 -172.508 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.551 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 72.5 Cg_exo -51.86 -30.26 37.94 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 122.252 1.968 . . . . 0.41 112.728 175.472 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.804 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 96.4 mt -84.42 -42.78 15.31 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.468 -0.333 . . . . 0.71 111.038 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.754 HD23 ' HG2' ' A' ' 37' ' ' PRO . 95.5 mt -60.93 -57.88 10.77 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-O 122.13 0.967 . . . . 0.34 109.692 176.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -64.01 -29.57 75.26 Favored Glycine 0 N--CA 1.434 -1.464 0 CA-C-N 113.334 -1.757 . . . . 1.12 113.011 -178.299 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 22.8 t 60.37 24.85 14.35 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.469 0.652 . . . . 2.64 110.358 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -78.95 -15.92 57.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.538 -0.756 . . . . 4.35 111.032 -177.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.438 ' HA ' ' HD3' ' A' ' 175' ' ' ARG . 11.7 mmt180 -100.55 36.86 1.81 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.734 0.778 . . . . 8.45 109.719 178.623 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 65.7 tp . . . . . 0 C--O 1.244 0.767 0 CA-C-N 114.687 -1.142 . . . . 7.69 108.833 178.528 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.6 m . . . . . 0 N--CA 1.453 -0.283 0 N-CA-C 109.071 -0.714 . . . . 1.58 109.071 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.9 m -150.65 170.57 18.86 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 105.161 -2.163 . . . . 1.17 105.161 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.87 ' HB ' HD11 ' A' ' 118' ' ' LEU . 6.8 pt -63.74 -19.59 24.64 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.102 0 CA-C-O 121.416 0.627 . . . . 0.38 110.521 178.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.734 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 37.3 m-85 -73.5 0.9 11.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.858 -0.61 . . . . 0.3 111.997 -175.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -80.19 -8.73 59.57 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 108.203 -1.036 . . . . 2.11 108.203 176.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.812 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 58.1 m-85 -121.79 117.29 26.21 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 114.537 -1.211 . . . . 0.31 111.427 -174.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -48.92 138.49 11.39 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 112.876 -1.965 . . . . 2.86 110.534 173.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.914 HG13 ' HZ ' ' A' ' 74' ' ' PHE . 98.9 t -112.76 163.4 9.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 108.146 -1.057 . . . . 0.67 108.146 175.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.737 ' O ' ' HB3' ' A' ' 105' ' ' MET . 19.9 mt -134.9 121.88 21.19 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.9 -0.407 . . . . 0.69 109.9 -175.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.856 ' HA ' ' HE2' ' A' ' 105' ' ' MET . 29.9 t70 -63.96 177.36 0.79 Allowed 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 108.372 -0.973 . . . . 1.87 108.372 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.631 ' HA ' ' C ' ' A' ' 105' ' ' MET . . . -59.55 -4.38 0.62 Allowed 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 114.314 1.228 . . . . 0.59 114.314 -163.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -119.33 14.8 12.98 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.765 0.654 . . . . 2.34 112.765 173.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.709 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 10.6 m170 73.13 24.22 2.52 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 122.184 0.992 . . . . 1.47 109.695 174.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.421 ' HE3' ' HB2' ' A' ' 26' ' ' LYS . 16.3 mtmt -85.55 127.81 61.64 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 113.814 -1.539 . . . . 4.25 106.929 166.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.598 ' HA ' HD23 ' A' ' 21' ' ' LEU . 93.3 Cg_exo -50.76 112.44 0.77 Allowed 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 121.359 1.373 . . . . 0.54 112.607 -174.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.521 ' HE2' ' CD2' ' A' ' 72' ' ' LEU . 24.2 t80 -81.47 142.61 32.77 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 113.481 -1.69 . . . . 1.2 112.1 178.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.544 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.8 t-20 -77.73 82.37 4.13 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.648 -1.16 . . . . 1.51 109.904 178.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.661 HD13 HG21 ' A' ' 20' ' ' VAL . 62.1 tp -63.72 -45.16 91.21 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.559 0.695 . . . . 0.28 110.822 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.685 HG13 ' HB3' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -66.13 1.69 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 114.759 -1.109 . . . . 1.02 113.596 -171.764 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.544 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 11.0 pt20 -74.37 -5.34 41.77 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.342 0.591 . . . . 1.02 110.175 172.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.866 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 70.8 m-70 -104.3 24.06 12.14 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.84 0.828 . . . . 0.28 109.428 174.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.734 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 19.7 mtmm -82.69 110.01 17.36 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 114.608 -1.178 . . . . 1.56 109.535 171.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.27 -36.49 2.38 Favored Glycine 0 N--CA 1.44 -1.085 0 C-N-CA 120.534 -0.841 . . . . 0.2 112.031 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.449 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 40.1 m -131.01 133.41 24.72 Favored Pre-proline 0 N--CA 1.435 -1.213 0 N-CA-C 108.3 -1.0 . . . . 0.29 108.3 173.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.757 ' HG2' HD23 ' A' ' 171' ' ' LEU . 3.1 Cg_endo -42.56 152.3 0.19 Allowed 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.824 3.016 . . . . 0.18 112.566 177.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.866 ' HB2' HG22 ' A' ' 70' ' ' THR . 0.5 OUTLIER -136.98 140.76 42.41 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 106.872 -1.529 . . . . 0.31 106.872 179.395 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.891 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 1.3 mm? -106.65 111.09 23.47 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.077 -1.083 . . . . 1.19 108.077 176.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.872 HG23 ' HB2' ' A' ' 72' ' ' LEU . 2.4 mt -94.87 122.9 46.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-N 115.856 -0.611 . . . . 0.37 109.485 176.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.891 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -110.88 128.01 55.64 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 116.068 -0.514 . . . . 0.42 109.919 -176.182 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.618 ' OD1' ' HB ' ' A' ' 140' ' ' THR . 2.3 p30 -82.27 94.85 7.41 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 107.938 -1.134 . . . . 2.35 107.938 167.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.777 ' O ' ' HA ' ' A' ' 75' ' ' PRO . 19.3 m . . . . . 0 C--N 1.319 -0.753 0 CA-C-O 121.507 0.67 . . . . 1.03 110.615 -166.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.45 ' O ' ' HG3' ' A' ' 55' ' ' GLU . . . . . . . . 0 N--CA 1.452 -0.243 0 N-CA-C 112.476 -0.25 . . . . 0.51 112.476 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.44 ' HA2' ' HB ' ' A' ' 56' ' ' THR . . . -53.88 -23.98 24.93 Favored Glycine 0 C--O 1.218 -0.889 0 CA-C-O 119.523 -0.599 . . . . 0.5 114.398 -175.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.431 ' HA ' ' CE2' ' A' ' 139' ' ' PHE . 0.6 OUTLIER -67.74 -55.49 12.9 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 118.42 1.11 . . . . 0.7 110.642 -178.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.45 ' HG3' ' O ' ' A' ' 52' ' ' GLY . 2.7 pp20? -66.31 -31.24 71.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.521 0.677 . . . . 2.61 109.348 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.697 ' HA ' ' CG2' ' A' ' 160' ' ' VAL . 53.9 m -59.68 -60.15 4.31 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 114.597 -1.183 . . . . 0.33 110.691 175.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 1.024 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -61.27 -44.99 96.33 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.979 -1.01 . . . . 0.22 111.293 -177.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.618 ' HA ' ' HE1' ' A' ' 102' ' ' PHE . 95.9 m -55.25 -52.29 63.89 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.57 0.7 . . . . 0.26 110.344 -177.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.8 m -72.79 -36.07 67.52 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.916 -1.038 . . . . 0.48 111.309 -176.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.682 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 19.3 mt -65.87 -50.11 65.72 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 121.303 0.573 . . . . 0.43 110.374 -177.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.817 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 6.8 t80 -55.74 -53.54 55.31 Favored 'General case' 0 C--O 1.198 -1.613 0 CA-C-N 114.608 -1.178 . . . . 0.31 110.44 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.481 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 9.7 m-80 -73.11 -24.67 60.66 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 112.182 0.438 . . . . 1.21 112.182 -173.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.477 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 33.6 ttpt -82.46 -22.36 35.22 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.768 -0.827 . . . . 1.54 108.768 -178.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.77 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 37.8 m-85 -123.73 -5.73 8.05 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 114.767 1.395 . . . . 0.31 114.767 -172.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.69 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 11.1 ptmt -64.64 -25.74 68.09 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 107.931 -1.137 . . . . 1.35 107.931 170.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.2 m -48.01 -41.84 26.48 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 114.106 -1.406 . . . . 1.28 110.672 172.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.409 HE21 ' HD1' ' A' ' 64' ' ' TYR . 51.0 mt-30 -82.73 -37.93 23.99 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 111.747 0.277 . . . . 1.11 111.747 175.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 149.66 -8.55 0.86 Allowed Glycine 0 CA--C 1.519 0.332 0 N-CA-C 111.088 -0.805 . . . . 0.18 111.088 -176.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.77 ' HD2' ' HB2' ' A' ' 64' ' ' TYR . 18.5 t80 -63.53 144.92 56.59 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 115.024 -0.588 . . . . 0.18 111.24 -177.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.866 HG22 ' HB2' ' A' ' 38' ' ' LEU . 3.0 t -133.27 152.25 51.93 Favored 'General case' 0 N--CA 1.411 -2.396 0 N-CA-C 108.726 -0.842 . . . . 0.2 108.726 171.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 1.024 HG11 ' HB1' ' A' ' 57' ' ' ALA . 37.4 t -106.78 102.12 13.48 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.361 0 N-CA-C 107.645 -1.243 . . . . 0.17 107.645 158.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.872 ' HB2' HG23 ' A' ' 40' ' ' ILE . 88.5 mt -84.27 118.73 24.37 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 107.742 -1.207 . . . . 1.04 107.742 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.757 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -97.84 113.06 24.77 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 120.385 -0.526 . . . . 0.51 110.598 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.914 ' HZ ' HG13 ' A' ' 20' ' ' VAL . 34.5 m-85 -106.52 96.68 14.52 Favored Pre-proline 0 C--N 1.309 -1.171 0 N-CA-C 109.445 -0.576 . . . . 0.44 109.445 176.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.777 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 74.2 Cg_endo -80.43 75.08 5.24 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.481 2.787 . . . . 1.3 114.778 -166.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 108' ' ' ILE . 76.2 p . . . . . 0 N--CA 1.476 0.859 0 C-N-CA 126.028 1.731 . . . . 1.44 115.234 -177.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.503 ' HB3' ' CD2' ' A' ' 102' ' ' PHE . . . . . . . . 0 CA--C 1.513 -0.472 0 CA-C-O 120.855 0.36 . . . . 0.55 111.082 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.41 ' H ' ' HB1' ' A' ' 100' ' ' ALA . 36.3 mm-40 -96.99 22.96 7.72 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.488 -0.778 . . . . 1.99 111.332 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.7 ' HB3' ' O ' ' A' ' 71' ' ' VAL . 2.9 m-85 -111.61 -176.63 0.39 Allowed Pre-proline 0 CA--C 1.514 -0.41 0 CA-C-O 121.561 0.695 . . . . 0.84 110.764 -177.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.67 ' HD3' ' CE2' ' A' ' 61' ' ' TYR . 8.6 Cg_exo -81.51 78.26 3.63 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 123.93 3.086 . . . . 0.62 109.449 157.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.757 HG13 ' HB3' ' A' ' 73' ' ' ALA . 4.0 mp -84.32 127.83 39.46 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 N-CA-C 108.09 -1.078 . . . . 1.34 108.09 178.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.856 ' HE2' ' HA ' ' A' ' 22' ' ' ASP . 3.4 mmt -96.82 -175.52 3.3 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.565 -0.743 . . . . 3.03 110.404 -169.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.638 ' O ' ' HG2' ' A' ' 107' ' ' LYS . . . -84.98 32.93 0.53 Allowed 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 113.013 0.746 . . . . 1.46 113.013 -167.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.638 ' HG2' ' O ' ' A' ' 106' ' ' ALA . 15.2 ptpt 53.83 127.6 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 123.467 1.603 . . . . 1.76 112.654 -177.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.785 HG13 HG13 ' A' ' 110' ' ' VAL . 20.4 pt -128.59 160.66 38.74 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 CA-C-N 113.538 -1.665 . . . . 0.82 108.681 177.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.54 52.31 0.2 Allowed 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.148 -0.933 . . . . 1.73 110.985 -178.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.785 HG13 HG13 ' A' ' 108' ' ' ILE . 0.7 OUTLIER -62.3 95.57 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-O 121.533 0.683 . . . . 0.77 109.379 179.611 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.1 t30 . . . . . 0 N--CA 1.439 -0.996 0 CA-C-N 114.683 -1.144 . . . . 1.9 108.389 -176.806 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.587 ' CE1' ' H ' ' A' ' 118' ' ' LEU . 4.0 t-80 . . . . . 0 N--CA 1.425 -1.69 0 N-CA-C 104.808 -2.293 . . . . 0.42 104.808 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -27.29 -45.75 0.07 OUTLIER 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 124.272 3.314 . . . . 0.4 113.913 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.87 HD11 ' HB ' ' A' ' 15' ' ' ILE . 24.0 tp -64.86 -50.81 65.15 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.608 0.763 . . . . 0.39 111.854 178.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.672 ' OH ' HG22 ' A' ' 40' ' ' ILE . 36.4 m-85 -75.9 -33.01 59.9 Favored 'General case' 0 CA--C 1.505 -0.788 0 O-C-N 122.203 -0.311 . . . . 3.04 111.509 178.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -56.51 -38.85 72.35 Favored 'General case' 0 CA--C 1.493 -1.239 0 N-CA-C 106.927 -1.509 . . . . 2.44 106.927 170.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.812 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 56.6 t80 -67.43 -32.18 72.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.224 -0.898 . . . . 0.56 110.661 175.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.766 ' HE3' ' HG ' ' A' ' 118' ' ' LEU . 0.6 OUTLIER -74.64 -54.5 7.31 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.248 -0.433 . . . . 0.71 110.142 -171.075 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.407 ' HE2' ' HB2' ' A' ' 123' ' ' LYS . 1.2 ptmm? -70.29 -24.57 63.06 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.191 -0.459 . . . . 1.46 111.396 176.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.512 ' HG3' ' O ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -74.43 -27.91 60.82 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 119.151 -1.02 . . . . 1.99 110.118 176.231 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 90.8 m -78.27 -43.04 29.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.887 -0.597 . . . . 0.59 110.265 175.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 41.0 tttm . . . . . 0 C--N 1.325 -0.475 0 N-CA-C 108.884 -0.784 . . . . 1.85 108.884 178.878 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.606 ' HB3' ' HG3' ' A' ' 156' ' ' PRO . 12.6 m-90 . . . . . 0 CA--C 1.518 -0.283 0 CA-C-O 121.279 0.561 . . . . 1.97 110.983 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.481 ' HB3' ' H ' ' A' ' 139' ' ' PHE . 6.1 m-20 -43.06 -156.22 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.725 -1.125 . . . . 2.04 112.157 157.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.718 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 2.8 m-85 -28.74 -47.25 0.05 Allowed 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 116.337 1.977 . . . . 1.93 116.337 -168.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.618 ' HB ' ' OD1' ' A' ' 42' ' ' ASN . 9.7 m 36.12 91.8 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.386 0.994 . . . . 0.6 113.21 176.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.634 ' HB3' HD12 ' A' ' 39' ' ' LEU . 0.7 OUTLIER -83.41 163.26 20.67 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.464 -0.789 . . . . 0.62 110.685 -175.023 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.531 ' HA ' ' HA ' ' A' ' 153' ' ' ARG . 76.4 m-85 -129.77 122.26 28.47 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 105.52 -2.03 . . . . 0.57 105.52 168.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.832 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 7.3 tp -80.19 103.51 10.11 Favored 'General case' 0 N--CA 1.422 -1.865 0 C-N-CA 118.528 -1.269 . . . . 0.43 108.372 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.715 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 42.9 mm -90.23 139.54 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.734 0 CA-C-N 112.965 -1.925 . . . . 0.19 107.468 -179.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.546 ' HA ' HD13 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -93.92 -176.95 4.18 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 119.71 -0.796 . . . . 0.98 111.276 -169.197 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.639 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 35.3 mtm180 -51.94 -41.45 62.06 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.994 0.426 . . . . 2.22 111.18 -177.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -95.65 14.68 22.21 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 109.646 -0.501 . . . . 2.0 109.646 -175.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.489 ' HA2' HG22 ' A' ' 144' ' ' ILE . . . 78.38 30.83 48.44 Favored Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 121.223 -0.513 . . . . 0.17 113.915 179.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 49.5 t -103.85 115.3 63.63 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 118.224 1.012 . . . . 1.12 111.428 177.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.706 ' HD3' HG23 ' A' ' 15' ' ' ILE . 29.6 Cg_endo -66.58 117.93 5.13 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 123.44 2.76 . . . . 0.41 110.86 177.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 16.0 m -119.42 -9.83 11.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 120.704 0.287 . . . . 1.45 110.247 -176.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.832 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 18.3 mm-40 -145.13 166.57 25.02 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-N 115.749 -0.659 . . . . 1.17 110.659 175.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.54 HH11 ' HG2' ' A' ' 153' ' ' ARG . 0.0 OUTLIER -147.58 126.65 12.87 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.757 -1.11 . . . . 2.16 109.253 161.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.682 ' HZ ' ' HB2' ' A' ' 166' ' ' LYS . 91.1 m-85 -99.28 148.37 24.21 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.028 -0.987 . . . . 0.32 109.563 -174.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 16.1 m -88.19 149.4 44.99 Favored Pre-proline 0 C--N 1.311 -1.085 0 N-CA-C 109.234 -0.654 . . . . 1.11 109.234 -179.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.606 ' HG3' ' HB3' ' A' ' 137' ' ' TRP . 33.8 Cg_endo -64.29 96.02 0.22 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 121.841 1.694 . . . . 0.78 108.446 170.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 151.07 -17.3 0.92 Allowed Glycine 0 N--CA 1.433 -1.561 0 N-CA-C 109.019 -1.632 . . . . 0.5 109.019 -164.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.413 ' HB1' ' HB2' ' A' ' 162' ' ' ASP . . . -92.18 145.91 24.13 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.919 -1.141 . . . . 0.5 107.919 166.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.594 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 31.1 t -109.94 -178.23 3.47 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.895 -0.409 . . . . 1.42 109.895 -174.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.697 ' CG2' ' HA ' ' A' ' 56' ' ' THR . 57.8 t -41.44 -51.11 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.301 0 O-C-N 124.081 0.863 . . . . 0.28 110.732 178.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 7.6 tttm -60.62 -46.11 91.51 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.088 -0.96 . . . . 3.46 111.108 -174.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.413 ' HB2' ' HB1' ' A' ' 158' ' ' ALA . 42.0 m-20 -66.53 -30.64 71.0 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.912 -1.04 . . . . 1.4 110.333 -173.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.54 HD12 ' CG2' ' A' ' 56' ' ' THR . 60.1 mt -81.89 -45.23 20.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.674 -0.694 . . . . 0.21 111.25 177.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.609 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 52.3 mt-10 -53.96 -43.15 69.66 Favored 'General case' 0 C--O 1.215 -0.747 0 CA-C-O 120.907 0.384 . . . . 0.67 111.379 -177.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -59.15 -19.18 42.71 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 112.279 0.474 . . . . 0.87 112.279 -176.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.682 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 75.4 mmtt -103.17 -27.3 12.61 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.54 0.686 . . . . 1.71 109.948 173.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.609 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 13.7 tp -77.27 -50.86 11.94 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.95 -1.023 . . . . 0.16 112.409 -177.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.471 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 73.4 mt -54.33 -45.8 99.16 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 115.734 -0.666 . . . . 0.26 112.201 -174.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.471 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 82.2 Cg_exo -51.42 -29.48 31.26 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.343 2.029 . . . . 0.41 113.015 173.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.771 HD12 HD11 ' A' ' 143' ' ' LEU . 73.6 mt -88.81 -42.12 12.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.663 -0.244 . . . . 0.71 111.251 178.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.757 HD23 ' HG2' ' A' ' 37' ' ' PRO . 93.0 mt -60.37 -56.4 21.89 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-O 122.052 0.93 . . . . 0.34 109.649 175.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.323 0 CA-C-N 113.385 -1.734 . . . . 1.12 112.106 178.137 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.4 p . . . . . 0 CA--C 1.527 0.065 0 CA-C-O 121.348 0.594 . . . . 1.58 110.352 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 85.7 p 178.21 152.75 0.3 Allowed 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 105.708 -1.96 . . . . 1.17 105.708 -178.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.848 ' HB ' HD11 ' A' ' 118' ' ' LEU . 5.1 pt -64.63 -18.36 23.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-N 114.769 -1.105 . . . . 0.38 111.519 -176.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.85 ' HB3' HG13 ' A' ' 31' ' ' VAL . 36.5 m-85 -70.45 -7.75 45.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.946 -0.57 . . . . 0.3 111.871 -176.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -68.29 -17.43 64.27 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.385 -0.969 . . . . 2.11 108.385 175.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.697 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 55.9 m-85 -115.67 108.03 15.86 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 115.12 -0.945 . . . . 0.31 111.096 -176.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -45.8 144.01 1.89 Allowed 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 113.687 -1.597 . . . . 2.86 110.396 171.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.706 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 35.7 t -110.66 169.17 3.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 N-CA-C 107.485 -1.302 . . . . 0.67 107.485 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.851 ' HB2' ' HE1' ' A' ' 105' ' ' MET . 61.6 mt -132.12 123.22 26.69 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 118.538 0.608 . . . . 0.69 111.605 -177.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.516 ' N ' ' HB2' ' A' ' 28' ' ' TYR . 14.7 t70 -62.03 161.51 10.67 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.187 -1.412 . . . . 1.87 107.187 167.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.816 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . . . -52.88 -15.39 0.75 Allowed 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 114.793 1.405 . . . . 0.59 114.793 -165.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.56 ' HB2' ' HE2' ' A' ' 26' ' ' LYS . 38.2 m-20 -91.93 -2.33 56.84 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.417 0.525 . . . . 2.34 112.417 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.64 ' CD2' ' HB1' ' A' ' 106' ' ' ALA . 68.8 m-70 82.84 11.27 0.54 Allowed 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.59 0.71 . . . . 1.47 109.477 -177.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.56 ' HE2' ' HB2' ' A' ' 24' ' ' ASP . 17.5 mtmt -77.0 120.7 82.79 Favored Pre-proline 0 C--N 1.323 -0.575 0 N-CA-C 107.148 -1.427 . . . . 4.25 107.148 169.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.716 ' HA ' HD23 ' A' ' 21' ' ' LEU . 78.9 Cg_exo -49.42 114.32 1.27 Allowed 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 122.055 1.837 . . . . 0.54 113.062 -174.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.565 ' HB3' HG12 ' A' ' 20' ' ' VAL . 6.8 t80 -81.32 139.14 35.56 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 113.53 -1.668 . . . . 1.2 111.356 176.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.65 ' ND2' HG23 ' A' ' 31' ' ' VAL . 2.6 t-20 -72.35 90.66 1.29 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.691 -1.141 . . . . 1.51 109.847 176.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.769 ' HG ' ' CD1' ' A' ' 16' ' ' PHE . 29.4 tp -70.65 -41.36 72.22 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.081 0.467 . . . . 0.28 109.949 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.85 HG13 ' HB3' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -63.47 0.64 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 115.181 -0.918 . . . . 1.02 113.054 -174.873 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.553 ' HB3' ' OD1' ' A' ' 29' ' ' ASN . 3.6 pt20 -74.35 -7.18 51.99 Favored 'General case' 0 CA--C 1.509 -0.623 0 O-C-N 121.92 -0.488 . . . . 1.02 110.762 176.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.914 ' HB2' HD22 ' A' ' 38' ' ' LEU . 63.3 m-70 -104.98 30.16 5.76 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.697 0.761 . . . . 0.28 109.647 173.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.774 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 23.6 mtmt -86.23 110.39 19.58 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 114.81 -1.086 . . . . 1.56 109.599 172.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 128.48 -41.1 1.61 Allowed Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 111.204 -0.758 . . . . 0.2 111.204 -176.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.457 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 18.0 m -129.25 130.63 23.37 Favored Pre-proline 0 N--CA 1.436 -1.171 0 N-CA-C 109.139 -0.689 . . . . 0.29 109.139 171.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.802 ' HG2' HD23 ' A' ' 171' ' ' LEU . 5.4 Cg_endo -43.51 150.77 0.43 Allowed 'Trans proline' 0 CA--C 1.513 -0.528 0 C-N-CA 124.768 3.645 . . . . 0.18 113.522 178.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.914 HD22 ' HB2' ' A' ' 33' ' ' HIS . 1.2 pt? -130.13 149.0 52.03 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 107.491 -1.3 . . . . 0.31 107.491 174.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 1.005 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 1.5 mm? -111.35 112.46 24.23 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.329 -0.989 . . . . 1.19 108.329 174.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.868 HG23 ' HB2' ' A' ' 72' ' ' LEU . 4.2 mt -96.93 125.23 49.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 C-N-CA 119.98 -0.688 . . . . 0.37 110.369 177.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 1.005 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -109.98 123.03 48.92 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 116.245 -0.434 . . . . 0.42 109.967 -175.543 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.703 ' ND2' ' HB ' ' A' ' 140' ' ' THR . 2.3 p-10 -81.21 94.07 6.61 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 107.696 -1.224 . . . . 2.35 107.696 170.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.859 ' O ' ' HA ' ' A' ' 75' ' ' PRO . 1.2 p . . . . . 0 C--N 1.294 -1.844 0 CA-C-N 115.262 -0.881 . . . . 1.03 111.626 -160.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 0.116 0 N-CA-C 112.307 -0.317 . . . . 0.51 112.307 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -41.57 -43.57 3.94 Favored Glycine 0 C--O 1.223 -0.547 0 O-C-N 124.013 0.478 . . . . 0.5 113.791 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.551 ' HA ' ' CZ ' ' A' ' 139' ' ' PHE . 0.1 OUTLIER -59.48 -60.12 4.36 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.739 0.269 . . . . 0.7 111.634 -174.852 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -60.86 -34.72 75.03 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.347 0.594 . . . . 2.61 109.632 -176.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.672 ' OG1' ' HA ' ' A' ' 159' ' ' SER . 72.1 m -62.63 -59.64 4.64 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.699 -1.137 . . . . 0.33 110.1 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 1.094 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -60.55 -49.28 78.18 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.042 -0.981 . . . . 0.22 111.424 -177.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.649 ' N ' ' HE1' ' A' ' 102' ' ' PHE . 37.6 m -55.15 -51.95 64.83 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.464 0.649 . . . . 0.26 110.479 -177.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.497 ' HA ' ' ND2' ' A' ' 62' ' ' ASN . 29.7 m -71.03 -31.8 68.38 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.264 -0.88 . . . . 0.48 111.442 -176.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.708 HD21 ' HG3' ' A' ' 164' ' ' GLU . 14.6 mt -71.91 -50.74 26.6 Favored 'General case' 0 CA--C 1.494 -1.186 0 CA-C-O 120.924 0.392 . . . . 0.43 110.6 -177.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.81 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 3.0 t80 -51.47 -60.34 3.24 Favored 'General case' 0 C--O 1.203 -1.374 0 CA-C-N 114.645 -1.161 . . . . 0.31 109.752 178.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 1.046 ' HA ' ' HG3' ' A' ' 65' ' ' LYS . 4.3 p30 -70.06 -24.55 63.26 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 121.11 -0.236 . . . . 1.21 111.006 -171.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.519 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 35.3 ttpt -76.48 -21.31 55.99 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.184 -1.043 . . . . 1.54 108.184 -177.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.783 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 65.4 m-85 -130.12 10.13 5.35 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 114.679 1.363 . . . . 0.31 114.679 -176.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 1.046 ' HG3' ' HA ' ' A' ' 62' ' ' ASN . 27.9 mtmt -54.11 -38.29 65.25 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 106.588 -1.634 . . . . 1.35 106.588 169.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -48.5 -42.17 32.19 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 111.697 -2.501 . . . . 1.28 112.908 -177.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.406 HE21 ' HD1' ' A' ' 64' ' ' TYR . 47.0 mt-30 -85.06 -36.3 21.3 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.671 -0.412 . . . . 1.11 111.751 177.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.456 ' HA3' ' HB2' ' A' ' 36' ' ' SER . . . 147.38 -5.73 1.03 Allowed Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 110.829 -0.909 . . . . 0.18 110.829 -176.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.783 ' HD2' ' HB2' ' A' ' 64' ' ' TYR . 17.1 t80 -66.9 139.25 57.72 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 114.951 -0.625 . . . . 0.18 110.973 -177.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.901 HG22 ' HB2' ' A' ' 38' ' ' LEU . 1.6 t -132.82 149.51 52.26 Favored 'General case' 0 N--CA 1.414 -2.238 0 N-CA-C 108.653 -0.869 . . . . 0.2 108.653 172.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 1.094 HG11 ' HB1' ' A' ' 57' ' ' ALA . 29.7 t -102.7 101.52 12.28 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.23 0 N-CA-C 108.058 -1.089 . . . . 0.17 108.058 160.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.868 ' HB2' HG23 ' A' ' 40' ' ' ILE . 66.1 mt -84.67 119.65 25.49 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 108.218 -1.03 . . . . 1.04 108.218 178.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.741 ' HB1' HG11 ' A' ' 43' ' ' VAL . . . -100.39 112.32 24.66 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 121.328 0.585 . . . . 0.51 111.632 -178.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.843 ' CG ' ' HG2' ' A' ' 105' ' ' MET . 2.9 m-85 -103.59 95.17 6.91 Favored Pre-proline 0 C--N 1.316 -0.872 0 N-CA-C 109.275 -0.639 . . . . 0.44 109.275 176.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.859 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 76.3 Cg_endo -83.5 95.75 0.78 Allowed 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.249 1.966 . . . . 1.3 113.84 -169.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.774 ' HB2' HG23 ' A' ' 110' ' ' VAL . 47.4 t . . . . . 0 CA--C 1.509 -0.634 0 CA-C-O 121.865 0.84 . . . . 1.44 112.628 -176.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.453 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . . . . . . 0 CA--C 1.512 -0.515 0 CA-C-O 121.124 0.488 . . . . 0.55 111.546 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -99.76 21.28 12.7 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.47 -0.786 . . . . 1.99 111.925 -178.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.708 ' HB3' ' O ' ' A' ' 71' ' ' VAL . 0.4 OUTLIER -109.43 177.8 1.17 Allowed Pre-proline 0 CA--C 1.511 -0.528 0 CA-C-O 121.317 0.579 . . . . 0.84 110.131 177.037 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.693 ' HD3' ' CE2' ' A' ' 61' ' ' TYR . 6.6 Cg_exo -80.81 76.16 4.66 Favored 'Trans proline' 0 N--CA 1.445 -1.37 0 C-N-CA 123.94 3.093 . . . . 0.62 110.003 162.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.654 HG12 ' HB3' ' A' ' 73' ' ' ALA . 34.8 mt -74.55 138.01 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 107.288 -1.375 . . . . 1.34 107.288 176.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.851 ' HE1' ' HB2' ' A' ' 21' ' ' LEU . 1.1 ppp? -96.62 -171.62 2.31 Favored 'General case' 0 N--CA 1.434 -1.255 0 C-N-CA 120.229 -0.588 . . . . 3.03 112.093 -170.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.816 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . . . -64.97 -7.69 12.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.417 -0.81 . . . . 1.46 112.194 -178.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.838 ' HB2' ' O ' ' A' ' 75' ' ' PRO . 3.9 ptpp? 66.04 133.72 0.02 OUTLIER 'General case' 0 CA--C 1.498 -1.036 0 C-N-CA 125.29 1.436 . . . . 1.76 110.702 -168.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.745 HG13 ' HB2' ' A' ' 116' ' ' HIS . 0.2 OUTLIER -135.78 171.54 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.857 0 CA-C-N 113.554 -1.657 . . . . 0.82 107.468 170.176 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.411 ' ND2' HD21 ' A' ' 111' ' ' ASN . 4.9 m120 -64.83 64.18 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 114.946 -1.025 . . . . 1.73 112.916 178.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.774 HG23 ' HB2' ' A' ' 76' ' ' SER . 3.2 m -71.4 95.99 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 117.857 -1.537 . . . . 0.77 107.867 172.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.411 HD21 ' ND2' ' A' ' 109' ' ' ASN . 25.3 p30 . . . . . 0 C--N 1.315 -0.921 0 CA-C-N 113.601 -1.636 . . . . 1.9 108.065 -169.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.745 ' HB2' HG13 ' A' ' 108' ' ' ILE . 1.6 t-80 . . . . . 0 N--CA 1.431 -1.412 0 N-CA-C 107.703 -1.221 . . . . 0.42 107.703 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -28.4 -49.92 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 124.683 3.589 . . . . 0.4 113.792 -178.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.848 HD11 ' HB ' ' A' ' 15' ' ' ILE . 48.0 tp -61.14 -51.6 68.4 Favored 'General case' 0 C--O 1.22 -0.468 0 C-N-CA 122.745 0.418 . . . . 0.39 111.787 178.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.688 ' HA ' ' HB2' ' A' ' 122' ' ' MET . 29.7 m-85 -76.53 -33.68 58.57 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 112.489 0.551 . . . . 3.04 112.489 -179.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.566 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 42.5 mt-10 -60.49 -34.92 74.76 Favored 'General case' 0 CA--C 1.491 -1.325 0 N-CA-C 107.121 -1.437 . . . . 2.44 107.121 171.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.697 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 45.0 t80 -69.48 -34.22 74.03 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 119.262 -0.975 . . . . 0.56 110.234 173.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.688 ' HB2' ' HA ' ' A' ' 119' ' ' TYR . 40.4 mtt -74.86 -52.23 11.87 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.89 -0.595 . . . . 0.71 112.057 -169.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.422 ' HB2' ' HE2' ' A' ' 123' ' ' LYS . 0.2 OUTLIER -69.56 -24.44 63.71 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 120.366 -0.534 . . . . 1.46 109.853 176.863 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.566 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 17.0 tttt -65.58 -38.15 88.7 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.248 -0.433 . . . . 1.99 110.309 170.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 36.2 m -65.43 -61.23 2.23 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.936 -0.574 . . . . 0.59 111.426 -176.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.495 ' HD2' ' O ' ' A' ' 151' ' ' VAL . 36.8 ttmt . . . . . 0 C--N 1.33 -0.269 0 N-CA-C 109.957 -0.386 . . . . 1.85 109.957 177.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.545 ' HB3' ' HG3' ' A' ' 156' ' ' PRO . 6.4 m-90 . . . . . 0 N--CA 1.448 -0.538 0 N-CA-C 109.509 -0.552 . . . . 1.97 109.509 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.494 ' N ' HD22 ' A' ' 138' ' ' ASN . 0.9 OUTLIER -45.26 -153.93 0.0 OUTLIER 'General case' 0 C--O 1.209 -1.029 0 C-N-CA 123.846 0.859 . . . . 2.04 111.163 162.342 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.649 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 2.0 m-85 -27.5 -48.89 0.04 OUTLIER 'General case' 0 C--O 1.21 -0.983 0 N-CA-C 115.239 1.57 . . . . 1.93 115.239 -169.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.703 ' HB ' ' ND2' ' A' ' 42' ' ' ASN . 8.6 m 39.17 108.46 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 122.746 1.26 . . . . 0.6 113.84 173.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.69 ' HB3' HD12 ' A' ' 39' ' ' LEU . 1.4 m -100.64 165.25 11.49 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 114.811 -1.086 . . . . 0.62 110.014 -170.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.624 ' HA ' ' HA ' ' A' ' 153' ' ' ARG . 28.4 m-85 -128.38 125.96 39.7 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 105.916 -1.883 . . . . 0.57 105.916 163.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.851 HD11 HD12 ' A' ' 170' ' ' LEU . 1.6 tp -81.17 104.11 11.43 Favored 'General case' 0 C--N 1.288 -2.103 0 C-N-CA 118.565 -1.254 . . . . 0.43 108.563 178.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.685 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 28.3 mm -92.65 136.89 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.992 0 CA-C-N 113.097 -1.865 . . . . 0.19 107.592 -178.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.576 ' HA ' HD13 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -90.85 -174.18 3.95 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 119.704 -0.798 . . . . 0.98 111.52 -170.793 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.724 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 41.0 mtt85 -55.81 -40.19 72.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.015 -0.539 . . . . 2.22 111.109 -177.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.5 18.01 16.33 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.668 0.747 . . . . 2.0 109.085 -177.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.647 ' HA3' ' CE2' ' A' ' 16' ' ' PHE . . . 73.6 32.69 59.19 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 114.805 -1.089 . . . . 0.17 114.853 177.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.402 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 58.3 t -93.93 126.49 48.98 Favored Pre-proline 0 C--N 1.314 -0.962 0 CA-C-N 118.235 1.018 . . . . 1.12 110.72 175.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.47 ' HA ' HD13 ' A' ' 144' ' ' ILE . 12.2 Cg_endo -78.22 105.13 1.94 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.898 2.399 . . . . 0.41 110.073 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.495 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 4.6 t -93.94 -72.21 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 106.603 -1.628 . . . . 1.45 106.603 -178.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.816 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 0.3 OUTLIER -88.96 164.69 15.0 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 114.4 -1.273 . . . . 1.17 111.18 -177.476 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.624 ' HA ' ' HA ' ' A' ' 142' ' ' PHE . 0.0 OUTLIER -135.36 150.97 50.06 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 113.009 -1.905 . . . . 2.16 107.136 156.219 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.556 ' O ' ' HA ' ' A' ' 140' ' ' THR . 92.2 m-85 -125.46 145.44 50.08 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 108.442 -0.947 . . . . 0.32 108.442 -171.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.413 ' OG ' ' HD2' ' A' ' 156' ' ' PRO . 21.2 t -72.34 154.37 91.94 Favored Pre-proline 0 C--N 1.315 -0.918 0 N-CA-C 108.375 -0.972 . . . . 1.11 108.375 174.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.545 ' HG3' ' HB3' ' A' ' 137' ' ' TRP . 9.6 Cg_endo -51.45 -41.49 59.66 Favored 'Trans proline' 0 CA--C 1.519 -0.259 0 C-N-CA 122.185 1.923 . . . . 0.78 111.126 174.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -58.71 -19.35 42.42 Favored Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 114.645 -1.161 . . . . 0.5 113.725 176.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -70.62 136.41 49.13 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 109.005 -0.739 . . . . 0.5 109.005 177.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.672 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 19.8 m -108.46 -178.35 3.57 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 120.776 0.322 . . . . 1.42 110.705 -170.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.619 HG22 ' HA ' ' A' ' 56' ' ' THR . 46.7 t -44.8 -50.41 2.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 114.927 -1.033 . . . . 0.28 111.313 -178.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 26.0 tttm -64.75 -39.6 93.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.041 -0.527 . . . . 3.46 111.205 -176.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.512 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 32.7 m-20 -68.64 -39.54 80.69 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.52 -0.764 . . . . 1.4 109.632 -172.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.563 HD13 ' OH ' ' A' ' 41' ' ' TYR . 54.1 mt -75.1 -43.7 44.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 114.953 -1.021 . . . . 0.21 110.78 177.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.718 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 28.1 mt-10 -56.42 -39.9 73.82 Favored 'General case' 0 C--O 1.217 -0.624 0 N-CA-C 111.973 0.36 . . . . 0.67 111.973 -177.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.512 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 10.0 pt-20 -61.34 -23.91 66.08 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.673 -0.411 . . . . 0.87 111.249 -176.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.556 ' HB3' HD22 ' A' ' 143' ' ' LEU . 72.3 mmtt -99.08 -14.82 19.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.623 0.725 . . . . 1.71 109.759 175.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.718 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 12.8 tp -92.8 -51.91 4.86 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.059 -0.973 . . . . 0.16 112.385 -174.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.511 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 78.1 mt -53.03 -48.59 91.35 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.541 -0.754 . . . . 0.26 112.901 -171.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.511 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 74.2 Cg_exo -52.69 -33.9 61.66 Favored 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 121.974 1.783 . . . . 0.41 112.321 176.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.851 HD12 HD11 ' A' ' 143' ' ' LEU . 93.1 mt -77.18 -46.68 22.52 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 116.016 -0.538 . . . . 0.71 110.75 178.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.802 HD23 ' HG2' ' A' ' 37' ' ' PRO . 89.5 mt -58.33 -56.67 19.11 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 121.66 0.743 . . . . 0.34 110.37 177.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.265 0 CA-C-N 113.688 -1.597 . . . . 1.12 112.819 179.368 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.3 p . . . . . 0 N--CA 1.452 -0.343 0 CA-C-O 121.467 0.651 . . . . 1.58 109.543 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.532 ' HB3' ' O ' ' A' ' 147' ' ' ASP . 1.4 m -153.53 169.22 23.74 Favored 'General case' 0 N--CA 1.427 -1.575 0 N-CA-C 105.107 -2.182 . . . . 1.17 105.107 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.864 HD12 HD21 ' A' ' 30' ' ' LEU . 5.0 pt -61.55 -21.82 26.42 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.16 0 CA-C-O 121.777 0.799 . . . . 0.38 109.566 172.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.95 ' HB3' HG12 ' A' ' 31' ' ' VAL . 25.0 m-85 -70.6 -7.4 43.85 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.848 1.055 . . . . 0.3 113.848 -172.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -77.85 -5.32 50.52 Favored 'General case' 0 CA--C 1.502 -0.865 0 N-CA-C 107.951 -1.129 . . . . 2.11 107.951 178.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.795 ' HE2' ' HB2' ' A' ' 121' ' ' TYR . 41.9 m-85 -120.06 112.02 18.61 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 114.313 -1.312 . . . . 0.31 110.204 -175.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.92 149.52 2.63 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 113.521 -1.672 . . . . 2.86 110.632 174.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.798 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 35.6 t -112.12 158.62 12.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 107.874 -1.158 . . . . 0.67 107.874 174.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.9 ' O ' ' HB3' ' A' ' 105' ' ' MET . 96.0 mt -126.88 109.04 11.55 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 119.183 -0.437 . . . . 0.69 110.87 -174.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 17.0 t70 -46.81 158.0 0.14 Allowed 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 107.972 -1.121 . . . . 1.87 107.972 170.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.631 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . . . -53.79 -10.32 0.29 Allowed 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 113.251 0.834 . . . . 0.59 113.251 -167.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.539 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 25.9 t0 -93.46 -6.16 47.57 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 122.943 0.497 . . . . 2.34 111.899 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.688 ' CD2' ' HB1' ' A' ' 106' ' ' ALA . 60.8 m-70 82.38 24.5 0.19 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.77 0.795 . . . . 1.47 109.206 -177.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.414 ' HA ' ' HD3' ' A' ' 26' ' ' LYS . 27.2 mmtt -106.74 125.69 32.1 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 114.307 -1.315 . . . . 4.25 108.362 176.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.619 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 73.0 Cg_exo -52.67 114.7 1.81 Allowed 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.329 2.019 . . . . 0.54 114.561 -167.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.737 ' HE2' HD23 ' A' ' 72' ' ' LEU . 6.9 t80 -81.76 128.06 33.6 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 113.391 -1.732 . . . . 1.2 109.285 165.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.462 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 0.4 OUTLIER -74.63 91.55 2.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 122.341 1.067 . . . . 1.51 110.976 -179.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.864 HD21 HD12 ' A' ' 15' ' ' ILE . 52.2 tp -58.0 -36.21 72.33 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.009 -0.996 . . . . 0.28 110.589 -178.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.95 HG12 ' HB3' ' A' ' 16' ' ' PHE . 3.6 m -66.75 -1.22 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 114.768 -1.105 . . . . 1.02 113.178 -172.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.462 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 18.3 pt20 -77.2 -15.28 59.56 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 119.406 -0.917 . . . . 1.02 109.542 175.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.989 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 95.9 m-70 -86.83 27.86 0.95 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.959 0.885 . . . . 0.28 109.6 174.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 45.7 mttm -80.7 124.32 28.93 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 114.275 -1.33 . . . . 1.56 109.747 172.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.96 -40.06 2.68 Favored Glycine 0 N--CA 1.438 -1.22 0 C-N-CA 120.671 -0.776 . . . . 0.2 112.045 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.497 ' HB2' ' HA3' ' A' ' 68' ' ' GLY . 16.7 m -124.28 126.52 25.51 Favored Pre-proline 0 N--CA 1.435 -1.221 0 N-CA-C 108.689 -0.856 . . . . 0.29 108.689 175.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.832 ' HG3' ' CB ' ' A' ' 170' ' ' LEU . 2.9 Cg_endo -42.67 157.34 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 124.271 3.314 . . . . 0.18 113.015 176.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.814 ' HB2' HG22 ' A' ' 70' ' ' THR . 0.8 OUTLIER -145.08 143.36 30.38 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 107.575 -1.269 . . . . 0.31 107.575 -177.386 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 1.051 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 1.9 mm? -108.08 114.03 27.63 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.014 -0.735 . . . . 1.19 109.014 178.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.68 HG23 HD13 ' A' ' 72' ' ' LEU . 1.2 mt -96.23 125.61 49.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 C-N-CA 120.422 -0.511 . . . . 0.37 110.087 177.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 1.051 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.6 OUTLIER -107.07 133.09 52.22 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 120.449 -0.501 . . . . 0.42 110.254 -176.684 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.647 HD22 ' N ' ' A' ' 42' ' ' ASN . 0.3 OUTLIER -92.38 91.91 7.88 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 105.526 -2.027 . . . . 2.35 105.526 174.396 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.765 HG11 ' HB1' ' A' ' 73' ' ' ALA . 2.8 p . . . . . 0 C--N 1.302 -1.467 0 N-CA-C 112.813 0.672 . . . . 1.03 112.813 -160.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.561 ' O ' ' HG2' ' A' ' 55' ' ' GLU . . . . . . . . 0 N--CA 1.444 -0.784 0 N-CA-C 111.397 -0.681 . . . . 0.51 111.397 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -56.52 -24.91 48.57 Favored Glycine 0 C--O 1.222 -0.623 0 CA-C-O 119.792 -0.449 . . . . 0.5 113.326 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.513 ' HA ' ' CZ ' ' A' ' 139' ' ' PHE . 0.4 OUTLIER -61.09 -60.94 2.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.509 0.654 . . . . 0.7 110.298 179.167 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.561 ' HG2' ' O ' ' A' ' 52' ' ' GLY . 11.9 pt-20 -63.28 -21.21 66.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.647 -0.706 . . . . 2.61 110.349 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.671 ' HA ' HG22 ' A' ' 160' ' ' VAL . 54.1 m -73.01 -59.93 2.47 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.065 -0.971 . . . . 0.33 109.617 178.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 1.097 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -60.66 -42.04 96.23 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.552 -1.204 . . . . 0.22 110.876 -178.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.557 ' HA ' ' CD1' ' A' ' 102' ' ' PHE . 85.7 m -57.18 -57.31 13.16 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.541 -0.754 . . . . 0.26 110.471 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 22.7 m -70.6 -33.26 70.85 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.474 -0.784 . . . . 0.48 111.694 -174.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.77 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 18.7 mt -65.07 -47.67 76.48 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-O 121.435 0.636 . . . . 0.43 110.321 -178.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.863 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 10.0 t80 -59.7 -49.73 76.58 Favored 'General case' 0 C--O 1.205 -1.262 0 CA-C-N 114.757 -1.11 . . . . 0.31 111.045 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -72.35 -24.34 61.27 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 120.658 0.266 . . . . 1.21 110.659 -173.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.641 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 35.3 ttpt -85.76 -25.13 26.57 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 109.338 -0.616 . . . . 1.54 109.338 -178.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.822 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 32.5 m-85 -124.07 -6.74 7.78 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 115.491 1.663 . . . . 0.31 115.491 -169.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.693 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 3.8 ptmt -64.96 -26.99 68.53 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 108.004 -1.11 . . . . 1.35 108.004 170.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.6 t -47.63 -34.02 7.45 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.022 -1.444 . . . . 1.28 110.526 173.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.425 ' OE1' ' HB3' ' A' ' 171' ' ' LEU . 47.7 mt-30 -90.43 -39.65 12.51 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.681 0.277 . . . . 1.11 111.218 174.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.497 ' HA3' ' HB2' ' A' ' 36' ' ' SER . . . 151.81 -3.53 0.42 Allowed Glycine 0 CA--C 1.52 0.386 0 N-CA-C 111.23 -0.748 . . . . 0.18 111.23 -177.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.822 ' HD2' ' HB2' ' A' ' 64' ' ' TYR . 20.7 t80 -70.31 140.64 52.31 Favored 'General case' 0 C--O 1.218 -0.595 0 C-N-CA 123.029 0.532 . . . . 0.18 111.544 -177.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.989 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 2.2 t -134.49 145.57 48.92 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 108.818 -0.808 . . . . 0.2 108.818 174.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 1.097 HG11 ' HB1' ' A' ' 57' ' ' ALA . 42.8 t -104.94 99.99 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.257 0 N-CA-C 108.359 -0.978 . . . . 0.17 108.359 160.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.774 HD12 ' H ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -96.51 120.97 37.79 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 118.842 -1.143 . . . . 1.04 108.044 174.422 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.765 ' HB1' HG11 ' A' ' 43' ' ' VAL . . . -108.16 128.69 54.92 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 116.214 -0.448 . . . . 0.51 110.0 179.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.907 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 2.6 m-30 -102.43 105.62 44.59 Favored Pre-proline 0 C--N 1.312 -1.056 0 N-CA-C 108.162 -1.051 . . . . 0.44 108.162 175.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.914 ' HG2' ' HB3' ' A' ' 107' ' ' LYS . 59.7 Cg_endo -74.8 68.04 5.64 Favored 'Trans proline' 0 N--CA 1.474 0.324 0 C-N-CA 123.545 2.83 . . . . 1.3 114.98 -168.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.402 ' HB3' ' CG2' ' A' ' 110' ' ' VAL . 85.3 p . . . . . 0 N--CA 1.483 1.179 0 C-N-CA 126.978 2.111 . . . . 1.44 116.542 178.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.566 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . . . . . . 0 CA--C 1.505 -0.758 0 CA-C-O 121.048 0.451 . . . . 0.55 111.386 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -91.6 26.52 2.3 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.435 -0.802 . . . . 1.99 110.437 176.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.577 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 25.9 p90 -146.76 155.76 48.29 Favored Pre-proline 0 N--CA 1.441 -0.886 0 N-CA-C 108.712 -0.847 . . . . 0.84 108.712 175.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.686 ' HG2' ' HA ' ' A' ' 72' ' ' LEU . 35.9 Cg_endo -60.25 88.97 0.08 OUTLIER 'Trans proline' 0 CA--C 1.513 -0.53 0 C-N-CA 124.638 3.559 . . . . 0.62 114.137 -171.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.66 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 18.3 mt -100.6 126.78 54.16 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.348 0 N-CA-C 107.631 -1.248 . . . . 1.34 107.631 174.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.907 ' HG3' ' CE1' ' A' ' 74' ' ' PHE . 13.4 mmt -103.02 -159.82 0.75 Allowed 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.211 -0.904 . . . . 3.03 113.176 -158.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.688 ' HB1' ' CD2' ' A' ' 25' ' ' HIS . . . -65.81 -3.58 5.23 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.074 -0.966 . . . . 1.46 112.65 -172.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.914 ' HB3' ' HG2' ' A' ' 75' ' ' PRO . 14.3 ptpt 58.47 129.06 0.01 OUTLIER 'General case' 0 CA--C 1.494 -1.201 0 CA-C-O 122.889 1.328 . . . . 1.76 110.38 -168.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.499 HD11 ' CE2' ' A' ' 119' ' ' TYR . 1.7 pp -138.1 167.92 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.657 0 CA-C-N 114.05 -1.432 . . . . 0.82 108.382 173.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -46.27 110.67 0.29 Allowed 'General case' 0 C--N 1.296 -1.732 0 O-C-N 124.393 1.058 . . . . 1.73 110.006 171.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.502 ' CB ' ' HB3' ' A' ' 42' ' ' ASN . 5.5 m -117.77 91.45 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.135 0 N-CA-C 107.271 -1.381 . . . . 0.77 107.271 163.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.9 t30 . . . . . 0 C--N 1.312 -1.023 0 CA-C-N 114.188 -1.369 . . . . 1.9 109.225 -174.599 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.647 ' CE1' ' H ' ' A' ' 118' ' ' LEU . 2.7 t-80 . . . . . 0 N--CA 1.424 -1.732 0 N-CA-C 106.5 -1.667 . . . . 0.42 106.5 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -26.82 -48.12 0.08 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 124.456 3.437 . . . . 0.4 113.537 178.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.827 ' HG ' ' HE3' ' A' ' 122' ' ' MET . 48.3 tp -60.15 -52.74 64.02 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.364 0.665 . . . . 0.39 112.288 177.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.736 ' HE2' ' CD2' ' A' ' 74' ' ' PHE . 70.2 m-85 -77.28 -35.12 55.45 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-N 116.663 -0.244 . . . . 3.04 111.511 -178.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.486 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 7.0 mm-40 -56.79 -36.1 69.49 Favored 'General case' 0 CA--C 1.491 -1.319 0 N-CA-C 107.803 -1.184 . . . . 2.44 107.803 170.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.795 ' HB2' ' HE2' ' A' ' 18' ' ' PHE . 60.8 t80 -69.86 -31.89 69.96 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 119.252 -0.979 . . . . 0.56 110.403 174.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.827 ' HE3' ' HG ' ' A' ' 118' ' ' LEU . 1.1 ttm -76.63 -55.06 5.85 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.551 -0.295 . . . . 0.71 111.244 -170.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.412 ' HE2' ' HB2' ' A' ' 123' ' ' LYS . 0.4 OUTLIER -69.29 -24.77 64.0 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.337 -0.392 . . . . 1.46 110.551 178.913 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.486 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 12.8 pttp -72.41 -28.64 63.11 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 119.384 -0.926 . . . . 1.99 109.696 175.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.447 ' HB ' ' HG2' ' A' ' 150' ' ' PRO . 97.4 m -76.57 -57.08 4.06 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.974 -0.557 . . . . 0.59 111.053 178.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 71.6 tttt . . . . . 0 N--CA 1.453 -0.319 0 CA-C-O 121.29 0.567 . . . . 1.85 112.005 -177.997 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.916 ' HB3' ' HG3' ' A' ' 156' ' ' PRO . 9.7 m-90 . . . . . 0 N--CA 1.454 -0.25 0 CA-C-O 120.961 0.41 . . . . 1.97 111.441 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.464 ' OD1' ' HD1' ' A' ' 139' ' ' PHE . 5.2 t-20 -38.96 -153.13 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 125.727 1.611 . . . . 2.04 111.565 157.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.674 ' CD1' HG23 ' A' ' 43' ' ' VAL . 2.4 m-85 -25.59 -52.18 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 115.461 1.652 . . . . 1.93 115.461 -169.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.616 ' HA ' ' O ' ' A' ' 154' ' ' PHE . 1.9 m 32.67 106.0 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.422 1.268 . . . . 0.6 114.422 175.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.741 ' HB3' HD12 ' A' ' 39' ' ' LEU . 2.8 m -92.58 174.04 7.48 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 114.084 -1.416 . . . . 0.62 111.393 -169.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.557 ' CD1' ' HB2' ' A' ' 153' ' ' ARG . 57.6 m-85 -138.64 123.01 18.29 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 105.985 -1.858 . . . . 0.57 105.985 165.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.932 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 2.9 tp -79.64 104.06 9.97 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 118.345 -1.342 . . . . 0.43 108.48 -179.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.726 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 40.2 mm -91.57 140.45 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.96 0 CA-C-N 113.647 -1.615 . . . . 0.19 107.873 -178.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.438 ' HA ' HD13 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -94.64 -172.26 2.7 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 120.062 -0.655 . . . . 0.98 111.515 -169.588 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.782 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 17.1 mtm180 -55.8 -36.77 67.78 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 123.168 0.293 . . . . 2.22 111.28 -176.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.532 ' O ' ' HB3' ' A' ' 14' ' ' SER . 34.8 t70 -102.2 23.22 11.98 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.33 -0.618 . . . . 2.0 109.33 -178.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.679 ' HA2' HG22 ' A' ' 144' ' ' ILE . . . 67.12 38.69 92.43 Favored Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 120.863 -0.684 . . . . 0.17 114.305 177.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 42.7 t -104.7 128.37 26.99 Favored Pre-proline 0 C--N 1.313 -0.979 0 CA-C-N 118.187 0.993 . . . . 1.12 110.618 173.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.447 ' HG2' ' HB ' ' A' ' 125' ' ' THR . 1.3 Cg_endo -71.12 118.85 5.9 Favored 'Trans proline' 0 CA--C 1.531 0.335 0 C-N-CA 122.662 2.241 . . . . 0.41 110.814 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.428 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 14.2 t -119.71 -7.0 11.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.825 -0.435 . . . . 1.45 109.825 -175.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.932 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 6.0 mm-40 -155.14 168.13 28.06 Favored 'General case' 0 CA--C 1.5 -0.948 0 CA-C-O 121.52 0.676 . . . . 1.17 111.007 176.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.557 ' HB2' ' CD1' ' A' ' 142' ' ' PHE . 1.4 ttm180 -147.91 132.99 18.24 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 113.851 -1.522 . . . . 2.16 108.726 164.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.616 ' O ' ' HA ' ' A' ' 140' ' ' THR . 96.7 m-85 -114.27 146.72 40.08 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.678 -0.692 . . . . 0.32 109.338 -168.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 15.8 m -65.1 150.14 95.85 Favored Pre-proline 0 C--N 1.313 -1.014 0 N-CA-C 109.001 -0.74 . . . . 1.11 109.001 175.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.916 ' HG3' ' HB3' ' A' ' 137' ' ' TRP . 38.5 Cg_endo -66.39 -16.31 50.91 Favored 'Trans proline' 0 CA--C 1.514 -0.519 0 C-N-CA 122.57 2.18 . . . . 0.78 110.974 177.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -88.31 2.07 84.83 Favored Glycine 0 N--CA 1.439 -1.158 0 CA-C-N 114.473 -1.239 . . . . 0.5 112.72 173.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -76.46 153.07 35.9 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.272 -0.64 . . . . 0.5 109.272 173.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.584 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 24.4 m -112.31 169.64 8.73 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 116.3 -0.409 . . . . 1.42 110.245 -175.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.671 HG22 ' HA ' ' A' ' 56' ' ' THR . 88.7 t -40.9 -52.53 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 O-C-N 124.363 1.039 . . . . 0.28 111.788 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 52.3 tttm -66.4 -32.99 74.71 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.031 -0.531 . . . . 3.46 111.166 -173.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -69.99 -31.45 69.15 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.859 -0.61 . . . . 1.4 109.847 -176.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.564 HD12 ' CG2' ' A' ' 56' ' ' THR . 70.1 mt -83.89 -43.24 17.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 115.184 -0.916 . . . . 0.21 110.954 176.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.582 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 35.0 mt-10 -53.05 -42.94 66.25 Favored 'General case' 0 C--O 1.216 -0.668 0 N-CA-C 111.723 0.268 . . . . 0.67 111.723 -177.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -54.88 -29.01 54.64 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 112.254 0.464 . . . . 0.87 112.254 -177.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.789 ' HB3' HD22 ' A' ' 143' ' ' LEU . 35.8 mmtm -94.68 -20.84 19.2 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.651 0.739 . . . . 1.71 110.103 177.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.582 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 14.1 tp -86.46 -49.34 7.67 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.617 -1.174 . . . . 0.16 112.413 -174.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.517 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 78.0 mt -55.66 -47.47 98.61 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.385 -0.825 . . . . 0.26 112.557 -172.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.517 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 76.5 Cg_exo -53.54 -28.53 45.81 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 122.356 2.037 . . . . 0.41 112.756 174.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.832 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 80.1 mt -86.23 -47.1 9.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.357 -0.383 . . . . 0.71 111.14 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.78 HD23 ' HG2' ' A' ' 37' ' ' PRO . 84.9 mt -57.45 -57.86 10.82 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-O 122.113 0.959 . . . . 0.34 109.781 176.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.393 0 CA-C-N 113.36 -1.745 . . . . 1.12 112.214 -178.708 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.8 p . . . . . 0 C--O 1.235 0.298 0 CA-C-O 121.307 0.575 . . . . 1.58 110.086 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 79.7 p 177.12 153.7 0.23 Allowed 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 105.842 -1.911 . . . . 1.17 105.842 -178.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.847 ' HB ' ' CD1' ' A' ' 118' ' ' LEU . 5.8 pt -69.26 -12.39 15.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 CA-C-N 115.063 -0.972 . . . . 0.38 112.133 -170.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.659 ' CD1' ' HA ' ' A' ' 31' ' ' VAL . 48.0 m-85 -74.83 -8.2 55.74 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 120.752 0.31 . . . . 0.3 111.184 -178.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -63.24 -21.13 66.03 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 108.91 -0.774 . . . . 2.11 108.91 170.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.835 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 60.8 m-85 -117.63 105.35 11.95 Favored 'General case' 0 CA--C 1.49 -1.341 0 CA-C-N 114.614 -1.175 . . . . 0.31 110.253 176.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -58.25 158.95 6.51 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 114.88 -1.054 . . . . 2.86 108.165 172.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.739 HG13 ' HZ ' ' A' ' 74' ' ' PHE . 20.3 t -108.33 169.28 3.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 107.393 -1.336 . . . . 0.67 107.393 -175.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.794 ' O ' ' HB2' ' A' ' 105' ' ' MET . 33.0 mt -127.21 141.52 51.71 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 109.534 -0.543 . . . . 0.69 109.534 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -71.21 -173.55 0.87 Allowed 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.24 -1.022 . . . . 1.87 108.24 174.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.75 ' HA ' ' CA ' ' A' ' 106' ' ' ALA . . . -66.93 -3.05 6.08 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 112.494 0.553 . . . . 0.59 112.494 -176.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 29.1 t70 -102.84 -3.25 26.55 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.803 -0.359 . . . . 2.34 110.832 176.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.656 ' CD2' ' HB3' ' A' ' 106' ' ' ALA . 1.9 m170 75.72 20.94 1.75 Allowed 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.741 0.781 . . . . 1.47 109.417 -178.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.477 ' HA ' ' HD3' ' A' ' 26' ' ' LYS . 45.9 mmtt -102.15 135.46 19.64 Favored Pre-proline 0 N--CA 1.443 -0.804 0 CA-C-N 114.397 -1.274 . . . . 4.25 108.45 171.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.64 ' HA ' HD23 ' A' ' 21' ' ' LEU . 84.7 Cg_exo -47.21 115.29 1.27 Allowed 'Trans proline' 0 C--N 1.335 -0.178 0 C-N-CA 123.341 2.694 . . . . 0.54 115.361 -165.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.622 ' OH ' ' HB3' ' A' ' 103' ' ' PRO . 0.2 OUTLIER -78.0 142.94 37.94 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 112.947 -1.933 . . . . 1.2 108.977 164.928 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.587 HD21 HG22 ' A' ' 31' ' ' VAL . 2.7 t-20 -79.72 86.24 5.33 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.537 -0.542 . . . . 1.51 109.537 178.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.701 HD21 HD12 ' A' ' 15' ' ' ILE . 68.2 tp -67.61 -42.47 82.35 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.576 0.703 . . . . 0.28 110.01 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.659 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 1.6 m -69.56 -0.61 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.398 -1.274 . . . . 1.02 112.855 -167.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.528 ' HB3' ' OD1' ' A' ' 29' ' ' ASN . 10.2 pt20 -75.03 -11.32 60.07 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.541 0.686 . . . . 1.02 109.289 174.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.953 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 91.0 m-70 -95.83 22.53 7.22 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 115.315 -0.857 . . . . 0.28 109.495 176.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.533 ' CE ' ' HB ' ' A' ' 31' ' ' VAL . 45.6 mttm -77.77 126.86 31.5 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 114.475 -1.239 . . . . 1.56 108.382 167.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.22 -44.81 1.42 Allowed Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 120.295 -0.955 . . . . 0.2 111.926 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.542 ' HB2' ' HA3' ' A' ' 68' ' ' GLY . 21.6 m -127.07 133.57 25.19 Favored Pre-proline 0 N--CA 1.435 -1.203 0 N-CA-C 108.9 -0.778 . . . . 0.29 108.9 174.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.771 ' HG3' ' CB ' ' A' ' 170' ' ' LEU . 6.1 Cg_endo -43.88 152.83 0.32 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 124.086 3.191 . . . . 0.18 112.891 177.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.872 ' HB2' HG22 ' A' ' 70' ' ' THR . 0.8 OUTLIER -139.02 152.97 48.04 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 106.375 -1.713 . . . . 0.31 106.375 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.975 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 2.8 mp -120.59 128.19 52.81 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.776 -0.578 . . . . 1.19 109.546 177.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.607 HD12 ' CE ' ' A' ' 122' ' ' MET . 1.0 OUTLIER -109.89 125.11 67.09 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-N 115.248 -0.887 . . . . 0.37 109.92 179.304 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.975 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.6 OUTLIER -110.62 124.94 52.83 Favored 'General case' 0 C--O 1.215 -0.729 0 CA-C-N 115.674 -0.693 . . . . 0.42 110.971 -172.031 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.678 ' OD1' ' HB3' ' A' ' 76' ' ' SER . 0.7 OUTLIER -77.83 121.96 24.8 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 105.726 -1.953 . . . . 2.35 105.726 165.177 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.712 HG13 ' HA ' ' A' ' 75' ' ' PRO . 1.5 p . . . . . 0 C--N 1.297 -1.703 0 C-N-CA 119.158 -1.017 . . . . 1.03 113.109 -164.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.467 0 N-CA-C 112.097 -0.401 . . . . 0.51 112.097 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -47.19 -40.83 14.63 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 112.115 -0.394 . . . . 0.5 112.115 177.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.0 -62.09 1.99 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.754 0.312 . . . . 0.7 110.407 -178.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.0 mp0 -59.55 -34.2 72.38 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.716 -0.675 . . . . 2.61 111.539 -178.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.643 ' HA ' HG22 ' A' ' 160' ' ' VAL . 97.0 m -68.47 -58.39 4.4 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.598 -0.728 . . . . 0.33 109.211 -176.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 1.097 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -59.5 -42.75 92.9 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.526 -1.216 . . . . 0.22 111.157 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.53 ' HA ' ' HD1' ' A' ' 102' ' ' PHE . 60.4 m -58.83 -56.86 16.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.86 -0.609 . . . . 0.26 110.923 -177.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 26.6 m -68.34 -35.36 77.65 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.417 -0.811 . . . . 0.48 111.344 -175.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.835 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 20.3 mt -65.61 -50.69 64.13 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-O 121.311 0.577 . . . . 0.43 110.432 -176.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.922 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 6.7 t80 -55.16 -51.89 65.03 Favored 'General case' 0 C--O 1.205 -1.268 0 CA-C-N 114.814 -1.085 . . . . 0.31 110.969 178.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.407 HD21 ' HB3' ' A' ' 101' ' ' GLU . 36.9 m-80 -73.71 -24.49 59.93 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 116.488 -0.324 . . . . 1.21 110.961 -170.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.527 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 34.9 ttpt -85.84 -23.5 27.11 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 109.039 -0.726 . . . . 1.54 109.039 -178.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.609 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 28.2 m-85 -124.86 -3.72 7.65 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 115.504 1.668 . . . . 0.31 115.504 -170.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.676 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 40.5 pttt -67.58 -26.23 66.17 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 107.897 -1.149 . . . . 1.35 107.897 170.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.3 m -49.23 -28.24 4.42 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 113.854 -1.521 . . . . 1.28 111.294 172.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.436 HE21 ' HD1' ' A' ' 64' ' ' TYR . 50.7 mt-30 -99.18 -34.54 10.32 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.496 0.189 . . . . 1.11 111.481 173.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.542 ' HA3' ' HB2' ' A' ' 36' ' ' SER . . . 150.95 -6.06 0.6 Allowed Glycine 0 CA--C 1.521 0.408 0 N-CA-C 111.863 -0.495 . . . . 0.18 111.863 -177.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.835 ' HE2' ' HB3' ' A' ' 60' ' ' LEU . 19.3 t80 -71.15 143.13 50.66 Favored 'General case' 0 C--O 1.218 -0.598 0 C-N-CA 122.705 0.402 . . . . 0.18 111.605 -176.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.953 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 4.8 t -134.65 153.99 51.73 Favored 'General case' 0 CA--C 1.483 -1.606 0 N-CA-C 108.354 -0.98 . . . . 0.2 108.354 172.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 1.097 HG11 ' HB1' ' A' ' 57' ' ' ALA . 42.7 t -113.27 99.86 9.51 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.407 0 N-CA-C 108.586 -0.894 . . . . 0.17 108.586 160.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.797 ' HA ' ' HG2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -94.73 120.47 35.0 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 118.498 -1.281 . . . . 1.04 107.735 174.423 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.951 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -109.53 127.39 54.43 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.915 0.864 . . . . 0.51 111.085 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.797 ' CG ' ' HG2' ' A' ' 105' ' ' MET . 5.8 m-30 -102.92 106.95 53.12 Favored Pre-proline 0 C--N 1.313 -1.009 0 CA-C-N 114.565 -1.198 . . . . 0.44 108.806 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.75 ' O ' ' HB2' ' A' ' 107' ' ' LYS . 65.2 Cg_endo -77.21 93.13 1.09 Allowed 'Trans proline' 0 C--O 1.221 -0.334 0 C-N-CA 122.474 2.116 . . . . 1.3 113.4 -168.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.678 ' HB3' ' OD1' ' A' ' 42' ' ' ASN . 70.6 p . . . . . 0 C--N 1.325 -0.459 0 CA-C-N 114.633 -1.167 . . . . 1.44 114.042 -167.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.663 0 CA-C-O 121.344 0.592 . . . . 0.55 111.528 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.407 ' HB3' HD21 ' A' ' 62' ' ' ASN . 21.8 mm-40 -86.04 24.25 1.34 Allowed 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.123 -0.944 . . . . 1.99 110.068 172.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.61 ' HB2' ' O ' ' A' ' 71' ' ' VAL . 26.1 p90 -147.69 156.07 44.95 Favored Pre-proline 0 N--CA 1.446 -0.673 0 N-CA-C 109.048 -0.723 . . . . 0.84 109.048 176.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.797 ' HG2' ' HA ' ' A' ' 72' ' ' LEU . 14.0 Cg_endo -54.13 101.81 0.08 OUTLIER 'Trans proline' 0 N--CA 1.479 0.639 0 C-N-CA 124.838 3.692 . . . . 0.62 114.97 -172.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.951 HD12 ' HB3' ' A' ' 73' ' ' ALA . 4.8 mm -101.84 122.15 53.7 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 N-CA-C 108.724 -0.843 . . . . 1.34 108.724 173.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.797 ' HG2' ' CG ' ' A' ' 74' ' ' PHE . 0.3 OUTLIER -81.61 -171.21 3.2 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.767 -0.651 . . . . 3.03 110.474 -176.005 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.75 ' CA ' ' HA ' ' A' ' 23' ' ' ALA . . . -66.49 -23.04 66.2 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 121.024 -0.271 . . . . 1.46 110.949 -177.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.75 ' HB2' ' O ' ' A' ' 75' ' ' PRO . 4.9 ptpp? 94.42 139.19 0.02 OUTLIER 'General case' 0 CA--C 1.493 -1.227 0 O-C-N 125.8 1.937 . . . . 1.76 109.13 -167.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.838 HG13 ' HB2' ' A' ' 116' ' ' HIS . 0.2 OUTLIER -130.87 176.7 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.099 0 N-CA-C 106.284 -1.747 . . . . 0.82 106.284 166.808 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -82.55 68.66 9.09 Favored 'General case' 0 C--N 1.293 -1.886 0 C-N-CA 120.299 -0.56 . . . . 1.73 110.156 -178.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.588 HG13 HD11 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -65.37 96.3 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 CA-C-N 115.54 -0.755 . . . . 0.77 110.434 -176.192 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 5.5 t-20 . . . . . 0 N--CA 1.448 -0.553 0 CA-C-N 115.118 -0.946 . . . . 1.9 108.681 171.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.838 ' HB2' HG13 ' A' ' 108' ' ' ILE . 7.8 t-80 . . . . . 0 N--CA 1.424 -1.756 0 CA-C-O 118.003 -0.999 . . . . 0.42 108.698 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -29.3 -41.77 0.07 OUTLIER 'Trans proline' 0 CA--C 1.535 0.525 0 C-N-CA 124.247 3.298 . . . . 0.4 113.323 179.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.847 ' CD1' ' HB ' ' A' ' 15' ' ' ILE . 22.1 tp -65.59 -50.94 63.24 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 123.435 0.694 . . . . 0.39 111.928 177.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.552 ' OH ' HG22 ' A' ' 40' ' ' ILE . 48.0 m-85 -75.91 -33.45 59.9 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 111.678 0.251 . . . . 3.04 111.678 176.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.465 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 21.9 mm-40 -58.38 -33.41 69.58 Favored 'General case' 0 CA--C 1.498 -1.037 0 N-CA-C 107.807 -1.183 . . . . 2.44 107.807 168.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.835 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 76.0 t80 -71.91 -31.08 66.03 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 119.581 -0.847 . . . . 0.56 110.682 171.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.629 ' HE2' HG21 ' A' ' 15' ' ' ILE . 49.1 mtt -74.65 -51.62 13.93 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 120.403 -0.519 . . . . 0.71 110.595 -170.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.462 ' HB2' ' HE2' ' A' ' 123' ' ' LYS . 0.1 OUTLIER -70.8 -25.89 63.07 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.936 -0.574 . . . . 1.46 111.192 176.734 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.579 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 10.0 ptmm? -70.02 -27.16 64.45 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 119.584 -0.847 . . . . 1.99 109.516 176.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 62.6 m -85.22 -56.99 3.26 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.495 -0.775 . . . . 0.59 110.839 178.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.535 ' HG2' HH22 ' A' ' 153' ' ' ARG . 20.7 ttmm . . . . . 0 C--N 1.326 -0.431 0 N-CA-C 109.819 -0.437 . . . . 1.85 109.819 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.223 -0.324 0 N-CA-C 111.671 0.248 . . . . 1.97 111.671 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.482 ' O ' ' N ' ' A' ' 140' ' ' THR . 8.5 m120 -37.04 -152.29 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 126.043 1.737 . . . . 2.04 112.685 158.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.743 ' HD1' ' HD2' ' A' ' 41' ' ' TYR . 0.2 OUTLIER -29.05 -22.54 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 116.76 2.134 . . . . 1.93 116.76 -171.411 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.7 ' HA ' ' O ' ' A' ' 154' ' ' PHE . 3.3 m -5.37 121.75 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 115.494 1.664 . . . . 0.6 115.494 168.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.461 ' CB ' HD23 ' A' ' 39' ' ' LEU . 0.7 OUTLIER -97.45 176.36 5.9 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.649 -1.16 . . . . 0.62 110.938 -177.661 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.506 ' HA ' ' HA ' ' A' ' 153' ' ' ARG . 23.7 m-85 -131.24 123.7 28.97 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 105.498 -2.038 . . . . 0.57 105.498 162.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.873 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 6.4 tp -79.87 104.33 10.38 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 118.075 -1.45 . . . . 0.43 108.289 178.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.702 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 45.8 mm -89.24 138.58 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.688 0 CA-C-N 112.722 -2.036 . . . . 0.19 107.586 -178.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.484 ' HA ' HD13 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -92.07 -174.83 3.9 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 119.282 -0.967 . . . . 0.98 110.939 -169.342 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.644 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 71.6 mtm180 -54.21 -38.88 66.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.98 0.419 . . . . 2.22 111.511 -177.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -95.91 15.56 20.1 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.31 -0.626 . . . . 2.0 109.31 -176.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.589 ' HA2' HG22 ' A' ' 144' ' ' ILE . . . 74.39 33.92 55.46 Favored Glycine 0 N--CA 1.442 -0.91 0 CA-C-N 115.821 -0.627 . . . . 0.17 114.499 -178.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.488 ' HA ' ' HD2' ' A' ' 150' ' ' PRO . 49.9 t -103.57 109.69 62.45 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-N 118.415 1.108 . . . . 1.12 111.633 176.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.827 ' HD3' HG23 ' A' ' 15' ' ' ILE . 6.5 Cg_endo -57.38 113.35 1.45 Allowed 'Trans proline' 0 CA--C 1.53 0.325 0 C-N-CA 123.715 2.943 . . . . 0.41 111.159 173.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.591 HG23 ' HG2' ' A' ' 152' ' ' GLU . 22.9 m -115.76 -16.86 8.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.331 0.586 . . . . 1.45 110.189 -177.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.873 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 53.9 mm-40 -139.61 167.48 22.01 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-N 115.376 -0.829 . . . . 1.17 110.088 178.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.535 HH22 ' HG2' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -148.22 129.95 15.11 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 114.608 -1.178 . . . . 2.16 108.664 163.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.7 ' O ' ' HA ' ' A' ' 140' ' ' THR . 94.2 m-85 -108.68 137.06 47.23 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.951 -0.568 . . . . 0.32 109.879 -170.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 20.1 m -62.77 156.61 64.34 Favored Pre-proline 0 C--N 1.323 -0.556 0 N-CA-C 109.393 -0.595 . . . . 1.11 109.393 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.58 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 14.1 Cg_endo -56.72 -48.22 19.73 Favored 'Trans proline' 0 CA--C 1.527 0.167 0 C-N-CA 121.765 1.643 . . . . 0.78 111.462 -177.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -55.64 -7.2 1.39 Allowed Glycine 0 CA--C 1.528 0.844 0 N-CA-C 115.692 1.037 . . . . 0.5 115.692 172.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -71.94 140.04 48.99 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 118.777 1.288 . . . . 0.5 109.256 176.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 22.2 t -103.69 170.26 8.04 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 109.629 -0.508 . . . . 1.42 109.629 -173.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.643 HG22 ' HA ' ' A' ' 56' ' ' THR . 60.5 t -41.14 -53.43 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 114.877 -1.056 . . . . 0.28 111.698 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 14.7 ttpp -63.58 -40.24 96.45 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.039 0.447 . . . . 3.46 111.104 -173.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -66.12 -30.43 70.92 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.432 -0.804 . . . . 1.4 109.795 -174.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.58 ' HA ' ' CE2' ' A' ' 154' ' ' PHE . 48.5 mt -82.77 -46.56 19.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.87 -1.059 . . . . 0.21 110.992 175.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.591 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 47.4 mt-10 -52.77 -43.33 65.74 Favored 'General case' 0 C--O 1.217 -0.626 0 O-C-N 123.314 0.384 . . . . 0.67 111.254 -175.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -55.51 -27.47 48.81 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.418 0.525 . . . . 0.87 112.418 -177.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.596 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 14.0 mmmm -97.98 -18.88 18.37 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.421 0.629 . . . . 1.71 109.938 176.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.566 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 12.4 tp -86.2 -49.14 7.95 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.029 -0.987 . . . . 0.16 112.142 -176.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.439 HD11 ' HB3' ' A' ' 164' ' ' GLU . 81.0 mt -55.47 -44.7 99.78 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-N 115.501 -0.772 . . . . 0.26 112.799 -173.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.419 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 72.3 Cg_exo -51.96 -35.33 60.14 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 122.002 1.802 . . . . 0.41 112.375 173.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.771 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 96.6 mt -80.91 -44.25 18.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.358 -0.383 . . . . 0.71 111.378 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.728 HD23 ' HG2' ' A' ' 37' ' ' PRO . 90.9 mt -59.88 -59.28 5.68 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 122.028 0.918 . . . . 0.34 109.899 176.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.434 0 CA-C-N 113.327 -1.76 . . . . 1.12 113.298 -177.526 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.0 t . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 121.079 0.466 . . . . 1.58 109.806 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 99.5 p -168.49 177.07 5.44 Favored 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 107.48 -1.304 . . . . 1.17 107.48 -177.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.981 HD12 HD21 ' A' ' 30' ' ' LEU . 5.2 pt -83.7 -18.77 9.92 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 CA-C-N 114.863 -1.062 . . . . 0.38 109.817 176.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.745 ' CD1' ' HA ' ' A' ' 31' ' ' VAL . 48.4 m-85 -70.95 -5.78 33.54 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.255 0.55 . . . . 0.3 110.713 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -69.18 -18.22 63.89 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.201 -0.909 . . . . 2.11 108.665 172.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.806 ' HE2' ' HB2' ' A' ' 121' ' ' TYR . 61.1 m-85 -119.35 108.05 14.12 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-O 121.781 0.801 . . . . 0.31 111.509 -178.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -48.48 146.88 2.69 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 113.488 -1.687 . . . . 2.86 110.336 170.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.781 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 37.1 t -110.86 165.0 6.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 109.393 -0.595 . . . . 0.67 109.393 -175.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.819 ' O ' ' HB3' ' A' ' 105' ' ' MET . 97.1 mt -126.49 111.28 14.23 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-O 119.505 -0.283 . . . . 0.69 111.332 -176.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.408 ' HA ' ' HE2' ' A' ' 105' ' ' MET . 13.4 t70 -53.9 161.84 1.08 Allowed 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 107.03 -1.47 . . . . 1.87 107.03 170.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.613 ' HA ' ' N ' ' A' ' 106' ' ' ALA . . . -57.02 -11.1 1.34 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 113.153 0.797 . . . . 0.59 113.153 -164.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 10.9 t70 -90.21 -4.18 57.38 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 122.386 0.274 . . . . 2.34 111.598 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.636 ' CD2' ' HB1' ' A' ' 106' ' ' ALA . 74.4 m-70 79.95 20.71 0.57 Allowed 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.93 0.872 . . . . 1.47 108.995 -177.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.455 ' HA ' ' HD3' ' A' ' 26' ' ' LYS . 11.3 mmtp -104.69 125.96 32.55 Favored Pre-proline 0 N--CA 1.441 -0.892 0 CA-C-N 114.344 -1.298 . . . . 4.25 108.398 175.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.675 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 80.3 Cg_exo -48.79 114.74 1.34 Allowed 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.995 2.463 . . . . 0.54 114.917 -168.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.813 ' HE2' HD23 ' A' ' 72' ' ' LEU . 8.8 t80 -83.8 128.3 34.44 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 113.589 -1.641 . . . . 1.2 109.313 164.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.429 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 1.7 p-10 -75.29 99.53 4.1 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 122.777 1.275 . . . . 1.51 110.143 176.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.981 HD21 HD12 ' A' ' 15' ' ' ILE . 61.7 tp -61.62 -32.82 72.97 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.507 -1.224 . . . . 0.28 110.591 178.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.745 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 3.7 m -63.77 -6.12 2.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 114.793 -1.094 . . . . 1.02 113.164 -169.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.429 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 9.7 pt20 -72.81 -7.88 52.85 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.006 -0.678 . . . . 1.02 109.737 177.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.923 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 90.1 m-70 -98.94 22.11 10.68 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.8 0.81 . . . . 0.28 109.866 176.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.524 ' HE2' ' HB ' ' A' ' 31' ' ' VAL . 62.2 mttm -78.75 122.09 25.58 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 114.683 -1.144 . . . . 1.56 109.156 169.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.05 -41.09 2.08 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.585 -0.817 . . . . 0.2 111.912 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.545 ' HB2' ' HA3' ' A' ' 68' ' ' GLY . 52.7 m -129.77 132.93 24.49 Favored Pre-proline 0 N--CA 1.437 -1.121 0 N-CA-C 108.839 -0.801 . . . . 0.29 108.839 173.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.779 ' HG3' ' CB ' ' A' ' 170' ' ' LEU . 4.2 Cg_endo -43.29 152.22 0.27 Allowed 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.951 3.1 . . . . 0.18 112.55 176.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.875 ' HB2' HG22 ' A' ' 70' ' ' THR . 0.7 OUTLIER -137.04 150.8 48.3 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.353 -1.721 . . . . 0.31 106.353 179.171 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.97 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 1.8 mp -116.26 122.61 45.49 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 121.419 0.628 . . . . 1.19 109.536 176.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.078 HG22 ' OH ' ' A' ' 119' ' ' TYR . 0.9 OUTLIER -102.51 123.6 55.93 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 CA-C-N 114.908 -1.042 . . . . 0.37 109.394 177.45 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.97 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.3 OUTLIER -109.25 129.7 55.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.31 -0.405 . . . . 0.42 110.569 -175.013 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.877 HD21 ' HE2' ' A' ' 142' ' ' PHE . 2.9 m-80 -78.89 93.13 4.98 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.213 -1.402 . . . . 2.35 107.213 169.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.714 HG12 ' CG ' ' A' ' 139' ' ' PHE . 34.9 m . . . . . 0 C--N 1.308 -1.234 0 C-N-CA 119.038 -1.065 . . . . 1.03 111.227 -170.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.893 0 N-CA-C 110.32 -1.112 . . . . 0.51 110.32 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -45.31 -47.98 11.06 Favored Glycine 0 C--O 1.223 -0.592 0 CA-C-N 115.011 -0.595 . . . . 0.5 113.222 175.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.01 -61.88 2.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.877 0.338 . . . . 0.7 111.524 -174.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -62.06 -23.88 66.75 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.268 0.556 . . . . 2.61 111.149 -178.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.653 ' HA ' HG22 ' A' ' 160' ' ' VAL . 23.4 m -75.79 -57.66 3.75 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.518 -0.765 . . . . 0.33 110.363 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 1.069 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -57.87 -38.48 75.81 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.942 -1.026 . . . . 0.22 110.949 -179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.543 ' HA ' ' CD1' ' A' ' 102' ' ' PHE . 54.8 m -60.92 -57.78 11.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.837 -0.619 . . . . 0.26 110.415 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 26.6 m -66.74 -37.84 85.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.378 -0.828 . . . . 0.48 111.534 -175.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.802 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 18.9 mt -65.3 -48.0 74.65 Favored 'General case' 0 CA--C 1.503 -0.849 0 CA-C-O 121.049 0.452 . . . . 0.43 110.679 -175.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.88 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 8.7 t80 -56.58 -50.96 70.38 Favored 'General case' 0 C--O 1.203 -1.394 0 CA-C-N 115.217 -0.901 . . . . 0.31 110.453 178.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -72.21 -24.57 61.42 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 120.745 0.307 . . . . 1.21 110.502 -172.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.3 ttmm -82.62 -26.35 32.32 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 109.107 -0.701 . . . . 1.54 109.107 -177.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.759 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 30.2 m-85 -127.61 -5.77 5.81 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 115.452 1.649 . . . . 0.31 115.452 -168.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.704 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 11.5 ptmt -63.65 -28.18 69.73 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 108.033 -1.099 . . . . 1.35 108.033 170.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.4 m -48.77 -34.83 12.97 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 113.84 -1.527 . . . . 1.28 110.782 172.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -93.64 -30.91 14.7 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.679 0.276 . . . . 1.11 111.52 176.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.545 ' HA3' ' HB2' ' A' ' 36' ' ' SER . . . 144.79 -7.64 1.71 Allowed Glycine 0 CA--C 1.519 0.323 0 N-CA-C 111.431 -0.668 . . . . 0.18 111.431 -177.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.802 ' HE2' ' HB3' ' A' ' 60' ' ' LEU . 21.5 t80 -69.52 141.71 53.82 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 122.744 0.418 . . . . 0.18 111.122 -177.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.923 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 3.8 t -133.91 152.17 51.76 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 107.985 -1.117 . . . . 0.2 107.985 173.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 1.069 HG11 ' HB1' ' A' ' 57' ' ' ALA . 33.4 t -110.82 100.32 10.52 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.454 0 N-CA-C 108.158 -1.053 . . . . 0.17 108.158 159.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.813 HD23 ' HE2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -96.7 121.5 38.61 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 107.829 -1.174 . . . . 1.04 107.829 175.18 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 1.032 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -111.28 116.81 31.65 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 115.705 -0.679 . . . . 0.51 110.295 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.955 ' HD2' HD12 ' A' ' 108' ' ' ILE . 1.4 m-30 -89.66 108.07 22.89 Favored Pre-proline 0 C--N 1.314 -0.951 0 N-CA-C 107.918 -1.141 . . . . 0.44 107.918 173.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.948 ' HG2' ' HB3' ' A' ' 107' ' ' LYS . 73.2 Cg_endo -75.24 64.22 6.24 Favored 'Trans proline' 0 N--CA 1.476 0.459 0 C-N-CA 123.632 2.888 . . . . 1.3 115.199 -168.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.3 t . . . . . 0 N--CA 1.483 1.211 0 N-CA-C 116.589 2.07 . . . . 1.44 116.589 175.247 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.523 ' HB1' ' CE1' ' A' ' 102' ' ' PHE . . . . . . . . 0 CA--C 1.513 -0.479 0 CA-C-O 121.306 0.574 . . . . 0.55 112.011 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -93.05 11.97 25.72 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.242 -0.89 . . . . 1.99 109.589 177.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.616 ' CE2' HD11 ' A' ' 104' ' ' ILE . 7.5 p90 -134.48 163.39 51.56 Favored Pre-proline 0 N--CA 1.444 -0.725 0 N-CA-C 108.175 -1.046 . . . . 0.84 108.175 178.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.806 ' HG2' ' HA ' ' A' ' 72' ' ' LEU . 26.4 Cg_endo -57.12 97.03 0.07 OUTLIER 'Trans proline' 0 N--CA 1.477 0.554 0 C-N-CA 123.57 2.847 . . . . 0.62 114.063 -173.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 1.032 HD12 ' HB3' ' A' ' 73' ' ' ALA . 7.6 mm -99.59 123.55 52.41 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.931 0 N-CA-C 107.969 -1.123 . . . . 1.34 107.969 173.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.842 ' HG3' ' CE1' ' A' ' 74' ' ' PHE . 13.5 mmt -100.99 -163.87 1.06 Allowed 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.304 -0.862 . . . . 3.03 111.791 -165.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.636 ' HB1' ' CD2' ' A' ' 25' ' ' HIS . . . -71.37 4.07 3.24 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.228 -0.897 . . . . 1.46 113.337 -169.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.948 ' HB3' ' HG2' ' A' ' 75' ' ' PRO . 15.8 ptpt 53.77 123.57 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.048 0 CA-C-O 122.701 1.239 . . . . 1.76 111.5 -170.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.955 HD12 ' HD2' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -122.73 177.68 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.689 0 N-CA-C 108.249 -1.019 . . . . 0.82 108.249 171.183 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.434 HD22 ' C ' ' A' ' 109' ' ' ASN . 0.1 OUTLIER -70.87 72.16 0.55 Allowed 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 114.46 -1.246 . . . . 1.73 111.252 179.946 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 110' ' ' VAL . 13.7 m -72.28 92.49 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 CA-C-O 122.338 1.066 . . . . 0.77 108.202 175.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 . . . . . 0 N--CA 1.436 -1.135 0 CA-C-N 114.442 -1.254 . . . . 1.9 109.525 -175.072 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.899 ' CB ' HG13 ' A' ' 108' ' ' ILE . 5.9 t-80 . . . . . 0 N--CA 1.425 -1.717 0 N-CA-C 106.995 -1.483 . . . . 0.42 106.995 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -26.42 -46.28 0.07 OUTLIER 'Trans proline' 0 C--O 1.219 -0.471 0 C-N-CA 124.456 3.437 . . . . 0.4 113.592 178.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.898 HD11 ' HB ' ' A' ' 15' ' ' ILE . 42.3 tp -61.63 -51.64 67.64 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.168 0.587 . . . . 0.39 112.251 177.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 1.078 ' OH ' HG22 ' A' ' 40' ' ' ILE . 46.5 m-85 -79.74 -33.39 40.84 Favored 'General case' 0 CA--C 1.489 -1.403 0 CA-C-O 121.238 0.542 . . . . 3.04 109.789 -177.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.491 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 13.3 tt0 -56.41 -40.7 75.12 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 107.017 -1.475 . . . . 2.44 107.017 172.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.806 ' HB2' ' HE2' ' A' ' 18' ' ' PHE . 88.8 t80 -65.97 -33.91 76.9 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 114.915 -1.038 . . . . 0.56 110.203 174.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.688 ' HE3' ' HG ' ' A' ' 118' ' ' LEU . 2.1 ttm -75.36 -54.93 6.24 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.207 -0.451 . . . . 0.71 110.955 -168.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.478 ' HB2' ' HE2' ' A' ' 123' ' ' LYS . 0.1 OUTLIER -68.77 -26.11 65.05 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 116.13 -0.486 . . . . 1.46 110.904 178.349 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.491 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 12.6 pttp -74.95 -26.71 59.8 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 119.587 -0.845 . . . . 1.99 109.838 177.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.47 HG21 ' HG2' ' A' ' 150' ' ' PRO . 52.6 m -71.45 -57.69 4.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.832 -0.622 . . . . 0.59 111.359 177.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 42.8 tttp . . . . . 0 N--CA 1.452 -0.374 0 C-N-CA 120.181 -0.607 . . . . 1.85 112.294 -174.006 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.466 ' HB3' ' HG3' ' A' ' 156' ' ' PRO . 10.7 m-90 . . . . . 0 N--CA 1.453 -0.283 0 CA-C-O 121.51 0.671 . . . . 1.97 112.492 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.612 ' HB3' ' HB3' ' A' ' 156' ' ' PRO . 8.5 t-20 -39.46 -154.93 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.895 1.678 . . . . 2.04 112.064 157.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.714 ' CG ' HG12 ' A' ' 43' ' ' VAL . 2.2 m-85 -27.96 -44.96 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 115.66 1.726 . . . . 1.93 115.66 -166.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.743 ' HA ' ' O ' ' A' ' 154' ' ' PHE . 26.9 m 33.87 97.38 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.793 1.035 . . . . 0.6 113.793 171.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.644 ' HB3' HD23 ' A' ' 39' ' ' LEU . 5.0 m -86.45 170.82 11.62 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.534 -1.212 . . . . 0.62 111.892 -171.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.877 ' HE2' HD21 ' A' ' 42' ' ' ASN . 88.8 m-85 -133.39 121.87 22.93 Favored 'General case' 0 CA--C 1.489 -1.366 0 N-CA-C 106.111 -1.811 . . . . 0.57 106.111 162.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.825 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 7.7 tp -79.6 104.56 10.28 Favored 'General case' 0 N--CA 1.422 -1.838 0 C-N-CA 118.089 -1.444 . . . . 0.43 108.291 178.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.743 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 47.9 mm -89.62 140.28 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.938 0 CA-C-N 112.709 -2.041 . . . . 0.19 107.731 -178.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.613 ' OD1' HG12 ' A' ' 149' ' ' VAL . 0.0 OUTLIER -91.94 -174.23 3.73 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 119.588 -0.845 . . . . 0.98 111.61 -170.276 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.758 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 35.8 mtt85 -56.28 -38.39 71.14 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 122.468 0.307 . . . . 2.22 111.556 -176.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -100.76 21.39 13.61 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.036 -1.098 . . . . 2.0 108.036 -178.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.651 ' HA2' HG22 ' A' ' 144' ' ' ILE . . . 69.31 37.45 80.3 Favored Glycine 0 N--CA 1.435 -1.388 0 CA-C-N 114.661 -1.154 . . . . 0.17 115.263 176.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.613 HG12 ' OD1' ' A' ' 145' ' ' ASP . 4.3 p -106.69 122.05 43.1 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 119.469 1.634 . . . . 1.12 110.806 171.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.624 ' HD3' HG23 ' A' ' 15' ' ' ILE . 11.6 Cg_endo -64.64 124.17 12.82 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 123.253 2.636 . . . . 0.41 111.468 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.9 m -124.54 -9.43 6.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 120.758 0.313 . . . . 1.45 110.468 -177.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.825 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 19.9 mm-40 -142.82 166.06 25.68 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 121.266 0.555 . . . . 1.17 110.861 175.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.527 ' HA ' ' O ' ' A' ' 141' ' ' SER . 5.8 ttm180 -148.14 135.61 20.62 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.551 -1.204 . . . . 2.16 108.849 166.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.743 ' O ' ' HA ' ' A' ' 140' ' ' THR . 97.2 m-85 -117.23 155.05 30.09 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.08 -0.711 . . . . 0.32 109.08 -169.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.441 ' HB3' ' HD2' ' A' ' 156' ' ' PRO . 22.3 m -83.22 163.04 52.22 Favored Pre-proline 0 C--N 1.316 -0.857 0 N-CA-C 109.497 -0.557 . . . . 1.11 109.497 175.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.612 ' HB3' ' HB3' ' A' ' 138' ' ' ASN . 20.1 Cg_endo -60.48 -31.13 92.1 Favored 'Trans proline' 0 CA--C 1.52 -0.176 0 C-N-CA 122.238 1.959 . . . . 0.78 110.681 174.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -68.97 -16.55 70.67 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 114.367 -1.288 . . . . 0.5 112.938 174.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.402 ' HB3' ' HB3' ' A' ' 154' ' ' PHE . . . -76.84 137.52 39.25 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 108.572 -0.899 . . . . 0.5 108.572 176.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.485 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 6.0 m -116.37 -177.06 3.09 Favored 'General case' 0 N--CA 1.436 -1.156 0 C-N-CA 120.48 -0.488 . . . . 1.42 110.727 -170.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.653 HG22 ' HA ' ' A' ' 56' ' ' THR . 54.9 t -42.43 -50.28 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.23 -0.895 . . . . 0.28 111.799 -178.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -68.62 -35.05 76.79 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.046 0.451 . . . . 3.46 111.081 -174.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.411 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 15.9 m-20 -69.91 -34.9 74.11 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.644 0.735 . . . . 1.4 109.737 -177.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.548 HD12 HG21 ' A' ' 56' ' ' THR . 54.8 mt -81.03 -49.1 18.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 114.797 -1.092 . . . . 0.21 111.369 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.604 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 39.3 mt-10 -52.41 -42.78 64.36 Favored 'General case' 0 C--O 1.216 -0.685 0 O-C-N 123.211 0.319 . . . . 0.67 111.082 -176.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 12.7 pt-20 -56.51 -25.73 52.42 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.418 -0.355 . . . . 0.87 111.535 -175.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.436 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 31.1 mmtp -96.84 -31.1 12.78 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.645 0.736 . . . . 1.71 109.857 176.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.604 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 14.7 tp -75.08 -48.56 23.29 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.302 -1.317 . . . . 0.16 112.149 -175.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.478 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 72.5 mt -56.31 -46.78 99.76 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.412 -0.813 . . . . 0.26 112.629 -172.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.478 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 73.4 Cg_exo -52.24 -26.02 25.52 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.233 1.956 . . . . 0.41 112.738 174.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.779 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 89.6 mt -89.92 -46.82 8.27 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 122.334 -0.228 . . . . 0.71 111.294 178.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.732 HD23 ' HG2' ' A' ' 37' ' ' PRO . 93.0 mt -59.22 -55.84 29.77 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-O 122.119 0.961 . . . . 0.34 109.874 176.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.701 0 CA-C-N 113.332 -1.758 . . . . 1.12 113.473 -174.759 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.1 t . . . . . 0 N--CA 1.452 -0.33 0 CA-C-O 121.187 0.517 . . . . 1.58 109.698 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.9 m -159.02 155.41 27.42 Favored 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 105.534 -2.024 . . . . 1.17 105.534 -176.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.903 ' HB ' HD11 ' A' ' 118' ' ' LEU . 5.9 pt -57.73 -18.91 10.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-N 115.011 -0.995 . . . . 0.38 111.805 -177.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.83 ' HB3' HG13 ' A' ' 31' ' ' VAL . 26.1 m-85 -70.16 -0.01 7.04 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.998 0.74 . . . . 0.3 112.998 -173.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -78.67 -17.09 56.48 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.429 -0.952 . . . . 2.11 108.429 177.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.63 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 39.8 m-85 -111.98 112.2 23.67 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 114.56 -1.2 . . . . 0.31 111.636 -172.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -45.21 137.02 4.76 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 113.599 -1.637 . . . . 2.86 111.072 172.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.864 HG13 ' HZ ' ' A' ' 74' ' ' PHE . 65.3 t -112.19 164.47 8.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 107.877 -1.157 . . . . 0.67 107.877 178.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.706 HD23 ' HA ' ' A' ' 27' ' ' PRO . 60.0 mt -130.85 157.68 42.22 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.692 0.282 . . . . 0.69 111.053 -177.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.533 ' HB3' ' HE3' ' A' ' 26' ' ' LYS . 20.5 t70 -85.18 172.94 10.8 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 106.795 -1.558 . . . . 1.87 106.795 163.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.695 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . . . -62.78 -3.83 1.76 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.28 0.844 . . . . 0.59 113.28 -170.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.674 ' HB2' ' HE2' ' A' ' 26' ' ' LYS . 47.7 m-20 -117.05 17.42 14.89 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.764 -0.374 . . . . 2.34 111.526 176.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.464 ' HA ' HD13 ' A' ' 21' ' ' LEU . 91.5 m-70 74.55 15.02 3.43 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-O 121.839 0.828 . . . . 1.47 109.17 174.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.674 ' HE2' ' HB2' ' A' ' 24' ' ' ASP . 35.2 mtmt -77.81 109.15 8.9 Favored Pre-proline 0 N--CA 1.446 -0.634 0 N-CA-C 107.367 -1.345 . . . . 4.25 107.367 169.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.706 ' HA ' HD23 ' A' ' 21' ' ' LEU . 93.7 Cg_exo -48.39 116.22 1.94 Allowed 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.503 2.135 . . . . 0.54 113.501 -171.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.799 ' OH ' ' HB3' ' A' ' 103' ' ' PRO . 0.2 OUTLIER -76.45 146.73 38.37 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 113.721 -1.581 . . . . 1.2 111.649 176.273 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.546 ' OD1' ' HB3' ' A' ' 32' ' ' GLN . 2.3 t-20 -84.9 96.69 9.42 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.171 -0.922 . . . . 1.51 109.597 175.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.702 HD13 HG21 ' A' ' 20' ' ' VAL . 61.4 tp -79.13 -45.99 18.89 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.877 -0.601 . . . . 0.28 110.914 -177.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.849 HG12 ' HE2' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -65.31 -0.08 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.435 0 CA-C-N 115.611 -0.722 . . . . 1.02 112.771 -173.594 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.546 ' HB3' ' OD1' ' A' ' 29' ' ' ASN . 3.9 pt20 -76.71 -12.49 60.0 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 119.832 -0.747 . . . . 1.02 109.323 175.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.934 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 92.8 m-70 -92.98 24.75 3.53 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 122.405 1.098 . . . . 0.28 108.685 175.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.849 ' HE2' HG12 ' A' ' 31' ' ' VAL . 36.8 mttm -77.67 109.73 11.9 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 113.419 -1.718 . . . . 1.56 109.446 170.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.35 -38.04 2.48 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 120.191 -1.004 . . . . 0.2 112.348 177.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.479 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 17.1 m -126.98 133.77 25.4 Favored Pre-proline 0 N--CA 1.437 -1.082 0 N-CA-C 108.748 -0.834 . . . . 0.29 108.748 172.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.724 ' HG3' ' CB ' ' A' ' 170' ' ' LEU . 5.3 Cg_endo -44.27 158.13 0.15 Allowed 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 124.136 3.224 . . . . 0.18 112.732 176.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.809 ' HB2' HG22 ' A' ' 70' ' ' THR . 1.0 OUTLIER -145.14 141.2 28.55 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.296 -1.372 . . . . 0.31 107.296 -179.215 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 1.015 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 2.2 mm? -106.38 112.96 26.2 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.838 -0.801 . . . . 1.19 108.838 178.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.705 HG13 HG13 ' A' ' 144' ' ' ILE . 1.3 mt -96.59 123.98 49.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 109.403 -0.591 . . . . 0.37 109.403 176.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 1.015 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.5 OUTLIER -110.68 131.2 55.26 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.433 -0.349 . . . . 0.42 110.561 -174.552 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.508 ' HB2' HG21 ' A' ' 110' ' ' VAL . 0.6 OUTLIER -79.1 117.53 20.22 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 105.874 -1.898 . . . . 2.35 105.874 166.598 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.702 HG23 ' HA ' ' A' ' 75' ' ' PRO . 35.0 m . . . . . 0 C--N 1.307 -1.261 0 O-C-N 120.973 -1.079 . . . . 1.03 111.603 -172.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.281 0 N-CA-C 113.713 0.245 . . . . 0.51 113.713 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.409 ' HA2' ' HB ' ' A' ' 56' ' ' THR . . . -55.58 -24.13 38.27 Favored Glycine 0 C--O 1.223 -0.562 0 C-N-CA 121.604 -0.331 . . . . 0.5 112.557 175.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.65 -50.3 69.85 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.345 -0.613 . . . . 0.7 109.345 175.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -61.85 -29.98 70.54 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.292 -0.867 . . . . 2.61 109.813 177.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.576 ' CG2' HD12 ' A' ' 163' ' ' ILE . 67.1 m -73.6 -59.07 2.89 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 114.177 -1.374 . . . . 0.33 110.133 -175.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.998 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -59.13 -43.42 92.0 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.664 -1.153 . . . . 0.22 111.129 -178.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.496 ' HA ' ' CD1' ' A' ' 102' ' ' PHE . 54.3 m -55.53 -58.0 9.59 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.572 0.701 . . . . 0.26 110.599 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 86.5 m -68.25 -38.61 81.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.745 -1.116 . . . . 0.48 111.772 -176.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.759 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 16.2 mt -63.05 -48.65 77.8 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 121.499 0.666 . . . . 0.43 110.293 -177.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.861 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 10.6 t80 -59.35 -48.71 80.6 Favored 'General case' 0 C--O 1.203 -1.345 0 CA-C-N 114.718 -1.128 . . . . 0.31 110.881 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.428 ' N ' HD22 ' A' ' 62' ' ' ASN . 1.0 OUTLIER -73.52 -23.94 60.08 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 120.577 0.227 . . . . 1.21 110.686 -173.751 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.416 ' HB2' ' HE2' ' A' ' 63' ' ' LYS . 24.2 ttmm -84.4 -25.42 29.08 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 108.687 -0.857 . . . . 1.54 108.687 -177.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.718 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 44.5 m-85 -127.88 -2.21 5.92 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 115.583 1.697 . . . . 0.31 115.583 -170.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.678 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 15.0 pttp -67.26 -24.99 65.85 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 108.332 -0.988 . . . . 1.35 108.332 171.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.8 m -47.99 -38.01 16.01 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 114.035 -1.439 . . . . 1.28 110.978 173.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -86.61 -37.69 17.84 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 111.915 0.339 . . . . 1.11 111.915 174.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 149.83 -4.41 0.64 Allowed Glycine 0 N--CA 1.45 -0.367 0 N-CA-C 111.265 -0.734 . . . . 0.18 111.265 -177.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.759 ' HE2' ' HB3' ' A' ' 60' ' ' LEU . 22.9 t80 -67.6 141.36 56.81 Favored 'General case' 0 C--O 1.22 -0.461 0 C-N-CA 122.794 0.437 . . . . 0.18 111.323 -178.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.934 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 1.5 t -135.92 144.56 45.55 Favored 'General case' 0 CA--C 1.487 -1.476 0 N-CA-C 109.016 -0.735 . . . . 0.2 109.016 173.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.998 HG11 ' HB1' ' A' ' 57' ' ' ALA . 38.6 t -104.07 101.37 12.17 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.199 0 N-CA-C 108.613 -0.884 . . . . 0.17 108.613 160.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.691 ' HA ' ' HG2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -96.11 121.66 38.11 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 118.475 -1.29 . . . . 1.04 108.113 173.174 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.999 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -108.64 140.05 42.57 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.405 0.621 . . . . 0.51 110.351 179.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.864 ' HZ ' HG13 ' A' ' 20' ' ' VAL . 6.4 m-30 -115.31 110.39 45.36 Favored Pre-proline 0 C--N 1.311 -1.091 0 CA-C-N 115.507 -0.77 . . . . 0.44 109.234 -177.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.702 ' HA ' HG23 ' A' ' 43' ' ' VAL . 60.4 Cg_endo -78.18 46.58 2.13 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.567 2.844 . . . . 1.3 115.454 -164.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.474 ' O ' ' HD3' ' A' ' 107' ' ' LYS . 73.6 p . . . . . 0 N--CA 1.478 0.967 0 N-CA-C 117.215 2.302 . . . . 1.44 117.215 176.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.511 -0.536 0 CA-C-O 121.226 0.536 . . . . 0.55 111.826 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -85.33 8.74 17.59 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.166 -0.925 . . . . 1.99 109.876 175.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.613 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 16.9 p90 -138.81 161.22 59.53 Favored Pre-proline 0 N--CA 1.442 -0.842 0 CA-C-N 115.588 -0.733 . . . . 0.84 109.619 -178.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.799 ' HB3' ' OH ' ' A' ' 28' ' ' TYR . 18.2 Cg_endo -57.41 110.98 0.69 Allowed 'Trans proline' 0 CA--C 1.51 -0.701 0 C-N-CA 124.122 3.215 . . . . 0.62 114.1 -175.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.999 HD12 ' HB3' ' A' ' 73' ' ' ALA . 7.0 mm -108.56 134.24 51.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 C-N-CA 119.925 -0.71 . . . . 1.34 109.227 172.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.833 ' HG2' ' CG ' ' A' ' 74' ' ' PHE . 0.0 OUTLIER -89.54 -177.08 5.22 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.988 -0.551 . . . . 3.03 109.657 179.577 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.695 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . . . -57.25 -51.53 68.97 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.241 0.544 . . . . 1.46 110.418 -177.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.695 ' HB3' ' HG2' ' A' ' 75' ' ' PRO . 13.9 ptpt 128.57 121.96 0.0 OUTLIER 'General case' 0 CA--C 1.492 -1.28 0 C-N-CA 127.407 2.283 . . . . 1.76 106.036 -176.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.637 HD11 ' HD2' ' A' ' 74' ' ' PHE . 2.1 pp -129.41 156.58 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.242 0 N-CA-C 106.161 -1.792 . . . . 0.82 106.161 177.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -52.06 117.82 3.04 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 123.696 0.623 . . . . 1.73 109.942 -179.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.508 HG21 ' HB2' ' A' ' 42' ' ' ASN . 3.5 m -113.67 86.83 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.621 0 N-CA-C 107.625 -1.25 . . . . 0.77 107.625 169.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 . . . . . 0 N--CA 1.445 -0.704 0 CA-C-N 113.844 -1.525 . . . . 1.9 109.435 -178.519 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.582 ' HB2' ' HB ' ' A' ' 108' ' ' ILE . 6.4 t-80 . . . . . 0 N--CA 1.419 -2.006 0 N-CA-C 107.166 -1.42 . . . . 0.42 107.166 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.581 ' HB2' ' CD1' ' A' ' 18' ' ' PHE . 11.5 Cg_exo -33.9 -41.35 0.2 Allowed 'Trans proline' 0 C--O 1.218 -0.483 0 C-N-CA 123.872 3.048 . . . . 0.4 113.099 -178.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.911 ' HG ' ' HE3' ' A' ' 122' ' ' MET . 33.5 tp -63.65 -48.53 76.86 Favored 'General case' 0 C--O 1.222 -0.369 0 C-N-CA 123.208 0.603 . . . . 0.39 111.726 176.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.689 ' HA ' ' HB2' ' A' ' 122' ' ' MET . 23.3 m-85 -78.04 -34.36 50.59 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 111.944 0.35 . . . . 3.04 111.944 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.51 ' HA ' ' HD2' ' A' ' 123' ' ' LYS . 0.8 OUTLIER -60.32 -35.82 76.51 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 106.809 -1.552 . . . . 2.44 106.809 171.617 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.63 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 55.1 t80 -70.29 -30.69 67.76 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 119.525 -0.87 . . . . 0.56 110.051 173.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.911 ' HE3' ' HG ' ' A' ' 118' ' ' LEU . 1.5 ttm -76.15 -54.58 6.6 Favored 'General case' 0 CA--C 1.509 -0.616 0 C-N-CA 120.388 -0.525 . . . . 0.71 110.479 -169.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.623 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -70.78 -25.43 62.89 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.297 -0.41 . . . . 1.46 111.437 179.398 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.52 ' N ' ' HD3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -71.67 -29.0 64.12 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 119.552 -0.859 . . . . 1.99 109.609 178.244 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 27.1 m -92.21 -24.94 18.88 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.571 -0.741 . . . . 0.59 111.52 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.484 ' HE2' ' HA ' ' A' ' 151' ' ' VAL . 23.5 mmtm . . . . . 0 C--N 1.325 -0.472 0 N-CA-C 112.387 0.514 . . . . 1.85 112.387 -173.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.665 ' HB3' ' HG3' ' A' ' 156' ' ' PRO . 0.7 OUTLIER . . . . . 0 CA--C 1.52 -0.208 0 CA-C-O 120.516 0.198 . . . . 1.97 111.122 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.48 ' HB3' ' H ' ' A' ' 139' ' ' PHE . 12.7 m120 -35.56 -153.6 0.0 OUTLIER 'General case' 0 C--O 1.207 -1.168 0 CA-C-N 114.527 -1.215 . . . . 2.04 112.409 155.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.694 ' O ' ' HB3' ' A' ' 41' ' ' TYR . 0.9 OUTLIER -29.65 -21.97 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 117.495 2.406 . . . . 1.93 117.495 -172.162 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.674 ' HA ' ' O ' ' A' ' 154' ' ' PHE . 0.2 OUTLIER -7.58 120.32 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 120.141 1.337 . . . . 0.6 114.559 173.948 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.61 ' O ' ' HA ' ' A' ' 153' ' ' ARG . 1.0 OUTLIER -104.9 163.63 12.38 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.33 -1.305 . . . . 0.62 111.101 -167.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.512 ' CG ' ' HG2' ' A' ' 122' ' ' MET . 97.4 m-85 -125.1 123.24 39.3 Favored 'General case' 0 CA--C 1.491 -1.32 0 N-CA-C 106.28 -1.748 . . . . 0.57 106.28 166.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.748 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 5.0 tp -79.46 102.25 8.66 Favored 'General case' 0 N--CA 1.425 -1.713 0 C-N-CA 118.242 -1.383 . . . . 0.43 108.157 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.705 HG13 HG13 ' A' ' 40' ' ' ILE . 39.1 mm -88.24 141.4 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 CA-C-N 113.8 -1.546 . . . . 0.19 107.611 -177.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.457 ' HA ' HD13 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -95.81 -174.83 3.24 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 119.359 -0.936 . . . . 0.98 111.234 -168.377 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.581 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 57.0 mtm180 -55.13 -40.11 70.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.818 0.342 . . . . 2.22 111.619 -176.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -92.44 14.39 16.79 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 109.443 -0.577 . . . . 2.0 109.443 -178.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.548 ' HA2' HG22 ' A' ' 144' ' ' ILE . . . 73.6 33.87 57.64 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 121.211 -0.519 . . . . 0.17 113.601 -178.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.447 ' HA ' ' HD2' ' A' ' 150' ' ' PRO . 31.7 t -107.41 107.39 60.33 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 117.961 0.88 . . . . 1.12 111.239 176.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.697 ' HD3' HG23 ' A' ' 15' ' ' ILE . 5.9 Cg_exo -47.4 125.3 10.49 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 123.888 3.059 . . . . 0.41 112.158 173.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.484 ' HA ' ' HE2' ' A' ' 126' ' ' LYS . 44.2 t -116.13 -37.12 2.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 109.046 -0.724 . . . . 1.45 109.046 -177.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.748 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 6.8 mm-40 -130.86 167.07 19.55 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 115.612 -0.722 . . . . 1.17 111.665 -175.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.61 ' HA ' ' O ' ' A' ' 141' ' ' SER . 20.4 ttm180 -138.87 133.07 31.47 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.022 -0.99 . . . . 2.16 109.655 165.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.674 ' O ' ' HA ' ' A' ' 140' ' ' THR . 96.3 m-85 -117.03 137.25 52.37 Favored 'General case' 0 C--O 1.213 -0.837 0 CA-C-N 116.336 -0.393 . . . . 0.32 109.982 -172.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.568 ' HA ' HG23 ' A' ' 140' ' ' THR . 37.4 m -67.13 153.43 94.63 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 109.381 -0.6 . . . . 1.11 109.381 179.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.665 ' HG3' ' HB3' ' A' ' 137' ' ' TRP . 10.0 Cg_endo -53.26 -48.27 22.94 Favored 'Trans proline' 0 N--CA 1.473 0.272 0 C-N-CA 122.647 2.232 . . . . 0.78 112.732 -174.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -67.05 10.34 0.84 Allowed Glycine 0 CA--C 1.527 0.841 0 N-CA-C 114.937 0.735 . . . . 0.5 114.937 176.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -74.45 146.21 43.02 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-N 118.481 1.141 . . . . 0.5 108.669 171.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.552 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 90.9 p -102.61 171.61 7.33 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 120.513 -0.475 . . . . 1.42 109.864 -174.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.574 HG22 ' HA ' ' A' ' 56' ' ' THR . 58.3 t -42.28 -48.97 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 O-C-N 124.202 0.939 . . . . 0.28 110.767 175.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.46 ' HE3' ' HB2' ' A' ' 161' ' ' LYS . 37.2 ttmt -71.75 -31.89 67.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.429 -0.805 . . . . 3.46 111.249 -172.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -67.03 -38.0 85.13 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.565 0.698 . . . . 1.4 109.634 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.576 HD12 ' CG2' ' A' ' 56' ' ' THR . 73.8 mt -82.3 -39.8 16.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 114.903 -1.044 . . . . 0.21 111.022 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.556 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 30.2 mt-10 -53.4 -44.54 68.76 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-O 120.503 0.192 . . . . 0.67 111.478 -178.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -57.15 -24.8 56.79 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.956 0.354 . . . . 0.87 111.956 -174.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.626 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 44.0 mmtm -98.15 -24.86 15.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.532 0.682 . . . . 1.71 109.987 175.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.556 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 10.0 tp -78.4 -50.09 12.35 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.97 -1.014 . . . . 0.16 112.353 -177.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.478 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 70.6 mt -55.61 -46.63 99.7 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 115.499 -0.773 . . . . 0.26 112.352 -173.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.478 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 53.3 Cg_exo -54.92 -26.76 50.36 Favored 'Trans proline' 0 C--N 1.356 0.921 0 C-N-CA 122.128 1.885 . . . . 0.41 112.669 174.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.724 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 62.4 mt -86.32 -42.48 13.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.725 -0.216 . . . . 0.71 111.267 177.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.703 HD23 ' HG2' ' A' ' 37' ' ' PRO . 97.3 mt -60.04 -54.11 49.84 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 122.127 0.965 . . . . 0.34 109.53 176.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.106 0 CA-C-N 113.365 -1.743 . . . . 1.12 113.142 179.981 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 43.6 t . . . . . 0 C--O 1.235 0.307 0 CA-C-O 120.993 0.425 . . . . 1.58 110.22 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 91.4 p 178.52 157.98 0.49 Allowed 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 105.823 -1.918 . . . . 1.17 105.823 -177.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.818 HG23 ' HD3' ' A' ' 150' ' ' PRO . 6.7 pt -67.66 -17.63 22.72 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 CA-C-N 114.949 -1.023 . . . . 0.38 110.745 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.83 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 45.9 m-85 -74.74 -3.48 31.78 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 116.113 -0.494 . . . . 0.3 111.607 -176.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -67.14 -12.59 60.41 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.991 -1.114 . . . . 2.11 107.991 170.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.64 ' HE2' ' HB2' ' A' ' 121' ' ' TYR . 61.1 m-85 -129.07 109.81 11.5 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 114.794 -1.094 . . . . 0.31 110.007 -175.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -55.98 157.64 4.36 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 114.116 -1.402 . . . . 2.86 109.488 174.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.762 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 40.4 t -109.65 161.02 8.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 107.792 -1.188 . . . . 0.67 107.792 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.852 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 55.2 mt -126.09 122.49 35.91 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 120.552 -0.459 . . . . 0.69 109.901 -178.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.607 ' HA ' ' SD ' ' A' ' 105' ' ' MET . 0.8 OUTLIER -59.44 -175.85 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.387 0 O-C-N 124.31 1.006 . . . . 1.87 109.469 -179.179 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.717 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . . . -62.19 -3.93 1.52 Allowed 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 113.19 0.811 . . . . 0.59 113.19 -171.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -118.68 12.64 13.12 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.505 -0.478 . . . . 2.34 111.73 175.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.852 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 6.3 m170 72.3 26.06 2.74 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.677 0.751 . . . . 1.47 110.266 174.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.43 ' HA ' ' HD3' ' A' ' 26' ' ' LYS . 54.2 mmtt -102.5 133.21 20.65 Favored Pre-proline 0 N--CA 1.448 -0.533 0 CA-C-N 114.618 -1.174 . . . . 4.25 107.879 171.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.631 ' HA ' HD23 ' A' ' 21' ' ' LEU . 83.5 Cg_exo -51.38 112.8 0.89 Allowed 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.111 1.874 . . . . 0.54 114.208 -166.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.782 ' CE2' HD21 ' A' ' 72' ' ' LEU . 50.0 t80 -83.58 126.0 32.37 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 113.79 -1.55 . . . . 1.2 108.617 165.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.573 HD21 ' NE2' ' A' ' 32' ' ' GLN . 0.1 OUTLIER -67.67 82.0 0.18 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.911 0.862 . . . . 1.51 110.848 -178.068 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.744 ' HB2' HG23 ' A' ' 20' ' ' VAL . 44.5 tp -51.98 -37.76 54.22 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.536 -0.756 . . . . 0.28 109.653 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.634 HG13 ' HB3' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -67.75 0.13 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 114.687 -1.142 . . . . 1.02 113.0 -173.857 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.573 ' NE2' HD21 ' A' ' 29' ' ' ASN . 3.4 pt20 -72.7 -18.87 61.5 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 119.815 -0.754 . . . . 1.02 108.968 173.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.93 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 79.4 m-70 -92.33 29.86 1.6 Allowed 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 115.497 -0.774 . . . . 0.28 109.749 175.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.83 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 29.0 mtmt -92.35 111.04 22.47 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 114.896 -1.047 . . . . 1.56 109.584 173.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.94 -38.14 2.03 Favored Glycine 0 N--CA 1.443 -0.899 0 N-CA-C 110.759 -0.936 . . . . 0.2 110.759 -177.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.425 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 15.0 m -132.24 136.03 27.42 Favored Pre-proline 0 N--CA 1.435 -1.202 0 N-CA-C 109.127 -0.694 . . . . 0.29 109.127 169.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.687 ' O ' ' HA ' ' A' ' 69' ' ' PHE . 10.3 Cg_endo -47.42 156.83 0.9 Allowed 'Trans proline' 0 CA--C 1.511 -0.651 0 C-N-CA 124.481 3.454 . . . . 0.18 113.499 178.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.872 ' HB2' HG22 ' A' ' 70' ' ' THR . 0.9 OUTLIER -133.65 152.06 51.8 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 106.978 -1.49 . . . . 0.31 106.978 173.4 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.85 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 1.6 mm? -110.82 117.23 32.84 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.896 -1.15 . . . . 1.19 107.896 174.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.764 HD12 ' CE ' ' A' ' 122' ' ' MET . 9.1 mt -98.92 119.05 46.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 C-N-CA 119.714 -0.795 . . . . 0.37 110.195 178.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.85 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -105.11 127.29 52.83 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.469 -0.787 . . . . 0.42 109.916 -176.239 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.796 ' HB2' HG11 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -78.39 104.93 9.31 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 106.233 -1.765 . . . . 2.35 106.233 165.81 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.533 ' HB ' ' CE1' ' A' ' 139' ' ' PHE . 4.5 m . . . . . 0 C--N 1.308 -1.21 0 C-N-CA 118.986 -1.086 . . . . 1.03 111.32 -171.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.524 0 N-CA-C 110.472 -1.051 . . . . 0.51 110.472 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -45.96 -41.12 10.31 Favored Glycine 0 C--O 1.216 -1.03 0 CA-C-N 114.635 -0.782 . . . . 0.5 113.132 176.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -64.82 -52.2 58.05 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.948 0.404 . . . . 0.7 111.006 -178.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -63.29 -29.15 70.53 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.711 -0.677 . . . . 2.61 109.984 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.891 HG21 HD12 ' A' ' 163' ' ' ILE . 87.7 m -75.14 -55.74 5.43 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.207 -0.906 . . . . 0.33 109.159 -179.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 1.013 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -54.1 -43.93 70.8 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.58 -1.191 . . . . 0.22 111.379 -178.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.458 ' HA ' ' CD1' ' A' ' 102' ' ' PHE . 30.3 m -61.68 -54.5 41.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.395 0.617 . . . . 0.26 110.142 -177.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.7 m -68.34 -35.61 78.03 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.235 -0.893 . . . . 0.48 111.591 -176.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.719 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 0.6 OUTLIER -63.83 -52.82 58.39 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-O 121.774 0.797 . . . . 0.43 110.162 -176.822 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.892 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 8.1 t80 -55.31 -49.19 72.8 Favored 'General case' 0 C--O 1.204 -1.337 0 CA-C-N 113.83 -1.532 . . . . 0.31 110.597 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.863 ' HA ' ' HE2' ' A' ' 65' ' ' LYS . 28.7 m-80 -72.97 -24.71 60.82 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 116.638 -0.255 . . . . 1.21 110.632 -173.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.415 ' HD2' ' CE2' ' A' ' 64' ' ' TYR . 39.2 ttmt -81.47 -29.59 33.68 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 108.674 -0.862 . . . . 1.54 108.674 -178.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.657 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 42.3 m-85 -125.5 -2.97 7.37 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 116.185 1.92 . . . . 0.31 116.185 -168.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.863 ' HE2' ' HA ' ' A' ' 62' ' ' ASN . 47.3 pttt -65.25 -24.94 67.46 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 107.906 -1.146 . . . . 1.35 107.906 170.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.5 t -48.63 -38.91 22.25 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 113.882 -1.508 . . . . 1.28 110.483 172.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -86.53 -36.13 19.13 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 111.818 0.303 . . . . 1.11 111.818 173.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 149.4 -7.47 0.84 Allowed Glycine 0 CA--C 1.521 0.408 0 N-CA-C 111.888 -0.485 . . . . 0.18 111.888 -175.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.719 ' HE2' ' HB3' ' A' ' 60' ' ' LEU . 17.9 t80 -65.34 142.47 58.22 Favored 'General case' 0 C--O 1.22 -0.45 0 C-N-CA 123.036 0.534 . . . . 0.18 111.586 -177.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.93 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 1.6 t -133.9 147.75 51.15 Favored 'General case' 0 N--CA 1.423 -1.799 0 N-CA-C 108.521 -0.918 . . . . 0.2 108.521 170.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 1.013 HG11 ' HB1' ' A' ' 57' ' ' ALA . 36.5 t -98.93 101.9 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.734 0 N-CA-C 107.832 -1.173 . . . . 0.17 107.832 158.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.782 HD21 ' CE2' ' A' ' 28' ' ' TYR . 6.3 mt -83.69 119.56 24.93 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 108.051 -1.092 . . . . 1.04 108.051 177.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.509 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -95.84 111.22 23.25 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.401 -0.592 . . . . 0.51 109.401 177.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 1.009 ' HD2' HD12 ' A' ' 108' ' ' ILE . 3.3 m-85 -101.18 91.95 2.28 Favored Pre-proline 0 C--N 1.312 -1.026 0 N-CA-C 107.386 -1.338 . . . . 0.44 107.386 172.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.654 ' O ' ' HB2' ' A' ' 107' ' ' LYS . 80.8 Cg_endo -77.11 77.72 3.7 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.854 2.369 . . . . 1.3 114.626 -166.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 C--N 1.32 -0.675 0 C-N-CA 126.744 2.018 . . . . 1.44 116.185 -178.713 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.624 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . . . . . . 0 CA--C 1.514 -0.422 0 CA-C-O 120.546 0.212 . . . . 0.55 110.634 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -91.2 -20.69 21.69 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.195 -0.457 . . . . 1.99 111.1 173.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.768 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 0.7 OUTLIER -89.52 175.04 4.21 Favored Pre-proline 0 N--CA 1.443 -0.784 0 CA-C-N 116.476 -0.329 . . . . 0.84 110.373 -177.513 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.768 ' HD2' ' HB2' ' A' ' 102' ' ' PHE . 70.7 Cg_endo -69.29 103.56 1.1 Allowed 'Trans proline' 0 C--N 1.336 -0.093 0 C-N-CA 122.818 2.345 . . . . 0.62 112.381 178.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.624 HD11 ' HB3' ' A' ' 100' ' ' ALA . 3.9 mp -101.1 120.75 51.07 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.018 0 N-CA-C 107.684 -1.228 . . . . 1.34 107.684 175.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.789 ' HG3' ' CE1' ' A' ' 74' ' ' PHE . 27.3 mmt -87.33 -164.54 1.1 Allowed 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.992 -1.004 . . . . 3.03 111.494 -169.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.717 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . . . -68.58 -16.22 63.79 Favored 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 120.315 -0.554 . . . . 1.46 111.07 -172.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.654 ' HB2' ' O ' ' A' ' 75' ' ' PRO . 10.5 ptpt 81.1 139.68 0.07 Allowed 'General case' 0 CA--C 1.493 -1.215 0 O-C-N 125.71 1.881 . . . . 1.76 108.397 -163.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 1.009 HD12 ' HD2' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -131.26 159.84 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.599 0 N-CA-C 104.785 -2.302 . . . . 0.82 104.785 169.604 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -64.48 80.53 0.04 OUTLIER 'General case' 0 C--N 1.287 -2.148 0 O-C-N 123.603 0.564 . . . . 1.73 110.427 177.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.821 ' HA ' ' OH ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -78.81 90.38 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 C-N-CA 118.701 -1.2 . . . . 0.77 108.2 -179.711 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.443 ' N ' ' OH ' ' A' ' 119' ' ' TYR . 2.1 t-20 . . . . . 0 N--CA 1.441 -0.889 0 CA-C-N 113.354 -1.748 . . . . 1.9 107.499 178.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.658 ' CB ' HG13 ' A' ' 108' ' ' ILE . 8.6 t-80 . . . . . 0 N--CA 1.418 -2.026 0 N-CA-C 107.542 -1.281 . . . . 0.42 107.542 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.589 ' HB2' ' CD1' ' A' ' 18' ' ' PHE . 5.4 Cg_exo -33.43 -37.72 0.1 OUTLIER 'Trans proline' 0 C--O 1.214 -0.717 1 C-N-CA 125.403 4.068 . . . . 0.4 114.064 -172.905 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.773 ' CD1' ' HB ' ' A' ' 15' ' ' ILE . 7.5 tp -63.5 -60.32 3.5 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 114.046 1.128 . . . . 0.39 114.046 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.821 ' OH ' ' HA ' ' A' ' 110' ' ' VAL . 3.8 p90 -82.7 -25.82 32.61 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 107.486 -1.302 . . . . 3.04 107.486 -177.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.62 ' HA ' ' HD2' ' A' ' 123' ' ' LYS . 1.9 tm-20 -59.25 -39.86 84.14 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.334 -1.358 . . . . 2.44 107.334 172.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.64 ' HB2' ' HE2' ' A' ' 18' ' ' PHE . 29.6 t80 -64.21 -29.3 70.41 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.007 -0.997 . . . . 0.56 110.145 169.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.764 ' CE ' HD12 ' A' ' 40' ' ' ILE . 66.9 mtt -73.4 -55.3 6.55 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 121.134 0.493 . . . . 0.71 110.797 -173.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.705 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -70.45 -22.49 62.69 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.154 -0.93 . . . . 1.46 110.817 177.754 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.61 ' HG3' ' O ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -73.37 -26.3 60.95 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 119.636 -0.826 . . . . 1.99 109.502 171.318 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 93.2 m -74.87 -55.91 5.31 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.221 0.534 . . . . 0.59 110.06 173.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.696 ' HG2' ' NH2' ' A' ' 153' ' ' ARG . 22.7 ttmm . . . . . 0 C--N 1.325 -0.493 0 CA-C-N 115.669 -0.696 . . . . 1.85 109.424 177.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.78 ' HB3' ' HG3' ' A' ' 156' ' ' PRO . 6.8 m-90 . . . . . 0 CA--C 1.519 -0.219 0 CA-C-O 121.01 0.433 . . . . 1.97 111.78 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.482 ' O ' ' N ' ' A' ' 140' ' ' THR . 10.7 t-20 -39.5 -155.32 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 113.852 -1.522 . . . . 2.04 111.37 157.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.607 ' HD2' ' HD2' ' A' ' 41' ' ' TYR . 1.6 m-85 -29.12 -25.06 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 117.924 2.565 . . . . 1.93 117.924 -171.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.69 ' HA ' ' O ' ' A' ' 154' ' ' PHE . 29.5 m -0.6 105.96 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 114.472 1.286 . . . . 0.6 114.472 175.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.616 ' HB3' HD12 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -86.12 170.33 12.3 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.167 -1.378 . . . . 0.62 110.302 -172.912 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.531 ' O ' HD13 ' A' ' 39' ' ' LEU . 86.7 m-85 -127.68 127.47 43.79 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 105.803 -1.925 . . . . 0.57 105.803 164.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.827 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 9.1 tp -80.55 104.71 11.26 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 118.238 -1.385 . . . . 0.43 108.534 176.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.759 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 41.7 mm -93.6 141.0 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.929 0 CA-C-N 113.746 -1.57 . . . . 0.19 107.154 -177.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.708 ' HA ' HD13 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -92.39 178.18 5.91 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 120.508 -0.477 . . . . 0.98 111.518 -171.736 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.462 ' CG ' ' HD3' ' A' ' 37' ' ' PRO . 66.8 mtm180 -48.71 -46.39 40.59 Favored 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 123.135 0.574 . . . . 2.22 111.494 -178.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -96.41 24.04 6.21 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.187 -0.672 . . . . 2.0 109.187 -178.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.535 ' HA2' ' CG2' ' A' ' 144' ' ' ILE . . . 71.68 42.6 53.94 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.083 -0.962 . . . . 0.17 113.789 175.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.482 ' O ' HG23 ' A' ' 151' ' ' VAL . 49.9 t -103.87 114.85 64.23 Favored Pre-proline 0 C--N 1.311 -1.074 0 C-N-CA 119.631 -0.828 . . . . 1.12 110.882 177.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.818 ' HD3' HG23 ' A' ' 15' ' ' ILE . 21.6 Cg_endo -67.02 113.06 2.68 Favored 'Trans proline' 0 CA--C 1.529 0.27 0 C-N-CA 122.998 2.465 . . . . 0.41 110.251 176.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 149' ' ' VAL . 16.3 t -113.66 -28.06 2.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-O 121.398 0.618 . . . . 1.45 109.788 -173.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.827 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 17.3 mm-40 -137.37 168.24 20.03 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 115.077 -0.965 . . . . 1.17 110.423 -177.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.696 ' NH2' ' HG2' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -145.92 137.71 25.1 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 114.59 -1.187 . . . . 2.16 108.901 161.729 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.716 ' HZ ' ' HB2' ' A' ' 166' ' ' LYS . 94.0 m-85 -112.25 145.56 39.72 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.126 -0.488 . . . . 0.32 110.161 -170.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 10.2 m -63.79 152.12 87.41 Favored Pre-proline 0 C--N 1.317 -0.842 0 N-CA-C 109.345 -0.613 . . . . 1.11 109.345 175.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.78 ' HG3' ' HB3' ' A' ' 137' ' ' TRP . 43.8 Cg_endo -66.69 -22.88 49.62 Favored 'Trans proline' 0 CA--C 1.512 -0.585 0 C-N-CA 122.28 1.987 . . . . 0.78 110.7 178.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -85.38 13.73 53.92 Favored Glycine 0 N--CA 1.44 -1.085 0 CA-C-N 114.773 -1.103 . . . . 0.5 112.87 173.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -87.63 149.83 24.04 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.225 -0.657 . . . . 0.5 109.225 172.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.5 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 17.5 m -108.66 171.99 7.1 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 121.181 0.515 . . . . 1.42 111.526 -174.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.776 ' HA ' HG23 ' A' ' 56' ' ' THR . 52.0 t -39.07 -55.74 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 114.463 -1.244 . . . . 0.28 111.853 176.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -64.56 -31.87 73.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.472 -0.786 . . . . 3.46 111.567 -174.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.446 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 23.6 m-20 -75.75 -32.62 60.05 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.24 -0.891 . . . . 1.4 110.305 -173.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.891 HD12 HG21 ' A' ' 56' ' ' THR . 57.3 mt -83.3 -44.48 18.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.234 -0.894 . . . . 0.21 110.913 177.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.578 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 37.9 mt-10 -54.31 -40.44 67.96 Favored 'General case' 0 C--O 1.218 -0.575 0 CA-C-N 116.613 -0.267 . . . . 0.67 111.506 -178.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 9.2 pt-20 -56.9 -27.24 60.52 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 112.1 0.407 . . . . 0.87 112.1 -177.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.716 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 46.2 mmtm -96.69 -26.04 15.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.394 0.616 . . . . 1.71 110.276 175.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.578 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 12.1 tp -76.96 -49.49 15.38 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.068 -0.969 . . . . 0.16 112.031 -177.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.509 HG13 ' O ' ' A' ' 164' ' ' GLU . 81.8 mt -53.29 -44.82 98.21 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-N 115.511 -0.768 . . . . 0.26 112.165 -174.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.427 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 85.5 Cg_exo -50.37 -39.35 53.78 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.133 1.889 . . . . 0.41 112.917 172.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.708 HD13 ' HA ' ' A' ' 145' ' ' ASP . 96.0 mt -79.34 -43.52 23.37 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.728 -0.389 . . . . 0.71 111.284 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.63 HD21 ' HB2' ' A' ' 69' ' ' PHE . 95.7 mt -57.93 -54.11 50.58 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 122.083 0.944 . . . . 0.34 109.674 176.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.235 0 CA-C-N 113.297 -1.774 . . . . 1.12 113.397 -177.995 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.2 t . . . . . 0 CA--C 1.533 0.289 0 CA-C-O 121.307 0.575 . . . . 1.58 109.853 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 65.5 p 179.05 152.34 0.36 Allowed 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 105.47 -2.048 . . . . 1.17 105.47 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.827 ' HB ' HD11 ' A' ' 118' ' ' LEU . 5.6 pt -64.99 -12.95 14.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-N 115.061 -0.972 . . . . 0.38 112.187 -171.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.769 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 43.6 m-85 -75.44 0.96 15.24 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.378 0.51 . . . . 0.3 112.378 -175.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -73.43 -19.26 61.01 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 108.242 -1.021 . . . . 2.11 108.242 174.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.694 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 57.1 m-85 -111.34 107.34 16.57 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 114.628 -1.169 . . . . 0.31 111.045 -174.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -51.07 140.96 14.91 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 113.843 -1.526 . . . . 2.86 109.03 174.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.783 HG13 ' HZ ' ' A' ' 74' ' ' PHE . 40.3 t -110.32 166.27 5.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 108.118 -1.067 . . . . 0.67 108.118 -177.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.713 ' O ' ' HB2' ' A' ' 105' ' ' MET . 24.7 mt -127.0 143.61 51.25 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.884 -0.413 . . . . 0.69 109.884 179.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.442 ' OD2' ' HE2' ' A' ' 26' ' ' LYS . 18.6 m-20 -77.59 177.37 8.13 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 106.742 -1.577 . . . . 1.87 106.742 165.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.759 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . . . -64.39 -5.25 4.89 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 113.068 0.766 . . . . 0.59 113.068 -171.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.902 ' HB2' ' HG2' ' A' ' 26' ' ' LYS . 15.8 m-20 -94.66 -8.1 38.88 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 111.591 0.219 . . . . 2.34 111.591 178.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.545 ' HB2' ' O ' ' A' ' 24' ' ' ASP . 49.0 m-70 80.8 -0.66 1.83 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.506 0.723 . . . . 1.47 109.829 -175.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.902 ' HG2' ' HB2' ' A' ' 24' ' ' ASP . 6.4 ptmt -67.1 120.0 68.77 Favored Pre-proline 0 N--CA 1.45 -0.472 0 N-CA-C 108.158 -1.053 . . . . 4.25 108.158 165.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.635 ' HA ' HD23 ' A' ' 21' ' ' LEU . 90.0 Cg_exo -50.26 116.54 2.54 Favored 'Trans proline' 0 N--CA 1.465 -0.19 0 C-N-CA 122.638 2.225 . . . . 0.54 113.828 -175.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.834 ' HE2' HD23 ' A' ' 72' ' ' LEU . 15.0 t80 -79.74 143.66 34.32 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 113.865 -1.516 . . . . 1.2 111.212 174.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.488 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.7 t-20 -80.72 82.47 6.71 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.085 -0.962 . . . . 1.51 109.931 178.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.794 HD21 HD12 ' A' ' 15' ' ' ILE . 59.2 tp -57.91 -41.33 82.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.302 0.572 . . . . 0.28 109.784 177.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.71 HG12 ' HG3' ' A' ' 34' ' ' LYS . 2.0 t -68.16 -3.72 2.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 114.638 -1.165 . . . . 1.02 112.256 -170.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.488 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 3.4 pt20 -70.18 -17.25 63.16 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.919 -0.771 . . . . 1.02 108.919 175.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.904 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 92.4 m-70 -92.68 23.58 4.01 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.318 -0.855 . . . . 0.28 109.644 177.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.769 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 10.1 mtmt -81.99 121.76 26.93 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 114.639 -1.164 . . . . 1.56 109.335 168.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.42 -42.05 1.89 Allowed Glycine 0 N--CA 1.436 -1.31 0 C-N-CA 120.633 -0.794 . . . . 0.2 111.67 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.484 ' HB2' ' HA3' ' A' ' 68' ' ' GLY . 19.3 m -128.69 127.86 23.52 Favored Pre-proline 0 N--CA 1.435 -1.183 0 N-CA-C 108.462 -0.94 . . . . 0.29 108.462 173.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.805 ' HG3' ' CB ' ' A' ' 170' ' ' LEU . 4.9 Cg_endo -42.74 152.61 0.18 Allowed 'Trans proline' 0 CA--C 1.508 -0.777 0 C-N-CA 124.401 3.401 . . . . 0.18 113.205 178.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.853 HD13 ' HB2' ' A' ' 33' ' ' HIS . 0.9 OUTLIER -137.5 142.33 41.47 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.052 -1.431 . . . . 0.31 107.361 -178.341 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.989 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 1.8 mm? -107.79 114.78 28.98 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.473 -0.936 . . . . 1.19 108.473 176.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.825 HG23 HD13 ' A' ' 72' ' ' LEU . 1.1 mt -95.38 127.99 46.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 C-N-CA 119.81 -0.756 . . . . 0.37 109.647 177.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.989 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 1.1 m-85 -112.47 124.43 52.48 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.215 -0.448 . . . . 0.42 110.435 -175.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.667 HD22 ' HB ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -83.01 92.54 7.39 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 107.31 -1.367 . . . . 2.35 107.31 173.691 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.761 HG23 ' HB3' ' A' ' 139' ' ' PHE . 11.1 p . . . . . 0 C--N 1.312 -1.026 0 CA-C-O 121.02 0.438 . . . . 1.03 111.394 -161.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.869 0 N-CA-C 111.388 -0.685 . . . . 0.51 111.388 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.535 ' HA2' ' HB ' ' A' ' 56' ' ' THR . . . -61.98 -19.12 58.56 Favored Glycine 0 C--O 1.22 -0.746 0 CA-C-O 119.688 -0.506 . . . . 0.5 114.359 -177.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -77.19 -57.0 4.08 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 118.305 1.053 . . . . 0.7 109.983 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.18 -39.27 72.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.575 0.703 . . . . 2.61 109.587 173.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.714 HG23 ' HA ' ' A' ' 160' ' ' VAL . 18.3 m -57.06 -59.28 5.3 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 114.625 -1.171 . . . . 0.33 111.296 174.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 1.061 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -55.98 -45.45 78.97 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.869 -0.605 . . . . 0.22 111.047 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.586 ' HA ' ' HE1' ' A' ' 102' ' ' PHE . 92.1 m -55.02 -51.33 66.62 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.589 0.709 . . . . 0.26 110.354 -178.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 28.1 m -72.96 -36.79 67.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.861 -1.063 . . . . 0.48 111.483 -177.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.712 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 14.5 mt -64.23 -52.67 57.61 Favored 'General case' 0 CA--C 1.498 -1.054 0 CA-C-O 121.311 0.577 . . . . 0.43 110.381 -178.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.794 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 2.1 t80 -51.73 -53.26 41.37 Favored 'General case' 0 C--O 1.199 -1.586 0 CA-C-N 114.218 -1.356 . . . . 0.31 110.167 178.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.412 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 6.1 m-80 -72.91 -25.56 61.1 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 112.097 0.406 . . . . 1.21 112.097 -170.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.453 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 35.4 ttpt -84.06 -23.24 30.94 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 119.401 -0.92 . . . . 1.54 108.924 -178.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.654 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 36.7 m-85 -122.37 -4.31 8.87 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 114.959 1.466 . . . . 0.31 114.959 -172.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.722 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 13.7 ptmt -64.93 -25.31 67.82 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 108.238 -1.023 . . . . 1.35 108.238 171.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.9 m -47.76 -41.9 24.33 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.113 -1.403 . . . . 1.28 110.74 172.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -85.37 -33.09 22.09 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.059 0.392 . . . . 1.11 112.059 175.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.484 ' HA3' ' HB2' ' A' ' 36' ' ' SER . . . 145.82 -7.46 1.47 Allowed Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 111.454 -0.659 . . . . 0.18 111.454 -177.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.712 ' HE2' ' HB3' ' A' ' 60' ' ' LEU . 19.5 t80 -64.38 140.86 58.91 Favored 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 122.709 0.403 . . . . 0.18 111.027 -178.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.904 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 1.6 t -134.34 151.3 51.15 Favored 'General case' 0 N--CA 1.413 -2.294 0 N-CA-C 108.425 -0.954 . . . . 0.2 108.425 173.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 1.061 HG11 ' HB1' ' A' ' 57' ' ' ALA . 50.2 t -109.16 100.27 10.42 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.341 0 N-CA-C 107.488 -1.301 . . . . 0.17 107.488 159.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.834 HD23 ' HE2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -89.85 121.07 31.63 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 118.254 -1.378 . . . . 1.04 108.375 177.496 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.86 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -98.09 112.68 24.55 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.914 -0.585 . . . . 0.51 110.842 -177.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.849 ' CD2' ' HE2' ' A' ' 119' ' ' TYR . 3.1 m-30 -96.56 102.16 10.74 Favored Pre-proline 0 C--N 1.31 -1.143 0 N-CA-C 108.827 -0.805 . . . . 0.44 108.827 176.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.717 ' HG2' ' HB3' ' A' ' 107' ' ' LYS . 87.8 Cg_endo -80.33 71.02 7.27 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 123.239 2.626 . . . . 1.3 114.302 -166.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 77.3 p . . . . . 0 N--CA 1.475 0.798 0 N-CA-C 116.767 2.136 . . . . 1.44 116.767 179.491 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.629 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . . . . . . 0 CA--C 1.51 -0.586 0 CA-C-O 120.82 0.343 . . . . 0.55 110.235 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -104.57 28.51 6.93 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.637 -0.711 . . . . 1.99 111.012 178.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.873 ' HB3' ' O ' ' A' ' 71' ' ' VAL . 3.5 m-85 -113.14 -177.11 0.42 Allowed Pre-proline 0 CA--C 1.513 -0.454 0 CA-C-O 121.853 0.835 . . . . 0.84 111.426 -177.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.706 ' HD3' ' CE2' ' A' ' 61' ' ' TYR . 12.9 Cg_exo -79.87 71.73 6.89 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 124.095 3.197 . . . . 0.62 110.442 156.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.86 HG13 ' HB3' ' A' ' 73' ' ' ALA . 5.3 mp -73.77 119.92 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 108.143 -1.058 . . . . 1.34 108.143 173.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.828 ' HG2' ' CG ' ' A' ' 74' ' ' PHE . 0.3 OUTLIER -80.26 -175.53 5.14 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.079 -0.509 . . . . 3.03 110.768 -173.358 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.759 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . . . -71.36 -0.01 9.19 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.592 -0.731 . . . . 1.46 111.958 -176.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.776 ' H ' ' HG3' ' A' ' 105' ' ' MET . 3.1 ptpp? 70.45 137.59 0.04 OUTLIER 'General case' 0 CA--C 1.499 -1.001 0 C-N-CA 125.256 1.422 . . . . 1.76 110.604 -170.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.701 HG13 ' CB ' ' A' ' 116' ' ' HIS . 0.1 OUTLIER -140.51 167.44 18.12 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 CA-C-N 113.262 -1.79 . . . . 0.82 106.358 168.297 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.518 ' O ' HG12 ' A' ' 108' ' ' ILE . 0.2 OUTLIER -49.72 119.13 3.25 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.785 -0.82 . . . . 1.73 108.785 168.556 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.667 ' HB ' HD22 ' A' ' 42' ' ' ASN . 0.0 OUTLIER -128.28 87.84 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 C-N-CA 119.442 -0.903 . . . . 0.77 108.688 166.763 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.5 t30 . . . . . 0 N--CA 1.438 -1.032 0 CA-C-N 113.981 -1.463 . . . . 1.9 108.908 176.64 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.701 ' CB ' HG13 ' A' ' 108' ' ' ILE . 0.9 OUTLIER . . . . . 0 N--CA 1.43 -1.455 0 N-CA-C 107.057 -1.46 . . . . 0.42 107.057 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -27.44 -50.42 0.11 Allowed 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 124.701 3.6 . . . . 0.4 113.891 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.827 HD11 ' HB ' ' A' ' 15' ' ' ILE . 64.7 tp -57.12 -53.41 58.39 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 122.912 0.485 . . . . 0.39 112.259 176.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.849 ' HE2' ' CD2' ' A' ' 74' ' ' PHE . 80.0 m-85 -77.38 -35.37 54.49 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 112.299 0.481 . . . . 3.04 112.299 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.73 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 5.7 mm-40 -57.48 -34.0 68.57 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 107.221 -1.399 . . . . 2.44 107.221 172.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.694 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 70.8 t80 -71.48 -33.5 69.34 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 119.262 -0.975 . . . . 0.56 111.065 173.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.651 ' HE3' ' HG ' ' A' ' 118' ' ' LEU . 1.8 ttm -74.64 -55.0 6.37 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.275 -0.42 . . . . 0.71 110.465 -171.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.463 ' HB2' ' HE2' ' A' ' 123' ' ' LYS . 0.6 OUTLIER -70.57 -25.74 63.22 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 116.514 -0.312 . . . . 1.46 111.42 178.029 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.73 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 9.4 pttp -68.58 -27.28 65.92 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 119.486 -0.886 . . . . 1.99 109.485 177.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 29.1 m -89.47 -28.01 19.97 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.244 -0.889 . . . . 0.59 110.703 176.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.541 ' HB3' ' NH2' ' A' ' 153' ' ' ARG . 39.9 mmtt . . . . . 0 C--N 1.326 -0.428 0 CA-C-N 116.087 -0.506 . . . . 1.85 110.945 -177.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.604 ' HB3' ' HG3' ' A' ' 156' ' ' PRO . 2.4 m95 . . . . . 0 N--CA 1.452 -0.363 0 CA-C-O 120.877 0.37 . . . . 1.97 111.599 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.414 ' O ' ' N ' ' A' ' 140' ' ' THR . 1.6 m120 -39.48 -155.61 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 126.603 1.961 . . . . 2.04 114.128 165.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.761 ' HB3' HG23 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -34.14 -22.19 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 116.063 1.875 . . . . 1.93 116.063 -177.084 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.459 ' OG1' ' HD3' ' A' ' 156' ' ' PRO . 3.7 m 10.49 108.12 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 119.965 1.257 . . . . 0.6 113.911 166.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.514 ' CB ' HD12 ' A' ' 39' ' ' LEU . 0.9 OUTLIER -90.75 161.08 15.48 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 114.066 -1.425 . . . . 0.62 110.484 -167.34 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.478 ' HA ' ' HA ' ' A' ' 153' ' ' ARG . 38.6 m-85 -124.64 122.82 38.59 Favored 'General case' 0 CA--C 1.494 -1.206 0 N-CA-C 106.389 -1.708 . . . . 0.57 106.389 168.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.787 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 8.9 tp -79.73 104.88 10.62 Favored 'General case' 0 N--CA 1.425 -1.708 0 C-N-CA 118.348 -1.341 . . . . 0.43 108.416 179.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.679 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 39.3 mm -92.0 142.05 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.717 0 CA-C-N 112.744 -2.025 . . . . 0.19 107.605 -178.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.439 ' HA ' HD13 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -94.43 -175.57 3.67 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 119.131 -1.028 . . . . 0.98 111.316 -170.194 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.67 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 29.9 mtm180 -52.33 -39.6 60.85 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 121.097 0.475 . . . . 2.22 110.909 -178.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -97.33 20.99 10.66 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.334 0.588 . . . . 2.0 109.711 -175.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.7 ' HA3' ' CE2' ' A' ' 16' ' ' PHE . . . 68.73 35.58 80.55 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 115.812 -0.631 . . . . 0.17 114.185 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.467 ' HA ' ' HD2' ' A' ' 150' ' ' PRO . 65.5 t -106.17 108.31 61.46 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 118.387 1.093 . . . . 1.12 111.666 175.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.689 ' HD3' HG23 ' A' ' 15' ' ' ILE . 5.3 Cg_endo -52.05 114.78 1.78 Allowed 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 123.876 3.051 . . . . 0.41 111.256 171.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.959 HG13 ' HG2' ' A' ' 152' ' ' GLU . 13.8 p -116.79 -21.88 4.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-O 121.489 0.661 . . . . 1.45 109.488 -177.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.959 ' HG2' HG13 ' A' ' 151' ' ' VAL . 30.1 mm-40 -138.25 167.54 21.63 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 115.351 -0.841 . . . . 1.17 110.372 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.541 ' NH2' ' HB3' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -145.14 146.29 31.72 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.137 -0.938 . . . . 2.16 109.571 161.517 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.632 ' CE2' ' HA ' ' A' ' 163' ' ' ILE . 93.2 m-85 -121.95 140.46 52.42 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.874 -0.603 . . . . 0.32 109.457 -172.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 6.3 m -68.14 158.57 83.73 Favored Pre-proline 0 C--N 1.315 -0.913 0 N-CA-C 109.847 -0.427 . . . . 1.11 109.847 178.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.604 ' HG3' ' HB3' ' A' ' 137' ' ' TRP . 18.4 Cg_endo -59.46 -32.4 96.31 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.137 1.891 . . . . 0.78 110.624 174.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -73.06 -0.0 49.29 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 114.515 -1.221 . . . . 0.5 113.724 173.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -85.97 146.15 26.81 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.83 -0.804 . . . . 0.5 108.83 173.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 4.0 t -110.35 -178.83 3.6 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-O 121.082 0.468 . . . . 1.42 110.259 -173.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.714 ' HA ' HG23 ' A' ' 56' ' ' THR . 60.8 t -45.84 -57.25 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 114.609 -1.178 . . . . 0.28 111.79 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 42.5 tttm -63.46 -38.44 91.14 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 120.624 0.25 . . . . 3.46 111.034 -172.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.41 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 61.9 m-20 -57.26 -43.27 82.85 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.812 0.815 . . . . 1.4 109.124 -177.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.632 ' HA ' ' CE2' ' A' ' 154' ' ' PHE . 90.5 mt -75.52 -47.29 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 CA-C-N 114.216 -1.356 . . . . 0.21 111.017 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.624 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 58.2 mt-10 -55.39 -43.49 75.23 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-O 121.089 0.471 . . . . 0.67 111.07 -176.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 10.5 pt-20 -63.63 -16.21 60.31 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 116.269 -0.423 . . . . 0.87 111.684 -173.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.577 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 31.5 mmmt -104.51 -21.34 13.46 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.47 0.653 . . . . 1.71 109.964 172.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.601 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 12.8 tp -84.96 -49.53 8.26 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.997 -1.001 . . . . 0.16 112.289 -176.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.574 ' N ' ' HD2' ' A' ' 169' ' ' PRO . 64.1 mt -57.46 -43.7 99.14 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.661 -0.699 . . . . 0.26 112.4 -174.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 168' ' ' ILE . 8.0 Cg_endo -53.65 -20.62 17.12 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 121.894 1.729 . . . . 0.41 112.939 172.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.805 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 99.3 mt -96.42 -43.14 7.78 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 122.416 -0.178 . . . . 0.71 111.205 177.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.648 HD21 ' HB2' ' A' ' 69' ' ' PHE . 96.6 mt -60.08 -56.95 15.31 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-O 121.962 0.887 . . . . 0.34 108.738 173.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.424 -2.154 0 CA-C-N 113.892 -1.504 . . . . 1.12 110.552 178.838 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.1 m . . . . . 0 N--CA 1.463 0.179 0 CA-C-O 121.507 0.67 . . . . 1.58 110.007 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 90.9 p -178.48 151.81 0.62 Allowed 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.678 -1.971 . . . . 1.17 105.678 175.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.882 HG21 ' HE1' ' A' ' 122' ' ' MET . 6.5 pt -69.12 -13.99 17.95 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 CA-C-N 114.787 -1.097 . . . . 0.38 111.801 -171.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.824 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 54.8 m-85 -77.21 -3.26 38.72 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.273 -0.421 . . . . 0.3 111.189 -177.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -69.24 -21.06 63.94 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.275 -1.009 . . . . 2.11 108.275 172.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.753 ' HE2' ' HB2' ' A' ' 121' ' ' TYR . 49.6 m-85 -114.14 111.1 21.03 Favored 'General case' 0 CA--C 1.503 -0.853 0 CA-C-N 114.718 -1.128 . . . . 0.31 111.84 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -50.42 150.35 2.66 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.142 -1.39 . . . . 2.86 109.941 169.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.762 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 38.0 t -111.43 164.02 7.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 N-CA-C 108.894 -0.78 . . . . 0.67 108.894 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.759 ' O ' ' HB3' ' A' ' 105' ' ' MET . 89.6 mt -126.4 113.11 16.45 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 120.873 -0.331 . . . . 0.69 111.65 -176.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.716 ' HA ' ' HE2' ' A' ' 105' ' ' MET . 12.1 t70 -51.6 160.42 0.63 Allowed 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 107.779 -1.193 . . . . 1.87 107.779 169.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.635 ' HA ' ' C ' ' A' ' 105' ' ' MET . . . -54.53 -16.69 2.53 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 114.147 1.166 . . . . 0.59 114.147 -163.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.543 ' HB2' ' HE2' ' A' ' 26' ' ' LYS . 33.4 m-20 -96.15 5.32 51.35 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 112.325 0.491 . . . . 2.34 112.325 178.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.695 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 82.8 m-70 78.13 15.21 1.43 Allowed 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.699 0.762 . . . . 1.47 109.163 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.543 ' HE2' ' HB2' ' A' ' 24' ' ' ASP . 13.2 mtmt -79.64 119.15 75.89 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 107.212 -1.403 . . . . 4.25 107.212 169.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.61 ' HA ' HD23 ' A' ' 21' ' ' LEU . 84.6 Cg_exo -51.7 113.91 1.36 Allowed 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 121.582 1.521 . . . . 0.54 113.157 -173.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.56 ' HB3' HG12 ' A' ' 20' ' ' VAL . 32.3 t80 -79.35 144.8 33.86 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.074 -1.421 . . . . 1.2 111.366 175.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.441 ' OD1' ' HB3' ' A' ' 32' ' ' GLN . 2.4 t-20 -78.85 85.38 4.83 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.026 -0.988 . . . . 1.51 109.934 178.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.616 ' HG ' ' CD1' ' A' ' 16' ' ' PHE . 49.1 tp -63.26 -42.37 99.14 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.393 -0.821 . . . . 0.28 110.471 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.804 ' HA ' ' CE1' ' A' ' 16' ' ' PHE . 2.0 t -68.99 -0.64 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 114.424 -1.262 . . . . 1.02 112.481 -167.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.441 ' HB3' ' OD1' ' A' ' 29' ' ' ASN . 10.4 pt20 -76.52 -5.26 46.79 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.531 0.681 . . . . 1.02 110.321 177.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.955 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 87.9 m-70 -100.71 24.29 9.31 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.843 0.83 . . . . 0.28 109.335 173.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.824 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 0.5 OUTLIER -82.82 110.42 17.82 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.724 -1.125 . . . . 1.56 109.311 171.762 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.26 -37.42 2.2 Favored Glycine 0 N--CA 1.437 -1.249 0 C-N-CA 120.917 -0.659 . . . . 0.2 111.506 -177.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.479 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 17.6 m -132.33 133.11 23.34 Favored Pre-proline 0 N--CA 1.435 -1.197 0 N-CA-C 108.626 -0.879 . . . . 0.29 108.626 173.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.8 ' HG3' ' CB ' ' A' ' 170' ' ' LEU . 6.8 Cg_endo -44.04 153.45 0.31 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 124.124 3.216 . . . . 0.18 112.614 178.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.895 ' HB2' HG22 ' A' ' 70' ' ' THR . 0.7 OUTLIER -140.61 139.41 34.89 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.027 -1.471 . . . . 0.31 107.027 -179.919 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.818 ' HB3' ' CE1' ' A' ' 41' ' ' TYR . 3.0 mp -107.17 116.66 32.32 Favored 'General case' 0 C--N 1.293 -1.881 0 O-C-N 121.518 -0.739 . . . . 1.19 109.449 176.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.914 HG23 ' HB2' ' A' ' 72' ' ' LEU . 2.6 mt -95.77 120.35 45.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-N 115.557 -0.747 . . . . 0.37 109.761 176.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.818 ' CE1' ' HB3' ' A' ' 39' ' ' LEU . 0.5 OUTLIER -103.87 124.95 49.88 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.493 -0.776 . . . . 0.42 110.041 -174.555 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.675 ' OD1' ' HB ' ' A' ' 140' ' ' THR . 0.2 OUTLIER -75.61 125.66 29.47 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 104.309 -2.478 . . . . 2.35 104.309 168.525 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.703 ' O ' ' HA ' ' A' ' 75' ' ' PRO . 2.8 p . . . . . 0 C--N 1.294 -1.817 0 C-N-CA 117.665 -1.614 . . . . 1.03 113.114 -169.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 N-CA-C 112.077 -0.409 . . . . 0.51 112.077 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -47.55 -45.16 23.18 Favored Glycine 0 C--O 1.224 -0.517 0 O-C-N 123.792 0.348 . . . . 0.5 113.686 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.456 ' HA ' ' CZ ' ' A' ' 139' ' ' PHE . 1.1 t80 -61.38 -62.97 1.45 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.049 0.389 . . . . 0.7 112.049 -172.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -59.24 -40.14 84.98 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.188 0.518 . . . . 2.61 111.121 -178.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.55 ' HA ' ' CG2' ' A' ' 160' ' ' VAL . 40.8 m -54.97 -59.92 4.09 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.163 -0.926 . . . . 0.33 111.193 174.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 1.027 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -61.81 -42.55 99.16 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.417 -0.811 . . . . 0.22 111.15 -176.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.597 ' N ' ' HE1' ' A' ' 102' ' ' PHE . 61.5 m -55.33 -51.08 67.92 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.814 0.816 . . . . 0.26 109.825 -177.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 26.5 m -72.11 -35.15 69.1 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 114.402 -1.272 . . . . 0.48 111.22 -177.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.64 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 17.4 mt -67.57 -50.04 60.35 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 121.365 0.602 . . . . 0.43 110.413 -176.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.847 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 8.4 t80 -59.36 -47.21 86.29 Favored 'General case' 0 C--O 1.205 -1.27 0 CA-C-N 114.967 -1.015 . . . . 0.31 110.502 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -73.76 -24.29 59.84 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 112.022 0.379 . . . . 1.21 112.022 -174.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.48 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 32.2 ttpt -84.54 -25.99 28.36 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 120.02 -0.672 . . . . 1.54 109.275 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.734 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 35.9 m-85 -123.2 -5.79 8.34 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 115.121 1.526 . . . . 0.31 115.121 -169.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.71 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 41.4 pttt -65.48 -26.59 67.99 Favored 'General case' 0 CA--C 1.5 -0.975 0 N-CA-C 108.434 -0.95 . . . . 1.35 108.434 172.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.2 t -47.91 -41.86 25.65 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.458 -1.246 . . . . 1.28 110.733 172.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.403 HE21 ' HD1' ' A' ' 64' ' ' TYR . 48.0 mt-30 -82.03 -37.41 26.56 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 111.821 0.304 . . . . 1.11 111.821 175.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.429 ' HA3' ' HB2' ' A' ' 36' ' ' SER . . . 150.58 -7.95 0.72 Allowed Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 111.622 -0.591 . . . . 0.18 111.622 -176.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.734 ' HD2' ' HB2' ' A' ' 64' ' ' TYR . 13.7 t80 -64.41 143.33 57.98 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 122.777 0.431 . . . . 0.18 110.841 -178.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.955 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 5.3 t -132.91 148.16 52.29 Favored 'General case' 0 N--CA 1.416 -2.127 0 N-CA-C 108.848 -0.797 . . . . 0.2 108.848 168.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 1.027 HG11 ' HB1' ' A' ' 57' ' ' ALA . 21.8 t -100.07 100.78 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.419 0 N-CA-C 107.199 -1.408 . . . . 0.17 107.199 158.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.914 ' HB2' HG23 ' A' ' 40' ' ' ILE . 79.8 mt -84.26 118.87 24.45 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 107.085 -1.45 . . . . 1.04 107.085 178.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.618 ' HB3' HG12 ' A' ' 104' ' ' ILE . . . -96.44 113.41 24.99 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.939 -0.704 . . . . 0.51 109.838 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.882 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 5.0 m-85 -108.96 95.22 16.62 Favored Pre-proline 0 N--CA 1.433 -1.286 0 N-CA-C 107.337 -1.357 . . . . 0.44 107.337 -177.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.891 ' HB2' ' HG2' ' A' ' 107' ' ' LYS . 3.4 Cg_endo -67.33 148.37 79.71 Favored 'Trans proline' 0 N--CA 1.429 -2.314 0 N-CA-C 109.091 -1.157 . . . . 1.3 109.091 -174.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.439 ' O ' ' HD3' ' A' ' 107' ' ' LYS . 29.2 p . . . . . 0 C--N 1.287 -2.117 0 CA-C-O 121.988 0.899 . . . . 1.44 112.76 -177.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.51 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . . . . . . 0 CA--C 1.51 -0.571 0 CA-C-O 121.381 0.61 . . . . 0.55 111.518 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.638 ' O ' ' HD2' ' A' ' 61' ' ' TYR . 62.6 mm-40 -100.92 48.12 0.9 Allowed 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 114.665 -1.152 . . . . 1.99 110.837 176.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.721 ' HB3' ' O ' ' A' ' 71' ' ' VAL . 1.6 m-85 -128.25 175.98 3.07 Favored Pre-proline 0 CA--C 1.511 -0.543 0 CA-C-O 121.466 0.651 . . . . 0.84 109.724 172.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.674 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 14.4 Cg_exo -76.48 77.75 3.51 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 123.519 2.813 . . . . 0.62 109.936 158.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.618 HG12 ' HB3' ' A' ' 73' ' ' ALA . 76.4 mt -80.44 126.52 39.55 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.504 0 N-CA-C 107.978 -1.119 . . . . 1.34 107.978 176.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.882 ' HG3' ' CE1' ' A' ' 74' ' ' PHE . 7.1 mmt -105.56 -168.12 1.41 Allowed 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 121.727 0.775 . . . . 3.03 113.032 -163.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.629 ' N ' ' HA ' ' A' ' 23' ' ' ALA . . . -76.47 6.81 5.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.637 -1.165 . . . . 1.46 113.755 -167.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.891 ' HG2' ' HB2' ' A' ' 75' ' ' PRO . 57.1 mttp 65.99 139.29 0.03 OUTLIER 'General case' 0 CA--C 1.491 -1.315 0 CA-C-O 122.51 1.148 . . . . 1.76 110.847 -169.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.846 HD12 ' HD2' ' A' ' 74' ' ' PHE . 0.1 OUTLIER -138.45 163.71 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.576 0 N-CA-C 106.428 -1.693 . . . . 0.82 106.428 165.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.531 HD22 ' C ' ' A' ' 109' ' ' ASN . 0.2 OUTLIER -73.16 83.56 1.33 Allowed 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 120.612 0.244 . . . . 1.73 110.375 -177.428 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.65 HG13 HD11 ' A' ' 108' ' ' ILE . 2.6 m -80.25 90.15 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-O 121.848 0.832 . . . . 0.77 109.299 176.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 . . . . . 0 N--CA 1.44 -0.973 0 CA-C-N 114.177 -1.374 . . . . 1.9 107.988 179.952 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.826 ' HB3' HG13 ' A' ' 108' ' ' ILE . 1.6 t-80 . . . . . 0 N--CA 1.439 -1.017 0 N-CA-C 107.557 -1.275 . . . . 0.42 107.557 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -24.99 -48.03 0.06 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 124.678 3.585 . . . . 0.4 113.847 178.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.767 HD11 ' HB ' ' A' ' 15' ' ' ILE . 38.5 tp -69.35 -45.92 68.24 Favored 'General case' 0 C--O 1.216 -0.684 0 C-N-CA 122.598 0.359 . . . . 0.39 111.827 -179.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.668 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 9.7 m-85 -82.54 -32.16 28.75 Favored 'General case' 0 CA--C 1.491 -1.303 0 CA-C-O 121.709 0.766 . . . . 3.04 110.9 -175.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.531 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 2.9 tm-20 -64.03 -35.03 79.38 Favored 'General case' 0 N--CA 1.424 -1.749 0 N-CA-C 107.031 -1.47 . . . . 2.44 107.031 172.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.753 ' HB2' ' HE2' ' A' ' 18' ' ' PHE . 28.7 t80 -72.45 -26.75 61.94 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.96 -1.018 . . . . 0.56 110.253 170.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.882 ' HE1' HG21 ' A' ' 15' ' ' ILE . 15.4 mmt -71.95 -55.93 6.59 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 121.66 0.743 . . . . 0.71 110.287 -170.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.668 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -72.84 -25.48 61.14 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.214 -0.903 . . . . 1.46 110.565 178.655 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.531 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 27.2 tttt -60.96 -38.42 85.82 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 109.079 -0.712 . . . . 1.99 109.079 169.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.44 ' HB ' ' O ' ' A' ' 122' ' ' MET . 96.2 m -65.43 -55.71 16.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.29 -0.868 . . . . 0.59 110.644 177.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm . . . . . 0 N--CA 1.452 -0.369 0 N-CA-C 113.392 0.886 . . . . 1.85 113.392 -174.68 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.547 ' HB3' ' HG3' ' A' ' 156' ' ' PRO . 1.9 m-90 . . . . . 0 CA--C 1.507 -0.696 0 CA-C-O 120.558 0.218 . . . . 1.97 110.525 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.534 ' HB2' ' HB3' ' A' ' 156' ' ' PRO . 6.6 m120 -39.46 -154.23 0.0 OUTLIER 'General case' 0 C--O 1.203 -1.366 0 O-C-N 124.822 1.326 . . . . 2.04 111.5 160.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.622 ' HD2' ' CD2' ' A' ' 41' ' ' TYR . 2.2 m-85 -31.35 -25.19 0.0 OUTLIER 'General case' 0 CA--C 1.567 1.597 0 N-CA-C 117.691 2.478 . . . . 1.93 117.691 -171.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.728 ' HA ' ' O ' ' A' ' 154' ' ' PHE . 1.4 m 6.56 101.3 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 120.495 1.498 . . . . 0.6 114.086 170.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.515 ' O ' ' HA ' ' A' ' 153' ' ' ARG . 4.5 m -89.12 176.03 7.14 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.22 -0.9 . . . . 0.62 112.195 -170.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.562 ' HA ' ' O ' ' A' ' 152' ' ' GLU . 79.5 m-85 -134.25 124.44 25.93 Favored 'General case' 0 CA--C 1.491 -1.297 0 N-CA-C 106.422 -1.695 . . . . 0.57 106.422 161.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.821 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 5.8 tp -80.52 103.97 10.74 Favored 'General case' 0 N--CA 1.423 -1.82 0 C-N-CA 118.487 -1.285 . . . . 0.43 108.342 177.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.768 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 27.9 mm -90.76 141.35 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.822 0 CA-C-N 113.41 -1.723 . . . . 0.19 107.656 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.54 ' OD1' HG12 ' A' ' 149' ' ' VAL . 0.0 OUTLIER -94.71 -173.68 3.08 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 119.541 -0.863 . . . . 0.98 111.234 -169.905 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.503 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 44.2 mtm180 -54.83 -36.48 65.05 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.14 0.275 . . . . 2.22 111.326 -177.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -104.05 20.97 17.26 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 121.569 0.7 . . . . 2.0 109.245 -176.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.643 ' HA2' ' CG2' ' A' ' 144' ' ' ILE . . . 70.43 36.37 69.26 Favored Glycine 0 N--CA 1.435 -1.396 0 CA-C-N 114.624 -1.171 . . . . 0.17 115.126 175.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.54 HG12 ' OD1' ' A' ' 145' ' ' ASP . 5.2 p -103.67 129.98 24.34 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 119.528 1.664 . . . . 1.12 110.379 172.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.529 ' HA ' HD13 ' A' ' 144' ' ' ILE . 3.6 Cg_exo -69.84 121.33 8.0 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.6 2.2 . . . . 0.41 110.493 179.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 22.1 t -114.7 -27.01 2.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-O 121.426 0.631 . . . . 1.45 109.401 -176.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.821 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 60.7 mm-40 -138.17 165.47 26.57 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.363 -0.835 . . . . 1.17 111.441 -178.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.524 ' HB2' ' CD1' ' A' ' 142' ' ' PHE . 2.6 ttm180 -145.6 125.2 13.26 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.761 -1.109 . . . . 2.16 109.146 165.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.728 ' O ' ' HA ' ' A' ' 140' ' ' THR . 91.2 m-85 -107.19 149.95 27.14 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.203 -0.908 . . . . 0.32 108.74 -169.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 19.4 m -76.98 158.51 80.13 Favored Pre-proline 0 C--N 1.313 -0.998 0 N-CA-C 108.795 -0.817 . . . . 1.11 108.795 175.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.547 ' HG3' ' HB3' ' A' ' 137' ' ' TRP . 10.8 Cg_endo -54.52 -48.91 18.86 Favored 'Trans proline' 0 N--CA 1.465 -0.202 0 C-N-CA 121.874 1.716 . . . . 0.78 110.685 178.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -59.52 -2.0 1.45 Allowed Glycine 0 CA--C 1.529 0.964 0 CA-C-N 114.753 -1.112 . . . . 0.5 114.902 174.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -84.69 134.07 34.37 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 107.982 -1.118 . . . . 0.5 107.982 171.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.534 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 6.8 t -110.68 -174.58 2.51 Favored 'General case' 0 N--CA 1.435 -1.177 0 C-N-CA 119.976 -0.69 . . . . 1.42 110.757 -167.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.55 ' CG2' ' HA ' ' A' ' 56' ' ' THR . 64.0 t -45.44 -50.92 2.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 114.7 -1.137 . . . . 0.28 111.202 -176.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -68.79 -35.07 76.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.137 -0.483 . . . . 3.46 111.22 -174.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.451 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 28.2 m-20 -68.91 -35.17 76.52 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.779 0.799 . . . . 1.4 109.553 -177.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.46 ' HA ' ' CE2' ' A' ' 154' ' ' PHE . 46.5 mt -80.56 -48.08 20.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 114.494 -1.23 . . . . 0.21 111.354 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.631 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 49.3 mt-10 -53.81 -39.3 65.4 Favored 'General case' 0 C--O 1.217 -0.631 0 CA-C-O 120.888 0.375 . . . . 0.67 111.39 -176.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 12.1 pt-20 -60.86 -21.93 63.74 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.636 0.255 . . . . 0.87 111.544 -176.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.582 ' HB3' HD22 ' A' ' 143' ' ' LEU . 35.7 mmtp -100.07 -22.85 15.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.382 0.61 . . . . 1.71 110.13 174.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.631 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 12.9 tp -85.8 -50.03 7.46 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.037 -0.983 . . . . 0.16 112.36 -174.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.557 ' N ' ' HD2' ' A' ' 169' ' ' PRO . 73.8 mt -54.09 -46.95 98.55 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.628 -0.715 . . . . 0.26 112.643 -173.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 168' ' ' ILE . 14.7 Cg_endo -58.62 -16.23 29.31 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.192 1.928 . . . . 0.41 113.026 175.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.8 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 95.4 mt -97.11 -41.31 8.4 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 122.006 -0.433 . . . . 0.71 110.784 177.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.664 HD23 ' HG2' ' A' ' 37' ' ' PRO . 96.0 mt -63.28 -53.61 50.22 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-O 122.21 1.005 . . . . 0.34 109.727 175.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.55 0 CA-C-N 113.323 -1.762 . . . . 1.12 112.365 -176.579 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.9 m . . . . . 0 C--O 1.233 0.194 0 CA-C-O 121.514 0.673 . . . . 1.58 110.175 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 80.0 p 178.85 177.8 0.47 Allowed 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 105.89 -1.893 . . . . 1.17 105.89 -173.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.879 HG23 ' HD3' ' A' ' 150' ' ' PRO . 3.7 pt -89.71 -15.36 8.8 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 CA-C-N 115.579 -0.737 . . . . 0.38 110.378 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.816 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 36.3 m-85 -70.52 -13.23 62.02 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.259 0.552 . . . . 0.3 110.854 -179.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -63.93 -24.67 67.82 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.64 -0.874 . . . . 2.11 108.64 173.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.599 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 50.9 m-85 -112.49 105.6 13.87 Favored 'General case' 0 CA--C 1.495 -1.145 0 CA-C-N 114.972 -1.013 . . . . 0.31 110.341 178.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -52.16 146.19 9.4 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.68 -1.145 . . . . 2.86 109.903 174.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.733 HG23 HD22 ' A' ' 30' ' ' LEU . 54.7 t -109.26 159.17 8.85 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 107.464 -1.31 . . . . 0.67 107.464 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.857 ' O ' ' HB2' ' A' ' 105' ' ' MET . 26.2 mt -126.99 167.82 15.38 Favored 'General case' 0 N--CA 1.433 -1.312 0 C-N-CA 120.323 -0.551 . . . . 0.69 110.279 -176.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -86.69 -179.27 6.55 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.64 -0.874 . . . . 1.87 108.64 175.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.683 ' HA ' ' N ' ' A' ' 106' ' ' ALA . . . -63.58 -9.13 11.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 118.527 0.603 . . . . 0.59 111.415 -178.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.494 ' HB2' ' HE2' ' A' ' 26' ' ' LYS . 11.8 m-20 -107.85 7.74 28.3 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.559 -0.291 . . . . 2.34 111.562 174.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.693 ' CD2' ' HB3' ' A' ' 106' ' ' ALA . 3.8 m170 72.29 15.1 5.37 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 121.68 0.753 . . . . 1.47 110.181 174.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.494 ' HE2' ' HB2' ' A' ' 24' ' ' ASP . 27.5 mtmt -76.39 133.38 71.35 Favored Pre-proline 0 C--O 1.221 -0.426 0 N-CA-C 107.228 -1.397 . . . . 4.25 107.228 165.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.679 ' HA ' HD23 ' A' ' 21' ' ' LEU . 85.2 Cg_exo -48.86 115.94 1.91 Allowed 'Trans proline' 0 CA--C 1.532 0.418 0 C-N-CA 122.11 1.873 . . . . 0.54 113.719 -175.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.68 ' H ' ' HA ' ' A' ' 21' ' ' LEU . 0.4 OUTLIER -77.32 153.07 34.19 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.32 -1.309 . . . . 1.2 109.031 168.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.608 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.1 t-20 -92.32 84.15 5.13 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.446 0.641 . . . . 1.51 109.34 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.733 HD22 HG23 ' A' ' 20' ' ' VAL . 64.0 tp -67.27 -47.41 70.75 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.499 -0.773 . . . . 0.28 110.746 -178.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.836 HG12 ' HG3' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -69.55 -0.68 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.351 -0.841 . . . . 1.02 112.704 -168.199 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.608 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 3.9 pt20 -75.08 -11.04 60.0 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.393 -0.595 . . . . 1.02 109.393 174.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.952 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 89.5 m-70 -95.81 18.05 13.91 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.933 0.873 . . . . 0.28 109.124 175.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.836 ' HG3' HG12 ' A' ' 31' ' ' VAL . 23.7 mtmt -77.69 110.97 12.98 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 114.464 -1.244 . . . . 1.56 108.874 166.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 131.86 -44.99 1.16 Allowed Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 120.754 -0.736 . . . . 0.2 111.499 -178.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.466 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 43.4 m -129.05 134.93 26.87 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 108.721 -0.844 . . . . 0.29 108.721 172.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.726 ' HG3' ' CB ' ' A' ' 170' ' ' LEU . 5.2 Cg_endo -42.38 153.9 0.13 Allowed 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 124.403 3.402 . . . . 0.18 113.093 177.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.876 ' HB2' HG22 ' A' ' 70' ' ' THR . 0.6 OUTLIER -138.32 143.6 40.02 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 113.737 -1.574 . . . . 0.31 106.847 179.79 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 1.037 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 1.6 mm? -109.78 117.87 35.01 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.199 -1.038 . . . . 1.19 108.199 178.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.817 HG22 ' OH ' ' A' ' 119' ' ' TYR . 5.8 mt -108.24 129.85 61.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 C-N-CA 120.107 -0.637 . . . . 0.37 109.679 -178.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 1.037 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.5 OUTLIER -114.31 130.28 56.66 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 116.132 -0.485 . . . . 0.42 111.315 -168.664 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.714 ' ND2' ' HB ' ' A' ' 140' ' ' THR . 2.5 p-10 -84.36 93.54 8.28 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 107.798 -1.186 . . . . 2.35 107.798 166.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.913 HG11 ' HB1' ' A' ' 73' ' ' ALA . 2.7 p . . . . . 0 C--N 1.301 -1.524 0 CA-C-N 115.444 -0.798 . . . . 1.03 111.481 -161.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.612 ' O ' ' HG3' ' A' ' 55' ' ' GLU . . . . . . . . 0 CA--C 1.518 0.278 0 N-CA-C 113.721 0.249 . . . . 0.51 113.721 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -54.06 -21.5 17.87 Favored Glycine 0 C--O 1.221 -0.712 0 C-N-CA 121.379 -0.439 . . . . 0.5 113.676 -177.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.58 ' HA ' ' CZ ' ' A' ' 139' ' ' PHE . 0.1 OUTLIER -65.14 -61.53 2.08 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 117.595 0.697 . . . . 0.7 109.921 179.825 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.612 ' HG3' ' O ' ' A' ' 52' ' ' GLY . 0.1 OUTLIER -59.57 -21.8 60.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.612 -0.722 . . . . 2.61 110.044 179.896 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.661 ' HA ' ' CG2' ' A' ' 160' ' ' VAL . 29.6 m -77.4 -59.76 2.65 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 114.814 -1.085 . . . . 0.33 110.623 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 1.023 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -61.19 -35.08 76.2 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.339 -0.846 . . . . 0.22 110.684 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.653 ' HA ' ' CD1' ' A' ' 102' ' ' PHE . 89.6 m -60.21 -59.18 5.83 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.742 -0.663 . . . . 0.26 110.59 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 56.5 m -70.0 -35.13 74.14 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-N 115.515 -0.766 . . . . 0.48 111.936 -176.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.755 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 21.7 mt -62.33 -52.03 65.29 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 121.302 0.572 . . . . 0.43 110.481 -177.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.762 ' HD1' ' HA ' ' A' ' 70' ' ' THR . 34.3 t80 -51.86 -56.01 16.61 Favored 'General case' 0 C--O 1.204 -1.298 0 CA-C-N 114.584 -1.189 . . . . 0.31 111.108 177.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -71.62 -23.93 61.79 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 122.395 0.278 . . . . 1.21 111.078 -172.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.575 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 37.3 ttpt -86.03 -20.68 28.46 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 109.312 -0.625 . . . . 1.54 109.312 -177.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.646 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 44.1 m-85 -128.02 -6.43 5.52 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 114.547 1.314 . . . . 0.31 114.547 -171.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.739 ' HD2' ' CZ ' ' A' ' 61' ' ' TYR . 13.6 ptmt -63.57 -24.46 67.81 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 108.1 -1.074 . . . . 1.35 108.1 171.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -47.88 -38.57 16.56 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 113.963 -1.471 . . . . 1.28 110.81 172.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -89.35 -32.42 17.32 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.702 0.287 . . . . 1.11 111.67 175.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 147.45 -1.88 0.76 Allowed Glycine 0 C--N 1.332 0.319 0 N-CA-C 111.674 -0.57 . . . . 0.18 111.674 -178.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.755 ' HE2' ' HB3' ' A' ' 60' ' ' LEU . 25.3 t80 -69.51 145.02 53.0 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-O 121.4 0.619 . . . . 0.18 112.003 -177.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.952 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 1.6 t -135.59 152.93 51.74 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 108.839 -0.8 . . . . 0.2 108.839 173.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 1.023 HG11 ' HB1' ' A' ' 57' ' ' ALA . 51.9 t -113.35 101.65 12.78 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.426 0 N-CA-C 108.422 -0.955 . . . . 0.17 108.422 158.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.919 ' HA ' ' HB2' ' A' ' 103' ' ' PRO . 0.4 OUTLIER -94.4 122.05 36.56 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 107.222 -1.399 . . . . 1.04 107.222 173.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.913 ' HB1' HG11 ' A' ' 43' ' ' VAL . . . -108.49 130.34 55.26 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.397 0.618 . . . . 0.51 111.596 -178.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.671 ' CE1' ' HG2' ' A' ' 105' ' ' MET . 3.8 m-30 -109.07 102.82 50.36 Favored Pre-proline 0 C--N 1.319 -0.735 0 N-CA-C 108.72 -0.844 . . . . 0.44 108.72 177.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.837 ' HG2' ' HD2' ' A' ' 107' ' ' LYS . 60.7 Cg_endo -76.87 45.36 1.65 Allowed 'Trans proline' 0 N--CA 1.481 0.784 0 C-N-CA 123.676 2.918 . . . . 1.3 116.076 -163.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.471 ' C ' ' HB2' ' A' ' 107' ' ' LYS . 30.8 t . . . . . 0 N--CA 1.479 0.989 0 N-CA-C 117.128 2.27 . . . . 1.44 117.128 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.58 0 CA-C-O 121.184 0.516 . . . . 0.55 111.558 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -102.87 28.61 6.03 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 115.548 -0.751 . . . . 1.99 109.984 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.653 ' CD1' ' HA ' ' A' ' 58' ' ' THR . 40.3 p90 -151.64 165.25 17.83 Favored Pre-proline 0 N--CA 1.443 -0.822 0 N-CA-C 108.042 -1.096 . . . . 0.84 108.042 176.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.919 ' HB2' ' HA ' ' A' ' 72' ' ' LEU . 74.2 Cg_exo -50.92 132.03 36.29 Favored 'Trans proline' 0 CA--C 1.512 -0.59 0 C-N-CA 123.489 2.793 . . . . 0.62 113.8 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.524 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 50.6 mt -140.76 140.26 33.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 107.461 -1.311 . . . . 1.34 107.461 170.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.857 ' HB2' ' O ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -118.91 -179.22 3.75 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 120.779 -0.368 . . . . 3.03 110.98 -173.319 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.693 ' HB3' ' CD2' ' A' ' 25' ' ' HIS . . . -69.74 104.35 2.41 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 108.928 -0.767 . . . . 1.46 108.928 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.837 ' HD2' ' HG2' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -43.72 132.26 5.08 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-O 122.075 0.94 . . . . 1.76 112.888 -174.679 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.848 HG13 ' HB2' ' A' ' 116' ' ' HIS . 0.1 OUTLIER -119.49 173.25 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.012 0 CA-C-N 113.887 -1.506 . . . . 0.82 108.734 176.035 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.551 HD22 ' C ' ' A' ' 109' ' ' ASN . 0.1 OUTLIER -74.26 87.4 1.97 Allowed 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 114.555 -1.202 . . . . 1.73 110.595 -174.831 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.524 HG11 ' CB ' ' A' ' 42' ' ' ASN . 6.6 m -84.4 89.38 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 CA-C-O 122.311 1.053 . . . . 0.77 108.84 178.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.5 t30 . . . . . 0 C--N 1.315 -0.928 0 CA-C-N 113.683 -1.599 . . . . 1.9 107.945 179.793 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.848 ' HB2' HG13 ' A' ' 108' ' ' ILE . 3.5 t-80 . . . . . 0 N--CA 1.42 -1.956 0 N-CA-C 108.791 -0.818 . . . . 0.42 108.791 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 116' ' ' HIS . 11.9 Cg_exo -31.2 -45.86 0.17 Allowed 'Trans proline' 0 C--O 1.217 -0.539 0 C-N-CA 124.358 3.372 . . . . 0.4 113.031 -179.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.874 HD11 ' HB ' ' A' ' 15' ' ' ILE . 27.4 tp -60.11 -53.05 62.3 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.289 0.636 . . . . 0.39 112.597 175.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.817 ' OH ' HG22 ' A' ' 40' ' ' ILE . 3.1 m-85 -77.91 -32.88 51.95 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-O 121.343 0.592 . . . . 3.04 110.834 -176.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.73 -40.01 95.87 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 106.726 -1.583 . . . . 2.44 106.726 174.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.808 ' HA ' ' HE2' ' A' ' 124' ' ' LYS . 81.4 t80 -65.26 -29.64 70.44 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.308 -0.86 . . . . 0.56 109.791 173.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.665 ' CE ' HD12 ' A' ' 40' ' ' ILE . 40.8 mtt -75.01 -55.95 5.23 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.837 -0.62 . . . . 0.71 110.958 -168.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.444 ' HE2' ' HB2' ' A' ' 123' ' ' LYS . 0.3 OUTLIER -70.41 -30.47 67.35 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.972 -0.558 . . . . 1.46 111.235 179.725 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.808 ' HE2' ' HA ' ' A' ' 121' ' ' TYR . 46.0 pttt -76.32 -26.65 56.01 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 119.238 -0.985 . . . . 1.99 111.422 -178.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.488 HG22 ' HG3' ' A' ' 126' ' ' LYS . 51.7 m -73.75 -44.93 54.79 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.915 0.388 . . . . 0.59 110.314 176.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.765 ' HD2' ' HB2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.318 0 CA-C-O 121.24 0.543 . . . . 1.85 111.506 178.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.656 ' HB3' ' HG3' ' A' ' 156' ' ' PRO . 21.7 m-90 . . . . . 0 CA--C 1.508 -0.653 0 N-CA-C 110.033 -0.358 . . . . 1.97 110.033 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.666 ' HB2' ' CB ' ' A' ' 156' ' ' PRO . 7.6 m120 -49.63 -157.71 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.129 -0.941 . . . . 2.04 110.581 164.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.708 ' CD1' HG23 ' A' ' 43' ' ' VAL . 4.3 m-85 -28.81 -47.09 0.05 Allowed 'General case' 0 CA--C 1.56 1.34 0 N-CA-C 116.533 2.049 . . . . 1.93 116.533 -166.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.714 ' HB ' ' ND2' ' A' ' 42' ' ' ASN . 7.2 m 38.02 98.53 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 120.239 1.381 . . . . 0.6 113.902 175.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.726 ' HB3' HD12 ' A' ' 39' ' ' LEU . 1.2 m -90.72 163.06 14.63 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.153 -0.93 . . . . 0.62 111.831 -174.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.418 ' O ' HD13 ' A' ' 39' ' ' LEU . 88.4 m-85 -126.92 126.06 42.61 Favored 'General case' 0 CA--C 1.493 -1.234 0 N-CA-C 106.215 -1.772 . . . . 0.57 106.215 166.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.775 HD11 HD12 ' A' ' 170' ' ' LEU . 10.7 tp -79.4 105.03 10.42 Favored 'General case' 0 N--CA 1.418 -2.06 0 C-N-CA 118.326 -1.349 . . . . 0.43 108.109 177.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.674 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 24.4 mm -92.24 135.17 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.783 0 CA-C-N 112.821 -1.99 . . . . 0.19 107.256 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.707 ' HA ' HD13 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -89.71 -177.14 5.19 Favored 'General case' 0 C--N 1.31 -1.109 0 C-N-CA 120.43 -0.508 . . . . 0.98 110.81 -168.192 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.584 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 47.9 mtm180 -53.97 -42.65 69.17 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 122.581 0.353 . . . . 2.22 111.902 -176.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -94.54 23.18 5.48 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.164 -0.68 . . . . 2.0 109.164 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.68 ' HA3' ' CE2' ' A' ' 16' ' ' PHE . . . 71.3 37.42 63.12 Favored Glycine 0 N--CA 1.441 -1.002 0 CA-C-N 115.149 -0.932 . . . . 0.17 113.64 176.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.461 ' HA ' ' HD2' ' A' ' 150' ' ' PRO . 46.5 t -103.88 107.46 56.82 Favored Pre-proline 0 C--N 1.316 -0.885 0 C-N-CA 119.809 -0.756 . . . . 1.12 111.43 177.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.879 ' HD3' HG23 ' A' ' 15' ' ' ILE . 15.6 Cg_endo -61.3 127.12 21.06 Favored 'Trans proline' 0 CA--C 1.516 -0.384 0 C-N-CA 123.396 2.731 . . . . 0.41 110.201 174.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.754 ' HA ' ' HG2' ' A' ' 126' ' ' LYS . 4.5 m -135.08 -31.85 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 C-N-CA 120.494 -0.482 . . . . 1.45 112.079 -178.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.762 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 14.4 mm-40 -112.95 159.54 19.0 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.543 -0.54 . . . . 1.17 109.543 174.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 141' ' ' SER . 0.0 OUTLIER -140.3 131.73 26.88 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 120.281 -0.568 . . . . 2.16 109.604 165.257 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.796 ' HZ ' ' HB2' ' A' ' 166' ' ' LYS . 97.9 m-85 -104.55 145.43 30.31 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.135 -0.939 . . . . 0.32 109.284 -174.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 3.2 p -78.51 158.1 76.62 Favored Pre-proline 0 C--N 1.314 -0.95 0 N-CA-C 108.985 -0.746 . . . . 1.11 108.985 176.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.666 ' CB ' ' HB2' ' A' ' 138' ' ' ASN . 11.3 Cg_endo -55.6 -45.05 42.37 Favored 'Trans proline' 0 CA--C 1.517 -0.331 0 C-N-CA 121.618 1.546 . . . . 0.78 110.754 178.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -52.87 -16.16 3.85 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-N 114.255 -1.339 . . . . 0.5 114.468 173.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -87.39 137.08 32.65 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 117.767 0.784 . . . . 0.5 109.304 175.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.417 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 68.1 m -114.14 -172.37 2.08 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 120.957 0.408 . . . . 1.42 112.033 -170.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.661 ' CG2' ' HA ' ' A' ' 56' ' ' THR . 57.8 t -40.04 -56.65 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 114.88 -1.055 . . . . 0.28 112.552 -175.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.75 -31.53 69.55 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.623 0.249 . . . . 3.46 110.917 -172.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -66.43 -37.94 86.31 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.316 0.579 . . . . 1.4 109.631 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.479 HD12 ' CG2' ' A' ' 56' ' ' THR . 81.7 mt -79.89 -43.72 22.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.389 -0.823 . . . . 0.21 111.257 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.592 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 36.7 mt-10 -54.01 -43.24 69.92 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-N 116.565 -0.289 . . . . 0.67 111.413 -177.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -59.56 -19.97 52.31 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.41 0.522 . . . . 0.87 112.41 -175.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.796 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 19.1 mmtp -101.9 -23.91 14.09 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.277 -0.569 . . . . 1.71 110.697 171.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.592 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 12.9 tp -76.8 -54.05 7.12 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.415 -0.811 . . . . 0.16 111.959 -178.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.469 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 72.1 mt -51.52 -45.5 90.71 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.085 -0.961 . . . . 0.26 112.296 -174.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.469 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 88.8 Cg_exo -49.45 -44.26 35.39 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 122.049 1.833 . . . . 0.41 112.71 173.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.775 HD12 HD11 ' A' ' 143' ' ' LEU . 90.5 mt -76.9 -38.82 52.8 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 120.911 -0.316 . . . . 0.71 111.093 -179.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.719 HD23 ' HG2' ' A' ' 37' ' ' PRO . 82.2 mt -59.45 -59.95 4.63 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-O 121.926 0.869 . . . . 0.34 109.908 177.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.571 0 CA-C-N 113.476 -1.693 . . . . 1.12 112.638 179.163 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.9 p . . . . . 0 CA--C 1.523 -0.08 0 CA-C-O 121.04 0.448 . . . . 1.58 110.36 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.514 ' HB3' ' O ' ' A' ' 147' ' ' ASP . 1.5 m -161.16 151.58 17.83 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 105.878 -1.897 . . . . 1.17 105.878 -176.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.924 ' HB ' HD11 ' A' ' 118' ' ' LEU . 4.8 pt -64.61 -16.01 18.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-N 114.927 -1.033 . . . . 0.38 112.015 -172.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.829 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 41.6 m-85 -69.73 -3.12 14.01 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 112.117 0.414 . . . . 0.3 112.117 -178.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -71.84 -25.1 61.84 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.37 -0.974 . . . . 2.11 108.37 174.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.586 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 50.1 m-85 -108.51 110.41 21.9 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 114.407 -1.27 . . . . 0.31 111.162 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -53.73 142.82 22.3 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.069 -1.423 . . . . 2.86 110.215 174.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.851 HG13 ' HZ ' ' A' ' 74' ' ' PHE . 53.7 t -110.71 161.97 8.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 N-CA-C 108.031 -1.1 . . . . 0.67 108.031 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.73 ' O ' ' HB2' ' A' ' 105' ' ' MET . 25.5 mt -130.61 152.44 49.98 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 120.603 -0.439 . . . . 0.69 110.455 -178.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -73.92 -178.46 3.27 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.332 -0.618 . . . . 1.87 109.332 176.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.633 ' HA ' ' N ' ' A' ' 106' ' ' ALA . . . -64.35 -4.41 3.8 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.803 0.335 . . . . 0.59 111.647 -178.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.525 ' HB2' ' HE2' ' A' ' 26' ' ' LYS . 9.7 m-20 -116.95 9.08 13.63 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.704 -0.226 . . . . 2.34 111.452 175.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.652 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 11.1 m170 73.02 11.93 5.12 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-O 121.419 0.628 . . . . 1.47 110.25 174.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.525 ' HE2' ' HB2' ' A' ' 24' ' ' ASP . 26.6 mtmt -69.52 130.68 90.43 Favored Pre-proline 0 N--CA 1.453 -0.322 0 N-CA-C 107.211 -1.403 . . . . 4.25 107.211 165.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.688 ' HA ' HD23 ' A' ' 21' ' ' LEU . 79.7 Cg_exo -51.16 114.79 1.68 Allowed 'Trans proline' 0 CA--C 1.53 0.28 0 C-N-CA 121.895 1.73 . . . . 0.54 113.147 -176.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.542 ' H ' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -76.93 149.9 35.99 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.174 -1.375 . . . . 1.2 110.602 173.179 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.506 ' OD1' ' HB3' ' A' ' 32' ' ' GLN . 2.4 t-20 -93.41 81.57 4.41 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.954 -0.758 . . . . 1.51 108.954 177.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.722 HD21 HD12 ' A' ' 15' ' ' ILE . 61.1 tp -62.01 -41.79 98.46 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.506 -0.77 . . . . 0.28 110.294 -178.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.721 ' HA ' ' CE1' ' A' ' 16' ' ' PHE . 1.6 t -70.12 -1.32 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.099 -0.955 . . . . 1.02 111.93 -170.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.506 ' HB3' ' OD1' ' A' ' 29' ' ' ASN . 2.3 pt20 -74.72 -10.36 59.44 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.06 -0.718 . . . . 1.02 109.06 174.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.962 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 93.9 m-70 -99.41 25.6 6.84 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 121.934 0.873 . . . . 0.28 109.649 176.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.829 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 14.8 mtmt -83.73 132.39 34.85 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 114.297 -1.32 . . . . 1.56 109.155 169.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.83 -42.02 2.03 Favored Glycine 0 N--CA 1.438 -1.233 0 C-N-CA 120.759 -0.734 . . . . 0.2 111.765 -178.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.516 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 15.7 m -125.31 124.95 25.2 Favored Pre-proline 0 N--CA 1.435 -1.21 0 N-CA-C 108.082 -1.081 . . . . 0.29 108.082 173.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.886 ' HG3' ' HB3' ' A' ' 170' ' ' LEU . 2.2 Cg_endo -39.65 153.9 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 124.266 3.31 . . . . 0.18 113.346 176.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.878 ' HB2' HG22 ' A' ' 70' ' ' THR . 0.9 OUTLIER -139.34 143.58 37.86 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.427 -1.323 . . . . 0.31 107.427 -179.209 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 1.046 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 1.2 mm? -107.8 121.71 45.28 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.66 -0.867 . . . . 1.19 108.66 176.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.719 HG13 HG13 ' A' ' 144' ' ' ILE . 1.3 mt -105.57 125.61 60.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 C-N-CA 120.109 -0.636 . . . . 0.37 109.551 177.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 1.046 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.4 OUTLIER -109.38 123.29 49.09 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 116.091 -0.504 . . . . 0.42 109.992 -174.408 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.657 ' ND2' ' HB ' ' A' ' 140' ' ' THR . 2.7 p-10 -80.56 93.22 6.04 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 122.3 1.047 . . . . 2.35 108.185 171.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.781 ' O ' ' HA ' ' A' ' 75' ' ' PRO . 7.7 p . . . . . 0 C--N 1.306 -1.317 0 CA-C-N 115.388 -0.824 . . . . 1.03 111.367 -164.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.835 0 N-CA-C 109.895 -1.282 . . . . 0.51 109.895 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -45.43 -46.13 11.71 Favored Glycine 0 C--O 1.219 -0.833 0 CA-C-N 114.821 -0.689 . . . . 0.5 113.65 177.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.559 ' HB3' ' OE2' ' A' ' 55' ' ' GLU . 0.6 OUTLIER -60.84 -61.43 2.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.186 0.493 . . . . 0.7 110.872 -175.469 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.559 ' OE2' ' HB3' ' A' ' 54' ' ' TYR . 0.2 OUTLIER -54.04 -31.87 52.71 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.62 0.724 . . . . 2.61 110.995 178.243 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.737 ' HA ' HG22 ' A' ' 160' ' ' VAL . 52.9 m -75.84 -58.99 2.95 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.079 -0.964 . . . . 0.33 110.684 -174.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 1.095 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -59.2 -40.3 85.33 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.876 -1.056 . . . . 0.22 110.828 -178.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.506 ' HA ' ' CD1' ' A' ' 102' ' ' PHE . 96.9 m -58.64 -55.17 38.53 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 115.695 -0.684 . . . . 0.26 110.358 179.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 61.5 m -69.4 -39.68 77.79 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.182 -0.917 . . . . 0.48 111.736 -176.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.764 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 17.4 mt -64.87 -47.65 77.11 Favored 'General case' 0 CA--C 1.498 -1.038 0 CA-C-O 121.055 0.455 . . . . 0.43 110.367 -175.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.86 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 7.8 t80 -54.56 -54.39 41.96 Favored 'General case' 0 C--O 1.197 -1.68 0 CA-C-N 114.904 -1.043 . . . . 0.31 110.32 177.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.404 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 9.0 m-80 -72.54 -24.33 61.11 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 111.866 0.321 . . . . 1.21 111.866 -171.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.534 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 36.7 ttpt -83.6 -20.73 33.19 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 108.688 -0.856 . . . . 1.54 108.688 -178.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.717 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 47.9 m-85 -128.52 -1.93 5.51 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 115.835 1.791 . . . . 0.31 115.835 -173.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.721 ' HG2' ' O ' ' A' ' 61' ' ' TYR . 11.9 ptmt -65.8 -26.97 67.93 Favored 'General case' 0 CA--C 1.497 -1.092 0 N-CA-C 107.834 -1.173 . . . . 1.35 107.834 171.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.3 m -47.73 -38.68 15.89 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 113.893 -1.503 . . . . 1.28 110.837 173.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -86.14 -39.63 16.49 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 111.621 0.23 . . . . 1.11 111.621 174.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.41 ' HA3' ' HB2' ' A' ' 36' ' ' SER . . . 149.63 -3.28 0.61 Allowed Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.263 -0.735 . . . . 0.18 111.263 -176.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.764 ' HE2' ' HB3' ' A' ' 60' ' ' LEU . 28.1 t80 -71.07 140.75 50.79 Favored 'General case' 0 C--O 1.222 -0.346 0 C-N-CA 122.856 0.462 . . . . 0.18 111.381 -177.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.962 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 3.7 t -132.96 152.42 51.93 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 108.452 -0.944 . . . . 0.2 108.452 175.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 1.095 HG11 ' HB1' ' A' ' 57' ' ' ALA . 42.2 t -111.83 101.54 12.68 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.532 0 N-CA-C 108.286 -1.005 . . . . 0.17 108.286 160.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.517 ' HA ' ' HB2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -95.06 121.74 36.99 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 118.37 -1.332 . . . . 1.04 107.73 172.984 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.895 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -111.51 128.27 55.96 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 120.581 -0.448 . . . . 0.51 110.71 178.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.851 ' HZ ' HG13 ' A' ' 20' ' ' VAL . 5.3 m-30 -100.8 112.62 65.03 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 116.149 -0.478 . . . . 0.44 110.057 -178.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.781 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 73.6 Cg_endo -80.65 82.45 2.47 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 123.213 2.609 . . . . 1.3 113.504 -169.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.552 ' HB2' ' CG2' ' A' ' 110' ' ' VAL . 19.3 t . . . . . 0 C--O 1.237 0.43 0 CA-C-O 122.782 1.277 . . . . 1.44 114.403 -174.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.532 ' HB1' ' CE1' ' A' ' 102' ' ' PHE . . . . . . . . 0 CA--C 1.518 -0.262 0 CA-C-O 121.152 0.501 . . . . 0.55 112.329 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -94.91 30.28 2.14 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 115.344 -0.844 . . . . 1.99 110.784 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.583 ' CE2' HD11 ' A' ' 104' ' ' ILE . 27.2 p90 -150.07 157.01 37.92 Favored Pre-proline 0 N--CA 1.446 -0.663 0 N-CA-C 108.332 -0.988 . . . . 0.84 108.332 177.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.698 ' HD3' ' CE2' ' A' ' 61' ' ' TYR . 97.7 Cg_exo -51.2 84.12 0.02 OUTLIER 'Trans proline' 0 N--CA 1.479 0.673 0 C-N-CA 124.794 3.663 . . . . 0.62 116.081 -172.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.895 HD12 ' HB3' ' A' ' 73' ' ' ALA . 7.5 mm -85.89 120.6 36.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.092 -1.077 . . . . 1.34 108.092 170.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.783 ' HG2' ' CG ' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -76.53 -177.69 4.31 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.753 -0.832 . . . . 3.03 108.753 178.272 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.633 ' N ' ' HA ' ' A' ' 23' ' ' ALA . . . -63.44 -53.75 47.35 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.384 -0.598 . . . . 1.46 109.384 -177.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.664 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 17.4 ptpt 146.15 151.07 0.0 OUTLIER 'General case' 0 CA--C 1.489 -1.385 0 O-C-N 125.823 1.952 . . . . 1.76 108.371 174.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.555 ' CD1' HG13 ' A' ' 110' ' ' VAL . 2.0 pp -152.08 174.53 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 CA-C-N 113.726 -1.579 . . . . 0.82 107.802 169.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -74.24 87.15 1.95 Allowed 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.462 -0.79 . . . . 1.73 110.932 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.555 HG13 ' CD1' ' A' ' 108' ' ' ILE . 3.6 m -86.0 95.81 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 C-N-CA 118.145 -1.422 . . . . 0.77 108.187 169.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.3 t30 . . . . . 0 C--N 1.311 -1.076 0 CA-C-N 113.63 -1.623 . . . . 1.9 107.815 178.358 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.613 ' CE1' ' H ' ' A' ' 118' ' ' LEU . 2.1 t-80 . . . . . 0 N--CA 1.423 -1.794 0 N-CA-C 106.275 -1.75 . . . . 0.42 106.275 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -27.23 -50.13 0.1 Allowed 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 124.503 3.469 . . . . 0.4 113.598 -178.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.924 HD11 ' HB ' ' A' ' 15' ' ' ILE . 29.1 tp -63.51 -49.28 74.16 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.922 0.489 . . . . 0.39 112.171 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.693 ' OH ' HG22 ' A' ' 40' ' ' ILE . 25.5 m-85 -79.97 -33.96 39.05 Favored 'General case' 0 CA--C 1.492 -1.258 0 CA-C-O 120.935 0.398 . . . . 3.04 110.881 -176.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.478 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 4.7 tt0 -60.42 -37.36 80.63 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 106.589 -1.634 . . . . 2.44 106.589 174.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.586 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 51.5 t80 -68.53 -33.07 73.46 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.047 -0.979 . . . . 0.56 110.492 174.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.698 ' HE3' ' HG ' ' A' ' 118' ' ' LEU . 2.9 ttm -75.77 -55.58 5.5 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.09 -0.504 . . . . 0.71 110.418 -169.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.416 ' HB2' ' HE2' ' A' ' 123' ' ' LYS . 0.8 OUTLIER -70.82 -25.44 62.85 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 120.616 -0.433 . . . . 1.46 111.721 178.294 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.478 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -72.35 -29.73 64.07 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 119.379 -0.928 . . . . 1.99 109.394 178.447 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 88.0 m -87.26 -31.2 20.39 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.489 -0.778 . . . . 0.59 111.285 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.678 ' HG3' ' HB2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.382 0 N-CA-C 112.727 0.64 . . . . 1.85 112.727 -172.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.574 ' HB3' ' HG3' ' A' ' 156' ' ' PRO . 8.9 m-90 . . . . . 0 CA--C 1.51 -0.586 0 CA-C-O 120.872 0.368 . . . . 1.97 110.446 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.593 ' HB2' ' CB ' ' A' ' 156' ' ' PRO . 3.4 m120 -43.86 -155.71 0.0 OUTLIER 'General case' 0 C--O 1.212 -0.884 0 CA-C-N 114.784 -1.098 . . . . 2.04 111.298 163.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.684 ' HD2' ' HD2' ' A' ' 41' ' ' TYR . 2.9 m-85 -27.4 -52.51 0.07 Allowed 'General case' 0 C--O 1.209 -1.076 0 N-CA-C 115.724 1.75 . . . . 1.93 115.724 -166.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.657 ' HB ' ' ND2' ' A' ' 42' ' ' ASN . 7.5 m 41.6 109.17 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 120.542 1.519 . . . . 0.6 113.648 173.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.788 ' HB3' HD12 ' A' ' 39' ' ' LEU . 3.5 m -106.0 158.53 16.73 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 114.825 -1.08 . . . . 0.62 111.085 -167.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.573 ' CD1' ' HB2' ' A' ' 153' ' ' ARG . 63.6 m-85 -125.38 124.34 41.29 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 106.899 -1.519 . . . . 0.57 106.899 166.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.776 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 7.1 tp -79.88 104.01 10.17 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 118.337 -1.345 . . . . 0.43 108.369 179.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.746 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 32.3 mm -92.94 137.92 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.612 0 CA-C-N 113.574 -1.648 . . . . 0.19 107.803 -175.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.64 ' OD1' HG12 ' A' ' 149' ' ' VAL . 0.0 OUTLIER -89.18 -173.72 4.15 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 119.74 -0.784 . . . . 0.98 111.592 -168.14 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.759 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 21.1 mtm180 -56.24 -37.7 70.11 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-O 121.373 0.606 . . . . 2.22 110.543 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.514 ' O ' ' HB3' ' A' ' 14' ' ' SER . 27.6 t70 -93.48 13.74 20.81 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.736 -0.838 . . . . 2.0 108.736 -176.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.719 ' HA2' HG22 ' A' ' 144' ' ' ILE . . . 67.6 33.98 82.6 Favored Glycine 0 N--CA 1.434 -1.437 0 CA-C-N 115.359 -0.837 . . . . 0.17 114.404 -177.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.64 HG12 ' OD1' ' A' ' 145' ' ' ASP . 9.2 p -105.15 114.02 64.0 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 119.206 1.503 . . . . 1.12 111.44 172.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.716 ' HD3' HG23 ' A' ' 15' ' ' ILE . 2.5 Cg_endo -49.71 126.93 17.49 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 123.869 3.046 . . . . 0.41 111.771 174.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 23.0 t -120.09 -32.26 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.397 0.617 . . . . 1.45 109.345 -178.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.776 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 47.8 mm-40 -132.03 167.19 20.12 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-N 115.303 -0.862 . . . . 1.17 111.032 -177.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.599 ' HA ' ' O ' ' A' ' 141' ' ' SER . 1.6 ttm180 -146.33 132.74 19.63 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.266 -0.879 . . . . 2.16 110.744 163.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.57 ' HZ ' ' HB2' ' A' ' 166' ' ' LYS . 98.8 m-85 -110.97 151.55 27.81 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 114.713 -1.13 . . . . 0.32 109.614 -170.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 43.2 t -72.99 156.0 90.02 Favored Pre-proline 0 C--N 1.317 -0.821 0 N-CA-C 109.029 -0.73 . . . . 1.11 109.029 174.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.593 ' CB ' ' HB2' ' A' ' 138' ' ' ASN . 22.8 Cg_endo -61.44 -29.89 85.96 Favored 'Trans proline' 0 CA--C 1.517 -0.341 0 C-N-CA 121.852 1.702 . . . . 0.78 110.247 171.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -73.41 -1.64 57.94 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 114.225 -1.352 . . . . 0.5 113.058 172.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -93.01 140.22 29.7 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 108.421 -0.955 . . . . 0.5 108.421 172.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.553 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 6.7 t -114.2 -170.82 1.79 Allowed 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 120.305 -0.558 . . . . 1.42 111.148 -170.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.737 HG22 ' HA ' ' A' ' 56' ' ' THR . 38.2 t -46.83 -49.47 6.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 114.556 -1.202 . . . . 0.28 111.612 -175.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 50.3 tttp -67.41 -39.9 85.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.873 0.368 . . . . 3.46 111.201 -175.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.429 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 31.2 m-20 -64.25 -37.45 87.51 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.716 -0.674 . . . . 1.4 109.946 -177.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.543 HD12 HG21 ' A' ' 56' ' ' THR . 88.6 mt -80.01 -47.69 21.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.069 -0.969 . . . . 0.21 111.281 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.677 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 30.7 mt-10 -54.5 -40.62 68.71 Favored 'General case' 0 C--O 1.215 -0.714 0 O-C-N 123.151 0.282 . . . . 0.67 111.572 -176.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 10.1 pt-20 -59.57 -21.07 59.79 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.667 0.27 . . . . 0.87 111.493 -175.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.57 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 12.6 mmmm -104.1 -23.92 13.24 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.432 0.634 . . . . 1.71 109.904 175.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.677 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 12.7 tp -79.2 -52.29 8.36 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.725 -1.125 . . . . 0.16 112.106 -178.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.484 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 74.4 mt -53.36 -45.03 98.64 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.31 -0.859 . . . . 0.26 111.959 -174.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.484 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 92.3 Cg_exo -49.06 -44.93 31.2 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 121.929 1.753 . . . . 0.41 112.23 171.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.886 ' HB3' ' HG3' ' A' ' 37' ' ' PRO . 43.5 mt -74.26 -42.78 59.07 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.926 0.343 . . . . 0.71 111.926 -178.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.813 HD23 ' HG2' ' A' ' 37' ' ' PRO . 89.3 mt -60.62 -54.91 39.69 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 122.197 0.998 . . . . 0.34 109.643 177.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.381 0 CA-C-N 113.377 -1.738 . . . . 1.12 114.059 -175.216 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.2 m . . . . . 0 C--O 1.234 0.274 0 CA-C-O 121.365 0.602 . . . . 1.58 110.121 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.435 ' HB3' ' O ' ' A' ' 147' ' ' ASP . 5.9 m -164.76 152.21 11.45 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 104.498 -2.408 . . . . 1.17 104.498 179.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.861 ' HB ' HD11 ' A' ' 118' ' ' LEU . 4.9 pt -62.09 -11.81 6.79 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 CA-C-N 115.59 -0.732 . . . . 0.38 112.302 -172.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.776 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 53.0 m-85 -75.34 0.75 15.7 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.949 0.722 . . . . 0.3 112.949 -176.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -82.2 -19.27 40.15 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.41 -0.959 . . . . 2.11 108.41 175.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.701 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 50.0 m-85 -106.3 113.92 27.73 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 114.855 -1.066 . . . . 0.31 111.791 -178.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -48.56 136.56 12.93 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 113.404 -1.725 . . . . 2.86 111.032 174.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.931 HG13 ' HZ ' ' A' ' 74' ' ' PHE . 94.4 t -112.18 163.91 8.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 108.92 -0.77 . . . . 0.67 108.92 178.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.699 HD23 ' HA ' ' A' ' 27' ' ' PRO . 47.2 mt -130.83 148.97 52.66 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 110.113 -0.328 . . . . 0.69 110.113 -178.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -76.53 177.01 7.77 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.281 -1.377 . . . . 1.87 107.281 166.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.79 ' HA ' ' N ' ' A' ' 106' ' ' ALA . . . -64.62 -4.7 4.43 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.238 0.459 . . . . 0.59 112.238 -176.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.571 ' HB2' ' HE2' ' A' ' 26' ' ' LYS . 54.6 m-20 -105.05 3.03 30.06 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.444 -0.344 . . . . 2.34 111.273 178.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.536 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 71.7 m-70 75.48 2.77 3.87 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 122.724 0.41 . . . . 1.47 109.944 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.571 ' HE2' ' HB2' ' A' ' 24' ' ' ASP . 22.1 mtmt -63.01 118.04 38.75 Favored Pre-proline 0 CA--C 1.512 -0.501 0 N-CA-C 106.777 -1.564 . . . . 4.25 106.777 166.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.699 ' HA ' HD23 ' A' ' 21' ' ' LEU . 96.5 Cg_exo -51.2 114.5 1.57 Allowed 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 121.488 1.458 . . . . 0.54 112.222 -177.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.751 ' HE2' HD23 ' A' ' 72' ' ' LEU . 3.6 t80 -78.73 139.17 38.49 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 113.839 -1.528 . . . . 1.2 110.823 177.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.469 ' OD1' ' HB3' ' A' ' 32' ' ' GLN . 2.6 t-20 -80.9 82.76 6.79 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.595 -0.729 . . . . 1.51 109.288 178.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.791 HD13 HG21 ' A' ' 20' ' ' VAL . 52.7 tp -58.44 -43.38 88.75 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.657 -0.701 . . . . 0.28 110.454 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.707 HG12 ' HG3' ' A' ' 34' ' ' LYS . 1.8 t -69.1 -0.26 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 114.918 -1.037 . . . . 1.02 112.384 -168.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.469 ' HB3' ' OD1' ' A' ' 29' ' ' ASN . 9.3 pt20 -77.1 -8.9 58.28 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.247 -0.649 . . . . 1.02 109.247 174.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.919 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 91.2 m-70 -98.95 29.7 3.71 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 122.042 0.925 . . . . 0.28 109.007 175.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.776 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 5.7 mtmt -92.31 109.29 20.67 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 114.25 -1.341 . . . . 1.56 109.768 174.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.73 -38.44 1.99 Allowed Glycine 0 N--CA 1.436 -1.328 0 N-CA-C 111.319 -0.712 . . . . 0.2 111.319 -177.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.465 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 25.4 m -127.49 130.91 23.63 Favored Pre-proline 0 N--CA 1.433 -1.282 0 N-CA-C 108.192 -1.04 . . . . 0.29 108.192 171.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.824 ' HG2' HD23 ' A' ' 171' ' ' LEU . 2.7 Cg_endo -43.43 157.82 0.11 Allowed 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 124.135 3.223 . . . . 0.18 113.016 176.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.777 ' HB2' HG22 ' A' ' 70' ' ' THR . 0.7 OUTLIER -143.12 144.0 32.05 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 106.981 -1.488 . . . . 0.31 106.981 -179.105 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.786 HD23 ' CE1' ' A' ' 69' ' ' PHE . 2.7 mm? -107.92 113.39 26.56 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.075 -0.713 . . . . 1.19 109.075 177.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.919 HG23 HD13 ' A' ' 72' ' ' LEU . 0.9 OUTLIER -97.0 125.35 50.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 109.676 -0.49 . . . . 0.37 109.676 177.219 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.765 ' CE1' HG13 ' A' ' 71' ' ' VAL . 2.4 m-85 -108.26 155.73 20.16 Favored 'General case' 0 C--O 1.216 -0.698 0 CA-C-O 120.899 0.38 . . . . 0.42 111.537 -171.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.745 ' OD1' ' HB2' ' A' ' 76' ' ' SER . 7.0 t30 -105.33 115.35 30.12 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.306 -1.368 . . . . 2.35 107.306 165.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.817 ' O ' ' HA ' ' A' ' 75' ' ' PRO . 34.7 m . . . . . 0 C--N 1.31 -1.151 0 CA-C-O 121.223 0.535 . . . . 1.03 112.124 -171.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.44 0 N-CA-C 110.208 -1.157 . . . . 0.51 110.208 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.452 ' HA2' ' HB ' ' A' ' 56' ' ' THR . . . -61.7 -15.65 48.45 Favored Glycine 0 C--O 1.216 -0.991 0 CA-C-N 114.729 -0.735 . . . . 0.5 112.433 175.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -68.43 -59.99 2.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 117.358 0.579 . . . . 0.7 109.844 178.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -51.85 -32.63 32.68 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.861 0.838 . . . . 2.61 110.456 174.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.808 ' HA ' HG22 ' A' ' 160' ' ' VAL . 43.3 m -72.83 -59.36 2.75 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 114.396 -1.274 . . . . 0.33 110.578 -175.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 1.073 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -58.52 -42.17 87.1 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.693 -1.14 . . . . 0.22 111.115 -178.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.542 ' HA ' ' CD1' ' A' ' 102' ' ' PHE . 91.5 m -59.63 -55.14 38.16 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.566 0.698 . . . . 0.26 110.442 -178.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 61.4 m -66.82 -36.89 83.42 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.655 -1.157 . . . . 0.48 111.406 -177.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.776 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 14.9 mt -65.42 -47.98 74.38 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 121.364 0.602 . . . . 0.43 110.345 -177.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.875 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 6.7 t80 -59.22 -46.3 88.82 Favored 'General case' 0 C--O 1.207 -1.135 0 CA-C-N 114.896 -1.047 . . . . 0.31 110.489 178.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.69 -25.12 60.09 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 116.416 -0.357 . . . . 1.21 110.981 -174.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.427 ' HB2' ' HE2' ' A' ' 63' ' ' LYS . 6.5 tppt? -80.0 -32.72 39.7 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 108.316 -0.994 . . . . 1.54 108.316 -178.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.763 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 46.0 m-85 -125.67 -2.04 7.32 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 115.802 1.779 . . . . 0.31 115.802 -165.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.675 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 16.3 pttp -67.13 -23.33 65.8 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 107.881 -1.155 . . . . 1.35 107.881 169.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 29.2 t -48.57 -36.94 16.63 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 114.161 -1.381 . . . . 1.28 110.565 169.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.536 HE21 ' HD1' ' A' ' 64' ' ' TYR . 48.0 mt-30 -90.31 -32.44 16.51 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 111.875 0.324 . . . . 1.11 111.875 175.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 142.25 -6.81 2.27 Favored Glycine 0 C--N 1.331 0.264 0 N-CA-C 111.119 -0.792 . . . . 0.18 111.119 -176.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.786 ' CE1' HD23 ' A' ' 39' ' ' LEU . 19.9 t80 -66.91 138.61 57.42 Favored 'General case' 0 C--O 1.22 -0.463 0 C-N-CA 123.045 0.538 . . . . 0.18 111.17 -177.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.919 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 2.0 t -133.51 144.21 49.26 Favored 'General case' 0 N--CA 1.428 -1.573 0 N-CA-C 109.39 -0.596 . . . . 0.2 109.39 175.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 1.073 HG11 ' HB1' ' A' ' 57' ' ' ALA . 19.6 t -103.28 100.61 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.465 0 N-CA-C 108.614 -0.884 . . . . 0.17 108.614 162.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.919 HD13 HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -98.73 120.09 38.58 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.237 -0.985 . . . . 1.04 108.414 174.636 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 1.042 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -105.49 131.22 53.17 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.64 0.733 . . . . 0.51 111.304 -177.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.931 ' HZ ' HG13 ' A' ' 20' ' ' VAL . 3.0 m-30 -107.76 108.94 62.08 Favored Pre-proline 0 C--N 1.31 -1.116 0 CA-C-N 114.998 -1.001 . . . . 0.44 108.905 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.817 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 18.0 Cg_endo -82.13 87.48 1.4 Allowed 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.551 2.167 . . . . 1.3 113.321 -171.052 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.745 ' HB2' ' OD1' ' A' ' 42' ' ' ASN . 1.6 t . . . . . 0 CA--C 1.506 -0.739 0 CA-C-N 115.157 -0.929 . . . . 1.44 113.013 -173.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.634 0 CA-C-O 121.114 0.483 . . . . 0.55 111.24 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -87.4 -5.39 58.87 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.353 -0.839 . . . . 1.99 110.108 174.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.709 ' HB2' ' O ' ' A' ' 71' ' ' VAL . 16.6 p90 -121.09 160.26 45.98 Favored Pre-proline 0 N--CA 1.44 -0.932 0 CA-C-N 115.639 -0.71 . . . . 0.84 110.37 -175.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.69 ' HG2' ' HA ' ' A' ' 72' ' ' LEU . 44.0 Cg_endo -61.65 95.99 0.13 Allowed 'Trans proline' 0 N--CA 1.479 0.624 0 C-N-CA 124.71 3.606 . . . . 0.62 114.284 -174.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 1.042 HD12 ' HB3' ' A' ' 73' ' ' ALA . 4.8 mm -87.02 129.8 37.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 108.591 -0.892 . . . . 1.34 108.591 171.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.772 ' HG2' ' CG ' ' A' ' 74' ' ' PHE . 0.1 OUTLIER -82.66 174.03 11.38 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.709 -0.848 . . . . 3.03 108.709 177.114 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.79 ' N ' ' HA ' ' A' ' 23' ' ' ALA . . . -56.09 -56.51 19.98 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.16 0.505 . . . . 1.46 110.127 -176.046 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.816 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 4.7 ptpp? 144.33 137.03 0.0 OUTLIER 'General case' 0 CA--C 1.488 -1.416 0 O-C-N 125.734 1.896 . . . . 1.76 106.952 176.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.496 HD12 HG22 ' A' ' 110' ' ' VAL . 2.9 pp -136.21 163.32 34.32 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.281 0 CA-C-N 113.945 -1.479 . . . . 0.82 107.497 177.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -71.19 57.58 0.23 Allowed 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 122.947 0.499 . . . . 1.73 111.894 -173.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.604 HG23 ' CB ' ' A' ' 76' ' ' SER . 0.0 OUTLIER -61.16 94.83 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 N-CA-C 108.92 -0.77 . . . . 0.77 108.92 -178.121 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.8 t30 . . . . . 0 N--CA 1.441 -0.918 0 CA-C-N 114.245 -1.343 . . . . 1.9 108.717 -177.221 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.62 ' CE1' ' H ' ' A' ' 118' ' ' LEU . 3.2 t-80 . . . . . 0 N--CA 1.422 -1.828 0 N-CA-C 105.636 -1.987 . . . . 0.42 105.636 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -29.38 -44.31 0.1 OUTLIER 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 124.128 3.219 . . . . 0.4 113.577 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.861 HD11 ' HB ' ' A' ' 15' ' ' ILE . 39.4 tp -59.63 -52.25 66.34 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.495 0.718 . . . . 0.39 112.079 176.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.665 ' HA ' ' HB2' ' A' ' 122' ' ' MET . 43.0 m-85 -77.39 -36.27 53.55 Favored 'General case' 0 CA--C 1.5 -0.953 0 N-CA-C 111.871 0.322 . . . . 3.04 111.871 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.727 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 7.0 mm-40 -59.33 -32.81 70.42 Favored 'General case' 0 CA--C 1.494 -1.182 0 N-CA-C 107.828 -1.175 . . . . 2.44 107.828 172.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.701 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 55.0 t80 -70.81 -33.71 70.99 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 119.731 -0.788 . . . . 0.56 110.651 172.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.745 ' HE3' ' HG ' ' A' ' 118' ' ' LEU . 2.6 ttm -73.59 -55.22 6.58 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.903 -0.589 . . . . 0.71 110.102 -168.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 126' ' ' LYS . 0.2 OUTLIER -71.31 -24.13 62.07 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.088 -0.505 . . . . 1.46 111.614 176.372 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.727 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 9.8 pttp -68.71 -27.54 66.03 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 119.088 -1.045 . . . . 1.99 108.889 175.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 56.0 m -76.73 -50.04 14.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.463 -0.79 . . . . 0.59 109.546 173.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.654 ' HB3' ' NH2' ' A' ' 153' ' ' ARG . 31.4 mttm . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 115.902 -0.59 . . . . 1.85 111.077 176.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.602 ' HB2' ' OG1' ' A' ' 140' ' ' THR . 12.0 m-90 . . . . . 0 N--CA 1.448 -0.561 0 N-CA-C 108.159 -1.052 . . . . 1.97 108.159 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.663 ' HB2' ' CB ' ' A' ' 156' ' ' PRO . 11.5 m120 -45.25 -155.31 0.0 OUTLIER 'General case' 0 C--O 1.21 -1.019 0 C-N-CA 123.907 0.883 . . . . 2.04 111.403 163.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.599 ' HA ' HG12 ' A' ' 43' ' ' VAL . 1.3 m-85 -30.47 -27.65 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.308 0 N-CA-C 117.317 2.34 . . . . 1.93 117.317 -167.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.664 ' HA ' ' O ' ' A' ' 154' ' ' PHE . 3.1 m 9.08 108.55 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 115.162 1.541 . . . . 0.6 115.162 169.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.603 ' OG ' HD12 ' A' ' 39' ' ' LEU . 3.1 t -105.84 165.59 11.08 Favored 'General case' 0 C--O 1.207 -1.177 0 CA-C-N 114.903 -1.044 . . . . 0.62 110.855 -173.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.439 ' HA ' ' HA ' ' A' ' 153' ' ' ARG . 15.1 m-85 -121.51 125.22 46.3 Favored 'General case' 0 CA--C 1.49 -1.337 0 N-CA-C 106.486 -1.672 . . . . 0.57 106.486 167.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.768 HD23 ' HG3' ' A' ' 152' ' ' GLU . 11.1 tp -80.36 104.14 10.7 Favored 'General case' 0 N--CA 1.419 -2.004 0 C-N-CA 118.222 -1.391 . . . . 0.43 108.457 178.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.681 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 41.1 mm -89.21 141.7 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.658 0 CA-C-N 113.012 -1.904 . . . . 0.19 107.701 -177.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.665 ' HA ' HD13 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -93.46 -176.01 3.97 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 119.938 -0.705 . . . . 0.98 111.137 -170.865 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.728 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 50.4 mtm180 -54.49 -37.12 64.92 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.878 0.37 . . . . 2.22 111.301 -177.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.435 ' O ' ' HB3' ' A' ' 14' ' ' SER . 7.5 m-20 -94.36 13.96 22.0 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.716 -0.22 . . . . 2.0 110.782 -178.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.638 ' HA3' ' CE2' ' A' ' 16' ' ' PHE . . . 73.14 36.82 56.04 Favored Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 120.858 -0.687 . . . . 0.17 113.286 -176.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.474 ' HA ' ' HD2' ' A' ' 150' ' ' PRO . 52.6 t -107.82 106.32 58.24 Favored Pre-proline 0 C--N 1.317 -0.829 0 CA-C-N 117.701 0.75 . . . . 1.12 111.078 175.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.708 ' HG3' ' HG3' ' A' ' 122' ' ' MET . 2.1 Cg_endo -51.48 117.24 3.28 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 123.746 2.964 . . . . 0.41 111.462 172.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.873 HG23 ' HG2' ' A' ' 152' ' ' GLU . 27.5 m -118.33 -13.02 10.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 121.133 0.492 . . . . 1.45 109.754 -178.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.873 ' HG2' HG23 ' A' ' 151' ' ' VAL . 17.2 mm-40 -145.99 165.9 27.65 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.582 -0.736 . . . . 1.17 109.652 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.654 ' NH2' ' HB3' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -148.03 144.23 27.77 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.634 -0.712 . . . . 2.16 110.044 159.459 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.706 ' HZ ' ' HB2' ' A' ' 166' ' ' LYS . 91.5 m-85 -120.58 148.25 44.12 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.333 -0.849 . . . . 0.32 108.802 -166.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.426 ' HB3' ' HD2' ' A' ' 156' ' ' PRO . 10.8 m -74.56 162.67 72.67 Favored Pre-proline 0 C--N 1.316 -0.889 0 N-CA-C 109.654 -0.498 . . . . 1.11 109.654 178.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.663 ' CB ' ' HB2' ' A' ' 138' ' ' ASN . 28.6 Cg_endo -63.82 -33.04 66.3 Favored 'Trans proline' 0 CA--C 1.516 -0.386 0 C-N-CA 121.973 1.782 . . . . 0.78 110.42 174.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -63.96 -5.54 14.84 Favored Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 113.926 -1.488 . . . . 0.5 113.822 170.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -87.74 142.32 27.92 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 117.765 0.782 . . . . 0.5 109.408 174.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.467 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 20.3 t -109.92 -179.82 3.91 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 120.881 0.372 . . . . 1.42 110.414 -172.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.808 HG22 ' HA ' ' A' ' 56' ' ' THR . 62.9 t -43.68 -52.13 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.082 -0.963 . . . . 0.28 111.452 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.33 -27.58 62.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.956 -0.566 . . . . 3.46 111.486 -173.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -71.12 -37.75 72.32 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 109.144 -0.687 . . . . 1.4 109.144 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.546 ' HA ' ' CE2' ' A' ' 154' ' ' PHE . 75.0 mt -77.35 -49.09 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-N 115.027 -0.988 . . . . 0.21 110.639 176.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.673 ' HG3' HD21 ' A' ' 60' ' ' LEU . 25.5 mt-10 -51.78 -45.47 63.82 Favored 'General case' 0 C--O 1.219 -0.54 0 O-C-N 123.302 0.376 . . . . 0.67 111.305 -177.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -56.31 -23.34 36.3 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.041 0.386 . . . . 0.87 112.041 -175.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.706 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 14.2 mmmm -102.1 -23.91 14.01 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.342 0.591 . . . . 1.71 110.064 174.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.668 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 7.5 tp -76.74 -48.06 19.91 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.262 -0.881 . . . . 0.16 111.95 -177.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.5 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 80.6 mt -53.76 -46.39 98.41 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.616 -0.72 . . . . 0.26 112.175 -174.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.5 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 58.0 Cg_exo -54.65 -22.93 30.53 Favored 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 122.311 2.007 . . . . 0.41 113.12 174.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.763 ' HB3' ' HG3' ' A' ' 37' ' ' PRO . 31.2 mt -92.98 -38.5 11.63 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 111.68 0.252 . . . . 0.71 111.68 178.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.824 HD23 ' HG2' ' A' ' 37' ' ' PRO . 94.9 mt -63.29 -52.04 63.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-O 122.212 1.006 . . . . 0.34 109.313 175.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.563 0 CA-C-N 113.265 -1.789 . . . . 1.12 114.184 -174.963 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.2 t . . . . . 0 C--O 1.233 0.221 0 CA-C-O 121.834 0.826 . . . . 1.58 108.794 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.438 ' HB2' ' O ' ' A' ' 147' ' ' ASP . 92.0 p -179.91 152.69 0.48 Allowed 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 104.831 -2.285 . . . . 1.17 104.831 -177.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.984 HD12 HD21 ' A' ' 30' ' ' LEU . 4.7 pt -66.96 -12.66 15.42 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 CA-C-N 115.371 -0.831 . . . . 0.38 112.021 -171.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.656 ' CD1' ' HA ' ' A' ' 31' ' ' VAL . 54.9 m-85 -76.28 6.97 4.74 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.028 0.442 . . . . 0.3 111.167 178.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -81.7 -27.74 33.8 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 107.24 -1.393 . . . . 2.11 107.24 174.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.654 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 50.9 m-85 -105.05 121.02 42.92 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 113.963 -1.472 . . . . 0.31 111.008 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -60.18 150.08 30.99 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.29 -1.323 . . . . 2.86 109.818 173.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.852 HG13 ' HZ ' ' A' ' 74' ' ' PHE . 53.0 t -112.23 170.66 3.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 107.71 -1.219 . . . . 0.67 107.71 178.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.702 HD23 ' HA ' ' A' ' 27' ' ' PRO . 88.7 mt -132.37 141.05 48.74 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 118.334 0.515 . . . . 0.69 111.409 -176.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -74.36 169.07 18.42 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 106.878 -1.527 . . . . 1.87 106.878 166.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.82 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . . . -62.4 -3.73 1.53 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 114.046 1.128 . . . . 0.59 114.046 -167.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.531 ' HB2' ' HE2' ' A' ' 26' ' ' LYS . 64.7 m-20 -111.5 12.06 21.37 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 121.008 -0.277 . . . . 2.34 111.349 176.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.558 ' CD2' ' HB1' ' A' ' 106' ' ' ALA . 72.1 m-70 77.13 8.96 2.77 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.366 0.603 . . . . 1.47 109.72 177.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.531 ' HE2' ' HB2' ' A' ' 24' ' ' ASP . 21.1 mtmt -74.65 119.3 76.0 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 107.54 -1.282 . . . . 4.25 107.54 169.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.702 ' HA ' HD23 ' A' ' 21' ' ' LEU . 93.9 Cg_exo -50.39 115.27 1.83 Allowed 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.329 2.019 . . . . 0.54 114.203 -172.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.616 ' CE2' ' HB3' ' A' ' 103' ' ' PRO . 0.2 OUTLIER -78.6 120.4 23.23 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 113.275 -1.784 . . . . 1.2 109.635 169.201 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -72.96 103.1 3.65 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 122.446 1.117 . . . . 1.51 108.82 174.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.984 HD21 HD12 ' A' ' 15' ' ' ILE . 67.3 tp -71.4 -31.48 67.32 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.834 -1.076 . . . . 0.28 110.343 -178.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.656 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 3.3 m -66.14 -4.13 2.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 114.439 -1.255 . . . . 1.02 113.109 -167.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 -74.67 -6.64 49.84 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.557 0.694 . . . . 1.02 110.01 175.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.957 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 88.6 m-70 -102.13 24.97 9.36 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 115.339 -0.846 . . . . 0.28 109.397 176.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.556 ' HE3' ' HB ' ' A' ' 31' ' ' VAL . 93.0 mttt -83.99 123.79 30.36 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 114.426 -1.261 . . . . 1.56 109.323 170.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.14 -36.08 4.07 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.366 -0.921 . . . . 0.2 111.925 178.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.457 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 22.5 m -130.38 132.33 23.95 Favored Pre-proline 0 N--CA 1.436 -1.162 0 N-CA-C 108.252 -1.018 . . . . 0.29 108.252 171.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.752 ' HD3' ' HG2' ' A' ' 146' ' ' ARG . 5.1 Cg_endo -43.18 153.86 0.18 Allowed 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.899 3.066 . . . . 0.18 112.795 176.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.844 ' HB2' HG22 ' A' ' 70' ' ' THR . 0.7 OUTLIER -139.65 149.17 43.42 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 106.313 -1.736 . . . . 0.31 106.313 -179.733 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.989 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 2.3 mp -116.3 130.84 56.98 Favored 'General case' 0 C--N 1.292 -1.92 0 O-C-N 121.629 -0.669 . . . . 1.19 109.606 176.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.935 HG22 ' OH ' ' A' ' 119' ' ' TYR . 1.1 mt -111.72 126.75 69.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 CA-C-N 115.065 -0.971 . . . . 0.37 109.596 178.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.989 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.6 OUTLIER -111.86 124.72 52.95 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.954 -0.566 . . . . 0.42 110.992 -171.662 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.622 ' ND2' ' HB2' ' A' ' 76' ' ' SER . 0.9 OUTLIER -79.66 95.12 5.84 Favored 'General case' 0 CA--C 1.504 -0.827 0 N-CA-C 107.206 -1.405 . . . . 2.35 107.206 167.194 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.765 ' O ' ' HA ' ' A' ' 75' ' ' PRO . 4.1 p . . . . . 0 C--N 1.294 -1.831 0 CA-C-N 114.833 -1.076 . . . . 1.03 109.649 -172.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.452 0 N-CA-C 110.301 -1.12 . . . . 0.51 110.301 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.404 ' HA3' ' CG ' ' A' ' 139' ' ' PHE . . . -49.85 -46.69 40.06 Favored Glycine 0 C--O 1.222 -0.62 0 CA-C-N 114.424 -0.888 . . . . 0.5 113.969 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -59.31 -59.14 5.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.328 0.564 . . . . 0.7 111.554 -171.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.14 -27.87 69.67 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.291 0.567 . . . . 2.61 110.48 -177.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.702 HG23 ' HA ' ' A' ' 160' ' ' VAL . 31.8 m -75.83 -57.77 3.68 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.084 -0.962 . . . . 0.33 110.02 -175.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 1.055 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -60.3 -41.67 93.88 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.202 -0.908 . . . . 0.22 111.039 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.536 ' HA ' ' CD2' ' A' ' 102' ' ' PHE . 96.7 m -57.69 -55.69 31.53 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.433 0.635 . . . . 0.26 110.466 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 27.3 m -69.46 -36.11 76.27 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.001 -0.999 . . . . 0.48 111.484 -175.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.749 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 16.3 mt -66.93 -47.07 72.82 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-O 120.974 0.416 . . . . 0.43 110.472 -176.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.857 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 5.0 t80 -55.31 -56.14 23.4 Favored 'General case' 0 C--O 1.198 -1.637 0 CA-C-N 115.208 -0.905 . . . . 0.31 109.916 177.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -69.75 -24.04 63.47 Favored 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 122.707 0.403 . . . . 1.21 111.566 -173.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.405 ' HE2' ' HB2' ' A' ' 63' ' ' LYS . 13.8 tppt? -76.01 -32.25 59.3 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 108.388 -0.968 . . . . 1.54 108.388 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.713 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 48.4 m-85 -125.86 -2.44 7.18 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 115.7 1.741 . . . . 0.31 115.7 -166.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.765 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 12.6 ptmt -63.84 -29.27 70.48 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 107.686 -1.227 . . . . 1.35 107.686 170.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.6 m -47.94 -36.63 12.76 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 113.822 -1.536 . . . . 1.28 111.009 173.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.506 HE21 ' HD1' ' A' ' 64' ' ' TYR . 49.7 mt-30 -88.44 -39.75 14.0 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 120.96 -0.296 . . . . 1.11 111.619 173.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.425 ' HA3' ' HB2' ' A' ' 36' ' ' SER . . . 151.49 -4.03 0.47 Allowed Glycine 0 CA--C 1.52 0.388 0 N-CA-C 111.505 -0.638 . . . . 0.18 111.505 -175.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.749 ' HE2' ' HB3' ' A' ' 60' ' ' LEU . 21.4 t80 -71.2 142.59 50.64 Favored 'General case' 0 C--O 1.222 -0.392 0 C-N-CA 122.644 0.377 . . . . 0.18 111.131 -177.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.957 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 2.3 t -133.76 153.15 51.92 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 108.063 -1.088 . . . . 0.2 108.063 173.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 1.055 HG11 ' HB1' ' A' ' 57' ' ' ALA . 25.6 t -112.97 99.5 8.79 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.541 0 N-CA-C 108.018 -1.104 . . . . 0.17 108.018 160.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.511 HD12 ' H ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -93.68 120.2 33.65 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 118.365 -1.334 . . . . 1.04 107.557 174.554 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.769 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -112.21 117.23 31.99 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.538 0.685 . . . . 0.51 110.901 -178.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.852 ' HZ ' HG13 ' A' ' 20' ' ' VAL . 5.3 m-30 -93.31 112.54 56.86 Favored Pre-proline 0 C--N 1.318 -0.779 0 CA-C-N 115.241 -0.891 . . . . 0.44 109.388 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.765 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 44.2 Cg_endo -82.29 87.4 1.4 Allowed 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.082 1.855 . . . . 1.3 112.694 -172.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.622 ' HB2' ' ND2' ' A' ' 42' ' ' ASN . 7.0 t . . . . . 0 C--N 1.321 -0.655 0 CA-C-N 114.382 -1.281 . . . . 1.44 111.765 -177.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.514 -0.434 0 CA-C-O 121.048 0.452 . . . . 0.55 111.36 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -85.86 22.52 1.65 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.308 -0.86 . . . . 1.99 110.606 -177.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.566 ' HB3' ' CD2' ' A' ' 61' ' ' TYR . 19.1 p90 -147.33 163.67 26.89 Favored Pre-proline 0 N--CA 1.447 -0.609 0 CA-C-N 115.711 -0.677 . . . . 0.84 109.312 -178.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.657 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 71.3 Cg_exo -57.12 89.39 0.04 OUTLIER 'Trans proline' 0 N--CA 1.478 0.608 0 C-N-CA 124.608 3.538 . . . . 0.62 115.44 -172.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.769 HD12 ' HB3' ' A' ' 73' ' ' ALA . 3.6 mm -89.52 127.54 42.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 108.259 -1.015 . . . . 1.34 108.259 171.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.847 ' HG2' ' CG ' ' A' ' 74' ' ' PHE . 0.7 OUTLIER -88.83 -171.37 3.28 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.8 0.333 . . . . 3.03 111.563 -172.206 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.82 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . . . -61.19 -16.88 49.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.808 -0.633 . . . . 1.46 111.795 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.752 ' HB2' ' O ' ' A' ' 75' ' ' PRO . 3.7 ptpp? 78.27 128.2 0.05 OUTLIER 'General case' 0 CA--C 1.494 -1.193 0 O-C-N 125.477 1.736 . . . . 1.76 109.846 -166.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.771 HD12 HG22 ' A' ' 110' ' ' VAL . 2.4 pp -128.87 163.64 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.162 0 CA-C-N 113.028 -1.897 . . . . 0.82 107.042 171.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.15 58.1 0.16 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 123.897 0.748 . . . . 1.73 111.556 -172.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.771 HG22 HD12 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -63.91 96.64 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 CA-C-O 120.849 0.357 . . . . 0.77 111.08 -171.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 3.5 t-20 . . . . . 0 N--CA 1.445 -0.681 0 N-CA-C 108.337 -0.986 . . . . 1.9 108.337 167.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.649 ' CE1' ' H ' ' A' ' 118' ' ' LEU . 2.0 t-80 . . . . . 0 N--CA 1.43 -1.456 0 N-CA-C 106.254 -1.758 . . . . 0.42 106.254 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -30.31 -46.26 0.14 Allowed 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 124.303 3.336 . . . . 0.4 113.621 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.836 HD11 ' HB ' ' A' ' 15' ' ' ILE . 22.6 tp -62.64 -51.34 67.64 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.174 0.589 . . . . 0.39 111.886 178.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.935 ' OH ' HG22 ' A' ' 40' ' ' ILE . 36.6 m-85 -76.58 -36.55 57.51 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 112.285 0.476 . . . . 3.04 112.285 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.793 ' HA ' ' HD2' ' A' ' 123' ' ' LYS . 48.5 mt-10 -61.61 -30.79 70.92 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 107.462 -1.31 . . . . 2.44 107.462 174.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.654 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 59.5 t80 -71.62 -32.87 68.43 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.426 -0.806 . . . . 0.56 110.682 171.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.737 ' HE3' ' HG ' ' A' ' 118' ' ' LEU . 2.5 ttm -73.73 -52.46 13.13 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.178 -0.465 . . . . 0.71 110.367 -169.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.793 ' HD2' ' HA ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -71.04 -24.73 62.4 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.196 -0.456 . . . . 1.46 111.079 175.463 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.767 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -65.0 -30.75 71.76 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.461 0.648 . . . . 1.99 109.741 172.257 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 85.9 m -79.51 -47.32 15.78 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.245 -0.889 . . . . 0.59 111.038 178.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.566 ' HE3' ' O ' ' A' ' 151' ' ' VAL . 19.9 ttmm . . . . . 0 C--N 1.326 -0.441 0 CA-C-O 121.06 0.457 . . . . 1.85 111.982 -178.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.777 ' HB3' ' HG3' ' A' ' 156' ' ' PRO . 2.3 m-90 . . . . . 0 CA--C 1.51 -0.565 0 N-CA-C 110.229 -0.286 . . . . 1.97 110.229 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -42.26 -155.8 0.0 OUTLIER 'General case' 0 C--O 1.205 -1.245 0 C-N-CA 124.022 0.929 . . . . 2.04 110.535 159.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.645 ' HD2' ' CD2' ' A' ' 41' ' ' TYR . 5.0 m-85 -26.04 -46.72 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.046 0 N-CA-C 116.025 1.861 . . . . 1.93 116.025 -163.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.689 ' HA ' ' O ' ' A' ' 154' ' ' PHE . 5.7 m 28.34 96.16 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 119.675 1.125 . . . . 0.6 113.664 171.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.674 ' HB3' HD23 ' A' ' 39' ' ' LEU . 1.6 m -85.07 170.74 12.65 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.041 -0.982 . . . . 0.62 111.714 -170.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.47 ' HA ' ' O ' ' A' ' 152' ' ' GLU . 81.1 m-85 -130.46 120.3 23.97 Favored 'General case' 0 CA--C 1.496 -1.116 0 N-CA-C 105.886 -1.894 . . . . 0.57 105.886 161.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.756 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 4.9 tp -78.82 103.64 8.91 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 118.054 -1.458 . . . . 0.43 108.062 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.748 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 45.6 mm -88.77 141.27 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.788 0 CA-C-N 113.474 -1.694 . . . . 0.19 107.564 -177.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.446 ' HA ' HD13 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -92.37 -176.05 4.2 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 119.179 -1.008 . . . . 0.98 110.601 -171.92 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.752 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 11.5 mtm180 -54.55 -40.89 69.14 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.141 0.496 . . . . 2.22 111.031 -176.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.438 ' O ' ' HB2' ' A' ' 14' ' ' SER . 5.0 m-20 -94.83 18.01 12.61 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.558 -0.534 . . . . 2.0 109.558 -175.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.56 ' HA3' ' CE2' ' A' ' 16' ' ' PHE . . . 73.12 33.68 59.11 Favored Glycine 0 N--CA 1.44 -1.077 0 CA-C-N 115.688 -0.687 . . . . 0.17 114.128 178.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.512 ' HA ' ' HD2' ' A' ' 150' ' ' PRO . 62.1 t -107.45 106.93 59.63 Favored Pre-proline 0 C--N 1.314 -0.953 0 CA-C-N 118.298 1.049 . . . . 1.12 111.291 176.077 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.577 ' HG3' ' HG3' ' A' ' 122' ' ' MET . 5.7 Cg_exo -46.34 122.9 6.04 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 124.155 3.237 . . . . 0.41 112.087 171.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.566 ' O ' ' HE3' ' A' ' 126' ' ' LYS . 46.8 t -117.99 -29.66 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 109.369 -0.604 . . . . 1.45 109.369 -176.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.756 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 31.0 mm-40 -136.84 167.03 22.23 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.562 -0.745 . . . . 1.17 110.848 -177.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.452 ' HA ' ' O ' ' A' ' 141' ' ' SER . 0.2 OUTLIER -144.02 131.37 20.89 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.473 -0.785 . . . . 2.16 109.712 163.552 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.689 ' O ' ' HA ' ' A' ' 140' ' ' THR . 96.8 m-85 -111.02 152.32 26.98 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.866 -0.606 . . . . 0.32 109.63 -170.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 12.5 m -74.76 156.94 86.31 Favored Pre-proline 0 C--N 1.319 -0.719 0 N-CA-C 109.469 -0.567 . . . . 1.11 109.469 176.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.777 ' HG3' ' HB3' ' A' ' 137' ' ' TRP . 34.4 Cg_endo -64.88 -24.89 60.46 Favored 'Trans proline' 0 CA--C 1.519 -0.267 0 C-N-CA 122.181 1.92 . . . . 0.78 111.039 177.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -80.44 5.6 63.54 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 114.691 -1.14 . . . . 0.5 113.453 173.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -79.19 151.33 31.3 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.388 -0.597 . . . . 0.5 109.388 173.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 33.8 t -108.34 169.33 8.71 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 109.494 -0.558 . . . . 1.42 109.494 -177.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.702 ' HA ' HG23 ' A' ' 56' ' ' THR . 99.3 t -40.14 -59.48 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 O-C-N 124.356 1.035 . . . . 0.28 111.683 178.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.484 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 0.9 OUTLIER -65.74 -30.26 70.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.299 -0.409 . . . . 3.46 111.986 -173.483 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -65.25 -35.95 82.63 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-O 122.247 1.022 . . . . 1.4 108.756 -178.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.585 ' HA ' ' CE2' ' A' ' 154' ' ' PHE . 54.5 mt -78.17 -44.25 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 CA-C-N 113.7 -1.591 . . . . 0.21 110.483 175.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.623 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 47.7 mt-10 -54.93 -43.12 73.07 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 116.048 -0.524 . . . . 0.67 111.492 -177.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 161' ' ' LYS . 7.0 pt-20 -61.03 -16.69 46.36 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.235 0.457 . . . . 0.87 112.235 -176.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.633 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 34.0 mmtp -100.72 -28.89 12.58 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.667 0.746 . . . . 1.71 109.793 172.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.623 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 12.5 tp -78.84 -50.97 10.37 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.857 -1.065 . . . . 0.16 112.749 -175.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.494 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 63.3 mt -55.14 -45.78 99.79 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.85 -0.614 . . . . 0.26 112.387 -174.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.494 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 58.2 Cg_exo -56.14 -17.29 19.54 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 122.081 1.854 . . . . 0.41 113.124 174.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.751 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 78.0 mt -97.7 -42.72 7.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.741 -0.209 . . . . 0.71 111.08 176.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.714 HD23 ' HG2' ' A' ' 37' ' ' PRO . 93.7 mt -61.08 -52.1 66.37 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-O 122.165 0.983 . . . . 0.34 109.595 175.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.331 0 CA-C-N 113.565 -1.652 . . . . 1.12 112.923 -178.655 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.1 t . . . . . 0 CA--C 1.529 0.169 0 CA-C-O 120.965 0.412 . . . . 1.58 110.318 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 27.8 m -163.64 151.55 13.05 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 104.854 -2.276 . . . . 1.17 104.854 -179.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.882 ' HB ' HD11 ' A' ' 118' ' ' LEU . 6.3 pt -58.93 -20.55 17.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 CA-C-N 115.042 -0.981 . . . . 0.38 111.756 -174.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.812 ' HB3' HG13 ' A' ' 31' ' ' VAL . 42.2 m-85 -67.2 -6.24 17.19 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.293 0.849 . . . . 0.3 113.293 -175.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -78.4 -15.78 58.31 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 107.873 -1.158 . . . . 2.11 107.873 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.566 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 37.3 m-85 -107.61 115.88 30.94 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 114.577 -1.192 . . . . 0.31 110.829 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -55.62 144.32 27.06 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 113.896 -1.502 . . . . 2.86 110.054 175.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.851 HG13 ' HZ ' ' A' ' 74' ' ' PHE . 66.5 t -112.14 166.14 6.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 107.879 -1.156 . . . . 0.67 107.879 179.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.756 ' HB2' ' HE1' ' A' ' 105' ' ' MET . 55.7 mt -125.6 146.59 49.63 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 109.949 -0.389 . . . . 0.69 109.949 178.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.583 ' HB3' ' HE3' ' A' ' 26' ' ' LYS . 16.5 t70 -77.8 169.79 17.68 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 106.146 -1.798 . . . . 1.87 106.146 165.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.674 ' HA ' ' N ' ' A' ' 106' ' ' ALA . . . -63.68 -3.65 2.45 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 113.253 0.834 . . . . 0.59 113.253 -168.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.937 ' HB2' ' HE2' ' A' ' 26' ' ' LYS . 3.3 m-20 -107.0 6.01 28.67 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 111.451 0.167 . . . . 2.34 111.451 176.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.582 ' CD2' ' HB1' ' A' ' 106' ' ' ALA . 59.9 m-70 79.85 6.04 1.86 Allowed 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.521 0.677 . . . . 1.47 109.61 177.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.937 ' HE2' ' HB2' ' A' ' 24' ' ' ASP . 29.8 mtmt -66.68 115.94 29.66 Favored Pre-proline 0 N--CA 1.447 -0.595 0 N-CA-C 107.656 -1.238 . . . . 4.25 107.656 167.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.659 ' HA ' HD23 ' A' ' 21' ' ' LEU . 75.4 Cg_exo -48.76 114.86 1.38 Allowed 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 121.796 1.664 . . . . 0.54 112.313 -178.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.508 ' CE2' ' HB3' ' A' ' 103' ' ' PRO . 0.8 OUTLIER -78.39 151.55 32.74 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 113.573 -1.649 . . . . 1.2 111.761 179.589 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.615 ' OD1' ' HB3' ' A' ' 32' ' ' GLN . 2.8 t-20 -86.82 90.2 8.22 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.8 -1.091 . . . . 1.51 109.836 174.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.676 HD23 ' HA ' ' A' ' 16' ' ' PHE . 63.2 tp -71.56 -43.79 65.7 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.179 0.514 . . . . 0.28 110.601 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.812 HG13 ' HB3' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -67.56 0.89 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.18 -0.918 . . . . 1.02 113.174 -172.12 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.615 ' HB3' ' OD1' ' A' ' 29' ' ' ASN . 3.7 pt20 -72.54 -11.88 60.84 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.553 0.692 . . . . 1.02 109.322 172.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.956 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 91.6 m-70 -98.73 21.18 11.76 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 115.267 -0.879 . . . . 0.28 109.087 176.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.788 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 11.0 mtmm -80.1 110.4 15.47 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.541 -1.209 . . . . 1.56 109.118 169.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 133.45 -43.06 1.3 Allowed Glycine 0 N--CA 1.439 -1.106 0 C-N-CA 120.75 -0.738 . . . . 0.2 111.841 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.422 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 72.3 m -126.88 138.09 31.91 Favored Pre-proline 0 N--CA 1.439 -0.987 0 N-CA-C 108.576 -0.898 . . . . 0.29 108.576 173.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.825 ' HD3' ' HG2' ' A' ' 146' ' ' ARG . 3.2 Cg_endo -43.37 149.15 0.58 Allowed 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 123.574 2.85 . . . . 0.18 112.079 174.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.91 ' HB2' HG22 ' A' ' 70' ' ' THR . 0.6 OUTLIER -135.78 150.24 49.41 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 106.051 -1.833 . . . . 0.31 106.051 178.475 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.942 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 2.7 mp -116.21 129.34 56.25 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 109.206 -0.664 . . . . 1.19 109.206 175.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.862 HG22 ' OH ' ' A' ' 119' ' ' TYR . 1.2 mt -111.02 123.71 67.16 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 CA-C-N 115.025 -0.989 . . . . 0.37 109.002 178.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.942 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.5 OUTLIER -108.74 123.64 49.33 Favored 'General case' 0 C--O 1.215 -0.738 0 CA-C-N 115.996 -0.547 . . . . 0.42 110.796 -172.267 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.636 ' HB2' HG11 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -76.56 122.09 24.11 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 104.88 -2.267 . . . . 2.35 104.88 165.948 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.807 HG11 ' HB1' ' A' ' 73' ' ' ALA . 2.5 p . . . . . 0 C--N 1.298 -1.631 0 C-N-CA 118.724 -1.19 . . . . 1.03 112.94 -165.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.728 0 N-CA-C 110.128 -1.189 . . . . 0.51 110.128 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -37.13 -50.99 1.63 Allowed Glycine 0 C--O 1.223 -0.566 0 CA-C-N 114.364 -0.918 . . . . 0.5 114.952 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.471 ' HA ' ' CZ ' ' A' ' 139' ' ' PHE . 0.1 OUTLIER -57.71 -59.18 5.59 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 117.743 0.772 . . . . 0.7 111.469 -172.41 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -62.56 -26.96 68.85 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.733 -0.667 . . . . 2.61 110.136 -178.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.726 ' HA ' HG22 ' A' ' 160' ' ' VAL . 77.5 m -71.91 -59.61 2.66 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 114.891 -1.05 . . . . 0.33 109.916 -177.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 1.055 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -60.59 -39.9 89.79 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 114.675 -1.148 . . . . 0.22 111.371 -178.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.543 ' HA ' ' CD1' ' A' ' 102' ' ' PHE . 89.8 m -58.57 -58.71 7.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.598 0.713 . . . . 0.26 110.6 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.4 m -68.31 -33.78 74.95 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 114.955 -1.021 . . . . 0.48 111.473 -174.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.749 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 20.6 mt -67.53 -50.58 58.02 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 121.25 0.547 . . . . 0.43 110.37 -177.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.812 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 10.5 t80 -54.83 -50.3 68.92 Favored 'General case' 0 C--O 1.204 -1.325 0 CA-C-N 114.983 -1.008 . . . . 0.31 110.681 177.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.415 ' N ' HD22 ' A' ' 62' ' ' ASN . 0.9 OUTLIER -72.48 -25.7 61.53 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 122.443 0.297 . . . . 1.21 110.75 -171.119 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.501 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 35.3 ttpt -86.47 -23.28 26.03 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 109.044 -0.724 . . . . 1.54 109.044 -178.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.772 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 30.4 m-85 -123.51 -5.49 8.19 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 115.291 1.589 . . . . 0.31 115.291 -169.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.679 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -64.63 -23.22 67.19 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 108.055 -1.091 . . . . 1.35 108.055 169.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 37.5 t -47.19 -40.35 15.84 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 114.118 -1.401 . . . . 1.28 110.848 171.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.453 HE21 ' HD1' ' A' ' 64' ' ' TYR . 49.8 mt-30 -90.06 -32.35 16.76 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 120.725 0.298 . . . . 1.11 111.337 177.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 143.44 -5.67 1.86 Allowed Glycine 0 N--CA 1.449 -0.468 0 N-CA-C 111.364 -0.694 . . . . 0.18 111.364 -175.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.772 ' HD2' ' HB2' ' A' ' 64' ' ' TYR . 24.6 t80 -66.92 141.32 57.67 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 120.978 0.418 . . . . 0.18 110.822 -178.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.956 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 5.3 t -132.55 152.96 51.42 Favored 'General case' 0 N--CA 1.422 -1.835 0 N-CA-C 107.991 -1.114 . . . . 0.2 107.991 174.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 1.055 HG11 ' HB1' ' A' ' 57' ' ' ALA . 38.2 t -112.09 99.86 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.702 0 N-CA-C 107.65 -1.241 . . . . 0.17 107.65 158.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.622 HD12 HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -93.46 121.23 34.65 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 106.911 -1.514 . . . . 1.04 106.911 174.33 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 1.023 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -108.02 121.16 44.23 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.961 0.886 . . . . 0.51 111.265 -178.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.913 ' CG ' ' HG2' ' A' ' 105' ' ' MET . 2.6 m-30 -95.7 101.04 7.13 Favored Pre-proline 0 C--N 1.314 -0.935 0 CA-C-N 114.379 -1.282 . . . . 0.44 109.009 178.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.715 ' HA ' HG13 ' A' ' 43' ' ' VAL . 87.8 Cg_endo -82.12 74.99 4.94 Favored 'Trans proline' 0 CA--C 1.512 -0.612 0 C-N-CA 122.798 2.332 . . . . 1.3 113.423 -167.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.8 p . . . . . 0 N--CA 1.469 0.505 0 N-CA-C 116.967 2.21 . . . . 1.44 116.967 -177.146 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.46 0 CA-C-O 121.041 0.448 . . . . 0.55 111.231 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -95.33 26.3 3.89 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.792 -0.64 . . . . 1.99 111.033 178.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.543 ' CD1' ' HA ' ' A' ' 58' ' ' THR . 12.7 p90 -146.18 164.71 23.45 Favored Pre-proline 0 N--CA 1.448 -0.527 0 N-CA-C 108.571 -0.9 . . . . 0.84 108.571 176.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.71 ' HD3' ' CE2' ' A' ' 61' ' ' TYR . 52.7 Cg_exo -59.07 85.79 0.06 OUTLIER 'Trans proline' 0 N--CA 1.482 0.832 0 C-N-CA 124.697 3.598 . . . . 0.62 115.35 -173.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 1.023 HD12 ' HB3' ' A' ' 73' ' ' ALA . 3.9 mm -85.56 131.67 33.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 108.61 -0.885 . . . . 1.34 108.61 171.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.913 ' HG2' ' CG ' ' A' ' 74' ' ' PHE . 1.9 ppp? -96.68 -175.64 3.36 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.149 0.5 . . . . 3.03 110.482 -176.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.674 ' N ' ' HA ' ' A' ' 23' ' ' ALA . . . -79.33 19.5 0.59 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.391 -0.822 . . . . 1.46 112.654 -170.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.699 ' HG2' ' HG2' ' A' ' 75' ' ' PRO . 50.7 mttp 60.92 131.25 0.01 OUTLIER 'General case' 0 CA--C 1.496 -1.114 0 CA-C-O 122.365 1.079 . . . . 1.76 110.784 -168.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.595 ' CD1' HG13 ' A' ' 110' ' ' VAL . 2.4 pp -128.01 163.9 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.392 0 N-CA-C 106.326 -1.731 . . . . 0.82 106.326 160.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -76.53 84.29 3.23 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 120.38 -0.528 . . . . 1.73 110.439 -172.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.636 HG11 ' HB2' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -79.28 90.33 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.225 0 C-N-CA 119.325 -0.95 . . . . 0.77 109.128 179.594 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.5 t30 . . . . . 0 N--CA 1.445 -0.717 0 CA-C-N 114.252 -1.34 . . . . 1.9 108.608 175.346 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.591 ' CE1' ' H ' ' A' ' 118' ' ' LEU . 1.6 t-80 . . . . . 0 N--CA 1.433 -1.311 0 N-CA-C 107.13 -1.433 . . . . 0.42 107.13 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -24.09 -46.9 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 124.805 3.67 . . . . 0.4 113.988 -178.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.882 HD11 ' HB ' ' A' ' 15' ' ' ILE . 24.8 tp -67.97 -50.31 56.53 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.012 0.525 . . . . 0.39 111.783 -178.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.862 ' OH ' HG22 ' A' ' 40' ' ' ILE . 16.6 m-85 -80.96 -34.19 33.31 Favored 'General case' 0 CA--C 1.483 -1.611 0 CA-C-O 121.504 0.668 . . . . 3.04 110.378 -176.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.598 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 5.6 tp10 -63.09 -34.37 77.44 Favored 'General case' 0 N--CA 1.419 -1.987 0 N-CA-C 106.889 -1.523 . . . . 2.44 106.889 175.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.625 ' HD1' ' HE3' ' A' ' 124' ' ' LYS . 43.4 t80 -72.31 -28.86 63.34 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.591 -0.732 . . . . 0.56 109.82 170.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.855 ' HE3' ' HG ' ' A' ' 118' ' ' LEU . 2.9 ttm -75.66 -56.12 5.0 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.11 -0.636 . . . . 0.71 110.393 -169.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.436 ' HD2' ' HA ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -72.29 -23.28 61.17 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 120.773 -0.371 . . . . 1.46 111.948 176.849 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.625 ' HE3' ' HD1' ' A' ' 121' ' ' TYR . 12.4 pttp -70.53 -27.66 64.34 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 119.201 -0.999 . . . . 1.99 109.823 175.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 38.8 m -89.73 -24.81 21.44 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.683 -0.689 . . . . 0.59 110.341 176.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.471 ' HE2' ' HA ' ' A' ' 151' ' ' VAL . 29.9 mmtm . . . . . 0 C--N 1.324 -0.502 0 CA-C-N 115.614 -0.721 . . . . 1.85 110.78 -178.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.893 ' HB3' ' HG3' ' A' ' 156' ' ' PRO . 9.7 m-90 . . . . . 0 CA--C 1.511 -0.535 0 N-CA-C 109.777 -0.453 . . . . 1.97 109.777 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.615 ' HB2' ' CB ' ' A' ' 156' ' ' PRO . 9.6 m120 -44.49 -156.89 0.0 OUTLIER 'General case' 0 C--O 1.211 -0.937 0 O-C-N 123.849 0.718 . . . . 2.04 111.311 161.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.653 ' CD1' HG23 ' A' ' 43' ' ' VAL . 3.9 m-85 -31.41 -26.38 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.338 0 N-CA-C 118.036 2.606 . . . . 1.93 118.036 -168.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.688 ' HA ' ' O ' ' A' ' 154' ' ' PHE . 1.9 m 7.49 103.43 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 120.5 1.5 . . . . 0.6 114.678 171.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.526 ' HB3' HD23 ' A' ' 39' ' ' LEU . 1.1 m -91.56 173.61 7.8 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.552 -1.204 . . . . 0.62 111.039 -172.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.526 ' HA ' ' HA ' ' A' ' 153' ' ' ARG . 60.5 m-85 -132.52 122.68 25.23 Favored 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 105.858 -1.904 . . . . 0.57 105.858 164.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.787 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 7.3 tp -80.0 104.6 10.68 Favored 'General case' 0 N--CA 1.422 -1.834 0 C-N-CA 118.302 -1.359 . . . . 0.43 108.474 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.741 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 36.8 mm -89.03 141.84 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.741 0 CA-C-N 112.854 -1.976 . . . . 0.19 107.581 -177.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.507 ' HA ' HD13 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -94.38 -175.34 3.61 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 119.411 -0.916 . . . . 0.98 111.395 -170.358 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.825 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 30.7 mtm180 -55.98 -33.42 64.81 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.803 0.335 . . . . 2.22 111.566 -176.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -103.78 22.99 13.48 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 109.864 -0.421 . . . . 2.0 109.864 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.595 ' HA2' HG22 ' A' ' 144' ' ' ILE . . . 70.18 37.09 71.93 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 121.219 -0.515 . . . . 0.17 114.184 177.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.511 ' HA ' ' HD2' ' A' ' 150' ' ' PRO . 57.8 t -107.04 108.3 61.79 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 118.192 0.996 . . . . 1.12 111.243 174.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.785 ' HD3' HG23 ' A' ' 15' ' ' ILE . 8.5 Cg_endo -58.3 110.13 0.6 Allowed 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 123.757 2.971 . . . . 0.41 111.307 174.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.697 HG23 ' HG2' ' A' ' 152' ' ' GLU . 17.8 m -108.86 -23.41 4.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.299 0.571 . . . . 1.45 109.569 -176.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.787 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 47.2 mm-40 -133.3 168.22 18.97 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-N 115.298 -0.865 . . . . 1.17 110.434 179.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.549 HH11 ' HG2' ' A' ' 153' ' ' ARG . 0.0 OUTLIER -144.63 148.63 34.54 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 114.614 -1.176 . . . . 2.16 108.582 163.019 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.688 ' O ' ' HA ' ' A' ' 140' ' ' THR . 91.9 m-85 -121.77 144.36 48.85 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 110.207 -0.294 . . . . 0.32 110.207 -169.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 12.9 p -63.87 149.5 93.12 Favored Pre-proline 0 C--N 1.318 -0.787 0 N-CA-C 109.536 -0.542 . . . . 1.11 109.536 174.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.893 ' HG3' ' HB3' ' A' ' 137' ' ' TRP . 30.3 Cg_endo -63.2 -26.38 72.42 Favored 'Trans proline' 0 CA--C 1.511 -0.659 0 C-N-CA 122.349 2.033 . . . . 0.78 110.714 176.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -79.2 16.67 8.87 Favored Glycine 0 N--CA 1.438 -1.177 0 CA-C-N 113.785 -1.552 . . . . 0.5 113.405 171.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -95.64 152.98 17.96 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 109.514 -0.55 . . . . 0.5 109.514 170.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.587 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 22.9 t -113.44 176.83 4.86 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 109.71 -0.478 . . . . 1.42 109.71 -175.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.726 HG22 ' HA ' ' A' ' 56' ' ' THR . 48.4 t -45.62 -48.38 4.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 O-C-N 124.04 0.837 . . . . 0.28 110.9 178.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.589 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 40.8 tttm -65.54 -41.16 93.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.823 -0.626 . . . . 3.46 111.148 -175.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -64.93 -34.26 77.99 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 121.732 0.777 . . . . 1.4 109.47 -173.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.593 HD12 ' CG2' ' A' ' 56' ' ' THR . 46.3 mt -80.54 -46.21 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 CA-C-N 114.451 -1.249 . . . . 0.21 111.106 177.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.529 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 36.5 mt-10 -53.09 -44.26 67.45 Favored 'General case' 0 C--O 1.218 -0.587 0 N-CA-C 111.688 0.255 . . . . 0.67 111.688 -175.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.589 ' HG2' ' O ' ' A' ' 161' ' ' LYS . 4.5 pt-20 -62.35 -14.23 37.57 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.568 0.581 . . . . 0.87 112.568 -175.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.682 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 13.0 mmmt -105.3 -23.9 12.79 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.009 -0.737 . . . . 1.71 109.009 175.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.529 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 10.5 tp -83.26 -50.77 8.07 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.48 -1.236 . . . . 0.16 112.222 -176.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 164' ' ' GLU . 65.4 mt -54.32 -44.94 99.31 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 115.586 -0.734 . . . . 0.26 112.077 -175.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.47 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 86.8 Cg_exo -50.53 -24.59 12.78 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 122.182 1.921 . . . . 0.41 113.287 173.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.732 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 88.1 mt -95.19 -42.5 8.54 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 122.28 -0.263 . . . . 0.71 111.547 177.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.766 HD23 ' HG2' ' A' ' 37' ' ' PRO . 89.1 mt -61.45 -52.4 64.72 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-O 122.19 0.995 . . . . 0.34 109.883 177.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.648 0 CA-C-N 113.065 -1.88 . . . . 1.12 114.356 -172.18 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.5 m . . . . . 0 C--O 1.235 0.292 0 CA-C-O 121.062 0.458 . . . . 1.58 110.582 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.8 m -145.39 -176.42 5.11 Favored 'General case' 0 N--CA 1.423 -1.785 0 N-CA-C 104.896 -2.261 . . . . 1.17 104.896 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.73 HG23 ' HD3' ' A' ' 150' ' ' PRO . 5.7 pt -81.42 -17.73 11.83 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.481 0 CA-C-O 121.447 0.641 . . . . 0.38 109.847 177.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.775 ' HB3' HG13 ' A' ' 31' ' ' VAL . 39.7 m-85 -71.0 -2.75 16.37 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.503 -0.771 . . . . 0.3 112.45 -176.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -77.2 -20.5 55.28 Favored 'General case' 0 CA--C 1.501 -0.904 0 N-CA-C 107.595 -1.261 . . . . 2.11 107.595 176.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.601 ' CD2' ' HA ' ' A' ' 118' ' ' LEU . 58.1 m-85 -113.39 122.32 47.0 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 114.334 -1.303 . . . . 0.31 111.8 -174.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -48.19 139.4 8.48 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 112.561 -2.109 . . . . 2.86 111.709 172.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.875 HG13 ' HZ ' ' A' ' 74' ' ' PHE . 79.2 t -113.43 166.34 7.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 107.637 -1.246 . . . . 0.67 107.637 174.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.72 HD23 ' HA ' ' A' ' 27' ' ' PRO . 80.4 mt -132.88 131.87 41.44 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 120.001 -0.68 . . . . 0.69 112.47 -177.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 15.1 t70 -64.43 159.23 21.8 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 106.457 -1.683 . . . . 1.87 106.457 165.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.768 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . . . -60.51 -6.76 1.74 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 113.801 1.038 . . . . 0.59 113.801 -165.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.608 ' HB2' ' HE2' ' A' ' 26' ' ' LYS . 54.7 m-20 -97.14 -0.19 47.38 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.751 0.278 . . . . 2.34 111.751 176.241 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.674 ' CD2' ' HB1' ' A' ' 106' ' ' ALA . 72.9 m-70 83.64 10.06 0.51 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.727 0.775 . . . . 1.47 109.01 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.608 ' HE2' ' HB2' ' A' ' 24' ' ' ASP . 21.7 mtmt -75.16 119.31 76.37 Favored Pre-proline 0 N--CA 1.447 -0.609 0 CA-C-N 114.298 -1.319 . . . . 4.25 107.578 168.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.72 ' HA ' HD23 ' A' ' 21' ' ' LEU . 47.3 Cg_exo -45.79 116.33 1.36 Allowed 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 122.415 2.076 . . . . 0.54 113.16 -176.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.762 ' OH ' ' HB3' ' A' ' 103' ' ' PRO . 0.1 OUTLIER -75.81 147.47 39.15 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 113.885 -1.507 . . . . 1.2 111.299 177.821 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.518 ' N ' ' HD1' ' A' ' 28' ' ' TYR . 2.5 t-20 -82.47 97.22 8.3 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 114.838 -1.074 . . . . 1.51 108.803 175.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.71 HD13 HG21 ' A' ' 20' ' ' VAL . 61.1 tp -83.82 -45.31 13.43 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.647 -0.706 . . . . 0.28 110.888 -176.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.775 HG13 ' HB3' ' A' ' 16' ' ' PHE . 0.1 OUTLIER -67.28 0.25 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.316 -0.857 . . . . 1.02 112.801 -171.712 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.451 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 28.7 pt20 -74.01 -12.21 60.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.418 0.627 . . . . 1.02 109.477 172.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.918 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 90.5 m-70 -97.7 20.49 11.85 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 121.876 0.845 . . . . 0.28 109.092 175.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.743 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 18.3 mtmt -80.42 114.18 19.13 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 114.381 -1.281 . . . . 1.56 109.245 169.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.87 -38.9 2.22 Favored Glycine 0 N--CA 1.434 -1.489 0 C-N-CA 120.607 -0.806 . . . . 0.2 111.927 178.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.455 ' HB2' ' HA3' ' A' ' 68' ' ' GLY . 20.2 m -129.49 128.02 23.09 Favored Pre-proline 0 N--CA 1.434 -1.257 0 N-CA-C 108.377 -0.972 . . . . 0.29 108.377 172.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.823 ' HG3' ' CB ' ' A' ' 170' ' ' LEU . 1.8 Cg_endo -41.18 151.92 0.12 Allowed 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 124.393 3.395 . . . . 0.18 113.097 177.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.842 ' HB2' HG22 ' A' ' 70' ' ' THR . 0.8 OUTLIER -136.96 145.1 43.79 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 106.949 -1.5 . . . . 0.31 106.949 -179.41 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.994 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 1.2 mm? -111.63 117.4 32.82 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.992 -0.744 . . . . 1.19 108.992 178.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.784 HD12 ' CE ' ' A' ' 122' ' ' MET . 8.2 mt -101.65 124.38 55.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-N 116.112 -0.495 . . . . 0.37 110.932 178.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.994 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -111.05 123.0 49.33 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.484 -0.78 . . . . 0.42 109.948 -174.194 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.804 ' HB3' HG11 ' A' ' 110' ' ' VAL . 1.3 p30 -81.79 94.97 7.14 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.855 -1.165 . . . . 2.35 107.855 169.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.787 HG11 ' HB1' ' A' ' 73' ' ' ALA . 1.4 p . . . . . 0 C--N 1.306 -1.306 0 CA-C-N 115.447 -0.797 . . . . 1.03 113.059 -159.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.919 0 N-CA-C 110.761 -0.935 . . . . 0.51 110.761 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -58.19 -43.37 95.42 Favored Glycine 0 C--O 1.222 -0.604 0 CA-C-N 115.469 -0.366 . . . . 0.5 112.805 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.537 ' HA ' ' CZ ' ' A' ' 139' ' ' PHE . 1.0 OUTLIER -64.44 -54.57 30.5 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.074 0.464 . . . . 0.7 110.776 -174.903 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.479 ' CD ' ' H ' ' A' ' 55' ' ' GLU . 1.9 pm0 -66.44 -22.95 66.22 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.542 -0.754 . . . . 2.61 111.115 -178.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.785 HG23 ' HA ' ' A' ' 160' ' ' VAL . 30.4 m -79.92 -57.45 3.64 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 109.44 -0.578 . . . . 0.33 109.44 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 1.029 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -54.08 -40.51 67.28 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.145 -0.934 . . . . 0.22 110.838 -179.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.457 ' HA ' ' HD2' ' A' ' 102' ' ' PHE . 99.8 m -60.04 -57.1 14.29 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.609 -0.723 . . . . 0.26 110.647 178.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 22.3 m -66.76 -35.18 79.49 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.461 -0.79 . . . . 0.48 111.312 -176.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.716 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 0.6 OUTLIER -66.72 -52.37 45.33 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 121.595 0.712 . . . . 0.43 110.409 -175.416 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.854 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 8.0 t80 -55.92 -54.6 42.77 Favored 'General case' 0 C--O 1.205 -1.27 0 CA-C-N 114.413 -1.267 . . . . 0.31 110.777 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -67.34 -24.16 65.69 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.73 -0.214 . . . . 1.21 111.018 -174.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.438 ' HB2' ' HE2' ' A' ' 63' ' ' LYS . 24.4 ttmm -85.5 -27.34 25.69 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 108.965 -0.754 . . . . 1.54 108.965 -176.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.784 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 48.3 m-85 -123.67 -4.75 8.16 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 115.289 1.588 . . . . 0.31 115.289 -169.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.676 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 12.9 pttp -67.86 -24.28 65.23 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 107.709 -1.219 . . . . 1.35 107.709 171.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.3 t -48.76 -37.61 19.47 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 113.855 -1.521 . . . . 1.28 110.18 171.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.44 HE21 ' HD1' ' A' ' 64' ' ' TYR . 50.4 mt-30 -88.06 -35.18 17.67 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 111.948 0.351 . . . . 1.11 111.948 173.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.455 ' HA3' ' HB2' ' A' ' 36' ' ' SER . . . 147.51 -7.3 1.11 Allowed Glycine 0 CA--C 1.52 0.388 0 N-CA-C 111.619 -0.592 . . . . 0.18 111.619 -176.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.784 ' HD2' ' HB2' ' A' ' 64' ' ' TYR . 17.9 t80 -67.07 140.37 57.61 Favored 'General case' 0 C--O 1.217 -0.61 0 C-N-CA 123.003 0.521 . . . . 0.18 111.251 -177.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.918 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 2.2 t -134.17 143.19 47.76 Favored 'General case' 0 CA--C 1.482 -1.657 0 N-CA-C 108.189 -1.041 . . . . 0.2 108.189 174.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 1.029 HG11 ' HB1' ' A' ' 57' ' ' ALA . 39.9 t -98.6 98.87 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.535 0 C-N-CA 118.959 -1.096 . . . . 0.17 108.182 161.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.827 HD23 ' HB2' ' A' ' 103' ' ' PRO . 8.4 mt -85.94 119.01 25.78 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 107.36 -1.348 . . . . 1.04 107.36 175.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.887 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -111.67 116.28 30.52 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.826 0.822 . . . . 0.51 111.694 -178.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.875 ' HZ ' HG13 ' A' ' 20' ' ' VAL . 2.8 m-30 -98.38 99.09 6.65 Favored Pre-proline 0 C--N 1.315 -0.904 0 CA-C-N 114.519 -1.219 . . . . 0.44 109.051 178.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.769 ' O ' ' HB2' ' A' ' 107' ' ' LYS . 80.7 Cg_endo -78.34 93.22 1.1 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.214 1.943 . . . . 1.3 113.361 -171.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.759 ' HA ' HG23 ' A' ' 110' ' ' VAL . 84.3 p . . . . . 0 C--N 1.323 -0.56 0 CA-C-N 114.93 -1.032 . . . . 1.44 111.886 -175.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.307 0 CA-C-O 121.52 0.676 . . . . 0.55 112.457 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -92.81 14.05 18.51 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 114.664 -1.153 . . . . 1.99 110.231 176.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.664 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 17.2 p90 -140.36 161.99 52.09 Favored Pre-proline 0 N--CA 1.444 -0.754 0 N-CA-C 108.859 -0.793 . . . . 0.84 108.859 -179.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.827 ' HB2' HD23 ' A' ' 72' ' ' LEU . 30.9 Cg_endo -58.95 92.82 0.08 OUTLIER 'Trans proline' 0 CA--C 1.514 -0.489 0 C-N-CA 123.965 3.11 . . . . 0.62 114.398 -172.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.887 HD12 ' HB3' ' A' ' 73' ' ' ALA . 5.4 mm -82.4 124.62 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 108.325 -0.991 . . . . 1.34 108.325 170.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.768 ' HG3' ' N ' ' A' ' 106' ' ' ALA . 0.0 OUTLIER -78.66 172.1 14.18 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.074 -1.421 . . . . 3.03 110.812 -176.933 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.768 ' N ' ' HG3' ' A' ' 105' ' ' MET . . . -61.0 -0.15 0.28 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.359 -0.837 . . . . 1.46 112.575 178.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.769 ' HB2' ' O ' ' A' ' 75' ' ' PRO . 12.3 ptpt 60.72 144.58 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.244 0 C-N-CA 124.941 1.297 . . . . 1.76 110.742 -168.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.604 HG13 ' HB2' ' A' ' 116' ' ' HIS . 0.3 OUTLIER -133.72 176.62 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.074 0 CA-C-N 113.615 -1.629 . . . . 0.82 108.331 168.086 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -70.05 66.85 0.28 Allowed 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 114.759 -1.11 . . . . 1.73 109.795 176.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.965 ' HA ' ' OH ' ' A' ' 119' ' ' TYR . 0.6 OUTLIER -72.6 92.64 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-O 122.11 0.957 . . . . 0.77 109.589 -172.657 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.7 t30 . . . . . 0 C--N 1.313 -0.983 0 N-CA-C 104.684 -2.339 . . . . 1.9 104.684 169.659 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.62 ' CE1' ' HB3' ' A' ' 118' ' ' LEU . 4.9 t-80 . . . . . 0 N--CA 1.418 -2.051 0 N-CA-C 107.998 -1.112 . . . . 0.42 107.998 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.491 ' HB2' ' CD1' ' A' ' 18' ' ' PHE . 11.2 Cg_exo -31.47 -43.45 0.13 Allowed 'Trans proline' 0 C--O 1.215 -0.668 1 C-N-CA 125.531 4.154 . . . . 0.4 114.241 -174.115 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.708 HD22 HG22 ' A' ' 20' ' ' VAL . 4.8 tp -62.45 -60.17 3.92 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 113.471 0.915 . . . . 0.39 113.471 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.965 ' OH ' ' HA ' ' A' ' 110' ' ' VAL . 3.4 p90 -81.02 -25.66 37.0 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 109.113 -0.699 . . . . 3.04 109.113 -177.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.53 -39.23 90.3 Favored 'General case' 0 CA--C 1.495 -1.161 0 N-CA-C 106.546 -1.65 . . . . 2.44 106.546 173.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.46 ' HA ' ' HG2' ' A' ' 124' ' ' LYS . 71.4 t80 -65.45 -26.09 67.8 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.85 -1.068 . . . . 0.56 109.892 171.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.784 ' CE ' HD12 ' A' ' 40' ' ' ILE . 65.2 mtt -75.93 -56.89 4.24 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.182 -0.463 . . . . 0.71 111.716 -173.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.622 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -70.39 -24.04 62.88 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.779 -0.646 . . . . 1.46 110.65 179.621 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.46 ' HG2' ' HA ' ' A' ' 121' ' ' TYR . 17.1 ptmt -74.05 -28.41 61.4 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 119.722 -0.791 . . . . 1.99 109.456 174.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 51.8 m -76.83 -42.62 39.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.852 -0.613 . . . . 0.59 110.484 173.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.428 ' HD3' ' C ' ' A' ' 151' ' ' VAL . 8.0 tptm . . . . . 0 C--N 1.325 -0.471 0 CA-C-N 116.258 -0.428 . . . . 1.85 111.447 -175.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.45 ' HB3' ' HG3' ' A' ' 156' ' ' PRO . 10.2 m-90 . . . . . 0 CA--C 1.501 -0.916 0 N-CA-C 109.886 -0.413 . . . . 1.97 109.886 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.577 ' HB2' ' CB ' ' A' ' 156' ' ' PRO . 3.4 m120 -47.54 -158.29 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.154 -0.93 . . . . 2.04 110.073 162.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.655 ' HD2' ' HD2' ' A' ' 41' ' ' TYR . 5.7 m-85 -28.42 -53.63 0.1 Allowed 'General case' 0 CA--C 1.552 1.033 0 N-CA-C 115.944 1.831 . . . . 1.93 115.944 -164.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.595 ' HB ' ' OD1' ' A' ' 42' ' ' ASN . 8.5 m 42.75 93.92 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 120.44 1.473 . . . . 0.6 112.832 174.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.71 ' HB3' HD12 ' A' ' 39' ' ' LEU . 2.5 m -88.98 161.69 16.47 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.744 -0.662 . . . . 0.62 111.556 -172.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.423 ' O ' HD13 ' A' ' 39' ' ' LEU . 70.3 m-85 -122.72 126.49 47.65 Favored 'General case' 0 CA--C 1.487 -1.471 0 N-CA-C 105.872 -1.899 . . . . 0.57 105.872 165.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.803 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 11.3 tp -80.39 101.96 9.32 Favored 'General case' 0 N--CA 1.418 -2.042 0 C-N-CA 117.823 -1.551 . . . . 0.43 107.877 176.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.706 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 39.1 mm -89.22 135.13 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.671 0 CA-C-N 113.018 -1.901 . . . . 0.19 107.311 -178.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.478 ' HA ' HD13 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -91.35 -174.85 4.06 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 119.201 -1.0 . . . . 0.98 111.545 -167.586 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.655 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 53.5 mtm180 -54.66 -36.23 64.37 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.157 0.503 . . . . 2.22 110.983 -177.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -100.11 23.28 10.16 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.625 -0.509 . . . . 2.0 109.625 -178.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.635 ' HA3' ' CE2' ' A' ' 16' ' ' PHE . . . 65.76 34.44 88.79 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 115.943 -0.571 . . . . 0.17 114.002 178.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 64.1 t -103.07 116.19 62.8 Favored Pre-proline 0 C--N 1.314 -0.944 0 CA-C-N 118.024 0.912 . . . . 1.12 110.875 175.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.73 ' HD3' HG23 ' A' ' 15' ' ' ILE . 36.5 Cg_endo -66.13 109.05 1.45 Allowed 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 123.757 2.971 . . . . 0.41 110.664 178.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.557 HG23 ' HG2' ' A' ' 152' ' ' GLU . 19.6 m -113.71 -12.11 11.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 121.062 0.458 . . . . 1.45 110.486 -172.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.803 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 33.8 mm-40 -142.83 165.83 26.3 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-N 115.563 -0.744 . . . . 1.17 109.611 177.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.525 ' HA ' ' O ' ' A' ' 141' ' ' SER . 0.0 OUTLIER -148.65 122.41 9.28 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.404 -0.816 . . . . 2.16 110.76 165.347 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.683 ' HZ ' ' HB2' ' A' ' 166' ' ' LYS . 88.1 m-85 -95.67 155.81 16.59 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.616 -1.175 . . . . 0.32 109.291 -175.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 12.0 m -82.83 160.89 59.98 Favored Pre-proline 0 C--N 1.314 -0.937 0 N-CA-C 108.733 -0.84 . . . . 1.11 108.733 175.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.577 ' CB ' ' HB2' ' A' ' 138' ' ' ASN . 14.5 Cg_endo -58.76 -48.8 13.42 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 121.317 1.344 . . . . 0.78 110.479 173.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -48.59 -12.8 0.22 Allowed Glycine 0 CA--C 1.537 1.422 0 CA-C-N 114.588 -1.187 . . . . 0.5 115.54 167.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -87.64 138.88 31.08 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 118.464 1.132 . . . . 0.5 109.285 173.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 15.5 m -111.99 -173.03 2.16 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 112.819 0.674 . . . . 1.42 112.819 -168.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.785 ' HA ' HG23 ' A' ' 56' ' ' THR . 83.0 t -40.98 -60.49 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 114.134 -1.394 . . . . 0.28 112.335 -178.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -62.88 -39.16 93.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.287 -0.415 . . . . 3.46 110.534 -173.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.486 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 7.7 m-20 -55.56 -49.0 73.86 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 115.322 -0.854 . . . . 1.4 109.844 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.667 HD12 HG21 ' A' ' 56' ' ' THR . 81.4 mt -73.4 -46.75 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 CA-C-N 114.581 -1.19 . . . . 0.21 111.691 -177.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.487 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 49.5 mt-10 -54.75 -45.19 74.14 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-O 120.804 0.335 . . . . 0.67 111.251 -177.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 11.5 pt-20 -63.35 -15.42 57.37 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 111.993 0.368 . . . . 0.87 111.993 -173.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.683 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 28.3 mmmt -104.75 -22.97 13.12 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.607 0.717 . . . . 1.71 109.783 173.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.549 HD21 HD11 ' A' ' 171' ' ' LEU . 8.3 tp -83.61 -48.88 9.74 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.762 -1.108 . . . . 0.16 112.296 -176.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.486 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 68.9 mt -55.05 -46.06 99.73 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.617 -0.72 . . . . 0.26 112.302 -174.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.486 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 84.8 Cg_exo -51.39 -27.05 22.84 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.287 1.992 . . . . 0.41 113.178 173.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.823 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 74.8 mt -89.67 -42.58 11.28 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.846 -0.161 . . . . 0.71 111.124 178.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.728 HD23 ' HG2' ' A' ' 37' ' ' PRO . 91.9 mt -59.87 -58.26 9.31 Favored 'General case' 0 CA--C 1.505 -0.75 0 CA-C-O 121.996 0.903 . . . . 0.34 109.86 176.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.591 0 CA-C-N 113.338 -1.755 . . . . 1.12 112.171 -178.555 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.3 t . . . . . 0 C--O 1.234 0.244 0 CA-C-O 121.475 0.655 . . . . 1.58 109.899 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 96.5 p 179.78 168.49 1.2 Allowed 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 105.044 -2.206 . . . . 1.17 105.044 -177.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.892 ' HB ' HD11 ' A' ' 118' ' ' LEU . 4.8 pt -67.62 -12.96 16.14 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 CA-C-O 121.399 0.619 . . . . 0.38 110.274 177.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.787 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 33.4 m-85 -75.3 4.04 7.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.661 -0.699 . . . . 0.3 111.893 -175.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.57 -7.28 59.57 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.474 -0.936 . . . . 2.11 108.474 175.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.925 ' HE2' ' HB2' ' A' ' 121' ' ' TYR . 58.1 m-85 -125.67 113.66 17.65 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-N 114.988 -1.006 . . . . 0.31 111.964 -175.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -50.78 142.15 11.91 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 113.546 -1.661 . . . . 2.86 110.21 172.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.966 HG13 ' HZ ' ' A' ' 74' ' ' PHE . 68.8 t -113.8 169.6 5.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.5 -0.773 . . . . 0.67 109.114 -178.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.772 HD23 ' HA ' ' A' ' 27' ' ' PRO . 94.2 mt -127.53 150.51 49.66 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.019 0.438 . . . . 0.69 111.399 178.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.38 165.1 18.5 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 106.318 -1.734 . . . . 1.87 106.318 162.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.604 ' HA ' ' N ' ' A' ' 106' ' ' ALA . . . -59.53 -7.73 1.57 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 113.721 1.008 . . . . 0.59 113.721 -169.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.554 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 1.3 m-20 -99.08 2.06 45.75 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.914 0.339 . . . . 2.34 111.914 176.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.554 ' HB2' ' O ' ' A' ' 24' ' ' ASP . 83.2 m-70 80.55 17.36 0.61 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.611 0.72 . . . . 1.47 109.266 178.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.405 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 11.9 mmtt -86.13 120.46 72.44 Favored Pre-proline 0 CA--C 1.508 -0.654 0 N-CA-C 107.682 -1.229 . . . . 4.25 107.682 172.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.772 ' HA ' HD23 ' A' ' 21' ' ' LEU . 86.1 Cg_exo -53.21 112.39 0.92 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 121.742 1.628 . . . . 0.54 113.087 -172.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.831 ' HE2' HD23 ' A' ' 72' ' ' LEU . 9.0 t80 -79.22 116.78 19.7 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 113.487 -1.688 . . . . 1.2 109.735 172.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.505 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.7 p-10 -71.43 89.15 0.92 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 122.653 1.216 . . . . 1.51 109.95 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.863 HD21 HD12 ' A' ' 15' ' ' ILE . 58.9 tp -50.93 -39.99 56.16 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 113.939 -1.482 . . . . 0.28 111.947 -179.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.574 HG13 ' HB3' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -66.47 1.03 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 114.046 1.128 . . . . 1.02 114.046 -170.478 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.505 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 28.4 pt20 -77.82 -6.81 55.38 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.043 -0.663 . . . . 1.02 109.679 171.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.927 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 93.8 m-70 -101.54 24.52 9.6 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 122.001 0.905 . . . . 0.28 109.005 174.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.787 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 21.5 mtmm -83.54 110.56 18.32 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 114.344 -1.298 . . . . 1.56 108.686 169.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 131.78 -41.58 1.49 Allowed Glycine 0 N--CA 1.442 -0.959 0 C-N-CA 120.629 -0.796 . . . . 0.2 111.538 -178.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.446 ' HB2' ' HA3' ' A' ' 68' ' ' GLY . 35.9 m -129.38 136.93 29.9 Favored Pre-proline 0 N--CA 1.433 -1.295 0 N-CA-C 108.796 -0.816 . . . . 0.29 108.796 172.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.822 ' HG3' ' CB ' ' A' ' 170' ' ' LEU . 7.0 Cg_endo -44.96 153.08 0.45 Allowed 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 124.069 3.18 . . . . 0.18 112.563 176.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.81 ' HB2' HG22 ' A' ' 70' ' ' THR . 1.0 OUTLIER -140.13 146.28 38.65 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 106.889 -1.523 . . . . 0.31 106.889 179.098 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 1.017 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 3.5 mp -113.3 115.3 27.94 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.484 -0.76 . . . . 1.19 109.853 176.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.877 HG23 HD13 ' A' ' 72' ' ' LEU . 0.8 OUTLIER -95.46 116.97 38.4 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 CA-C-N 115.071 -0.968 . . . . 0.37 108.681 176.961 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 1.017 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.4 OUTLIER -101.14 130.6 47.23 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 119.622 -0.831 . . . . 0.42 109.637 -176.207 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.521 ' OD1' ' HB ' ' A' ' 140' ' ' THR . 0.5 OUTLIER -77.59 122.97 26.01 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 104.4 -2.444 . . . . 2.35 104.4 163.923 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.787 HG12 ' HA ' ' A' ' 139' ' ' PHE . 28.2 m . . . . . 0 C--N 1.3 -1.574 0 C-N-CA 118.702 -1.199 . . . . 1.03 111.797 -171.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.226 -0.354 0 CA-C-O 120.174 -0.236 . . . . 0.51 113.167 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.486 ' HA2' ' HB ' ' A' ' 56' ' ' THR . . . -51.39 -25.09 11.98 Favored Glycine 0 C--O 1.219 -0.814 0 CA-C-O 119.909 -0.384 . . . . 0.5 113.414 176.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.531 ' HA ' ' CE2' ' A' ' 139' ' ' PHE . 0.8 OUTLIER -66.13 -55.01 18.58 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 117.745 0.772 . . . . 0.7 109.421 175.724 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -61.34 -31.32 71.18 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.238 -0.892 . . . . 2.61 109.745 178.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.688 HG23 ' HA ' ' A' ' 160' ' ' VAL . 74.0 m -66.61 -54.82 19.25 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 114.496 -1.229 . . . . 0.33 109.533 179.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 1.028 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -57.98 -48.7 79.21 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.647 -1.16 . . . . 0.22 111.625 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.432 ' HA ' ' CD1' ' A' ' 102' ' ' PHE . 18.5 m -55.89 -54.62 42.38 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-O 121.61 0.719 . . . . 0.26 110.745 -179.048 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.6 m -69.24 -33.38 73.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.026 -0.988 . . . . 0.48 111.549 -175.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.732 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 18.2 mt -71.63 -48.2 49.44 Favored 'General case' 0 CA--C 1.492 -1.272 0 CA-C-N 116.54 -0.3 . . . . 0.43 110.634 -177.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.877 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 6.7 t80 -53.45 -62.26 1.77 Allowed 'General case' 0 C--O 1.194 -1.819 0 O-C-N 124.09 0.869 . . . . 0.31 109.49 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.654 ' HA ' ' CG ' ' A' ' 65' ' ' LYS . 1.8 p30 -67.93 -25.63 65.57 Favored 'General case' 0 C--N 1.314 -0.966 0 O-C-N 122.887 0.117 . . . . 1.21 110.908 -168.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.473 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 36.4 ttpt -79.7 -20.65 46.01 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 107.936 -1.135 . . . . 1.54 107.936 -177.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.68 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 49.9 m-85 -126.5 0.86 6.92 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 115.22 1.563 . . . . 0.31 115.22 -174.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.654 ' CG ' ' HA ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -60.82 -34.59 74.77 Favored 'General case' 0 CA--C 1.496 -1.128 0 N-CA-C 105.986 -1.857 . . . . 1.35 105.986 170.107 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.2 m -47.43 -34.36 7.13 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 112.3 -2.227 . . . . 1.28 111.782 178.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -94.63 -36.06 11.94 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 120.863 -0.335 . . . . 1.11 111.584 174.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.446 ' HA3' ' HB2' ' A' ' 36' ' ' SER . . . 149.31 -0.56 0.49 Allowed Glycine 0 CA--C 1.52 0.35 0 N-CA-C 111.869 -0.492 . . . . 0.18 111.869 -178.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.732 ' HE2' ' HB3' ' A' ' 60' ' ' LEU . 14.4 t80 -74.12 141.58 45.59 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 122.743 0.417 . . . . 0.18 111.182 -177.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.927 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 5.5 t -134.54 142.49 47.0 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 108.675 -0.861 . . . . 0.2 108.675 172.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 1.028 HG11 ' HB1' ' A' ' 57' ' ' ALA . 41.2 t -101.82 99.61 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.249 0 N-CA-C 107.746 -1.205 . . . . 0.17 107.746 160.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.961 HD12 ' H ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -96.44 119.25 34.58 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 107.689 -1.226 . . . . 1.04 107.689 176.15 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.914 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -102.35 140.55 36.48 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.426 0.631 . . . . 0.51 111.156 -176.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.966 ' HZ ' HG13 ' A' ' 20' ' ' VAL . 3.1 m-30 -121.41 96.17 47.96 Favored Pre-proline 0 C--N 1.304 -1.39 0 N-CA-C 108.288 -1.005 . . . . 0.44 108.288 -177.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 1.018 ' HG2' ' HB3' ' A' ' 107' ' ' LYS . 93.3 Cg_endo -79.34 72.43 6.52 Favored 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 122.562 2.175 . . . . 1.3 114.149 -167.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.592 ' HB3' HG23 ' A' ' 110' ' ' VAL . 79.0 p . . . . . 0 C--N 1.323 -0.561 0 N-CA-C 117.023 2.231 . . . . 1.44 117.023 178.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.491 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . . . . . . 0 CA--C 1.51 -0.593 0 CA-C-O 120.994 0.426 . . . . 0.55 111.649 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -86.41 10.1 16.12 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.721 -0.672 . . . . 1.99 110.955 -176.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.573 ' HB3' ' CD2' ' A' ' 61' ' ' TYR . 0.7 OUTLIER -125.18 174.63 3.7 Favored Pre-proline 0 N--CA 1.448 -0.543 0 CA-C-N 115.514 -0.766 . . . . 0.84 109.553 177.262 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.641 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 12.1 Cg_exo -76.74 84.1 1.96 Allowed 'Trans proline' 0 CA--C 1.517 -0.344 0 C-N-CA 123.702 2.935 . . . . 0.62 113.632 -177.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.914 HG13 ' HB3' ' A' ' 73' ' ' ALA . 3.9 mp -84.91 133.33 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 N-CA-C 109.1 -0.704 . . . . 1.34 109.1 173.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.811 ' HG2' ' CG ' ' A' ' 74' ' ' PHE . 0.1 OUTLIER -86.98 -179.43 6.49 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.336 -0.847 . . . . 3.03 110.576 -175.602 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.678 ' O ' ' HG2' ' A' ' 107' ' ' LYS . . . -76.85 19.06 0.31 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.063 -0.971 . . . . 1.46 112.388 -173.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 1.018 ' HB3' ' HG2' ' A' ' 75' ' ' PRO . 12.1 ptmt 51.22 128.13 0.0 OUTLIER 'General case' 0 CA--C 1.504 -0.803 0 C-N-CA 125.685 1.594 . . . . 1.76 113.645 -173.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.837 HD11 HG13 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -124.34 173.42 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.922 0 CA-C-N 113.141 -1.845 . . . . 0.82 108.371 171.978 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -69.43 58.69 0.12 Allowed 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.131 -0.94 . . . . 1.73 112.35 179.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.837 HG13 HD11 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -68.97 93.35 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 C-N-CA 119.49 -0.884 . . . . 0.77 110.295 178.654 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 . . . . . 0 C--N 1.315 -0.932 0 N-CA-C 106.187 -1.783 . . . . 1.9 106.187 168.671 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.791 ' CB ' HG13 ' A' ' 108' ' ' ILE . 2.2 t-80 . . . . . 0 N--CA 1.43 -1.451 0 N-CA-C 106.992 -1.485 . . . . 0.42 106.992 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -28.16 -46.63 0.1 OUTLIER 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 124.729 3.619 . . . . 0.4 113.606 -178.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.892 HD11 ' HB ' ' A' ' 15' ' ' ILE . 37.9 tp -64.86 -51.43 62.09 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 122.977 0.511 . . . . 0.39 112.007 178.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.663 ' HA ' ' HB2' ' A' ' 122' ' ' MET . 31.9 m-85 -77.77 -31.95 52.25 Favored 'General case' 0 CA--C 1.497 -1.085 0 O-C-N 122.185 -0.322 . . . . 3.04 110.664 -178.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.524 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 0.2 OUTLIER -59.29 -39.45 83.0 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 106.656 -1.609 . . . . 2.44 106.656 172.068 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.925 ' HB2' ' HE2' ' A' ' 18' ' ' PHE . 65.0 t80 -65.98 -30.79 71.41 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 119.647 -0.821 . . . . 0.56 110.183 175.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.776 ' HE3' ' HG ' ' A' ' 118' ' ' LEU . 1.5 ttm -75.4 -55.37 5.76 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.573 -0.74 . . . . 0.71 110.744 -170.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.491 ' HB2' ' HE2' ' A' ' 123' ' ' LYS . 1.0 OUTLIER -70.79 -25.68 62.99 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.398 -0.365 . . . . 1.46 111.164 177.045 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.524 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -73.18 -26.26 61.11 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 119.355 -0.938 . . . . 1.99 109.991 178.442 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 65.7 m -85.41 -42.11 14.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.969 -0.559 . . . . 0.59 110.43 174.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.477 ' HE3' ' O ' ' A' ' 151' ' ' VAL . 39.9 tttm . . . . . 0 C--N 1.324 -0.514 0 N-CA-C 109.118 -0.697 . . . . 1.85 109.118 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.889 ' HB3' ' HG3' ' A' ' 156' ' ' PRO . 0.8 OUTLIER . . . . . 0 CA--C 1.512 -0.498 0 CA-C-O 120.481 0.181 . . . . 1.97 110.881 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.494 ' O ' ' N ' ' A' ' 140' ' ' THR . 7.7 m120 -34.87 -151.35 0.0 OUTLIER 'General case' 0 C--O 1.205 -1.267 0 CA-C-N 113.837 -1.529 . . . . 2.04 111.8 156.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.787 ' HA ' HG12 ' A' ' 43' ' ' VAL . 0.6 OUTLIER -28.69 -21.01 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 118.098 2.629 . . . . 1.93 118.098 -171.702 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.523 ' HA ' ' O ' ' A' ' 154' ' ' PHE . 0.9 OUTLIER -9.05 113.27 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 120.191 1.36 . . . . 0.6 113.951 170.438 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.663 ' HA ' ' HA ' ' A' ' 41' ' ' TYR . 0.7 OUTLIER -90.47 171.77 9.19 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.851 -1.068 . . . . 0.62 110.089 -174.132 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.634 ' HA ' ' HA ' ' A' ' 153' ' ' ARG . 10.6 m-85 -126.04 120.26 29.79 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 105.372 -2.084 . . . . 0.57 105.372 161.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.902 HD23 ' HB2' ' A' ' 152' ' ' GLU . 1.1 tp -79.67 105.42 10.96 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 118.69 -1.204 . . . . 0.43 108.52 -178.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.769 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 45.1 mm -92.81 145.5 7.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 CA-C-N 113.975 -1.466 . . . . 0.19 107.933 -176.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.64 -174.88 2.91 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 119.532 -0.867 . . . . 0.98 111.357 -170.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.593 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 32.1 mtm180 -51.08 -42.23 60.47 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 121.077 0.465 . . . . 2.22 111.444 -176.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -98.8 21.56 11.3 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.97 -0.559 . . . . 2.0 109.955 -175.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.485 ' HA3' ' CE2' ' A' ' 16' ' ' PHE . . . 71.64 34.2 63.14 Favored Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 115.732 -0.667 . . . . 0.17 113.908 178.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.475 ' HA ' ' HD2' ' A' ' 150' ' ' PRO . 43.0 t -112.07 107.03 56.13 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 117.988 0.894 . . . . 1.12 111.544 176.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.67 ' HG3' ' HG3' ' A' ' 122' ' ' MET . 4.4 Cg_exo -45.39 118.53 2.16 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 124.441 3.427 . . . . 0.41 112.403 173.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.477 ' O ' ' HE3' ' A' ' 126' ' ' LYS . 1.8 t -103.64 -20.8 5.55 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.879 0 N-CA-C 108.116 -1.068 . . . . 1.45 108.116 178.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.902 ' HB2' HD23 ' A' ' 143' ' ' LEU . 0.0 OUTLIER -152.5 167.65 28.11 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 113.998 -1.455 . . . . 1.17 110.957 -168.531 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.634 ' HA ' ' HA ' ' A' ' 142' ' ' PHE . 0.0 OUTLIER -141.82 129.21 21.22 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 107.091 -1.448 . . . . 2.16 107.091 159.301 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.711 ' HZ ' ' HB2' ' A' ' 166' ' ' LYS . 70.0 m-85 -101.34 141.02 34.83 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.902 -0.407 . . . . 0.32 109.902 -173.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 18.3 m -64.54 150.58 93.43 Favored Pre-proline 0 C--N 1.325 -0.497 0 N-CA-C 109.979 -0.378 . . . . 1.11 109.979 177.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.889 ' HG3' ' HB3' ' A' ' 137' ' ' TRP . 18.6 Cg_endo -57.41 -50.29 11.33 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.138 1.892 . . . . 0.78 112.253 -174.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -66.89 16.44 0.29 Allowed Glycine 0 CA--C 1.526 0.758 0 N-CA-C 114.829 0.692 . . . . 0.5 114.829 175.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -78.59 154.23 30.49 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 118.262 1.031 . . . . 0.5 108.572 169.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.435 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 50.1 m -106.97 167.36 9.94 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 109.64 -0.504 . . . . 1.42 109.64 -177.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.688 ' HA ' HG23 ' A' ' 56' ' ' THR . 91.2 t -40.81 -54.59 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 O-C-N 124.2 0.938 . . . . 0.28 111.731 178.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.435 ' NZ ' ' HB2' ' A' ' 161' ' ' LYS . 0.1 OUTLIER -70.13 -27.65 64.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.232 -0.44 . . . . 3.46 111.409 -172.856 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -68.0 -35.22 77.94 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.478 0.656 . . . . 1.4 109.59 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.609 HD12 ' CG2' ' A' ' 56' ' ' THR . 47.4 mt -80.42 -44.55 22.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 114.988 -1.006 . . . . 0.21 110.522 176.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.604 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 41.2 mt-10 -50.84 -41.73 57.95 Favored 'General case' 0 C--O 1.217 -0.653 0 CA-C-N 116.122 -0.49 . . . . 0.67 111.503 -177.115 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -60.88 -26.77 67.65 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 112.486 0.55 . . . . 0.87 112.486 -175.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.711 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 40.8 mmtm -100.93 -5.35 26.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.544 0.688 . . . . 1.71 109.83 175.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.604 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 11.9 tp -97.82 -51.1 4.2 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.119 -0.946 . . . . 0.16 111.971 -176.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.485 HD11 ' HB3' ' A' ' 164' ' ' GLU . 69.5 mt -56.24 -46.72 99.76 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 112.957 0.725 . . . . 0.26 112.957 -171.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.463 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 63.3 Cg_exo -53.67 -25.03 32.03 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.092 1.861 . . . . 0.41 112.577 175.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.822 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 94.8 mt -86.66 -45.41 11.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.241 -0.436 . . . . 0.71 110.744 177.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.779 HD23 ' HG2' ' A' ' 37' ' ' PRO . 96.5 mt -59.89 -54.83 41.54 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-O 122.048 0.928 . . . . 0.34 110.204 177.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.401 0 CA-C-N 113.305 -1.77 . . . . 1.12 112.962 -179.08 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.8 m . . . . . 0 C--O 1.235 0.3 0 CA-C-O 120.81 0.338 . . . . 1.58 110.407 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.466 ' HB3' ' O ' ' A' ' 147' ' ' ASP . 3.1 m -159.78 152.39 21.29 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 107.075 -1.454 . . . . 1.17 107.075 -173.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.94 ' HB ' HD11 ' A' ' 118' ' ' LEU . 4.6 pt -66.54 -13.63 16.53 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 CA-C-N 114.079 -1.418 . . . . 0.38 112.298 -173.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.828 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 57.1 m-85 -70.45 -8.11 48.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.819 0.342 . . . . 0.3 111.908 -178.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -64.88 -25.86 68.07 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 108.103 -1.073 . . . . 2.11 108.103 175.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.858 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 61.4 m-85 -109.52 113.72 26.75 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 114.191 -1.368 . . . . 0.31 111.632 -176.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -47.72 142.26 4.79 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 113.122 -1.854 . . . . 2.86 110.652 169.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.769 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 54.8 t -111.66 159.2 11.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 108.395 -0.965 . . . . 0.67 108.395 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.729 HD23 ' HA ' ' A' ' 27' ' ' PRO . 74.9 mt -124.05 121.08 34.25 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 121.103 -0.239 . . . . 0.69 110.889 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.81 ' HA ' ' HE2' ' A' ' 105' ' ' MET . 6.2 t0 -62.1 170.5 2.18 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 107.314 -1.365 . . . . 1.87 107.314 173.062 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.617 ' HA ' ' C ' ' A' ' 105' ' ' MET . . . -53.05 -20.31 3.48 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 114.673 1.36 . . . . 0.59 114.673 -164.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 7.9 t70 -103.31 11.66 36.44 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.541 -0.463 . . . . 2.34 111.665 -177.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.676 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 54.7 m-70 76.04 18.42 2.0 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.823 0.82 . . . . 1.47 109.503 176.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.743 ' HE2' ' HA ' ' A' ' 26' ' ' LYS . 10.6 mmpt? -88.98 127.97 53.77 Favored Pre-proline 0 N--CA 1.445 -0.691 0 N-CA-C 107.488 -1.301 . . . . 4.25 107.488 171.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.729 ' HA ' HD23 ' A' ' 21' ' ' LEU . 80.0 Cg_exo -49.82 114.08 1.23 Allowed 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 122.242 1.961 . . . . 0.54 113.206 -171.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.551 ' HB3' HG12 ' A' ' 20' ' ' VAL . 49.5 t80 -79.99 146.71 31.88 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 113.813 -1.54 . . . . 1.2 111.675 173.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.501 ' OD1' ' HB3' ' A' ' 32' ' ' GLN . 2.5 t-20 -86.34 92.39 8.79 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 114.917 -1.038 . . . . 1.51 109.289 175.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.65 HD23 ' HA ' ' A' ' 16' ' ' PHE . 54.0 tp -72.62 -41.25 65.75 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.756 -0.656 . . . . 0.28 109.976 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.799 ' HA ' ' CE1' ' A' ' 16' ' ' PHE . 1.5 t -70.22 -0.83 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 114.698 -1.137 . . . . 1.02 112.517 -167.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.501 ' HB3' ' OD1' ' A' ' 29' ' ' ASN . 30.1 pt20 -76.14 -6.92 53.44 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.342 0.591 . . . . 1.02 109.687 174.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.931 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 93.0 m-70 -100.29 28.53 4.91 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 115.279 -0.873 . . . . 0.28 108.798 175.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.828 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 8.0 mtmt -90.45 118.16 29.71 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 114.687 -1.142 . . . . 1.56 109.595 173.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.66 -40.4 1.97 Allowed Glycine 0 N--CA 1.439 -1.159 0 N-CA-C 111.239 -0.745 . . . . 0.2 111.239 -177.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.469 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 40.7 m -126.97 135.69 27.74 Favored Pre-proline 0 N--CA 1.435 -1.204 0 N-CA-C 108.583 -0.895 . . . . 0.29 108.583 172.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.704 ' HG3' ' HB2' ' A' ' 170' ' ' LEU . 5.9 Cg_endo -44.5 155.36 0.27 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.837 3.025 . . . . 0.18 112.591 175.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.887 ' HB2' HG22 ' A' ' 70' ' ' THR . 0.7 OUTLIER -141.68 149.83 41.09 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 106.59 -1.633 . . . . 0.31 106.59 -179.752 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.862 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 2.3 mp -119.89 118.63 31.26 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.603 -0.686 . . . . 1.19 110.188 177.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.871 HG23 ' HB2' ' A' ' 72' ' ' LEU . 2.2 mt -103.11 127.95 56.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-N 115.408 -0.815 . . . . 0.37 110.374 178.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.862 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.3 OUTLIER -114.81 128.53 56.35 Favored 'General case' 0 C--O 1.218 -0.597 0 CA-C-N 116.055 -0.52 . . . . 0.42 111.225 -172.089 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.533 ' OD1' ' HB3' ' A' ' 76' ' ' SER . 0.3 OUTLIER -76.51 105.53 7.62 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 106.024 -1.843 . . . . 2.35 106.024 165.428 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.968 HG11 ' HB1' ' A' ' 73' ' ' ALA . 2.4 p . . . . . 0 C--N 1.293 -1.869 0 C-N-CA 119.27 -0.972 . . . . 1.03 113.372 -164.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.257 0 N-CA-C 113.851 0.3 . . . . 0.51 113.851 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.15 -21.81 59.88 Favored Glycine 0 C--O 1.219 -0.829 0 C-N-CA 121.147 -0.549 . . . . 0.5 113.475 -175.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.7 -56.89 16.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 117.815 0.807 . . . . 0.7 109.437 177.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -60.15 -32.59 71.17 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.869 -1.06 . . . . 2.61 110.145 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.559 ' HA ' ' CG2' ' A' ' 160' ' ' VAL . 92.4 m -71.44 -59.53 2.71 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 114.827 -1.079 . . . . 0.33 109.94 -175.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 1.127 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -63.07 -42.56 99.69 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.439 -1.255 . . . . 0.22 111.454 -175.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.557 ' HA ' ' CD1' ' A' ' 102' ' ' PHE . 6.4 m -58.53 -56.89 16.26 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.237 0.541 . . . . 0.26 111.059 -179.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.4 m -68.29 -33.31 74.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.634 -0.712 . . . . 0.48 111.213 -173.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.743 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 20.6 mt -67.74 -48.33 66.75 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-O 121.29 0.566 . . . . 0.43 110.077 -178.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.916 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 10.9 t80 -59.3 -46.52 88.34 Favored 'General case' 0 C--O 1.205 -1.267 0 CA-C-N 115.053 -0.976 . . . . 0.31 110.427 178.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -73.52 -26.96 61.11 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 116.625 -0.261 . . . . 1.21 111.551 -172.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.497 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 34.4 ttpt -85.96 -23.8 26.77 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 108.83 -0.804 . . . . 1.54 108.83 -177.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.682 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 30.1 m-85 -122.98 -6.66 8.42 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 115.21 1.559 . . . . 0.31 115.21 -169.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.659 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 26.6 pttt -66.82 -23.77 66.08 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 108.242 -1.022 . . . . 1.35 108.242 170.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.8 t -49.25 -36.18 19.71 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 114.292 -1.322 . . . . 1.28 110.504 171.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -92.31 -30.3 15.91 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.041 0.386 . . . . 1.11 112.041 176.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 143.0 -6.39 2.04 Favored Glycine 0 CA--C 1.52 0.372 0 N-CA-C 111.576 -0.61 . . . . 0.18 111.576 -176.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.743 ' HE2' ' HB3' ' A' ' 60' ' ' LEU . 23.1 t80 -67.58 143.57 56.01 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-N 115.329 -0.436 . . . . 0.18 111.209 -178.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.931 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 7.1 t -132.59 152.65 51.56 Favored 'General case' 0 N--CA 1.415 -2.181 0 N-CA-C 108.095 -1.076 . . . . 0.2 108.095 172.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 1.127 HG11 ' HB1' ' A' ' 57' ' ' ALA . 33.4 t -106.2 101.18 12.07 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.501 0 N-CA-C 107.482 -1.303 . . . . 0.17 107.482 157.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.871 ' HB2' HG23 ' A' ' 40' ' ' ILE . 65.9 mt -85.87 120.3 27.13 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.48 -1.304 . . . . 1.04 107.48 177.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.968 ' HB1' HG11 ' A' ' 43' ' ' VAL . . . -99.49 112.09 24.35 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.918 -0.713 . . . . 0.51 110.49 177.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.965 ' HD2' HD12 ' A' ' 108' ' ' ILE . 4.6 m-85 -99.04 95.37 3.21 Favored Pre-proline 0 N--CA 1.438 -1.041 0 N-CA-C 106.593 -1.632 . . . . 0.44 106.593 176.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.86 ' HB2' ' HG2' ' A' ' 107' ' ' LYS . 9.8 Cg_endo -71.22 142.69 42.16 Favored 'Trans proline' 0 N--CA 1.431 -2.155 0 C-N-CA 120.49 0.793 . . . . 1.3 110.281 -172.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.533 ' HB3' ' OD1' ' A' ' 42' ' ' ASN . 57.2 p . . . . . 0 C--N 1.297 -1.7 0 CA-C-O 122.175 0.988 . . . . 1.44 112.678 -177.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.478 0 CA-C-O 121.225 0.536 . . . . 0.55 111.942 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -83.33 17.55 2.07 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.077 -0.965 . . . . 1.99 110.687 -178.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.6 ' HB3' ' CD2' ' A' ' 61' ' ' TYR . 13.0 p90 -143.65 165.98 22.01 Favored Pre-proline 0 N--CA 1.445 -0.723 0 N-CA-C 109.497 -0.557 . . . . 0.84 109.497 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.662 ' HD3' ' CE2' ' A' ' 61' ' ' TYR . 31.2 Cg_exo -62.4 95.78 0.15 Allowed 'Trans proline' 0 CA--C 1.52 -0.202 0 C-N-CA 123.962 3.108 . . . . 0.62 113.19 -174.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.8 HD12 ' HB3' ' A' ' 73' ' ' ALA . 4.0 mm -90.48 116.14 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 107.513 -1.292 . . . . 1.34 107.513 175.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.81 ' HE2' ' HA ' ' A' ' 22' ' ' ASP . 1.2 mmt -92.93 -174.1 3.49 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.456 -0.793 . . . . 3.03 111.704 -166.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.518 ' N ' ' HA ' ' A' ' 23' ' ' ALA . . . -71.58 130.91 42.38 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.003 -0.998 . . . . 1.46 108.741 172.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.86 ' HG2' ' HB2' ' A' ' 75' ' ' PRO . 92.4 mttt -62.81 131.73 49.8 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-O 121.836 0.827 . . . . 1.76 109.265 176.015 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.965 HD12 ' HD2' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -122.36 165.39 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.419 0 N-CA-C 105.167 -2.16 . . . . 0.82 105.167 169.855 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -78.7 69.44 4.87 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 119.78 -0.768 . . . . 1.73 110.309 -178.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.482 HG13 HD11 ' A' ' 108' ' ' ILE . 0.1 OUTLIER -67.36 92.89 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-O 122.101 0.953 . . . . 0.77 108.853 178.51 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.6 t30 . . . . . 0 N--CA 1.438 -1.064 0 CA-C-N 113.286 -1.779 . . . . 1.9 106.555 177.691 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.611 ' CB ' HG13 ' A' ' 108' ' ' ILE . 5.5 t-80 . . . . . 0 N--CA 1.426 -1.639 0 N-CA-C 107.058 -1.46 . . . . 0.42 107.058 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -30.93 -45.33 0.14 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 124.364 3.376 . . . . 0.4 113.211 -178.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.94 HD11 ' HB ' ' A' ' 15' ' ' ILE . 43.3 tp -65.05 -50.36 66.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.905 -0.589 . . . . 0.39 111.83 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.546 ' OH ' HG22 ' A' ' 40' ' ' ILE . 32.9 m-85 -76.34 -33.04 58.98 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 112.026 0.38 . . . . 3.04 112.026 178.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.61 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 43.9 mt-10 -57.94 -37.49 74.21 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 107.111 -1.44 . . . . 2.44 107.111 170.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.858 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 74.3 t80 -66.25 -35.65 80.97 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.368 -0.833 . . . . 0.56 110.646 173.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.65 ' HE2' HG21 ' A' ' 15' ' ' ILE . 53.1 mtt -73.61 -55.08 6.75 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.75 -0.659 . . . . 0.71 110.806 -168.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.47 ' HB2' ' HE2' ' A' ' 123' ' ' LYS . 0.2 OUTLIER -70.0 -24.26 63.28 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.108 -0.496 . . . . 1.46 111.144 177.785 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.61 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 9.5 pttp -72.57 -30.14 64.14 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 119.61 -0.836 . . . . 1.99 109.624 174.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 87.8 m -76.86 -48.0 19.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.775 -0.648 . . . . 0.59 110.514 176.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.767 ' HG2' HH22 ' A' ' 153' ' ' ARG . 22.8 ttmm . . . . . 0 N--CA 1.452 -0.367 0 CA-C-N 116.283 -0.417 . . . . 1.85 110.848 -179.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.466 0.337 0 N-CA-C 111.414 0.154 . . . . 1.97 111.414 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.691 ' HB2' ' HB3' ' A' ' 156' ' ' PRO . 1.8 m120 -38.2 -153.05 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 125.507 1.523 . . . . 2.04 111.955 158.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.705 ' CD1' HG23 ' A' ' 43' ' ' VAL . 1.6 m-85 -25.27 -46.56 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 114.815 1.413 . . . . 1.93 114.815 -167.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.757 ' HA ' ' O ' ' A' ' 154' ' ' PHE . 16.3 m 25.75 101.3 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.719 1.377 . . . . 0.6 114.719 172.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.541 ' CB ' HD23 ' A' ' 39' ' ' LEU . 0.7 OUTLIER -86.12 169.18 13.36 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.61 -1.177 . . . . 0.62 110.235 -175.058 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -126.04 124.41 40.59 Favored 'General case' 0 CA--C 1.495 -1.15 0 N-CA-C 105.118 -2.179 . . . . 0.57 105.118 162.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.763 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 7.3 tp -79.99 105.56 11.36 Favored 'General case' 0 N--CA 1.422 -1.867 0 C-N-CA 118.143 -1.423 . . . . 0.43 108.682 178.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.692 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 39.7 mm -91.59 138.16 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.022 0 CA-C-N 112.542 -2.117 . . . . 0.19 107.118 -178.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.541 ' HA ' HD13 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -92.04 179.94 5.45 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 120.396 -0.522 . . . . 0.98 111.055 -170.273 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.606 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 40.1 mtm180 -47.36 -42.6 21.92 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 122.893 0.477 . . . . 2.22 111.626 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.466 ' O ' ' HB3' ' A' ' 14' ' ' SER . 8.1 m-20 -96.72 23.43 7.02 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 109.685 -0.487 . . . . 2.0 109.685 -176.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.623 ' HA2' HG22 ' A' ' 144' ' ' ILE . . . 65.26 37.88 94.48 Favored Glycine 0 N--CA 1.437 -1.275 0 CA-C-N 115.666 -0.697 . . . . 0.17 114.139 178.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.49 ' HA ' ' HD2' ' A' ' 150' ' ' PRO . 6.9 p -108.74 110.1 61.22 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 118.615 1.208 . . . . 1.12 111.73 173.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.691 ' HD3' HG23 ' A' ' 15' ' ' ILE . 10.2 Cg_endo -57.09 115.05 2.22 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 124.081 3.187 . . . . 0.41 111.168 175.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.787 HG23 ' HG2' ' A' ' 152' ' ' GLU . 17.6 m -116.27 -17.86 7.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-O 121.187 0.518 . . . . 1.45 109.982 -177.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.787 ' HG2' HG23 ' A' ' 151' ' ' VAL . 24.6 mm-40 -138.57 167.24 22.36 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-N 115.49 -0.777 . . . . 1.17 109.956 -179.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.767 HH22 ' HG2' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -148.43 141.6 25.03 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 114.904 -1.044 . . . . 2.16 108.937 163.267 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.757 ' O ' ' HA ' ' A' ' 140' ' ' THR . 79.7 m-85 -117.45 151.12 37.72 Favored 'General case' 0 C--O 1.217 -0.632 0 N-CA-C 109.483 -0.562 . . . . 0.32 109.483 -174.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.531 ' HB3' ' HD2' ' A' ' 156' ' ' PRO . 51.1 m -73.27 163.76 66.07 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 109.388 -0.597 . . . . 1.11 109.388 177.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.691 ' HB3' ' HB2' ' A' ' 138' ' ' ASN . 10.6 Cg_endo -53.15 -67.02 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.763 2.309 . . . . 0.78 112.729 -179.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -57.2 15.37 0.01 OUTLIER Glycine 0 CA--C 1.53 0.999 0 N-CA-C 116.368 1.307 . . . . 0.5 116.368 172.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -79.85 138.09 37.11 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 119.061 1.431 . . . . 0.5 107.392 167.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.499 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 8.6 t -104.85 173.47 6.29 Favored 'General case' 0 N--CA 1.429 -1.51 0 C-N-CA 119.988 -0.685 . . . . 1.42 110.072 -169.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.559 ' CG2' ' HA ' ' A' ' 56' ' ' THR . 69.3 t -43.57 -54.76 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 114.358 -1.292 . . . . 0.28 112.126 -177.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.84 -29.96 68.39 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.98 0.419 . . . . 3.46 110.78 -173.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -71.05 -31.41 67.84 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.642 0.734 . . . . 1.4 109.123 -176.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.52 HG21 HD22 ' A' ' 39' ' ' LEU . 33.1 mt -82.58 -45.33 19.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 114.492 -1.231 . . . . 0.21 110.741 176.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.574 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 41.8 mt-10 -51.2 -41.87 60.53 Favored 'General case' 0 C--O 1.218 -0.595 0 CA-C-N 116.308 -0.405 . . . . 0.67 111.362 -178.015 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -60.8 -20.69 62.05 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 112.056 0.391 . . . . 0.87 112.056 -174.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.693 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 31.3 mmtp -100.38 -24.44 14.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.477 0.656 . . . . 1.71 110.273 172.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.574 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 10.8 tp -80.73 -49.02 11.71 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.183 -0.917 . . . . 0.16 112.183 -175.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.463 HD11 ' HB3' ' A' ' 164' ' ' GLU . 73.1 mt -55.75 -43.7 99.31 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.478 -0.783 . . . . 0.26 112.568 -173.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.408 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 85.5 Cg_exo -49.98 -33.67 34.99 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 122.02 1.813 . . . . 0.41 112.659 172.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.704 ' HB2' ' HG3' ' A' ' 37' ' ' PRO . 91.3 mt -86.01 -42.67 13.78 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 121.122 -0.231 . . . . 0.71 111.348 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.644 HD21 ' HB2' ' A' ' 69' ' ' PHE . 93.8 mt -59.39 -53.2 60.95 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 122.264 1.031 . . . . 0.34 109.624 175.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.425 0 CA-C-N 113.321 -1.763 . . . . 1.12 113.958 -174.515 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.5 m . . . . . 0 C--O 1.233 0.224 0 N-CA-C 109.585 -0.524 . . . . 1.58 109.585 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.9 m -166.16 159.19 14.99 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 105.431 -2.062 . . . . 1.17 105.431 -177.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.891 ' HB ' HD11 ' A' ' 118' ' ' LEU . 8.0 pt -59.99 -20.18 19.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 CA-C-N 116.015 -0.538 . . . . 0.38 111.437 -176.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.736 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 40.3 m-85 -68.68 -2.75 9.87 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.059 0.457 . . . . 0.3 111.632 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.96 -12.99 61.37 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 108.469 -0.937 . . . . 2.11 108.469 172.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.74 ' HE2' ' HB2' ' A' ' 121' ' ' TYR . 58.5 m-85 -129.73 111.3 12.5 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 114.837 -1.074 . . . . 0.31 110.871 -173.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -51.38 150.27 3.64 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 113.792 -1.549 . . . . 2.86 110.099 172.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.809 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 34.4 t -111.04 157.06 12.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 115.457 -0.792 . . . . 0.67 108.906 -178.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.835 ' O ' ' HB3' ' A' ' 105' ' ' MET . 96.2 mt -122.31 116.09 23.47 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 116.546 -0.297 . . . . 0.69 110.502 -177.138 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.516 ' HA ' ' SD ' ' A' ' 105' ' ' MET . 6.2 t70 -58.29 170.87 0.64 Allowed 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 107.624 -1.25 . . . . 1.87 107.624 174.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.65 ' HA ' ' C ' ' A' ' 105' ' ' MET . . . -54.56 -26.34 31.55 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 118.761 0.709 . . . . 0.59 112.515 -168.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.42 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 8.8 t70 -78.22 -7.51 57.21 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.47 -0.332 . . . . 2.34 111.047 -178.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.605 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 57.1 m-70 80.09 19.53 0.6 Allowed 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 122.01 0.91 . . . . 1.47 108.628 -177.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.862 ' HE2' ' HA ' ' A' ' 26' ' ' LYS . 9.3 mmpt? -99.83 128.96 29.69 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 114.071 -1.422 . . . . 4.25 108.388 172.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.732 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 74.9 Cg_exo -47.12 115.73 1.44 Allowed 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 123.136 2.557 . . . . 0.54 114.989 -170.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.783 ' CE2' HD21 ' A' ' 72' ' ' LEU . 34.5 t80 -80.08 146.61 31.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.123 -1.399 . . . . 1.2 110.356 166.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.634 ' OD1' ' HB3' ' A' ' 32' ' ' GLN . 2.6 t-20 -76.56 90.76 3.34 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.662 -0.699 . . . . 1.51 110.133 179.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.711 ' HG ' ' CD1' ' A' ' 16' ' ' PHE . 56.3 tp -69.34 -46.51 66.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.162 0.506 . . . . 0.28 110.191 178.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.704 HG13 ' HB3' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -66.2 0.7 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 115.315 -0.857 . . . . 1.02 113.289 -171.598 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.634 ' HB3' ' OD1' ' A' ' 29' ' ' ASN . 3.8 pt20 -72.07 -16.22 62.02 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.109 -0.7 . . . . 1.02 109.109 172.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.981 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 91.2 m-70 -93.99 22.99 5.21 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 121.85 0.833 . . . . 0.28 109.356 178.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.736 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 29.7 mtmt -84.91 109.97 18.53 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 114.266 -1.334 . . . . 1.56 108.834 169.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 130.78 -38.05 2.0 Favored Glycine 0 N--CA 1.439 -1.113 0 C-N-CA 120.987 -0.625 . . . . 0.2 111.774 -178.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.458 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 22.7 m -133.99 137.04 27.46 Favored Pre-proline 0 N--CA 1.435 -1.192 0 N-CA-C 108.91 -0.774 . . . . 0.29 108.91 172.037 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.694 ' HG2' HD23 ' A' ' 171' ' ' LEU . 7.4 Cg_endo -45.81 156.54 0.43 Allowed 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 124.057 3.171 . . . . 0.18 112.94 178.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.838 ' HB2' HG22 ' A' ' 70' ' ' THR . 0.9 OUTLIER -141.07 145.65 36.11 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 106.745 -1.576 . . . . 0.31 106.745 178.823 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 1.055 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 1.5 mm? -107.2 111.88 24.49 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.199 -1.038 . . . . 1.19 108.199 177.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.765 HG13 HG13 ' A' ' 144' ' ' ILE . 4.9 mt -95.27 124.51 47.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 C-N-CA 119.622 -0.831 . . . . 0.37 109.954 177.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 1.055 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 1.3 m-85 -106.94 124.39 49.55 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.212 -0.904 . . . . 0.42 110.355 -174.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.42 ' HB3' HG11 ' A' ' 110' ' ' VAL . 0.8 OUTLIER -80.04 90.03 5.39 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 106.421 -1.696 . . . . 2.35 106.421 169.997 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.876 ' HA ' ' HA ' ' A' ' 139' ' ' PHE . 5.9 p . . . . . 0 C--N 1.3 -1.552 0 C-N-CA 120.175 -0.61 . . . . 1.03 110.865 -166.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.81 0 N-CA-C 111.603 -0.599 . . . . 0.51 111.603 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.562 ' HA2' ' HB ' ' A' ' 56' ' ' THR . . . -75.05 -17.16 80.28 Favored Glycine 0 C--O 1.221 -0.718 0 CA-C-O 119.628 -0.54 . . . . 0.5 114.404 -174.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -71.22 -58.54 3.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 118.44 1.12 . . . . 0.7 109.152 177.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -62.67 -24.21 67.52 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.241 -0.89 . . . . 2.61 110.223 178.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.664 HG23 ' HA ' ' A' ' 160' ' ' VAL . 16.2 m -74.57 -57.5 3.89 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.278 -0.874 . . . . 0.33 110.306 177.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 1.049 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -58.13 -40.54 81.53 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.76 -0.655 . . . . 0.22 110.986 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.524 ' HA ' ' CD1' ' A' ' 102' ' ' PHE . 86.9 m -57.01 -56.05 26.76 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-O 121.379 0.609 . . . . 0.26 110.532 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.6 m -69.78 -37.7 76.46 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.116 -0.947 . . . . 0.48 111.46 -176.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.713 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 15.2 mt -62.15 -50.06 73.36 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-O 121.523 0.677 . . . . 0.43 110.302 -177.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.913 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 10.8 t80 -57.7 -51.51 69.24 Favored 'General case' 0 C--O 1.2 -1.544 0 CA-C-N 114.46 -1.245 . . . . 0.31 111.052 -179.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.528 ' HA ' ' HD3' ' A' ' 65' ' ' LYS . 5.1 m-80 -73.63 -24.26 60.0 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 120.635 0.255 . . . . 1.21 111.182 -173.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -80.53 -26.52 38.0 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 108.548 -0.908 . . . . 1.54 108.548 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.72 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 45.0 m-85 -124.74 -1.53 7.92 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 115.522 1.675 . . . . 0.31 115.522 -169.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.638 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -64.86 -20.74 66.58 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 107.507 -1.294 . . . . 1.35 107.507 169.218 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -46.72 -44.5 18.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 113.794 -1.548 . . . . 1.28 111.014 171.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.463 ' OE1' ' HA ' ' A' ' 64' ' ' TYR . 23.4 mp0 -86.33 -33.11 20.69 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.454 -0.339 . . . . 1.11 111.731 178.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 143.69 -1.52 1.35 Allowed Glycine 0 N--CA 1.452 -0.293 0 N-CA-C 111.562 -0.615 . . . . 0.18 111.562 -174.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.72 ' HD2' ' HB2' ' A' ' 64' ' ' TYR . 22.0 t80 -68.73 142.77 54.88 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 122.989 0.515 . . . . 0.18 111.25 -178.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.981 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 1.9 t -133.92 147.01 51.04 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 107.633 -1.247 . . . . 0.2 107.633 170.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 1.049 HG11 ' HB1' ' A' ' 57' ' ' ALA . 39.1 t -99.02 99.12 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.441 0 N-CA-C 107.338 -1.356 . . . . 0.17 107.338 157.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.783 HD21 ' CE2' ' A' ' 28' ' ' TYR . 4.2 mt -84.88 118.51 24.55 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 107.895 -1.15 . . . . 1.04 107.895 177.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.88 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -116.58 112.62 21.57 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 119.879 -0.729 . . . . 0.51 110.937 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.809 ' CZ ' HG13 ' A' ' 20' ' ' VAL . 1.6 m-30 -91.75 110.26 42.31 Favored Pre-proline 0 C--N 1.318 -0.77 0 N-CA-C 107.741 -1.207 . . . . 0.44 107.741 173.141 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.893 ' HG2' ' HB3' ' A' ' 107' ' ' LYS . 60.9 Cg_endo -72.2 40.77 0.46 Allowed 'Trans proline' 0 N--CA 1.48 0.73 0 C-N-CA 123.961 3.107 . . . . 1.3 116.629 -165.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.491 ' HA ' ' O ' ' A' ' 108' ' ' ILE . 4.8 t . . . . . 0 N--CA 1.474 0.759 0 N-CA-C 115.845 1.794 . . . . 1.44 115.845 175.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.698 0 CA-C-O 120.78 0.324 . . . . 0.55 110.94 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -88.09 12.07 14.52 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.96 -0.563 . . . . 1.99 110.604 175.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.673 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 15.5 p90 -128.93 160.71 62.03 Favored Pre-proline 0 N--CA 1.438 -1.037 0 N-CA-C 108.209 -1.034 . . . . 0.84 108.209 175.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.762 ' HG2' ' HA ' ' A' ' 72' ' ' LEU . 57.6 Cg_endo -64.27 104.27 0.5 Allowed 'Trans proline' 0 N--CA 1.472 0.222 0 C-N-CA 123.432 2.755 . . . . 0.62 113.2 -171.156 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.88 HD12 ' HB3' ' A' ' 73' ' ' ALA . 5.4 mm -100.48 121.03 50.75 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.818 0 N-CA-C 108.053 -1.091 . . . . 1.34 108.053 175.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.835 ' HB3' ' O ' ' A' ' 21' ' ' LEU . 20.1 mmt -97.68 -159.26 0.72 Allowed 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.32 -0.854 . . . . 3.03 113.246 -163.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.706 ' O ' ' HG2' ' A' ' 107' ' ' LYS . . . -56.96 -27.53 61.37 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.29 -0.868 . . . . 1.46 112.623 -173.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.893 ' HB3' ' HG2' ' A' ' 75' ' ' PRO . 4.5 ptpp? 76.88 133.94 0.06 Allowed 'General case' 0 CA--C 1.481 -1.684 0 O-C-N 125.044 1.465 . . . . 1.76 108.802 -163.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.7 HG13 ' CB ' ' A' ' 116' ' ' HIS . 0.1 OUTLIER -134.65 162.59 38.53 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 CA-C-N 113.4 -1.727 . . . . 0.82 108.206 173.824 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -75.93 70.04 2.61 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.248 -0.887 . . . . 1.73 111.438 -171.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.554 HG13 HD11 ' A' ' 108' ' ' ILE . 2.4 m -70.91 91.56 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 CA-C-O 121.493 0.663 . . . . 0.77 111.272 -173.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 . . . . . 0 C--N 1.316 -0.849 0 CA-C-N 114.608 -1.178 . . . . 1.9 108.51 168.917 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.7 ' CB ' HG13 ' A' ' 108' ' ' ILE . 3.2 t-80 . . . . . 0 N--CA 1.431 -1.4 0 N-CA-C 105.846 -1.909 . . . . 0.42 105.846 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -30.89 -49.44 0.22 Allowed 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 123.899 3.066 . . . . 0.4 113.141 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.891 HD11 ' HB ' ' A' ' 15' ' ' ILE . 40.0 tp -58.7 -52.16 66.89 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.459 0.704 . . . . 0.39 112.389 176.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.777 ' HE2' ' CD2' ' A' ' 74' ' ' PHE . 65.5 m-85 -75.6 -36.54 60.28 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-N 116.472 -0.331 . . . . 3.04 111.652 -178.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.425 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 42.8 mt-10 -56.5 -36.79 69.57 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 107.137 -1.431 . . . . 2.44 107.137 171.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.74 ' HB2' ' HE2' ' A' ' 18' ' ' PHE . 49.5 t80 -68.36 -31.11 70.27 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 119.825 -0.75 . . . . 0.56 111.167 175.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.658 ' HE3' ' HG ' ' A' ' 118' ' ' LEU . 0.5 OUTLIER -74.4 -56.41 4.89 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.27 0.557 . . . . 0.71 109.958 -171.748 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.643 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -72.28 -24.3 61.32 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.221 -0.9 . . . . 1.46 112.258 178.912 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.663 ' HG2' ' HA ' ' A' ' 121' ' ' TYR . 16.0 ptmt -68.05 -34.37 76.32 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 118.945 -1.102 . . . . 1.99 109.318 175.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 44.3 m -77.11 -43.88 32.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.206 -0.906 . . . . 0.59 110.126 178.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 123' ' ' LYS . 27.5 mtpp . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 1.85 110.849 175.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.755 ' HB3' ' HG3' ' A' ' 156' ' ' PRO . 0.2 OUTLIER . . . . . 0 CA--C 1.515 -0.37 0 N-CA-C 110.143 -0.318 . . . . 1.97 110.143 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.482 ' O ' ' N ' ' A' ' 140' ' ' THR . 7.1 m120 -36.23 -154.91 0.0 OUTLIER 'General case' 0 C--O 1.206 -1.188 0 O-C-N 125.052 1.47 . . . . 2.04 112.672 163.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.876 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 0.5 OUTLIER -31.63 -21.29 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 117.362 2.356 . . . . 1.93 117.362 -170.277 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.482 ' N ' ' O ' ' A' ' 138' ' ' ASN . 5.9 m 5.62 114.73 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 120.56 1.527 . . . . 0.6 113.906 165.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.563 ' HB3' ' CE1' ' A' ' 41' ' ' TYR . 0.8 OUTLIER -94.14 159.88 14.95 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 114.114 -1.403 . . . . 0.62 110.764 -164.527 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.482 ' O ' HD13 ' A' ' 39' ' ' LEU . 48.2 m-85 -122.5 125.53 45.96 Favored 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 106.306 -1.739 . . . . 0.57 106.306 167.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.754 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 9.8 tp -80.67 105.95 12.3 Favored 'General case' 0 N--CA 1.424 -1.752 0 C-N-CA 117.927 -1.509 . . . . 0.43 108.592 177.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.765 HG13 HG13 ' A' ' 40' ' ' ILE . 40.7 mm -92.29 141.29 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.926 0 CA-C-N 112.981 -1.918 . . . . 0.19 107.228 -178.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.638 ' HA ' HD13 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -91.98 179.09 5.69 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 120.716 -0.394 . . . . 0.98 111.641 -170.188 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.521 ' CG ' ' HD3' ' A' ' 37' ' ' PRO . 17.4 mtm180 -50.43 -41.71 52.9 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 122.845 0.458 . . . . 2.22 111.392 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.443 ' C ' ' HE2' ' A' ' 16' ' ' PHE . 4.8 m-20 -93.96 12.8 24.86 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 109.476 -0.565 . . . . 2.0 109.476 -176.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.642 ' HA3' ' CE2' ' A' ' 16' ' ' PHE . . . 76.36 32.12 52.6 Favored Glycine 0 N--CA 1.433 -1.52 0 CA-C-N 115.354 -0.839 . . . . 0.17 113.911 178.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.472 ' HA ' ' HD2' ' A' ' 150' ' ' PRO . 7.1 p -108.53 109.62 61.45 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 118.806 1.303 . . . . 1.12 111.923 174.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.665 ' HD3' HG23 ' A' ' 15' ' ' ILE . 1.9 Cg_endo -50.48 124.3 12.98 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 124.294 3.33 . . . . 0.41 112.106 174.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.762 HG23 ' HG2' ' A' ' 152' ' ' GLU . 15.9 m -125.0 -15.11 4.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.929 0.395 . . . . 1.45 110.385 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.762 ' HG2' HG23 ' A' ' 151' ' ' VAL . 13.7 mm-40 -140.99 166.9 23.53 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 116.107 -0.497 . . . . 1.17 110.598 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.499 ' HB3' ' CZ ' ' A' ' 153' ' ' ARG . 0.0 OUTLIER -148.07 143.92 27.52 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.254 -0.884 . . . . 2.16 109.697 162.315 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.625 ' HZ ' ' HB2' ' A' ' 166' ' ' LYS . 91.0 m-85 -120.35 138.02 53.96 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.691 -0.686 . . . . 0.32 110.436 -171.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.495 ' OG ' ' HD2' ' A' ' 156' ' ' PRO . 8.2 t -65.49 151.74 93.76 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 107.853 -1.166 . . . . 1.11 107.853 177.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.755 ' HG3' ' HB3' ' A' ' 137' ' ' TRP . 25.2 Cg_endo -59.32 -25.19 77.47 Favored 'Trans proline' 0 N--CA 1.474 0.376 0 C-N-CA 123.056 2.504 . . . . 0.78 113.221 -176.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -75.94 -2.96 73.06 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.961 -0.563 . . . . 0.5 113.853 174.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -70.44 146.78 50.1 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 117.659 0.729 . . . . 0.5 109.502 175.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.54 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 17.1 m -104.66 170.09 8.08 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.566 -0.531 . . . . 1.42 109.566 -178.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.664 ' HA ' HG23 ' A' ' 56' ' ' THR . 87.1 t -40.52 -55.51 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 O-C-N 124.286 0.991 . . . . 0.28 111.409 177.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 161' ' ' LYS . 0.1 OUTLIER -70.42 -28.52 65.12 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.225 -0.443 . . . . 3.46 111.366 -173.033 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.416 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 4.4 m-20 -65.72 -35.54 81.02 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.583 0.706 . . . . 1.4 109.265 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.59 ' HA ' ' CE2' ' A' ' 154' ' ' PHE . 72.1 mt -83.27 -43.0 18.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 114.432 -1.258 . . . . 0.21 110.952 178.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.603 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 46.0 mt-10 -51.98 -43.38 63.57 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-O 120.842 0.353 . . . . 0.67 111.19 -179.111 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 13.1 pt-20 -60.64 -17.04 44.85 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 112.149 0.425 . . . . 0.87 112.149 -174.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.625 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 13.7 mmmm -106.0 -25.28 12.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.259 0.552 . . . . 1.71 109.941 172.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.603 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 12.0 tp -76.81 -49.35 16.02 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.138 -0.937 . . . . 0.16 111.979 -177.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.456 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 67.1 mt -55.28 -44.12 99.46 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.718 -0.674 . . . . 0.26 111.91 -175.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.456 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 86.0 Cg_exo -50.26 -24.01 10.87 Favored 'Trans proline' 0 C--N 1.353 0.816 0 C-N-CA 122.499 2.132 . . . . 0.41 113.592 172.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.674 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 86.2 mt -97.78 -40.3 8.61 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 120.636 -0.426 . . . . 0.71 111.118 177.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.694 HD23 ' HG2' ' A' ' 37' ' ' PRO . 95.6 mt -59.92 -59.29 5.66 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 122.141 0.972 . . . . 0.34 109.102 175.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.526 0 CA-C-N 113.358 -1.746 . . . . 1.12 111.713 -178.926 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.4 m . . . . . 0 N--CA 1.474 0.741 0 N-CA-C 111.822 0.304 . . . . 1.58 111.822 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 86.8 p 177.9 154.59 0.33 Allowed 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 106.173 -1.788 . . . . 1.17 106.173 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.835 ' HB ' HD11 ' A' ' 118' ' ' LEU . 5.1 pt -70.25 -17.59 20.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-N 115.068 -0.969 . . . . 0.38 112.236 -172.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.764 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 51.9 m-85 -69.91 -3.33 15.48 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.186 0.517 . . . . 0.3 111.463 -178.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -71.97 -17.99 62.02 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.249 -1.019 . . . . 2.11 108.249 176.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.726 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 72.5 m-85 -117.84 112.54 20.51 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 114.818 -1.083 . . . . 0.31 110.881 -175.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -47.9 142.06 5.24 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 113.494 -1.685 . . . . 2.86 110.452 172.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.827 HG13 ' HZ ' ' A' ' 74' ' ' PHE . 54.9 t -111.13 164.6 6.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 107.466 -1.309 . . . . 0.67 107.466 176.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.627 HD23 ' HA ' ' A' ' 27' ' ' PRO . 10.3 mt -133.16 125.68 30.0 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.224 -0.658 . . . . 0.69 109.224 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.533 ' HA ' ' SD ' ' A' ' 105' ' ' MET . 17.2 m-20 -56.21 178.6 0.05 OUTLIER 'General case' 0 CA--C 1.514 -0.408 0 O-C-N 123.768 0.667 . . . . 1.87 110.086 177.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.606 ' HA ' ' N ' ' A' ' 106' ' ' ALA . . . -61.41 -1.79 0.6 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.826 0.676 . . . . 0.59 112.826 -175.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -112.95 4.95 17.06 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.135 0.421 . . . . 2.34 112.135 175.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.766 ' CD2' ' HB3' ' A' ' 106' ' ' ALA . 8.0 m170 72.59 19.63 4.05 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.752 0.787 . . . . 1.47 110.241 177.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.485 ' HE3' ' HB2' ' A' ' 26' ' ' LYS . 2.9 mtmt -84.05 135.54 42.08 Favored Pre-proline 0 CA--C 1.509 -0.614 0 N-CA-C 106.591 -1.633 . . . . 4.25 106.591 164.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.627 ' HA ' HD23 ' A' ' 21' ' ' LEU . 80.4 Cg_exo -53.27 113.26 1.2 Allowed 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 121.187 1.258 . . . . 0.54 112.868 -178.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.622 ' HB3' HG12 ' A' ' 20' ' ' VAL . 45.8 t80 -78.86 144.01 35.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 113.701 -1.59 . . . . 1.2 110.969 173.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.689 HD21 HG22 ' A' ' 31' ' ' VAL . 2.5 t-20 -79.31 81.38 5.58 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 115.147 -0.933 . . . . 1.51 109.573 178.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.661 ' HG ' ' CD1' ' A' ' 16' ' ' PHE . 54.7 tp -60.79 -39.64 89.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.228 0.537 . . . . 0.28 109.558 177.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.713 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 1.1 m -72.11 -0.04 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.022 -0.99 . . . . 1.02 112.47 -168.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.59 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 3.8 pt20 -73.44 -13.92 61.16 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.359 -0.608 . . . . 1.02 109.359 173.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.845 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 91.6 m-70 -94.35 21.98 6.51 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-O 121.812 0.815 . . . . 0.28 109.561 176.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.764 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 45.5 mtmt -85.74 109.7 18.81 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 114.553 -1.203 . . . . 1.56 108.76 169.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 134.68 -41.02 1.5 Allowed Glycine 0 N--CA 1.435 -1.373 0 N-CA-C 111.308 -0.717 . . . . 0.2 111.308 -177.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 41.2 m -131.71 136.28 28.18 Favored Pre-proline 0 N--CA 1.438 -1.066 0 N-CA-C 108.616 -0.883 . . . . 0.29 108.616 171.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.736 ' HG2' HD23 ' A' ' 171' ' ' LEU . 3.5 Cg_endo -43.17 156.94 0.11 Allowed 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.936 3.091 . . . . 0.18 112.875 175.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.843 ' HB2' HG22 ' A' ' 70' ' ' THR . 1.0 OUTLIER -144.62 140.51 28.76 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 107.525 -1.287 . . . . 0.31 107.525 -179.736 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.941 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 1.7 mm? -106.04 112.17 25.11 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.403 -0.962 . . . . 1.19 108.403 176.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.816 HG23 ' HB2' ' A' ' 72' ' ' LEU . 5.1 mt -98.63 130.06 48.04 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 CA-C-N 115.95 -0.568 . . . . 0.37 109.95 177.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.941 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.4 OUTLIER -117.56 140.5 49.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.636 -0.711 . . . . 0.42 110.492 -172.604 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.615 ' OD1' ' HB ' ' A' ' 140' ' ' THR . 22.8 p-10 -92.54 105.1 17.33 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 108.116 -1.068 . . . . 2.35 108.116 168.323 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.723 ' O ' ' HA ' ' A' ' 75' ' ' PRO . 3.3 m . . . . . 0 C--N 1.31 -1.14 0 O-C-N 121.228 -0.92 . . . . 1.03 110.529 -170.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.693 0 N-CA-C 110.913 -0.875 . . . . 0.51 110.913 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.445 ' HA2' ' HB ' ' A' ' 56' ' ' THR . . . -70.17 -17.98 74.45 Favored Glycine 0 C--O 1.217 -0.919 0 C-N-CA 121.264 -0.493 . . . . 0.5 113.208 -178.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.411 ' HA ' ' CE2' ' A' ' 139' ' ' PHE . 1.1 t80 -74.14 -56.67 4.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 117.786 0.793 . . . . 0.7 109.896 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -62.93 -21.79 66.3 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.269 0.557 . . . . 2.61 110.115 176.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.706 ' HA ' HG22 ' A' ' 160' ' ' VAL . 16.0 m -76.34 -53.91 7.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.421 -0.809 . . . . 0.33 109.669 177.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 1.089 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -55.03 -43.06 73.37 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 114.905 -1.043 . . . . 0.22 110.758 177.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.497 ' HA ' ' CD1' ' A' ' 102' ' ' PHE . 39.4 m -60.84 -56.98 14.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.472 -0.785 . . . . 0.26 110.515 -178.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 98.6 m -66.29 -38.99 89.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.995 -1.002 . . . . 0.48 112.238 -175.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.785 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 18.7 mt -64.39 -48.5 75.21 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-O 121.425 0.631 . . . . 0.43 110.275 -176.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.877 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 13.5 t80 -56.84 -47.89 79.29 Favored 'General case' 0 C--O 1.207 -1.182 0 CA-C-N 114.545 -1.207 . . . . 0.31 110.897 178.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.587 ' HA ' ' HE3' ' A' ' 65' ' ' LYS . 1.1 m-80 -73.84 -25.5 60.11 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 116.602 -0.272 . . . . 1.21 111.132 -171.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.408 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 33.8 ttpt -86.21 -23.15 26.56 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 109.015 -0.735 . . . . 1.54 109.015 -178.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.743 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 29.1 m-85 -125.47 -4.53 7.21 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 115.808 1.781 . . . . 0.31 115.808 -169.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.65 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 22.2 pttp -67.04 -25.28 66.19 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 108.009 -1.108 . . . . 1.35 108.009 169.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.5 m -48.85 -30.25 5.58 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 114.203 -1.362 . . . . 1.28 111.27 172.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -96.26 -36.64 10.84 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.592 0.234 . . . . 1.11 111.547 174.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 149.83 -5.49 0.7 Allowed Glycine 0 C--O 1.237 0.319 0 N-CA-C 111.17 -0.772 . . . . 0.18 111.17 -176.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.785 ' HE2' ' HB3' ' A' ' 60' ' ' LEU . 21.6 t80 -69.59 141.53 53.73 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 115.368 -0.416 . . . . 0.18 111.089 -177.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.877 ' HA ' ' CD1' ' A' ' 61' ' ' TYR . 5.5 t -133.46 146.37 51.09 Favored 'General case' 0 N--CA 1.421 -1.898 0 N-CA-C 108.826 -0.805 . . . . 0.2 108.826 173.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 1.089 HG11 ' HB1' ' A' ' 57' ' ' ALA . 25.1 t -100.7 103.3 14.63 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.376 0 N-CA-C 107.485 -1.302 . . . . 0.17 107.485 157.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.816 ' HB2' HG23 ' A' ' 40' ' ' ILE . 35.8 mt -83.94 120.7 26.41 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.626 -1.25 . . . . 1.04 107.626 178.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.725 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -95.08 115.76 27.84 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.229 0.538 . . . . 0.51 109.601 178.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.827 ' HZ ' HG13 ' A' ' 20' ' ' VAL . 11.5 m-85 -113.96 97.28 44.45 Favored Pre-proline 0 C--N 1.308 -1.218 0 N-CA-C 108.517 -0.92 . . . . 0.44 108.517 -178.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.723 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 2.0 Cg_endo -67.66 142.36 58.17 Favored 'Trans proline' 0 N--CA 1.438 -1.773 0 C-N-CA 121.175 1.25 . . . . 1.3 110.748 -175.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.474 ' CB ' HG23 ' A' ' 110' ' ' VAL . 8.1 t . . . . . 0 C--N 1.297 -1.678 0 CA-C-O 121.807 0.813 . . . . 1.44 110.009 173.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.439 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . . . . . . 0 CA--C 1.518 -0.269 0 CA-C-O 120.732 0.301 . . . . 0.55 110.891 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -104.02 28.51 6.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.931 -0.577 . . . . 1.99 111.507 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.721 ' HE2' ' HB2' ' A' ' 73' ' ' ALA . 1.1 p90 -135.47 176.89 2.52 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 108.756 -0.831 . . . . 0.84 108.756 173.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.598 ' HD3' ' CE2' ' A' ' 61' ' ' TYR . 18.9 Cg_exo -71.28 97.1 0.75 Allowed 'Trans proline' 0 CA--C 1.518 -0.276 0 C-N-CA 123.067 2.511 . . . . 0.62 112.884 -179.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.725 HG13 ' HB3' ' A' ' 73' ' ' ALA . 4.2 mp -92.61 138.6 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 N-CA-C 108.475 -0.935 . . . . 1.34 108.475 174.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.627 ' HB3' ' O ' ' A' ' 21' ' ' LEU . 13.5 mmt -101.19 179.84 4.25 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.755 -0.657 . . . . 3.03 109.997 -177.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.777 ' O ' ' HG2' ' A' ' 107' ' ' LYS . . . -83.83 34.11 0.49 Allowed 'General case' 0 CA--C 1.5 -0.944 0 C-N-CA 120.65 -0.42 . . . . 1.46 111.89 -168.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.777 ' HG2' ' O ' ' A' ' 106' ' ' ALA . 8.9 ptpt 56.02 144.78 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 123.953 1.835 . . . . 1.76 111.979 -174.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.538 HD12 ' HB3' ' A' ' 116' ' ' HIS . 35.7 pt -139.75 170.69 14.99 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 CA-C-N 112.324 -2.216 . . . . 0.82 107.478 175.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -80.68 50.8 1.38 Allowed 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.684 -0.689 . . . . 1.73 110.747 -176.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.474 HG23 ' CB ' ' A' ' 76' ' ' SER . 0.0 OUTLIER -64.36 94.33 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 CA-C-O 122.021 0.915 . . . . 0.77 110.884 -175.434 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 . . . . . 0 C--N 1.316 -0.881 0 N-CA-C 105.787 -1.931 . . . . 1.9 105.787 176.912 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.65 ' CE1' ' H ' ' A' ' 118' ' ' LEU . 3.5 t-80 . . . . . 0 N--CA 1.429 -1.52 0 N-CA-C 105.18 -2.156 . . . . 0.42 105.18 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -28.67 -47.97 0.12 Allowed 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 124.125 3.217 . . . . 0.4 113.568 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.835 HD11 ' HB ' ' A' ' 15' ' ' ILE . 28.1 tp -62.46 -51.67 66.58 Favored 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 123.365 0.666 . . . . 0.39 111.875 177.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.804 ' OH ' HG22 ' A' ' 40' ' ' ILE . 32.6 m-85 -75.69 -32.65 60.21 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-N 116.458 -0.337 . . . . 3.04 111.856 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -57.84 -40.15 79.39 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 107.169 -1.419 . . . . 2.44 107.169 170.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.726 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 31.6 t80 -66.65 -31.67 72.5 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.194 -0.912 . . . . 0.56 110.549 175.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.7 ' HE2' HG21 ' A' ' 15' ' ' ILE . 45.9 mtt -74.99 -52.86 10.05 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.488 -0.778 . . . . 0.71 110.958 -171.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.425 ' HE2' ' HB2' ' A' ' 123' ' ' LYS . 0.5 OUTLIER -71.61 -25.97 62.39 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 121.057 -0.257 . . . . 1.46 111.403 176.563 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.522 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 19.4 ptmt -72.17 -31.18 65.7 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 119.665 -0.814 . . . . 1.99 109.725 179.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 39.0 m -90.78 -38.31 13.08 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.394 -0.821 . . . . 0.59 111.004 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.466 ' HE3' ' HA ' ' A' ' 126' ' ' LYS . 1.6 tpmt? . . . . . 0 C--N 1.32 -0.693 0 CA-C-N 115.686 -0.688 . . . . 1.85 110.576 -174.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.701 ' HB3' ' HG3' ' A' ' 156' ' ' PRO . 0.5 OUTLIER . . . . . 0 CA--C 1.511 -0.551 0 N-CA-C 109.905 -0.405 . . . . 1.97 109.905 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.517 ' CG ' ' H ' ' A' ' 139' ' ' PHE . 60.6 t30 -31.99 -152.14 0.0 OUTLIER 'General case' 0 C--O 1.2 -1.506 0 O-C-N 125.359 1.662 . . . . 2.04 111.979 158.099 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.699 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 2.1 m-85 -27.64 -28.29 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.264 0 N-CA-C 118.037 2.606 . . . . 1.93 118.037 -167.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.685 ' HA ' ' O ' ' A' ' 154' ' ' PHE . 7.7 m 12.29 102.3 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 120.105 1.32 . . . . 0.6 114.373 172.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.699 ' HB3' HD12 ' A' ' 39' ' ' LEU . 1.6 m -90.11 167.52 12.68 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.571 -1.195 . . . . 0.62 111.473 -170.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.452 ' HA ' ' O ' ' A' ' 152' ' ' GLU . 95.2 m-85 -129.95 125.79 36.28 Favored 'General case' 0 CA--C 1.49 -1.339 0 N-CA-C 106.404 -1.702 . . . . 0.57 106.404 163.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.693 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 4.9 tp -80.33 102.94 9.86 Favored 'General case' 0 N--CA 1.422 -1.851 0 C-N-CA 118.204 -1.398 . . . . 0.43 108.125 176.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.674 HG22 ' HA2' ' A' ' 148' ' ' GLY . 43.2 mm -90.84 137.26 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.738 0 CA-C-N 113.724 -1.58 . . . . 0.19 107.625 -176.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.607 ' OD1' HG12 ' A' ' 149' ' ' VAL . 0.0 OUTLIER -88.74 -175.62 4.96 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 119.527 -0.869 . . . . 0.98 111.675 -168.914 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.663 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 33.8 mtm180 -53.65 -37.15 62.85 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-O 120.976 0.417 . . . . 2.22 111.037 -178.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.402 ' C ' ' HE2' ' A' ' 16' ' ' PHE . 25.3 t70 -103.17 19.43 19.59 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.413 -0.958 . . . . 2.0 108.413 -175.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.729 ' HA3' ' CE2' ' A' ' 16' ' ' PHE . . . 71.86 35.08 61.92 Favored Glycine 0 N--CA 1.439 -1.13 0 CA-C-N 114.794 -1.094 . . . . 0.17 115.531 176.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.607 HG12 ' OD1' ' A' ' 145' ' ' ASP . 10.0 p -106.06 113.51 63.51 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 119.356 1.578 . . . . 1.12 111.398 172.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.672 ' HD3' HG23 ' A' ' 15' ' ' ILE . 2.5 Cg_endo -51.11 115.55 2.11 Favored 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 124.027 3.152 . . . . 0.41 111.799 172.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 26.2 t -108.27 -28.58 2.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.707 0.765 . . . . 1.45 109.098 -176.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.693 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 22.6 mm-40 -136.86 166.39 23.73 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.509 -1.223 . . . . 1.17 110.317 -176.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.489 ' HA ' ' O ' ' A' ' 141' ' ' SER . 1.5 ttm180 -143.78 140.7 30.05 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.826 -1.079 . . . . 2.16 109.17 165.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.685 ' O ' ' HA ' ' A' ' 140' ' ' THR . 97.3 m-85 -120.8 149.95 41.77 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.932 -0.766 . . . . 0.32 108.932 -171.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 62.9 m -78.51 160.04 73.33 Favored Pre-proline 0 C--N 1.317 -0.83 0 N-CA-C 108.549 -0.908 . . . . 1.11 108.549 175.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.701 ' HG3' ' HB3' ' A' ' 137' ' ' TRP . 32.0 Cg_endo -63.74 -22.14 69.65 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.028 1.819 . . . . 0.78 111.896 178.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -78.93 -7.1 88.57 Favored Glycine 0 N--CA 1.446 -0.7 0 CA-C-N 115.696 -0.683 . . . . 0.5 112.626 173.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -72.88 144.99 47.19 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 108.62 -0.881 . . . . 0.5 108.62 174.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 14.5 m -110.91 173.74 6.19 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 120.835 -0.346 . . . . 1.42 110.168 -172.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.706 HG22 ' HA ' ' A' ' 56' ' ' THR . 58.9 t -40.7 -55.93 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 114.93 -1.032 . . . . 0.28 111.384 177.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.427 ' HB2' ' HE2' ' A' ' 161' ' ' LYS . 12.9 tppt? -67.25 -29.87 69.61 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.217 -0.447 . . . . 3.46 111.299 -171.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.44 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 8.0 m-20 -68.88 -38.27 79.58 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 121.481 0.657 . . . . 1.4 109.545 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.599 ' HA ' ' CZ ' ' A' ' 154' ' ' PHE . 71.3 mt -77.82 -43.68 28.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 114.76 -1.109 . . . . 0.21 110.715 178.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.605 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 53.9 mt-10 -55.02 -43.3 73.55 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-N 116.523 -0.308 . . . . 0.67 111.5 -176.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.44 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 8.6 pt-20 -58.45 -23.01 56.46 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.716 0.294 . . . . 0.87 111.7 -176.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.658 ' HB3' HD22 ' A' ' 143' ' ' LEU . 45.9 mmtm -99.51 -25.94 14.27 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.591 0.71 . . . . 1.71 109.982 176.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.6 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 13.6 tp -79.06 -50.76 10.55 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.897 -1.047 . . . . 0.16 112.215 -177.038 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.452 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 73.6 mt -54.57 -44.6 99.2 Favored Pre-proline 0 CA--C 1.537 0.452 0 CA-C-N 115.511 -0.768 . . . . 0.26 112.637 -173.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.452 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 53.8 Cg_exo -54.54 -33.06 76.88 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.077 1.851 . . . . 0.41 112.762 173.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.722 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 78.5 mt -83.23 -40.64 19.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.652 -0.249 . . . . 0.71 111.288 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.736 HD23 ' HG2' ' A' ' 37' ' ' PRO . 87.0 mt -61.76 -60.42 3.69 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 121.996 0.903 . . . . 0.34 109.603 175.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.315 0 CA-C-N 113.406 -1.724 . . . . 1.12 112.526 -178.988 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.9 t . . . . . 0 N--CA 1.454 -0.247 0 CA-C-O 121.022 0.439 . . . . 1.58 110.246 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.455 ' HB3' ' O ' ' A' ' 147' ' ' ASP . 5.9 m -158.51 151.83 22.94 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 105.975 -1.861 . . . . 1.17 105.975 -177.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.953 ' HB ' HD11 ' A' ' 118' ' ' LEU . 5.8 pt -61.75 -16.04 14.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 CA-C-N 114.32 -1.309 . . . . 0.38 111.823 -174.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.782 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 46.9 m-85 -73.79 5.9 3.68 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 113.028 0.751 . . . . 0.3 113.028 -174.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -79.81 -17.82 52.41 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 107.694 -1.224 . . . . 2.11 107.694 175.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.749 ' HE2' ' HB2' ' A' ' 121' ' ' TYR . 51.5 m-85 -112.07 115.29 28.65 Favored 'General case' 0 N--CA 1.434 -1.257 0 CA-C-N 114.078 -1.419 . . . . 0.31 111.432 -171.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -50.66 142.02 11.79 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 113.752 -1.567 . . . . 2.86 110.752 174.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.73 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 37.9 t -112.34 158.53 12.72 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 107.981 -1.118 . . . . 0.67 107.981 176.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.739 HD23 ' HA ' ' A' ' 27' ' ' PRO . 60.4 mt -126.66 135.0 50.59 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 120.454 -0.499 . . . . 0.69 111.347 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.502 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 15.8 t70 -63.88 159.36 19.88 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 106.193 -1.78 . . . . 1.87 106.193 164.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.761 ' HA ' ' CA ' ' A' ' 106' ' ' ALA . . . -57.35 -3.92 0.19 Allowed 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.973 1.101 . . . . 0.59 113.973 -166.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.482 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 23.3 t70 -100.16 0.01 39.7 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 111.454 0.168 . . . . 2.34 111.454 177.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.632 ' CD2' ' HB1' ' A' ' 106' ' ' ALA . 78.8 m-70 80.57 20.1 0.5 Allowed 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 121.811 0.815 . . . . 1.47 109.427 177.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.484 ' HA ' ' HD3' ' A' ' 26' ' ' LYS . 12.0 mmtp -96.13 123.42 55.21 Favored Pre-proline 0 N--CA 1.441 -0.904 0 CA-C-N 114.499 -1.228 . . . . 4.25 108.543 173.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.739 ' HA ' HD23 ' A' ' 21' ' ' LEU . 95.9 Cg_exo -49.18 114.14 1.18 Allowed 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 122.924 2.416 . . . . 0.54 114.165 -167.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.628 ' HB3' HG12 ' A' ' 20' ' ' VAL . 2.1 t80 -83.86 136.67 34.02 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 113.109 -1.86 . . . . 1.2 110.019 169.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.522 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 0.3 OUTLIER -81.89 83.16 7.29 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.499 0.666 . . . . 1.51 110.806 179.366 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.655 ' HG ' ' CD1' ' A' ' 16' ' ' PHE . 56.8 tp -50.4 -37.73 39.16 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.432 0.634 . . . . 0.28 110.383 178.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.62 HG13 ' HB3' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -69.43 -0.35 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 114.551 -1.204 . . . . 1.02 113.129 -172.502 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.522 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 3.6 pt20 -71.42 -20.25 62.14 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.731 -0.84 . . . . 1.02 108.731 172.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.966 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 93.4 m-70 -91.83 24.8 3.01 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 115.205 -0.907 . . . . 0.28 110.07 177.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.782 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 38.1 mtmt -86.04 109.33 18.73 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 114.587 -1.188 . . . . 1.56 109.2 170.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 133.65 -43.13 1.3 Allowed Glycine 0 N--CA 1.438 -1.17 0 C-N-CA 120.861 -0.685 . . . . 0.2 111.741 -177.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.457 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 69.3 m -127.15 136.77 29.37 Favored Pre-proline 0 N--CA 1.434 -1.229 0 N-CA-C 108.637 -0.875 . . . . 0.29 108.637 172.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.804 ' HG3' ' CB ' ' A' ' 170' ' ' LEU . 3.3 Cg_endo -42.49 153.32 0.15 Allowed 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 123.985 3.123 . . . . 0.18 112.763 175.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.841 ' HB2' HG22 ' A' ' 70' ' ' THR . 0.6 OUTLIER -140.48 141.87 35.36 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.123 -1.436 . . . . 0.31 107.123 179.964 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 1.016 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 1.2 mm? -107.53 112.77 25.69 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.284 -1.006 . . . . 1.19 108.284 177.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.095 HG22 ' OH ' ' A' ' 119' ' ' TYR . 2.3 mt -100.71 124.06 54.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 120.082 -0.647 . . . . 0.37 110.183 179.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 1.016 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.6 OUTLIER -110.2 124.81 52.26 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.145 -0.934 . . . . 0.42 110.715 -171.83 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.562 ' OD1' ' HB ' ' A' ' 140' ' ' THR . 8.2 p-10 -80.96 96.7 7.17 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.624 -1.251 . . . . 2.35 107.624 169.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.9 ' HA ' ' HA ' ' A' ' 139' ' ' PHE . 10.7 p . . . . . 0 C--N 1.306 -1.318 0 O-C-N 121.179 -0.951 . . . . 1.03 111.802 -165.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.736 0 N-CA-C 111.512 -0.635 . . . . 0.51 111.512 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.684 ' HA2' ' HB ' ' A' ' 56' ' ' THR . . . -63.94 -16.07 59.03 Favored Glycine 0 C--O 1.22 -0.753 0 CA-C-O 119.594 -0.559 . . . . 0.5 114.327 -177.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -73.23 -56.87 4.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 118.34 1.07 . . . . 0.7 109.351 177.009 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -60.34 -26.37 66.53 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-O 121.838 0.828 . . . . 2.61 109.572 175.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.684 ' HB ' ' HA2' ' A' ' 53' ' ' GLY . 15.4 m -75.33 -54.65 6.72 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 114.28 -1.327 . . . . 0.33 109.441 -176.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 1.086 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -57.32 -43.39 83.26 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 114.709 -1.132 . . . . 0.22 110.644 176.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.558 ' HA ' ' HD2' ' A' ' 102' ' ' PHE . 74.2 m -58.76 -56.03 27.52 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.794 -0.639 . . . . 0.26 110.675 -179.046 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 61.8 m -68.82 -37.11 78.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.458 -0.792 . . . . 0.48 111.891 -175.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.786 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 17.1 mt -64.57 -46.93 80.66 Favored 'General case' 0 CA--C 1.502 -0.888 0 CA-C-O 121.265 0.555 . . . . 0.43 110.359 -176.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.877 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 8.1 t80 -58.08 -52.2 66.53 Favored 'General case' 0 C--O 1.202 -1.443 0 CA-C-N 114.856 -1.066 . . . . 0.31 110.64 178.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -70.19 -25.67 63.53 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 120.718 0.294 . . . . 1.21 110.81 -172.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.55 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 36.2 ttpt -84.84 -23.4 29.06 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.946 -0.761 . . . . 1.54 108.946 -177.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.636 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 43.1 m-85 -126.88 -4.25 6.4 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 116.084 1.883 . . . . 0.31 116.084 -171.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.737 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 12.8 ptmt -64.04 -27.29 69.01 Favored 'General case' 0 CA--C 1.496 -1.114 0 N-CA-C 108.052 -1.092 . . . . 1.35 108.052 171.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.0 t -48.61 -35.26 13.23 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 114.154 -1.384 . . . . 1.28 111.033 173.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -92.57 -33.15 14.55 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.079 0.4 . . . . 1.11 112.079 175.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.405 ' HA3' ' HB2' ' A' ' 36' ' ' SER . . . 147.9 -5.54 0.95 Allowed Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 111.711 -0.556 . . . . 0.18 111.711 -176.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.786 ' HE2' ' HB3' ' A' ' 60' ' ' LEU . 18.5 t80 -69.97 144.71 52.24 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-O 121.047 0.451 . . . . 0.18 111.447 -178.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.966 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 1.5 t -134.92 149.96 50.34 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 108.283 -1.006 . . . . 0.2 108.283 173.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 1.086 HG11 ' HB1' ' A' ' 57' ' ' ALA . 45.2 t -106.34 100.1 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.322 0 N-CA-C 108.001 -1.111 . . . . 0.17 108.001 157.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.852 ' HA ' ' HG2' ' A' ' 103' ' ' PRO . 4.9 mt -85.6 118.66 25.24 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.68 -1.23 . . . . 1.04 107.68 177.099 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 1.003 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -107.83 112.04 24.49 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 119.363 -0.935 . . . . 0.51 110.957 178.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.796 ' HD2' HD13 ' A' ' 108' ' ' ILE . 3.0 m-85 -93.35 99.59 3.44 Favored Pre-proline 0 C--N 1.311 -1.096 0 CA-C-N 114.445 -1.252 . . . . 0.44 108.425 176.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.807 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 92.2 Cg_endo -83.82 93.15 0.79 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.501 2.134 . . . . 1.3 113.286 -167.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.641 ' HA ' ' O ' ' A' ' 108' ' ' ILE . 44.0 m . . . . . 0 CA--C 1.499 -0.982 0 N-CA-C 115.08 1.511 . . . . 1.44 115.08 -172.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.539 ' HB1' ' CE2' ' A' ' 102' ' ' PHE . . . . . . . . 0 CA--C 1.506 -0.717 0 CA-C-O 120.727 0.298 . . . . 0.55 111.07 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -94.31 29.94 2.08 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.906 -0.588 . . . . 1.99 110.335 175.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.656 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 18.3 p90 -143.23 160.94 50.25 Favored Pre-proline 0 N--CA 1.442 -0.852 0 N-CA-C 108.161 -1.051 . . . . 0.84 108.161 175.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.852 ' HG2' ' HA ' ' A' ' 72' ' ' LEU . 36.0 Cg_endo -58.94 90.68 0.07 OUTLIER 'Trans proline' 0 N--CA 1.476 0.455 0 C-N-CA 123.982 3.121 . . . . 0.62 114.419 -172.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 1.003 HD12 ' HB3' ' A' ' 73' ' ' ALA . 2.8 mm -80.0 123.22 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 108.809 -0.811 . . . . 1.34 108.809 171.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.713 ' HG3' ' H ' ' A' ' 107' ' ' LYS . 0.8 OUTLIER -77.13 170.03 17.26 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.412 -1.267 . . . . 3.03 111.11 -177.568 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.761 ' CA ' ' HA ' ' A' ' 23' ' ' ALA . . . -69.33 11.42 0.24 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.688 -0.687 . . . . 1.46 112.377 178.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.797 ' HB2' ' O ' ' A' ' 75' ' ' PRO . 2.6 ptpp? 67.4 143.43 0.04 OUTLIER 'General case' 0 CA--C 1.495 -1.163 0 CA-C-O 123.363 1.554 . . . . 1.76 112.092 -175.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.914 HG13 HG22 ' A' ' 110' ' ' VAL . 36.1 pt -136.28 159.27 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.197 0 CA-C-N 111.81 -2.45 . . . . 0.82 106.557 175.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.35 64.27 0.58 Allowed 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 110.506 -0.183 . . . . 1.73 110.506 176.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.914 HG22 HG13 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -74.59 92.37 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.751 0 C-N-CA 119.644 -0.823 . . . . 0.77 109.928 -176.241 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.6 t30 . . . . . 0 N--CA 1.443 -0.796 0 CA-C-N 114.219 -1.355 . . . . 1.9 107.683 170.552 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.709 ' HB3' HD12 ' A' ' 108' ' ' ILE . 2.1 t-80 . . . . . 0 N--CA 1.438 -1.065 0 CA-C-O 118.709 -0.663 . . . . 0.42 109.356 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -26.43 -45.04 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 124.886 3.724 . . . . 0.4 114.049 179.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.953 HD11 ' HB ' ' A' ' 15' ' ' ILE . 48.0 tp -65.14 -51.0 63.86 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 122.894 0.478 . . . . 0.39 112.288 179.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 1.095 ' OH ' HG22 ' A' ' 40' ' ' ILE . 24.1 m-85 -80.57 -32.33 36.6 Favored 'General case' 0 CA--C 1.486 -1.512 0 CA-C-O 121.433 0.635 . . . . 3.04 109.752 -176.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.549 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 4.4 tm-20 -60.07 -37.06 78.78 Favored 'General case' 0 N--CA 1.426 -1.635 0 N-CA-C 106.186 -1.783 . . . . 2.44 106.186 172.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.749 ' HB2' ' HE2' ' A' ' 18' ' ' PHE . 79.2 t80 -68.56 -30.45 69.23 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.135 -0.939 . . . . 0.56 110.605 173.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.705 ' CE ' HD12 ' A' ' 40' ' ' ILE . 53.3 mtt -75.83 -55.34 5.73 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.09 -0.505 . . . . 0.71 111.815 -170.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.702 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -70.48 -23.65 62.72 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.194 -0.457 . . . . 1.46 110.78 177.495 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.62 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 10.4 ptmt -72.96 -27.04 61.59 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 119.701 -0.799 . . . . 1.99 109.429 172.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 89.2 m -71.66 -50.99 25.45 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 116.044 -0.526 . . . . 0.59 109.59 172.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.769 ' HG2' HH22 ' A' ' 153' ' ' ARG . 23.2 ttmm . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 115.95 -0.568 . . . . 1.85 110.05 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.647 ' HB3' ' HG3' ' A' ' 156' ' ' PRO . 7.0 m-90 . . . . . 0 N--CA 1.452 -0.352 0 N-CA-C 110.574 -0.158 . . . . 1.97 110.574 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.416 ' HB3' ' H ' ' A' ' 139' ' ' PHE . 94.6 m-20 -39.48 -158.57 0.0 OUTLIER 'General case' 0 C--O 1.207 -1.162 0 C-N-CA 124.795 1.238 . . . . 2.04 113.017 163.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.9 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 0.1 OUTLIER -33.39 -26.71 0.01 OUTLIER 'General case' 0 C--O 1.203 -1.384 0 N-CA-C 116.427 2.01 . . . . 1.93 116.427 -171.24 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.562 ' HB ' ' OD1' ' A' ' 42' ' ' ASN . 14.1 m 23.11 109.65 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 120.909 1.686 . . . . 0.6 114.601 165.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.85 ' O ' ' HA ' ' A' ' 153' ' ' ARG . 0.8 OUTLIER -107.08 138.29 43.54 Favored 'General case' 0 C--O 1.199 -1.583 0 CA-C-N 114.933 -1.031 . . . . 0.62 112.389 -161.867 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.534 ' O ' HD13 ' A' ' 39' ' ' LEU . 50.9 m-85 -103.52 127.51 50.91 Favored 'General case' 0 CA--C 1.488 -1.424 0 N-CA-C 107.666 -1.235 . . . . 0.57 107.666 175.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.794 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 7.5 tp -80.65 103.23 10.36 Favored 'General case' 0 N--CA 1.417 -2.099 0 C-N-CA 118.07 -1.452 . . . . 0.43 107.947 174.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.753 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 45.8 mm -94.82 139.17 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.782 0 CA-C-N 113.131 -1.85 . . . . 0.19 107.394 -179.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.29 -175.36 3.8 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 119.64 -0.824 . . . . 0.98 111.329 -169.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.598 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 47.5 mtm180 -52.51 -41.04 63.1 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 123.356 0.41 . . . . 2.22 111.036 -177.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.455 ' O ' ' HB3' ' A' ' 14' ' ' SER . 34.1 m-20 -98.86 22.63 9.88 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.471 -0.566 . . . . 2.0 109.471 -176.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.569 ' HA2' HG22 ' A' ' 144' ' ' ILE . . . 67.53 39.66 90.98 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 114.728 0.651 . . . . 0.17 114.728 177.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.423 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 93.4 t -100.84 127.94 31.03 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-N 118.278 1.039 . . . . 1.12 110.497 173.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.524 ' HA ' HD13 ' A' ' 144' ' ' ILE . 10.2 Cg_endo -77.3 110.0 2.91 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.692 2.262 . . . . 0.41 110.319 178.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.451 ' O ' ' HE3' ' A' ' 126' ' ' LYS . 17.2 t -107.87 -28.28 2.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 121.433 0.635 . . . . 1.45 109.546 -173.027 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.794 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 5.5 mm-40 -135.75 164.64 27.43 Favored 'General case' 0 CA--C 1.501 -0.933 0 CA-C-N 115.328 -0.851 . . . . 1.17 110.511 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.85 ' HA ' ' O ' ' A' ' 141' ' ' SER . 0.0 OUTLIER -149.42 139.19 21.82 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.805 -1.088 . . . . 2.16 110.31 157.813 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.557 ' CZ ' ' HA ' ' A' ' 163' ' ' ILE . 86.8 m-85 -113.95 152.77 30.37 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.242 -1.344 . . . . 0.32 109.141 -160.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 15.3 m -71.37 157.03 90.85 Favored Pre-proline 0 C--N 1.312 -1.058 0 N-CA-C 109.464 -0.569 . . . . 1.11 109.464 176.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.647 ' HG3' ' HB3' ' A' ' 137' ' ' TRP . 18.4 Cg_endo -60.87 -26.62 83.42 Favored 'Trans proline' 0 CA--C 1.517 -0.348 0 C-N-CA 122.197 1.931 . . . . 0.78 110.179 171.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -81.55 7.87 60.48 Favored Glycine 0 N--CA 1.441 -1.01 0 CA-C-N 114.036 -1.438 . . . . 0.5 113.124 174.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -88.07 146.41 25.46 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.563 -0.903 . . . . 0.5 108.563 171.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 87.5 p -110.86 176.86 4.86 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 120.813 -0.355 . . . . 1.42 110.772 -173.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.636 HG22 ' HA ' ' A' ' 56' ' ' THR . 61.1 t -44.49 -46.57 2.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.211 -0.904 . . . . 0.28 110.582 174.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -68.97 -37.44 78.79 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.664 -0.698 . . . . 3.46 111.052 -174.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -65.26 -41.02 94.67 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.566 0.698 . . . . 1.4 109.551 -177.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.63 HD13 ' OH ' ' A' ' 41' ' ' TYR . 73.7 mt -77.78 -45.66 27.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 114.637 -1.165 . . . . 0.21 111.472 -179.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.62 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 25.2 mt-10 -52.97 -41.37 64.49 Favored 'General case' 0 C--O 1.22 -0.495 0 N-CA-C 111.994 0.368 . . . . 0.67 111.994 -176.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -63.3 -19.58 64.72 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.46 -0.496 . . . . 0.87 111.889 -174.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.594 ' HB3' HD22 ' A' ' 143' ' ' LEU . 13.0 mmmm -103.03 -11.12 18.37 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.42 0.628 . . . . 1.71 110.018 174.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.62 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 13.9 tp -93.05 -53.78 4.0 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.99 -1.005 . . . . 0.16 112.168 -176.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.551 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 64.1 mt -53.28 -48.2 93.28 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.282 -0.872 . . . . 0.26 112.59 -172.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.551 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 72.5 Cg_exo -51.86 -30.26 37.94 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 122.252 1.968 . . . . 0.41 112.728 175.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.804 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 96.4 mt -84.42 -42.78 15.31 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.468 -0.333 . . . . 0.71 111.038 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.754 HD23 ' HG2' ' A' ' 37' ' ' PRO . 95.5 mt -60.93 -57.88 10.77 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-O 122.13 0.967 . . . . 0.34 109.692 176.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.464 0 CA-C-N 113.334 -1.757 . . . . 1.12 113.011 -178.299 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.665 0 N-CA-C 111.814 -0.514 . . . . 5.22 111.814 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 95.1 mmm -106.71 141.48 37.9 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.761 0.315 . . . . 4.85 110.848 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 88.7 110.34 1.13 Allowed Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.908 -0.663 . . . . 1.55 112.896 177.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.6 m -98.28 -32.92 11.3 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.071 -0.714 . . . . 1.58 109.071 175.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.9 m -150.65 170.57 18.86 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 105.161 -2.163 . . . . 1.17 105.161 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.87 ' HB ' HD11 ' A' ' 118' ' ' LEU . 6.8 pt -63.74 -19.59 24.64 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.102 0 CA-C-O 121.416 0.627 . . . . 0.38 110.521 178.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.734 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 37.3 m-85 -73.5 0.9 11.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.858 -0.61 . . . . 0.3 111.997 -175.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -80.19 -8.73 59.57 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 108.203 -1.036 . . . . 2.11 108.203 176.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.812 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 58.1 m-85 -121.79 117.29 26.21 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 114.537 -1.211 . . . . 0.31 111.427 -174.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -48.92 138.49 11.39 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 112.876 -1.965 . . . . 2.86 110.534 173.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.914 HG13 ' HZ ' ' A' ' 74' ' ' PHE . 98.9 t -112.76 163.4 9.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 108.146 -1.057 . . . . 0.67 108.146 175.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.737 ' O ' ' HB3' ' A' ' 105' ' ' MET . 19.9 mt -134.9 121.88 21.19 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.9 -0.407 . . . . 0.69 109.9 -175.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.856 ' HA ' ' HE2' ' A' ' 105' ' ' MET . 29.9 t70 -63.96 177.36 0.79 Allowed 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 108.372 -0.973 . . . . 1.87 108.372 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.631 ' HA ' ' C ' ' A' ' 105' ' ' MET . . . -59.55 -4.38 0.62 Allowed 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 114.314 1.228 . . . . 0.59 114.314 -163.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -119.33 14.8 12.98 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.765 0.654 . . . . 2.34 112.765 173.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.709 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 10.6 m170 73.13 24.22 2.52 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 122.184 0.992 . . . . 1.47 109.695 174.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.421 ' HE3' ' HB2' ' A' ' 26' ' ' LYS . 16.3 mtmt -85.55 127.81 61.64 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 113.814 -1.539 . . . . 4.25 106.929 166.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.598 ' HA ' HD23 ' A' ' 21' ' ' LEU . 93.3 Cg_exo -50.76 112.44 0.77 Allowed 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 121.359 1.373 . . . . 0.54 112.607 -174.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.521 ' HE2' ' CD2' ' A' ' 72' ' ' LEU . 24.2 t80 -81.47 142.61 32.77 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 113.481 -1.69 . . . . 1.2 112.1 178.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.544 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.8 t-20 -77.73 82.37 4.13 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.648 -1.16 . . . . 1.51 109.904 178.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.661 HD13 HG21 ' A' ' 20' ' ' VAL . 62.1 tp -63.72 -45.16 91.21 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.559 0.695 . . . . 0.28 110.822 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.685 HG13 ' HB3' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -66.13 1.69 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 114.759 -1.109 . . . . 1.02 113.596 -171.764 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.544 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 11.0 pt20 -74.37 -5.34 41.77 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.342 0.591 . . . . 1.02 110.175 172.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.866 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 70.8 m-70 -104.3 24.06 12.14 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.84 0.828 . . . . 0.28 109.428 174.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.734 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 19.7 mtmm -82.69 110.01 17.36 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 114.608 -1.178 . . . . 1.56 109.535 171.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.27 -36.49 2.38 Favored Glycine 0 N--CA 1.44 -1.085 0 C-N-CA 120.534 -0.841 . . . . 0.2 112.031 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.449 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 40.1 m -131.01 133.41 24.72 Favored Pre-proline 0 N--CA 1.435 -1.213 0 N-CA-C 108.3 -1.0 . . . . 0.29 108.3 173.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.757 ' HG2' HD23 ' A' ' 171' ' ' LEU . 3.1 Cg_endo -42.56 152.3 0.19 Allowed 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.824 3.016 . . . . 0.18 112.566 177.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.866 ' HB2' HG22 ' A' ' 70' ' ' THR . 0.5 OUTLIER -136.98 140.76 42.41 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 106.872 -1.529 . . . . 0.31 106.872 179.395 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.891 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 1.3 mm? -106.65 111.09 23.47 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.077 -1.083 . . . . 1.19 108.077 176.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.872 HG23 ' HB2' ' A' ' 72' ' ' LEU . 2.4 mt -94.87 122.9 46.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-N 115.856 -0.611 . . . . 0.37 109.485 176.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.891 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -110.88 128.01 55.64 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 116.068 -0.514 . . . . 0.42 109.919 -176.182 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.618 ' OD1' ' HB ' ' A' ' 140' ' ' THR . 2.3 p30 -82.27 94.85 7.41 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 107.938 -1.134 . . . . 2.35 107.938 167.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.777 ' O ' ' HA ' ' A' ' 75' ' ' PRO . 19.3 m -102.69 137.14 31.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 121.507 0.67 . . . . 1.03 110.615 -166.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.488 ' CB ' ' HE2' ' A' ' 46' ' ' LYS . . . -88.56 100.61 13.21 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.914 -0.585 . . . . 0.88 109.704 177.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.694 ' HA ' ' HB2' ' A' ' 98' ' ' PHE . 5.1 p -28.94 -81.79 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 O-C-N 125.162 1.539 . . . . 1.78 113.631 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.488 ' HE2' ' CB ' ' A' ' 44' ' ' ALA . 0.3 OUTLIER 56.31 -168.48 0.1 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.665 0.745 . . . . 5.84 112.51 -179.716 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 32.6 t -145.61 116.47 7.75 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.091 -0.959 . . . . 3.55 109.783 178.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.36 -25.99 3.6 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 121.017 -0.611 . . . . 2.91 113.2 177.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.411 ' HD2' ' HZ1' ' A' ' 46' ' ' LYS . 86.3 t80 -100.07 115.78 30.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.571 0.701 . . . . 4.63 111.717 -178.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.636 ' OG1' ' HB2' ' A' ' 54' ' ' TYR . 12.9 t -127.31 -169.62 2.07 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 107.511 -1.292 . . . . 1.93 107.511 171.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 55.5 tttt -148.89 63.87 1.05 Allowed 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.577 -0.449 . . . . 2.01 109.903 178.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.45 ' O ' ' HG3' ' A' ' 55' ' ' GLU . . . 76.63 -47.35 2.43 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 121.15 -0.548 . . . . 0.51 112.476 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.44 ' HA2' ' HB ' ' A' ' 56' ' ' THR . . . -53.88 -23.98 24.93 Favored Glycine 0 C--O 1.218 -0.889 0 CA-C-O 119.523 -0.599 . . . . 0.5 114.398 -175.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.636 ' HB2' ' OG1' ' A' ' 50' ' ' THR . 0.6 OUTLIER -67.74 -55.49 12.9 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 118.42 1.11 . . . . 0.7 110.642 -178.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.45 ' HG3' ' O ' ' A' ' 52' ' ' GLY . 2.7 pp20? -66.31 -31.24 71.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.521 0.677 . . . . 2.61 109.348 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.697 ' HA ' ' CG2' ' A' ' 160' ' ' VAL . 53.9 m -59.68 -60.15 4.31 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 114.597 -1.183 . . . . 0.33 110.691 175.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 1.024 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -61.27 -44.99 96.33 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.979 -1.01 . . . . 0.22 111.293 -177.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.618 ' HA ' ' HE1' ' A' ' 102' ' ' PHE . 95.9 m -55.25 -52.29 63.89 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.57 0.7 . . . . 0.26 110.344 -177.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.8 m -72.79 -36.07 67.52 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.916 -1.038 . . . . 0.48 111.309 -176.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.682 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 19.3 mt -65.87 -50.11 65.72 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 121.303 0.573 . . . . 0.43 110.374 -177.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.817 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 6.8 t80 -55.74 -53.54 55.31 Favored 'General case' 0 C--O 1.198 -1.613 0 CA-C-N 114.608 -1.178 . . . . 0.31 110.44 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.481 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 9.7 m-80 -73.11 -24.67 60.66 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 112.182 0.438 . . . . 1.21 112.182 -173.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.477 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 33.6 ttpt -82.46 -22.36 35.22 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.768 -0.827 . . . . 1.54 108.768 -178.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.77 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 37.8 m-85 -123.73 -5.73 8.05 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 114.767 1.395 . . . . 0.31 114.767 -172.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.69 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 11.1 ptmt -64.64 -25.74 68.09 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 107.931 -1.137 . . . . 1.35 107.931 170.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.2 m -48.01 -41.84 26.48 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 114.106 -1.406 . . . . 1.28 110.672 172.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.409 HE21 ' HD1' ' A' ' 64' ' ' TYR . 51.0 mt-30 -82.73 -37.93 23.99 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 111.747 0.277 . . . . 1.11 111.747 175.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 149.66 -8.55 0.86 Allowed Glycine 0 CA--C 1.519 0.332 0 N-CA-C 111.088 -0.805 . . . . 0.18 111.088 -176.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.77 ' HD2' ' HB2' ' A' ' 64' ' ' TYR . 18.5 t80 -63.53 144.92 56.59 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 115.024 -0.588 . . . . 0.18 111.24 -177.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.866 HG22 ' HB2' ' A' ' 38' ' ' LEU . 3.0 t -133.27 152.25 51.93 Favored 'General case' 0 N--CA 1.411 -2.396 0 N-CA-C 108.726 -0.842 . . . . 0.2 108.726 171.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 1.024 HG11 ' HB1' ' A' ' 57' ' ' ALA . 37.4 t -106.78 102.12 13.48 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.361 0 N-CA-C 107.645 -1.243 . . . . 0.17 107.645 158.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.872 ' HB2' HG23 ' A' ' 40' ' ' ILE . 88.5 mt -84.27 118.73 24.37 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 107.742 -1.207 . . . . 1.04 107.742 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.757 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -97.84 113.06 24.77 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 120.385 -0.526 . . . . 0.51 110.598 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.914 ' HZ ' HG13 ' A' ' 20' ' ' VAL . 34.5 m-85 -106.52 96.68 14.52 Favored Pre-proline 0 C--N 1.309 -1.171 0 N-CA-C 109.445 -0.576 . . . . 0.44 109.445 176.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.777 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 74.2 Cg_endo -80.43 75.08 5.24 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.481 2.787 . . . . 1.3 114.778 -166.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 108' ' ' ILE . 76.2 p -18.25 133.02 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 126.028 1.731 . . . . 1.44 115.234 -177.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.471 ' C ' ' HG3' ' A' ' 83' ' ' GLU . 0.8 OUTLIER -91.1 84.7 5.74 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 114.876 -1.056 . . . . 1.81 109.243 -179.152 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.736 ' HA ' ' HG3' ' A' ' 83' ' ' GLU . 67.3 mt-30 -52.31 -10.97 0.16 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 114.956 -1.02 . . . . 3.34 111.716 -178.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.666 ' HA ' ' HD3' ' A' ' 91' ' ' LYS . 67.9 m-85 -63.58 -20.52 65.72 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.747 -0.66 . . . . 2.68 110.215 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.61 ' HA3' HE22 ' A' ' 82' ' ' GLN . . . -68.66 -47.26 57.36 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.649 -0.705 . . . . 1.98 111.698 176.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 119.82 -35.57 3.78 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.674 -0.774 . . . . 1.49 112.764 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.712 ' HG3' ' HB2' ' A' ' 113' ' ' GLU . 0.8 OUTLIER -85.04 -5.29 59.35 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 111.935 0.346 . . . . 1.74 111.935 -175.28 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.736 ' HG3' ' HA ' ' A' ' 78' ' ' GLN . 5.1 mm-40 -59.45 150.71 63.81 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-O 121.852 0.834 . . . . 3.07 113.246 -161.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.685 ' HB2' ' N ' ' A' ' 137' ' ' TRP . 94.9 Cg_endo -71.0 -31.84 14.4 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 123.931 3.087 . . . . 1.75 111.783 -167.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -70.81 -46.15 47.59 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.879 -0.677 . . . . 2.2 111.935 178.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.738 HD22 ' HB2' ' A' ' 89' ' ' GLU . 64.2 t30 -177.63 -105.59 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 122.177 0.191 . . . . 4.2 110.499 176.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.677 ' HG3' ' H ' ' A' ' 88' ' ' GLU . 6.6 pt-20 176.37 -72.03 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.726 0.298 . . . . 3.02 111.039 -175.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.677 ' H ' ' HG3' ' A' ' 87' ' ' GLU . 61.5 mm-40 -82.8 -11.6 58.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.843 0.354 . . . . 3.92 111.377 -176.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.738 ' HB2' HD22 ' A' ' 86' ' ' ASN . 14.5 tt0 -56.4 -60.95 2.78 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.659 -0.7 . . . . 2.65 112.373 -169.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.583 HG12 ' HB2' ' A' ' 78' ' ' GLN . 31.1 pt -77.36 3.71 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 111.979 0.363 . . . . 2.15 111.979 -178.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.666 ' HD3' ' HA ' ' A' ' 79' ' ' PHE . 50.1 mtmt -100.9 -39.24 7.87 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.646 0.26 . . . . 2.79 110.368 178.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 88' ' ' GLU . 11.8 pt-20 -87.17 -38.49 16.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.486 -0.325 . . . . 3.29 110.489 178.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -91.32 161.36 15.06 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.017 0.437 . . . . 3.42 109.942 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.7 p -80.12 112.31 17.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.675 -0.693 . . . . 2.63 110.326 174.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.546 ' SG ' ' HA ' ' A' ' 90' ' ' ILE . 3.7 m -140.77 121.9 14.73 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 121.399 0.619 . . . . 2.83 110.428 178.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.5 p -69.4 163.38 25.35 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 114.732 -1.122 . . . . 2.98 108.813 169.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -66.18 50.74 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.455 -0.338 . . . . 2.72 111.689 177.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.727 ' CZ ' ' HE2' ' A' ' 102' ' ' PHE . 64.8 t80 65.0 -89.07 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.464 0.706 . . . . 2.12 110.503 -178.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 25.2 ttmm 65.39 140.46 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 123.763 0.825 . . . . 2.69 111.726 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.503 ' HB3' ' CD2' ' A' ' 102' ' ' PHE . . . -170.69 -151.34 0.08 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.614 -0.721 . . . . 0.55 111.082 -172.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.41 ' H ' ' HB1' ' A' ' 100' ' ' ALA . 36.3 mm-40 -96.99 22.96 7.72 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.488 -0.778 . . . . 1.99 111.332 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.727 ' HE2' ' CZ ' ' A' ' 98' ' ' PHE . 2.9 m-85 -111.61 -176.63 0.39 Allowed Pre-proline 0 CA--C 1.514 -0.41 0 CA-C-O 121.561 0.695 . . . . 0.84 110.764 -177.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.67 ' HD3' ' CE2' ' A' ' 61' ' ' TYR . 8.6 Cg_exo -81.51 78.26 3.63 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 123.93 3.086 . . . . 0.62 109.449 157.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.757 HG13 ' HB3' ' A' ' 73' ' ' ALA . 4.0 mp -84.32 127.83 39.46 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 N-CA-C 108.09 -1.078 . . . . 1.34 108.09 178.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.856 ' HE2' ' HA ' ' A' ' 22' ' ' ASP . 3.4 mmt -96.82 -175.52 3.3 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.565 -0.743 . . . . 3.03 110.404 -169.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.638 ' O ' ' HG2' ' A' ' 107' ' ' LYS . . . -84.98 32.93 0.53 Allowed 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 113.013 0.746 . . . . 1.46 113.013 -167.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.638 ' HG2' ' O ' ' A' ' 106' ' ' ALA . 15.2 ptpt 53.83 127.6 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 123.467 1.603 . . . . 1.76 112.654 -177.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.785 HG13 HG13 ' A' ' 110' ' ' VAL . 20.4 pt -128.59 160.66 38.74 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 CA-C-N 113.538 -1.665 . . . . 0.82 108.681 177.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.511 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 0.2 OUTLIER -71.54 52.31 0.2 Allowed 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.148 -0.933 . . . . 1.73 110.985 -178.338 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.785 HG13 HG13 ' A' ' 108' ' ' ILE . 0.7 OUTLIER -62.3 95.57 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-O 121.533 0.683 . . . . 0.77 109.379 179.611 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.602 ' ND2' ' H ' ' A' ' 112' ' ' GLY . 3.1 t30 177.6 -179.12 0.23 Allowed 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 114.683 -1.144 . . . . 1.9 108.389 -176.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.602 ' H ' ' ND2' ' A' ' 111' ' ' ASN . . . -73.82 12.6 4.83 Favored Glycine 0 N--CA 1.44 -1.037 0 N-CA-C 115.998 1.159 . . . . 1.47 115.998 -176.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.712 ' HB2' ' HG3' ' A' ' 82' ' ' GLN . 15.0 tt0 -107.57 -47.36 3.64 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 119.987 1.894 . . . . 2.81 113.084 178.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.404 ' HB3' ' HB3' ' A' ' 109' ' ' ASN . 18.2 t-20 -129.43 -32.9 1.93 Allowed 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.8 -0.36 . . . . 2.16 111.183 -178.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.511 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . 45.91 -109.53 0.21 Allowed 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.286 -0.87 . . . . 1.26 110.14 -172.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.587 ' CE1' ' H ' ' A' ' 118' ' ' LEU . 4.0 t-80 177.46 137.25 0.22 Allowed Pre-proline 0 N--CA 1.425 -1.69 0 N-CA-C 104.808 -2.293 . . . . 0.42 104.808 171.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -27.29 -45.75 0.07 OUTLIER 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 124.272 3.314 . . . . 0.4 113.913 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.87 HD11 ' HB ' ' A' ' 15' ' ' ILE . 24.0 tp -64.86 -50.81 65.15 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.608 0.763 . . . . 0.39 111.854 178.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.672 ' OH ' HG22 ' A' ' 40' ' ' ILE . 36.4 m-85 -75.9 -33.01 59.9 Favored 'General case' 0 CA--C 1.505 -0.788 0 O-C-N 122.203 -0.311 . . . . 3.04 111.509 178.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -56.51 -38.85 72.35 Favored 'General case' 0 CA--C 1.493 -1.239 0 N-CA-C 106.927 -1.509 . . . . 2.44 106.927 170.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.812 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 56.6 t80 -67.43 -32.18 72.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.224 -0.898 . . . . 0.56 110.661 175.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.766 ' HE3' ' HG ' ' A' ' 118' ' ' LEU . 0.6 OUTLIER -74.64 -54.5 7.31 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.248 -0.433 . . . . 0.71 110.142 -171.075 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.407 ' HE2' ' HB2' ' A' ' 123' ' ' LYS . 1.2 ptmm? -70.29 -24.57 63.06 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.191 -0.459 . . . . 1.46 111.396 176.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.512 ' HG3' ' O ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -74.43 -27.91 60.82 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 119.151 -1.02 . . . . 1.99 110.118 176.231 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 90.8 m -78.27 -43.04 29.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.887 -0.597 . . . . 0.59 110.265 175.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.438 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 41.0 tttm -148.74 104.88 3.44 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 108.884 -0.784 . . . . 1.85 108.884 178.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 126' ' ' LYS . 23.0 Cg_exo -64.84 -73.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.992 3.128 . . . . 1.69 114.332 -167.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.762 ' HA3' ' HB3' ' A' ' 133' ' ' LYS . . . -152.36 -176.62 25.18 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 119.628 -1.272 . . . . 2.59 113.005 -174.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.635 HD12 ' H ' ' A' ' 129' ' ' ILE . 4.2 mp -74.36 -19.73 17.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.454 -0.943 . . . . 3.58 108.454 178.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.508 ' HG ' ' H ' ' A' ' 131' ' ' ALA . 9.7 tp -77.56 -168.57 1.21 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.805 -1.089 . . . . 3.47 109.417 173.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.508 ' H ' ' HG ' ' A' ' 130' ' ' LEU . . . -60.75 -37.76 82.91 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.135 -1.061 . . . . 3.28 108.135 165.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.404 ' O ' ' HB3' ' A' ' 130' ' ' LEU . 0.6 OUTLIER -149.77 147.42 27.99 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 114.483 -1.235 . . . . 3.56 110.883 176.845 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.762 ' HB3' ' HA3' ' A' ' 128' ' ' GLY . 47.2 tptt -166.0 162.91 18.3 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.552 -1.277 . . . . 5.17 107.552 175.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -140.11 56.02 1.62 Allowed 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.415 -0.514 . . . . 1.59 111.707 -178.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.658 HG22 ' HB3' ' A' ' 84' ' ' PRO . 73.6 mt 67.74 120.38 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 O-C-N 123.92 0.762 . . . . 2.0 110.835 178.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 84' ' ' PRO . 2.7 tmtm? -160.61 33.16 0.16 Allowed 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.712 -0.617 . . . . 4.81 111.877 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.685 ' N ' ' HB2' ' A' ' 84' ' ' PRO . 12.6 m-90 -143.16 174.05 11.04 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.279 0.561 . . . . 1.97 110.983 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.481 ' HB3' ' H ' ' A' ' 139' ' ' PHE . 6.1 m-20 -43.06 -156.22 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.725 -1.125 . . . . 2.04 112.157 157.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.718 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 2.8 m-85 -28.74 -47.25 0.05 Allowed 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 116.337 1.977 . . . . 1.93 116.337 -168.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.618 ' HB ' ' OD1' ' A' ' 42' ' ' ASN . 9.7 m 36.12 91.8 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.386 0.994 . . . . 0.6 113.21 176.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.634 ' HB3' HD12 ' A' ' 39' ' ' LEU . 0.7 OUTLIER -83.41 163.26 20.67 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.464 -0.789 . . . . 0.62 110.685 -175.023 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.531 ' HA ' ' HA ' ' A' ' 153' ' ' ARG . 76.4 m-85 -129.77 122.26 28.47 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 105.52 -2.03 . . . . 0.57 105.52 168.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.832 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 7.3 tp -80.19 103.51 10.11 Favored 'General case' 0 N--CA 1.422 -1.865 0 C-N-CA 118.528 -1.269 . . . . 0.43 108.372 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.715 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 42.9 mm -90.23 139.54 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.734 0 CA-C-N 112.965 -1.925 . . . . 0.19 107.468 -179.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.546 ' HA ' HD13 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -93.92 -176.95 4.18 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 119.71 -0.796 . . . . 0.98 111.276 -169.197 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.639 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 35.3 mtm180 -51.94 -41.45 62.06 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.994 0.426 . . . . 2.22 111.18 -177.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -95.65 14.68 22.21 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 109.646 -0.501 . . . . 2.0 109.646 -175.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.489 ' HA2' HG22 ' A' ' 144' ' ' ILE . . . 78.38 30.83 48.44 Favored Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 121.223 -0.513 . . . . 0.17 113.915 179.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 49.5 t -103.85 115.3 63.63 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 118.224 1.012 . . . . 1.12 111.428 177.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.706 ' HD3' HG23 ' A' ' 15' ' ' ILE . 29.6 Cg_endo -66.58 117.93 5.13 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 123.44 2.76 . . . . 0.41 110.86 177.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 16.0 m -119.42 -9.83 11.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 120.704 0.287 . . . . 1.45 110.247 -176.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.832 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 18.3 mm-40 -145.13 166.57 25.02 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-N 115.749 -0.659 . . . . 1.17 110.659 175.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.54 HH11 ' HG2' ' A' ' 153' ' ' ARG . 0.0 OUTLIER -147.58 126.65 12.87 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.757 -1.11 . . . . 2.16 109.253 161.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.682 ' HZ ' ' HB2' ' A' ' 166' ' ' LYS . 91.1 m-85 -99.28 148.37 24.21 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.028 -0.987 . . . . 0.32 109.563 -174.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 16.1 m -88.19 149.4 44.99 Favored Pre-proline 0 C--N 1.311 -1.085 0 N-CA-C 109.234 -0.654 . . . . 1.11 109.234 -179.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.606 ' HG3' ' HB3' ' A' ' 137' ' ' TRP . 33.8 Cg_endo -64.29 96.02 0.22 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 121.841 1.694 . . . . 0.78 108.446 170.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 151.07 -17.3 0.92 Allowed Glycine 0 N--CA 1.433 -1.561 0 N-CA-C 109.019 -1.632 . . . . 0.5 109.019 -164.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.413 ' HB1' ' HB2' ' A' ' 162' ' ' ASP . . . -92.18 145.91 24.13 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.919 -1.141 . . . . 0.5 107.919 166.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.594 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 31.1 t -109.94 -178.23 3.47 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.895 -0.409 . . . . 1.42 109.895 -174.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.697 ' CG2' ' HA ' ' A' ' 56' ' ' THR . 57.8 t -41.44 -51.11 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.301 0 O-C-N 124.081 0.863 . . . . 0.28 110.732 178.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 7.6 tttm -60.62 -46.11 91.51 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.088 -0.96 . . . . 3.46 111.108 -174.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.413 ' HB2' ' HB1' ' A' ' 158' ' ' ALA . 42.0 m-20 -66.53 -30.64 71.0 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.912 -1.04 . . . . 1.4 110.333 -173.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.54 HD12 ' CG2' ' A' ' 56' ' ' THR . 60.1 mt -81.89 -45.23 20.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.674 -0.694 . . . . 0.21 111.25 177.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.609 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 52.3 mt-10 -53.96 -43.15 69.66 Favored 'General case' 0 C--O 1.215 -0.747 0 CA-C-O 120.907 0.384 . . . . 0.67 111.379 -177.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -59.15 -19.18 42.71 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 112.279 0.474 . . . . 0.87 112.279 -176.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.682 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 75.4 mmtt -103.17 -27.3 12.61 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.54 0.686 . . . . 1.71 109.948 173.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.609 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 13.7 tp -77.27 -50.86 11.94 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.95 -1.023 . . . . 0.16 112.409 -177.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.471 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 73.4 mt -54.33 -45.8 99.16 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 115.734 -0.666 . . . . 0.26 112.201 -174.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.471 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 82.2 Cg_exo -51.42 -29.48 31.26 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.343 2.029 . . . . 0.41 113.015 173.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.771 HD12 HD11 ' A' ' 143' ' ' LEU . 73.6 mt -88.81 -42.12 12.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.663 -0.244 . . . . 0.71 111.251 178.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.757 HD23 ' HG2' ' A' ' 37' ' ' PRO . 93.0 mt -60.37 -56.4 21.89 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-O 122.052 0.93 . . . . 0.34 109.649 175.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -64.52 -18.05 63.0 Favored Glycine 0 N--CA 1.436 -1.323 0 CA-C-N 113.385 -1.734 . . . . 1.12 112.106 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 21.8 t 63.09 73.86 0.44 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.37 0.605 . . . . 2.64 111.367 174.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -82.39 -21.18 35.94 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.659 -0.7 . . . . 4.35 110.127 174.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.429 ' HB3' HD12 ' A' ' 176' ' ' LEU . 4.6 mmp_? 66.53 -80.11 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.329 -0.85 . . . . 8.45 111.455 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.429 HD12 ' HB3' ' A' ' 175' ' ' ARG . 6.6 mp . . . . . 0 C--O 1.245 0.86 0 CA-C-O 118.661 -0.685 . . . . 7.69 109.283 178.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.642 ' N ' ' HG ' ' A' ' 13' ' ' SER . . . . . . . . 0 N--CA 1.482 1.704 0 N-CA-C 111.681 -0.567 . . . . 5.22 111.681 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 66.2 mtt -76.18 90.39 3.12 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.284 0.564 . . . . 4.85 110.006 178.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.06 43.91 1.98 Allowed Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.664 -0.698 . . . . 1.55 112.355 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.642 ' HG ' ' N ' ' A' ' 10' ' ' GLY . 3.4 p -111.11 15.28 21.68 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.348 0.594 . . . . 1.58 110.352 175.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 85.7 p 178.21 152.75 0.3 Allowed 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 105.708 -1.96 . . . . 1.17 105.708 -178.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.848 ' HB ' HD11 ' A' ' 118' ' ' LEU . 5.1 pt -64.63 -18.36 23.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-N 114.769 -1.105 . . . . 0.38 111.519 -176.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.85 ' HB3' HG13 ' A' ' 31' ' ' VAL . 36.5 m-85 -70.45 -7.75 45.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.946 -0.57 . . . . 0.3 111.871 -176.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -68.29 -17.43 64.27 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.385 -0.969 . . . . 2.11 108.385 175.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.697 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 55.9 m-85 -115.67 108.03 15.86 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 115.12 -0.945 . . . . 0.31 111.096 -176.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -45.8 144.01 1.89 Allowed 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 113.687 -1.597 . . . . 2.86 110.396 171.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.706 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 35.7 t -110.66 169.17 3.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 N-CA-C 107.485 -1.302 . . . . 0.67 107.485 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.851 ' HB2' ' HE1' ' A' ' 105' ' ' MET . 61.6 mt -132.12 123.22 26.69 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 118.538 0.608 . . . . 0.69 111.605 -177.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.516 ' N ' ' HB2' ' A' ' 28' ' ' TYR . 14.7 t70 -62.03 161.51 10.67 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.187 -1.412 . . . . 1.87 107.187 167.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.816 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . . . -52.88 -15.39 0.75 Allowed 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 114.793 1.405 . . . . 0.59 114.793 -165.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.56 ' HB2' ' HE2' ' A' ' 26' ' ' LYS . 38.2 m-20 -91.93 -2.33 56.84 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.417 0.525 . . . . 2.34 112.417 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.64 ' CD2' ' HB1' ' A' ' 106' ' ' ALA . 68.8 m-70 82.84 11.27 0.54 Allowed 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.59 0.71 . . . . 1.47 109.477 -177.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.56 ' HE2' ' HB2' ' A' ' 24' ' ' ASP . 17.5 mtmt -77.0 120.7 82.79 Favored Pre-proline 0 C--N 1.323 -0.575 0 N-CA-C 107.148 -1.427 . . . . 4.25 107.148 169.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.716 ' HA ' HD23 ' A' ' 21' ' ' LEU . 78.9 Cg_exo -49.42 114.32 1.27 Allowed 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 122.055 1.837 . . . . 0.54 113.062 -174.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.565 ' HB3' HG12 ' A' ' 20' ' ' VAL . 6.8 t80 -81.32 139.14 35.56 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 113.53 -1.668 . . . . 1.2 111.356 176.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.65 ' ND2' HG23 ' A' ' 31' ' ' VAL . 2.6 t-20 -72.35 90.66 1.29 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.691 -1.141 . . . . 1.51 109.847 176.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.769 ' HG ' ' CD1' ' A' ' 16' ' ' PHE . 29.4 tp -70.65 -41.36 72.22 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.081 0.467 . . . . 0.28 109.949 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.85 HG13 ' HB3' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -63.47 0.64 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 115.181 -0.918 . . . . 1.02 113.054 -174.873 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.553 ' HB3' ' OD1' ' A' ' 29' ' ' ASN . 3.6 pt20 -74.35 -7.18 51.99 Favored 'General case' 0 CA--C 1.509 -0.623 0 O-C-N 121.92 -0.488 . . . . 1.02 110.762 176.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.914 ' HB2' HD22 ' A' ' 38' ' ' LEU . 63.3 m-70 -104.98 30.16 5.76 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.697 0.761 . . . . 0.28 109.647 173.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.774 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 23.6 mtmt -86.23 110.39 19.58 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 114.81 -1.086 . . . . 1.56 109.599 172.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 128.48 -41.1 1.61 Allowed Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 111.204 -0.758 . . . . 0.2 111.204 -176.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.457 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 18.0 m -129.25 130.63 23.37 Favored Pre-proline 0 N--CA 1.436 -1.171 0 N-CA-C 109.139 -0.689 . . . . 0.29 109.139 171.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.802 ' HG2' HD23 ' A' ' 171' ' ' LEU . 5.4 Cg_endo -43.51 150.77 0.43 Allowed 'Trans proline' 0 CA--C 1.513 -0.528 0 C-N-CA 124.768 3.645 . . . . 0.18 113.522 178.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.914 HD22 ' HB2' ' A' ' 33' ' ' HIS . 1.2 pt? -130.13 149.0 52.03 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 107.491 -1.3 . . . . 0.31 107.491 174.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 1.005 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 1.5 mm? -111.35 112.46 24.23 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.329 -0.989 . . . . 1.19 108.329 174.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.868 HG23 ' HB2' ' A' ' 72' ' ' LEU . 4.2 mt -96.93 125.23 49.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 C-N-CA 119.98 -0.688 . . . . 0.37 110.369 177.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 1.005 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -109.98 123.03 48.92 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 116.245 -0.434 . . . . 0.42 109.967 -175.543 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.734 ' ND2' ' HB ' ' A' ' 135' ' ' ILE . 2.3 p-10 -81.21 94.07 6.61 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 107.696 -1.224 . . . . 2.35 107.696 170.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.859 ' O ' ' HA ' ' A' ' 75' ' ' PRO . 1.2 p -104.59 131.88 52.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 CA-C-N 115.262 -0.881 . . . . 1.03 111.626 -160.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -81.4 100.49 9.29 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 119.647 -0.821 . . . . 0.88 109.546 174.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 1.051 ' HA ' ' HB2' ' A' ' 98' ' ' PHE . 23.1 p -12.85 -76.12 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 O-C-N 125.595 1.81 . . . . 1.78 114.037 172.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? 65.72 173.46 0.22 Allowed 'General case' 0 C--O 1.237 0.412 0 CA-C-O 122.191 0.996 . . . . 5.84 113.055 176.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.746 ' HB2' ' HA ' ' A' ' 95' ' ' CYS . 49.1 t -149.66 114.67 5.4 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 114.434 -1.257 . . . . 3.55 108.66 170.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.66 -2.33 86.01 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 120.879 -0.677 . . . . 2.91 114.076 176.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -144.31 133.74 23.29 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 117.964 0.882 . . . . 4.63 112.385 -177.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.456 ' CB ' ' HB2' ' A' ' 54' ' ' TYR . 15.0 t -137.15 149.14 47.09 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.338 -0.986 . . . . 1.93 108.338 170.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.608 ' HB3' ' HB2' ' A' ' 156' ' ' PRO . 30.7 ttmt -93.88 46.45 1.18 Allowed 'General case' 0 C--O 1.223 -0.339 0 CA-C-N 118.507 0.594 . . . . 2.01 109.984 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.16 -35.41 3.81 Favored Glycine 0 CA--C 1.516 0.116 0 C-N-CA 120.934 -0.651 . . . . 0.51 112.307 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -41.57 -43.57 3.94 Favored Glycine 0 C--O 1.223 -0.547 0 O-C-N 124.013 0.478 . . . . 0.5 113.791 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.551 ' HA ' ' CZ ' ' A' ' 139' ' ' PHE . 0.1 OUTLIER -59.48 -60.12 4.36 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.739 0.269 . . . . 0.7 111.634 -174.852 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -60.86 -34.72 75.03 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.347 0.594 . . . . 2.61 109.632 -176.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.672 ' OG1' ' HA ' ' A' ' 159' ' ' SER . 72.1 m -62.63 -59.64 4.64 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.699 -1.137 . . . . 0.33 110.1 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 1.094 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -60.55 -49.28 78.18 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.042 -0.981 . . . . 0.22 111.424 -177.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.649 ' N ' ' HE1' ' A' ' 102' ' ' PHE . 37.6 m -55.15 -51.95 64.83 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.464 0.649 . . . . 0.26 110.479 -177.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.497 ' HA ' ' ND2' ' A' ' 62' ' ' ASN . 29.7 m -71.03 -31.8 68.38 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.264 -0.88 . . . . 0.48 111.442 -176.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.708 HD21 ' HG3' ' A' ' 164' ' ' GLU . 14.6 mt -71.91 -50.74 26.6 Favored 'General case' 0 CA--C 1.494 -1.186 0 CA-C-O 120.924 0.392 . . . . 0.43 110.6 -177.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.81 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 3.0 t80 -51.47 -60.34 3.24 Favored 'General case' 0 C--O 1.203 -1.374 0 CA-C-N 114.645 -1.161 . . . . 0.31 109.752 178.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 1.046 ' HA ' ' HG3' ' A' ' 65' ' ' LYS . 4.3 p30 -70.06 -24.55 63.26 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 121.11 -0.236 . . . . 1.21 111.006 -171.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.519 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 35.3 ttpt -76.48 -21.31 55.99 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.184 -1.043 . . . . 1.54 108.184 -177.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.783 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 65.4 m-85 -130.12 10.13 5.35 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 114.679 1.363 . . . . 0.31 114.679 -176.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 1.046 ' HG3' ' HA ' ' A' ' 62' ' ' ASN . 27.9 mtmt -54.11 -38.29 65.25 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 106.588 -1.634 . . . . 1.35 106.588 169.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -48.5 -42.17 32.19 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 111.697 -2.501 . . . . 1.28 112.908 -177.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.406 HE21 ' HD1' ' A' ' 64' ' ' TYR . 47.0 mt-30 -85.06 -36.3 21.3 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.671 -0.412 . . . . 1.11 111.751 177.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.456 ' HA3' ' HB2' ' A' ' 36' ' ' SER . . . 147.38 -5.73 1.03 Allowed Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 110.829 -0.909 . . . . 0.18 110.829 -176.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.783 ' HD2' ' HB2' ' A' ' 64' ' ' TYR . 17.1 t80 -66.9 139.25 57.72 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 114.951 -0.625 . . . . 0.18 110.973 -177.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.901 HG22 ' HB2' ' A' ' 38' ' ' LEU . 1.6 t -132.82 149.51 52.26 Favored 'General case' 0 N--CA 1.414 -2.238 0 N-CA-C 108.653 -0.869 . . . . 0.2 108.653 172.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 1.094 HG11 ' HB1' ' A' ' 57' ' ' ALA . 29.7 t -102.7 101.52 12.28 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.23 0 N-CA-C 108.058 -1.089 . . . . 0.17 108.058 160.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.868 ' HB2' HG23 ' A' ' 40' ' ' ILE . 66.1 mt -84.67 119.65 25.49 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 108.218 -1.03 . . . . 1.04 108.218 178.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.741 ' HB1' HG11 ' A' ' 43' ' ' VAL . . . -100.39 112.32 24.66 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 121.328 0.585 . . . . 0.51 111.632 -178.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.843 ' CG ' ' HG2' ' A' ' 105' ' ' MET . 2.9 m-85 -103.59 95.17 6.91 Favored Pre-proline 0 C--N 1.316 -0.872 0 N-CA-C 109.275 -0.639 . . . . 0.44 109.275 176.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.859 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 76.3 Cg_endo -83.5 95.75 0.78 Allowed 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.249 1.966 . . . . 1.3 113.84 -169.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.774 ' HB2' HG23 ' A' ' 110' ' ' VAL . 47.4 t -39.11 132.92 1.27 Allowed 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 121.865 0.84 . . . . 1.44 112.628 -176.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.603 ' HB2' ' HD2' ' A' ' 79' ' ' PHE . 21.3 p-10 -74.92 106.27 6.35 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-N 114.451 -1.25 . . . . 1.81 107.888 176.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 1.065 ' HA ' ' HG2' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -49.12 -9.69 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 113.95 -1.477 . . . . 3.34 112.088 173.886 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.603 ' HD2' ' HB2' ' A' ' 77' ' ' ASN . 72.7 m-85 -76.4 31.97 0.12 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 114.438 1.273 . . . . 2.68 114.438 -165.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.461 ' HA3' HE22 ' A' ' 82' ' ' GLN . . . -135.13 -77.55 0.09 OUTLIER Glycine 0 CA--C 1.518 0.228 0 C-N-CA 119.443 -1.36 . . . . 1.98 113.838 -179.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 142.95 16.3 0.28 Allowed Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.335 -0.706 . . . . 1.49 111.335 -171.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.726 ' HG3' ' HB3' ' A' ' 113' ' ' GLU . 4.1 pm0 -139.46 13.07 2.56 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 110.125 -0.324 . . . . 1.74 110.125 -173.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 1.065 ' HG2' ' HA ' ' A' ' 78' ' ' GLN . 2.9 mp0 -63.43 152.42 85.38 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.413 -0.812 . . . . 3.07 110.387 -173.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.574 ' HB2' ' N ' ' A' ' 137' ' ' TRP . 55.2 Cg_endo -84.48 128.37 4.04 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.317 2.678 . . . . 1.75 112.452 -175.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.408 ' CA ' ' HA ' ' A' ' 137' ' ' TRP . . . 97.99 -62.39 0.92 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.795 -0.717 . . . . 2.2 113.642 172.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -133.9 101.65 5.15 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.83 -0.433 . . . . 4.2 109.83 -177.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -86.62 32.29 0.66 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.94 -0.573 . . . . 3.02 111.459 -171.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.84 ' HA ' ' HD3' ' A' ' 91' ' ' LYS . 8.5 tp10 -166.84 -32.42 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 112.149 0.426 . . . . 3.92 112.149 178.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.532 ' O ' ' HB3' ' A' ' 93' ' ' PHE . 35.4 tt0 -56.2 -30.23 62.01 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.541 0.571 . . . . 2.65 112.541 -174.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.672 ' HA ' ' SG ' ' A' ' 95' ' ' CYS . 2.1 pt -99.18 4.32 10.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.211 0.529 . . . . 2.15 111.631 -178.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.84 ' HD3' ' HA ' ' A' ' 88' ' ' GLU . 11.4 mtpp -114.28 -50.81 2.79 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.878 -0.601 . . . . 2.79 110.205 -175.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 88' ' ' GLU . 15.8 pt-20 -72.98 -22.76 60.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.94 -0.573 . . . . 3.29 110.076 176.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.532 ' HB3' ' O ' ' A' ' 89' ' ' GLU . 34.0 t80 -118.08 145.7 44.66 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.605 -0.725 . . . . 3.42 110.117 -174.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 49.4 t -67.37 122.23 18.06 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.467 0 CA-C-O 121.273 0.559 . . . . 2.63 110.442 176.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.746 ' HA ' ' HB2' ' A' ' 47' ' ' CYS . 84.7 m -131.96 128.82 39.25 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 115.413 -0.812 . . . . 2.83 110.426 178.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.567 ' O ' ' HB2' ' A' ' 45' ' ' SER . 31.2 p -52.58 148.84 6.53 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 114.992 -1.003 . . . . 2.98 108.904 171.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -73.74 31.08 0.08 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.987 0.422 . . . . 2.72 110.972 -177.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 1.051 ' HB2' ' HA ' ' A' ' 45' ' ' SER . 55.6 t80 57.11 104.41 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.554 -1.203 . . . . 2.12 111.893 -175.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.433 ' HA ' ' CD1' ' A' ' 104' ' ' ILE . 33.7 ttpt -128.83 138.05 51.84 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.485 -0.561 . . . . 2.69 109.485 173.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.453 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . -160.59 -158.49 0.61 Allowed 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 121.124 0.488 . . . . 0.55 111.546 -168.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -99.76 21.28 12.7 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.47 -0.786 . . . . 1.99 111.925 -178.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.816 ' HE2' ' CZ ' ' A' ' 98' ' ' PHE . 0.4 OUTLIER -109.43 177.8 1.17 Allowed Pre-proline 0 CA--C 1.511 -0.528 0 CA-C-O 121.317 0.579 . . . . 0.84 110.131 177.037 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.693 ' HD3' ' CE2' ' A' ' 61' ' ' TYR . 6.6 Cg_exo -80.81 76.16 4.66 Favored 'Trans proline' 0 N--CA 1.445 -1.37 0 C-N-CA 123.94 3.093 . . . . 0.62 110.003 162.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.654 HG12 ' HB3' ' A' ' 73' ' ' ALA . 34.8 mt -74.55 138.01 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 107.288 -1.375 . . . . 1.34 107.288 176.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.851 ' HE1' ' HB2' ' A' ' 21' ' ' LEU . 1.1 ppp? -96.62 -171.62 2.31 Favored 'General case' 0 N--CA 1.434 -1.255 0 C-N-CA 120.229 -0.588 . . . . 3.03 112.093 -170.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.816 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . . . -64.97 -7.69 12.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.417 -0.81 . . . . 1.46 112.194 -178.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.838 ' HB2' ' O ' ' A' ' 75' ' ' PRO . 3.9 ptpp? 66.04 133.72 0.02 OUTLIER 'General case' 0 CA--C 1.498 -1.036 0 C-N-CA 125.29 1.436 . . . . 1.76 110.702 -168.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.745 HG13 ' HB2' ' A' ' 116' ' ' HIS . 0.2 OUTLIER -135.78 171.54 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.857 0 CA-C-N 113.554 -1.657 . . . . 0.82 107.468 170.176 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.662 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 4.9 m120 -64.83 64.18 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 114.946 -1.025 . . . . 1.73 112.916 178.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.774 HG23 ' HB2' ' A' ' 76' ' ' SER . 3.2 m -71.4 95.99 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 117.857 -1.537 . . . . 0.77 107.867 172.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.554 ' HB2' ' O ' ' A' ' 82' ' ' GLN . 25.3 p30 178.47 179.9 0.34 Allowed 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 113.601 -1.636 . . . . 1.9 108.065 -169.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -86.89 11.44 64.61 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 119.927 -1.13 . . . . 1.47 115.164 -170.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.726 ' HB3' ' HG3' ' A' ' 82' ' ' GLN . 3.3 pt-20 -104.52 -44.6 4.86 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 119.492 1.646 . . . . 2.81 112.438 -178.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.482 ' N ' ' HG3' ' A' ' 113' ' ' GLU . 0.8 OUTLIER -130.03 -36.34 1.55 Allowed 'General case' 0 CA--C 1.508 -0.667 0 O-C-N 121.792 -0.567 . . . . 2.16 110.5 -175.898 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.662 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . 52.46 -146.46 0.51 Allowed 'General case' 0 N--CA 1.444 -0.771 0 O-C-N 123.74 0.65 . . . . 1.26 109.251 -177.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.745 ' HB2' HG13 ' A' ' 108' ' ' ILE . 1.6 t-80 -160.5 139.38 7.73 Favored Pre-proline 0 N--CA 1.431 -1.412 0 N-CA-C 107.703 -1.221 . . . . 0.42 107.703 176.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -28.4 -49.92 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 124.683 3.589 . . . . 0.4 113.792 -178.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.848 HD11 ' HB ' ' A' ' 15' ' ' ILE . 48.0 tp -61.14 -51.6 68.4 Favored 'General case' 0 C--O 1.22 -0.468 0 C-N-CA 122.745 0.418 . . . . 0.39 111.787 178.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.688 ' HA ' ' HB2' ' A' ' 122' ' ' MET . 29.7 m-85 -76.53 -33.68 58.57 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 112.489 0.551 . . . . 3.04 112.489 -179.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.566 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 42.5 mt-10 -60.49 -34.92 74.76 Favored 'General case' 0 CA--C 1.491 -1.325 0 N-CA-C 107.121 -1.437 . . . . 2.44 107.121 171.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.697 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 45.0 t80 -69.48 -34.22 74.03 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 119.262 -0.975 . . . . 0.56 110.234 173.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.688 ' HB2' ' HA ' ' A' ' 119' ' ' TYR . 40.4 mtt -74.86 -52.23 11.87 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.89 -0.595 . . . . 0.71 112.057 -169.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.422 ' HB2' ' HE2' ' A' ' 123' ' ' LYS . 0.2 OUTLIER -69.56 -24.44 63.71 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 120.366 -0.534 . . . . 1.46 109.853 176.863 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.566 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 17.0 tttt -65.58 -38.15 88.7 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.248 -0.433 . . . . 1.99 110.309 170.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 36.2 m -65.43 -61.23 2.23 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.936 -0.574 . . . . 0.59 111.426 -176.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.495 ' HD2' ' O ' ' A' ' 151' ' ' VAL . 36.8 ttmt -140.64 127.74 12.12 Favored Pre-proline 0 C--N 1.33 -0.269 0 N-CA-C 109.957 -0.386 . . . . 1.85 109.957 177.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 126' ' ' LYS . 27.4 Cg_exo -64.06 1.64 1.45 Allowed 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 123.743 2.962 . . . . 1.69 114.085 -178.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 81.84 70.73 1.33 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 121.164 -0.541 . . . . 2.59 113.545 170.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 76.7 mt 73.31 -57.76 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 122.823 0.449 . . . . 3.58 111.241 177.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 38.6 tp -104.18 151.04 23.81 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.736 0.303 . . . . 3.47 110.242 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -78.58 60.89 2.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.936 0.398 . . . . 3.28 111.165 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.444 ' HB ' ' H ' ' A' ' 133' ' ' LYS . 5.2 m -98.26 -100.86 0.21 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.508 -0.314 . . . . 3.56 110.453 178.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.444 ' H ' ' HB ' ' A' ' 132' ' ' THR . 50.4 mttp -161.9 -87.98 0.03 OUTLIER 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.746 0.784 . . . . 5.17 110.916 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -103.45 164.65 11.52 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.978 -1.01 . . . . 1.59 112.366 -167.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.875 ' H ' HD13 ' A' ' 135' ' ' ILE . 0.1 OUTLIER -64.69 46.68 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-N 113.862 -1.517 . . . . 2.0 110.998 169.119 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.506 ' HA ' ' HB3' ' A' ' 84' ' ' PRO . 9.2 tmtt? -75.75 44.34 0.29 Allowed 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.382 0.611 . . . . 4.81 112.497 -167.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.574 ' N ' ' HB2' ' A' ' 84' ' ' PRO . 6.4 m-90 -136.46 174.29 10.77 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.509 -0.552 . . . . 1.97 109.509 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.494 ' N ' HD22 ' A' ' 138' ' ' ASN . 0.9 OUTLIER -45.26 -153.93 0.0 OUTLIER 'General case' 0 C--O 1.209 -1.029 0 C-N-CA 123.846 0.859 . . . . 2.04 111.163 162.342 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.649 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 2.0 m-85 -27.5 -48.89 0.04 OUTLIER 'General case' 0 C--O 1.21 -0.983 0 N-CA-C 115.239 1.57 . . . . 1.93 115.239 -169.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.703 ' HB ' ' ND2' ' A' ' 42' ' ' ASN . 8.6 m 39.17 108.46 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 122.746 1.26 . . . . 0.6 113.84 173.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.69 ' HB3' HD12 ' A' ' 39' ' ' LEU . 1.4 m -100.64 165.25 11.49 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 114.811 -1.086 . . . . 0.62 110.014 -170.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.624 ' HA ' ' HA ' ' A' ' 153' ' ' ARG . 28.4 m-85 -128.38 125.96 39.7 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 105.916 -1.883 . . . . 0.57 105.916 163.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.851 HD11 HD12 ' A' ' 170' ' ' LEU . 1.6 tp -81.17 104.11 11.43 Favored 'General case' 0 C--N 1.288 -2.103 0 C-N-CA 118.565 -1.254 . . . . 0.43 108.563 178.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.685 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 28.3 mm -92.65 136.89 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.992 0 CA-C-N 113.097 -1.865 . . . . 0.19 107.592 -178.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.576 ' HA ' HD13 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -90.85 -174.18 3.95 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 119.704 -0.798 . . . . 0.98 111.52 -170.793 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.724 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 41.0 mtt85 -55.81 -40.19 72.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.015 -0.539 . . . . 2.22 111.109 -177.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.5 18.01 16.33 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.668 0.747 . . . . 2.0 109.085 -177.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.647 ' HA3' ' CE2' ' A' ' 16' ' ' PHE . . . 73.6 32.69 59.19 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 114.805 -1.089 . . . . 0.17 114.853 177.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.402 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 58.3 t -93.93 126.49 48.98 Favored Pre-proline 0 C--N 1.314 -0.962 0 CA-C-N 118.235 1.018 . . . . 1.12 110.72 175.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.47 ' HA ' HD13 ' A' ' 144' ' ' ILE . 12.2 Cg_endo -78.22 105.13 1.94 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.898 2.399 . . . . 0.41 110.073 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.495 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 4.6 t -93.94 -72.21 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 106.603 -1.628 . . . . 1.45 106.603 -178.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.816 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 0.3 OUTLIER -88.96 164.69 15.0 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 114.4 -1.273 . . . . 1.17 111.18 -177.476 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.836 ' HD3' HG22 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -135.36 150.97 50.06 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 113.009 -1.905 . . . . 2.16 107.136 156.219 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.556 ' O ' ' HA ' ' A' ' 140' ' ' THR . 92.2 m-85 -125.46 145.44 50.08 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 108.442 -0.947 . . . . 0.32 108.442 -171.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.413 ' OG ' ' HD2' ' A' ' 156' ' ' PRO . 21.2 t -72.34 154.37 91.94 Favored Pre-proline 0 C--N 1.315 -0.918 0 N-CA-C 108.375 -0.972 . . . . 1.11 108.375 174.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.608 ' HB2' ' HB3' ' A' ' 51' ' ' LYS . 9.6 Cg_endo -51.45 -41.49 59.66 Favored 'Trans proline' 0 CA--C 1.519 -0.259 0 C-N-CA 122.185 1.923 . . . . 0.78 111.126 174.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -58.71 -19.35 42.42 Favored Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 114.645 -1.161 . . . . 0.5 113.725 176.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -70.62 136.41 49.13 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 109.005 -0.739 . . . . 0.5 109.005 177.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.672 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 19.8 m -108.46 -178.35 3.57 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 120.776 0.322 . . . . 1.42 110.705 -170.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.619 HG22 ' HA ' ' A' ' 56' ' ' THR . 46.7 t -44.8 -50.41 2.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 114.927 -1.033 . . . . 0.28 111.313 -178.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 26.0 tttm -64.75 -39.6 93.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.041 -0.527 . . . . 3.46 111.205 -176.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.512 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 32.7 m-20 -68.64 -39.54 80.69 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.52 -0.764 . . . . 1.4 109.632 -172.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.563 HD13 ' OH ' ' A' ' 41' ' ' TYR . 54.1 mt -75.1 -43.7 44.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 114.953 -1.021 . . . . 0.21 110.78 177.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.718 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 28.1 mt-10 -56.42 -39.9 73.82 Favored 'General case' 0 C--O 1.217 -0.624 0 N-CA-C 111.973 0.36 . . . . 0.67 111.973 -177.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.512 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 10.0 pt-20 -61.34 -23.91 66.08 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.673 -0.411 . . . . 0.87 111.249 -176.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.556 ' HB3' HD22 ' A' ' 143' ' ' LEU . 72.3 mmtt -99.08 -14.82 19.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.623 0.725 . . . . 1.71 109.759 175.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.718 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 12.8 tp -92.8 -51.91 4.86 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.059 -0.973 . . . . 0.16 112.385 -174.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.511 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 78.1 mt -53.03 -48.59 91.35 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.541 -0.754 . . . . 0.26 112.901 -171.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.511 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 74.2 Cg_exo -52.69 -33.9 61.66 Favored 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 121.974 1.783 . . . . 0.41 112.321 176.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.851 HD12 HD11 ' A' ' 143' ' ' LEU . 93.1 mt -77.18 -46.68 22.52 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 116.016 -0.538 . . . . 0.71 110.75 178.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.802 HD23 ' HG2' ' A' ' 37' ' ' PRO . 89.5 mt -58.33 -56.67 19.11 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 121.66 0.743 . . . . 0.34 110.37 177.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -49.31 -33.8 16.86 Favored Glycine 0 N--CA 1.437 -1.265 0 CA-C-N 113.688 -1.597 . . . . 1.12 112.819 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 33.7 m 58.01 48.11 13.75 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 112.234 0.457 . . . . 2.64 112.234 173.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -75.8 -36.31 59.77 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.361 -0.607 . . . . 4.35 109.361 172.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 53.9 mtm180 68.27 -65.46 0.26 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 114.559 -1.201 . . . . 8.45 112.291 174.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 92.3 mt . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.753 -0.641 . . . . 7.69 110.062 -179.817 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.579 0 N-CA-C 111.772 -0.531 . . . . 5.22 111.772 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 65.1 mtt -93.58 -28.32 16.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.203 0.525 . . . . 4.85 110.025 178.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -88.36 133.94 12.12 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.589 -0.732 . . . . 1.55 111.855 179.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.3 p -111.03 -24.45 10.34 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.467 0.651 . . . . 1.58 109.543 178.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.532 ' HB3' ' O ' ' A' ' 147' ' ' ASP . 1.4 m -153.53 169.22 23.74 Favored 'General case' 0 N--CA 1.427 -1.575 0 N-CA-C 105.107 -2.182 . . . . 1.17 105.107 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.864 HD12 HD21 ' A' ' 30' ' ' LEU . 5.0 pt -61.55 -21.82 26.42 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.16 0 CA-C-O 121.777 0.799 . . . . 0.38 109.566 172.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.95 ' HB3' HG12 ' A' ' 31' ' ' VAL . 25.0 m-85 -70.6 -7.4 43.85 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.848 1.055 . . . . 0.3 113.848 -172.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -77.85 -5.32 50.52 Favored 'General case' 0 CA--C 1.502 -0.865 0 N-CA-C 107.951 -1.129 . . . . 2.11 107.951 178.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.795 ' HE2' ' HB2' ' A' ' 121' ' ' TYR . 41.9 m-85 -120.06 112.02 18.61 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 114.313 -1.312 . . . . 0.31 110.204 -175.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.92 149.52 2.63 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 113.521 -1.672 . . . . 2.86 110.632 174.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.798 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 35.6 t -112.12 158.62 12.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 107.874 -1.158 . . . . 0.67 107.874 174.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.9 ' O ' ' HB3' ' A' ' 105' ' ' MET . 96.0 mt -126.88 109.04 11.55 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 119.183 -0.437 . . . . 0.69 110.87 -174.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 17.0 t70 -46.81 158.0 0.14 Allowed 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 107.972 -1.121 . . . . 1.87 107.972 170.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.631 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . . . -53.79 -10.32 0.29 Allowed 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 113.251 0.834 . . . . 0.59 113.251 -167.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.539 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 25.9 t0 -93.46 -6.16 47.57 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 122.943 0.497 . . . . 2.34 111.899 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.688 ' CD2' ' HB1' ' A' ' 106' ' ' ALA . 60.8 m-70 82.38 24.5 0.19 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.77 0.795 . . . . 1.47 109.206 -177.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.414 ' HA ' ' HD3' ' A' ' 26' ' ' LYS . 27.2 mmtt -106.74 125.69 32.1 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 114.307 -1.315 . . . . 4.25 108.362 176.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.619 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 73.0 Cg_exo -52.67 114.7 1.81 Allowed 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.329 2.019 . . . . 0.54 114.561 -167.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.737 ' HE2' HD23 ' A' ' 72' ' ' LEU . 6.9 t80 -81.76 128.06 33.6 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 113.391 -1.732 . . . . 1.2 109.285 165.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.462 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 0.4 OUTLIER -74.63 91.55 2.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 122.341 1.067 . . . . 1.51 110.976 -179.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.864 HD21 HD12 ' A' ' 15' ' ' ILE . 52.2 tp -58.0 -36.21 72.33 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.009 -0.996 . . . . 0.28 110.589 -178.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.95 HG12 ' HB3' ' A' ' 16' ' ' PHE . 3.6 m -66.75 -1.22 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 114.768 -1.105 . . . . 1.02 113.178 -172.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.462 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 18.3 pt20 -77.2 -15.28 59.56 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 119.406 -0.917 . . . . 1.02 109.542 175.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.989 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 95.9 m-70 -86.83 27.86 0.95 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.959 0.885 . . . . 0.28 109.6 174.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 45.7 mttm -80.7 124.32 28.93 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 114.275 -1.33 . . . . 1.56 109.747 172.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.96 -40.06 2.68 Favored Glycine 0 N--CA 1.438 -1.22 0 C-N-CA 120.671 -0.776 . . . . 0.2 112.045 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.497 ' HB2' ' HA3' ' A' ' 68' ' ' GLY . 16.7 m -124.28 126.52 25.51 Favored Pre-proline 0 N--CA 1.435 -1.221 0 N-CA-C 108.689 -0.856 . . . . 0.29 108.689 175.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.832 ' HG3' ' CB ' ' A' ' 170' ' ' LEU . 2.9 Cg_endo -42.67 157.34 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 124.271 3.314 . . . . 0.18 113.015 176.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.814 ' HB2' HG22 ' A' ' 70' ' ' THR . 0.8 OUTLIER -145.08 143.36 30.38 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 107.575 -1.269 . . . . 0.31 107.575 -177.386 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 1.051 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 1.9 mm? -108.08 114.03 27.63 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.014 -0.735 . . . . 1.19 109.014 178.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.68 HG23 HD13 ' A' ' 72' ' ' LEU . 1.2 mt -96.23 125.61 49.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 C-N-CA 120.422 -0.511 . . . . 0.37 110.087 177.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 1.051 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.6 OUTLIER -107.07 133.09 52.22 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 120.449 -0.501 . . . . 0.42 110.254 -176.684 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.647 HD22 ' N ' ' A' ' 42' ' ' ASN . 0.3 OUTLIER -92.38 91.91 7.88 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 105.526 -2.027 . . . . 2.35 105.526 174.396 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.765 HG11 ' HB1' ' A' ' 73' ' ' ALA . 2.8 p -107.91 131.82 57.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 112.813 0.672 . . . . 1.03 112.813 -160.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -81.06 100.91 9.25 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.579 -0.737 . . . . 0.88 109.285 169.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.766 ' HA ' ' HB3' ' A' ' 98' ' ' PHE . 4.3 p -22.02 100.52 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 O-C-N 125.197 1.56 . . . . 1.78 112.692 175.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -63.49 109.73 1.73 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.641 -1.163 . . . . 5.84 112.373 -171.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 26.2 p -118.93 114.92 23.32 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.054 -1.091 . . . . 3.55 108.054 165.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.85 -58.23 0.99 Allowed Glycine 0 CA--C 1.526 0.745 0 C-N-CA 120.902 -0.666 . . . . 2.91 113.557 -177.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -93.35 110.96 22.5 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.233 0.54 . . . . 4.63 112.315 -170.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.8 t -115.58 132.79 56.52 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.081 -1.081 . . . . 1.93 108.081 169.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.707 ' O ' ' HA2' ' A' ' 157' ' ' GLY . 28.3 mtpp -90.28 13.0 16.47 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 121.877 -0.515 . . . . 2.01 110.972 -178.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.561 ' O ' ' HG2' ' A' ' 55' ' ' GLU . . . 105.01 -29.2 12.1 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.675 -0.774 . . . . 0.51 111.397 -177.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -56.52 -24.91 48.57 Favored Glycine 0 C--O 1.222 -0.623 0 CA-C-O 119.792 -0.449 . . . . 0.5 113.326 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.603 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 0.4 OUTLIER -61.09 -60.94 2.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.509 0.654 . . . . 0.7 110.298 179.167 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.561 ' HG2' ' O ' ' A' ' 52' ' ' GLY . 11.9 pt-20 -63.28 -21.21 66.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.647 -0.706 . . . . 2.61 110.349 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.671 ' HA ' HG22 ' A' ' 160' ' ' VAL . 54.1 m -73.01 -59.93 2.47 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.065 -0.971 . . . . 0.33 109.617 178.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 1.097 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -60.66 -42.04 96.23 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.552 -1.204 . . . . 0.22 110.876 -178.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.557 ' HA ' ' CD1' ' A' ' 102' ' ' PHE . 85.7 m -57.18 -57.31 13.16 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.541 -0.754 . . . . 0.26 110.471 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 22.7 m -70.6 -33.26 70.85 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.474 -0.784 . . . . 0.48 111.694 -174.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.77 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 18.7 mt -65.07 -47.67 76.48 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-O 121.435 0.636 . . . . 0.43 110.321 -178.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.863 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 10.0 t80 -59.7 -49.73 76.58 Favored 'General case' 0 C--O 1.205 -1.262 0 CA-C-N 114.757 -1.11 . . . . 0.31 111.045 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -72.35 -24.34 61.27 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 120.658 0.266 . . . . 1.21 110.659 -173.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.641 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 35.3 ttpt -85.76 -25.13 26.57 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 109.338 -0.616 . . . . 1.54 109.338 -178.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.822 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 32.5 m-85 -124.07 -6.74 7.78 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 115.491 1.663 . . . . 0.31 115.491 -169.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.693 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 3.8 ptmt -64.96 -26.99 68.53 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 108.004 -1.11 . . . . 1.35 108.004 170.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.6 t -47.63 -34.02 7.45 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.022 -1.444 . . . . 1.28 110.526 173.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.425 ' OE1' ' HB3' ' A' ' 171' ' ' LEU . 47.7 mt-30 -90.43 -39.65 12.51 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.681 0.277 . . . . 1.11 111.218 174.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.497 ' HA3' ' HB2' ' A' ' 36' ' ' SER . . . 151.81 -3.53 0.42 Allowed Glycine 0 CA--C 1.52 0.386 0 N-CA-C 111.23 -0.748 . . . . 0.18 111.23 -177.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.822 ' HD2' ' HB2' ' A' ' 64' ' ' TYR . 20.7 t80 -70.31 140.64 52.31 Favored 'General case' 0 C--O 1.218 -0.595 0 C-N-CA 123.029 0.532 . . . . 0.18 111.544 -177.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.989 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 2.2 t -134.49 145.57 48.92 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 108.818 -0.808 . . . . 0.2 108.818 174.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 1.097 HG11 ' HB1' ' A' ' 57' ' ' ALA . 42.8 t -104.94 99.99 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.257 0 N-CA-C 108.359 -0.978 . . . . 0.17 108.359 160.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.774 HD12 ' H ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -96.51 120.97 37.79 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 118.842 -1.143 . . . . 1.04 108.044 174.422 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.765 ' HB1' HG11 ' A' ' 43' ' ' VAL . . . -108.16 128.69 54.92 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 116.214 -0.448 . . . . 0.51 110.0 179.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.907 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 2.6 m-30 -102.43 105.62 44.59 Favored Pre-proline 0 C--N 1.312 -1.056 0 N-CA-C 108.162 -1.051 . . . . 0.44 108.162 175.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.914 ' HG2' ' HB3' ' A' ' 107' ' ' LYS . 59.7 Cg_endo -74.8 68.04 5.64 Favored 'Trans proline' 0 N--CA 1.474 0.324 0 C-N-CA 123.545 2.83 . . . . 1.3 114.98 -168.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.402 ' HB3' ' CG2' ' A' ' 110' ' ' VAL . 85.3 p 2.47 132.22 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 126.978 2.111 . . . . 1.44 116.542 178.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.444 ' C ' ' H ' ' A' ' 79' ' ' PHE . 1.3 p30 -87.71 75.09 9.03 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 123.287 1.518 . . . . 1.81 107.056 178.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.776 ' HG3' HG13 ' A' ' 90' ' ' ILE . 11.4 mm100 -51.97 -13.83 0.34 Allowed 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 113.733 -1.576 . . . . 3.34 110.151 175.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.444 ' H ' ' C ' ' A' ' 77' ' ' ASN . 99.0 m-85 -71.26 -14.86 62.37 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.555 -1.202 . . . . 2.68 110.871 -179.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.98 -46.93 12.3 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 111.552 -0.619 . . . . 1.98 111.552 175.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 106.88 29.32 4.68 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.966 -0.635 . . . . 1.49 113.848 175.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.848 ' HG3' ' HG2' ' A' ' 113' ' ' GLU . 4.3 pm0 -132.23 -18.23 2.6 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 122.448 -0.442 . . . . 1.74 111.187 173.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.573 ' HB2' ' NE2' ' A' ' 78' ' ' GLN . 4.2 mm-40 -61.45 150.61 80.08 Favored Pre-proline 0 C--N 1.315 -0.907 0 CA-C-N 115.26 -0.882 . . . . 3.07 112.221 -163.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 110' ' ' VAL . 53.1 Cg_endo -71.55 134.49 24.39 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 123.784 2.989 . . . . 1.75 114.871 -161.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 77.11 -85.96 1.0 Allowed Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.021 -0.99 . . . . 2.2 113.186 173.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.627 ' HB3' ' CB ' ' A' ' 89' ' ' GLU . 18.1 m120 -85.62 52.3 2.42 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.892 0.377 . . . . 4.2 111.319 -171.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.613 ' HA ' ' NE2' ' A' ' 78' ' ' GLN . 34.4 tt0 -57.74 -50.37 73.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.983 -0.553 . . . . 3.02 111.165 -178.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.506 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 39.3 mm-40 -77.43 -27.08 52.11 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.163 -0.471 . . . . 3.92 111.757 -178.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.627 ' CB ' ' HB3' ' A' ' 86' ' ' ASN . 10.6 tp10 -54.11 -61.61 2.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.659 -0.7 . . . . 2.65 111.978 -171.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.776 HG13 ' HG3' ' A' ' 78' ' ' GLN . 22.7 mm -73.88 -11.6 14.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.737 -0.665 . . . . 2.15 112.034 -167.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.506 ' HE2' ' HA ' ' A' ' 88' ' ' GLU . 49.9 mtmt -85.36 -42.11 14.86 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.375 -0.375 . . . . 2.79 111.026 -179.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -100.44 -24.21 14.55 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 111.742 0.275 . . . . 3.29 111.742 -176.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -89.74 162.62 15.46 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.82 -0.352 . . . . 3.42 110.166 177.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.4 t -81.24 111.21 17.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.933 -0.576 . . . . 2.63 110.178 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.689 ' SG ' ' HA ' ' A' ' 90' ' ' ILE . 1.2 m -139.71 121.8 15.75 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 121.48 0.657 . . . . 2.83 111.326 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.9 p -84.7 160.54 20.31 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 107.461 -1.311 . . . . 2.98 107.461 163.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -61.94 106.7 0.74 Allowed 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 107.884 -1.154 . . . . 2.72 107.884 174.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.766 ' HB3' ' HA ' ' A' ' 45' ' ' SER . 0.0 OUTLIER -45.93 117.07 1.38 Allowed 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 115.121 -0.945 . . . . 2.12 110.548 -173.237 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.446 ' HA ' HD12 ' A' ' 104' ' ' ILE . 35.1 ttmt -108.98 146.58 33.65 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.749 -0.659 . . . . 2.69 109.637 178.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.566 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . -147.71 -165.58 2.29 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-O 121.048 0.451 . . . . 0.55 111.386 -172.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -91.6 26.52 2.3 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.435 -0.802 . . . . 1.99 110.437 176.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.577 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 25.9 p90 -146.76 155.76 48.29 Favored Pre-proline 0 N--CA 1.441 -0.886 0 N-CA-C 108.712 -0.847 . . . . 0.84 108.712 175.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.686 ' HG2' ' HA ' ' A' ' 72' ' ' LEU . 35.9 Cg_endo -60.25 88.97 0.08 OUTLIER 'Trans proline' 0 CA--C 1.513 -0.53 0 C-N-CA 124.638 3.559 . . . . 0.62 114.137 -171.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.66 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 18.3 mt -100.6 126.78 54.16 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.348 0 N-CA-C 107.631 -1.248 . . . . 1.34 107.631 174.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.907 ' HG3' ' CE1' ' A' ' 74' ' ' PHE . 13.4 mmt -103.02 -159.82 0.75 Allowed 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.211 -0.904 . . . . 3.03 113.176 -158.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.688 ' HB1' ' CD2' ' A' ' 25' ' ' HIS . . . -65.81 -3.58 5.23 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.074 -0.966 . . . . 1.46 112.65 -172.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.914 ' HB3' ' HG2' ' A' ' 75' ' ' PRO . 14.3 ptpt 58.47 129.06 0.01 OUTLIER 'General case' 0 CA--C 1.494 -1.201 0 CA-C-O 122.889 1.328 . . . . 1.76 110.38 -168.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.499 HD11 ' CE2' ' A' ' 119' ' ' TYR . 1.7 pp -138.1 167.92 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.657 0 CA-C-N 114.05 -1.432 . . . . 0.82 108.382 173.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.556 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 0.2 OUTLIER -46.27 110.67 0.29 Allowed 'General case' 0 C--N 1.296 -1.732 0 O-C-N 124.393 1.058 . . . . 1.73 110.006 171.584 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.502 ' CB ' ' HB3' ' A' ' 42' ' ' ASN . 5.5 m -117.77 91.45 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.135 0 N-CA-C 107.271 -1.381 . . . . 0.77 107.271 163.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.699 ' ND2' ' H ' ' A' ' 112' ' ' GLY . 3.9 t30 177.13 -178.13 0.17 Allowed 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.188 -1.369 . . . . 1.9 109.225 -174.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.699 ' H ' ' ND2' ' A' ' 111' ' ' ASN . . . -77.45 3.23 59.86 Favored Glycine 0 N--CA 1.43 -1.727 0 N-CA-C 118.24 2.056 . . . . 1.47 118.24 -163.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.848 ' HG2' ' HG3' ' A' ' 82' ' ' GLN . 7.8 pt-20 -105.78 -43.99 4.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 121.233 2.517 . . . . 2.81 113.315 -175.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -128.0 -32.78 2.27 Favored 'General case' 0 CA--C 1.5 -0.976 0 C-N-CA 119.979 -0.688 . . . . 2.16 109.16 177.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 1.097 ' HB3' ' HG2' ' A' ' 120' ' ' GLU . . . 42.81 -144.95 0.08 Allowed 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 114.409 -1.269 . . . . 1.26 108.931 -167.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.647 ' CE1' ' H ' ' A' ' 118' ' ' LEU . 2.7 t-80 -136.73 138.48 26.4 Favored Pre-proline 0 N--CA 1.424 -1.732 0 N-CA-C 106.5 -1.667 . . . . 0.42 106.5 169.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -26.82 -48.12 0.08 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 124.456 3.437 . . . . 0.4 113.537 178.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.827 ' HG ' ' HE3' ' A' ' 122' ' ' MET . 48.3 tp -60.15 -52.74 64.02 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.364 0.665 . . . . 0.39 112.288 177.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.736 ' HE2' ' CD2' ' A' ' 74' ' ' PHE . 70.2 m-85 -77.28 -35.12 55.45 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-N 116.663 -0.244 . . . . 3.04 111.511 -178.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 1.097 ' HG2' ' HB3' ' A' ' 115' ' ' ALA . 7.0 mm-40 -56.79 -36.1 69.49 Favored 'General case' 0 CA--C 1.491 -1.319 0 N-CA-C 107.803 -1.184 . . . . 2.44 107.803 170.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.795 ' HB2' ' HE2' ' A' ' 18' ' ' PHE . 60.8 t80 -69.86 -31.89 69.96 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 119.252 -0.979 . . . . 0.56 110.403 174.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.827 ' HE3' ' HG ' ' A' ' 118' ' ' LEU . 1.1 ttm -76.63 -55.06 5.85 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.551 -0.295 . . . . 0.71 111.244 -170.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.412 ' HE2' ' HB2' ' A' ' 123' ' ' LYS . 0.4 OUTLIER -69.29 -24.77 64.0 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.337 -0.392 . . . . 1.46 110.551 178.913 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.486 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 12.8 pttp -72.41 -28.64 63.11 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 119.384 -0.926 . . . . 1.99 109.696 175.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.447 ' HB ' ' HG2' ' A' ' 150' ' ' PRO . 97.4 m -76.57 -57.08 4.06 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.974 -0.557 . . . . 0.59 111.053 178.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.603 ' HG2' ' H ' ' A' ' 128' ' ' GLY . 71.6 tttt -143.08 128.54 10.08 Favored Pre-proline 0 N--CA 1.453 -0.319 0 CA-C-O 121.29 0.567 . . . . 1.85 112.005 -177.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.738 ' HA ' ' NH2' ' A' ' 153' ' ' ARG . 2.8 Cg_exo -76.87 10.63 2.24 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 123.237 2.625 . . . . 1.69 111.811 172.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.603 ' H ' ' HG2' ' A' ' 126' ' ' LYS . . . 84.37 -133.4 11.81 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.88 -0.676 . . . . 2.59 112.18 178.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 22.3 pt -92.18 -9.79 9.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 120.955 0.407 . . . . 3.58 110.983 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.401 ' HG ' ' OG1' ' A' ' 132' ' ' THR . 49.4 tp -132.27 113.76 13.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.884 -0.598 . . . . 3.47 109.741 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.71 ' HA ' ' HB2' ' A' ' 127' ' ' PRO . . . -76.6 69.32 3.0 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.975 -0.557 . . . . 3.28 111.389 -174.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.401 ' OG1' ' HG ' ' A' ' 130' ' ' LEU . 28.8 m -102.2 -74.28 0.63 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.707 -0.679 . . . . 3.56 111.284 179.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.421 ' HB3' ' H ' ' A' ' 134' ' ' ALA . 20.6 tptm -164.58 -98.96 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.98 0.419 . . . . 5.17 110.944 -178.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.549 ' HB1' HD13 ' A' ' 135' ' ' ILE . . . -100.62 177.22 5.07 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.342 -0.39 . . . . 1.59 110.646 -176.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.848 ' H ' HD13 ' A' ' 135' ' ' ILE . 0.1 OUTLIER -42.72 -42.46 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 O-C-N 123.95 0.781 . . . . 2.0 111.53 178.532 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.674 ' HB3' ' CE3' ' A' ' 137' ' ' TRP . 76.7 tttt 73.62 -9.22 1.23 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.939 0.895 . . . . 4.81 112.88 168.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.916 ' HB3' ' HG3' ' A' ' 156' ' ' PRO . 9.7 m-90 -133.64 175.2 9.65 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.961 0.41 . . . . 1.97 111.441 -175.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.464 ' OD1' ' HD1' ' A' ' 139' ' ' PHE . 5.2 t-20 -38.96 -153.13 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 125.727 1.611 . . . . 2.04 111.565 157.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.674 ' CD1' HG23 ' A' ' 43' ' ' VAL . 2.4 m-85 -25.59 -52.18 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 115.461 1.652 . . . . 1.93 115.461 -169.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.616 ' HA ' ' O ' ' A' ' 154' ' ' PHE . 1.9 m 32.67 106.0 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.422 1.268 . . . . 0.6 114.422 175.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.741 ' HB3' HD12 ' A' ' 39' ' ' LEU . 2.8 m -92.58 174.04 7.48 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 114.084 -1.416 . . . . 0.62 111.393 -169.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.557 ' CD1' ' HB2' ' A' ' 153' ' ' ARG . 57.6 m-85 -138.64 123.01 18.29 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 105.985 -1.858 . . . . 0.57 105.985 165.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.932 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 2.9 tp -79.64 104.06 9.97 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 118.345 -1.342 . . . . 0.43 108.48 -179.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.726 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 40.2 mm -91.57 140.45 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.96 0 CA-C-N 113.647 -1.615 . . . . 0.19 107.873 -178.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.438 ' HA ' HD13 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -94.64 -172.26 2.7 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 120.062 -0.655 . . . . 0.98 111.515 -169.588 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.782 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 17.1 mtm180 -55.8 -36.77 67.78 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 123.168 0.293 . . . . 2.22 111.28 -176.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.532 ' O ' ' HB3' ' A' ' 14' ' ' SER . 34.8 t70 -102.2 23.22 11.98 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.33 -0.618 . . . . 2.0 109.33 -178.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.679 ' HA2' HG22 ' A' ' 144' ' ' ILE . . . 67.12 38.69 92.43 Favored Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 120.863 -0.684 . . . . 0.17 114.305 177.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 42.7 t -104.7 128.37 26.99 Favored Pre-proline 0 C--N 1.313 -0.979 0 CA-C-N 118.187 0.993 . . . . 1.12 110.618 173.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.447 ' HG2' ' HB ' ' A' ' 125' ' ' THR . 1.3 Cg_endo -71.12 118.85 5.9 Favored 'Trans proline' 0 CA--C 1.531 0.335 0 C-N-CA 122.662 2.241 . . . . 0.41 110.814 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.428 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 14.2 t -119.71 -7.0 11.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.825 -0.435 . . . . 1.45 109.825 -175.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.932 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 6.0 mm-40 -155.14 168.13 28.06 Favored 'General case' 0 CA--C 1.5 -0.948 0 CA-C-O 121.52 0.676 . . . . 1.17 111.007 176.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.738 ' NH2' ' HA ' ' A' ' 127' ' ' PRO . 1.4 ttm180 -147.91 132.99 18.24 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 113.851 -1.522 . . . . 2.16 108.726 164.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.616 ' O ' ' HA ' ' A' ' 140' ' ' THR . 96.7 m-85 -114.27 146.72 40.08 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.678 -0.692 . . . . 0.32 109.338 -168.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 15.8 m -65.1 150.14 95.85 Favored Pre-proline 0 C--N 1.313 -1.014 0 N-CA-C 109.001 -0.74 . . . . 1.11 109.001 175.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.916 ' HG3' ' HB3' ' A' ' 137' ' ' TRP . 38.5 Cg_endo -66.39 -16.31 50.91 Favored 'Trans proline' 0 CA--C 1.514 -0.519 0 C-N-CA 122.57 2.18 . . . . 0.78 110.974 177.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.707 ' HA2' ' O ' ' A' ' 51' ' ' LYS . . . -88.31 2.07 84.83 Favored Glycine 0 N--CA 1.439 -1.158 0 CA-C-N 114.473 -1.239 . . . . 0.5 112.72 173.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -76.46 153.07 35.9 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.272 -0.64 . . . . 0.5 109.272 173.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.584 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 24.4 m -112.31 169.64 8.73 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 116.3 -0.409 . . . . 1.42 110.245 -175.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.671 HG22 ' HA ' ' A' ' 56' ' ' THR . 88.7 t -40.9 -52.53 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 O-C-N 124.363 1.039 . . . . 0.28 111.788 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 52.3 tttm -66.4 -32.99 74.71 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.031 -0.531 . . . . 3.46 111.166 -173.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -69.99 -31.45 69.15 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.859 -0.61 . . . . 1.4 109.847 -176.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.564 HD12 ' CG2' ' A' ' 56' ' ' THR . 70.1 mt -83.89 -43.24 17.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 115.184 -0.916 . . . . 0.21 110.954 176.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.582 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 35.0 mt-10 -53.05 -42.94 66.25 Favored 'General case' 0 C--O 1.216 -0.668 0 N-CA-C 111.723 0.268 . . . . 0.67 111.723 -177.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -54.88 -29.01 54.64 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 112.254 0.464 . . . . 0.87 112.254 -177.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.789 ' HB3' HD22 ' A' ' 143' ' ' LEU . 35.8 mmtm -94.68 -20.84 19.2 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.651 0.739 . . . . 1.71 110.103 177.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.582 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 14.1 tp -86.46 -49.34 7.67 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.617 -1.174 . . . . 0.16 112.413 -174.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.517 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 78.0 mt -55.66 -47.47 98.61 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.385 -0.825 . . . . 0.26 112.557 -172.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.517 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 76.5 Cg_exo -53.54 -28.53 45.81 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 122.356 2.037 . . . . 0.41 112.756 174.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.832 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 80.1 mt -86.23 -47.1 9.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.357 -0.383 . . . . 0.71 111.14 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.78 HD23 ' HG2' ' A' ' 37' ' ' PRO . 84.9 mt -57.45 -57.86 10.82 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-O 122.113 0.959 . . . . 0.34 109.781 176.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -66.15 -21.08 69.71 Favored Glycine 0 N--CA 1.435 -1.393 0 CA-C-N 113.36 -1.745 . . . . 1.12 112.214 -178.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 40.9 m 62.97 68.53 0.63 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.457 0.646 . . . . 2.64 110.604 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -76.35 -6.66 52.57 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.333 -0.848 . . . . 4.35 110.442 177.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 29.7 ttp180 -143.0 122.51 13.2 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.392 -0.822 . . . . 8.45 109.0 176.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.5 mm? . . . . . 0 C--O 1.246 0.916 0 CA-C-O 118.312 -0.851 . . . . 7.69 109.806 179.619 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.879 0 N-CA-C 112.483 -0.247 . . . . 5.22 112.483 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -134.16 177.7 7.54 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.082 -0.34 . . . . 4.85 110.082 178.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.67 88.56 1.83 Allowed Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.887 -0.673 . . . . 1.55 112.153 -178.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.8 p -121.67 14.32 10.94 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.307 0.575 . . . . 1.58 110.086 177.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 79.7 p 177.12 153.7 0.23 Allowed 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 105.842 -1.911 . . . . 1.17 105.842 -178.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.847 ' HB ' ' CD1' ' A' ' 118' ' ' LEU . 5.8 pt -69.26 -12.39 15.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 CA-C-N 115.063 -0.972 . . . . 0.38 112.133 -170.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.659 ' CD1' ' HA ' ' A' ' 31' ' ' VAL . 48.0 m-85 -74.83 -8.2 55.74 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 120.752 0.31 . . . . 0.3 111.184 -178.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -63.24 -21.13 66.03 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 108.91 -0.774 . . . . 2.11 108.91 170.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.835 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 60.8 m-85 -117.63 105.35 11.95 Favored 'General case' 0 CA--C 1.49 -1.341 0 CA-C-N 114.614 -1.175 . . . . 0.31 110.253 176.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -58.25 158.95 6.51 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 114.88 -1.054 . . . . 2.86 108.165 172.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.739 HG13 ' HZ ' ' A' ' 74' ' ' PHE . 20.3 t -108.33 169.28 3.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 107.393 -1.336 . . . . 0.67 107.393 -175.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.794 ' O ' ' HB2' ' A' ' 105' ' ' MET . 33.0 mt -127.21 141.52 51.71 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 109.534 -0.543 . . . . 0.69 109.534 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -71.21 -173.55 0.87 Allowed 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.24 -1.022 . . . . 1.87 108.24 174.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.75 ' HA ' ' CA ' ' A' ' 106' ' ' ALA . . . -66.93 -3.05 6.08 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 112.494 0.553 . . . . 0.59 112.494 -176.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 29.1 t70 -102.84 -3.25 26.55 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.803 -0.359 . . . . 2.34 110.832 176.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.656 ' CD2' ' HB3' ' A' ' 106' ' ' ALA . 1.9 m170 75.72 20.94 1.75 Allowed 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.741 0.781 . . . . 1.47 109.417 -178.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.477 ' HA ' ' HD3' ' A' ' 26' ' ' LYS . 45.9 mmtt -102.15 135.46 19.64 Favored Pre-proline 0 N--CA 1.443 -0.804 0 CA-C-N 114.397 -1.274 . . . . 4.25 108.45 171.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.64 ' HA ' HD23 ' A' ' 21' ' ' LEU . 84.7 Cg_exo -47.21 115.29 1.27 Allowed 'Trans proline' 0 C--N 1.335 -0.178 0 C-N-CA 123.341 2.694 . . . . 0.54 115.361 -165.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.622 ' OH ' ' HB3' ' A' ' 103' ' ' PRO . 0.2 OUTLIER -78.0 142.94 37.94 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 112.947 -1.933 . . . . 1.2 108.977 164.928 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.587 HD21 HG22 ' A' ' 31' ' ' VAL . 2.7 t-20 -79.72 86.24 5.33 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.537 -0.542 . . . . 1.51 109.537 178.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.701 HD21 HD12 ' A' ' 15' ' ' ILE . 68.2 tp -67.61 -42.47 82.35 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.576 0.703 . . . . 0.28 110.01 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.659 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 1.6 m -69.56 -0.61 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.398 -1.274 . . . . 1.02 112.855 -167.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.528 ' HB3' ' OD1' ' A' ' 29' ' ' ASN . 10.2 pt20 -75.03 -11.32 60.07 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.541 0.686 . . . . 1.02 109.289 174.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.953 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 91.0 m-70 -95.83 22.53 7.22 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 115.315 -0.857 . . . . 0.28 109.495 176.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.533 ' CE ' ' HB ' ' A' ' 31' ' ' VAL . 45.6 mttm -77.77 126.86 31.5 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 114.475 -1.239 . . . . 1.56 108.382 167.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.22 -44.81 1.42 Allowed Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 120.295 -0.955 . . . . 0.2 111.926 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.542 ' HB2' ' HA3' ' A' ' 68' ' ' GLY . 21.6 m -127.07 133.57 25.19 Favored Pre-proline 0 N--CA 1.435 -1.203 0 N-CA-C 108.9 -0.778 . . . . 0.29 108.9 174.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.771 ' HG3' ' CB ' ' A' ' 170' ' ' LEU . 6.1 Cg_endo -43.88 152.83 0.32 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 124.086 3.191 . . . . 0.18 112.891 177.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.872 ' HB2' HG22 ' A' ' 70' ' ' THR . 0.8 OUTLIER -139.02 152.97 48.04 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 106.375 -1.713 . . . . 0.31 106.375 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.975 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 2.8 mp -120.59 128.19 52.81 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.776 -0.578 . . . . 1.19 109.546 177.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.607 HD12 ' CE ' ' A' ' 122' ' ' MET . 1.0 OUTLIER -109.89 125.11 67.09 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-N 115.248 -0.887 . . . . 0.37 109.92 179.304 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.975 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.6 OUTLIER -110.62 124.94 52.83 Favored 'General case' 0 C--O 1.215 -0.729 0 CA-C-N 115.674 -0.693 . . . . 0.42 110.971 -172.031 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.702 ' HB3' HG21 ' A' ' 135' ' ' ILE . 0.7 OUTLIER -77.83 121.96 24.8 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 105.726 -1.953 . . . . 2.35 105.726 165.177 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.712 HG13 ' HA ' ' A' ' 75' ' ' PRO . 1.5 p -130.24 140.01 49.95 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 C-N-CA 119.158 -1.017 . . . . 1.03 113.109 -164.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.416 ' HB2' HD22 ' A' ' 138' ' ' ASN . . . -75.91 102.61 5.63 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.742 -0.663 . . . . 0.88 109.504 173.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.547 ' OG ' ' HB2' ' A' ' 75' ' ' PRO . 1.1 m -46.78 77.17 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 113.436 -1.711 . . . . 1.78 114.392 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt 46.89 50.84 13.26 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.872 0.844 . . . . 5.84 110.769 177.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.739 ' SG ' HG23 ' A' ' 90' ' ' ILE . 23.6 p -150.35 141.96 23.56 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.232 -0.895 . . . . 3.55 109.93 -177.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.34 -111.64 3.9 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.863 -0.684 . . . . 2.91 112.782 176.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.402 ' HD1' ' OE1' ' A' ' 89' ' ' GLU . 96.1 m-85 -112.57 126.52 55.43 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.628 0.728 . . . . 4.63 112.339 -174.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.3 p -75.06 -33.03 61.66 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.823 -1.08 . . . . 1.93 109.931 174.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.738 ' O ' ' HA2' ' A' ' 157' ' ' GLY . 28.2 mmmt 54.41 16.59 1.31 Allowed 'General case' 0 C--N 1.345 0.401 0 C-N-CA 124.726 1.21 . . . . 2.01 113.133 -179.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.94 -11.83 59.1 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.275 -0.964 . . . . 0.51 112.097 -177.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -47.19 -40.83 14.63 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 112.115 -0.394 . . . . 0.5 112.115 177.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.573 ' CZ ' ' HD2' ' A' ' 98' ' ' PHE . 0.1 OUTLIER -57.0 -62.09 1.99 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.754 0.312 . . . . 0.7 110.407 -178.76 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.0 mp0 -59.55 -34.2 72.38 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.716 -0.675 . . . . 2.61 111.539 -178.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.643 ' HA ' HG22 ' A' ' 160' ' ' VAL . 97.0 m -68.47 -58.39 4.4 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.598 -0.728 . . . . 0.33 109.211 -176.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 1.097 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -59.5 -42.75 92.9 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.526 -1.216 . . . . 0.22 111.157 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.53 ' HA ' ' HD1' ' A' ' 102' ' ' PHE . 60.4 m -58.83 -56.86 16.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.86 -0.609 . . . . 0.26 110.923 -177.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 26.6 m -68.34 -35.36 77.65 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.417 -0.811 . . . . 0.48 111.344 -175.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.835 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 20.3 mt -65.61 -50.69 64.13 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-O 121.311 0.577 . . . . 0.43 110.432 -176.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.922 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 6.7 t80 -55.16 -51.89 65.03 Favored 'General case' 0 C--O 1.205 -1.268 0 CA-C-N 114.814 -1.085 . . . . 0.31 110.969 178.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.407 HD21 ' HB3' ' A' ' 101' ' ' GLU . 36.9 m-80 -73.71 -24.49 59.93 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 116.488 -0.324 . . . . 1.21 110.961 -170.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.527 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 34.9 ttpt -85.84 -23.5 27.11 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 109.039 -0.726 . . . . 1.54 109.039 -178.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.609 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 28.2 m-85 -124.86 -3.72 7.65 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 115.504 1.668 . . . . 0.31 115.504 -170.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.676 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 40.5 pttt -67.58 -26.23 66.17 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 107.897 -1.149 . . . . 1.35 107.897 170.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.3 m -49.23 -28.24 4.42 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 113.854 -1.521 . . . . 1.28 111.294 172.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.436 HE21 ' HD1' ' A' ' 64' ' ' TYR . 50.7 mt-30 -99.18 -34.54 10.32 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.496 0.189 . . . . 1.11 111.481 173.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.542 ' HA3' ' HB2' ' A' ' 36' ' ' SER . . . 150.95 -6.06 0.6 Allowed Glycine 0 CA--C 1.521 0.408 0 N-CA-C 111.863 -0.495 . . . . 0.18 111.863 -177.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.835 ' HE2' ' HB3' ' A' ' 60' ' ' LEU . 19.3 t80 -71.15 143.13 50.66 Favored 'General case' 0 C--O 1.218 -0.598 0 C-N-CA 122.705 0.402 . . . . 0.18 111.605 -176.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.953 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 4.8 t -134.65 153.99 51.73 Favored 'General case' 0 CA--C 1.483 -1.606 0 N-CA-C 108.354 -0.98 . . . . 0.2 108.354 172.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 1.097 HG11 ' HB1' ' A' ' 57' ' ' ALA . 42.7 t -113.27 99.86 9.51 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.407 0 N-CA-C 108.586 -0.894 . . . . 0.17 108.586 160.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.797 ' HA ' ' HG2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -94.73 120.47 35.0 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 118.498 -1.281 . . . . 1.04 107.735 174.423 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.951 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -109.53 127.39 54.43 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.915 0.864 . . . . 0.51 111.085 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.797 ' CG ' ' HG2' ' A' ' 105' ' ' MET . 5.8 m-30 -102.92 106.95 53.12 Favored Pre-proline 0 C--N 1.313 -1.009 0 CA-C-N 114.565 -1.198 . . . . 0.44 108.806 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.75 ' O ' ' HB2' ' A' ' 107' ' ' LYS . 65.2 Cg_endo -77.21 93.13 1.09 Allowed 'Trans proline' 0 C--O 1.221 -0.334 0 C-N-CA 122.474 2.116 . . . . 1.3 113.4 -168.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.678 ' HB3' ' OD1' ' A' ' 42' ' ' ASN . 70.6 p -43.1 145.51 0.51 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.633 -1.167 . . . . 1.44 114.042 -167.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.448 ' OD1' ' HB2' ' A' ' 79' ' ' PHE . 43.5 t-20 -92.56 119.06 31.65 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 114.608 -1.178 . . . . 1.81 109.918 -176.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.888 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . 3.7 pp0? -77.84 -12.67 60.0 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.618 -0.719 . . . . 3.34 111.89 -177.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.448 ' HB2' ' OD1' ' A' ' 77' ' ' ASN . 25.3 m-85 -70.59 29.48 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.069 0.766 . . . . 2.68 113.069 -174.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.542 ' HA3' HE22 ' A' ' 82' ' ' GLN . . . -142.98 174.86 23.44 Favored Glycine 0 N--CA 1.439 -1.141 0 N-CA-C 110.621 -0.991 . . . . 1.98 110.621 177.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -100.99 55.12 0.8 Allowed Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.136 -1.031 . . . . 1.49 112.369 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.553 ' HG3' ' HG2' ' A' ' 113' ' ' GLU . 0.4 OUTLIER -173.74 26.01 0.01 OUTLIER 'General case' 0 C--O 1.215 -0.752 0 N-CA-C 112.174 0.435 . . . . 1.74 112.174 -178.879 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.773 ' HG2' ' HA ' ' A' ' 78' ' ' GLN . 0.0 OUTLIER -81.97 142.09 47.92 Favored Pre-proline 0 C--N 1.318 -0.804 0 C-N-CA 119.358 -0.937 . . . . 3.07 110.823 -178.774 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.552 ' HG2' HD21 ' A' ' 42' ' ' ASN . 89.7 Cg_endo -83.77 6.25 5.89 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.263 2.642 . . . . 1.75 113.598 -170.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.78 -55.39 14.45 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 110.315 -1.114 . . . . 2.2 110.315 175.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.435 ' HB3' ' HB2' ' A' ' 89' ' ' GLU . 66.5 t30 -178.15 8.88 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.817 -0.691 . . . . 4.2 109.573 174.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.468 ' OE1' ' HG3' ' A' ' 83' ' ' GLU . 1.1 mm-40 59.32 32.24 21.74 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 115.727 -0.67 . . . . 3.02 111.106 -174.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -177.83 -39.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.39 -0.823 . . . . 3.92 109.835 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.435 ' HB2' ' HB3' ' A' ' 86' ' ' ASN . 36.0 tt0 -50.18 -54.3 21.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.252 -0.885 . . . . 2.65 112.081 -177.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.888 ' HB ' ' HB3' ' A' ' 78' ' ' GLN . 23.3 mt -74.14 -19.71 17.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.203 -0.453 . . . . 2.15 111.152 -174.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.483 ' HG2' ' HB2' ' A' ' 78' ' ' GLN . 24.0 mttm -79.82 -45.56 18.51 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.332 0.587 . . . . 2.79 109.751 178.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -80.62 -13.58 58.92 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.017 -0.992 . . . . 3.29 110.901 -173.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.513 ' HB3' ' HB2' ' A' ' 47' ' ' CYS . 4.3 t80 -112.01 149.15 32.42 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.354 -0.61 . . . . 3.42 109.354 177.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.9 p -63.34 112.27 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.47 0.652 . . . . 2.63 110.96 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 3.9 p -101.11 127.37 47.69 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.535 0.683 . . . . 2.83 111.116 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.9 m -150.76 145.06 25.51 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 107.699 -1.223 . . . . 2.98 107.699 174.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.437 ' O ' ' HG3' ' A' ' 99' ' ' LYS . 18.5 pttp -54.37 110.76 0.66 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.824 -0.806 . . . . 2.72 108.824 177.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.788 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 24.7 p90 -63.56 -26.05 68.52 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.796 -1.093 . . . . 2.12 111.864 -163.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 97' ' ' LYS . 56.1 mtmt 60.39 111.15 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.74 0.781 . . . . 2.69 111.747 177.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.788 ' HB2' ' CE2' ' A' ' 98' ' ' PHE . . . -127.28 -168.63 1.91 Allowed 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.498 -0.774 . . . . 0.55 111.528 -172.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.407 ' HB3' HD21 ' A' ' 62' ' ' ASN . 21.8 mm-40 -86.04 24.25 1.34 Allowed 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.123 -0.944 . . . . 1.99 110.068 172.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.61 ' HB2' ' O ' ' A' ' 71' ' ' VAL . 26.1 p90 -147.69 156.07 44.95 Favored Pre-proline 0 N--CA 1.446 -0.673 0 N-CA-C 109.048 -0.723 . . . . 0.84 109.048 176.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.797 ' HG2' ' HA ' ' A' ' 72' ' ' LEU . 14.0 Cg_endo -54.13 101.81 0.08 OUTLIER 'Trans proline' 0 N--CA 1.479 0.639 0 C-N-CA 124.838 3.692 . . . . 0.62 114.97 -172.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.951 HD12 ' HB3' ' A' ' 73' ' ' ALA . 4.8 mm -101.84 122.15 53.7 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 N-CA-C 108.724 -0.843 . . . . 1.34 108.724 173.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.797 ' HG2' ' CG ' ' A' ' 74' ' ' PHE . 0.3 OUTLIER -81.61 -171.21 3.2 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.767 -0.651 . . . . 3.03 110.474 -176.005 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.75 ' CA ' ' HA ' ' A' ' 23' ' ' ALA . . . -66.49 -23.04 66.2 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 121.024 -0.271 . . . . 1.46 110.949 -177.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.75 ' HB2' ' O ' ' A' ' 75' ' ' PRO . 4.9 ptpp? 94.42 139.19 0.02 OUTLIER 'General case' 0 CA--C 1.493 -1.227 0 O-C-N 125.8 1.937 . . . . 1.76 109.13 -167.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.838 HG13 ' HB2' ' A' ' 116' ' ' HIS . 0.2 OUTLIER -130.87 176.7 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.099 0 N-CA-C 106.284 -1.747 . . . . 0.82 106.284 166.808 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.604 ' HB3' ' HB3' ' A' ' 114' ' ' ASN . 2.9 t-20 -82.55 68.66 9.09 Favored 'General case' 0 C--N 1.293 -1.886 0 C-N-CA 120.299 -0.56 . . . . 1.73 110.156 -178.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.588 HG13 HD11 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -65.37 96.3 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 CA-C-N 115.54 -0.755 . . . . 0.77 110.434 -176.192 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.425 ' O ' ' HB2' ' A' ' 115' ' ' ALA . 5.5 t-20 177.51 -176.71 0.17 Allowed 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.118 -0.946 . . . . 1.9 108.681 171.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.693 ' HA2' ' HE3' ' A' ' 123' ' ' LYS . . . -41.26 -37.94 1.76 Allowed Glycine 0 CA--C 1.529 0.925 0 N-CA-C 117.517 1.767 . . . . 1.47 117.517 -172.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.553 ' HG2' ' HG3' ' A' ' 82' ' ' GLN . 14.8 mm-40 -103.59 -43.62 5.32 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.312 1.556 . . . . 2.81 113.525 -164.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.604 ' HB3' ' HB3' ' A' ' 109' ' ' ASN . 3.0 t30 -128.58 26.97 5.58 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 119.354 -0.938 . . . . 2.16 109.297 -166.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.425 ' HB2' ' O ' ' A' ' 111' ' ' ASN . . . -60.96 168.83 2.21 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 114.892 -1.049 . . . . 1.26 109.276 175.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.838 ' HB2' HG13 ' A' ' 108' ' ' ILE . 7.8 t-80 -90.26 142.94 28.86 Favored Pre-proline 0 N--CA 1.424 -1.756 0 CA-C-O 118.003 -0.999 . . . . 0.42 108.698 -171.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -29.3 -41.77 0.07 OUTLIER 'Trans proline' 0 CA--C 1.535 0.525 0 C-N-CA 124.247 3.298 . . . . 0.4 113.323 179.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.847 ' CD1' ' HB ' ' A' ' 15' ' ' ILE . 22.1 tp -65.59 -50.94 63.24 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 123.435 0.694 . . . . 0.39 111.928 177.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.552 ' OH ' HG22 ' A' ' 40' ' ' ILE . 48.0 m-85 -75.91 -33.45 59.9 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 111.678 0.251 . . . . 3.04 111.678 176.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.465 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 21.9 mm-40 -58.38 -33.41 69.58 Favored 'General case' 0 CA--C 1.498 -1.037 0 N-CA-C 107.807 -1.183 . . . . 2.44 107.807 168.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.835 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 76.0 t80 -71.91 -31.08 66.03 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 119.581 -0.847 . . . . 0.56 110.682 171.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.629 ' HE2' HG21 ' A' ' 15' ' ' ILE . 49.1 mtt -74.65 -51.62 13.93 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 120.403 -0.519 . . . . 0.71 110.595 -170.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 1.059 ' HD2' ' HB2' ' A' ' 134' ' ' ALA . 0.1 OUTLIER -70.8 -25.89 63.07 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.936 -0.574 . . . . 1.46 111.192 176.734 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.579 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 10.0 ptmm? -70.02 -27.16 64.45 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 119.584 -0.847 . . . . 1.99 109.516 176.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 62.6 m -85.22 -56.99 3.26 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.495 -0.775 . . . . 0.59 110.839 178.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.535 ' HG2' HH22 ' A' ' 153' ' ' ARG . 20.7 ttmm -133.9 112.64 12.5 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 109.819 -0.437 . . . . 1.85 109.819 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 126' ' ' LYS . 39.0 Cg_exo -61.01 -79.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 123.922 3.081 . . . . 1.69 113.389 -172.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.522 ' HA2' ' CZ ' ' A' ' 153' ' ' ARG . . . -158.07 13.28 0.25 Allowed Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 119.518 -1.325 . . . . 2.59 113.549 -178.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 1.018 HG12 HH12 ' A' ' 153' ' ' ARG . 48.8 mm 71.39 -42.48 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-O 121.584 0.707 . . . . 3.58 109.586 -173.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.47 ' HG ' ' H ' ' A' ' 131' ' ' ALA . 24.4 tp -94.8 174.0 7.32 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.74 -1.207 . . . . 3.47 107.74 170.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.47 ' H ' ' HG ' ' A' ' 130' ' ' LEU . . . -75.0 80.84 2.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.095 0.474 . . . . 3.28 110.887 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.9 m -157.44 159.22 37.1 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.062 -0.517 . . . . 3.56 109.665 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -97.25 141.06 30.82 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.697 0.284 . . . . 5.17 110.793 174.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 1.059 ' HB2' ' HD2' ' A' ' 123' ' ' LYS . . . 76.18 -167.34 0.07 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 113.818 1.044 . . . . 1.59 113.818 166.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.934 ' H ' HD13 ' A' ' 135' ' ' ILE . 0.1 OUTLIER -54.38 -25.73 14.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 114.393 -1.276 . . . . 2.0 112.091 179.124 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.668 ' HB3' ' CE3' ' A' ' 137' ' ' TRP . 7.7 mtmt 78.29 -64.47 0.27 Allowed 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.343 0.592 . . . . 4.81 111.67 -179.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.668 ' CE3' ' HB3' ' A' ' 136' ' ' LYS . 0.2 OUTLIER -104.97 177.97 4.7 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.909 -1.041 . . . . 1.97 111.671 -169.169 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.482 ' O ' ' N ' ' A' ' 140' ' ' THR . 8.5 m120 -37.04 -152.29 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 126.043 1.737 . . . . 2.04 112.685 158.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.743 ' HD1' ' HD2' ' A' ' 41' ' ' TYR . 0.2 OUTLIER -29.05 -22.54 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 116.76 2.134 . . . . 1.93 116.76 -171.411 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.7 ' HA ' ' O ' ' A' ' 154' ' ' PHE . 3.3 m -5.37 121.75 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 115.494 1.664 . . . . 0.6 115.494 168.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.461 ' CB ' HD23 ' A' ' 39' ' ' LEU . 0.7 OUTLIER -97.45 176.36 5.9 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.649 -1.16 . . . . 0.62 110.938 -177.661 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.649 ' HE1' HG23 ' A' ' 135' ' ' ILE . 23.7 m-85 -131.24 123.7 28.97 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 105.498 -2.038 . . . . 0.57 105.498 162.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.873 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 6.4 tp -79.87 104.33 10.38 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 118.075 -1.45 . . . . 0.43 108.289 178.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.702 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 45.8 mm -89.24 138.58 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.688 0 CA-C-N 112.722 -2.036 . . . . 0.19 107.586 -178.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.484 ' HA ' HD13 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -92.07 -174.83 3.9 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 119.282 -0.967 . . . . 0.98 110.939 -169.342 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.644 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 71.6 mtm180 -54.21 -38.88 66.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.98 0.419 . . . . 2.22 111.511 -177.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -95.91 15.56 20.1 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.31 -0.626 . . . . 2.0 109.31 -176.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.589 ' HA2' HG22 ' A' ' 144' ' ' ILE . . . 74.39 33.92 55.46 Favored Glycine 0 N--CA 1.442 -0.91 0 CA-C-N 115.821 -0.627 . . . . 0.17 114.499 -178.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.488 ' HA ' ' HD2' ' A' ' 150' ' ' PRO . 49.9 t -103.57 109.69 62.45 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-N 118.415 1.108 . . . . 1.12 111.633 176.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.827 ' HD3' HG23 ' A' ' 15' ' ' ILE . 6.5 Cg_endo -57.38 113.35 1.45 Allowed 'Trans proline' 0 CA--C 1.53 0.325 0 C-N-CA 123.715 2.943 . . . . 0.41 111.159 173.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.591 HG23 ' HG2' ' A' ' 152' ' ' GLU . 22.9 m -115.76 -16.86 8.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.331 0.586 . . . . 1.45 110.189 -177.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.873 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 53.9 mm-40 -139.61 167.48 22.01 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-N 115.376 -0.829 . . . . 1.17 110.088 178.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 1.018 HH12 HG12 ' A' ' 129' ' ' ILE . 0.0 OUTLIER -148.22 129.95 15.11 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 114.608 -1.178 . . . . 2.16 108.664 163.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.7 ' O ' ' HA ' ' A' ' 140' ' ' THR . 94.2 m-85 -108.68 137.06 47.23 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.951 -0.568 . . . . 0.32 109.879 -170.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 20.1 m -62.77 156.61 64.34 Favored Pre-proline 0 C--N 1.323 -0.556 0 N-CA-C 109.393 -0.595 . . . . 1.11 109.393 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.735 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 14.1 Cg_endo -56.72 -48.22 19.73 Favored 'Trans proline' 0 CA--C 1.527 0.167 0 C-N-CA 121.765 1.643 . . . . 0.78 111.462 -177.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.738 ' HA2' ' O ' ' A' ' 51' ' ' LYS . . . -55.64 -7.2 1.39 Allowed Glycine 0 CA--C 1.528 0.844 0 N-CA-C 115.692 1.037 . . . . 0.5 115.692 172.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -71.94 140.04 48.99 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 118.777 1.288 . . . . 0.5 109.256 176.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 22.2 t -103.69 170.26 8.04 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 109.629 -0.508 . . . . 1.42 109.629 -173.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.643 HG22 ' HA ' ' A' ' 56' ' ' THR . 60.5 t -41.14 -53.43 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 114.877 -1.056 . . . . 0.28 111.698 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 14.7 ttpp -63.58 -40.24 96.45 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.039 0.447 . . . . 3.46 111.104 -173.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -66.12 -30.43 70.92 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.432 -0.804 . . . . 1.4 109.795 -174.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.58 ' HA ' ' CE2' ' A' ' 154' ' ' PHE . 48.5 mt -82.77 -46.56 19.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.87 -1.059 . . . . 0.21 110.992 175.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.591 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 47.4 mt-10 -52.77 -43.33 65.74 Favored 'General case' 0 C--O 1.217 -0.626 0 O-C-N 123.314 0.384 . . . . 0.67 111.254 -175.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -55.51 -27.47 48.81 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.418 0.525 . . . . 0.87 112.418 -177.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.596 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 14.0 mmmm -97.98 -18.88 18.37 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.421 0.629 . . . . 1.71 109.938 176.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.566 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 12.4 tp -86.2 -49.14 7.95 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.029 -0.987 . . . . 0.16 112.142 -176.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.439 HD11 ' HB3' ' A' ' 164' ' ' GLU . 81.0 mt -55.47 -44.7 99.78 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-N 115.501 -0.772 . . . . 0.26 112.799 -173.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.419 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 72.3 Cg_exo -51.96 -35.33 60.14 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 122.002 1.802 . . . . 0.41 112.375 173.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.771 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 96.6 mt -80.91 -44.25 18.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.358 -0.383 . . . . 0.71 111.378 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.728 HD23 ' HG2' ' A' ' 37' ' ' PRO . 90.9 mt -59.88 -59.28 5.68 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 122.028 0.918 . . . . 0.34 109.899 176.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -57.05 -36.9 76.39 Favored Glycine 0 N--CA 1.434 -1.434 0 CA-C-N 113.327 -1.76 . . . . 1.12 113.298 -177.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 36.9 t 68.5 9.49 7.32 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.866 0.467 . . . . 2.64 111.156 177.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -93.82 -16.68 23.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.479 -0.328 . . . . 4.35 111.413 -177.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 67.17 -80.07 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 O-C-N 123.86 0.725 . . . . 8.45 111.073 -176.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 44.0 tp . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.403 -0.808 . . . . 7.69 109.378 -178.494 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.583 0 N-CA-C 111.506 -0.637 . . . . 5.22 111.506 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -90.78 136.48 33.04 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.01 0.434 . . . . 4.85 109.869 178.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.67 37.52 5.5 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 111.043 -0.823 . . . . 1.55 111.043 -174.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.0 t -102.33 -2.56 28.73 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.079 0.466 . . . . 1.58 109.806 -177.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 99.5 p -168.49 177.07 5.44 Favored 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 107.48 -1.304 . . . . 1.17 107.48 -177.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.981 HD12 HD21 ' A' ' 30' ' ' LEU . 5.2 pt -83.7 -18.77 9.92 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 CA-C-N 114.863 -1.062 . . . . 0.38 109.817 176.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.745 ' CD1' ' HA ' ' A' ' 31' ' ' VAL . 48.4 m-85 -70.95 -5.78 33.54 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.255 0.55 . . . . 0.3 110.713 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -69.18 -18.22 63.89 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.201 -0.909 . . . . 2.11 108.665 172.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.806 ' HE2' ' HB2' ' A' ' 121' ' ' TYR . 61.1 m-85 -119.35 108.05 14.12 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-O 121.781 0.801 . . . . 0.31 111.509 -178.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -48.48 146.88 2.69 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 113.488 -1.687 . . . . 2.86 110.336 170.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.781 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 37.1 t -110.86 165.0 6.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 109.393 -0.595 . . . . 0.67 109.393 -175.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.819 ' O ' ' HB3' ' A' ' 105' ' ' MET . 97.1 mt -126.49 111.28 14.23 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-O 119.505 -0.283 . . . . 0.69 111.332 -176.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.408 ' HA ' ' HE2' ' A' ' 105' ' ' MET . 13.4 t70 -53.9 161.84 1.08 Allowed 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 107.03 -1.47 . . . . 1.87 107.03 170.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.613 ' HA ' ' N ' ' A' ' 106' ' ' ALA . . . -57.02 -11.1 1.34 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 113.153 0.797 . . . . 0.59 113.153 -164.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 10.9 t70 -90.21 -4.18 57.38 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 122.386 0.274 . . . . 2.34 111.598 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.636 ' CD2' ' HB1' ' A' ' 106' ' ' ALA . 74.4 m-70 79.95 20.71 0.57 Allowed 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.93 0.872 . . . . 1.47 108.995 -177.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.455 ' HA ' ' HD3' ' A' ' 26' ' ' LYS . 11.3 mmtp -104.69 125.96 32.55 Favored Pre-proline 0 N--CA 1.441 -0.892 0 CA-C-N 114.344 -1.298 . . . . 4.25 108.398 175.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.675 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 80.3 Cg_exo -48.79 114.74 1.34 Allowed 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.995 2.463 . . . . 0.54 114.917 -168.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.813 ' HE2' HD23 ' A' ' 72' ' ' LEU . 8.8 t80 -83.8 128.3 34.44 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 113.589 -1.641 . . . . 1.2 109.313 164.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.429 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 1.7 p-10 -75.29 99.53 4.1 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 122.777 1.275 . . . . 1.51 110.143 176.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.981 HD21 HD12 ' A' ' 15' ' ' ILE . 61.7 tp -61.62 -32.82 72.97 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.507 -1.224 . . . . 0.28 110.591 178.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.745 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 3.7 m -63.77 -6.12 2.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 114.793 -1.094 . . . . 1.02 113.164 -169.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.429 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 9.7 pt20 -72.81 -7.88 52.85 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.006 -0.678 . . . . 1.02 109.737 177.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.923 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 90.1 m-70 -98.94 22.11 10.68 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.8 0.81 . . . . 0.28 109.866 176.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.524 ' HE2' ' HB ' ' A' ' 31' ' ' VAL . 62.2 mttm -78.75 122.09 25.58 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 114.683 -1.144 . . . . 1.56 109.156 169.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.05 -41.09 2.08 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.585 -0.817 . . . . 0.2 111.912 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.545 ' HB2' ' HA3' ' A' ' 68' ' ' GLY . 52.7 m -129.77 132.93 24.49 Favored Pre-proline 0 N--CA 1.437 -1.121 0 N-CA-C 108.839 -0.801 . . . . 0.29 108.839 173.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.779 ' HG3' ' CB ' ' A' ' 170' ' ' LEU . 4.2 Cg_endo -43.29 152.22 0.27 Allowed 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.951 3.1 . . . . 0.18 112.55 176.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.875 ' HB2' HG22 ' A' ' 70' ' ' THR . 0.7 OUTLIER -137.04 150.8 48.3 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.353 -1.721 . . . . 0.31 106.353 179.171 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.97 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 1.8 mp -116.26 122.61 45.49 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 121.419 0.628 . . . . 1.19 109.536 176.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.078 HG22 ' OH ' ' A' ' 119' ' ' TYR . 0.9 OUTLIER -102.51 123.6 55.93 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 CA-C-N 114.908 -1.042 . . . . 0.37 109.394 177.45 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.97 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.3 OUTLIER -109.25 129.7 55.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.31 -0.405 . . . . 0.42 110.569 -175.013 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.877 HD21 ' HE2' ' A' ' 142' ' ' PHE . 2.9 m-80 -78.89 93.13 4.98 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.213 -1.402 . . . . 2.35 107.213 169.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.714 HG12 ' CG ' ' A' ' 139' ' ' PHE . 34.9 m -104.31 145.67 12.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 C-N-CA 119.038 -1.065 . . . . 1.03 111.227 -170.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.687 ' O ' ' HG2' ' A' ' 46' ' ' LYS . . . -94.74 104.3 16.21 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 114.334 -1.303 . . . . 0.88 109.233 174.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.623 ' HA ' ' HB3' ' A' ' 98' ' ' PHE . 2.1 p -38.54 93.17 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.619 0 O-C-N 124.377 1.048 . . . . 1.78 111.469 168.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.687 ' HG2' ' O ' ' A' ' 44' ' ' ALA . 65.6 mmtt -102.8 153.29 20.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.839 -0.619 . . . . 5.84 110.451 -177.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.535 ' HB2' ' HA ' ' A' ' 95' ' ' CYS . 49.1 t -111.18 114.48 27.75 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 108.35 -0.981 . . . . 3.55 108.35 167.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 63.1 32.82 85.45 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-N 116.078 -0.51 . . . . 2.91 113.766 -178.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.542 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 14.5 m-85 -142.16 145.35 34.09 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 117.727 0.764 . . . . 4.63 112.499 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.5 t -159.93 169.48 23.4 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.21 -0.904 . . . . 1.93 108.607 177.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.706 ' HB3' ' HB2' ' A' ' 156' ' ' PRO . 8.5 tppt? -125.71 9.5 7.67 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.173 -0.677 . . . . 2.01 109.173 173.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 116.13 -30.88 6.3 Favored Glycine 0 N--CA 1.443 -0.893 0 N-CA-C 110.32 -1.112 . . . . 0.51 110.32 -170.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -45.31 -47.98 11.06 Favored Glycine 0 C--O 1.223 -0.592 0 CA-C-N 115.011 -0.595 . . . . 0.5 113.222 175.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.601 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 0.2 OUTLIER -61.01 -61.88 2.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.877 0.338 . . . . 0.7 111.524 -174.182 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -62.06 -23.88 66.75 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.268 0.556 . . . . 2.61 111.149 -178.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.653 ' HA ' HG22 ' A' ' 160' ' ' VAL . 23.4 m -75.79 -57.66 3.75 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.518 -0.765 . . . . 0.33 110.363 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 1.069 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -57.87 -38.48 75.81 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.942 -1.026 . . . . 0.22 110.949 -179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.543 ' HA ' ' CD1' ' A' ' 102' ' ' PHE . 54.8 m -60.92 -57.78 11.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.837 -0.619 . . . . 0.26 110.415 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 26.6 m -66.74 -37.84 85.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.378 -0.828 . . . . 0.48 111.534 -175.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.802 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 18.9 mt -65.3 -48.0 74.65 Favored 'General case' 0 CA--C 1.503 -0.849 0 CA-C-O 121.049 0.452 . . . . 0.43 110.679 -175.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.88 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 8.7 t80 -56.58 -50.96 70.38 Favored 'General case' 0 C--O 1.203 -1.394 0 CA-C-N 115.217 -0.901 . . . . 0.31 110.453 178.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -72.21 -24.57 61.42 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 120.745 0.307 . . . . 1.21 110.502 -172.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.3 ttmm -82.62 -26.35 32.32 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 109.107 -0.701 . . . . 1.54 109.107 -177.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.759 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 30.2 m-85 -127.61 -5.77 5.81 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 115.452 1.649 . . . . 0.31 115.452 -168.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.704 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 11.5 ptmt -63.65 -28.18 69.73 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 108.033 -1.099 . . . . 1.35 108.033 170.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.4 m -48.77 -34.83 12.97 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 113.84 -1.527 . . . . 1.28 110.782 172.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -93.64 -30.91 14.7 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.679 0.276 . . . . 1.11 111.52 176.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.545 ' HA3' ' HB2' ' A' ' 36' ' ' SER . . . 144.79 -7.64 1.71 Allowed Glycine 0 CA--C 1.519 0.323 0 N-CA-C 111.431 -0.668 . . . . 0.18 111.431 -177.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.802 ' HE2' ' HB3' ' A' ' 60' ' ' LEU . 21.5 t80 -69.52 141.71 53.82 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 122.744 0.418 . . . . 0.18 111.122 -177.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.923 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 3.8 t -133.91 152.17 51.76 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 107.985 -1.117 . . . . 0.2 107.985 173.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 1.069 HG11 ' HB1' ' A' ' 57' ' ' ALA . 33.4 t -110.82 100.32 10.52 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.454 0 N-CA-C 108.158 -1.053 . . . . 0.17 108.158 159.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.813 HD23 ' HE2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -96.7 121.5 38.61 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 107.829 -1.174 . . . . 1.04 107.829 175.18 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 1.032 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -111.28 116.81 31.65 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 115.705 -0.679 . . . . 0.51 110.295 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.955 ' HD2' HD12 ' A' ' 108' ' ' ILE . 1.4 m-30 -89.66 108.07 22.89 Favored Pre-proline 0 C--N 1.314 -0.951 0 N-CA-C 107.918 -1.141 . . . . 0.44 107.918 173.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.948 ' HG2' ' HB3' ' A' ' 107' ' ' LYS . 73.2 Cg_endo -75.24 64.22 6.24 Favored 'Trans proline' 0 N--CA 1.476 0.459 0 C-N-CA 123.632 2.888 . . . . 1.3 115.199 -168.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.3 t 13.17 125.51 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 116.589 2.07 . . . . 1.44 116.589 175.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.505 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 0.3 OUTLIER -79.85 70.54 6.4 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.074 -0.966 . . . . 1.81 109.045 174.627 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.649 ' HA ' ' HG3' ' A' ' 83' ' ' GLU . 21.9 mt-30 -48.99 -8.74 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 114.354 -1.294 . . . . 3.34 111.798 176.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.502 ' H ' ' C ' ' A' ' 77' ' ' ASN . 93.6 m-85 -64.22 -14.73 57.38 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.055 -0.975 . . . . 2.68 110.329 177.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.476 ' HA3' HE22 ' A' ' 82' ' ' GLN . . . -97.77 152.87 20.01 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 111.129 -0.788 . . . . 1.98 111.129 174.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.17 45.92 3.2 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.879 -0.677 . . . . 1.49 113.579 -175.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.741 ' HG3' ' HB3' ' A' ' 113' ' ' GLU . 4.1 pm0 -140.97 -16.27 0.87 Allowed 'General case' 0 C--N 1.324 -0.528 0 O-C-N 122.483 -0.422 . . . . 1.74 111.251 176.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.649 ' HG3' ' HA ' ' A' ' 78' ' ' GLN . 7.1 mm-40 -60.03 150.44 70.02 Favored Pre-proline 0 N--CA 1.464 0.273 0 CA-C-O 121.198 0.523 . . . . 3.07 112.153 -165.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.497 ' HB2' ' O ' ' A' ' 137' ' ' TRP . 83.7 Cg_endo -84.44 -15.28 6.39 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.174 2.583 . . . . 1.75 112.836 -168.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.638 ' HA3' ' HB2' ' A' ' 44' ' ' ALA . . . -86.27 69.98 3.06 Favored Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 110.864 -0.894 . . . . 2.2 110.864 175.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 68.21 -97.92 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.877 -0.786 . . . . 4.2 108.877 -172.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.455 ' O ' ' HB3' ' A' ' 78' ' ' GLN . 6.3 pt-20 170.23 -73.09 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 O-C-N 123.892 0.745 . . . . 3.02 110.089 175.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.435 ' H ' ' HG3' ' A' ' 87' ' ' GLU . 16.0 mm-40 -91.34 5.59 48.68 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 111.784 0.29 . . . . 3.92 111.784 -175.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.478 ' HA ' ' HG2' ' A' ' 92' ' ' GLU . 20.6 tt0 -58.64 -34.98 71.8 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.758 0.651 . . . . 2.65 112.758 -169.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.804 HG13 ' HD3' ' A' ' 91' ' ' LYS . 38.9 pt -81.46 -6.66 10.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.625 -0.43 . . . . 2.15 111.452 -178.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.804 ' HD3' HG13 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -105.08 -37.72 6.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.821 0.343 . . . . 2.79 110.557 177.073 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.478 ' HG2' ' HA ' ' A' ' 89' ' ' GLU . 15.9 pt-20 -79.17 -23.84 43.64 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.233 0.54 . . . . 3.29 109.816 177.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -131.27 133.71 45.68 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.842 -0.799 . . . . 3.42 108.842 176.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 53.0 t -60.67 109.66 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.021 0.439 . . . . 2.63 110.689 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.556 ' HB2' HG22 ' A' ' 90' ' ' ILE . 58.5 m -133.49 120.34 20.71 Favored 'General case' 0 CA--C 1.503 -0.827 0 CA-C-N 115.612 -0.722 . . . . 2.83 109.496 173.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.1 p -90.79 162.79 14.7 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 114.873 -1.058 . . . . 2.98 109.757 175.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 67.8 mttt -39.23 114.92 0.44 Allowed 'General case' 0 C--N 1.315 -0.907 0 O-C-N 124.248 0.967 . . . . 2.72 111.005 173.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.623 ' HB3' ' HA ' ' A' ' 45' ' ' SER . 0.0 OUTLIER -59.75 100.08 0.08 Allowed 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 108.507 -0.923 . . . . 2.12 108.507 171.398 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -94.57 132.4 39.3 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.521 -0.763 . . . . 2.69 109.044 177.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.6 ' HB2' ' CE1' ' A' ' 98' ' ' PHE . . . -128.91 -175.38 3.53 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.306 0.574 . . . . 0.55 112.011 -169.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -93.05 11.97 25.72 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.242 -0.89 . . . . 1.99 109.589 177.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.616 ' CE2' HD11 ' A' ' 104' ' ' ILE . 7.5 p90 -134.48 163.39 51.56 Favored Pre-proline 0 N--CA 1.444 -0.725 0 N-CA-C 108.175 -1.046 . . . . 0.84 108.175 178.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.806 ' HG2' ' HA ' ' A' ' 72' ' ' LEU . 26.4 Cg_endo -57.12 97.03 0.07 OUTLIER 'Trans proline' 0 N--CA 1.477 0.554 0 C-N-CA 123.57 2.847 . . . . 0.62 114.063 -173.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 1.032 HD12 ' HB3' ' A' ' 73' ' ' ALA . 7.6 mm -99.59 123.55 52.41 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.931 0 N-CA-C 107.969 -1.123 . . . . 1.34 107.969 173.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.842 ' HG3' ' CE1' ' A' ' 74' ' ' PHE . 13.5 mmt -100.99 -163.87 1.06 Allowed 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.304 -0.862 . . . . 3.03 111.791 -165.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.636 ' HB1' ' CD2' ' A' ' 25' ' ' HIS . . . -71.37 4.07 3.24 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.228 -0.897 . . . . 1.46 113.337 -169.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.948 ' HB3' ' HG2' ' A' ' 75' ' ' PRO . 15.8 ptpt 53.77 123.57 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.048 0 CA-C-O 122.701 1.239 . . . . 1.76 111.5 -170.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.955 HD12 ' HD2' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -122.73 177.68 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.689 0 N-CA-C 108.249 -1.019 . . . . 0.82 108.249 171.183 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.792 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 0.1 OUTLIER -70.87 72.16 0.55 Allowed 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 114.46 -1.246 . . . . 1.73 111.252 179.946 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 110' ' ' VAL . 13.7 m -72.28 92.49 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 CA-C-O 122.338 1.066 . . . . 0.77 108.202 175.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.408 HD22 ' HD3' ' A' ' 84' ' ' PRO . 2.2 t-20 176.27 -177.05 0.13 Allowed 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 114.442 -1.254 . . . . 1.9 109.525 -175.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -91.47 18.97 50.31 Favored Glycine 0 N--CA 1.432 -1.591 0 N-CA-C 115.361 0.904 . . . . 1.47 115.361 -172.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.741 ' HB3' ' HG3' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -105.38 -45.96 4.33 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 119.494 1.647 . . . . 2.81 111.72 179.314 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.606 ' N ' ' HG3' ' A' ' 113' ' ' GLU . 28.8 t-20 -132.02 -37.34 1.14 Allowed 'General case' 0 CA--C 1.508 -0.646 0 C-N-CA 119.685 -0.806 . . . . 2.16 110.568 -177.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.792 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . 52.6 178.87 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.841 0.829 . . . . 1.26 110.875 -177.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.899 ' CB ' HG13 ' A' ' 108' ' ' ILE . 5.9 t-80 -113.56 136.61 21.97 Favored Pre-proline 0 N--CA 1.425 -1.717 0 N-CA-C 106.995 -1.483 . . . . 0.42 106.995 163.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -26.42 -46.28 0.07 OUTLIER 'Trans proline' 0 C--O 1.219 -0.471 0 C-N-CA 124.456 3.437 . . . . 0.4 113.592 178.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.898 HD11 ' HB ' ' A' ' 15' ' ' ILE . 42.3 tp -61.63 -51.64 67.64 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.168 0.587 . . . . 0.39 112.251 177.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 1.078 ' OH ' HG22 ' A' ' 40' ' ' ILE . 46.5 m-85 -79.74 -33.39 40.84 Favored 'General case' 0 CA--C 1.489 -1.403 0 CA-C-O 121.238 0.542 . . . . 3.04 109.789 -177.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.491 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 13.3 tt0 -56.41 -40.7 75.12 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 107.017 -1.475 . . . . 2.44 107.017 172.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.806 ' HB2' ' HE2' ' A' ' 18' ' ' PHE . 88.8 t80 -65.97 -33.91 76.9 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 114.915 -1.038 . . . . 0.56 110.203 174.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.688 ' HE3' ' HG ' ' A' ' 118' ' ' LEU . 2.1 ttm -75.36 -54.93 6.24 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.207 -0.451 . . . . 0.71 110.955 -168.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.655 ' HD2' ' HB1' ' A' ' 134' ' ' ALA . 0.1 OUTLIER -68.77 -26.11 65.05 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 116.13 -0.486 . . . . 1.46 110.904 178.349 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.491 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 12.6 pttp -74.95 -26.71 59.8 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 119.587 -0.845 . . . . 1.99 109.838 177.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.47 HG21 ' HG2' ' A' ' 150' ' ' PRO . 52.6 m -71.45 -57.69 4.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.832 -0.622 . . . . 0.59 111.359 177.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.738 ' HG2' ' H ' ' A' ' 128' ' ' GLY . 42.8 tttp -146.51 130.23 8.39 Favored Pre-proline 0 N--CA 1.452 -0.374 0 C-N-CA 120.181 -0.607 . . . . 1.85 112.294 -174.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.723 ' HA ' ' NH2' ' A' ' 153' ' ' ARG . 12.9 Cg_exo -71.57 -2.31 11.14 Favored 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 123.51 2.806 . . . . 1.69 111.803 171.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.738 ' H ' ' HG2' ' A' ' 126' ' ' LYS . . . 96.37 -143.13 16.53 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.942 -0.572 . . . . 2.59 111.9 178.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 31.7 pt -102.63 3.03 10.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.151 0.5 . . . . 3.58 110.454 177.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.632 HD23 ' H ' ' A' ' 130' ' ' LEU . 2.4 pt? -124.98 153.86 42.11 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.729 -0.668 . . . . 3.47 109.686 -177.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -81.51 76.65 8.43 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.098 0.475 . . . . 3.28 110.46 -178.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.556 HG21 ' HZ3' ' A' ' 137' ' ' TRP . 40.4 m -140.57 126.55 19.5 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.002 -0.544 . . . . 3.56 110.049 178.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.428 ' HB2' ' HE3' ' A' ' 133' ' ' LYS . 39.8 mtmt -43.66 -73.79 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.836 0.68 . . . . 5.17 112.836 -173.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.655 ' HB1' ' HD2' ' A' ' 123' ' ' LYS . . . -146.12 101.72 3.54 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.133 -0.485 . . . . 1.59 112.296 -168.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.835 ' HA ' HG21 ' A' ' 140' ' ' THR . 5.3 mt 67.01 -78.93 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 O-C-N 123.72 0.637 . . . . 2.0 110.543 173.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.722 ' HB3' ' CE3' ' A' ' 137' ' ' TRP . 2.1 tmtp? 73.13 -30.7 0.21 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.856 1.263 . . . . 4.81 112.489 175.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.722 ' CE3' ' HB3' ' A' ' 136' ' ' LYS . 10.7 m-90 -111.86 174.51 5.84 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.51 0.671 . . . . 1.97 112.492 -174.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.612 ' HB3' ' HB3' ' A' ' 156' ' ' PRO . 8.5 t-20 -39.46 -154.93 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.895 1.678 . . . . 2.04 112.064 157.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.714 ' CG ' HG12 ' A' ' 43' ' ' VAL . 2.2 m-85 -27.96 -44.96 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 115.66 1.726 . . . . 1.93 115.66 -166.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.835 HG21 ' HA ' ' A' ' 135' ' ' ILE . 26.9 m 33.87 97.38 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.793 1.035 . . . . 0.6 113.793 171.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.644 ' HB3' HD23 ' A' ' 39' ' ' LEU . 5.0 m -86.45 170.82 11.62 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.534 -1.212 . . . . 0.62 111.892 -171.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.877 ' HE2' HD21 ' A' ' 42' ' ' ASN . 88.8 m-85 -133.39 121.87 22.93 Favored 'General case' 0 CA--C 1.489 -1.366 0 N-CA-C 106.111 -1.811 . . . . 0.57 106.111 162.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.825 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 7.7 tp -79.6 104.56 10.28 Favored 'General case' 0 N--CA 1.422 -1.838 0 C-N-CA 118.089 -1.444 . . . . 0.43 108.291 178.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.743 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 47.9 mm -89.62 140.28 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.938 0 CA-C-N 112.709 -2.041 . . . . 0.19 107.731 -178.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.613 ' OD1' HG12 ' A' ' 149' ' ' VAL . 0.0 OUTLIER -91.94 -174.23 3.73 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 119.588 -0.845 . . . . 0.98 111.61 -170.276 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.758 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 35.8 mtt85 -56.28 -38.39 71.14 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 122.468 0.307 . . . . 2.22 111.556 -176.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -100.76 21.39 13.61 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.036 -1.098 . . . . 2.0 108.036 -178.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.651 ' HA2' HG22 ' A' ' 144' ' ' ILE . . . 69.31 37.45 80.3 Favored Glycine 0 N--CA 1.435 -1.388 0 CA-C-N 114.661 -1.154 . . . . 0.17 115.263 176.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.613 HG12 ' OD1' ' A' ' 145' ' ' ASP . 4.3 p -106.69 122.05 43.1 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 119.469 1.634 . . . . 1.12 110.806 171.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.624 ' HD3' HG23 ' A' ' 15' ' ' ILE . 11.6 Cg_endo -64.64 124.17 12.82 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 123.253 2.636 . . . . 0.41 111.468 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.9 m -124.54 -9.43 6.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 120.758 0.313 . . . . 1.45 110.468 -177.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.825 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 19.9 mm-40 -142.82 166.06 25.68 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 121.266 0.555 . . . . 1.17 110.861 175.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.723 ' NH2' ' HA ' ' A' ' 127' ' ' PRO . 5.8 ttm180 -148.14 135.61 20.62 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.551 -1.204 . . . . 2.16 108.849 166.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.743 ' O ' ' HA ' ' A' ' 140' ' ' THR . 97.2 m-85 -117.23 155.05 30.09 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.08 -0.711 . . . . 0.32 109.08 -169.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.441 ' HB3' ' HD2' ' A' ' 156' ' ' PRO . 22.3 m -83.22 163.04 52.22 Favored Pre-proline 0 C--N 1.316 -0.857 0 N-CA-C 109.497 -0.557 . . . . 1.11 109.497 175.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.706 ' HB2' ' HB3' ' A' ' 51' ' ' LYS . 20.1 Cg_endo -60.48 -31.13 92.1 Favored 'Trans proline' 0 CA--C 1.52 -0.176 0 C-N-CA 122.238 1.959 . . . . 0.78 110.681 174.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -68.97 -16.55 70.67 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 114.367 -1.288 . . . . 0.5 112.938 174.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.402 ' HB3' ' HB3' ' A' ' 154' ' ' PHE . . . -76.84 137.52 39.25 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 108.572 -0.899 . . . . 0.5 108.572 176.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.485 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 6.0 m -116.37 -177.06 3.09 Favored 'General case' 0 N--CA 1.436 -1.156 0 C-N-CA 120.48 -0.488 . . . . 1.42 110.727 -170.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.653 HG22 ' HA ' ' A' ' 56' ' ' THR . 54.9 t -42.43 -50.28 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.23 -0.895 . . . . 0.28 111.799 -178.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -68.62 -35.05 76.79 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.046 0.451 . . . . 3.46 111.081 -174.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.411 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 15.9 m-20 -69.91 -34.9 74.11 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.644 0.735 . . . . 1.4 109.737 -177.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.548 HD12 HG21 ' A' ' 56' ' ' THR . 54.8 mt -81.03 -49.1 18.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 114.797 -1.092 . . . . 0.21 111.369 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.604 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 39.3 mt-10 -52.41 -42.78 64.36 Favored 'General case' 0 C--O 1.216 -0.685 0 O-C-N 123.211 0.319 . . . . 0.67 111.082 -176.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 12.7 pt-20 -56.51 -25.73 52.42 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.418 -0.355 . . . . 0.87 111.535 -175.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.436 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 31.1 mmtp -96.84 -31.1 12.78 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.645 0.736 . . . . 1.71 109.857 176.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.604 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 14.7 tp -75.08 -48.56 23.29 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.302 -1.317 . . . . 0.16 112.149 -175.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.478 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 72.5 mt -56.31 -46.78 99.76 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.412 -0.813 . . . . 0.26 112.629 -172.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.478 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 73.4 Cg_exo -52.24 -26.02 25.52 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.233 1.956 . . . . 0.41 112.738 174.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.779 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 89.6 mt -89.92 -46.82 8.27 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 122.334 -0.228 . . . . 0.71 111.294 178.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.732 HD23 ' HG2' ' A' ' 37' ' ' PRO . 93.0 mt -59.22 -55.84 29.77 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-O 122.119 0.961 . . . . 0.34 109.874 176.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -74.58 -44.04 27.76 Favored Glycine 0 N--CA 1.43 -1.701 0 CA-C-N 113.332 -1.758 . . . . 1.12 113.473 -174.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 86.8 p 54.67 -148.91 0.46 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.09 0.556 . . . . 2.64 110.794 -175.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -92.99 -4.11 53.25 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.974 0.416 . . . . 4.35 110.586 176.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 61.1 mtt180 -90.53 131.6 36.17 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.906 -0.588 . . . . 8.45 111.117 -174.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.2 mm? . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.545 -0.74 . . . . 7.69 109.49 177.142 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.818 0 N-CA-C 112.155 -0.378 . . . . 5.22 112.155 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.8 ttt -84.29 78.49 9.79 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.083 0.468 . . . . 4.85 109.79 176.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -98.35 140.4 15.0 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.588 -0.815 . . . . 1.55 112.192 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.1 t -93.52 -0.25 56.39 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.187 0.517 . . . . 1.58 109.698 176.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.9 m -159.02 155.41 27.42 Favored 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 105.534 -2.024 . . . . 1.17 105.534 -176.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.903 ' HB ' HD11 ' A' ' 118' ' ' LEU . 5.9 pt -57.73 -18.91 10.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-N 115.011 -0.995 . . . . 0.38 111.805 -177.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.83 ' HB3' HG13 ' A' ' 31' ' ' VAL . 26.1 m-85 -70.16 -0.01 7.04 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.998 0.74 . . . . 0.3 112.998 -173.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -78.67 -17.09 56.48 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.429 -0.952 . . . . 2.11 108.429 177.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.63 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 39.8 m-85 -111.98 112.2 23.67 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 114.56 -1.2 . . . . 0.31 111.636 -172.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -45.21 137.02 4.76 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 113.599 -1.637 . . . . 2.86 111.072 172.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.864 HG13 ' HZ ' ' A' ' 74' ' ' PHE . 65.3 t -112.19 164.47 8.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 107.877 -1.157 . . . . 0.67 107.877 178.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.706 HD23 ' HA ' ' A' ' 27' ' ' PRO . 60.0 mt -130.85 157.68 42.22 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.692 0.282 . . . . 0.69 111.053 -177.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.533 ' HB3' ' HE3' ' A' ' 26' ' ' LYS . 20.5 t70 -85.18 172.94 10.8 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 106.795 -1.558 . . . . 1.87 106.795 163.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.695 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . . . -62.78 -3.83 1.76 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.28 0.844 . . . . 0.59 113.28 -170.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.674 ' HB2' ' HE2' ' A' ' 26' ' ' LYS . 47.7 m-20 -117.05 17.42 14.89 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.764 -0.374 . . . . 2.34 111.526 176.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.464 ' HA ' HD13 ' A' ' 21' ' ' LEU . 91.5 m-70 74.55 15.02 3.43 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-O 121.839 0.828 . . . . 1.47 109.17 174.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.674 ' HE2' ' HB2' ' A' ' 24' ' ' ASP . 35.2 mtmt -77.81 109.15 8.9 Favored Pre-proline 0 N--CA 1.446 -0.634 0 N-CA-C 107.367 -1.345 . . . . 4.25 107.367 169.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.706 ' HA ' HD23 ' A' ' 21' ' ' LEU . 93.7 Cg_exo -48.39 116.22 1.94 Allowed 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.503 2.135 . . . . 0.54 113.501 -171.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.799 ' OH ' ' HB3' ' A' ' 103' ' ' PRO . 0.2 OUTLIER -76.45 146.73 38.37 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 113.721 -1.581 . . . . 1.2 111.649 176.273 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.546 ' OD1' ' HB3' ' A' ' 32' ' ' GLN . 2.3 t-20 -84.9 96.69 9.42 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.171 -0.922 . . . . 1.51 109.597 175.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.702 HD13 HG21 ' A' ' 20' ' ' VAL . 61.4 tp -79.13 -45.99 18.89 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.877 -0.601 . . . . 0.28 110.914 -177.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.849 HG12 ' HE2' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -65.31 -0.08 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.435 0 CA-C-N 115.611 -0.722 . . . . 1.02 112.771 -173.594 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.546 ' HB3' ' OD1' ' A' ' 29' ' ' ASN . 3.9 pt20 -76.71 -12.49 60.0 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 119.832 -0.747 . . . . 1.02 109.323 175.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.934 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 92.8 m-70 -92.98 24.75 3.53 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 122.405 1.098 . . . . 0.28 108.685 175.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.849 ' HE2' HG12 ' A' ' 31' ' ' VAL . 36.8 mttm -77.67 109.73 11.9 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 113.419 -1.718 . . . . 1.56 109.446 170.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.35 -38.04 2.48 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 120.191 -1.004 . . . . 0.2 112.348 177.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.479 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 17.1 m -126.98 133.77 25.4 Favored Pre-proline 0 N--CA 1.437 -1.082 0 N-CA-C 108.748 -0.834 . . . . 0.29 108.748 172.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.724 ' HG3' ' CB ' ' A' ' 170' ' ' LEU . 5.3 Cg_endo -44.27 158.13 0.15 Allowed 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 124.136 3.224 . . . . 0.18 112.732 176.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.809 ' HB2' HG22 ' A' ' 70' ' ' THR . 1.0 OUTLIER -145.14 141.2 28.55 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.296 -1.372 . . . . 0.31 107.296 -179.215 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 1.015 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 2.2 mm? -106.38 112.96 26.2 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.838 -0.801 . . . . 1.19 108.838 178.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.705 HG13 HG13 ' A' ' 144' ' ' ILE . 1.3 mt -96.59 123.98 49.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 109.403 -0.591 . . . . 0.37 109.403 176.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 1.015 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.5 OUTLIER -110.68 131.2 55.26 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.433 -0.349 . . . . 0.42 110.561 -174.552 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.508 ' HB2' HG21 ' A' ' 110' ' ' VAL . 0.6 OUTLIER -79.1 117.53 20.22 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 105.874 -1.898 . . . . 2.35 105.874 166.598 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.702 HG23 ' HA ' ' A' ' 75' ' ' PRO . 35.0 m -126.39 155.74 36.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 O-C-N 120.973 -1.079 . . . . 1.03 111.603 -172.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.511 ' HB1' HD13 ' A' ' 90' ' ' ILE . . . -103.75 103.27 13.14 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.363 -0.835 . . . . 0.88 109.955 176.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.562 ' HA ' ' HB3' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -28.36 139.12 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 114.134 -1.394 . . . . 1.78 113.317 174.177 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -55.19 96.47 0.02 OUTLIER 'General case' 0 C--O 1.234 0.25 0 CA-C-N 114.567 -1.197 . . . . 5.84 112.872 -172.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.77 ' HB3' HG22 ' A' ' 90' ' ' ILE . 37.4 t -164.04 118.43 1.49 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.974 -1.012 . . . . 3.55 108.879 169.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 100.87 -74.52 0.4 Allowed Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.717 -0.754 . . . . 2.91 112.624 178.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.579 ' HE2' ' HD3' ' A' ' 51' ' ' LYS . 66.4 t80 -164.37 139.31 5.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.105 0.478 . . . . 4.63 111.305 -178.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 15.3 p -117.52 126.48 52.65 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.39 -0.823 . . . . 1.93 109.849 175.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.579 ' HD3' ' HE2' ' A' ' 49' ' ' TYR . 0.3 OUTLIER -66.36 167.72 10.04 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 109.922 -0.399 . . . . 2.01 109.922 178.447 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -55.97 -10.46 3.64 Favored Glycine 0 C--N 1.335 0.519 0 O-C-N 123.29 0.368 . . . . 0.51 113.713 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.409 ' HA2' ' HB ' ' A' ' 56' ' ' THR . . . -55.58 -24.13 38.27 Favored Glycine 0 C--O 1.223 -0.562 0 C-N-CA 121.604 -0.331 . . . . 0.5 112.557 175.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.433 ' CZ ' ' CE1' ' A' ' 98' ' ' PHE . 0.2 OUTLIER -63.65 -50.3 69.85 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.345 -0.613 . . . . 0.7 109.345 175.879 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -61.85 -29.98 70.54 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.292 -0.867 . . . . 2.61 109.813 177.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.576 ' CG2' HD12 ' A' ' 163' ' ' ILE . 67.1 m -73.6 -59.07 2.89 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 114.177 -1.374 . . . . 0.33 110.133 -175.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.998 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -59.13 -43.42 92.0 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.664 -1.153 . . . . 0.22 111.129 -178.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.496 ' HA ' ' CD1' ' A' ' 102' ' ' PHE . 54.3 m -55.53 -58.0 9.59 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.572 0.701 . . . . 0.26 110.599 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 86.5 m -68.25 -38.61 81.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.745 -1.116 . . . . 0.48 111.772 -176.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.759 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 16.2 mt -63.05 -48.65 77.8 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 121.499 0.666 . . . . 0.43 110.293 -177.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.861 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 10.6 t80 -59.35 -48.71 80.6 Favored 'General case' 0 C--O 1.203 -1.345 0 CA-C-N 114.718 -1.128 . . . . 0.31 110.881 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.428 ' N ' HD22 ' A' ' 62' ' ' ASN . 1.0 OUTLIER -73.52 -23.94 60.08 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 120.577 0.227 . . . . 1.21 110.686 -173.751 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.416 ' HB2' ' HE2' ' A' ' 63' ' ' LYS . 24.2 ttmm -84.4 -25.42 29.08 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 108.687 -0.857 . . . . 1.54 108.687 -177.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.718 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 44.5 m-85 -127.88 -2.21 5.92 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 115.583 1.697 . . . . 0.31 115.583 -170.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.678 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 15.0 pttp -67.26 -24.99 65.85 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 108.332 -0.988 . . . . 1.35 108.332 171.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.8 m -47.99 -38.01 16.01 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 114.035 -1.439 . . . . 1.28 110.978 173.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -86.61 -37.69 17.84 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 111.915 0.339 . . . . 1.11 111.915 174.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 149.83 -4.41 0.64 Allowed Glycine 0 N--CA 1.45 -0.367 0 N-CA-C 111.265 -0.734 . . . . 0.18 111.265 -177.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.759 ' HE2' ' HB3' ' A' ' 60' ' ' LEU . 22.9 t80 -67.6 141.36 56.81 Favored 'General case' 0 C--O 1.22 -0.461 0 C-N-CA 122.794 0.437 . . . . 0.18 111.323 -178.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.934 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 1.5 t -135.92 144.56 45.55 Favored 'General case' 0 CA--C 1.487 -1.476 0 N-CA-C 109.016 -0.735 . . . . 0.2 109.016 173.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.998 HG11 ' HB1' ' A' ' 57' ' ' ALA . 38.6 t -104.07 101.37 12.17 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.199 0 N-CA-C 108.613 -0.884 . . . . 0.17 108.613 160.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.691 ' HA ' ' HG2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -96.11 121.66 38.11 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 118.475 -1.29 . . . . 1.04 108.113 173.174 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.999 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -108.64 140.05 42.57 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.405 0.621 . . . . 0.51 110.351 179.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.864 ' HZ ' HG13 ' A' ' 20' ' ' VAL . 6.4 m-30 -115.31 110.39 45.36 Favored Pre-proline 0 C--N 1.311 -1.091 0 CA-C-N 115.507 -0.77 . . . . 0.44 109.234 -177.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.702 ' HA ' HG23 ' A' ' 43' ' ' VAL . 60.4 Cg_endo -78.18 46.58 2.13 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.567 2.844 . . . . 1.3 115.454 -164.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.474 ' O ' ' HD3' ' A' ' 107' ' ' LYS . 73.6 p 40.11 137.54 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 117.215 2.302 . . . . 1.44 117.215 176.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.5 ' OD1' ' HB3' ' A' ' 79' ' ' PHE . 50.7 t-20 -87.32 64.34 8.21 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 113.556 -1.656 . . . . 1.81 107.605 177.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.683 ' HA ' ' HG2' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -56.4 -14.32 2.9 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 114.007 -1.451 . . . . 3.34 110.578 176.779 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.5 ' HB3' ' OD1' ' A' ' 77' ' ' ASN . 77.9 t80 -69.78 -21.8 63.39 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 114.04 -1.436 . . . . 2.68 110.957 -178.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.06 -45.39 9.02 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.585 -0.734 . . . . 1.98 111.51 178.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.68 38.07 3.54 Favored Glycine 0 CA--C 1.506 -0.498 0 C-N-CA 120.895 -0.669 . . . . 1.49 112.902 177.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -145.76 27.79 1.19 Allowed 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.769 -0.456 . . . . 1.74 109.769 174.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.683 ' HG2' ' HA ' ' A' ' 78' ' ' GLN . 1.2 mm-40 -81.65 146.38 56.63 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-O 121.73 0.776 . . . . 3.07 111.789 -173.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.42 -41.33 1.24 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 124.375 3.384 . . . . 1.75 112.7 -173.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -112.05 135.75 12.99 Favored Glycine 0 N--CA 1.437 -1.276 0 C-N-CA 120.884 -0.674 . . . . 2.2 111.975 -175.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.631 ' HB3' ' HB3' ' A' ' 89' ' ' GLU . 2.4 m-20 59.37 40.47 20.95 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.225 0.536 . . . . 4.2 110.147 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -47.59 -42.45 23.97 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 114.508 -1.224 . . . . 3.02 112.775 -176.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -103.87 -7.26 20.61 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.348 0.594 . . . . 3.92 110.384 -172.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.631 ' HB3' ' HB3' ' A' ' 86' ' ' ASN . 12.2 tp10 -91.48 -62.33 1.46 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.546 -0.752 . . . . 2.65 112.265 -172.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.77 HG22 ' HB3' ' A' ' 47' ' ' CYS . 18.7 pt -83.58 6.86 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 112.95 0.722 . . . . 2.15 112.95 -167.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 42.0 mtmt -85.57 -68.06 0.76 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.991 0.424 . . . . 2.79 110.658 178.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -82.49 -15.3 52.96 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.489 -0.778 . . . . 3.29 111.264 -174.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -105.98 144.83 32.15 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.142 -0.688 . . . . 3.42 109.142 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 6.0 p -67.71 111.74 2.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.915 0.864 . . . . 2.63 112.033 -175.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.556 ' HA ' ' HB2' ' A' ' 47' ' ' CYS . 9.1 p -106.76 121.66 44.82 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 114.826 -1.079 . . . . 2.83 109.501 173.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 12.2 p -68.74 139.54 55.34 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.806 -0.812 . . . . 2.98 108.806 174.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.565 ' HD3' ' HB1' ' A' ' 23' ' ' ALA . 18.6 ptpt -62.4 105.04 0.56 Allowed 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.306 -0.998 . . . . 2.72 108.306 178.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.817 ' CE1' ' HB2' ' A' ' 100' ' ' ALA . 0.0 OUTLIER -53.94 114.28 1.53 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.628 -1.169 . . . . 2.12 111.537 -170.578 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -107.95 136.27 47.95 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.221 -0.899 . . . . 2.69 109.118 175.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.817 ' HB2' ' CE1' ' A' ' 98' ' ' PHE . . . -134.64 -166.04 1.75 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.226 0.536 . . . . 0.55 111.826 -173.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -85.33 8.74 17.59 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.166 -0.925 . . . . 1.99 109.876 175.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.613 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 16.9 p90 -138.81 161.22 59.53 Favored Pre-proline 0 N--CA 1.442 -0.842 0 CA-C-N 115.588 -0.733 . . . . 0.84 109.619 -178.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.799 ' HB3' ' OH ' ' A' ' 28' ' ' TYR . 18.2 Cg_endo -57.41 110.98 0.69 Allowed 'Trans proline' 0 CA--C 1.51 -0.701 0 C-N-CA 124.122 3.215 . . . . 0.62 114.1 -175.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.999 HD12 ' HB3' ' A' ' 73' ' ' ALA . 7.0 mm -108.56 134.24 51.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 C-N-CA 119.925 -0.71 . . . . 1.34 109.227 172.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.833 ' HG2' ' CG ' ' A' ' 74' ' ' PHE . 0.0 OUTLIER -89.54 -177.08 5.22 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.988 -0.551 . . . . 3.03 109.657 179.577 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.695 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . . . -57.25 -51.53 68.97 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.241 0.544 . . . . 1.46 110.418 -177.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.695 ' HB3' ' HG2' ' A' ' 75' ' ' PRO . 13.9 ptpt 128.57 121.96 0.0 OUTLIER 'General case' 0 CA--C 1.492 -1.28 0 C-N-CA 127.407 2.283 . . . . 1.76 106.036 -176.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.637 HD11 ' HD2' ' A' ' 74' ' ' PHE . 2.1 pp -129.41 156.58 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.242 0 N-CA-C 106.161 -1.792 . . . . 0.82 106.161 177.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.8 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 2.5 t-20 -52.06 117.82 3.04 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 123.696 0.623 . . . . 1.73 109.942 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.508 HG21 ' HB2' ' A' ' 42' ' ' ASN . 3.5 m -113.67 86.83 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.621 0 N-CA-C 107.625 -1.25 . . . . 0.77 107.625 169.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 173.4 -175.6 0.06 Allowed 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 113.844 -1.525 . . . . 1.9 109.435 -178.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -35.62 -54.57 1.06 Allowed Glycine 0 CA--C 1.507 -0.413 0 N-CA-C 118.199 2.039 . . . . 1.47 118.199 178.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.16 -45.79 25.55 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 117.215 -1.794 . . . . 2.81 114.366 -148.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -129.58 -33.41 1.86 Allowed 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.104 -0.702 . . . . 2.16 109.104 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.8 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . 47.48 -166.78 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.169 -1.378 . . . . 1.26 109.594 -167.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.582 ' HB2' ' HB ' ' A' ' 108' ' ' ILE . 6.4 t-80 -113.83 138.03 22.56 Favored Pre-proline 0 N--CA 1.419 -2.006 0 N-CA-C 107.166 -1.42 . . . . 0.42 107.166 162.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.581 ' HB2' ' CD1' ' A' ' 18' ' ' PHE . 11.5 Cg_exo -33.9 -41.35 0.2 Allowed 'Trans proline' 0 C--O 1.218 -0.483 0 C-N-CA 123.872 3.048 . . . . 0.4 113.099 -178.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.911 ' HG ' ' HE3' ' A' ' 122' ' ' MET . 33.5 tp -63.65 -48.53 76.86 Favored 'General case' 0 C--O 1.222 -0.369 0 C-N-CA 123.208 0.603 . . . . 0.39 111.726 176.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.689 ' HA ' ' HB2' ' A' ' 122' ' ' MET . 23.3 m-85 -78.04 -34.36 50.59 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 111.944 0.35 . . . . 3.04 111.944 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.686 ' HG2' ' HB3' ' A' ' 115' ' ' ALA . 0.8 OUTLIER -60.32 -35.82 76.51 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 106.809 -1.552 . . . . 2.44 106.809 171.617 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.63 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 55.1 t80 -70.29 -30.69 67.76 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 119.525 -0.87 . . . . 0.56 110.051 173.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.911 ' HE3' ' HG ' ' A' ' 118' ' ' LEU . 1.5 ttm -76.15 -54.58 6.6 Favored 'General case' 0 CA--C 1.509 -0.616 0 C-N-CA 120.388 -0.525 . . . . 0.71 110.479 -169.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.623 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -70.78 -25.43 62.89 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.297 -0.41 . . . . 1.46 111.437 179.398 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.52 ' N ' ' HD3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -71.67 -29.0 64.12 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 119.552 -0.859 . . . . 1.99 109.609 178.244 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 27.1 m -92.21 -24.94 18.88 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.571 -0.741 . . . . 0.59 111.52 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.484 ' HE2' ' HA ' ' A' ' 151' ' ' VAL . 23.5 mmtm -146.41 106.49 4.09 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 112.387 0.514 . . . . 1.85 112.387 -173.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.68 ' HA ' ' NH2' ' A' ' 153' ' ' ARG . 3.6 Cg_exo -79.9 -10.28 14.13 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.654 2.236 . . . . 1.69 110.978 167.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.707 ' HA3' ' HB3' ' A' ' 153' ' ' ARG . . . 87.52 -140.93 17.01 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.758 -0.656 . . . . 2.59 113.65 170.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 25.6 pt -67.78 -21.04 26.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 112.237 0.458 . . . . 3.58 112.237 -175.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.3 pp -136.02 141.01 44.29 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.745 -0.382 . . . . 3.47 110.534 178.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.21 97.47 0.54 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.778 -0.646 . . . . 3.28 111.341 -178.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.557 ' O ' ' HB3' ' A' ' 127' ' ' PRO . 14.8 t -142.21 -164.6 1.84 Allowed 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.375 -0.602 . . . . 3.56 109.375 177.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.422 ' HE2' ' HB3' ' A' ' 133' ' ' LYS . 52.4 mtpt -89.15 -90.6 0.13 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.495 0.664 . . . . 5.17 111.175 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.491 ' HA ' ' CB ' ' A' ' 123' ' ' LYS . . . -92.74 172.34 8.41 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.246 -0.888 . . . . 1.59 111.665 -173.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.752 ' O ' ' HB2' ' A' ' 136' ' ' LYS . 0.1 OUTLIER -36.05 -37.78 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 O-C-N 124.552 1.157 . . . . 2.0 113.039 -176.12 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.862 ' HB3' ' CE3' ' A' ' 137' ' ' TRP . 28.1 mtmt 108.12 -65.28 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 124.902 1.281 . . . . 4.81 112.752 177.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.862 ' CE3' ' HB3' ' A' ' 136' ' ' LYS . 0.7 OUTLIER -121.14 -175.81 3.14 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.139 -1.391 . . . . 1.97 111.122 -156.837 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.48 ' HB3' ' H ' ' A' ' 139' ' ' PHE . 12.7 m120 -35.56 -153.6 0.0 OUTLIER 'General case' 0 C--O 1.207 -1.168 0 CA-C-N 114.527 -1.215 . . . . 2.04 112.409 155.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.694 ' O ' ' HB3' ' A' ' 41' ' ' TYR . 0.9 OUTLIER -29.65 -21.97 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 117.495 2.406 . . . . 1.93 117.495 -172.162 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.674 ' HA ' ' O ' ' A' ' 154' ' ' PHE . 0.2 OUTLIER -7.58 120.32 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 120.141 1.337 . . . . 0.6 114.559 173.948 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.61 ' O ' ' HA ' ' A' ' 153' ' ' ARG . 1.0 OUTLIER -104.9 163.63 12.38 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.33 -1.305 . . . . 0.62 111.101 -167.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.567 ' CE2' HG23 ' A' ' 135' ' ' ILE . 97.4 m-85 -125.1 123.24 39.3 Favored 'General case' 0 CA--C 1.491 -1.32 0 N-CA-C 106.28 -1.748 . . . . 0.57 106.28 166.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.748 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 5.0 tp -79.46 102.25 8.66 Favored 'General case' 0 N--CA 1.425 -1.713 0 C-N-CA 118.242 -1.383 . . . . 0.43 108.157 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.705 HG13 HG13 ' A' ' 40' ' ' ILE . 39.1 mm -88.24 141.4 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 CA-C-N 113.8 -1.546 . . . . 0.19 107.611 -177.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.457 ' HA ' HD13 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -95.81 -174.83 3.24 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 119.359 -0.936 . . . . 0.98 111.234 -168.377 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.581 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 57.0 mtm180 -55.13 -40.11 70.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.818 0.342 . . . . 2.22 111.619 -176.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -92.44 14.39 16.79 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 109.443 -0.577 . . . . 2.0 109.443 -178.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.548 ' HA2' HG22 ' A' ' 144' ' ' ILE . . . 73.6 33.87 57.64 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 121.211 -0.519 . . . . 0.17 113.601 -178.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.447 ' HA ' ' HD2' ' A' ' 150' ' ' PRO . 31.7 t -107.41 107.39 60.33 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 117.961 0.88 . . . . 1.12 111.239 176.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.697 ' HD3' HG23 ' A' ' 15' ' ' ILE . 5.9 Cg_exo -47.4 125.3 10.49 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 123.888 3.059 . . . . 0.41 112.158 173.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.484 ' HA ' ' HE2' ' A' ' 126' ' ' LYS . 44.2 t -116.13 -37.12 2.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 109.046 -0.724 . . . . 1.45 109.046 -177.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.748 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 6.8 mm-40 -130.86 167.07 19.55 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 115.612 -0.722 . . . . 1.17 111.665 -175.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.707 ' HB3' ' HA3' ' A' ' 128' ' ' GLY . 20.4 ttm180 -138.87 133.07 31.47 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.022 -0.99 . . . . 2.16 109.655 165.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.674 ' O ' ' HA ' ' A' ' 140' ' ' THR . 96.3 m-85 -117.03 137.25 52.37 Favored 'General case' 0 C--O 1.213 -0.837 0 CA-C-N 116.336 -0.393 . . . . 0.32 109.982 -172.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.568 ' HA ' HG23 ' A' ' 140' ' ' THR . 37.4 m -67.13 153.43 94.63 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 109.381 -0.6 . . . . 1.11 109.381 179.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.665 ' HG3' ' HB3' ' A' ' 137' ' ' TRP . 10.0 Cg_endo -53.26 -48.27 22.94 Favored 'Trans proline' 0 N--CA 1.473 0.272 0 C-N-CA 122.647 2.232 . . . . 0.78 112.732 -174.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -67.05 10.34 0.84 Allowed Glycine 0 CA--C 1.527 0.841 0 N-CA-C 114.937 0.735 . . . . 0.5 114.937 176.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -74.45 146.21 43.02 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-N 118.481 1.141 . . . . 0.5 108.669 171.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.552 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 90.9 p -102.61 171.61 7.33 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 120.513 -0.475 . . . . 1.42 109.864 -174.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.574 HG22 ' HA ' ' A' ' 56' ' ' THR . 58.3 t -42.28 -48.97 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 O-C-N 124.202 0.939 . . . . 0.28 110.767 175.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.46 ' HE3' ' HB2' ' A' ' 161' ' ' LYS . 37.2 ttmt -71.75 -31.89 67.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.429 -0.805 . . . . 3.46 111.249 -172.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -67.03 -38.0 85.13 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.565 0.698 . . . . 1.4 109.634 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.576 HD12 ' CG2' ' A' ' 56' ' ' THR . 73.8 mt -82.3 -39.8 16.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 114.903 -1.044 . . . . 0.21 111.022 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.556 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 30.2 mt-10 -53.4 -44.54 68.76 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-O 120.503 0.192 . . . . 0.67 111.478 -178.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -57.15 -24.8 56.79 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.956 0.354 . . . . 0.87 111.956 -174.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.626 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 44.0 mmtm -98.15 -24.86 15.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.532 0.682 . . . . 1.71 109.987 175.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.556 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 10.0 tp -78.4 -50.09 12.35 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.97 -1.014 . . . . 0.16 112.353 -177.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.478 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 70.6 mt -55.61 -46.63 99.7 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 115.499 -0.773 . . . . 0.26 112.352 -173.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.478 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 53.3 Cg_exo -54.92 -26.76 50.36 Favored 'Trans proline' 0 C--N 1.356 0.921 0 C-N-CA 122.128 1.885 . . . . 0.41 112.669 174.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.724 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 62.4 mt -86.32 -42.48 13.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.725 -0.216 . . . . 0.71 111.267 177.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.703 HD23 ' HG2' ' A' ' 37' ' ' PRO . 97.3 mt -60.04 -54.11 49.84 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 122.127 0.965 . . . . 0.34 109.53 176.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -69.74 -1.95 34.12 Favored Glycine 0 N--CA 1.439 -1.106 0 CA-C-N 113.365 -1.743 . . . . 1.12 113.142 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 60.6 m 56.48 78.09 0.23 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.375 0.67 . . . . 2.64 112.558 175.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -66.95 -29.57 69.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.854 -0.612 . . . . 4.35 110.314 172.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -112.59 159.42 18.86 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.599 -0.728 . . . . 8.45 109.474 176.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 41.9 tp . . . . . 0 C--O 1.246 0.895 0 CA-C-O 118.632 -0.699 . . . . 7.69 110.368 -178.967 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.765 0 N-CA-C 111.924 -0.471 . . . . 5.22 111.924 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 95.7 mmm -104.4 0.12 28.67 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.455 0.645 . . . . 4.85 109.652 178.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 130.89 83.35 0.28 Allowed Glycine 0 N--CA 1.441 -1.015 0 CA-C-N 115.081 -0.963 . . . . 1.55 111.416 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 43.6 t -119.7 1.6 11.08 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.993 0.425 . . . . 1.58 110.22 179.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 91.4 p 178.52 157.98 0.49 Allowed 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 105.823 -1.918 . . . . 1.17 105.823 -177.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.818 HG23 ' HD3' ' A' ' 150' ' ' PRO . 6.7 pt -67.66 -17.63 22.72 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 CA-C-N 114.949 -1.023 . . . . 0.38 110.745 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.83 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 45.9 m-85 -74.74 -3.48 31.78 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 116.113 -0.494 . . . . 0.3 111.607 -176.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -67.14 -12.59 60.41 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.991 -1.114 . . . . 2.11 107.991 170.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.64 ' HE2' ' HB2' ' A' ' 121' ' ' TYR . 61.1 m-85 -129.07 109.81 11.5 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 114.794 -1.094 . . . . 0.31 110.007 -175.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -55.98 157.64 4.36 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 114.116 -1.402 . . . . 2.86 109.488 174.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.762 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 40.4 t -109.65 161.02 8.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 107.792 -1.188 . . . . 0.67 107.792 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.852 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 55.2 mt -126.09 122.49 35.91 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 120.552 -0.459 . . . . 0.69 109.901 -178.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.607 ' HA ' ' SD ' ' A' ' 105' ' ' MET . 0.8 OUTLIER -59.44 -175.85 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.387 0 O-C-N 124.31 1.006 . . . . 1.87 109.469 -179.179 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.717 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . . . -62.19 -3.93 1.52 Allowed 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 113.19 0.811 . . . . 0.59 113.19 -171.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -118.68 12.64 13.12 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.505 -0.478 . . . . 2.34 111.73 175.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.852 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 6.3 m170 72.3 26.06 2.74 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.677 0.751 . . . . 1.47 110.266 174.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.43 ' HA ' ' HD3' ' A' ' 26' ' ' LYS . 54.2 mmtt -102.5 133.21 20.65 Favored Pre-proline 0 N--CA 1.448 -0.533 0 CA-C-N 114.618 -1.174 . . . . 4.25 107.879 171.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.631 ' HA ' HD23 ' A' ' 21' ' ' LEU . 83.5 Cg_exo -51.38 112.8 0.89 Allowed 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.111 1.874 . . . . 0.54 114.208 -166.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.782 ' CE2' HD21 ' A' ' 72' ' ' LEU . 50.0 t80 -83.58 126.0 32.37 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 113.79 -1.55 . . . . 1.2 108.617 165.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.573 HD21 ' NE2' ' A' ' 32' ' ' GLN . 0.1 OUTLIER -67.67 82.0 0.18 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.911 0.862 . . . . 1.51 110.848 -178.068 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.744 ' HB2' HG23 ' A' ' 20' ' ' VAL . 44.5 tp -51.98 -37.76 54.22 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.536 -0.756 . . . . 0.28 109.653 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.634 HG13 ' HB3' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -67.75 0.13 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 114.687 -1.142 . . . . 1.02 113.0 -173.857 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.573 ' NE2' HD21 ' A' ' 29' ' ' ASN . 3.4 pt20 -72.7 -18.87 61.5 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 119.815 -0.754 . . . . 1.02 108.968 173.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.93 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 79.4 m-70 -92.33 29.86 1.6 Allowed 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 115.497 -0.774 . . . . 0.28 109.749 175.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.83 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 29.0 mtmt -92.35 111.04 22.47 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 114.896 -1.047 . . . . 1.56 109.584 173.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.94 -38.14 2.03 Favored Glycine 0 N--CA 1.443 -0.899 0 N-CA-C 110.759 -0.936 . . . . 0.2 110.759 -177.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.425 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 15.0 m -132.24 136.03 27.42 Favored Pre-proline 0 N--CA 1.435 -1.202 0 N-CA-C 109.127 -0.694 . . . . 0.29 109.127 169.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.687 ' O ' ' HA ' ' A' ' 69' ' ' PHE . 10.3 Cg_endo -47.42 156.83 0.9 Allowed 'Trans proline' 0 CA--C 1.511 -0.651 0 C-N-CA 124.481 3.454 . . . . 0.18 113.499 178.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.872 ' HB2' HG22 ' A' ' 70' ' ' THR . 0.9 OUTLIER -133.65 152.06 51.8 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 106.978 -1.49 . . . . 0.31 106.978 173.4 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.85 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 1.6 mm? -110.82 117.23 32.84 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.896 -1.15 . . . . 1.19 107.896 174.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.764 HD12 ' CE ' ' A' ' 122' ' ' MET . 9.1 mt -98.92 119.05 46.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 C-N-CA 119.714 -0.795 . . . . 0.37 110.195 178.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.85 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -105.11 127.29 52.83 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.469 -0.787 . . . . 0.42 109.916 -176.239 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.796 ' HB2' HG11 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -78.39 104.93 9.31 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 106.233 -1.765 . . . . 2.35 106.233 165.81 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.533 ' HB ' ' CE1' ' A' ' 139' ' ' PHE . 4.5 m -107.91 132.73 54.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 C-N-CA 118.986 -1.086 . . . . 1.03 111.32 -171.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.401 ' O ' ' N ' ' A' ' 46' ' ' LYS . . . -77.26 102.71 6.81 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 114.845 -1.07 . . . . 0.88 108.357 171.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.497 ' HA ' ' HB2' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -58.72 65.19 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.683 0 O-C-N 124.535 1.147 . . . . 1.78 112.107 175.462 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.658 ' HG2' ' HG2' ' A' ' 89' ' ' GLU . 86.8 mttt -89.24 174.75 7.67 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.098 -0.501 . . . . 5.84 110.544 -177.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.45 ' HB2' ' HA ' ' A' ' 95' ' ' CYS . 13.1 t -111.57 117.16 32.2 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.061 -0.518 . . . . 3.55 110.07 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 74.65 -5.59 29.36 Favored Glycine 0 CA--C 1.521 0.447 0 CA-C-N 116.168 -0.469 . . . . 2.91 113.3 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.409 ' HB2' ' CB ' ' A' ' 46' ' ' LYS . 29.1 m-85 -93.35 154.33 18.04 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.566 0.698 . . . . 4.63 112.487 -174.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.4 t -168.49 142.53 3.21 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.636 -1.165 . . . . 1.93 108.309 175.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.714 ' O ' ' HA2' ' A' ' 157' ' ' GLY . 27.8 mmmt -104.09 7.5 36.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.294 0.569 . . . . 2.01 109.559 176.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 111.61 -35.51 4.68 Favored Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 110.472 -1.051 . . . . 0.51 110.472 -171.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -45.96 -41.12 10.31 Favored Glycine 0 C--O 1.216 -1.03 0 CA-C-N 114.635 -0.782 . . . . 0.5 113.132 176.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -64.82 -52.2 58.05 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.948 0.404 . . . . 0.7 111.006 -178.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -63.29 -29.15 70.53 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.711 -0.677 . . . . 2.61 109.984 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.891 HG21 HD12 ' A' ' 163' ' ' ILE . 87.7 m -75.14 -55.74 5.43 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.207 -0.906 . . . . 0.33 109.159 -179.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 1.013 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -54.1 -43.93 70.8 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.58 -1.191 . . . . 0.22 111.379 -178.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.458 ' HA ' ' CD1' ' A' ' 102' ' ' PHE . 30.3 m -61.68 -54.5 41.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.395 0.617 . . . . 0.26 110.142 -177.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.7 m -68.34 -35.61 78.03 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.235 -0.893 . . . . 0.48 111.591 -176.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.719 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 0.6 OUTLIER -63.83 -52.82 58.39 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-O 121.774 0.797 . . . . 0.43 110.162 -176.822 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.892 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 8.1 t80 -55.31 -49.19 72.8 Favored 'General case' 0 C--O 1.204 -1.337 0 CA-C-N 113.83 -1.532 . . . . 0.31 110.597 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.863 ' HA ' ' HE2' ' A' ' 65' ' ' LYS . 28.7 m-80 -72.97 -24.71 60.82 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 116.638 -0.255 . . . . 1.21 110.632 -173.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.415 ' HD2' ' CE2' ' A' ' 64' ' ' TYR . 39.2 ttmt -81.47 -29.59 33.68 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 108.674 -0.862 . . . . 1.54 108.674 -178.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.657 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 42.3 m-85 -125.5 -2.97 7.37 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 116.185 1.92 . . . . 0.31 116.185 -168.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.863 ' HE2' ' HA ' ' A' ' 62' ' ' ASN . 47.3 pttt -65.25 -24.94 67.46 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 107.906 -1.146 . . . . 1.35 107.906 170.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.5 t -48.63 -38.91 22.25 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 113.882 -1.508 . . . . 1.28 110.483 172.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -86.53 -36.13 19.13 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 111.818 0.303 . . . . 1.11 111.818 173.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 149.4 -7.47 0.84 Allowed Glycine 0 CA--C 1.521 0.408 0 N-CA-C 111.888 -0.485 . . . . 0.18 111.888 -175.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.719 ' HE2' ' HB3' ' A' ' 60' ' ' LEU . 17.9 t80 -65.34 142.47 58.22 Favored 'General case' 0 C--O 1.22 -0.45 0 C-N-CA 123.036 0.534 . . . . 0.18 111.586 -177.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.93 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 1.6 t -133.9 147.75 51.15 Favored 'General case' 0 N--CA 1.423 -1.799 0 N-CA-C 108.521 -0.918 . . . . 0.2 108.521 170.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 1.013 HG11 ' HB1' ' A' ' 57' ' ' ALA . 36.5 t -98.93 101.9 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.734 0 N-CA-C 107.832 -1.173 . . . . 0.17 107.832 158.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.782 HD21 ' CE2' ' A' ' 28' ' ' TYR . 6.3 mt -83.69 119.56 24.93 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 108.051 -1.092 . . . . 1.04 108.051 177.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.509 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -95.84 111.22 23.25 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.401 -0.592 . . . . 0.51 109.401 177.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 1.009 ' HD2' HD12 ' A' ' 108' ' ' ILE . 3.3 m-85 -101.18 91.95 2.28 Favored Pre-proline 0 C--N 1.312 -1.026 0 N-CA-C 107.386 -1.338 . . . . 0.44 107.386 172.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.654 ' O ' ' HB2' ' A' ' 107' ' ' LYS . 80.8 Cg_endo -77.11 77.72 3.7 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.854 2.369 . . . . 1.3 114.626 -166.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.6 m -5.42 126.43 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 126.744 2.018 . . . . 1.44 116.185 -178.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.674 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 9.9 t30 -72.88 72.3 1.09 Allowed 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 113.351 -1.75 . . . . 1.81 109.315 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.564 ' HA ' ' HG3' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -47.42 -10.84 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 113.919 -1.491 . . . . 3.34 113.182 177.897 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.443 ' HB2' ' ND2' ' A' ' 77' ' ' ASN . 98.6 m-85 -65.8 -14.26 61.04 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.223 -0.444 . . . . 2.68 110.529 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.605 ' HA3' HE22 ' A' ' 82' ' ' GLN . . . -87.95 -179.32 47.38 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 116.039 -0.528 . . . . 1.98 112.053 176.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -117.12 30.09 6.46 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.903 -0.665 . . . . 1.49 112.251 -178.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.605 HE22 ' HA3' ' A' ' 80' ' ' GLY . 4.2 pm0 -136.21 -6.57 2.06 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 110.046 -0.353 . . . . 1.74 110.046 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.564 ' HG3' ' HA ' ' A' ' 78' ' ' GLN . 11.2 mm-40 -61.42 140.19 94.78 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.873 -0.603 . . . . 3.07 111.368 -168.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.416 ' HB2' ' O ' ' A' ' 137' ' ' TRP . 65.5 Cg_endo -81.61 177.97 7.05 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.962 2.442 . . . . 1.75 112.986 -167.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 86' ' ' ASN . . . 95.1 -38.72 3.04 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.585 -0.817 . . . . 2.2 112.457 178.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.758 ' HB3' ' HB2' ' A' ' 89' ' ' GLU . 63.7 t30 175.31 -12.74 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 122.733 0.413 . . . . 4.2 110.046 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 38.0 mt-10 75.22 -67.06 0.26 Allowed 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.519 0.728 . . . . 3.02 112.047 174.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -86.11 -2.54 58.43 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.923 0.392 . . . . 3.92 111.453 -175.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.758 ' HB2' ' HB3' ' A' ' 86' ' ' ASN . 4.4 tp10 -51.61 -61.63 2.13 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.465 0.65 . . . . 2.65 111.673 -176.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.809 HG23 ' HB2' ' A' ' 95' ' ' CYS . 4.3 mt -94.43 67.19 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.84 0.829 . . . . 2.15 110.888 -170.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -172.08 -39.87 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 106.246 -1.761 . . . . 2.79 106.246 175.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -73.24 -55.26 6.68 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 113.659 -1.61 . . . . 3.29 109.116 166.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -84.98 141.69 30.15 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 115.964 -0.562 . . . . 3.42 110.771 -176.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 79.8 t -69.65 111.72 3.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.731 -0.668 . . . . 2.63 109.439 173.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.809 ' HB2' HG23 ' A' ' 90' ' ' ILE . 36.5 m -138.29 127.18 23.87 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.527 0.68 . . . . 2.83 111.751 -173.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.3 p -64.73 159.86 21.33 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 114.688 -1.142 . . . . 2.98 108.796 167.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.463 ' HE3' ' HB1' ' A' ' 23' ' ' ALA . 14.0 pttm -74.67 53.49 0.56 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.463 0.649 . . . . 2.72 110.81 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.531 ' CD2' HG12 ' A' ' 104' ' ' ILE . 24.3 t80 68.57 -87.51 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.083 -0.962 . . . . 2.12 111.606 178.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt 70.54 148.74 0.08 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.583 0.753 . . . . 2.69 111.064 -176.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.624 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . -171.32 -164.3 0.33 Allowed 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 115.919 -0.582 . . . . 0.55 110.634 -172.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -91.2 -20.69 21.69 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.195 -0.457 . . . . 1.99 111.1 173.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.768 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 0.7 OUTLIER -89.52 175.04 4.21 Favored Pre-proline 0 N--CA 1.443 -0.784 0 CA-C-N 116.476 -0.329 . . . . 0.84 110.373 -177.513 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.768 ' HD2' ' HB2' ' A' ' 102' ' ' PHE . 70.7 Cg_endo -69.29 103.56 1.1 Allowed 'Trans proline' 0 C--N 1.336 -0.093 0 C-N-CA 122.818 2.345 . . . . 0.62 112.381 178.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.624 HD11 ' HB3' ' A' ' 100' ' ' ALA . 3.9 mp -101.1 120.75 51.07 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.018 0 N-CA-C 107.684 -1.228 . . . . 1.34 107.684 175.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.789 ' HG3' ' CE1' ' A' ' 74' ' ' PHE . 27.3 mmt -87.33 -164.54 1.1 Allowed 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.992 -1.004 . . . . 3.03 111.494 -169.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.717 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . . . -68.58 -16.22 63.79 Favored 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 120.315 -0.554 . . . . 1.46 111.07 -172.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.674 ' HD3' ' HA ' ' A' ' 77' ' ' ASN . 10.5 ptpt 81.1 139.68 0.07 Allowed 'General case' 0 CA--C 1.493 -1.215 0 O-C-N 125.71 1.881 . . . . 1.76 108.397 -163.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 1.009 HD12 ' HD2' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -131.26 159.84 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.599 0 N-CA-C 104.785 -2.302 . . . . 0.82 104.785 169.604 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.548 ' ND2' ' HG2' ' A' ' 113' ' ' GLU . 2.5 t30 -64.48 80.53 0.04 OUTLIER 'General case' 0 C--N 1.287 -2.148 0 O-C-N 123.603 0.564 . . . . 1.73 110.427 177.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.821 ' HA ' ' OH ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -78.81 90.38 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 C-N-CA 118.701 -1.2 . . . . 0.77 108.2 -179.711 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.443 ' N ' ' OH ' ' A' ' 119' ' ' TYR . 2.1 t-20 176.84 -179.06 0.17 Allowed 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 113.354 -1.748 . . . . 1.9 107.499 178.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -89.04 36.65 3.44 Favored Glycine 0 N--CA 1.44 -1.058 0 CA-C-O 118.686 -1.063 . . . . 1.47 115.656 -172.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.627 ' HG3' ' N ' ' A' ' 114' ' ' ASN . 0.8 OUTLIER -105.05 -44.54 4.76 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 120.067 1.933 . . . . 2.81 111.095 171.795 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.627 ' N ' ' HG3' ' A' ' 113' ' ' GLU . 52.4 t30 -132.09 -34.62 1.26 Allowed 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 109.307 -0.627 . . . . 2.16 109.307 -177.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.536 ' HA ' ' OH ' ' A' ' 119' ' ' TYR . . . 56.0 -164.44 0.14 Allowed 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 114.611 -1.177 . . . . 1.26 110.919 177.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.658 ' CB ' HG13 ' A' ' 108' ' ' ILE . 8.6 t-80 -150.25 121.31 3.95 Favored Pre-proline 0 N--CA 1.418 -2.026 0 N-CA-C 107.542 -1.281 . . . . 0.42 107.542 175.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.589 ' HB2' ' CD1' ' A' ' 18' ' ' PHE . 5.4 Cg_exo -33.43 -37.72 0.1 OUTLIER 'Trans proline' 0 C--O 1.214 -0.717 1 C-N-CA 125.403 4.068 . . . . 0.4 114.064 -172.905 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.773 ' CD1' ' HB ' ' A' ' 15' ' ' ILE . 7.5 tp -63.5 -60.32 3.5 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 114.046 1.128 . . . . 0.39 114.046 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.821 ' OH ' ' HA ' ' A' ' 110' ' ' VAL . 3.8 p90 -82.7 -25.82 32.61 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 107.486 -1.302 . . . . 3.04 107.486 -177.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.62 ' HA ' ' HD2' ' A' ' 123' ' ' LYS . 1.9 tm-20 -59.25 -39.86 84.14 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.334 -1.358 . . . . 2.44 107.334 172.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.64 ' HB2' ' HE2' ' A' ' 18' ' ' PHE . 29.6 t80 -64.21 -29.3 70.41 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.007 -0.997 . . . . 0.56 110.145 169.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.764 ' CE ' HD12 ' A' ' 40' ' ' ILE . 66.9 mtt -73.4 -55.3 6.55 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 121.134 0.493 . . . . 0.71 110.797 -173.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.705 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -70.45 -22.49 62.69 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.154 -0.93 . . . . 1.46 110.817 177.754 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.61 ' HG3' ' O ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -73.37 -26.3 60.95 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 119.636 -0.826 . . . . 1.99 109.502 171.318 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 93.2 m -74.87 -55.91 5.31 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.221 0.534 . . . . 0.59 110.06 173.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.696 ' HG2' ' NH2' ' A' ' 153' ' ' ARG . 22.7 ttmm -137.74 102.45 8.57 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.669 -0.696 . . . . 1.85 109.424 177.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -69.65 -55.74 0.17 Allowed 'Trans proline' 0 CA--C 1.52 -0.2 0 C-N-CA 123.552 2.835 . . . . 1.69 112.25 -170.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.685 ' HA3' ' HB ' ' A' ' 132' ' ' THR . . . -158.37 170.88 35.13 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 120.762 -0.733 . . . . 2.59 111.668 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.446 HD12 ' HB2' ' A' ' 130' ' ' LEU . 2.3 pp -106.7 -5.86 10.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.408 0.623 . . . . 3.58 110.11 176.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.446 ' HB2' HD12 ' A' ' 129' ' ' ILE . 19.0 tp -128.06 38.9 3.94 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.069 -0.969 . . . . 3.47 109.57 -176.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 58.88 40.59 22.52 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.733 -1.121 . . . . 3.28 110.011 -171.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.685 ' HB ' ' HA3' ' A' ' 128' ' ' GLY . 0.7 OUTLIER -90.34 149.08 22.46 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.725 -1.125 . . . . 3.56 109.614 -179.178 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.461 ' HD2' ' N ' ' A' ' 133' ' ' LYS . 0.6 OUTLIER -92.68 -24.61 18.57 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.069 0.461 . . . . 5.17 111.038 -178.026 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.568 ' HB1' HD13 ' A' ' 135' ' ' ILE . . . -157.63 -164.63 1.59 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.85 -0.614 . . . . 1.59 110.145 -175.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.977 ' H ' HD13 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -53.91 -40.44 44.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.868 -0.605 . . . . 2.0 110.861 172.857 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.696 ' HB3' ' CE3' ' A' ' 137' ' ' TRP . 6.0 tmtt? 64.39 -38.89 0.22 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 124.673 1.189 . . . . 4.81 114.04 174.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.78 ' HB3' ' HG3' ' A' ' 156' ' ' PRO . 6.8 m-90 -100.22 177.73 4.98 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 122.889 0.476 . . . . 1.97 111.78 -177.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.482 ' O ' ' N ' ' A' ' 140' ' ' THR . 10.7 t-20 -39.5 -155.32 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 113.852 -1.522 . . . . 2.04 111.37 157.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.607 ' HD2' ' HD2' ' A' ' 41' ' ' TYR . 1.6 m-85 -29.12 -25.06 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 117.924 2.565 . . . . 1.93 117.924 -171.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.69 ' HA ' ' O ' ' A' ' 154' ' ' PHE . 29.5 m -0.6 105.96 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 114.472 1.286 . . . . 0.6 114.472 175.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.616 ' HB3' HD12 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -86.12 170.33 12.3 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.167 -1.378 . . . . 0.62 110.302 -172.912 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.531 ' O ' HD13 ' A' ' 39' ' ' LEU . 86.7 m-85 -127.68 127.47 43.79 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 105.803 -1.925 . . . . 0.57 105.803 164.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.827 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 9.1 tp -80.55 104.71 11.26 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 118.238 -1.385 . . . . 0.43 108.534 176.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.759 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 41.7 mm -93.6 141.0 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.929 0 CA-C-N 113.746 -1.57 . . . . 0.19 107.154 -177.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.708 ' HA ' HD13 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -92.39 178.18 5.91 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 120.508 -0.477 . . . . 0.98 111.518 -171.736 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.462 ' CG ' ' HD3' ' A' ' 37' ' ' PRO . 66.8 mtm180 -48.71 -46.39 40.59 Favored 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 123.135 0.574 . . . . 2.22 111.494 -178.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -96.41 24.04 6.21 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.187 -0.672 . . . . 2.0 109.187 -178.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.535 ' HA2' ' CG2' ' A' ' 144' ' ' ILE . . . 71.68 42.6 53.94 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.083 -0.962 . . . . 0.17 113.789 175.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.482 ' O ' HG23 ' A' ' 151' ' ' VAL . 49.9 t -103.87 114.85 64.23 Favored Pre-proline 0 C--N 1.311 -1.074 0 C-N-CA 119.631 -0.828 . . . . 1.12 110.882 177.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.818 ' HD3' HG23 ' A' ' 15' ' ' ILE . 21.6 Cg_endo -67.02 113.06 2.68 Favored 'Trans proline' 0 CA--C 1.529 0.27 0 C-N-CA 122.998 2.465 . . . . 0.41 110.251 176.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 149' ' ' VAL . 16.3 t -113.66 -28.06 2.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-O 121.398 0.618 . . . . 1.45 109.788 -173.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.827 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 17.3 mm-40 -137.37 168.24 20.03 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 115.077 -0.965 . . . . 1.17 110.423 -177.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.696 ' NH2' ' HG2' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -145.92 137.71 25.1 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 114.59 -1.187 . . . . 2.16 108.901 161.729 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.716 ' HZ ' ' HB2' ' A' ' 166' ' ' LYS . 94.0 m-85 -112.25 145.56 39.72 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.126 -0.488 . . . . 0.32 110.161 -170.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 10.2 m -63.79 152.12 87.41 Favored Pre-proline 0 C--N 1.317 -0.842 0 N-CA-C 109.345 -0.613 . . . . 1.11 109.345 175.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.78 ' HG3' ' HB3' ' A' ' 137' ' ' TRP . 43.8 Cg_endo -66.69 -22.88 49.62 Favored 'Trans proline' 0 CA--C 1.512 -0.585 0 C-N-CA 122.28 1.987 . . . . 0.78 110.7 178.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.714 ' HA2' ' O ' ' A' ' 51' ' ' LYS . . . -85.38 13.73 53.92 Favored Glycine 0 N--CA 1.44 -1.085 0 CA-C-N 114.773 -1.103 . . . . 0.5 112.87 173.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -87.63 149.83 24.04 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.225 -0.657 . . . . 0.5 109.225 172.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.5 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 17.5 m -108.66 171.99 7.1 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 121.181 0.515 . . . . 1.42 111.526 -174.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.776 ' HA ' HG23 ' A' ' 56' ' ' THR . 52.0 t -39.07 -55.74 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 114.463 -1.244 . . . . 0.28 111.853 176.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -64.56 -31.87 73.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.472 -0.786 . . . . 3.46 111.567 -174.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.446 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 23.6 m-20 -75.75 -32.62 60.05 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.24 -0.891 . . . . 1.4 110.305 -173.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.891 HD12 HG21 ' A' ' 56' ' ' THR . 57.3 mt -83.3 -44.48 18.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.234 -0.894 . . . . 0.21 110.913 177.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.578 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 37.9 mt-10 -54.31 -40.44 67.96 Favored 'General case' 0 C--O 1.218 -0.575 0 CA-C-N 116.613 -0.267 . . . . 0.67 111.506 -178.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 9.2 pt-20 -56.9 -27.24 60.52 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 112.1 0.407 . . . . 0.87 112.1 -177.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.716 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 46.2 mmtm -96.69 -26.04 15.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.394 0.616 . . . . 1.71 110.276 175.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.578 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 12.1 tp -76.96 -49.49 15.38 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.068 -0.969 . . . . 0.16 112.031 -177.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.509 HG13 ' O ' ' A' ' 164' ' ' GLU . 81.8 mt -53.29 -44.82 98.21 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-N 115.511 -0.768 . . . . 0.26 112.165 -174.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.427 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 85.5 Cg_exo -50.37 -39.35 53.78 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.133 1.889 . . . . 0.41 112.917 172.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.708 HD13 ' HA ' ' A' ' 145' ' ' ASP . 96.0 mt -79.34 -43.52 23.37 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.728 -0.389 . . . . 0.71 111.284 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.63 HD21 ' HB2' ' A' ' 69' ' ' PHE . 95.7 mt -57.93 -54.11 50.58 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 122.083 0.944 . . . . 0.34 109.674 176.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -66.98 -4.86 29.82 Favored Glycine 0 N--CA 1.437 -1.235 0 CA-C-N 113.297 -1.774 . . . . 1.12 113.397 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 31.9 t 63.78 51.65 2.35 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.146 0.498 . . . . 2.64 110.917 175.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -62.75 -40.96 98.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.059 -0.519 . . . . 4.35 110.403 177.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -96.81 151.38 19.72 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.533 -0.543 . . . . 8.45 109.533 177.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.4 mm? . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.625 -0.702 . . . . 7.69 110.121 -177.129 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.668 0 N-CA-C 112.529 -0.228 . . . . 5.22 112.529 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 60.9 mtm 57.43 87.09 0.07 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.718 0.771 . . . . 4.85 109.878 -174.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.623 ' CA ' ' HB2' ' A' ' 17' ' ' ASP . . . -59.82 -61.15 7.52 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 114.403 -1.272 . . . . 1.55 114.931 -170.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.2 t 63.74 16.89 10.09 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.307 0.575 . . . . 1.58 109.853 -170.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 65.5 p 179.05 152.34 0.36 Allowed 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 105.47 -2.048 . . . . 1.17 105.47 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.827 ' HB ' HD11 ' A' ' 118' ' ' LEU . 5.6 pt -64.99 -12.95 14.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-N 115.061 -0.972 . . . . 0.38 112.187 -171.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.769 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 43.6 m-85 -75.44 0.96 15.24 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.378 0.51 . . . . 0.3 112.378 -175.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.623 ' HB2' ' CA ' ' A' ' 12' ' ' GLY . 38.6 t70 -73.43 -19.26 61.01 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 108.242 -1.021 . . . . 2.11 108.242 174.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.694 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 57.1 m-85 -111.34 107.34 16.57 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 114.628 -1.169 . . . . 0.31 111.045 -174.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -51.07 140.96 14.91 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 113.843 -1.526 . . . . 2.86 109.03 174.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.783 HG13 ' HZ ' ' A' ' 74' ' ' PHE . 40.3 t -110.32 166.27 5.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 108.118 -1.067 . . . . 0.67 108.118 -177.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.713 ' O ' ' HB2' ' A' ' 105' ' ' MET . 24.7 mt -127.0 143.61 51.25 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.884 -0.413 . . . . 0.69 109.884 179.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.442 ' OD2' ' HE2' ' A' ' 26' ' ' LYS . 18.6 m-20 -77.59 177.37 8.13 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 106.742 -1.577 . . . . 1.87 106.742 165.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.759 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . . . -64.39 -5.25 4.89 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 113.068 0.766 . . . . 0.59 113.068 -171.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.902 ' HB2' ' HG2' ' A' ' 26' ' ' LYS . 15.8 m-20 -94.66 -8.1 38.88 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 111.591 0.219 . . . . 2.34 111.591 178.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.545 ' HB2' ' O ' ' A' ' 24' ' ' ASP . 49.0 m-70 80.8 -0.66 1.83 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.506 0.723 . . . . 1.47 109.829 -175.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.902 ' HG2' ' HB2' ' A' ' 24' ' ' ASP . 6.4 ptmt -67.1 120.0 68.77 Favored Pre-proline 0 N--CA 1.45 -0.472 0 N-CA-C 108.158 -1.053 . . . . 4.25 108.158 165.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.635 ' HA ' HD23 ' A' ' 21' ' ' LEU . 90.0 Cg_exo -50.26 116.54 2.54 Favored 'Trans proline' 0 N--CA 1.465 -0.19 0 C-N-CA 122.638 2.225 . . . . 0.54 113.828 -175.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.834 ' HE2' HD23 ' A' ' 72' ' ' LEU . 15.0 t80 -79.74 143.66 34.32 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 113.865 -1.516 . . . . 1.2 111.212 174.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.488 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.7 t-20 -80.72 82.47 6.71 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.085 -0.962 . . . . 1.51 109.931 178.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.794 HD21 HD12 ' A' ' 15' ' ' ILE . 59.2 tp -57.91 -41.33 82.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.302 0.572 . . . . 0.28 109.784 177.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.71 HG12 ' HG3' ' A' ' 34' ' ' LYS . 2.0 t -68.16 -3.72 2.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 114.638 -1.165 . . . . 1.02 112.256 -170.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.488 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 3.4 pt20 -70.18 -17.25 63.16 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.919 -0.771 . . . . 1.02 108.919 175.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.904 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 92.4 m-70 -92.68 23.58 4.01 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.318 -0.855 . . . . 0.28 109.644 177.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.769 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 10.1 mtmt -81.99 121.76 26.93 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 114.639 -1.164 . . . . 1.56 109.335 168.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.42 -42.05 1.89 Allowed Glycine 0 N--CA 1.436 -1.31 0 C-N-CA 120.633 -0.794 . . . . 0.2 111.67 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.484 ' HB2' ' HA3' ' A' ' 68' ' ' GLY . 19.3 m -128.69 127.86 23.52 Favored Pre-proline 0 N--CA 1.435 -1.183 0 N-CA-C 108.462 -0.94 . . . . 0.29 108.462 173.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.805 ' HG3' ' CB ' ' A' ' 170' ' ' LEU . 4.9 Cg_endo -42.74 152.61 0.18 Allowed 'Trans proline' 0 CA--C 1.508 -0.777 0 C-N-CA 124.401 3.401 . . . . 0.18 113.205 178.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.853 HD13 ' HB2' ' A' ' 33' ' ' HIS . 0.9 OUTLIER -137.5 142.33 41.47 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.052 -1.431 . . . . 0.31 107.361 -178.341 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.989 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 1.8 mm? -107.79 114.78 28.98 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.473 -0.936 . . . . 1.19 108.473 176.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.825 HG23 HD13 ' A' ' 72' ' ' LEU . 1.1 mt -95.38 127.99 46.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 C-N-CA 119.81 -0.756 . . . . 0.37 109.647 177.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.989 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 1.1 m-85 -112.47 124.43 52.48 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.215 -0.448 . . . . 0.42 110.435 -175.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.667 HD22 ' HB ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -83.01 92.54 7.39 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 107.31 -1.367 . . . . 2.35 107.31 173.691 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.761 HG23 ' HB3' ' A' ' 139' ' ' PHE . 11.1 p -103.48 147.0 10.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-O 121.02 0.438 . . . . 1.03 111.394 -161.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -88.35 103.72 16.09 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.815 -0.63 . . . . 0.88 111.424 -175.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.581 ' O ' HD12 ' A' ' 90' ' ' ILE . 0.3 OUTLIER -56.41 91.63 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.279 -0.873 . . . . 1.78 111.022 170.726 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.463 ' HG2' ' N ' ' A' ' 47' ' ' CYS . 38.4 ttmt -141.94 169.9 16.72 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.185 -0.672 . . . . 5.84 109.185 -179.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.463 ' N ' ' HG2' ' A' ' 46' ' ' LYS . 8.8 t -108.67 117.91 35.42 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.916 0.388 . . . . 3.55 110.049 -176.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 69.25 51.47 27.28 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.564 -0.744 . . . . 2.91 112.586 -178.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -141.86 149.06 39.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.283 0.563 . . . . 4.63 111.901 -177.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 7.3 t -179.28 164.9 1.41 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 107.585 -1.265 . . . . 1.93 107.585 -179.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.735 ' H ' ' HZ ' ' A' ' 139' ' ' PHE . 29.7 ttmt -134.78 20.24 3.54 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.775 -0.824 . . . . 2.01 108.775 175.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 108.14 -40.03 2.68 Favored Glycine 0 N--CA 1.443 -0.869 0 CA-C-N 115.263 -0.88 . . . . 0.51 111.388 -175.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.535 ' HA2' ' HB ' ' A' ' 56' ' ' THR . . . -61.98 -19.12 58.56 Favored Glycine 0 C--O 1.22 -0.746 0 CA-C-O 119.688 -0.506 . . . . 0.5 114.359 -177.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -77.19 -57.0 4.08 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 118.305 1.053 . . . . 0.7 109.983 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.18 -39.27 72.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.575 0.703 . . . . 2.61 109.587 173.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.714 HG23 ' HA ' ' A' ' 160' ' ' VAL . 18.3 m -57.06 -59.28 5.3 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 114.625 -1.171 . . . . 0.33 111.296 174.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 1.061 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -55.98 -45.45 78.97 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.869 -0.605 . . . . 0.22 111.047 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.586 ' HA ' ' HE1' ' A' ' 102' ' ' PHE . 92.1 m -55.02 -51.33 66.62 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.589 0.709 . . . . 0.26 110.354 -178.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 28.1 m -72.96 -36.79 67.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.861 -1.063 . . . . 0.48 111.483 -177.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.712 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 14.5 mt -64.23 -52.67 57.61 Favored 'General case' 0 CA--C 1.498 -1.054 0 CA-C-O 121.311 0.577 . . . . 0.43 110.381 -178.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.794 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 2.1 t80 -51.73 -53.26 41.37 Favored 'General case' 0 C--O 1.199 -1.586 0 CA-C-N 114.218 -1.356 . . . . 0.31 110.167 178.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.412 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 6.1 m-80 -72.91 -25.56 61.1 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 112.097 0.406 . . . . 1.21 112.097 -170.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.453 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 35.4 ttpt -84.06 -23.24 30.94 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 119.401 -0.92 . . . . 1.54 108.924 -178.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.654 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 36.7 m-85 -122.37 -4.31 8.87 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 114.959 1.466 . . . . 0.31 114.959 -172.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.722 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 13.7 ptmt -64.93 -25.31 67.82 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 108.238 -1.023 . . . . 1.35 108.238 171.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.9 m -47.76 -41.9 24.33 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.113 -1.403 . . . . 1.28 110.74 172.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -85.37 -33.09 22.09 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.059 0.392 . . . . 1.11 112.059 175.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.484 ' HA3' ' HB2' ' A' ' 36' ' ' SER . . . 145.82 -7.46 1.47 Allowed Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 111.454 -0.659 . . . . 0.18 111.454 -177.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.712 ' HE2' ' HB3' ' A' ' 60' ' ' LEU . 19.5 t80 -64.38 140.86 58.91 Favored 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 122.709 0.403 . . . . 0.18 111.027 -178.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.904 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 1.6 t -134.34 151.3 51.15 Favored 'General case' 0 N--CA 1.413 -2.294 0 N-CA-C 108.425 -0.954 . . . . 0.2 108.425 173.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 1.061 HG11 ' HB1' ' A' ' 57' ' ' ALA . 50.2 t -109.16 100.27 10.42 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.341 0 N-CA-C 107.488 -1.301 . . . . 0.17 107.488 159.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.834 HD23 ' HE2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -89.85 121.07 31.63 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 118.254 -1.378 . . . . 1.04 108.375 177.496 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.86 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -98.09 112.68 24.55 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.914 -0.585 . . . . 0.51 110.842 -177.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.849 ' CD2' ' HE2' ' A' ' 119' ' ' TYR . 3.1 m-30 -96.56 102.16 10.74 Favored Pre-proline 0 C--N 1.31 -1.143 0 N-CA-C 108.827 -0.805 . . . . 0.44 108.827 176.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.717 ' HG2' ' HB3' ' A' ' 107' ' ' LYS . 87.8 Cg_endo -80.33 71.02 7.27 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 123.239 2.626 . . . . 1.3 114.302 -166.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 77.3 p 2.8 130.35 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 116.767 2.136 . . . . 1.44 116.767 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.621 ' C ' ' HG3' ' A' ' 83' ' ' GLU . 12.5 t30 -80.52 76.19 7.37 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 113.185 -1.825 . . . . 1.81 107.611 -179.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.982 ' HG3' HG21 ' A' ' 90' ' ' ILE . 7.6 mm-40 -48.16 -12.64 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.462 1.505 . . . . 3.34 111.574 -176.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.507 ' H ' ' C ' ' A' ' 77' ' ' ASN . 92.5 m-85 -90.04 29.53 1.2 Allowed 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.504 -1.225 . . . . 2.68 111.195 -175.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.488 ' HA3' HE22 ' A' ' 82' ' ' GLN . . . -109.64 -42.17 1.26 Allowed Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.653 -0.784 . . . . 1.98 112.831 -177.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 115.57 19.15 5.85 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.727 -0.749 . . . . 1.49 112.609 -176.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.488 HE22 ' HA3' ' A' ' 80' ' ' GLY . 0.8 OUTLIER -170.03 24.72 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 113.103 0.779 . . . . 1.74 113.103 -177.022 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.621 ' HG3' ' C ' ' A' ' 77' ' ' ASN . 6.1 mm-40 -89.03 153.95 49.41 Favored Pre-proline 0 C--N 1.314 -0.941 0 CA-C-O 121.366 0.603 . . . . 3.07 112.586 -173.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.562 ' HB3' ' HA ' ' A' ' 138' ' ' ASN . 89.2 Cg_exo -54.91 -0.66 0.13 Allowed 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 124.624 3.549 . . . . 1.75 114.811 176.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -97.68 13.08 64.3 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 121.123 -0.561 . . . . 2.2 112.088 176.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.545 HD21 ' HB2' ' A' ' 89' ' ' GLU . 4.1 p-10 50.04 37.19 13.56 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.329 1.052 . . . . 4.2 112.526 179.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 58.8 -86.33 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 114.439 1.274 . . . . 3.02 114.439 169.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.532 ' O ' ' HG2' ' A' ' 92' ' ' GLU . 33.5 mm-40 -58.95 -38.91 80.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.496 -0.775 . . . . 3.92 112.307 -166.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.545 ' HB2' HD21 ' A' ' 86' ' ' ASN . 32.3 tt0 -65.91 -14.14 60.98 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.019 0.438 . . . . 2.65 111.941 -173.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.982 HG21 ' HG3' ' A' ' 78' ' ' GLN . 12.0 mm -97.09 -29.36 3.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.444 0.64 . . . . 2.15 109.973 178.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -85.61 -41.72 14.98 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.595 -0.729 . . . . 2.79 111.353 -174.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.532 ' HG2' ' O ' ' A' ' 88' ' ' GLU . 10.4 pt-20 -84.41 -16.63 42.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.787 0.327 . . . . 3.29 110.706 -178.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.446 ' HB3' ' O ' ' A' ' 89' ' ' GLU . 19.0 t80 -113.55 158.77 20.35 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.014 -0.539 . . . . 3.42 109.713 -176.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 6.1 p -65.81 111.83 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.45 0.643 . . . . 2.63 110.341 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.445 ' HB3' HG23 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -96.03 123.78 39.78 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 121.625 0.726 . . . . 2.83 111.614 -178.86 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.451 ' C ' ' H ' ' A' ' 98' ' ' PHE . 14.2 p -90.8 149.68 21.88 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 108.114 -1.069 . . . . 2.98 108.114 166.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.423 ' H ' ' HG2' ' A' ' 97' ' ' LYS . 17.6 ptmt -73.29 41.86 0.11 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.917 0.389 . . . . 2.72 110.563 176.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.711 ' CZ ' ' HE2' ' A' ' 102' ' ' PHE . 61.9 t80 61.91 -85.97 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.185 -0.916 . . . . 2.12 110.749 -175.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.412 ' CG ' ' HG3' ' A' ' 97' ' ' LYS . 30.3 mtmm 69.51 144.85 0.05 Allowed 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 124.145 0.978 . . . . 2.69 111.816 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.629 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . -176.29 -152.96 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.971 -1.013 . . . . 0.55 110.235 -174.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -104.57 28.51 6.93 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.637 -0.711 . . . . 1.99 111.012 178.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.873 ' HB3' ' O ' ' A' ' 71' ' ' VAL . 3.5 m-85 -113.14 -177.11 0.42 Allowed Pre-proline 0 CA--C 1.513 -0.454 0 CA-C-O 121.853 0.835 . . . . 0.84 111.426 -177.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.706 ' HD3' ' CE2' ' A' ' 61' ' ' TYR . 12.9 Cg_exo -79.87 71.73 6.89 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 124.095 3.197 . . . . 0.62 110.442 156.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.86 HG13 ' HB3' ' A' ' 73' ' ' ALA . 5.3 mp -73.77 119.92 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 108.143 -1.058 . . . . 1.34 108.143 173.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.828 ' HG2' ' CG ' ' A' ' 74' ' ' PHE . 0.3 OUTLIER -80.26 -175.53 5.14 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.079 -0.509 . . . . 3.03 110.768 -173.358 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.759 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . . . -71.36 -0.01 9.19 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.592 -0.731 . . . . 1.46 111.958 -176.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.776 ' H ' ' HG3' ' A' ' 105' ' ' MET . 3.1 ptpp? 70.45 137.59 0.04 OUTLIER 'General case' 0 CA--C 1.499 -1.001 0 C-N-CA 125.256 1.422 . . . . 1.76 110.604 -170.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.701 HG13 ' CB ' ' A' ' 116' ' ' HIS . 0.1 OUTLIER -140.51 167.44 18.12 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 CA-C-N 113.262 -1.79 . . . . 0.82 106.358 168.297 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.664 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 0.2 OUTLIER -49.72 119.13 3.25 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.785 -0.82 . . . . 1.73 108.785 168.556 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.667 ' HB ' HD22 ' A' ' 42' ' ' ASN . 0.0 OUTLIER -128.28 87.84 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 C-N-CA 119.442 -0.903 . . . . 0.77 108.688 166.763 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.5 t30 171.81 179.59 0.07 Allowed 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 113.981 -1.463 . . . . 1.9 108.908 176.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 3.84 -72.38 0.0 OUTLIER Glycine 0 CA--C 1.528 0.893 0 N-CA-C 118.602 2.201 . . . . 1.47 118.602 168.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -86.23 -46.65 10.16 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 114.462 1.282 . . . . 2.81 114.462 -151.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -129.11 -34.68 1.87 Allowed 'General case' 0 CA--C 1.504 -0.793 0 C-N-CA 119.412 -0.915 . . . . 2.16 111.06 -174.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.664 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . 46.42 -134.07 0.96 Allowed 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 108.833 -0.802 . . . . 1.26 108.833 -172.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.701 ' CB ' HG13 ' A' ' 108' ' ' ILE . 0.9 OUTLIER -161.55 139.99 7.16 Favored Pre-proline 0 N--CA 1.43 -1.455 0 N-CA-C 107.057 -1.46 . . . . 0.42 107.057 178.689 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -27.44 -50.42 0.11 Allowed 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 124.701 3.6 . . . . 0.4 113.891 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.827 HD11 ' HB ' ' A' ' 15' ' ' ILE . 64.7 tp -57.12 -53.41 58.39 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 122.912 0.485 . . . . 0.39 112.259 176.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.849 ' HE2' ' CD2' ' A' ' 74' ' ' PHE . 80.0 m-85 -77.38 -35.37 54.49 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 112.299 0.481 . . . . 3.04 112.299 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.73 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 5.7 mm-40 -57.48 -34.0 68.57 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 107.221 -1.399 . . . . 2.44 107.221 172.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.694 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 70.8 t80 -71.48 -33.5 69.34 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 119.262 -0.975 . . . . 0.56 111.065 173.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.651 ' HE3' ' HG ' ' A' ' 118' ' ' LEU . 1.8 ttm -74.64 -55.0 6.37 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.275 -0.42 . . . . 0.71 110.465 -171.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.568 ' HD2' ' CB ' ' A' ' 134' ' ' ALA . 0.6 OUTLIER -70.57 -25.74 63.22 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 116.514 -0.312 . . . . 1.46 111.42 178.029 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.73 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 9.4 pttp -68.58 -27.28 65.92 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 119.486 -0.886 . . . . 1.99 109.485 177.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 29.1 m -89.47 -28.01 19.97 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.244 -0.889 . . . . 0.59 110.703 176.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.541 ' HB3' ' NH2' ' A' ' 153' ' ' ARG . 39.9 mmtt -134.04 89.97 27.6 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.087 -0.506 . . . . 1.85 110.945 -177.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -61.51 -40.45 47.5 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.367 2.711 . . . . 1.69 113.851 -175.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.531 ' HA2' ' CZ ' ' A' ' 153' ' ' ARG . . . 149.35 145.99 4.24 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 119.76 -1.21 . . . . 2.59 113.229 178.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.435 HG23 HH12 ' A' ' 153' ' ' ARG . 24.8 pt -68.66 -19.74 24.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.222 0.534 . . . . 3.58 110.839 178.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.725 HD23 ' H ' ' A' ' 130' ' ' LEU . 2.6 pt? -104.18 8.59 36.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.563 0.697 . . . . 3.47 110.009 179.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 60.02 56.83 3.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.131 -1.395 . . . . 3.28 112.472 177.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 90.3 m -105.24 -81.48 0.53 Allowed 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.876 -0.33 . . . . 3.56 111.453 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 73.1 tttt -179.38 -37.2 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.871 0.367 . . . . 5.17 111.282 -175.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.738 ' HB1' HD13 ' A' ' 135' ' ' ILE . . . -142.46 -167.93 2.62 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.2 -0.455 . . . . 1.59 111.266 -174.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.755 ' H ' HD13 ' A' ' 135' ' ' ILE . 0.2 OUTLIER -51.59 -42.21 29.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 115.585 -0.734 . . . . 2.0 110.18 171.594 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.416 ' HD3' HD11 ' A' ' 130' ' ' LEU . 61.3 tttm 68.09 -38.01 0.35 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.595 1.158 . . . . 4.81 112.797 177.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.604 ' HB3' ' HG3' ' A' ' 156' ' ' PRO . 2.4 m95 -98.85 177.03 5.4 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 122.928 0.491 . . . . 1.97 111.599 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.562 ' HA ' ' HB3' ' A' ' 84' ' ' PRO . 1.6 m120 -39.48 -155.61 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 126.603 1.961 . . . . 2.04 114.128 165.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.761 ' HB3' HG23 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -34.14 -22.19 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 116.063 1.875 . . . . 1.93 116.063 -177.084 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.613 ' HB ' ' HB ' ' A' ' 135' ' ' ILE . 3.7 m 10.49 108.12 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 119.965 1.257 . . . . 0.6 113.911 166.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.514 ' CB ' HD12 ' A' ' 39' ' ' LEU . 0.9 OUTLIER -90.75 161.08 15.48 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 114.066 -1.425 . . . . 0.62 110.484 -167.34 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.478 ' HA ' ' HA ' ' A' ' 153' ' ' ARG . 38.6 m-85 -124.64 122.82 38.59 Favored 'General case' 0 CA--C 1.494 -1.206 0 N-CA-C 106.389 -1.708 . . . . 0.57 106.389 168.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.787 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 8.9 tp -79.73 104.88 10.62 Favored 'General case' 0 N--CA 1.425 -1.708 0 C-N-CA 118.348 -1.341 . . . . 0.43 108.416 179.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.679 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 39.3 mm -92.0 142.05 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.717 0 CA-C-N 112.744 -2.025 . . . . 0.19 107.605 -178.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.439 ' HA ' HD13 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -94.43 -175.57 3.67 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 119.131 -1.028 . . . . 0.98 111.316 -170.194 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.67 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 29.9 mtm180 -52.33 -39.6 60.85 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 121.097 0.475 . . . . 2.22 110.909 -178.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -97.33 20.99 10.66 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.334 0.588 . . . . 2.0 109.711 -175.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.7 ' HA3' ' CE2' ' A' ' 16' ' ' PHE . . . 68.73 35.58 80.55 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 115.812 -0.631 . . . . 0.17 114.185 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.467 ' HA ' ' HD2' ' A' ' 150' ' ' PRO . 65.5 t -106.17 108.31 61.46 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 118.387 1.093 . . . . 1.12 111.666 175.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.689 ' HD3' HG23 ' A' ' 15' ' ' ILE . 5.3 Cg_endo -52.05 114.78 1.78 Allowed 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 123.876 3.051 . . . . 0.41 111.256 171.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.959 HG13 ' HG2' ' A' ' 152' ' ' GLU . 13.8 p -116.79 -21.88 4.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-O 121.489 0.661 . . . . 1.45 109.488 -177.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.959 ' HG2' HG13 ' A' ' 151' ' ' VAL . 30.1 mm-40 -138.25 167.54 21.63 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 115.351 -0.841 . . . . 1.17 110.372 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.541 ' NH2' ' HB3' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -145.14 146.29 31.72 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.137 -0.938 . . . . 2.16 109.571 161.517 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.632 ' CE2' ' HA ' ' A' ' 163' ' ' ILE . 93.2 m-85 -121.95 140.46 52.42 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.874 -0.603 . . . . 0.32 109.457 -172.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 6.3 m -68.14 158.57 83.73 Favored Pre-proline 0 C--N 1.315 -0.913 0 N-CA-C 109.847 -0.427 . . . . 1.11 109.847 178.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.604 ' HG3' ' HB3' ' A' ' 137' ' ' TRP . 18.4 Cg_endo -59.46 -32.4 96.31 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.137 1.891 . . . . 0.78 110.624 174.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -73.06 -0.0 49.29 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 114.515 -1.221 . . . . 0.5 113.724 173.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -85.97 146.15 26.81 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.83 -0.804 . . . . 0.5 108.83 173.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 4.0 t -110.35 -178.83 3.6 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-O 121.082 0.468 . . . . 1.42 110.259 -173.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.714 ' HA ' HG23 ' A' ' 56' ' ' THR . 60.8 t -45.84 -57.25 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 114.609 -1.178 . . . . 0.28 111.79 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 42.5 tttm -63.46 -38.44 91.14 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 120.624 0.25 . . . . 3.46 111.034 -172.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.41 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 61.9 m-20 -57.26 -43.27 82.85 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.812 0.815 . . . . 1.4 109.124 -177.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.632 ' HA ' ' CE2' ' A' ' 154' ' ' PHE . 90.5 mt -75.52 -47.29 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 CA-C-N 114.216 -1.356 . . . . 0.21 111.017 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.624 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 58.2 mt-10 -55.39 -43.49 75.23 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-O 121.089 0.471 . . . . 0.67 111.07 -176.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 10.5 pt-20 -63.63 -16.21 60.31 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 116.269 -0.423 . . . . 0.87 111.684 -173.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.577 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 31.5 mmmt -104.51 -21.34 13.46 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.47 0.653 . . . . 1.71 109.964 172.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.601 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 12.8 tp -84.96 -49.53 8.26 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.997 -1.001 . . . . 0.16 112.289 -176.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.574 ' N ' ' HD2' ' A' ' 169' ' ' PRO . 64.1 mt -57.46 -43.7 99.14 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.661 -0.699 . . . . 0.26 112.4 -174.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 168' ' ' ILE . 8.0 Cg_endo -53.65 -20.62 17.12 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 121.894 1.729 . . . . 0.41 112.939 172.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.805 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 99.3 mt -96.42 -43.14 7.78 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 122.416 -0.178 . . . . 0.71 111.205 177.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.648 HD21 ' HB2' ' A' ' 69' ' ' PHE . 96.6 mt -60.08 -56.95 15.31 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-O 121.962 0.887 . . . . 0.34 108.738 173.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -97.27 53.74 1.33 Allowed Glycine 0 N--CA 1.424 -2.154 0 CA-C-N 113.892 -1.504 . . . . 1.12 110.552 178.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.452 ' OG ' ' HD3' ' A' ' 146' ' ' ARG . 3.4 p -72.08 68.75 0.71 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.644 -0.778 . . . . 2.64 112.389 -177.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -76.82 -22.95 52.88 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.406 -0.961 . . . . 4.35 108.406 168.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 53.23 61.73 3.01 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 114.899 -1.046 . . . . 8.45 112.435 167.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 7.2 mp . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.531 -0.747 . . . . 7.69 109.572 176.243 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.802 0 N-CA-C 112.565 -0.214 . . . . 5.22 112.565 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.9 ptm 175.06 -30.58 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 122.913 0.485 . . . . 4.85 109.736 178.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 171.56 68.96 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.58 -0.819 . . . . 1.55 112.505 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.1 m -135.93 2.82 2.89 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.507 0.67 . . . . 1.58 110.007 175.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 90.9 p -178.48 151.81 0.62 Allowed 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.678 -1.971 . . . . 1.17 105.678 175.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.882 HG21 ' HE1' ' A' ' 122' ' ' MET . 6.5 pt -69.12 -13.99 17.95 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 CA-C-N 114.787 -1.097 . . . . 0.38 111.801 -171.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.824 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 54.8 m-85 -77.21 -3.26 38.72 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.273 -0.421 . . . . 0.3 111.189 -177.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -69.24 -21.06 63.94 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.275 -1.009 . . . . 2.11 108.275 172.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.753 ' HE2' ' HB2' ' A' ' 121' ' ' TYR . 49.6 m-85 -114.14 111.1 21.03 Favored 'General case' 0 CA--C 1.503 -0.853 0 CA-C-N 114.718 -1.128 . . . . 0.31 111.84 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -50.42 150.35 2.66 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.142 -1.39 . . . . 2.86 109.941 169.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.762 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 38.0 t -111.43 164.02 7.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 N-CA-C 108.894 -0.78 . . . . 0.67 108.894 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.759 ' O ' ' HB3' ' A' ' 105' ' ' MET . 89.6 mt -126.4 113.11 16.45 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 120.873 -0.331 . . . . 0.69 111.65 -176.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.716 ' HA ' ' HE2' ' A' ' 105' ' ' MET . 12.1 t70 -51.6 160.42 0.63 Allowed 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 107.779 -1.193 . . . . 1.87 107.779 169.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.635 ' HA ' ' C ' ' A' ' 105' ' ' MET . . . -54.53 -16.69 2.53 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 114.147 1.166 . . . . 0.59 114.147 -163.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.543 ' HB2' ' HE2' ' A' ' 26' ' ' LYS . 33.4 m-20 -96.15 5.32 51.35 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 112.325 0.491 . . . . 2.34 112.325 178.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.695 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 82.8 m-70 78.13 15.21 1.43 Allowed 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.699 0.762 . . . . 1.47 109.163 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.543 ' HE2' ' HB2' ' A' ' 24' ' ' ASP . 13.2 mtmt -79.64 119.15 75.89 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 107.212 -1.403 . . . . 4.25 107.212 169.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.61 ' HA ' HD23 ' A' ' 21' ' ' LEU . 84.6 Cg_exo -51.7 113.91 1.36 Allowed 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 121.582 1.521 . . . . 0.54 113.157 -173.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.56 ' HB3' HG12 ' A' ' 20' ' ' VAL . 32.3 t80 -79.35 144.8 33.86 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.074 -1.421 . . . . 1.2 111.366 175.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.441 ' OD1' ' HB3' ' A' ' 32' ' ' GLN . 2.4 t-20 -78.85 85.38 4.83 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.026 -0.988 . . . . 1.51 109.934 178.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.616 ' HG ' ' CD1' ' A' ' 16' ' ' PHE . 49.1 tp -63.26 -42.37 99.14 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.393 -0.821 . . . . 0.28 110.471 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.804 ' HA ' ' CE1' ' A' ' 16' ' ' PHE . 2.0 t -68.99 -0.64 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 114.424 -1.262 . . . . 1.02 112.481 -167.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.441 ' HB3' ' OD1' ' A' ' 29' ' ' ASN . 10.4 pt20 -76.52 -5.26 46.79 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.531 0.681 . . . . 1.02 110.321 177.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.955 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 87.9 m-70 -100.71 24.29 9.31 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.843 0.83 . . . . 0.28 109.335 173.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.824 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 0.5 OUTLIER -82.82 110.42 17.82 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.724 -1.125 . . . . 1.56 109.311 171.762 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.26 -37.42 2.2 Favored Glycine 0 N--CA 1.437 -1.249 0 C-N-CA 120.917 -0.659 . . . . 0.2 111.506 -177.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.479 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 17.6 m -132.33 133.11 23.34 Favored Pre-proline 0 N--CA 1.435 -1.197 0 N-CA-C 108.626 -0.879 . . . . 0.29 108.626 173.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.8 ' HG3' ' CB ' ' A' ' 170' ' ' LEU . 6.8 Cg_endo -44.04 153.45 0.31 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 124.124 3.216 . . . . 0.18 112.614 178.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.895 ' HB2' HG22 ' A' ' 70' ' ' THR . 0.7 OUTLIER -140.61 139.41 34.89 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.027 -1.471 . . . . 0.31 107.027 -179.919 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.818 ' HB3' ' CE1' ' A' ' 41' ' ' TYR . 3.0 mp -107.17 116.66 32.32 Favored 'General case' 0 C--N 1.293 -1.881 0 O-C-N 121.518 -0.739 . . . . 1.19 109.449 176.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.914 HG23 ' HB2' ' A' ' 72' ' ' LEU . 2.6 mt -95.77 120.35 45.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-N 115.557 -0.747 . . . . 0.37 109.761 176.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.818 ' CE1' ' HB3' ' A' ' 39' ' ' LEU . 0.5 OUTLIER -103.87 124.95 49.88 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.493 -0.776 . . . . 0.42 110.041 -174.555 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.675 ' OD1' ' HB ' ' A' ' 140' ' ' THR . 0.2 OUTLIER -75.61 125.66 29.47 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 104.309 -2.478 . . . . 2.35 104.309 168.525 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.703 ' O ' ' HA ' ' A' ' 75' ' ' PRO . 2.8 p -133.14 123.88 48.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 C-N-CA 117.665 -1.614 . . . . 1.03 113.114 -169.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.59 98.07 3.3 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.125 -0.943 . . . . 0.88 108.842 172.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.672 ' HA ' ' HB3' ' A' ' 98' ' ' PHE . 3.4 p -48.04 82.4 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 113.954 -1.475 . . . . 1.78 112.138 169.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.823 ' HE3' ' HB3' ' A' ' 49' ' ' TYR . 27.3 mtpp -101.49 163.86 12.05 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.282 -0.636 . . . . 5.84 109.282 178.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 33.9 t -110.12 116.95 32.47 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 120.934 0.397 . . . . 3.55 109.997 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 66.97 25.24 73.25 Favored Glycine 0 CA--C 1.519 0.319 0 CA-C-N 115.749 -0.66 . . . . 2.91 112.69 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.823 ' HB3' ' HE3' ' A' ' 46' ' ' LYS . 0.3 OUTLIER -136.23 135.11 38.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.014 0.435 . . . . 4.63 111.494 -177.542 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -147.9 141.32 25.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.517 -0.765 . . . . 1.93 110.148 178.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.548 ' HD3' ' OD1' ' A' ' 138' ' ' ASN . 27.8 mtpp -112.7 48.55 1.0 Allowed 'General case' 0 C--O 1.223 -0.333 0 N-CA-C 110.232 -0.284 . . . . 2.01 110.232 176.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.13 -42.12 3.03 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.775 -0.726 . . . . 0.51 112.077 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -47.55 -45.16 23.18 Favored Glycine 0 C--O 1.224 -0.517 0 O-C-N 123.792 0.348 . . . . 0.5 113.686 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.639 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 1.1 t80 -61.38 -62.97 1.45 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.049 0.389 . . . . 0.7 112.049 -172.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -59.24 -40.14 84.98 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.188 0.518 . . . . 2.61 111.121 -178.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.55 ' HA ' ' CG2' ' A' ' 160' ' ' VAL . 40.8 m -54.97 -59.92 4.09 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.163 -0.926 . . . . 0.33 111.193 174.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 1.027 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -61.81 -42.55 99.16 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.417 -0.811 . . . . 0.22 111.15 -176.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.597 ' N ' ' HE1' ' A' ' 102' ' ' PHE . 61.5 m -55.33 -51.08 67.92 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.814 0.816 . . . . 0.26 109.825 -177.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 26.5 m -72.11 -35.15 69.1 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 114.402 -1.272 . . . . 0.48 111.22 -177.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.64 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 17.4 mt -67.57 -50.04 60.35 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 121.365 0.602 . . . . 0.43 110.413 -176.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.847 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 8.4 t80 -59.36 -47.21 86.29 Favored 'General case' 0 C--O 1.205 -1.27 0 CA-C-N 114.967 -1.015 . . . . 0.31 110.502 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -73.76 -24.29 59.84 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 112.022 0.379 . . . . 1.21 112.022 -174.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.48 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 32.2 ttpt -84.54 -25.99 28.36 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 120.02 -0.672 . . . . 1.54 109.275 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.734 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 35.9 m-85 -123.2 -5.79 8.34 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 115.121 1.526 . . . . 0.31 115.121 -169.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.71 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 41.4 pttt -65.48 -26.59 67.99 Favored 'General case' 0 CA--C 1.5 -0.975 0 N-CA-C 108.434 -0.95 . . . . 1.35 108.434 172.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.2 t -47.91 -41.86 25.65 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.458 -1.246 . . . . 1.28 110.733 172.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.403 HE21 ' HD1' ' A' ' 64' ' ' TYR . 48.0 mt-30 -82.03 -37.41 26.56 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 111.821 0.304 . . . . 1.11 111.821 175.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.429 ' HA3' ' HB2' ' A' ' 36' ' ' SER . . . 150.58 -7.95 0.72 Allowed Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 111.622 -0.591 . . . . 0.18 111.622 -176.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.734 ' HD2' ' HB2' ' A' ' 64' ' ' TYR . 13.7 t80 -64.41 143.33 57.98 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 122.777 0.431 . . . . 0.18 110.841 -178.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.955 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 5.3 t -132.91 148.16 52.29 Favored 'General case' 0 N--CA 1.416 -2.127 0 N-CA-C 108.848 -0.797 . . . . 0.2 108.848 168.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 1.027 HG11 ' HB1' ' A' ' 57' ' ' ALA . 21.8 t -100.07 100.78 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.419 0 N-CA-C 107.199 -1.408 . . . . 0.17 107.199 158.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.914 ' HB2' HG23 ' A' ' 40' ' ' ILE . 79.8 mt -84.26 118.87 24.45 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 107.085 -1.45 . . . . 1.04 107.085 178.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.618 ' HB3' HG12 ' A' ' 104' ' ' ILE . . . -96.44 113.41 24.99 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.939 -0.704 . . . . 0.51 109.838 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.882 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 5.0 m-85 -108.96 95.22 16.62 Favored Pre-proline 0 N--CA 1.433 -1.286 0 N-CA-C 107.337 -1.357 . . . . 0.44 107.337 -177.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.891 ' HB2' ' HG2' ' A' ' 107' ' ' LYS . 3.4 Cg_endo -67.33 148.37 79.71 Favored 'Trans proline' 0 N--CA 1.429 -2.314 0 N-CA-C 109.091 -1.157 . . . . 1.3 109.091 -174.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.599 ' HB2' ' OE1' ' A' ' 83' ' ' GLU . 29.2 p -76.17 141.31 41.89 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-O 121.988 0.899 . . . . 1.44 112.76 -177.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.415 ' C ' ' H ' ' A' ' 79' ' ' PHE . 62.2 t30 -69.28 62.7 0.14 Allowed 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 113.56 -1.655 . . . . 1.81 108.622 170.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.82 ' HA ' ' HG3' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -51.24 -13.34 0.18 Allowed 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 114.577 -1.192 . . . . 3.34 111.135 174.313 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.415 ' H ' ' C ' ' A' ' 77' ' ' ASN . 50.1 t80 -66.7 -13.61 61.5 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.979 -1.01 . . . . 2.68 110.519 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.32 -135.36 5.05 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.192 -0.528 . . . . 1.98 112.109 175.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -159.02 54.32 0.37 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.932 -0.652 . . . . 1.49 112.153 178.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.59 ' HG3' ' HB3' ' A' ' 113' ' ' GLU . 3.5 pm0 -153.97 5.5 0.3 Allowed 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.348 0.594 . . . . 1.74 110.77 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.82 ' HG3' ' HA ' ' A' ' 78' ' ' GLN . 15.8 mm-40 -80.17 137.51 52.9 Favored Pre-proline 0 C--N 1.308 -1.208 0 N-CA-C 114.443 1.275 . . . . 3.07 114.443 -159.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.707 ' HD3' HD22 ' A' ' 111' ' ' ASN . 0.0 OUTLIER -34.1 148.25 0.03 OUTLIER 'Trans proline' 0 C--O 1.235 0.357 1 C-N-CA 126.521 4.814 . . . . 1.75 116.447 176.351 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.67 -46.75 3.7 Favored Glycine 0 N--CA 1.441 -0.995 0 CA-C-N 114.857 -1.065 . . . . 2.2 113.972 167.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.502 ' O ' ' HB2' ' A' ' 87' ' ' GLU . 27.0 t-20 -171.69 -34.48 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.852 1.056 . . . . 4.2 113.852 -170.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.502 ' HB2' ' O ' ' A' ' 86' ' ' ASN . 52.1 mt-10 76.36 -63.17 0.4 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.787 0.435 . . . . 3.02 111.737 -177.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.695 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 41.5 mm-40 -68.51 -45.49 72.14 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.535 0.939 . . . . 3.92 113.535 -168.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -48.37 -54.29 14.47 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.719 0.637 . . . . 2.65 112.719 -168.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.704 HG23 ' HB2' ' A' ' 95' ' ' CYS . 4.0 mp -65.69 -26.03 37.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 111.976 0.361 . . . . 2.15 111.976 -171.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.695 ' HE2' ' HA ' ' A' ' 88' ' ' GLU . 38.6 mtmt -80.65 -37.27 31.23 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.208 0.527 . . . . 2.79 110.58 -178.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 88' ' ' GLU . 32.1 mm-40 -90.26 -39.26 12.87 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.558 -0.746 . . . . 3.29 110.614 -173.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -88.97 162.22 16.18 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.082 -0.963 . . . . 3.42 109.435 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 73.3 t -79.21 107.66 11.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 108.949 -0.759 . . . . 2.63 108.949 173.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.704 ' HB2' HG23 ' A' ' 90' ' ' ILE . 33.2 m -152.84 122.41 6.81 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.202 -0.908 . . . . 2.83 108.855 178.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.423 HG22 ' HG3' ' A' ' 97' ' ' LYS . 1.4 m -146.23 123.83 11.8 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.485 -0.486 . . . . 2.98 110.432 174.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.816 ' HB2' ' HD2' ' A' ' 99' ' ' LYS . 99.5 mttt 72.71 -26.48 0.18 Allowed 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.059 -0.973 . . . . 2.72 113.207 172.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.95 ' HZ ' ' HE2' ' A' ' 102' ' ' PHE . 0.2 OUTLIER 67.87 -41.08 0.43 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.938 1.295 . . . . 2.12 110.913 -176.152 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.816 ' HD2' ' HB2' ' A' ' 97' ' ' LYS . 0.0 OUTLIER 66.42 142.8 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.223 1.009 . . . . 2.69 113.124 173.67 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.556 ' HB2' ' CE1' ' A' ' 98' ' ' PHE . . . -176.06 -167.63 0.23 Allowed 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 115.179 -0.919 . . . . 0.55 111.518 -168.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.638 ' O ' ' HD2' ' A' ' 61' ' ' TYR . 62.6 mm-40 -100.92 48.12 0.9 Allowed 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 114.665 -1.152 . . . . 1.99 110.837 176.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.95 ' HE2' ' HZ ' ' A' ' 98' ' ' PHE . 1.6 m-85 -128.25 175.98 3.07 Favored Pre-proline 0 CA--C 1.511 -0.543 0 CA-C-O 121.466 0.651 . . . . 0.84 109.724 172.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.674 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 14.4 Cg_exo -76.48 77.75 3.51 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 123.519 2.813 . . . . 0.62 109.936 158.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.618 HG12 ' HB3' ' A' ' 73' ' ' ALA . 76.4 mt -80.44 126.52 39.55 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.504 0 N-CA-C 107.978 -1.119 . . . . 1.34 107.978 176.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.882 ' HG3' ' CE1' ' A' ' 74' ' ' PHE . 7.1 mmt -105.56 -168.12 1.41 Allowed 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 121.727 0.775 . . . . 3.03 113.032 -163.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.629 ' N ' ' HA ' ' A' ' 23' ' ' ALA . . . -76.47 6.81 5.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.637 -1.165 . . . . 1.46 113.755 -167.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.891 ' HG2' ' HB2' ' A' ' 75' ' ' PRO . 57.1 mttp 65.99 139.29 0.03 OUTLIER 'General case' 0 CA--C 1.491 -1.315 0 CA-C-O 122.51 1.148 . . . . 1.76 110.847 -169.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.846 HD12 ' HD2' ' A' ' 74' ' ' PHE . 0.1 OUTLIER -138.45 163.71 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.576 0 N-CA-C 106.428 -1.693 . . . . 0.82 106.428 165.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.55 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 0.2 OUTLIER -73.16 83.56 1.33 Allowed 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 120.612 0.244 . . . . 1.73 110.375 -177.428 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.65 HG13 HD11 ' A' ' 108' ' ' ILE . 2.6 m -80.25 90.15 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-O 121.848 0.832 . . . . 0.77 109.299 176.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.707 HD22 ' HD3' ' A' ' 84' ' ' PRO . 2.9 t-20 174.77 -177.17 0.09 Allowed 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 114.177 -1.374 . . . . 1.9 107.988 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -91.44 37.46 3.38 Favored Glycine 0 N--CA 1.435 -1.395 0 C-N-CA 120.12 -1.038 . . . . 1.47 114.49 -177.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.59 ' HB3' ' HG3' ' A' ' 82' ' ' GLN . 0.2 OUTLIER -105.28 -50.41 3.23 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 118.974 -1.09 . . . . 2.81 110.849 170.664 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -131.86 -42.12 1.02 Allowed 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 118.781 -1.167 . . . . 2.16 111.568 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.55 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . 54.52 139.57 0.0 OUTLIER 'General case' 0 C--N 1.345 0.404 0 CA-C-O 122.13 0.967 . . . . 1.26 111.651 -176.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.826 ' HB3' HG13 ' A' ' 108' ' ' ILE . 1.6 t-80 -88.26 143.12 32.22 Favored Pre-proline 0 C--N 1.312 -1.028 0 O-C-N 120.602 -1.311 . . . . 0.42 107.557 178.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -24.99 -48.03 0.06 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 124.678 3.585 . . . . 0.4 113.847 178.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.767 HD11 ' HB ' ' A' ' 15' ' ' ILE . 38.5 tp -69.35 -45.92 68.24 Favored 'General case' 0 C--O 1.216 -0.684 0 C-N-CA 122.598 0.359 . . . . 0.39 111.827 -179.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.668 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 9.7 m-85 -82.54 -32.16 28.75 Favored 'General case' 0 CA--C 1.491 -1.303 0 CA-C-O 121.709 0.766 . . . . 3.04 110.9 -175.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.531 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 2.9 tm-20 -64.03 -35.03 79.38 Favored 'General case' 0 N--CA 1.424 -1.749 0 N-CA-C 107.031 -1.47 . . . . 2.44 107.031 172.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.753 ' HB2' ' HE2' ' A' ' 18' ' ' PHE . 28.7 t80 -72.45 -26.75 61.94 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.96 -1.018 . . . . 0.56 110.253 170.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.882 ' HE1' HG21 ' A' ' 15' ' ' ILE . 15.4 mmt -71.95 -55.93 6.59 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 121.66 0.743 . . . . 0.71 110.287 -170.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.668 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -72.84 -25.48 61.14 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.214 -0.903 . . . . 1.46 110.565 178.655 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.531 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 27.2 tttt -60.96 -38.42 85.82 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 109.079 -0.712 . . . . 1.99 109.079 169.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.44 ' HB ' ' O ' ' A' ' 122' ' ' MET . 96.2 m -65.43 -55.71 16.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.29 -0.868 . . . . 0.59 110.644 177.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -155.47 122.3 2.71 Favored Pre-proline 0 N--CA 1.452 -0.369 0 N-CA-C 113.392 0.886 . . . . 1.85 113.392 -174.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.799 ' HA ' ' NH2' ' A' ' 153' ' ' ARG . 1.6 Cg_endo -87.99 61.41 3.32 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 124.673 3.582 . . . . 1.69 109.418 166.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -62.89 139.4 44.87 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.039 -0.982 . . . . 2.59 113.274 -173.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 71.9 mt 72.33 -41.93 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 123.559 0.744 . . . . 3.58 111.539 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.8 112.72 13.29 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.906 0.384 . . . . 3.47 110.94 -178.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.455 ' HA ' ' HB2' ' A' ' 127' ' ' PRO . . . -79.35 38.52 0.36 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.376 0.608 . . . . 3.28 110.774 177.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 28.1 m -77.22 -76.75 0.16 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.492 -0.777 . . . . 3.56 110.716 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -153.33 -76.21 0.12 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 122.074 0.94 . . . . 5.17 109.053 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.617 ' HB1' HD13 ' A' ' 135' ' ' ILE . . . -135.59 -164.13 1.49 Allowed 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.279 -1.328 . . . . 1.59 110.159 -173.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.876 ' H ' HD13 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -41.75 -61.4 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 O-C-N 124.495 1.122 . . . . 2.0 111.971 177.432 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.886 ' HB3' ' CZ3' ' A' ' 137' ' ' TRP . 3.1 tmtp? 77.7 -27.67 0.17 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.064 0.946 . . . . 4.81 113.257 167.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.886 ' CZ3' ' HB3' ' A' ' 136' ' ' LYS . 1.9 m-90 -104.23 176.89 5.01 Favored 'General case' 0 CA--C 1.507 -0.696 0 O-C-N 122.235 -0.291 . . . . 1.97 110.525 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.548 ' OD1' ' HD3' ' A' ' 51' ' ' LYS . 6.6 m120 -39.46 -154.23 0.0 OUTLIER 'General case' 0 C--O 1.203 -1.366 0 O-C-N 124.822 1.326 . . . . 2.04 111.5 160.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.622 ' HD2' ' CD2' ' A' ' 41' ' ' TYR . 2.2 m-85 -31.35 -25.19 0.0 OUTLIER 'General case' 0 CA--C 1.567 1.597 0 N-CA-C 117.691 2.478 . . . . 1.93 117.691 -171.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.728 ' HA ' ' O ' ' A' ' 154' ' ' PHE . 1.4 m 6.56 101.3 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 120.495 1.498 . . . . 0.6 114.086 170.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.515 ' O ' ' HA ' ' A' ' 153' ' ' ARG . 4.5 m -89.12 176.03 7.14 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.22 -0.9 . . . . 0.62 112.195 -170.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.562 ' HA ' ' O ' ' A' ' 152' ' ' GLU . 79.5 m-85 -134.25 124.44 25.93 Favored 'General case' 0 CA--C 1.491 -1.297 0 N-CA-C 106.422 -1.695 . . . . 0.57 106.422 161.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.821 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 5.8 tp -80.52 103.97 10.74 Favored 'General case' 0 N--CA 1.423 -1.82 0 C-N-CA 118.487 -1.285 . . . . 0.43 108.342 177.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.768 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 27.9 mm -90.76 141.35 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.822 0 CA-C-N 113.41 -1.723 . . . . 0.19 107.656 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.54 ' OD1' HG12 ' A' ' 149' ' ' VAL . 0.0 OUTLIER -94.71 -173.68 3.08 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 119.541 -0.863 . . . . 0.98 111.234 -169.905 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.503 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 44.2 mtm180 -54.83 -36.48 65.05 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.14 0.275 . . . . 2.22 111.326 -177.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -104.05 20.97 17.26 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 121.569 0.7 . . . . 2.0 109.245 -176.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.643 ' HA2' ' CG2' ' A' ' 144' ' ' ILE . . . 70.43 36.37 69.26 Favored Glycine 0 N--CA 1.435 -1.396 0 CA-C-N 114.624 -1.171 . . . . 0.17 115.126 175.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.54 HG12 ' OD1' ' A' ' 145' ' ' ASP . 5.2 p -103.67 129.98 24.34 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 119.528 1.664 . . . . 1.12 110.379 172.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.529 ' HA ' HD13 ' A' ' 144' ' ' ILE . 3.6 Cg_exo -69.84 121.33 8.0 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.6 2.2 . . . . 0.41 110.493 179.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 22.1 t -114.7 -27.01 2.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-O 121.426 0.631 . . . . 1.45 109.401 -176.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.821 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 60.7 mm-40 -138.17 165.47 26.57 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.363 -0.835 . . . . 1.17 111.441 -178.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.799 ' NH2' ' HA ' ' A' ' 127' ' ' PRO . 2.6 ttm180 -145.6 125.2 13.26 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.761 -1.109 . . . . 2.16 109.146 165.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.728 ' O ' ' HA ' ' A' ' 140' ' ' THR . 91.2 m-85 -107.19 149.95 27.14 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.203 -0.908 . . . . 0.32 108.74 -169.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 19.4 m -76.98 158.51 80.13 Favored Pre-proline 0 C--N 1.313 -0.998 0 N-CA-C 108.795 -0.817 . . . . 1.11 108.795 175.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.547 ' HG3' ' HB3' ' A' ' 137' ' ' TRP . 10.8 Cg_endo -54.52 -48.91 18.86 Favored 'Trans proline' 0 N--CA 1.465 -0.202 0 C-N-CA 121.874 1.716 . . . . 0.78 110.685 178.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -59.52 -2.0 1.45 Allowed Glycine 0 CA--C 1.529 0.964 0 CA-C-N 114.753 -1.112 . . . . 0.5 114.902 174.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -84.69 134.07 34.37 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 107.982 -1.118 . . . . 0.5 107.982 171.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.534 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 6.8 t -110.68 -174.58 2.51 Favored 'General case' 0 N--CA 1.435 -1.177 0 C-N-CA 119.976 -0.69 . . . . 1.42 110.757 -167.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.55 ' CG2' ' HA ' ' A' ' 56' ' ' THR . 64.0 t -45.44 -50.92 2.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 114.7 -1.137 . . . . 0.28 111.202 -176.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -68.79 -35.07 76.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.137 -0.483 . . . . 3.46 111.22 -174.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.451 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 28.2 m-20 -68.91 -35.17 76.52 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.779 0.799 . . . . 1.4 109.553 -177.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.46 ' HA ' ' CE2' ' A' ' 154' ' ' PHE . 46.5 mt -80.56 -48.08 20.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 114.494 -1.23 . . . . 0.21 111.354 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.631 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 49.3 mt-10 -53.81 -39.3 65.4 Favored 'General case' 0 C--O 1.217 -0.631 0 CA-C-O 120.888 0.375 . . . . 0.67 111.39 -176.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 12.1 pt-20 -60.86 -21.93 63.74 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.636 0.255 . . . . 0.87 111.544 -176.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.582 ' HB3' HD22 ' A' ' 143' ' ' LEU . 35.7 mmtp -100.07 -22.85 15.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.382 0.61 . . . . 1.71 110.13 174.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.631 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 12.9 tp -85.8 -50.03 7.46 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.037 -0.983 . . . . 0.16 112.36 -174.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.557 ' N ' ' HD2' ' A' ' 169' ' ' PRO . 73.8 mt -54.09 -46.95 98.55 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.628 -0.715 . . . . 0.26 112.643 -173.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 168' ' ' ILE . 14.7 Cg_endo -58.62 -16.23 29.31 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.192 1.928 . . . . 0.41 113.026 175.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.8 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 95.4 mt -97.11 -41.31 8.4 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 122.006 -0.433 . . . . 0.71 110.784 177.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.664 HD23 ' HG2' ' A' ' 37' ' ' PRO . 96.0 mt -63.28 -53.61 50.22 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-O 122.21 1.005 . . . . 0.34 109.727 175.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -75.93 -11.46 84.68 Favored Glycine 0 N--CA 1.433 -1.55 0 CA-C-N 113.323 -1.762 . . . . 1.12 112.365 -176.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 8.7 t 62.9 92.39 0.06 Allowed 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.421 0.629 . . . . 2.64 110.538 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -58.29 -42.13 85.94 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.695 -0.684 . . . . 4.35 110.63 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 77.6 mtm180 56.74 -156.33 0.29 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.125 -0.488 . . . . 8.45 110.74 178.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 37.8 tp . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.244 -0.884 . . . . 7.69 109.263 176.315 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.9 0 N-CA-C 112.072 -0.411 . . . . 5.22 112.072 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.423 ' SD ' ' N ' ' A' ' 11' ' ' MET . 1.6 mpt? -79.62 55.54 2.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.268 0.556 . . . . 4.85 109.717 178.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.67 179.68 16.27 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.136 -1.186 . . . . 1.55 110.136 -170.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.9 m -141.31 13.17 2.18 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.514 0.673 . . . . 1.58 110.175 177.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 80.0 p 178.85 177.8 0.47 Allowed 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 105.89 -1.893 . . . . 1.17 105.89 -173.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.879 HG23 ' HD3' ' A' ' 150' ' ' PRO . 3.7 pt -89.71 -15.36 8.8 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 CA-C-N 115.579 -0.737 . . . . 0.38 110.378 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.816 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 36.3 m-85 -70.52 -13.23 62.02 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.259 0.552 . . . . 0.3 110.854 -179.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -63.93 -24.67 67.82 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.64 -0.874 . . . . 2.11 108.64 173.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.599 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 50.9 m-85 -112.49 105.6 13.87 Favored 'General case' 0 CA--C 1.495 -1.145 0 CA-C-N 114.972 -1.013 . . . . 0.31 110.341 178.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -52.16 146.19 9.4 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.68 -1.145 . . . . 2.86 109.903 174.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.733 HG23 HD22 ' A' ' 30' ' ' LEU . 54.7 t -109.26 159.17 8.85 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 107.464 -1.31 . . . . 0.67 107.464 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.857 ' O ' ' HB2' ' A' ' 105' ' ' MET . 26.2 mt -126.99 167.82 15.38 Favored 'General case' 0 N--CA 1.433 -1.312 0 C-N-CA 120.323 -0.551 . . . . 0.69 110.279 -176.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -86.69 -179.27 6.55 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.64 -0.874 . . . . 1.87 108.64 175.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.683 ' HA ' ' N ' ' A' ' 106' ' ' ALA . . . -63.58 -9.13 11.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 118.527 0.603 . . . . 0.59 111.415 -178.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.494 ' HB2' ' HE2' ' A' ' 26' ' ' LYS . 11.8 m-20 -107.85 7.74 28.3 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.559 -0.291 . . . . 2.34 111.562 174.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.693 ' CD2' ' HB3' ' A' ' 106' ' ' ALA . 3.8 m170 72.29 15.1 5.37 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 121.68 0.753 . . . . 1.47 110.181 174.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.494 ' HE2' ' HB2' ' A' ' 24' ' ' ASP . 27.5 mtmt -76.39 133.38 71.35 Favored Pre-proline 0 C--O 1.221 -0.426 0 N-CA-C 107.228 -1.397 . . . . 4.25 107.228 165.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.679 ' HA ' HD23 ' A' ' 21' ' ' LEU . 85.2 Cg_exo -48.86 115.94 1.91 Allowed 'Trans proline' 0 CA--C 1.532 0.418 0 C-N-CA 122.11 1.873 . . . . 0.54 113.719 -175.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.68 ' H ' ' HA ' ' A' ' 21' ' ' LEU . 0.4 OUTLIER -77.32 153.07 34.19 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.32 -1.309 . . . . 1.2 109.031 168.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.608 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.1 t-20 -92.32 84.15 5.13 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.446 0.641 . . . . 1.51 109.34 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.733 HD22 HG23 ' A' ' 20' ' ' VAL . 64.0 tp -67.27 -47.41 70.75 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.499 -0.773 . . . . 0.28 110.746 -178.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.836 HG12 ' HG3' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -69.55 -0.68 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.351 -0.841 . . . . 1.02 112.704 -168.199 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.608 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 3.9 pt20 -75.08 -11.04 60.0 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.393 -0.595 . . . . 1.02 109.393 174.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.952 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 89.5 m-70 -95.81 18.05 13.91 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.933 0.873 . . . . 0.28 109.124 175.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.836 ' HG3' HG12 ' A' ' 31' ' ' VAL . 23.7 mtmt -77.69 110.97 12.98 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 114.464 -1.244 . . . . 1.56 108.874 166.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 131.86 -44.99 1.16 Allowed Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 120.754 -0.736 . . . . 0.2 111.499 -178.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.466 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 43.4 m -129.05 134.93 26.87 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 108.721 -0.844 . . . . 0.29 108.721 172.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.726 ' HG3' ' CB ' ' A' ' 170' ' ' LEU . 5.2 Cg_endo -42.38 153.9 0.13 Allowed 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 124.403 3.402 . . . . 0.18 113.093 177.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.876 ' HB2' HG22 ' A' ' 70' ' ' THR . 0.6 OUTLIER -138.32 143.6 40.02 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 113.737 -1.574 . . . . 0.31 106.847 179.79 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 1.037 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 1.6 mm? -109.78 117.87 35.01 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.199 -1.038 . . . . 1.19 108.199 178.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.817 HG22 ' OH ' ' A' ' 119' ' ' TYR . 5.8 mt -108.24 129.85 61.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 C-N-CA 120.107 -0.637 . . . . 0.37 109.679 -178.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 1.037 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.5 OUTLIER -114.31 130.28 56.66 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 116.132 -0.485 . . . . 0.42 111.315 -168.664 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.79 ' ND2' ' HB ' ' A' ' 135' ' ' ILE . 2.5 p-10 -84.36 93.54 8.28 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 107.798 -1.186 . . . . 2.35 107.798 166.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.913 HG11 ' HB1' ' A' ' 73' ' ' ALA . 2.7 p -105.33 154.99 6.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-N 115.444 -0.798 . . . . 1.03 111.481 -161.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.427 ' HB1' ' OD1' ' A' ' 86' ' ' ASN . . . -103.96 103.06 12.85 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 114.983 -1.008 . . . . 0.88 110.405 176.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.872 ' HA ' ' HB2' ' A' ' 98' ' ' PHE . 1.4 p -24.77 124.63 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 114.283 -1.326 . . . . 1.78 113.085 170.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.407 ' HG3' ' O ' ' A' ' 46' ' ' LYS . 20.7 ptmt -60.46 105.22 0.41 Allowed 'General case' 0 C--O 1.232 0.156 0 CA-C-N 114.984 -1.007 . . . . 5.84 112.714 -170.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.493 ' SG ' ' HB3' ' A' ' 95' ' ' CYS . 9.3 p -163.91 114.66 1.32 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.266 -0.879 . . . . 3.55 109.266 172.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 69.84 -50.18 0.68 Allowed Glycine 0 CA--C 1.524 0.637 0 C-N-CA 121.258 -0.496 . . . . 2.91 113.397 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -119.23 118.98 32.74 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.442 0.639 . . . . 4.63 112.459 -174.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.853 HG21 ' HD2' ' A' ' 54' ' ' TYR . 7.8 m -145.08 93.33 2.38 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.466 -0.939 . . . . 1.93 108.466 170.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.629 ' HB3' ' HB2' ' A' ' 156' ' ' PRO . 54.4 tttp -79.26 59.19 2.74 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.543 0.572 . . . . 2.01 112.543 -167.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.612 ' O ' ' HG3' ' A' ' 55' ' ' GLU . . . 79.67 -33.97 2.09 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 120.904 -0.665 . . . . 0.51 113.721 172.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -54.06 -21.5 17.87 Favored Glycine 0 C--O 1.221 -0.712 0 C-N-CA 121.379 -0.439 . . . . 0.5 113.676 -177.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.853 ' HD2' HG21 ' A' ' 50' ' ' THR . 0.1 OUTLIER -65.14 -61.53 2.08 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 117.595 0.697 . . . . 0.7 109.921 179.825 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.612 ' HG3' ' O ' ' A' ' 52' ' ' GLY . 0.1 OUTLIER -59.57 -21.8 60.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.612 -0.722 . . . . 2.61 110.044 179.896 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.661 ' HA ' ' CG2' ' A' ' 160' ' ' VAL . 29.6 m -77.4 -59.76 2.65 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 114.814 -1.085 . . . . 0.33 110.623 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 1.023 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -61.19 -35.08 76.2 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.339 -0.846 . . . . 0.22 110.684 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.653 ' HA ' ' CD1' ' A' ' 102' ' ' PHE . 89.6 m -60.21 -59.18 5.83 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.742 -0.663 . . . . 0.26 110.59 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 56.5 m -70.0 -35.13 74.14 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-N 115.515 -0.766 . . . . 0.48 111.936 -176.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.755 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 21.7 mt -62.33 -52.03 65.29 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 121.302 0.572 . . . . 0.43 110.481 -177.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.762 ' HD1' ' HA ' ' A' ' 70' ' ' THR . 34.3 t80 -51.86 -56.01 16.61 Favored 'General case' 0 C--O 1.204 -1.298 0 CA-C-N 114.584 -1.189 . . . . 0.31 111.108 177.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -71.62 -23.93 61.79 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 122.395 0.278 . . . . 1.21 111.078 -172.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.575 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 37.3 ttpt -86.03 -20.68 28.46 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 109.312 -0.625 . . . . 1.54 109.312 -177.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.646 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 44.1 m-85 -128.02 -6.43 5.52 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 114.547 1.314 . . . . 0.31 114.547 -171.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.739 ' HD2' ' CZ ' ' A' ' 61' ' ' TYR . 13.6 ptmt -63.57 -24.46 67.81 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 108.1 -1.074 . . . . 1.35 108.1 171.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -47.88 -38.57 16.56 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 113.963 -1.471 . . . . 1.28 110.81 172.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -89.35 -32.42 17.32 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.702 0.287 . . . . 1.11 111.67 175.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 147.45 -1.88 0.76 Allowed Glycine 0 C--N 1.332 0.319 0 N-CA-C 111.674 -0.57 . . . . 0.18 111.674 -178.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.755 ' HE2' ' HB3' ' A' ' 60' ' ' LEU . 25.3 t80 -69.51 145.02 53.0 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-O 121.4 0.619 . . . . 0.18 112.003 -177.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.952 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 1.6 t -135.59 152.93 51.74 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 108.839 -0.8 . . . . 0.2 108.839 173.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 1.023 HG11 ' HB1' ' A' ' 57' ' ' ALA . 51.9 t -113.35 101.65 12.78 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.426 0 N-CA-C 108.422 -0.955 . . . . 0.17 108.422 158.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.919 ' HA ' ' HB2' ' A' ' 103' ' ' PRO . 0.4 OUTLIER -94.4 122.05 36.56 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 107.222 -1.399 . . . . 1.04 107.222 173.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.913 ' HB1' HG11 ' A' ' 43' ' ' VAL . . . -108.49 130.34 55.26 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.397 0.618 . . . . 0.51 111.596 -178.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.671 ' CE1' ' HG2' ' A' ' 105' ' ' MET . 3.8 m-30 -109.07 102.82 50.36 Favored Pre-proline 0 C--N 1.319 -0.735 0 N-CA-C 108.72 -0.844 . . . . 0.44 108.72 177.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.837 ' HG2' ' HD2' ' A' ' 107' ' ' LYS . 60.7 Cg_endo -76.87 45.36 1.65 Allowed 'Trans proline' 0 N--CA 1.481 0.784 0 C-N-CA 123.676 2.918 . . . . 1.3 116.076 -163.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.471 ' C ' ' HB2' ' A' ' 107' ' ' LYS . 30.8 t 46.03 146.82 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 117.128 2.27 . . . . 1.44 117.128 178.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.453 ' C ' ' H ' ' A' ' 79' ' ' PHE . 8.7 t-20 -100.25 62.05 1.09 Allowed 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 113.938 -1.483 . . . . 1.81 107.264 174.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.819 ' HA ' ' HG3' ' A' ' 83' ' ' GLU . 18.2 mp0 -54.15 -8.51 0.2 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 114.344 -1.298 . . . . 3.34 111.775 -178.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.453 ' H ' ' C ' ' A' ' 77' ' ' ASN . 41.8 m-85 -64.29 -16.78 62.8 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.895 -1.048 . . . . 2.68 110.464 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -99.31 143.84 16.77 Favored Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 111.185 -0.766 . . . . 1.98 111.185 173.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.01 63.56 4.46 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.673 -0.775 . . . . 1.49 113.048 -177.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.548 ' HG2' ' HB3' ' A' ' 111' ' ' ASN . 3.9 pm0 -151.82 -13.25 0.19 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.22 -0.289 . . . . 1.74 110.22 174.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.819 ' HG3' ' HA ' ' A' ' 78' ' ' GLN . 5.2 mm-40 -63.44 155.82 73.3 Favored Pre-proline 0 CA--C 1.531 0.235 0 N-CA-C 113.291 0.849 . . . . 3.07 113.291 -168.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.545 ' HB3' ' O ' ' A' ' 137' ' ' TRP . 98.3 Cg_exo -23.87 -91.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.674 1 C-N-CA 126.813 5.008 . . . . 1.75 116.474 178.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.498 ' H ' ' HB2' ' A' ' 84' ' ' PRO . . . -124.12 -24.6 1.8 Allowed Glycine 0 C--O 1.227 -0.311 0 C-N-CA 120.323 -0.941 . . . . 2.2 113.265 -172.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.741 ' HB3' HG12 ' A' ' 90' ' ' ILE . 15.3 m120 -96.73 38.31 1.23 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.103 -0.332 . . . . 4.2 110.103 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -54.27 -42.39 69.93 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.163 -0.926 . . . . 3.02 111.449 -174.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.678 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 0.7 OUTLIER -112.16 -22.13 11.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.496 -0.32 . . . . 3.92 111.028 176.705 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.477 ' HB3' HD22 ' A' ' 86' ' ' ASN . 2.9 tp10 -53.45 -60.19 3.61 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.891 -0.595 . . . . 2.65 112.474 -172.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.741 HG12 ' HB3' ' A' ' 86' ' ' ASN . 28.6 mm -50.74 -40.21 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 112.79 0.663 . . . . 2.15 112.79 -176.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.678 ' HE2' ' HA ' ' A' ' 88' ' ' GLU . 18.2 pttt -89.2 18.32 5.17 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.911 0.386 . . . . 2.79 111.952 -172.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -146.2 -1.21 0.75 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.86 0.362 . . . . 3.29 110.791 170.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -121.47 159.9 25.3 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.261 -0.427 . . . . 3.42 109.984 -175.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 75.0 t -81.47 111.48 18.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.553 -0.536 . . . . 2.63 109.553 172.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.681 ' SG ' ' HA ' ' A' ' 90' ' ' ILE . 0.0 OUTLIER -132.68 126.07 31.73 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.089 0.471 . . . . 2.83 110.641 -176.949 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.452 ' C ' ' H ' ' A' ' 98' ' ' PHE . 1.6 p -70.8 151.02 45.26 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 108.141 -1.059 . . . . 2.98 108.141 166.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.72 12.29 0.52 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.522 -0.308 . . . . 2.72 111.518 -174.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.872 ' HB2' ' HA ' ' A' ' 45' ' ' SER . 8.4 t80 67.23 98.04 0.05 Allowed 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 123.93 0.769 . . . . 2.12 110.543 -177.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.405 ' HA ' HD12 ' A' ' 104' ' ' ILE . 21.8 ttmm -119.67 137.64 53.78 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.664 -0.865 . . . . 2.69 108.664 169.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -139.82 -164.66 1.73 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.184 0.516 . . . . 0.55 111.558 -169.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -102.87 28.61 6.03 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 115.548 -0.751 . . . . 1.99 109.984 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.653 ' CD1' ' HA ' ' A' ' 58' ' ' THR . 40.3 p90 -151.64 165.25 17.83 Favored Pre-proline 0 N--CA 1.443 -0.822 0 N-CA-C 108.042 -1.096 . . . . 0.84 108.042 176.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.919 ' HB2' ' HA ' ' A' ' 72' ' ' LEU . 74.2 Cg_exo -50.92 132.03 36.29 Favored 'Trans proline' 0 CA--C 1.512 -0.59 0 C-N-CA 123.489 2.793 . . . . 0.62 113.8 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.524 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 50.6 mt -140.76 140.26 33.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 107.461 -1.311 . . . . 1.34 107.461 170.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.857 ' HB2' ' O ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -118.91 -179.22 3.75 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 120.779 -0.368 . . . . 3.03 110.98 -173.319 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.693 ' HB3' ' CD2' ' A' ' 25' ' ' HIS . . . -69.74 104.35 2.41 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 108.928 -0.767 . . . . 1.46 108.928 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.837 ' HD2' ' HG2' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -43.72 132.26 5.08 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-O 122.075 0.94 . . . . 1.76 112.888 -174.679 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.848 HG13 ' HB2' ' A' ' 116' ' ' HIS . 0.1 OUTLIER -119.49 173.25 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.012 0 CA-C-N 113.887 -1.506 . . . . 0.82 108.734 176.035 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.612 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 0.1 OUTLIER -74.26 87.4 1.97 Allowed 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 114.555 -1.202 . . . . 1.73 110.595 -174.831 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.524 HG11 ' CB ' ' A' ' 42' ' ' ASN . 6.6 m -84.4 89.38 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 CA-C-O 122.311 1.053 . . . . 0.77 108.84 178.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.643 ' ND2' ' H ' ' A' ' 112' ' ' GLY . 5.5 t30 175.42 -178.84 0.12 Allowed 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 113.683 -1.599 . . . . 1.9 107.945 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.643 ' H ' ' ND2' ' A' ' 111' ' ' ASN . . . -48.48 -28.81 6.88 Favored Glycine 0 N--CA 1.441 -0.988 0 N-CA-C 117.766 1.866 . . . . 1.47 117.766 -168.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.564 ' C ' HD22 ' A' ' 114' ' ' ASN . 9.5 pt-20 -104.68 -43.19 5.19 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 120.412 2.106 . . . . 2.81 114.367 -161.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.564 HD22 ' C ' ' A' ' 113' ' ' GLU . 0.9 OUTLIER -126.49 20.81 7.26 Favored 'General case' 0 C--N 1.32 -0.678 0 O-C-N 121.589 -0.694 . . . . 2.16 109.847 -172.701 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.612 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -48.28 131.94 16.41 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 123.792 0.683 . . . . 1.26 109.409 174.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.848 ' HB2' HG13 ' A' ' 108' ' ' ILE . 3.5 t-80 -71.12 139.0 84.74 Favored Pre-proline 0 N--CA 1.42 -1.956 0 CA-C-N 115.153 -0.93 . . . . 0.42 108.791 -168.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 116' ' ' HIS . 11.9 Cg_exo -31.2 -45.86 0.17 Allowed 'Trans proline' 0 C--O 1.217 -0.539 0 C-N-CA 124.358 3.372 . . . . 0.4 113.031 -179.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.874 HD11 ' HB ' ' A' ' 15' ' ' ILE . 27.4 tp -60.11 -53.05 62.3 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.289 0.636 . . . . 0.39 112.597 175.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.817 ' OH ' HG22 ' A' ' 40' ' ' ILE . 3.1 m-85 -77.91 -32.88 51.95 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-O 121.343 0.592 . . . . 3.04 110.834 -176.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.487 ' HG2' ' HB3' ' A' ' 115' ' ' ALA . 0.6 OUTLIER -62.73 -40.01 95.87 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 106.726 -1.583 . . . . 2.44 106.726 174.148 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.808 ' HA ' ' HE2' ' A' ' 124' ' ' LYS . 81.4 t80 -65.26 -29.64 70.44 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.308 -0.86 . . . . 0.56 109.791 173.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.665 ' CE ' HD12 ' A' ' 40' ' ' ILE . 40.8 mtt -75.01 -55.95 5.23 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.837 -0.62 . . . . 0.71 110.958 -168.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.444 ' HE2' ' HB2' ' A' ' 123' ' ' LYS . 0.3 OUTLIER -70.41 -30.47 67.35 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.972 -0.558 . . . . 1.46 111.235 179.725 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.808 ' HE2' ' HA ' ' A' ' 121' ' ' TYR . 46.0 pttt -76.32 -26.65 56.01 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 119.238 -0.985 . . . . 1.99 111.422 -178.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.488 HG22 ' HG3' ' A' ' 126' ' ' LYS . 51.7 m -73.75 -44.93 54.79 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.915 0.388 . . . . 0.59 110.314 176.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.765 ' HD2' ' HB2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -151.71 129.51 5.87 Favored Pre-proline 0 C--O 1.235 0.318 0 CA-C-O 121.24 0.543 . . . . 1.85 111.506 178.918 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.709 ' HA ' ' NH2' ' A' ' 153' ' ' ARG . 12.8 Cg_endo -60.45 -134.56 0.0 OUTLIER 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 123.725 2.95 . . . . 1.69 112.581 173.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.533 ' H ' ' HB2' ' A' ' 127' ' ' PRO . . . -132.69 177.98 18.44 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 119.536 -1.316 . . . . 2.59 112.917 -176.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 23.8 pt -63.57 -22.03 29.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.024 0.44 . . . . 3.58 111.134 178.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.543 ' HB3' HG23 ' A' ' 132' ' ' THR . 0.2 OUTLIER -102.94 16.96 25.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.509 0.671 . . . . 3.47 109.36 178.539 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 58.56 30.85 20.36 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.179 -0.919 . . . . 3.28 109.676 -170.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.543 HG23 ' HB3' ' A' ' 130' ' ' LEU . 33.1 p -62.05 123.86 19.24 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.248 -0.887 . . . . 3.56 110.094 179.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 37.7 mtmt -71.94 -73.58 0.18 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.453 0.644 . . . . 5.17 110.089 -177.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.414 ' O ' ' HZ3' ' A' ' 137' ' ' TRP . . . -92.47 171.43 9.04 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.484 -0.78 . . . . 1.59 109.859 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.828 ' H ' HD13 ' A' ' 135' ' ' ILE . 0.1 OUTLIER -99.7 46.32 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 121.375 0.607 . . . . 2.0 110.372 179.32 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.506 ' CA ' ' HA ' ' A' ' 84' ' ' PRO . 19.5 ttmm -80.28 53.91 1.88 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.488 -0.778 . . . . 4.81 111.423 -176.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.656 ' HB3' ' HG3' ' A' ' 156' ' ' PRO . 21.7 m-90 -143.27 172.52 12.63 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.409 -0.36 . . . . 1.97 110.033 178.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.666 ' HB2' ' CB ' ' A' ' 156' ' ' PRO . 7.6 m120 -49.63 -157.71 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.129 -0.941 . . . . 2.04 110.581 164.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.708 ' CD1' HG23 ' A' ' 43' ' ' VAL . 4.3 m-85 -28.81 -47.09 0.05 Allowed 'General case' 0 CA--C 1.56 1.34 0 N-CA-C 116.533 2.049 . . . . 1.93 116.533 -166.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.714 ' HB ' ' ND2' ' A' ' 42' ' ' ASN . 7.2 m 38.02 98.53 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 120.239 1.381 . . . . 0.6 113.902 175.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.726 ' HB3' HD12 ' A' ' 39' ' ' LEU . 1.2 m -90.72 163.06 14.63 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.153 -0.93 . . . . 0.62 111.831 -174.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.542 ' CZ ' HG21 ' A' ' 135' ' ' ILE . 88.4 m-85 -126.92 126.06 42.61 Favored 'General case' 0 CA--C 1.493 -1.234 0 N-CA-C 106.215 -1.772 . . . . 0.57 106.215 166.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.775 HD11 HD12 ' A' ' 170' ' ' LEU . 10.7 tp -79.4 105.03 10.42 Favored 'General case' 0 N--CA 1.418 -2.06 0 C-N-CA 118.326 -1.349 . . . . 0.43 108.109 177.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.674 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 24.4 mm -92.24 135.17 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.783 0 CA-C-N 112.821 -1.99 . . . . 0.19 107.256 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.707 ' HA ' HD13 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -89.71 -177.14 5.19 Favored 'General case' 0 C--N 1.31 -1.109 0 C-N-CA 120.43 -0.508 . . . . 0.98 110.81 -168.192 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.735 ' HD3' ' HB3' ' A' ' 173' ' ' SER . 47.9 mtm180 -53.97 -42.65 69.17 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 122.581 0.353 . . . . 2.22 111.902 -176.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -94.54 23.18 5.48 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.164 -0.68 . . . . 2.0 109.164 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.68 ' HA3' ' CE2' ' A' ' 16' ' ' PHE . . . 71.3 37.42 63.12 Favored Glycine 0 N--CA 1.441 -1.002 0 CA-C-N 115.149 -0.932 . . . . 0.17 113.64 176.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.461 ' HA ' ' HD2' ' A' ' 150' ' ' PRO . 46.5 t -103.88 107.46 56.82 Favored Pre-proline 0 C--N 1.316 -0.885 0 C-N-CA 119.809 -0.756 . . . . 1.12 111.43 177.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.879 ' HD3' HG23 ' A' ' 15' ' ' ILE . 15.6 Cg_endo -61.3 127.12 21.06 Favored 'Trans proline' 0 CA--C 1.516 -0.384 0 C-N-CA 123.396 2.731 . . . . 0.41 110.201 174.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.754 ' HA ' ' HG2' ' A' ' 126' ' ' LYS . 4.5 m -135.08 -31.85 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 C-N-CA 120.494 -0.482 . . . . 1.45 112.079 -178.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.762 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 14.4 mm-40 -112.95 159.54 19.0 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.543 -0.54 . . . . 1.17 109.543 174.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.709 ' NH2' ' HA ' ' A' ' 127' ' ' PRO . 0.0 OUTLIER -140.3 131.73 26.88 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 120.281 -0.568 . . . . 2.16 109.604 165.257 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.796 ' HZ ' ' HB2' ' A' ' 166' ' ' LYS . 97.9 m-85 -104.55 145.43 30.31 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.135 -0.939 . . . . 0.32 109.284 -174.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 3.2 p -78.51 158.1 76.62 Favored Pre-proline 0 C--N 1.314 -0.95 0 N-CA-C 108.985 -0.746 . . . . 1.11 108.985 176.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.666 ' CB ' ' HB2' ' A' ' 138' ' ' ASN . 11.3 Cg_endo -55.6 -45.05 42.37 Favored 'Trans proline' 0 CA--C 1.517 -0.331 0 C-N-CA 121.618 1.546 . . . . 0.78 110.754 178.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.46 ' HA3' ' HE3' ' A' ' 51' ' ' LYS . . . -52.87 -16.16 3.85 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-N 114.255 -1.339 . . . . 0.5 114.468 173.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -87.39 137.08 32.65 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 117.767 0.784 . . . . 0.5 109.304 175.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.417 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 68.1 m -114.14 -172.37 2.08 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 120.957 0.408 . . . . 1.42 112.033 -170.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.661 ' CG2' ' HA ' ' A' ' 56' ' ' THR . 57.8 t -40.04 -56.65 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 114.88 -1.055 . . . . 0.28 112.552 -175.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.75 -31.53 69.55 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.623 0.249 . . . . 3.46 110.917 -172.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -66.43 -37.94 86.31 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.316 0.579 . . . . 1.4 109.631 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.479 HD12 ' CG2' ' A' ' 56' ' ' THR . 81.7 mt -79.89 -43.72 22.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.389 -0.823 . . . . 0.21 111.257 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.592 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 36.7 mt-10 -54.01 -43.24 69.92 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-N 116.565 -0.289 . . . . 0.67 111.413 -177.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -59.56 -19.97 52.31 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.41 0.522 . . . . 0.87 112.41 -175.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.796 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 19.1 mmtp -101.9 -23.91 14.09 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.277 -0.569 . . . . 1.71 110.697 171.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.592 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 12.9 tp -76.8 -54.05 7.12 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.415 -0.811 . . . . 0.16 111.959 -178.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.469 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 72.1 mt -51.52 -45.5 90.71 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.085 -0.961 . . . . 0.26 112.296 -174.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.469 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 88.8 Cg_exo -49.45 -44.26 35.39 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 122.049 1.833 . . . . 0.41 112.71 173.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.775 HD12 HD11 ' A' ' 143' ' ' LEU . 90.5 mt -76.9 -38.82 52.8 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 120.911 -0.316 . . . . 0.71 111.093 -179.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.719 HD23 ' HG2' ' A' ' 37' ' ' PRO . 82.2 mt -59.45 -59.95 4.63 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-O 121.926 0.869 . . . . 0.34 109.908 177.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -60.97 -34.59 88.36 Favored Glycine 0 N--CA 1.432 -1.571 0 CA-C-N 113.476 -1.693 . . . . 1.12 112.638 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.735 ' HB3' ' HD3' ' A' ' 146' ' ' ARG . 26.3 p 48.51 73.55 0.21 Allowed 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.486 0.714 . . . . 2.64 111.74 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -92.96 -18.94 22.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.616 -0.72 . . . . 4.35 111.017 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -172.05 -36.46 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.129 -0.487 . . . . 8.45 111.039 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 9.7 tt . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.531 -0.747 . . . . 7.69 109.553 -177.955 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.803 0 N-CA-C 111.966 -0.453 . . . . 5.22 111.966 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -60.03 -46.83 88.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.927 0.394 . . . . 4.85 110.936 -179.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.77 117.44 5.11 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.848 -0.691 . . . . 1.55 112.481 178.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.9 p -92.81 11.4 27.17 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.04 0.448 . . . . 1.58 110.36 176.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.514 ' HB3' ' O ' ' A' ' 147' ' ' ASP . 1.5 m -161.16 151.58 17.83 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 105.878 -1.897 . . . . 1.17 105.878 -176.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.924 ' HB ' HD11 ' A' ' 118' ' ' LEU . 4.8 pt -64.61 -16.01 18.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-N 114.927 -1.033 . . . . 0.38 112.015 -172.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.829 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 41.6 m-85 -69.73 -3.12 14.01 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 112.117 0.414 . . . . 0.3 112.117 -178.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -71.84 -25.1 61.84 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.37 -0.974 . . . . 2.11 108.37 174.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.586 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 50.1 m-85 -108.51 110.41 21.9 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 114.407 -1.27 . . . . 0.31 111.162 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -53.73 142.82 22.3 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.069 -1.423 . . . . 2.86 110.215 174.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.851 HG13 ' HZ ' ' A' ' 74' ' ' PHE . 53.7 t -110.71 161.97 8.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 N-CA-C 108.031 -1.1 . . . . 0.67 108.031 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.73 ' O ' ' HB2' ' A' ' 105' ' ' MET . 25.5 mt -130.61 152.44 49.98 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 120.603 -0.439 . . . . 0.69 110.455 -178.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -73.92 -178.46 3.27 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.332 -0.618 . . . . 1.87 109.332 176.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.633 ' HA ' ' N ' ' A' ' 106' ' ' ALA . . . -64.35 -4.41 3.8 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.803 0.335 . . . . 0.59 111.647 -178.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.525 ' HB2' ' HE2' ' A' ' 26' ' ' LYS . 9.7 m-20 -116.95 9.08 13.63 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.704 -0.226 . . . . 2.34 111.452 175.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.652 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 11.1 m170 73.02 11.93 5.12 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-O 121.419 0.628 . . . . 1.47 110.25 174.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.525 ' HE2' ' HB2' ' A' ' 24' ' ' ASP . 26.6 mtmt -69.52 130.68 90.43 Favored Pre-proline 0 N--CA 1.453 -0.322 0 N-CA-C 107.211 -1.403 . . . . 4.25 107.211 165.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.688 ' HA ' HD23 ' A' ' 21' ' ' LEU . 79.7 Cg_exo -51.16 114.79 1.68 Allowed 'Trans proline' 0 CA--C 1.53 0.28 0 C-N-CA 121.895 1.73 . . . . 0.54 113.147 -176.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.542 ' H ' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -76.93 149.9 35.99 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.174 -1.375 . . . . 1.2 110.602 173.179 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.506 ' OD1' ' HB3' ' A' ' 32' ' ' GLN . 2.4 t-20 -93.41 81.57 4.41 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.954 -0.758 . . . . 1.51 108.954 177.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.722 HD21 HD12 ' A' ' 15' ' ' ILE . 61.1 tp -62.01 -41.79 98.46 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.506 -0.77 . . . . 0.28 110.294 -178.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.721 ' HA ' ' CE1' ' A' ' 16' ' ' PHE . 1.6 t -70.12 -1.32 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.099 -0.955 . . . . 1.02 111.93 -170.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.506 ' HB3' ' OD1' ' A' ' 29' ' ' ASN . 2.3 pt20 -74.72 -10.36 59.44 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.06 -0.718 . . . . 1.02 109.06 174.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.962 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 93.9 m-70 -99.41 25.6 6.84 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 121.934 0.873 . . . . 0.28 109.649 176.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.829 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 14.8 mtmt -83.73 132.39 34.85 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 114.297 -1.32 . . . . 1.56 109.155 169.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.83 -42.02 2.03 Favored Glycine 0 N--CA 1.438 -1.233 0 C-N-CA 120.759 -0.734 . . . . 0.2 111.765 -178.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.516 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 15.7 m -125.31 124.95 25.2 Favored Pre-proline 0 N--CA 1.435 -1.21 0 N-CA-C 108.082 -1.081 . . . . 0.29 108.082 173.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.886 ' HG3' ' HB3' ' A' ' 170' ' ' LEU . 2.2 Cg_endo -39.65 153.9 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 124.266 3.31 . . . . 0.18 113.346 176.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.878 ' HB2' HG22 ' A' ' 70' ' ' THR . 0.9 OUTLIER -139.34 143.58 37.86 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.427 -1.323 . . . . 0.31 107.427 -179.209 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 1.046 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 1.2 mm? -107.8 121.71 45.28 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.66 -0.867 . . . . 1.19 108.66 176.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.719 HG13 HG13 ' A' ' 144' ' ' ILE . 1.3 mt -105.57 125.61 60.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 C-N-CA 120.109 -0.636 . . . . 0.37 109.551 177.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 1.046 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.4 OUTLIER -109.38 123.29 49.09 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 116.091 -0.504 . . . . 0.42 109.992 -174.408 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.68 ' ND2' ' HB ' ' A' ' 135' ' ' ILE . 2.7 p-10 -80.56 93.22 6.04 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 122.3 1.047 . . . . 2.35 108.185 171.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.781 ' O ' ' HA ' ' A' ' 75' ' ' PRO . 7.7 p -105.67 125.48 61.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 115.388 -0.824 . . . . 1.03 111.367 -164.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.712 ' HB1' ' HB2' ' A' ' 86' ' ' ASN . . . -85.36 98.44 10.55 Favored 'General case' 0 N--CA 1.434 -1.248 0 C-N-CA 119.036 -1.066 . . . . 0.88 108.941 169.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.824 ' HA ' ' HB3' ' A' ' 98' ' ' PHE . 15.2 t -25.65 101.15 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 114.125 -1.398 . . . . 1.78 112.828 170.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.873 ' HB3' ' HB2' ' A' ' 49' ' ' TYR . 13.4 mtpt -103.47 145.03 30.61 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.748 -0.834 . . . . 5.84 108.748 173.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.9 t -110.13 114.1 27.33 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.991 -0.744 . . . . 3.55 108.991 178.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.27 16.66 75.44 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 121.042 -0.599 . . . . 2.91 112.927 -175.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.873 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 63.4 m-85 -125.95 164.16 21.41 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 117.031 0.415 . . . . 4.63 110.9 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.4 t -172.12 137.61 0.93 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.856 -0.611 . . . . 1.93 110.255 177.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.503 ' O ' ' HA2' ' A' ' 157' ' ' GLY . 21.0 mmmt -98.01 12.18 35.12 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.086 0.47 . . . . 2.01 109.969 176.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 109.55 -34.13 5.67 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 109.895 -1.282 . . . . 0.51 109.895 -170.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -45.43 -46.13 11.71 Favored Glycine 0 C--O 1.219 -0.833 0 CA-C-N 114.821 -0.689 . . . . 0.5 113.65 177.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.559 ' HB3' ' OE2' ' A' ' 55' ' ' GLU . 0.6 OUTLIER -60.84 -61.43 2.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.186 0.493 . . . . 0.7 110.872 -175.469 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.559 ' OE2' ' HB3' ' A' ' 54' ' ' TYR . 0.2 OUTLIER -54.04 -31.87 52.71 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.62 0.724 . . . . 2.61 110.995 178.243 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.737 ' HA ' HG22 ' A' ' 160' ' ' VAL . 52.9 m -75.84 -58.99 2.95 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.079 -0.964 . . . . 0.33 110.684 -174.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 1.095 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -59.2 -40.3 85.33 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.876 -1.056 . . . . 0.22 110.828 -178.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.506 ' HA ' ' CD1' ' A' ' 102' ' ' PHE . 96.9 m -58.64 -55.17 38.53 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 115.695 -0.684 . . . . 0.26 110.358 179.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 61.5 m -69.4 -39.68 77.79 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.182 -0.917 . . . . 0.48 111.736 -176.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.764 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 17.4 mt -64.87 -47.65 77.11 Favored 'General case' 0 CA--C 1.498 -1.038 0 CA-C-O 121.055 0.455 . . . . 0.43 110.367 -175.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.86 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 7.8 t80 -54.56 -54.39 41.96 Favored 'General case' 0 C--O 1.197 -1.68 0 CA-C-N 114.904 -1.043 . . . . 0.31 110.32 177.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.404 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 9.0 m-80 -72.54 -24.33 61.11 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 111.866 0.321 . . . . 1.21 111.866 -171.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.534 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 36.7 ttpt -83.6 -20.73 33.19 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 108.688 -0.856 . . . . 1.54 108.688 -178.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.717 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 47.9 m-85 -128.52 -1.93 5.51 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 115.835 1.791 . . . . 0.31 115.835 -173.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.721 ' HG2' ' O ' ' A' ' 61' ' ' TYR . 11.9 ptmt -65.8 -26.97 67.93 Favored 'General case' 0 CA--C 1.497 -1.092 0 N-CA-C 107.834 -1.173 . . . . 1.35 107.834 171.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.3 m -47.73 -38.68 15.89 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 113.893 -1.503 . . . . 1.28 110.837 173.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -86.14 -39.63 16.49 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 111.621 0.23 . . . . 1.11 111.621 174.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.41 ' HA3' ' HB2' ' A' ' 36' ' ' SER . . . 149.63 -3.28 0.61 Allowed Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.263 -0.735 . . . . 0.18 111.263 -176.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.764 ' HE2' ' HB3' ' A' ' 60' ' ' LEU . 28.1 t80 -71.07 140.75 50.79 Favored 'General case' 0 C--O 1.222 -0.346 0 C-N-CA 122.856 0.462 . . . . 0.18 111.381 -177.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.962 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 3.7 t -132.96 152.42 51.93 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 108.452 -0.944 . . . . 0.2 108.452 175.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 1.095 HG11 ' HB1' ' A' ' 57' ' ' ALA . 42.2 t -111.83 101.54 12.68 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.532 0 N-CA-C 108.286 -1.005 . . . . 0.17 108.286 160.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.517 ' HA ' ' HB2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -95.06 121.74 36.99 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 118.37 -1.332 . . . . 1.04 107.73 172.984 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.895 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -111.51 128.27 55.96 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 120.581 -0.448 . . . . 0.51 110.71 178.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.851 ' HZ ' HG13 ' A' ' 20' ' ' VAL . 5.3 m-30 -100.8 112.62 65.03 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 116.149 -0.478 . . . . 0.44 110.057 -178.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.781 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 73.6 Cg_endo -80.65 82.45 2.47 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 123.213 2.609 . . . . 1.3 113.504 -169.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.552 ' HB2' ' CG2' ' A' ' 110' ' ' VAL . 19.3 t -35.02 143.59 0.04 OUTLIER 'General case' 0 C--O 1.237 0.43 0 CA-C-O 122.782 1.277 . . . . 1.44 114.403 -174.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.606 ' HB2' ' HD1' ' A' ' 79' ' ' PHE . 17.3 p30 -92.55 131.32 37.77 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-N 113.069 -1.878 . . . . 1.81 109.828 -178.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.791 ' HA ' ' HG2' ' A' ' 83' ' ' GLU . 9.7 pt20 -61.33 -8.22 3.67 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.661 -1.154 . . . . 3.34 110.251 171.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.606 ' HD1' ' HB2' ' A' ' 77' ' ' ASN . 82.3 m-85 -76.46 32.36 0.13 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.698 -1.137 . . . . 2.68 113.384 -167.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -135.8 -57.99 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.052 -1.07 . . . . 1.98 112.984 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 110.57 36.71 1.86 Allowed Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 111.316 -0.714 . . . . 1.49 111.316 -173.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.634 ' HG3' ' HB2' ' A' ' 113' ' ' GLU . 0.4 OUTLIER -156.65 7.6 0.19 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.099 -0.551 . . . . 1.74 111.089 -176.558 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.791 ' HG2' ' HA ' ' A' ' 78' ' ' GLN . 2.7 mp0 -57.94 147.75 62.68 Favored Pre-proline 0 N--CA 1.468 0.461 0 CA-C-O 121.439 0.637 . . . . 3.07 111.261 -162.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.704 ' HB2' ' O ' ' A' ' 137' ' ' TRP . 40.9 Cg_endo -79.64 102.98 1.53 Allowed 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 123.6 2.867 . . . . 1.75 111.6 -172.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.46 -59.25 4.64 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.656 -0.783 . . . . 2.2 112.753 175.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.86 HD21 ' HG2' ' A' ' 46' ' ' LYS . 6.2 m-20 -81.76 20.68 0.92 Allowed 'General case' 0 C--N 1.328 -0.366 0 O-C-N 122.61 -0.347 . . . . 4.2 111.801 -177.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -55.47 -26.98 45.56 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 123.431 0.457 . . . . 3.02 111.284 178.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.646 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 39.5 mm-40 -111.85 -3.77 14.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.294 -0.412 . . . . 3.92 111.373 178.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -93.09 -61.18 1.63 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.093 0.473 . . . . 2.65 111.58 -173.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.813 HG22 ' HB2' ' A' ' 95' ' ' CYS . 7.6 pt -73.32 -23.25 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 113.132 0.79 . . . . 2.15 113.132 -168.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.646 ' HE2' ' HA ' ' A' ' 88' ' ' GLU . 56.2 pttt -72.79 -29.34 63.19 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 111.681 0.252 . . . . 2.79 111.681 -175.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -115.9 -24.9 7.94 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.925 -0.31 . . . . 3.29 111.772 -176.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -100.24 158.86 15.57 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.085 -0.339 . . . . 3.42 110.085 176.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 82.2 t -76.61 110.08 11.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.17 -0.468 . . . . 2.63 110.195 177.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.813 ' HB2' HG22 ' A' ' 90' ' ' ILE . 65.6 m -153.03 120.67 6.0 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.202 -0.453 . . . . 2.83 110.104 176.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.425 ' C ' ' H ' ' A' ' 98' ' ' PHE . 7.6 p -145.13 120.37 10.19 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.689 -0.232 . . . . 2.98 110.725 176.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.563 ' HA ' ' CB ' ' A' ' 75' ' ' PRO . 99.3 mttt 71.36 -27.31 0.17 Allowed 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 113.244 0.831 . . . . 2.72 113.244 176.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.824 ' HB3' ' HA ' ' A' ' 45' ' ' SER . 0.2 OUTLIER 67.09 -36.96 0.29 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.032 1.333 . . . . 2.12 111.523 -176.098 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.414 ' H ' ' C ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER 66.48 136.29 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.659 0.784 . . . . 2.69 111.69 174.901 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.779 ' HB2' ' CE1' ' A' ' 98' ' ' PHE . . . -162.15 -179.42 7.06 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.152 0.501 . . . . 0.55 112.329 -173.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -94.91 30.28 2.14 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 115.344 -0.844 . . . . 1.99 110.784 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.583 ' CE2' HD11 ' A' ' 104' ' ' ILE . 27.2 p90 -150.07 157.01 37.92 Favored Pre-proline 0 N--CA 1.446 -0.663 0 N-CA-C 108.332 -0.988 . . . . 0.84 108.332 177.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.698 ' HD3' ' CE2' ' A' ' 61' ' ' TYR . 97.7 Cg_exo -51.2 84.12 0.02 OUTLIER 'Trans proline' 0 N--CA 1.479 0.673 0 C-N-CA 124.794 3.663 . . . . 0.62 116.081 -172.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.895 HD12 ' HB3' ' A' ' 73' ' ' ALA . 7.5 mm -85.89 120.6 36.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.092 -1.077 . . . . 1.34 108.092 170.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.783 ' HG2' ' CG ' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -76.53 -177.69 4.31 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.753 -0.832 . . . . 3.03 108.753 178.272 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.633 ' N ' ' HA ' ' A' ' 23' ' ' ALA . . . -63.44 -53.75 47.35 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.384 -0.598 . . . . 1.46 109.384 -177.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.664 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 17.4 ptpt 146.15 151.07 0.0 OUTLIER 'General case' 0 CA--C 1.489 -1.385 0 O-C-N 125.823 1.952 . . . . 1.76 108.371 174.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.555 ' CD1' HG13 ' A' ' 110' ' ' VAL . 2.0 pp -152.08 174.53 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 CA-C-N 113.726 -1.579 . . . . 0.82 107.802 169.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.766 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 29.0 t-20 -74.24 87.15 1.95 Allowed 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.462 -0.79 . . . . 1.73 110.932 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.555 HG13 ' CD1' ' A' ' 108' ' ' ILE . 3.6 m -86.0 95.81 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 C-N-CA 118.145 -1.422 . . . . 0.77 108.187 169.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.559 ' ND2' ' H ' ' A' ' 112' ' ' GLY . 2.3 t30 179.09 -179.17 0.36 Allowed 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 113.63 -1.623 . . . . 1.9 107.815 178.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.559 ' H ' ' ND2' ' A' ' 111' ' ' ASN . . . -78.45 9.27 35.77 Favored Glycine 0 N--CA 1.437 -1.291 0 N-CA-C 115.894 1.118 . . . . 1.47 115.894 -172.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.634 ' HB2' ' HG3' ' A' ' 82' ' ' GLN . 6.8 mt-10 -105.31 -45.4 4.49 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 119.855 1.828 . . . . 2.81 114.514 -172.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -127.77 -34.47 2.18 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.388 -0.967 . . . . 2.16 108.388 -174.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.766 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . 52.28 -169.42 0.04 OUTLIER 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 114.153 -1.385 . . . . 1.26 111.264 176.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.613 ' CE1' ' H ' ' A' ' 118' ' ' LEU . 2.1 t-80 -140.94 134.33 14.71 Favored Pre-proline 0 N--CA 1.423 -1.794 0 N-CA-C 106.275 -1.75 . . . . 0.42 106.275 171.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -27.23 -50.13 0.1 Allowed 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 124.503 3.469 . . . . 0.4 113.598 -178.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.924 HD11 ' HB ' ' A' ' 15' ' ' ILE . 29.1 tp -63.51 -49.28 74.16 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.922 0.489 . . . . 0.39 112.171 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.693 ' OH ' HG22 ' A' ' 40' ' ' ILE . 25.5 m-85 -79.97 -33.96 39.05 Favored 'General case' 0 CA--C 1.492 -1.258 0 CA-C-O 120.935 0.398 . . . . 3.04 110.881 -176.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.478 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 4.7 tt0 -60.42 -37.36 80.63 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 106.589 -1.634 . . . . 2.44 106.589 174.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.586 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 51.5 t80 -68.53 -33.07 73.46 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.047 -0.979 . . . . 0.56 110.492 174.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.698 ' HE3' ' HG ' ' A' ' 118' ' ' LEU . 2.9 ttm -75.77 -55.58 5.5 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.09 -0.504 . . . . 0.71 110.418 -169.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.416 ' HB2' ' HE2' ' A' ' 123' ' ' LYS . 0.8 OUTLIER -70.82 -25.44 62.85 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 120.616 -0.433 . . . . 1.46 111.721 178.294 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.478 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -72.35 -29.73 64.07 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 119.379 -0.928 . . . . 1.99 109.394 178.447 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 88.0 m -87.26 -31.2 20.39 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.489 -0.778 . . . . 0.59 111.285 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.678 ' HG3' ' HB2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -133.66 110.38 12.29 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 112.727 0.64 . . . . 1.85 112.727 -172.17 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.467 ' HB2' ' O ' ' A' ' 130' ' ' LEU . 6.7 Cg_exo -76.1 -17.86 16.88 Favored 'Trans proline' 0 CA--C 1.531 0.336 0 C-N-CA 123.654 2.903 . . . . 1.69 111.037 169.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 81.44 -131.3 10.31 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.564 -0.743 . . . . 2.59 112.812 175.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 38.0 mt -75.92 -23.87 16.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.343 0.592 . . . . 3.58 110.427 -179.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.753 HD13 ' H ' ' A' ' 131' ' ' ALA . 0.3 OUTLIER -96.05 158.69 15.33 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.554 -0.748 . . . . 3.47 109.033 -179.033 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.753 ' H ' HD13 ' A' ' 130' ' ' LEU . . . -67.08 -14.49 62.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.294 -0.412 . . . . 3.28 110.763 174.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.499 ' H ' HD12 ' A' ' 130' ' ' LEU . 4.4 m -149.91 -110.25 0.06 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.365 -0.379 . . . . 3.56 110.741 176.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.64 ' HG3' ' HG ' ' A' ' 130' ' ' LEU . 67.4 mttm 58.36 135.98 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.717 0.77 . . . . 5.17 112.22 -171.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -116.64 61.34 0.73 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.205 -0.452 . . . . 1.59 111.942 -175.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.68 ' HB ' ' ND2' ' A' ' 42' ' ' ASN . 16.0 pt 38.78 43.36 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 O-C-N 123.913 0.758 . . . . 2.0 112.037 178.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.534 ' HD3' ' O ' ' A' ' 136' ' ' LYS . 8.0 tmtm? -90.06 38.84 0.94 Allowed 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.76 0.791 . . . . 4.81 110.957 -172.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.704 ' O ' ' HB2' ' A' ' 84' ' ' PRO . 8.9 m-90 -133.63 174.08 10.81 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.108 -0.496 . . . . 1.97 110.446 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.593 ' HB2' ' CB ' ' A' ' 156' ' ' PRO . 3.4 m120 -43.86 -155.71 0.0 OUTLIER 'General case' 0 C--O 1.212 -0.884 0 CA-C-N 114.784 -1.098 . . . . 2.04 111.298 163.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.684 ' HD2' ' HD2' ' A' ' 41' ' ' TYR . 2.9 m-85 -27.4 -52.51 0.07 Allowed 'General case' 0 C--O 1.209 -1.076 0 N-CA-C 115.724 1.75 . . . . 1.93 115.724 -166.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.657 ' HB ' ' ND2' ' A' ' 42' ' ' ASN . 7.5 m 41.6 109.17 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 120.542 1.519 . . . . 0.6 113.648 173.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.788 ' HB3' HD12 ' A' ' 39' ' ' LEU . 3.5 m -106.0 158.53 16.73 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 114.825 -1.08 . . . . 0.62 111.085 -167.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.637 ' CE2' HG21 ' A' ' 135' ' ' ILE . 63.6 m-85 -125.38 124.34 41.29 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 106.899 -1.519 . . . . 0.57 106.899 166.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.776 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 7.1 tp -79.88 104.01 10.17 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 118.337 -1.345 . . . . 0.43 108.369 179.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.746 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 32.3 mm -92.94 137.92 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.612 0 CA-C-N 113.574 -1.648 . . . . 0.19 107.803 -175.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.64 ' OD1' HG12 ' A' ' 149' ' ' VAL . 0.0 OUTLIER -89.18 -173.72 4.15 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 119.74 -0.784 . . . . 0.98 111.592 -168.14 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.759 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 21.1 mtm180 -56.24 -37.7 70.11 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-O 121.373 0.606 . . . . 2.22 110.543 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.514 ' O ' ' HB3' ' A' ' 14' ' ' SER . 27.6 t70 -93.48 13.74 20.81 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.736 -0.838 . . . . 2.0 108.736 -176.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.719 ' HA2' HG22 ' A' ' 144' ' ' ILE . . . 67.6 33.98 82.6 Favored Glycine 0 N--CA 1.434 -1.437 0 CA-C-N 115.359 -0.837 . . . . 0.17 114.404 -177.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.64 HG12 ' OD1' ' A' ' 145' ' ' ASP . 9.2 p -105.15 114.02 64.0 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 119.206 1.503 . . . . 1.12 111.44 172.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.716 ' HD3' HG23 ' A' ' 15' ' ' ILE . 2.5 Cg_endo -49.71 126.93 17.49 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 123.869 3.046 . . . . 0.41 111.771 174.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 23.0 t -120.09 -32.26 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.397 0.617 . . . . 1.45 109.345 -178.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.776 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 47.8 mm-40 -132.03 167.19 20.12 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-N 115.303 -0.862 . . . . 1.17 111.032 -177.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.599 ' HA ' ' O ' ' A' ' 141' ' ' SER . 1.6 ttm180 -146.33 132.74 19.63 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.266 -0.879 . . . . 2.16 110.744 163.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.57 ' HZ ' ' HB2' ' A' ' 166' ' ' LYS . 98.8 m-85 -110.97 151.55 27.81 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 114.713 -1.13 . . . . 0.32 109.614 -170.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 43.2 t -72.99 156.0 90.02 Favored Pre-proline 0 C--N 1.317 -0.821 0 N-CA-C 109.029 -0.73 . . . . 1.11 109.029 174.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.593 ' CB ' ' HB2' ' A' ' 138' ' ' ASN . 22.8 Cg_endo -61.44 -29.89 85.96 Favored 'Trans proline' 0 CA--C 1.517 -0.341 0 C-N-CA 121.852 1.702 . . . . 0.78 110.247 171.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.503 ' HA2' ' O ' ' A' ' 51' ' ' LYS . . . -73.41 -1.64 57.94 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 114.225 -1.352 . . . . 0.5 113.058 172.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -93.01 140.22 29.7 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 108.421 -0.955 . . . . 0.5 108.421 172.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.553 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 6.7 t -114.2 -170.82 1.79 Allowed 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 120.305 -0.558 . . . . 1.42 111.148 -170.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.737 HG22 ' HA ' ' A' ' 56' ' ' THR . 38.2 t -46.83 -49.47 6.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 114.556 -1.202 . . . . 0.28 111.612 -175.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 50.3 tttp -67.41 -39.9 85.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.873 0.368 . . . . 3.46 111.201 -175.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.429 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 31.2 m-20 -64.25 -37.45 87.51 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.716 -0.674 . . . . 1.4 109.946 -177.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.543 HD12 HG21 ' A' ' 56' ' ' THR . 88.6 mt -80.01 -47.69 21.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.069 -0.969 . . . . 0.21 111.281 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.677 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 30.7 mt-10 -54.5 -40.62 68.71 Favored 'General case' 0 C--O 1.215 -0.714 0 O-C-N 123.151 0.282 . . . . 0.67 111.572 -176.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 10.1 pt-20 -59.57 -21.07 59.79 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.667 0.27 . . . . 0.87 111.493 -175.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.57 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 12.6 mmmm -104.1 -23.92 13.24 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.432 0.634 . . . . 1.71 109.904 175.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.677 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 12.7 tp -79.2 -52.29 8.36 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.725 -1.125 . . . . 0.16 112.106 -178.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.484 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 74.4 mt -53.36 -45.03 98.64 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.31 -0.859 . . . . 0.26 111.959 -174.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.484 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 92.3 Cg_exo -49.06 -44.93 31.2 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 121.929 1.753 . . . . 0.41 112.23 171.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.886 ' HB3' ' HG3' ' A' ' 37' ' ' PRO . 43.5 mt -74.26 -42.78 59.07 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.926 0.343 . . . . 0.71 111.926 -178.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.813 HD23 ' HG2' ' A' ' 37' ' ' PRO . 89.3 mt -60.62 -54.91 39.69 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 122.197 0.998 . . . . 0.34 109.643 177.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -67.26 -62.83 4.14 Favored Glycine 0 N--CA 1.435 -1.381 0 CA-C-N 113.377 -1.738 . . . . 1.12 114.059 -175.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 9.7 t -167.69 97.68 0.47 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.969 0.385 . . . . 2.64 110.044 -172.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -61.96 -39.91 93.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.966 -0.561 . . . . 4.35 111.104 -175.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 50.1 ttp180 64.82 90.74 0.08 Allowed 'General case' 0 N--CA 1.465 0.28 0 O-C-N 123.718 0.636 . . . . 8.45 111.946 175.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.0 mm? . . . . . 0 C--O 1.249 1.07 0 CA-C-N 115.63 -0.714 . . . . 7.69 109.682 178.025 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.694 0 N-CA-C 112.162 -0.375 . . . . 5.22 112.162 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 27.2 ttt -173.82 -32.46 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.685 -0.487 . . . . 4.85 109.685 -176.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.583 ' HA2' ' OD2' ' A' ' 17' ' ' ASP . . . -57.65 118.09 11.85 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.376 -0.829 . . . . 1.55 112.472 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.2 m -123.6 -5.75 8.12 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.365 0.602 . . . . 1.58 110.121 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.435 ' HB3' ' O ' ' A' ' 147' ' ' ASP . 5.9 m -164.76 152.21 11.45 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 104.498 -2.408 . . . . 1.17 104.498 179.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.861 ' HB ' HD11 ' A' ' 118' ' ' LEU . 4.9 pt -62.09 -11.81 6.79 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 CA-C-N 115.59 -0.732 . . . . 0.38 112.302 -172.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.776 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 53.0 m-85 -75.34 0.75 15.7 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.949 0.722 . . . . 0.3 112.949 -176.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.583 ' OD2' ' HA2' ' A' ' 12' ' ' GLY . 58.3 m-20 -82.2 -19.27 40.15 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.41 -0.959 . . . . 2.11 108.41 175.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.701 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 50.0 m-85 -106.3 113.92 27.73 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 114.855 -1.066 . . . . 0.31 111.791 -178.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -48.56 136.56 12.93 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 113.404 -1.725 . . . . 2.86 111.032 174.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.931 HG13 ' HZ ' ' A' ' 74' ' ' PHE . 94.4 t -112.18 163.91 8.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 108.92 -0.77 . . . . 0.67 108.92 178.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.699 HD23 ' HA ' ' A' ' 27' ' ' PRO . 47.2 mt -130.83 148.97 52.66 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 110.113 -0.328 . . . . 0.69 110.113 -178.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -76.53 177.01 7.77 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.281 -1.377 . . . . 1.87 107.281 166.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.79 ' HA ' ' N ' ' A' ' 106' ' ' ALA . . . -64.62 -4.7 4.43 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.238 0.459 . . . . 0.59 112.238 -176.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.571 ' HB2' ' HE2' ' A' ' 26' ' ' LYS . 54.6 m-20 -105.05 3.03 30.06 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.444 -0.344 . . . . 2.34 111.273 178.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.536 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 71.7 m-70 75.48 2.77 3.87 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 122.724 0.41 . . . . 1.47 109.944 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.571 ' HE2' ' HB2' ' A' ' 24' ' ' ASP . 22.1 mtmt -63.01 118.04 38.75 Favored Pre-proline 0 CA--C 1.512 -0.501 0 N-CA-C 106.777 -1.564 . . . . 4.25 106.777 166.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.699 ' HA ' HD23 ' A' ' 21' ' ' LEU . 96.5 Cg_exo -51.2 114.5 1.57 Allowed 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 121.488 1.458 . . . . 0.54 112.222 -177.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.751 ' HE2' HD23 ' A' ' 72' ' ' LEU . 3.6 t80 -78.73 139.17 38.49 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 113.839 -1.528 . . . . 1.2 110.823 177.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.469 ' OD1' ' HB3' ' A' ' 32' ' ' GLN . 2.6 t-20 -80.9 82.76 6.79 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.595 -0.729 . . . . 1.51 109.288 178.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.791 HD13 HG21 ' A' ' 20' ' ' VAL . 52.7 tp -58.44 -43.38 88.75 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.657 -0.701 . . . . 0.28 110.454 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.707 HG12 ' HG3' ' A' ' 34' ' ' LYS . 1.8 t -69.1 -0.26 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 114.918 -1.037 . . . . 1.02 112.384 -168.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.469 ' HB3' ' OD1' ' A' ' 29' ' ' ASN . 9.3 pt20 -77.1 -8.9 58.28 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.247 -0.649 . . . . 1.02 109.247 174.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.919 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 91.2 m-70 -98.95 29.7 3.71 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 122.042 0.925 . . . . 0.28 109.007 175.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.776 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 5.7 mtmt -92.31 109.29 20.67 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 114.25 -1.341 . . . . 1.56 109.768 174.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.73 -38.44 1.99 Allowed Glycine 0 N--CA 1.436 -1.328 0 N-CA-C 111.319 -0.712 . . . . 0.2 111.319 -177.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.465 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 25.4 m -127.49 130.91 23.63 Favored Pre-proline 0 N--CA 1.433 -1.282 0 N-CA-C 108.192 -1.04 . . . . 0.29 108.192 171.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.824 ' HG2' HD23 ' A' ' 171' ' ' LEU . 2.7 Cg_endo -43.43 157.82 0.11 Allowed 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 124.135 3.223 . . . . 0.18 113.016 176.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.777 ' HB2' HG22 ' A' ' 70' ' ' THR . 0.7 OUTLIER -143.12 144.0 32.05 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 106.981 -1.488 . . . . 0.31 106.981 -179.105 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.786 HD23 ' CE1' ' A' ' 69' ' ' PHE . 2.7 mm? -107.92 113.39 26.56 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.075 -0.713 . . . . 1.19 109.075 177.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.919 HG23 HD13 ' A' ' 72' ' ' LEU . 0.9 OUTLIER -97.0 125.35 50.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 109.676 -0.49 . . . . 0.37 109.676 177.219 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.765 ' CE1' HG13 ' A' ' 71' ' ' VAL . 2.4 m-85 -108.26 155.73 20.16 Favored 'General case' 0 C--O 1.216 -0.698 0 CA-C-O 120.899 0.38 . . . . 0.42 111.537 -171.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.793 HD21 ' HG3' ' A' ' 84' ' ' PRO . 7.0 t30 -105.33 115.35 30.12 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.306 -1.368 . . . . 2.35 107.306 165.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.817 ' O ' ' HA ' ' A' ' 75' ' ' PRO . 34.7 m -126.71 159.4 36.32 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 CA-C-O 121.223 0.535 . . . . 1.03 112.124 -171.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.553 ' HB1' ' HA3' ' A' ' 48' ' ' GLY . . . -87.28 154.24 20.85 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 108.083 -1.081 . . . . 0.88 108.083 166.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.586 ' HA ' ' HB3' ' A' ' 98' ' ' PHE . 59.8 m -75.45 -159.44 0.1 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 110.135 -0.32 . . . . 1.78 110.135 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 51.7 tttm -61.49 -17.12 53.2 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.512 0.672 . . . . 5.84 110.195 -179.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.474 ' HB3' HG22 ' A' ' 90' ' ' ILE . 48.3 t -109.37 130.13 55.51 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 107.798 -1.186 . . . . 3.55 107.798 170.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.764 ' HA2' ' HG2' ' A' ' 89' ' ' GLU . . . 147.36 -121.5 1.4 Allowed Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 110.838 -0.905 . . . . 2.91 110.838 -174.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -165.84 121.15 1.26 Allowed 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.339 0.59 . . . . 4.63 111.786 177.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.731 HG21 ' HD2' ' A' ' 54' ' ' TYR . 62.6 p -92.77 96.5 10.19 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.433 -0.803 . . . . 1.93 110.023 175.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.587 ' HB3' ' HB2' ' A' ' 156' ' ' PRO . 14.0 tppt? -65.4 -13.51 58.81 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.049 0.452 . . . . 2.01 111.882 -176.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 131.9 -16.3 5.03 Favored Glycine 0 CA--C 1.507 -0.44 0 N-CA-C 110.208 -1.157 . . . . 0.51 110.208 -172.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.452 ' HA2' ' HB ' ' A' ' 56' ' ' THR . . . -61.7 -15.65 48.45 Favored Glycine 0 C--O 1.216 -0.991 0 CA-C-N 114.729 -0.735 . . . . 0.5 112.433 175.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.731 ' HD2' HG21 ' A' ' 50' ' ' THR . 0.4 OUTLIER -68.43 -59.99 2.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 117.358 0.579 . . . . 0.7 109.844 178.035 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -51.85 -32.63 32.68 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.861 0.838 . . . . 2.61 110.456 174.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.808 ' HA ' HG22 ' A' ' 160' ' ' VAL . 43.3 m -72.83 -59.36 2.75 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 114.396 -1.274 . . . . 0.33 110.578 -175.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 1.073 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -58.52 -42.17 87.1 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.693 -1.14 . . . . 0.22 111.115 -178.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.542 ' HA ' ' CD1' ' A' ' 102' ' ' PHE . 91.5 m -59.63 -55.14 38.16 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.566 0.698 . . . . 0.26 110.442 -178.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 61.4 m -66.82 -36.89 83.42 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.655 -1.157 . . . . 0.48 111.406 -177.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.776 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 14.9 mt -65.42 -47.98 74.38 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 121.364 0.602 . . . . 0.43 110.345 -177.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.875 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 6.7 t80 -59.22 -46.3 88.82 Favored 'General case' 0 C--O 1.207 -1.135 0 CA-C-N 114.896 -1.047 . . . . 0.31 110.489 178.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.69 -25.12 60.09 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 116.416 -0.357 . . . . 1.21 110.981 -174.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.427 ' HB2' ' HE2' ' A' ' 63' ' ' LYS . 6.5 tppt? -80.0 -32.72 39.7 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 108.316 -0.994 . . . . 1.54 108.316 -178.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.763 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 46.0 m-85 -125.67 -2.04 7.32 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 115.802 1.779 . . . . 0.31 115.802 -165.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.675 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 16.3 pttp -67.13 -23.33 65.8 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 107.881 -1.155 . . . . 1.35 107.881 169.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 29.2 t -48.57 -36.94 16.63 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 114.161 -1.381 . . . . 1.28 110.565 169.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.536 HE21 ' HD1' ' A' ' 64' ' ' TYR . 48.0 mt-30 -90.31 -32.44 16.51 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 111.875 0.324 . . . . 1.11 111.875 175.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 142.25 -6.81 2.27 Favored Glycine 0 C--N 1.331 0.264 0 N-CA-C 111.119 -0.792 . . . . 0.18 111.119 -176.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.786 ' CE1' HD23 ' A' ' 39' ' ' LEU . 19.9 t80 -66.91 138.61 57.42 Favored 'General case' 0 C--O 1.22 -0.463 0 C-N-CA 123.045 0.538 . . . . 0.18 111.17 -177.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.919 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 2.0 t -133.51 144.21 49.26 Favored 'General case' 0 N--CA 1.428 -1.573 0 N-CA-C 109.39 -0.596 . . . . 0.2 109.39 175.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 1.073 HG11 ' HB1' ' A' ' 57' ' ' ALA . 19.6 t -103.28 100.61 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.465 0 N-CA-C 108.614 -0.884 . . . . 0.17 108.614 162.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.919 HD13 HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -98.73 120.09 38.58 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.237 -0.985 . . . . 1.04 108.414 174.636 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 1.042 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -105.49 131.22 53.17 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.64 0.733 . . . . 0.51 111.304 -177.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.931 ' HZ ' HG13 ' A' ' 20' ' ' VAL . 3.0 m-30 -107.76 108.94 62.08 Favored Pre-proline 0 C--N 1.31 -1.116 0 CA-C-N 114.998 -1.001 . . . . 0.44 108.905 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.817 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 18.0 Cg_endo -82.13 87.48 1.4 Allowed 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.551 2.167 . . . . 1.3 113.321 -171.052 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.745 ' HB2' ' OD1' ' A' ' 42' ' ' ASN . 1.6 t -40.51 135.51 1.52 Allowed 'General case' 0 CA--C 1.506 -0.739 0 CA-C-N 115.157 -0.929 . . . . 1.44 113.013 -173.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.527 ' C ' ' H ' ' A' ' 79' ' ' PHE . 4.8 p-10 -77.14 89.42 3.63 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 114.493 -1.23 . . . . 1.81 109.372 178.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 1.036 ' HA ' ' HG2' ' A' ' 83' ' ' GLU . 3.7 mt-30 -54.41 -7.92 0.18 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 113.674 -1.603 . . . . 3.34 109.941 167.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.537 ' HA ' ' HD3' ' A' ' 91' ' ' LYS . 59.5 m-85 -63.59 -12.71 35.39 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.59 -1.187 . . . . 2.68 111.969 -178.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -94.06 -125.34 4.18 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.485 -0.864 . . . . 1.98 111.864 177.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -170.32 71.25 0.12 Allowed Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 111.073 -0.811 . . . . 1.49 111.073 174.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.73 ' HG3' ' HG2' ' A' ' 113' ' ' GLU . 5.2 pm0 -169.16 -27.95 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.961 -0.619 . . . . 1.74 110.022 -172.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 1.036 ' HG2' ' HA ' ' A' ' 78' ' ' GLN . 0.0 OUTLIER -60.82 166.99 3.86 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 114.743 -1.117 . . . . 3.07 111.86 -165.482 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.793 ' HG3' HD21 ' A' ' 42' ' ' ASN . 31.3 Cg_exo -15.81 -58.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.804 1 C-N-CA 127.155 5.236 . . . . 1.75 115.781 -175.001 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 169.38 37.85 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 119.834 -1.174 . . . . 2.2 112.674 177.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.821 ' HB2' ' HG2' ' A' ' 78' ' ' GLN . 19.1 m120 -112.63 -43.4 3.47 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.726 -0.39 . . . . 4.2 110.686 -179.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.63 ' O ' ' HE2' ' A' ' 91' ' ' LYS . 22.8 tt0 68.33 -64.23 0.31 Allowed 'General case' 0 C--O 1.223 -0.301 0 C-N-CA 123.956 0.902 . . . . 3.02 113.072 170.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.492 ' O ' ' HG2' ' A' ' 92' ' ' GLU . 20.6 tp10 -115.86 -0.58 12.82 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.792 0.329 . . . . 3.92 110.473 -175.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.818 ' HB2' ' HB3' ' A' ' 86' ' ' ASN . 11.1 tp10 -49.49 -61.31 2.17 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.586 -0.733 . . . . 2.65 112.387 -170.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.887 HG12 ' HB2' ' A' ' 78' ' ' GLN . 24.4 pt -93.01 8.25 5.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.917 -0.313 . . . . 2.15 111.519 -176.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.63 ' HE2' ' O ' ' A' ' 87' ' ' GLU . 47.9 mtmt -97.1 -37.47 10.12 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.845 0.355 . . . . 2.79 110.317 179.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.492 ' HG2' ' O ' ' A' ' 88' ' ' GLU . 9.2 pt-20 -86.46 -27.67 23.95 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 116.003 -0.544 . . . . 3.29 109.989 176.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.454 ' HB3' ' SG ' ' A' ' 47' ' ' CYS . 17.2 t80 -113.38 152.97 29.31 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.99 0.424 . . . . 3.42 110.179 -176.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.2 p -70.82 123.39 24.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.96 -0.564 . . . . 2.63 110.686 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.692 ' SG ' ' HB ' ' A' ' 90' ' ' ILE . 1.4 p -108.6 120.04 41.28 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.369 0.604 . . . . 2.83 111.164 177.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.583 ' O ' ' HB3' ' A' ' 45' ' ' SER . 4.5 m -85.75 141.35 29.76 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 107.297 -1.372 . . . . 2.98 107.297 165.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.511 ' HD2' ' HB1' ' A' ' 23' ' ' ALA . 22.1 pttm -67.36 115.03 6.55 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 108.358 -0.978 . . . . 2.72 108.358 177.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.762 ' CE1' ' HB2' ' A' ' 100' ' ' ALA . 0.0 OUTLIER -59.27 115.8 3.47 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.099 -0.955 . . . . 2.12 110.066 -172.501 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -105.83 111.88 24.72 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.292 -0.867 . . . . 2.69 110.496 -178.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.762 ' HB2' ' CE1' ' A' ' 98' ' ' PHE . . . -107.09 -160.63 0.74 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.068 -0.969 . . . . 0.55 111.24 -177.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -87.4 -5.39 58.87 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.353 -0.839 . . . . 1.99 110.108 174.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.709 ' HB2' ' O ' ' A' ' 71' ' ' VAL . 16.6 p90 -121.09 160.26 45.98 Favored Pre-proline 0 N--CA 1.44 -0.932 0 CA-C-N 115.639 -0.71 . . . . 0.84 110.37 -175.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.69 ' HG2' ' HA ' ' A' ' 72' ' ' LEU . 44.0 Cg_endo -61.65 95.99 0.13 Allowed 'Trans proline' 0 N--CA 1.479 0.624 0 C-N-CA 124.71 3.606 . . . . 0.62 114.284 -174.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 1.042 HD12 ' HB3' ' A' ' 73' ' ' ALA . 4.8 mm -87.02 129.8 37.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 108.591 -0.892 . . . . 1.34 108.591 171.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.772 ' HG2' ' CG ' ' A' ' 74' ' ' PHE . 0.1 OUTLIER -82.66 174.03 11.38 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.709 -0.848 . . . . 3.03 108.709 177.114 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.79 ' N ' ' HA ' ' A' ' 23' ' ' ALA . . . -56.09 -56.51 19.98 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.16 0.505 . . . . 1.46 110.127 -176.046 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.816 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 4.7 ptpp? 144.33 137.03 0.0 OUTLIER 'General case' 0 CA--C 1.488 -1.416 0 O-C-N 125.734 1.896 . . . . 1.76 106.952 176.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.496 HD12 HG22 ' A' ' 110' ' ' VAL . 2.9 pp -136.21 163.32 34.32 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.281 0 CA-C-N 113.945 -1.479 . . . . 0.82 107.497 177.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.689 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 1.0 OUTLIER -71.19 57.58 0.23 Allowed 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 122.947 0.499 . . . . 1.73 111.894 -173.83 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.604 HG23 ' CB ' ' A' ' 76' ' ' SER . 0.0 OUTLIER -61.16 94.83 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 N-CA-C 108.92 -0.77 . . . . 0.77 108.92 -178.121 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.61 ' ND2' ' H ' ' A' ' 112' ' ' GLY . 3.8 t30 176.27 -177.4 0.13 Allowed 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 114.245 -1.343 . . . . 1.9 108.717 -177.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.61 ' H ' ' ND2' ' A' ' 111' ' ' ASN . . . -55.82 -34.66 61.48 Favored Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 116.573 1.389 . . . . 1.47 116.573 -177.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.73 ' HG2' ' HG3' ' A' ' 82' ' ' GLN . 0.5 OUTLIER -87.73 -42.79 12.38 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 119.59 1.695 . . . . 2.81 113.538 -156.403 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -129.84 -33.8 1.77 Allowed 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.449 -0.501 . . . . 2.16 110.308 -176.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 1.037 ' HB3' ' HG2' ' A' ' 120' ' ' GLU . . . 39.44 -132.19 0.22 Allowed 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 114.694 -1.139 . . . . 1.26 110.33 -173.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.62 ' CE1' ' H ' ' A' ' 118' ' ' LEU . 3.2 t-80 -152.94 137.4 10.77 Favored Pre-proline 0 N--CA 1.422 -1.828 0 N-CA-C 105.636 -1.987 . . . . 0.42 105.636 170.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -29.38 -44.31 0.1 OUTLIER 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 124.128 3.219 . . . . 0.4 113.577 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.861 HD11 ' HB ' ' A' ' 15' ' ' ILE . 39.4 tp -59.63 -52.25 66.34 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.495 0.718 . . . . 0.39 112.079 176.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.665 ' HA ' ' HB2' ' A' ' 122' ' ' MET . 43.0 m-85 -77.39 -36.27 53.55 Favored 'General case' 0 CA--C 1.5 -0.953 0 N-CA-C 111.871 0.322 . . . . 3.04 111.871 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 1.037 ' HG2' ' HB3' ' A' ' 115' ' ' ALA . 7.0 mm-40 -59.33 -32.81 70.42 Favored 'General case' 0 CA--C 1.494 -1.182 0 N-CA-C 107.828 -1.175 . . . . 2.44 107.828 172.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.701 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 55.0 t80 -70.81 -33.71 70.99 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 119.731 -0.788 . . . . 0.56 110.651 172.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.745 ' HE3' ' HG ' ' A' ' 118' ' ' LEU . 2.6 ttm -73.59 -55.22 6.58 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.903 -0.589 . . . . 0.71 110.102 -168.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.676 ' HD2' ' HB2' ' A' ' 134' ' ' ALA . 0.2 OUTLIER -71.31 -24.13 62.07 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.088 -0.505 . . . . 1.46 111.614 176.372 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.727 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 9.8 pttp -68.71 -27.54 66.03 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 119.088 -1.045 . . . . 1.99 108.889 175.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 56.0 m -76.73 -50.04 14.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.463 -0.79 . . . . 0.59 109.546 173.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.654 ' HB3' ' NH2' ' A' ' 153' ' ' ARG . 31.4 mttm -138.22 109.81 8.28 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.902 -0.59 . . . . 1.85 111.077 176.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 126' ' ' LYS . 7.4 Cg_exo -72.49 -46.67 0.44 Allowed 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 123.084 2.523 . . . . 1.69 111.348 -177.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.517 ' HA2' ' CZ ' ' A' ' 153' ' ' ARG . . . -178.03 142.84 5.75 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.789 -0.72 . . . . 2.59 111.913 177.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.614 HG23 HH12 ' A' ' 153' ' ' ARG . 22.1 pt -66.41 -27.91 41.85 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 N-CA-C 108.252 -1.018 . . . . 3.58 108.252 170.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 38.4 tp -93.75 141.84 28.04 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 107.265 -1.383 . . . . 3.47 107.265 165.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -69.71 79.56 0.44 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.107 0.48 . . . . 3.28 110.985 -177.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 8.0 m -118.16 -93.36 0.51 Allowed 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 116.123 -0.489 . . . . 3.56 111.508 -179.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 61.5 tttp 179.46 -49.12 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.75 0.31 . . . . 5.17 111.197 -175.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.676 ' HB2' ' HD2' ' A' ' 123' ' ' LYS . . . -154.08 -174.15 4.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.297 0.57 . . . . 1.59 112.408 -172.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.939 ' H ' HD13 ' A' ' 135' ' ' ILE . 0.1 OUTLIER -69.45 46.95 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-N 114.7 -1.136 . . . . 2.0 111.118 173.235 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.495 ' C ' ' HA ' ' A' ' 84' ' ' PRO . 21.6 tttp -76.17 48.83 0.53 Allowed 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.495 0.664 . . . . 4.81 111.963 -172.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.66 ' C ' ' HB3' ' A' ' 84' ' ' PRO . 12.0 m-90 -144.56 173.06 12.14 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.159 -1.052 . . . . 1.97 108.159 178.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.663 ' HB2' ' CB ' ' A' ' 156' ' ' PRO . 11.5 m120 -45.25 -155.31 0.0 OUTLIER 'General case' 0 C--O 1.21 -1.019 0 C-N-CA 123.907 0.883 . . . . 2.04 111.403 163.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.599 ' HA ' HG12 ' A' ' 43' ' ' VAL . 1.3 m-85 -30.47 -27.65 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.308 0 N-CA-C 117.317 2.34 . . . . 1.93 117.317 -167.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.664 ' HA ' ' O ' ' A' ' 154' ' ' PHE . 3.1 m 9.08 108.55 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 115.162 1.541 . . . . 0.6 115.162 169.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.603 ' OG ' HD12 ' A' ' 39' ' ' LEU . 3.1 t -105.84 165.59 11.08 Favored 'General case' 0 C--O 1.207 -1.177 0 CA-C-N 114.903 -1.044 . . . . 0.62 110.855 -173.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.497 ' CE2' HG23 ' A' ' 135' ' ' ILE . 15.1 m-85 -121.51 125.22 46.3 Favored 'General case' 0 CA--C 1.49 -1.337 0 N-CA-C 106.486 -1.672 . . . . 0.57 106.486 167.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.768 HD23 ' HG3' ' A' ' 152' ' ' GLU . 11.1 tp -80.36 104.14 10.7 Favored 'General case' 0 N--CA 1.419 -2.004 0 C-N-CA 118.222 -1.391 . . . . 0.43 108.457 178.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.681 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 41.1 mm -89.21 141.7 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.658 0 CA-C-N 113.012 -1.904 . . . . 0.19 107.701 -177.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.665 ' HA ' HD13 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -93.46 -176.01 3.97 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 119.938 -0.705 . . . . 0.98 111.137 -170.865 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.728 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 50.4 mtm180 -54.49 -37.12 64.92 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.878 0.37 . . . . 2.22 111.301 -177.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.435 ' O ' ' HB3' ' A' ' 14' ' ' SER . 7.5 m-20 -94.36 13.96 22.0 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.716 -0.22 . . . . 2.0 110.782 -178.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.638 ' HA3' ' CE2' ' A' ' 16' ' ' PHE . . . 73.14 36.82 56.04 Favored Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 120.858 -0.687 . . . . 0.17 113.286 -176.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.474 ' HA ' ' HD2' ' A' ' 150' ' ' PRO . 52.6 t -107.82 106.32 58.24 Favored Pre-proline 0 C--N 1.317 -0.829 0 CA-C-N 117.701 0.75 . . . . 1.12 111.078 175.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.708 ' HG3' ' HG3' ' A' ' 122' ' ' MET . 2.1 Cg_endo -51.48 117.24 3.28 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 123.746 2.964 . . . . 0.41 111.462 172.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.873 HG23 ' HG2' ' A' ' 152' ' ' GLU . 27.5 m -118.33 -13.02 10.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 121.133 0.492 . . . . 1.45 109.754 -178.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.873 ' HG2' HG23 ' A' ' 151' ' ' VAL . 17.2 mm-40 -145.99 165.9 27.65 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.582 -0.736 . . . . 1.17 109.652 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.654 ' NH2' ' HB3' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -148.03 144.23 27.77 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.634 -0.712 . . . . 2.16 110.044 159.459 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.706 ' HZ ' ' HB2' ' A' ' 166' ' ' LYS . 91.5 m-85 -120.58 148.25 44.12 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.333 -0.849 . . . . 0.32 108.802 -166.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.426 ' HB3' ' HD2' ' A' ' 156' ' ' PRO . 10.8 m -74.56 162.67 72.67 Favored Pre-proline 0 C--N 1.316 -0.889 0 N-CA-C 109.654 -0.498 . . . . 1.11 109.654 178.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.663 ' CB ' ' HB2' ' A' ' 138' ' ' ASN . 28.6 Cg_endo -63.82 -33.04 66.3 Favored 'Trans proline' 0 CA--C 1.516 -0.386 0 C-N-CA 121.973 1.782 . . . . 0.78 110.42 174.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -63.96 -5.54 14.84 Favored Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 113.926 -1.488 . . . . 0.5 113.822 170.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -87.74 142.32 27.92 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 117.765 0.782 . . . . 0.5 109.408 174.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.467 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 20.3 t -109.92 -179.82 3.91 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 120.881 0.372 . . . . 1.42 110.414 -172.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.808 HG22 ' HA ' ' A' ' 56' ' ' THR . 62.9 t -43.68 -52.13 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.082 -0.963 . . . . 0.28 111.452 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.33 -27.58 62.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.956 -0.566 . . . . 3.46 111.486 -173.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -71.12 -37.75 72.32 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 109.144 -0.687 . . . . 1.4 109.144 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.546 ' HA ' ' CE2' ' A' ' 154' ' ' PHE . 75.0 mt -77.35 -49.09 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-N 115.027 -0.988 . . . . 0.21 110.639 176.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.673 ' HG3' HD21 ' A' ' 60' ' ' LEU . 25.5 mt-10 -51.78 -45.47 63.82 Favored 'General case' 0 C--O 1.219 -0.54 0 O-C-N 123.302 0.376 . . . . 0.67 111.305 -177.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -56.31 -23.34 36.3 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.041 0.386 . . . . 0.87 112.041 -175.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.706 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 14.2 mmmm -102.1 -23.91 14.01 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.342 0.591 . . . . 1.71 110.064 174.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.668 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 7.5 tp -76.74 -48.06 19.91 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.262 -0.881 . . . . 0.16 111.95 -177.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.5 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 80.6 mt -53.76 -46.39 98.41 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.616 -0.72 . . . . 0.26 112.175 -174.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.5 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 58.0 Cg_exo -54.65 -22.93 30.53 Favored 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 122.311 2.007 . . . . 0.41 113.12 174.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.763 ' HB3' ' HG3' ' A' ' 37' ' ' PRO . 31.2 mt -92.98 -38.5 11.63 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 111.68 0.252 . . . . 0.71 111.68 178.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.824 HD23 ' HG2' ' A' ' 37' ' ' PRO . 94.9 mt -63.29 -52.04 63.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-O 122.212 1.006 . . . . 0.34 109.313 175.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -73.63 -32.14 59.78 Favored Glycine 0 N--CA 1.433 -1.563 0 CA-C-N 113.265 -1.789 . . . . 1.12 114.184 -174.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 19.4 m -151.8 -169.48 3.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 117.615 0.708 . . . . 2.64 111.423 -175.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -93.02 -56.61 2.91 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.843 0.312 . . . . 4.35 111.843 -179.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 9.2 tpm_? -147.74 106.51 3.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.018 0.437 . . . . 8.45 111.715 -176.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 4.3 mm? . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.69 -0.671 . . . . 7.69 109.352 172.345 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.657 0 CA-C-O 120.133 -0.26 . . . . 5.22 112.506 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.6 ptm -171.39 -29.56 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.884 0.342 . . . . 4.85 111.206 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.43 74.94 0.83 Allowed Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.513 -0.851 . . . . 1.55 112.973 179.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.2 t -110.76 3.77 19.4 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.834 0.826 . . . . 1.58 108.794 173.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.438 ' HB2' ' O ' ' A' ' 147' ' ' ASP . 92.0 p -179.91 152.69 0.48 Allowed 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 104.831 -2.285 . . . . 1.17 104.831 -177.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.984 HD12 HD21 ' A' ' 30' ' ' LEU . 4.7 pt -66.96 -12.66 15.42 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 CA-C-N 115.371 -0.831 . . . . 0.38 112.021 -171.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.656 ' CD1' ' HA ' ' A' ' 31' ' ' VAL . 54.9 m-85 -76.28 6.97 4.74 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.028 0.442 . . . . 0.3 111.167 178.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -81.7 -27.74 33.8 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 107.24 -1.393 . . . . 2.11 107.24 174.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.654 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 50.9 m-85 -105.05 121.02 42.92 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 113.963 -1.472 . . . . 0.31 111.008 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -60.18 150.08 30.99 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.29 -1.323 . . . . 2.86 109.818 173.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.852 HG13 ' HZ ' ' A' ' 74' ' ' PHE . 53.0 t -112.23 170.66 3.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 107.71 -1.219 . . . . 0.67 107.71 178.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.702 HD23 ' HA ' ' A' ' 27' ' ' PRO . 88.7 mt -132.37 141.05 48.74 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 118.334 0.515 . . . . 0.69 111.409 -176.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -74.36 169.07 18.42 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 106.878 -1.527 . . . . 1.87 106.878 166.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.82 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . . . -62.4 -3.73 1.53 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 114.046 1.128 . . . . 0.59 114.046 -167.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.531 ' HB2' ' HE2' ' A' ' 26' ' ' LYS . 64.7 m-20 -111.5 12.06 21.37 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 121.008 -0.277 . . . . 2.34 111.349 176.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.558 ' CD2' ' HB1' ' A' ' 106' ' ' ALA . 72.1 m-70 77.13 8.96 2.77 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.366 0.603 . . . . 1.47 109.72 177.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.531 ' HE2' ' HB2' ' A' ' 24' ' ' ASP . 21.1 mtmt -74.65 119.3 76.0 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 107.54 -1.282 . . . . 4.25 107.54 169.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.702 ' HA ' HD23 ' A' ' 21' ' ' LEU . 93.9 Cg_exo -50.39 115.27 1.83 Allowed 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.329 2.019 . . . . 0.54 114.203 -172.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.616 ' CE2' ' HB3' ' A' ' 103' ' ' PRO . 0.2 OUTLIER -78.6 120.4 23.23 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 113.275 -1.784 . . . . 1.2 109.635 169.201 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -72.96 103.1 3.65 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 122.446 1.117 . . . . 1.51 108.82 174.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.984 HD21 HD12 ' A' ' 15' ' ' ILE . 67.3 tp -71.4 -31.48 67.32 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.834 -1.076 . . . . 0.28 110.343 -178.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.656 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 3.3 m -66.14 -4.13 2.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 114.439 -1.255 . . . . 1.02 113.109 -167.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 -74.67 -6.64 49.84 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.557 0.694 . . . . 1.02 110.01 175.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.957 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 88.6 m-70 -102.13 24.97 9.36 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 115.339 -0.846 . . . . 0.28 109.397 176.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.556 ' HE3' ' HB ' ' A' ' 31' ' ' VAL . 93.0 mttt -83.99 123.79 30.36 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 114.426 -1.261 . . . . 1.56 109.323 170.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.14 -36.08 4.07 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.366 -0.921 . . . . 0.2 111.925 178.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.457 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 22.5 m -130.38 132.33 23.95 Favored Pre-proline 0 N--CA 1.436 -1.162 0 N-CA-C 108.252 -1.018 . . . . 0.29 108.252 171.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.752 ' HD3' ' HG2' ' A' ' 146' ' ' ARG . 5.1 Cg_endo -43.18 153.86 0.18 Allowed 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.899 3.066 . . . . 0.18 112.795 176.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.844 ' HB2' HG22 ' A' ' 70' ' ' THR . 0.7 OUTLIER -139.65 149.17 43.42 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 106.313 -1.736 . . . . 0.31 106.313 -179.733 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.989 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 2.3 mp -116.3 130.84 56.98 Favored 'General case' 0 C--N 1.292 -1.92 0 O-C-N 121.629 -0.669 . . . . 1.19 109.606 176.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.935 HG22 ' OH ' ' A' ' 119' ' ' TYR . 1.1 mt -111.72 126.75 69.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 CA-C-N 115.065 -0.971 . . . . 0.37 109.596 178.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.989 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.6 OUTLIER -111.86 124.72 52.95 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.954 -0.566 . . . . 0.42 110.992 -171.662 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.703 ' HB3' HG21 ' A' ' 135' ' ' ILE . 0.9 OUTLIER -79.66 95.12 5.84 Favored 'General case' 0 CA--C 1.504 -0.827 0 N-CA-C 107.206 -1.405 . . . . 2.35 107.206 167.194 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.765 ' O ' ' HA ' ' A' ' 75' ' ' PRO . 4.1 p -105.89 147.17 11.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 CA-C-N 114.833 -1.076 . . . . 1.03 109.649 -172.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.444 ' O ' ' HB3' ' A' ' 46' ' ' LYS . . . -106.6 95.76 5.98 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 119.035 -1.066 . . . . 0.88 109.879 172.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.94 ' HA ' ' HB2' ' A' ' 98' ' ' PHE . 9.2 p 17.64 -81.28 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 O-C-N 125.636 1.835 . . . . 1.78 113.824 165.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.548 ' HG3' ' HB2' ' A' ' 49' ' ' TYR . 0.0 OUTLIER 60.67 145.92 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.831 1.252 . . . . 5.84 112.939 174.074 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.986 ' HB2' ' HA ' ' A' ' 95' ' ' CYS . 46.7 t -111.2 115.31 29.15 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.801 -0.636 . . . . 3.55 110.158 178.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 63.11 13.4 48.57 Favored Glycine 0 CA--C 1.522 0.522 0 CA-C-N 115.968 -0.56 . . . . 2.91 113.624 179.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.548 ' HB2' ' HG3' ' A' ' 46' ' ' LYS . 36.7 m-85 -108.52 167.71 9.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.337 0.589 . . . . 4.63 111.866 -177.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.5 t -177.2 143.26 0.38 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.925 -1.034 . . . . 1.93 108.469 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.744 ' O ' ' HA2' ' A' ' 157' ' ' GLY . 21.9 mtpt -108.52 11.85 26.5 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.902 -0.777 . . . . 2.01 108.902 176.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 120.81 -29.32 5.87 Favored Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 110.301 -1.12 . . . . 0.51 110.301 -173.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.404 ' HA3' ' CG ' ' A' ' 139' ' ' PHE . . . -49.85 -46.69 40.06 Favored Glycine 0 C--O 1.222 -0.62 0 CA-C-N 114.424 -0.888 . . . . 0.5 113.969 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.472 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 0.2 OUTLIER -59.31 -59.14 5.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.328 0.564 . . . . 0.7 111.554 -171.855 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.14 -27.87 69.67 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.291 0.567 . . . . 2.61 110.48 -177.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.702 HG23 ' HA ' ' A' ' 160' ' ' VAL . 31.8 m -75.83 -57.77 3.68 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.084 -0.962 . . . . 0.33 110.02 -175.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 1.055 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -60.3 -41.67 93.88 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.202 -0.908 . . . . 0.22 111.039 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.536 ' HA ' ' CD2' ' A' ' 102' ' ' PHE . 96.7 m -57.69 -55.69 31.53 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.433 0.635 . . . . 0.26 110.466 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 27.3 m -69.46 -36.11 76.27 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.001 -0.999 . . . . 0.48 111.484 -175.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.749 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 16.3 mt -66.93 -47.07 72.82 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-O 120.974 0.416 . . . . 0.43 110.472 -176.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.857 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 5.0 t80 -55.31 -56.14 23.4 Favored 'General case' 0 C--O 1.198 -1.637 0 CA-C-N 115.208 -0.905 . . . . 0.31 109.916 177.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -69.75 -24.04 63.47 Favored 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 122.707 0.403 . . . . 1.21 111.566 -173.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.405 ' HE2' ' HB2' ' A' ' 63' ' ' LYS . 13.8 tppt? -76.01 -32.25 59.3 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 108.388 -0.968 . . . . 1.54 108.388 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.713 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 48.4 m-85 -125.86 -2.44 7.18 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 115.7 1.741 . . . . 0.31 115.7 -166.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.765 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 12.6 ptmt -63.84 -29.27 70.48 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 107.686 -1.227 . . . . 1.35 107.686 170.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.6 m -47.94 -36.63 12.76 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 113.822 -1.536 . . . . 1.28 111.009 173.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.506 HE21 ' HD1' ' A' ' 64' ' ' TYR . 49.7 mt-30 -88.44 -39.75 14.0 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 120.96 -0.296 . . . . 1.11 111.619 173.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.425 ' HA3' ' HB2' ' A' ' 36' ' ' SER . . . 151.49 -4.03 0.47 Allowed Glycine 0 CA--C 1.52 0.388 0 N-CA-C 111.505 -0.638 . . . . 0.18 111.505 -175.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.749 ' HE2' ' HB3' ' A' ' 60' ' ' LEU . 21.4 t80 -71.2 142.59 50.64 Favored 'General case' 0 C--O 1.222 -0.392 0 C-N-CA 122.644 0.377 . . . . 0.18 111.131 -177.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.957 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 2.3 t -133.76 153.15 51.92 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 108.063 -1.088 . . . . 0.2 108.063 173.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 1.055 HG11 ' HB1' ' A' ' 57' ' ' ALA . 25.6 t -112.97 99.5 8.79 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.541 0 N-CA-C 108.018 -1.104 . . . . 0.17 108.018 160.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.511 HD12 ' H ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -93.68 120.2 33.65 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 118.365 -1.334 . . . . 1.04 107.557 174.554 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.769 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -112.21 117.23 31.99 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.538 0.685 . . . . 0.51 110.901 -178.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.852 ' HZ ' HG13 ' A' ' 20' ' ' VAL . 5.3 m-30 -93.31 112.54 56.86 Favored Pre-proline 0 C--N 1.318 -0.779 0 CA-C-N 115.241 -0.891 . . . . 0.44 109.388 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.765 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 44.2 Cg_endo -82.29 87.4 1.4 Allowed 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.082 1.855 . . . . 1.3 112.694 -172.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.622 ' HB2' ' ND2' ' A' ' 42' ' ' ASN . 7.0 t -43.18 140.56 1.48 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.382 -1.281 . . . . 1.44 111.765 -177.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.728 HD22 ' HB2' ' A' ' 79' ' ' PHE . 1.5 p-10 -112.82 132.28 55.33 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 113.989 -1.46 . . . . 1.81 110.379 -169.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.843 ' HA ' ' HG2' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -50.17 -8.96 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.636 -1.166 . . . . 3.34 113.396 -178.431 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.728 ' HB2' HD22 ' A' ' 77' ' ' ASN . 69.8 m-85 -65.24 -14.09 59.87 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.618 0.599 . . . . 2.68 112.618 -168.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -98.21 -23.58 12.69 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.318 -0.944 . . . . 1.98 112.664 -177.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.18 13.21 82.96 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 111.411 -0.676 . . . . 1.49 111.411 -176.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.493 ' NE2' ' HB3' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -123.2 20.17 9.82 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 122.765 0.426 . . . . 1.74 110.111 -175.979 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.843 ' HG2' ' HA ' ' A' ' 78' ' ' GLN . 0.0 OUTLIER -74.03 143.54 80.88 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-O 121.913 0.863 . . . . 3.07 112.885 -165.664 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.73 ' HB2' ' O ' ' A' ' 137' ' ' TRP . 80.0 Cg_endo -78.05 -43.57 0.19 Allowed 'Trans proline' 0 N--CA 1.478 0.605 0 C-N-CA 124.992 3.795 . . . . 1.75 113.867 -171.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -58.02 -24.44 54.5 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 121.364 -0.446 . . . . 2.2 112.941 -174.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.468 ' O ' ' HB3' ' A' ' 87' ' ' GLU . 43.5 t-20 177.02 -86.62 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.97 -1.122 . . . . 4.2 107.97 177.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.468 ' HB3' ' O ' ' A' ' 86' ' ' ASN . 13.8 pt-20 154.71 -41.31 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 O-C-N 124.859 1.349 . . . . 3.02 108.26 173.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.414 ' O ' ' HG2' ' A' ' 92' ' ' GLU . 11.1 tp10 -106.16 -26.15 11.71 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.001 -1.0 . . . . 3.92 111.213 -175.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.436 ' HA ' ' HG2' ' A' ' 92' ' ' GLU . 31.8 tt0 -50.71 -45.34 58.39 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.943 0.72 . . . . 2.65 112.943 -170.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.615 ' HA ' ' SG ' ' A' ' 95' ' ' CYS . 33.2 pt -82.54 10.57 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.985 0.422 . . . . 2.15 111.861 -176.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.409 ' HE3' ' OE2' ' A' ' 88' ' ' GLU . 48.2 mtmt -124.47 -42.79 2.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.145 0.498 . . . . 2.79 109.832 176.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.436 ' HG2' ' HA ' ' A' ' 89' ' ' GLU . 12.0 pt-20 -66.92 -22.09 65.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.636 -0.711 . . . . 3.29 109.66 175.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -129.69 148.48 51.58 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.428 -0.953 . . . . 3.42 108.428 176.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 8.9 p -78.23 117.28 23.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-O 121.4 0.619 . . . . 2.63 110.159 176.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.986 ' HA ' ' HB2' ' A' ' 47' ' ' CYS . 61.8 m -119.08 126.71 52.31 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.344 0.592 . . . . 2.83 110.965 -178.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.5 p -64.43 157.32 26.79 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 114.648 -1.16 . . . . 2.98 108.667 169.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -75.64 43.8 0.26 Allowed 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 111.845 0.313 . . . . 2.72 111.845 -174.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.94 ' HB2' ' HA ' ' A' ' 45' ' ' SER . 0.9 OUTLIER 65.57 -92.36 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.743 -0.662 . . . . 2.12 110.721 177.782 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt 63.93 139.52 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 O-C-N 123.632 0.582 . . . . 2.69 111.12 -175.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.489 ' HB2' ' CE1' ' A' ' 98' ' ' PHE . . . -164.6 -173.21 2.94 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.048 0.452 . . . . 0.55 111.36 -176.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -85.86 22.52 1.65 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.308 -0.86 . . . . 1.99 110.606 -177.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.636 ' CZ ' ' HZ ' ' A' ' 98' ' ' PHE . 19.1 p90 -147.33 163.67 26.89 Favored Pre-proline 0 N--CA 1.447 -0.609 0 CA-C-N 115.711 -0.677 . . . . 0.84 109.312 -178.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.657 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 71.3 Cg_exo -57.12 89.39 0.04 OUTLIER 'Trans proline' 0 N--CA 1.478 0.608 0 C-N-CA 124.608 3.538 . . . . 0.62 115.44 -172.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.769 HD12 ' HB3' ' A' ' 73' ' ' ALA . 3.6 mm -89.52 127.54 42.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 108.259 -1.015 . . . . 1.34 108.259 171.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.847 ' HG2' ' CG ' ' A' ' 74' ' ' PHE . 0.7 OUTLIER -88.83 -171.37 3.28 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.8 0.333 . . . . 3.03 111.563 -172.206 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.82 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . . . -61.19 -16.88 49.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.808 -0.633 . . . . 1.46 111.795 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.752 ' HB2' ' O ' ' A' ' 75' ' ' PRO . 3.7 ptpp? 78.27 128.2 0.05 OUTLIER 'General case' 0 CA--C 1.494 -1.193 0 O-C-N 125.477 1.736 . . . . 1.76 109.846 -166.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.771 HD12 HG22 ' A' ' 110' ' ' VAL . 2.4 pp -128.87 163.64 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.162 0 CA-C-N 113.028 -1.897 . . . . 0.82 107.042 171.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.615 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 0.1 OUTLIER -70.15 58.1 0.16 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 123.897 0.748 . . . . 1.73 111.556 -172.576 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.771 HG22 HD12 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -63.91 96.64 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 CA-C-O 120.849 0.357 . . . . 0.77 111.08 -171.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.867 HD21 ' HA ' ' A' ' 136' ' ' LYS . 3.5 t-20 176.59 177.74 0.25 Allowed 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 108.337 -0.986 . . . . 1.9 108.337 167.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 29.1 -104.06 0.01 OUTLIER Glycine 0 C--N 1.331 0.273 0 O-C-N 124.7 1.25 . . . . 1.47 115.803 167.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -107.3 -32.41 7.79 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 113.438 0.903 . . . . 2.81 113.438 -169.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.578 ' HB2' ' HB3' ' A' ' 109' ' ' ASN . 14.9 m-80 -94.69 1.06 55.5 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-O 118.939 -0.553 . . . . 2.16 111.264 -169.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.615 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -36.53 -91.48 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.171 0 O-C-N 124.647 1.217 . . . . 1.26 112.796 -170.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.649 ' CE1' ' H ' ' A' ' 118' ' ' LEU . 2.0 t-80 176.9 138.47 0.22 Allowed Pre-proline 0 N--CA 1.43 -1.456 0 N-CA-C 106.254 -1.758 . . . . 0.42 106.254 173.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -30.31 -46.26 0.14 Allowed 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 124.303 3.336 . . . . 0.4 113.621 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.836 HD11 ' HB ' ' A' ' 15' ' ' ILE . 22.6 tp -62.64 -51.34 67.64 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.174 0.589 . . . . 0.39 111.886 178.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.935 ' OH ' HG22 ' A' ' 40' ' ' ILE . 36.6 m-85 -76.58 -36.55 57.51 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 112.285 0.476 . . . . 3.04 112.285 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.793 ' HA ' ' HD2' ' A' ' 123' ' ' LYS . 48.5 mt-10 -61.61 -30.79 70.92 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 107.462 -1.31 . . . . 2.44 107.462 174.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.654 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 59.5 t80 -71.62 -32.87 68.43 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.426 -0.806 . . . . 0.56 110.682 171.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.737 ' HE3' ' HG ' ' A' ' 118' ' ' LEU . 2.5 ttm -73.73 -52.46 13.13 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.178 -0.465 . . . . 0.71 110.367 -169.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.793 ' HD2' ' HA ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -71.04 -24.73 62.4 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.196 -0.456 . . . . 1.46 111.079 175.463 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.767 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -65.0 -30.75 71.76 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.461 0.648 . . . . 1.99 109.741 172.257 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 85.9 m -79.51 -47.32 15.78 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.245 -0.889 . . . . 0.59 111.038 178.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.566 ' HE3' ' O ' ' A' ' 151' ' ' VAL . 19.9 ttmm -140.42 121.8 9.37 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 121.06 0.457 . . . . 1.85 111.982 -178.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.521 ' HD3' ' HA ' ' A' ' 126' ' ' LYS . 6.1 Cg_exo -78.97 32.27 0.46 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.711 2.94 . . . . 1.69 111.966 175.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.526 ' H ' ' HG2' ' A' ' 126' ' ' LYS . . . 85.93 165.6 40.93 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.569 -0.741 . . . . 2.59 113.242 172.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.42 HG13 ' O ' ' A' ' 153' ' ' ARG . 14.1 mt -73.95 -36.42 45.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 108.353 -0.98 . . . . 3.58 108.353 173.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.816 HD23 ' H ' ' A' ' 130' ' ' LEU . 2.2 pt? -90.17 147.22 23.72 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.531 -1.213 . . . . 3.47 108.213 169.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.92 87.54 0.73 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.974 0.416 . . . . 3.28 110.731 -176.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.735 HG21 ' HZ3' ' A' ' 137' ' ' TRP . 28.0 m -149.06 127.72 12.43 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.998 -0.547 . . . . 3.56 110.278 179.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -41.46 -67.79 0.23 Allowed 'General case' 0 N--CA 1.47 0.539 0 O-C-N 123.919 0.762 . . . . 5.17 112.105 -173.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -118.38 178.09 4.58 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.844 -0.617 . . . . 1.59 110.304 -179.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.832 ' H ' HD13 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -34.43 -51.48 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 O-C-N 124.439 1.087 . . . . 2.0 111.791 173.292 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.891 ' HB3' ' CZ3' ' A' ' 137' ' ' TRP . 5.4 tmtp? 55.84 -14.04 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 116.11 1.892 . . . . 4.81 116.11 174.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.891 ' CZ3' ' HB3' ' A' ' 136' ' ' LYS . 2.3 m-90 -115.39 175.34 5.56 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 119.277 0.944 . . . . 1.97 110.229 176.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -42.26 -155.8 0.0 OUTLIER 'General case' 0 C--O 1.205 -1.245 0 C-N-CA 124.022 0.929 . . . . 2.04 110.535 159.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.645 ' HD2' ' CD2' ' A' ' 41' ' ' TYR . 5.0 m-85 -26.04 -46.72 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.046 0 N-CA-C 116.025 1.861 . . . . 1.93 116.025 -163.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.689 ' HA ' ' O ' ' A' ' 154' ' ' PHE . 5.7 m 28.34 96.16 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 119.675 1.125 . . . . 0.6 113.664 171.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.674 ' HB3' HD23 ' A' ' 39' ' ' LEU . 1.6 m -85.07 170.74 12.65 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.041 -0.982 . . . . 0.62 111.714 -170.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.56 ' CE1' HG23 ' A' ' 135' ' ' ILE . 81.1 m-85 -130.46 120.3 23.97 Favored 'General case' 0 CA--C 1.496 -1.116 0 N-CA-C 105.886 -1.894 . . . . 0.57 105.886 161.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.756 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 4.9 tp -78.82 103.64 8.91 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 118.054 -1.458 . . . . 0.43 108.062 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.748 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 45.6 mm -88.77 141.27 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.788 0 CA-C-N 113.474 -1.694 . . . . 0.19 107.564 -177.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.446 ' HA ' HD13 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -92.37 -176.05 4.2 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 119.179 -1.008 . . . . 0.98 110.601 -171.92 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.752 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 11.5 mtm180 -54.55 -40.89 69.14 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.141 0.496 . . . . 2.22 111.031 -176.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.438 ' O ' ' HB2' ' A' ' 14' ' ' SER . 5.0 m-20 -94.83 18.01 12.61 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.558 -0.534 . . . . 2.0 109.558 -175.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.56 ' HA3' ' CE2' ' A' ' 16' ' ' PHE . . . 73.12 33.68 59.11 Favored Glycine 0 N--CA 1.44 -1.077 0 CA-C-N 115.688 -0.687 . . . . 0.17 114.128 178.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.512 ' HA ' ' HD2' ' A' ' 150' ' ' PRO . 62.1 t -107.45 106.93 59.63 Favored Pre-proline 0 C--N 1.314 -0.953 0 CA-C-N 118.298 1.049 . . . . 1.12 111.291 176.077 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.577 ' HG3' ' HG3' ' A' ' 122' ' ' MET . 5.7 Cg_exo -46.34 122.9 6.04 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 124.155 3.237 . . . . 0.41 112.087 171.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.566 ' O ' ' HE3' ' A' ' 126' ' ' LYS . 46.8 t -117.99 -29.66 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 109.369 -0.604 . . . . 1.45 109.369 -176.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.756 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 31.0 mm-40 -136.84 167.03 22.23 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.562 -0.745 . . . . 1.17 110.848 -177.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.452 ' HA ' ' O ' ' A' ' 141' ' ' SER . 0.2 OUTLIER -144.02 131.37 20.89 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.473 -0.785 . . . . 2.16 109.712 163.552 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.689 ' O ' ' HA ' ' A' ' 140' ' ' THR . 96.8 m-85 -111.02 152.32 26.98 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.866 -0.606 . . . . 0.32 109.63 -170.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 12.5 m -74.76 156.94 86.31 Favored Pre-proline 0 C--N 1.319 -0.719 0 N-CA-C 109.469 -0.567 . . . . 1.11 109.469 176.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.777 ' HG3' ' HB3' ' A' ' 137' ' ' TRP . 34.4 Cg_endo -64.88 -24.89 60.46 Favored 'Trans proline' 0 CA--C 1.519 -0.267 0 C-N-CA 122.181 1.92 . . . . 0.78 111.039 177.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.744 ' HA2' ' O ' ' A' ' 51' ' ' LYS . . . -80.44 5.6 63.54 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 114.691 -1.14 . . . . 0.5 113.453 173.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -79.19 151.33 31.3 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.388 -0.597 . . . . 0.5 109.388 173.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 33.8 t -108.34 169.33 8.71 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 109.494 -0.558 . . . . 1.42 109.494 -177.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.702 ' HA ' HG23 ' A' ' 56' ' ' THR . 99.3 t -40.14 -59.48 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 O-C-N 124.356 1.035 . . . . 0.28 111.683 178.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.484 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 0.9 OUTLIER -65.74 -30.26 70.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.299 -0.409 . . . . 3.46 111.986 -173.483 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -65.25 -35.95 82.63 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-O 122.247 1.022 . . . . 1.4 108.756 -178.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.585 ' HA ' ' CE2' ' A' ' 154' ' ' PHE . 54.5 mt -78.17 -44.25 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 CA-C-N 113.7 -1.591 . . . . 0.21 110.483 175.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.623 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 47.7 mt-10 -54.93 -43.12 73.07 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 116.048 -0.524 . . . . 0.67 111.492 -177.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 161' ' ' LYS . 7.0 pt-20 -61.03 -16.69 46.36 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.235 0.457 . . . . 0.87 112.235 -176.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.633 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 34.0 mmtp -100.72 -28.89 12.58 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.667 0.746 . . . . 1.71 109.793 172.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.623 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 12.5 tp -78.84 -50.97 10.37 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.857 -1.065 . . . . 0.16 112.749 -175.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.494 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 63.3 mt -55.14 -45.78 99.79 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.85 -0.614 . . . . 0.26 112.387 -174.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.494 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 58.2 Cg_exo -56.14 -17.29 19.54 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 122.081 1.854 . . . . 0.41 113.124 174.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.751 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 78.0 mt -97.7 -42.72 7.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.741 -0.209 . . . . 0.71 111.08 176.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.714 HD23 ' HG2' ' A' ' 37' ' ' PRO . 93.7 mt -61.08 -52.1 66.37 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-O 122.165 0.983 . . . . 0.34 109.595 175.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -77.38 26.96 1.83 Allowed Glycine 0 N--CA 1.436 -1.331 0 CA-C-N 113.565 -1.652 . . . . 1.12 112.923 -178.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 29.1 t -124.99 97.07 5.1 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.184 0.516 . . . . 2.64 109.991 177.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -85.08 -20.55 30.2 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.55 -0.537 . . . . 4.35 109.55 176.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.443 ' HG2' ' O ' ' A' ' 175' ' ' ARG . 19.5 ttm180 64.92 21.3 12.3 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 114.815 -1.084 . . . . 8.45 110.64 175.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 58.6 tp . . . . . 0 C--O 1.25 1.103 0 CA-C-N 115.258 -0.883 . . . . 7.69 109.687 176.312 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.566 0 N-CA-C 111.935 -0.466 . . . . 5.22 111.935 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 23.4 ptp -78.47 150.25 33.03 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.759 0.314 . . . . 4.85 110.428 178.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.405 ' HA3' ' CE1' ' A' ' 121' ' ' TYR . . . 106.28 89.55 2.11 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.863 -0.684 . . . . 1.55 112.439 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.1 t -97.05 -23.72 16.13 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.965 0.412 . . . . 1.58 110.318 178.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 27.8 m -163.64 151.55 13.05 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 104.854 -2.276 . . . . 1.17 104.854 -179.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.882 ' HB ' HD11 ' A' ' 118' ' ' LEU . 6.3 pt -58.93 -20.55 17.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 CA-C-N 115.042 -0.981 . . . . 0.38 111.756 -174.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.812 ' HB3' HG13 ' A' ' 31' ' ' VAL . 42.2 m-85 -67.2 -6.24 17.19 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.293 0.849 . . . . 0.3 113.293 -175.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -78.4 -15.78 58.31 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 107.873 -1.158 . . . . 2.11 107.873 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.566 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 37.3 m-85 -107.61 115.88 30.94 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 114.577 -1.192 . . . . 0.31 110.829 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -55.62 144.32 27.06 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 113.896 -1.502 . . . . 2.86 110.054 175.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.851 HG13 ' HZ ' ' A' ' 74' ' ' PHE . 66.5 t -112.14 166.14 6.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 107.879 -1.156 . . . . 0.67 107.879 179.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.756 ' HB2' ' HE1' ' A' ' 105' ' ' MET . 55.7 mt -125.6 146.59 49.63 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 109.949 -0.389 . . . . 0.69 109.949 178.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.583 ' HB3' ' HE3' ' A' ' 26' ' ' LYS . 16.5 t70 -77.8 169.79 17.68 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 106.146 -1.798 . . . . 1.87 106.146 165.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.674 ' HA ' ' N ' ' A' ' 106' ' ' ALA . . . -63.68 -3.65 2.45 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 113.253 0.834 . . . . 0.59 113.253 -168.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.937 ' HB2' ' HE2' ' A' ' 26' ' ' LYS . 3.3 m-20 -107.0 6.01 28.67 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 111.451 0.167 . . . . 2.34 111.451 176.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.582 ' CD2' ' HB1' ' A' ' 106' ' ' ALA . 59.9 m-70 79.85 6.04 1.86 Allowed 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.521 0.677 . . . . 1.47 109.61 177.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.937 ' HE2' ' HB2' ' A' ' 24' ' ' ASP . 29.8 mtmt -66.68 115.94 29.66 Favored Pre-proline 0 N--CA 1.447 -0.595 0 N-CA-C 107.656 -1.238 . . . . 4.25 107.656 167.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.659 ' HA ' HD23 ' A' ' 21' ' ' LEU . 75.4 Cg_exo -48.76 114.86 1.38 Allowed 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 121.796 1.664 . . . . 0.54 112.313 -178.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.508 ' CE2' ' HB3' ' A' ' 103' ' ' PRO . 0.8 OUTLIER -78.39 151.55 32.74 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 113.573 -1.649 . . . . 1.2 111.761 179.589 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.615 ' OD1' ' HB3' ' A' ' 32' ' ' GLN . 2.8 t-20 -86.82 90.2 8.22 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.8 -1.091 . . . . 1.51 109.836 174.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.676 HD23 ' HA ' ' A' ' 16' ' ' PHE . 63.2 tp -71.56 -43.79 65.7 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.179 0.514 . . . . 0.28 110.601 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.812 HG13 ' HB3' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -67.56 0.89 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.18 -0.918 . . . . 1.02 113.174 -172.12 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.615 ' HB3' ' OD1' ' A' ' 29' ' ' ASN . 3.7 pt20 -72.54 -11.88 60.84 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.553 0.692 . . . . 1.02 109.322 172.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.956 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 91.6 m-70 -98.73 21.18 11.76 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 115.267 -0.879 . . . . 0.28 109.087 176.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.788 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 11.0 mtmm -80.1 110.4 15.47 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.541 -1.209 . . . . 1.56 109.118 169.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 133.45 -43.06 1.3 Allowed Glycine 0 N--CA 1.439 -1.106 0 C-N-CA 120.75 -0.738 . . . . 0.2 111.841 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.422 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 72.3 m -126.88 138.09 31.91 Favored Pre-proline 0 N--CA 1.439 -0.987 0 N-CA-C 108.576 -0.898 . . . . 0.29 108.576 173.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.825 ' HD3' ' HG2' ' A' ' 146' ' ' ARG . 3.2 Cg_endo -43.37 149.15 0.58 Allowed 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 123.574 2.85 . . . . 0.18 112.079 174.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.91 ' HB2' HG22 ' A' ' 70' ' ' THR . 0.6 OUTLIER -135.78 150.24 49.41 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 106.051 -1.833 . . . . 0.31 106.051 178.475 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.942 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 2.7 mp -116.21 129.34 56.25 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 109.206 -0.664 . . . . 1.19 109.206 175.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.862 HG22 ' OH ' ' A' ' 119' ' ' TYR . 1.2 mt -111.02 123.71 67.16 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 CA-C-N 115.025 -0.989 . . . . 0.37 109.002 178.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.942 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.5 OUTLIER -108.74 123.64 49.33 Favored 'General case' 0 C--O 1.215 -0.738 0 CA-C-N 115.996 -0.547 . . . . 0.42 110.796 -172.267 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.636 ' HB2' HG11 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -76.56 122.09 24.11 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 104.88 -2.267 . . . . 2.35 104.88 165.948 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.807 HG11 ' HB1' ' A' ' 73' ' ' ALA . 2.5 p -133.07 145.91 33.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 C-N-CA 118.724 -1.19 . . . . 1.03 112.94 -165.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -94.46 102.46 14.42 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 114.919 -1.037 . . . . 0.88 110.043 174.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.593 ' OG ' ' HB2' ' A' ' 75' ' ' PRO . 13.0 m -47.71 81.27 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 O-C-N 124.284 0.99 . . . . 1.78 111.373 167.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.786 ' HE2' ' HB3' ' A' ' 49' ' ' TYR . 18.9 mmmt -97.0 157.36 15.94 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.396 0.617 . . . . 5.84 111.741 -174.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.493 ' HB2' ' HA ' ' A' ' 95' ' ' CYS . 29.9 t -111.63 117.02 31.79 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.135 -0.939 . . . . 3.55 109.18 173.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 60.25 41.65 98.39 Favored Glycine 0 CA--C 1.52 0.347 0 CA-C-N 115.796 -0.638 . . . . 2.91 113.508 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.786 ' HB3' ' HE2' ' A' ' 46' ' ' LYS . 72.5 t80 -161.55 133.53 5.7 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.199 0.523 . . . . 4.63 111.31 178.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.4 t -143.39 143.25 31.56 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.69 -0.856 . . . . 1.93 108.69 175.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.645 ' O ' ' HA2' ' A' ' 157' ' ' GLY . 48.9 tttt -95.11 15.1 19.9 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 121.948 0.88 . . . . 2.01 108.838 176.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 116.66 -38.71 2.92 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 110.128 -1.189 . . . . 0.51 110.128 -173.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -37.13 -50.99 1.63 Allowed Glycine 0 C--O 1.223 -0.566 0 CA-C-N 114.364 -0.918 . . . . 0.5 114.952 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.498 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 0.1 OUTLIER -57.71 -59.18 5.59 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 117.743 0.772 . . . . 0.7 111.469 -172.41 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -62.56 -26.96 68.85 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.733 -0.667 . . . . 2.61 110.136 -178.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.726 ' HA ' HG22 ' A' ' 160' ' ' VAL . 77.5 m -71.91 -59.61 2.66 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 114.891 -1.05 . . . . 0.33 109.916 -177.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 1.055 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -60.59 -39.9 89.79 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 114.675 -1.148 . . . . 0.22 111.371 -178.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.543 ' HA ' ' CD1' ' A' ' 102' ' ' PHE . 89.8 m -58.57 -58.71 7.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.598 0.713 . . . . 0.26 110.6 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.4 m -68.31 -33.78 74.95 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 114.955 -1.021 . . . . 0.48 111.473 -174.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.749 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 20.6 mt -67.53 -50.58 58.02 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 121.25 0.547 . . . . 0.43 110.37 -177.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.812 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 10.5 t80 -54.83 -50.3 68.92 Favored 'General case' 0 C--O 1.204 -1.325 0 CA-C-N 114.983 -1.008 . . . . 0.31 110.681 177.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.415 ' N ' HD22 ' A' ' 62' ' ' ASN . 0.9 OUTLIER -72.48 -25.7 61.53 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 122.443 0.297 . . . . 1.21 110.75 -171.119 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.501 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 35.3 ttpt -86.47 -23.28 26.03 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 109.044 -0.724 . . . . 1.54 109.044 -178.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.772 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 30.4 m-85 -123.51 -5.49 8.19 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 115.291 1.589 . . . . 0.31 115.291 -169.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.679 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -64.63 -23.22 67.19 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 108.055 -1.091 . . . . 1.35 108.055 169.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 37.5 t -47.19 -40.35 15.84 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 114.118 -1.401 . . . . 1.28 110.848 171.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.453 HE21 ' HD1' ' A' ' 64' ' ' TYR . 49.8 mt-30 -90.06 -32.35 16.76 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 120.725 0.298 . . . . 1.11 111.337 177.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 143.44 -5.67 1.86 Allowed Glycine 0 N--CA 1.449 -0.468 0 N-CA-C 111.364 -0.694 . . . . 0.18 111.364 -175.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.772 ' HD2' ' HB2' ' A' ' 64' ' ' TYR . 24.6 t80 -66.92 141.32 57.67 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 120.978 0.418 . . . . 0.18 110.822 -178.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.956 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 5.3 t -132.55 152.96 51.42 Favored 'General case' 0 N--CA 1.422 -1.835 0 N-CA-C 107.991 -1.114 . . . . 0.2 107.991 174.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 1.055 HG11 ' HB1' ' A' ' 57' ' ' ALA . 38.2 t -112.09 99.86 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.702 0 N-CA-C 107.65 -1.241 . . . . 0.17 107.65 158.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.622 HD12 HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -93.46 121.23 34.65 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 106.911 -1.514 . . . . 1.04 106.911 174.33 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 1.023 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -108.02 121.16 44.23 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.961 0.886 . . . . 0.51 111.265 -178.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.913 ' CG ' ' HG2' ' A' ' 105' ' ' MET . 2.6 m-30 -95.7 101.04 7.13 Favored Pre-proline 0 C--N 1.314 -0.935 0 CA-C-N 114.379 -1.282 . . . . 0.44 109.009 178.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.715 ' HA ' HG13 ' A' ' 43' ' ' VAL . 87.8 Cg_endo -82.12 74.99 4.94 Favored 'Trans proline' 0 CA--C 1.512 -0.612 0 C-N-CA 122.798 2.332 . . . . 1.3 113.423 -167.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.8 p 0.69 128.51 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 116.967 2.21 . . . . 1.44 116.967 -177.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.56 ' ND2' ' HB2' ' A' ' 79' ' ' PHE . 9.8 t30 -69.58 74.81 0.4 Allowed 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 112.468 -2.151 . . . . 1.81 109.062 177.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.626 ' HA ' ' HG3' ' A' ' 83' ' ' GLU . 1.0 OUTLIER -50.29 -11.63 0.07 Allowed 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.741 1.216 . . . . 3.34 111.887 177.865 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.56 ' HB2' ' ND2' ' A' ' 77' ' ' ASN . 98.4 m-85 -68.55 29.82 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.859 -1.064 . . . . 2.68 113.019 -173.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.444 ' H ' ' C ' ' A' ' 78' ' ' GLN . . . -144.21 -136.21 3.05 Favored Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 110.943 -0.863 . . . . 1.98 110.943 176.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -152.92 34.51 0.79 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.644 -0.789 . . . . 1.49 111.745 177.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.0 pm0 -128.94 -9.35 4.89 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.027 -0.087 . . . . 1.74 110.948 -177.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.626 ' HG3' ' HA ' ' A' ' 78' ' ' GLN . 4.1 mm-40 -62.19 142.35 95.75 Favored Pre-proline 0 CA--C 1.535 0.366 0 N-CA-C 112.438 0.533 . . . . 3.07 112.438 -168.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.666 ' HB3' ' N ' ' A' ' 137' ' ' TRP . 31.4 Cg_exo -19.28 -85.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.754 1 C-N-CA 127.242 5.295 . . . . 1.75 116.557 -178.93 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.484 ' H ' ' HB2' ' A' ' 84' ' ' PRO . . . -134.72 32.89 2.55 Favored Glycine 0 CA--C 1.5 -0.863 0 N-CA-C 110.195 -1.162 . . . . 2.2 110.195 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 1.053 ' HB2' HG12 ' A' ' 90' ' ' ILE . 2.7 p-10 -149.82 33.36 0.68 Allowed 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.525 -0.838 . . . . 4.2 110.048 -173.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.512 ' C ' ' HD3' ' A' ' 91' ' ' LYS . 1.8 pm0 -82.66 11.53 5.73 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.071 -0.968 . . . . 3.02 109.81 178.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -158.92 -42.75 0.06 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.12 -0.946 . . . . 3.92 109.316 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.654 ' O ' ' HB2' ' A' ' 93' ' ' PHE . 13.3 tp10 -48.88 -60.27 2.89 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 114.833 -1.076 . . . . 2.65 111.856 -177.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 1.053 HG12 ' HB2' ' A' ' 86' ' ' ASN . 29.0 pt -97.75 23.29 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 O-C-N 121.948 -0.47 . . . . 2.15 111.47 -175.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.512 ' HD3' ' C ' ' A' ' 87' ' ' GLU . 47.0 mtpt -101.48 -46.29 5.03 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.89 -0.595 . . . . 2.79 110.894 177.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -122.39 2.41 9.68 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.827 -0.624 . . . . 3.29 111.628 -177.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.654 ' HB2' ' O ' ' A' ' 89' ' ' GLU . 96.0 m-85 -108.47 169.04 8.89 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.909 -0.774 . . . . 3.42 108.909 173.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.6 t -65.47 125.13 21.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.433 -0.349 . . . . 2.63 110.975 -178.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.493 ' HA ' ' HB2' ' A' ' 47' ' ' CYS . 4.8 p -144.9 134.45 23.28 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.942 -0.572 . . . . 2.83 110.883 175.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.411 ' O ' ' HB3' ' A' ' 45' ' ' SER . 0.5 OUTLIER -79.33 152.12 30.65 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 106.138 -1.801 . . . . 2.98 106.138 161.291 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -79.73 50.65 1.19 Allowed 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 119.445 -0.902 . . . . 2.72 110.237 175.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.68 ' CE1' ' HB2' ' A' ' 100' ' ' ALA . 0.9 OUTLIER 60.49 -105.65 0.23 Allowed 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 114.254 -1.339 . . . . 2.12 110.431 178.877 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp 61.37 109.53 0.02 OUTLIER 'General case' 0 C--N 1.334 -0.09 0 CA-C-O 121.715 0.769 . . . . 2.69 111.593 -175.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.68 ' HB2' ' CE1' ' A' ' 98' ' ' PHE . . . -131.26 -159.69 0.99 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.493 -0.776 . . . . 0.55 111.231 -174.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -95.33 26.3 3.89 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.792 -0.64 . . . . 1.99 111.033 178.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.67 ' CZ ' ' HZ ' ' A' ' 98' ' ' PHE . 12.7 p90 -146.18 164.71 23.45 Favored Pre-proline 0 N--CA 1.448 -0.527 0 N-CA-C 108.571 -0.9 . . . . 0.84 108.571 176.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.71 ' HD3' ' CE2' ' A' ' 61' ' ' TYR . 52.7 Cg_exo -59.07 85.79 0.06 OUTLIER 'Trans proline' 0 N--CA 1.482 0.832 0 C-N-CA 124.697 3.598 . . . . 0.62 115.35 -173.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 1.023 HD12 ' HB3' ' A' ' 73' ' ' ALA . 3.9 mm -85.56 131.67 33.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 108.61 -0.885 . . . . 1.34 108.61 171.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.913 ' HG2' ' CG ' ' A' ' 74' ' ' PHE . 1.9 ppp? -96.68 -175.64 3.36 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.149 0.5 . . . . 3.03 110.482 -176.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.674 ' N ' ' HA ' ' A' ' 23' ' ' ALA . . . -79.33 19.5 0.59 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.391 -0.822 . . . . 1.46 112.654 -170.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.699 ' HG2' ' HG2' ' A' ' 75' ' ' PRO . 50.7 mttp 60.92 131.25 0.01 OUTLIER 'General case' 0 CA--C 1.496 -1.114 0 CA-C-O 122.365 1.079 . . . . 1.76 110.784 -168.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.595 ' CD1' HG13 ' A' ' 110' ' ' VAL . 2.4 pp -128.01 163.9 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.392 0 N-CA-C 106.326 -1.731 . . . . 0.82 106.326 160.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.667 ' HB3' ' HB2' ' A' ' 114' ' ' ASN . 1.9 t30 -76.53 84.29 3.23 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 120.38 -0.528 . . . . 1.73 110.439 -172.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.636 HG11 ' HB2' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -79.28 90.33 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.225 0 C-N-CA 119.325 -0.95 . . . . 0.77 109.128 179.594 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.5 t30 174.86 161.26 0.21 Allowed 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 114.252 -1.34 . . . . 1.9 108.608 175.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 45.73 -123.51 6.44 Favored Glycine 0 CA--C 1.518 0.28 0 N-CA-C 115.319 0.888 . . . . 1.47 115.319 164.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.22 2.39 26.82 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 114.866 -0.667 . . . . 2.81 111.237 -169.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.667 ' HB2' ' HB3' ' A' ' 109' ' ' ASN . 0.1 OUTLIER -112.05 1.54 16.4 Favored 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 108.278 -1.008 . . . . 2.16 108.278 -168.957 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.519 ' HB3' ' CD ' ' A' ' 120' ' ' GLU . . . -49.16 139.17 11.28 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 112.753 -2.021 . . . . 1.26 110.363 176.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.591 ' CE1' ' H ' ' A' ' 118' ' ' LEU . 1.6 t-80 -80.03 139.63 53.31 Favored Pre-proline 0 N--CA 1.433 -1.311 0 N-CA-C 107.13 -1.433 . . . . 0.42 107.13 -173.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -24.09 -46.9 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 124.805 3.67 . . . . 0.4 113.988 -178.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.882 HD11 ' HB ' ' A' ' 15' ' ' ILE . 24.8 tp -67.97 -50.31 56.53 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.012 0.525 . . . . 0.39 111.783 -178.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.862 ' OH ' HG22 ' A' ' 40' ' ' ILE . 16.6 m-85 -80.96 -34.19 33.31 Favored 'General case' 0 CA--C 1.483 -1.611 0 CA-C-O 121.504 0.668 . . . . 3.04 110.378 -176.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.598 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 5.6 tp10 -63.09 -34.37 77.44 Favored 'General case' 0 N--CA 1.419 -1.987 0 N-CA-C 106.889 -1.523 . . . . 2.44 106.889 175.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.625 ' HD1' ' HE3' ' A' ' 124' ' ' LYS . 43.4 t80 -72.31 -28.86 63.34 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.591 -0.732 . . . . 0.56 109.82 170.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.855 ' HE3' ' HG ' ' A' ' 118' ' ' LEU . 2.9 ttm -75.66 -56.12 5.0 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.11 -0.636 . . . . 0.71 110.393 -169.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.436 ' HD2' ' HA ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -72.29 -23.28 61.17 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 120.773 -0.371 . . . . 1.46 111.948 176.849 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.625 ' HE3' ' HD1' ' A' ' 121' ' ' TYR . 12.4 pttp -70.53 -27.66 64.34 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 119.201 -0.999 . . . . 1.99 109.823 175.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 38.8 m -89.73 -24.81 21.44 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.683 -0.689 . . . . 0.59 110.341 176.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.471 ' HE2' ' HA ' ' A' ' 151' ' ' VAL . 29.9 mmtm -138.38 82.55 22.91 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.614 -0.721 . . . . 1.85 110.78 -178.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.532 ' O ' ' HA ' ' A' ' 134' ' ' ALA . 23.7 Cg_exo -26.94 -84.53 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.816 1 C-N-CA 125.515 4.143 . . . . 1.69 115.057 -177.065 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.447 ' HA2' ' NE ' ' A' ' 153' ' ' ARG . . . 167.62 57.3 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.241 -0.98 . . . . 2.59 112.761 -177.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 15.7 mt 61.62 29.34 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-O 122.512 1.149 . . . . 3.58 109.126 -178.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.563 ' HG ' ' H ' ' A' ' 131' ' ' ALA . 32.0 tp -161.46 -178.68 6.78 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.38 -1.282 . . . . 3.47 108.485 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.563 ' H ' ' HG ' ' A' ' 130' ' ' LEU . . . -73.1 -20.2 61.0 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.297 0.57 . . . . 3.28 109.887 174.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.32 -146.13 0.29 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.318 -0.856 . . . . 3.56 109.171 176.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 5.0 tptm 78.46 -165.17 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.199 0.6 . . . . 5.17 110.2 177.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.532 ' HA ' ' O ' ' A' ' 127' ' ' PRO . . . -165.16 -170.77 2.0 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.588 -0.278 . . . . 1.59 110.348 -176.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.559 HG22 ' HB ' ' A' ' 140' ' ' THR . 0.6 OUTLIER -67.01 52.42 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.913 0 CA-C-N 115.965 -0.561 . . . . 2.0 109.803 168.126 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.641 ' HD3' ' O ' ' A' ' 136' ' ' LYS . 9.9 tmtt? -86.99 39.47 0.86 Allowed 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.718 0.77 . . . . 4.81 111.29 -169.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.893 ' HB3' ' HG3' ' A' ' 156' ' ' PRO . 9.7 m-90 -142.16 175.46 9.73 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.758 -0.656 . . . . 1.97 109.777 -177.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.615 ' HB2' ' CB ' ' A' ' 156' ' ' PRO . 9.6 m120 -44.49 -156.89 0.0 OUTLIER 'General case' 0 C--O 1.211 -0.937 0 O-C-N 123.849 0.718 . . . . 2.04 111.311 161.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.653 ' CD1' HG23 ' A' ' 43' ' ' VAL . 3.9 m-85 -31.41 -26.38 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.338 0 N-CA-C 118.036 2.606 . . . . 1.93 118.036 -168.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.688 ' HA ' ' O ' ' A' ' 154' ' ' PHE . 1.9 m 7.49 103.43 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 120.5 1.5 . . . . 0.6 114.678 171.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.526 ' HB3' HD23 ' A' ' 39' ' ' LEU . 1.1 m -91.56 173.61 7.8 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.552 -1.204 . . . . 0.62 111.039 -172.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.526 ' HA ' ' HA ' ' A' ' 153' ' ' ARG . 60.5 m-85 -132.52 122.68 25.23 Favored 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 105.858 -1.904 . . . . 0.57 105.858 164.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.787 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 7.3 tp -80.0 104.6 10.68 Favored 'General case' 0 N--CA 1.422 -1.834 0 C-N-CA 118.302 -1.359 . . . . 0.43 108.474 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.741 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 36.8 mm -89.03 141.84 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.741 0 CA-C-N 112.854 -1.976 . . . . 0.19 107.581 -177.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.507 ' HA ' HD13 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -94.38 -175.34 3.61 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 119.411 -0.916 . . . . 0.98 111.395 -170.358 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.825 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 30.7 mtm180 -55.98 -33.42 64.81 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.803 0.335 . . . . 2.22 111.566 -176.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -103.78 22.99 13.48 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 109.864 -0.421 . . . . 2.0 109.864 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.595 ' HA2' HG22 ' A' ' 144' ' ' ILE . . . 70.18 37.09 71.93 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 121.219 -0.515 . . . . 0.17 114.184 177.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.511 ' HA ' ' HD2' ' A' ' 150' ' ' PRO . 57.8 t -107.04 108.3 61.79 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 118.192 0.996 . . . . 1.12 111.243 174.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.785 ' HD3' HG23 ' A' ' 15' ' ' ILE . 8.5 Cg_endo -58.3 110.13 0.6 Allowed 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 123.757 2.971 . . . . 0.41 111.307 174.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.697 HG23 ' HG2' ' A' ' 152' ' ' GLU . 17.8 m -108.86 -23.41 4.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.299 0.571 . . . . 1.45 109.569 -176.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.787 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 47.2 mm-40 -133.3 168.22 18.97 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-N 115.298 -0.865 . . . . 1.17 110.434 179.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.549 HH11 ' HG2' ' A' ' 153' ' ' ARG . 0.0 OUTLIER -144.63 148.63 34.54 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 114.614 -1.176 . . . . 2.16 108.582 163.019 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.688 ' O ' ' HA ' ' A' ' 140' ' ' THR . 91.9 m-85 -121.77 144.36 48.85 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 110.207 -0.294 . . . . 0.32 110.207 -169.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 12.9 p -63.87 149.5 93.12 Favored Pre-proline 0 C--N 1.318 -0.787 0 N-CA-C 109.536 -0.542 . . . . 1.11 109.536 174.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.893 ' HG3' ' HB3' ' A' ' 137' ' ' TRP . 30.3 Cg_endo -63.2 -26.38 72.42 Favored 'Trans proline' 0 CA--C 1.511 -0.659 0 C-N-CA 122.349 2.033 . . . . 0.78 110.714 176.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.645 ' HA2' ' O ' ' A' ' 51' ' ' LYS . . . -79.2 16.67 8.87 Favored Glycine 0 N--CA 1.438 -1.177 0 CA-C-N 113.785 -1.552 . . . . 0.5 113.405 171.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -95.64 152.98 17.96 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 109.514 -0.55 . . . . 0.5 109.514 170.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.587 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 22.9 t -113.44 176.83 4.86 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 109.71 -0.478 . . . . 1.42 109.71 -175.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.726 HG22 ' HA ' ' A' ' 56' ' ' THR . 48.4 t -45.62 -48.38 4.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 O-C-N 124.04 0.837 . . . . 0.28 110.9 178.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.589 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 40.8 tttm -65.54 -41.16 93.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.823 -0.626 . . . . 3.46 111.148 -175.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -64.93 -34.26 77.99 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 121.732 0.777 . . . . 1.4 109.47 -173.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.593 HD12 ' CG2' ' A' ' 56' ' ' THR . 46.3 mt -80.54 -46.21 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 CA-C-N 114.451 -1.249 . . . . 0.21 111.106 177.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.529 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 36.5 mt-10 -53.09 -44.26 67.45 Favored 'General case' 0 C--O 1.218 -0.587 0 N-CA-C 111.688 0.255 . . . . 0.67 111.688 -175.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.589 ' HG2' ' O ' ' A' ' 161' ' ' LYS . 4.5 pt-20 -62.35 -14.23 37.57 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.568 0.581 . . . . 0.87 112.568 -175.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.682 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 13.0 mmmt -105.3 -23.9 12.79 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.009 -0.737 . . . . 1.71 109.009 175.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.529 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 10.5 tp -83.26 -50.77 8.07 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.48 -1.236 . . . . 0.16 112.222 -176.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 164' ' ' GLU . 65.4 mt -54.32 -44.94 99.31 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 115.586 -0.734 . . . . 0.26 112.077 -175.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.47 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 86.8 Cg_exo -50.53 -24.59 12.78 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 122.182 1.921 . . . . 0.41 113.287 173.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.732 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 88.1 mt -95.19 -42.5 8.54 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 122.28 -0.263 . . . . 0.71 111.547 177.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.766 HD23 ' HG2' ' A' ' 37' ' ' PRO . 89.1 mt -61.45 -52.4 64.72 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-O 122.19 0.995 . . . . 0.34 109.883 177.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -74.56 -58.39 4.2 Favored Glycine 0 N--CA 1.431 -1.648 0 CA-C-N 113.065 -1.88 . . . . 1.12 114.356 -172.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 30.8 t -152.11 88.02 1.36 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.176 0.512 . . . . 2.64 111.539 -170.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -93.03 -4.34 52.72 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.881 -0.599 . . . . 4.35 110.015 176.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.617 ' HA ' ' NE ' ' A' ' 175' ' ' ARG . 3.5 mmp_? -110.03 97.89 7.29 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.538 -0.755 . . . . 8.45 110.319 177.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 49.2 tp . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.265 -0.874 . . . . 7.69 109.696 179.404 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.635 0 N-CA-C 111.971 -0.451 . . . . 5.22 111.971 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -76.08 127.01 32.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.969 0.414 . . . . 4.85 109.985 178.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.465 ' H ' ' CG ' ' A' ' 17' ' ' ASP . . . 110.2 59.82 0.5 Allowed Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.439 -0.664 . . . . 1.55 111.439 -176.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.5 m -125.94 -22.67 4.1 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.062 0.458 . . . . 1.58 110.582 -178.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.8 m -145.39 -176.42 5.11 Favored 'General case' 0 N--CA 1.423 -1.785 0 N-CA-C 104.896 -2.261 . . . . 1.17 104.896 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.73 HG23 ' HD3' ' A' ' 150' ' ' PRO . 5.7 pt -81.42 -17.73 11.83 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.481 0 CA-C-O 121.447 0.641 . . . . 0.38 109.847 177.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.775 ' HB3' HG13 ' A' ' 31' ' ' VAL . 39.7 m-85 -71.0 -2.75 16.37 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.503 -0.771 . . . . 0.3 112.45 -176.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.465 ' CG ' ' H ' ' A' ' 12' ' ' GLY . 7.1 m-20 -77.2 -20.5 55.28 Favored 'General case' 0 CA--C 1.501 -0.904 0 N-CA-C 107.595 -1.261 . . . . 2.11 107.595 176.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.601 ' CD2' ' HA ' ' A' ' 118' ' ' LEU . 58.1 m-85 -113.39 122.32 47.0 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 114.334 -1.303 . . . . 0.31 111.8 -174.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -48.19 139.4 8.48 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 112.561 -2.109 . . . . 2.86 111.709 172.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.875 HG13 ' HZ ' ' A' ' 74' ' ' PHE . 79.2 t -113.43 166.34 7.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 107.637 -1.246 . . . . 0.67 107.637 174.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.72 HD23 ' HA ' ' A' ' 27' ' ' PRO . 80.4 mt -132.88 131.87 41.44 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 120.001 -0.68 . . . . 0.69 112.47 -177.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 15.1 t70 -64.43 159.23 21.8 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 106.457 -1.683 . . . . 1.87 106.457 165.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.768 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . . . -60.51 -6.76 1.74 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 113.801 1.038 . . . . 0.59 113.801 -165.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.608 ' HB2' ' HE2' ' A' ' 26' ' ' LYS . 54.7 m-20 -97.14 -0.19 47.38 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.751 0.278 . . . . 2.34 111.751 176.241 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.674 ' CD2' ' HB1' ' A' ' 106' ' ' ALA . 72.9 m-70 83.64 10.06 0.51 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.727 0.775 . . . . 1.47 109.01 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.608 ' HE2' ' HB2' ' A' ' 24' ' ' ASP . 21.7 mtmt -75.16 119.31 76.37 Favored Pre-proline 0 N--CA 1.447 -0.609 0 CA-C-N 114.298 -1.319 . . . . 4.25 107.578 168.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.72 ' HA ' HD23 ' A' ' 21' ' ' LEU . 47.3 Cg_exo -45.79 116.33 1.36 Allowed 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 122.415 2.076 . . . . 0.54 113.16 -176.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.762 ' OH ' ' HB3' ' A' ' 103' ' ' PRO . 0.1 OUTLIER -75.81 147.47 39.15 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 113.885 -1.507 . . . . 1.2 111.299 177.821 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.518 ' N ' ' HD1' ' A' ' 28' ' ' TYR . 2.5 t-20 -82.47 97.22 8.3 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 114.838 -1.074 . . . . 1.51 108.803 175.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.71 HD13 HG21 ' A' ' 20' ' ' VAL . 61.1 tp -83.82 -45.31 13.43 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.647 -0.706 . . . . 0.28 110.888 -176.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.775 HG13 ' HB3' ' A' ' 16' ' ' PHE . 0.1 OUTLIER -67.28 0.25 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.316 -0.857 . . . . 1.02 112.801 -171.712 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.451 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 28.7 pt20 -74.01 -12.21 60.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.418 0.627 . . . . 1.02 109.477 172.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.918 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 90.5 m-70 -97.7 20.49 11.85 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 121.876 0.845 . . . . 0.28 109.092 175.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.743 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 18.3 mtmt -80.42 114.18 19.13 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 114.381 -1.281 . . . . 1.56 109.245 169.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.87 -38.9 2.22 Favored Glycine 0 N--CA 1.434 -1.489 0 C-N-CA 120.607 -0.806 . . . . 0.2 111.927 178.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.455 ' HB2' ' HA3' ' A' ' 68' ' ' GLY . 20.2 m -129.49 128.02 23.09 Favored Pre-proline 0 N--CA 1.434 -1.257 0 N-CA-C 108.377 -0.972 . . . . 0.29 108.377 172.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.823 ' HG3' ' CB ' ' A' ' 170' ' ' LEU . 1.8 Cg_endo -41.18 151.92 0.12 Allowed 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 124.393 3.395 . . . . 0.18 113.097 177.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.842 ' HB2' HG22 ' A' ' 70' ' ' THR . 0.8 OUTLIER -136.96 145.1 43.79 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 106.949 -1.5 . . . . 0.31 106.949 -179.41 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.994 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 1.2 mm? -111.63 117.4 32.82 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.992 -0.744 . . . . 1.19 108.992 178.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.784 HD12 ' CE ' ' A' ' 122' ' ' MET . 8.2 mt -101.65 124.38 55.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-N 116.112 -0.495 . . . . 0.37 110.932 178.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.994 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -111.05 123.0 49.33 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.484 -0.78 . . . . 0.42 109.948 -174.194 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.804 ' HB3' HG11 ' A' ' 110' ' ' VAL . 1.3 p30 -81.79 94.97 7.14 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.855 -1.165 . . . . 2.35 107.855 169.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.787 HG11 ' HB1' ' A' ' 73' ' ' ALA . 1.4 p -105.18 133.35 49.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-N 115.447 -0.797 . . . . 1.03 113.059 -159.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.594 ' HB1' ' SG ' ' A' ' 47' ' ' CYS . . . -76.05 101.7 5.38 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.618 -0.719 . . . . 0.88 109.639 171.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.701 ' HB3' ' O ' ' A' ' 96' ' ' THR . 48.8 m -37.87 83.24 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 125.485 1.514 . . . . 1.78 113.977 176.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.483 ' HE2' ' HB2' ' A' ' 46' ' ' LYS . 8.7 ptmm? 36.19 55.3 1.03 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.112 1.365 . . . . 5.84 114.052 176.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.594 ' SG ' ' HB1' ' A' ' 44' ' ' ALA . 28.1 p -111.33 116.45 31.0 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 119.9 -0.72 . . . . 3.55 110.819 177.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.86 -73.82 1.21 Allowed Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.85 -0.614 . . . . 2.91 113.456 175.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -129.95 145.93 51.64 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.131 0.491 . . . . 4.63 111.138 -173.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 76.1 p -82.68 -20.39 36.26 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.058 -0.719 . . . . 1.93 109.058 174.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.636 ' HB2' ' HB2' ' A' ' 156' ' ' PRO . 31.5 mmmt 63.56 -1.46 0.59 Allowed 'General case' 0 C--N 1.347 0.469 0 C-N-CA 124.555 1.142 . . . . 2.01 112.557 -178.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.77 -19.75 48.73 Favored Glycine 0 N--CA 1.442 -0.919 0 N-CA-C 110.761 -0.935 . . . . 0.51 110.761 -172.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -58.19 -43.37 95.42 Favored Glycine 0 C--O 1.222 -0.604 0 CA-C-N 115.469 -0.366 . . . . 0.5 112.805 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.651 ' CE1' ' HE2' ' A' ' 98' ' ' PHE . 1.0 OUTLIER -64.44 -54.57 30.5 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.074 0.464 . . . . 0.7 110.776 -174.903 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.479 ' CD ' ' H ' ' A' ' 55' ' ' GLU . 1.9 pm0 -66.44 -22.95 66.22 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.542 -0.754 . . . . 2.61 111.115 -178.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.785 HG23 ' HA ' ' A' ' 160' ' ' VAL . 30.4 m -79.92 -57.45 3.64 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 109.44 -0.578 . . . . 0.33 109.44 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 1.029 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -54.08 -40.51 67.28 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.145 -0.934 . . . . 0.22 110.838 -179.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.457 ' HA ' ' HD2' ' A' ' 102' ' ' PHE . 99.8 m -60.04 -57.1 14.29 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.609 -0.723 . . . . 0.26 110.647 178.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 22.3 m -66.76 -35.18 79.49 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.461 -0.79 . . . . 0.48 111.312 -176.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.716 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 0.6 OUTLIER -66.72 -52.37 45.33 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 121.595 0.712 . . . . 0.43 110.409 -175.416 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.854 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 8.0 t80 -55.92 -54.6 42.77 Favored 'General case' 0 C--O 1.205 -1.27 0 CA-C-N 114.413 -1.267 . . . . 0.31 110.777 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -67.34 -24.16 65.69 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.73 -0.214 . . . . 1.21 111.018 -174.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.438 ' HB2' ' HE2' ' A' ' 63' ' ' LYS . 24.4 ttmm -85.5 -27.34 25.69 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 108.965 -0.754 . . . . 1.54 108.965 -176.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.784 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 48.3 m-85 -123.67 -4.75 8.16 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 115.289 1.588 . . . . 0.31 115.289 -169.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.676 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 12.9 pttp -67.86 -24.28 65.23 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 107.709 -1.219 . . . . 1.35 107.709 171.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.3 t -48.76 -37.61 19.47 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 113.855 -1.521 . . . . 1.28 110.18 171.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.44 HE21 ' HD1' ' A' ' 64' ' ' TYR . 50.4 mt-30 -88.06 -35.18 17.67 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 111.948 0.351 . . . . 1.11 111.948 173.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.455 ' HA3' ' HB2' ' A' ' 36' ' ' SER . . . 147.51 -7.3 1.11 Allowed Glycine 0 CA--C 1.52 0.388 0 N-CA-C 111.619 -0.592 . . . . 0.18 111.619 -176.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.784 ' HD2' ' HB2' ' A' ' 64' ' ' TYR . 17.9 t80 -67.07 140.37 57.61 Favored 'General case' 0 C--O 1.217 -0.61 0 C-N-CA 123.003 0.521 . . . . 0.18 111.251 -177.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.918 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 2.2 t -134.17 143.19 47.76 Favored 'General case' 0 CA--C 1.482 -1.657 0 N-CA-C 108.189 -1.041 . . . . 0.2 108.189 174.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 1.029 HG11 ' HB1' ' A' ' 57' ' ' ALA . 39.9 t -98.6 98.87 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.535 0 C-N-CA 118.959 -1.096 . . . . 0.17 108.182 161.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.827 HD23 ' HB2' ' A' ' 103' ' ' PRO . 8.4 mt -85.94 119.01 25.78 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 107.36 -1.348 . . . . 1.04 107.36 175.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.887 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -111.67 116.28 30.52 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.826 0.822 . . . . 0.51 111.694 -178.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.875 ' HZ ' HG13 ' A' ' 20' ' ' VAL . 2.8 m-30 -98.38 99.09 6.65 Favored Pre-proline 0 C--N 1.315 -0.904 0 CA-C-N 114.519 -1.219 . . . . 0.44 109.051 178.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.769 ' O ' ' HB2' ' A' ' 107' ' ' LYS . 80.7 Cg_endo -78.34 93.22 1.1 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.214 1.943 . . . . 1.3 113.361 -171.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.759 ' HA ' HG23 ' A' ' 110' ' ' VAL . 84.3 p -43.54 142.99 1.03 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.93 -1.032 . . . . 1.44 111.886 -175.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.487 ' HB3' ' HD3' ' A' ' 107' ' ' LYS . 0.3 OUTLIER -95.55 130.92 42.24 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 121.672 0.748 . . . . 1.81 111.247 -175.967 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.511 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . 0.0 OUTLIER -75.31 -9.22 58.37 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.821 -1.081 . . . . 3.34 110.765 177.461 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -69.26 31.68 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.066 0.765 . . . . 2.68 113.066 -177.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.521 ' HA3' HE22 ' A' ' 82' ' ' GLN . . . -145.25 -144.6 4.15 Favored Glycine 0 CA--C 1.518 0.226 0 C-N-CA 120.822 -0.704 . . . . 1.98 112.37 -179.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -152.25 75.56 0.24 Allowed Glycine 0 CA--C 1.509 -0.282 0 N-CA-C 111.424 -0.67 . . . . 1.49 111.424 176.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.592 ' HG3' ' HB3' ' A' ' 111' ' ' ASN . 4.4 pm0 -172.82 -20.74 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.357 0.599 . . . . 1.74 111.307 -172.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' A' ' 77' ' ' ASN . 0.3 OUTLIER -75.39 158.58 83.43 Favored Pre-proline 0 C--N 1.308 -1.231 0 CA-C-N 114.423 -1.262 . . . . 3.07 114.048 -149.816 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.615 ' HB3' ' O ' ' A' ' 137' ' ' TRP . 2.8 Cg_exo -33.9 147.85 0.03 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 125.296 3.998 . . . . 1.75 114.695 173.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 79.91 25.88 57.06 Favored Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 120.393 -0.908 . . . . 2.2 111.212 -178.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.559 ' HA ' ' HD3' ' A' ' 136' ' ' LYS . 92.6 m-20 64.44 35.9 9.23 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.086 0.555 . . . . 4.2 111.885 174.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 60.62 23.64 13.41 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.784 -0.644 . . . . 3.02 112.426 176.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.678 ' HA ' ' HE3' ' A' ' 91' ' ' LYS . 12.6 pt-20 -134.64 -45.53 0.74 Allowed 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.132 -0.627 . . . . 3.92 112.491 -177.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.479 ' O ' ' HD1' ' A' ' 93' ' ' PHE . 26.9 tt0 -52.56 -58.43 6.79 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.455 0.539 . . . . 2.65 112.455 -170.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.537 HG12 ' SG ' ' A' ' 47' ' ' CYS . 3.0 mt -68.73 -34.2 63.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 112.405 0.52 . . . . 2.15 112.405 -171.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.678 ' HE3' ' HA ' ' A' ' 88' ' ' GLU . 0.0 OUTLIER -81.65 2.01 31.48 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.952 -0.299 . . . . 2.79 111.429 -175.622 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.444 ' HG3' ' O ' ' A' ' 88' ' ' GLU . 44.7 mt-10 -119.32 -45.27 2.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.463 -0.335 . . . . 3.29 110.811 177.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.479 ' HD1' ' O ' ' A' ' 89' ' ' GLU . 76.2 m-85 -73.06 159.49 33.53 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.074 -0.343 . . . . 3.42 110.074 177.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 79.6 t -67.63 110.36 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.123 -0.489 . . . . 2.63 110.081 178.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 1.8 p -114.2 139.8 49.08 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.953 0.882 . . . . 2.83 111.364 -178.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.701 ' O ' ' HB3' ' A' ' 45' ' ' SER . 7.4 m -143.22 146.72 33.91 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 106.092 -1.818 . . . . 2.98 106.092 172.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 52.4 pttt -64.16 98.54 0.23 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.797 0.808 . . . . 2.72 109.137 -178.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.785 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 0.1 OUTLIER -62.82 120.61 11.61 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 113.739 -1.573 . . . . 2.12 111.1 -164.416 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -92.65 132.34 36.97 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.122 -0.944 . . . . 2.69 110.477 176.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.785 ' HB2' ' CE2' ' A' ' 98' ' ' PHE . . . -131.36 -171.5 2.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.52 0.676 . . . . 0.55 112.457 -170.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -92.81 14.05 18.51 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 114.664 -1.153 . . . . 1.99 110.231 176.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.664 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 17.2 p90 -140.36 161.99 52.09 Favored Pre-proline 0 N--CA 1.444 -0.754 0 N-CA-C 108.859 -0.793 . . . . 0.84 108.859 -179.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.827 ' HB2' HD23 ' A' ' 72' ' ' LEU . 30.9 Cg_endo -58.95 92.82 0.08 OUTLIER 'Trans proline' 0 CA--C 1.514 -0.489 0 C-N-CA 123.965 3.11 . . . . 0.62 114.398 -172.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.887 HD12 ' HB3' ' A' ' 73' ' ' ALA . 5.4 mm -82.4 124.62 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 108.325 -0.991 . . . . 1.34 108.325 170.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.768 ' HG3' ' N ' ' A' ' 106' ' ' ALA . 0.0 OUTLIER -78.66 172.1 14.18 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.074 -1.421 . . . . 3.03 110.812 -176.933 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.768 ' N ' ' HG3' ' A' ' 105' ' ' MET . . . -61.0 -0.15 0.28 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.359 -0.837 . . . . 1.46 112.575 178.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.769 ' HB2' ' O ' ' A' ' 75' ' ' PRO . 12.3 ptpt 60.72 144.58 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.244 0 C-N-CA 124.941 1.297 . . . . 1.76 110.742 -168.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.604 HG13 ' HB2' ' A' ' 116' ' ' HIS . 0.3 OUTLIER -133.72 176.62 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.074 0 CA-C-N 113.615 -1.629 . . . . 0.82 108.331 168.086 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.429 HD21 ' CD ' ' A' ' 82' ' ' GLN . 2.7 t30 -70.05 66.85 0.28 Allowed 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 114.759 -1.11 . . . . 1.73 109.795 176.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.965 ' HA ' ' OH ' ' A' ' 119' ' ' TYR . 0.6 OUTLIER -72.6 92.64 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-O 122.11 0.957 . . . . 0.77 109.589 -172.657 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.592 ' HB3' ' HG3' ' A' ' 82' ' ' GLN . 4.7 t30 176.95 177.91 0.27 Allowed 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 104.684 -2.339 . . . . 1.9 104.684 169.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.42 ' H ' ' ND2' ' A' ' 111' ' ' ASN . . . -85.52 48.46 4.0 Favored Glycine 0 CA--C 1.498 -0.984 0 C-N-CA 119.581 -1.295 . . . . 1.47 114.214 -177.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -105.66 -47.98 3.77 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 119.046 -1.062 . . . . 2.81 110.699 169.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -131.15 -35.51 1.37 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.402 -0.962 . . . . 2.16 108.402 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.673 ' HA ' ' OH ' ' A' ' 119' ' ' TYR . . . 55.84 -166.22 0.11 Allowed 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 114.139 -1.391 . . . . 1.26 111.894 172.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.62 ' CE1' ' HB3' ' A' ' 118' ' ' LEU . 4.9 t-80 -149.55 121.98 4.31 Favored Pre-proline 0 N--CA 1.418 -2.051 0 N-CA-C 107.998 -1.112 . . . . 0.42 107.998 177.065 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.491 ' HB2' ' CD1' ' A' ' 18' ' ' PHE . 11.2 Cg_exo -31.47 -43.45 0.13 Allowed 'Trans proline' 0 C--O 1.215 -0.668 1 C-N-CA 125.531 4.154 . . . . 0.4 114.241 -174.115 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.708 HD22 HG22 ' A' ' 20' ' ' VAL . 4.8 tp -62.45 -60.17 3.92 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 113.471 0.915 . . . . 0.39 113.471 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.965 ' OH ' ' HA ' ' A' ' 110' ' ' VAL . 3.4 p90 -81.02 -25.66 37.0 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 109.113 -0.699 . . . . 3.04 109.113 -177.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.53 -39.23 90.3 Favored 'General case' 0 CA--C 1.495 -1.161 0 N-CA-C 106.546 -1.65 . . . . 2.44 106.546 173.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.46 ' HA ' ' HG2' ' A' ' 124' ' ' LYS . 71.4 t80 -65.45 -26.09 67.8 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.85 -1.068 . . . . 0.56 109.892 171.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.784 ' CE ' HD12 ' A' ' 40' ' ' ILE . 65.2 mtt -75.93 -56.89 4.24 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.182 -0.463 . . . . 0.71 111.716 -173.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.622 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -70.39 -24.04 62.88 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.779 -0.646 . . . . 1.46 110.65 179.621 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.46 ' HG2' ' HA ' ' A' ' 121' ' ' TYR . 17.1 ptmt -74.05 -28.41 61.4 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 119.722 -0.791 . . . . 1.99 109.456 174.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 51.8 m -76.83 -42.62 39.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.852 -0.613 . . . . 0.59 110.484 173.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.428 ' HD3' ' C ' ' A' ' 151' ' ' VAL . 8.0 tptm -120.23 106.43 40.72 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.258 -0.428 . . . . 1.85 111.447 -175.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.406 ' HB3' ' C ' ' A' ' 131' ' ' ALA . 63.5 Cg_exo -53.99 -35.97 82.58 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.206 2.604 . . . . 1.69 110.67 169.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 102.72 -132.28 10.94 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.595 -0.729 . . . . 2.59 111.948 176.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 51.5 mt -79.44 -40.79 21.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.585 0.707 . . . . 3.58 109.275 175.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.954 ' HB3' ' HB2' ' A' ' 133' ' ' LYS . 19.6 tp -93.08 142.31 27.43 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.406 -0.961 . . . . 3.47 108.406 175.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.406 ' C ' ' HB3' ' A' ' 127' ' ' PRO . . . -71.28 4.87 2.54 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.854 0.687 . . . . 3.28 112.854 -171.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 3.8 m -145.37 3.71 1.02 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.208 0.528 . . . . 3.56 110.564 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.954 ' HB2' ' HB3' ' A' ' 130' ' ' LEU . 26.3 tttp -58.36 133.63 55.89 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.377 -0.829 . . . . 5.17 111.34 -168.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -94.05 172.06 8.46 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.042 -1.096 . . . . 1.59 108.042 169.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.672 HG22 HG21 ' A' ' 140' ' ' THR . 1.4 pp -92.68 61.38 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 CA-C-O 121.793 0.806 . . . . 2.0 110.442 -178.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.571 ' C ' ' HA ' ' A' ' 84' ' ' PRO . 13.6 ttmm -95.54 35.43 1.35 Allowed 'General case' 0 C--O 1.237 0.427 0 CA-C-N 114.885 -1.052 . . . . 4.81 111.36 -175.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.615 ' O ' ' HB3' ' A' ' 84' ' ' PRO . 10.2 m-90 -127.62 173.12 10.15 Favored 'General case' 0 C--N 1.313 -1.007 0 O-C-N 121.708 -0.62 . . . . 1.97 109.886 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.577 ' HB2' ' CB ' ' A' ' 156' ' ' PRO . 3.4 m120 -47.54 -158.29 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.154 -0.93 . . . . 2.04 110.073 162.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.655 ' HD2' ' HD2' ' A' ' 41' ' ' TYR . 5.7 m-85 -28.42 -53.63 0.1 Allowed 'General case' 0 CA--C 1.552 1.033 0 N-CA-C 115.944 1.831 . . . . 1.93 115.944 -164.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.672 HG21 HG22 ' A' ' 135' ' ' ILE . 8.5 m 42.75 93.92 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 120.44 1.473 . . . . 0.6 112.832 174.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.71 ' HB3' HD12 ' A' ' 39' ' ' LEU . 2.5 m -88.98 161.69 16.47 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.744 -0.662 . . . . 0.62 111.556 -172.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.536 ' CZ ' HG21 ' A' ' 135' ' ' ILE . 70.3 m-85 -122.72 126.49 47.65 Favored 'General case' 0 CA--C 1.487 -1.471 0 N-CA-C 105.872 -1.899 . . . . 0.57 105.872 165.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.803 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 11.3 tp -80.39 101.96 9.32 Favored 'General case' 0 N--CA 1.418 -2.042 0 C-N-CA 117.823 -1.551 . . . . 0.43 107.877 176.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.706 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 39.1 mm -89.22 135.13 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.671 0 CA-C-N 113.018 -1.901 . . . . 0.19 107.311 -178.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.478 ' HA ' HD13 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -91.35 -174.85 4.06 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 119.201 -1.0 . . . . 0.98 111.545 -167.586 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.655 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 53.5 mtm180 -54.66 -36.23 64.37 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.157 0.503 . . . . 2.22 110.983 -177.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -100.11 23.28 10.16 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.625 -0.509 . . . . 2.0 109.625 -178.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.635 ' HA3' ' CE2' ' A' ' 16' ' ' PHE . . . 65.76 34.44 88.79 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 115.943 -0.571 . . . . 0.17 114.002 178.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 64.1 t -103.07 116.19 62.8 Favored Pre-proline 0 C--N 1.314 -0.944 0 CA-C-N 118.024 0.912 . . . . 1.12 110.875 175.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.73 ' HD3' HG23 ' A' ' 15' ' ' ILE . 36.5 Cg_endo -66.13 109.05 1.45 Allowed 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 123.757 2.971 . . . . 0.41 110.664 178.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.557 HG23 ' HG2' ' A' ' 152' ' ' GLU . 19.6 m -113.71 -12.11 11.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 121.062 0.458 . . . . 1.45 110.486 -172.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.803 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 33.8 mm-40 -142.83 165.83 26.3 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-N 115.563 -0.744 . . . . 1.17 109.611 177.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.525 ' HA ' ' O ' ' A' ' 141' ' ' SER . 0.0 OUTLIER -148.65 122.41 9.28 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.404 -0.816 . . . . 2.16 110.76 165.347 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.683 ' HZ ' ' HB2' ' A' ' 166' ' ' LYS . 88.1 m-85 -95.67 155.81 16.59 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.616 -1.175 . . . . 0.32 109.291 -175.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 12.0 m -82.83 160.89 59.98 Favored Pre-proline 0 C--N 1.314 -0.937 0 N-CA-C 108.733 -0.84 . . . . 1.11 108.733 175.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.636 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 14.5 Cg_endo -58.76 -48.8 13.42 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 121.317 1.344 . . . . 0.78 110.479 173.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.554 ' HA2' ' O ' ' A' ' 51' ' ' LYS . . . -48.59 -12.8 0.22 Allowed Glycine 0 CA--C 1.537 1.422 0 CA-C-N 114.588 -1.187 . . . . 0.5 115.54 167.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -87.64 138.88 31.08 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 118.464 1.132 . . . . 0.5 109.285 173.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 15.5 m -111.99 -173.03 2.16 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 112.819 0.674 . . . . 1.42 112.819 -168.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.785 ' HA ' HG23 ' A' ' 56' ' ' THR . 83.0 t -40.98 -60.49 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 114.134 -1.394 . . . . 0.28 112.335 -178.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -62.88 -39.16 93.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.287 -0.415 . . . . 3.46 110.534 -173.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.486 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 7.7 m-20 -55.56 -49.0 73.86 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 115.322 -0.854 . . . . 1.4 109.844 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.667 HD12 HG21 ' A' ' 56' ' ' THR . 81.4 mt -73.4 -46.75 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 CA-C-N 114.581 -1.19 . . . . 0.21 111.691 -177.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.487 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 49.5 mt-10 -54.75 -45.19 74.14 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-O 120.804 0.335 . . . . 0.67 111.251 -177.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 11.5 pt-20 -63.35 -15.42 57.37 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 111.993 0.368 . . . . 0.87 111.993 -173.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.683 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 28.3 mmmt -104.75 -22.97 13.12 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.607 0.717 . . . . 1.71 109.783 173.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.549 HD21 HD11 ' A' ' 171' ' ' LEU . 8.3 tp -83.61 -48.88 9.74 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.762 -1.108 . . . . 0.16 112.296 -176.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.486 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 68.9 mt -55.05 -46.06 99.73 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.617 -0.72 . . . . 0.26 112.302 -174.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.486 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 84.8 Cg_exo -51.39 -27.05 22.84 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.287 1.992 . . . . 0.41 113.178 173.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.823 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 74.8 mt -89.67 -42.58 11.28 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.846 -0.161 . . . . 0.71 111.124 178.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.728 HD23 ' HG2' ' A' ' 37' ' ' PRO . 91.9 mt -59.87 -58.26 9.31 Favored 'General case' 0 CA--C 1.505 -0.75 0 CA-C-O 121.996 0.903 . . . . 0.34 109.86 176.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -61.22 -59.16 10.46 Favored Glycine 0 N--CA 1.432 -1.591 0 CA-C-N 113.338 -1.755 . . . . 1.12 112.171 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 34.7 t 61.7 -87.99 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.083 0.553 . . . . 2.64 111.778 174.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -82.72 -22.96 34.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.248 0.546 . . . . 4.35 110.2 178.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -84.86 -52.92 5.67 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.47 -0.786 . . . . 8.45 109.796 177.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 95.0 mt . . . . . 0 C--O 1.246 0.894 0 CA-C-N 115.606 -0.725 . . . . 7.69 109.679 177.955 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.651 0 N-CA-C 111.988 -0.445 . . . . 5.22 111.988 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 61.9 mtt -78.62 90.47 4.56 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.759 -0.46 . . . . 4.85 109.759 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.85 90.96 2.17 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.246 -0.742 . . . . 1.55 111.246 -175.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.3 t -117.27 -1.43 11.81 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.475 0.655 . . . . 1.58 109.899 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 96.5 p 179.78 168.49 1.2 Allowed 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 105.044 -2.206 . . . . 1.17 105.044 -177.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.892 ' HB ' HD11 ' A' ' 118' ' ' LEU . 4.8 pt -67.62 -12.96 16.14 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 CA-C-O 121.399 0.619 . . . . 0.38 110.274 177.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.787 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 33.4 m-85 -75.3 4.04 7.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.661 -0.699 . . . . 0.3 111.893 -175.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.57 -7.28 59.57 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.474 -0.936 . . . . 2.11 108.474 175.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.925 ' HE2' ' HB2' ' A' ' 121' ' ' TYR . 58.1 m-85 -125.67 113.66 17.65 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-N 114.988 -1.006 . . . . 0.31 111.964 -175.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -50.78 142.15 11.91 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 113.546 -1.661 . . . . 2.86 110.21 172.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.966 HG13 ' HZ ' ' A' ' 74' ' ' PHE . 68.8 t -113.8 169.6 5.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.5 -0.773 . . . . 0.67 109.114 -178.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.772 HD23 ' HA ' ' A' ' 27' ' ' PRO . 94.2 mt -127.53 150.51 49.66 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.019 0.438 . . . . 0.69 111.399 178.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.38 165.1 18.5 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 106.318 -1.734 . . . . 1.87 106.318 162.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.604 ' HA ' ' N ' ' A' ' 106' ' ' ALA . . . -59.53 -7.73 1.57 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 113.721 1.008 . . . . 0.59 113.721 -169.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.554 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 1.3 m-20 -99.08 2.06 45.75 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.914 0.339 . . . . 2.34 111.914 176.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.554 ' HB2' ' O ' ' A' ' 24' ' ' ASP . 83.2 m-70 80.55 17.36 0.61 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.611 0.72 . . . . 1.47 109.266 178.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.405 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 11.9 mmtt -86.13 120.46 72.44 Favored Pre-proline 0 CA--C 1.508 -0.654 0 N-CA-C 107.682 -1.229 . . . . 4.25 107.682 172.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.772 ' HA ' HD23 ' A' ' 21' ' ' LEU . 86.1 Cg_exo -53.21 112.39 0.92 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 121.742 1.628 . . . . 0.54 113.087 -172.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.831 ' HE2' HD23 ' A' ' 72' ' ' LEU . 9.0 t80 -79.22 116.78 19.7 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 113.487 -1.688 . . . . 1.2 109.735 172.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.505 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.7 p-10 -71.43 89.15 0.92 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 122.653 1.216 . . . . 1.51 109.95 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.863 HD21 HD12 ' A' ' 15' ' ' ILE . 58.9 tp -50.93 -39.99 56.16 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 113.939 -1.482 . . . . 0.28 111.947 -179.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.574 HG13 ' HB3' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -66.47 1.03 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 114.046 1.128 . . . . 1.02 114.046 -170.478 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.505 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 28.4 pt20 -77.82 -6.81 55.38 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.043 -0.663 . . . . 1.02 109.679 171.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.927 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 93.8 m-70 -101.54 24.52 9.6 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 122.001 0.905 . . . . 0.28 109.005 174.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.787 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 21.5 mtmm -83.54 110.56 18.32 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 114.344 -1.298 . . . . 1.56 108.686 169.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 131.78 -41.58 1.49 Allowed Glycine 0 N--CA 1.442 -0.959 0 C-N-CA 120.629 -0.796 . . . . 0.2 111.538 -178.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.446 ' HB2' ' HA3' ' A' ' 68' ' ' GLY . 35.9 m -129.38 136.93 29.9 Favored Pre-proline 0 N--CA 1.433 -1.295 0 N-CA-C 108.796 -0.816 . . . . 0.29 108.796 172.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.822 ' HG3' ' CB ' ' A' ' 170' ' ' LEU . 7.0 Cg_endo -44.96 153.08 0.45 Allowed 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 124.069 3.18 . . . . 0.18 112.563 176.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.81 ' HB2' HG22 ' A' ' 70' ' ' THR . 1.0 OUTLIER -140.13 146.28 38.65 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 106.889 -1.523 . . . . 0.31 106.889 179.098 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 1.017 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 3.5 mp -113.3 115.3 27.94 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.484 -0.76 . . . . 1.19 109.853 176.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.877 HG23 HD13 ' A' ' 72' ' ' LEU . 0.8 OUTLIER -95.46 116.97 38.4 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 CA-C-N 115.071 -0.968 . . . . 0.37 108.681 176.961 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 1.017 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.4 OUTLIER -101.14 130.6 47.23 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 119.622 -0.831 . . . . 0.42 109.637 -176.207 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.521 ' OD1' ' HB ' ' A' ' 140' ' ' THR . 0.5 OUTLIER -77.59 122.97 26.01 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 104.4 -2.444 . . . . 2.35 104.4 163.923 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.787 HG12 ' HA ' ' A' ' 139' ' ' PHE . 28.2 m -128.62 156.35 40.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 C-N-CA 118.702 -1.199 . . . . 1.03 111.797 -171.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -83.37 158.13 22.26 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 107.476 -1.305 . . . . 0.88 107.476 165.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.587 ' HA ' ' HB3' ' A' ' 98' ' ' PHE . 26.1 m -86.72 -159.79 0.52 Allowed 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 116.133 -0.485 . . . . 1.78 109.975 -174.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -75.7 71.54 2.58 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.223 0.535 . . . . 5.84 110.247 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.643 ' HB2' ' HD2' ' A' ' 93' ' ' PHE . 28.4 p -163.7 -176.95 4.89 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.994 -0.548 . . . . 3.55 109.975 -178.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.662 ' HA3' ' HG3' ' A' ' 89' ' ' GLU . . . 52.73 -121.01 13.38 Favored Glycine 0 N--CA 1.451 -0.351 0 O-C-N 123.971 0.794 . . . . 2.91 113.226 175.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -130.13 111.49 12.5 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.337 0.589 . . . . 4.63 111.356 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -75.84 93.48 3.19 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.106 -0.952 . . . . 1.93 110.521 177.016 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -59.21 163.15 3.96 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.558 -0.292 . . . . 2.01 110.649 178.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -51.89 -20.3 6.07 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-N 116.069 -0.514 . . . . 0.51 113.167 -179.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.486 ' HA2' ' HB ' ' A' ' 56' ' ' THR . . . -51.39 -25.09 11.98 Favored Glycine 0 C--O 1.219 -0.814 0 CA-C-O 119.909 -0.384 . . . . 0.5 113.414 176.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.531 ' HA ' ' CE2' ' A' ' 139' ' ' PHE . 0.8 OUTLIER -66.13 -55.01 18.58 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 117.745 0.772 . . . . 0.7 109.421 175.724 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -61.34 -31.32 71.18 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.238 -0.892 . . . . 2.61 109.745 178.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.688 HG23 ' HA ' ' A' ' 160' ' ' VAL . 74.0 m -66.61 -54.82 19.25 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 114.496 -1.229 . . . . 0.33 109.533 179.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 1.028 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -57.98 -48.7 79.21 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.647 -1.16 . . . . 0.22 111.625 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.432 ' HA ' ' CD1' ' A' ' 102' ' ' PHE . 18.5 m -55.89 -54.62 42.38 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-O 121.61 0.719 . . . . 0.26 110.745 -179.048 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.6 m -69.24 -33.38 73.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.026 -0.988 . . . . 0.48 111.549 -175.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.732 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 18.2 mt -71.63 -48.2 49.44 Favored 'General case' 0 CA--C 1.492 -1.272 0 CA-C-N 116.54 -0.3 . . . . 0.43 110.634 -177.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.877 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 6.7 t80 -53.45 -62.26 1.77 Allowed 'General case' 0 C--O 1.194 -1.819 0 O-C-N 124.09 0.869 . . . . 0.31 109.49 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.654 ' HA ' ' CG ' ' A' ' 65' ' ' LYS . 1.8 p30 -67.93 -25.63 65.57 Favored 'General case' 0 C--N 1.314 -0.966 0 O-C-N 122.887 0.117 . . . . 1.21 110.908 -168.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.473 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 36.4 ttpt -79.7 -20.65 46.01 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 107.936 -1.135 . . . . 1.54 107.936 -177.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.68 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 49.9 m-85 -126.5 0.86 6.92 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 115.22 1.563 . . . . 0.31 115.22 -174.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.654 ' CG ' ' HA ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -60.82 -34.59 74.77 Favored 'General case' 0 CA--C 1.496 -1.128 0 N-CA-C 105.986 -1.857 . . . . 1.35 105.986 170.107 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.2 m -47.43 -34.36 7.13 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 112.3 -2.227 . . . . 1.28 111.782 178.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -94.63 -36.06 11.94 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 120.863 -0.335 . . . . 1.11 111.584 174.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.446 ' HA3' ' HB2' ' A' ' 36' ' ' SER . . . 149.31 -0.56 0.49 Allowed Glycine 0 CA--C 1.52 0.35 0 N-CA-C 111.869 -0.492 . . . . 0.18 111.869 -178.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.732 ' HE2' ' HB3' ' A' ' 60' ' ' LEU . 14.4 t80 -74.12 141.58 45.59 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 122.743 0.417 . . . . 0.18 111.182 -177.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.927 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 5.5 t -134.54 142.49 47.0 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 108.675 -0.861 . . . . 0.2 108.675 172.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 1.028 HG11 ' HB1' ' A' ' 57' ' ' ALA . 41.2 t -101.82 99.61 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.249 0 N-CA-C 107.746 -1.205 . . . . 0.17 107.746 160.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.961 HD12 ' H ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -96.44 119.25 34.58 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 107.689 -1.226 . . . . 1.04 107.689 176.15 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.914 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -102.35 140.55 36.48 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.426 0.631 . . . . 0.51 111.156 -176.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.966 ' HZ ' HG13 ' A' ' 20' ' ' VAL . 3.1 m-30 -121.41 96.17 47.96 Favored Pre-proline 0 C--N 1.304 -1.39 0 N-CA-C 108.288 -1.005 . . . . 0.44 108.288 -177.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 1.018 ' HG2' ' HB3' ' A' ' 107' ' ' LYS . 93.3 Cg_endo -79.34 72.43 6.52 Favored 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 122.562 2.175 . . . . 1.3 114.149 -167.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.592 ' HB3' HG23 ' A' ' 110' ' ' VAL . 79.0 p -0.78 130.17 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 117.023 2.231 . . . . 1.44 117.023 178.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -79.61 103.01 9.23 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 113.334 -1.757 . . . . 1.81 109.757 -178.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 1.061 ' HA ' ' HG2' ' A' ' 83' ' ' GLU . 0.4 OUTLIER -59.54 -13.27 8.5 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.751 -1.113 . . . . 3.34 113.018 -178.931 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -67.28 -11.67 58.14 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.183 0.438 . . . . 2.68 112.183 -175.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.595 ' HA3' HD21 ' A' ' 109' ' ' ASN . . . -86.37 -21.31 52.19 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.56 -0.829 . . . . 1.98 113.581 -174.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.407 ' HA2' ' HE2' ' A' ' 91' ' ' LYS . . . 64.47 30.25 77.36 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.432 -0.89 . . . . 1.49 111.176 -174.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.755 ' HG2' ' HB3' ' A' ' 113' ' ' GLU . 0.6 OUTLIER -133.74 2.49 3.44 Favored 'General case' 0 CA--C 1.498 -1.031 0 CA-C-N 114.99 -0.605 . . . . 1.74 110.238 -176.917 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 1.061 ' HG2' ' HA ' ' A' ' 78' ' ' GLN . 0.0 OUTLIER -79.19 142.32 59.04 Favored Pre-proline 0 C--N 1.308 -1.212 0 CA-C-O 121.821 0.819 . . . . 3.07 111.695 -160.891 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 83' ' ' GLU . 52.1 Cg_endo -79.02 170.6 17.63 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 123.954 3.102 . . . . 1.75 113.91 -164.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.27 -78.18 2.04 Favored Glycine 0 N--CA 1.443 -0.845 0 N-CA-C 109.851 -1.3 . . . . 2.2 109.851 -170.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.899 ' HB2' ' HB2' ' A' ' 89' ' ' GLU . 45.6 m-80 -144.77 118.55 9.25 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.646 -0.872 . . . . 4.2 108.646 171.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -71.33 64.42 0.39 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.898 0.856 . . . . 3.02 110.172 177.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 171.35 -24.71 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.4 -1.273 . . . . 3.92 108.886 -174.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.899 ' HB2' ' HB2' ' A' ' 86' ' ' ASN . 72.7 tt0 -63.52 -16.82 61.82 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.862 -1.063 . . . . 2.65 111.003 -178.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.923 ' HB ' ' HB3' ' A' ' 78' ' ' GLN . 1.1 mt -121.1 -50.2 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-N 116.02 -0.537 . . . . 2.15 111.61 -176.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.738 ' HB3' ' HB2' ' A' ' 78' ' ' GLN . 22.5 pttp -73.22 -24.41 60.49 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.874 0.694 . . . . 2.79 112.874 -172.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -124.5 27.83 6.82 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.714 0.769 . . . . 3.29 110.66 177.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.643 ' HD2' ' HB2' ' A' ' 47' ' ' CYS . 20.3 t80 -133.79 145.55 49.88 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.997 -1.112 . . . . 3.42 107.997 170.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.1 t -67.0 112.34 2.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.83 0.348 . . . . 2.63 110.87 -176.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.564 ' HB3' ' SG ' ' A' ' 47' ' ' CYS . 18.7 p -131.54 122.46 26.17 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.301 0.572 . . . . 2.83 111.927 -176.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.568 ' O ' ' HB3' ' A' ' 45' ' ' SER . 17.3 m -87.6 153.12 21.64 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 107.557 -1.275 . . . . 2.98 107.557 162.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -64.31 117.55 7.38 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.206 -0.665 . . . . 2.72 109.206 177.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.699 ' HE1' ' HB2' ' A' ' 100' ' ' ALA . 0.0 OUTLIER -62.78 113.98 3.35 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.436 -0.802 . . . . 2.12 110.224 -176.988 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.523 ' NZ ' ' HB2' ' A' ' 99' ' ' LYS . 9.0 mtmp? -118.59 127.55 53.71 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.691 -0.686 . . . . 2.69 109.8 174.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.85 ' H ' HD13 ' A' ' 104' ' ' ILE . . . -128.93 -159.24 0.94 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.847 -0.615 . . . . 0.55 111.649 -170.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -86.41 10.1 16.12 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.721 -0.672 . . . . 1.99 110.955 -176.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.636 ' CE2' ' HZ ' ' A' ' 98' ' ' PHE . 0.7 OUTLIER -125.18 174.63 3.7 Favored Pre-proline 0 N--CA 1.448 -0.543 0 CA-C-N 115.514 -0.766 . . . . 0.84 109.553 177.262 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.641 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 12.1 Cg_exo -76.74 84.1 1.96 Allowed 'Trans proline' 0 CA--C 1.517 -0.344 0 C-N-CA 123.702 2.935 . . . . 0.62 113.632 -177.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.914 HG13 ' HB3' ' A' ' 73' ' ' ALA . 3.9 mp -84.91 133.33 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 N-CA-C 109.1 -0.704 . . . . 1.34 109.1 173.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.811 ' HG2' ' CG ' ' A' ' 74' ' ' PHE . 0.1 OUTLIER -86.98 -179.43 6.49 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.336 -0.847 . . . . 3.03 110.576 -175.602 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.678 ' O ' ' HG2' ' A' ' 107' ' ' LYS . . . -76.85 19.06 0.31 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.063 -0.971 . . . . 1.46 112.388 -173.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 1.018 ' HB3' ' HG2' ' A' ' 75' ' ' PRO . 12.1 ptmt 51.22 128.13 0.0 OUTLIER 'General case' 0 CA--C 1.504 -0.803 0 C-N-CA 125.685 1.594 . . . . 1.76 113.645 -173.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.837 HD11 HG13 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -124.34 173.42 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.922 0 CA-C-N 113.141 -1.845 . . . . 0.82 108.371 171.978 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.595 HD21 ' HA3' ' A' ' 80' ' ' GLY . 1.3 m120 -69.43 58.69 0.12 Allowed 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.131 -0.94 . . . . 1.73 112.35 179.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.837 HG13 HD11 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -68.97 93.35 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 C-N-CA 119.49 -0.884 . . . . 0.77 110.295 178.654 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 175.41 -178.32 0.12 Allowed 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 106.187 -1.783 . . . . 1.9 106.187 168.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.03 48.35 3.83 Favored Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 119.505 -1.331 . . . . 1.47 115.33 -175.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.755 ' HB3' ' HG2' ' A' ' 82' ' ' GLN . 29.1 tt0 -107.49 -47.85 3.55 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 118.697 -1.201 . . . . 2.81 110.297 158.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -131.52 -36.81 1.24 Allowed 'General case' 0 CA--C 1.503 -0.833 0 C-N-CA 120.608 -0.437 . . . . 2.16 110.356 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . 55.93 -160.51 0.2 Allowed 'General case' 0 N--CA 1.439 -0.983 0 O-C-N 124.031 0.832 . . . . 1.26 109.14 -174.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.791 ' CB ' HG13 ' A' ' 108' ' ' ILE . 2.2 t-80 -140.94 137.14 16.73 Favored Pre-proline 0 C--N 1.302 -1.476 0 N-CA-C 106.992 -1.485 . . . . 0.42 106.992 173.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -28.16 -46.63 0.1 OUTLIER 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 124.729 3.619 . . . . 0.4 113.606 -178.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.892 HD11 ' HB ' ' A' ' 15' ' ' ILE . 37.9 tp -64.86 -51.43 62.09 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 122.977 0.511 . . . . 0.39 112.007 178.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.663 ' HA ' ' HB2' ' A' ' 122' ' ' MET . 31.9 m-85 -77.77 -31.95 52.25 Favored 'General case' 0 CA--C 1.497 -1.085 0 O-C-N 122.185 -0.322 . . . . 3.04 110.664 -178.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.524 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 0.2 OUTLIER -59.29 -39.45 83.0 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 106.656 -1.609 . . . . 2.44 106.656 172.068 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.925 ' HB2' ' HE2' ' A' ' 18' ' ' PHE . 65.0 t80 -65.98 -30.79 71.41 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 119.647 -0.821 . . . . 0.56 110.183 175.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.776 ' HE3' ' HG ' ' A' ' 118' ' ' LEU . 1.5 ttm -75.4 -55.37 5.76 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.573 -0.74 . . . . 0.71 110.744 -170.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.561 ' HD2' ' HB2' ' A' ' 134' ' ' ALA . 1.0 OUTLIER -70.79 -25.68 62.99 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.398 -0.365 . . . . 1.46 111.164 177.045 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.524 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -73.18 -26.26 61.11 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 119.355 -0.938 . . . . 1.99 109.991 178.442 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 65.7 m -85.41 -42.11 14.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.969 -0.559 . . . . 0.59 110.43 174.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.477 ' HE3' ' O ' ' A' ' 151' ' ' VAL . 39.9 tttm -141.88 90.55 8.5 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 109.118 -0.697 . . . . 1.85 109.118 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 126' ' ' LYS . 25.8 Cg_endo -61.76 -73.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.619 2.879 . . . . 1.69 113.799 -171.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.667 ' HA3' ' HB ' ' A' ' 132' ' ' THR . . . -155.78 168.38 33.34 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.16 -1.019 . . . . 2.59 112.558 -177.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.883 ' H ' HD13 ' A' ' 129' ' ' ILE . 0.2 OUTLIER -100.51 -18.94 6.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.275 0.56 . . . . 3.58 110.22 177.391 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.423 HD22 ' HA ' ' A' ' 130' ' ' LEU . 0.2 OUTLIER -100.12 34.01 2.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.225 -0.898 . . . . 3.47 108.65 179.033 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 52.18 34.45 14.45 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.15 -0.932 . . . . 3.28 109.107 -166.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.667 ' HB ' ' HA3' ' A' ' 128' ' ' GLY . 1.6 m -76.05 157.49 32.91 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.592 -1.185 . . . . 3.56 110.746 -173.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -74.58 -38.67 62.59 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.248 0.547 . . . . 5.17 110.389 175.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.6 ' HB1' HD13 ' A' ' 135' ' ' ILE . . . -147.53 -157.95 0.86 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.565 -0.743 . . . . 1.59 111.365 -169.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.98 ' HA ' ' HD3' ' A' ' 153' ' ' ARG . 0.0 OUTLIER -38.06 -61.52 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 O-C-N 124.322 1.014 . . . . 2.0 111.794 174.634 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.699 ' HB3' ' HE3' ' A' ' 137' ' ' TRP . 20.2 mtmt 125.5 -70.05 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.195 0 O-C-N 125.03 1.456 . . . . 4.81 110.844 -178.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.889 ' HB3' ' HG3' ' A' ' 156' ' ' PRO . 0.8 OUTLIER -120.27 -175.45 3.0 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 113.043 -1.89 . . . . 1.97 110.881 -158.527 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.494 ' O ' ' N ' ' A' ' 140' ' ' THR . 7.7 m120 -34.87 -151.35 0.0 OUTLIER 'General case' 0 C--O 1.205 -1.267 0 CA-C-N 113.837 -1.529 . . . . 2.04 111.8 156.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.787 ' HA ' HG12 ' A' ' 43' ' ' VAL . 0.6 OUTLIER -28.69 -21.01 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 118.098 2.629 . . . . 1.93 118.098 -171.702 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.523 ' HA ' ' O ' ' A' ' 154' ' ' PHE . 0.9 OUTLIER -9.05 113.27 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 120.191 1.36 . . . . 0.6 113.951 170.438 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.663 ' HA ' ' HA ' ' A' ' 41' ' ' TYR . 0.7 OUTLIER -90.47 171.77 9.19 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.851 -1.068 . . . . 0.62 110.089 -174.132 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.634 ' HA ' ' HA ' ' A' ' 153' ' ' ARG . 10.6 m-85 -126.04 120.26 29.79 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 105.372 -2.084 . . . . 0.57 105.372 161.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.902 HD23 ' HB2' ' A' ' 152' ' ' GLU . 1.1 tp -79.67 105.42 10.96 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 118.69 -1.204 . . . . 0.43 108.52 -178.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.769 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 45.1 mm -92.81 145.5 7.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 CA-C-N 113.975 -1.466 . . . . 0.19 107.933 -176.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.64 -174.88 2.91 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 119.532 -0.867 . . . . 0.98 111.357 -170.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.593 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 32.1 mtm180 -51.08 -42.23 60.47 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 121.077 0.465 . . . . 2.22 111.444 -176.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -98.8 21.56 11.3 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.97 -0.559 . . . . 2.0 109.955 -175.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.485 ' HA3' ' CE2' ' A' ' 16' ' ' PHE . . . 71.64 34.2 63.14 Favored Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 115.732 -0.667 . . . . 0.17 113.908 178.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.475 ' HA ' ' HD2' ' A' ' 150' ' ' PRO . 43.0 t -112.07 107.03 56.13 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 117.988 0.894 . . . . 1.12 111.544 176.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.67 ' HG3' ' HG3' ' A' ' 122' ' ' MET . 4.4 Cg_exo -45.39 118.53 2.16 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 124.441 3.427 . . . . 0.41 112.403 173.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.477 ' O ' ' HE3' ' A' ' 126' ' ' LYS . 1.8 t -103.64 -20.8 5.55 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.879 0 N-CA-C 108.116 -1.068 . . . . 1.45 108.116 178.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.902 ' HB2' HD23 ' A' ' 143' ' ' LEU . 0.0 OUTLIER -152.5 167.65 28.11 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 113.998 -1.455 . . . . 1.17 110.957 -168.531 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.98 ' HD3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -141.82 129.21 21.22 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 107.091 -1.448 . . . . 2.16 107.091 159.301 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.711 ' HZ ' ' HB2' ' A' ' 166' ' ' LYS . 70.0 m-85 -101.34 141.02 34.83 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.902 -0.407 . . . . 0.32 109.902 -173.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 18.3 m -64.54 150.58 93.43 Favored Pre-proline 0 C--N 1.325 -0.497 0 N-CA-C 109.979 -0.378 . . . . 1.11 109.979 177.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.889 ' HG3' ' HB3' ' A' ' 137' ' ' TRP . 18.6 Cg_endo -57.41 -50.29 11.33 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.138 1.892 . . . . 0.78 112.253 -174.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -66.89 16.44 0.29 Allowed Glycine 0 CA--C 1.526 0.758 0 N-CA-C 114.829 0.692 . . . . 0.5 114.829 175.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -78.59 154.23 30.49 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 118.262 1.031 . . . . 0.5 108.572 169.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.435 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 50.1 m -106.97 167.36 9.94 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 109.64 -0.504 . . . . 1.42 109.64 -177.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.688 ' HA ' HG23 ' A' ' 56' ' ' THR . 91.2 t -40.81 -54.59 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 O-C-N 124.2 0.938 . . . . 0.28 111.731 178.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.435 ' NZ ' ' HB2' ' A' ' 161' ' ' LYS . 0.1 OUTLIER -70.13 -27.65 64.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.232 -0.44 . . . . 3.46 111.409 -172.856 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -68.0 -35.22 77.94 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.478 0.656 . . . . 1.4 109.59 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.609 HD12 ' CG2' ' A' ' 56' ' ' THR . 47.4 mt -80.42 -44.55 22.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 114.988 -1.006 . . . . 0.21 110.522 176.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.604 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 41.2 mt-10 -50.84 -41.73 57.95 Favored 'General case' 0 C--O 1.217 -0.653 0 CA-C-N 116.122 -0.49 . . . . 0.67 111.503 -177.115 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -60.88 -26.77 67.65 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 112.486 0.55 . . . . 0.87 112.486 -175.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.711 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 40.8 mmtm -100.93 -5.35 26.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.544 0.688 . . . . 1.71 109.83 175.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.604 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 11.9 tp -97.82 -51.1 4.2 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.119 -0.946 . . . . 0.16 111.971 -176.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.485 HD11 ' HB3' ' A' ' 164' ' ' GLU . 69.5 mt -56.24 -46.72 99.76 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 112.957 0.725 . . . . 0.26 112.957 -171.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.463 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 63.3 Cg_exo -53.67 -25.03 32.03 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.092 1.861 . . . . 0.41 112.577 175.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.822 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 94.8 mt -86.66 -45.41 11.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.241 -0.436 . . . . 0.71 110.744 177.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.779 HD23 ' HG2' ' A' ' 37' ' ' PRO . 96.5 mt -59.89 -54.83 41.54 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-O 122.048 0.928 . . . . 0.34 110.204 177.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -62.7 -10.85 33.1 Favored Glycine 0 N--CA 1.435 -1.401 0 CA-C-N 113.305 -1.77 . . . . 1.12 112.962 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 6.2 t 58.54 70.42 0.65 Allowed 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.236 0.541 . . . . 2.64 110.359 177.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -66.37 -23.14 66.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.72 -0.673 . . . . 4.35 110.333 178.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 71.28 -67.22 0.26 Allowed 'General case' 0 N--CA 1.465 0.301 0 O-C-N 124.093 0.871 . . . . 8.45 111.282 175.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 22.7 tp . . . . . 0 C--O 1.247 0.921 0 CA-C-O 118.743 -0.646 . . . . 7.69 109.37 177.754 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.822 0 N-CA-C 111.833 -0.507 . . . . 5.22 111.833 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -118.72 140.54 49.77 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.817 0.341 . . . . 4.85 110.092 176.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -128.52 156.38 20.94 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.868 -0.682 . . . . 1.55 112.234 -177.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.8 m -108.96 -10.16 15.07 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.81 0.338 . . . . 1.58 110.407 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.466 ' HB3' ' O ' ' A' ' 147' ' ' ASP . 3.1 m -159.78 152.39 21.29 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 107.075 -1.454 . . . . 1.17 107.075 -173.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.94 ' HB ' HD11 ' A' ' 118' ' ' LEU . 4.6 pt -66.54 -13.63 16.53 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 CA-C-N 114.079 -1.418 . . . . 0.38 112.298 -173.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.828 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 57.1 m-85 -70.45 -8.11 48.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.819 0.342 . . . . 0.3 111.908 -178.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -64.88 -25.86 68.07 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 108.103 -1.073 . . . . 2.11 108.103 175.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.858 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 61.4 m-85 -109.52 113.72 26.75 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 114.191 -1.368 . . . . 0.31 111.632 -176.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -47.72 142.26 4.79 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 113.122 -1.854 . . . . 2.86 110.652 169.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.769 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 54.8 t -111.66 159.2 11.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 108.395 -0.965 . . . . 0.67 108.395 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.729 HD23 ' HA ' ' A' ' 27' ' ' PRO . 74.9 mt -124.05 121.08 34.25 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 121.103 -0.239 . . . . 0.69 110.889 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.81 ' HA ' ' HE2' ' A' ' 105' ' ' MET . 6.2 t0 -62.1 170.5 2.18 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 107.314 -1.365 . . . . 1.87 107.314 173.062 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.617 ' HA ' ' C ' ' A' ' 105' ' ' MET . . . -53.05 -20.31 3.48 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 114.673 1.36 . . . . 0.59 114.673 -164.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 7.9 t70 -103.31 11.66 36.44 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.541 -0.463 . . . . 2.34 111.665 -177.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.676 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 54.7 m-70 76.04 18.42 2.0 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.823 0.82 . . . . 1.47 109.503 176.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.743 ' HE2' ' HA ' ' A' ' 26' ' ' LYS . 10.6 mmpt? -88.98 127.97 53.77 Favored Pre-proline 0 N--CA 1.445 -0.691 0 N-CA-C 107.488 -1.301 . . . . 4.25 107.488 171.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.729 ' HA ' HD23 ' A' ' 21' ' ' LEU . 80.0 Cg_exo -49.82 114.08 1.23 Allowed 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 122.242 1.961 . . . . 0.54 113.206 -171.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.551 ' HB3' HG12 ' A' ' 20' ' ' VAL . 49.5 t80 -79.99 146.71 31.88 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 113.813 -1.54 . . . . 1.2 111.675 173.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.501 ' OD1' ' HB3' ' A' ' 32' ' ' GLN . 2.5 t-20 -86.34 92.39 8.79 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 114.917 -1.038 . . . . 1.51 109.289 175.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.65 HD23 ' HA ' ' A' ' 16' ' ' PHE . 54.0 tp -72.62 -41.25 65.75 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.756 -0.656 . . . . 0.28 109.976 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.799 ' HA ' ' CE1' ' A' ' 16' ' ' PHE . 1.5 t -70.22 -0.83 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 114.698 -1.137 . . . . 1.02 112.517 -167.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.501 ' HB3' ' OD1' ' A' ' 29' ' ' ASN . 30.1 pt20 -76.14 -6.92 53.44 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.342 0.591 . . . . 1.02 109.687 174.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.931 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 93.0 m-70 -100.29 28.53 4.91 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 115.279 -0.873 . . . . 0.28 108.798 175.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.828 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 8.0 mtmt -90.45 118.16 29.71 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 114.687 -1.142 . . . . 1.56 109.595 173.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.66 -40.4 1.97 Allowed Glycine 0 N--CA 1.439 -1.159 0 N-CA-C 111.239 -0.745 . . . . 0.2 111.239 -177.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.469 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 40.7 m -126.97 135.69 27.74 Favored Pre-proline 0 N--CA 1.435 -1.204 0 N-CA-C 108.583 -0.895 . . . . 0.29 108.583 172.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.704 ' HG3' ' HB2' ' A' ' 170' ' ' LEU . 5.9 Cg_endo -44.5 155.36 0.27 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.837 3.025 . . . . 0.18 112.591 175.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.887 ' HB2' HG22 ' A' ' 70' ' ' THR . 0.7 OUTLIER -141.68 149.83 41.09 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 106.59 -1.633 . . . . 0.31 106.59 -179.752 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.862 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 2.3 mp -119.89 118.63 31.26 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.603 -0.686 . . . . 1.19 110.188 177.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.871 HG23 ' HB2' ' A' ' 72' ' ' LEU . 2.2 mt -103.11 127.95 56.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-N 115.408 -0.815 . . . . 0.37 110.374 178.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.862 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.3 OUTLIER -114.81 128.53 56.35 Favored 'General case' 0 C--O 1.218 -0.597 0 CA-C-N 116.055 -0.52 . . . . 0.42 111.225 -172.089 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.718 ' HB3' HG21 ' A' ' 135' ' ' ILE . 0.3 OUTLIER -76.51 105.53 7.62 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 106.024 -1.843 . . . . 2.35 106.024 165.428 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.968 HG11 ' HB1' ' A' ' 73' ' ' ALA . 2.4 p -113.91 128.61 70.76 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 C-N-CA 119.27 -0.972 . . . . 1.03 113.372 -164.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.18 109.06 3.39 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 114.623 -1.172 . . . . 0.88 108.481 167.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.435 ' OG ' ' HE2' ' A' ' 107' ' ' LYS . 2.7 m -64.37 178.88 0.65 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.09 -0.959 . . . . 1.78 111.641 -175.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 95' ' ' CYS . 45.1 tttp -57.9 99.86 0.05 OUTLIER 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.233 0.54 . . . . 5.84 111.892 -169.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.488 ' HB3' ' HB3' ' A' ' 95' ' ' CYS . 18.1 p -142.18 -165.12 1.95 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.28 -0.873 . . . . 3.55 108.776 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -55.33 -19.08 15.98 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 121.099 -0.572 . . . . 2.91 113.654 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -130.34 149.43 52.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 117.739 0.77 . . . . 4.63 112.385 -177.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.736 HG21 ' HB2' ' A' ' 54' ' ' TYR . 10.3 m -130.71 -26.88 2.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.186 -0.916 . . . . 1.93 110.363 177.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.573 ' CB ' ' HB2' ' A' ' 156' ' ' PRO . 10.5 mmmm 62.44 37.35 13.59 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-N 114.949 -1.023 . . . . 2.01 112.483 173.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.77 -23.12 1.33 Allowed Glycine 0 C--N 1.334 0.433 0 C-N-CA 121.045 -0.598 . . . . 0.51 113.851 173.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.15 -21.81 59.88 Favored Glycine 0 C--O 1.219 -0.829 0 C-N-CA 121.147 -0.549 . . . . 0.5 113.475 -175.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.736 ' HB2' HG21 ' A' ' 50' ' ' THR . 0.1 OUTLIER -59.7 -56.89 16.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 117.815 0.807 . . . . 0.7 109.437 177.852 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -60.15 -32.59 71.17 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.869 -1.06 . . . . 2.61 110.145 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.559 ' HA ' ' CG2' ' A' ' 160' ' ' VAL . 92.4 m -71.44 -59.53 2.71 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 114.827 -1.079 . . . . 0.33 109.94 -175.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 1.127 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -63.07 -42.56 99.69 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.439 -1.255 . . . . 0.22 111.454 -175.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.557 ' HA ' ' CD1' ' A' ' 102' ' ' PHE . 6.4 m -58.53 -56.89 16.26 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.237 0.541 . . . . 0.26 111.059 -179.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.4 m -68.29 -33.31 74.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.634 -0.712 . . . . 0.48 111.213 -173.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.743 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 20.6 mt -67.74 -48.33 66.75 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-O 121.29 0.566 . . . . 0.43 110.077 -178.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.916 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 10.9 t80 -59.3 -46.52 88.34 Favored 'General case' 0 C--O 1.205 -1.267 0 CA-C-N 115.053 -0.976 . . . . 0.31 110.427 178.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -73.52 -26.96 61.11 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 116.625 -0.261 . . . . 1.21 111.551 -172.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.497 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 34.4 ttpt -85.96 -23.8 26.77 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 108.83 -0.804 . . . . 1.54 108.83 -177.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.682 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 30.1 m-85 -122.98 -6.66 8.42 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 115.21 1.559 . . . . 0.31 115.21 -169.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.659 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 26.6 pttt -66.82 -23.77 66.08 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 108.242 -1.022 . . . . 1.35 108.242 170.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.8 t -49.25 -36.18 19.71 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 114.292 -1.322 . . . . 1.28 110.504 171.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -92.31 -30.3 15.91 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.041 0.386 . . . . 1.11 112.041 176.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 143.0 -6.39 2.04 Favored Glycine 0 CA--C 1.52 0.372 0 N-CA-C 111.576 -0.61 . . . . 0.18 111.576 -176.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.743 ' HE2' ' HB3' ' A' ' 60' ' ' LEU . 23.1 t80 -67.58 143.57 56.01 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-N 115.329 -0.436 . . . . 0.18 111.209 -178.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.931 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 7.1 t -132.59 152.65 51.56 Favored 'General case' 0 N--CA 1.415 -2.181 0 N-CA-C 108.095 -1.076 . . . . 0.2 108.095 172.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 1.127 HG11 ' HB1' ' A' ' 57' ' ' ALA . 33.4 t -106.2 101.18 12.07 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.501 0 N-CA-C 107.482 -1.303 . . . . 0.17 107.482 157.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.871 ' HB2' HG23 ' A' ' 40' ' ' ILE . 65.9 mt -85.87 120.3 27.13 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.48 -1.304 . . . . 1.04 107.48 177.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.968 ' HB1' HG11 ' A' ' 43' ' ' VAL . . . -99.49 112.09 24.35 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.918 -0.713 . . . . 0.51 110.49 177.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.965 ' HD2' HD12 ' A' ' 108' ' ' ILE . 4.6 m-85 -99.04 95.37 3.21 Favored Pre-proline 0 N--CA 1.438 -1.041 0 N-CA-C 106.593 -1.632 . . . . 0.44 106.593 176.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.86 ' HB2' ' HG2' ' A' ' 107' ' ' LYS . 9.8 Cg_endo -71.22 142.69 42.16 Favored 'Trans proline' 0 N--CA 1.431 -2.155 0 C-N-CA 120.49 0.793 . . . . 1.3 110.281 -172.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.533 ' HB3' ' OD1' ' A' ' 42' ' ' ASN . 57.2 p -75.32 133.66 41.21 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 122.175 0.988 . . . . 1.44 112.678 -177.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.465 ' OD1' ' HD2' ' A' ' 79' ' ' PHE . 66.7 t30 -70.02 87.52 0.56 Allowed 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 113.597 -1.638 . . . . 1.81 109.192 174.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 1.018 ' HA ' ' HG2' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -56.64 -11.03 1.15 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.16 -0.927 . . . . 3.34 111.852 177.326 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.465 ' HD2' ' OD1' ' A' ' 77' ' ' ASN . 47.0 m-85 -75.78 31.57 0.11 Allowed 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 113.379 0.881 . . . . 2.68 113.379 -173.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.461 ' HA3' HE22 ' A' ' 82' ' ' GLN . . . -133.03 -133.38 3.38 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.622 -0.799 . . . . 1.98 112.388 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -154.5 36.47 0.69 Allowed Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 111.724 -0.55 . . . . 1.49 111.724 175.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.563 ' HG3' ' HB3' ' A' ' 113' ' ' GLU . 3.2 pm0 -145.3 4.96 1.07 Allowed 'General case' 0 C--O 1.221 -0.397 0 CA-C-N 115.953 -0.123 . . . . 1.74 111.032 -177.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 1.018 ' HG2' ' HA ' ' A' ' 78' ' ' GLN . 2.5 mp0 -60.89 139.7 93.73 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 120.854 0.359 . . . . 3.07 110.358 -169.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.717 ' HG2' HD21 ' A' ' 42' ' ' ASN . 60.1 Cg_endo -86.44 150.96 9.08 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.969 2.446 . . . . 1.75 112.282 -175.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 81.09 33.37 29.49 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 110.688 -0.965 . . . . 2.2 110.688 -175.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 74.87 96.93 0.07 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.309 -0.945 . . . . 4.2 110.442 -176.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.659 ' HA ' ' HB2' ' A' ' 83' ' ' GLU . 2.9 pm0 -55.6 -31.65 62.43 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.702 -1.135 . . . . 3.02 110.811 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.529 ' O ' ' HG2' ' A' ' 92' ' ' GLU . 37.8 tt0 -68.23 -42.57 79.56 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.121 -0.945 . . . . 3.92 111.663 -175.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -54.2 -59.37 4.75 Favored 'General case' 0 N--CA 1.464 0.237 0 O-C-N 123.258 0.348 . . . . 2.65 111.892 -173.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 5.6 pt -76.8 15.51 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.467 0.543 . . . . 2.15 112.467 -176.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.5 ttmt -120.56 -46.96 2.35 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.926 0.393 . . . . 2.79 110.524 177.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.529 ' HG2' ' O ' ' A' ' 88' ' ' GLU . 15.4 pt-20 -73.29 -20.36 60.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.99 -0.55 . . . . 3.29 109.562 176.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -115.24 127.03 55.22 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 108.725 -0.843 . . . . 3.42 108.725 173.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 96.9 t -65.64 112.25 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.141 0.495 . . . . 2.63 110.78 -178.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.666 ' SG ' ' HG2' ' A' ' 78' ' ' GLN . 26.7 p -106.42 121.63 44.64 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-O 121.826 0.822 . . . . 2.83 111.068 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.415 ' O ' ' HB3' ' A' ' 45' ' ' SER . 13.2 p -91.56 160.83 15.21 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.84 -1.073 . . . . 2.98 108.751 169.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.579 ' H ' ' HD2' ' A' ' 97' ' ' LYS . 0.1 OUTLIER -54.36 125.0 17.67 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.821 -1.177 . . . . 2.72 107.821 171.933 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.529 ' HZ ' ' CE2' ' A' ' 102' ' ' PHE . 2.9 p90 -77.97 38.14 0.26 Allowed 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.257 0.551 . . . . 2.12 110.439 -172.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -31.72 113.92 0.13 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.687 1.195 . . . . 2.69 112.502 -170.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.426 ' H ' HG12 ' A' ' 104' ' ' ILE . . . -122.34 -162.27 0.99 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.021 -0.991 . . . . 0.55 111.942 -168.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -83.33 17.55 2.07 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.077 -0.965 . . . . 1.99 110.687 -178.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.6 ' HB3' ' CD2' ' A' ' 61' ' ' TYR . 13.0 p90 -143.65 165.98 22.01 Favored Pre-proline 0 N--CA 1.445 -0.723 0 N-CA-C 109.497 -0.557 . . . . 0.84 109.497 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.662 ' HD3' ' CE2' ' A' ' 61' ' ' TYR . 31.2 Cg_exo -62.4 95.78 0.15 Allowed 'Trans proline' 0 CA--C 1.52 -0.202 0 C-N-CA 123.962 3.108 . . . . 0.62 113.19 -174.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.8 HD12 ' HB3' ' A' ' 73' ' ' ALA . 4.0 mm -90.48 116.14 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 107.513 -1.292 . . . . 1.34 107.513 175.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.81 ' HE2' ' HA ' ' A' ' 22' ' ' ASP . 1.2 mmt -92.93 -174.1 3.49 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.456 -0.793 . . . . 3.03 111.704 -166.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.518 ' N ' ' HA ' ' A' ' 23' ' ' ALA . . . -71.58 130.91 42.38 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.003 -0.998 . . . . 1.46 108.741 172.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.86 ' HG2' ' HB2' ' A' ' 75' ' ' PRO . 92.4 mttt -62.81 131.73 49.8 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-O 121.836 0.827 . . . . 1.76 109.265 176.015 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.965 HD12 ' HD2' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -122.36 165.39 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.419 0 N-CA-C 105.167 -2.16 . . . . 0.82 105.167 169.855 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.457 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 1.9 t30 -78.7 69.44 4.87 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 119.78 -0.768 . . . . 1.73 110.309 -178.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.482 HG13 HD11 ' A' ' 108' ' ' ILE . 0.1 OUTLIER -67.36 92.89 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-O 122.101 0.953 . . . . 0.77 108.853 178.51 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.599 ' ND2' ' H ' ' A' ' 112' ' ' GLY . 4.6 t30 175.8 -179.84 0.15 Allowed 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 113.286 -1.779 . . . . 1.9 106.555 177.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.599 ' H ' ' ND2' ' A' ' 111' ' ' ASN . . . -79.73 24.31 3.3 Favored Glycine 0 N--CA 1.435 -1.371 0 N-CA-C 116.232 1.253 . . . . 1.47 116.232 -172.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.588 ' HG3' ' N ' ' A' ' 114' ' ' ASN . 0.0 OUTLIER -106.66 -44.2 4.52 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 120.306 2.053 . . . . 2.81 111.693 176.342 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.588 ' N ' ' HG3' ' A' ' 113' ' ' GLU . 4.2 t-20 -132.4 -36.35 1.12 Allowed 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 109.836 -0.431 . . . . 2.16 109.836 -178.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.531 ' HB3' ' HG2' ' A' ' 120' ' ' GLU . . . 50.49 -150.86 0.22 Allowed 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.898 -1.046 . . . . 1.26 109.524 -177.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.611 ' CB ' HG13 ' A' ' 108' ' ' ILE . 5.5 t-80 -151.08 138.81 12.37 Favored Pre-proline 0 N--CA 1.426 -1.639 0 N-CA-C 107.058 -1.46 . . . . 0.42 107.058 174.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -30.93 -45.33 0.14 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 124.364 3.376 . . . . 0.4 113.211 -178.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.94 HD11 ' HB ' ' A' ' 15' ' ' ILE . 43.3 tp -65.05 -50.36 66.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.905 -0.589 . . . . 0.39 111.83 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.546 ' OH ' HG22 ' A' ' 40' ' ' ILE . 32.9 m-85 -76.34 -33.04 58.98 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 112.026 0.38 . . . . 3.04 112.026 178.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.61 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 43.9 mt-10 -57.94 -37.49 74.21 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 107.111 -1.44 . . . . 2.44 107.111 170.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.858 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 74.3 t80 -66.25 -35.65 80.97 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.368 -0.833 . . . . 0.56 110.646 173.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.65 ' HE2' HG21 ' A' ' 15' ' ' ILE . 53.1 mtt -73.61 -55.08 6.75 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.75 -0.659 . . . . 0.71 110.806 -168.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.63 ' HB3' ' HA ' ' A' ' 134' ' ' ALA . 0.2 OUTLIER -70.0 -24.26 63.28 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.108 -0.496 . . . . 1.46 111.144 177.785 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.61 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 9.5 pttp -72.57 -30.14 64.14 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 119.61 -0.836 . . . . 1.99 109.624 174.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 87.8 m -76.86 -48.0 19.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.775 -0.648 . . . . 0.59 110.514 176.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.767 ' HG2' HH22 ' A' ' 153' ' ' ARG . 22.8 ttmm -144.57 113.04 5.06 Favored Pre-proline 0 N--CA 1.452 -0.367 0 CA-C-N 116.283 -0.417 . . . . 1.85 110.848 -179.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 126' ' ' LYS . 11.9 Cg_exo -71.72 -54.29 0.15 Allowed 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 123.798 2.999 . . . . 1.69 112.25 -178.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.54 ' HA2' ' CZ ' ' A' ' 153' ' ' ARG . . . 178.56 168.47 37.89 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.139 -1.029 . . . . 2.59 112.524 178.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.413 ' H ' HG12 ' A' ' 129' ' ' ILE . 6.9 pt -72.28 -17.11 18.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.5 0.667 . . . . 3.58 109.987 173.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.688 HD23 ' H ' ' A' ' 130' ' ' LEU . 2.3 pt? -120.19 177.52 4.98 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.028 -0.987 . . . . 3.47 109.28 177.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -75.54 72.86 2.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.202 0.525 . . . . 3.28 111.328 -178.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.42 HG21 ' HG2' ' A' ' 136' ' ' LYS . 1.5 m -151.81 168.97 23.41 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.677 -0.86 . . . . 3.56 108.677 178.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -119.79 167.59 11.93 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.74 0.305 . . . . 5.17 110.729 175.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.63 ' HA ' ' HB3' ' A' ' 123' ' ' LYS . . . 67.74 -166.97 0.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.185 -0.916 . . . . 1.59 112.122 173.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.963 ' H ' HD13 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -71.29 -23.19 22.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 114.889 -1.05 . . . . 2.0 110.509 176.513 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.824 ' HB3' ' CE3' ' A' ' 137' ' ' TRP . 9.8 mtmp? 72.55 -60.58 0.53 Allowed 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 121.528 0.68 . . . . 4.81 112.601 -176.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.824 ' CE3' ' HB3' ' A' ' 136' ' ' LYS . 0.1 OUTLIER -109.42 -179.91 3.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.492 -1.231 . . . . 1.97 111.414 -163.765 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.691 ' HB2' ' HB3' ' A' ' 156' ' ' PRO . 1.8 m120 -38.2 -153.05 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 125.507 1.523 . . . . 2.04 111.955 158.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.705 ' CD1' HG23 ' A' ' 43' ' ' VAL . 1.6 m-85 -25.27 -46.56 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 114.815 1.413 . . . . 1.93 114.815 -167.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.757 ' HA ' ' O ' ' A' ' 154' ' ' PHE . 16.3 m 25.75 101.3 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.719 1.377 . . . . 0.6 114.719 172.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.541 ' CB ' HD23 ' A' ' 39' ' ' LEU . 0.7 OUTLIER -86.12 169.18 13.36 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.61 -1.177 . . . . 0.62 110.235 -175.058 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.584 ' HE1' HG23 ' A' ' 135' ' ' ILE . 42.7 m-85 -126.04 124.41 40.59 Favored 'General case' 0 CA--C 1.495 -1.15 0 N-CA-C 105.118 -2.179 . . . . 0.57 105.118 162.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.763 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 7.3 tp -79.99 105.56 11.36 Favored 'General case' 0 N--CA 1.422 -1.867 0 C-N-CA 118.143 -1.423 . . . . 0.43 108.682 178.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.692 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 39.7 mm -91.59 138.16 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.022 0 CA-C-N 112.542 -2.117 . . . . 0.19 107.118 -178.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.541 ' HA ' HD13 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -92.04 179.94 5.45 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 120.396 -0.522 . . . . 0.98 111.055 -170.273 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.606 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 40.1 mtm180 -47.36 -42.6 21.92 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 122.893 0.477 . . . . 2.22 111.626 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.466 ' O ' ' HB3' ' A' ' 14' ' ' SER . 8.1 m-20 -96.72 23.43 7.02 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 109.685 -0.487 . . . . 2.0 109.685 -176.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.623 ' HA2' HG22 ' A' ' 144' ' ' ILE . . . 65.26 37.88 94.48 Favored Glycine 0 N--CA 1.437 -1.275 0 CA-C-N 115.666 -0.697 . . . . 0.17 114.139 178.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.49 ' HA ' ' HD2' ' A' ' 150' ' ' PRO . 6.9 p -108.74 110.1 61.22 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 118.615 1.208 . . . . 1.12 111.73 173.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.691 ' HD3' HG23 ' A' ' 15' ' ' ILE . 10.2 Cg_endo -57.09 115.05 2.22 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 124.081 3.187 . . . . 0.41 111.168 175.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.787 HG23 ' HG2' ' A' ' 152' ' ' GLU . 17.6 m -116.27 -17.86 7.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-O 121.187 0.518 . . . . 1.45 109.982 -177.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.787 ' HG2' HG23 ' A' ' 151' ' ' VAL . 24.6 mm-40 -138.57 167.24 22.36 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-N 115.49 -0.777 . . . . 1.17 109.956 -179.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.767 HH22 ' HG2' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -148.43 141.6 25.03 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 114.904 -1.044 . . . . 2.16 108.937 163.267 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.757 ' O ' ' HA ' ' A' ' 140' ' ' THR . 79.7 m-85 -117.45 151.12 37.72 Favored 'General case' 0 C--O 1.217 -0.632 0 N-CA-C 109.483 -0.562 . . . . 0.32 109.483 -174.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.531 ' HB3' ' HD2' ' A' ' 156' ' ' PRO . 51.1 m -73.27 163.76 66.07 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 109.388 -0.597 . . . . 1.11 109.388 177.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.691 ' HB3' ' HB2' ' A' ' 138' ' ' ASN . 10.6 Cg_endo -53.15 -67.02 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.763 2.309 . . . . 0.78 112.729 -179.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' A' ' 51' ' ' LYS . . . -57.2 15.37 0.01 OUTLIER Glycine 0 CA--C 1.53 0.999 0 N-CA-C 116.368 1.307 . . . . 0.5 116.368 172.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -79.85 138.09 37.11 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 119.061 1.431 . . . . 0.5 107.392 167.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.499 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 8.6 t -104.85 173.47 6.29 Favored 'General case' 0 N--CA 1.429 -1.51 0 C-N-CA 119.988 -0.685 . . . . 1.42 110.072 -169.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.559 ' CG2' ' HA ' ' A' ' 56' ' ' THR . 69.3 t -43.57 -54.76 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 114.358 -1.292 . . . . 0.28 112.126 -177.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.84 -29.96 68.39 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.98 0.419 . . . . 3.46 110.78 -173.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -71.05 -31.41 67.84 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.642 0.734 . . . . 1.4 109.123 -176.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.52 HG21 HD22 ' A' ' 39' ' ' LEU . 33.1 mt -82.58 -45.33 19.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 114.492 -1.231 . . . . 0.21 110.741 176.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.574 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 41.8 mt-10 -51.2 -41.87 60.53 Favored 'General case' 0 C--O 1.218 -0.595 0 CA-C-N 116.308 -0.405 . . . . 0.67 111.362 -178.015 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -60.8 -20.69 62.05 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 112.056 0.391 . . . . 0.87 112.056 -174.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.693 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 31.3 mmtp -100.38 -24.44 14.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.477 0.656 . . . . 1.71 110.273 172.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.574 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 10.8 tp -80.73 -49.02 11.71 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.183 -0.917 . . . . 0.16 112.183 -175.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.463 HD11 ' HB3' ' A' ' 164' ' ' GLU . 73.1 mt -55.75 -43.7 99.31 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.478 -0.783 . . . . 0.26 112.568 -173.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.408 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 85.5 Cg_exo -49.98 -33.67 34.99 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 122.02 1.813 . . . . 0.41 112.659 172.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.704 ' HB2' ' HG3' ' A' ' 37' ' ' PRO . 91.3 mt -86.01 -42.67 13.78 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 121.122 -0.231 . . . . 0.71 111.348 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.644 HD21 ' HB2' ' A' ' 69' ' ' PHE . 93.8 mt -59.39 -53.2 60.95 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 122.264 1.031 . . . . 0.34 109.624 175.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -80.88 15.71 19.34 Favored Glycine 0 N--CA 1.435 -1.425 0 CA-C-N 113.321 -1.763 . . . . 1.12 113.958 -174.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.516 ' HB3' ' HD3' ' A' ' 146' ' ' ARG . 13.8 t -73.34 -5.9 42.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 117.249 0.525 . . . . 2.64 110.48 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -65.17 -27.42 68.69 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.216 0.531 . . . . 4.35 110.459 175.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 175' ' ' ARG . 0.3 OUTLIER -115.43 16.49 16.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.653 -0.703 . . . . 8.45 109.524 178.708 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 41.3 tp . . . . . 0 C--O 1.248 1.016 0 CA-C-N 115.259 -0.882 . . . . 7.69 109.46 -177.403 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.782 0 N-CA-C 111.747 -0.541 . . . . 5.22 111.747 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 53.3 ttp -77.95 88.1 4.13 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.021 0.439 . . . . 4.85 110.357 178.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.93 52.21 0.66 Allowed Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.58 -0.819 . . . . 1.55 112.486 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.5 m -89.33 -25.24 21.73 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.585 -0.524 . . . . 1.58 109.585 177.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.9 m -166.16 159.19 14.99 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 105.431 -2.062 . . . . 1.17 105.431 -177.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.891 ' HB ' HD11 ' A' ' 118' ' ' LEU . 8.0 pt -59.99 -20.18 19.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 CA-C-N 116.015 -0.538 . . . . 0.38 111.437 -176.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.736 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 40.3 m-85 -68.68 -2.75 9.87 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.059 0.457 . . . . 0.3 111.632 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.96 -12.99 61.37 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 108.469 -0.937 . . . . 2.11 108.469 172.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.74 ' HE2' ' HB2' ' A' ' 121' ' ' TYR . 58.5 m-85 -129.73 111.3 12.5 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 114.837 -1.074 . . . . 0.31 110.871 -173.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -51.38 150.27 3.64 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 113.792 -1.549 . . . . 2.86 110.099 172.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.809 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 34.4 t -111.04 157.06 12.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 115.457 -0.792 . . . . 0.67 108.906 -178.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.835 ' O ' ' HB3' ' A' ' 105' ' ' MET . 96.2 mt -122.31 116.09 23.47 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 116.546 -0.297 . . . . 0.69 110.502 -177.138 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.516 ' HA ' ' SD ' ' A' ' 105' ' ' MET . 6.2 t70 -58.29 170.87 0.64 Allowed 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 107.624 -1.25 . . . . 1.87 107.624 174.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.65 ' HA ' ' C ' ' A' ' 105' ' ' MET . . . -54.56 -26.34 31.55 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 118.761 0.709 . . . . 0.59 112.515 -168.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.42 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 8.8 t70 -78.22 -7.51 57.21 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.47 -0.332 . . . . 2.34 111.047 -178.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.605 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 57.1 m-70 80.09 19.53 0.6 Allowed 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 122.01 0.91 . . . . 1.47 108.628 -177.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.862 ' HE2' ' HA ' ' A' ' 26' ' ' LYS . 9.3 mmpt? -99.83 128.96 29.69 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 114.071 -1.422 . . . . 4.25 108.388 172.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.732 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 74.9 Cg_exo -47.12 115.73 1.44 Allowed 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 123.136 2.557 . . . . 0.54 114.989 -170.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.783 ' CE2' HD21 ' A' ' 72' ' ' LEU . 34.5 t80 -80.08 146.61 31.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.123 -1.399 . . . . 1.2 110.356 166.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.634 ' OD1' ' HB3' ' A' ' 32' ' ' GLN . 2.6 t-20 -76.56 90.76 3.34 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.662 -0.699 . . . . 1.51 110.133 179.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.711 ' HG ' ' CD1' ' A' ' 16' ' ' PHE . 56.3 tp -69.34 -46.51 66.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.162 0.506 . . . . 0.28 110.191 178.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.704 HG13 ' HB3' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -66.2 0.7 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 115.315 -0.857 . . . . 1.02 113.289 -171.598 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.634 ' HB3' ' OD1' ' A' ' 29' ' ' ASN . 3.8 pt20 -72.07 -16.22 62.02 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.109 -0.7 . . . . 1.02 109.109 172.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.981 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 91.2 m-70 -93.99 22.99 5.21 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 121.85 0.833 . . . . 0.28 109.356 178.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.736 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 29.7 mtmt -84.91 109.97 18.53 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 114.266 -1.334 . . . . 1.56 108.834 169.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 130.78 -38.05 2.0 Favored Glycine 0 N--CA 1.439 -1.113 0 C-N-CA 120.987 -0.625 . . . . 0.2 111.774 -178.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.458 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 22.7 m -133.99 137.04 27.46 Favored Pre-proline 0 N--CA 1.435 -1.192 0 N-CA-C 108.91 -0.774 . . . . 0.29 108.91 172.037 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.694 ' HG2' HD23 ' A' ' 171' ' ' LEU . 7.4 Cg_endo -45.81 156.54 0.43 Allowed 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 124.057 3.171 . . . . 0.18 112.94 178.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.838 ' HB2' HG22 ' A' ' 70' ' ' THR . 0.9 OUTLIER -141.07 145.65 36.11 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 106.745 -1.576 . . . . 0.31 106.745 178.823 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 1.055 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 1.5 mm? -107.2 111.88 24.49 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.199 -1.038 . . . . 1.19 108.199 177.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.765 HG13 HG13 ' A' ' 144' ' ' ILE . 4.9 mt -95.27 124.51 47.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 C-N-CA 119.622 -0.831 . . . . 0.37 109.954 177.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 1.055 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 1.3 m-85 -106.94 124.39 49.55 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.212 -0.904 . . . . 0.42 110.355 -174.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.622 ' ND2' HD12 ' A' ' 135' ' ' ILE . 0.8 OUTLIER -80.04 90.03 5.39 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 106.421 -1.696 . . . . 2.35 106.421 169.997 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.876 ' HA ' ' HA ' ' A' ' 139' ' ' PHE . 5.9 p -106.71 137.41 37.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 C-N-CA 120.175 -0.61 . . . . 1.03 110.865 -166.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.658 ' HA ' ' HB3' ' A' ' 76' ' ' SER . . . -84.21 118.61 24.26 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 115.896 -0.593 . . . . 0.88 109.653 173.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.419 ' HA ' ' HB2' ' A' ' 98' ' ' PHE . 1.3 p -47.8 148.95 1.4 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.517 -0.765 . . . . 1.78 109.608 169.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.856 ' HB2' ' HB3' ' A' ' 49' ' ' TYR . 0.0 OUTLIER -157.09 166.21 33.92 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 119.574 -0.85 . . . . 5.84 112.5 -166.177 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.888 ' HB2' ' HA ' ' A' ' 95' ' ' CYS . 53.3 t -126.15 114.03 17.82 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 114.516 -1.22 . . . . 3.55 107.708 164.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 54.48 42.38 75.43 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 121.212 -0.518 . . . . 2.91 113.156 -177.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.856 ' HB3' ' HB2' ' A' ' 46' ' ' LYS . 50.6 t80 -131.9 132.4 43.58 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.474 0.654 . . . . 4.63 111.589 -176.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.8 t -162.46 166.44 24.96 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.113 -1.069 . . . . 1.93 108.113 175.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.81 ' H ' ' HZ ' ' A' ' 139' ' ' PHE . 29.4 mtpp -129.35 13.12 6.06 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.635 -0.876 . . . . 2.01 108.635 177.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 119.28 -29.01 6.32 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.481 -0.781 . . . . 0.51 111.603 -175.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.562 ' HA2' ' HB ' ' A' ' 56' ' ' THR . . . -75.05 -17.16 80.28 Favored Glycine 0 C--O 1.221 -0.718 0 CA-C-O 119.628 -0.54 . . . . 0.5 114.404 -174.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -71.22 -58.54 3.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 118.44 1.12 . . . . 0.7 109.152 177.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -62.67 -24.21 67.52 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.241 -0.89 . . . . 2.61 110.223 178.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.664 HG23 ' HA ' ' A' ' 160' ' ' VAL . 16.2 m -74.57 -57.5 3.89 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.278 -0.874 . . . . 0.33 110.306 177.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 1.049 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -58.13 -40.54 81.53 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.76 -0.655 . . . . 0.22 110.986 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.524 ' HA ' ' CD1' ' A' ' 102' ' ' PHE . 86.9 m -57.01 -56.05 26.76 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-O 121.379 0.609 . . . . 0.26 110.532 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.6 m -69.78 -37.7 76.46 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.116 -0.947 . . . . 0.48 111.46 -176.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.713 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 15.2 mt -62.15 -50.06 73.36 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-O 121.523 0.677 . . . . 0.43 110.302 -177.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.913 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 10.8 t80 -57.7 -51.51 69.24 Favored 'General case' 0 C--O 1.2 -1.544 0 CA-C-N 114.46 -1.245 . . . . 0.31 111.052 -179.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.528 ' HA ' ' HD3' ' A' ' 65' ' ' LYS . 5.1 m-80 -73.63 -24.26 60.0 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 120.635 0.255 . . . . 1.21 111.182 -173.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -80.53 -26.52 38.0 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 108.548 -0.908 . . . . 1.54 108.548 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.72 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 45.0 m-85 -124.74 -1.53 7.92 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 115.522 1.675 . . . . 0.31 115.522 -169.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.638 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -64.86 -20.74 66.58 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 107.507 -1.294 . . . . 1.35 107.507 169.218 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -46.72 -44.5 18.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 113.794 -1.548 . . . . 1.28 111.014 171.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.463 ' OE1' ' HA ' ' A' ' 64' ' ' TYR . 23.4 mp0 -86.33 -33.11 20.69 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.454 -0.339 . . . . 1.11 111.731 178.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 143.69 -1.52 1.35 Allowed Glycine 0 N--CA 1.452 -0.293 0 N-CA-C 111.562 -0.615 . . . . 0.18 111.562 -174.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.72 ' HD2' ' HB2' ' A' ' 64' ' ' TYR . 22.0 t80 -68.73 142.77 54.88 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 122.989 0.515 . . . . 0.18 111.25 -178.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.981 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 1.9 t -133.92 147.01 51.04 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 107.633 -1.247 . . . . 0.2 107.633 170.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 1.049 HG11 ' HB1' ' A' ' 57' ' ' ALA . 39.1 t -99.02 99.12 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.441 0 N-CA-C 107.338 -1.356 . . . . 0.17 107.338 157.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.783 HD21 ' CE2' ' A' ' 28' ' ' TYR . 4.2 mt -84.88 118.51 24.55 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 107.895 -1.15 . . . . 1.04 107.895 177.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.88 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -116.58 112.62 21.57 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 119.879 -0.729 . . . . 0.51 110.937 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.809 ' CZ ' HG13 ' A' ' 20' ' ' VAL . 1.6 m-30 -91.75 110.26 42.31 Favored Pre-proline 0 C--N 1.318 -0.77 0 N-CA-C 107.741 -1.207 . . . . 0.44 107.741 173.141 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.893 ' HG2' ' HB3' ' A' ' 107' ' ' LYS . 60.9 Cg_endo -72.2 40.77 0.46 Allowed 'Trans proline' 0 N--CA 1.48 0.73 0 C-N-CA 123.961 3.107 . . . . 1.3 116.629 -165.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.658 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 4.8 t 46.61 149.54 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 115.845 1.794 . . . . 1.44 115.845 175.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.496 ' HB3' ' HA ' ' A' ' 109' ' ' ASN . 57.8 t30 -102.2 55.51 0.79 Allowed 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 114.324 -1.307 . . . . 1.81 107.749 177.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.871 ' HA ' ' HG3' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -52.59 -15.31 0.66 Allowed 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 113.365 -1.743 . . . . 3.34 110.367 175.216 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -66.24 -20.32 66.08 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.647 -1.161 . . . . 2.68 110.586 -178.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.19 -71.06 1.18 Allowed Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 111.093 -0.803 . . . . 1.98 111.093 174.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 131.63 40.04 0.23 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.771 -0.728 . . . . 1.49 112.722 177.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -149.17 25.22 0.9 Allowed 'General case' 0 CA--C 1.507 -0.687 0 CA-C-O 120.961 0.41 . . . . 1.74 110.882 178.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.871 ' HG3' ' HA ' ' A' ' 78' ' ' GLN . 9.2 mm-40 -90.4 152.09 45.11 Favored Pre-proline 0 C--N 1.31 -1.141 0 CA-C-N 115.446 -0.797 . . . . 3.07 111.278 -172.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -73.8 127.55 11.66 Favored 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 123.195 2.597 . . . . 1.75 112.754 -172.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.65 -64.24 4.15 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.725 -0.67 . . . . 2.2 112.307 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -134.83 126.9 29.77 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.375 -0.231 . . . . 4.2 110.375 -178.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.586 ' HG2' ' HG3' ' A' ' 88' ' ' GLU . 0.0 OUTLIER -123.41 -61.1 1.43 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.428 -0.351 . . . . 3.02 111.082 178.772 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.586 ' HG3' ' HG2' ' A' ' 87' ' ' GLU . 13.2 mt-10 -97.18 -12.78 22.64 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 122.019 -0.426 . . . . 3.92 111.788 -173.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -60.9 -37.33 81.87 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-O 121.212 0.53 . . . . 2.65 109.749 174.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.623 ' HB ' ' NE2' ' A' ' 78' ' ' GLN . 5.5 mm -73.83 -12.02 15.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.717 -0.674 . . . . 2.15 110.157 -178.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.49 ' HD3' ' HA ' ' A' ' 88' ' ' GLU . 38.6 mtpt -93.18 -47.23 7.04 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.36 -0.836 . . . . 2.79 110.472 179.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -80.18 -18.01 50.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 3.29 111.129 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -110.18 138.04 47.09 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.265 -0.643 . . . . 3.42 109.265 178.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 98.6 t -67.68 110.28 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.588 -0.523 . . . . 2.63 109.588 177.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.888 ' HA ' ' HB2' ' A' ' 47' ' ' CYS . 29.0 m -130.08 134.02 47.08 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.413 0.625 . . . . 2.83 110.758 -176.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.513 ' C ' ' H ' ' A' ' 98' ' ' PHE . 2.4 p -62.7 145.63 54.24 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.083 -0.962 . . . . 2.98 109.218 169.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -76.1 26.67 0.12 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.704 0.288 . . . . 2.72 110.958 -177.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.629 ' HZ ' ' CZ ' ' A' ' 102' ' ' PHE . 3.4 t80 65.98 113.56 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 124.328 1.017 . . . . 2.12 111.44 177.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -140.5 113.68 8.46 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.469 -0.787 . . . . 2.69 109.098 174.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.466 ' HB2' ' CE1' ' A' ' 98' ' ' PHE . . . -120.1 -166.48 1.31 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.585 -0.734 . . . . 0.55 110.94 -173.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -88.09 12.07 14.52 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.96 -0.563 . . . . 1.99 110.604 175.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.673 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 15.5 p90 -128.93 160.71 62.03 Favored Pre-proline 0 N--CA 1.438 -1.037 0 N-CA-C 108.209 -1.034 . . . . 0.84 108.209 175.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.762 ' HG2' ' HA ' ' A' ' 72' ' ' LEU . 57.6 Cg_endo -64.27 104.27 0.5 Allowed 'Trans proline' 0 N--CA 1.472 0.222 0 C-N-CA 123.432 2.755 . . . . 0.62 113.2 -171.156 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.88 HD12 ' HB3' ' A' ' 73' ' ' ALA . 5.4 mm -100.48 121.03 50.75 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.818 0 N-CA-C 108.053 -1.091 . . . . 1.34 108.053 175.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.835 ' HB3' ' O ' ' A' ' 21' ' ' LEU . 20.1 mmt -97.68 -159.26 0.72 Allowed 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.32 -0.854 . . . . 3.03 113.246 -163.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.706 ' O ' ' HG2' ' A' ' 107' ' ' LYS . . . -56.96 -27.53 61.37 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.29 -0.868 . . . . 1.46 112.623 -173.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.893 ' HB3' ' HG2' ' A' ' 75' ' ' PRO . 4.5 ptpp? 76.88 133.94 0.06 Allowed 'General case' 0 CA--C 1.481 -1.684 0 O-C-N 125.044 1.465 . . . . 1.76 108.802 -163.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.7 HG13 ' CB ' ' A' ' 116' ' ' HIS . 0.1 OUTLIER -134.65 162.59 38.53 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 CA-C-N 113.4 -1.727 . . . . 0.82 108.206 173.824 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.563 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 2.1 t30 -75.93 70.04 2.61 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.248 -0.887 . . . . 1.73 111.438 -171.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.554 HG13 HD11 ' A' ' 108' ' ' ILE . 2.4 m -70.91 91.56 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 CA-C-O 121.493 0.663 . . . . 0.77 111.272 -173.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 175.1 177.66 0.16 Allowed 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.608 -1.178 . . . . 1.9 108.51 168.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 43.85 -116.14 1.4 Allowed Glycine 0 N--CA 1.448 -0.501 0 O-C-N 124.412 1.07 . . . . 1.47 115.327 166.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.38 -13.78 15.27 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 114.378 1.251 . . . . 2.81 114.378 -166.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.402 ' O ' ' C ' ' A' ' 115' ' ' ALA . 2.5 t-20 -111.51 -37.62 5.17 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 119.003 -1.079 . . . . 2.16 112.884 -168.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.563 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . 22.51 -106.89 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 O-C-N 124.266 0.979 . . . . 1.26 111.786 -175.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.7 ' CB ' HG13 ' A' ' 108' ' ' ILE . 3.2 t-80 -170.53 140.56 1.49 Allowed Pre-proline 0 N--CA 1.431 -1.4 0 N-CA-C 105.846 -1.909 . . . . 0.42 105.846 169.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -30.89 -49.44 0.22 Allowed 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 123.899 3.066 . . . . 0.4 113.141 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.891 HD11 ' HB ' ' A' ' 15' ' ' ILE . 40.0 tp -58.7 -52.16 66.89 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.459 0.704 . . . . 0.39 112.389 176.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.777 ' HE2' ' CD2' ' A' ' 74' ' ' PHE . 65.5 m-85 -75.6 -36.54 60.28 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-N 116.472 -0.331 . . . . 3.04 111.652 -178.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.425 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 42.8 mt-10 -56.5 -36.79 69.57 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 107.137 -1.431 . . . . 2.44 107.137 171.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.74 ' HB2' ' HE2' ' A' ' 18' ' ' PHE . 49.5 t80 -68.36 -31.11 70.27 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 119.825 -0.75 . . . . 0.56 111.167 175.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.658 ' HE3' ' HG ' ' A' ' 118' ' ' LEU . 0.5 OUTLIER -74.4 -56.41 4.89 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.27 0.557 . . . . 0.71 109.958 -171.748 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.643 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -72.28 -24.3 61.32 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.221 -0.9 . . . . 1.46 112.258 178.912 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.663 ' HG2' ' HA ' ' A' ' 121' ' ' TYR . 16.0 ptmt -68.05 -34.37 76.32 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 118.945 -1.102 . . . . 1.99 109.318 175.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 44.3 m -77.11 -43.88 32.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.206 -0.906 . . . . 0.59 110.126 178.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.408 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 27.5 mtpp -134.79 103.74 10.92 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 1.85 110.849 175.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 126' ' ' LYS . 7.1 Cg_exo -74.38 -52.83 0.12 Allowed 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.579 2.853 . . . . 1.69 111.969 -176.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.718 ' HA3' ' HB ' ' A' ' 132' ' ' THR . . . -161.29 160.41 32.12 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.102 -1.046 . . . . 2.59 112.878 177.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 27.7 pt -101.81 -13.79 8.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.658 -0.867 . . . . 3.58 108.658 170.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.43 HD23 ' H ' ' A' ' 130' ' ' LEU . 1.6 pt? -128.7 -148.81 0.39 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.561 -1.2 . . . . 3.47 108.258 174.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.61 82.66 0.6 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.205 0.526 . . . . 3.28 109.658 171.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.718 ' HB ' ' HA3' ' A' ' 128' ' ' GLY . 11.4 m -150.26 146.81 27.02 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.258 -0.428 . . . . 3.56 110.411 -175.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -125.21 3.03 7.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.107 -0.497 . . . . 5.17 111.076 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.619 ' H ' HG22 ' A' ' 132' ' ' THR . . . -153.55 -90.26 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.364 -0.38 . . . . 1.59 110.753 -177.145 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.815 ' O ' ' HG2' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -125.24 -32.2 1.05 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.919 0 CA-C-N 116.013 -0.539 . . . . 2.0 110.047 176.436 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.815 ' HG2' ' O ' ' A' ' 135' ' ' ILE . 21.9 ptmt 93.16 -68.0 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 126.652 1.981 . . . . 4.81 110.78 -170.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.765 ' HE3' ' C ' ' A' ' 136' ' ' LYS . 0.2 OUTLIER -114.91 -178.21 3.31 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 123.594 0.758 . . . . 1.97 110.143 -162.988 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.495 HD22 ' HB3' ' A' ' 44' ' ' ALA . 7.1 m120 -36.23 -154.91 0.0 OUTLIER 'General case' 0 C--O 1.206 -1.188 0 O-C-N 125.052 1.47 . . . . 2.04 112.672 163.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.876 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 0.5 OUTLIER -31.63 -21.29 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 117.362 2.356 . . . . 1.93 117.362 -170.277 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.723 HG21 ' O ' ' A' ' 135' ' ' ILE . 5.9 m 5.62 114.73 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 120.56 1.527 . . . . 0.6 113.906 165.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.563 ' HB3' ' CE1' ' A' ' 41' ' ' TYR . 0.8 OUTLIER -94.14 159.88 14.95 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 114.114 -1.403 . . . . 0.62 110.764 -164.527 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.482 ' O ' HD13 ' A' ' 39' ' ' LEU . 48.2 m-85 -122.5 125.53 45.96 Favored 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 106.306 -1.739 . . . . 0.57 106.306 167.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.754 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 9.8 tp -80.67 105.95 12.3 Favored 'General case' 0 N--CA 1.424 -1.752 0 C-N-CA 117.927 -1.509 . . . . 0.43 108.592 177.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.765 HG13 HG13 ' A' ' 40' ' ' ILE . 40.7 mm -92.29 141.29 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.926 0 CA-C-N 112.981 -1.918 . . . . 0.19 107.228 -178.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.638 ' HA ' HD13 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -91.98 179.09 5.69 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 120.716 -0.394 . . . . 0.98 111.641 -170.188 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.521 ' CG ' ' HD3' ' A' ' 37' ' ' PRO . 17.4 mtm180 -50.43 -41.71 52.9 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 122.845 0.458 . . . . 2.22 111.392 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.443 ' C ' ' HE2' ' A' ' 16' ' ' PHE . 4.8 m-20 -93.96 12.8 24.86 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 109.476 -0.565 . . . . 2.0 109.476 -176.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.642 ' HA3' ' CE2' ' A' ' 16' ' ' PHE . . . 76.36 32.12 52.6 Favored Glycine 0 N--CA 1.433 -1.52 0 CA-C-N 115.354 -0.839 . . . . 0.17 113.911 178.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.472 ' HA ' ' HD2' ' A' ' 150' ' ' PRO . 7.1 p -108.53 109.62 61.45 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 118.806 1.303 . . . . 1.12 111.923 174.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.665 ' HD3' HG23 ' A' ' 15' ' ' ILE . 1.9 Cg_endo -50.48 124.3 12.98 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 124.294 3.33 . . . . 0.41 112.106 174.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.762 HG23 ' HG2' ' A' ' 152' ' ' GLU . 15.9 m -125.0 -15.11 4.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.929 0.395 . . . . 1.45 110.385 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.762 ' HG2' HG23 ' A' ' 151' ' ' VAL . 13.7 mm-40 -140.99 166.9 23.53 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 116.107 -0.497 . . . . 1.17 110.598 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.637 ' HD3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -148.07 143.92 27.52 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.254 -0.884 . . . . 2.16 109.697 162.315 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.625 ' HZ ' ' HB2' ' A' ' 166' ' ' LYS . 91.0 m-85 -120.35 138.02 53.96 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.691 -0.686 . . . . 0.32 110.436 -171.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.495 ' OG ' ' HD2' ' A' ' 156' ' ' PRO . 8.2 t -65.49 151.74 93.76 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 107.853 -1.166 . . . . 1.11 107.853 177.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.755 ' HG3' ' HB3' ' A' ' 137' ' ' TRP . 25.2 Cg_endo -59.32 -25.19 77.47 Favored 'Trans proline' 0 N--CA 1.474 0.376 0 C-N-CA 123.056 2.504 . . . . 0.78 113.221 -176.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.659 ' HA2' ' O ' ' A' ' 51' ' ' LYS . . . -75.94 -2.96 73.06 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.961 -0.563 . . . . 0.5 113.853 174.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -70.44 146.78 50.1 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 117.659 0.729 . . . . 0.5 109.502 175.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.54 ' HA ' ' OG1' ' A' ' 56' ' ' THR . 17.1 m -104.66 170.09 8.08 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.566 -0.531 . . . . 1.42 109.566 -178.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.664 ' HA ' HG23 ' A' ' 56' ' ' THR . 87.1 t -40.52 -55.51 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 O-C-N 124.286 0.991 . . . . 0.28 111.409 177.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 161' ' ' LYS . 0.1 OUTLIER -70.42 -28.52 65.12 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.225 -0.443 . . . . 3.46 111.366 -173.033 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.416 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 4.4 m-20 -65.72 -35.54 81.02 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.583 0.706 . . . . 1.4 109.265 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.59 ' HA ' ' CE2' ' A' ' 154' ' ' PHE . 72.1 mt -83.27 -43.0 18.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 114.432 -1.258 . . . . 0.21 110.952 178.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.603 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 46.0 mt-10 -51.98 -43.38 63.57 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-O 120.842 0.353 . . . . 0.67 111.19 -179.111 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 13.1 pt-20 -60.64 -17.04 44.85 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 112.149 0.425 . . . . 0.87 112.149 -174.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.625 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 13.7 mmmm -106.0 -25.28 12.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.259 0.552 . . . . 1.71 109.941 172.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.603 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 12.0 tp -76.81 -49.35 16.02 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.138 -0.937 . . . . 0.16 111.979 -177.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.456 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 67.1 mt -55.28 -44.12 99.46 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.718 -0.674 . . . . 0.26 111.91 -175.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.456 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 86.0 Cg_exo -50.26 -24.01 10.87 Favored 'Trans proline' 0 C--N 1.353 0.816 0 C-N-CA 122.499 2.132 . . . . 0.41 113.592 172.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.674 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 86.2 mt -97.78 -40.3 8.61 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 120.636 -0.426 . . . . 0.71 111.118 177.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.694 HD23 ' HG2' ' A' ' 37' ' ' PRO . 95.6 mt -59.92 -59.29 5.66 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 122.141 0.972 . . . . 0.34 109.102 175.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -72.22 -27.37 70.16 Favored Glycine 0 N--CA 1.433 -1.526 0 CA-C-N 113.358 -1.746 . . . . 1.12 111.713 -178.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 73.7 m 71.03 119.64 0.04 OUTLIER 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.835 0.826 . . . . 2.64 112.121 178.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -72.34 -1.81 16.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.917 -1.038 . . . . 4.35 111.226 178.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -42.08 -36.02 1.05 Allowed 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.02 0.928 . . . . 8.45 113.188 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 99.1 mt . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.576 -0.726 . . . . 7.69 110.455 -179.522 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.933 0 N-CA-C 112.325 -0.31 . . . . 5.22 112.325 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -141.14 34.48 1.72 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.498 0.666 . . . . 4.85 109.872 178.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.472 ' C ' ' H ' ' A' ' 14' ' ' SER . . . 121.76 -127.45 6.87 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 115.396 -0.82 . . . . 1.55 111.721 -175.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.4 m 69.99 -14.12 0.39 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.348 0.659 . . . . 1.58 111.822 179.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.472 ' H ' ' C ' ' A' ' 12' ' ' GLY . 86.8 p 177.9 154.59 0.33 Allowed 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 106.173 -1.788 . . . . 1.17 106.173 179.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.835 ' HB ' HD11 ' A' ' 118' ' ' LEU . 5.1 pt -70.25 -17.59 20.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-N 115.068 -0.969 . . . . 0.38 112.236 -172.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.764 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 51.9 m-85 -69.91 -3.33 15.48 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.186 0.517 . . . . 0.3 111.463 -178.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -71.97 -17.99 62.02 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.249 -1.019 . . . . 2.11 108.249 176.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.726 ' CE2' ' HB2' ' A' ' 121' ' ' TYR . 72.5 m-85 -117.84 112.54 20.51 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 114.818 -1.083 . . . . 0.31 110.881 -175.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -47.9 142.06 5.24 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 113.494 -1.685 . . . . 2.86 110.452 172.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.827 HG13 ' HZ ' ' A' ' 74' ' ' PHE . 54.9 t -111.13 164.6 6.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 107.466 -1.309 . . . . 0.67 107.466 176.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.627 HD23 ' HA ' ' A' ' 27' ' ' PRO . 10.3 mt -133.16 125.68 30.0 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.224 -0.658 . . . . 0.69 109.224 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.533 ' HA ' ' SD ' ' A' ' 105' ' ' MET . 17.2 m-20 -56.21 178.6 0.05 OUTLIER 'General case' 0 CA--C 1.514 -0.408 0 O-C-N 123.768 0.667 . . . . 1.87 110.086 177.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.606 ' HA ' ' N ' ' A' ' 106' ' ' ALA . . . -61.41 -1.79 0.6 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.826 0.676 . . . . 0.59 112.826 -175.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -112.95 4.95 17.06 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.135 0.421 . . . . 2.34 112.135 175.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.766 ' CD2' ' HB3' ' A' ' 106' ' ' ALA . 8.0 m170 72.59 19.63 4.05 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.752 0.787 . . . . 1.47 110.241 177.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.485 ' HE3' ' HB2' ' A' ' 26' ' ' LYS . 2.9 mtmt -84.05 135.54 42.08 Favored Pre-proline 0 CA--C 1.509 -0.614 0 N-CA-C 106.591 -1.633 . . . . 4.25 106.591 164.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.627 ' HA ' HD23 ' A' ' 21' ' ' LEU . 80.4 Cg_exo -53.27 113.26 1.2 Allowed 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 121.187 1.258 . . . . 0.54 112.868 -178.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.622 ' HB3' HG12 ' A' ' 20' ' ' VAL . 45.8 t80 -78.86 144.01 35.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 113.701 -1.59 . . . . 1.2 110.969 173.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.689 HD21 HG22 ' A' ' 31' ' ' VAL . 2.5 t-20 -79.31 81.38 5.58 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 115.147 -0.933 . . . . 1.51 109.573 178.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.661 ' HG ' ' CD1' ' A' ' 16' ' ' PHE . 54.7 tp -60.79 -39.64 89.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.228 0.537 . . . . 0.28 109.558 177.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.713 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 1.1 m -72.11 -0.04 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.022 -0.99 . . . . 1.02 112.47 -168.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.59 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 3.8 pt20 -73.44 -13.92 61.16 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.359 -0.608 . . . . 1.02 109.359 173.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.845 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 91.6 m-70 -94.35 21.98 6.51 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-O 121.812 0.815 . . . . 0.28 109.561 176.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.764 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 45.5 mtmt -85.74 109.7 18.81 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 114.553 -1.203 . . . . 1.56 108.76 169.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 134.68 -41.02 1.5 Allowed Glycine 0 N--CA 1.435 -1.373 0 N-CA-C 111.308 -0.717 . . . . 0.2 111.308 -177.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 41.2 m -131.71 136.28 28.18 Favored Pre-proline 0 N--CA 1.438 -1.066 0 N-CA-C 108.616 -0.883 . . . . 0.29 108.616 171.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.736 ' HG2' HD23 ' A' ' 171' ' ' LEU . 3.5 Cg_endo -43.17 156.94 0.11 Allowed 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.936 3.091 . . . . 0.18 112.875 175.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.843 ' HB2' HG22 ' A' ' 70' ' ' THR . 1.0 OUTLIER -144.62 140.51 28.76 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 107.525 -1.287 . . . . 0.31 107.525 -179.736 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.941 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 1.7 mm? -106.04 112.17 25.11 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.403 -0.962 . . . . 1.19 108.403 176.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.816 HG23 ' HB2' ' A' ' 72' ' ' LEU . 5.1 mt -98.63 130.06 48.04 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 CA-C-N 115.95 -0.568 . . . . 0.37 109.95 177.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.941 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.4 OUTLIER -117.56 140.5 49.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.636 -0.711 . . . . 0.42 110.492 -172.604 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.615 ' OD1' ' HB ' ' A' ' 140' ' ' THR . 22.8 p-10 -92.54 105.1 17.33 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 108.116 -1.068 . . . . 2.35 108.116 168.323 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.723 ' O ' ' HA ' ' A' ' 75' ' ' PRO . 3.3 m -106.29 132.25 53.93 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 O-C-N 121.228 -0.92 . . . . 1.03 110.529 -170.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -81.46 96.19 7.31 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 119.285 -0.966 . . . . 0.88 110.215 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.2 p -21.26 -82.92 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 O-C-N 125.635 1.835 . . . . 1.78 113.016 175.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.755 ' HG2' ' H ' ' A' ' 47' ' ' CYS . 20.7 ttmm 51.51 -144.6 0.57 Allowed 'General case' 0 CA--C 1.537 0.448 0 O-C-N 123.87 0.732 . . . . 5.84 110.503 174.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.755 ' H ' ' HG2' ' A' ' 46' ' ' LYS . 12.7 t -159.1 116.48 2.76 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 109.679 -0.489 . . . . 3.55 109.679 176.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 65.13 66.0 2.66 Favored Glycine 0 CA--C 1.519 0.32 0 CA-C-N 115.869 -0.605 . . . . 2.91 113.319 178.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -152.15 123.89 7.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 117.197 0.499 . . . . 4.63 111.594 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.8 t -139.5 154.46 47.7 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.21 -0.45 . . . . 1.93 110.374 172.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.657 ' HB2' ' HB2' ' A' ' 156' ' ' PRO . 22.4 mmmt -114.73 14.42 17.49 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.905 -0.406 . . . . 2.01 109.905 174.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 107.98 -26.58 16.88 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 110.913 -0.875 . . . . 0.51 110.913 -174.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.445 ' HA2' ' HB ' ' A' ' 56' ' ' THR . . . -70.17 -17.98 74.45 Favored Glycine 0 C--O 1.217 -0.919 0 C-N-CA 121.264 -0.493 . . . . 0.5 113.208 -178.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.411 ' HA ' ' CE2' ' A' ' 139' ' ' PHE . 1.1 t80 -74.14 -56.67 4.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 117.786 0.793 . . . . 0.7 109.896 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -62.93 -21.79 66.3 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.269 0.557 . . . . 2.61 110.115 176.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.706 ' HA ' HG22 ' A' ' 160' ' ' VAL . 16.0 m -76.34 -53.91 7.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.421 -0.809 . . . . 0.33 109.669 177.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 1.089 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -55.03 -43.06 73.37 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 114.905 -1.043 . . . . 0.22 110.758 177.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.497 ' HA ' ' CD1' ' A' ' 102' ' ' PHE . 39.4 m -60.84 -56.98 14.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.472 -0.785 . . . . 0.26 110.515 -178.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 98.6 m -66.29 -38.99 89.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.995 -1.002 . . . . 0.48 112.238 -175.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.785 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 18.7 mt -64.39 -48.5 75.21 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-O 121.425 0.631 . . . . 0.43 110.275 -176.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.877 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 13.5 t80 -56.84 -47.89 79.29 Favored 'General case' 0 C--O 1.207 -1.182 0 CA-C-N 114.545 -1.207 . . . . 0.31 110.897 178.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.587 ' HA ' ' HE3' ' A' ' 65' ' ' LYS . 1.1 m-80 -73.84 -25.5 60.11 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 116.602 -0.272 . . . . 1.21 111.132 -171.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.408 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 33.8 ttpt -86.21 -23.15 26.56 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 109.015 -0.735 . . . . 1.54 109.015 -178.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.743 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 29.1 m-85 -125.47 -4.53 7.21 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 115.808 1.781 . . . . 0.31 115.808 -169.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.65 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 22.2 pttp -67.04 -25.28 66.19 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 108.009 -1.108 . . . . 1.35 108.009 169.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.5 m -48.85 -30.25 5.58 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 114.203 -1.362 . . . . 1.28 111.27 172.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -96.26 -36.64 10.84 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.592 0.234 . . . . 1.11 111.547 174.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 149.83 -5.49 0.7 Allowed Glycine 0 C--O 1.237 0.319 0 N-CA-C 111.17 -0.772 . . . . 0.18 111.17 -176.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.785 ' HE2' ' HB3' ' A' ' 60' ' ' LEU . 21.6 t80 -69.59 141.53 53.73 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 115.368 -0.416 . . . . 0.18 111.089 -177.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.877 ' HA ' ' CD1' ' A' ' 61' ' ' TYR . 5.5 t -133.46 146.37 51.09 Favored 'General case' 0 N--CA 1.421 -1.898 0 N-CA-C 108.826 -0.805 . . . . 0.2 108.826 173.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 1.089 HG11 ' HB1' ' A' ' 57' ' ' ALA . 25.1 t -100.7 103.3 14.63 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.376 0 N-CA-C 107.485 -1.302 . . . . 0.17 107.485 157.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.816 ' HB2' HG23 ' A' ' 40' ' ' ILE . 35.8 mt -83.94 120.7 26.41 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.626 -1.25 . . . . 1.04 107.626 178.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.725 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -95.08 115.76 27.84 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.229 0.538 . . . . 0.51 109.601 178.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.827 ' HZ ' HG13 ' A' ' 20' ' ' VAL . 11.5 m-85 -113.96 97.28 44.45 Favored Pre-proline 0 C--N 1.308 -1.218 0 N-CA-C 108.517 -0.92 . . . . 0.44 108.517 -178.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.723 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 2.0 Cg_endo -67.66 142.36 58.17 Favored 'Trans proline' 0 N--CA 1.438 -1.773 0 C-N-CA 121.175 1.25 . . . . 1.3 110.748 -175.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.486 ' OG ' ' HB3' ' A' ' 83' ' ' GLU . 8.1 t -87.17 146.56 25.97 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 121.807 0.813 . . . . 1.44 110.009 173.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.829 ' HB2' ' HD2' ' A' ' 79' ' ' PHE . 30.6 p-10 -105.34 125.54 51.1 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 113.991 -1.459 . . . . 1.81 108.851 -178.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.713 ' HB2' ' HB3' ' A' ' 91' ' ' LYS . 2.6 pp0? -55.68 -8.25 0.37 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.88 -1.055 . . . . 3.34 111.692 176.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.829 ' HD2' ' HB2' ' A' ' 77' ' ' ASN . 63.2 m-85 -66.36 -20.71 66.15 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.71 -0.677 . . . . 2.68 112.667 -167.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.82 -24.62 34.8 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.338 -0.934 . . . . 1.98 112.676 -177.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 70.18 54.6 10.78 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 110.289 -1.124 . . . . 1.49 110.289 -173.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.69 HE21 ' HB3' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -159.57 -14.18 0.06 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.577 0.584 . . . . 1.74 112.577 -170.959 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.593 ' CD ' ' HA ' ' A' ' 78' ' ' GLN . 0.0 OUTLIER -62.09 137.1 95.58 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-O 121.841 0.829 . . . . 3.07 111.42 -160.198 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.415 ' HB2' ' C ' ' A' ' 137' ' ' TRP . 12.4 Cg_endo -59.07 116.86 3.56 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 124.613 3.542 . . . . 1.75 114.744 -164.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 98.78 -99.86 2.21 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.242 -0.89 . . . . 2.2 112.894 171.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.415 ' HB2' ' NZ ' ' A' ' 46' ' ' LYS . 10.1 m120 -91.53 83.22 5.36 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.782 -0.451 . . . . 4.2 109.782 -176.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -66.49 -85.35 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 114.704 -1.134 . . . . 3.02 112.813 -170.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.602 ' O ' ' HG2' ' A' ' 92' ' ' GLU . 20.9 mt-10 -59.46 -21.96 60.82 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.409 0.522 . . . . 3.92 112.409 -168.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.575 ' O ' ' HB3' ' A' ' 93' ' ' PHE . 64.5 tt0 -58.42 -12.88 4.31 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.108 -0.496 . . . . 2.65 111.845 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.546 ' HB ' ' HB3' ' A' ' 78' ' ' GLN . 46.9 mt -96.79 -32.96 4.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 O-C-N 121.745 -0.597 . . . . 2.15 111.745 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.713 ' HB3' ' HB2' ' A' ' 78' ' ' GLN . 21.5 pttp -91.19 -20.99 21.37 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.586 0.587 . . . . 2.79 112.586 -172.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.602 ' HG2' ' O ' ' A' ' 88' ' ' GLU . 0.3 OUTLIER -114.18 13.94 18.09 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.204 0.526 . . . . 3.29 111.04 175.368 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.575 ' HB3' ' O ' ' A' ' 89' ' ' GLU . 44.2 t80 -128.06 153.47 46.75 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.092 -0.707 . . . . 3.42 109.092 171.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.8 t -65.08 112.02 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.596 -0.275 . . . . 2.63 110.648 -179.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 2.8 p -117.27 124.59 49.4 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.71 0.766 . . . . 2.83 112.246 -177.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 19.8 p -92.42 155.88 17.57 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 107.372 -1.344 . . . . 2.98 107.372 165.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.8 pttm -76.14 57.99 1.18 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.26 0.553 . . . . 2.72 111.479 -179.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.639 ' HD2' HG12 ' A' ' 104' ' ' ILE . 38.9 t80 69.43 -86.23 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.722 -1.126 . . . . 2.12 112.331 173.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt 74.94 136.07 0.06 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.829 0.852 . . . . 2.69 111.412 -179.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.479 ' HB2' ' CZ ' ' A' ' 98' ' ' PHE . . . -168.81 -165.85 0.6 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.576 -0.738 . . . . 0.55 110.891 -173.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -104.02 28.51 6.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.931 -0.577 . . . . 1.99 111.507 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.721 ' HE2' ' HB2' ' A' ' 73' ' ' ALA . 1.1 p90 -135.47 176.89 2.52 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 108.756 -0.831 . . . . 0.84 108.756 173.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.598 ' HD3' ' CE2' ' A' ' 61' ' ' TYR . 18.9 Cg_exo -71.28 97.1 0.75 Allowed 'Trans proline' 0 CA--C 1.518 -0.276 0 C-N-CA 123.067 2.511 . . . . 0.62 112.884 -179.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.725 HG13 ' HB3' ' A' ' 73' ' ' ALA . 4.2 mp -92.61 138.6 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 N-CA-C 108.475 -0.935 . . . . 1.34 108.475 174.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.627 ' HB3' ' O ' ' A' ' 21' ' ' LEU . 13.5 mmt -101.19 179.84 4.25 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.755 -0.657 . . . . 3.03 109.997 -177.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.777 ' O ' ' HG2' ' A' ' 107' ' ' LYS . . . -83.83 34.11 0.49 Allowed 'General case' 0 CA--C 1.5 -0.944 0 C-N-CA 120.65 -0.42 . . . . 1.46 111.89 -168.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.777 ' HG2' ' O ' ' A' ' 106' ' ' ALA . 8.9 ptpt 56.02 144.78 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 123.953 1.835 . . . . 1.76 111.979 -174.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.538 HD12 ' HB3' ' A' ' 116' ' ' HIS . 35.7 pt -139.75 170.69 14.99 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 CA-C-N 112.324 -2.216 . . . . 0.82 107.478 175.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.569 ' HA ' ' OD1' ' A' ' 77' ' ' ASN . 1.6 t30 -80.68 50.8 1.38 Allowed 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.684 -0.689 . . . . 1.73 110.747 -176.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.474 HG23 ' CB ' ' A' ' 76' ' ' SER . 0.0 OUTLIER -64.36 94.33 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 CA-C-O 122.021 0.915 . . . . 0.77 110.884 -175.434 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.69 ' HB3' HE21 ' A' ' 82' ' ' GLN . 12.7 t-20 175.55 -179.74 0.14 Allowed 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 105.787 -1.931 . . . . 1.9 105.787 176.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -85.08 41.35 3.05 Favored Glycine 0 N--CA 1.439 -1.148 0 C-N-CA 119.982 -1.104 . . . . 1.47 114.474 -177.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.52 ' HB3' ' HG2' ' A' ' 82' ' ' GLN . 2.3 tp10 -105.88 -51.03 3.06 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 119.248 -0.981 . . . . 2.81 109.846 165.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -133.18 -31.88 1.23 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.829 -0.623 . . . . 2.16 110.796 176.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . 52.85 -102.64 0.14 Allowed 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.078 -0.964 . . . . 1.26 109.969 -169.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.65 ' CE1' ' H ' ' A' ' 118' ' ' LEU . 3.5 t-80 173.35 138.71 0.13 Allowed Pre-proline 0 N--CA 1.429 -1.52 0 N-CA-C 105.18 -2.156 . . . . 0.42 105.18 174.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -28.67 -47.97 0.12 Allowed 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 124.125 3.217 . . . . 0.4 113.568 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.835 HD11 ' HB ' ' A' ' 15' ' ' ILE . 28.1 tp -62.46 -51.67 66.58 Favored 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 123.365 0.666 . . . . 0.39 111.875 177.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.804 ' OH ' HG22 ' A' ' 40' ' ' ILE . 32.6 m-85 -75.69 -32.65 60.21 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-N 116.458 -0.337 . . . . 3.04 111.856 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -57.84 -40.15 79.39 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 107.169 -1.419 . . . . 2.44 107.169 170.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.726 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 31.6 t80 -66.65 -31.67 72.5 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.194 -0.912 . . . . 0.56 110.549 175.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.7 ' HE2' HG21 ' A' ' 15' ' ' ILE . 45.9 mtt -74.99 -52.86 10.05 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.488 -0.778 . . . . 0.71 110.958 -171.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.425 ' HE2' ' HB2' ' A' ' 123' ' ' LYS . 0.5 OUTLIER -71.61 -25.97 62.39 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 121.057 -0.257 . . . . 1.46 111.403 176.563 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.522 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 19.4 ptmt -72.17 -31.18 65.7 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 119.665 -0.814 . . . . 1.99 109.725 179.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 39.0 m -90.78 -38.31 13.08 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.394 -0.821 . . . . 0.59 111.004 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.466 ' HE3' ' HA ' ' A' ' 126' ' ' LYS . 1.6 tpmt? -126.26 88.94 53.35 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.686 -0.688 . . . . 1.85 110.576 -174.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -74.23 -0.0 9.05 Favored 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 122.895 2.396 . . . . 1.69 112.119 176.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 97.92 158.9 30.42 Favored Glycine 0 N--CA 1.442 -0.937 0 CA-C-N 115.675 -0.693 . . . . 2.59 111.673 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.655 HD12 ' H ' ' A' ' 129' ' ' ILE . 3.7 mp -69.94 -25.18 27.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.402 0.62 . . . . 3.58 109.647 -179.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 34.1 tp -77.99 -9.78 59.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.371 -0.831 . . . . 3.47 110.542 175.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 56.69 40.72 29.08 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 114.76 -1.109 . . . . 3.28 111.431 -179.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.9 m -74.22 -76.94 0.12 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.942 -0.572 . . . . 3.56 111.533 -175.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 46.5 tttm -176.2 -83.3 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.405 0.622 . . . . 5.17 109.65 -174.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -119.03 -176.47 3.12 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.786 -0.643 . . . . 1.59 110.612 -178.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.506 ' HB ' ' ND2' ' A' ' 42' ' ' ASN . 0.4 OUTLIER -50.71 84.82 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 O-C-N 124.28 0.988 . . . . 2.0 109.953 168.741 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.8 ' HB3' ' CE3' ' A' ' 137' ' ' TRP . 26.0 mtmt -36.42 -67.01 0.19 Allowed 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 114.399 1.259 . . . . 4.81 114.399 -172.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.8 ' CE3' ' HB3' ' A' ' 136' ' ' LYS . 0.5 OUTLIER -109.62 -172.32 2.02 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 113.644 -1.616 . . . . 1.97 109.905 -164.215 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.517 ' CG ' ' H ' ' A' ' 139' ' ' PHE . 60.6 t30 -31.99 -152.14 0.0 OUTLIER 'General case' 0 C--O 1.2 -1.506 0 O-C-N 125.359 1.662 . . . . 2.04 111.979 158.099 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.699 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 2.1 m-85 -27.64 -28.29 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.264 0 N-CA-C 118.037 2.606 . . . . 1.93 118.037 -167.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.685 ' HA ' ' O ' ' A' ' 154' ' ' PHE . 7.7 m 12.29 102.3 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 120.105 1.32 . . . . 0.6 114.373 172.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.699 ' HB3' HD12 ' A' ' 39' ' ' LEU . 1.6 m -90.11 167.52 12.68 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.571 -1.195 . . . . 0.62 111.473 -170.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.464 ' CE2' HG23 ' A' ' 135' ' ' ILE . 95.2 m-85 -129.95 125.79 36.28 Favored 'General case' 0 CA--C 1.49 -1.339 0 N-CA-C 106.404 -1.702 . . . . 0.57 106.404 163.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.693 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 4.9 tp -80.33 102.94 9.86 Favored 'General case' 0 N--CA 1.422 -1.851 0 C-N-CA 118.204 -1.398 . . . . 0.43 108.125 176.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.674 HG22 ' HA2' ' A' ' 148' ' ' GLY . 43.2 mm -90.84 137.26 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.738 0 CA-C-N 113.724 -1.58 . . . . 0.19 107.625 -176.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.607 ' OD1' HG12 ' A' ' 149' ' ' VAL . 0.0 OUTLIER -88.74 -175.62 4.96 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 119.527 -0.869 . . . . 0.98 111.675 -168.914 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.663 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 33.8 mtm180 -53.65 -37.15 62.85 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-O 120.976 0.417 . . . . 2.22 111.037 -178.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.402 ' C ' ' HE2' ' A' ' 16' ' ' PHE . 25.3 t70 -103.17 19.43 19.59 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.413 -0.958 . . . . 2.0 108.413 -175.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.729 ' HA3' ' CE2' ' A' ' 16' ' ' PHE . . . 71.86 35.08 61.92 Favored Glycine 0 N--CA 1.439 -1.13 0 CA-C-N 114.794 -1.094 . . . . 0.17 115.531 176.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.607 HG12 ' OD1' ' A' ' 145' ' ' ASP . 10.0 p -106.06 113.51 63.51 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 119.356 1.578 . . . . 1.12 111.398 172.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.672 ' HD3' HG23 ' A' ' 15' ' ' ILE . 2.5 Cg_endo -51.11 115.55 2.11 Favored 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 124.027 3.152 . . . . 0.41 111.799 172.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 26.2 t -108.27 -28.58 2.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.707 0.765 . . . . 1.45 109.098 -176.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.693 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 22.6 mm-40 -136.86 166.39 23.73 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.509 -1.223 . . . . 1.17 110.317 -176.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.489 ' HA ' ' O ' ' A' ' 141' ' ' SER . 1.5 ttm180 -143.78 140.7 30.05 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.826 -1.079 . . . . 2.16 109.17 165.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.685 ' O ' ' HA ' ' A' ' 140' ' ' THR . 97.3 m-85 -120.8 149.95 41.77 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.932 -0.766 . . . . 0.32 108.932 -171.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 62.9 m -78.51 160.04 73.33 Favored Pre-proline 0 C--N 1.317 -0.83 0 N-CA-C 108.549 -0.908 . . . . 1.11 108.549 175.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.701 ' HG3' ' HB3' ' A' ' 137' ' ' TRP . 32.0 Cg_endo -63.74 -22.14 69.65 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.028 1.819 . . . . 0.78 111.896 178.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 51' ' ' LYS . . . -78.93 -7.1 88.57 Favored Glycine 0 N--CA 1.446 -0.7 0 CA-C-N 115.696 -0.683 . . . . 0.5 112.626 173.071 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -72.88 144.99 47.19 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 108.62 -0.881 . . . . 0.5 108.62 174.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 14.5 m -110.91 173.74 6.19 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 120.835 -0.346 . . . . 1.42 110.168 -172.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.706 HG22 ' HA ' ' A' ' 56' ' ' THR . 58.9 t -40.7 -55.93 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 114.93 -1.032 . . . . 0.28 111.384 177.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.427 ' HB2' ' HE2' ' A' ' 161' ' ' LYS . 12.9 tppt? -67.25 -29.87 69.61 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.217 -0.447 . . . . 3.46 111.299 -171.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.44 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 8.0 m-20 -68.88 -38.27 79.58 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 121.481 0.657 . . . . 1.4 109.545 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.599 ' HA ' ' CZ ' ' A' ' 154' ' ' PHE . 71.3 mt -77.82 -43.68 28.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 114.76 -1.109 . . . . 0.21 110.715 178.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.605 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 53.9 mt-10 -55.02 -43.3 73.55 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-N 116.523 -0.308 . . . . 0.67 111.5 -176.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.44 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 8.6 pt-20 -58.45 -23.01 56.46 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.716 0.294 . . . . 0.87 111.7 -176.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.658 ' HB3' HD22 ' A' ' 143' ' ' LEU . 45.9 mmtm -99.51 -25.94 14.27 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.591 0.71 . . . . 1.71 109.982 176.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.6 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 13.6 tp -79.06 -50.76 10.55 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.897 -1.047 . . . . 0.16 112.215 -177.038 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.452 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 73.6 mt -54.57 -44.6 99.2 Favored Pre-proline 0 CA--C 1.537 0.452 0 CA-C-N 115.511 -0.768 . . . . 0.26 112.637 -173.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.452 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 53.8 Cg_exo -54.54 -33.06 76.88 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.077 1.851 . . . . 0.41 112.762 173.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.722 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 78.5 mt -83.23 -40.64 19.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.652 -0.249 . . . . 0.71 111.288 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.736 HD23 ' HG2' ' A' ' 37' ' ' PRO . 87.0 mt -61.76 -60.42 3.69 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 121.996 0.903 . . . . 0.34 109.603 175.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -55.41 -53.83 38.46 Favored Glycine 0 N--CA 1.436 -1.315 0 CA-C-N 113.406 -1.724 . . . . 1.12 112.526 -178.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 23.2 t 55.96 44.04 26.3 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.249 0.547 . . . . 2.64 111.054 175.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -92.89 -39.12 11.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.941 -0.572 . . . . 4.35 111.085 -177.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 48.95 70.32 0.48 Allowed 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.538 0.685 . . . . 8.45 110.961 -176.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 80.1 mt . . . . . 0 C--O 1.251 1.135 0 CA-C-O 118.36 -0.828 . . . . 7.69 109.71 177.647 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.624 0 N-CA-C 112.31 -0.316 . . . . 5.22 112.31 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 86.4 mtp -113.94 176.28 5.11 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 110.212 -0.292 . . . . 4.85 110.212 177.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 163.57 174.65 33.67 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.754 -0.736 . . . . 1.55 111.459 178.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.9 t -116.42 -5.09 11.75 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.022 0.439 . . . . 1.58 110.246 176.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.455 ' HB3' ' O ' ' A' ' 147' ' ' ASP . 5.9 m -158.51 151.83 22.94 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 105.975 -1.861 . . . . 1.17 105.975 -177.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.953 ' HB ' HD11 ' A' ' 118' ' ' LEU . 5.8 pt -61.75 -16.04 14.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 CA-C-N 114.32 -1.309 . . . . 0.38 111.823 -174.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.782 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 46.9 m-85 -73.79 5.9 3.68 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 113.028 0.751 . . . . 0.3 113.028 -174.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -79.81 -17.82 52.41 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 107.694 -1.224 . . . . 2.11 107.694 175.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.749 ' HE2' ' HB2' ' A' ' 121' ' ' TYR . 51.5 m-85 -112.07 115.29 28.65 Favored 'General case' 0 N--CA 1.434 -1.257 0 CA-C-N 114.078 -1.419 . . . . 0.31 111.432 -171.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -50.66 142.02 11.79 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 113.752 -1.567 . . . . 2.86 110.752 174.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.73 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 37.9 t -112.34 158.53 12.72 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 107.981 -1.118 . . . . 0.67 107.981 176.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.739 HD23 ' HA ' ' A' ' 27' ' ' PRO . 60.4 mt -126.66 135.0 50.59 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 120.454 -0.499 . . . . 0.69 111.347 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.502 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 15.8 t70 -63.88 159.36 19.88 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 106.193 -1.78 . . . . 1.87 106.193 164.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.761 ' HA ' ' CA ' ' A' ' 106' ' ' ALA . . . -57.35 -3.92 0.19 Allowed 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.973 1.101 . . . . 0.59 113.973 -166.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.482 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 23.3 t70 -100.16 0.01 39.7 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 111.454 0.168 . . . . 2.34 111.454 177.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.632 ' CD2' ' HB1' ' A' ' 106' ' ' ALA . 78.8 m-70 80.57 20.1 0.5 Allowed 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 121.811 0.815 . . . . 1.47 109.427 177.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.484 ' HA ' ' HD3' ' A' ' 26' ' ' LYS . 12.0 mmtp -96.13 123.42 55.21 Favored Pre-proline 0 N--CA 1.441 -0.904 0 CA-C-N 114.499 -1.228 . . . . 4.25 108.543 173.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.739 ' HA ' HD23 ' A' ' 21' ' ' LEU . 95.9 Cg_exo -49.18 114.14 1.18 Allowed 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 122.924 2.416 . . . . 0.54 114.165 -167.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.628 ' HB3' HG12 ' A' ' 20' ' ' VAL . 2.1 t80 -83.86 136.67 34.02 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 113.109 -1.86 . . . . 1.2 110.019 169.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.522 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 0.3 OUTLIER -81.89 83.16 7.29 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.499 0.666 . . . . 1.51 110.806 179.366 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.655 ' HG ' ' CD1' ' A' ' 16' ' ' PHE . 56.8 tp -50.4 -37.73 39.16 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.432 0.634 . . . . 0.28 110.383 178.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.62 HG13 ' HB3' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -69.43 -0.35 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 114.551 -1.204 . . . . 1.02 113.129 -172.502 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.522 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 3.6 pt20 -71.42 -20.25 62.14 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.731 -0.84 . . . . 1.02 108.731 172.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.966 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 93.4 m-70 -91.83 24.8 3.01 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 115.205 -0.907 . . . . 0.28 110.07 177.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.782 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 38.1 mtmt -86.04 109.33 18.73 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 114.587 -1.188 . . . . 1.56 109.2 170.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 133.65 -43.13 1.3 Allowed Glycine 0 N--CA 1.438 -1.17 0 C-N-CA 120.861 -0.685 . . . . 0.2 111.741 -177.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.457 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 69.3 m -127.15 136.77 29.37 Favored Pre-proline 0 N--CA 1.434 -1.229 0 N-CA-C 108.637 -0.875 . . . . 0.29 108.637 172.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.804 ' HG3' ' CB ' ' A' ' 170' ' ' LEU . 3.3 Cg_endo -42.49 153.32 0.15 Allowed 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 123.985 3.123 . . . . 0.18 112.763 175.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.841 ' HB2' HG22 ' A' ' 70' ' ' THR . 0.6 OUTLIER -140.48 141.87 35.36 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.123 -1.436 . . . . 0.31 107.123 179.964 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 1.016 ' HB3' ' HE1' ' A' ' 41' ' ' TYR . 1.2 mm? -107.53 112.77 25.69 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.284 -1.006 . . . . 1.19 108.284 177.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.095 HG22 ' OH ' ' A' ' 119' ' ' TYR . 2.3 mt -100.71 124.06 54.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 120.082 -0.647 . . . . 0.37 110.183 179.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 1.016 ' HE1' ' HB3' ' A' ' 39' ' ' LEU . 0.6 OUTLIER -110.2 124.81 52.26 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.145 -0.934 . . . . 0.42 110.715 -171.83 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.562 ' OD1' ' HB ' ' A' ' 140' ' ' THR . 8.2 p-10 -80.96 96.7 7.17 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.624 -1.251 . . . . 2.35 107.624 169.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.9 ' HA ' ' HA ' ' A' ' 139' ' ' PHE . 10.7 p -105.02 141.42 20.45 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 O-C-N 121.179 -0.951 . . . . 1.03 111.802 -165.061 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -89.04 106.19 18.27 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.566 -0.531 . . . . 0.88 109.566 173.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.913 ' HA ' ' HB3' ' A' ' 98' ' ' PHE . 3.3 p -44.57 108.28 0.11 Allowed 'General case' 0 C--N 1.327 -0.374 0 O-C-N 123.985 0.803 . . . . 1.78 110.334 172.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.918 ' HB3' ' HB2' ' A' ' 49' ' ' TYR . 60.8 mttm -138.69 157.93 45.18 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.276 0.56 . . . . 5.84 111.584 -174.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.595 ' H ' HG13 ' A' ' 94' ' ' VAL . 44.9 t -122.81 117.66 26.17 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.231 -0.895 . . . . 3.55 108.936 178.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 69.5 23.88 76.37 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.463 -0.875 . . . . 2.91 111.162 -175.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.918 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 13.3 m-85 -131.31 136.85 48.48 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.437 0.637 . . . . 4.63 111.013 -179.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.2 t -173.85 163.93 4.2 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 106.806 -1.553 . . . . 1.93 106.806 -178.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.898 ' H ' ' HZ ' ' A' ' 139' ' ' PHE . 10.3 tppt? -124.46 9.58 8.46 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.171 -1.048 . . . . 2.01 108.171 173.03 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 117.94 -33.5 4.88 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 114.664 -1.153 . . . . 0.51 111.512 -174.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.684 ' HA2' ' HB ' ' A' ' 56' ' ' THR . . . -63.94 -16.07 59.03 Favored Glycine 0 C--O 1.22 -0.753 0 CA-C-O 119.594 -0.559 . . . . 0.5 114.327 -177.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.705 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 1.0 OUTLIER -73.23 -56.87 4.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 118.34 1.07 . . . . 0.7 109.351 177.009 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -60.34 -26.37 66.53 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-O 121.838 0.828 . . . . 2.61 109.572 175.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.684 ' HB ' ' HA2' ' A' ' 53' ' ' GLY . 15.4 m -75.33 -54.65 6.72 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 114.28 -1.327 . . . . 0.33 109.441 -176.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 1.086 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -57.32 -43.39 83.26 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 114.709 -1.132 . . . . 0.22 110.644 176.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.558 ' HA ' ' HD2' ' A' ' 102' ' ' PHE . 74.2 m -58.76 -56.03 27.52 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.794 -0.639 . . . . 0.26 110.675 -179.046 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 61.8 m -68.82 -37.11 78.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.458 -0.792 . . . . 0.48 111.891 -175.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.786 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 17.1 mt -64.57 -46.93 80.66 Favored 'General case' 0 CA--C 1.502 -0.888 0 CA-C-O 121.265 0.555 . . . . 0.43 110.359 -176.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.877 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 8.1 t80 -58.08 -52.2 66.53 Favored 'General case' 0 C--O 1.202 -1.443 0 CA-C-N 114.856 -1.066 . . . . 0.31 110.64 178.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -70.19 -25.67 63.53 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 120.718 0.294 . . . . 1.21 110.81 -172.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.55 ' HE3' ' CE2' ' A' ' 64' ' ' TYR . 36.2 ttpt -84.84 -23.4 29.06 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.946 -0.761 . . . . 1.54 108.946 -177.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.636 ' HB2' ' HD2' ' A' ' 69' ' ' PHE . 43.1 m-85 -126.88 -4.25 6.4 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 116.084 1.883 . . . . 0.31 116.084 -171.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.737 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 12.8 ptmt -64.04 -27.29 69.01 Favored 'General case' 0 CA--C 1.496 -1.114 0 N-CA-C 108.052 -1.092 . . . . 1.35 108.052 171.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.0 t -48.61 -35.26 13.23 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 114.154 -1.384 . . . . 1.28 111.033 173.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -92.57 -33.15 14.55 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.079 0.4 . . . . 1.11 112.079 175.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.405 ' HA3' ' HB2' ' A' ' 36' ' ' SER . . . 147.9 -5.54 0.95 Allowed Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 111.711 -0.556 . . . . 0.18 111.711 -176.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.786 ' HE2' ' HB3' ' A' ' 60' ' ' LEU . 18.5 t80 -69.97 144.71 52.24 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-O 121.047 0.451 . . . . 0.18 111.447 -178.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.966 ' HB ' ' CE1' ' A' ' 33' ' ' HIS . 1.5 t -134.92 149.96 50.34 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 108.283 -1.006 . . . . 0.2 108.283 173.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 1.086 HG11 ' HB1' ' A' ' 57' ' ' ALA . 45.2 t -106.34 100.1 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.322 0 N-CA-C 108.001 -1.111 . . . . 0.17 108.001 157.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.852 ' HA ' ' HG2' ' A' ' 103' ' ' PRO . 4.9 mt -85.6 118.66 25.24 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.68 -1.23 . . . . 1.04 107.68 177.099 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 1.003 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -107.83 112.04 24.49 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 119.363 -0.935 . . . . 0.51 110.957 178.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.796 ' HD2' HD13 ' A' ' 108' ' ' ILE . 3.0 m-85 -93.35 99.59 3.44 Favored Pre-proline 0 C--N 1.311 -1.096 0 CA-C-N 114.445 -1.252 . . . . 0.44 108.425 176.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.807 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 92.2 Cg_endo -83.82 93.15 0.79 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.501 2.134 . . . . 1.3 113.286 -167.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.641 ' HA ' ' O ' ' A' ' 108' ' ' ILE . 44.0 m -25.73 135.42 0.02 OUTLIER 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 115.08 1.511 . . . . 1.44 115.08 -172.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.729 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 58.0 t30 -71.5 82.86 0.82 Allowed 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 112.452 -2.158 . . . . 1.81 107.774 -179.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 1.002 ' HA ' ' HG3' ' A' ' 83' ' ' GLU . 75.6 mm-40 -49.38 -13.94 0.09 Allowed 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 114.589 -1.187 . . . . 3.34 111.059 -179.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.504 ' H ' ' C ' ' A' ' 77' ' ' ASN . 41.1 t80 -81.71 -13.59 57.63 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 114.121 -1.4 . . . . 2.68 110.894 -174.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.942 ' HA3' HD21 ' A' ' 109' ' ' ASN . . . -76.3 -27.11 62.35 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.652 -0.785 . . . . 1.98 111.684 179.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.52 25.89 60.14 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.928 -0.654 . . . . 1.49 112.452 179.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.677 ' NE2' HD22 ' A' ' 109' ' ' ASN . 0.2 OUTLIER -142.63 33.25 1.44 Allowed 'General case' 0 CA--C 1.503 -0.849 0 CA-C-O 120.67 0.271 . . . . 1.74 110.481 176.468 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 1.002 ' HG3' ' HA ' ' A' ' 78' ' ' GLN . 13.6 mm-40 -88.89 148.98 42.61 Favored Pre-proline 0 C--N 1.306 -1.283 0 CA-C-N 115.963 -0.562 . . . . 3.07 111.017 -166.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.543 ' HB2' ' O ' ' A' ' 137' ' ' TRP . 96.7 Cg_endo -78.91 98.53 1.2 Allowed 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 123.185 2.59 . . . . 1.75 113.483 -170.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.89 9.12 78.26 Favored Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 115.908 -0.587 . . . . 2.2 112.6 176.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.498 ' O ' ' HB2' ' A' ' 83' ' ' GLU . 2.8 t30 -158.67 158.99 34.82 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.125 -0.695 . . . . 4.2 109.125 -177.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -162.8 -57.64 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.926 -0.31 . . . . 3.02 110.783 177.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -139.59 21.28 2.53 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.422 0.527 . . . . 3.92 112.422 -168.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.409 ' O ' ' HB3' ' A' ' 93' ' ' PHE . 12.6 pt-20 -88.04 -17.87 30.19 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 121.691 -0.631 . . . . 2.65 110.362 177.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.842 ' HA ' ' HB ' ' A' ' 94' ' ' VAL . 8.4 pt -78.37 -159.88 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.621 -0.718 . . . . 2.15 112.195 -178.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.444 ' HG3' ' H ' ' A' ' 92' ' ' GLU . 60.4 pttt 55.37 -68.21 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.837 1.655 . . . . 2.79 113.64 176.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.444 ' H ' ' HG3' ' A' ' 91' ' ' LYS . 10.7 pt-20 -90.75 9.27 30.69 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.0 0.429 . . . . 3.29 111.012 -176.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.508 ' HD2' HG23 ' A' ' 94' ' ' VAL . 46.9 t80 -160.86 -77.1 0.06 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.415 0.626 . . . . 3.42 110.472 -176.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.842 ' HB ' ' HA ' ' A' ' 90' ' ' ILE . 64.9 t -73.28 153.73 7.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.141 -0.936 . . . . 2.63 110.3 179.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 96.0 m -81.96 124.07 29.43 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-O 121.162 0.506 . . . . 2.83 112.126 -171.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.507 ' O ' ' HB2' ' A' ' 97' ' ' LYS . 2.7 m -70.01 153.74 42.83 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 108.258 -1.016 . . . . 2.98 108.258 168.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 96' ' ' THR . 67.3 mttm 77.72 -42.58 0.38 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 123.73 0.812 . . . . 2.72 111.385 -176.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.913 ' HB3' ' HA ' ' A' ' 45' ' ' SER . 0.0 OUTLIER 71.77 -45.74 0.63 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.382 1.073 . . . . 2.12 110.209 -174.604 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt 64.03 125.52 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 122.168 0.985 . . . . 2.69 112.397 172.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.61 ' HB2' ' CE1' ' A' ' 98' ' ' PHE . . . -144.68 -177.24 5.4 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.351 -0.84 . . . . 0.55 111.07 -174.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -94.31 29.94 2.08 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.906 -0.588 . . . . 1.99 110.335 175.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.656 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 18.3 p90 -143.23 160.94 50.25 Favored Pre-proline 0 N--CA 1.442 -0.852 0 N-CA-C 108.161 -1.051 . . . . 0.84 108.161 175.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.852 ' HG2' ' HA ' ' A' ' 72' ' ' LEU . 36.0 Cg_endo -58.94 90.68 0.07 OUTLIER 'Trans proline' 0 N--CA 1.476 0.455 0 C-N-CA 123.982 3.121 . . . . 0.62 114.419 -172.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 1.003 HD12 ' HB3' ' A' ' 73' ' ' ALA . 2.8 mm -80.0 123.22 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 108.809 -0.811 . . . . 1.34 108.809 171.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.713 ' HG3' ' H ' ' A' ' 107' ' ' LYS . 0.8 OUTLIER -77.13 170.03 17.26 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.412 -1.267 . . . . 3.03 111.11 -177.568 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.761 ' CA ' ' HA ' ' A' ' 23' ' ' ALA . . . -69.33 11.42 0.24 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.688 -0.687 . . . . 1.46 112.377 178.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.797 ' HB2' ' O ' ' A' ' 75' ' ' PRO . 2.6 ptpp? 67.4 143.43 0.04 OUTLIER 'General case' 0 CA--C 1.495 -1.163 0 CA-C-O 123.363 1.554 . . . . 1.76 112.092 -175.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.914 HG13 HG22 ' A' ' 110' ' ' VAL . 36.1 pt -136.28 159.27 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.197 0 CA-C-N 111.81 -2.45 . . . . 0.82 106.557 175.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.942 HD21 ' HA3' ' A' ' 80' ' ' GLY . 0.8 OUTLIER -72.35 64.27 0.58 Allowed 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 110.506 -0.183 . . . . 1.73 110.506 176.26 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.914 HG22 HG13 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -74.59 92.37 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.751 0 C-N-CA 119.644 -0.823 . . . . 0.77 109.928 -176.241 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.6 t30 174.05 178.86 0.11 Allowed 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 114.219 -1.355 . . . . 1.9 107.683 170.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 36.29 -105.01 0.03 OUTLIER Glycine 0 CA--C 1.518 0.278 0 O-C-N 124.706 1.254 . . . . 1.47 116.023 161.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -108.19 -24.1 11.67 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 114.309 1.226 . . . . 2.81 114.309 -163.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.65 ' HB3' ' HB3' ' A' ' 109' ' ' ASN . 0.2 OUTLIER -118.78 20.17 12.93 Favored 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 119.993 -0.683 . . . . 2.16 109.593 -165.444 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -50.69 133.32 25.89 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.132 -0.94 . . . . 1.26 109.202 173.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.709 ' HB3' HD12 ' A' ' 108' ' ' ILE . 2.1 t-80 -69.06 143.16 93.96 Favored Pre-proline 0 N--CA 1.438 -1.065 0 CA-C-N 115.739 -0.664 . . . . 0.42 109.356 -170.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -26.43 -45.04 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 124.886 3.724 . . . . 0.4 114.049 179.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.953 HD11 ' HB ' ' A' ' 15' ' ' ILE . 48.0 tp -65.14 -51.0 63.86 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 122.894 0.478 . . . . 0.39 112.288 179.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 1.095 ' OH ' HG22 ' A' ' 40' ' ' ILE . 24.1 m-85 -80.57 -32.33 36.6 Favored 'General case' 0 CA--C 1.486 -1.512 0 CA-C-O 121.433 0.635 . . . . 3.04 109.752 -176.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.549 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 4.4 tm-20 -60.07 -37.06 78.78 Favored 'General case' 0 N--CA 1.426 -1.635 0 N-CA-C 106.186 -1.783 . . . . 2.44 106.186 172.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.749 ' HB2' ' HE2' ' A' ' 18' ' ' PHE . 79.2 t80 -68.56 -30.45 69.23 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.135 -0.939 . . . . 0.56 110.605 173.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.705 ' CE ' HD12 ' A' ' 40' ' ' ILE . 53.3 mtt -75.83 -55.34 5.73 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.09 -0.505 . . . . 0.71 111.815 -170.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.702 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -70.48 -23.65 62.72 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.194 -0.457 . . . . 1.46 110.78 177.495 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.62 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 10.4 ptmt -72.96 -27.04 61.59 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 119.701 -0.799 . . . . 1.99 109.429 172.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 89.2 m -71.66 -50.99 25.45 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 116.044 -0.526 . . . . 0.59 109.59 172.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.769 ' HG2' HH22 ' A' ' 153' ' ' ARG . 23.2 ttmm -148.87 114.15 3.69 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.95 -0.568 . . . . 1.85 110.05 179.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.51 ' HD3' ' HA ' ' A' ' 126' ' ' LYS . 15.4 Cg_exo -69.21 -58.89 0.1 OUTLIER 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.688 2.925 . . . . 1.69 113.088 -174.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.562 ' HA2' ' CZ ' ' A' ' 153' ' ' ARG . . . -171.76 157.2 27.26 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.286 -0.959 . . . . 2.59 112.766 -178.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.693 HG12 HH12 ' A' ' 153' ' ' ARG . 34.9 mm -99.39 -20.18 5.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.731 0.777 . . . . 3.58 109.378 178.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.74 HD23 ' H ' ' A' ' 130' ' ' LEU . 1.8 pt? -114.02 -136.59 0.36 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.984 -1.007 . . . . 3.47 110.129 -176.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.38 92.23 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 108.806 -0.813 . . . . 3.28 108.806 170.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.417 ' OG1' ' HB2' ' A' ' 127' ' ' PRO . 2.9 t -100.34 157.02 16.92 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 113.356 0.873 . . . . 3.56 113.356 -162.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 22.1 tptm 166.35 -43.7 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 113.308 -1.769 . . . . 5.17 107.173 -174.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -175.94 179.52 1.32 Allowed 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 114.221 -1.354 . . . . 1.59 110.149 -178.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.558 ' HB ' ' OD1' ' A' ' 42' ' ' ASN . 1.7 pt -64.52 61.22 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 C-N-CA 124.392 1.077 . . . . 2.0 109.783 166.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.538 ' HB3' ' CZ3' ' A' ' 137' ' ' TRP . 75.5 tttt -72.74 0.54 10.53 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.997 0.919 . . . . 4.81 112.728 -167.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.647 ' HB3' ' HG3' ' A' ' 156' ' ' PRO . 7.0 m-90 -111.28 175.0 5.6 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.335 -0.393 . . . . 1.97 110.574 -176.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.416 ' HB3' ' H ' ' A' ' 139' ' ' PHE . 94.6 m-20 -39.48 -158.57 0.0 OUTLIER 'General case' 0 C--O 1.207 -1.162 0 C-N-CA 124.795 1.238 . . . . 2.04 113.017 163.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.9 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 0.1 OUTLIER -33.39 -26.71 0.01 OUTLIER 'General case' 0 C--O 1.203 -1.384 0 N-CA-C 116.427 2.01 . . . . 1.93 116.427 -171.24 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.562 ' HB ' ' OD1' ' A' ' 42' ' ' ASN . 14.1 m 23.11 109.65 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 120.909 1.686 . . . . 0.6 114.601 165.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.85 ' O ' ' HA ' ' A' ' 153' ' ' ARG . 0.8 OUTLIER -107.08 138.29 43.54 Favored 'General case' 0 C--O 1.199 -1.583 0 CA-C-N 114.933 -1.031 . . . . 0.62 112.389 -161.867 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.534 ' O ' HD13 ' A' ' 39' ' ' LEU . 50.9 m-85 -103.52 127.51 50.91 Favored 'General case' 0 CA--C 1.488 -1.424 0 N-CA-C 107.666 -1.235 . . . . 0.57 107.666 175.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.794 ' HB3' ' HB2' ' A' ' 152' ' ' GLU . 7.5 tp -80.65 103.23 10.36 Favored 'General case' 0 N--CA 1.417 -2.099 0 C-N-CA 118.07 -1.452 . . . . 0.43 107.947 174.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.753 ' HB ' ' O ' ' A' ' 38' ' ' LEU . 45.8 mm -94.82 139.17 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.782 0 CA-C-N 113.131 -1.85 . . . . 0.19 107.394 -179.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.29 -175.36 3.8 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 119.64 -0.824 . . . . 0.98 111.329 -169.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.598 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 47.5 mtm180 -52.51 -41.04 63.1 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 123.356 0.41 . . . . 2.22 111.036 -177.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.455 ' O ' ' HB3' ' A' ' 14' ' ' SER . 34.1 m-20 -98.86 22.63 9.88 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.471 -0.566 . . . . 2.0 109.471 -176.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.569 ' HA2' HG22 ' A' ' 144' ' ' ILE . . . 67.53 39.66 90.98 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 114.728 0.651 . . . . 0.17 114.728 177.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.423 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 93.4 t -100.84 127.94 31.03 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-N 118.278 1.039 . . . . 1.12 110.497 173.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.524 ' HA ' HD13 ' A' ' 144' ' ' ILE . 10.2 Cg_endo -77.3 110.0 2.91 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.692 2.262 . . . . 0.41 110.319 178.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.451 ' O ' ' HE3' ' A' ' 126' ' ' LYS . 17.2 t -107.87 -28.28 2.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 121.433 0.635 . . . . 1.45 109.546 -173.027 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.794 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 5.5 mm-40 -135.75 164.64 27.43 Favored 'General case' 0 CA--C 1.501 -0.933 0 CA-C-N 115.328 -0.851 . . . . 1.17 110.511 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.85 ' HA ' ' O ' ' A' ' 141' ' ' SER . 0.0 OUTLIER -149.42 139.19 21.82 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.805 -1.088 . . . . 2.16 110.31 157.813 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.557 ' CZ ' ' HA ' ' A' ' 163' ' ' ILE . 86.8 m-85 -113.95 152.77 30.37 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.242 -1.344 . . . . 0.32 109.141 -160.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 15.3 m -71.37 157.03 90.85 Favored Pre-proline 0 C--N 1.312 -1.058 0 N-CA-C 109.464 -0.569 . . . . 1.11 109.464 176.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.647 ' HG3' ' HB3' ' A' ' 137' ' ' TRP . 18.4 Cg_endo -60.87 -26.62 83.42 Favored 'Trans proline' 0 CA--C 1.517 -0.348 0 C-N-CA 122.197 1.931 . . . . 0.78 110.179 171.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -81.55 7.87 60.48 Favored Glycine 0 N--CA 1.441 -1.01 0 CA-C-N 114.036 -1.438 . . . . 0.5 113.124 174.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -88.07 146.41 25.46 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.563 -0.903 . . . . 0.5 108.563 171.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 87.5 p -110.86 176.86 4.86 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 120.813 -0.355 . . . . 1.42 110.772 -173.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.636 HG22 ' HA ' ' A' ' 56' ' ' THR . 61.1 t -44.49 -46.57 2.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.211 -0.904 . . . . 0.28 110.582 174.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -68.97 -37.44 78.79 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.664 -0.698 . . . . 3.46 111.052 -174.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -65.26 -41.02 94.67 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.566 0.698 . . . . 1.4 109.551 -177.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.63 HD13 ' OH ' ' A' ' 41' ' ' TYR . 73.7 mt -77.78 -45.66 27.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 114.637 -1.165 . . . . 0.21 111.472 -179.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.62 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 25.2 mt-10 -52.97 -41.37 64.49 Favored 'General case' 0 C--O 1.22 -0.495 0 N-CA-C 111.994 0.368 . . . . 0.67 111.994 -176.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -63.3 -19.58 64.72 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.46 -0.496 . . . . 0.87 111.889 -174.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.594 ' HB3' HD22 ' A' ' 143' ' ' LEU . 13.0 mmmm -103.03 -11.12 18.37 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.42 0.628 . . . . 1.71 110.018 174.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.62 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 13.9 tp -93.05 -53.78 4.0 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.99 -1.005 . . . . 0.16 112.168 -176.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.551 ' HB ' ' HD3' ' A' ' 169' ' ' PRO . 64.1 mt -53.28 -48.2 93.28 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.282 -0.872 . . . . 0.26 112.59 -172.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.551 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 72.5 Cg_exo -51.86 -30.26 37.94 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 122.252 1.968 . . . . 0.41 112.728 175.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.804 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 96.4 mt -84.42 -42.78 15.31 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.468 -0.333 . . . . 0.71 111.038 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.754 HD23 ' HG2' ' A' ' 37' ' ' PRO . 95.5 mt -60.93 -57.88 10.77 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-O 122.13 0.967 . . . . 0.34 109.692 176.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -64.01 -29.57 75.26 Favored Glycine 0 N--CA 1.434 -1.464 0 CA-C-N 113.334 -1.757 . . . . 1.12 113.011 -178.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 22.8 t 60.37 24.85 14.35 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.469 0.652 . . . . 2.64 110.358 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -78.95 -15.92 57.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.538 -0.756 . . . . 4.35 111.032 -177.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.438 ' HA ' ' HD3' ' A' ' 175' ' ' ARG . 11.7 mmt180 -100.55 36.86 1.81 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.734 0.778 . . . . 8.45 109.719 178.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 65.7 tp . . . . . 0 C--O 1.244 0.767 0 CA-C-N 114.687 -1.142 . . . . 7.69 108.833 178.528 . . . . . . . . 0 0 . 1 stop_ save_